abbreviation,addedBy,biggId,charge,chargedFormula,cheBlId,cheBlId2,description,ehmnId,fullName,hepatonetId,hmdb,inchiString,keggId,lastModified,lmId,met_id,miriam,modifiedBy,neutralFormula,pdmapName,pubChemId,reconMap,smile,synonyms,url
10fthf5glu,,,-6,C40H45N11O19,,,10-formyltetrahydrofolate-[Glu](5),,10-formyltetrahydrofolate-[Glu](5),,,,,2016-11-22T15:11:43Z,,1,,,,,,10fthf5glu,,,http://vmh.uni.lu/_api/metabolites/1/?format=pcsv
10fthf6glu,,,-7,C45H51N12O22,,,10-formyltetrahydrofolate-[Glu](6),,10-formyltetrahydrofolate-[Glu](6),,,"InChI=1/C45H58N12O22/c46-45-55-36-35(38(67)56-45)48-21(17-47-36)18-57(19-58)22-3-1-20(2-4-22)37(66)54-28(44(78)79)9-15-33(63)52-26(42(74)75)7-13-31(61)50-24(40(70)71)5-11-29(59)49-23(39(68)69)6-12-30(60)51-25(41(72)73)8-14-32(62)53-27(43(76)77)10-16-34(64)65/h1-4,19,21,23-28,48H,5-18H2,(H,49,59)(H,50,61)(H,51,60)(H,52,63)(H,53,62)(H,54,66)(H,64,65)(H,68,69)(H,70,71)(H,72,73)(H,74,75)(H,76,77)(H,78,79)(H4,46,47,55,56,67)/p-7/t21?,23?,24?,25?,26?,27?,28-/m1/s1",,2016-11-22T15:11:43Z,,2,,,,,,10fthf6glu,,,http://vmh.uni.lu/_api/metabolites/2/?format=pcsv
10fthf7glu,,,-8,C50H57N13O25,,,10-formyltetrahydrofolate-[Glu](7),,10-formyltetrahydrofolate-[Glu](7),,,,,2016-11-22T15:11:43Z,,3,,,,,,10fthf7glu,,,http://vmh.uni.lu/_api/metabolites/3/?format=pcsv
10fthf,,,-2,C20H21N7O7,CHEBI:15637,,10-Formyltetrahydrofolate,,10-Formyltetrahydrofolate,,,"InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)23-11(7-22-16)8-27(9-28)12-3-1-10(2-4-12)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,11,13,23H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,22,25,26,32)/p-2/t11-,13+/m1/s1",C00234,2016-11-22T15:11:43Z,,4,,,,,122347,10fthf,,,http://vmh.uni.lu/_api/metabolites/4/?format=pcsv
11docrtsl,,,0,C21H30O4,CHEBI:28324,,"Human Metabolome Database (HMDB): Cortexolone is the precursor of cortisol. Accumulation of Cortexolone can happen in a defect known as congenital adrenal hyperplasia, which is due to 11-beta-hydroxylase deficiency, resulting in androgen excess, virilization, and hypertension. (PMID: 2022736) A 17-hydroxycorticosteroid with glucocorticoid and anti-inflammatory activities. (PubChem).",,11-deoxycortisol,,HMDB00015,"InChI=1S/C21H30O4/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22/h11,15-17,22,25H,3-10,12H2,1-2H3/t15-,16+,17+,19+,20+,21+/m1/s1",C05488,2016-12-05T15:48:03Z,,5,,,,,,11docrtsl,,"11-Deoxy-17-hydroxy-Corticosterone, 11-Deoxy-17-hydroxycorticosterone, 11-Deoxy-Cortisol, 11-Deoxycortisol, 11-Deoxyhydrocortisone, 11-Desoxy-17-hydroxycorticosterone, 11-Desoxycortisol, 11-Desoxyhydrocortisone, 11-Dioxy-Cortisol, 11-Dioxycortisol, 17,21-Dihydroxy-4-pregnene-3,20-dione, 17,21-Dihydroxypregn-4-ene-3,20-dione, 17,21-Dihydroxyprogesterone, 17-Hydroxy-11-deoxycorticosterone, 17alpha-Hydroxycortexone, 20-Dione 17,21-Dihydroxypregn-4-ene-3, 4-Pregnene-17alpha,21-diol-3,20-dione, Cortodoxone, Reichstein S, Reichstein'S compound S, Reichstein'S substance S",http://vmh.uni.lu/_api/metabolites/5/?format=pcsv
11docrtstrn,,,0,C21H30O3,CHEBI:16973,,11-deoxycorticosterone,,11-deoxycorticosterone,,,"InChI=1S/C21H30O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h11,15-18,22H,3-10,12H2,1-2H3/t15-,16-,17-,18+,20-,21-/m0/s1",C03205,2016-11-22T15:11:43Z,,6,,,,,6166,11docrtstrn,,,http://vmh.uni.lu/_api/metabolites/6/?format=pcsv
13dampp,,,2,C3H12N2,CHEBI:15725,,"Human Metabolome Database (HMDB): 1,3-Diaminopropane is a stable, flammable and highly hydroscopic fluid. It is a polyamine that is normally quite toxic if swallowed, inhaled or absorbed through the skin. It is a catabolic byproduct of spermidine. It is also a precursor in the enzymatic synthesis of beta-alanine. 1, 3-Diaminopropane is involved in the arginine/proline metabolic pathways and the beta-alanine metabolic pathway.",,trimethylenediaminium,,HMDB00002,InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2/p+2,C00986,2016-12-05T15:48:03Z,,7,,,,,428,13dampp,,"1,3-Diamino-N-propane, 1,3-Propanediamine, 1,3-Propylenediamine, 1,3-Trimethylenediamine, 3-Aminopropylamine, a,w-Propanediamine, Propane-1,3-diamine, Trimethylenediamine",http://vmh.uni.lu/_api/metabolites/7/?format=pcsv
h2o,,,0,H2O,CHEBI:15377,,"Human Metabolome Database (HMDB): Water is a chemical substance that is essential to all known forms of life. It appears colorless to the naked eye in small quantities, though it is actually slightly blue in color. It covers 71% of Earth's surface. Current estimates suggest that there are 1.4 billion cubic kilometers (330 million m3) of it available on Earth, and it exists in many forms. It appears mostly in the oceans (saltwater) and polar ice caps, but it is also present as clouds, rain water, rivers, freshwater aquifers, lakes, and sea ice. Water in these bodies perpetually moves through a cycle of evaporation, precipitation, and runoff to the sea. Clean water is essential to human life. In many parts of the world, it is in short supply. From a biological standpoint, water has many distinct properties that are critical for the proliferation of life that set it apart from other substances. It carries out this role by allowing organic compounds to react in ways that ultimately allow replication. All known forms of life depend on water. Water is vital both as a solvent in which many of the body's solutes dissolve and as an essential part of many metabolic processes within the body. Metabolism is the sum total of anabolism and catabolism. In anabolism, water is removed from molecules (through energy requiring enzymatic chemical reactions) in order to grow larger molecules (e.g. starches, triglycerides and proteins for storage of fuels and information). In catabolism, water is used to break bonds in order to generate smaller molecules (e.g. glucose, fatty acids and amino acids to be used for fuels for energy use or other purposes). Water is thus essential and central to these metabolic processes. Water is also central to photosynthesis and respiration. Photosynthetic cells use the sun's energy to split off water's hydrogen from oxygen. Hydrogen is combined with CO2 (absorbed from air or water) to form glucose and release oxygen. All living cells use such fuels and oxidize the hydrogen and carbon to capture the sun's energy and reform water and CO2 in the process (cellular respiration). Water is also central to acid-base neutrality and enzyme function. An acid, a hydrogen ion (H+, that is, a proton) donor, can be neutralized by a base, a proton acceptor such as hydroxide ion (OH-) to form water. Water is considered to be neutral, with a pH (the negative log of the hydrogen ion concentration) of 7. Acids have pH values less than 7 while bases have values greater than 7. Stomach acid (HCl) is useful to digestion. However, its corrosive effect on the esophagus during reflux can temporarily be neutralized by ingestion of a base such as aluminum hydroxide to produce the neutral molecules water and the salt aluminum chloride. Human biochemistry that involves enzymes usually performs optimally around a biologically neutral pH of 7.4. (Wikipedia).",,Water,,HMDB02111,InChI=1S/H2O/h1H2,C00001,2016-12-05T15:48:03Z,,8,,,,H2O,962,h2o,,"Dihydrogen oxide, Steam",http://vmh.uni.lu/_api/metabolites/8/?format=pcsv
o2,,,0,O2,CHEBI:15379,,"Human Metabolome Database (HMDB): Oxygen is the third most abundant element in the universe after hydrogen and helium and the most abundant element by mass in the Earth's crust. Diatomic oxygen gas constitutes 20.9% of the volume of air. All major classes of structural molecules in living organisms, such as proteins, carbohydrates, and fats, contain oxygen, as do the major inorganic compounds that comprise animal shells, teeth, and bone. Oxygen in the form of O2 is produced from water by cyanobacteria, algae and plants during photosynthesis and is used in cellular respiration for all living organisms. Green algae and cyanobacteria in marine environments provide about 70% of the free oxygen produced on earth and the rest is produced by terrestrial plants. Oxygen is used in mitochondria to help generate adenosine triphosphate (ATP) during oxidative phosphorylation. For animals, a constant supply of oxygen is indispensable for cardiac viability and function. To meet this demand, an adult human, at rest, inhales 1.8 to 2.4 grams of oxygen per minute. This amounts to more than 6 billion tonnes of oxygen inhaled by humanity per year. At a resting pulse rate, the heart consumes approximately 8-15 ml O2/min/100 g tissue. This is significantly more than that consumed by the brain (approximately 3 ml O2/min/100 g tissue) and can increase to more than 70 ml O2/min/100 g myocardial tissue during vigorous exercise. As a general rule, mammalian heart muscle cannot produce enough energy under anaerobic conditions to maintain essential cellular processes; thus, a constant supply of oxygen is indispensable to sustain cardiac function and viability. However, the role of oxygen and oxygen-associated processes in living systems is complex, and they and can be either beneficial or contribute to cardiac dysfunction and death (through reactive oxygen species). Reactive oxygen species (ROS) are a family of oxygen-derived free radicals that are produced in mammalian cells under normal and pathologic conditions. Many ROS, such as the superoxide anion (O2-)and hydrogen peroxide (H2O2), act within blood vessels, altering mechanisms mediating mechanical signal transduction and autoregulation of cerebral blood flow. Reactive oxygen species are believed to be involved in cellular signaling in blood vessels in both normal and pathologic states. The major pathway for the production of ROS is by way of the one-electron reduction of molecular oxygen to form an oxygen radical, the superoxide anion (O2-). Within the vasculature there are several enzymatic sources of O2-, including xanthine oxidase, the mitochondrial electron transport chain, and nitric oxide (NO) synthases. Studies in recent years, however, suggest that the major contributor to O2- levels in vascular cells is the membrane-bound enzyme NADPH-oxidase. Produced O2- can react with other radicals, such as NO, or spontaneously dismutate to produce hydrogen peroxide (H2O2). In cells, the latter reaction is an important pathway for normal O2- breakdown and is usually catalyzed by the enzyme superoxide dismutase (SOD). Once formed, H2O2 can undergo various reactions, both enzymatic and nonenzymatic. The antioxidant enzymes catalase and glutathione peroxidase act to limit ROS accumulation within cells by breaking down H2O2 to H2O. Metabolism of H2O2 can also produce other, more damaging ROS. For example, the endogenous enzyme myeloperoxidase uses H2O2 as a substrate to form the highly reactive compound hypochlorous acid. Alternatively, H2O2 can undergo Fenton or Haber-Weiss chemistry, reacting with Fe2+/Fe3+ ions to form toxic hydroxyl radicals (-.OH). (PMID: 17027622, 15765131).",,O2,,HMDB01377,InChI=1S/O2/c1-2,C00007,2016-12-05T15:48:03Z,,9,,,,O2,977,o2,,"Dioxygen, Molecular oxygen, O2, Oxygen, Oxygen molecule",http://vmh.uni.lu/_api/metabolites/9/?format=pcsv
bamppald,,,1,C3H8NO,CHEBI:58374,,beta-Aminopropion aldehyde,,beta-Aminopropion aldehyde,,,"InChI=1/C3H7NO/c4-2-1-3-5/h3H,1-2,4H2",C05665,2016-11-22T15:11:43Z,,10,,,,,75,bamppald,,,http://vmh.uni.lu/_api/metabolites/10/?format=pcsv
h2o2,,,0,H2O2,CHEBI:16240,,"Human Metabolome Database (HMDB): Hydrogen peroxide (H2O2) is a very pale blue liquid which appears colourless in a dilute solution, slightly more viscous than water. It is a weak acid. It has strong oxidizing properties and is therefore a powerful bleaching agent that is mostly used for bleaching paper, but has also found use as a disinfectant and as an oxidizer. Hydrogen peroxide in the form of carbamide peroxide is widely used for tooth whitening (bleaching), both in professionally- and in self-administered products. Hydrogen peroxide (H2O2) is a well-documented component of living cells. It plays important roles in host defense and oxidative biosynthetic reactions. In addition there is growing evidence that at low levels, H2O2 also functions as a signaling agent, particularly in higher organisms. H2O2 has increasingly been viewed as an important cellular signaling agent in its own right, capable of modulating both contractile and growth-promoting pathways with more far-reaching effects. Due to the accumulation of hydrogen peroxide in the skin of patients with the depigmentation disorder vitiligo, the human epidermis cannot have the normal capacity for autocrine synthesis, transport and degradation of acetylcholine as well as the muscarinic (m1-m5) and nicotinic signal transduction in keratinocytes and melanocytes. Accumulating evidence suggests that hydrogen peroxide (H(2)O(2)) plays an important role in cancer development. Experimental data have shown that cancer cells produce high amounts of H(2)O(2). An increase in the cellular levels of H(2)O(2) has been linked to several key alterations in cancer, including DNA alterations, cell proliferation, apoptosis resistance, metastasis, angiogenesis and hypoxia-inducible factor 1 (HIF-1) activation. (PMID: 17150302, 17335854, 16677071, 16607324, 16514169).",,Hydrogen peroxide,,HMDB03125,InChI=1S/H2O2/c1-2/h1-2H,C00027,2016-12-05T15:48:03Z,,11,,,,hydrogen peroxide,784,h2o2,,"Adeka Super EL, Albone, Albone 35, Albone DS, Anti-Keim 50, Asepticper, Baquashock, CIX, Clarigel Gold, Crestal Whitestrips, Crystacide, Dentasept, Deslime LP, Hioxyl, Hipox, Hybrite, Hydrogen dioxide, Hydrogen peroxide, Inhibine, Lase Peroxide, Lensan A, Magic Bleaching, Metrokur, Mirasept, Nite White Excel 2, Odosat D, Opalescence Xtra, Oxigenal, Oxydol, Oxyfull, Oxysept, Oxysept I, Pegasyl, Perhydrol, Perone, Peroxaan, Peroxclean, Quasar Brite, Select Bleach, Superoxol, T-Stuff, Whiteness HP, Whitespeed, Xtra White",http://vmh.uni.lu/_api/metabolites/11/?format=pcsv
nh4,,,1,H4N,CHEBI:16134,,"Human Metabolome Database (HMDB): Ammonia is a colorless alkaline gas with a characteristic sharp smell. Ammonia is one of the most abundant nitrogen-containing compounds in the atmosphere. It is an irritant with a characteristic pungent odor, which is widely used in industry. Inasmuch as ammonia is highly soluble in water and, upon inhalation, is deposited in the upper airways, occupational exposures to ammonia have commonly been associated with sinusitis, upper airway irritation, and eye irritation. Acute exposures to high levels of ammonia have also been associated with diseases of the lower airways and interstitial lung. Ammonia has been shown to be a neurotoxin that predominantly affects astrocytes. Disturbed mitochondrial function and oxidative stress, factors implicated in the induction of the mitochondrial permeability transition, appear to be involved in the mechanism of ammonia neurotoxicity. Ammonia is formed in nearly all tissues and organs of the vertebrate organism; it is the most common endogenous neurotoxic compounds. Ammonia can affect the glutamatergic and GABAergic neuronal systems, the two prevailing neuronal systems of the cortical structures. Ammonia is well recognized to be central in the pathogenesis of hepatic encephalopathy and has been of importance to generations dating back to the early Egyptians. The gut produces ammonia which is metabolized in the liver and almost all organ systems are involved in ammonia metabolism. Colonic bacteria produce ammonia by splitting urea and other amino acids, however this does not explain hyperammonemia and hepatic encephalopathy. The alternative explanation is that hyperammonemia is the result of intestinal breakdown of amino acids, especially glutamine. The intestines have significant glutaminase activity, predominantly located in the enterocytes. On the other hand, this organ has only a little glutamine synthetase activity, making it a major glutamine-consuming organ. In addition to the intestine, the kidney is an important source of blood ammonia in patients with liver disease. Ammonia is also taken up by the muscle and brain in hepatic coma, and there is confirmation that ammonia is metabolized in muscle. The excessive formation of ammonia in the brains of Alzheimer's disease patients has been demonstrated, and it has been shown that some Alzheimer's disease patients exhibit elevated blood ammonia concentrations. Ammonia is the most important natural modulator of lysosomal protein processing: there is evidence for the involvement of aberrant lysosomal processing of beta-amyloid precursor protein (beta-APP) in the formation of amyloid deposits. Inflammatory processes and activation of microglia are widely believed to be implicated in the pathology of Alzheimer's disease. Ammonia is able to affect the characteristic functions of microglia, such as endocytosis, and cytokine production. Based on these facts, an ammonia-based hypothesis for Alzheimer's disease has been suggested. (PMID: 17006913, 16167195, 15377862, 15369278, 12020619).",,Ammonium,,HMDB00051,InChI=1S/H3N/h1H3/p+1,C00014,2016-12-05T15:48:03Z,,12,,,,ammonia,223,nh4,," Ammonia anhydrous,  Ammonia inhalant,  Ammonia solution strong [usan],  Ammonia water,  Ammoniak,  Liquid ammonia, Am-fol, Ammonia, Ammonia (conc 20% or greater), Ammonia gas, Ammonia solution, Ammonia solution strong (NF), Ammonia water (JP15), Ammoniac [french], Ammoniaca [italian], Ammoniacum gummi, Ammoniak kconzentrierter, Ammoniak [german], Ammoniakgas, Ammonium ion, Amoniak [polish], Anhydrous ammonia, Aromatic ammonia vaporole, Azane, NH(3), NH3, Nitro-sil, Primaeres amin, Sekundaeres amin, Spirit of hartshorn, Tertiaeres amin",http://vmh.uni.lu/_api/metabolites/12/?format=pcsv
2425dhvitd2,,,0,C28H44O3,,,"24R,25-Dihyoxyvitamin D2",,"24R,25-Dihyoxyvitamin D2",,,,,2016-11-22T15:11:43Z,,13,,,,,,2425dhvitd2,,,http://vmh.uni.lu/_api/metabolites/13/?format=pcsv
h,,,1,H,CHEBI:24636,,proton,,proton,,,InChI=1S/p+1/i/hH,C00282,2016-11-22T15:11:43Z,,14,,,,,1038,h,,,http://vmh.uni.lu/_api/metabolites/14/?format=pcsv
nadph,,,-4,C21H26N7O17P3,CHEBI:16474,,"Human Metabolome Database (HMDB): Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed.).",,Nicotinamide adenine dinucleotide phosphate - reduced,,HMDB00221,"InChI=1S/C21H30N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35)/p-4/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",C00005,2016-12-05T15:48:03Z,,15,,,,NADPH,22833512,nadph,,"2'-(Dihydrogen phosphate) 5'-(trihydrogen pyrophosphate) Adenosine 5'-ester with 1,4-dihydro-1-b-D-ribofuranosylnicotinamide, 2'-(Dihydrogen phosphate) 5'-(trihydrogen pyrophosphate) Adenosine 5'-ester with 1,4-dihydro-1-beta-delta-ribofuranosylnicotinamide, Adenosine 5'-(trihydrogen diphosphate) 2'-(dihydrogen phosphate) P'-5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide, Adenosine 5'-(trihydrogen diphosphate) 2'-(dihydrogen phosphate) P'-5'-ester with 1,4-dihydro-1-beta-delta-ribofuranosyl-3-pyridinecarboxamide, b-NADPH, b-Nicotinamide-adenine-dinucleotide-phosphorate, b-Nicotinamide-adenine-dinucleotide-phosphoric acid, beta-NADPH, beta-Nicotinamide-adenine-dinucleotide-phosphorate, beta-Nicotinamide-adenine-dinucleotide-phosphoric acid, Dihydrocodehydrogenase II, Dihydronicotinamide adenine dinucleotide phosphate, Dihydronicotinamide adenine dinucleotide-P, Dihydrotriphosphopyridine nucleotide reduced, NADP-reduced, NADPH, Nicotinamide adenine dinucleotide phosphate - reduced, Nicotinamide-adenine-dinucleotide-phosphorate, Nicotinamide-adenine-dinucleotide-phosphoric acid, Reduced Codehydrase II, Reduced Coenzyme II, Reduced Cozymase II, Reduced triphosphopyridine nucleotide, Triphosphopyridine nucleotide reduced",http://vmh.uni.lu/_api/metabolites/15/?format=pcsv
1a2425thvitd2,,,0,C28H44O4,,,"Human Metabolome Database (HMDB): 1-alpha,24R,25-Trihydroxyvitamin D2 is a metabolite of vitamin D2 produced in vitro by perfusing isolated rat kidneys with 1,25-dihydroxyvitamin D2. It has been well established that 1,25-dihydroxyvitamin D3 is converted into various further metabolites in the kidney as a result of chemical reactions such as C-23, C-24, and C-26 hydroxylations, C-24 ketonization, and C-23:C-26 lactonization. (PMID: 3490274).",,"1-alpha,24R,25-Trihydroxyvitamin D2",,HMDB06227,"InChI=1/C28H44O4/c1-18(13-15-28(6,32)26(3,4)31)23-11-12-24-20(8-7-14-27(23,24)5)9-10-21-16-22(29)17-25(30)19(21)2/h9-10,13,15,18,22-25,29-32H,2,7-8,11-12,14,16-17H2,1,3-6H3/b15-13+,20-9+,21-10-/t18-,22-,23-,24+,25+,27-,28-/m1/s1",,2016-12-05T15:48:03Z,,16,,,,,,1a2425thvitd2,,"(24R)-1alpha,24,25-trihydroxyergocalciferol, (24R)-1alpha,24,25-trihydroxyvitamin D2, (5Z,7E,22E)-(1S,3R,24R)-9,10-seco-5,7,10(19),22-ergostatetraene-1,3,24,25-tetrol, 1-alpha,24R,25-Trihydroxyvitamin D2",http://vmh.uni.lu/_api/metabolites/16/?format=pcsv
nadp,,,-3,C21H25N7O17P3,CHEBI:18009,,"Human Metabolome Database (HMDB): Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5-phosphate (NMN) coupled by pyrophosphate linkage to the 5-phosphate adenosine 2,5-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed.) Hydrogen carrier in biochemical redox systems. In the hexose monophosphoric acid system it is reduced to Dihydrocoenzyme II and reoxidation in the presence of flavoproteins (Dictionary of Organic Compounds).",,Nicotinamide adenine dinucleotide phosphate,,HMDB00217,"InChI=1S/C21H28N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1-4,7-8,10-11,13-16,20-21,29-31H,5-6H2,(H7-,22,23,24,25,32,33,34,35,36,37,38,39)/p-3/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",C00006,2016-12-05T15:48:03Z,,17,,,,NADP(+);NADP+,5886,nadp,,"Adenine-nicotinamide dinucleotide phosphate, b-NADP, b-Nicotinamide adenine dinucleotide phosphate, b-TPN, beta-NADP, beta-Nicotinamide adenine dinucleotide phosphate, beta-TPN, Codehydrase II, Codehydrogenase II, Coenzyme II, Cozymase II, NAD phosphate, NADP, NADP+, Nicotinamide adenine dinucleotide phosphate, Nicotinamide-adenine dinucleotide phosphate, TPN, Triphosphopyridine nucleotide",http://vmh.uni.lu/_api/metabolites/17/?format=pcsv
2425dhvitd3,,,0,C27H44O3,CHEBI:28818,,"(24R)-24,25-dihydroxycalciol",,"(24R)-24,25-dihydroxycalciol",,,"InChI=1S/C27H44O3/c1-18-8-12-22(28)17-21(18)11-10-20-7-6-16-27(5)23(13-14-24(20)27)19(2)9-15-25(29)26(3,4)30/h10-11,19,22-25,28-30H,1,6-9,12-17H2,2-5H3/b20-10+,21-11-/t19-,22+,23-,24+,25-,27-/m1/s1",,2016-11-22T15:11:43Z,,18,,,,,,2425dhvitd3,,,http://vmh.uni.lu/_api/metabolites/18/?format=pcsv
1a2425thvitd3,,,0,C27H44O4,,,calcitetrol,,calcitetrol,,,"InChI=1S/C27H44O4/c1-17(8-13-25(30)26(3,4)31)22-11-12-23-19(7-6-14-27(22,23)5)9-10-20-15-21(28)16-24(29)18(20)2/h9-10,17,21-25,28-31H,2,6-8,11-16H2,1,3-5H3/b19-9+,20-10-/t17-,21-,22-,23+,24+,25-,27-/m1/s1",C18231,2016-11-22T15:11:43Z,,19,,,,,,1a2425thvitd3,,,http://vmh.uni.lu/_api/metabolites/19/?format=pcsv
1a25dhvitd2,,,0,C28H44O3,,,"Human Metabolome Database (HMDB): Ercalcitriol is the active circulating metabolite of vitamin D2. Vitamin D2 is modified by 25-hydroxylase in the liver and 25-hydroxyvitamin D *-hydroxylase in the kidney to form the active metabolite, ercalcitriol, which is then metabolized by 25-hydroxyvitamin D-24-hydroxylase (24-OHase, CYP24A1, EC 1.14.13.13). The binding of ercalcitriol or their analogs to Vitamin D receptor (VDR), a nuclear receptor, activates VDR to interact with retinoid X receptor (RXR) and forms the VDR/RXR/cofactor complex, which binds to Vitamin D response elements in the promoter region of target genes to regulate gene transcription. The kidney is the major site of 25-hydroxyvitamin D*-hydroxylase (CYP27B1, EC 1.14.13.13), which is responsible for the activation of 25-hydroxyvitamin D. Of all the steroid hormones, ercalcitriol represents the most difficult challenge to the analytical biochemist with respect to quantization. Ercalcitriol circulates at pmol concentrations, is highly lipophilic and its precursor, 25-hydroxyvitamin D2, circulates at nmol levels. (PMID: 16242929, 17867378, 17197173).",,"1-alpha,25-Dihydroxyvitamin D2",,HMDB06225,"InChI=1/C28H44O3/c1-18(9-10-19(2)27(4,5)31)24-13-14-25-21(8-7-15-28(24,25)6)11-12-22-16-23(29)17-26(30)20(22)3/h9-12,18-19,23-26,29-31H,3,7-8,13-17H2,1-2,4-6H3/b10-9+,21-11+,22-12-/t18-,19+,23-,24-,25+,26+,28-/m1/s1",,2016-12-05T15:48:03Z,,20,,,,,,1a25dhvitd2,,"1,25-Dihydroxycalciferol, 1,25-Dihydroxyergocalciferol, 1,25-Dihydroxyvitamin D2, 1a,25-Dihydroxycalciferol, 1a,25-Dihydroxyergocalciferol, 1a,25-Dihydroxyvitamin D2, Ro 17-6218",http://vmh.uni.lu/_api/metabolites/20/?format=pcsv
1a25dhvitd3,,,0,C27H44O3,,,"Human Metabolome Database (HMDB): The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (calcifediol). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.--PubChem.",,calcitriol,,HMDB01903,"InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1",C01673,2016-12-05T15:48:03Z,,21,,,,,5280453,1a25dhvitd3,,"(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol, 1,25 Dihydroxycholecalciferol, 1,25-Dihydroxycholecalciferol, 1,25-Dihydroxyvitamin D, 1,25-Dihydroxyvitamin D3, 1-alpha,25-Dihydroxyvitamin D3, 1a,25-(OH)2D3, 1a,25-Dihydroxycholecalciferol, 1a,25-Dihydroxyvitamin D3, 25-Dihydroxycholecalciferol, Calcijex, Calcitriol, Dihydroxyvitamin D3, Ro 21-5535, Rocaltrol, Silkis, Soltriol, Topitriol, Toptriol",http://vmh.uni.lu/_api/metabolites/21/?format=pcsv
1mncam,,,1,C7H9N2O,CHEBI:16797,,Human Metabolome Database (HMDB): 1-Methylnicotinamide is a metabolite of nicotinamide and is produced primarily in the liver. It has anti-inflammatory properties (PMID 16197374). It is a product of nicotinamide N-methyltransferase [EC 2.1.1.1] in the pathway of nicotinate and nicotinamide metabolism (KEGG). 1-Methylnicotinamide may be an endogenous activator of prostacyclin production and thus may regulate thrombotic as well as inflammatory processes in the cardiovascular system (PMID: 17641676).,,1-methylnicotinamide,,HMDB00699,"InChI=1S/C7H8N2O/c1-9-4-2-3-6(5-9)7(8)10/h2-5H,1H3,(H-,8,10)/p+1",C02918,2016-12-05T15:48:03Z,,22,,,,,457,1mncam,,"1-Methyl-3-carbamoylpyridinium, 1-Methyl-3-carbamoylpyridinium cation, 1-Methylnicotinamide, 3-Amido-N-methylpyridinium: 1-methyl-3-Pyridinecarboxamide, 3-Carbamoyl-1-methyl-Pyridinium, I-Methyl nicotinamide, N'-Methylnicotinamide, N'Methylnicotinamide, N-1-Methylnicotinamide, N-Methyl-3-carbamidopyridinium, N-Methyl-3-carbamoylpyridinium ion, N1-Methylnicotinamide, Trigonellinamide",http://vmh.uni.lu/_api/metabolites/22/?format=pcsv
atp,,,-4,C10H12N5O13P3,CHEBI:15422,,"Human Metabolome Database (HMDB): Adenosine triphosphate (ATP) is a nucleotide consisting of a purine base (adenine) attached to the first carbon atom of ribose (a pentose sugar). Three phosphate groups are esterified at the fifth carbon atom of the ribose. ATP is incorporated into nucleic acids by polymerases in the processes of DNA replication and transcription. ATP contributes to cellular energy charge and participates in overall energy balance, maintaining cellular homeostasis. ATP can act as an extracellular signaling molecule via interactions with specific purinergic receptors to mediate a wide variety of processes as diverse as neurotransmission, inflammation, apoptosis, and bone remodelling. Extracellular ATP and its metabolite adenosine have also been shown to exert a variety of effects on nearly every cell type in human skin, and ATP seems to play a direct role in triggering skin inflammatory, regenerative, and fibrotic responses to mechanical injury, an indirect role in melanocyte proliferation and apoptosis, and a complex role in Langerhans cell-directed adaptive immunity. During exercise, intracellular homeostasis depends on the matching of adenosine triphosphate (ATP) supply and ATP demand. Metabolites play a useful role in communicating the extent of ATP demand to the metabolic supply pathways. Effects as different as proliferation or differentiation, chemotaxis, release of cytokines or lysosomal constituents, and generation of reactive oxygen or nitrogen species are elicited upon stimulation of blood cells with extracellular ATP. The increased concentration of adenosine triphosphate (ATP) in erythrocytes from patients with chronic renal failure (CRF) has been observed in many studies but the mechanism leading to these abnormalities still is controversial. (PMID: 15490415, 15129319, 14707763, 14696970, 11157473).",,ATP,,HMDB00538,"InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/p-4/t4-,6-,7-,10-/m1/s1",C00002,2016-12-05T15:48:03Z,,23,,,,ATP,5957,atp,,"5'-(Tetrahydrogen triphosphate) Adenosine, 5'-ATP, Adenosine 5'-triphosphate, Adenosine 5'-triphosphorate, Adenosine 5'-triphosphoric acid, Adenosine triphosphate, Adenylpyrophosphorate, Adenylpyrophosphoric acid, Adephos, Adetol, Adynol, Atipi, ATP, Atriphos, Cardenosine, Fosfobion, Glucobasin, Myotriphos, Phosphobion, Striadyne, Triadenyl, Triphosphaden, Triphosphoric acid adenosine ester",http://vmh.uni.lu/_api/metabolites/23/?format=pcsv
adp,,,-3,C10H12N5O10P2,CHEBI:16761,,"Human Metabolome Database (HMDB): Adenosine diphosphate, abbreviated ADP, is a nucleotide. It is an ester of pyrophosphoric acid with the nucleotide adenine. ADP consists of the pyrophosphate group, the pentose sugar ribose, and the nucleobase adenine. ADP is the product of ATP dephosphorylation by ATPases. ADP is converted back to ATP by ATP synthases.",,ADP,,HMDB01341,"InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",C00008,2016-12-05T15:48:03Z,,24,,,,ADP,6022,adp,,"Adenosindiphosphorsaeure, Adenosine 5'-pyrophosphate, Adenosine diphosphate, Adenosine pyrophosphate, Adenosine-5'-diphosphate, Adenosine-5-diphosphate, Adenosine-diphosphate, ADP",http://vmh.uni.lu/_api/metabolites/24/?format=pcsv
pi,,,-2,HO4P,CHEBI:18367,,hydrogenphosphate,,hydrogenphosphate,,,"InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)/p-2",C00009,2016-11-22T15:11:43Z,,25,,,,phosphate(3-),1004,pi,,,http://vmh.uni.lu/_api/metabolites/25/?format=pcsv
1pipdn2c,,,0,C6H9NO2,CHEBI:30912,,"Human Metabolome Database (HMDB): delta 1-Piperidine-2-carboxylic acid (P2C), an intermediate of the L-lysine metabolic pathway in the brain; the uptake of P2C into the synaptosome of the cerebral cortex was Na+ and temperature-dependent (PMID 7654748 ).",,1-piperideine-2-carboxylate,,HMDB01084,"InChI=1S/C6H9NO2/c8-6(9)5-3-1-2-4-7-5/h1-4H2,(H,8,9)",C04092,2016-12-05T15:48:03Z,,26,,,,,,1pipdn2c,,"1,2-Didehydropiperidine-2-carboxylate, delta(1)-Piperideine-2-carboxylate, Delta1-piperideine-2-carboxylate",http://vmh.uni.lu/_api/metabolites/26/?format=pcsv
nadh,,,-2,C21H27N7O14P2,CHEBI:16908,,"Human Metabolome Database (HMDB): NADH is the reduced form of NAD+, and NAD+ is the oxidized form of NADH, A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). It forms NADP with the addition of a phosphate group to the 2' position of the adenosyl nucleotide through an ester linkage.(Dorland, 27th ed).",,Nicotinamide adenine dinucleotide - reduced,,HMDB01487,"InChI=1S/C21H29N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1,3-4,7-8,10-11,13-16,20-21,29-32H,2,5-6H2,(H2,23,33)(H,34,35)(H,36,37)(H2,22,24,25)/p-2/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",C00004,2016-12-05T15:48:03Z,,27,,,,NADH,439153,nadh,,"1,4-Dihydronicotinamide adenine dinucleotide, b-DPNH, b-NADH, beta-DPNH, beta-NADH, Dihydrocodehydrogenase I, Dihydrocozymase, Dihydronicotinamide adenine dinucleotide, Dihydronicotinamide mononucleotide, DPNH, ENADA, NADH, NADH2, Reduced codehydrogenase I, Reduced diphosphopyridine nucleotide, Reduced nicotinamide adenine diphosphate, Reduced nicotinamide-adenine dinucleotide",http://vmh.uni.lu/_api/metabolites/27/?format=pcsv
Lpipecol,,,0,C6H11NO2,CHEBI:30633,,"Human Metabolome Database (HMDB): L-Pipecolic acid is a normal human metabolite present in human blood, where is present as the primary enantiomer of pipecolic acid. L-Pipecolic acid is a cyclic imino acid produced during the degradation of lysine, accumulates in body fluids of infants with generalized genetic peroxisomal disorders, including Zellweger syndrome (OMIM 214100), neonatal adrenoleukodystrophy (OMIM 202370), and infantile Refsum disease (OMIM 266510). L-Pipecolic acid levels are also elevated in patients with chronic liver diseases. L-Pipecolic acid is the substrate of delta1-piperideine-2-carboxylate reductase [EC 1.5.1.21] in the pathway of lysine degradation. (PMID: 2717271, 8305590, 1050990).",,L-pipecolic acid,,HMDB00716,"InChI=1S/C6H11NO2/c8-6(9)5-3-1-2-4-7-5/h5,7H,1-4H2,(H,8,9)/t5-/m0/s1",C00408,2016-12-05T15:48:03Z,,28,,,,,439227,Lpipecol,,"(-)-Pipecolate, (-)-Pipecolic acid, (S)-(-)-2-Piperidinecarboxylate, (S)-(-)-2-Piperidinecarboxylic acid, (S)-(-)-Pipecolate, (S)-(-)-Pipecolic acid, (S)-2-Piperidinecarboxylate, (S)-2-Piperidinecarboxylic acid, (S)-Pipecolate, (S)-Pipecolic acid, (S)-Pipecolinate, (S)-Pipecolinic acid, (S)-Piperidine-2-carboxylate, (S)-Piperidine-2-carboxylic acid, L-(-)-Pipecolate, L-(-)-Pipecolic acid, L-Homoproline, L-Pipecolate, L-Pipecolic acid, L-Pipecolinate, L-Pipecolinic acid, L-Piperidine-2-carboxylate, L-Piperidine-2-carboxylic acid",http://vmh.uni.lu/_api/metabolites/28/?format=pcsv
nad,,,-1,C21H26N7O14P2,CHEBI:15846,,"Human Metabolome Database (HMDB): NAD (or Nicotinamide adenine dinucleotide) is used extensively in glycolysis and the citric acid cycle of cellular respiration. The reducing potential stored in NADH can be converted to ATP through the electron transport chain or used for anabolic metabolism. ATP ""energy"" is necessary for an organism to live. Green plants obtain ATP through photosynthesis, while other organisms obtain it by cellular respiration. (wikipedia). Nicotinamide adenine dinucleotide is a A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed).",,Nicotinamide adenine dinucleotide,,HMDB00902,"InChI=1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/p-1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",C00003,2016-12-05T15:48:03Z,,29,,,,NAD(+);NAD+,5893,nad,,"3-Carbamoyl-1-beta-D-ribofuranosylpyridinium hydroxide 5'-ester with adenosine 5'-pyrophosphate inner salt, 3-Carbamoyl-1-beta-delta-ribofuranosylpyridinium hydroxide 5'-ester with adenosine 5'-pyrophosphate inner salt, 3-Carbamoyl-1-D-ribofuranosylpyridinium hydroxide 5'-ester with adenosine 5'-pyrophosphate, 3-Carbamoyl-1-delta-ribofuranosylpyridinium hydroxide 5'-ester with adenosine 5'-pyrophosphate, Adenine-nicotinamide dinucleotide, beta-Diphosphopyridine nucleotide, beta-NAD, beta-Nicotinamide adenine dinucleotide, beta-Nicotinamide adenine dinucleotide trihydrate, CO-I, Codehydrase I, Codehydrogenase I, Coenzyme I, Cozymase, Cozymase I, Diphosphopyridine nucleotide, Diphosphopyridine nucleotide oxidized, Endopride, NAD trihydrate, NAD-oxidized, Nicotinamide adenine dinucleotide, Nicotinamide adenine dinucleotide oxidized, Nicotinamide dinucleotide, Nicotineamide adenine dinucleotide, Oxidized diphosphopyridine nucleotide, Pyridine nucleotide diphosphate, [(3S,2R,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[(3S,2R,4R,5R)-5-(3-carbamoylpyridyl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxyphosphoryl) hydrogen phosphate, [adenylate-32-P]-NAD",http://vmh.uni.lu/_api/metabolites/29/?format=pcsv
25hvitd2,,,0,C28H44O2,,,"Human Metabolome Database (HMDB): 9,10-Secoergosta-5,7,10(19),22-tetraene-3,25-diol. Biologically active metabolite of vitamin D2 which is more active in curing rickets than its parent. The compound is believed to attach to the same receptor as vitamin D2 and 25-hydroxyvitamin D3.",,25-Hydroxyvitamin D2,,HMDB01438,"InChI=1/C28H44O2/c1-19-10-14-24(29)18-23(19)13-12-22-8-7-17-28(6)25(15-16-26(22)28)20(2)9-11-21(3)27(4,5)30/h9,11-13,20-21,24-26,29-30H,1,7-8,10,14-18H2,2-6H3/b11-9+,22-12+,23-13-/t20-,21+,24+,25?,26+,28-/m1/s1",,2016-12-05T15:48:03Z,,30,,,,,,25hvitd2,,"25-Hydroxycalciferol, 25-Hydroxyergocalciferol, 25-Hydroxyvitamin D, 9,10-Secoergosta-5,7,10(19),22-tetraene-3b,25-diol, Ercalcidiol",http://vmh.uni.lu/_api/metabolites/30/?format=pcsv
25hvitd3,,,0,C27H44O2,CHEBI:17933,,"Human Metabolome Database (HMDB): The major circulating metabolite of vitamin D3 (calciferon). It is produced in the liver and is the best indicator of the body's vitamin D stores. It is effective in the treatment of rickets and osteomalacia, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.",,calcidiol,,HMDB03550,"InChI=1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1",C01561,2016-12-05T15:48:03Z,,31,,,,,,25hvitd3,,"25-Hydroxy-cholecalciferol, 25-Hydroxycholecalciferol, 25-Hydroxyvitamin D3, 5,6-cis-25-Hydroxyvitamin D3, 9,10-Secocholesta-5,7,10(19)-triene-3b,25-diol, Calcidiol, Calcifediol, Calcifediol anhydrous, Calderol, Didrogyl, Hidroferol",http://vmh.uni.lu/_api/metabolites/31/?format=pcsv
24nph,,,0,C6H5NO4,CHEBI:16318,,"Human Metabolome Database (HMDB): 4-Nitrocatechol is the by-product of the hydroxylation of 4-Nitrophenol by the human cytochrome P450 (CYP) 2E1. This reaction is a useful metabolic marker for the presence of functional cytochrome P450 2E1 in mammalian cell microsomes. Hepatic and extrahepatic microsomal cytochrome P450 isozymes further catalyze the reduction of p-nitrocatechol to p-aminophenol. (PMID: 8267647, 8214571, 8267647).",,2-hydroxy-4-nitrophenolate,,HMDB02916,"InChI=1S/C6H5NO4/c8-5-2-1-4(7(10)11)3-6(5)9/h1-3,8-9H",C02235,2016-12-05T15:48:03Z,,32,,,,,,24nph,,"1,2-Dihydroxy-4-nitrobenzene, 3,4-Dihydroxy-1-nitrobenzene, 3,4-Dihydroxynitrobenzene, 4-Nitro-1,2-benzenediol, 4-Nitro-1,2-dihydroxybenzene, 4-Nitro-Pyrocatechol4-Nitropyrocatechol NSC 80651, 4-Nitrobenzcatechin, p-Nitrocatechol",http://vmh.uni.lu/_api/metabolites/32/?format=pcsv
2amac,,,0,C3H5NO2,CHEBI:17123,,2-aminoacrylic acid,,2-aminoacrylic acid,,,"InChI=1S/C3H5NO2/c1-2(4)3(5)6/h1,4H2,(H,5,6)",C02218,2016-11-22T15:11:43Z,,33,,,,,,2amac,,,http://vmh.uni.lu/_api/metabolites/33/?format=pcsv
pyr,,,-1,C3H3O3,CHEBI:32816,,"Human Metabolome Database (HMDB): Pyruvic acid is an intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed.) Biological Source: Intermediate in primary metabolism including fermentation processes. Present in muscle in redox equilibrium with Lactic acid. A common constituent, as a chiral cyclic acetal linked to saccharide residues, of bacterial polysaccharides. Isolated from cane sugar fermentation broth and peppermint. Constituent of Bauhinia purpurea, Cicer arietinum (chickpea), Delonix regia, Pisum sativum (pea) and Trigonella caerulea (sweet trefoil) Use/Importance: Reagent for regeneration of carbonyl compdounds from semicarbazones, phenylhydrazones and oximes. Flavoring ingredient (Dictionary of Organic Compounds).",,pyruvate,,HMDB00243,"InChI=1S/C3H4O3/c1-2(4)3(5)6/h1H3,(H,5,6)/p-1",C00022,2016-12-05T15:48:03Z,,34,,,,,1060,pyr,,"2-Oxopropanoate, 2-Oxopropanoic acid, 2-Oxopropionate, 2-Oxopropionic acid, a-Ketopropionate, a-Ketopropionic acid, Acetylformate, Acetylformic acid, alpha-Ketopropionate, alpha-Ketopropionic acid, BTS, Pyroracemate, Pyroracemic acid, Pyruvate",http://vmh.uni.lu/_api/metabolites/34/?format=pcsv
paps,,,-4,C10H11N5O13P2S,CHEBI:17980,,"Human Metabolome Database (HMDB): 3'-Phosphoadenosine-5'-phosphosulfate. Key intermediate in the formation by living cells of sulfate esters of phenols, alcohols, steroids, sulfated polysaccharides, and simple esters, such as choline sulfate. It is formed from sulfate ion and ATP in a two-step process. This compound also is an important step in the process of sulfur fixation in plants and microorganisms.",,"(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[(sulfonatooxy)phosphinato]oxy}methyl)oxolan-3-yl phosphate",,HMDB01134,"InChI=1S/C10H15N5O13P2S/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7(27-29(17,18)19)4(26-10)1-25-30(20,21)28-31(22,23)24/h2-4,6-7,10,16H,1H2,(H,20,21)(H2,11,12,13)(H2,17,18,19)(H,22,23,24)/p-4/t4-,6-,7-,10-/m1/s1",C00053,2016-12-05T15:48:04Z,,35,,,,,10214,paps,,"3'-Phospho-5'-adenylyl sulfate, 3'-Phospho-5'-adenylyl sulphate, 3'-Phosphoadenosine 5'-phosphosulfate, 3'-Phosphoadenosine 5'-phosphosulphate, 3'-Phosphoadenosine-5'-phosphosulfate, 3'-Phosphoadenosine-5'-phosphosulphate, 3'-Phosphoadenylyl sulfate, 3'-Phosphoadenylyl sulphate, 3'-Phosphoadenylyl-sulfate, 3'-Phosphoadenylyl-sulphate, 5-Phosphoadenosine 3-phosphosulfate, 5-Phosphoadenosine 3-phosphosulphate, PAPS, Phosphoadenosine Phosphosulfate, Phosphoadenosine Phosphosulphate",http://vmh.uni.lu/_api/metabolites/35/?format=pcsv
Lcyst,,,-1,C3H6NO5S,CHEBI:17285,,Human Metabolome Database (HMDB): Cysteic acid is a crystalline amino acid formed in the oxidation of cysteine; it is a precursor of taurine.,,L-cysteate(1-),,HMDB02757,"InChI=1S/C3H7NO5S/c4-2(3(5)6)1-10(7,8)9/h2H,1,4H2,(H,5,6)(H,7,8,9)/p-1/t2-/m0/s1",C57006,2016-12-05T15:48:04Z,,36,,,,,72886,Lcyst,,"2-Amino-3-sulfopropanoate, 2-Amino-3-sulfopropanoic acid, 2-Amino-3-sulfopropionate, 2-Amino-3-sulfopropionic acid, 3-Sulfoalanine, beta-Sulfoalanine, Cepteate, Cepteic acid, Cipteate, Cipteic acid, Cysteate, Cysteinate, Cysteinesulfonate, Cysteinesulfonic acid, Cysteinic acid, Cysterate, Cysteric acid, L-Cysteate, L-Cysteic acid",http://vmh.uni.lu/_api/metabolites/36/?format=pcsv
pap,,,-4,C10H11N5O10P2,CHEBI:17985,,"Human Metabolome Database (HMDB): Adenosine 3', 5'-diphosphate or PAP is a nucleotide that is closely related to ADP. It has two phosphate groups attached to the 5' and 3' positions of the pentose sugar ribose (instead of pyrophosphoric acid at the 5' position, as found in ADP), and the nucleobase adenine. PAP is converted to PAPS by Sulfotransferase and then back to PAP after the sulfotransferase reaction. Sulfotransferase (STs) catalyze the transfer reaction of the sulfate group from the ubiquitous donor 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to an acceptor group of numerous substrates. This reaction, often referred to as sulfuryl transfer, sulfation, or sulfonation, is widely observed from bacteria to humans and plays a key role in various biological processes such as cell communication, growth and development, and defense. PAP also appears to a role in bipolar depression. Phosphatases converting 3'-phosphoadenosine 5'-phosphate (PAP) into adenosine 5'-phosphate are of fundamental importance in living cells as the accumulation of PAP is toxic to several cellular systems. These enzymes are lithium-sensitive and we have characterized a human PAP phosphatase as a potential target of lithium therapy.",,"adenosine 3',5'-bismonophosphate(4-)",,HMDB00061,"InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7(25-27(20,21)22)4(24-10)1-23-26(17,18)19/h2-4,6-7,10,16H,1H2,(H2,11,12,13)(H2,17,18,19)(H2,20,21,22)/p-4/t4-,6-,7-,10-/m1/s1",C00054,2016-12-05T15:48:04Z,,37,,,,,159296,pap,,"3'-Phosphoryl-AMP, 3,5-ADP, 3,5-Diphosphoadenosine, 3-Phosphoadenosine 5-phosphate, 5-(Dihydrogen phosphate) 3-Adenylate, 5-(Dihydrogen phosphate)3'-Adenylic acid, Adenosine 3',5'-bisphosphate, Adenosine 3,5-bis, Adenosine 3,5-bisphosphate",http://vmh.uni.lu/_api/metabolites/37/?format=pcsv
L2aadp,,,-1,C6H10NO4,CHEBI:37023,,"Human Metabolome Database (HMDB): Aminoadipic acid (2-aminoadipate) is a metabolite in the principal biochemical pathway of lysine. It is an intermediate in the metabolism (i.e. breakdown or degradation) of lysine and saccharopine.(Wikipedia).   It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-methyl-D-aspartate; (NMDA). Aminoadipic has also been shown to inhibit the production of kynurenic acid in brain tissue slices (PMID: 8566117). Kynurenic acid is a broad spectrum excitatory amino acid receptor antagonist. Recent studies have shown that aminoadipic acid is elevated in prostate biopsy tissues from prostate cancer patients (PMID: 23737455).  Mutations in DHTKD1 (dehydrogenase E1 and transketolase domain-containing protein 1) have been shown to cause human 2-aminoadipic and 2-oxoadipic aciduria via impaired turnover of decarboxylation 2-oxoadipate to glutaryl-CoA, which is the last step in the lysine degradation pathway (PMID: 23141293).  Aging, diabetes, sepsis and renal failure are known to catalyze the oxidation of lysyl residues to 2-aminoadipic acid in human skin collagen and potentially other tissues (PMID: 18448817).  Proteolytic breakdown of these tissues can lead to the release of free 2-aminoadipic acid.  Studies in rats indicate that aminoadipic acid (along with the 3 branched chain amino acid â€“ Leu, Val and Ile) levels are elevated in the pre-diabetic phase and so aminoadipic acid may serve as a predictive biomarker for the development of diabetes. (PMID: 15389298). Long-term hyperglycemia of endothelial cells leads to elevated levels of aminoadipate which is though to be a sign of lysine breakdown through oxidative stress and reactive oxygen species (ROS) (PMID: 21961526).  2-aminoadipate is a potential small-molecule marker of oxidative stress (PMID: 21647514) 


",,L-2-aminoadipate(1-),,HMDB00510,"InChI=1S/C6H11NO4/c7-4(6(10)11)2-1-3-5(8)9/h4H,1-3,7H2,(H,8,9)(H,10,11)/p-1/t4-/m0/s1",C00956,2016-12-05T15:48:04Z,,38,,,,,92136,L2aadp,,"(+/-)-2-Aminoadipate, (+/-)-2-Aminoadipic acid, 2-Aminoadipate, 2-Aminoadipic acid, a-Aminoadipate, a-Aminoadipic acid, alpha-Amino-adipic acid, alpha-Aminoadipate, alpha-Aminoadipic acid, Aminoadipate, DL-2-Aminoadipate, DL-2-Aminoadipic acid, DL-2-Aminohexanedioate, DL-2-Aminohexanedioic acid, DL-a-Aminoadipate, DL-a-Aminoadipic acid, DL-alpha-Aminoadipate, DL-alpha-Aminoadipic acid, L-2-Aminoadipate, L-2-Aminoadipic acid, L-2-Aminohexanedioate, L-2-Aminohexanedioic acid, L-alpha-Aminoadipate, L-alpha-Aminoadipic acid",http://vmh.uni.lu/_api/metabolites/38/?format=pcsv
akg,,,-2,C5H4O5,CHEBI:30915,,"Human Metabolome Database (HMDB): Alpha-ketoglutaric acid is an important biological compound and is a key intermediate in the Krebs cycle. Alpha-ketoglutaric acid occurs naturally within cells. One of its functions is to combine with ammonia to form glutamic acid and then glutamine. Another function is to combine with nitrogen released in the cell, therefore preventing nitrogen overload. (wikipedia).",,2-Oxoglutarate,,HMDB00208,"InChI=1S/C5H6O5/c6-3(5(9)10)1-2-4(7)8/h1-2H2,(H,7,8)(H,9,10)/p-2",C00026,2016-12-05T15:48:04Z,,39,,,,2-oxoglutaric acid,51,akg,,"2-Ketoglutarate, 2-Ketoglutaric acid, 2-Oxo-1,5-pentanedioate, 2-Oxo-1,5-pentanedioic acid, 2-Oxoglutarate, 2-Oxoglutaric acid, 2-Oxopentanedioate, 2-Oxopentanedioic acid, alpha-Ketoglutaric acid, Oxoglutarate",http://vmh.uni.lu/_api/metabolites/39/?format=pcsv
2dr1p,,,-2,C5H9O7P,CHEBI:28542,,2-Deoxy-D-ribose 1-phosphate,,2-Deoxy-D-ribose 1-phosphate,,,"InChI=1S/C5H11O7P/c6-2-4-3(7)1-5(11-4)12-13(8,9)10/h3-7H,1-2H2,(H2,8,9,10)/p-2/t3-,4+,5?/m0/s1",C00672,2016-11-22T15:11:43Z,,40,,,,,5460448,2dr1p,,,http://vmh.uni.lu/_api/metabolites/40/?format=pcsv
drib,,,0,C5H10O4,CHEBI:28816,,"Human Metabolome Database (HMDB): Deoxyribose is an aldopentose, a monosaccharide containing five carbon atoms, and including an aldehyde functional group. It is derived from the pentose sugar ribose by the replacement of the hydroxyl group at the 2 position with hydrogen, leading to the net loss of an oxygen atom, and has chemical formula C5H10O4. In deoxyribose, the carbon furthest from the attached carbon is stripped of the oxygen atom in what would be a hydroxyl group in ribose. The common base adenine (a purine derivative) coupled to deoxyribose is called deoxyadenosine. The 5-triphosphate derivative of adenosine, commonly called adenosine triphosphate (ATP) is an important energy transport molecule in cells. -- Wikipedia.",,2-deoxy-D-ribose,,HMDB03224,"InChI=1S/C5H10O4/c6-2-1-4(8)5(9)3-7/h2,4-5,7-9H,1,3H2/t4-,5+/m0/s1",C01801,2016-12-05T15:48:04Z,,41,,,,,22833604,drib,,2'-Deoxy-D-ribose,http://vmh.uni.lu/_api/metabolites/41/?format=pcsv
2hb,,,-1,C4H7O3,,,"Human Metabolome Database (HMDB): 2-Hydroxybutyric acid (alpha-hydroxybutyrate) is an organic acid derived from alpha-ketobutyrate. Alpha-ketobutyrate is produced by amino acid catabolism (threonine and methionine) and glutathione anabolism (cysteine formation pathway) and is metabolized to propionyl-CoA and carbon dioxide (PMID: 20526369). 2-Hydroxybutyric acid is formed as a by-product during the formation of Alpha-ketobutyrate via a reaction catalyzed by lactate dehydrogenase (LDH) or alphaâ€“hydroxybutyrate dehydrogenase (alphaâ€“HBDH). Alpha-hydroxybutyric acid is primarily produced in mammalian hepatic tissues that catabolize L-threonine or synthesize glutathione. Oxidative stress or detoxification of xenobiotics in the liver can dramatically increase the rate of hepatic glutathione synthesis. Under such metabolic stress conditions, supplies of L-cysteine for glutathione synthesis become limiting, so homocysteine is diverted from the transmethylation pathway (which forms methionine) into the transsulfuration pathway (which forms cystathionine). 2-Hydroxybutyrate is released as a byproduct when cystathionine is cleaved to cysteine that is incorporated into glutathione. Chronic shifts in the rate of glutathione synthesis may be reflected by urinary excretion of 2-hydroxybutyrate. 2-hydroxybutyrate is an early marker for both insulin resistance and impaired glucose regulation that appears to arise due to increased lipid oxidation and oxidative stress (PMID: 20526369). 2-Hydroxybutyric acid is often found in the urine of patients suffering from lactic acidosis and ketoacidosis. 2-Hydroxybutyric acid generally appears at high concentrations in situations related to deficient energy metabolism (e.g., birth asphyxia) and also in inherited metabolic diseases affecting the central nervous system during neonatal development, such as ""cerebral"" lactic acidosis, glutaric aciduria type II, dihydrolipoyl dehydrogenase (E3) deficiency, and propionic acidemia. More recently it has been noted that elevated levels of alpha-hydroxybutyrate in the plasma is a good marker for early stage type II diabetes (PMID:19166731). It was concluded from studies done in the mid 1970's that an increased NADH2/NAD ratio was the most important factor for the production of 2-hydorxybutyric acid (PMID:168632).",,2-Hydroxybutyrate,,HMDB00008,"InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(H,6,7)",C05984,2016-12-05T15:48:04Z,,42,,,,,,2hb,,"(RS)-2-Hydroxybutyrate, (RS)-2-Hydroxybutyric acid, 2-Hydroxy-Butanoate, 2-Hydroxy-Butanoic acid, 2-Hydroxy-DL-Butyrate, 2-Hydroxy-DL-Butyric acid, 2-Hydroxy-N-butyrate, 2-Hydroxy-N-butyric acid, 2-Hydroxybutanoate, 2-Hydroxybutanoic acid, 2-Hydroxybutyrate, a-Hydroxy-N-butyrate, a-Hydroxy-N-butyric acid, a-Hydroxybutanoate, a-Hydroxybutanoic acid, a-Hydroxybutyrate, a-Hydroxybutyric acid, alpha-Hydroxy-N-butyrate, alpha-Hydroxy-N-butyric acid, alpha-Hydroxybutanoate, alpha-Hydroxybutanoic acid, alpha-Hydroxybutyrate, alpha-Hydroxybutyric acid, DL-2-Hydroxybutanoate, DL-2-Hydroxybutanoic acid, DL-a-Hydroxybutyrate, DL-a-Hydroxybutyric acid, DL-alpha-Hydroxybutyrate, DL-alpha-Hydroxybutyric acid",http://vmh.uni.lu/_api/metabolites/42/?format=pcsv
2obut,,,-1,C4H5O3,CHEBI:30831,,"Human Metabolome Database (HMDB): 2-Ketobutyric acid is a substance that is involved in the metabolism of many amino acids (glycine, methionine, valine, leucine, serine, threonine, isoleucine) as well as propanoate metabolism and C-5 branched dibasic acid metabolism. More specifically, alpha-ketobutyric acid is a product of the lysis of cystathionine. It is also one of the degradation products of threonine. It can be converted to propionyl-CoA (and subsequently methylmalonyl CoA, which can be converted to succinyl CoA, a citric acid cycle intermediate), and thus enter the citric acid cycle.",,2-Oxobutanoate,,HMDB00005,"InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)/p-1",C00109,2016-12-05T15:48:04Z,,43,,,,,58,2obut,,"2-Ketobutanoate, 2-Ketobutanoic acid, 2-Ketobutyrate, 2-Oxo-Butanoate, 2-Oxo-Butanoic acid, 2-Oxo-Butyrate, 2-Oxo-Butyric acid, 2-Oxo-N-butyrate, 2-Oxo-N-butyric acid, 2-Oxobutanoate, 2-Oxobutanoic acid, 2-Oxobutyrate, 2-Oxobutyric acid, 3-Methylpyruvate, 3-Methylpyruvic acid, a-Keto-N-Butyrate, a-Keto-N-Butyric acid, a-Ketobutyrate, a-Ketobutyric acid, a-Oxo-N-butyrate, a-Oxo-N-butyric acid, a-Oxobutyrate, a-Oxobutyric acid, alpha-Keto-N-butyrate, alpha-Keto-N-butyric acid, alpha-Ketobutric acid, alpha-Ketobutyrate, alpha-Ketobutyric acid, alpha-Oxo-N-butyrate, alpha-Oxo-N-butyric acid, alpha-Oxobutyrate, alpha-Oxobutyric acid, Methyl-Pyruvate, Methyl-Pyruvic acid, Propionyl-formate, Propionyl-formic acid",http://vmh.uni.lu/_api/metabolites/43/?format=pcsv
hco3,,,-1,CHO3,CHEBI:17544,,"Human Metabolome Database (HMDB): Bicarbonate, or hydrogen carbonate, is a simple single carbon molecule that plays surprisingly important roles in diverse biological processes. Among these are photosynthesis, the Krebs cycle, whole-body and cellular pH regulation, and volume regulation. Since bicarbonate is charged it is not permeable to lipid bilayers. Mammalian membranes thus contain bicarbonate transport proteins to facilitate the specific transmembrane movement of HCO3(-). Bicarbonate ion is an anion that consists of one central carbon atom surrounded by three oxygen atoms in a trigonal planar arrangement, with a hydrogen atom attached to one of the oxygens. The bicarbonate ion carries a negative one formal charge and is the conjugate base of carbonic acid, H2CO3. The carbonate radical is an elusive and strong one-electron oxidant. Bicarbonate in equilibrium with carbon dioxide constitutes the main physiological buffer. The bicarbonate-carbon dioxide pair stimulates the oxidation, peroxidation and nitration of several biological targets. The demonstration that the carbonate radical existed as an independent species in aqueous solutions at physiological pH and temperature renewed the interest in the pathophysiological roles of this radical and related species. The carbonate radical has been proposed to be a key mediator of the oxidative damage resulting from peroxynitrite production, xanthine oxidase turnover and superoxide dismutase1 peroxidase activity. The carbonate radical has also been proposed to be responsible for the stimulatory effects of the bicarbonate-carbon dioxide pair on oxidations mediated by hydrogen peroxide/transition metal ions. The ultimate precursor of the carbonate radical anion being bicarbonate, carbon dioxide, peroxymonocarbonate or complexes of transition metal ions with bicarbonate-derived species remains a matter of debate. The carbonate radical mediates some of the pathogenic effects of peroxynitrite. The carbonate radical as the oxidant produced from superoxide dismutase (EC 1.15.1.1, SOD1) peroxidase activity. Peroxymonocarbonate is a biological oxidant, whose existence is in equilibrium with hydrogen peroxide and bicarbonate. (PMID: 17505962, 17215880).",,Bicarbonate,,HMDB00595,"InChI=1S/CH2O3/c2-1(3)4/h(H2,2,3,4)/p-1",C00288,2016-12-05T15:48:04Z,,44,,,,hydrogencarbonate,769,hco3,,"Bicarbonate, Bicarbonate (HCO3-), Bicarbonate anion, Bicarbonate ion, Bicarbonate ion (HCO31-), Bicarbonate ions, Carbonate, Carbonate (HCO31-), Carbonate ion (HCO31-), Carbonic acid, Hydrocarbonate(1-), Hydrogen carbonate, Hydrogen carbonate (HCO3-), Hydrogen carbonate anion, Hydrogen carbonate ion, Hydrogen carbonate ion (HCO3-), Hydrogencarbonate, Hydrogentrioxocarbonate, Monohydrogen carbonate",http://vmh.uni.lu/_api/metabolites/44/?format=pcsv
na1,,,1,Na,CHEBI:29101,,"Human Metabolome Database (HMDB): Sodium ions are necessary for regulation of blood and body fluids, transmission of nerve impulses, heart activity, and certain metabolic functions. Physiologically, it exists as an ion in the body. Sodium is needed by animals, which maintain high concentrations in their blood and extracellular fluids, but the ion is not needed by plants. The human requirement for sodium in the diet is less than 500 mg per day, which is typically less than a tenth as much as many diets ""seasoned to taste."" Most people consume far more sodium than is physiologically needed. For certain people with salt-sensitive blood pressure, this extra intake may cause a negative effect on health.",,Sodium,,HMDB00588,InChI=1S/Na/q+1,C01330,2016-12-05T15:48:04Z,,45,,,,Na+,923,na1,,"Sodium, Sodium ion",http://vmh.uni.lu/_api/metabolites/45/?format=pcsv
2mcit,,,-3,C7H7O7,CHEBI:15598,,"Human Metabolome Database (HMDB): Methylcitric acid (MCA) is elevated in body fluids of patients with propionic acidaemia (PA; OMIM 232000, 232050), methylmalonic aciduria (MMA; OMIM 251000, 251120) and multiple carboxylase deficiency (OMIM 253260, 253270). MCA is formed by condensation of accumulated propionyl- CoA and oxalacetate by the enzyme si-citrate synthase (EC 4.1.3.7). MCA molecule has two stereogenic centers so that it can occur in the form of four stereoisomers. Only two stereoisomers of MCA, (2S, 3S) and (2R, 3S), were found in human urine. (PMID: 17295121).",,2-methylcitrate(3-),,HMDB00379,"InChI=1S/C7H10O7/c1-3(5(10)11)7(14,6(12)13)2-4(8)9/h3,14H,2H2,1H3,(H,8,9)(H,10,11)(H,12,13)/p-3",,2016-12-05T15:48:04Z,,46,,,,,,2mcit,,"(2S,3S)-2-methylcitrate, 2-Hydroxy-1,2,3-butanetricarboxylic acid, 2-Hydroxybutane-1,2,3-tricarboxylate, 2-Hydroxybutane-1,2,3-tricarboxylic acid, 2-Methylcitrate, 2-Methylcitric acid",http://vmh.uni.lu/_api/metabolites/46/?format=pcsv
2oxoadp,,,-2,C6H6O5,CHEBI:15753,,"Human Metabolome Database (HMDB): 2-Oxoadipic acid is produced from lysine in the cytosol of cells via the saccharopine and the pipecolic acid pathways. Catabolites of hydroxylysine and tryptophan enter these pathways as 2-aminoadipic- -semialdehyde and 2-oxoadipate, respectively. In the matrix of mitochondria, 2-oxoadipate is decarboxylated to glutaryl-CoA by the 2-oxoadipate dehydrogenase complex and then converted to acetyl-CoA. 2-Oxoadipic aciduria is an in-born error of metabolism of lysine, tryptophan, and hydroxylysine, in which abnormal quantities of 2-aminoadipic acid are found in body fluids along with 2-oxoadipic acid. Patients with 2-Oxoadipic acidemias are mentally retarded with hypotonia or seizures. 2-Oxoadipic Aciduria can occur in patients with Kearns-Sayre Syndrome, a progressive disorder with onset prior to 20 years of age in which multiple organ systems are affected, including progressive external ophthalmoplegia, retinopathy, and the age of onset, and these are associated classically with abnormalities in cardiac conduction, cerebellar signs, and elevated cerebrospinal fluid protein. (PMID: 10655159, 16183823, 11083877).",,2-oxoadipate(2-),,HMDB00225,"InChI=1S/C6H8O5/c7-4(6(10)11)2-1-3-5(8)9/h1-3H2,(H,8,9)(H,10,11)/p-2",C00322,2016-12-05T15:48:04Z,,47,,,,,,2oxoadp,,"2-Keto-adipate, 2-Ketoadipate, 2-Ketoadipic acid, 2-Oxo-hexanedioate, 2-Oxo-hexanedioic acid, 2-Oxoadipate, 2-Oxoadipic acid, 2-Oxohexanedioate, 2-Oxohexanedioic acid, 2-Oxohexanedionic acid, a-Ketoadipate, a-Ketoadipic acid, a-Oxoadipate, a-Oxoadipic acid, alpha-Ketoadipate, alpha-Ketoadipic acid, alpha-Oxoadipate, alpha-Oxoadipic acid, Oxoadipate",http://vmh.uni.lu/_api/metabolites/47/?format=pcsv
coa,,,-4,C21H32N7O16P3S,CHEBI:15346,,"Human Metabolome Database (HMDB): Coenzyme A (CoA, CoASH, or HSCoA) is a coenzyme, notable for its role in the synthesis and oxidization of fatty acids, and the oxidation of pyruvate in the citric acid cycle. It is adapted from beta-mercaptoethylamine, panthothenate and adenosine triphosphate. Coenzyme A is synthesized in a five-step process from pantothenate and cysteine. In the first step Pantothenate (vitamin B5) is phosphorylated to 4'-phosphopantothenate by the enzyme pantothenate kinase (PanK; CoaA; CoaX)In the second step, a cysteine is added to 4'-phosphopantothenate by the enzyme phosphopantothenoylcysteine synthetase (PPC-DC; CoaB) to form 4'-phospho-N-pantothenoylcysteine (PPC). In the third step, PPC is decarboxylated to 4'-phosphopantetheine by phosphopantothenoylcysteine decarboxylase (CoaC). In the fourth step, 4'-phosphopantetheine is adenylylated to form dephospho-CoA by the enzyme phosphopantetheine adenylyl transferase (CoaD)Finally, dephospho-CoA is phosphorylated using ATP to coenzyme A by the enzyme dephosphocoenzyme A kinase (CoaE). Since coenzyme A is, in chemical terms, a thiol, it can react with carboxylic acids to form thioesters, thus functioning as an acyl group carrier. CoA assists in transferring fatty acids from the cytoplasm to mitochondria. A molecule of coenzyme A carrying an acetyl group is also referred to as acetyl-CoA. When it is not attached to an acyl group, it is usually referred to as 'CoASH' or 'HSCoA'. Coenzyme A is also the source of the phosphopantetheine group that is added as a prosthetic group to proteins such as acyl carrier protein and formyltetrahydrofolate dehydrogenase Acetyl-CoA is an important molecule itself. It is the precursor to HMG CoA, which is a vital component in cholesterol and ketone synthesis. Furthermore, it contributes an acetyl group to choline to produce acetylcholine, in a reaction catalysed by choline acetyltransferase. Its main task is conveying the carbon atoms within the acetyl group to the citric acid cycle to be oxidized for energy production. -- Wikipedia.",,Coenzyme A,,HMDB01423,"InChI=1S/C21H36N7O16P3S/c1-21(2,16(31)19(32)24-4-3-12(29)23-5-6-48)8-41-47(38,39)44-46(36,37)40-7-11-15(43-45(33,34)35)14(30)20(42-11)28-10-27-13-17(22)25-9-26-18(13)28/h9-11,14-16,20,30-31,48H,3-8H2,1-2H3,(H,23,29)(H,24,32)(H,36,37)(H,38,39)(H2,22,25,26)(H2,33,34,35)/p-4/t11-,14-,15-,16+,20-/m1/s1",C00010,2016-12-05T15:48:04Z,,48,,,,coenzyme A,6816,coa,,"Acetoacetyl coenzyme A sodium salt, CoA, CoA hydrate, CoA-SH, CoASH, Coenzyme A, Coenzyme A hydrate, Coenzyme A-SH, Coenzyme ASH, Coenzymes A, Depot-Zeel, Propionyl CoA, Propionyl Coenzyme A, S-Propanoate, S-Propanoate CoA, S-Propanoate Coenzyme A, S-Propanoic acid, S-Propionate CoA, S-Propionate Coenzyme A, Zeel, [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]methyl 3-hydroxy-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)-2,2-dimethyl-4-oxobutyl dihydrogen diphosphate",http://vmh.uni.lu/_api/metabolites/48/?format=pcsv
co2,,,0,CO2,CHEBI:16526,,"Human Metabolome Database (HMDB): Carbon dioxide is a colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. Carbon dioxide is produced during respiration by all animals, fungi and microorganisms that depend on living and decaying plants for food, either directly or indirectly. It is, therefore, a major component of the carbon cycle. Additionally, carbon dioxide is used by plants during photosynthesis to make sugars which may either be consumed again in respiration or used as the raw material to produce polysaccharides such as starch and cellulose, proteins and the wide variety of other organic compounds required for plant growth and development. When inhaled at concentrations much higher than usual atmospheric levels, it can produce a sour taste in the mouth and a stinging sensation in the nose and throat. These effects result from the gas dissolving in the mucous membranes and saliva, forming a weak solution of carbonic acid. Carbon dioxide is used by the food industry, the oil industry, and the chemical industry. Carbon dioxide is used to produce carbonated soft drinks and soda water. Traditionally, the carbonation in beer and sparkling wine comes about through natural fermentation, but some manufacturers carbonate these drinks artificially.",,carbon dioxide,,HMDB01967,InChI=1S/CO2/c2-1-3,C00011,2016-12-05T15:48:04Z,,49,,,,CO2,280,co2,,"Carbon oxide, Carbon-12 dioxide, Carbonic acid anhydride, Carbonic acid gas, Carbonic anhydride",http://vmh.uni.lu/_api/metabolites/49/?format=pcsv
glutcoa,,,-5,C26H37N7O19P3S,CHEBI:15524,,glutaryl-CoA(5-),,glutaryl-CoA(5-),,,"InChI=1S/C26H42N7O19P3S/c1-26(2,21(39)24(40)29-7-6-15(34)28-8-9-56-17(37)5-3-4-16(35)36)11-49-55(46,47)52-54(44,45)48-10-14-20(51-53(41,42)43)19(38)25(50-14)33-13-32-18-22(27)30-12-31-23(18)33/h12-14,19-21,25,38-39H,3-11H2,1-2H3,(H,28,34)(H,29,40)(H,35,36)(H,44,45)(H,46,47)(H2,27,30,31)(H2,41,42,43)/p-5/t14-,19-,20-,21+,25-/m1/s1",C00527,2016-11-22T15:11:44Z,,50,,,,,439252,glutcoa,,,http://vmh.uni.lu/_api/metabolites/50/?format=pcsv
34dhmald,,,0,C8H8O4,,,"3,4-Dihydroxymandelaldehyde",,"3,4-Dihydroxymandelaldehyde",,,"InChI=1/C8H8O4/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-4,8,10-12H",C05577,2016-11-22T15:11:44Z,,51,,,,,151725,34dhmald,,,http://vmh.uni.lu/_api/metabolites/51/?format=pcsv
34dhoxpeg,,,0,C8H10O4,,,"Human Metabolome Database (HMDB): 3,4-Dihydroxyphenylglycol (DOPEG) is a normal norepinephrine metabolite present in CSF, plasma and urine in humans (PMID 6875564). In healthy individuals there is a tendency for free DOPEG to increase and for conjugated DOPEG to decrease with age; plasmatic DOPEG levels are significantly lower in depressed patients as compared to healthy controls (PMID 6671452).",,"3,4-Dihydroxyphenylethyleneglycol",,HMDB00318,"InChI=1/C8H10O4/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8-12H,4H2",C05576,2016-12-05T15:48:04Z,,52,,,,,91528,34dhoxpeg,,"(3,4-Dihydroxyphenyl)ethylene glycol, 1-(3,4-Dihydroxyphenyl)-1,2-ethanediol, 3,4-Dihydroxyphenethyl glycol, 3,4-Dihydroxyphenylethyl glycol, 3,4-Dihydroxyphenylethyleneglycol, 4-(1,2-Dihydroxyethyl)-1,2-benzenediol, DHPG, DL-3,4-Dihydroxyphenylglycol, DOPEG",http://vmh.uni.lu/_api/metabolites/52/?format=pcsv
34dhpha,,,-1,C8H7O4,CHEBI:41941,,"Human Metabolome Database (HMDB): 3,4-dihydroxyphenylacetic acid (DOPAC) is a phenolic acid. DOPAC is a neuronal metabolite of dopamine (DA). DA undergoes monoamine oxidase-catalyzed oxidative deamination to 3,4-dihydroxyphenylacetaldehyde (DOPAL), which is metabolized primarily to DOPAC via aldehyde dehydrogenase (ALDH2). The biotransformation of DOPAL is critical as previous studies have demonstrated this DA-derived aldehyde to be a reactive electrophile and toxic to dopaminergic cells. Known inhibitors of mitochondrial ALDH2, such as 4-hydroxy-2-nonenal (4HNE) inhibit ALDH2-mediated oxidation of the endogenous neurotoxin DOPAL. 4HNE is one of the resulting products of oxidative stress, thus linking oxidative stress to the uncontrolled production of an endogenous neurotoxin relevant to Parkinson's disease. In early onset Parkinson disease there is markedly reduced activities of both monoamine oxidase (MAO) A and B. The amount of DOPAC, which is produced during dopamine oxidation by MAO, is greatly reduced as a result of increased parkin overexpression. Administration of methamphetamine to animals causes loss of DA terminals in the brain, and significant decreases in Dopamine and dihydroxyphenylacetic acid (DOPAC) in the striata. Renal dopamine produced in the residual tubular units may be enhanced during a sodium challenge, thus behaving appropriately as a compensatory natriuretic hormone; however the renal dopaminergic system in patients afflicted with renal parenchymal disorders should address parameters other than free urinary dopamine, namely the urinary excretion of L-DOPA and metabolites. DOPAC is one of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements. DOPAC exhibits a considerable antiproliferative effect in LNCaP prostate cancer and HCT116 colon cancer cells. The antiproliferative activity of DOPAC may be due to its catechol structure. A similar association of the catechol moiety in the B-ring with antiproliferative activity was demonstrated for flavanones. (PMID: 16956664, 16455660, 8561959, 11369822, 10443478, 16365058).",,"(3,4-dihydroxyphenyl)acetate",,HMDB01336,"InChI=1S/C8H8O4/c9-6-2-1-5(3-7(6)10)4-8(11)12/h1-3,9-10H,4H2,(H,11,12)/p-1",C01161,2016-12-05T15:48:04Z,,53,,,,DOPAC,,34dhpha,,"(3,4-dihydroxyphenyl)-Acetic acid, (3,4-Dihydroxyphenyl)acetate, (3,4-Dihydroxyphenyl)acetic acid, 2-(3,4-Dihydroxyphenyl)acetic acid, 3,4-DHPOP, 3,4-Dihydroxy-Benzeneacetic acid, 3,4-Dihydroxy-phenylacetic acid, 3,4-Dihydroxybenzeneacetate, 3,4-Dihydroxybenzeneacetic acid, 3,4-Dihydroxyphenyl acetate, 3,4-Dihydroxyphenyl acetic acid, 3,4-Dihydroxyphenylacetate, 3,4-Dihydroxyphenylacetic acid, DHY, Dihydroxyphenylacetate, Dihydroxyphenylacetic acid, DOPAC, Dopacetate, Dopacetic acid, HAA, Homogentisic acid, Homoprotocatechuate, Homoprotocatechuic acid",http://vmh.uni.lu/_api/metabolites/53/?format=pcsv
amet,,,1,C15H23N6O5S,CHEBI:15414,,"Human Metabolome Database (HMDB): Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed).
S-Adenosylmethionine is only found in individuals that have used or taken this drug. It is a physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed)S-Adenosylmethionine (SAMe) is a natural substance present in the cells of the body. It is a direct metabolite of the essential amino acid L-methionine. SAMe plays a crucial biochemical role in the body by donating a one-carbon methyl group in a process called transmethylation. SAMe, formed from the reaction of L-methionine and adenosine triphosphate catalyzed by the enzyme S-adenosylmethionine synthetase, is the methyl-group donor in the biosynthesis of both DNA and RNA nucleic acids, phospholipids, proteins, epinephrine, melatonin, creatine and other molecules.",,S-Adenosyl-L-methionine,,HMDB01185,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/p+1/t7-,8+,10+,11+,14+,27?/m0/s1",C00019,2016-12-05T15:48:04Z,,54,,,,S-adenosyl-L-methionine,34756,amet,,"(3S)-5'-[(3-amino-3-carboxypropyl)methylsulfonio]-5'-deoxyadenosine, 2-S-Adenosyl-L-methionine, 5'-Deoxyadenosine-5'-L-methionine disulfate ditosylate, 5'-Deoxyadenosine-5'-L-methionine disulphate ditosylate, Active methionine, Ademetionine, Adenosylmethionine, AdoMet, Donamet, L-S-Adenosylmethionine, S-(5'-Adenosyl)-L-methionine, S-(5'-Deoxyadenosin-5'-yl)-L-methionine, S-Adenosyl methionine, S-Adenosyl-L-methionine, S-Adenosyl-L-Methionine Disulfate Tosylate, S-Adenosyl-L-Methionine Disulphate Tosylate, S-Adenosyl-methionine, S-Adenosylmethionine",http://vmh.uni.lu/_api/metabolites/54/?format=pcsv
ahcys,,,0,C14H20N6O5S,CHEBI:16680,,"Human Metabolome Database (HMDB): S-Adenosylhomocysteine (AdoHcy) is the immediate precursor of all of the homocysteine produced in the body. The reaction is catalyzed by S-adenosylhomocysteine hydrolase and is reversible with the equilibrium favoring formation of AdoHcy. In vivo, the reaction is driven in the direction of homocysteine formation by the action of the enzyme adenosine deaminase, which converts the second product of the S-adenosylhomocysteine hydrolase reaction, adenosine, to inosine. Except for methyl transfer from betaine and from methylcobalamin in the methionine synthase reaction, AdoHcy is the product of all methylation reactions that involve S-adenosylmethionine (AdoMet) as the methyl donor. Methylation is significant in epigenetic regulation of protein expression via DNA and histone methylation. The inhibition of these AdoMet-mediated processes by AdoHcy is a proven mechanism for metabolic alteration. Because the conversion of AdoHcy to homocysteine is reversible, with the equilibrium favoring the formation of AdoHcy, increases in plasma homocysteine are accompanied by an elevation of AdoHcy in most cases. Disturbances in the transmethylation pathway indicated by abnormal S-adenosylmethionine, S-adenosylhomocysteine or their ratio have been reported in many neurodegenerative diseases, such as dementia, depression or Parkinson's disease. (PMID: 18065573, 17892439).",,S-Adenosyl-L-homocysteine,,HMDB00939,"InChI=1S/C14H20N6O5S/c15-6(14(23)24)1-2-26-3-7-9(21)10(22)13(25-7)20-5-19-8-11(16)17-4-18-12(8)20/h4-7,9-10,13,21-22H,1-3,15H2,(H,23,24)(H2,16,17,18)/t6-,7+,9+,10+,13+/m0/s1",C00021,2016-12-05T15:48:04Z,,55,,,,S-adenosyl-L-homocysteine,439155,ahcys,,"(S)-5'-(S)-(3-Amino-3-carboxypropyl)-5'-thioadenosine, 2-S-Adenosyl-L-homocysteine, 5'-Deoxy-S-adenosyl-L-homocysteine, 5'-S-(3-Amino-3-carboxypropyl)-5'-thio-L-Adenosine, Adenosyl-homo-CYS, Adenosyl-L-homocysteine, Adenosylhomo-CYS, Adenosylhomocysteine, Adohcy, Formycinylhomocysteine, L-5'-S-(3-Amino-3-carboxypropyl)-5'-thior-Adenosine, L-S-Adenosyl-Homocysteine, L-S-Adenosylhomocysteine, S-(5'-Adenosyl)-L-homocysteine, S-(5'-Deoxyadenosin-5'-yl)-L-homocysteine, S-(5'-Deoxyadenosine-5')-L-homocysteine, S-Adenosyl-homocysteine, S-Adenosyl-L-homocysteine, SAH",http://vmh.uni.lu/_api/metabolites/55/?format=pcsv
homoval,,,-1,C9H9O4,,,Human Metabolome Database (HMDB): Homovanillic acid is a dopamine metabolite occurring in human biofluids. A high proportion of patients with neuroblastoma excrete increased amounts of it in their urine. Homovanillic acid is a major catecholamine metabolite. It is used as a reagent to detect oxidative enzymes.(Wikipedia).,,Homovanillate,,HMDB00118,"InChI=1S/C9H10O4/c1-13-8-4-6(5-9(11)12)2-3-7(8)10/h2-4,10H,5H2,1H3,(H,11,12)",C05582,2016-12-05T15:48:04Z,,56,,,,,1738,homoval,,"(4-Hydroxy-3-methoxyphenyl)acetate, (4-Hydroxy-3-methoxyphenyl)acetic acid, 3-Methoxy-4-hydroxy-phenylacetic acid, 3-Methoxy-4-hydroxyphenylacetate, 3-Methoxy-4-hydroxyphenylacetic acid, 4-hydroxy 3-methoxyphenylacetic acid, 4-Hydroxy-3-methoxybenzeneacetate, 4-Hydroxy-3-methoxybenzeneacetic acid, 4-Hydroxy-3-methoxyphenylacetic acid, Homovanilate, Homovanilic acid, Homovanillate, Homovanillinic acid, Vanilacetate, Vanilacetic acid",http://vmh.uni.lu/_api/metabolites/56/?format=pcsv
34dhphe,,,0,C9H11NO4,CHEBI:15765,,"Human Metabolome Database (HMDB): L-Dopa is the naturally occurring form of dihydroxyphenylalanine and the immediate precursor of dopamine. Unlike dopamine itself, L-Dopa can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to dopamine. In particular, it is metabolized to dopamine by aromatic L-amino acid decarboxylase. Pyridoxal phosphate (vitamin B6) is a required cofactor for this decarboxylation, and may be administered along with levodopa, usually as pyridoxine. L-Dopa is used for the treatment of Parkinsonian disorders and Dopa-Responsive Dystonia and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. Peripheral tissue conversion may be the mechanism of the adverse effects of levodopa. It is standard clinical practice to co-administer a peripheral DOPA decarboxylase inhibitor - carbidopa or benserazide - and often a catechol-O-methyl transferase (COMT) inhibitor, to prevent synthesis of dopamine in peripheral tissue.",,L-dopa,,HMDB00181,"InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1",C00355,2016-12-05T15:48:04Z,,57,,,,L-dopa,,34dhphe,,"(-)-3-(3,4-dihydroxyphenyl)-L-alanine, (-)-Dopa, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid, 3,4-Dihydroxy-L-phenylalanine, 3,4-Dihydroxyphenyl-L-alanine, 3,4-Dihydroxyphenylalanine, 3-(3,4-Dihydroxyphenyl)-L-alanine, 3-Hydroxy-L-tyrosine, b-(3,4-Dihydroxyphenyl)-a-L-alanine, b-(3,4-Dihydroxyphenyl)-L-alanine, b-(3,4-Dihydroxyphenyl)alanine, Bendopa, beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine, beta-(3,4-Dihydroxyphenyl)-L-alanine, beta-(3,4-Dihydroxyphenyl)alanine, Cidandopa, Dihydroxy-L-phenylalanine, Dihydroxyphenylalanine, Dopaflex, Dopaidan, Dopal, Dopalina, Dopar, Doparkine, Doparl, Dopasol, Dopaston, Dopastone, Dopastral, Dopicar, Doprin, Eldopal, Eldopar, Eldopatec, Eurodopa, Helfo-dopa, Insulamina, L-(-)-Dopa, L-3-(3,4-Dihydroxyphenyl)-Alanine, L-4-5-Dihydroxyphenylalanine, L-b-(3,4-Dihydroxyphenyl)-a-alanine, L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine, L-Dihydroxyphenylalanine, L-Dopa, Laradopa, Larodopa, Ledopa, Levedopa, Levodopa, Levopa, Maipedopa, Parda, Pardopa, Prodopa, Syndopa, Veldopa, Weldopa",http://vmh.uni.lu/_api/metabolites/57/?format=pcsv
34dhpac,,,0,C8H8O3,,,"Human Metabolome Database (HMDB): 3,4-Dihydroxyphenylacetaldehyde (DOPAL) is a metabolite of the monoamine oxidase-catalyzed oxidative deamination of dopamine. Aldehydes are highly reactive molecules formed during the biotransformation of numerous endogenous and exogenous compounds, including biogenic amines. DOPAL generates a free radical and activates mitochondrial permeability transition, a mechanism implicated in neuron death. There is an increasing body of evidence suggesting that these compounds are neurotoxic, and it has been recently hypothesized that neurodegenerative disorders may be associated with increased levels of this biogenic aldehyde. It is possible to speculate that reduced detoxification of 3,4- dihydroxymandelaldehyde from impaired or deficient aldehyde dehydrogenase function may be a contributing factor in the suggested neurotoxicity of these compounds. Aldehyde dehydrogenases are a group of NAD(P)+ -dependent enzymes that catalyze the oxidation of aldehydes, such as those derived from catecholamines, to their corresponding carboxylic acids. To date, 19 aldehyde dehydrogenase genes have been identified in the human genome. Mutations in these genes and subsequent inborn errors in aldehyde metabolism are the molecular basis of several diseases. Several pharmaceutical agents and environmental toxins (i.e.: 4-hydroxy-2-nonenal) are also known to disrupt or inhibit aldehyde dehydrogenase function. (PMID: 17379813, 14697885, 11164826, 16956664.",,"3,4-Dihydroxyphenylacetaldehyde",,HMDB03791,"InChI=1S/C8H8O3/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,4-5,10-11H,3H2",C04043,2016-12-05T15:48:04Z,,58,,,,,,34dhpac,,"3,4-Dihydroxy-Benzeneacetaldehyde, Protocatechuatealdehyde",http://vmh.uni.lu/_api/metabolites/58/?format=pcsv
34dhoxmand,,,-1,C8H7O5,,,"3,4-Dihydroxymandelate",,"3,4-Dihydroxymandelate",,,"InChI=1S/C8H8O5/c9-5-2-1-4(3-6(5)10)7(11)8(12)13/h1-3,7,9-11H,(H,12,13)/p-1",C05580,2016-11-22T15:11:44Z,,59,,,,,85782,34dhoxmand,,,http://vmh.uni.lu/_api/metabolites/59/?format=pcsv
34hpp,,,-1,C9H7O4,CHEBI:15999,,"Human Metabolome Database (HMDB): 4-Hydroxyphenylpyruvic acid (4-HPPA) is a keto acid that is involved in the tyrosine catabolism pathway. It is a product of the enzyme (R)-4-hydroxyphenyllactate dehydrogenase [EC 1.1.1.222] and is formed during tyrosine metabolism. The conversion from tyrosine to 4-HPPA is catalyzed by tyrosine aminotransferase. Additionally, 4-HPPA can be converted to homogentisic acid which is one of the precursors to ochronotic pigment. The enzyme 4-hydroxyphenylpyruvic acid dioxygenase (HPD) catalyzes the reaction that converts 4-hydroxyphenylpyruvic acid to homogentisic acid. A deficiency in the catalytic activity of HPD is known to lead to tyrosinemia type III, an autosomal recessive disorder characterized by elevated levels of blood tyrosine and massive excretion of tyrosine derivatives into urine. It has been shown that hawkinsinuria, an autosomal dominant disorder characterized by the excretion of 'hawkinsin,' may also be a result of HPD deficiency (PMID: 11073718). There are two isomers of HPPA, specifically 4HPPA and 3HPPA, of which 4HPPA is the most common.",,3-(4-hydroxyphenyl)pyruvate,,HMDB00707,"InChI=1S/C9H8O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,10H,5H2,(H,12,13)/p-1",C01179,2016-12-05T15:48:04Z,,60,,,,,979,34hpp,,"(p-hydroxyphenyl)-Pyruvate, (p-hydroxyphenyl)-Pyruvic acid, (p-Hydroxyphenyl)pyruvate, (p-Hydroxyphenyl)pyruvic acid, 3-(4-Hydroxyphenyl)-2-oxo-propanoate, 3-(4-Hydroxyphenyl)-2-oxo-propanoic acid, 3-(4-Hydroxyphenyl)-2-oxopropionate, 3-(4-Hydroxyphenyl)-2-oxopropionic acid, 3-(4-Hydroxyphenyl)pyruvate, 3-(4-Hydroxyphenyl)pyruvic acid, 3-(p-Hydroxyphenyl)-2-oxopropionate, 3-(p-Hydroxyphenyl)-2-oxopropionic acid, 3-(p-Hydroxyphenyl)pyruvate, 3-(p-Hydroxyphenyl)pyruvic acid, 4-Hydroxy-a-oxobenzenepropanoate, 4-Hydroxy-a-oxobenzenepropanoic acid, 4-Hydroxy-alpha-oxobenzenepropanoate, 4-Hydroxy-alpha-oxobenzenepropanoic acid, 4-Hydroxyphenylpyruvate, 4HPPA, HPPA, Hydroxyphenylpyruvate, Hydroxyphenylpyruvic acid, p-Hydroxyphenylpyruvic, Testacid",http://vmh.uni.lu/_api/metabolites/60/?format=pcsv
34hpl,,,-1,C9H9O4,CHEBI:36659,,Human Metabolome Database (HMDB): Hydroxyphenyllactic acid or 4-hydroxyphenyllactate (the L-form) is a tyrosine metabolite. The level of L-hydroxyphenyllactic acid is elevated in patients with a deficiency of the enzyme p-hydroxyphenylpyruvate oxidase (EC 1.14.2.2). (PMID 4720815 ). L-hydroxyphenyllactate is present in relatively higher concentrations in the cerebrospinal fluid and urine of patients with phenylketonuria (PKU) and tyrosinemia. (PMID: 3126358).  However the D-form of hydroxyphneyllactate is of bacterial origin and is also found in individuals with bacterial overgrowth or unusual gut microflora (PMID: 3126358).  Microbial hydroxyphenyllactate is likely derived from phenolic or polyphenolic compounds in the diet.  Bifidobacteria and lactobacilli produced considerable amounts of phenyllactic and p-hydroxyphenyllactic acids (PMID: 23061754).  It has also been shown that hydroxyphenyllactate decreases ROS (reactive oxygen species) production in both mitochondria and neutrophils and so hydroxyphenyllactate may function as a natural anti-oxidant (PMID: 23061754).,,3-(4-hydroxyphenyl)lactate,,HMDB00755,"InChI=1S/C9H10O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,8,10-11H,5H2,(H,12,13)/p-1",C03672,2016-12-05T15:48:04Z,,61,,,,,,34hpl,,"(RS)-3-(4-Hydroxyphenyl)lactate, (RS)-3-(4-Hydroxyphenyl)lactic acid, 2-Hydroxy-3-(4-hydroxyphenyl)propanoate, 2-Hydroxy-3-(4-hydroxyphenyl)propanoic acid, 2-Hydroxy-3-(p-hydroxyphenyl)propionate, 2-Hydroxy-3-(p-hydroxyphenyl)propionic acid, 3-(4-Hydroxyphenyl)-DL-lactate, 3-(4-Hydroxyphenyl)-DL-lactic acid, 3-(4-Hydroxyphenyl)lactate, 3-(4-Hydroxyphenyl)lactic acid, 3-(p-Hydroxyphenyl)-Lactate, 3-(p-Hydroxyphenyl)-Lactic acid, 4-Hydroxyphenyllactate, 4-Hydroxyphenyllactic acid, a,4-Dihydroxybenzenepropanoate, a,4-Dihydroxybenzenepropanoic acid, b-(4-Hydroxyphenyl)lactate, b-(4-Hydroxyphenyl)lactic acid, b-(p-Hydroxyphenyl)-DL-lactate, b-(p-Hydroxyphenyl)-DL-lactic acid, b-(p-Hydroxyphenyl)lactate, b-(p-Hydroxyphenyl)lactic acid, beta-(4-Hydroxyphenyl)lactate, beta-(4-Hydroxyphenyl)lactic acid, beta-(p-Hydroxyphenyl)-DL-lactate, beta-(p-Hydroxyphenyl)-DL-lactic acid, beta-(p-Hydroxyphenyl)lactate, beta-(p-Hydroxyphenyl)lactic acid, DL-3-(4-Hydroxyphenyl)lactate, DL-3-(4-Hydroxyphenyl)lactic acid, DL-p-Hydroxyphenyllactate, DL-p-Hydroxyphenyllactic acid, HPLA, Hydroxyphenyllactate",http://vmh.uni.lu/_api/metabolites/61/?format=pcsv
hgentis,,,-1,C8H7O4,CHEBI:44747,,Human Metabolome Database (HMDB): Homogentisic acid is an intermediate of the metabolic breakdown of tyrosine and phenylalanine; it occurs in the urine in cases of alkaptonuria. (OMIN 203500) Homogentisic acid is the primary precursor of melanin synthesis in Vibrio cholerae.,,homogentisate,,HMDB00130,"InChI=1S/C8H8O4/c9-6-1-2-7(10)5(3-6)4-8(11)12/h1-3,9-10H,4H2,(H,11,12)/p-1",C00544,2016-12-05T15:48:04Z,,62,,,,,780,hgentis,,"(2,5-dihydroxyphenyl)-Acetate, (2,5-dihydroxyphenyl)-Acetic acid, 2,5-Dihydroxy-a-toluate, 2,5-Dihydroxy-a-toluic acid, 2,5-Dihydroxy-alpha-toluate, 2,5-Dihydroxy-alpha-toluic acid, 2,5-Dihydroxy-benzeneacetate, 2,5-Dihydroxy-benzeneacetic acid, 2,5-Dihydroxyphenylacetate, 2,5-Dihydroxyphenylacetic acid, Alcapton, Homogentisate, Homogentisate acid, Homogentisinate, Homogentisinic acid, Melanic acid",http://vmh.uni.lu/_api/metabolites/62/?format=pcsv
35cgmp,,,-1,C10H11N5O7P,CHEBI:16356,,"Human Metabolome Database (HMDB): Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed).",,"3',5'-cyclic GMP(1-)",,HMDB01314,"InChI=1S/C10H12N5O7P/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,16H,1H2,(H,18,19)(H3,11,13,14,17)/p-1/t3-,5-,6-,9-/m1/s1",C00942,2016-12-05T15:48:04Z,,63,,,,,24316,35cgmp,,"3',5'-Cyclic GMP, 3',5'-Guanosine, 3',5'-Guanosine monophosphate, cGMP, Cyclic 3',5'-guanosine monophosphate, Cyclic GMP, Cyclic guanosine 3',5'-monophosphate, Cyclic-GMP, Guanosine 3',5'-cyclic phosphate, Guanosine 3',5'-cyclic-monophosphate, Guanosine 3',5'-monophosphate, Guanosine cyclic-monophosphate, Guanosine-cyclic-phosphoric-acid",http://vmh.uni.lu/_api/metabolites/63/?format=pcsv
3aib,,,0,C4H9NO2,CHEBI:33094,,"Human Metabolome Database (HMDB): Beta-Aminoisobutyric acid is a non-protein amino acid originating from the catabolism of thymine and valine. The concentration of beta-Aminoisobutyric acid is normally low in urine as beta-Aminoisobutyric acid is further catabolized by b-aminoisobutyrate aminotransferases to methylmalonic acid semialdehyde and propionyl-CoA. beta-Aminoisobutyric acid occurs in two isomeric forms and both enantiomers of beta-Aminoisobutyric acid can be detected in human urine and plasma. In plasma, the S-enantiomer is the predominant type due to active renal reabsorption. In contrast, urine almost exclusively contains the R-enantiomer of beta-Aminoisobutyric acid, which is eliminated both by filtration and tubular secretion. Persistently increased levels of beta-Aminoisobutyric acid have been observed in individuals with a deficiency of R (-) -b-aminoisobutyrate-pyruvate aminotransferase. In addition, transient high levels of beta-Aminoisobutyric acid have been observed under a variety of pathological conditions such as lead poisoning, starvation, in total body irradiation and in a number of malignancies. The S-enantiomer of beta-Aminoisobutyric acid is predominantly derived from the catabolism of valine. It has been suggested that an altered homoeostasis of b-alanine underlies some of the clinical abnormalities encountered in patients with a dihydropyrimidine dehydrogenase (DPD) deficiency. DPD constitutes the first step of the pyrimidine degradation pathway, in which the pyrimidine bases uracil and thymine are catabolized to b-alanine and the R-enantiomer of beta-Aminoisobutyric acid respectively. In normal individuals with an intact pyrimidine degradation pathway, R-methylmalonic acid semialdehyde can be synthesized directly from the catabolism of thymine. Hence, there might be less cross-over between the valine and thymine pathway, allowing the conversion of S-methylmalonic acid semialdehyde into S-beta-Aminoisobutyric acid and the subsequent accumulation of S-beta-Aminoisobutyric acid in plasma. (PMID: 14705962, 14292857, 14453202).",,(S)-3-aminoisobutyric acid,,HMDB02166,"InChI=1S/C4H9NO2/c1-3(2-5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1",C03284,2016-12-05T15:48:04Z,,64,,,,,,3aib,,"(+)-a-Methyl-b-alanine, (+)-alpha-Methyl-beta-alanine, (+)-b-Aminoisobutyric acid, (+)-beta-Aminoisobutyric acid, (S)-3-amino-2-methyl-Propanoate, (S)-3-amino-2-methyl-Propanoic acid, (S)-3-Amino-2-methylpropanoate, (S)-3-Amino-2-methylpropanoic acid, (S)-3-Amino-isobutanoate, (S)-3-Amino-isobutanoic acid, (S)-3-Amino-isobutyrate, (S)-3-Amino-isobutyric acid, (S)-b-Aminoisobutyric acid, (S)-beta-Aminoisobutyric acid, L-2-Methyl-b-Alanine, L-2-Methyl-beta-Alanine, L-3-Amino-2-methylpropanoate, L-3-Amino-2-methylpropanoic acid, L-3-Amino-2-methylpropionic acid, L-3-Amino-isobutanoate, L-3-Amino-isobutanoic acid, L-3-Amino-isobutyrate, L-3-Amino-isobutyric acid, L-b-Aminoisobutyrate, L-b-Aminoisobutyric acid, L-beta-Aminoisobutyrate, L-beta-Aminoisobutyric acid, S-b-Aminoisobutyrate, S-beta-Aminoisobutyrate, S-beta-Aminoisobutyric acid",http://vmh.uni.lu/_api/metabolites/64/?format=pcsv
2mop,,,-1,C4H5O3,CHEBI:16256,,2-methyl-3-oxopropanoate,,2-methyl-3-oxopropanoate,,,"InChI=1S/C4H6O3/c1-3(2-5)4(6)7/h2-3H,1H3,(H,6,7)/p-1",C00349,2016-11-22T15:11:44Z,,65,,,,,296,2mop,,,http://vmh.uni.lu/_api/metabolites/65/?format=pcsv
glu_L,,,-1,C5H8NO4,CHEBI:16015,,"Human Metabolome Database (HMDB): Glutamic acid (Glu), also referred to as glutamate (the anion), is one of the 20 proteinogenic amino acids. It is not among the essential amino acids. Glutamate is a key molecule in cellular metabolism. In humans, dietary proteins are broken down by digestion into amino acids, which serves as metabolic fuel or other functional roles in the body. Glutamate is the most abundant fast excitatory neurotransmitter in the mammalian nervous system. At chemical synapses, glutamate is stored in vesicles. Nerve impulses trigger release of glutamate from the pre-synaptic cell. In the opposing post-synaptic cell, glutamate receptors, such as the NMDA receptor, bind glutamate and are activated. Because of its role in synaptic plasticity, it is believed that glutamic acid is involved in cognitive functions like learning and memory in the brain. Glutamate transporters are found in neuronal and glial membranes. They rapidly remove glutamate from the extracellular space. In brain injury or disease, they can work in reverse and excess glutamate can accumulate outside cells. This process causes calcium ions to enter cells via NMDA receptor channels, leading to neuronal damage and eventual cell death, and is called excitotoxicity. The mechanisms of cell death include: * Damage to mitochondria from excessively high intracellular Ca2+. * Glu/Ca2+-mediated promotion of transcription factors for pro-apoptotic genes, or downregulation of transcription factors for anti-apoptotic genes. Excitotoxicity due to glutamate occurs as part of the ischemic cascade and is associated with stroke and diseases like amyotrophic lateral sclerosis, lathyrism, and Alzheimer's disease. glutamic acid has been implicated in epileptic seizures. Microinjection of glutamic acid into neurons produces spontaneous depolarization around one second apart, and this firing pattern is similar to what is known as paroxysmal depolarizing shift in epileptic attacks. This change in the resting membrane potential at seizure foci could cause spontaneous opening of voltage activated calcium channels, leading to glutamic acid release and further depolarization. (http://en.wikipedia.org/wiki/Glutamic_acid).",,L-glutamate(1-),,HMDB00148,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/p-1/t3-/m0/s1",C00025,2016-12-05T15:48:04Z,,66,,,,L-Glutamate;L-glutamate;L-glutamic acid,33032,glu_L,,"(2S)-2-Aminopentanedioate, (2S)-2-Aminopentanedioic acid, (S)-(+)-Glutamate, (S)-(+)-Glutamic acid, (S)-2-Aminopentanedioate, (S)-2-Aminopentanedioic acid, (S)-Glutamate, (S)-Glutamic acid, 1-Amino-propane-1,3-dicarboxylate, 1-Amino-propane-1,3-dicarboxylic acid, 1-Aminopropane-1,3-dicarboxylate, 1-Aminopropane-1,3-dicarboxylic acid, 2-Aminoglutarate, 2-Aminoglutaric acid, 2-Aminopentanedioate, 2-Aminopentanedioic acid, a-Aminoglutarate, a-Aminoglutaric acid, a-Glutamate, a-Glutamic acid, Aciglut, alpha-Aminoglutarate, alpha-Aminoglutaric acid, alpha-Glutamate, alpha-Glutamic acid, Aminoglutarate, Aminoglutaric acid, E, Glt, Glu, Glusate, Glut, Glutacid, Glutamicol, Glutamidex, Glutaminate, Glutaminic acid, Glutaminol, Glutaton, L-(+)-Glutamate, L-(+)-Glutamic acid, L-a-Aminoglutarate, L-a-Aminoglutaric acid, L-alpha-Aminoglutarate, L-alpha-Aminoglutaric acid, L-Glu, L-Glutamate, L-Glutaminate, L-Glutaminic acid",http://vmh.uni.lu/_api/metabolites/66/?format=pcsv
3dphb,,,-1,C57H85O3,,,3-Decaprenyl-4-hydroxybenzoate,,3-Decaprenyl-4-hydroxybenzoate,,,"InChI=1/C57H86O3/c1-44(2)21-12-22-45(3)23-13-24-46(4)25-14-26-47(5)27-15-28-48(6)29-16-30-49(7)31-17-32-50(8)33-18-34-51(9)35-19-36-52(10)37-20-38-53(11)39-40-54-43-55(57(59)60)41-42-56(54)58/h21,23,25,27,29,31,33,35,37,39,41-43,58H,12-20,22,24,26,28,30,32,34,36,38,40H2,1-11H3,(H,59,60)/b45-23+,46-25+,47-27+,48-29+,49-31+,50-33+,51-35+,52-37+,53-39+",,2016-11-22T15:11:44Z,,67,,,,,,3dphb,,,http://vmh.uni.lu/_api/metabolites/67/?format=pcsv
3dpdhb,,,-1,C57H85O4,,,"3-Decaprenyl-4,5-dihdydroxybenzoate",,"3-Decaprenyl-4,5-dihdydroxybenzoate",,,"InChI=1S/C57H86O4/c1-43(2)21-12-22-44(3)23-13-24-45(4)25-14-26-46(5)27-15-28-47(6)29-16-30-48(7)31-17-32-49(8)33-18-34-50(9)35-19-36-51(10)37-20-38-52(11)39-40-53-41-54(57(60)61)42-55(58)56(53)59/h21,23,25,27,29,31,33,35,37,39,41-42,58-59H,12-20,22,24,26,28,30,32,34,36,38,40H2,1-11H3,(H,60,61)/p-1/b44-23+,45-25+,46-27+,47-29+,48-31+,49-33+,50-35+,51-37+,52-39+",,2016-11-22T15:11:44Z,,68,,,,,,3dpdhb,,,http://vmh.uni.lu/_api/metabolites/68/?format=pcsv
3dsphgn,,,1,C18H38NO2,CHEBI:17862,,(2S)-1-hydroxy-3-oxooctadecan-2-aminium,,(2S)-1-hydroxy-3-oxooctadecan-2-aminium,,,"InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h17,20H,2-16,19H2,1H3/p+1/t17-/m0/s1",C02934,2016-11-22T15:11:44Z,,69,,,,,,3dsphgn,,,http://vmh.uni.lu/_api/metabolites/69/?format=pcsv
sphgn,,,1,C18H40NO2,CHEBI:16566,,Human Metabolome Database (HMDB): Sphinganine is a blocker postlysosomal cholesterol transport by inhibition of low-density lipoprotein-induced esterification of cholesterol and cause unesterified cholesterol to accumulate in perinuclear vesicles. It has been suggested the possibility that endogenous sphinganine may inhibit cholesterol transport in Niemann-Pick Type C (NPC) disease. (PMID 1817037).,,sphinganine(1+),,HMDB00269,"InChI=1S/C18H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h17-18,20-21H,2-16,19H2,1H3/p+1/t17-,18+/m0/s1",C00836,2016-12-05T15:48:04Z,,70,,,,,91486,sphgn,,"2-Amino-D-erythro-1,3-Octadecanediol, C18-dihydro-Sphingosine, C18-Dihydrosphingosine, D-Erythro-1,3-Dihydroxy-2-aminooctadecane, D-Erythro-2-Amino-1,3-octadecanediol, D-Erythro-C18-Dihydrosphingosine, D-Erythro-Sphinganine, Dihydro-C18-sphingosine, Dihydrosphingosine, Erythro-Sphinganine, Octadecasphinganine, Sphinganine, [R-(R*,S*)]-2-amino-1,3-Octadecanediol",http://vmh.uni.lu/_api/metabolites/70/?format=pcsv
3hanthrn,,,0,C7H7NO3,CHEBI:15793,,3-hydroxyanthranilate,,3-hydroxyanthranilate,,,"InChI=1S/C7H7NO3/c8-6-4(7(10)11)2-1-3-5(6)9/h1-3,9H,8H2,(H,10,11)",C00632,2016-11-22T15:11:44Z,,71,,,,,,3hanthrn,,,http://vmh.uni.lu/_api/metabolites/71/?format=pcsv
cmusa,,,-1,C7H6NO5,CHEBI:995,,"cis,cis-2-amino-3-(3-oxoprop-1-enyl)but-2-enedioate",,"cis,cis-2-amino-3-(3-oxoprop-1-enyl)but-2-enedioate",,,"InChI=1S/C7H7NO5/c8-5(7(12)13)4(6(10)11)2-1-3-9/h1-3H,8H2,(H,10,11)(H,12,13)/p-2/b2-1-,5-4-",C04409,2016-11-22T15:11:44Z,,72,,,,,5280673,cmusa,,,http://vmh.uni.lu/_api/metabolites/72/?format=pcsv
b2coa,,,-4,C25H36N7O17P3S,CHEBI:15473,,crotonoyl-CoA(4-),,crotonoyl-CoA(4-),,,"InChI=1S/C25H40N7O17P3S/c1-4-5-16(34)53-9-8-27-15(33)6-7-28-23(37)20(36)25(2,3)11-46-52(43,44)49-51(41,42)45-10-14-19(48-50(38,39)40)18(35)24(47-14)32-13-31-17-21(26)29-12-30-22(17)32/h4-5,12-14,18-20,24,35-36H,6-11H2,1-3H3,(H,27,33)(H,28,37)(H,41,42)(H,43,44)(H2,26,29,30)(H2,38,39,40)/p-4/b5-4+/t14-,18-,19-,20+,24-/m1/s1",C00877,2016-11-22T15:11:44Z,,73,,,,crotonoyl-CoA,5280381,b2coa,,,http://vmh.uni.lu/_api/metabolites/73/?format=pcsv
3hbcoa_R,,,-4,C25H38N7O18P3S,CHEBi:15452,,(R)-3-hydroxybutanoyl-CoA(4-),,(R)-3-hydroxybutanoyl-CoA(4-),,,"InChI=1S/C25H42N7O18P3S/c1-13(33)8-16(35)54-7-6-27-15(34)4-5-28-23(38)20(37)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-19(49-51(39,40)41)18(36)24(48-14)32-12-31-17-21(26)29-11-30-22(17)32/h11-14,18-20,24,33,36-37H,4-10H2,1-3H3,(H,27,34)(H,28,38)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/p-4/t13-,14-,18-,19-,20+,24-/m1/s1",C03561,2016-11-22T15:11:44Z,,74,,,,,11966146,3hbcoa_R,,,http://vmh.uni.lu/_api/metabolites/74/?format=pcsv
3hibutcoa,,,-4,C25H38N7O18P3S,CHEBI:15481,,(S)-3-Hydroxyisobutyryl-CoA,,(S)-3-Hydroxyisobutyryl-CoA,,,"InChI=1S/C25H42N7O18P3S/c1-13(8-33)24(38)54-7-6-27-15(34)4-5-28-22(37)19(36)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-18(49-51(39,40)41)17(35)23(48-14)32-12-31-16-20(26)29-11-30-21(16)32/h11-14,17-19,23,33,35-36H,4-10H2,1-3H3,(H,27,34)(H,28,37)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/p-4/t13-,14+,17+,18+,19-,23+/m0/s1",C06000,2016-11-22T15:11:44Z,,75,,,,,,3hibutcoa,,,http://vmh.uni.lu/_api/metabolites/75/?format=pcsv
3hmp,,,-1,C4H7O3,CHEBI:11805,,"Human Metabolome Database (HMDB): (S)-3-Hydroxyisobutyric (3-HIBA) acid is an organic acid. 3-HIBA is an intermediate in L-valine metabolism. 3-HIBA plays an important role in the diagnosis of the very rare inherited metabolic diseases 3-hydroxyisobutyric aciduria (OMIM 236795) and methylmalonic semialdehyde dehydrogenase deficiency (OMIM 603178). Patients with 3-hydroxyisobutyric aciduria excrete a significant amount of 3-HIBA not only during the acute stage but also when stable. 3-hydroxyisobutyric aciduria is caused by a 3-hydroxyisobutyryl-CoA dehydrogenase deficiency (PMID: 18329219). The severity of this disease varies from case to case. Most patients exhibit dysmorphic features, such as a small triangular face, a long philtrum, low set ears and micrognathia (PMID: 113770040, 10686279). Lactic acidemia is also found in the affected patients, indicating that mitochondrial dysfunction is involved. 3-hydroxyisobutyrate appears to specifically inhibit the function of the respiratory chain complex I-III and mitochondrial creatine kinase (PMID: 18329219).",,3-hydroxy-2-methylpropanoate,,HMDB00023,"InChI=1S/C4H8O3/c1-3(2-5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/p-1",C06001,2016-12-05T15:48:04Z,,76,,,,,,3hmp,,"(S)-3-Hydroxyisobutyric acid, 2-Methyl-L-(+)-Hydracrylate, 2-Methyl-L-(+)-Hydracrylic acid, 3-Hydroxy(iso)butyric acid, 3-Hydroxy-2-methyl-(S)-Propanoate, 3-Hydroxy-2-methyl-(S)-Propanoic acid, 3-Hydroxy-2-methylpropanoate, 3-Hydroxy-2-methylpropanoic acid, 3-Hydroxy-isobutyrate, 3-Hydroxyisobutyrate, 3-Hydroxyisobutyric acid",http://vmh.uni.lu/_api/metabolites/76/?format=pcsv
hLkynr,,,0,C10H12N2O4,CHEBI:17380,,3-hydroxy-L-kynurenine,,3-hydroxy-L-kynurenine,,HMDB01152,"InChI=1S/C10H12N2O4/c11-6(10(15)16)4-8(14)5-2-1-3-7(13)9(5)12/h1-3,6,13H,4,11-12H2,(H,15,16)/t6-/m0/s1",C03227,2016-11-22T15:11:44Z,,77,,,,,11811,hLkynr,,,http://vmh.uni.lu/_api/metabolites/77/?format=pcsv
42A3HP24DB,,,-1,C10H8NO5,,,"4-(2-Amino-3-hydroxyphenyl)-2,4-dioxobutanoate",,"4-(2-Amino-3-hydroxyphenyl)-2,4-dioxobutanoate",,,"InChI=1/C10H9NO5/c11-9-5(2-1-3-6(9)12)7(13)4-8(14)10(15)16/h1-3,12H,4,11H2,(H,15,16)",C05645,2016-11-22T15:11:44Z,,78,,,,,440741,42A3HP24DB,,,http://vmh.uni.lu/_api/metabolites/78/?format=pcsv
dopa,,,1,C8H12NO2,CHEBI:18243,,"Human Metabolome Database (HMDB): Dopamine is a member of the catecholamine (Neurotransmitters) family in the brain, and is a precursor to epinephrine (adrenaline) and norepinephrine (noradrenaline). Dopamine is synthesized in the body (mainly by nervous tissue and adrenal glands) first by the hydration of the amino acid tyrosine to DOPA by tyrosine hydroxylase and then by the decarboxylation of DOPA by aromatic-L-amino-acid decarboxylase. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (Dopamine receptors) mediates its action. --PubChem.",,dopaminium(1+),,HMDB00073,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2/p+1",C03758,2016-12-05T15:48:04Z,,79,,,,dopamine,681,dopa,,"2-(3,4-Dihydroxyphenyl)ethylamine, 3,4-Dihydroxyphenethylamine, 3,4-Dihydroxyphenylethylamine, 3-Hydroxytyramine, 4-(2-Aminoethyl)-1,2-benzenediol, 4-(2-Aminoethyl)-Pyrocatechol, 4-(2-Aminoethyl)catechol, 4-(2-Aminoethyl)pyrocatechol, a-(3,4-Dihydroxyphenyl)-b-aminoethane, alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane, Deoxyepinephrine, Dopamin, Dopamine, Dopaminum, Dopastat, Dophamine, Dynatra, Hydroxytyramin, Hydroxytyramine, Intropin, Oxytyramine, Revivan",http://vmh.uni.lu/_api/metabolites/79/?format=pcsv
3hpcoa,,,-4,C24H36N7O18P3S,CHEBI:27762,,3-hydroxypropanoyl-CoA(4-),,3-hydroxypropanoyl-CoA(4-),,,"InChI=1S/C24H40N7O18P3S/c1-24(2,19(36)22(37)27-5-3-14(33)26-6-8-53-15(34)4-7-32)10-46-52(43,44)49-51(41,42)45-9-13-18(48-50(38,39)40)17(35)23(47-13)31-12-30-16-20(25)28-11-29-21(16)31/h11-13,17-19,23,32,35-36H,3-10H2,1-2H3,(H,26,33)(H,27,37)(H,41,42)(H,43,44)(H2,25,28,29)(H2,38,39,40)/p-4/t13-,17-,18-,19+,23-/m1/s1",C05668,2016-11-22T15:11:44Z,,80,,,,,440753,3hpcoa,,,http://vmh.uni.lu/_api/metabolites/80/?format=pcsv
3hpp,,,-1,C3H5O3,CHEBI:33404,,Human Metabolome Database (HMDB): 3-Hydroxypropionic acid is a carboxylic acid. It is used in the production of various chemicals such as acrylates in industry. It can be produced by certain microbes. Its chemical structure is similar to L-serine.,,3-hydroxypropionate,,HMDB00700,"InChI=1S/C3H6O3/c4-2-1-3(5)6/h4H,1-2H2,(H,5,6)/p-1",C01013,2016-12-05T15:48:04Z,,81,,,,,68152,3hpp,,"2-Deoxyglycerate, 2-Deoxyglyceric acid, 3-Hydroxypropanoate, 3-Hydroxypropanoic acid, 3-Hydroxypropionate, 3-Hydroxypropionic acid, b-Hydroxypropionate, b-Hydroxypropionic acid, b-Lactate, b-Lactic acid, beta-Hydroxypropionate, beta-Hydroxypropionic acid, beta-Lactate, beta-Lactic acid, Ethylenelactate, Ethylenelactic acid, Hydracrylic acid, Hydroxypropionate",http://vmh.uni.lu/_api/metabolites/81/?format=pcsv
msa,,,-1,C3H3O3,CHEBI:17960,,3-oxopropanoate,,3-oxopropanoate,,,"InChI=1S/C3H4O3/c4-2-1-3(5)6/h2H,1H2,(H,5,6)/p-1",C00222,2016-11-22T15:11:44Z,,82,,,,,868,msa,,,http://vmh.uni.lu/_api/metabolites/82/?format=pcsv
3hxkynam,,,1,C9H13N2O2,,,3-Hydroxykynurenamine,,3-Hydroxykynurenamine,,,"InChI=1/C9H12N2O2/c10-5-4-7(12)6-2-1-3-8(13)9(6)11/h1-3,13H,4-5,10-11H2",C05636,2016-11-22T15:11:44Z,,83,,,,,440736,,,,http://vmh.uni.lu/_api/metabolites/83/?format=pcsv
48dhoxquin,,,0,C9H7NO2,CHEBI:28883,,"quinoline-4,8-diol",,"quinoline-4,8-diol",,,"InChI=1S/C9H7NO2/c11-7-4-5-10-9-6(7)2-1-3-8(9)12/h1-5,12H,(H,10,11)",C05637,2016-11-22T15:11:44Z,,84,,,,,440737,,,,http://vmh.uni.lu/_api/metabolites/84/?format=pcsv
3mox4hpac,,,0,C9H10O3,CHEBI:28111,,(4-hydroxy-3-methoxyphenyl)acetaldehyde,,(4-hydroxy-3-methoxyphenyl)acetaldehyde,,,"InChI=1S/C9H10O3/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,5-6,11H,4H2,1H3",C05581,2016-11-22T15:11:44Z,,85,,,,homovanillin,151276,3mox4hpac,,,http://vmh.uni.lu/_api/metabolites/85/?format=pcsv
3mlda,,,-1,C6H7N2O2,CHEBI:8122,,"Human Metabolome Database (HMDB): Methylimidazoleacetic acid is the main metabolite of histamine. This end product of histamine catabolism is formed by N-methylation in the imidazole ring to methylhistamine by histamine methyltransferase (EC 2.1.1.8) and a subsequent oxidative deamination in the side chain by type B monoamine oxidase (EC 1.4.3.4). From studies is known that as much as 70 to 80 percent of the histamine metabolized in the body is excreted in the urine as Methylimidazoleacetic acid. Thus, urinary Methylimidazoleacetic acid being the major and specific histamine metabolite is a clear marker of any changes in histamine metabolism in the body. The urinary excretion of methylimidazoleacetic acid is considered a reliable indicator of histamine turnover rate in the body. The excretion of Methylimidazoleacetic acid is higher in men than women however; this gender difference is abolished when corrected for creatinine excretion. A possible explanation is that basal histamine turnover is related to body size. There is no significant difference in Methylimidazoleacetic acid excretion between smokers and non-smokers when analysing absolute values (mg/24 h). When using Methylimidazoleacetic acid values corrected for creatinine excretion female smokers have significantly higher Methylimidazoleacetic acid excretion compared to nonsmokers. (PMID: 11411609, 7130180, 10350179, 10202992).",,3-Methylimidazoleacetic acid,,HMDB02820,"InChI=1/C6H8N2O2/c1-8-3-5(7-4-8)2-6(9)10/h3-4H,2H2,1H3,(H,9,10)",C05828,2016-12-05T15:48:04Z,,86,,,,,75810,3mlda,,"1,4-Methyl-imidazoleacetic acid, 1,4-Methylimidazoleacetate, 1-Methyl-1H-Imidazole-4-acetate, 1-Methyl-1H-Imidazole-4-acetic acid, 1-Methyl-4-imidazoleacetate, 1-Methyl-4-imidazoleacetic acid, 1-Methylimidazole-4-acetate, Methylimidazole acetate, Methylimidazoleacetate, Methylimidazoleacetic acid, MIAA, N Tau-methylimidazoleacetic acid, Tele-methylimidazoleacetate, Tele-methylimidazoleacetic acid",http://vmh.uni.lu/_api/metabolites/86/?format=pcsv
3mob,,,-1,C5H7O3,CHEBI:11851,,"Human Metabolome Database (HMDB): Alpha-ketoisovaleric acid is a branched chain organic acid which is a precursor to leucine and valine synthesis. It is also a degradation product from valine. The enzyme dihydroxy-acid dehydratase catalyzes the fourth step in the biosynthesis of isoleucine and valine, through the dehydration of 2, 3-dihydroxy-isovaleic acid into alpha-ketoisovaleric acid.",,3-methyl-2-oxobutanoate,,HMDB00019,"InChI=1S/C5H8O3/c1-3(2)4(6)5(7)8/h3H,1-2H3,(H,7,8)/p-1",C00141,2016-12-05T15:48:04Z,,87,,,,,49,3mob,,"2-Keto-3-Methylbutyrate, 2-Keto-3-Methylbutyric acid, 2-Ketoisovalerate, 2-Ketoisovaleric acid, 2-Ketoisvaleric acid, 2-Oxo-3-methyl-butyrate, 2-Oxo-3-methylbutanoate, 2-Oxo-3-methylbutanoic acid, 2-Oxo-3-methylbutyrate, 2-Oxo-3-methylbutyric acid, 2-Oxoisovalerate, 2-Oxoisovaleric acid, 3-Methyl-2-oxo-Butanoate, 3-Methyl-2-oxo-Butanoic acid, 3-Methyl-2-oxo-Butyrate, 3-Methyl-2-oxo-Butyric acid, 3-Methyl-2-oxobutanoate, 3-Methyl-2-oxobutanoic acid, 3-Methyl-2-oxobutinoate, 3-Methyl-2-oxobutinoic acid, 3-Methyl-2-oxobutyrate, 3-Methyl-2-oxobutyric acid, a-Keto-b-Methylbutyrate, a-Keto-b-Methylbutyric acid, a-Keto-Isovalerate, a-Keto-Isovaleric acid, a-Ketoisovalerate, a-Ketoisovaleric acid, a-Oxo-b-methylbutyrate, a-Oxo-b-methylbutyric acid, a-Oxoisovalerate, a-Oxoisovaleric acid, alpha-Keto-beta-Methylbutyrate, alpha-Keto-beta-Methylbutyric acid, alpha-Keto-Isovalerate, alpha-Keto-Isovaleric acid, alpha-Ketoisovalerate, alpha-Ketoisovaleric acid, alpha-Oxo-beta-methylbutyrate, alpha-Oxo-beta-methylbutyric acid, alpha-Oxoisovalerate, alpha-Oxoisovaleric acid, Dimethylpyruvate, Dimethylpyruvic acid, Isopropylglyoxylate, Isopropylglyoxylic acid, Ketovaline",http://vmh.uni.lu/_api/metabolites/87/?format=pcsv
3mop,,,-1,C6H9O3,CHEBI:28654,,"Human Metabolome Database (HMDB): 3-Methyl-2-oxovaleric acid is a metabolite of isoleucine in man, animals and bacteria. It is the alpha-keto acid analogue of isoleucine. 3-Methyl-2-oxovaleric acid is produced from isoleucine by cytosolic branched chain aminotransferase 1 (EC:2.6.1.42), whereupon it is further degraded by branched chain keto acid dehydrogenase E1 to 2-Methyl-1-hydroxybutyl-ThPP. It is used as a clinical marker for maple syrup urine disease (MSUD). MSUD is caused by a deficiency of the branched-chain -keto acid dehydrogenase compex resulting in an accumulation of branched-chain amino acids and the corresponding -keto-and -hydroxy acids in blood, urine and cerebrospinal fluid causing neurological damage and mental retardation.",,3-methyl-2-oxopentanoate,,HMDB00491,"InChI=1S/C6H10O3/c1-3-4(2)5(7)6(8)9/h4H,3H2,1-2H3,(H,8,9)/p-1",C03465,2016-12-05T15:48:04Z,,88,,,,,47,3mop,,"(3R)-3-Methyl-2-oxopentanoate, (3R)-3-Methyl-2-oxopentanoic acid, (R)-3-methyl-2-oxopentanoate, (R)-3-methyl-2-oxopentanoic acid, (S)-3-methyl-2-oxopentanoate, (S)-3-methyl-2-oxopentanoic acid, 2-Keto-3-methylvalerate, 2-Keto-3-methylvaleric acid, 2-Oxo-3-methyl-N-valerate, 2-Oxo-3-methyl-N-valeric acid, 2-Oxo-3-methylpentanoate, 2-Oxo-3-methylpentanoic acid, 2-Oxo-3-methylvalerate, 2-Oxo-3-methylvaleric acid, 2-Oxoisoleucine, 2-Oxokolavenate, 2-Oxokolavenic acid, 3-Methyl-2-oxo-pentanoate, 3-Methyl-2-oxo-pentanoic acid, 3-Methyl-2-oxo-Valerate, 3-Methyl-2-oxo-Valeric acid, 3-Methyl-2-oxopentanoate, 3-Methyl-2-oxopentanoic acid, 3-Methyl-2-oxovalerate, 3-Methyl-2-oxovaleric, a-Keto-b-Methyl-N-valerate, a-Keto-b-Methyl-N-valeric acid, a-Keto-b-methylvalerate, a-Keto-b-methylvaleric acid, a-Oxo-b-methyl-N-valerate, a-Oxo-b-methyl-N-valeric acid, a-Oxo-b-methylvalerate, a-Oxo-b-methylvaleric acid, alpha-Keto-beta-Methyl-N-valerate, alpha-Keto-beta-Methyl-N-valeric acid, alpha-Keto-beta-methylvalerate, alpha-Keto-beta-methylvaleric acid, alpha-Oxo-beta-methyl-N-valerate, alpha-Oxo-beta-methyl-N-valeric acid, alpha-Oxo-beta-methylvalerate, alpha-Oxo-beta-methylvaleric acid",http://vmh.uni.lu/_api/metabolites/88/?format=pcsv
3m4hpga,,,0,C9H10O4,,,3-Methoxy-4-hydroxyphenylglycolaldehyde,,3-Methoxy-4-hydroxyphenylglycolaldehyde,,,"InChI=1/C9H10O4/c1-13-9-4-6(8(12)5-10)2-3-7(9)11/h2-5,8,11-12H,1H3",C05583,2016-11-22T15:11:44Z,,89,,,,,440729,3m4hpga,,,http://vmh.uni.lu/_api/metabolites/89/?format=pcsv
3mox4hoxm,,,-1,C9H9O5,CHEBI:20106,,"Human Metabolome Database (HMDB): Vanillylmandelic acid is one of the products of the catabolism of catecholamines (epinephrine, norepinephrine and dopamine). High levels of vanillylmandelic acid can indicate an adrenal gland tumor (pheochromocytoma) or another type of tumor that produces catecholamines. (WebMD).",,3-Methoxy-4-hydroxymandelate,,HMDB00291,"InChI=1S/C9H10O5/c1-14-7-4-5(2-3-6(7)10)8(11)9(12)13/h2-4,8,10-11H,1H3,(H,12,13)/p-1",C05584,2016-12-05T15:48:04Z,,90,,,,,1245,3mox4hoxm,,"(4-Hydroxy-3-methoxyphenyl)glycolate, (4-Hydroxy-3-methoxyphenyl)glycolic acid, 3-Methoxy-4-hydroxy-mandelic acid, 3-Methoxy-4-hydroxymandelate, 3-Methoxy-4-hydroxymandelic acid, 3-Methoxy-4-hydroxyphenylhydroxyacetate, 3-Methoxy-4-hydroxyphenylhydroxyacetic acid, 4'-Hydroxy-3'-methoxymandelate, 4'-Hydroxy-3'-methoxymandelic acid, 4-Hydroxy 3-methoxymandelic acid, 4-Hydroxy-3-methoxy-DL-mandelate, 4-Hydroxy-3-methoxy-DL-mandelic acid, 4-Hydroxy-3-methoxy-Mandelate, 4-Hydroxy-3-methoxy-Mandelic acid, 4-Hydroxy-3-methoxymandelate, 4-Hydroxy-3-methoxymandelic acid, DL-3-Methoxy-4-hydroxymandelate, DL-3-Methoxy-4-hydroxymandelic acid, DL-4-Hydroxy-3-methoxymandelate, DL-4-Hydroxy-3-methoxymandelic acid, DL-vanillomandelate, DL-vanillomandelic acid, DL-vanillylmandelate, DL-vanillylmandelic acid, HMMA, Hydroxymethoxymandelic acid, Lopac-H-0131, Vainillylmandelic acid, Vanillinmandelate, Vanillinmandelic acid, Vanillomandelate, Vanillomandelic acid, Vanillyl-mandelic acid, Vanillylmandelate, Vanillylmandellic acid, Vanillymandelic acid, Vanilmandelate, Vanilmandelic acid, Vanilylmandelic acid, Vanyl-mandelic acid, Vanylmandelic acid, VMA",http://vmh.uni.lu/_api/metabolites/90/?format=pcsv
3moxtyr,,,1,C9H14NO2,,,Human Metabolome Database (HMDB): The O-methylated derivative of dopamine. Dopamine is methylated by catechol-O-methyltransferase (COMT) to make 3-Methoxytyramine. This compound can be broken down to homovanillic acid by monoamine oxidase and aldehyde dehydrogenase. Elevated concentrations of this compound are indicated for a variety of brain and carcinoid tumors as well as certain mental disorders.,,3-Methoxytyramine,,HMDB00022,"InChI=1/C9H13NO2/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,6,11H,4-5,10H2,1H3",C05587,2016-12-05T15:48:04Z,,91,,,,,1669,3moxtyr,,"3-Methoxy-4-hydroxyphenylethyl amine, 3-Methoxytyramine, 3-O-Methyldopamine, 4-(2-Amino-ethyl)-2-methoxy-phenol, 4-(2-Aminoethyl)-2-methoxy-Phenol, 4-(2-Aminoethyl)-2-methoxyphenol, 5-(2-Aminoethyl)guaiacol",http://vmh.uni.lu/_api/metabolites/91/?format=pcsv
3amp,,,-2,C10H12N5O7P,,,3'-AMP(2-),,3'-AMP(2-),,,"InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(17)7(4(1-16)21-10)22-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/p-2/t4-,6-,7-,10-/m1/s1",C01367,2016-11-22T15:11:44Z,,92,,,,,,,,,http://vmh.uni.lu/_api/metabolites/92/?format=pcsv
adn,,,0,C10H13N5O4,CHEBI:16335,,"Human Metabolome Database (HMDB): Adenosine is a nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. For instance, adenosine plays an important role in energy transfer - as adenosine triphosphate (ATP) and adenosine diphosphate (ADP). It also plays a role in signal transduction as cyclic adenosine monophosphate, cAMP. Adenosine itself is both a neurotransmitter and potent vasodilator. When administered intravenously, adenosine causes transient heart block in the AV node. Because of the effects of adenosine on AV node-dependent supraventricular tachycardia, adenosine is considered a class V antiarrhythmic agent.",,Adenosine,,HMDB00050,"InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",C00212,2016-12-05T15:48:04Z,,93,,,,adenosine,60961,adn,,"1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-D-Ribofuranose, 1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-delta-Ribofuranose, 6-Amino-9beta-D-ribofuranosyl-9H-purine, 6-Amino-9beta-delta-ribofuranosyl-9H-purine, 9-beta-D-Arabinofuranosyladenine, 9-beta-D-Ribofuranosidoadenine, 9-beta-D-Ribofuranosyl-9H-purin-6-amine, 9-beta-D-Ribofuranosyladenine, 9-beta-delta-Arabinofuranosyladenine, 9-beta-delta-Ribofuranosidoadenine, 9-beta-delta-Ribofuranosyl-9H-purin-6-amine, 9-beta-delta-Ribofuranosyladenine, 9beta-D-ribofuranosyl-9H-Purin-6-amine, 9beta-D-Ribofuranosyladenine, 9beta-delta-ribofuranosyl-9H-Purin-6-amine, 9beta-delta-Ribofuranosyladenine, Adenine nucleoside, Adenine riboside, Adenine-9beta-D-Ribofuranoside, Adenine-9beta-delta-Ribofuranoside, Adenocard, Adenocor, Adenoscan, Adenosin, b-D-Adenosine, beta-Adenosine, beta-D-Adenosine, beta-delta-Adenosine, Boniton, Myocol, Nucleocardyl, Sandesin",http://vmh.uni.lu/_api/metabolites/93/?format=pcsv
3sala,,,-2,C3H5NO4S,CHEBI:16345,,3-Sulfino-L-alanine,,3-Sulfino-L-alanine,,,"InChI=1S/C3H7NO4S/c4-2(3(5)6)1-9(7)8/h2H,1,4H2,(H,5,6)(H,7,8)/p-2/t2-/m0/s1",C00606,2016-11-22T15:11:44Z,,94,,,,,28167170,3sala,,,http://vmh.uni.lu/_api/metabolites/94/?format=pcsv
asp_L,,,-1,C4H6NO4,CHEBI:17053,,"Human Metabolome Database (HMDB): Aspartic acid (Asp, D), also known as aspartate, the name of its anion, is one of the 20 natural proteinogenic amino acids which are the building blocks of proteins. As its name indicates, aspartic acid is the carboxylic acid analog of asparagine. As a neurotransmitter, aspartic acid may provide resistance to fatigue and thus lead to endurance, although the evidence to support this idea is not strong. (http://en.wikipedia.org/wiki/Aspartic_acid) Aspartic acid is a nonessential amino acid which is made from glutamic acid by enzymes using vitamin B6. The amino acid has important roles in the urea cycle and DNA metabolism. Aspartic acid is a major excitatory neurotransmitter, which is sometimes found to be increased in epileptic and stroke patients. It is decreased in depressed patients and in patients with brain atrophy. Aspartic acid supplements are being evaluated. Five grams can raise blood levels. Magnesium and zinc may be natural inhibitors of some of the actions of aspartic acid. Aspartic acid, with the amino acid phenylalanine, is a part of a new natural sweetener, aspartame. This sweetener is an advance in artificial sweeteners, and is probably safe in normal doses to all except phenylketonurics. The jury is still out on the long term effects it has on many brain neurohormones. Aspartic acid may be a significant immunostimulant of the thymus and can protect against some of the damaging effects of radiation. Many claims have been made for the special value of administering aspartic acid in the form of potassium and magnesium salts. Since aspartic acid is relatively nontoxic, studies are now in progress to elucidate its pharmacological and therapeutic roles. (http://www.dcnutrition.com/AminoAcids).",,L-aspartate(1-),,HMDB00191,"InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/p-1/t2-/m0/s1",C00049,2016-12-05T15:48:04Z,,95,,,,,5960,asp_L,," Asp, (+)-Aspartate, (+)-Aspartic acid, (2S)-Aspartate, (2S)-Aspartic acid, (L)-Aspartate, (L)-Aspartic acid, (R)-2-aminosuccinate, (S)-(+)-Aspartate, (S)-(+)-Aspartic acid, (S)-2-aminosuccinate, (S)-2-aminosuccinic acid, (S)-amino-Butanedioate, (S)-amino-Butanedioic acid, (S)-Aminobutanedioate, (S)-Aminobutanedioic acid, (S)-Aspartate, (S)-Aspartic acid, 2-Amino-3-methylsuccinate, 2-Amino-3-methylsuccinic acid, 2-Aminosuccinate, 2-Aminosuccinic acid, alpha-Aminosuccinate, alpha-Aminosuccinic acid, Aminosuccinate, Asparagate, Asparagic acid, Asparaginate, Asparaginic acid, Asparatate, Aspartate, H-Asp-OH, L-(+)-Aspartate, L-(+)-Aspartic acid, L-Aminosuccinate, L-Aminosuccinic acid, L-Asparagate, L-Asparagic acid, L-Asparaginate, L-Asparaginic acid, L-Aspartate",http://vmh.uni.lu/_api/metabolites/95/?format=pcsv
hyptaur,,,0,C2H7NO2S,CHEBI:16668,,Human Metabolome Database (HMDB): Hypotaurine is a product of enzyme cysteamine dioxygenase [EC 1.13.11.19] in taurine and hypotaurine metabolism pathway (KEGG). It may function as an antioxidant and a protective agent under physiological conditions (PMID 14992269).,,Hypotaurine,,HMDB00965,"InChI=1S/C2H7NO2S/c3-1-2-6(4)5/h1-3H2,(H,4,5)",C00519,2016-12-05T15:48:04Z,,96,,,,,107812,hyptaur,,"2-Amino-Ethanesulfinate, 2-Amino-Ethanesulfinic acid, 2-Aminoethanesulfinate, 2-Aminoethanesulfinic acid, 2-Aminoethylsulfinate, 2-Aminoethylsulfinic acid, Cystaminesulfinate, Cystaminesulfinic acid, Hypotaurine",http://vmh.uni.lu/_api/metabolites/96/?format=pcsv
3snpyr,,,-2,C3H2O5S,,,3-Sulfinopyruvate,,3-Sulfinopyruvate,,,"InChI=1S/C3H4O5S/c4-2(3(5)6)1-9(7)8/h1H2,(H,5,6)(H,7,8)",C05527,2016-11-22T15:11:44Z,,97,,,,,,3snpyr,,,http://vmh.uni.lu/_api/metabolites/97/?format=pcsv
so3,,,-2,O3S,CHEBI:48854,,Sulfite,,Sulfite,,,"InChI=1S/H2O3S/c1-4(2)3/h(H2,1,2,3)/p-2",C00094,2016-11-22T15:11:44Z,,98,,,,,1100,so3,,,http://vmh.uni.lu/_api/metabolites/98/?format=pcsv
adrnl,,,1,C9H14NO3,CHEBI:33568,,"Human Metabolome Database (HMDB): Epinephrine is a catecholamine, a sympathomimetic monoamine derived from the amino acids phenylalanine and tyrosine. It is the active sympathomimetic hormone secreted from the adrenal medulla in most species. It stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels. It is used in asthma and cardiac failure and to delay absorption of local anesthetics. Epinephrine also constricts arterioles in the skin and gut while dilating arterioles in leg muscles. It elevates the blood sugar level by increasing hydrolysis of glycogen to glucose in the liver, and at the same time begins the breakdown of lipids in adipocytes. Epinephrine has a suppressive effect on the immune system.",,Adrenaline,,HMDB00068,"InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3",C00788,2016-12-05T15:48:04Z,,99,,,,,838,adrnl,,"(-)-(R)-Epinephrine, (-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol, (-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol, (-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol, (-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol, (-)-Adrenaline, (-)-Epinephrine, (R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol, (R)-Adrenaline, (R)-Epinephrine, 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol, Adnephrine, Adrenal, Adrenalin, Adrenaline, Adrenine, Adrin, Ana-Kit, Bosmin, Bronkaid Mist, Chelafrin, Epifrin, Epiglaufrin, Epinefrina, Epinephran, Epinephrine, Epipen, Epirenan, Eppy, Exadrin, Glauposine, Hemisine, Hemostasin, Hemostatin, Hypernephrin, Isoptoepinal, L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol, L-Adrenaline, L-Epinephrine, L-Epirenamine, L-Methylaminoethanolcatechol, Levoepinephrine, Levorenen, Levorenin, Levorenine, Levoreninum, Lyodrin, Methylarterenol, Mucidrina, Nephridine, Nieraline, Paranephrin, Primatene Mist, R-(-)-Epinephrine, Renaglandin, Renaleptine, Renalina, Renoform, Renostypticin, Renostyptin, Scurenaline, Simplene, Styptirenal, Supracapsulin, Supranephrane, Suprarenaline, Suprarenin, Surrenine, Sus-phrine, Takamina, Vasoconstrictine, Vasotonin",http://vmh.uni.lu/_api/metabolites/99/?format=pcsv
mma,,,1,C1H6N,CHEBI:16830,,"Human Metabolome Database (HMDB): Methylamine occurs endogenously from amine catabolism and its tissue levels increase in some pathological conditions, including diabetes. Interestingly, methylamine and ammonia levels are reciprocally controlled by a semicarbazide-sensitive amine oxidase activity that deaminates methylamine to formaldehyde with the production of ammonia and hydrogen peroxide. Methylamine also targets the voltage-operated neuronal potassium channels, probably inducing release of neurotransmitter(s). Semicarbazide-sensitive amine oxidase (SSAO) catalyzes the deamination of primary amines. Such deamination has been shown capable of regulating glucose transport in adipose cells. It has been independently discovered that the primary structure of vascular adhesion protein-1 (VAP-1) is identical to SSAO. Increased serum SSAO activities have been found in patients with diabetic mellitus, vascular disorders and Alzheimer's disease. The SSAO-catalyzed deamination of endogenous substrates like methylamine led to production of toxic formaldehyde. Chronic elevated methylamine increases the excretion of malondialdehyde and microalbuminuria. Amine oxidase substrates such as methylamine have been shown to stimulate glucose uptake by increasing the recruitment of the glucose transporter GLUT4 from vesicles within the cell to the cell surface. Inhibition of this effect by the presence of semicarbazide and catalase led to the suggestion that the process is mediated by the H (2) O (2) produced in the oxidation of these amines. (PMID: 16049393, 12686132, 17406961).",,methylammonium,,HMDB00164,"InChI=1S/CH5N/c1-2/h2H2,1H3/p+1",C00218,2016-12-05T15:48:04Z,,100,,,,methylamine,6329,mma,,"Aminomethane, Anhydrous methylamine, Carbinamine, Imizin, Mercurialin, Methanamine, Methyl group, Methyl of gamma-N-methylasparagine, Methylamine, Methylamine anhydrous, Methylamine aqueous solution, Methylamine solution, Methylamine solutions, Methylaminen, Metilamine, Metyloamina, MMA, Monomethylamine, N-Methylamine, NMA, NME",http://vmh.uni.lu/_api/metabolites/100/?format=pcsv
nrpphr,,,1,C8H12NO3,CHEBI:18357,,Human Metabolome Database (HMDB): Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic.,,Norepinephrine,,HMDB00216,"InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2",C00547,2016-12-05T15:48:04Z,,101,,,,,439260,nrpphr,,"(-)-(R)-Norepinephrine, (-)-alpha-(Aminomethyl)protocatechuyl alcohol, (-)-Arterenol, (-)-Noradrenaline, (-)-Norepinephrine, (R)-(-)-Norepinephrine, (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol, (R)-Noradrenaline, (R)-Norepinephrine, 4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol, 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol, Adrenor, Aktamin, Arterenol, L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol, L-3,4-Dihydroxyphenylethanolamine, L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol, L-Arterenol, L-Noradrenaline, L-Norepinephrine, Levarterenol, Levoarterenol, Levonor, Levonoradrenaline, Levonorepinephrine, Levophed, Nor-Epirenan, Noradrenalin, Noradrenaline, Norartrinal, Norepirenamine, Sympathin E",http://vmh.uni.lu/_api/metabolites/101/?format=pcsv
4abut,,,0,C4H9NO2,CHEBI:16865,,"Human Metabolome Database (HMDB): Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter found in the nervous systems of widely divergent species. It is the chief inhibitory neurotransmitter in the vertebrate central nervous system. In vertebrates, GABA acts at inhibitory synapses in the brain. GABA acts by binding to specific transmembrane receptors in the plasma membrane of both pre- and postsynaptic neurons. This binding causes the opening of ion channels to allow either the flow of negatively-charged chloride ions into the cell or positively-charged potassium ions out of the cell. This will typically result in a negative change in the transmembrane potential, usually causing hyperpolarization. Three general classes of GABA receptor are known. These include GABAA and GABAC ionotropic receptors, which are ion channels themselves, and GABAB metabotropic receptors, which are G protein-coupled receptors that open ion channels via intermediaries (G proteins). Neurons that produce GABA as their output are called GABAergic neurons, and have chiefly inhibitory action at receptors in the vertebrate. Medium Spiny Cells are a typical example of inhibitory CNS GABAergic cells. GABA exhibits excitatory actions in insects, mediating muscle activation at synapses between nerves and muscle cells and also the stimulation of certain glands. GABA has also been shown to have excitatory roles in the vertebrate, most notably in the developing cortex. Organisms synthesize GABA from glutamate using the enzyme L-glutamic acid decarboxylase and pyridoxal phosphate as a cofactor. It is worth noting that this involves converting the principal excitatory neurotransmitter (glutamate) into the principal inhibitory one (GABA). Drugs that act as agonists of GABA receptors (known as GABA analogues or GABAergic drugs) or increase the available amount of GABA typically have relaxing, anti-anxiety and anti-convulsive effects. (http://en.wikipedia.org/wiki/GABA) Doses of GABA 1 to 3 g orally also have been used effectively to raise the IQ of mentally retarded persons. GABA is found to be deficient in cerebrospinal fluid and brain in many studies of experimental and human epilepsy. Benzodiazepines (such as Valium) are useful in status epilepticus because they act on GABA receptors. GABA increases in the brain after administration of many seizure medications. Hence, GABA is clearly an antiepileptic nutrient. Inhibitors of GAM metabolism can also produce convulsions. Spasticity and involuntary movement syndromes, e.g., Parkinson's, Friedreich's ataxia, tardive dyskinesia, and Huntington's chorea are all marked by low GABA when amino acid levels are studied. Trials of 2 to 3 g of GABA given orally have been effective in various epilepsy and spasticity syndromes. Agents that elevate GABA also are useful in lowering hypertension. Three grams orally have been effective in control of blood pressure. GABA is decreased in various encephalopathies. GABA can reduce appetite and is decreased in hypoglycemics. GABA reduces blood sugar in diabetics. Chronic brain syndromes can also be marked by deficiency of GABA; GABA has many promising uses in therapy. Cerebrospinal fluid levels of GABA may be useful in diagnosing very serious diseases. Vitamin B6, manganese, taurine and lysine can increase both GABA synthesis and effects, while aspartic acid and glutamic acid probably inhibit GABA effects. (http://www.dcnutrition.com/AminoAcids/Detail.CFM)The brain's principal inhibitory neurotransmitter, GABA, along with serotonin and norepinephrine, is one of several neurotransmitters that appear to be involved in the pathogenesis of anxiety and mood disorders. There are two principal subtypes of postsynaptic GABA receptor complexes, the GABA-A and GABA-B receptor complexes. Activation of the GABA-B receptor by GABA causes neuronal membrane hyperpolarization and a resultant inhibition of neurotransmitter release. In addition to binding sites for GABA, the GABA-A receptor has binding sites for benzodiazepines, barbiturates, and neurosteroids. GABA-A receptors are coupled to chloride ion channels; activation of the receptor induces increased inward chloride ion flux, resulting in membrane hyperpolarization and neuronal inhibition. After release into the synapse, free GABA that does not bind to either the GABA-A or GABA-B receptor complexes can be taken up by neurons and glial cells. Four different membrane transporter proteins, known as GAT-1, GAT-2, GAT-3, and BGT-1, which differ in their distribution in the CNS, are believed to mediate the uptake of synaptic GABA into neurons and glial cells. The GABA-A receptor subtype regulates neuronal excitability and rapid changes in fear arousal, such as anxiety, panic, and the acute stress response. Drugs that stimulate GABA-A receptors, such as the benzodiazepines and barbiturates, have anxiolytic and anti-seizure effects via GABA-A-mediated reduction of neuronal excitability, which effectively raises the seizure threshold. In support of the anticonvulsant and anxiolytic effects of the GABA-A receptor are findings that GABA-A antagonists produce convulsions in animals and the demonstration that there is decreased GABA-A receptor binding in a positron emission tomography (PET) study of patients with panic disorder. Low plasma GABA has been reported in some depressed patients and, in fact, may be a useful trait marker for mood disorders. (The Role Of GABA In The Pathogenesis And Treatment Of Anxiety And Other Neuropsychiatric Disorders: http://www.vcu-cme.org/gaba/overview.html).",,4-Aminobutanoate,,HMDB00112,"InChI=1S/C4H9NO2/c5-3-1-2-4(6)7/h1-3,5H2,(H,6,7)",C00334,2016-12-05T15:48:04Z,,102,,,,,119,4abut,,"3-Carboxypropylamine, 4-Aminobutanoate, 4-Aminobutanoic acid, 4-Aminobutyrate, 4-Aminobutyric acid, Aminalon, GABA, Gaballon, Gamarex, gamma Aminobutyrate, gamma Aminobutyric acid, gamma-Aminobutyrate, gamma-Aminobutyric acid, Gammalon, Gammalone, Gammar, Gammasol, Mielogen, Mielomade, Omega-Aminobutyrate, Omega-Aminobutyric acid, Piperidate, Piperidic acid, Piperidinate, Piperidinic acid, w-Aminobutyrate, w-Aminobutyric acid",http://vmh.uni.lu/_api/metabolites/102/?format=pcsv
coucoa,,,-4,C30H38N7O18P3S1,CHEBI:15499,,4-coumaroyl-CoA(4-),,4-coumaroyl-CoA(4-),,,"InChI=1S/C30H42N7O18P3S/c1-30(2,25(42)28(43)33-10-9-20(39)32-11-12-59-21(40)8-5-17-3-6-18(38)7-4-17)14-52-58(49,50)55-57(47,48)51-13-19-24(54-56(44,45)46)23(41)29(53-19)37-16-36-22-26(31)34-15-35-27(22)37/h3-8,15-16,19,23-25,29,38,41-42H,9-14H2,1-2H3,(H,32,39)(H,33,43)(H,47,48)(H,49,50)(H2,31,34,35)(H2,44,45,46)/p-4/t19-,23-,24-,25+,29-/m1/s1",C00223,2016-11-22T15:11:44Z,,103,,,,,147899,coucoa,,,http://vmh.uni.lu/_api/metabolites/103/?format=pcsv
4hbzcoa,,,-4,C28H36N7O18P3S,,,4-hydroxybenoyl-CoA,,4-hydroxybenoyl-CoA,,,"InChI=1/C28H40N7O18P3S/c1-28(2,22(39)25(40)31-8-7-18(37)30-9-10-57-27(41)15-3-5-16(36)6-4-15)12-50-56(47,48)53-55(45,46)49-11-17-21(52-54(42,43)44)20(38)26(51-17)35-14-34-19-23(29)32-13-33-24(19)35/h3-6,13-14,17,20-22,26,36,38-39H,7-12H2,1-2H3,(H,30,37)(H,31,40)(H,45,46)(H,47,48)(H2,29,32,33)(H2,42,43,44)/t17-,20?,21-,22+,26-/m1/s1",C02949,2016-11-22T15:11:44Z,,104,,,,,,4hbzcoa,,,http://vmh.uni.lu/_api/metabolites/104/?format=pcsv
accoa,,,-4,C23H34N7O17P3S,CHEBI:15351,,"Human Metabolome Database (HMDB): The main function of coenzyme A is to carry acyl groups (such as the acetyl group) or thioesters. Acetyl-CoA is an important molecule itself. It is the precursor to HMG CoA, which is a vital component in cholesterol and ketone synthesis. (wikipedia). acetyl CoA participates in the biosynthesis of fatty acids and sterols, in the oxidation of fatty acids and in the metabolism of many amino acids. It also acts as a biological acetylating agent.",,Acetyl-CoA,,HMDB01206,"InChI=1S/C23H38N7O17P3S/c1-12(31)51-7-6-25-14(32)4-5-26-21(35)18(34)23(2,3)9-44-50(41,42)47-49(39,40)43-8-13-17(46-48(36,37)38)16(33)22(45-13)30-11-29-15-19(24)27-10-28-20(15)30/h10-11,13,16-18,22,33-34H,4-9H2,1-3H3,(H,25,32)(H,26,35)(H,39,40)(H,41,42)(H2,24,27,28)(H2,36,37,38)/p-4/t13-,16-,17-,18+,22-/m1/s1",C00024,2016-12-05T15:48:04Z,,105,,,,acetyl-CoA,444493,accoa,,"Ac-CoA, Ac-Coenzyme A, Ac-S-CoA, Ac-S-Coenzyme A, Acetyl coenzyme-A, Acetyl-CoA, Acetyl-Coenzyme A, Acetyl-S-CoA, Acetyl-S-Coenzyme A, Acetylcoenzyme-A, S-Acetate CoA, S-Acetate Coenzyme A, S-Acetyl coenzyme A",http://vmh.uni.lu/_api/metabolites/105/?format=pcsv
4hbz,,,-1,C7H5O3,CHEBI:30763,,"Human Metabolome Database (HMDB): 4-Hydroxybenzoic acid, or p-hydroxybenzoic acid, is a phenolic derivative of benzoic acid. It a white crystalline solid that is slightly soluble in water and chloroform, but well soluble in alcohols, ether, and acetone.",,4-hydroxybenzoate,,HMDB00500,"InChI=1S/C7H6O3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H,(H,9,10)/p-1",C00156,2016-12-05T15:48:04Z,,106,,,,,,4hbz,,"4-Carboxyphenol, 4-Hydroxy-benzoate, 4-Hydroxy-benzoesaeure, 4-Hydroxy-benzoic acid, 4-Hydroxybenzoate, 4-Hydroxybenzoic acid, p-Carboxyphenol, p-Hydroxy-Benzoate, p-Hydroxy-Benzoic acid, p-Hydroxybenzoate, p-Hydroxybenzoic acid, p-Salicylate, p-Salicylic acid, Paraben-acid",http://vmh.uni.lu/_api/metabolites/106/?format=pcsv
4hdebrisoquine,,,1,C10H14N3O,,,"Human Metabolome Database (HMDB): Debrisoquine is metabolized to 4-hydroxydebrisoquine by CYP2D6. Due to this, it has been used widely to determine the hydroxylation capacity of the enzyme.(PMID:15843230).",,4 hydroxy debrisoquine,,HMDB06468,"InChI=1/C10H13N3O/c11-10(12)13-5-7-3-1-2-4-8(7)9(14)6-13/h1-4,9,14H,5-6H2,(H3,11,12)",,2016-12-05T15:48:04Z,,107,,,,,,4hdebrisoquine,,4 Hydroxy debrisoquine,http://vmh.uni.lu/_api/metabolites/107/?format=pcsv
4hglusa,,,0,C5H9NO4,CHEBI:27809,,Human Metabolome Database (HMDB): L-4-Hydroxyglutamate semialdehyde is an intermediate in Arginine and proline metabolism. L-4-Hydroxyglutamate semialdehyde is the 4th to last step in the synthesis of Glyoxylate and is converted from L-erythro-4-Hydroxyglutamate via the enzyme 1-pyrroline-5-carboxylate dehydrogenase (EC 1.5.1.12). It is then converted to L-1-Pyrroline-3-hydroxy-5-carboxylate via enzymtic reaction.,,L-4-hydroxyglutamic semialdehyde,,HMDB06556,"InChI=1S/C5H9NO4/c6-4(5(9)10)1-3(8)2-7/h2-4,8H,1,6H2,(H,9,10)/t3-,4+/m1/s1",C05938,2016-12-05T15:48:04Z,,108,,,,,,4hglusa,,,http://vmh.uni.lu/_api/metabolites/108/?format=pcsv
e4hglu,,,-1,C5H8NO5,,,erythro-4-hydroxy-L-glutamate(1-),,erythro-4-hydroxy-L-glutamate(1-),,,"InChI=1S/C5H9NO5/c6-2(4(8)9)1-3(7)5(10)11/h2-3,7H,1,6H2,(H,8,9)(H,10,11)/p-1/t2-,3+/m0/s1",C05947,2016-11-22T15:11:44Z,,109,,,,,440854,e4hglu,,,http://vmh.uni.lu/_api/metabolites/109/?format=pcsv
4hoxpacd,,,0,C8H8O2,CHEBI:15621,,(4-hydroxyphenyl)acetaldehyde,,(4-hydroxyphenyl)acetaldehyde,,,"InChI=1S/C8H8O2/c9-6-5-7-1-3-8(10)4-2-7/h1-4,6,10H,5H2",C03765,2016-11-22T15:11:44Z,,110,,,,,440113,4hoxpacd,,,http://vmh.uni.lu/_api/metabolites/110/?format=pcsv
4hphac,,,-1,C8H7O3,CHEBI:18101,,Human Metabolome Database (HMDB): p-Hydroxyphenylacetic acid is an oxidative deaminated metabolite of p-tyramine. Also a metabolite of tyrosine via enteric bacteria. The bacterial origin of this compound was confirmed by the finding that this compound in urine decreased significantly after the use of the antibiotic neomycin.,,4-hydroxyphenylacetate,,HMDB00020,"InChI=1S/C8H8O3/c9-7-3-1-6(2-4-7)5-8(10)11/h1-4,9H,5H2,(H,10,11)/p-1",C00642,2016-12-05T15:48:04Z,,111,,,,,127,4hphac,,"(4-hydroxy-phenyl)-acetate, (4-hydroxy-phenyl)-acetic acid, (4-Hydroxy-phenyl)-essigsaeure, (4-hydroxyphenyl)acetate, (4-hydroxyphenyl)acetic acid, (p-hydroxyphenyl)-Acetate, (p-hydroxyphenyl)-Acetic acid, (p-Hydroxyphenyl)acetate, (p-Hydroxyphenyl)acetic acid, 4-Hydroxy-Benzeneacetate, 4-Hydroxy-Benzeneacetic acid, 4-Hydroxybenzeneacetate, 4-Hydroxybenzeneacetic acid, 4-hydroxyphenyl-acetic acid, 4-Hydroxyphenylacetate, 4-Hydroxyphenylacetic acid, p-Hydroxyphenylacetate, p-Hydroxyphenylacetic acid, Parahydroxy phenylacetate, Parahydroxy phenylacetic acid, Parahydroxyphenylacetate",http://vmh.uni.lu/_api/metabolites/111/?format=pcsv
4mop,,,-1,C6H9O3,CHEBI:48430,,Human Metabolome Database (HMDB): Ketoleucine is a metabolite that accumulates in Maple Syrup Urine Disease (MSUD) and shown to compromise brain energy metabolism by blocking the respiratory chain; this is of relevance to the understanding of the pathophysiology of the neurological dysfunction of MSUD patients. (PMID 14636955).,,4-methyl-2-oxopentanoate,,HMDB00695,"InChI=1S/C6H10O3/c1-4(2)3-5(7)6(8)9/h4H,3H2,1-2H3,(H,8,9)/p-1",C00233,2016-12-05T15:48:04Z,,112,,,,,70,4mop,,"2-Keto-4-Methylvalerate, 2-Keto-4-Methylvaleric acid, 2-Ketoisocaproate, 2-Ketoisocaproic acid, 2-Oxo-4-methylpentanoate, 2-Oxo-4-methylpentanoic acid, 2-Oxo-4-methylvalerate, 2-Oxo-4-methylvaleric acid, 2-Oxoisocaproate, 2-Oxoisocaproic acid, 2-Oxoleucine, 4-Methyl-2-oxo-Valerate, 4-Methyl-2-oxo-Valeric acid, 4-Methyl-2-oxopentanoate, 4-Methyl-2-oxopentanoic acid, a-Ketoisocaproate, a-Ketoisocaproic acid, a-Ketoisocapronate, a-Ketoisocapronic acid, a-Oxoisocaproate, a-Oxoisocaproic acid, alpha-Keto-isocaproate, alpha-Keto-isocaproic acid, alpha-Ketoisocaproate, alpha-Ketoisocaproic acid, alpha-Ketoisocapronate, alpha-Ketoisocapronic acid, alpha-Oxoisocaproate, alpha-Oxoisocaproic acid, Ketoisocaproate, Ketoisocaproic acid, Methyloxovalerate, Methyloxovaleric acid, Oxoisocaproate, Oxoisocaproic acid",http://vmh.uni.lu/_api/metabolites/112/?format=pcsv
4mptnl,,,0,C6H12O,CHEBI:17998,,4-methylpentanal,,4-methylpentanal,,,"InChI=1S/C6H12O/c1-6(2)4-3-5-7/h5-6H,3-4H2,1-2H3",C02373,2016-11-22T15:11:44Z,,113,,,,,,4mptnl,,,http://vmh.uni.lu/_api/metabolites/113/?format=pcsv
4mtolbutamide,,,0,C12H18N2O4S,,,Human Metabolome Database (HMDB): 4-Hydroxy tolbutamide is a hydroxylation byproduct of tolbutamide. Tolbutamide is a first generation potassium channel blocker. It is a sulfonylurea oral hypoglycemic drug sold under the brand name Orinase. This drug may be used in the management of type II diabetes if diet alone is not effective. Tolbutamide stimulates the secretion of insulin by the pancreas.,,4 hydroxy tolbutamide,,HMDB06408,"InChI=1/C12H18N2O4S/c1-2-3-8-13-12(16)14-19(17,18)11-6-4-10(9-15)5-7-11/h4-7,15H,2-3,8-9H2,1H3,(H2,13,14,16)",,2016-12-05T15:48:04Z,,114,,,,,,4mtolbutamide,,"1-Butyl-3-(4-hydroxymethylphenyl)sulfonylurea, 4 Hydroxy tolbutamide, 4-Hydroxytolbutamide , Hydroxymethyltolbutamide, Hydroxytolbutamide, Methylhydroxytolbutamide",http://vmh.uni.lu/_api/metabolites/114/?format=pcsv
4nphsf,,,-1,C6H4NO6S,CHEBI:35422,,"Human Metabolome Database (HMDB): 4-Nitrophenyl sulfate is a minor metabolic byproduct of parathion metabolism that is excreted in the urine (PMID: 1956875). Parathion is an organophosphate compound developed in the 1940's. It is a potent insecticide and acaricide. It is highly toxic to non-target organisms, including humans. 4-Nitrophenyl sulfate is also used as a model substrate to investigate the influence of drug therapy, disease, nutrient deficiencies and other physiologically altered conditions on conjugative drug metabolism in animal studies.(PMID: 16844228).",,4-Nitrophenyl sulfate,,HMDB06492,"InChI=1S/C6H5NO6S/c8-7(9)5-1-3-6(4-2-5)13-14(10,11)12/h1-4H,(H,10,11,12)",,2016-12-05T15:48:04Z,,115,,,,,,4nphsf,,"4-Nitrophenyl, Mono (4-nitrophenyl)-sulfate, Mono (4-nitrophenyl)-sulphate, p-Nitro-Phenol, P-Nitrophenol sulfate, P-Nitrophenol sulphate, P-Nitrophenyl sulfate, P-Nitrophenyl sulphate, Para-nitrophenyl sulfate, Para-nitrophenyl sulphate",http://vmh.uni.lu/_api/metabolites/115/?format=pcsv
4nph,,,0,C6H5NO3,CHEBI:16836,,4-nitrophenolate,,4-nitrophenolate,,,"InChI=1S/C6H5NO3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H",C00870,2016-11-22T15:11:45Z,,116,,,,,,4nph,,,http://vmh.uni.lu/_api/metabolites/116/?format=pcsv
4pyrdx,,,0,C8H9NO4,CHEBI:17405,,"Human Metabolome Database (HMDB): 4-Pyridoxic acid is the catabolic product of vitamin B6 (also known as pyridoxine, pyridoxal and pyradoxamine) which is excreted in the urine. Urinary levels of 4-pyridoxic acid are lower in females than in males and will be reduced in persons with riboflavin deficiency. 4-Pyridoxic acid is formed by the action of aldehyde oxidase I (an endogenous enzyme) and by microbial enzymes (pyridoxal 4-dehydrogenase), an NAD-dependent aldehyde dehydrogenase. 4-pyridoxic acid can be further broken down by the gut microflora via 4-pyridoxic acid dehydrogenase. This enzyme catalyzes the four electron oxidation of 4-pyridoxic acid to 3-hydroxy-2-methylpyridine-4,5-dicarboxylate, using nicotinamide adenine dinucleotide as a cofactor.",,4-pyridoxate,,HMDB00017,"InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)",C00847,2016-12-05T15:48:04Z,,117,,,,,,4pyrdx,,"2-Methyl-3-hydroxy-4-carboxy-5-hydroxymethylpyridine, 3-Hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxylate, 3-Hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxylic acid, 3-Hydroxy-5-(hydroxymethyl)-2-methyl-Isonicotinate, 3-Hydroxy-5-(hydroxymethyl)-2-methyl-Isonicotinic acid, 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinate, 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinic acid, 3-Hydroxy-5-hydroxymethyl-2-methyl-isonicotinate, 3-Hydroxy-5-hydroxymethyl-2-methyl-isonicotinic acid, 3-Hydroxy-5-hydroxymethyl-2-methyl-isonicotinsaeure, 4-Pyridoxate, 4-Pyridoxinate, 4-Pyridoxinecarboxylate, 4-Pyridoxinecarboxylic acid, 4-Pyridoxinic acid, 4-Pyridoxinsaeure, 4-Pyridoxylate, 4-Pyridoxylic acid",http://vmh.uni.lu/_api/metabolites/117/?format=pcsv
5adtststeroneglc,,,0,C25H38O8,,,"Human Metabolome Database (HMDB): 5-alpha-Dihydrotestosterone glucuronide is a natural human metabolite of 5alpha-Dihydrotestosterone generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.",,5alpha-Dihydrotestosterone glucuronide,,HMDB06203,"InChI=1/C25H38O8/c1-24-9-7-13(26)11-12(24)3-4-14-15-5-6-17(25(15,2)10-8-16(14)24)32-23-20(29)18(27)19(28)21(33-23)22(30)31/h12,14-21,23,27-29H,3-11H2,1-2H3,(H,30,31)/t12-,14-,15-,16-,17-,18-,19-,20+,21-,23+,24-,25-/m0/s1",C03033,2016-12-05T15:48:04Z,,118,,,,,44263365,5adtststeroneglc,,"5-a-Dihydrotestosterone glucuronide, 5-alpha-Dihydrotestosterone glucuronide, 5alpha-Dihydrotestosterone glucuronide, Dihydrotestosterone 17-glucuronide, Dihydrotestosterone glucuronide, Stanolone glucuronate",http://vmh.uni.lu/_api/metabolites/118/?format=pcsv
5adtststerones,,,-1,C19H29O5S,,,"Human Metabolome Database (HMDB): 5a-Dihydrotestosterone sulfate is a sulfate derivative of 5a-Dihydrotestosterone produced through phase II metabolism. 5a-dihydrotestosterone (DHT) is a steroid similar to testosterone and androstenedione, that belongs to a class called androgens. DHT is a C19 steroid and possesses androgenic activity. Androgen production takes place mainly in the Leydig cells of the testes. Androgens circulate in the blood bound to proteins, especially sex hormone binding globulin (SHBG) and albumin. A trace amount of these steroids circulate in the unbound form in the blood and are referred to as the free fractions. DHT has at least three times the binding affinity for SHBG than testosterone. About 70% of DHT is derived from peripheral conversion of testosterone in males, while most of the DHT is derived from androstenedione in females.",,5alpha-Dihydrotestosterone sulfate,,HMDB06278,"InChI=1/C19H30O5S/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(24-25(21,22)23)19(15,2)10-8-16(14)18/h12,14-17H,3-11H2,1-2H3,(H,21,22,23)/t12-,14-,15-,16-,17-,18-,19-/m0/s1",,2016-12-05T15:48:04Z,,119,,,,,18665256,5adtststerones,,"5alpha-Dihydrotestosterone sulfate, 5alpha-Dihydrotestosterone sulphate, DHT-sulfate, DHT-sulphate, Dihydrotestosterone sulfate, Dihydrotestosterone sulphate",http://vmh.uni.lu/_api/metabolites/119/?format=pcsv
5adtststerone,,,0,C19H30O2,CHEBI:16330,,"Human Metabolome Database (HMDB): Dihydrotestosterone is a potent androgenic metabolite of testosterone. Dihydrotestosterone (DHT) is generated by a 5-alpha reduction of testosterone. Unlike testosterone, DHT cannot be aromatized to estradiol therefore DHT is considered a pure androgenic steroid. -- Pubchem; Dihydrotestosterone (DHT) (INN: androstanolone) is a biologically active metabolite of the hormone testosterone, formed primarily in the prostate gland, testes, hair follicles, and adrenal glands by the enzyme 5-alpha-reductase by means of reducing the alpha 4,5 double-bond. Dihydrotestosterone belongs to the class of compounds called androgens, also commonly called androgenic hormones or testoids. DHT is thought to be approximately 30 times more potent than testosterone because of increased affinity to the androgen receptor. -- Wikipedia.",,17beta-hydroxy-5alpha-androstan-3-one,,HMDB02961,"InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1",C03917,2016-12-05T15:48:04Z,,120,,,,,10635,5adtststerone,,"17-Hydroxy-androstan-3-one, 17-Hydroxyandrostan-3-one, 17b-Hydroxy-3-androstanone, 17beta-hydroxy-5alpha-androstan-3-one, 17beta-Hydroxyandrostan-3-one, 4,5a-Dihydrotestosterone, 4-Dihydrotestosterone, 5-a-Androstanolone, 5-alpha-Androstanolone, 5a-Androstan-17b-ol-3-one, 5A-Androstan-3-on-17B-ol, 5a-Dihydrotestosterone, 5alpha-androstan-17beta-ol-3-one, 5alpha-Dihydrotestosterone, 5B-Androstan-3-on-17B-ol, Anaboleen, Anabolex, Andractim, Androlone, Androstalone, Androstanolone, Cristerona MB, DHT, Dihydrotestosterone, Drolban, Neodrol, Proteina, Protona, Stanaprol, Stanolone, Stanorone",http://vmh.uni.lu/_api/metabolites/120/?format=pcsv
5aop,,,0,C5H9NO3,CHEBI:17549,,"Human Metabolome Database (HMDB): 5-Aminolevulinic acid is an intermediate in heme synthesis. This is the first compound in the porphyrin synthesis pathway. It is produced by the enzyme ALA synthase, from glycine and succinyl CoA. This reaction is known as the Shemin pathway. Aminolevulinic acid plus blue light illumination using a blue light photodynamic therapy illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses of the face or scalp.",,5-Amino-4-oxopentanoate,,HMDB01149,"InChI=1S/C5H9NO3/c6-3-4(7)1-2-5(8)9/h1-3,6H2,(H,8,9)",C00430,2016-12-05T15:48:04Z,,121,,,,,137,5aop,,"5-Amino-4-oxo-Pentanoate, 5-Amino-4-oxo-Pentanoic acid, 5-Amino-4-oxopentanoate, 5-Amino-4-oxopentanoic acid, 5-Amino-4-oxovalerate, 5-Amino-4-oxovaleric acid, 5-Amino-Levulinate, 5-Amino-Levulinic acid, 5-Aminolaevulinate, 5-Aminolaevulinic acid, 5-Aminolevulinate, Aladerm, Amino-levulinic acid, Aminolevulinate, Aminolevulinic acid, delta-Aminolevulinate, delta-Aminolevulinic acid, Kerastick",http://vmh.uni.lu/_api/metabolites/121/?format=pcsv
5dhf,,,-6,C39H43N11O18,,,pentaglutamyl folate (DHF),,pentaglutamyl folate (DHF),,,"InChI=1/C39H47N11O18/c40-39-49-31-30(33(58)50-39)43-19(16-42-31)15-41-18-3-1-17(2-4-18)32(57)48-24(38(67)68)8-13-28(54)46-22(36(63)64)6-11-26(52)44-20(34(59)60)5-10-25(51)45-21(35(61)62)7-12-27(53)47-23(37(65)66)9-14-29(55)56/h1-4,16,20-24,41H,5-15H2,(H,44,52)(H,45,51)(H,46,54)(H,47,53)(H,48,57)(H,55,56)(H,59,60)(H,61,62)(H,63,64)(H,65,66)(H,67,68)(H3,40,42,49,50,58)/t20-,21-,22-,23-,24-/m0/s1",,2016-11-22T15:11:45Z,,122,,,,,73374,5dhf,,,http://vmh.uni.lu/_api/metabolites/122/?format=pcsv
5fthf,,,-2,C20H21N7O7,CHEBI:15640,,5-formyltetrahydrofolate(2-),,5-formyltetrahydrofolate(2-),,,"InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/p-2/t12-,13-/m0/s1",C03479,2016-11-22T15:11:45Z,,123,,,,,143,5fthf,,,http://vmh.uni.lu/_api/metabolites/123/?format=pcsv
5htrp,,,0,C11H12N2O3,CHEBI:17780,,"Human Metabolome Database (HMDB): 5-Hydroxy-L-tryptophan is an aromatic amino acid naturally produced by the body from the essential amino acid l-tryptophan. 5-Hydroxy-L-tryptophan is the immediate precursor of the neurotransmitter serotonin. The conversion to serotonin is catalyzed by the enzyme aromatic l-amino acid decarboxylase (EC 4.1.1.28, AADC1 also known as dopa decarboxylase), an essential enzyme in the metabolism of the monoamine neurotransmitters. An accumulation of 5-Hydroxy-L-tryptophan in cerebrospinal fluid occurs in Aromatic l-amino acid decarboxylase deficiency (OMIM 608643), accompanied by an increased excretion in the urine of the patients, which are indicative of the disorder but not specific 5-Hydroxy-L-tryptophan is also increased in other disorders such as in Parkinson's patients with severe postural instability and gait disorders. Confirmation of the diagnosis AADC deficiency is then required by enzyme activity measurement or genetic analysis. The amount of endogenous 5-Hydroxy-L-tryptophan available for serotonin synthesis depends on the availability of tryptophan and on the activity of various enzymes, especially tryptophan hydroxylase (EC 1.14.16.4), indoleamine 2,3-dioxygenase (EC 1.13.11.52), and tryptophan 2,3-dioxygenase. (EC 1.13.11.11, TDO). 5-Hydroxy-L-tryptophan has been used clinically for over 30 years. In addition to depression, the therapeutic administration of 5-Hydroxy-L-tryptophan has been shown to be effective in treating a wide variety of conditions, including fibromyalgia, insomnia, binge eating associated with obesity, cerebellar ataxia, and chronic headaches. 5-Hydroxy-L-tryptophan easily crosses the blood-brain barrier and effectively increases central nervous system (CNS) synthesis of serotonin. Supplementation with 5-Hydroxy-L-tryptophan is hypothesized to normalize serotonin synthesis, which is putatively related to its antidepressant properties. (PMID: 9295177, 17240182, 16023217).",,5-hydroxy-L-tryptophan,,HMDB00472,"InChI=1S/C11H12N2O3/c12-9(11(15)16)3-6-5-13-10-2-1-7(14)4-8(6)10/h1-2,4-5,9,13-14H,3,12H2,(H,15,16)/t9-/m0/s1",C01017,2016-12-05T15:48:04Z,,124,,,,,439280,5htrp,,"(+-)-5-Hydroxytryptophan, (S)-5-Hydroxytryptophan, 5-Hydroxy-L-Tryptophan, 5-Hydroxy-tryptophan, 5-Hydroxyl-L-tryptophan, 5-Hydroxytryptophan, 5-Hydroxytryptophan L form, 5-Hydroxytryptophan L-form, Cincofarm, Hydroxytryptophan, L-5-Hydroxytryptophan, Levothym, Levotinine, Oxitriptan, Oxyfan, Oxytryptophan, Pretonine, Quietim, Serotonyl, Telesol, Triptene",http://vmh.uni.lu/_api/metabolites/124/?format=pcsv
srtn,,,1,C10H13N2O,CHEBI:28790,,"Human Metabolome Database (HMDB): Serotonin is a biochemical messenger and regulator, synthesized from the essential amino acid L-Tryptophan. Serotonin in the nervous system acts as a local transmitter at synapses, and as a paracrine or hormonal modulator of circuits upon diffusion, allowing a wide variety of ""state-dependent"" behavioral responses to different stimuli. Serotonin is widely distributed in the nervous system of vertebrates and invertebrates and some of its behavioral effects have been preserved along evolution. Such is the case of aggressive behavior and rhythmic motor patterns , including those responsible for feeding. In vertebrates, which display a wider and much more sophisticated behavioral repertoire, serotonin also modulates sleep, the arousal state , sexual behavior, and others, and deficiencies of the serotonergic system causes disorders such as depression, obsessive-compulsive disorder, phobias, posttraumatic stress disorder, epilepsy, and generalized anxiety disorder. Serotonin has three different modes of action in the nervous system: as transmitter, acting locally at synaptic boutons; upon diffusion at a distance from its release sites, producing paracrine (also called volume) effects, and by circulating in the blood stream, producing hormonal effects. The three modes can affect a single neuronal circuit. (PMID: 16047543).",,serotonin(1+),,HMDB00259,"InChI=1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2/p+1",C00780,2016-12-05T15:48:04Z,,125,,,,,5202,srtn,,"3-(2-Aminoethyl)-1H-indol-5-ol, 3-(2-Aminoethyl)indol-5-ol, 3-(b-Aminoethyl)-5-hydroxyindole, 5-HT, 5-HTA, 5-Hydroxy-3-(b-aminoethyl)indole, 5-Hydroxy-tryptamine, 5-Hydroxyltryptamine, 5-Hydroxytriptamine, 5-Hydroxytryptamine, Antemovis, DS substance, Enteramin, Enteramine",http://vmh.uni.lu/_api/metabolites/125/?format=pcsv
5homeprazole,,,0,C17H19N3O4S,,,5 hydroxy omeprazole,,5 hydroxy omeprazole,,,,,2016-11-22T15:11:45Z,,126,,,,,,5homeprazole,,,http://vmh.uni.lu/_api/metabolites/126/?format=pcsv
5hoxindact,,,0,C10H9NO2,CHEBI:50157,,"Human Metabolome Database (HMDB): 5-Hydroxyindoleacetaldehyde is a biogenic aldehyde of serotonin derived from the action of monoamine oxidase (MAO). (PMIDs 11306106, 2470392).",,(5-hydroxyindol-3-yl)acetaldehyde,,HMDB04073,"InChI=1S/C10H9NO2/c12-4-3-7-6-11-10-2-1-8(13)5-9(7)10/h1-2,4-6,11,13H,3H2",C05634,2016-12-05T15:48:04Z,,127,,,,(5-hydroxyindol-3-yl)acetaldehyde,,5hoxindact,,"(5-hydroxy-1H-indol-3-yl)acetaldehyde, (5-hydroxyindol-3-yl)acetaldehyde, 5-Hial, 5-Hydroxy-1H-Indole-3-acetaldehyde, 5-Hydroxyindole-3-acetaldehyde, Hydroxyindoleacetaldehyde",http://vmh.uni.lu/_api/metabolites/127/?format=pcsv
5hoxindoa,,,-1,C10H8NO3,,,"Human Metabolome Database (HMDB): 5-hydroxyindoleacetic acid (5HIAA) is a breakdown product of serotonin that is excreted in the urine. Serotonin is a hormone found at high levels in many body tissues. Serotonin and 5HIAA are produced in excess amounts by carcinoid tumors, and levels of these substances may be measured in the urine to test for carcinoid tumors. (NCI).",,5-Hydroxyindoleacetate,,HMDB00763,"InChI=1S/C10H9NO3/c12-7-1-2-9-8(4-7)6(5-11-9)3-10(13)14/h1-2,4-5,11-12H,3H2,(H,13,14)/p-1",C05635,2016-12-05T15:48:04Z,,128,,,,,,5hoxindoa,,"5-HIAA, 5-Hydroxy-1H-indole-3-acetate, 5-Hydroxy-1H-indole-3-acetic acid, 5-Hydroxy-3-indolylacetate, 5-Hydroxy-IAA, 5-Hydroxy-Indole-3-acetate, 5-Hydroxy-Indole-3-acetic acid, 5-Hydroxyheteroauxin, 5-Hydroxyindol-3-ylacetate, 5-Hydroxyindol-3-ylacetic acid, 5-Hydroxyindole acetate, 5-Hydroxyindole-3-acetate, 5-Hydroxyindole-3-acetic acid, 5-Hydroxyindoleacetate, 5-Hydroxyindoleacetic acid, 5-Oxyindoleacetate, 5-Oxyindoleacetic acid, 5HIAA, Hydroxyindoleacetate",http://vmh.uni.lu/_api/metabolites/128/?format=pcsv
5hoxnfkyn,,,0,C11H12N2O5,,,5-hydroxy-N-formylkynurenine,,5-hydroxy-N-formylkynurenine,,,"InChI=1S/C11H12N2O5/c12-8(11(17)18)4-10(16)7-3-6(15)1-2-9(7)13-5-14/h1-3,5,8,15H,4,12H2,(H,13,14)(H,17,18)",C05648,2016-11-22T15:11:45Z,,129,,,,,440744,5hoxnfkyn,,,http://vmh.uni.lu/_api/metabolites/129/?format=pcsv
5hxkyn,,,0,C10H12N2O4,,,5-hydroxykynurenine,,5-hydroxykynurenine,,,"InChI=1S/C10H12N2O4/c11-7-2-1-5(13)3-6(7)9(14)4-8(12)10(15)16/h1-3,8,13H,4,11-12H2,(H,15,16)",C05651,2016-11-22T15:11:45Z,,130,,,,,440745,,,,http://vmh.uni.lu/_api/metabolites/130/?format=pcsv
5hxkynam,,,1,C9H13N2O2,CHEBI:28715,,5-Hydroxykynurenamine,,5-Hydroxykynurenamine,,,"InChI=1/C9H12N2O2/c10-4-3-9(13)7-5-6(12)1-2-8(7)11/h1-2,5,12H,3-4,10-11H2",C05638,2016-11-22T15:11:45Z,,131,,,,,164719,,,,http://vmh.uni.lu/_api/metabolites/131/?format=pcsv
46dhoxquin,,,0,C9H7NO2,CHEBI:28799,,"4,6-Dihydroxyquinoline",,"4,6-Dihydroxyquinoline",,,"InChI=1S/C9H7NO2/c11-6-1-2-8-7(5-6)9(12)3-4-10-8/h1-5,11H,(H,10,12)",C05639,2016-11-22T15:11:45Z,,132,,,,,,,,,http://vmh.uni.lu/_api/metabolites/132/?format=pcsv
5mthf,,,-1,C20H24N7O6,CHEBI:15641,,"Human Metabolome Database (HMDB): 5 methyltetrahydrofolic acid (5-MTHF) is the most biologically active form of the B-vitamin known as folic acid, also known generically as folate. 5-MTHF functions, in concert with vitamin B12, as a methyl-group donor involved in the conversion of the amino acid homocysteine to methionine. Methyl (CH3) group donation is vital to many bodily processes, including serotonin, melatonin, and DNA synthesis. Therapeutically, 5-MTHF is instrumental in reducing homocysteine levels, preventing neural tube defects, and improving vascular endothelial function. Research on folate supplementation suggests it plays a key role in preventing cervical dysplasia and protecting against neoplasia in ulcerative colitis. Folic acid also shows promise as part of a nutritional protocol to treat vitiligo, and may reduce inflammation of the gingiva. Furthermore, certain neurological, cognitive, and psychiatric presentations may be secondary to folate deficiency. Such presentations include depression, peripheral neuropathy, myelopathy, restless legs syndrome, insomnia, dementia, forgetfulness, irritability, endogenous depression, organic psychosis, and schizophrenia-like syndromes. After ingestion, the process of conversion of folic acid to the metabolically active coenzyme forms is relatively complex. Synthesis of the active forms of folic acid requires several enzymes, adequate liver and intestinal function, and adequate supplies of riboflavin (B2), niacin (B3), pyridoxine (B6), zinc, vitamin C, and serine. After formation of the coenzyme forms of the vitamin in the liver, these metabolically active compounds are secreted into the small intestine with bile (the folate enterohepatic cycle), where they are reabsorbed and distributed to tissues throughout the body. Human pharmacokinetic studies indicate folic acid has high bioavailability, with large oral doses of folic acid substantially raising plasma levels in healthy subjects in a time and dose dependent manner. Red blood cells (RBCs) appear to be the storage depot for folic acid, as RBC levels remain elevated for periods in excess of 40 days following discontinuation of supplementation. Folic acid is poorly transported to the brain and rapidly cleared from the central nervous system. The primary methods of elimination of absorbed folic acid are fecal (through bile) and urinary. Despite the biochemical complexity of this process, evidence suggests oral supplementation with folic acid increases the body's pool of 5-MTHF in healthy individuals. However, enzyme defects, mal-absorption, digestive system pathology, and liver disease can result in impaired ability to activate folic acid. In fact, some individuals have a severe congenital deficiency of the enzyme Methyl tetrahydrofolate reductase (5-MTHFR), which is needed to convert folic acid to 5-MTHF. Milder forms of this enzyme defect likely interact with dietary folate status to determine risk for some disease conditions. In individuals with a genetic defect of this enzyme (whether mild or severe), supplementation with 5- MTHF might be preferable to folic acid supplementation. (PMID: 17176169).",,5-Methyltetrahydrofolate,,HMDB01396,"InChI=1S/C20H25N7O6/c1-27-12(9-23-16-15(27)18(31)26-20(21)25-16)8-22-11-4-2-10(3-5-11)17(30)24-13(19(32)33)6-7-14(28)29/h2-5,12-13,22H,6-9H2,1H3,(H,24,30)(H,28,29)(H,32,33)(H4,21,23,25,26,31)/p-2/t12-,13-/m0/s1",C00440,2016-12-05T15:48:04Z,,133,,,,,439234,5mthf,,"5-Methyl tetrahydrofolate, 5-Methyl-5,6,7,8-tetrahydrofolate, 5-Methyl-tetrahydrofolate, 5-Methyltetrahydrofolate, 5-Methyltetrahydropteroylglutamate, Methyl folate, Methyl-tetrahydrofolate, N( 5)-Methyltetrahydrofolate, N-(4-(((2-Amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-Glutamate, N-(4-(((2-Amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-Glutamic acid, N-(5-Methyl-5,6,7,8-tetrahydropteroyl)-L-glutamate, N-(5-Methyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid, N5-Methyl-tetrahydrofolate, N5-Methyl-tetrahydrofolic acid, N5-methyltetrahydrofolate, N5-methyltetrahydropteroyl mono-L-glutamate, [(6S)-5-methyl-5,6,7,8-tetrahydropteroyl]glutamate",http://vmh.uni.lu/_api/metabolites/133/?format=pcsv
5thf,,,-6,C39H45N11O18,,,pentaglutamyl folate (THF),,pentaglutamyl folate (THF),,,,,2016-11-22T15:11:45Z,,134,,,,,,5thf,,,http://vmh.uni.lu/_api/metabolites/134/?format=pcsv
6dhf,,,-7,C44H49N12O21,,,hexaglutamyl folate (DHF),,hexaglutamyl folate (DHF),,,"InChI=1/C44H54N12O21/c45-21(36(66)67)5-10-26(57)43(15-30(61)62,27(58)11-6-22(46)37(68)69)44(28(59)12-7-23(47)38(70)71,41(76)77-31(63)14-9-25(49)40(74)75)56(29(60)13-8-24(48)39(72)73)35(65)18-1-3-19(4-2-18)51-16-20-17-52-33-32(53-20)34(64)55-42(50)54-33/h1-4,17,21-25,51H,5-16,45-49H2,(H,61,62)(H,66,67)(H,68,69)(H,70,71)(H,72,73)(H,74,75)(H3,50,52,54,55,64)/t21-,22-,23-,24-,25-,44+/m0/s1",,2016-11-22T15:11:45Z,,135,,,,,169691,6dhf,,,http://vmh.uni.lu/_api/metabolites/135/?format=pcsv
6htststerone,,,0,C19H28O3,CHEBI:34477,,"Human Metabolome Database (HMDB): Testosterone is reported to have an acute vasodilating action in vitro, an effect that may impart a favourable haemodynamic response in patients with chronic heart failure.",,6 beta hydroxy testosterone,,HMDB06259,"InChI=1/C19H28O3/c1-18-7-5-11(20)9-15(18)16(21)10-12-13-3-4-17(22)19(13,2)8-6-14(12)18/h9,12-14,16-17,21-22H,3-8,10H2,1-2H3/t12-,13-,14-,16+,17-,18+,19-/m0/s1",C14497,2016-12-05T15:48:04Z,,136,,,,,65543,6htststerone,,"6 beta Hydroxy testosterone, 6,17-Dihydroxy-(6b,17b)-Androst-4-en-3-one, 6,17-Dihydroxy-(6beta,17beta)-Androst-4-en-3-one, 6,17-Dihydroxyandrost-4-en-3-one (ACD/Name 4.0), 6beta,17beta-Dihydroxyandrost-4-en-3-one, 6beta-Hydroxytestosterone",http://vmh.uni.lu/_api/metabolites/136/?format=pcsv
6thf,,,-7,C44H51N12O21,,,hexaglutamyl folate  (THF),,hexaglutamyl folate  (THF),,,"InChI=1/C44H54N12O21/c45-21(36(66)67)5-10-26(57)43(15-30(61)62,27(58)11-6-22(46)37(68)69)44(28(59)12-7-23(47)38(70)71,41(76)77-31(63)14-9-25(49)40(74)75)56(29(60)13-8-24(48)39(72)73)35(65)18-1-3-19(4-2-18)51-16-20-17-52-33-32(53-20)34(64)55-42(50)54-33/h1-4,17,21-25,51H,5-16,45-49H2,(H,61,62)(H,66,67)(H,68,69)(H,70,71)(H,72,73)(H,74,75)(H3,50,52,54,55,64)/p-1/t21u,22u,23u,24u,25u,43u,44-/m1/s1",,2016-11-22T15:11:45Z,,137,,,,,169691,6thf,,,http://vmh.uni.lu/_api/metabolites/137/?format=pcsv
7dhchsterol,,,0,C27H44O,CHEBI:17759,,"Human Metabolome Database (HMDB): 7-Dehydrocholesterol is a zoosterol (a sterol produced by animals rather than plants). It is a provitamin-D. The presence of this compound in skin enables humans to manufacture vitamin D3 from ultra-violet rays in the sun light, via an intermediate isomer provitamin D3. It is also found in breast milk.",,"cholesta-5,7-dien-3beta-ol",,HMDB00032,"InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9-10,18-19,21,23-25,28H,6-8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1",C01164,2016-12-05T15:48:04Z,,138,,,,,,7dhchsterol,,"(-)-7-dehydrocholesterol, (3b)-Cholesta-5,7-dien-3-ol, (3beta)-Cholesta-5,7-dien-3-ol, 10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol, 17-(1,5-Dimethylhexyl)-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, 5,7-Cholestadien-3-beta-ol, 5,7-Cholestandien-3-ol, 5,7-Cholestandien-3beta-ol, 7,8-Dehydro-cholesterol, 7,8-Didehydrocholesterol, 7-Dehydro-cholesterol, 7-Dehydrocholesterin, 7-Dehydrocholesterol, 7DHC, Cholesta-5,7-dien-3 beta -ol, Cholesta-5,7-dien-3-beta-ol, Cholesta-5,7-dien-3-ol, Cholesta-5,7-dien-3b-ol, Cholesta-5,7-dien-3beta-ol, Dehydrocholesterin, Dehydrocholesterol, Delta5,7-Cholestadien-3beta-ol, Delta5,7-Cholesterol, Delta7-Cholesterol, Provitamin D3, Provitamin-D3",http://vmh.uni.lu/_api/metabolites/138/?format=pcsv
7dhf,,,-8,C49H55N13O24,,,"Human Metabolome Database (HMDB): Heptaglutamyl folic acid is a naturally occurring form of folate. In contrast to synthetic folic acid, natural food folates are predominantly polyglutamates with a variable number of glutamate residues. (PMID 15831124). Approximately two-thirds of total folate intake from a mixed unfortified diet is in the polyglutamyl form, derived mainly from vegetables. These polyglutamates need to be hydrolysed to the monoglutamate form for normal absorption in the proximal small intestine. This process is controlled by the intestinal brush-border enzyme glutamate carboxypeptidase II (GCPII). (PMID 12042451).",,heptaglutamyl folate (DHF),,HMDB06559,"InChI=1/C54H68N14O27/c55-24(5-12-31(69)70)39(83)52(49(92)93,40(84)25(56)6-13-32(71)72)53(41(85)26(57)7-14-33(73)74,42(86)27(58)8-15-34(75)76)54(43(87)28(59)9-16-35(77)78,50(94)95-48(91)30(61)11-18-37(81)82)68(47(90)29(60)10-17-36(79)80)46(89)21-1-3-22(4-2-21)63-19-23-20-64-44-38(65-23)45(88)67-51(62)66-44/h1-4,20,24-30,63H,5-19,55-61H2,(H,69,70)(H,71,72)(H,73,74)(H,75,76)(H,77,78)(H,79,80)(H,81,82)(H,92,93)(H3,62,64,66,67,88)/t24-,25-,26-,27-,28-,29-,30-,54?/m0/s1",,2016-12-05T15:48:04Z,,139,,,,,,7dhf,,,http://vmh.uni.lu/_api/metabolites/139/?format=pcsv
7thf,,,-8,C49H57N13O24,,,heptaglutamyl folate (THF),,heptaglutamyl folate (THF),,,,,2016-11-22T15:11:45Z,,140,,,,,,7thf,,,http://vmh.uni.lu/_api/metabolites/140/?format=pcsv
m2mn,,,0,C26H45NO21,,,Human Metabolome Database (HMDB): (alpha-D-mannosyl)2-beta-D-mannosyl-N-acetylglucosamine is an intermediate in aminosugars metabolism. It is substrate of Lysosomal alpha-mannosidase.,,(alpha-D-mannosyl)2-beta-D-mannosyl-N-acetylglucosamine,,HMDB06537,"InChI=1/C26H45NO21/c1-6(32)27-11-15(36)20(10(5-31)42-23(11)41)46-25-18(39)22(14(35)8(3-29)44-25)48-26-19(40)21(13(34)9(4-30)45-26)47-24-17(38)16(37)12(33)7(2-28)43-24/h7-26,28-31,33-41H,2-5H2,1H3,(H,27,32)/t7-,8-,9-,10+,11+,12-,13-,14-,15+,16+,17+,18+,19+,20+,21+,22+,23+,24-,25+,26+/m0/s1",,2016-12-05T15:48:04Z,,141,,,,,53477854,m2mn,,"(alpha-D-mannosyl)2-beta-D-mannosyl-N-acetylglucosamine, (alpha-delta-mannosyl)2-beta-delta-mannosyl-N-acetylglucosamine, Not Available",http://vmh.uni.lu/_api/metabolites/141/?format=pcsv
man,,,0,C6H12O6,CHEBI:4208,,"Human Metabolome Database (HMDB): D-Mannose is a carbohydrate. High-mannose-type oligosaccharides have been shown to play important roles in protein quality control. Several intracellular proteins, such as lectins, chaperones and glycan-processing enzymes, are involved in this process. These include calnexin/calreticulin, UDP-glucose:glycoprotein glucosyltransferase (UGGT), cargo receptors (such as VIP36 and ERGIC-53), mannosidase-like proteins (e.g. EDEM and Htm1p) and ubiquitin ligase (Fbs). They are thought to recognize high-mannose-type glycans with subtly different structures. Mannose-binding lectin (MBL) is an important constituent of the innate immune system. This protein binds through multiple lectin domains to the repeating sugar arrays that decorate many microbial surfaces, and is then able to activate the complement system through a specific protease called MBL-associated protease-2. The primary pathway for the formation of L-fucose in procaryotic and eucaryotic cells is from D-mannose via an internal oxidation reduction and then epimerization of GDP-D-mannose to produce GDP-L-fucose. (PMID: 9488699, 16154739, 11414367).",,D-Mannose,,HMDB00169,,C00159,2016-12-05T15:48:04Z,,142,,,,D-mannose,18950,man,,"(+)-mannose, (+-)-mannose, Carubinose, D(+)-Mannose, D-Mannopyranose, D-Mannose, DL-mannose, Mannose, Seminose",http://vmh.uni.lu/_api/metabolites/142/?format=pcsv
mn,,,0,C14H25NO11,,,"Human Metabolome Database (HMDB): beta-1,4-mannose-N-acetylglucosamine is an intermediate in aminosugars metabolism. It is substrate of Lysosomal alpha-mannosidase.",,"beta-1,4-mannose-N-acetylglucosamine",,HMDB06535,"InChI=1/C14H25NO11/c1-4(18)15-7-9(20)12(6(3-17)24-13(7)23)26-14-11(22)10(21)8(19)5(2-16)25-14/h5-14,16-17,19-23H,2-3H2,1H3,(H,15,18)/t5-,6-,7-,8-,9-,10+,11+,12-,13-,14-/m1/s1",,2016-12-05T15:48:04Z,,143,,,,,53477853,mn,,"beta-1,4-Mannose-N-acetylglucosamine, Not Available",http://vmh.uni.lu/_api/metabolites/143/?format=pcsv
galgluside_hs,,,0,C30H56NO12FULLRCO,,,galactosyl glucosyl ceramide,,galactosyl glucosyl ceramide,,,,,2016-11-22T15:11:45Z,,144,,,,,,galgluside_hs,,,http://vmh.uni.lu/_api/metabolites/144/?format=pcsv
udpgal,,,-2,C15H22N2O17P2,CHEBI:18307,,"Human Metabolome Database (HMDB): Uridine diphosphategalactose (UDPgal) is a nucleoside diphosphate sugar which can be epimerized into UDPglucose for entry into the mainstream of carbohydrate metabolism. UDPgal is a pivotal compound in the metabolism of galactose. UDPgal is a product of the galactose-l-phosphate uridyl transferase (EC 2.7.7.10) reaction but may also be made from Glucose-l-P, involving uridine diphosphate galactose-4-epimerase (EC 5.1.3.2). UDPgal is the necessary galactosyl donor of galactose in the metabolism to incorporate it into complex oligosaccharides, glycoproteins and glycolipids (galactosides). Defective galactosylation of complex glycoconjugates exists in tissues from galactosemic patients. There is a tendency for galactosemic red cell UDPgal to be in the low normal range with a high uridine diphosphate glucose to UDP-gal ratio. This may reflect an inability of red cell UDPgal-4'-epimerase to maintain a normal ratio and consequently higher levels of UDPgal. In the more complex white blood cells and cultured fibroblasts, the UDPgal content and the uridine diphosphate glucose to UDPgal ratio of galactosemics are normal. Therefore, defective galactosylation observed in galactosemic fibroblasts must result from a defect in the transfer of galactose from UDPgal to these moieties. (PMID: 2122114, 7671968).",,UDP-D-galactose(2-),,HMDB00302,"InChI=1S/C15H24N2O17P2/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25)/p-2/t5-,6-,8+,9-,10+,11-,12-,13-,14?/m1/s1",C00052,2016-12-05T15:48:04Z,,145,,,,,6857410,udpgal,,"GDU, UDP Galactose, UDP-a-D-Galactose, UDP-alpha-D-Galactose, UDP-alpha-delta-Galactose, UDP-D-Galactopyranose, UDP-D-Galactose, UDP-delta-Galactopyranose, UDP-delta-Galactose, UDP-Gal, UDP-Galactopyranose, UDP-Galactose, Udpgal, UDPgalactose, UPG, Uridine 5'-(alpha-D-galactopyranosyl pyrophosphate), Uridine 5'-(alpha-delta-galactopyranosyl pyrophosphate), Uridine 5'-diphosphate galactose, Uridine 5'-diphosphogalactose, Uridine 5'-pyrophosphate a-D-galactopyranosyl ester, Uridine 5'-pyrophosphate a-D-galactosyl ester, Uridine 5'-pyrophosphate a-delta-galactopyranosyl ester, Uridine 5'-pyrophosphate a-delta-galactosyl ester, Uridine 5'-pyrophosphate alpha-D-galactosyl ester, Uridine 5'-pyrophosphate alpha-delta-galactosyl ester, Uridine 5'-pyrophosphate D-galactosyl ester, Uridine 5'-[3-(D-galactopyranosyl) dihydrogen diphosphate], Uridine diphosphate galactose, Uridine diphosphate-D-galactose, Uridine diphosphate-delta-galactose, Uridine diphosphate-galactose, Uridine diphosphogalactose, Uridine pyrophosphate a-D-galactopyranosyl ester, Uridine pyrophosphate a-delta-galactopyranosyl ester, Uridine pyrophosphate alpha-D-galactopyranosyl ester, Uridine pyrophosphate alpha-delta-galactopyranosyl ester, Uridine pyrophosphogalactose, Uridinediphosphate galactose, Uridinediphosphogalactose",http://vmh.uni.lu/_api/metabolites/145/?format=pcsv
thcrm_hs,,,0,C36H66NO17FULLRCO,CHEBI:18313,,trihexosyl ceramide,,trihexosyl ceramide,,,,,2016-11-22T15:11:45Z,,146,,,,,,thcrm_hs,,,http://vmh.uni.lu/_api/metabolites/146/?format=pcsv
udp,,,-3,C9H11N2O12P2,CHEBI:17659,,"Human Metabolome Database (HMDB): Uridine 5'-diphosphate is a uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. UDP is an important extracellular pyrimidine signaling molecule that mediates diverse biological effects via P1 and P2 purinergic receptors, such as the uptake of thymidine and proliferation of gliomas. (PMID: 14558596). UDP induces intracellular Ca(2+) responses and oscillations in HeLa cells, due to the activation of P2Ys (G-protein coupled ATP receptors). (PMID: 1257952).",,UDP,,HMDB00295,"InChI=1S/C9H14N2O12P2/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,10,12,15)(H2,16,17,18)/p-3/t4-,6-,7-,8-/m1/s1",C00015,2016-12-05T15:48:04Z,,147,,,,UDP,6031,udp,,"5'-UDP, UDP, Uridine 5'-diphosphate, Uridine 5'-pyrophosphate, Uridine 5'-pyrophosphorate, Uridine 5'-pyrophosphoric acid, Uridine diphosphate, Uridine pyrophosphate",http://vmh.uni.lu/_api/metabolites/147/?format=pcsv
T_antigen,,,0,C14H24NO10X,CHEBI:16117,,T antigen (core 1),,T antigen (core 1),,,,,2016-11-22T15:11:45Z,,148,,,,,,T_antigen,,,http://vmh.uni.lu/_api/metabolites/148/?format=pcsv
uacgam,,,-2,C17H25N3O17P2,CHEBI:16264,,UDP-N-acetyl-alpha-D-glucosamine(2-),,UDP-N-acetyl-alpha-D-glucosamine(2-),,,"InChI=1S/C17H27N3O17P2/c1-6(22)18-10-13(26)11(24)7(4-21)35-16(10)36-39(31,32)37-38(29,30)33-5-8-12(25)14(27)15(34-8)20-3-2-9(23)19-17(20)28/h2-3,7-8,10-16,21,24-27H,4-5H2,1H3,(H,18,22)(H,29,30)(H,31,32)(H,19,23,28)/p-2/t7-,8-,10-,11-,12-,13-,14-,15-,16-/m1/s1",C00043,2016-11-22T15:11:45Z,,149,,,,,445675,uacgam,,,http://vmh.uni.lu/_api/metabolites/149/?format=pcsv
gncore1,,,0,C22H37N2O15X,,,"GlcNAc-alpha-1,4-Core 1",,"GlcNAc-alpha-1,4-Core 1",,,,,2016-11-22T15:11:45Z,,150,,,,,,gncore1,,,http://vmh.uni.lu/_api/metabolites/150/?format=pcsv
core2,,,0,C22H37N2O15X,CHEBI:15876,,Core 2,,Core 2,,,,,2016-11-22T15:11:45Z,,151,,,,,,core2,,,http://vmh.uni.lu/_api/metabolites/151/?format=pcsv
gncore2,,,0,C30H50N3O20X,,,"GlcNAc-alpha-1,4-Core 2",,"GlcNAc-alpha-1,4-Core 2",,,,,2016-11-22T15:11:45Z,,152,,,,,,gncore2,,,http://vmh.uni.lu/_api/metabolites/152/?format=pcsv
acac,,,-1,C4H5O3,CHEBI:13705,,"Human Metabolome Database (HMDB): It is a weak organic acid and can be produced in the human liver under certain conditions of poor metabolism leading to excessive fatty acid breakdown (diabetes mellitus leading to diabetic ketoacidosis), it is then partially converted to acetone by decarboxylation and excreted either in urine or through respiration. Persistent mild hyperketonemia is a common finding in newborns. These compounds serve as an indispensable source of energy for extrahepatic tissues, especially the brain and lung of developing rats. Another important function of ketone bodies is to provide acetoacetyl-CoA and acetyl-CoA for synthesis of cholesterol, fatty acids, and complex lipids. During the early postnatal period, acetoacetate (AcAc) and beta-hydroxybutyrate are preferred over glucose as substrates for synthesis of phospholipids and sphingolipids in accord with requirements for brain growth and myelination. Thus, during the first 2 wk of postnatal development, when the accumulation of cholesterol and phospholipids accelerates, the proportion of ketone bodies incorporated into these lipids increases. On the other hand, an increased proportion of ketone bodies are utilized for cerebroside synthesis during the period of active myelination. In the lung, AcAc serves better than glucose as a precursor for the synthesis of lung phospholipids. The synthesized lipids, particularly dipalmityl phosphatidylcholine, are incorporated into surfactant, and thus have a potential role in supplying adequate surfactant lipids to maintain lung function during the early days of life. (PMID 3884391) The acid is also present in the metabolism of those undergoing starvation or prolonged physical exertion as part of gluconeogenesis. When ketone bodies are measured by way of urine concentration, acetoacetic acid, along with beta-hydroxybutyric acid or acetone, is what is detected.",,acetoacetate,,HMDB00060,"InChI=1S/C4H6O3/c1-3(5)2-4(6)7/h2H2,1H3,(H,6,7)/p-1",C00164,2016-12-05T15:48:04Z,,153,,,,,96,acac,,"3-Ketobutyrate, 3-Ketobutyric acid, 3-Oxo-butanoate, 3-Oxo-butanoic acid, 3-Oxobutyrate, 3-Oxobutyric acid, Acetoacetate, Diacetate, Diacetic acid",http://vmh.uni.lu/_api/metabolites/153/?format=pcsv
aacoa,,,-4,C25H36N7O18P3S,CHEBI:15345,,Acetoacetyl-CoA,,Acetoacetyl-CoA,,,"InChI=1S/C25H40N7O18P3S/c1-13(33)8-16(35)54-7-6-27-15(34)4-5-28-23(38)20(37)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-19(49-51(39,40)41)18(36)24(48-14)32-12-31-17-21(26)29-11-30-22(17)32/h11-12,14,18-20,24,36-37H,4-10H2,1-3H3,(H,27,34)(H,28,38)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/p-4/t14-,18-,19-,20+,24-/m1/s1",C00332,2016-11-22T15:11:45Z,,154,,,,acetoacetyl-CoA,439214,aacoa,,,http://vmh.uni.lu/_api/metabolites/154/?format=pcsv
amp,,,-2,C10H12N5O7P,CHEBI:16027,,"Human Metabolome Database (HMDB): Adenosine monophosphate, also known as 5'-adenylic acid and abbreviated AMP, is a nucleotide that is found in RNA. It is an ester of phosphoric acid with the nucleoside adenosine. AMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase adenine. AMP can be produced during ATP synthesis by the enzyme adenylate kinase. AMP has recently been approved as a 'Bitter Blocker' additive to foodstuffs. When AMP is added to bitter foods or foods with a bitter aftertaste it makes them seem 'sweeter'. This potentially makes lower calorie food products more palatable.",,AMP,,HMDB00045,"InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/p-2/t4-,6-,7-,10-/m1/s1",C00020,2016-12-05T15:48:04Z,,155,,,,AMP,6083,amp,,"5'-Adenosine monophosphate, 5'-Adenylate, 5'-Adenylic acid, 5'-AMP, Adenosine 5'-monophosphate, Adenosine 5'-phosphate, Adenosine 5'-phosphorate, Adenosine 5'-phosphoric acid, Adenosine phosphate, Adenosine-5'-monophosphorate, Adenosine-5'-monophosphoric acid, Adenosine-5-monophosphorate, Adenosine-5-monophosphoric acid, Adenosine-monophosphate, Adenosine-phosphate, Adenovite, Adenylate, Adenylic acid, AMP, Cardiomone, Lycedan, Muscle adenylate, Muscle adenylic acid, My-B-Den, My-beta-Den, Phosaden, Phosphaden, Phosphentaside",http://vmh.uni.lu/_api/metabolites/155/?format=pcsv
ppi,,,-3,HO7P2,CHEBI:18361,,"Human Metabolome Database (HMDB): In chemistry, the anion, the salts, and the esters of pyrophosphoric acid are called pyrophosphates. The anion is abbreviated PPi and is formed by the hydrolysis of ATP into AMP in cells. This hydrolysis is called pyrophosphorolysis. The pyrophosphate anion has the structure P2O74-, and is an acid anhydride of phosphate. It is unstable in aqueous solution and rapidly hydrolyzes into inorganic phosphate.",,Diphosphate,,HMDB00250,"InChI=1S/H4O7P2/c1-8(2,3)7-9(4,5)6/h(H2,1,2,3)(H2,4,5,6)/p-3",C00013,2016-12-05T15:48:04Z,,156,,,,,1023,ppi,,"(4-)Diphosphoric acid ion, (P2O74-)Diphosphate, Diphosphate, Diphosphoric acid, PPi, Pyrometaphosphate, Pyrophosphate, Pyrophosphate tetraanion, Pyrophosphate(4-) ion",http://vmh.uni.lu/_api/metabolites/156/?format=pcsv
aact,,,1,C3H8NO,,,ammonioacetone,,ammonioacetone,,,"InChI=1S/C3H7NO/c1-3(5)2-4/h2,4H2,1H3/p+1",C01888,2016-11-22T15:11:45Z,,157,,,,,215,aact,,,http://vmh.uni.lu/_api/metabolites/157/?format=pcsv
mthgxl,,,0,C3H4O2,CHEBI:17158,,methylglyoxal,,methylglyoxal,,,"InChI=1S/C3H4O2/c1-3(5)2-4/h2H,1H3",C00546,2016-11-22T15:11:45Z,,158,,,,,880,mthgxl,,,http://vmh.uni.lu/_api/metabolites/158/?format=pcsv
L2aadp6sa,,,0,C6H11NO3,CHEBI:17917,,"Human Metabolome Database (HMDB): Allysine is a derivative of Lysine, used in the production of elastin and collagen. It is produced by the actions of the enzyme lysyl oxidase in the extracellular matrix and is essential in the crosslink formation that stabilizes collagen and elastin.",,L-allysine,,HMDB01263,"InChI=1S/C6H11NO3/c7-5(6(9)10)3-1-2-4-8/h4-5H,1-3,7H2,(H,9,10)/t5-/m0/s1",C04076,2016-12-05T15:48:04Z,,159,,,,,207,L2aadp6sa,,"(2S)-2-amino-6-oxohexanoate, (2S)-2-amino-6-oxohexanoic acid, 2-Amino-5-formylvalerate, 2-Amino-5-formylvaleric acid, 2-Amino-hexanedioate, 2-Amino-hexanedioic acid, 2-Amino-hexanedioic acid semialdhyde, 2-Aminoadipate 6-semialdehyde, 2-Aminoadipate semialdehyde, 2-Aminoadipate-6-semialdehyde, 5-Formyl-Norvaline, 6-Oxo-L-norleucine, 6-Oxo-Norleucine, Allysine, alpha-Aminoadipic acid delta-semialdehyde, alpha-Aminoadipic delta-semialdehyde, alpha-Aminoadipic semialdehyde, L-2-Aminoadipate 6-semialdehyde, L-6-Oxonorleucine, L-Allysine",http://vmh.uni.lu/_api/metabolites/159/?format=pcsv
fucgalacglcgalgluside_hs,,,0,C50H89N2O26FULLRCO,,,Type IH glycolipid,,Type IH glycolipid,,,,,2016-11-22T15:11:45Z,,160,,,,,,fucgalacglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/160/?format=pcsv
udpacgal,,,-2,C17H25N3O17P2,CHEBI:16650,,UDP-N-acetyl-D-galactosamine(2-),,UDP-N-acetyl-D-galactosamine(2-),,,"InChI=1S/C17H27N3O17P2/c1-6(22)18-10-13(26)11(24)7(4-21)35-16(10)36-39(31,32)37-38(29,30)33-5-8-12(25)14(27)15(34-8)20-3-2-9(23)19-17(20)28/h2-3,7-8,10-16,21,24-27H,4-5H2,1H3,(H,18,22)(H,29,30)(H,31,32)(H,19,23,28)/p-2/t7-,8-,10-,11+,12-,13-,14-,15-,16?/m1/s1",C00203,2016-11-22T15:11:45Z,,161,,,,,6419712,udpacgal,,,http://vmh.uni.lu/_api/metabolites/161/?format=pcsv
acgalfucgalacglcgalgluside_hs,,,0,C58H102N3O31FULLRCO,,,Type IA glycolipid,,Type IA glycolipid,,,,,2016-11-22T15:11:45Z,,162,,,,,,acgalfucgalacglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/162/?format=pcsv
galfucgalacglcgalgluside_hs,,,0,C56H99N2O31FULLRCO,,,Type IB glycolipid,,Type IB glycolipid,,,,,2016-11-22T15:11:45Z,,163,,,,,,galfucgalacglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/163/?format=pcsv
fuc12gal14acglcgalgluside_hs,,,0,C50H89N2O26FULLRCO,,,Type IIH glycolipid,,Type IIH glycolipid,,,,,2016-11-22T15:11:45Z,,164,,,,,,fuc12gal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/164/?format=pcsv
galfuc12gal14acglcgalgluside_hs,,,0,C56H99N2O31FULLRCO,,,(Gal)3 (Glc)1 (GlcNAc)1 (LFuc)1 (Cer)1,,(Gal)3 (Glc)1 (GlcNAc)1 (LFuc)1 (Cer)1,,,,,2016-11-22T15:11:45Z,,165,,,,,,galfuc12gal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/165/?format=pcsv
acgalfuc12gal14acglcgalgluside_hs,,,0,C58H102N3O31FULLRCO,,,(Gal)2 (GalNAc)1 (Glc)1 (GlcNAc)1 (LFuc)1 (Cer)1,,(Gal)2 (GalNAc)1 (Glc)1 (GlcNAc)1 (LFuc)1 (Cer)1,,,,,2016-11-22T15:11:45Z,,166,,,,,,acgalfuc12gal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/166/?format=pcsv
fucgalacgalfuc12gal14acglcgalgluside_hs,,,0,C70H122N3O40FULLRCO,,,Type IIIH glycolipid,,Type IIIH glycolipid,,,,,2016-11-22T15:11:45Z,,167,,,,,,fucgalacgalfuc12gal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/167/?format=pcsv
acgalfucgalacgalfuc12gal14acglcgalgluside_hs,,,0,C78H135N4O45FULLRCO,,,Type IIIA glycolipid,,Type IIIA glycolipid,,,,,2016-11-22T15:11:45Z,,168,,,,,,acgalfucgalacgalfuc12gal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/168/?format=pcsv
fucgalacglcgal14acglcgalgluside_hs,,,0,C64H112N3O36FULLRCO,,,VI2Fuc-nLc6,,VI2Fuc-nLc6,,,,,2016-11-22T15:11:45Z,,169,,,,,,fucgalacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/169/?format=pcsv
acgalfucgalacglcgal14acglcgalgluside_hs,,,0,C72H125N4O41FULLRCO,,,(Gal)3 (GalNAc)1 (Glc)1 (GlcNAc)2 (LFuc)1 (Cer)1,,(Gal)3 (GalNAc)1 (Glc)1 (GlcNAc)2 (LFuc)1 (Cer)1,,,,,2016-11-22T15:11:45Z,,170,,,,,,acgalfucgalacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/170/?format=pcsv
fucgalacgalfucgalacglcgal14acglcgalgluside_hs,,,0,C84H145N4O50FULLRCO,,,(Gal)4 (GalNAc)1 (Glc)1 (GlcNAc)2 (LFuc)2 (Cer)1,,(Gal)4 (GalNAc)1 (Glc)1 (GlcNAc)2 (LFuc)2 (Cer)1,,,,,2016-11-22T15:11:45Z,,171,,,,,,fucgalacgalfucgalacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/171/?format=pcsv
acgalfucgalacgalfucgalacglcgal14acglcgalgluside_hs,,,0,C92H158N5O55FULLRCO,,,Type IIIAb,,Type IIIAb,,,,,2016-11-22T15:11:45Z,,172,,,,,,acgalfucgalacgalfucgalacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/172/?format=pcsv
galfucgalacglcgal14acglcgalgluside_hs,,,0,C70H122N3O41FULLRCO,,,(Gal)4 (Glc)1 (GlcNAc)2 (LFuc)1 (Cer)1,,(Gal)4 (Glc)1 (GlcNAc)2 (LFuc)1 (Cer)1,,,,,2016-11-22T15:11:45Z,,173,,,,,,galfucgalacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/173/?format=pcsv
fucfucgalacglcgalacglcgal14acglcgalgluside_hs,,,0,C84H145N4O50FULLRCO,,,(Gal)4 (Glc)1 (GlcNAc)3 (LFuc)2 (Cer)1,,(Gal)4 (Glc)1 (GlcNAc)3 (LFuc)2 (Cer)1,,,,,2016-11-22T15:11:45Z,,174,,,,,,fucfucgalacglcgalacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/174/?format=pcsv
galgalfucfucgalacglcgalacglcgal14acglcgalgluside_hs,,,0,C96H165N4O60FULLRCO,,,(Gal)6 (Glc)1 (GlcNAc)3 (LFuc)2 (Cer)1,,(Gal)6 (Glc)1 (GlcNAc)3 (LFuc)2 (Cer)1,,,,,2016-11-22T15:11:45Z,,175,,,,,,galgalfucfucgalacglcgalacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/175/?format=pcsv
sucsal,,,-1,C4H5O3,CHEBI:16265,,"Human Metabolome Database (HMDB): Succinic acid semialdehyde is an intermediate in the catabolism of gamma-aminobutyrate (PMID 16435183). Succinate semialdehyde dehydrogenase is an enzyme that catalyses the reaction of succinate semialdehyde and NAD+ to form succinate and NADH. Succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria) is a rare neurometabolic disorder of gamma-aminobutyric acid degradation. Symptoms include motor delay, hypotonia, speech delay, autistic features, seizures, and ataxia. Patients also exhibit behavioral problems, such as attention deficit, hyperactivity, anxiety, or aggression. (PMID: 18622364).",,Succinic semialdehyde,,HMDB01259,"InChI=1S/C4H6O3/c5-3-1-2-4(6)7/h3H,1-2H2,(H,6,7)/p-1",C00232,2016-12-05T15:48:04Z,,176,,,,succinic semialdehyde,1112,sucsal,,"2-Formylpropionic acid ethyl ester, 3-Formylpropanoate, 3-Formylpropanoic acid, 4-Oxobutanoate, 4-Oxobutanoic acid, beta-Formylpropionate, beta-Formylpropionic acid, Butryaldehydate, Butryaldehydic acid, gamma-Oxybutyrate, gamma-Oxybutyric acid, Succinaldehydate, Succinate semialdehyde, Succinic acid semialdehyde, Succinic semialdehyde",http://vmh.uni.lu/_api/metabolites/176/?format=pcsv
abt,,,0,C5H12O5,CHEBI:18403,,"Human Metabolome Database (HMDB): L-Arabitol has been reported in pentosuric acidemia (PMID 13525419). L-Arabinosinuia has been described in a patient, presented at the age of 16 months with delayed motor development and facial dysmorphism. (PMID 12359133) Congenital liver cirrhosis has been recently described in a patient with highly elevated plasma and urine levels of arabitol due to transaldolase deficiency. (Inherit Metab Dis 23(Suppl. 1):172, 2000.).",,L-arabinitol,,HMDB01851,"InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4-/m0/s1",C00532,2016-12-05T15:48:04Z,,177,,,,,439255,abt,," L(-)-Arabitol, 1,2,3,4,5-Pentahydroxypentane, Adonite Adonitol, Arabinitol, L-(+)-Arabitol, L-(-)-Arabinitol, L-(-)-Arabitol, L-Arabinitol, L-Arabinol",http://vmh.uni.lu/_api/metabolites/177/?format=pcsv
xylu_L,,,0,C5H10O5,CHEBI:17399,,"Human Metabolome Database (HMDB): L-Threo-2-pentulose, or L-xylulose, is a ketopentose, a monosaccharide containing five carbon atoms, and including a ketone functional group. It has chemical formula C5H10O5. L-Xylulose accumulates in the urine of pentosuria patients. Since L-xylulose is a reducing sugar like D-glucose, pentosuria patients have been wrongly diagnosed in the past to be diabetic.",,L-xylulose,,HMDB00751,"InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h3,5-8,10H,1-2H2/t3-,5+/m0/s1",C00312,2016-12-05T15:48:04Z,,178,,,,,22253,xylu_L,,L-Xylulose,http://vmh.uni.lu/_api/metabolites/178/?format=pcsv
4abutn,,,1,C4H10NO,CHEBI:17769,,Human Metabolome Database (HMDB): 4-Aminobutyraldehyde is a metabolite of putrescine. It is a substrate of human liver aldehyde dehydrogenase (EC 1.2.1.3) cytoplasmic (E1) and mitochondrial (E2) isozymes (PMID 3324802).,,4-Aminobutanal,,HMDB01080,"InChI=1S/C4H9NO/c5-3-1-2-4-6/h4H,1-3,5H2/p+1",C00555,2016-12-05T15:48:04Z,,179,,,,,118,4abutn,,"4-Amino-butanal, 4-Amino-butyraldehyde, 4-Aminobutanal, 4-Aminobutyraldehyde, gamma-Aminobutyraldehyde",http://vmh.uni.lu/_api/metabolites/179/?format=pcsv
2maacoa,,,-4,C26H38N7O18P3S,CHEBI:15476,,2-methylacetoacetyl-CoA(4-),,2-methylacetoacetyl-CoA(4-),,,"InChI=1S/C26H42N7O18P3S/c1-13(14(2)34)25(39)55-8-7-28-16(35)5-6-29-23(38)20(37)26(3,4)10-48-54(45,46)51-53(43,44)47-9-15-19(50-52(40,41)42)18(36)24(49-15)33-12-32-17-21(27)30-11-31-22(17)33/h11-13,15,18-20,24,36-37H,5-10H2,1-4H3,(H,28,35)(H,29,38)(H,43,44)(H,45,46)(H2,27,30,31)(H2,40,41,42)/p-4/t13?,15-,18-,19-,20+,24-/m1/s1",C03344,2016-11-22T15:11:45Z,,180,,,,,,2maacoa,,,http://vmh.uni.lu/_api/metabolites/180/?format=pcsv
ppcoa,,,-4,C24H36N7O17P3S,CHEBI:15539,,"Human Metabolome Database (HMDB): Propionyl-CoA is an intermediate in the metabolism of propanoate. Propionic aciduria is caused by an autosomal recessive disorder of propionyl coenzyme A (CoA) carboxylase deficiency (EC 6.4.1.3). In propionic aciduria, propionyl CoA accumulates within the mitochondria in massive quantities; free carnitine is then esterified, creating propionyl carnitine, which is then excreted in the urine. Because the supply of carnitine in the diet and from synthesis is limited, such patients readily develop carnitine deficiency as a result of the increased loss of acylcarnitine derivatives. This condition demands supplementation of free carnitine above the normal dietary intake to continue to remove (detoxify) the accumulating organic acids. Propionyl-CoA is a substrate for Acyl-CoA dehydrogenase (medium-chain specific, mitochondrial), Acetyl-coenzyme A synthetase 2-like (mitochondrial), Propionyl-CoA carboxylase alpha chain (mitochondrial), Methylmalonate-semialdehyde dehydrogenase (mitochondrial), Trifunctional enzyme beta subunit (mitochondrial), 3-ketoacyl-CoA thiolase (peroxisomal), Acyl-CoA dehydrogenase (long-chain specific, mitochondrial), Malonyl-CoA decarboxylase (mitochondrial), Acetyl-coenzyme A synthetase (cytoplasmic), 3-ketoacyl-CoA thiolase (mitochondrial) and Propionyl-CoA carboxylase beta chain (mitochondrial). (PMID: 10650319).",,Propanoyl-CoA,,HMDB01275,"InChI=1S/C24H40N7O17P3S/c1-4-15(33)52-8-7-26-14(32)5-6-27-22(36)19(35)24(2,3)10-45-51(42,43)48-50(40,41)44-9-13-18(47-49(37,38)39)17(34)23(46-13)31-12-30-16-20(25)28-11-29-21(16)31/h11-13,17-19,23,34-35H,4-10H2,1-3H3,(H,26,32)(H,27,36)(H,40,41)(H,42,43)(H2,25,28,29)(H2,37,38,39)/p-4/t13-,17-,18-,19+,23-/m1/s1",C00100,2016-12-05T15:48:04Z,,181,,,,propionyl-CoA,439164,ppcoa,,"2-Methylacetyl-CoA, 2-Methylacetyl-Coenzyme A, alpha-Methylacetyl-CoA, alpha-Methylacetyl-Coenzyme A, Propanoyl-CoA, Propanoyl-Coenzyme A, Propionyl-CoA, Propionyl-coenzyme A",http://vmh.uni.lu/_api/metabolites/181/?format=pcsv
3odcoa,,,-4,C31H48N7O18P3S,CHEBI:28528,,3-Oxodecanoyl-CoA,,3-Oxodecanoyl-CoA,,,"InChI=1S/C31H52N7O18P3S/c1-4-5-6-7-8-9-19(39)14-22(41)60-13-12-33-21(40)10-11-34-29(44)26(43)31(2,3)16-53-59(50,51)56-58(48,49)52-15-20-25(55-57(45,46)47)24(42)30(54-20)38-18-37-23-27(32)35-17-36-28(23)38/h17-18,20,24-26,30,42-43H,4-16H2,1-3H3,(H,33,40)(H,34,44)(H,48,49)(H,50,51)(H2,32,35,36)(H2,45,46,47)/p-4/t20-,24-,25-,26+,30-/m1/s1",C05265,2016-11-22T15:11:46Z,,182,,,,3-oxodecanoyl-CoA,440606,3odcoa,,,http://vmh.uni.lu/_api/metabolites/182/?format=pcsv
occoa,,,-4,C29H46N7O17P3S,CHEBI:15533,,"Human Metabolome Database (HMDB): Octanoyl-CoA is a substrate for Trifunctional enzyme beta subunit (mitochondrial), Acyl-coenzyme A oxidase 1 (peroxisomal), 3-ketoacyl-CoA thiolase (mitochondrial), 3-ketoacyl-CoA thiolase (peroxisomal), Nuclear receptor-binding factor 1, Acyl-CoA dehydrogenase (long-chain specific, mitochondrial), Acyl-coenzyme A oxidase 3 (peroxisomal), HPDHase, Acyl-CoA dehydrogenase (medium-chain specific, mitochondrial), Acyl-coenzyme A oxidase 2 (peroxisomal) and Peroxisomal carnitine O-octanoyltransferase.",,Octanoyl-CoA (n-C8:0CoA),,HMDB01070,"InChI=1S/C29H50N7O17P3S/c1-4-5-6-7-8-9-20(38)57-13-12-31-19(37)10-11-32-27(41)24(40)29(2,3)15-50-56(47,48)53-55(45,46)49-14-18-23(52-54(42,43)44)22(39)28(51-18)36-17-35-21-25(30)33-16-34-26(21)36/h16-18,22-24,28,39-40H,4-15H2,1-3H3,(H,31,37)(H,32,41)(H,45,46)(H,47,48)(H2,30,33,34)(H2,42,43,44)/p-4/t18-,22-,23-,24+,28-/m1/s1",C01944,2016-12-05T15:48:04Z,,183,,,,octanoyl-CoA,380,occoa,,"Capryloyl-CoA, Capryloyl-Coenzyme A, Octanoyl-CoA, Octanoyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/183/?format=pcsv
3oddcoa,,,-4,C33H52N7O18P3S,CHEBI:27868,,3-Oxododecanoyl-CoA,,3-Oxododecanoyl-CoA,,,"InChI=1S/C33H56N7O18P3S/c1-4-5-6-7-8-9-10-11-21(41)16-24(43)62-15-14-35-23(42)12-13-36-31(46)28(45)33(2,3)18-55-61(52,53)58-60(50,51)54-17-22-27(57-59(47,48)49)26(44)32(56-22)40-20-39-25-29(34)37-19-38-30(25)40/h19-20,22,26-28,32,44-45H,4-18H2,1-3H3,(H,35,42)(H,36,46)(H,50,51)(H,52,53)(H2,34,37,38)(H2,47,48,49)/p-4/t22-,26-,27-,28+,32-/m1/s1",C05263,2016-11-22T15:11:46Z,,184,,,,3-oxolauroyl-CoA,440604,3oddcoa,,,http://vmh.uni.lu/_api/metabolites/184/?format=pcsv
dcacoa,,,-4,C31H50N7O17P3S,CHEBI:28493,,"Human Metabolome Database (HMDB): Decanoyl CoA is a human liver acyl-CoA ester. It is selected to determine apparent kinetic constants for human liver acyl-CoA due to its relevance to the human diseases with cellular accumulation of this esters, especially to metabolic defects in the acyl-CoA dehydrogenation steps of the branched-chain amino acids, lysine, 5-hydroxy lysine, tryptophan, and fatty acid oxidation pathways. It is concluded that the substrate concentration is decisive for the glycine conjugate formation and that the occurrence in urine of acylglycines reflects an intramitochondrial accumulation of the corresponding acyl-CoA ester. (PMID: 3707752).",,Decanoyl-CoA (n-C10:0CoA),,HMDB06404,"InChI=1S/C31H54N7O17P3S/c1-4-5-6-7-8-9-10-11-22(40)59-15-14-33-21(39)12-13-34-29(43)26(42)31(2,3)17-52-58(49,50)55-57(47,48)51-16-20-25(54-56(44,45)46)24(41)30(53-20)38-19-37-23-27(32)35-18-36-28(23)38/h18-20,24-26,30,41-42H,4-17H2,1-3H3,(H,33,39)(H,34,43)(H,47,48)(H,49,50)(H2,32,35,36)(H2,44,45,46)/p-4/t20-,24-,25-,26+,30-/m1/s1",C05274,2016-12-05T15:48:04Z,,185,,,,decanoyl-CoA,440615,dcacoa,,"Decanoyl coenzyme a monohydrate, Decanoyl-CoA, Decanoyl-coenzyme a, S-Decanoate, S-Decanoate coenzyme a, S-Decanoic acid",http://vmh.uni.lu/_api/metabolites/185/?format=pcsv
3otdcoa,,,-4,C35H56N7O18P3S,CHEBI:28726,,3-Oxotetradecanoyl-CoA,,3-Oxotetradecanoyl-CoA,,,"InChI=1S/C35H60N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-23(43)18-26(45)64-17-16-37-25(44)14-15-38-33(48)30(47)35(2,3)20-57-63(54,55)60-62(52,53)56-19-24-29(59-61(49,50)51)28(46)34(58-24)42-22-41-27-31(36)39-21-40-32(27)42/h21-22,24,28-30,34,46-47H,4-20H2,1-3H3,(H,37,44)(H,38,48)(H,52,53)(H,54,55)(H2,36,39,40)(H2,49,50,51)/p-4/t24-,28-,29-,30+,34-/m1/s1",C05261,2016-11-22T15:11:46Z,,186,,,,3-oxotetradecanoyl-CoA,11966197,3otdcoa,,,http://vmh.uni.lu/_api/metabolites/186/?format=pcsv
ddcacoa,,,-4,C33H54N7O17P3S,CHEBI:15521,,Human Metabolome Database (HMDB): Lauroyl-CoA is a substrate for Protein FAM34A.,,Dodecanoyl-CoA (n-C12:0CoA),,HMDB03571,"InChI=1S/C33H58N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-24(42)61-17-16-35-23(41)14-15-36-31(45)28(44)33(2,3)19-54-60(51,52)57-59(49,50)53-18-22-27(56-58(46,47)48)26(43)32(55-22)40-21-39-25-29(34)37-20-38-30(25)40/h20-22,26-28,32,43-44H,4-19H2,1-3H3,(H,35,41)(H,36,45)(H,49,50)(H,51,52)(H2,34,37,38)(H2,46,47,48)/p-4/t22-,26-,27-,28+,32-/m1/s1",C01832,2016-12-05T15:48:04Z,,187,,,,lauroyl-CoA,165436,ddcacoa,,"Dodecanoyl-CoA, Dodecanoyl-Coenzyme A, Lauroyl coenzyme A",http://vmh.uni.lu/_api/metabolites/187/?format=pcsv
3ohdcoa,,,-4,C37H60N7O18P3S,CHEBI:15491,,3-oxopalmitoyl-CoA(4-),,3-oxopalmitoyl-CoA(4-),,,"InChI=1S/C37H64N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-25(45)20-28(47)66-19-18-39-27(46)16-17-40-35(50)32(49)37(2,3)22-59-65(56,57)62-64(54,55)58-21-26-31(61-63(51,52)53)30(48)36(60-26)44-24-43-29-33(38)41-23-42-34(29)44/h23-24,26,30-32,36,48-49H,4-22H2,1-3H3,(H,39,46)(H,40,50)(H,54,55)(H,56,57)(H2,38,41,42)(H2,51,52,53)/p-4/t26-,30-,31-,32+,36-/m1/s1",C05259,2016-11-22T15:11:46Z,,188,,,,3-oxopalmitoyl-CoA,169621,3ohdcoa,,,http://vmh.uni.lu/_api/metabolites/188/?format=pcsv
tdcoa,,,-4,C35H58N7O17P3S,CHEBI:15532,,"Human Metabolome Database (HMDB): Tetradecanoyl-CoA (or myristoyl-CoA) is an intermediate in fatty acid biosynthesis, fatty acid elongation and the beta oxidation of fatty acids. It is also used in the myristoylation of proteins. The first pass through the beta-oxidation process starts with the saturated fatty acid palmitoyl-CoA and produces myristoyl-CoA. A total of four enzymatic steps are required, starting with VLCAD CoA dehydrogenase (Very Long Chain) activity, followed by three enzymatic steps catalyzed by enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and ketoacyl-CoA thiolase, all present in the mitochondria. Myristoylation of proteins is also catalyzed by the presence of myristoyl-CoA along with Myristoyl-CoA:protein N-myristoyltransferase (NMT). Myristoylation is an irreversible, co-translational (during translation) protein modification found in animals, plants, fungi and viruses. In this protein modification a myristoyl group (derived from myristioyl CoA) is covalently attached via an amide bond to the alpha-amino group of an N-terminal amino acid of a nascent polypeptide. It is more common on glycine residues but also occurs on other amino acids. Myristoylation also occurs post-translationally, for example when previously internal glycine residues become exposed by caspase cleavage during apoptosis. Myristoylation plays a vital role in membrane targeting and signal transduction in plant responses to environmental stress. Compared to other species that possess a single functional myristoyl-CoA: protein N-myristoyltransferase (NMT) gene copy, human, mouse and cow possess 2 NMT genes, and more than 2 protein isoforms.",,Tetradecanoyl-CoA (n-C14:0CoA),,HMDB01521,"InChI=1S/C35H62N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-26(44)63-19-18-37-25(43)16-17-38-33(47)30(46)35(2,3)21-56-62(53,54)59-61(51,52)55-20-24-29(58-60(48,49)50)28(45)34(57-24)42-23-41-27-31(36)39-22-40-32(27)42/h22-24,28-30,34,45-46H,4-21H2,1-3H3,(H,37,43)(H,38,47)(H,51,52)(H,53,54)(H2,36,39,40)(H2,48,49,50)/p-4/t24-,28-,29-,30+,34-/m1/s1",C02593,2016-12-05T15:48:04Z,,189,,,,myristoyl-CoA,25244582,tdcoa,,"Myristoyl-CoA, Myristoyl-coenzyme A, N-C14:0CoA, N-C14:0Coenzyme A, S-Tetradecanoyl-coenzyme A, Tetradecanoyl CoA, Tetradecanoyl Coenzyme A, Tetradecanoyl-coenzyme A",http://vmh.uni.lu/_api/metabolites/189/?format=pcsv
3ohodcoa,,,-4,C39H64N7O18P3S,CHEBI:50571,,"Human Metabolome Database (HMDB): 3-Oxooctadecanoyl-CoA is a metabolite intermediate in the microsomal fatty acid chain elongation system. Microsomal electron-transport components NADPH-cytochrome P450 reductase (EC 1.6.2.4) and cytochrome b5 (EC 1.6.2.2) participate in the conversion from 3-Oxooctadecanoyl-CoA to beta-hydroxystearoyl-CoA, the first reductive step of the microsomal chain elongating system initiated by NADPH. (PMID: 6404652).",,3-Oxooctadecanoyl-CoA,,HMDB06498,"InChI=1S/C39H68N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-27(47)22-30(49)68-21-20-41-29(48)18-19-42-37(52)34(51)39(2,3)24-61-67(58,59)64-66(56,57)60-23-28-33(63-65(53,54)55)32(50)38(62-28)46-26-45-31-35(40)43-25-44-36(31)46/h25-26,28,32-34,38,50-51H,4-24H2,1-3H3,(H,41,48)(H,42,52)(H,56,57)(H,58,59)(H2,40,43,44)(H2,53,54,55)/p-4/t28-,32-,33-,34+,38-/m1/s1",C16216,2016-12-05T15:48:04Z,,190,,,,3-oxooctadecanoyl-CoA,22833663,3ohodcoa,,"3-Ketostearoyl-coa, 3-Ketostearoyl-coenzyme A, 3-Oxostearoyl-CoA, 3-Oxostearoyl-Coenzyme A, beta-Ketostearoyl-CoA, beta-Ketostearoyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/190/?format=pcsv
pmtcoa,,,-4,C37H62N7O17P3S,CHEBI:15525,,Human Metabolome Database (HMDB): Palmityl-CoA is a fatty acid coenzyme derivative which plays a key role in fatty acid oxidation and biosynthesis.,,Palmitoyl-CoA (n-C16:0CoA),,HMDB01338,"InChI=1S/C37H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-28(46)65-21-20-39-27(45)18-19-40-35(49)32(48)37(2,3)23-58-64(55,56)61-63(53,54)57-22-26-31(60-62(50,51)52)30(47)36(59-26)44-25-43-29-33(38)41-24-42-34(29)44/h24-26,30-32,36,47-48H,4-23H2,1-3H3,(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,38,41,42)(H2,50,51,52)/p-4/t26-,30-,31-,32+,36-/m1/s1",C00154,2016-12-05T15:48:04Z,,191,,,,palmitoyl-CoA,15667,pmtcoa,,"Hexadecanoyl CoA, Hexadecanoyl Coenzyme A, Palmitoyl CoA, Palmitoyl coenzyme a, Palmitoyl-CoA, Palmitoyl-Coenzyme A, Palmityl-CoA, Palmityl-Coenzyme A, S-Hexadecanoate, S-Hexadecanoate CoA, S-Hexadecanoate Coenzyme A, S-Hexadecanoic acid, S-Palmitoylcoenzyme a",http://vmh.uni.lu/_api/metabolites/191/?format=pcsv
3ohxccoa,,,-4,C47H80N7O18P3S,,,3-Oxohexacosyl-CoA,,3-Oxohexacosyl-CoA,,,"InChI=1S/C47H84N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-35(55)30-38(57)76-29-28-49-37(56)26-27-50-45(60)42(59)47(2,3)32-69-75(66,67)72-74(64,65)68-31-36-41(71-73(61,62)63)40(58)46(70-36)54-34-53-39-43(48)51-33-52-44(39)54/h33-34,36,40-42,46,58-59H,4-32H2,1-3H3,(H,49,56)(H,50,60)(H,64,65)(H,66,67)(H2,48,51,52)(H2,61,62,63)/t36-,40-,41-,42+,46-/m1/s1",,2016-11-22T15:11:46Z,,192,,,,,,,,,http://vmh.uni.lu/_api/metabolites/192/?format=pcsv
ttccoa,,,-4,C45H78N7O17P3S,CHEBI:52974,,tetracosanoyl-CoA  (n-C24:0CoA),,tetracosanoyl-CoA  (n-C24:0CoA),,,"InChI=1S/C45H82N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h32-34,38-40,44,55-56H,4-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/p-4/t34-,38-,39-,40+,44-/m1/s1",C16529,2016-11-22T15:11:46Z,,193,,,,tetracosanoyl-CoA,3082227,ttccoa,,,http://vmh.uni.lu/_api/metabolites/193/?format=pcsv
acald,,,0,C2H4O,CHEBI:15343,,"Human Metabolome Database (HMDB): Acetaldehyde is a colorless, flammable liquid used in the manufacture of acetic acid, perfumes, and flavors. It is also an intermediate in the metabolism of alcohol. It has a general narcotic action and also causes irritation of mucous membranes. Large doses may cause death from respiratory paralysis. Small amounts of acetaldehyde are produced naturally through gut microbial fermentation. Acetaldehyde is produced through the action of alcohol dehydrogenase on ethanol and is somewhate more toxic than ethanol. Acetaldehyde is linked to most of the negative clinical effects of alcohol. It has been shown to increase the risk of developing cirrhosis of the liver, multiple forms of cancer, and alcoholism.",,acetaldehyde,,HMDB00990,"InChI=1S/C2H4O/c1-2-3/h2H,1H3",C00084,2016-12-05T15:48:04Z,,194,,,,acetaldehyde,177,acald,,"Acetaldehyde, Acetic aldehyde, Aldehyde, Ethanal, Ethyl aldehyde",http://vmh.uni.lu/_api/metabolites/194/?format=pcsv
malcoa,,,-5,C24H33N7O19P3S,CHEBI:15531,,Human Metabolome Database (HMDB): Malonyl-CoA is a coenzyme A derivative which plays a key role in the fatty acid synthesis in the cytoplasmic and microsomal systems.,,Malonyl-CoA,,HMDB01175,"InChI=1S/C24H38N7O19P3S/c1-24(2,19(37)22(38)27-4-3-13(32)26-5-6-54-15(35)7-14(33)34)9-47-53(44,45)50-52(42,43)46-8-12-18(49-51(39,40)41)17(36)23(48-12)31-11-30-16-20(25)28-10-29-21(16)31/h10-12,17-19,23,36-37H,3-9H2,1-2H3,(H,26,32)(H,27,38)(H,33,34)(H,42,43)(H,44,45)(H2,25,28,29)(H2,39,40,41)/p-5/t12-,17-,18-,19+,23-/m1/s1",C00083,2016-12-05T15:48:04Z,,195,,,,malonyl-CoA,10663,malcoa,,"Malonyl CoA, Malonyl Coenzyme A, Malonyl-CoA, Malonyl-Coenzyme A, Omega-Carboxyacyl-CoA, Omega-Carboxyacyl-Coenzyme A, S-(Hydrogen malonyl)coenzyme A, S-(Hydrogen propanedioate, S-(Hydrogen propanedioate) CoA, S-(Hydrogen propanedioate) Coenzyme A, S-(Hydrogen propanedioic acid",http://vmh.uni.lu/_api/metabolites/195/?format=pcsv
ppa,,,-1,C3H5O2,CHEBI:30768,,"Human Metabolome Database (HMDB): Propionic acid (PA) is widely used as an antifungal agent in food. It is present naturally at low levels in dairy products and occurs ubiquitously, together with other short-chain fatty acids (SCFA), in the gastro-intestinal tract of humans and other mammals as an end-product of the microbial digestion of carbohydrates. It has significant physiological activity in animals. PA is irritant but produces no acute systemic effects and has no demonstrable genotoxic potential. (PMID 1628870) Propionic aciduria is one of the most frequent organic acidurias, a disease that comprise many various disorders. The outcome of patients born with Propionic aciduria is poor intellectual development patterns, with 60% having an IQ less than 75 and requiring special education. Successful liver and/or renal transplantations, in a few patients, have resulted in better quality of life but have not necessarily prevented neurological and various visceral complications. These results emphasize the need for permanent metabolic follow-up whatever the therapeutic strategy. (PMID 15868474) Decreased early mortality, less severe symptoms at diagnosis, and more favorable short-term neurodevelopmental outcome were recorded in patients identified through expanded newborn screening. (PMID 16763906).",,propionate,,HMDB00237,"InChI=1S/C3H6O2/c1-2-3(4)5/h2H2,1H3,(H,4,5)/p-1",C00163,2016-12-05T15:48:04Z,,196,,,,,1032,ppa,,"Adofeed, Antischim B, Carboxyethane, Ethanecarboxylate, Ethanecarboxylic acid, Ethylformate, Ethylformic acid, Luprosil, Metacetonate, Metacetonic acid, Methylacetate, Methylacetic acid, MonoProp, Propanate, Propanoate, Propanoic acid, Propcorn, Propionate, Propkorn, Prozoin, Pseudoacetate, Pseudoacetic acid, Toxi-Check",http://vmh.uni.lu/_api/metabolites/196/?format=pcsv
acetone,,,0,C3H6O,CHEBI:15347,,"Human Metabolome Database (HMDB): Acetone is one of the ketone bodies produced during ketoacidosis. Acetone is not regarded as a waste product of metabolism. However, its physiological role in biochemical machinery is not clear. A model for the role of acetone metabolism is presented that orders the events occurring in acetonemia in sequence: in diabetic ketosis or starvation, ketone body production (b-hydroxy-butyrate, acetoacetate) provides fuel for vital organs (heart, brain .) raising the chance of survival of the metabolic catastrophe. However, when ketone body production exceeds the degrading capacity, the accumulating acetoacetic acid presents a new challenge to the pH regulatory system. Acetone production and its further degradation to C3 fragments fulfill two purposes: the maintenance of pH buffering capacity and provision of fuel for peripheral tissues. Since ketosis develops under serious metabolic circumstances, all the mechanisms that balance or moderate the effects of ketosis enhance the chance for survival. From this point of view, the theory that transportable C3 fragments can serve as additional nutrients is a novel view of acetone metabolism which introduces a new approach to the study of acetone degradation, especially in understanding its physiological function and the interrelationship between liver and peripheral tissues. (PMID 10580530). Acetone is typically derived from acetoacetate through the action of microbial acetoacetate decarboxylases found in gut microflora. In chemistry, acetone is the simplest representative of the ketones. Acetone is a colorless, mobile, flammable liquid readily soluble in water, ethanol, ether, etc., and itself serves as an important solvent. Acetone is an irritant and inhalation may lead to hepatotoxic effects (causing liver damage).",,acetone,,HMDB01659,InChI=1S/C3H6O/c1-3(2)4/h1-2H3,C00207,2016-12-05T15:48:04Z,,197,,,,,180,acetone,,"Acetone, b-Ketopropane, beta-Ketopropane, Dimethyl ketone, Dimethylformaldehyde, Methyl ketone, Propanone, Pyroacetic ether",http://vmh.uni.lu/_api/metabolites/197/?format=pcsv
acgagbside_hs,,,0,C52H92N3O27FULLRCO,,,alpha GalNAc globoside,,alpha GalNAc globoside,,,,,2016-11-22T15:11:46Z,,198,,,,,,acgagbside_hs,,,http://vmh.uni.lu/_api/metabolites/198/?format=pcsv
acgal,,,0,C8H15NO6,CHEBI:28800,,N-acetyl-D-galactosamine,,N-acetyl-D-galactosamine,,,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6+,7-,8?/m1/s1",C01132,2016-11-22T15:11:46Z,,199,,,,,35717,acgal,,,http://vmh.uni.lu/_api/metabolites/199/?format=pcsv
acgal1p,,,-2,C8H14NO9P,CHEBI:55404,,"Human Metabolome Database (HMDB): N-Acetyl-D-galactosamine 1-phosphate is an intermediate in amino sugar metabolism. The enzyme UDP-N-acetylgalactosamine diphosphorylase catalyzes the conversion of this metabolite into UDP-N-acetyl-D-galactosamine. In the same pathway, the enzyme N-acetylgalactosamine kinase catalyzes the phosphorylation of this metabolite from N-Acetyl-D-galactosamine using ATP or ITP. These two reactions are irreversible and occur in the cytosol. (BiGG database).",,N-Acetyl-D-galactosamine 1-phosphate,,HMDB06480,"InChI=1S/C8H16NO9P/c1-3(11)9-5-7(13)6(12)4(2-10)17-8(5)18-19(14,15)16/h4-8,10,12-13H,2H2,1H3,(H,9,11)(H2,14,15,16)/t4-,5-,6+,7-,8?/m1/s1",,2016-12-05T15:48:04Z,,200,,,,,22833661,acgal1p,,"N- Acetyl-alpha-D-galactosamine 1-phosphate, N- Acetyl-alpha-delta-galactosamine 1-phosphate",http://vmh.uni.lu/_api/metabolites/200/?format=pcsv
itp,,,-4,C10H11N4O14P3,CHEBI:16039,,ITP(3-),,ITP(3-),,,"InChI=1S/C10H15N4O14P3/c15-6-4(1-25-30(21,22)28-31(23,24)27-29(18,19)20)26-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,21,22)(H,23,24)(H,11,12,17)(H2,18,19,20)/p-3/t4-,6-,7-,10-/m1/s1",C00081,2016-11-22T15:11:46Z,,201,,,,,8583,itp,,,http://vmh.uni.lu/_api/metabolites/201/?format=pcsv
idp,,,-3,C10H11N4O11P2,CHEBI:17808,,IDP(3-),,IDP(3-),,,"InChI=1S/C10H14N4O11P2/c15-6-4(1-23-27(21,22)25-26(18,19)20)24-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,21,22)(H,11,12,17)(H2,18,19,20)/p-3/t4-,6-,7-,10-/m1/s1",C00104,2016-11-22T15:11:46Z,,202,,,,,6831,idp,,,http://vmh.uni.lu/_api/metabolites/202/?format=pcsv
acgam,,,0,C8H15NO6,CHEBI:17411,,"Human Metabolome Database (HMDB): N-Acetyl-D-Glucosamine (N-acetlyglucosamine) is a monosaccharide derivative of glucose. Chemically it is an amide between glucosamine and acetic acid. A single N-acetlyglucosamine moiety linked to serine or threonine residues on nuclear and cytoplasmic proteins -O-GlcNAc, is an ubiquitous post-translational protein modification. O-GlcNAc modified proteins are involved in sensing the nutrient status of the surrounding cellular environment and adjusting the activity of cellular proteins accordingly. O-GlcNAc regulates cellular responses to hormones such as insulin, initiates a protective response to stress, modulates a cell's capacity to grow and divide, and regulates gene transcription. In humans, it exists in skin, cartilage and blood vessel as a component of hyaluronic acid, and bone tissue, cornea and aorta as a component of keratan sulfate. (PMID 16237703).",,N-acetyl-D-glucosamine,,HMDB00215,"InChI=1S/C8H15NO6/c1-4(12)9-5(2-10)7(14)8(15)6(13)3-11/h2,5-8,11,13-15H,3H2,1H3,(H,9,12)/t5-,6+,7+,8+/m0/s1",C00140,2016-12-05T15:48:04Z,,203,,,,,439174,acgam,,"2-(Acetylamino)-2-deoxyhexose, 2-Acetamido-2-deoxy-D-glucopyranose, 2-Acetamido-2-deoxy-D-glucose, 2-Acetamido-2-deoxyglucose, 2-Acetamido-D-glucose, 2-Acetylamino-2-deoxy-D-glucose, Acetylglucosamine, Glcnac, N-Acetylchitosamine, N-Acetylglucosamine, N-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide",http://vmh.uni.lu/_api/metabolites/203/?format=pcsv
acmana,,,0,C8H15NO6,CHEBI:17122,,N-acetyl-D-mannosamine,,N-acetyl-D-mannosamine,,,"InChI=1S/C8H15NO6/c1-4(12)9-5(2-10)7(14)8(15)6(13)3-11/h2,5-8,11,13-15H,3H2,1H3,(H,9,12)/t5-,6-,7-,8-/m0/s1",C00645,2016-11-22T15:11:46Z,,204,,,,,439281,acmana,,,http://vmh.uni.lu/_api/metabolites/204/?format=pcsv
gam6p,,,-1,C6H13NO8P,CHEBI:15873,,D-Glucosamine 6-phosphate,,D-Glucosamine 6-phosphate,,,,C00352,2016-11-22T15:11:46Z,,205,,,,,121988,gam6p,,,http://vmh.uni.lu/_api/metabolites/205/?format=pcsv
acgam6p,,,-2,C8H14NO9P,CHEBI:15784,,N-acetyl-D-glucosamine 6-phosphate(2-),,N-acetyl-D-glucosamine 6-phosphate(2-),,,"InChI=1S/C8H16NO9P/c1-3(10)9-5-7(12)6(11)4(18-8(5)13)2-17-19(14,15)16/h4-8,11-13H,2H2,1H3,(H,9,10)(H2,14,15,16)/p-2/t4-,5-,6-,7-,8?/m1/s1",C00357,2016-11-22T15:11:46Z,,206,,,,,440996,acgam6p,,,http://vmh.uni.lu/_api/metabolites/206/?format=pcsv
acgam1p,,,-2,C8H14NO9P,CHEBI:7125,,N-Acetyl-D-glucosamine 1-phosphate,,N-Acetyl-D-glucosamine 1-phosphate,,,"InChI=1S/C8H16NO9P/c1-3(11)9-5-7(13)6(12)4(2-10)17-8(5)18-19(14,15)16/h4-8,10,12-13H,2H2,1H3,(H,9,11)(H2,14,15,16)/t4-,5-,6-,7-,8?/m1/s1",C04256,2016-11-22T15:11:46Z,,207,,,,,440272,acgam1p,,,http://vmh.uni.lu/_api/metabolites/207/?format=pcsv
acgbgbside_hs,,,0,C52H92N3O27FULLRCO,,,beta GalNAc globoside,,beta GalNAc globoside,,,,,2016-11-22T15:11:46Z,,208,,,,,,acgbgbside_hs,,,http://vmh.uni.lu/_api/metabolites/208/?format=pcsv
acgpail_hs,,,-1,C17H29NO14PFULLRCO2FULLR2CO2,CHEBI:12194,,6-(N-acetyl-alpha-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol(1-),,6-(N-acetyl-alpha-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol(1-),,,,,2016-11-22T15:11:46Z,,209,,,,,,acgpail_hs,,,http://vmh.uni.lu/_api/metabolites/209/?format=pcsv
ac,,,-1,C2H3O2,CHEBI:15366,,"Human Metabolome Database (HMDB): Acetic acid is one of the simplest carboxylic acids. It is an important chemical reagent and industrial chemical that is used in the production of plastic soft drink bottles, photographic film; and polyvinyl acetate for wood glue, as well as many synthetic fibres and fabrics. In households diluted acetic acid is often used as a cleaning agent. In the food industry acetic acid is used as an acidity regulator. The acetyl group, derived from acetic acid, is fundamental to the biochemistry of virtually all forms of life. When bound to coenzyme A it is central to the metabolism of carbohydrates and fats. However, the concentration of free acetic acid in cells is kept at a low level to avoid disrupting the control of the pH of the cell contents. Acetic acid is produced and excreted by certain bacteria, notably the Acetobacter genus and Clostridium acetobutylicum. These bacteria are found universally in foodstuffs, water, and soil, and acetic acid is produced naturally as fruits and some other foods spoil. Acetic acid is also a component of the vaginal lubrication of humans and other primates, where it appears to serve as a mild antibacterial agent.",,acetate,,HMDB00042,"InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)/p-1",C00033,2016-12-05T15:48:04Z,,210,,,,,176,ac,,"Acetate, Ethanoate, Ethanoic acid, Ethylate, Ethylic acid, Glacial acetate, Glacial acetic acid, Kyselina octova, Methanecarboxylate, Methanecarboxylic acid, Vinegar, Vinegar acid",http://vmh.uni.lu/_api/metabolites/210/?format=pcsv
gpail_hs,,,0,C15H28NO13PFULLRCO2FULLR2CO2,CHEBI:17049,,6-(alpha-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol,,6-(alpha-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol,,,,,2016-11-22T15:11:47Z,,211,,,,,,gpail_hs,,,http://vmh.uni.lu/_api/metabolites/211/?format=pcsv
acglu,,,-2,C7H9NO5,CHEBI:44337,,"Human Metabolome Database (HMDB): N-acetylglutamic acid is an acetylated amino acid. N-Acetylglutamic acid (abbreviated NAcGlu) is biosynthesized from glutamic acid and acetyl-CoA by the enzyme N-acetylglutamate synthase (NAGS). NAcGlu activates carbamoyl phosphate synthetase in the urea cycle. A deficiency in N-Acetyl Glutamate Synthase or a genetic mutation in the gene coding for the enzyme, will lead to urea cycle failure in which ammonia is not converted to urea, but rather accumulated in blood leading to the condition called Type I Hyperammonemia. This is a severe neonatal disorder with fatal consequences, if not detected immediately upon birth.",,N-acetyl-L-glutamate(2-),,HMDB01138,"InChI=1S/C7H11NO5/c1-4(9)8-5(7(12)13)2-3-6(10)11/h5H,2-3H2,1H3,(H,8,9)(H,10,11)(H,12,13)/p-2/t5-/m0/s1",C00624,2016-12-05T15:48:04Z,,212,,,,,70914,acglu,,"2-Acetamido-L-Glutaraldehydate, 2-Acetamido-L-Glutaraldehydic acid, Ac-Glu-OH, Acetyl-glutamate, Acetyl-L-glutamate, Acetyl-L-glutamic acid, Acetylglutamate, Acetylglutamic acid, DL-Acetylglutamate, DL-Acetylglutamic acid, N-Ac-Glu-OH, N-Acetyl L-glutamate, N-Acetyl L-glutamic acid, N-Acetyl-DL-glutamate, N-Acetyl-DL-glutamic acid, N-Acetyl-Glutamate, N-Acetyl-Glutamic acid, N-Acetyl-L-glutamate, N-Acetyl-L-glutamic acid, N-Acetyl-L-glutamic acid-gamma-semialdehyde, N-Acetylglutamate, N-Acetylglutamic acid, N-Acetylglutamic gamma-semialdehyde",http://vmh.uni.lu/_api/metabolites/212/?format=pcsv
ach,,,1,C7H16NO2,CHEBI:15355,,"Human Metabolome Database (HMDB): Acetylcholine (ACh) is a neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. Its physiological and pharmacological effects, metabolism, release, and receptors have been well documented in several species. ACh has been considered an important excitatory neurotransmitter in the carotid body (CB). Various nicotinic and muscarinic ACh receptors are present in both afferent nerve endings and glomus cells. Therefore, ACh can depolarize or hyperpolarize the cell membrane depending on the available receptor type in the vicinity. Binding of ACh to its receptor can create a wide variety of cellular responses including opening cation channels (nicotinic ACh receptor activation), releasing Ca2+ from intracellular storage sites (via muscarinic ACh receptors), and modulating activities of K+ and Ca2+ channels. Interactions between ACh and other neurotransmitters (dopamine, adenosine, nitric oxide) have been known, and they may induce complicated responses. Cholinergic biology in the CB differs among species and even within the same species due to different genetic composition. Development and environment influence cholinergic biology. Pharmacological data clearly indicate that both muscarinic and nicotinic acetylcholine receptors have a role in the encoding of new memories. Localized lesions and antagonist infusions demonstrate the anatomical locus of these cholinergic effects, and computational modeling links the function of cholinergic modulation to specific cellular effects within these regions. Acetylcholine has been shown to increase the strength of afferent input relative to feedback, to contribute to theta rhythm oscillations, activate intrinsic mechanisms for persistent spiking, and increase the modification of synapses. These effects might enhance different types of encoding in different cortical structures. In particular, the effects in entorhinal and perirhinal cortex and hippocampus might be important for encoding new episodic memories. The role of ACh in attention has been repeatedly demonstrated in several tasks. Acetylcholine is linked to response accuracy in voluntary and reflexive attention and also to response speed in reflexive attention. It is well known that those with Attention-deficit/hyperactivity disorders tend to be inaccurate and slow to respond. (PMID: 17284361, 17011181, 15556286).",,acetylcholine,,HMDB00895,"InChI=1S/C7H16NO2/c1-7(9)10-6-5-8(2,3)4/h5-6H2,1-4H3/q+1",C01996,2016-12-05T15:48:04Z,,213,,,,,187,ach,,"Acetyl choline ion, Acetylcholine cation, Acetylcholinium: acetyl-Choline, ACh, Choline acetate, Choline acetate (ester), O-Acetylcholine",http://vmh.uni.lu/_api/metabolites/213/?format=pcsv
chol,,,1,C5H14NO,CHEBI:15354,,"Human Metabolome Database (HMDB): Choline is a basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. Choline is now considered to be an essential vitamin. While humans can synthesize small amounts (by converting phosphatidylethanolamine to phosphatidylcholine), it must be consumed in the diet to maintain health. Required levels are between 425 mg/day (female) and 550 mg/day (male). Milk, eggs, liver and peanuts are especially rich in choline. Most choline is found in phospholipids, namely phosphatidylcholine or lecithin. Choline can be oxidized to form betaine, which is a methyl source for many reactions (i.e. conversion of homocysteine e to methionine). Lack of sufficient amounts of choline in the diet can lead to a fatty liver condition and general liver damage. This arises from the lack of VLDL, which is necessary to transport fats away from the liver. Choline deficiency also leads to elevated serum levels of alanine amino transferase and is associated with increased incidence of liver cancer.",,Choline,,HMDB00097,"InChI=1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+1",C00114,2016-12-05T15:48:04Z,,214,,,,,305,chol,,"(2-Hydroxyethyl)trimethyl ammonium, (2-Hydroxyethyl)trimethylammonium, (beta-hydroxyethyl)trimethylammonium, 2-Hydroxy-N,N,N-trimethyl-ethanaminium, 2-Hydroxy-N,N,N-trimethylethanaminium, Bilineurine, Biocolina, Biocoline, Choline, Choline cation, Choline ion, Cholinum, Hepacholine, Hormocline, Lipotril, N,N,N-Trimethylethanol-ammonium, N,N,N-Trimethylethanolammonium, Neocolina, Paresan",http://vmh.uni.lu/_api/metabolites/214/?format=pcsv
cit,,,-3,C6H5O7,CHEBI:30769,,"Human Metabolome Database (HMDB): Citric acid (citrate) is a weak acid that is formed in the tricarboxylic acid cycle or that may be introduced with diet. The evaluation of plasma citric acid is scarcely used in the diagnosis of human diseases. On the contrary urinary citrate excretion is a common tool in the differential diagnosis of kidney stones, renal tubular acidosis and it plays also a role in bone diseases. The importance of hypocitraturia should be considered with regard to bone mass, urine crystallization and urolithiasis. (PMID 12957820) The secretory epithelial cells of the prostate gland of humans and other animals posses a unique citrate-related metabolic pathway regulated by testosterone and prolactin. This specialized hormone-regulated metabolic activity is responsible for the major prostate function of the production and secretion of extraordinarily high levels of citrate. The key regulatory enzymes directly associated with citrate production in the prostate cells are mitochondrial aspartate aminotransferase, pyruvate dehydrogenase, and mitochondrial aconitase. testosterone and prolactin are involved in the regulation of the corresponding genes associated with these enzymes. The regulatory regions of these genes contain the necessary response elements that confer the ability of both hormones to control gene transcription. Protein kinase c (PKC) is the signaling pathway for the prolactin regulation of the metabolic genes in prostate cells. testosterone and prolactin regulation of these metabolic genes (which are constitutively expressed in all mammalian cells) is specific for these citrate-producing cells. (PMID 12198595) Citric acid is found in citrus fruits, most concentrated in lemons and limes, where it can comprise as much as 8% of the dry weight of the fruit. Citric acid is a natural preservative and is also used to add an acidic (sour) taste to foods and soft drinks. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability. Intolerance to citric acid in the diet is known to exist. Little information is available as the condition appears to be rare, but like other types of food intolerance it is often described as a ""pseudo-allergic"" reaction.",,Citrate,,HMDB00094,"InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/p-3",C00158,2016-12-05T15:48:04Z,,215,,,,,311,cit,,"2-Hydroxy-1,2,3-propanetricarboxylate, 2-Hydroxy-1,2,3-propanetricarboxylic acid, 3-Carboxy-3-hydroxypentane-1,5-dioate, 3-Carboxy-3-hydroxypentane-1,5-dioic acid, Aciletten, Anhydrous citrate, Anhydrous citric acid, beta-Hydroxytricarballylate, beta-Hydroxytricarballylic acid, Chemfill, Citraclean, Citrate, Citretten, Citric acid, Citro, E 330, Hydrocerol A, Kyselina citronova, Suby G, Uro-trainer",http://vmh.uni.lu/_api/metabolites/215/?format=pcsv
oaa,,,-2,C4H2O5,CHEBI:30744,,"Human Metabolome Database (HMDB): Oxaloacetic acid, also known as oxosuccinic acid or oxalacetic acid, is a four-carbon dicarboxylic acid appearing as an intermediate of the citric acid cycle. In vivo, oxaloacetate (the ionized form of oxaloacetic acid) is formed by the oxidation of L-malate, catalyzed by malate dehydrogenase, and reacts with Acetyl-CoA to form citrate, catalyzed by citrate synthase.(wikipedia) A class of ketodicarboxylic acids derived from oxalic acid. Oxaloacetic acid is an intermediate in the citric acid cycle and is converted to aspartic acidD by a transamination reaction.",,Oxaloacetate,,HMDB00223,"InChI=1S/C4H4O5/c5-2(4(8)9)1-3(6)7/h1H2,(H,6,7)(H,8,9)/p-2",C00036,2016-12-05T15:48:04Z,,216,,,,,970,oaa,,"2-Ketosuccinate, 2-Ketosuccinic acid, 2-Oxobutanedioate, 2-Oxobutanedioic acid, 2-Oxosuccinate, 2-Oxosuccinic acid, a-Ketosuccinate, a-Ketosuccinic acid, alpha-Ketosuccinate, alpha-Ketosuccinic acid, Ketosuccinate, Ketosuccinic acid, OAA, Oxalacetate, Oxaloacetate, Oxaloacetic acid, Oxaloethanoate, Oxaloethanoic acid, Oxosuccinate, Oxosuccinic acid",http://vmh.uni.lu/_api/metabolites/216/?format=pcsv
acn13acngalgbside_hs,,,-2,C72H121N4O43FULLRCO,,,"sialyl (1,3) sialyl (2,6) galactosylgloboside",,"sialyl (1,3) sialyl (2,6) galactosylgloboside",,,,,2016-11-22T15:11:47Z,,217,,,,,,acn13acngalgbside_hs,,,http://vmh.uni.lu/_api/metabolites/217/?format=pcsv
acn23acngalgbside_hs,,,-2,C72H121N4O43FULLRCO,,,"sialyl (2,3) sialyl (2,6) galactosylgloboside",,"sialyl (2,3) sialyl (2,6) galactosylgloboside",,,,,2016-11-22T15:11:47Z,,218,,,,,,acn23acngalgbside_hs,,,http://vmh.uni.lu/_api/metabolites/218/?format=pcsv
acnacngal14acglcgalgluside_hs,,,-2,C66H111N4O38FULLRCO,,,"3',8'-LD1",,"3',8'-LD1",,,,,2016-11-22T15:11:47Z,,219,,,,,,acnacngal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/219/?format=pcsv
acnacngalgbside_hs,,,-2,C72H121N4O43FULLRCO,,,disialyl galactosylgloboside,,disialyl galactosylgloboside,,,,,2016-11-22T15:11:47Z,,220,,,,,,acnacngalgbside_hs,,,http://vmh.uni.lu/_api/metabolites/220/?format=pcsv
acmanap,,,-2,C8H14NO9P,CHEBI:28273,,N-acetyl-D-mannosamine 6-phosphate(2-),,N-acetyl-D-mannosamine 6-phosphate(2-),,,"InChI=1S/C8H16NO9P/c1-4(11)9-5(2-10)7(13)8(14)6(12)3-18-19(15,16)17/h2,5-8,12-14H,3H2,1H3,(H,9,11)(H2,15,16,17)/p-2",C04257,2016-11-22T15:11:47Z,,221,,,,,21918217,acmanap,,,http://vmh.uni.lu/_api/metabolites/221/?format=pcsv
pep,,,-3,C3H2O6P,CHEBI:18021,,"Human Metabolome Database (HMDB): Phosphoenolpyruvate (PEP) is an important chemical compound in biochemistry. It has a high energy phosphate bond, and is involved in glycolysis and gluconeogenesis. In glycolysis, PEP is formed by the action of the enzyme enolase on 2-phosphoglycerate. Metabolism of PEP to pyruvate by pyruvate kinase (PK) generates 1 molecule of adenosine triphosphate (ATP) via substrate-level phosphorylation. ATP is one of the major currencies of chemical energy within cells. In gluconeogenesis, PEP is formed from the decarboxylation of oxaloacetate and hydrolysis of 1 guanosine triphosphate molecule. This reaction is catalyzed by the enzyme phosphoenolpyruvate carboxykinase (PEPCK). This reaction is a rate-limiting step in gluconeogenesis. (wikipedia).",,Phosphoenolpyruvate,,HMDB00263,"InChI=1S/C3H5O6P/c1-2(3(4)5)9-10(6,7)8/h1H2,(H,4,5)(H2,6,7,8)/p-1",C00074,2016-12-05T15:48:04Z,,222,,,,phosphoenolpyruvate,1005,pep,,"2-Hydroxy-Acrylic acid dihydrogen phosphate, 2-Phosphonooxyprop-2-enoate, 2-Phosphonooxyprop-2-enoic acid, P-Enol-pyruvate, PEP, Phosphoenolpyruvate",http://vmh.uni.lu/_api/metabolites/222/?format=pcsv
acnamp,,,-3,C11H17NO12P,CHEBI:27438,,N-Acetylneuraminate 9-phosphate,,N-Acetylneuraminate 9-phosphate,,,"InChI=1S/C11H20NO12P/c1-4(13)12-7-5(14)2-11(19,10(17)18)24-9(7)8(16)6(15)3-23-25(20,21)22/h5-9,14-16,19H,2-3H2,1H3,(H,12,13)(H,17,18)(H2,20,21,22)/t5-,6+,7+,8+,9+,11?/m0/s1",C06241,2016-11-22T15:11:48Z,,223,,,,,440962,acnamp,,,http://vmh.uni.lu/_api/metabolites/223/?format=pcsv
man6p,,,-2,C6H11O9P,CHEBI:17369,,D-Mannose 6-phosphate,,D-Mannose 6-phosphate,,,,C00275,2016-11-22T15:11:48Z,,224,,,,D-mannose 6-phosphate,65127,man6p,,,http://vmh.uni.lu/_api/metabolites/224/?format=pcsv
kdnp,,,-3,C9H14O12P,,,2-keto-3-deoxy-D-glycero-D-galactononic acid 9-phosphate,,2-keto-3-deoxy-D-glycero-D-galactononic acid 9-phosphate,,,,,2016-11-22T15:11:48Z,,225,,,,,,kdnp,,,http://vmh.uni.lu/_api/metabolites/225/?format=pcsv
acnam,,,-1,C11H18NO9,CHEBI:17012,,"Human Metabolome Database (HMDB): N-Acetylneuraminic acid (NeuAc) or sialic acid is an acetyl derivative of the amino sugar neuraminic acid. It occurs in many glycoproteins, glycolipids, and polysaccharides in both mammals and bacteria. The most abundant sialic acid, NeuAc, is synthesized in vivo from N-acetylated D-mannosamine (ManNAc) or D-glucosamine (GlcNAc). NeuAc and its activated form, CMP-NeuAc, are biosynthesized in five consecutive reactions: UDP-N-acetylglucosamine (UDP-GlcNAc) N-acetylmannosamine (ManNAc) ManNAc 6-phosphate NeuAc 9-phosphate NeuAc CMP-NeuAc. CMP-NeuAc is transported into the Golgi apparatus and, with the aid of specific sialyltransferases, added onto nonreducing positions on oligosaccharide chains of glycoproteins and glycolipids. NeuAc is widely distributed throughout human tissues and found in several fluids, including serum, cerebrospinal fluid, saliva, urine, amniotic fluid, and breast milk. It is found in high levels in the brain, adrenal glands, and the heart. Serum and urine levels of the free acid are elevated in individuals suffering from renal failure. Serum and saliva Neu5Ac levels are also elevated in alcoholics. A disorder known as Salla disease or infantile NeuAc storage disease is also characterized by high serum and urine levels of this compound. The negative charge of is responsible for the slippery feel of saliva and mucins coating the body's organs. This particular sialic acid is known to act as a ""decoy"" for invading pathogens. Along with involvement in preventing infections (mucus associated with mucous membranes â€” mouth, nose, GI, respiratory tract), Neu5Ac acts as a receptor for influenza viruses, allowing attachment to mucous cells via hemagglutinin (an early step in acquiring influenzavirus infection). NeuAc is also becoming known as an agent necessary for mediating ganglioside distribution and structures in the brain. Sialic acid (SA) is an N-acetylated derivative of neuraminic acid that is an abundant terminal monosaccharide of glycoconjugates. Normal human serum SA is largely bound to glycoproteins or glycolipids (Total sialic acid, TSA, 1.5-2.5 mmol/L), with small amounts of free SA (1-3 umol/L). Negatively charged SA units stabilize glycoprotein conformation in cell surface receptors to increase cell rigidity. This enables signal recognition and adhesion to ligands, antibodies, enzymes and microbes. SA residues are antigenic determinant residues in carbohydrate chains of glycolipids and glycoproteins, chemical messengers in tissue and body fluids, and may regulate glomeruli basement membrane permeability. Sialic acids are structurally unique nine-carbon keto sugars occupying the interface between the host and commensal or pathogenic microorganisms. An important function of host sialic acid is to regulate innate immunity. Sialic acid is the moiety most actively recycled for metabolic purposes in the salvage pathways in glycosphingolipid metabolism. Sialic acid is indispensable for the neuritogenic activities of gangliosides constituents which are unique in that a sialic acid directly binds to the glucose of the cerebroside, they are mutually connected in tandem, and some are located in the internal parts of the sugar chain. Sialylation (sialic acid linked to galactose, N-acetylgalactosamine, or linked to another sialic acid) represents one of the most frequently occurring terminations of the oligosaccharide chains of glycoproteins and glycolipids. The biosynthesis of the various linkages is mediated by the different members of the sialyltransferase family. (PMID: 11425186 , 11287396 , 12770781 , 16624269 , 12510390 , 15007099 ).",,N-acetylneuraminate,,HMDB00230,"InChI=1S/C11H19NO9/c1-4(14)12-7-5(15)2-11(20,10(18)19)21-9(7)8(17)6(16)3-13/h5-9,13,15-17,20H,2-3H2,1H3,(H,12,14)(H,18,19)/p-1/t5-,6+,7+,8+,9+,11?/m0/s1",C19910,2016-12-05T15:48:04Z,,226,,,,,439197,acnam,,"5-(Acetylamino)-3,5-dideoxy-D-glycero-b-D-galacto-2-Nonulopyranosonate, 5-(Acetylamino)-3,5-dideoxy-D-glycero-b-D-galacto-2-Nonulopyranosonic acid, 5-(Acetylamino)-3,5-dideoxy-D-glycero-D-galacto-2-Nonulosonate, 5-(Acetylamino)-3,5-dideoxy-D-glycero-D-galacto-2-Nonulosonic acid, 5-(Acetylamino)-3,5-dideoxy-delta-glycero-beta-delta-galacto-2-Nonulopyranosonate, 5-(Acetylamino)-3,5-dideoxy-delta-glycero-beta-delta-galacto-2-Nonulopyranosonic acid, 5-(Acetylamino)-3,5-dideoxy-delta-glycero-delta-galacto-2-Nonulosonate, 5-(Acetylamino)-3,5-dideoxy-delta-glycero-delta-galacto-2-Nonulosonic acid, 5-Acetamido-3,5-dideoxy-D-glycero-D-galacto-Nonulosonate, 5-Acetamido-3,5-dideoxy-D-glycero-D-galacto-Nonulosonic acid, 5-Acetamido-3,5-dideoxy-delta-glycero-delta-galacto-Nonulosonate, 5-Acetamido-3,5-dideoxy-delta-glycero-delta-galacto-Nonulosonic acid, 5-N-Acetyl-b-D-neuraminic acid, 5-N-Acetyl-beta-D-neuraminic acid, 5-N-Acetyl-beta-delta-neuraminic acid, 5-N-Acetyl-D-neuraminate, 5-N-Acetyl-D-neuraminic acid, 5-N-Acetyl-delta-neuraminate, 5-N-Acetyl-delta-neuraminic acid, 5-N-Acetylneuraminate, 5-N-Acetylneuraminic acid, Aceneuramate, Aceneuramic acid, Acetylneuraminate, Acetylneuraminic acid, b-5-Acetamido-3,5-dideoxy-D-glycero-D-galacto-Nonulopyranosonate, b-5-Acetamido-3,5-dideoxy-D-glycero-D-galacto-Nonulopyranosonic acid, b-Sialic acid, beta-5-Acetamido-3,5-dideoxy-delta-glycero-delta-galacto-Nonulopyranosonate, beta-5-Acetamido-3,5-dideoxy-delta-glycero-delta-galacto-Nonulopyranosonic acid, beta-Sialic acid, Lactaminate, Lactaminic acid, N-Acetyl-b-D-neuraminate, N-Acetyl-b-D-neuraminic acid, N-Acetyl-b-neuraminate, N-Acetyl-beta-delta-neuraminate, N-Acetyl-beta-delta-neuraminic acid, N-Acetyl-beta-neuraminate, N-Acetyl-D-neuraminate, N-Acetyl-D-neuraminic acid, N-Acetyl-delta-neuraminate, N-Acetyl-delta-neuraminic acid, N-Acetyl-neuraminate, N-Acetyl-neuraminic acid, N-Acetylneuramate, N-Acetylneuramic acid, N-Acetylneuraminate, N-Acetylneuraminic acid, N-Acetylsialate, N-Acetylsialic acid, NAN, NANA, Neu5Ac, Sialic acid",http://vmh.uni.lu/_api/metabolites/226/?format=pcsv
acngalacglcgal14acglcgalgluside_hs,,,-1,C69H118N4O40FULLRCO,,,VI3NeuAc-nLc6Cer,,VI3NeuAc-nLc6Cer,,,,,2016-11-22T15:11:48Z,,227,,,,,,acngalacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/227/?format=pcsv
2mbcoa,,,-4,C26H40N7O17P3S,CHEBI:15477,,"Human Metabolome Database (HMDB): 2-Methylbutyryl-CoA is a a product of isoleucine catabolism. It is converted to Tiglyl-CoA by short/branched-chain acyl-CoA dehydrogenase. 2-Methylbutyryl-CoA dehydrogenase deficiency, also called 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency or MBHD, is an inherited disorder in which the body is unable to process the amino acid isoleucine properly. It is caused by a mutation in the HADH2 gene. Untreated MBHD can lead to progressive loss of motor skills, to mental retardation and to epilepsy. 2-Methylbutyryl-CoA is a substrate for Acyl-CoA dehydrogenase (short-chain specific, mitochondrial), Acyl-CoA dehydrogenase (medium-chain specific, mitochondrial) and Acyl-CoA dehydrogenase (long-chain specific, mitochondrial).",,2-methylbutanoyl-CoA(4-),,HMDB01041,"InChI=1S/C26H44N7O17P3S/c1-5-14(2)25(38)54-9-8-28-16(34)6-7-29-23(37)20(36)26(3,4)11-47-53(44,45)50-52(42,43)46-10-15-19(49-51(39,40)41)18(35)24(48-15)33-13-32-17-21(27)30-12-31-22(17)33/h12-15,18-20,24,35-36H,5-11H2,1-4H3,(H,28,34)(H,29,37)(H,42,43)(H,44,45)(H2,27,30,31)(H2,39,40,41)/p-4/t14?,15-,18-,19-,20+,24-/m1/s1",C01033,2016-12-05T15:48:04Z,,228,,,,,,2mbcoa,,"(S)-2-methylbutyryl-CoA, (S)-2-methylbutyryl-Coenzyme A, 2-Methylbutanoyl-CoA, 2-Methylbutanoyl-Coenzyme A, 2-Methylbutyryl-CoA, 2-Methylbutyryl-Coenzyme A, 3'-Phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-{[3-({2-[(2-methylbutanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-4-oxobutyl] dihydrogen diphosphate}, a-Methylbutyryl-CoA, alpha-Methylbutyryl-CoA, alpha-Methylbutyryl-Coenzyme A, Methylbutanoyl-CoA, Methylbutanoyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/228/?format=pcsv
fad,,,-2,C27H31N9O15P2,CHEBI:16238,,"Human Metabolome Database (HMDB): FAD is a condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972).",,Flavin adenine dinucleotide oxidized,,HMDB01248,"InChI=1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1",C00016,2016-12-05T15:48:04Z,,229,,,,FAD,643975,fad,,"1H-Purin-6-amine flavin dinucleotide, 1H-Purin-6-amine flavine dinucleotide, Adenine-flavin dinucleotide, Adenine-flavine dinucleotide, Adenine-riboflavin dinuceotide, Adenine-riboflavin dinucleotide, Adenine-riboflavine dinucleotide, FAD, Flamitajin B, Flanin F, Flavin adenine dinucleotide, Flavin adenine dinucleotide oxidized, Flavin-adenine dinucleotide, Flavine adenosine diphosphate, Flavine-adenine dinucleotide, Flavitan, Flaziren, Isoalloxazine-adenine dinucleotide, Riboflavin 5'-adenosine diphosphate, Riboflavin-adenine dinucleotide, Riboflavine-adenine dinucleotide",http://vmh.uni.lu/_api/metabolites/229/?format=pcsv
2mb2coa,,,-4,C26H38N7O17P3S,CHEBI:15478,,"Human Metabolome Database (HMDB): Tiglyl-CoA is a metabolite in the degradation of isoleucine to propionic acid pathway. A defect in the conversion of tiglyl-CoA to alpha-methyl-beta-hydroxybutyryl-CoA, results in episodic abdominal pain and acidosis in patients with Tiglic acidemia (OMIM 275190).",,2-methylcrotonoyl-CoA(4-),,HMDB02054,"InChI=1S/C26H42N7O17P3S/c1-5-14(2)25(38)54-9-8-28-16(34)6-7-29-23(37)20(36)26(3,4)11-47-53(44,45)50-52(42,43)46-10-15-19(49-51(39,40)41)18(35)24(48-15)33-13-32-17-21(27)30-12-31-22(17)33/h5,12-13,15,18-20,24,35-36H,6-11H2,1-4H3,(H,28,34)(H,29,37)(H,42,43)(H,44,45)(H2,27,30,31)(H2,39,40,41)/p-4/b14-5+/t15-,18-,19-,20+,24-/m1/s1",C03345,2016-12-05T15:48:04Z,,230,,,,,5280564,2mb2coa,,"(E)-2-Methylcrotonoyl-CoA, (E)-2-Methylcrotonoyl-Coenzyme A, 2-Methylbut-2-enoyl-CoA, 2-Methylbut-2-enoyl-Coenzyme A, 2-Methylcrotanoyl-CoA, 2-Methylcrotanoyl-Coenzyme A, 2-Methylcrotonoyl-CoA, 2-Methylcrotonoyl-Coenzyme A, 2-Methylcrotonyl-CoA, 2-Methylcrotonyl-Coenzyme A, Methylcrotonoyl-CoA, Methylcrotonoyl-Coenzyme A, Methylcrotonyl-CoA, Methylcrotonyl-Coenzyme A, Tigloyl-CoA, Tigloyl-Coenzyme A, Tiglyl-CoA, Tiglyl-coenzyme A, trans-2-Methylbut-2-enoyl-CoA, trans-2-Methylbut-2-enoyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/230/?format=pcsv
fadh2,,,-2,C27H33N9O15P2,CHEBI:17877,,"Human Metabolome Database (HMDB): FADH is the reduced form of flavin adenine dinucleotide (FAD). FAD is synthesized from riboflavin and two molecules of ATP. Riboflavin is phosphorylated by ATP to give riboflavin 5-phosphate (FMN). FAD is then formed from FMN by the transfer of an AMP moiety from a second molecule of ATP. FADH is generated in each round of fatty acid oxidation, and the fatty acyl chain is shortened by two carbon atoms as a result of these reactions; because oxidation is on the beta carbon, this series of reactions is called the beta-oxidation pathway. In the citric acid cycle FADH is involved in harvesting of high-energy electrons from carbon fuels; citric acid cycle itself neither generates a large amount of ATP nor includes oxygen as a reactant. Instead, the citric acid cycle removes electrons from acetyl CoA and uses these electrons to form FADH. (Biochemistry. Berg, Jeremy M. Tymoczko, John L. and Stryer, Lubert. New York: W. H. Freeman and Co. 2002.).",,Flavin adenine dinucleotide reduced,,HMDB01197,"InChI=1S/C27H35N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,32,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H2,33,34,42,43)/p-2/t14-,15+,16+,19-,20+,21+,26+/m0/s1",C01352,2016-12-05T15:48:04Z,,231,,,,FADH2,446013,fadh2,,"1,5-Dihydro-FAD, 1,5-Dihydro-P-5-ester with adenosine, 1,5-Dihydro-Riboflavin 5'-(trihydrogen diphosphate) P'->5'-ester with adenosine, Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with 5,10-dihydro-7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine, Adenosine 5'-(trihydrogen pyrophosphate), 5'->5'-ester with 5,10-dihydro-7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine, Adenosine 5'-{3-[D-ribo-5-(7,8-dimethyl-2,4-dioxo-1,2,3,4,5,10-tetrahydrobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen diphosphate}, Adenosine 5-(trihydrogen pyrophosphate), Adenosine pyrophosphate 5'-5'-ester with 5,10-dihydro-7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine, Adenosine pyrophosphate, 5'-5'-ester with 5,10-dihydro-7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine, Adenosine pyrophosphate, 5'->5'-ester with 5,10-dihydro-7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine, Benzo[gr]pteridine riboflavin 5'-(trihydrogen diphosphate) deriv, Benzo[g]pteridine riboflavin 5'-(trihydrogen diphosphate) deriv, Dihydro-FAD, Dihydroflavine-adenine dinucleotide, FADH2, FDA, Flavin adenine dinucleotide (reduced), Flavin adenine dinucleotide reduced, Reduced flavine adenine dinucleotide",http://vmh.uni.lu/_api/metabolites/231/?format=pcsv
btcoa,,,-4,C25H38N7O17P3S,CHEBI:15517,,"Human Metabolome Database (HMDB): Butyryl-CoA is an intermediate in the metabolism of Butanoate. It is a substrate for Acyl-coenzyme A oxidase 3 (peroxisomal), 3-ketoacyl-CoA thiolase (mitochondrial), 3-ketoacyl-CoA thiolase (peroxisomal), Acyl-coenzyme A oxidase 1 (peroxisomal), Acyl-CoA dehydrogenase (medium-chain specific, mitochondrial), Acyl-CoA dehydrogenase (long-chain specific, mitochondrial), Acyl-coenzyme A oxidase 2 (peroxisomal), Acetyl-CoA acetyltransferase (mitochondrial), Acetyl-CoA acetyltransferase (cytosolic), Acyl-CoA dehydrogenase (short-chain specific, mitochondrial) and Trifunctional enzyme beta subunit (mitochondrial).",,Butanoyl-CoA,,HMDB01088,"InChI=1S/C25H42N7O17P3S/c1-4-5-16(34)53-9-8-27-15(33)6-7-28-23(37)20(36)25(2,3)11-46-52(43,44)49-51(41,42)45-10-14-19(48-50(38,39)40)18(35)24(47-14)32-13-31-17-21(26)29-12-30-22(17)32/h12-14,18-20,24,35-36H,4-11H2,1-3H3,(H,27,33)(H,28,37)(H,41,42)(H,43,44)(H2,26,29,30)(H2,38,39,40)/p-4/t14-,18-,19-,20+,24-/m1/s1",C00136,2016-12-05T15:48:04Z,,232,,,,butyryl-CoA,265,btcoa,,"Butanoyl-CoA, Butanoyl-Coenzyme A, Butyryl-CoA, Butyryl-coenzyme A",http://vmh.uni.lu/_api/metabolites/232/?format=pcsv
ivcoa,,,-4,C26H40N7O17P3S,CHEBI:15487,,"Human Metabolome Database (HMDB): Isovaleryl-CoA is an intermediate metabolite in the catabolic pathway of leucine. The accumulation of derivatives of isovaleryl-CoA occurs in patients affected with isovaleric acidemia (IVA, OMIM 243500) an autosomal recessive inborn error of leucine metabolism caused by a deficiency of the mitochondrial enzyme isovaleryl-CoA dehydrogenase (IVD, EC 1.3.99.10, a flavoenzyme that catalyzes the conversion of isovaleryl-CoA to 3-methylcrotonyl-CoA). IVA was the first organic acidemia recognized in humans and can cause significant morbidity and mortality. Early diagnosis and treatment with a protein restricted diet and supplementation with carnitine and glycine are effective in promoting normal development in severely affected individuals. Both intra- and interfamilial variability have been recognized. Initially, two phenotypes with either an acute neonatal or a chronic intermittent presentation were described. More recently, a third group of individuals with mild biochemical abnormalities who can be asymptomatic have been identified through newborn screening of blood spots by tandem mass spectrometry. The majority of patients with IVA today are diagnosed pre-symptomatically through newborn screening by use of MS/MS which reveals elevations of the marker metabolite C5 acylcarnitine in dried blood spots. C5 acylcarnitine represents a mixture of isomers (isovalerylcarnitine, 2-methylbutyrylcarnitine, and pivaloylcarnitine). (PMID: 16602101, Am J Med Genet C Semin Med Genet. 2006 May 15;142(2):95-103.).",,Isovaleryl-CoA,,HMDB01113,"InChI=1S/C26H44N7O17P3S/c1-14(2)9-17(35)54-8-7-28-16(34)5-6-29-24(38)21(37)26(3,4)11-47-53(44,45)50-52(42,43)46-10-15-20(49-51(39,40)41)19(36)25(48-15)33-13-32-18-22(27)30-12-31-23(18)33/h12-15,19-21,25,36-37H,5-11H2,1-4H3,(H,28,34)(H,29,38)(H,42,43)(H,44,45)(H2,27,30,31)(H2,39,40,41)/p-4/t15-,19-,20-,21+,25-/m1/s1",C02939,2016-12-05T15:48:04Z,,233,,,,,439855,ivcoa,,"3-Methylbutanoyl-CoA, 3-Methylbutanoyl-Coenzyme A, 3-Methylbutyryl-CoA, 3-Methylbutyryl-Coenzyme A, Isovaleryl CoA, Isovaleryl coenzyme A, Isovaleryl-coenzyme A, S-(3-Methylbutanoate, S-(3-Methylbutanoate) coenzyme A, S-(3-Methylbutanoic acid, S-Isovalerate CoA, S-Isovalerate Coenzyme A",http://vmh.uni.lu/_api/metabolites/233/?format=pcsv
3mb2coa,,,-4,C26H38N7O17P3S,CHEBI:15486,,"Human Metabolome Database (HMDB): 3-Methylcrotonyl-CoA is an essential metabolite for leucine metabolism, a substrate of 3-methylcrotonyl-CoA carboxylase (EC 6.4.1.4), a biotin-dependent mitochondrial enzyme in the catabolism of leucine. (OMIM 609010).",,3-methylbut-2-enoyl-CoA(4-),,HMDB01493,"InChI=1S/C26H42N7O17P3S/c1-14(2)9-17(35)54-8-7-28-16(34)5-6-29-24(38)21(37)26(3,4)11-47-53(44,45)50-52(42,43)46-10-15-20(49-51(39,40)41)19(36)25(48-15)33-13-32-18-22(27)30-12-31-23(18)33/h9,12-13,15,19-21,25,36-37H,5-8,10-11H2,1-4H3,(H,28,34)(H,29,38)(H,42,43)(H,44,45)(H2,27,30,31)(H2,39,40,41)/p-4/t15-,19-,20-,21+,25-/m1/s1",C03069,2016-12-05T15:48:04Z,,234,,,,,,3mb2coa,,"3-Methylbut-2-enoyl-CoA, 3-Methylbut-2-enoyl-Coenzyme A, 3-Methylcrotonoyl-CoA, 3-Methylcrotonoyl-Coenzyme A, 3-Methylcrotonyl-CoA, 3-Methylcrotonyl-Coenzyme A, b-Methylcrotonyl-CoA (HMDB01493, b-Methylcrotonyl-Coenzyme A (HMDB01493, beta-Methylcrotonoyl-CoA, beta-Methylcrotonoyl-Coenzyme A, beta-Methylcrotonyl-CoA (HMDB01493, beta-Methylcrotonyl-Coenzyme A (HMDB01493, Dimethylacryloyl-CoA, Dimethylacryloyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/234/?format=pcsv
ibcoa,,,-4,C25H38N7O17P3S,CHEBI:15479,,"Human Metabolome Database (HMDB): Isobutyryl-CoA is a substrate for Acyl-CoA dehydrogenase (short-chain specific, mitochondrial), Acyl-CoA dehydrogenase (medium-chain specific, mitochondrial) and Acyl-CoA dehydrogenase (long-chain specific, mitochondrial).",,isobutyryl-CoA(4-),,HMDB01243,"InChI=1S/C25H42N7O17P3S/c1-13(2)24(37)53-8-7-27-15(33)5-6-28-22(36)19(35)25(3,4)10-46-52(43,44)49-51(41,42)45-9-14-18(48-50(38,39)40)17(34)23(47-14)32-12-31-16-20(26)29-11-30-21(16)32/h11-14,17-19,23,34-35H,5-10H2,1-4H3,(H,27,33)(H,28,36)(H,41,42)(H,43,44)(H2,26,29,30)(H2,38,39,40)/p-4/t14-,17-,18-,19+,23-/m1/s1",C00630,2016-12-05T15:48:04Z,,235,,,,,3036931,ibcoa,,"2-Methylpropanoyl-CoA, 2-Methylpropanoyl-Coenzyme A, 2-Methylpropionyl-CoA, 2-Methylpropionyl-Coenzyme A, alpha-Methylpropionyl-CoA, alpha-Methylpropionyl-Coenzyme A, Isobutyryl- CoA, Isobutyryl- Coenzyme A, Isobutyryl-coA, S-(2-Methylpropanoate, S-(2-Methylpropanoate)CoA, S-(2-Methylpropanoate)Coenzyme A, S-(2-Methylpropanoic acid, S-(2-Methylpropanoyl)-CoA, S-(2-Methylpropanoyl)-Coenzyme A",http://vmh.uni.lu/_api/metabolites/235/?format=pcsv
2mp2coa,,,-4,C25H36N7O17P3S,CHEBI:27754,,2-Methylprop-2-enoyl-CoA,,2-Methylprop-2-enoyl-CoA,,,"InChI=1S/C25H40N7O17P3S/c1-13(2)24(37)53-8-7-27-15(33)5-6-28-22(36)19(35)25(3,4)10-46-52(43,44)49-51(41,42)45-9-14-18(48-50(38,39)40)17(34)23(47-14)32-12-31-16-20(26)29-11-30-21(16)32/h11-12,14,17-19,23,34-35H,1,5-10H2,2-4H3,(H,27,33)(H,28,36)(H,41,42)(H,43,44)(H2,26,29,30)(H2,38,39,40)/p-4/t14-,17-,18-,19+,23-/m1/s1",C03460,2016-11-22T15:11:48Z,,236,,,,,,2mp2coa,,,http://vmh.uni.lu/_api/metabolites/236/?format=pcsv
hdd2coa,,,-4,C37H60N7O17P3S,CHEBI:28935,,trans-Hexadec-2-enoyl-CoA,,trans-Hexadec-2-enoyl-CoA,,HMDB06533,"InChI=1S/C37H64N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-28(46)65-21-20-39-27(45)18-19-40-35(49)32(48)37(2,3)23-58-64(55,56)61-63(53,54)57-22-26-31(60-62(50,51)52)30(47)36(59-26)44-25-43-29-33(38)41-24-42-34(29)44/h16-17,24-26,30-32,36,47-48H,4-15,18-23H2,1-3H3,(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,38,41,42)(H2,50,51,52)/p-4/b17-16+/t26-,30-,31-,32+,36-/m1/s1",C05272,2016-11-22T15:11:48Z,,237,,,,(E)-hexadec-2-enoyl-CoA,46173176,hdd2coa,,,http://vmh.uni.lu/_api/metabolites/237/?format=pcsv
ACP,,,-1,C11H21N2O7PRS,,,acyl carrier protein,,acyl carrier protein,,,,,2016-11-22T15:11:48Z,,238,,,,,,ACP,,,http://vmh.uni.lu/_api/metabolites/238/?format=pcsv
acACP,,,-1,C13H23N2O8PRS,,,Acetyl-ACP,,Acetyl-ACP,,,,,2016-11-22T15:11:48Z,,239,,,,,,acACP,,,http://vmh.uni.lu/_api/metabolites/239/?format=pcsv
acorn,,,0,C7H14N2O3,CHEBI:16543,,"Human Metabolome Database (HMDB): N-Acetylornithine is a minor components of deproteinized blood plasma of human blood. Human blood plasma contains a variable amount of acetylornithine, averaging 1.1 +/- 0.4 mumol/l (range 0.8--0.2 mumol/l). Urine contains a very small amount of acetylornithine, approximately 1 nmol/mg creatinine (1 mumol/day). (PMID: 508804).",,N(2)-acetyl-L-ornithine,,HMDB03357,"InChI=1S/C7H14N2O3/c1-5(10)9-6(7(11)12)3-2-4-8/h6H,2-4,8H2,1H3,(H,9,10)(H,11,12)/t6-/m0/s1",C00437,2016-12-05T15:48:04Z,,240,,,,,439232,acorn,,"(2S)-2-acetamido-5-aminopentanoate, (2S)-2-acetamido-5-aminopentanoic acid, Acetyl-Ornithine, AOR, N(2)-Acetyl-L-ornithine, N2-Acetyl-L-ornithine",http://vmh.uni.lu/_api/metabolites/240/?format=pcsv
orn,,,1,C5H13N2O2,CHEBI:15729,,"Human Metabolome Database (HMDB): Ornithine is an amino acid produced in the urea cycle by the splitting off of urea from arginine. It is a central part of the urea cycle, which allows for the disposal of excess nitrogen. L-Ornithine is also a precursor of citrulline and arginine. In order for ornithine produced in the cytosol to be converted to citrulline, it must first cross the inner mitochondrial membrane into the mitochondrial matrix where it is carbamylated by ornithine transcarbamylase. This transfer is mediated by the mitochondrial ornithine transporter (SLC25A15; AF112968; ORNT1). Mutations in the mitochondrial ornithine transporter result in hyperammonemia, hyperornithinemia, homocitrullinuria (HHH) syndrome, a disorder of the urea cycle. (PMID 16256388) The pathophysiology of the disease may involve diminished ornithine transport into mitochondria, resulting in ornithine accumulation in the cytoplasm and reduced ability to clear carbamoyl phosphate and ammonia loads. (OMIM 838970).",,Ornithine,,HMDB00214,"InChI=1S/C5H12N2O2/c6-3-1-2-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/p+1",C00077,2016-12-05T15:48:04Z,,241,,,,,6262,orn,,"(+)-S-Ornithine, (S)-2,5-Diaminopentanoate, (S)-2,5-Diaminopentanoic acid, (S)-a,D-Diaminovalerate, (S)-a,D-Diaminovaleric acid, (S)-Ornithine, 5-Amino-L-Norvaline, L-(-)-Ornithine, L-Ornithine",http://vmh.uni.lu/_api/metabolites/241/?format=pcsv
icit,,,-3,C6H5O7,CHEBI:30887,,Human Metabolome Database (HMDB): The citrate oxidation to isocitrate is catalyzed by the enzyme aconitase. Human prostatic secretion is remarkably rich in citric acid and low aconitase activity will therefore play a significant role in enabling accumulation of high citrate levels (PubMed ID 8115279).,,Isocitrate,,HMDB00193,"InChI=1S/C6H8O7/c7-3(8)1-2(5(10)11)4(9)6(12)13/h2,4,9H,1H2,(H,7,8)(H,10,11)(H,12,13)/p-3",C00311,2016-12-05T15:48:04Z,,242,,,,isocitric acid,1198,icit,,"1-Hydroxy-1,2,3-propanetricarboxylate, 1-Hydroxy-1,2,3-propanetricarboxylic acid, 1-Hydroxypropane-1,2,3-tricarboxylate, 1-Hydroxypropane-1,2,3-tricarboxylic acid, 1-Hydroxytricarballylate, 1-Hydroxytricarballylic acid, 3-Carboxy-2,3-dideoxy-1-hydroxypropan-1,2,3-tricarboxylate, 3-Carboxy-2,3-dideoxy-1-hydroxypropan-1,2,3-tricarboxylic acid, 3-Carboxy-2,3-dideoxy-Pentarate, 3-Carboxy-2,3-dideoxy-Pentaric acid, D-Isocitrate, I-CIT, Isocitrate, Threo-D(S)-iso-citrate, Threo-Ds-isocitrate",http://vmh.uni.lu/_api/metabolites/242/?format=pcsv
dhcholoylcoa,,,-4,C48H74N7O19P3S,CHEBI:27393,,"3alpha,7alpha-Dihydroxy-5beta-cholest-24-enoyl-CoA",,"3alpha,7alpha-Dihydroxy-5beta-cholest-24-enoyl-CoA",,,"InChI=1S/C48H78N7O19P3S/c1-26(30-10-11-31-36-32(13-16-48(30,31)6)47(5)15-12-29(56)20-28(47)21-33(36)57)8-7-9-27(2)45(62)78-19-18-50-35(58)14-17-51-43(61)40(60)46(3,4)23-71-77(68,69)74-76(66,67)70-22-34-39(73-75(63,64)65)38(59)44(72-34)55-25-54-37-41(49)52-24-53-42(37)55/h9,24-26,28-34,36,38-40,44,56-57,59-60H,7-8,10-23H2,1-6H3,(H,50,58)(H,51,61)(H,66,67)(H,68,69)(H2,49,52,53)(H2,63,64,65)/t26-,28+,29-,30-,31+,32+,33-,34-,36+,38-,39-,40+,44-,47+,48-/m1/s1",C05447,2016-11-22T15:11:48Z,,243,,,,,5280796,dhcholoylcoa,,,http://vmh.uni.lu/_api/metabolites/243/?format=pcsv
thcholoylcoa,,,-4,C48H76N7O20P3S,CHEBI:27403,,"3alpha,7alpha,24-Trihydroxy-5beta-cholestanoyl-CoA",,"3alpha,7alpha,24-Trihydroxy-5beta-cholestanoyl-CoA",,,"InChI=1S/C48H80N7O20P3S/c1-25(29-8-9-30-36-31(12-15-48(29,30)6)47(5)14-11-28(56)19-27(47)20-33(36)58)7-10-32(57)26(2)45(63)79-18-17-50-35(59)13-16-51-43(62)40(61)46(3,4)22-72-78(69,70)75-77(67,68)71-21-34-39(74-76(64,65)66)38(60)44(73-34)55-24-54-37-41(49)52-23-53-42(37)55/h23-34,36,38-40,44,56-58,60-61H,7-22H2,1-6H3,(H,50,59)(H,51,62)(H,67,68)(H,69,70)(H2,49,52,53)(H2,64,65,66)/t25-,26?,27+,28-,29-,30+,31+,32?,33-,34-,36+,38-,39-,40+,44-,47+,48-/m1/s1",C05448,2016-11-22T15:11:48Z,,244,,,,,46224536,thcholoylcoa,,,http://vmh.uni.lu/_api/metabolites/244/?format=pcsv
cholcoas,,,-4,C48H76N7O20P3S,CHEBI:37643,,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoyl-CoA(S)",,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoyl-CoA(S)",,,"InChI=1S/C48H80N7O20P3S/c1-25(29-10-11-30-36-31(20-34(58)48(29,30)6)47(5)14-12-28(56)18-27(47)19-32(36)57)8-7-9-26(2)45(63)79-17-16-50-35(59)13-15-51-43(62)40(61)46(3,4)22-72-78(69,70)75-77(67,68)71-21-33-39(74-76(64,65)66)38(60)44(73-33)55-24-54-37-41(49)52-23-53-42(37)55/h23-34,36,38-40,44,56-58,60-61H,7-22H2,1-6H3,(H,50,59)(H,51,62)(H,67,68)(H,69,70)(H2,49,52,53)(H2,64,65,66)/t25-,26+,27+,28-,29-,30+,31+,32-,33-,34+,36+,38-,39-,40+,44-,47+,48-/m1/s1",C05448,2016-11-22T15:11:48Z,,245,,,,,15942888,cholcoas,,,http://vmh.uni.lu/_api/metabolites/245/?format=pcsv
cholcoads,,,-4,C48H74N7O20P3S,CHEBI:52432,,"Human Metabolome Database (HMDB): 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl-CoA is an intermediate in bile acid synthesis. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl-CoA",,HMDB06889,"InChI=1S/C48H78N7O20P3S/c1-25(29-10-11-30-36-31(20-34(58)48(29,30)6)47(5)14-12-28(56)18-27(47)19-32(36)57)8-7-9-26(2)45(63)79-17-16-50-35(59)13-15-51-43(62)40(61)46(3,4)22-72-78(69,70)75-77(67,68)71-21-33-39(74-76(64,65)66)38(60)44(73-33)55-24-54-37-41(49)52-23-53-42(37)55/h9,23-25,27-34,36,38-40,44,56-58,60-61H,7-8,10-22H2,1-6H3,(H,50,59)(H,51,62)(H,67,68)(H,69,70)(H2,49,52,53)(H2,64,65,66)/t25-,27+,28-,29-,30+,31+,32-,33-,34+,36+,38-,39-,40+,44-,47+,48-/m1/s1",C05460,2016-12-05T15:48:04Z,,246,,,,,5280797,cholcoads,,"(24E)-3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA, (24E)-3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-Coenzyme A, 3a,7a,12a-Trihydroxy-5b-cholest-24-enoyl CoA, 3a,7a,12a-Trihydroxy-5b-cholest-24-enoyl coenzyme A, 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl CoA, 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl coenzyme A, 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl-CoA, 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/246/?format=pcsv
fmn,,,-2,C17H19N4O9P,CHEBI:17621,,FMN,,FMN,,,"InChI=1S/C17H21N4O9P/c1-7-3-9-10(4-8(7)2)21(15-13(18-9)16(25)20-17(26)19-15)5-11(22)14(24)12(23)6-30-31(27,28)29/h3-4,11-12,14,22-24H,5-6H2,1-2H3,(H3,20,25,26,27,28,29)/p-3/t11-,12+,14-/m0/s1",C00061,2016-11-22T15:11:48Z,,247,,,,,643976,fmn,,,http://vmh.uni.lu/_api/metabolites/247/?format=pcsv
ribflv,,,0,C17H20N4O6,CHEBI:17015,,"Human Metabolome Database (HMDB): Riboflavin or vitamin B2 is an easily absorbed, water-soluble micronutrient with a key role in maintaining human health. Like the other B vitamins, it supports energy production by aiding in the metabolizing of fats, carbohydrates, and proteins. Vitamin B2 is also required for red blood cell formation and respiration, antibody production, and for regulating human growth and reproduction. It is essential for healthy skin, nails, hair growth and general good health, including regulating thyroid activity. Riboflavin is found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables. Riboflavin is yellow or orange-yellow in color and in addition to being used as a food coloring it is also used to fortify some foods. It can be found in baby foods, breakfast cereals, sauces, processed cheese, fruit drinks and vitamin-enriched milk products. The richest natural source is yeast. It occurs in the free form only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as flavin mononucleotide and flavin adenine dinucleotide.",,Riboflavin,,HMDB00244,,C00255,2016-12-05T15:48:04Z,,248,,,,,493570,ribflv,,"(-)-Riboflavin, 1-Deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-D-ribitol, 6,7-Dimethyl-9-D-ribitylisoalloxazine, 6,7-Dimethyl-9-ribitylisoalloxazine, 7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-Benzo[g]pteridine-2,4(3H,10H)-dione, Beflavin, Beflavine, Benzo[g]pteridine riboflavin deriv., E 101, Flavaxin, Flavin BB, Flaxain, Food Yellow 15, Hyre, Lactobene, Lactoflavin, Lactoflavine, Ribipca, Ribocrisina, Riboderm, Riboflavine, Ribosyn, Ribotone, Ribovel, Russupteridine yellow III, San Yellow B, Vitaflavine, Vitamin B2, Vitamin G, Vitasan B2",http://vmh.uni.lu/_api/metabolites/248/?format=pcsv
acrn,,,0,C9H17NO4,CHEBI:15960,,"Human Metabolome Database (HMDB): L-Acetylcarnitine is an acetic acid ester of carnitine that facilitates movement of acetyl CoA into the matrices of mammalian mitochondria during the oxidation of fatty acids. In addition to his metabolic role, acetyl-L-carnitine (ALC) posses unique neuroprotective, neuromodulatory, and neurotrophic properties this may play an important role in counteracting various disease processes. (PubMed ID 15363640).",,O-acetylcarnitine,,HMDB00201,"InChI=1S/C9H17NO4/c1-7(11)14-8(5-9(12)13)6-10(2,3)4/h8H,5-6H2,1-4H3/t8-/m1/s1",C02571,2016-12-05T15:48:04Z,,249,,,,,,acrn,,"(+-)-Acetylcarnitine, (-)-Acetylcarnitine, (R)-Acetylcarnitine, Acetyl-carnitine , Acetyl-L-(-)-carnitine, Acetyl-L-carnitine, Acetylcarnitine, ALCAR, L-Acetylcarnitine, L-Carnitine acetyl ester, L-O-Acetylcarnitine, Levocarnitine acetyl, Nicetile, O-Acetyl-L-carnitine, O-Acetylcarnitine",http://vmh.uni.lu/_api/metabolites/249/?format=pcsv
5moxact,,,-1,C11H10NO3,,,5-Methoxyindoleacetate,,5-Methoxyindoleacetate,,,"InChI=1/C11H11NO3/c1-15-8-2-3-10-9(5-8)7(6-12-10)4-11(13)14/h2-3,5-6,12H,4H2,1H3,(H,13,14)",C05660,2016-11-22T15:11:48Z,,250,,,,,18986,5moxact,,,http://vmh.uni.lu/_api/metabolites/250/?format=pcsv
Nacsertn,,,0,C12H14N2O2,CHEBI:17697,,N-acetylserotonin,,N-acetylserotonin,,,"InChI=1S/C12H14N2O2/c1-8(15)13-5-4-9-7-14-12-3-2-10(16)6-11(9)12/h2-3,6-7,14,16H,4-5H2,1H3,(H,13,15)",C00978,2016-11-22T15:11:48Z,,251,,,,,903,Nacsertn,,,http://vmh.uni.lu/_api/metabolites/251/?format=pcsv
melatn,,,0,C13H16N2O2,CHEBI:16796,,"Human Metabolome Database (HMDB): Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B.Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958. In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence the name), that is located in the center of the brain (rostro-dorsal to the superior colliculus) but outside the blood-brain barrier. The secretion of melatonin increases in darkness and decreases during exposure to light, thereby regulating the circadian rhythms of several biological functions, including the sleep-wake cycle. In particular, melatonin regulates the sleep-wake cycle by chemically causing drowsiness and. lowering the body temperature. Melatonin is also implicated in the regulation of mood,learning and memory, immune activity, dreaming, fertility and reproduction. Melatonin is also an effective antioxidant. Most of the actions of melatonin are mediated through the binding and activation of melatonin receptors. Individuals with autism spectrum disorders(ASD) may have lower than normal levels of melatonin. A 2008 study found that unaffected parents of individuals with ASD also have lower melatonin levels, and that the deficits. were associated with low activity of the ASMT gene, which encodes the last enzyme of melatonin synthesis. Reduced melatonin production has also been proposed as a likely factor in the significantly higher cancer rates in night workers.",,melatonin,,HMDB01389,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",C01598,2016-12-05T15:48:04Z,,252,,,,,896,melatn,,"5-Methoxy-N-acetyltryptamine, Circadin, Melatol, Melatonin, Melatonin (synth.) standard-grade, Melatonin (synth.) ultra-pure, Melatonine, Melovine, MT6, N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide, N-(2-(5-Methoxyindol-3-yl)ethyl)-Acetamide, N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide, N-Acetyl-5-methoxy-tryptamine, N-Acetyl-5-methoxy-tryptamine Melatonine, N-Acetyl-5-methoxytryptamine, N-[2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide, N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-Acetamide, N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide, N-[2-(5-Methoxyindol-3-yl)ethyl]-Acetamide, N-[2-(5-Methoxyindol-3-yl)ethyl]acetamide, Regulin, {N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-} Acetamide, {N-[2-(5-methoxyindol-3-yl)ethyl]-} Acetamide",http://vmh.uni.lu/_api/metabolites/252/?format=pcsv
acetol,,,0,C3H6O2,CHEBI:27957,,"Human Metabolome Database (HMDB): Hydroxyacetone is an intermediate in glycine, serine and threonine metabolism (KEGG: C05235). It is generated from methylglyoxal via the oxidoreductases [EC 1.1.1.-].",,hydroxyacetone,,HMDB06961,"InChI=1S/C3H6O2/c1-3(5)2-4/h4H,2H2,1H3",C05235,2016-12-05T15:48:04Z,,253,,,,,8299,acetol,,"1-Hydroxy-2-propanone, 2-Ketopropyl alcohol, Acetol, Acetone alcohol, Methylketol, Pyruvic alcohol, Pyruvinalcohol",http://vmh.uni.lu/_api/metabolites/253/?format=pcsv
13dpg,,,-4,C3H4O10P2,CHEBI:16001,,3-Phospho-D-glyceroyl phosphate,,3-Phospho-D-glyceroyl phosphate,,,"1/C3H8O10P2/c4-2(1-12-14(6,7)8)3(5)13-15(9,10)11/h2,4H,1H2,(H2,6,7,8)(H2,9,10,11)/t2-/m1/s1/f/h6-7,9-10H",C00236,2016-11-22T15:11:48Z,,254,,,,3-phospho-D-glyceroyl dihydrogen phosphate;D-glyceraldehyde 3-phosphate,439191,13dpg,,,http://vmh.uni.lu/_api/metabolites/254/?format=pcsv
3pg,,,-3,C3H4O7P,CHEBI:17794,,3-Phospho-D-glycerate,,3-Phospho-D-glycerate,,,"InChI=1S/C3H7O7P/c4-2(3(5)6)1-10-11(7,8)9/h2,4H,1H2,(H,5,6)(H2,7,8,9)/p-3/t2-/m1/s1",C00597,2016-11-22T15:11:48Z,,255,,,,,439183,3pg,,,http://vmh.uni.lu/_api/metabolites/255/?format=pcsv
ins,,,0,C10H12N4O5,CHEBI:17596,,"Human Metabolome Database (HMDB): Inosine is a purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed).",,Inosine,,HMDB00195,"InChI=1S/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s1",C00294,2016-12-05T15:48:04Z,,256,,,,,6021,ins,,"(-)-Inosine, 1,9-Dihydro-9-b-D-ribofuranosyl-6H-Purin-6-one, 1,9-Dihydro-9-beta-D-ribofuranosyl-6H-purin-6-one, 1,9-Dihydro-9-beta-delta-ribofuranosyl-6H-purin-6-one, 9-b-D-Ribofuranosyl-Hypoxanthine, 9-b-D-Ribofuranosylhypoxanthine, 9-beta-D-Ribofuranosyl-Hypoxanthine, 9-beta-D-Ribofuranosylhypoxanthine, 9-beta-delta-Ribofuranosyl-Hypoxanthine, 9-beta-delta-Ribofuranosylhypoxanthine, 9beta-D-Ribofuranosylhypoxanthine, 9beta-delta-Ribofuranosylhypoxanthine, Atorel, beta-D-Ribofuranoside hypoxanthine-9, beta-delta-Ribofuranoside hypoxanthine-9, beta-Inosine, HXR, Hypoxanthine 9-beta-D-ribofuranoside, Hypoxanthine 9-beta-delta-ribofuranoside, Hypoxanthine D-riboside, Hypoxanthine nucleoside, Hypoxanthine ribonucleoside, Hypoxanthine riboside, Hypoxanthine-9 beta-D-Ribofuranoside, Hypoxanthine-9 beta-delta-Ribofuranoside, Hypoxanthine-9-beta-D-ribofuranoside, Hypoxanthine-9-beta-delta-ribofuranoside, Hypoxanthine-9-D-ribofuranoside, Hypoxanthine-9-delta-ribofuranoside, Hypoxanthine-ribose, Hypoxanthosine, Indole-3-carboxaldehyde, Ino, Inosie, Iso-prinosine, Oxiamin, Panholic-L, Pantholic-L, Ribonosine, Selfer, Trophicardyl",http://vmh.uni.lu/_api/metabolites/256/?format=pcsv
ade,,,0,C5H5N5,CHEBI:16708,,"Human Metabolome Database (HMDB): Adenine is a purine base. Adenine is found in both DNA and RNA. Adenine is a fundamental component of adenine nucleotides. Adenine forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose; it forms adenosine triphosphate (ATP), a nucleotide, when three phosphate groups are added to adenosine. Adenosine triphosphate is used in cellular metabolism as one of the basic methods of transferring chemical energy between chemical reactions. Purine inborn errors of metabolism (IEM) are serious hereditary disorders, which should be suspected in any case of neonatal fitting, failure to thrive, recurrent infections, neurological deficit, renal disease, self-mutilation and other manifestations. Investigation usually starts with uric acid (UA) determination in urine and plasma. (OMIM 300322, 229600, 603027, 232400, 232600, 232800, 201450, 220150, 232200, 162000, 164050, 278300). (PMID: 17052198, 17520339).",,Adenine,,HMDB00034,"InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10)",C00147,2016-12-05T15:48:04Z,,257,,,,,190,ade,,"1,6-Dihydro-6-iminopurine, 1H-Purin-6-amine, 1H-Purine-6-amine, 3,6-Dihydro-6-iminopurine, 6-Amino-1H-purine, 6-Amino-3H-purine, 6-Amino-7H-purine, 6-Amino-9H-purine, 6-Amino-Purine, 6-Aminopurine, 9H-Purin-6-amine, 9H-Purin-6-yl-amin, 9H-Purin-6-ylamine, 9H-Purine-6-amine, Ade, Adenin, Adenine, Adeninimine, Vitamin B4",http://vmh.uni.lu/_api/metabolites/257/?format=pcsv
adhap_hs,,,-2,C3H4O6PFULLRCO,CHEBI:15835,,acyl-dihydroxyacetone phosphate,,acyl-dihydroxyacetone phosphate,,,,,2016-11-22T15:11:48Z,,258,,,,,,adhap_hs,,,http://vmh.uni.lu/_api/metabolites/258/?format=pcsv
gtp,,,-4,C10H12N5O14P3,CHEBI:15996,,"Human Metabolome Database (HMDB): Guanosine triphosphate (GTP) is a guanine nucleotide containing three phosphate groups esterified to the sugar moiety. GTP functions as a carrier of phosphates and pyrophosphates involved in channeling chemical energy into specific biosynthetic pathways. GTP activates the signal transducing G proteins which are involved in various cellular processes including proliferation, differentiation, and activation of several intracellular kinase cascades. Proliferation and apoptosis are regulated in part by the hydrolysis of GTP by small GTPases Ras and Rho. Another type of small GTPase, Rab, plays a role in the docking and fusion of vesicles and may also be involved in vesicle formation. In addition to its role in signal transduction, GTP also serves as an energy-rich precursor of mononucleotide units in the enzymatic biosynthesis of DNA and RNA.",,GTP,,HMDB01273,"InChI=1S/C10H16N5O14P3/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,18)/p-4/t3-,5-,6-,9-/m1/s1",C00044,2016-12-05T15:48:04Z,,259,,,,GTP,6830,gtp,,"5'-GTP, GTG, GTP, Guanosine 5'-(tetrahydrogen triphosphate), Guanosine 5'-triphosphate, Guanosine 5'-triphosphorate, Guanosine 5'-triphosphoric acid, Guanosine mono(tetrahydrogen triphosphate) (ester), Guanosine Triphosphate, H4gtp",http://vmh.uni.lu/_api/metabolites/259/?format=pcsv
gdp,,,-3,C10H12N5O11P2,CHEBI:17552,,"Human Metabolome Database (HMDB): Guanosine 5'-(trihydrogen diphosphate). A guanine nucleotide containing two phosphate groups esterified to the sugar moiety. It is an ester of pyrophosphoric acid with the nucleoside guanosine. GDP consists of the pyrophosphate group, the pentose sugar ribose, and the nucleobase guanine. GDP is the product of GTP dephosphorylation by GTPases, e.g. the G-proteins that are involved in signal transduction.",,GDP,,HMDB01201,"InChI=1S/C10H15N5O11P2/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(25-9)1-24-28(22,23)26-27(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H2,19,20,21)(H3,11,13,14,18)/p-3/t3-,5-,6-,9-/m1/s1",C00035,2016-12-05T15:48:04Z,,260,,,,GDP,8977,gdp,,"5'-GDP, GDP, Guanosine 5'-(trihydrogen pyrophosphate), Guanosine 5'-diphosphate, Guanosine 5'-pyrophosphate, Guanosine mono(trihydrogen diphosphate), Guanosine pyrophosphate, Guanosine-5'-diphosphate, Guanosine-diphosphate, PpG",http://vmh.uni.lu/_api/metabolites/260/?format=pcsv
damp,,,-2,C10H12N5O6P,CHEBI:17713,,dAMP(2-),,dAMP(2-),,,"InChI=1S/C10H14N5O6P/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(21-7)2-20-22(17,18)19/h3-7,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)/p-2/t5-,6+,7+/m0/s1",C00360,2016-11-22T15:11:48Z,,261,,,,,12599,damp,,,http://vmh.uni.lu/_api/metabolites/261/?format=pcsv
datp,,,-4,C10H12N5O12P3,CHEBI:16284,,"Human Metabolome Database (HMDB): Deoxyadenosine triphosphate (dATP) is a purine nucleoside triphosphate used in cells for DNA synthesis. A nucleoside triphosphate is a molecule type that contains a nucleoside with three phosphates bound to it. dATP contains the sugar deoxyribose, a precursor in DNA synthesis whereby the two existing phosphate groups are cleaved with the remaining deoxyadenosine monophosphate being incorporated into DNA during replication. Due to its enzymatic incorporation into DNA, photoreactive dATP analogs such as N6-[4-azidobenzoylâ€“(2-aminoethyl)]-2?-deoxyadenosine-5?-triphosphate (AB-dATP) and N6-[4-[3-(trifluoromethyl)-diazirin-3-yl]benzoyl-(2-aminoethyl)]-2?-deoxyadenosine-5?-triphosphate (DB-dATP) have been used for DNA photoaffinity labeling. ",,dATP,,HMDB01532,"InChI=1S/C10H16N5O12P3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(25-7)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H,22,23)(H2,11,12,13)(H2,17,18,19)/p-4/t5-,6+,7+/m0/s1",C00131,2016-12-05T15:48:04Z,,262,,,,,15993,datp,,"2'-Deoxy-5'-ATP, 2'-Deoxy-ATP, 2'-Deoxyadenosine 5'-triphosphate, 2'-Deoxyadenosine triphosphate, dATP, Deoxy-ATP, Deoxyadenosine 5'-triphosphate, Deoxyadenosine triphosphate, Deoxyadenosine-triphosphate",http://vmh.uni.lu/_api/metabolites/262/?format=pcsv
dadp,,,-3,C10H12N5O9P2,CHEBI:16174,,"Human Metabolome Database (HMDB): Deoxyadenosine diphosphate has been identified in the mononuclear cells of a patient affected with in inherited adenosine deaminase deficiency (OMIM 102700) (PMID 6980023), and in in mononuclear cells of hemodialyzed patients. (PMID 11461945).",,dADP,,HMDB01508,"InChI=1S/C10H15N5O9P2/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(23-7)2-22-26(20,21)24-25(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H2,11,12,13)(H2,17,18,19)/p-3/t5-,6+,7+/m0/s1",C00206,2016-12-05T15:48:04Z,,263,,,,,188966,dadp,,"2'-Deoxyadenosine-5'-diphosphate, dADP, Deoxyadenosine diphosphate",http://vmh.uni.lu/_api/metabolites/263/?format=pcsv
ametam,,,2,C14H24N6O3S,CHEBI:15625,,"Human Metabolome Database (HMDB): S-Adenosylmethioninamine is a biological sulfonium compound known as the major biological methyl donor. It is also a donor of methylene groups, amino groups, ribosyl groups and aminopropyl groups (PMID 15130560). S-Adenosylmethioninamine is a prodcut of enzyme adenosylmethionine decarboxylase [EC 4.1.1.50] in methionine metabolism pathway (KEGG).",,S-Adenosylmethioninamine,,HMDB00988,"InChI=1S/C14H23N6O3S/c1-24(4-2-3-15)5-8-10(21)11(22)14(23-8)20-7-19-9-12(16)17-6-18-13(9)20/h6-8,10-11,14,21-22H,2-5,15H2,1H3,(H2,16,17,18)/q+1/p+1/t8-,10-,11-,14-,24?/m1/s1",C01137,2016-12-05T15:48:04Z,,264,,,,,439415,ametam,,"(5-deoxy-5-adenosyl)(3-aminopropyl) methylsulfonium salt, DAdoMet, Decarboxylated AdoMet, Decarboxylated S-adenosylmethionine, Decarboxylated SAM, S-Adenosyl-L-methioninamine, S-Adenosylmethioninamine",http://vmh.uni.lu/_api/metabolites/264/?format=pcsv
camp,,,-1,C10H11N5O6P,CHEBI:17489,,"Human Metabolome Database (HMDB): Cyclic AMP is an adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. cAMP is synthesized from ATP by adenylate cyclase. Adenylate cyclase is located at the cell membranes. Adenylate cyclase is activated by the hormones glucagon and adrenaline and by G protein. Liver adenylate cyclase responds more strongly to glucagon, and muscle adenylate cyclase responds more strongly to adrenaline. cAMP decomposition into AMP is catalyzed by the enzyme phosphodiesterase.",,"3',5'-cyclic AMP(1-)",,HMDB00058,"InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/p-1/t4-,6-,7-,10-/m1/s1",C00575,2016-12-05T15:48:04Z,,265,,,,cAMP,6076,camp,,"3'5'-Cyclic AMP, 6-(6-Amino-9H-purin-9-yl)tetrahydro-4H-furo[3,2-D][1,3,2]dioxaphosphinine-2,7-diol 2-oxide, Acrasin, Adenosine 3',5'-cyclic monophosphate, Adenosine 3',5'-cyclic phosphate, Adenosine 3',5'-cyclophosphate, Adenosine 3',5'-monophosphate, Adenosine 3,5'-cyclic monophosphorate, Adenosine 3,5'-cyclic monophosphoric acid, Adenosine cyclic monophosphate, Adenosine cyclic-monophosphate, Adenosine-cyclic-phosphate, Adenosine-cyclic-phosphoric-acid, cAMP, Cyclic 3',5'-adenylate, Cyclic 3',5'-adenylic acid, Cyclic 3',5'-AMP, Cyclic adenosine 3',5'-phosphate, Cyclic AMP",http://vmh.uni.lu/_api/metabolites/265/?format=pcsv
adpglc,,,-2,C16H23N5O15P2,CHEBI:15751,,"Human Metabolome Database (HMDB): Serves as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants.",,ADP alpha-D-glucoside(2-),,HMDB06557,"InChI=1S/C16H25N5O15P2/c17-13-7-14(19-3-18-13)21(4-20-7)15-11(26)9(24)6(33-15)2-32-37(28,29)36-38(30,31)35-16-12(27)10(25)8(23)5(1-22)34-16/h3-6,8-12,15-16,22-27H,1-2H2,(H,28,29)(H,30,31)(H2,17,18,19)/p-2/t5-,6-,8-,9-,10+,11-,12-,15-,16-/m1/s1",C00498,2016-12-05T15:48:04Z,,266,,,,,16500,adpglc,,"Adenosine 5'-(trihydrogen diphosphate) glucopyranosyl ester, Adenosine 5'-(trihydrogen diphosphate) P'-alpha-delta-glucopyranosyl ester, Adenosine 5'-(trihydrogen pyrophosphate) mono-D-glucosyl ester, Adenosine 5'-(trihydrogen pyrophosphate) mono-delta-glucosyl ester, Adenosine 5'-diphosphoglucose, Adenosine 5'-pyrophosphate a-delta-glucosyl ester, Adenosine 5'-pyrophosphate alpha-D-glucosyl ester, Adenosine 5'-pyrophosphate alpha-delta-glucosyl ester, Adenosine 5'-pyrophosphate glucosyl ester, Adenosine 5'-pyrophosphate mono-D-glucosyl ester, Adenosine 5'-pyrophosphate mono-delta-glucosyl ester, Adenosine diphosphate D-glucose, Adenosine diphosphate glucose, Adenosine diphosphoglucose, Adenosine pyrophosphate-glucose, Adenosine-5'-diphosphate-glucose, ADP-D-Glucose, ADP-Glucose",http://vmh.uni.lu/_api/metabolites/266/?format=pcsv
g1p,,,-2,C6H11O9P,CHEBI:16077,,D-Glucose 1-phosphate,,D-Glucose 1-phosphate,,,"InChI=1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/p-2/t2-,3-,4+,5-,6-/m1/s1",C00103,2016-11-22T15:11:48Z,,267,,,,,65533,g1p,,,http://vmh.uni.lu/_api/metabolites/267/?format=pcsv
adpman,,,-2,C16H23N5O15P2,CHEBI:28845,,"Human Metabolome Database (HMDB): ADP-mannose is one of the major substrates of human hydrolases. Nudix hydrolases catalyze the hydrolysis of a variety of nucleoside diphosphate derivatives, and ADP-sugar pyrophosphatase are non-specific nucleoside diphosphosugar or diphosphoalcohol (NDP-X) pyrophosphatases, which hydrolyse some nonreducing NDP-X substrates. It has been found in erythrocytes, placenta and liver. (PMID: 1128712, 10722730, 9693963).",,ADPmannose,,HMDB06369,"InChI=1S/C16H25N5O15P2/c17-13-7-14(19-3-18-13)21(4-20-7)15-11(26)9(24)6(33-15)2-32-37(28,29)36-38(30,31)35-16-12(27)10(25)8(23)5(1-22)34-16/h3-6,8-12,15-16,22-27H,1-2H2,(H,28,29)(H,30,31)(H2,17,18,19)/t5-,6-,8-,9-,10+,11-,12+,15-,16-/m1/s1",C06192,2016-12-05T15:48:04Z,,268,,,,,440940,adpman,,"Adenosine diphosphate-mannose, Apd-D-mannose",http://vmh.uni.lu/_api/metabolites/268/?format=pcsv
man1p,,,-2,C6H11O9P,CHEBI:35374,,"Human Metabolome Database (HMDB): D-Mannose 1-phosphate is a normal metabolite intermediate in the Fructose and mannose metabolism, and substrate of phosphomannomutase 1(PMM, EC: 5.4.2.8), an enzyme necessary for the synthesis of GDP-mannose. PMM converts mannose 6-phosphate to mannose-1-phosphate, which is required for the synthesis of GDP-mannose, a substrate for dolichol-linked oligosaccharide synthesis. Deficiency of phosphomannomutase in Carbohydrate-deficient glycoprotein syndrome (CDGS, a group of autosomal recessively transmitted disorders in which abnormally glycosylated proteins are formed) type 1 is associated with decreased synthesis of mannose 1-phosphate. (PMID: 9451026, 8549746, 12729595).",,D-Mannose 1-phosphate,,HMDB06330,"InChI=1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/t2-,3-,4+,5+,6?/m1/s1",C00636,2016-12-05T15:48:04Z,,269,,,,,644175,man1p,,"1-(Dihydrogen phosphate)-D-Mannopyranose, 1-(Dihydrogen phosphate)-delta-Mannopyranose, alpha-D-Mannose 1-phosphate, alpha-delta-Mannose 1-phosphate, D-Mannose 1-phosphates, D-Mannose-1-phosphate, delta-Mannose 1-phosphates, delta-Mannose-1-phosphate, Mannose 1-phosphate, Mannose 1-phosphate-Mannopyranose, Mannose-1-P",http://vmh.uni.lu/_api/metabolites/269/?format=pcsv
adprib,,,-2,C15H21N5O14P2,CHEBI:16960,,ADPribose,,ADPribose,,,"InChI=1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)/p-2/t5-,6-,8-,9-,10-,11-,14-,15?/m1/s1",C00301,2016-11-22T15:11:48Z,,270,,,,,445794,adprib,,,http://vmh.uni.lu/_api/metabolites/270/?format=pcsv
r5p,,,-2,C5H9O8P,CHEBI:17797,,alpha-D-Ribose 5-phosphate,,alpha-D-Ribose 5-phosphate,,,"InChI=1S/C5H11O8P/c6-3-2(1-12-14(9,10)11)13-5(8)4(3)7/h2-8H,1H2,(H2,9,10,11)/t2-,3-,4-,5+/m1/s1",C03736,2016-11-22T15:11:48Z,,271,,,,Ribulose-5-phosphate,440101,r5p,,,http://vmh.uni.lu/_api/metabolites/271/?format=pcsv
prpp,,,-5,C5H8O14P3,CHEBI:17111,,5-Phospho-alpha-D-ribose 1-diphosphate,,5-Phospho-alpha-D-ribose 1-diphosphate,,,"InChI=1S/C5H13O14P3/c6-3-2(1-16-20(8,9)10)17-5(4(3)7)18-22(14,15)19-21(11,12)13/h2-7H,1H2,(H,14,15)(H2,8,9,10)(H2,11,12,13)/p-5/t2-,3-,4-,5-/m1/s1",C00119,2016-11-22T15:11:48Z,,272,,,,,7339,prpp,,,http://vmh.uni.lu/_api/metabolites/272/?format=pcsv
adrncoa,,,-4,C43H66N7O17P3S,CHEBI:63544,,adrenyl coenzyme A,,adrenyl coenzyme A,,,"InChI=1/C43H70N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-34(52)71-27-26-45-33(51)24-25-46-41(55)38(54)43(2,3)29-64-70(61,62)67-69(59,60)63-28-32-37(66-68(56,57)58)36(53)42(65-32)50-31-49-35-39(44)47-30-48-40(35)50/h8-9,11-12,14-15,17-18,30-32,36-38,42,53-54H,4-7,10,13,16,19-29H2,1-3H3,(H,45,51)(H,46,55)(H,59,60)(H,61,62)(H2,44,47,48)(H2,56,57,58)/b9-8-,12-11-,15-14-,18-17-/t32-,36-,37-,38?,42-/m1/s1",C16170,2016-11-22T15:11:48Z,,273,,,,,,adrncoa,,,http://vmh.uni.lu/_api/metabolites/273/?format=pcsv
crn,,,0,C7H15NO3,CHEBI:16347,,"Human Metabolome Database (HMDB): Carnitine is not an essential amino acid; it can be synthesized in the body. However, it is so important in providing energy to muscles including the heart-that some researchers are now recommending carnitine supplements in the diet, particularly for people who do not consume much red meat, the main food source for carnitine. Carnitine has been described as a vitamin, an amino acid, or a metabimin, i.e., an essential metabolite. Like the B vitamins, carnitine contains nitrogen and is very soluble in water, and to some researchers carnitine is a vitamin (Liebovitz 1984). It was found that an animal (yellow mealworm) could not grow without carnitine in its diet. However, as it turned out, almost all other animals, including humans, do make their own carnitine; thus, it is no longer considered a vitamin. Nevertheless, in certain circumstances-such as deficiencies of methionine, lysine or vitamin C or kidney dialysis--carnitine shortages develop. Under these conditions, carnitine must be absorbed from food, and for this reason it is sometimes referred to as a ""metabimin"" or a conditionally essential metabolite. Like the other amino acids used or manufactured by the body, carnitine is an amine. But like choline, which is sometimes considered to be a B vitamin, carnitine is also an alcohol (specifically, a trimethylated carboxy-alcohol). Thus, carnitine is an unusual amino acid and has different functions than most other amino acids, which are most usually employed by the body in the construction of protein. Carnitine is an essential factor in fatty acid metabolism in mammals. It's most important known metabolic function is to transport fat into the mitochondria of muscle cells, including those in the heart, for oxidation. This is how the heart gets most of its energy. In humans, about 25% of carnitine is synthesized in the liver, kidney and brain from the amino acids lysine and methionine. Most of the carnitine in the body comes from dietary sources such as red meat and dairy products. Inborn errors of carnitine metabolism can lead to brain deterioration like that of Reye's syndrome, gradually worsening muscle weakness, Duchenne-like muscular dystrophy and extreme muscle weakness with fat accumulation in muscles. Borurn et al. (1979) describe carnitine as an essential nutrient for pre-term babies, certain types (non-ketotic) of hypoglycemics, kidney dialysis patients, cirrhosis, and in kwashiorkor, type IV hyperlipidemia, heart muscle disease (cardiomyopathy), and propionic or organic aciduria (acid urine resulting from genetic or other anomalies). In all these conditions and the inborn errors of carnitine metabolism, carnitine is essential to life and carnitine supplements are valuable. carnitine therapy may also be useful in a wide variety of clinical conditions. carnitine supplementation has improved some patients who have angina secondary to coronary artery disease. It may be worth a trial in any form of hyperlipidemia or muscle weakness. carnitine supplements may be useful in many forms of toxic or metabolic liver disease and in cases of heart muscle disease. Hearts undergoing severe arrhythmia quickly deplete their stores of carnitine. Athletes, particularly in Europe, have used carnitine supplements for improved endurance. carnitine may improve muscle building by improving fat utilization and may even be useful in treating obesity. carnitine joins a long list of nutrients which may be of value in treating pregnant women, hypothyroid individuals, and male infertility due to low motility of sperm. Even the Physician's Desk Reference gives indication for carnitine supplements as ""improving the tolerance of ischemic heart disease, myocardial insufficiencies, and type IV hyperlipoproteinemia. carnitine deficiency is noted in abnormal liver function, renal dialysis patients, and severe to moderate muscular weakness with associated anorexia."" (http://www.dcnutrition.com).",,L-Carnitine,,HMDB00062,"InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m1/s1",C15025,2016-12-05T15:48:04Z,,274,,,,,10917,crn,,"(-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate, (-)-carnitine, (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, (R)-carnitine, (S)-carnitine, 1-Carnitine, 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium, 3-Hydroxy-4-trimethylammoniobutanoate, 3-Hydroxy-4-trimethylammoniobutanoic acid, Bicarnesine, Carniking, Carniking 50, Carnilean, Carnipass, Carnipass 20, Carnitene, Carnitine, Carnitor, D-Carnitine, delta-Carnitine, DL-carnitine, gamma-Trimethyl-ammonium-beta-hydroxybutirate, gamma-Trimethyl-beta-hydroxybutyrobetaine, gamma-Trimethyl-hydroxybutyrobetaine, Karnitin, L-(-)-Carnitine, L-Carnitine, L-gamma-Trimethyl-beta-hydroxybutyrobetaine, Levocarnitina, Levocarnitine, Levocarnitinum, R-(-)-3-Hydroxy-4-trimethylaminobutyrate, Vitamin BT",http://vmh.uni.lu/_api/metabolites/274/?format=pcsv
adrncrn,,,0,C29H49NO4,,,Adrenyl carnitine,,Adrenyl carnitine,,,,,2016-11-22T15:11:48Z,,275,,,,,53477825,adrncrn,,,http://vmh.uni.lu/_api/metabolites/275/?format=pcsv
adrn,,,-1,C22H35O2,CHEBI:53487,,"Human Metabolome Database (HMDB): Adrenic acid, which is a prostacyclin inhibitor, appears to be potential prothrombotic agent. (PMID 1642692).",,adrenic acid,,HMDB02226,"InChI=1S/C22H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-21H2,1H3,(H,23,24)/b7-6-,10-9-,13-12-,16-15-",C16527,2016-12-05T15:48:04Z,,276,,,,,5497181,adrn,,"7,10,13,16-Docosatetraenoate, 7,10,13,16-Docosatetraenoic acid, 7,10,13,16-Docosatetraenoic acid (VAN) Adrenate, 7,10,13,16-Docosatetraenoic acid (VAN) Adrenic acid, 7Z,10Z,13Z,16Z-Docosatetraenoate, 7Z,10Z,13Z,16Z-Docosatetraenoic acid, Adrenate",http://vmh.uni.lu/_api/metabolites/276/?format=pcsv
adsel,,,-2,C10H12N5O10PSe,,,Adenylylselenate,,Adenylylselenate,,,"InChI=1/C10H14N5O10PSe/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-26(18,19)25-27(20,21)22/h2-4,6-7,10,16-17H,1H2,(H,18,19)(H2,11,12,13)(H,20,21,22)/t4-,6-,7-,10-/m1/s1",C05686,2016-11-22T15:11:48Z,,277,,,,,440758,,,,http://vmh.uni.lu/_api/metabolites/277/?format=pcsv
3padsel,,,-4,C10H11N5O13P2Se,,,3'-Phosphoadenylylselenate,,3'-Phosphoadenylylselenate,,,"InChI=1/C10H15N5O13P2Se/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7(27-29(17,18)19)4(26-10)1-25-30(20,21)28-31(22,23)24/h2-4,6-7,10,16H,1H2,(H,20,21)(H2,11,12,13)(H2,17,18,19)(H,22,23,24)/t4-,6-,7-,10-/m1/s1",C05696,2016-11-22T15:11:48Z,,278,,,,,24892762,,,,http://vmh.uni.lu/_api/metabolites/278/?format=pcsv
aps,,,-2,C10H12N5O10PS,CHEBI:17709,,5'-adenylyl sulfate(2-),,5'-adenylyl sulfate(2-),,,"InChI=1S/C10H14N5O10PS/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-26(18,19)25-27(20,21)22/h2-4,6-7,10,16-17H,1H2,(H,18,19)(H2,11,12,13)(H,20,21,22)/p-2/t4-,6-,7-,10-/m1/s1",C00224,2016-11-22T15:11:48Z,,279,,,,,10238,aps,,,http://vmh.uni.lu/_api/metabolites/279/?format=pcsv
dcamp,,,-4,C14H14N5O11P,CHEBI:15919,,"N6-(1,2-Dicarboxyethyl)-AMP",,"N6-(1,2-Dicarboxyethyl)-AMP",,,"InChI=1S/C14H18N5O11P/c20-7(21)1-5(14(24)25)18-11-8-12(16-3-15-11)19(4-17-8)13-10(23)9(22)6(30-13)2-29-31(26,27)28/h3-6,9-10,13,22-23H,1-2H2,(H,20,21)(H,24,25)(H,15,16,18)(H2,26,27,28)/p-4/t5?,6-,9-,10-,13-/m1/s1",C03794,2016-11-22T15:11:48Z,,280,,,,,447145,dcamp,,,http://vmh.uni.lu/_api/metabolites/280/?format=pcsv
fum,,,-2,C4H2O4,CHEBI:18012,,"Human Metabolome Database (HMDB): Fumaric acid is a precursor to L-malate in the Krebs tricarboxylic acid cycle. It is formed by the oxidation of succinate by succinate dehydrogenase. Fumarate is converted by fumarase to malate. A fumarate is a salt or ester of the organic compound fumaric acid, a dicarboxylic acid. (wikipedia).",,Fumarate,,HMDB00134,"InChI=1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/p-2/b2-1+",C00122,2016-12-05T15:48:04Z,,281,,,,,444972,fum,,"(2E)-But-2-enedioate, (2E)-But-2-enedioic acid, (E)-2-Butenedioate, (E)-2-Butenedioic acid, 2-(E)-Butenedioate, 2-(E)-Butenedioic acid, Allomaleate, Allomaleic acid, Boletate, Boletic acid, FC 33, Fumarate, Fumaric acid, Lichenate, Lichenic acid, Sodium fumarate, trans-1,2-Ethylenedicarboxylate, trans-1,2-Ethylenedicarboxylic acid, trans-2-Butenedioate, trans-2-Butenedioic acid, trans-Butenedioate, trans-Butenedioic acid",http://vmh.uni.lu/_api/metabolites/281/?format=pcsv
25aics,,,-4,C13H15N4O12P,CHEBI:18319,,(S)-2-[5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido]succinate,,(S)-2-[5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido]succinate,,,"InChI=1S/C13H19N4O12P/c14-10-7(11(22)16-4(13(23)24)1-6(18)19)15-3-17(10)12-9(21)8(20)5(29-12)2-28-30(25,26)27/h3-5,8-9,12,20-21H,1-2,14H2,(H,16,22)(H,18,19)(H,23,24)(H2,25,26,27)/p-4/t4?,5-,8-,9-,12-/m1/s1",C04823,2016-11-22T15:11:48Z,,282,,,,,160666,25aics,,,http://vmh.uni.lu/_api/metabolites/282/?format=pcsv
aicar,,,-2,C9H13N4O8P,CHEBI:18406,,5-Amino-1-(5-Phospho-D-ribosyl)imidazole-4-carboxamide,,5-Amino-1-(5-Phospho-D-ribosyl)imidazole-4-carboxamide,,,"InChI=1S/C9H15N4O8P/c10-7-4(8(11)16)12-2-13(7)9-6(15)5(14)3(21-9)1-20-22(17,18)19/h2-3,5-6,9,14-15H,1,10H2,(H2,11,16)(H2,17,18,19)/p-2/t3-,5-,6-,9-/m1/s1",C04677,2016-11-22T15:11:48Z,,283,,,,,65110,aicar,,,http://vmh.uni.lu/_api/metabolites/283/?format=pcsv
imp,,,-2,C10H11N4O8P,CHEBI:17202,,Human Metabolome Database (HMDB): Inosinic acid is a purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. Inosinic acid is a nucleotide present in muscle and other tissues. It is formed by the deamination of AMP and when hydrolysed produces inosine. Inosinic acid is the ribonucleotide of hypoxanthine and is the first compound formed during the synthesis of purine. (Wikipedia).,,IMP,,HMDB00175,"InChI=1S/C10H13N4O8P/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20)/p-2/t4-,6-,7-,10-/m1/s1",C00130,2016-12-05T15:48:04Z,,284,,,,,8582,imp,,"5'-IMP, 5'-Inosinate, 5'-Inosine monophosphate, 5'-Inosinic acid, IMP, Inosine 5'-monophosphate, Inosine 5'-phosphate, Inosine Monophosphate, Inosine-5'-monophosphate",http://vmh.uni.lu/_api/metabolites/284/?format=pcsv
aflatoxin,,,0,C17H12O6,CHEBI:2504,,aflatoxin B1,,aflatoxin B1,,,"InChI=1S/C17H12O6/c1-20-10-6-11-14(8-4-5-21-17(8)22-11)15-13(10)7-2-3-9(18)12(7)16(19)23-15/h4-6,8,17H,2-3H2,1H3/t8-,17+/m0/s1",C06800,2016-11-22T15:11:48Z,,285,,,,,186907,aflatoxin,,,http://vmh.uni.lu/_api/metabolites/285/?format=pcsv
ksi_pre18,,,-6,C163H262N11O132S5X,,,"keratan sulfate I biosynthesis, precursor 18",,"keratan sulfate I biosynthesis, precursor 18",,,,,2016-11-22T15:11:48Z,,286,,,,,,ksi_pre18,,,http://vmh.uni.lu/_api/metabolites/286/?format=pcsv
ksi_pre19,,,-6,C171H275N12O137S5X,,,"keratan sulfate I biosynthesis, precursor 19",,"keratan sulfate I biosynthesis, precursor 19",,,,,2016-11-22T15:11:48Z,,287,,,,,,ksi_pre19,,,http://vmh.uni.lu/_api/metabolites/287/?format=pcsv
ksi_pre21,,,-7,C177H284N12O145S6X,,,"keratan sulfate I biosynthesis, precursor 21",,"keratan sulfate I biosynthesis, precursor 21",,,,,2016-11-22T15:11:48Z,,288,,,,,,ksi_pre21,,,http://vmh.uni.lu/_api/metabolites/288/?format=pcsv
ksi_pre22,,,-7,C185H297N13O150S6X,,,"keratan sulfate I biosynthesis, precursor 22",,"keratan sulfate I biosynthesis, precursor 22",,,,,2016-11-22T15:11:49Z,,289,,,,,,ksi_pre22,,,http://vmh.uni.lu/_api/metabolites/289/?format=pcsv
ksi_pre24,,,-8,C191H306N13O158S7X,,,"keratan sulfate I biosynthesis, precursor 24",,"keratan sulfate I biosynthesis, precursor 24",,,,,2016-11-22T15:11:49Z,,290,,,,,,ksi_pre24,,,http://vmh.uni.lu/_api/metabolites/290/?format=pcsv
ksi_pre25,,,-8,C199H319N14O163S7X,,,"keratan sulfate I biosynthesis, precursor 25",,"keratan sulfate I biosynthesis, precursor 25",,,,,2016-11-22T15:11:49Z,,291,,,,,,ksi_pre25,,,http://vmh.uni.lu/_api/metabolites/291/?format=pcsv
ksi_pre27,,,-9,C205H328N14O171S8X,,,"keratan sulfate I biosynthesis, precursor 27",,"keratan sulfate I biosynthesis, precursor 27",,,,,2016-11-22T15:11:49Z,,292,,,,,,ksi_pre27,,,http://vmh.uni.lu/_api/metabolites/292/?format=pcsv
ksi_pre28,,,-9,C213H341N15O176S8X,,,"keratan sulfate I biosynthesis, precursor 28",,"keratan sulfate I biosynthesis, precursor 28",,,,,2016-11-22T15:11:49Z,,293,,,,,,ksi_pre28,,,http://vmh.uni.lu/_api/metabolites/293/?format=pcsv
ksi_pre30,,,-10,C219H350N15O184S9X,,,"keratan sulfate I biosynthesis, precursor 30",,"keratan sulfate I biosynthesis, precursor 30",,,,,2016-11-22T15:11:49Z,,294,,,,,,ksi_pre30,,,http://vmh.uni.lu/_api/metabolites/294/?format=pcsv
ksi_pre31,,,-10,C227H363N16O189S9X,,,"keratan sulfate I biosynthesis, precursor 31",,"keratan sulfate I biosynthesis, precursor 31",,,,,2016-11-22T15:11:49Z,,295,,,,,,ksi_pre31,,,http://vmh.uni.lu/_api/metabolites/295/?format=pcsv
ksi_pre33,,,-11,C233H372N16O197S10X,,,"keratan sulfate I biosynthesis, precursor 33",,"keratan sulfate I biosynthesis, precursor 33",,,,,2016-11-22T15:11:49Z,,296,,,,,,ksi_pre33,,,http://vmh.uni.lu/_api/metabolites/296/?format=pcsv
ksi_pre34,,,-11,C241H385N17O202S10X,,,"keratan sulfate I biosynthesis, precursor 34",,"keratan sulfate I biosynthesis, precursor 34",,,,,2016-11-22T15:11:49Z,,297,,,,,,ksi_pre34,,,http://vmh.uni.lu/_api/metabolites/297/?format=pcsv
ksii_core4_pre2,,,-1,C47H76N4O33X,,,"keratan sulfate II boisynthesis, precursor 2",,"keratan sulfate II boisynthesis, precursor 2",,,,,2016-11-22T15:11:49Z,,298,,,,,,ksii_core4_pre2,,,http://vmh.uni.lu/_api/metabolites/298/?format=pcsv
ksii_core4_pre3,,,-1,C55H89N5O38X,,,"keratan sulfate II biosynthesis, precursor 3",,"keratan sulfate II biosynthesis, precursor 3",,,,,2016-11-22T15:11:49Z,,299,,,,,,ksii_core4_pre3,,,http://vmh.uni.lu/_api/metabolites/299/?format=pcsv
ksii_core4_pre4,,,-1,C61H99N5O43X,,,"keratan sulfate II biosynthesis, precursor 4",,"keratan sulfate II biosynthesis, precursor 4",,,,,2016-11-22T15:11:49Z,,300,,,,,,ksii_core4_pre4,,,http://vmh.uni.lu/_api/metabolites/300/?format=pcsv
ksii_core4_pre5,,,-1,C69H112N6O48X,,,"keratan sulfate II biosynthesis, precursor 5",,"keratan sulfate II biosynthesis, precursor 5",,,,,2016-11-22T15:11:49Z,,301,,,,,,ksii_core4_pre5,,,http://vmh.uni.lu/_api/metabolites/301/?format=pcsv
ksii_core4_pre7,,,-2,C75H121N6O56SX,,,"keratan sulfate II biosynthesis, precursor 7",,"keratan sulfate II biosynthesis, precursor 7",,,,,2016-11-22T15:11:49Z,,302,,,,,,ksii_core4_pre7,,,http://vmh.uni.lu/_api/metabolites/302/?format=pcsv
ksii_core4_pre8,,,-2,C83H134N7O61SX,,,"keratan sulfate II biosynthesis, precursor 8",,"keratan sulfate II biosynthesis, precursor 8",,,,,2016-11-22T15:11:49Z,,303,,,,,,ksii_core4_pre8,,,http://vmh.uni.lu/_api/metabolites/303/?format=pcsv
ksii_core2_pre2,,,-1,C39H63N3O28X,,,"keratan sulfate II biosynthesis, precursor 2",,"keratan sulfate II biosynthesis, precursor 2",,,,,2016-11-22T15:11:49Z,,304,,,,,,ksii_core2_pre2,,,http://vmh.uni.lu/_api/metabolites/304/?format=pcsv
ksii_core2_pre3,,,-1,C47H76N4O33X,,,"keratan sulfate II biosynthesis, precursor 3",,"keratan sulfate II biosynthesis, precursor 3",,,,,2016-11-22T15:11:49Z,,305,,,,,,ksii_core2_pre3,,,http://vmh.uni.lu/_api/metabolites/305/?format=pcsv
ksii_core2_pre4,,,-1,C53H86N4O38X,,,"keratan sulfate II biosynthesis, precursor 4",,"keratan sulfate II biosynthesis, precursor 4",,,,,2016-11-22T15:11:49Z,,306,,,,,,ksii_core2_pre4,,,http://vmh.uni.lu/_api/metabolites/306/?format=pcsv
ksii_core2_pre5,,,-1,C61H99N5O43X,,,"keratan sulfate II biosynthesis, precursor 5",,"keratan sulfate II biosynthesis, precursor 5",,,,,2016-11-22T15:11:49Z,,307,,,,,,ksii_core2_pre5,,,http://vmh.uni.lu/_api/metabolites/307/?format=pcsv
ksii_core2_pre7,,,-2,C67H108N5O51SX,,,"keratan sulfate II biosynthesis, precursor 7",,"keratan sulfate II biosynthesis, precursor 7",,,,,2016-11-22T15:11:49Z,,308,,,,,,ksii_core2_pre7,,,http://vmh.uni.lu/_api/metabolites/308/?format=pcsv
ksii_core2_pre8,,,-2,C75H121N6O56SX,,,"keratan sulfate II biosynthesis, precursor 8",,"keratan sulfate II biosynthesis, precursor 8",,,,,2016-11-22T15:11:49Z,,309,,,,,,ksii_core2_pre8,,,http://vmh.uni.lu/_api/metabolites/309/?format=pcsv
ksi_pre1,,,-1,C79H129N5O57X,,,"keratan sulfate I biosynthesis, precursor 1",,"keratan sulfate I biosynthesis, precursor 1",,,,,2016-11-22T15:11:49Z,,310,,,,,,ksi_pre1,,,http://vmh.uni.lu/_api/metabolites/310/?format=pcsv
ksi_pre2,,,-1,C87H142N6O62X,,,"keratan sulfate I biosynthesis, precursor 2",,"keratan sulfate I biosynthesis, precursor 2",,,,,2016-11-22T15:11:49Z,,311,,,,,,ksi_pre2,,,http://vmh.uni.lu/_api/metabolites/311/?format=pcsv
ksi_pre3,,,-1,C93H152N6O67X,,,"keratan sulfate I biosynthesis, precursor 3",,"keratan sulfate I biosynthesis, precursor 3",,,,,2016-11-22T15:11:49Z,,312,,,,,,ksi_pre3,,,http://vmh.uni.lu/_api/metabolites/312/?format=pcsv
ksi_pre4,,,-1,C101H165N7O72X,,,"keratan sulfate I biosynthesis, precursor 4",,"keratan sulfate I biosynthesis, precursor 4",,,,,2016-11-22T15:11:49Z,,313,,,,,,ksi_pre4,,,http://vmh.uni.lu/_api/metabolites/313/?format=pcsv
ksi_pre6,,,-2,C107H174N7O80SX,,,"keratan sulfate I biosynthesis, precursor 6",,"keratan sulfate I biosynthesis, precursor 6",,,,,2016-11-22T15:11:49Z,,314,,,,,,ksi_pre6,,,http://vmh.uni.lu/_api/metabolites/314/?format=pcsv
ksi_pre7,,,-2,C115H187N8O85SX,,,"keratan sulfate I biosynthesis, precursor 7",,"keratan sulfate I biosynthesis, precursor 7",,,,,2016-11-22T15:11:49Z,,315,,,,,,ksi_pre7,,,http://vmh.uni.lu/_api/metabolites/315/?format=pcsv
ksi_pre9,,,-3,C121H196N8O93S2X,,,"keratan sulfate I biosynthesis, precursor 9",,"keratan sulfate I biosynthesis, precursor 9",,,,,2016-11-22T15:11:49Z,,316,,,,,,ksi_pre9,,,http://vmh.uni.lu/_api/metabolites/316/?format=pcsv
ksi_pre10,,,-3,C129H209N9O98S2X,,,"keratan sulfate I biosynthesis, precursor 10",,"keratan sulfate I biosynthesis, precursor 10",,,,,2016-11-22T15:11:49Z,,317,,,,,,ksi_pre10,,,http://vmh.uni.lu/_api/metabolites/317/?format=pcsv
ksi_pre12,,,-4,C135H218N9O106S3X,,,"keratan sulfate I biosynthesis, precursor 12",,"keratan sulfate I biosynthesis, precursor 12",,,,,2016-11-22T15:11:49Z,,318,,,,,,ksi_pre12,,,http://vmh.uni.lu/_api/metabolites/318/?format=pcsv
ksi_pre13,,,-4,C143H231N10O111S3X,,,"keratan sulfate I biosynthesis, precursor 13",,"keratan sulfate I biosynthesis, precursor 13",,,,,2016-11-22T15:11:49Z,,319,,,,,,ksi_pre13,,,http://vmh.uni.lu/_api/metabolites/319/?format=pcsv
ksi_pre15,,,-5,C149H240N10O119S4X,,,"keratan sulfate I biosynthesis, precursor 15",,"keratan sulfate I biosynthesis, precursor 15",,,,,2016-11-22T15:11:49Z,,320,,,,,,ksi_pre15,,,http://vmh.uni.lu/_api/metabolites/320/?format=pcsv
ksi_pre16,,,-5,C157H253N11O124S4X,,,"keratan sulfate I biosynthesis, precursor 16",,"keratan sulfate I biosynthesis, precursor 16",,,,,2016-11-22T15:11:49Z,,321,,,,,,ksi_pre16,,,http://vmh.uni.lu/_api/metabolites/321/?format=pcsv
ak2g_hs,,,0,C5H10O2FULLRFULLR2CO2,CHEBI:52595,,1-alkyl 2-acylglycerol,,1-alkyl 2-acylglycerol,,,,,2016-11-22T15:11:49Z,,322,,,,,,ak2g_hs,,,http://vmh.uni.lu/_api/metabolites/322/?format=pcsv
cdpchol,,,-1,C14H25N4O11P2,CHEBI:16436,,CDPcholine,,CDPcholine,,,"InChI=1S/C14H26N4O11P2/c1-18(2,3)6-7-26-30(22,23)29-31(24,25)27-8-9-11(19)12(20)13(28-9)17-5-4-10(15)16-14(17)21/h4-5,9,11-13,19-20H,6-8H2,1-3H3,(H3-,15,16,21,22,23,24,25)/t9-,11-,12-,13-/m1/s1",C00307,2016-11-22T15:11:49Z,,323,,,,,13804,cdpchol,,,http://vmh.uni.lu/_api/metabolites/323/?format=pcsv
ak2gchol_hs,,,0,C10H20O5NPFULLRFULLR2CO,CHEBI:36702,,1-alkyl 2-acylglycerol 3-phosphocholine,,1-alkyl 2-acylglycerol 3-phosphocholine,,,,C05212,2016-11-22T15:11:49Z,,324,,,,,,ak2gchol_hs,,,http://vmh.uni.lu/_api/metabolites/324/?format=pcsv
cmp,,,-2,C9H12N3O8P,CHEBI:17361,,"Human Metabolome Database (HMDB): Cytidine monophosphate, also known as 5'-cytidylic acid and abbreviated CMP, is a nucleotide. It is an ester of phosphoric acid with the nucleoside cytidine. CMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase cytosine. Cytidine monophosphate (CMP) is derived from cytidine triphosphate (CTP) with subsequent loss of two phosphates. The synthesis of the pyrimidines CTP and UTP occurs in the cytoplasm and starts with the formation of carbamoyl phosphate from glutamine and CO2. Next, aspartate undergoes a condensation reaction with carbamoyl-phosphate to form orotic acid. In a subsequent cyclization reaction, the enzyme Aspartate carbamoyltransferase forms N-carbamoyl-aspartate which is converted into dihydroorotic acid by Dihydroorotase. The latter is converted to orotate by Dihydroorotate oxidase. Orotate is covalently linked with a phosphorylated ribosyl unit with Orotate phosphoribosyltransferase (aka ""PRPP transferase"") catalyzing reaction, yielding orotidine monophosphate (OMP). Orotidine-5-phosphate is decarboxylated by Orotidine-5'-phosphate decarboxylase to form uridine monophosphate (UMP). UMP is phosphorylated by two kinases to uridine triphosphate (UTP) via two sequential reactions with ATP. CTP is subsequently formed by amination of UTP by the catalytic activity of CTP synthetase. Cytosine monophosphate (CMP) and uridine monophosphate (UMP) have been prescribed for the treatment of neuromuscular affections in humans. Patients treated with CMP/UMP recover from altered neurological functions. Additionally, the administration of CMP/UMP appears to favour the entry of glucose in the muscle and CMP/UMP may be important in maintaining the level of hepatic glycogen constant during exercise. [PMID:18663991].",,CMP,,HMDB00095,"InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/p-2/t4-,6-,7-,8-/m1/s1",C00055,2016-12-05T15:48:04Z,,325,,,,,6131,cmp,,"5'-CMP, 5-Cytidylate, 5-Cytidylic acid, CMP, Cytidine 5'-monophosphate, Cytidine 5'-monophosphorate, Cytidine 5'-monophosphoric acid, Cytidine 5'-phosphate, Cytidine 5'-phosphorate, Cytidine 5'-phosphoric acid, Cytidine mono(dihydrogen phosphate), Cytidine monophosphate, Cytidylate, Cytidylic acid",http://vmh.uni.lu/_api/metabolites/325/?format=pcsv
ak2gpe_hs,,,0,C7H16O5NPFULLRFULLR2CO,,,1-alkyl 2-acylglycerol 3-phosphoethanolamine,,1-alkyl 2-acylglycerol 3-phosphoethanolamine,,,,,2016-11-22T15:11:49Z,,326,,,,,,ak2gpe_hs,,,http://vmh.uni.lu/_api/metabolites/326/?format=pcsv
dak2gpe_hs,,,0,C7H14O5NPFULLRFULLR2CO,CHEBI:17476,,1-alkenyl 2-acylglycerol 3-phosphoethanolamine plasmalogen,,1-alkenyl 2-acylglycerol 3-phosphoethanolamine plasmalogen,,,,,2016-11-22T15:11:49Z,,327,,,,,,dak2gpe_hs,,,http://vmh.uni.lu/_api/metabolites/327/?format=pcsv
cdpea,,,-1,C11H19N4O11P2,CHEBI:16732,,Human Metabolome Database (HMDB): Cytidine is a molecule (known as a nucleoside) that is formed when cytosine is attached to a ribose ring (also known as a ribofuranose) via a beta-N1-glycosidic bond.,,CDP-ethanolamine(1-),,HMDB01564,"InChI=1S/C11H20N4O11P2/c12-2-4-23-27(19,20)26-28(21,22)24-5-6-8(16)9(17)10(25-6)15-3-1-7(13)14-11(15)18/h1,3,6,8-10,16-17H,2,4-5,12H2,(H,19,20)(H,21,22)(H2,13,14,18)/p-1/t6-,8-,9-,10-/m1/s1",C00570,2016-12-05T15:48:04Z,,328,,,,,123727,cdpea,,"CDP Ethanolamine, CDP-Ethanolamine, CDPethanolamine, Cytidine diphosphate ethanolamine",http://vmh.uni.lu/_api/metabolites/328/?format=pcsv
ak2gp_hs,,,-2,C5H9O6PFULLRFULLR2CO,,,1-alkyl 2-acylglycerol 3-phosphate,,1-alkyl 2-acylglycerol 3-phosphate,,,,C05977,2016-11-22T15:11:49Z,,329,,,,,,ak2gp_hs,,,http://vmh.uni.lu/_api/metabolites/329/?format=pcsv
akdhap_hs,,,-2,C3H4O6PFULLRC2H4,,,1-alkyldihydroxyacetone phosphate,,1-alkyldihydroxyacetone phosphate,,,,,2016-11-22T15:11:49Z,,330,,,,,,akdhap_hs,,,http://vmh.uni.lu/_api/metabolites/330/?format=pcsv
akgp_hs,,,-2,C4H10O4PFULLRCO2,CHEBI:17197,,O-alkylglycerone phosphate(2-),,O-alkylglycerone phosphate(2-),,,,,2016-11-22T15:11:49Z,,331,,,,,,akgp_hs,,,http://vmh.uni.lu/_api/metabolites/331/?format=pcsv
Rtotal2,,,-1,CO2FULLR2,,,R total 2 position,,R total 2 position,,,,,2016-11-22T15:11:49Z,,332,,,,,,Rtotal2,,,http://vmh.uni.lu/_api/metabolites/332/?format=pcsv
agm,,,2,C5H16N4,CHEBI:17431,,"Human Metabolome Database (HMDB): Agmatine ((4-aminobutyl)guanidine, NH2-CH2-CH2-CH2-CH2-NH-C(-NH2)(=NH)) is the decarboxylation product of the amino acid arginine and is an intermediate in polyamine biosynthesis. It is a putative neurotransmitter. It is synthesized in the brain, stored in synaptic vesicles, accumulated by uptake, released by membrane depolarization, and inactivated by agmatinase. Agmatine binds to 2-adrenergic receptor and imidazoline binding sites, and blocks NMDA receptors and other cation ligand-gated channels. Agmatine inhibits nitric oxide synthase (NOS), and induces the release of some peptide hormones. Treatment with exogenous agmatine exerts neuroprotective effects in animal models of neurotrauma. -- Wikipedia.",,agmatinium(2+),,HMDB01432,"InChI=1S/C5H14N4/c6-3-1-2-4-9-5(7)8/h1-4,6H2,(H4,7,8,9)/p+2",C00179,2016-12-05T15:48:04Z,,333,,,,,199,agm,,"(4-aminobutyl)-Guanidine, (4-Aminobutyl)guanidine, 1-(4-Aminobutyl)guanidine, 1-Amino-4-guanidinobutane, 1-Amino-4-guanidobutane, 4-Guanidino-1-butanamine, Agmatine, Argmatine, N-(4-Aminobutyl)guanidine, N-(Aminoiminomethyl)-1,4-Butanediamine, N-4-Aminobutylguanidine",http://vmh.uni.lu/_api/metabolites/333/?format=pcsv
ptrc,,,2,C4H14N2,CHEBI:17148,,"Human Metabolome Database (HMDB): Putrescine is a polyamine. Putrescine is related to cadaverine (another polyamine). Both are produced by the breakdown of amino acids in living and dead organisms and both are toxic in large doses. Putrescine and cadaverine are largely responsible for the foul odor of putrefying flesh, but also contribute to the odor of such processes as bad breath and bacterial vaginosis. Putrescine is also found in semen. Putrescine attacks s-adenosyl methionine and converts it to spermidine. Spermidine in turn attacks another s-adenosyl methionine and converts it to spermine. Putrescine is synthesized in small quantities by healthy living cells by the action of ornithine decarboxylase. The polyamines, of which putrescine is one of the simplest, appear to be growth factors necessary for cell division. Putrescine apparently has specific role in skin physiology and neuroprotection. (PMID: 15009201, 16364196). Pharmacological interventions have demonstrated convincingly that a steady supply of polyamines is a prerequisite for cell proliferation to occur. Genetic engineering of polyamine metabolism in transgenic rodents has shown that polyamines play a role in spermatogenesis, skin physiology, promotion of tumorigenesis and organ hypertrophy as well as neuronal protection. Transgenic activation of polyamine catabolism not only profoundly disturbs polyamine homeostasis in most tissues, but also creates a complex phenotype affecting skin, female fertility, fat depots, pancreatic integrity and regenerative growth. Transgenic expression of ornithine decarboxylase antizyme has suggested that this unique protein may act as a general tumor suppressor. Homozygous deficiency of the key biosynthetic enzymes of the polyamines, ornithine and S-adenosylmethionine decarboxylase is not compatible with murine embryogenesis.",,Putrescine,,HMDB01414,InChI=1S/C4H12N2/c5-3-1-2-4-6/h1-6H2/p+2,C00134,2016-12-05T15:48:04Z,,334,,,,,1045,ptrc,,"1,4-Butanediamine, 1,4-Butylenediamine, 1,4-Diaminobutane, 1,4-Tetramethylenediamine, Butylenediamine, Putrescin, Tetramethyldiamine, Tetramethylenediamine",http://vmh.uni.lu/_api/metabolites/334/?format=pcsv
urea,,,0,CH4N2O,CHEBI:16199,,"Human Metabolome Database (HMDB): Urea is a highly soluble organic compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Urea is formed in a cyclic pathway known simply as the urea cycle. In this cycle, amino groups donated by ammonia and L-aspartate are converted to urea. Urea is essentially a waste product; it has no physiological function. It is dissolved in blood (in humans in a concentration of 2.5 - 7.5 mmol/liter) and excreted by the kidney in the urine. In addition, a small amount of urea is excreted (along with sodium chloride and water) in human sweat.",,Urea,,HMDB00294,"InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4)",C00086,2016-12-05T15:48:04Z,,335,,,,,1176,urea,,"Alphadrate, ARF, B-I-k, beta-I-k, Bromisovalum, Bubber shet, Calmurid, Calmurid HC, Carbaderm, Carbamide, Carbamide resin, Carbonyl diamide, Carbonyl diamine, Carbonyldiamide, Carbonyldiamine, Carmol, Helicosol, Hyanit, Isourea, Keratinamin, Keratinamin kowa, Mocovina, Onychomal, Panafil, URE, Urea, Ureaphil, Ureophil",http://vmh.uni.lu/_api/metabolites/335/?format=pcsv
Rtotal2coa,,,-4,CO2FULLR2C21H31N7O15P3S,,,R total 2 coenzyme A,,R total 2 coenzyme A,,,,,2016-11-22T15:11:49Z,,336,,,,,,Rtotal2coa,,,http://vmh.uni.lu/_api/metabolites/336/?format=pcsv
alpa_hs,,,-2,C3H6O5PFULLRCO2,,,lysophosphatidic acid,,lysophosphatidic acid,,,,,2016-11-22T15:11:49Z,,337,,,,,,alpa_hs,,,http://vmh.uni.lu/_api/metabolites/337/?format=pcsv
pa_hs,,,-2,C3H5O4PFULLRCO2FULLR2CO2,,,phosphatidate(2-),,phosphatidate(2-),,,,,2016-11-22T15:11:49Z,,338,,,,,,pa_hs,,,http://vmh.uni.lu/_api/metabolites/338/?format=pcsv
acg5p,,,-3,C7H9NO8P,CHEBI:16878,,Human Metabolome Database (HMDB): N-Acetyl-L-glutamyl 5-phosphate is an intermediate in urea cycle and metabolism of amino groups. The enzyme N-acetyl-gamma-glutamyl-phosphate reductase [EC:1.2.1.38] catalyzes the conversion of this metabolite into N-acetyl-L-glutamate 5-semialdehyde. This reaction is irreversible and occurs in the mitochondria. (BiGG database).,,N-acetyl-L-gamma-glutamyl phosphate(3-),,HMDB06456,"InChI=1S/C7H12NO8P/c1-4(9)8-5(7(11)12)2-3-6(10)16-17(13,14)15/h5H,2-3H2,1H3,(H,8,9)(H,11,12)(H2,13,14,15)/p-3/t5-/m0/s1",C04133,2016-12-05T15:48:04Z,,339,,,,,440236,,,"(2S)-2-acetamido-5-oxo-5-(phosphonooxy)pentanoate, (2S)-2-acetamido-5-oxo-5-(phosphonooxy)pentanoic acid, N-Acetyl-5-glutamyl phosphate, N-Acetyl-5-oxo-5-(phosphonooxy)-L-norvaline, N-Acetyl-gamma-L-glutamyl phosphate, N-Acetyl-L-glutamate 5-phosphate",http://vmh.uni.lu/_api/metabolites/339/?format=pcsv
acg5sa,,,-1,C7H10NO4,CHEBI:29123,,Human Metabolome Database (HMDB): N-Acetyl-L-glutamate 5-semialdehyde is an intermediate in Urea cycle and metabolism of amino groups. N-Acetyl-L-glutamate 5-semialdehyde is the. second to last step in the synthesis of L-Ornithine and is converted. from N-Acetyl-L-glutamate 5-phosphate via the enzyme N-acetyl-gamma-glutamyl-phosphate reductase (EC 1.2.1.38). It is then converted to N-Acetylornithine via the enzyme acetylornithine aminotransferase (EC 2.6.1.11).,,2-acetamido-5-oxopentanoate,,HMDB06488,"InChI=1S/C7H11NO4/c1-5(10)8-6(7(11)12)3-2-4-9/h4,6H,2-3H2,1H3,(H,8,10)(H,11,12)/p-1/t6-/m0/s1",C01250,2016-12-05T15:48:04Z,,340,,,,,192878,,,"2-Acetamido-5-oxopentanoate, 2-Acetamido-5-oxopentanoic acid",http://vmh.uni.lu/_api/metabolites/340/?format=pcsv
alkylR1oh,,,0,C2H5OFULLR,,,hydroxy alkyl chain,,hydroxy alkyl chain,,,,,2016-11-22T15:11:49Z,,341,,,,,,alkylR1oh,,,http://vmh.uni.lu/_api/metabolites/341/?format=pcsv
Rtotal,,,-1,CO2FULLR,,,R total,,R total,,,,,2016-11-22T15:11:49Z,,342,,,,,,Rtotal,,,http://vmh.uni.lu/_api/metabolites/342/?format=pcsv
ala_L,,,0,C3H7NO2,CHEBI:16977,,"Human Metabolome Database (HMDB): Alanine is a nonessential amino acid made in the body from the conversion of the carbohydrate pyruvate or the breakdown of DNA and the dipeptides carnosine and anserine. It is highly concentrated in muscle and is one of the most important amino acids released by muscle, functioning as a major energy source. Plasma alanine is often decreased when the BCAA (Branched Chain Amino Acids) are deficient. This finding may relate to muscle metabolism. Alanine is highly concentrated in meat products and other high-protein foods like wheat germ and cottage cheese. Alanine is an important participant as well as regulator in glucose metabolism. Alanine levels parallel blood sugar levels in both diabetes and hypoglycemia, and alanine reduces both severe hypoglycemia and the ketosis of diabetes. It is an important amino acid for lymphocyte reproduction and immunity. Alanine therapy has helped dissolve kidney stones in experimental animals. Normal alanine metabolism, like that of other amino acids, is highly dependent upon enzymes that contain vitamin B6. Alanine, like GABA, taurine and glycine, is an inhibitory neurotransmitter in the brain. http://www.dcnutrition.com/AminoAcids/).",,L-alanine,,HMDB00161,"InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1",C00041,2016-12-05T15:48:04Z,,343,,,,,5950,ala_L,,"(2S)-2-Aminopropanoate, (2S)-2-Aminopropanoic acid, (S)-(+)-Alanine, (S)-2-amino-Propanoate, (S)-2-amino-Propanoic acid, (S)-2-Aminopropanoate, (S)-2-Aminopropanoic acid, (S)-Alanine, 2-Aminopropanoate, 2-Aminopropanoic acid, 2-Aminopropionate, 2-Aminopropionic acid, 2-Ammoniopropanoate, 2-Ammoniopropanoic acid, a-Alanine, a-Aminopropionate, a-Aminopropionic acid, Ala, Alanine, alpha-Alanine, alpha-Aminopropanoate, alpha-Aminopropanoic acid, alpha-Aminopropionate, alpha-Aminopropionic acid, L-(+)-Alanine, L-2-Aminopropanoate, L-2-Aminopropanoic acid, L-2-Aminopropionate, L-2-Aminopropionic acid, L-a-Alanine, L-a-Aminopropionate, L-a-Aminopropionic acid, L-alpha-Alanine, L-alpha-Aminopropionate, L-alpha-Aminopropionic acid",http://vmh.uni.lu/_api/metabolites/343/?format=pcsv
glx,,,-1,C2H1O3,CHEBI:35179,,"Human Metabolome Database (HMDB): Glyoxylic acid or oxoacetic acid is an organic compound that is both an aldehyde and a carboxylic acid. Glyoxylic acid is a liquid with a melting Point of -93 degree centigrade and a boiling Point of 111 degree centigrade. It is an intermediate of the glyoxylate cycle, which enables certain organisms to convert fatty acids into carbohydrates. The conjugate base of gloxylic acid is known as glyoxylate. This compound is an intermediate of the glyoxylate cycle, which enables organisms, such as bacteria, fungi and plants to convert fatty acids into carbohydrates. Glyoxylate is the byproduct of the amidation process in biosynthesis of several amidated peptides. The glyoxylate cycle is a metabolic pathway occurring in plants, and several microorganisms, such as E. coli and yeast. Recent research shows that it is present in vertebrates (including humans) and insects. The glyoxylate cycle allows these organisms to use fats for the synthesis of carbohydrates. [PMID: 16396466].",,glyoxylate,,HMDB00119,"InChI=1S/C2H2O3/c3-1-2(4)5/h1H,(H,4,5)/p-1",C00048,2016-12-05T15:48:04Z,,344,,,,,760,glx,,"a-Ketoacetate, a-Ketoacetic acid, alpha-Ketoacetate, alpha-Ketoacetic acid, Formylformate, Formylformic acid, Glyoxalate, Glyoxalic acid, Glyoxylate, Glyoxylic acid, Oxalaldehydate, Oxalaldehydic acid, Oxoacetate, Oxoacetic acid, Oxoethanoate, Oxoethanoic acid",http://vmh.uni.lu/_api/metabolites/344/?format=pcsv
gly,,,0,C2H5NO2,CHEBI:15428,,"Human Metabolome Database (HMDB): Glycine is a simple, nonessential amino acid, although experimental animals show reduced growth on low-glycine diets. The average adult ingests 3 to 5 grams of glycine daily. Glycine is involved in the body's production of DNA, phospholipids and collagen, and in release of energy. Glycine levels are effectively measured in plasma in both normal patients and those with inborn errors of glycine metabolism. (http://www.dcnutrition.com/AminoAcids/) Nonketotic hyperglycinaemia (OMIM 606899) is an autosomal recessive condition caused by deficient enzyme activity of the glycine cleavage enzyme system (EC 2.1.1.10). The glycine cleavage enzyme system comprises four proteins: P-, T-, H- and L-proteins (EC 1.4.4.2, EC 2.1.2.10 and EC 1.8.1.4 for P-, T- and L-proteins). Mutations have been described in the GLDC (OMIM 238300), AMT (OMIM 238310), and GCSH (OMIM 238330) genes encoding the P-, T-, and H-proteins respectively. The glycine cleavage system catalyses the oxidative conversion of glycine into carbon dioxide and ammonia, with the remaining one-carbon unit transferred to folate as methylenetetrahydrofolate. It is the main catabolic pathway for glycine and it also contributes to one-carbon metabolism. Patients with a deficiency of this enzyme system have increased glycine in plasma, urine and cerebrospinal fluid (CSF) with an increased CSF: plasma glycine ratio. (PMID 16151895).",,Glycine,,HMDB00123,"InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)",C00037,2016-12-05T15:48:04Z,,345,,,,glycine,750,gly,,"2-Aminoacetate, 2-Aminoacetic acid, Aciport, Amino-Acetate, Amino-Acetic acid, Aminoacetate, Aminoacetic acid, Aminoethanoate, Aminoethanoic acid, Glicoamin, Glycocoll, Glycolixir, Glycosthene, Gyn-Hydralin, Padil",http://vmh.uni.lu/_api/metabolites/345/?format=pcsv
ahandrostanglc,,,0,C25H38O8,CHEBI:37451,,"Human Metabolome Database (HMDB): Etiocholanolone glucuronide is a natural human metabolite of etiocholanolone generated in the liver by UDP glucuonyltransferase. Etiocholanolone (or 5-isoandrosterone) is a metabolite of testosterone. Classified a ketosteroid, it causes fever, immunostimulation and leukocytosis. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.",,3alpha-hydroxy-5beta-androstan-17-one 3-glucosiduronic acid,,HMDB04484,"InChI=1S/C25H38O8/c1-24-9-7-13(32-23-20(29)18(27)19(28)21(33-23)22(30)31)11-12(24)3-4-14-15-5-6-17(26)25(15,2)10-8-16(14)24/h12-16,18-21,23,27-29H,3-11H2,1-2H3,(H,30,31)/t12-,13-,14+,15+,16+,18+,19+,20-,21+,23-,24+,25+/m1/s1",C11136,2016-12-05T15:48:04Z,,346,,,,,443078,,,"17-Oxoandrostan-3-yl hexopyranosiduronic acid, 3alpha-Hydroxy-5beta-androstan-17-one 3-glucuronide, 3alpha-hydroxyetiocholan-17-one 3-glucuronide, 5alpha.-Androstan-3.alpha.-ol-17-one glucoronide, 5beta-Androstan-3alpha-ol-17-one 3-glucuronide, Etiocholan-3alpha-ol-17-one 3-glucuronide, Etiocholan-3alpha-ol-17-one 3-glucuronoside, etiocholanolone 3-glucuronide",http://vmh.uni.lu/_api/metabolites/346/?format=pcsv
hcys_L,,,0,C4H9NO2S,CHEBI:17588,,"Human Metabolome Database (HMDB): Homocysteine is a sulfur-containing amino acid that arises during methionine metabolism. Although its concentration in plasma is only about 10 micromolar (uM), even moderate hyperhomocysteinemia is associated with increased incidence of cardiovascular disease and Alzheimer's disease. Elevations in plasma homocysteine are commonly found as a result of vitamin deficiencies, polymorphisms of enzymes of methionine metabolism, and renal disease. Pyridoxal, folic acid, riboflavin, and Vitamin B(12) are all required for methionine metabolism, and deficiency of each of these vitamins result in elevated plasma homocysteine. A polymorphism of methylenetetrahydrofolate reductase (C677T), which is quite common in most populations with a homozygosity rate of 10-15 %, is associated with moderate hyperhomocysteinemia, especially in the context of marginal folate intake. Plasma homocysteine is inversely related to plasma creatinine in patients with renal disease. This is due to an impairment in homocysteine removal in renal disease. The role of these factors, and of modifiable lifestyle factors, in affecting methionine metabolism and in determining plasma homocysteine levels is discussed. Homocysteine is an independent cardiovascular disease (CVD) risk factor modifiable by nutrition and possibly exercise. Homocysteine was first identified as an important biological compound in 1932 and linked with human disease in 1962 when elevated urinary homocysteine levels were found in children with mental retardation. This condition, called homocysteinuria, was later associated with premature occlusive CVD, even in children. These observations led to research investigating the relationship of elevated homocysteine levels and CVD in a wide variety of populations including middle age and elderly men and women with and without traditional risk factors for CVD. (PMID 17136938, 15630149).",,L-homocysteine,,HMDB00742,"InChI=1S/C4H9NO2S/c5-3(1-2-8)4(6)7/h3,8H,1-2,5H2,(H,6,7)/t3-/m0/s1",C05330,2016-12-05T15:48:04Z,,347,,,,,91552,hcys_L,,"(+-)-homocysteine, (S)-2-amino-4-mercapto-Butanoate, (S)-2-amino-4-mercapto-Butanoic acid, 2-Amino-4-mercapto-Butanoate, 2-Amino-4-mercapto-Butanoic acid, 2-Amino-4-mercapto-Butyric acid, 2-Amino-4-mercapto-DL-Butyrate, 2-Amino-4-mercapto-DL-Butyric acid, 2-Amino-4-mercaptobutyric acid, 2-Amino-4-sulfanylbutanoate, 2-Amino-4-sulfanylbutanoic acid, D,L-Homocysteine, DL-2-amino-4-mercapto-Butyric acid, DL-2-Amino-4-mercaptobutyric acid, DL-Homocysteine, DL-homocysteine (free base), HCY, Homo-CYS, Homocysteine, L-2-Amino-4-mercapto-Butyric acid, L-Homocysteine, Usaf B-12",http://vmh.uni.lu/_api/metabolites/347/?format=pcsv
n2m2nmn,,,0,C50H84N4O36,,,reducing GlcNAc removed form of n2m2nmasn (w/o peptide),,reducing GlcNAc removed form of n2m2nmasn (w/o peptide),,,,,2016-11-22T15:11:49Z,,348,,,,,,n2m2nmn,,,http://vmh.uni.lu/_api/metabolites/348/?format=pcsv
n2m2mn,,,0,C42H71N3O31,,,"de-Fuc, reducing GlcNAc removed, de-Sia, de-Gal form of PA6 (w/o peptide linkage)",,"de-Fuc, reducing GlcNAc removed, de-Sia, de-Gal form of PA6 (w/o peptide linkage)",,,,,2016-11-22T15:11:49Z,,349,,,,,,n2m2mn,,,http://vmh.uni.lu/_api/metabolites/349/?format=pcsv
fprica,,,-2,C10H13N4O9P,CHEBI:18381,,5-Formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide,,5-Formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide,,,"InChI=1S/C10H15N4O9P/c11-8(18)5-9(13-3-15)14(2-12-5)10-7(17)6(16)4(23-10)1-22-24(19,20)21/h2-4,6-7,10,16-17H,1H2,(H2,11,18)(H,13,15)(H2,19,20,21)/p-2/t4-,6-,7-,10-/m1/s1",C04734,2016-11-22T15:11:49Z,,350,,,,,166760,fprica,,,http://vmh.uni.lu/_api/metabolites/350/?format=pcsv
thf,,,-2,C19H21N7O6,CHEBI:15635,,"Human Metabolome Database (HMDB): Tetrahydrofolate is a soluble coenzyme (vitamin B9) that is synthesized de novo by plants and microorganisms, and absorbed from the diet by animals. It is composed of three distinct parts: a pterin ring, a p-ABA (p-aminobenzoic acid) and a polyglutamate chain with a number of residues varying between 1 and 8. Only the tetra-reduced form of the molecule serves as a coenzyme for C1 transfer reactions. In biological systems, the C1-units exist under various oxidation states and the different tetrahydrofolate derivatives constitute a family of related molecules named indistinctly under the generic term folate. (PMID 16042593). Folate is important for cells and tissues that rapidly divide. Cancer cells divide rapidly, and drugs that interfere with folate metabolism are used to treat cancer. Methotrexate is a drug often used to treat cancer because it inhibits the production of the active form, tetrahydrofolate. Unfortunately, methotrexate can be toxic, producing side effects such as inflammation in the digestive tract that make it difficult to eat normally. -- Wikipedia; Signs of folic acid deficiency are often subtle. Diarrhea, loss of appetite, and weight loss can occur. Additional signs are weakness, sore tongue, headaches, heart palpitations, irritability, and behavioral disorders. Women with folate deficiency who become pregnant are more likely to give birth to low birth weight and premature infants, and infants with neural tube defects. In adults, anemia is a sign of advanced folate deficiency. In infants and children, folate deficiency can slow growth rate. Some of these symptoms can also result from a variety of medical conditions other than folate deficiency. It is important to have a physician evaluate these symptoms so that appropriate medical care can be given. -- Wikipedia; Folinic acid is a form of folate that can help 'rescue' or reverse the toxic effects of methotrexate. Folinic acid is not the same as folic acid. Folic acid supplements have little established role in cancer chemotherapy. There have been cases of severe adverse effects of accidental substitution of folic acid for folinic acid in patients receiving methotrexate cancer chemotherapy. It is important for anyone receiving methotrexate to follow medical advice on the use of folic or folinic acid supplements. -- Wikipedia. Low concentrations of folate, vitamin B12, or vitamin B6 may increase the level of homocysteine, an amino acid normally found in blood. There is evidence that an elevated homocysteine level is an independent risk factor for heart disease and stroke. The evidence suggests that high levels of homocysteine may damage coronary arteries or make it easier for blood clotting cells called platelets to clump together and form a clot. However, there is currently no evidence available to suggest that lowering homocysteine with vitamins will reduce your risk of heart disease. Clinical intervention trials are needed to determine whether supplementation with folic acid, vitamin B12 or vitamin B6 can lower your risk of developing coronary heart disease. -- Wikipedia.",,"5,6,7,8-Tetrahydrofolate",,HMDB01846,"InChI=1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/p-2/t11-,12-/m0/s1",C00101,2016-12-05T15:48:04Z,,351,,,,,91443,thf,,"(6S)-Tetrahydrofolate, (6S)-Tetrahydrofolic acid, 5,6,7,8-Tetrahydrofolate, 5,6,7,8-Tetrahydrofolic acid, Tetra-H-folate, Tetrahydrafolate, Tetrahydrofolate, Tetrahydrofolic acid, Tetrahydropteroyl mono-L-glutamate, Tetrahydropteroylglutamate",http://vmh.uni.lu/_api/metabolites/351/?format=pcsv
air,,,-2,C8H12N3O7P,CHEBI:28843,,5-amino-1-(5-phospho-D-ribosyl)imidazole,,5-amino-1-(5-phospho-D-ribosyl)imidazole,,,"InChI=1S/C8H14N3O7P/c9-5-1-10-3-11(5)8-7(13)6(12)4(18-8)2-17-19(14,15)16/h1,3-4,6-8,12-13H,2,9H2,(H2,14,15,16)/p-1/t4-,6-,7-,8?/m1/s1",C03373,2016-11-22T15:11:49Z,,352,,,,,161500,air,,,http://vmh.uni.lu/_api/metabolites/352/?format=pcsv
5aizc,,,-3,C9H11N3O9P,CHEBI:28413,,5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate,,5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate,,,"InChI=1S/C9H14N3O9P/c10-7-4(9(15)16)11-2-12(7)8-6(14)5(13)3(21-8)1-20-22(17,18)19/h2-3,5-6,8,13-14H,1,10H2,(H,15,16)(H2,17,18,19)/p-3/t3-,5-,6-,8-/m1/s1",C04751,2016-11-22T15:11:49Z,,353,,,,,165388,5aizc,,,http://vmh.uni.lu/_api/metabolites/353/?format=pcsv
ak2lgchol_hs,,,0,C10H21O5NPFULLR,,,1-alkyl 2-lysoglycerol 3-phosphocholine,,1-alkyl 2-lysoglycerol 3-phosphocholine,,,,C04317,2016-11-22T15:11:49Z,,354,,,,,,ak2lgchol_hs,,,http://vmh.uni.lu/_api/metabolites/354/?format=pcsv
succoa,,,-5,C25H35N7O19P3S,CHEBI:15380,,Succinyl-CoA,,Succinyl-CoA,,,"InChI=1S/C25H40N7O19P3S/c1-25(2,20(38)23(39)28-6-5-14(33)27-7-8-55-16(36)4-3-15(34)35)10-48-54(45,46)51-53(43,44)47-9-13-19(50-52(40,41)42)18(37)24(49-13)32-12-31-17-21(26)29-11-30-22(17)32/h11-13,18-20,24,37-38H,3-10H2,1-2H3,(H,27,33)(H,28,39)(H,34,35)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/p-5/t13-,18-,19-,20+,24-/m1/s1",C00091,2016-11-22T15:11:49Z,,355,,,,succinyl-CoA,439161,succoa,,,http://vmh.uni.lu/_api/metabolites/355/?format=pcsv
mal_L,,,-2,C4H4O5,CHEBI:30797,,"Human Metabolome Database (HMDB): Malic acid is a tart-tasting organic dicarboxylic acid that plays a role in many sour or tart foods. Apples contain malic acid, which contributes to the sourness of a green apple. Malic acid can make a wine taste tart, although the amount decreases with increasing fruit ripeness. (wikipedia). In its ionized form malic acid is called malate. Malate is an intermediate of the TCA cycle along with fumarate. It can also be formed from pyruvate as one of the anaplerotic reactions. In humans, malic acid is both derived from food sources and synthesized in the body through the citric acid cycle or Krebs cycle which takes place in the mitochondria. Malate's importance to the production of energy in the body during both aerobic and anaerobic conditions is well established. Under aerobic conditions, the oxidation of malate to oxaloacetate provides reducing equivalents to the mitochondria through the malate-aspartate redox shuttle. During anaerobic conditions, where a buildup of excess of reducing equivalents inhibits glycolysis, malic acid's simultaneous reduction to succinate and oxidation to oxaloacetate is capable of removing the accumulating reducing equivalents. This allows malic acid to reverse hypoxia's inhibition of glycolysis and energy production. In studies on rats it has been found that only tissue malate is depleted following exhaustive physical activity. Other key metabolites from the citric acid cycle needed for energy production were found to be unchanged. Because of this, a deficiency of malic acid has been hypothesized to be a major cause of physical exhaustion. Notably, the administration of malic acid to rats has been shown to elevate mitochondrial malate and increase mitochondrial respiration and energy production.",,(S)-malate(2-),,HMDB00156,"InChI=1S/C4H6O5/c5-2(4(8)9)1-3(6)7/h2,5H,1H2,(H,6,7)(H,8,9)/p-2/t2-/m0/s1",C00149,2016-12-05T15:48:04Z,,356,,,,,222656,mal_L,,"(-)-(S)-Malate, (-)-(S)-Malic acid, (-)-Hydroxysuccinate, (-)-Hydroxysuccinic acid, (-)-L-Malic acid, (-)-Malic acid, (2S)-2-Hydroxybutanedioate, (2S)-2-Hydroxybutanedioic acid, (S)-(-)-Hydroxysuccinate, (S)-(-)-Hydroxysuccinic acid, (S)-hydroxy-Butanedioate, (S)-hydroxy-Butanedioic acid, (S)-Hydroxybutanedioate, (S)-Hydroxybutanedioic acid, (S)-Malic acid, Apple acid, L-(-)-Malic acid, L-Apple acid, L-Hydroxybutanedioate, L-Hydroxybutanedioic acid, L-Hydroxysuccinate, L-Hydroxysuccinic acid, Malic acid, S-(-)-Malate, S-(-)-Malic acid, S-2-Hydroxybutanedioate, S-2-Hydroxybutanedioic acid",http://vmh.uni.lu/_api/metabolites/356/?format=pcsv
prgstrn,,,0,C21H30O2,,,"Human Metabolome Database (HMDB): The major progestational steroid that is secreted primarily by the corpus luteum and the placenta. Progesterone acts on the uterus, the mammary glands and the brain. It is required in embryo implantation, pregnancy maintenance, and the development of mammary tissue for milk production. Progesterone, converted from pregnenolone, also serves as an intermediate in the biosynthesis of gonadal steroid hormones and adrenal corticosteroids. -- Pubchem; Progesterone is a C-21 steroid hormone involved in the female menstrual cycle, pregnancy (supports gestation) and embryogenesis of humans and other species. Progesterone belongs to a class of hormones called progestagens, and is the major naturally occurring human progestagen. -- Wikipedia; During implantation and gestation, progesterone appears to decrease the maternal immune response to allow for the acceptance of the pregnancy. Progesterone decreases contractility of the uterine smooth muscle. The fetus metabolizes placental progesterone in the production of adrenal mineralo- and glucosteroids. A drop in progesterone levels is possibly one step that facilitates the onset of labor. In addition progesterone inhibits lactation during pregnancy. The fall in progesterone levels following delivery is one of the triggers for milk production. -- Wikipedia.",,progesterone,,HMDB01830,"InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1",C00410,2016-12-05T15:48:04Z,,357,,,,,5994,prgstrn,,"17a-Progesterone, 3,20-Pregnene-4, 4-Pregnen-3,20-dione, 4-Pregnene-3,20-dione, Agolutin, beta-Progesterone, Bio-luton, CIDR, Colprosterone, Corlutin, Corlutina, Corluvite, Corporin, Corpus luteum hormone, Crinone, Crinone progesterone gel, Curretab, Cyclogest, Cyclogesterin, D4-Pregnene-3,20-dione, Delalutin, delta(Sup 4)-Pregnene-3,20-dione, Duraprogen, Estima, Flavolutan, Fologenon, Gesterol, Gesterol 100, Gesterol 50, Gestiron, Gestone, Gestormone, Gestron, Glanducorpin, Gynlutin, Gynoluton, Gynolutone, Hormoflaveine, Hormoluton, Hydroxyprogesterone Caproate, Hydroxyprogesterone Caproic acid, Lingusorbs, Lipo-Lutin, Lucorteum, Lucorteum sol, Lugesteron, Luteal hormone, Luteocrin normale, Luteodyn, Luteogan, Luteohormone, Luteol, Luteopur, Luteosan, Luteostab, Luteovis, Luteum, Lutex, Lutidon, Lutociclina, Lutocuclin M, Lutocyclin, Lutocyclin m, Lutocylin, Lutocylol, Lutoform, Lutogyl, Lutren, Lutromone, Membrettes, Methylpregnone, MPA, Nalutron, Percutacrine, Percutacrine Luteinique, Piaponon, Pranone, Pregn-4-en-3,20-dione, Pregn-4-ene-3,20-dione, Pregnene-3,20-dione, Pregnenedione, Primolut, Prochieve, Progeffik, Progekan, Progestan, Progestasert, Progesterol, Progesterone, Progesteronum, Progestin, Progestogel, Progestol, Progeston, Progestone, Progestosol, Progestron, Progestronol, Projestaject, Prolets, Prolidon, Prolutin, Proluton, Prolutone, Prometrium, Prontogest, Protormone, Syngesterone, Syngestrets, Synovex S, Syntolutan, Utrogest, Utrogestan, Vitarrine",http://vmh.uni.lu/_api/metabolites/357/?format=pcsv
aprgstrn,,,0,C21H32O2,CHEBI:28453,,"Human Metabolome Database (HMDB): 20a-Dihydroprogesterone is a biologically active 20-alpha-reduced metabolite of progesterone. It is converted from progesterone to 20-alpha-hydroxypregn-4-en-3-one by the 20-alpha-hydroxysteroid dehydrogenase in the corpus luteum and the placenta. -- Pubchem; Progesterone is a C-21 steroid hormone involved in the female menstrual cycle, pregnancy (supports gestation) and embryogenesis of humans and other species. Progesterone belongs to a class of hormones called progestagens, and is the major naturally occurring human progestagen. -- Wikipedia; During implantation and gestation, progesterone appears to decrease the maternal immune response to allow for the acceptance of the pregnancy. Progesterone decreases contractility of the uterine smooth muscle. The fetus metabolizes placental progesterone in the production of adrenal mineralo- and glucosteroids. A drop in progesterone levels is possibly one step that facilitates the onset of labor. In addition progesterone inhibits lactation during pregnancy. The fall in progesterone levels following delivery is one of the triggers for milk production. -- Wikipedia.",,(20S)-20-hydroxypregn-4-en-3-one,,HMDB03069,"InChI=1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12-13,16-19,22H,4-11H2,1-3H3/t13-,16-,17+,18-,19-,20-,21+/m0/s1",C04042,2016-12-05T15:48:04Z,,358,,,,,,aprgstrn,,"(20S)-20-Hydroxypregn-4-en-3-one, 20(S)-Hydroxyprogesterone, 20-a-Dihydroprogesterone, 20-alpha-Dihydroprogesterone, 20-alpha-Hydroxydihydroprogesterone, 20-alpha-Hydroxyprogesterone, 20-alpha-Progerol, 20a-Dihydroprogesterone, 20a-Hydroxydihydroprogesterone, 20a-Hydroxypreg-4-en-3-one, 20a-Hydroxypregnen-2-one, 20a-Hydroxyprogesterone, 20a-Progerol, 20alpha-Dihydroprogesterone, 20alpha-Dihydroprognenolone, 20alpha-Hydroxy-4-pregnen-3-one, 20alpha-Hydroxydihydroprogesterone, 20alpha-Hydroxypreg-4-en-3-one, 20alpha-Hydroxypregn-4-en-3-one, 20alpha-Hydroxypregnen-2-one, 20alpha-hydroxyprogesterone, 20alpha-Progerol, Dihydrogesterone, Dihydroxyprogesterone, Progesterol-20-alpha, Progesterol-20a",http://vmh.uni.lu/_api/metabolites/358/?format=pcsv
xol7ah,,,0,C27H46O2,CHEBI:2290,,7alpha-hydroxy-5beta-cholestan-3-one,,7alpha-hydroxy-5beta-cholestan-3-one,,,"InChI=1S/C27H46O2/c1-17(2)7-6-8-18(3)21-9-10-22-25-23(12-14-27(21,22)5)26(4)13-11-20(28)15-19(26)16-24(25)29/h17-19,21-25,29H,6-16H2,1-5H3/t18-,19+,21-,22+,23+,24-,25+,26+,27-/m1/s1",C05451,2016-11-22T15:11:50Z,,359,,,,,5284270,xol7ah,,,http://vmh.uni.lu/_api/metabolites/359/?format=pcsv
xol7ah2,,,0,C27H48O2,CHEBI:28047,,"Human Metabolome Database (HMDB): 3alpha,7alpha-Dihydroxy-5beta-cholestane is an intermediate in bile acid synthesis. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",,"5beta-cholestane-3alpha,7alpha-diol",,HMDB06893,"InChI=1S/C27H48O2/c1-17(2)7-6-8-18(3)21-9-10-22-25-23(12-14-27(21,22)5)26(4)13-11-20(28)15-19(26)16-24(25)29/h17-25,28-29H,6-16H2,1-5H3/t18-,19+,20-,21-,22+,23+,24-,25+,26+,27-/m1/s1",C05452,2016-12-05T15:48:04Z,,360,,,,,3080603,xol7ah2,,"3a,7a-Dihydroxy-5b-cholestane, 3alpha,7alpha-dihydroxy-5beta-cholestane, 5b-Cholestane-3a,7a-diol, 5beta-Cholestane-3alpha,7alpha-diol, Dihydroxycoprostane",http://vmh.uni.lu/_api/metabolites/360/?format=pcsv
xoldioloneh,,,0,C27H46O3,CHEBI:2288,,"7alpha,12alpha-dihydroxy-5beta-cholestan-3-one",,"7alpha,12alpha-dihydroxy-5beta-cholestan-3-one",,,"InChI=1S/C27H46O3/c1-16(2)7-6-8-17(3)20-9-10-21-25-22(15-24(30)27(20,21)5)26(4)12-11-19(28)13-18(26)14-23(25)29/h16-18,20-25,29-30H,6-15H2,1-5H3/t17-,18+,20-,21+,22+,23-,24+,25+,26+,27-/m1/s1",C05453,2016-11-22T15:11:50Z,,361,,,,,5284271,xoldioloneh,,,http://vmh.uni.lu/_api/metabolites/361/?format=pcsv
xoltriol,,,0,C27H48O3,CHEBI:16496,,"Human Metabolome Database (HMDB): 5-b-Cholestane-3a ,7a ,12a-triol is an intermediate in Bile acid biosynthesis. 5-b-Cholestane-3a ,7a ,12a-triol is the second to last step of synthesis of 5beta-Cyprinolsulfate. It is converted from 7alpha,12alpha-Dihydroxy-5beta-cholestan-3-one via enzymatic reaction then it is coneverted to 3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane via the enzyme cytochrome P450(EC.1.14.13.15). This compound inhibits la-Hydroxylation, (PMID: 7937829). It is the byproduct of Cholestanetetraol 26-dehydrogenase (EC 1.1.1.161), and the reaction that cataylzes it is classified as a small molecule reaction. (BioCyc).",,"5beta-cholestane-3alpha,7alpha,12alpha-triol",,HMDB01457,"InChI=1S/C27H48O3/c1-16(2)7-6-8-17(3)20-9-10-21-25-22(15-24(30)27(20,21)5)26(4)12-11-19(28)13-18(26)14-23(25)29/h16-25,28-30H,6-15H2,1-5H3/t17-,18+,19-,20-,21+,22+,23-,24+,25+,26+,27-/m1/s1",C05454,2016-12-05T15:48:04Z,,362,,,,,160520,xoltriol,,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestane, 3alpha,7alpha,12alpha-Trihydroxycoprostane, 5-beta-Cholestane-3-alpha,7-alpha,12-alpha-triol",http://vmh.uni.lu/_api/metabolites/362/?format=pcsv
xol7aone,,,0,C27H44O2,CHEBI:17899,,"Human Metabolome Database (HMDB): 7a-Hydroxy-cholestene-3-one is a metabolite in bile acid synthesis. It is derived from 7a-hydroxy-cholesterol and can be further metabolized to 7a,12a,-dihydroxy-cholest-4-en-3-one. Analysis of 7a-Hydroxycholestene-3-one (HCO) in serum may serve as a novel, simple, and sensitive method for the detection of bile acid malabsorption in patients with chronic diarrhea of unknown origin (PMID 9952217).",,7alpha-hydroxycholest-4-en-3-one,,HMDB01993,"InChI=1S/C27H44O2/c1-17(2)7-6-8-18(3)21-9-10-22-25-23(12-14-27(21,22)5)26(4)13-11-20(28)15-19(26)16-24(25)29/h15,17-18,21-25,29H,6-14,16H2,1-5H3/t18-,21-,22+,23+,24-,25+,26+,27-/m1/s1",C05455,2016-12-05T15:48:04Z,,363,,,,,123743,xol7aone,,"7 alpha-3ox-C, 7 alpha-Hydroxy-4-cholesten-3-one, 7-a-Hydroxy-4-cholesten-3-one, 7-a-Hydroxycholest-4-en-3-one, 7-alpha-Hydroxy-4-cholesten-3-one, 7-alpha-Hydroxycholest-4-en-3-one, 7-Hydroxycholest-4-en-3-one, 7a-Hydroxy-4-cholesten-3-one-12alpha, 7alpha-Hydroxy-4-cholesten-3-one, 7alpha-Hydroxycholest-4-en-3-one, Cholest-4-en-7alpha-ol-3-one, HCO",http://vmh.uni.lu/_api/metabolites/363/?format=pcsv
xoldiolone,,,0,C27H44O3,CHEBI:28477,,"7alpha,12alpha-Dihydroxycholest-4-en-3-one",,"7alpha,12alpha-Dihydroxycholest-4-en-3-one",,,"InChI=1S/C27H44O3/c1-16(2)7-6-8-17(3)20-9-10-21-25-22(15-24(30)27(20,21)5)26(4)12-11-19(28)13-18(26)14-23(25)29/h13,16-17,20-25,29-30H,6-12,14-15H2,1-5H3/t17-,20-,21+,22+,23-,24+,25+,26+,27-/m1/s1",C17339,2016-11-22T15:11:50Z,,364,,,,,3081958,xoldiolone,,,http://vmh.uni.lu/_api/metabolites/364/?format=pcsv
asn_L,,,0,C4H8N2O3,CHEBI:17196,,"Human Metabolome Database (HMDB): Asparagine (Asn) is one of the 20 most common natural amino acids on Earth. It has carboxamide as the side chain's functional group. It is considered a non-essential amino acid. Asparagine is not an essential amino acid, which means that it can be synthesized from central metabolic pathway intermediates in humans and is not required in the diet. The precursor to asparagine is oxaloacetate. Oxaloacetate is converted to aspartate using a transaminase enzyme. The enzyme transfers the amino group from glutamate to oxaloacetate producing alpha-ketoglutarate and aspartate. The enzyme asparagine synthetase produces asparagine, AMP, glutamate, and pyrophosphate from aspartate, glutamine, and ATP. In the asparagine synthetase reaction, ATP is used to activate aspartate, forming beta-aspartyl-AMP. glutamine donates an ammonium group which reacts with beta-aspartyl-AMP to form asparagine and free AMP. Since the asparagine side chain can make efficient hydrogen bond interactions with the peptide backbone, asparagines are often found near the beginning and end of alpha-helices, and in turn motifs in beta sheets. Its role can be thought as ""capping"" the hydrogen bond interactions which would otherwise need to be satisfied by the polypeptide backbone. glutamines have an extra methylene group, have more conformational entropy and thus are less useful in this regard. Asparagine also provides key sites for N-linked glycosylation, modification of the protein chain with the addition of carbohydrate chains. A reaction between asparagine and reducing sugars or reactive carbonyls produces acrylamide (acrylic amide) in food when heated to sufficient temperature, i.e. baking. These occur primarily in baked goods such as french fries, potato chips, and roasted coffee. Asparagine was first isolated in 1806 from asparagus juice, in which it is abundant--hence its name--becoming the first amino acid to be isolated. The smell observed in the urine of some individuals after their consumption of asparagus is attributed to a byproduct of the metabolic breakdown of asparagine, asparagine-amino-succinic-acid monoamide. (However, some scientists disagree and implicate other substances in the smell, especially methanethiol). (http://en.wikipedia.org/wiki/Asparagine).",,L-asparagine,,HMDB00168,"InChI=1S/C4H8N2O3/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H2,6,7)(H,8,9)/t2-/m0/s1",C00152,2016-12-05T15:48:04Z,,365,,,,,6267,asn_L,,"(-)-Asparagine, (S)-2,4-Diamino-4-oxobutanoate, (S)-2,4-Diamino-4-oxobutanoic acid, (S)-Asparagine, 2-Aminosuccinamate, 2-Aminosuccinamic acid, a-Aminosuccinamate, a-Aminosuccinamic acid, Agedoite, alpha Amminosuccinamate, alpha Amminosuccinamic acid, alpha-Aminosuccinamate, alpha-Aminosuccinamic acid, Altheine, Asn, Asparagine, Asparagine acid, Asparamide, Aspartamate, Aspartamic acid, Aspartic acid amide, Aspartic acid b-amide, Aspartic acid beta amide, B2,4-(S)-diamino-4-oxo-utanoate, B2,4-(S)-diamino-4-oxo-utanoic acid, Crystal VI, L-2,4-Diamino-4-oxobutanoate, L-2,4-Diamino-4-oxobutanoic acid, L-Asparagine, L-Aspartamine, L-b-Asparagine, L-beta-Asparagine",http://vmh.uni.lu/_api/metabolites/365/?format=pcsv
cys_L,,,0,C3H7NO2S,CHEBI:17561,,"Human Metabolome Database (HMDB): Cysteine is a naturally occurring, sulfur-containing amino acid that is found in most proteins, although only in small quantities. Cysteine is unique amongst the twenty natural amino acids as it contains a thiol group. Thiol groups can undergo oxidation/reduction (redox) reactions; when cysteine is oxidized it can form cystine, which is two cysteine residues joined by a disulfide bond. This reaction is reversible: as reduction of this disulphide bond regenerates two cysteine molecules. The disulphide bonds of cystine are crucial to defining the structures of many proteins. Cysteine is often involved in electron-transfer reactions, and help the enzyme catalyze its reaction. Cysteine is also part of the antioxidant glutathione. N-acetyl-L-cysteine (NAC) is a form of cysteine where an acetyl group is attached to cysteine's nitrogen atom and is sold as a dietary supplement. Cysteine is named after cystine, which comes from the Greek word kustis meaning bladder - cystine was first isolated from kidney stones. As cysteine contains a sulphydryl group, it can undergo redox reactions. Oxidation of cysteine can produce a disulfide bond with another thiol, or further oxidation can produce sulphfinic or sulfonic acids. The cysteine thiol group is also a nucleophile and can undergo addition and substitution reactions. Thiol groups become much more reactive when they are ionized, and cysteine residues in proteins have pKa values close to neutrality, so are often in their reactive thiolate form in the cell. The thiol group also has a high affinity for heavy metals and proteins containing cysteine will bind metals such as mercury, lead and cadmium tightly. Due to this ability to undergo redox reactions, cysteine has antioxidant properties. Cysteine is an important source of sulfur in human metabolism, and although it is classified as a non-essential amino acid, cysteine may be essential for infants, the elderly, and individuals with certain metabolic disease or who suffer from malabsorption syndromes. Cysteine may at some point be recognized as an essential or conditionally essential amino acid. (http://en.wikipedia.org/wiki/Cysteine). Cysteine is important in energy metabolism. As cystine, it is a structural component of many tissues and hormones. Cysteine has clinical uses ranging from baldness to psoriasis to preventing smoker's hack. In some cases, oral cysteine therapy has proved excellent for treatment of asthmatics, enabling them to stop theophylline and other medications. Cysteine also enhances the effect of topically applied silver, tin and zinc salts in preventing dental cavities. In the future, cysteine may play a role in the treatment of cobalt toxicity, diabetes, psychosis, cancer and seizures. (http://www.dcnutrition.com/AminoAcids/).",,L-cysteine,,HMDB00574,"InChI=1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1",C00097,2016-12-05T15:48:04Z,,366,,,,L-cysteine,5862,cys_L,,"(+)-2-Amino-3-mercaptopropionic acid, (2R)-2-amino-3-mercaptopropanoate, (2R)-2-amino-3-mercaptopropanoic acid, (2R)-2-amino-3-sulfanylpropanoate, (2R)-2-amino-3-sulfanylpropanoic acid, (R)-(+)-cysteine, (R)-2-amino-3-mercapto-Propanoate, (R)-2-amino-3-mercapto-Propanoic acid, (R)-2-Amino-3-mercaptopropanoate, (R)-2-Amino-3-mercaptopropanoic acid, (R)-cysteine, 2-Amino-3-mercaptopropanoate, 2-Amino-3-mercaptopropanoic acid, 2-Amino-3-mercaptopropionate, 2-Amino-3-mercaptopropionic acid, 3-Mercapto-L-Alanine, Acetylcysteine, alpha-Amino-beta-thiolpropionic acid, B-Mercaptoalanine, beta-Mercaptoalanine, Carbocysteine, Cisteina, Cisteinum, Cystein, Cysteine, Cysteinum, Free cysteine, Half-cystine, L Cysteine, L-(+)-Cysteine, L-2-Amino-3-mercaptopropanoate, L-2-Amino-3-mercaptopropanoic acid, L-2-Amino-3-mercaptopropionic acid, L-Cystein, L-Cysteine, Polycysteine, Thioserine",http://vmh.uni.lu/_api/metabolites/366/?format=pcsv
ala_D,,,0,C3H7NO2,CHEBI:15570,,"Human Metabolome Database (HMDB): Alanine is a nonessential amino acid made in the body from the conversion of the carbohydrate pyruvate or the breakdown of DNA and the dipeptides carnosine and anserine. It is highly concentrated in muscle and is one of the most important amino acids released by muscle, functioning as a major energy source. Plasma alanine is often decreased when the BCAA (Branched Chain Amino Acids) are deficient. This finding may relate to muscle metabolism. Alanine is highly concentrated in meat products and other high-protein foods like wheat germ and cottage cheese. Alanine is an important participant as well as regulator in glucose metabolism. Alanine levels parallel blood sugar levels in both diabetes and hypoglycemia, and alanine reduces both severe hypoglycemia and the ketosis of diabetes. It is an important amino acid for lymphocyte reproduction and immunity. Alanine therapy has helped dissolve kidney stones in experimental animals. Normal alanine metabolism, like that of other amino acids, is highly dependent upon enzymes that contain vitamin B6. Alanine, like GABA, taurine and glycine, is an inhibitory neurotransmitter in the brain. http://www.dcnutrition.com/AminoAcids/).",,D-alanine,,HMDB01310,"InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m1/s1",C00133,2016-12-05T15:48:04Z,,367,,,,,71080,ala_D,,"(R)-Alanine, Alanine , D(-)-a -Alanine, D(-)-alpha-Alanine, D-(-)-Alanine, D-2-Aminopropionic acid, D-Alanine, D-alpha-Alanine, delta-(-)-Alanine, delta-2-Aminopropionic acid, delta-Alanine, delta-alpha-Alanine, Dl-Alanine",http://vmh.uni.lu/_api/metabolites/367/?format=pcsv
gln_L,,,0,C5H10N2O3,CHEBI:18050,,"Human Metabolome Database (HMDB): Glutamine (Gln) is one of the 20 amino acids encoded by the standard genetic code. Its side chain is an amide; it is formed by replacing a side-chain hydroxyl of glutamic acid with an amine functional group. glutamine is found in foods high in proteins, such as fish, red meat, beans, and dairy products. glutamine is a supplement that is used in weightlifting, bodybuilding, endurance and other sports, as well as by those who suffer from muscular cramps or pain particularly elderly people. The main use of glutamine within the diet of either group is as a means of replenishing the body's stores of amino acids that have been used during exercise or everyday activities. Studies which are looking into problems with excessive consumption of glutamine thus far have proved inconclusive. However, normal supplementation is healthy mainly because glutamine is supposed to be supplemented after prolonged periods of exercise (for example, a workout or exercise in which amino acids are required for use) and replenishes amino acid stores; this being the main reason glutamine is recommended during fasting or for people who suffer from physical trauma, immune deficiencies, or cancer. There is a significant body of evidence that links glutamine-enriched diets with intestinal effects; aiding maintenance of gut barrier function, intestinal cell proliferation and differentiation, as well as generally reducing septic morbidity and the symptoms of Irritable Bowel Syndrome. The reason for such ""cleansing"" properties is thought to stem from the fact that the intestinal extraction rate of glutamine is higher than that for other amino acids, and is therefore thought to be the most viable option when attempting to alleviate conditions relating to the gastrointestinal tract. These conditions were discovered after comparing plasma concentration within the gut between glutamine-enriched and non glutamine-enriched diets. However, even though glutamine is thought to have ""cleansing"" properties and effects, it is unknown to what extent glutamine has clinical benefits, due to the varied concentrations of glutamine in varieties of food. It is also known that glutamine has various effects in reducing healing time after operations. Hospital waiting times after abdominal surgery are reduced by providing parenteral nutrition regimens containing amounts of glutamine to patients. Clinical trials have revealed that patients on supplementation regimes containing glutamine have improved nitrogen balances, generation of cysteinyl-leukotrienes from polymorphonuclear neutrophil granulocytes and improved lymphocyte recovery and intestinal permeability (in postoperative patients) - in comparison to those who had no glutamine within their dietary regime; all without any side-effects. (http://en.wikipedia.org/wiki/glutamine).",,L-glutamine,,HMDB00641,"InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1",C00064,2016-12-05T15:48:04Z,,368,,,,,5961,gln_L,,"(2S)-2,5-diamino-5-oxopentanoate, (2S)-2,5-diamino-5-oxopentanoic acid, (2S)-2-amino-4-carbamoylbutanoate, (2S)-2-amino-4-carbamoylbutanoic acid, (S)-2,5-Diamino-5-oxopentanoate, (S)-2,5-Diamino-5-oxopentanoic acid, 2-Aminoglutaramic acid, Cebrogen, gamma-Glutamine, Glavamin, Glumin, Glutamic acid 5-amide, Glutamic acid amide, Glutamine, L-(+)-Glutamine, L-2-Aminoglutaramic acid, L-2-Aminoglutaramidic acid, L-Glutamic acid 5-amide, L-Glutamic acid gamma-amide, L-Glutamid, L-Glutamide, L-Glutamin, L-Glutamine, L-Glutaminsaeure-5-amid, Levoglutamid, Levoglutamida, Levoglutamide, Levoglutamidum, Levoglutamina, Polyglutamine, Stimulina",http://vmh.uni.lu/_api/metabolites/368/?format=pcsv
ser_L,,,0,C3H7NO3,CHEBI:17115,,"Human Metabolome Database (HMDB): Serine is a nonessential amino acid derived from glycine. Like all the amino acid building blocks of protein and peptides, serine can become essential under certain conditions, and is thus important in maintaining health and preventing disease. Low-average concentration of serine compared to other amino acids is found in muscle. Serine is highly concentrated in all cell membranes. (http://www.dcnutrition.com/AminoAcids/) L-Serine may be derived from four possible sources: dietary intake; biosynthesis from the glycolytic intermediate 3-phosphoglycerate; from glycine ; and by protein and phospholipid degradation. Little data is available on the relative contributions of each of these four sources of l-serine to serine homoeostasis. It is very likely that the predominant source of l-serine will be very different in different tissues and during different stages of human development. In the biosynthetic pathway, the glycolytic intermediate 3-phosphoglycerate is converted into phosphohydroxypyruvate, in a reaction catalyzed by 3-phosphoglycerate dehydrogenase (3- PGDH; EC 1.1.1.95). Phosphohydroxypyruvate is metabolized to phosphoserine by phosphohydroxypyruvate aminotransferase (EC 2.6.1.52) and, finally, phosphoserine is converted into l-serine by phosphoserine phosphatase (PSP; EC 3.1.3.3). In liver tissue, the serine biosynthetic pathway is regulated in response to dietary and hormonal changes. Of the three synthetic enzymes, the properties of 3-PGDH and PSP are the best documented. Hormonal factors such as glucagon and corticosteroids also influence 3-PGDH and PSP activities in interactions dependent upon the diet. L-serine plays a central role in cellular proliferation. L-Serine is the predominant source of one-carbon groups for the de novo synthesis of purine nucleotides and deoxythymidine monophosphate. It has long been recognized that, in cell cultures, L-serine is a conditional essential amino acid, because it cannot be synthesized in sufficient quantities to meet the cellular demands for its utilization. In recent years, L-serine and the products of its metabolism have been recognized not only to be essential for cell proliferation, but also to be necessary for specific functions in the central nervous system. The findings of altered levels of serine and glycine in patients with psychiatric disorders and the severe neurological abnormalities in patients with defects of L-serine synthesis underscore the importance of L-serine in brain development and function. (PMID 12534373).",,L-serine,,HMDB00187,"InChI=1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m0/s1",C00065,2016-12-05T15:48:04Z,,369,,,,,5951,ser_L,,"(-)-Serine, (S)-2-amino-3-hydroxy-Propanoate, (S)-2-amino-3-hydroxy-Propanoic acid, (S)-2-Amino-3-hydroxypropanoate, (S)-2-Amino-3-hydroxypropanoic acid, (S)-a-Amino-b-hydroxypropionate, (S)-a-Amino-b-hydroxypropionic acid, (S)-alpha-Amino-beta-hydroxypropionate, (S)-alpha-Amino-beta-hydroxypropionic acid, (S)-b-Amino-3-hydroxypropionate, (S)-b-Amino-3-hydroxypropionic acid, (S)-beta-Amino-3-hydroxypropionate, (S)-beta-Amino-3-hydroxypropionic acid, (S)-Serine, 2-Amino-3-hydroxypropanoate, 2-Amino-3-hydroxypropanoic acid, 3-Hydroxy-L-Alanine, b-Hydroxy-L-alanine, beta-Hydroxy-L-alanine, beta-Hydroxyalanine, L-(-)-Serine, L-3-Hydroxy-2-aminopropionate, L-3-Hydroxy-2-aminopropionic acid, L-3-Hydroxy-alanine, L-Ser, Serine",http://vmh.uni.lu/_api/metabolites/369/?format=pcsv
thr_L,,,0,C4H9NO3,CHEBI:16857,,"Human Metabolome Database (HMDB): Threonine is an essential amino acid in humans. It is abundant in human plasma, particularly in newborns. Severe deficiency of threonine causes neurological dysfunction and lameness in experimental animals. Threonine is an immunostimulant which promotes the growth of thymus gland. It also can probably promote cell immune defense function. This amino acid has been useful in the treatment of genetic spasticity disorders and multiple sclerosis at a dose of 1 gram daily. It is highly concentrated in meat products, cottage cheese and wheat germ. (http://www.dcnutrition.com/AminoAcids/) The threonine content of most of the infant formulas currently on the market is approximately 20% higher than the threonine concentration in human milk. Due to this high threonine content the plasma threonine concentrations are up to twice as high in premature infants fed these formulas than in infants fed human milk. The whey proteins which are used for infant formulas are sweet whey proteins. Sweet whey results from cheese production. Threonine catabolism in mammals appears to be due primarily (70-80%) to the activity of threonine dehydrogenase (EC 1.1.1.103) that oxidizes threonine to 2-amino-3-oxobutyrate, which forms glycine and acetyl CoA, whereas threonine dehydratase (EC 4.2.1.16) that catabolizes threonine into 2-oxobutyrate and ammonia, is significantly less active. Increasing the threonine plasma concentrations leads to accumulation of threonine and glycine in the brain. Such accumulation affects the neurotransmitter balance which may have consequences for the brain development during early postnatal life. Thus, excessive threonine intake during infant feeding should be avoided. (PMID 9853925).",,L-threonine,,HMDB00167,"InChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1",C00188,2016-12-05T15:48:04Z,,370,,,,,6288,thr_L,,"(2S,3R)-(-)-Threonine, (2S,3R)-2-Amino-3-hydroxybutyrate, (2S,3R)-2-Amino-3-hydroxybutyric acid, (R-(R*,S*))-2-Amino-3-hydroxybutanoate, (R-(R*,S*))-2-Amino-3-hydroxybutanoic acid, (S)-Threonine, 2-Amino-3-hydroxybutanoate, 2-Amino-3-hydroxybutanoic acid, 2-Amino-3-hydroxybutyrate, 2-Amino-3-hydroxybutyric acid, L-(-)-Threonine, L-2-Amino-3-hydroxybutyrate, L-2-Amino-3-hydroxybutyric acid, L-alpha-Amino-beta-hydroxybutyrate, L-alpha-Amino-beta-hydroxybutyric acid, Threonin, Threonine, [R-(R*,S*)]-2-amino-3-hydroxy-Butanoate, [R-(R*,S*)]-2-amino-3-hydroxy-Butanoic acid, [R-(R*,S*)]-2-Amino-3-hydroxybutanoate, [R-(R*,S*)]-2-Amino-3-hydroxybutanoic acid",http://vmh.uni.lu/_api/metabolites/370/?format=pcsv
meoh,,,0,CH4O1,CHEBI:17790,,"Human Metabolome Database (HMDB): It is the simplest alcohol, and is a light, volatile, colourless, flammable, poisonous liquid with a distinctive odor that is somewhat milder and sweeter than ethanol (Wikipedia). Methanol is responsible for accidental, suicidal, and epidemic poisonings, resulting in death or permanent sequelae. Toxicity is due to the metabolic products of alcohol dehydrogenase (ADH) and aldehyde dehydrogenase. (PMID 15627163). The rapid and accurate diagnosis of toxic alcohol poisoning due to methanol (methyl alcohol) is paramount in preventing serious adverse outcomes. The quantitative measurement of specific serum levels of methanol using gas chromatography is expensive, time consuming and generally only available at major tertiary-care facilities. (PMID 15862085).",,methanol,,HMDB01875,"InChI=1S/CH4O/c1-2/h2H,1H3",C00132,2016-12-05T15:48:04Z,,371,,,,,887,meoh,,"Alcool methylique, Alcool metilico, Carbinol, CH3OH, Colonial spirit, Columbian spirit, Columbian spirits, Hydroxymethane, Metanolo, Methanol, Methanol-water mixture, Methyl alcohol, Methyl hydroxide, Methylalkohol, Methylol, Metylowy alkohol, Monohydroxymethane, Pyro alcohol, Pyroxylic spirit, Spirit of wood, Wood alcohol, Wood naphtha, Wood spirit",http://vmh.uni.lu/_api/metabolites/371/?format=pcsv
fald,,,0,CH2O,CHEBI:16842,,"Human Metabolome Database (HMDB): Formaldehyde is a highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717) -- Pubchem; The chemical compound formaldehyde (also known as methanal), is a gas with a pungent smell. It is the simplest aldehyde. Its chemical formula is H2CO. Formaldehyde was first synthesized by the Russian chemist Aleksandr Butlerov in 1859 but was conclusively identified by August Wilhelm van Hofmann in 1867. Although formaldehyde is a gas at room temperature, it is readily soluble in water, and it is most commonly sold as a 37% solution in water called by trade names such as formalin or formol. In water, formaldehyde polymerizes, and formalin actually contains very little formaldehyde in the form of H2CO monomer. Usually, these solutions contain a few percent methanol to limit the extent of polymerization. Formaldehyde exhibits most of the general chemical properties of the aldehydes, except that is generally more reactive than other aldehydes. Formaldehyde is a potent electrophile. It can participate in electrophilic aromatic substitution reactions with aromatic compounds and can undergo electrophilic addition reactions with alkenes. In the presence of basic catalysts, formaldehyde undergoes a Cannizaro reaction to produce formic acid and methanol. Because formaldehyde resins are used in many construction materials, including plywood, carpet, and spray-on insulating foams, and because these resins slowly give off formaldehyde over time, formaldehyde is one of the more common indoor air pollutants. At concentrations above 0.1 mg/kg in air, inhaled formaldehyde can irritate the eyes and mucous membranes, resulting in watery eyes, headache, a burning sensation in the throat, and difficulty breathing. -- Wikipedia.",,formaldehyde,,HMDB01426,InChI=1S/CH2O/c1-2/h1H2,C00067,2016-12-05T15:48:04Z,,372,,,,,712,fald,," Methaldehyde,  Methylene glycol, Aldeide formica, Chlodithan, Chlodithane, Fannoform, Formaldehyde, Formalina, Formaline, Formalith, Formic aldehyde, Formol, Methanal, Methylene oxide, Oxomethylene, Paraform",http://vmh.uni.lu/_api/metabolites/372/?format=pcsv
12ppd_R,,,0,C3H8O2,CHEBI:16997,,"Human Metabolome Database (HMDB): Propylene glycol (1,2-propanediol) is an organic compound (a diol alcohol), usually a tasteless, odorless, and colorless clear oily liquid that is hygroscopic and miscible with water, acetone, and chloroform. It is manufactured by the hydration of propylene oxide. Propylene glycol is used as a solvent for intravenous, oral, and topical pharmaceutical preparations It is generally considered safe. However in large doses it can be toxic, especially if given over a short period of time. Intravenous lorazepam contains the largest amount of propylene glycol of commonly used drugs. In adults with normal liver and kidney function, the terminal half-life of propylene glycol ranges from 1.4 to 3.3 hours. Propylene glycol is metabolized by the liver to form lactate, acetate, and pyruvate. The nonmetabolized drug is excreted in the urine mainly as the glucuronide conjugate, approximately 12 to 45 percent is excreted unchanged in urine. Renal clearance decreases as the dose administered increases (390 ml/minute/173 m2 at a dose of 5 g/day but only 144 ml/minute/173 m2 at a dose of 21 g/day). These data suggest that renal clearance declines at higher propylene glycol doses because of saturation of proximal tubular secretion of the drug. As an acceptable level of propylene glycol has not been defined, the clinical implication of a propylene glycol level is unclear. The World Health Organization (WHO) recommends a maximum consumption of 25 mg/kg/day (1.8 g/day for a 75 kg male) of propylene glycol when used as a food additive, but this limit does not address its use as a drug solvent. No maximum dose is recommended in the literature for intravenous therapy with propylene glycol. Intoxication occurs at much higher doses than the WHO dose limit and is exclusive to pharmacologic exposure. Propylene glycol toxicity includes development of serum hyperosmolality, lactic acidosis, and kidney failure. It has been suggested that proximal tubular necrosis is the cause of acute kidney injury from propylene glycol. Along these lines, proximal tubular cell injury occurs in cultured human cells exposed to propylene glycol. Acute tubular necrosis was described with propylene glycol toxicity in a case of concomitant administration of intravenous lorazepam and trimethoprim sulfamethoxazole. Propylene glycol induced intoxication can also mimic sepsis or systemic inflammatory response syndrome (SIRS). Patients suspected of having sepsis with negative cultures should be evaluated for propylene glycol toxicity if they have been exposed to high dose lorazepam or other medications containing this solvent. (PMID: 17555487).",,"(R)-propane-1,2-diol",,HMDB01881,"InChI=1S/C3H8O2/c1-3(5)2-4/h3-5H,2H2,1H3/t3-/m1/s1",C00583,2016-12-05T15:48:04Z,,373,,,,,,12ppd_R,,"(RS)-1,2-Propanediol, 1,2-(RS)-Propanediol, 1,2-Dihydroxypropane, 1,2-Propanediol, 1,2-Propylene glycol, 1,2-Propylenglykol, 2,3-Propanediol, 2-Hydroxypropanol, a-Propylene glycol, Aliphatic alcohol, alpha-Propylene glycol, Chilisa FE, DL-1,2-Propanediol, Dl-Propylene glycol, Dowfrost, Glycol, Ilexan P, Inhibited 1,2-propylene glycol, Isopropylene glycol, Methyl glycol, Methylethyl glycol, Methylethylene glycol, Monopropylene glycol, Prolugen, Propane-1,2-diol, Propanediol, Propylene glycol, Propylene glycol usp, Propylenglycol, Sentry Propylene Glycol, Sirlene, Solar Winter Ban, Solargard P, Trimethyl glycol, Ucar 35",http://vmh.uni.lu/_api/metabolites/373/?format=pcsv
lald_D,,,0,C3H6O2,CHEBI:17167,,(R)-lactaldehyde,,(R)-lactaldehyde,,,"InChI=1S/C3H6O2/c1-3(5)2-4/h2-3,5H,1H3/t3-/m1/s1",C00937,2016-11-22T15:11:50Z,,374,,,,,439350,lald_D,,,http://vmh.uni.lu/_api/metabolites/374/?format=pcsv
12ppd_S,,,0,C3H8O2,,,"(S)-propane-1,2-diol",,"(S)-propane-1,2-diol",,,"InChI=1S/C3H8O2/c1-3(5)2-4/h3-5H,2H2,1H3/t3-/m0/s1",C02917,2016-11-22T15:11:50Z,,375,,,,,,12ppd_S,,,http://vmh.uni.lu/_api/metabolites/375/?format=pcsv
lald_L,,,0,C3H6O2,CHEBI:18419,,(S)-lactaldehyde,,(S)-lactaldehyde,,,"InChI=1S/C3H6O2/c1-3(5)2-4/h2-3,5H,1H3/t3-/m0/s1",C00424,2016-11-22T15:11:50Z,,376,,,,,439231,lald_L,,,http://vmh.uni.lu/_api/metabolites/376/?format=pcsv
etoh,,,0,C2H6O,CHEBI:16236,,"Human Metabolome Database (HMDB): Ethanol is a clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in alcoholic beverages. Indeed, ethanol has widespread use as a solvent of substances intended for human contact or consumption, including scents, flavorings, colorings, and medicines. Ethanol has a depressive effect on the central nervous system and because of its psychoactive effects, it is considered a drug. Ethanol has a complex mode of action and affects multiple systems in the brain, most notably it acts as an agonist to the GABA receptors. Death from ethanol consumption is possible when blood alcohol level reaches 0.4%. A blood level of 0.5% or more is commonly fatal. Levels of even less than 0.1% can cause intoxication, with unconsciousness often occurring at 0.3-0.4 %. Ethanol is metabolized by the body as an energy-providing carbohydrate nutrient, as it metabolizes into acetyl CoA, an intermediate common with glucose metabolism, that can be used for energy in the citric acid cycle or for biosynthesis. Ethanol within the human body is converted into acetaldehyde by alcohol dehydrogenase and then into acetic acid by acetaldehyde dehydrogenase. The product of the first step of this breakdown, acetaldehyde, is more toxic than ethanol. Acetaldehyde is linked to most of the clinical effects of alcohol. It has been shown to increase the risk of developing cirrhosis of the liver,[77] multiple forms of cancer, and alcoholism. Industrially, ethanol is produced both as a petrochemical, through the hydration of ethylene, and biologically, by fermenting sugars with yeast. Small amounts of ethanol are endogenously produced by gut microflora through anaerobic fermentation. However most ethanol detected in biofluids and tissues likely comes from consumption of alcoholic beverages. Absolute ethanol or anhydrous alcohol generally refers to purified ethanol, containing no more than one percent water. Absolute alcohol is not intended for human consumption. It often contains trace amounts of toxic benzene (used to remove water by azeotropic distillation). Consumption of this form of ethanol can be fatal over a short time period. Generally absolute or pure ethanol is used as a solvent for lab and industrial settings where water will disrupt a desired reaction. Pure ethanol is classed as 200 proof in the USA and Canada, equivalent to 175 degrees proof in the UK system.",,ethanol,,HMDB00108,"InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3",C00469,2016-12-05T15:48:04Z,,377,,,,ethanol,702,etoh,,"1-Hydroxyethane, Absolute alcohol, Absolute ethanol, Absolute ethyl alcohol, Aethanol, Aethylalkohol, Alcare Hand Degermer, Alcohol, Alcohols, Alcool ethylique, Alcool etilico, Algrain, Alkohol, Alkoholu etylowego, Anhydrol, Anhydrous alcohol, Cologne spirit, Cologne spirits, Dehydrated alcohol, Dehydrated ethanol, Denatured alcohol, Denatured ethanol, Desinfektol EL, Diluted Alcohol, Distilled spirits, Ethanol 200 proof, Ethanol solution, Ethicap, Ethyl alc, Ethyl alcohol, Ethyl alcohol anhydrous, Ethyl alcohol in alcoholic beverages, Ethyl alcohol usp, Ethyl hydrate, Ethyl hydroxide, Fermentation alcohol, Grain alcohol, Hinetoless, Hydroxyethane, Infinity Pure, Jaysol, Jaysol S, Lux, Methylcarbinol, Molasses alcohol, Potato alcohol, Punctilious ethyl alcohol, Pyro, Silent spirit, Spirit, Spirits of wine, Spirt, Synasol, Tecsol, Tecsol C, Thanol, Undenatured Ethanol",http://vmh.uni.lu/_api/metabolites/377/?format=pcsv
id3acald,,,0,C10H9NO,,,indol-3-ylacetaldehyde,,indol-3-ylacetaldehyde,,,"InChI=1S/C10H9NO/c12-6-5-8-7-11-10-4-2-1-3-9(8)10/h1-4,6-7,11H,5H2",C00637,2016-11-22T15:11:50Z,,378,,,,,800,id3acald,,,http://vmh.uni.lu/_api/metabolites/378/?format=pcsv
ind3ac,,,-1,C10H8NO2,CHEBI:30854,,"Human Metabolome Database (HMDB): Indoleacetic acid (IAA) is a breakdown product of tryptophan metabolism and is often produced by the action of bacteria in the mammalian gut. Some endogenous production of IAA in mammalian tissues also occurs. It may be produced by the decarboxylation of tryptamine or the oxidative deamination of tryptophan. IAA frequently occurs at low levels in urine and has been found in elevated levels in the urine of patients with phenylketonuria ((PMID: 13610897). Using material extracted from human urine, it was discovered by Kogl in 1933 that Indoleacetic acid is also an important plant hormone (PMID: 13610897). Specifically IAA is a member of the group of phytohormones called auxins. IAA is generally considered to be the most important native auxin. Plant cells synthesize IAA from tryptophan. (wikipedia) IAA and some derivatives can be oxidised by horseradish peroxidase (HRP) to cytotoxic species. IAA is only toxic after oxidative decarboxylation; the effect of IAA/HRP is thought to be due in part to the formation of methylene-oxindole, which may conjugate with DNA bases and protein thiols. IAA/HRP could be used as the basis for targeted cancer, a potential new role for plant auxins in cancer therapy. (PMID: 11163327).",,indole-3-acetate,,HMDB00197,"InChI=1S/C10H9NO2/c12-10(13)5-7-6-11-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H,12,13)/p-1",C00954,2016-12-05T15:48:04Z,,379,,,,,802,ind3ac,,"(1H-Indol-3-yl)-acetate, (1H-Indol-3-yl)-acetic acid, 1H-Indol-3-ylacetate, 1H-Indol-3-ylacetic acid, 1H-Indole-3-acetate, 1H-Indole-3-acetic acid, 2-(1H-Indol-3-yl)acetate, 2-(1H-Indol-3-yl)acetic acid, 2-(3-Indolyl)acetate, 2-(3-Indolyl)acetic acid, 3-(Carboxymethyl)indole, 3-IAA, 3-Indole-Acetic acid, 3-Indoleacetate, 3-Indoleacetic acid, 3-Indolylacetate, 3-Indolylacetic acid, alpha-Indol-3-yl-acetic acid, b-Indoleacetate, b-Indoleacetic acid, b-Indolylacetate, b-Indolylacetic acid, beta-Indole-3-acetic acid, beta-Indoleacetate, beta-Indoleacetic acid, beta-Indolylacetate, beta-Indolylacetic acid, Heteroauxin, Indol-3-ylacetate, Indol-3-ylacetic acid, Indole-3-acetate, Indole-3-acetic acid, Indoleacetate, Indoleacetic acid, Indolyl-3-acetate, Indolyl-3-acetic acid, Indolylacetate, Indolylacetic acid, Kyselina 3-indolyloctova, Rhizopin, Rhizopon A, Skatole carboxylate, Skatole carboxylic acid",http://vmh.uni.lu/_api/metabolites/379/?format=pcsv
pristanal,,,0,C19H38O,,,pristanal,,pristanal,,,"InChI=1S/C19H38O/c1-16(2)9-6-10-17(3)11-7-12-18(4)13-8-14-19(5)15-20/h15-19H,6-14H2,1-5H3",,2016-11-22T15:11:50Z,,380,,,,,14671060,pristanal,,,http://vmh.uni.lu/_api/metabolites/380/?format=pcsv
prist,,,-1,C19H37O2,CHEBI:51340,,"Human Metabolome Database (HMDB): Pristanic acid (2,6,10,14-tetramethylpentadecanoic acid) is a terpenoid acid present at micromolar concentrations in the plasma of healthy individuals. It is also found in the lipids from many sources such as freshwater sponges, krill, earthworms, whales, human milk fat, bovine depot fat, butterfat or Californian petroleum. It is usually present in combination with phytanic acid. In humans, pristanic acid is obtained from two sources: either directly from the diet or as the alpha oxidation product of phytanic acid. At physiological concentrations pristanic acid is a natural ligand for PPARalpha. In liver, pristanic acid is degraded by peroxisomal beta oxidation to propionyl-CoA. Together with phytanic acid, pristanic acid accumulates in several inherited disorders such as Zellweger syndrome. Pristanic acid is a branched chain fatty acid that arises from the breakdown of phytanic acid. It is present at micromolar concentrations in the plasma of healthy individuals. Pristanic acid is normally degraded by peroxisomal beta-oxidation. In patients affected with generalized peroxisomal disorders, degradation of both phytanic acid and pristanic acid is impaired owing to absence of functional peroxisomes. Pristanic acid has been found to activate the peroxisome proliferator-activated receptor {alpha} (PPAR{alpha}) in a concentration dependent manner.",,pristanic acid,,HMDB00795,"InChI=1S/C19H38O2/c1-15(2)9-6-10-16(3)11-7-12-17(4)13-8-14-18(5)19(20)21/h15-18H,6-14H2,1-5H3,(H,20,21)",,2016-12-05T15:48:04Z,,381,,,,,123929,prist,,"(2S)-pristanic acid, (2S,6R,10R)-2,6,10,14-tetramethylpentadecanoate, (2S,6R,10R)-2,6,10,14-tetramethylpentadecanoic acid , (2S,6R,10R)-pristanic acid, 2,6,10,14-Tetramethylpentadecanoate, 2,6,10,14-Tetramethylpentadecanoic acid, Pristanate:(2S,6R,10R)-pristanate",http://vmh.uni.lu/_api/metabolites/381/?format=pcsv
aldstrn,,,0,C21H28O5,,,"Human Metabolome Database (HMDB): Aldosterone is a steroid hormone produced by the adrenal cortex in the adrenal gland to regulate sodium and potassium balance in the blood. Specifically it regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. It is synthesized from cholesterol by aldosterone synthase, which is absent in other sections of the adrenal gland. It is the sole endogenous member of the class of mineralocorticoids. Aldosterone increases the permeability of the apical (luminal) membrane of the kidney's collecting ducts to potassium and sodium and activates their basolateral Na+/K+ pumps, stimulating ATP hydrolysis, reabsorbing sodium (Na+) ions and water into the blood, and excreting potassium (K+) ions into the urine.",,aldosterone,,HMDB00037,"InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1",C01780,2016-12-05T15:48:04Z,,382,,,,,5839,aldstrn,,"(+)-Aldosterone, (11b)-11,21-dihydroxy-3,20-dioxo-pregn-4-en-18-al, (11beta)-11,21-dihydroxy-3,20-dioxo-Pregn-4-en-18-al, 11,21-Dihydroxy-3,20-dioxopregn-4-en-18-al, 11-Hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-13-carbaldehyde, 11b,21-Dihydroxy-3,20-dioxo-pregn-4-en-18-al, 11beta,21-Dihydroxy-3,20-diketo-4-pregnen-18-al, 11beta,21-Dihydroxy-3,20-diketopregn-4-ene-18-al, 11beta,21-Dihydroxy-3,20-dioxo-pregn-4-en-18-al, 11beta,21-Dihydroxypregn-4-ene-3,18,20-trione, 18-Formyl-11beta,21-dihydroxy-4-pregnene-3,20-dione, 18-Oxocorticosterone, Aldocorten, Aldocortene, Aldocortin, Aldosterone, Aldosteronum, D-Aldosterone, delta-Aldosterone, Electrocortin, Elektrocortin, Reichstein X",http://vmh.uni.lu/_api/metabolites/382/?format=pcsv
dhap,,,-2,C3H5O6P,CHEBI:16108,,Dihydroxyacetone phosphate,,Dihydroxyacetone phosphate,,,"InChI=1S/C3H7O6P/c4-1-3(5)2-9-10(6,7)8/h4H,1-2H2,(H2,6,7,8)/p-2",C00111,2016-11-22T15:11:50Z,,383,,,,glycerone phosphate,668,dhap,,,http://vmh.uni.lu/_api/metabolites/383/?format=pcsv
dha,,,0,C3H6O3,CHEBI:16016,,glycerone,,glycerone,,,"InChI=1S/C3H6O3/c4-1-3(6)2-5/h4-5H,1-2H2",C00184,2016-11-22T15:11:50Z,,384,,,,,670,dha,,,http://vmh.uni.lu/_api/metabolites/384/?format=pcsv
arachd,,,-1,C20H31O2,CHEBI:15843,,"Human Metabolome Database (HMDB): Arachidonic acid is a polyunsaturated, essential fatty acid. It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid. Arachidonic acid mediates inflammation and the functioning of several organs and systems either directly or upon its conversion into eicosanoids. Arachidonic acid in cell membrane phospholipids is the substrate for the synthesis of a range of biologically active compounds (eicosanoids) including prostaglandins, thromboxanes, and leukotrienes. These compounds can act as mediators in their own right and can also act as regulators of other processes, such as platelet aggregation, blood clotting, smooth muscle contraction, leukocyte chemotaxis, inflammatory cytokine production, and immune function. Arachidonic acid can be metabolized by cytochrome p450 (CYP450) enzymes to 5,6-, 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acids (EETs), their corresponding dihydroxyeicosa-trienoic acids (DHETs), and 20-hydroxyeicosatetraenoic acid (20-HETE). The production of kidney CYP450 arachidonic acid metabolites is altered in diabetes, pregnancy, hepatorenal syndrome, and in various models of hypertension, and it is likely that changes in this system contribute to the abnormalities in renal function that are associated with many of these conditions. Phospholipase A2 (PLA2) catalyzes the hydrolysis of the sn-2 position of membrane glycerophospholipids to liberate arachidonic acid (PMID: 12736897, 12736897, 12700820, 12570747, 12432908).",,arachidonate,,HMDB01043,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/p-1/b7-6-,10-9-,13-12-,16-15-",C00219,2016-12-05T15:48:04Z,,385,,,,Arachidonic acid;arachidonic acid,444899,arachd,,"(all-Z)-5,8,11,14-Eicosatetraenoate, (all-Z)-5,8,11,14-Eicosatetraenoic acid, 5,8,11,14-All-cis-Eicosatetraenoate, 5,8,11,14-All-cis-Eicosatetraenoic acid, 5,8,11,14-Eicosatetraenoate, 5,8,11,14-Eicosatetraenoic acid, 5-cis,8-cis,11-cis,14-cis-Eicosatetraenoate, 5-cis,8-cis,11-cis,14-cis-Eicosatetraenoic acid, 5Z,8Z,11Z,14Z-Eicosatetraenoate, 5Z,8Z,11Z,14Z-Eicosatetraenoic acid, All-cis-5,8,11,14-Eicosatetraenoate, All-cis-5,8,11,14-Eicosatetraenoic acid, Arachidonic acid, cis-D5,8,11,14-Eicosatetraenoate, cis-D5,8,11,14-Eicosatetraenoic acid, Immunocytophyte",http://vmh.uni.lu/_api/metabolites/385/?format=pcsv
12HPET,,,-1,C20H31O4,CHEBI:15626,,"Human Metabolome Database (HMDB): 12-HPETE is one of the six monohydroperoxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid (Leukotrienes). Reduction of the hydroperoxide yields the more stable hydroxyl fatty acid (+/-)12-HETE. A family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system.",,"12-Hydroperoxyeicosa-5,8,10,14-tetraenoate",,HMDB04243,"InChI=1/C20H32O4/c1-2-3-4-5-10-13-16-19(24-23)17-14-11-8-6-7-9-12-15-18-20(21)22/h7-11,13-14,17,19,23H,2-6,12,15-16,18H2,1H3,(H,21,22)/b9-7-,11-8-,13-10-,17-14+/t19-/m0/s1",C05965,2016-12-05T15:48:04Z,,386,,,,,,12HPET,,"(5Z,8z,10e,14Z)-(12S)-12-hydroperoxyicosa-5,8,10,14-tetraenoate, (5Z,8z,10e,14Z)-(12S)-12-hydroperoxyicosa-5,8,10,14-tetraenoic acid, 12-Hpete, 12-Hydroperoxyeicosatetraenoate, 12-Hydroperoxyeicosatetraenoic acid, 12-Hydroperoxyicosatetraenoate, 12-Hydroperoxyicosatetraenoic acid",http://vmh.uni.lu/_api/metabolites/386/?format=pcsv
12RHPET,,,-1,C20H31O4,,,12R-Hydroperoxyeicosatetraenoate,,12R-Hydroperoxyeicosatetraenoate,,HMDB06222,"InChI=1/C20H32O4/c1-2-3-4-5-10-13-16-19(24-23)17-14-11-8-6-7-9-12-15-18-20(21)22/h7-11,13-14,17,19,23H,2-6,12,15-16,18H2,1H3,(H,21,22)/b9-7-,11-8-,13-10-,17-14+/t19-/m1/s1",C14812,2016-11-22T15:11:50Z,,387,,,,,,12RHPET,,,http://vmh.uni.lu/_api/metabolites/387/?format=pcsv
15HPET,,,-1,C20H31O4,,,15(S)-HPETE(1-),,15(S)-HPETE(1-),,,"InChI=1S/C20H32O4/c1-2-3-13-16-19(24-23)17-14-11-9-7-5-4-6-8-10-12-15-18-20(21)22/h4-5,8-11,14,17,19,23H,2-3,6-7,12-13,15-16,18H2,1H3,(H,21,22)/p-1/b5-4-,10-8-,11-9-,17-14+/t19-/m0/s1",C05966,2016-11-22T15:11:50Z,,388,,,,,5280893,15HPET,,,http://vmh.uni.lu/_api/metabolites/388/?format=pcsv
5HPET,,,-1,C20H31O4,,,5(S)-HPETE(1-),,5(S)-HPETE(1-),,,"InChI=1S/C20H32O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19(24-23)17-15-18-20(21)22/h6-7,9-10,12-14,16,19,23H,2-5,8,11,15,17-18H2,1H3,(H,21,22)/p-1/b7-6-,10-9-,13-12-,16-14+/t19-/m1/s1",C05356,2016-11-22T15:11:50Z,,389,,,,,5280778,5HPET,,,http://vmh.uni.lu/_api/metabolites/389/?format=pcsv
leuktrA4,,,-1,C20H29O3,CHEBI:15651,,"Human Metabolome Database (HMDB): Leukotriene A4 (LTA4) is the first metabolite in the series of reactions leading to the synthesis of all leukotrienes. 5-Lipoxygenase (5-LO) catalyzes the two-step conversion of arachidonic acid to LTA4.The first step consists of the oxidation of arachidonic acid to the unstable intermediate 5-hydroperoxyeicosatetraenoic acid (5-HPETE), and the second step is the dehydration of 5-HPETE to form LTA4. Leukotriene A4, an unstable epoxide, is hydrolyzed to leukotriene B4 or conjugated with glutathione to yield leukotriene C4 and its metabolites, leukotriene D4 and leukotriene E4. The leukotrienes participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. Recent studies also suggest a neuroendocrine role for leukotriene C4 in luteinizing hormone secretion. (PMID: 10591081, 2820055). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,leukotriene A4(1-),,HMDB01337,"InChI=1S/C20H30O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-19(23-18)16-14-17-20(21)22/h6-7,9-13,15,18-19H,2-5,8,14,16-17H2,1H3,(H,21,22)/p-1/b7-6-,10-9-,12-11+,15-13+/t18-,19-/m0/s1",C00909,2016-12-05T15:48:04Z,,390,,,,,5280383,leuktrA4,,"(5S,6S,7E,9E,11Z,14Z)-5,6-Epoxyicosa-7,9,11,14-tetraenoate, (5S,6S,7E,9E,11Z,14Z)-5,6-Epoxyicosa-7,9,11,14-tetraenoic acid, (7E,9E,11Z,14Z)-(5S,6S)-5,6-Epoxyeicosa-7,9,11,14-tetraenoate, (7E,9E,11Z,14Z)-(5S,6S)-5,6-Epoxyeicosa-7,9,11,14-tetraenoic acid, (7E,9E,11Z,14Z)-(5S,6S)-5,6-epoxyicosa- 7,9,11,14-tetraenoate, (7E,9E,11Z,14Z)-(5S,6S)-5,6-epoxyicosa- 7,9,11,14-tetraenoic acid, (7e,9e,11z,14z)-(5S,6S)-5,6-epoxyicosa-7,9,11,14-tetrenoioc acid, 5S,6S-Epoxy-7E,9E,11Z,14Z-eicosatetraenoate, 5S,6S-Epoxy-7E,9E,11Z,14Z-eicosatetraenoic acid, LTA4",http://vmh.uni.lu/_api/metabolites/390/?format=pcsv
dhcholestancoa,,,-4,C48H76N7O19P3S,CHEBI:48474,,"Human Metabolome Database (HMDB): First activated by a fatty acyl-CoA ligase activity, can then be converted to chenodeoxycholic acid by peroxisome rich fractions from rat and human liver (J Lipid Res. 1988 Aug;29(8):997-1004, PMID 3183523 ).",,"3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA",,HMDB02159,"InChI=1S/C48H80N7O19P3S/c1-26(30-10-11-31-36-32(13-16-48(30,31)6)47(5)15-12-29(56)20-28(47)21-33(36)57)8-7-9-27(2)45(62)78-19-18-50-35(58)14-17-51-43(61)40(60)46(3,4)23-71-77(68,69)74-76(66,67)70-22-34-39(73-75(63,64)65)38(59)44(72-34)55-25-54-37-41(49)52-24-53-42(37)55/h24-34,36,38-40,44,56-57,59-60H,7-23H2,1-6H3,(H,50,58)(H,51,61)(H,66,67)(H,68,69)(H2,49,52,53)(H2,63,64,65)/t26-,27?,28+,29-,30-,31+,32+,33-,34-,36+,38-,39-,40+,44-,47+,48-/m1/s1",C04644,2016-12-05T15:48:04Z,,391,,,,,440420,dhcholestancoa,,"3-alpha,7-alpha-Dihydroxy-5-beta-cholestanoyl-CoA, 3-alpha,7-alpha-Dihydroxy-5-beta-cholestanoyl-Coenzyme A, 3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA, 3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-Coenzyme A, DHCA",http://vmh.uni.lu/_api/metabolites/391/?format=pcsv
cholcoar,,,-4,C48H76N7O20P3S,CHEBI:37642,,"(25R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oyl-CoA(4-)",,"(25R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oyl-CoA(4-)",,,"InChI=1S/C48H80N7O20P3S/c1-25(29-10-11-30-36-31(20-34(58)48(29,30)6)47(5)14-12-28(56)18-27(47)19-32(36)57)8-7-9-26(2)45(63)79-17-16-50-35(59)13-15-51-43(62)40(61)46(3,4)22-72-78(69,70)75-77(67,68)71-21-33-39(74-76(64,65)66)38(60)44(73-33)55-24-54-37-41(49)52-23-53-42(37)55/h23-34,36,38-40,44,56-58,60-61H,7-22H2,1-6H3,(H,50,59)(H,51,62)(H,67,68)(H,69,70)(H2,49,52,53)(H2,64,65,66)/p-4/t25-,26-,27+,28-,29-,30+,31+,32-,33-,34+,36+,38-,39-,40+,44-,47+,48-/m1/s1",C05448,2016-11-22T15:11:50Z,,392,,,,,15942889,cholcoar,,,http://vmh.uni.lu/_api/metabolites/392/?format=pcsv
amuco,,,-1,C6H6NO4,CHEBI:16886,,2-aminomuconate(2-),,2-aminomuconate(2-),,,"InChI=1S/C6H7NO4/c7-4(6(10)11)2-1-3-5(8)9/h1-3H,7H2,(H,8,9)(H,10,11)/p-2/b3-1+,4-2-",C02220,2016-11-22T15:11:50Z,,393,,,,,,amuco,,,http://vmh.uni.lu/_api/metabolites/393/?format=pcsv
cgly,,,0,C5H10N2O3S,CHEBI:4047,,"Human Metabolome Database (HMDB): Cysteinylglycine is a naturally occurring dipeptide. It is derived from the breakdown of glutathione (a tripeptide). In plasma, cysteinylglycine is in a reduced, oxidized and protein-bound form (aminothiol) and interact via redox and disulphide exchange reactions, in a dynamic system referred to as redox thiol status (PMID 8642471). Spermatozoa of sub fertile men contain significantly higher thiol concentrations as compared with those of fertile men. The detrimental effect on embryo quality of a high homocysteine (Hcy, another member of the thiol group) concentration in the ejaculate and in follicular fluid is intriguing and may suggest that Hcy is inversely associated with fertility outcome (PMID 16556671). Rheumatoid arthritis (RA) is a chronic inflammatory disease which involves the synovial membrane of multiple diarthroidal joints causing damage to cartilage and bones. The damage process seems to be related to an overproduction of oxygen reactive species inducing an oxidative perturbation with an increase in some oxidized forms (disulfides and protein mixed disulfides) and a decrease in free thiols (PMID 15895891). Imipenem (thienamycin formamidine), is a broad-spectrum beta-lactam antibiotic, always used in combination with cilastatin in order to avoid the premature breakdown of imipenem by renal tubular dipeptidase. As this dipeptidase also hydrolyzes the glutathione metabolite cysteinylglycine, the therapeutic association of imipenem and cilastatin causes plasma levels of cysteinylglycine to increase significantly, while cysteine levels are decreased and homocysteine levels are unaffected. Therefore, antibiotic treatment using imipenem-cilastatin induces important metabolic changes that should not remain unrecognized (PMID 15843241).",,L-cysteinylglycine,,HMDB00078,"InChI=1S/C5H10N2O3S/c6-3(2-11)5(10)7-1-4(8)9/h3,11H,1-2,6H2,(H,7,10)(H,8,9)/t3-/m0/s1",C01419,2016-12-05T15:48:04Z,,394,,,,CysGly,439498,cgly,,"Cys-Gly, L-Cysteinylglycine, N-Cysteinyl Glycine, N-Cysteinyl-Glycine, N-L-Cysteinyl-Glycine, N-L-Cysteinylglycine",http://vmh.uni.lu/_api/metabolites/394/?format=pcsv
strch1,,,0,C66H112O56,,,"starch, structure 1 (1,6-{7[1,4-Glc], 4[1,4-Glc]})",,"starch, structure 1 (1,6-{7[1,4-Glc], 4[1,4-Glc]})",,,,,2016-11-22T15:11:50Z,,395,,,,,,strch1,,,http://vmh.uni.lu/_api/metabolites/395/?format=pcsv
glc_D,,,0,C6H12O6,CHEBI:4167,,"Human Metabolome Database (HMDB): Glucose is a monosaccharide containing six carbon atoms and an aldehyde group and is therefore referred to as an aldohexose. The glucose molecule can exist in an open-chain (acyclic) and ring (cyclic) form, the latter being the result of an intramolecular reaction between the aldehyde C atom and the C-5 hydroxyl group to form an intramolecular hemiacetal. In water solution both forms are in equilibrium and at pH 7 the cyclic one is the predominant. Glucose is a primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. In animals glucose arises from the breakdown of glycogen in a process known as glycogenolysis. Glucose is synthesized in the liver and kidneys from non-carbohydrate intermediates, such as pyruvate and glycerol, by a process known as gluconeogenesis.",,D-glucose,,HMDB00122,"InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6?/m1/s1",C00031,2016-12-05T15:48:04Z,,396,,,,,5793,glc_D,," Roferose ST, (+)-Glucose, Anhydrous dextrose, Cerelose, Cerelose 2001, Clearsweet 95, Clintose L, Corn sugar, CPC hydrate, D(+)-Glucose, Dextropur, Dextrose, Dextrosol, Glucodin, Glucolin, Glucose, Goldsugar, Grape sugar, Meritose, Staleydex 111, Staleydex 95M, Tabfine 097(HS), Vadex",http://vmh.uni.lu/_api/metabolites/396/?format=pcsv
strch2,,,0,C18H32O16,,,"starch, structure 2 (1,6-{2[1,4-Glc], [1,4-Glc]})",,"starch, structure 2 (1,6-{2[1,4-Glc], [1,4-Glc]})",,,,,2016-11-22T15:11:50Z,,397,,,,,,strch2,,,http://vmh.uni.lu/_api/metabolites/397/?format=pcsv
glygn2,,,0,C66H111O56X,,,"glycogen, structure 2 (glycogenin-1,6-{7[1,4-Glc], 4[1,4-Glc]})",,"glycogen, structure 2 (glycogenin-1,6-{7[1,4-Glc], 4[1,4-Glc]})",,,,,2016-11-22T15:11:50Z,,398,,,,,,glygn2,,,http://vmh.uni.lu/_api/metabolites/398/?format=pcsv
glygn4,,,0,C18H31O16X,,,"glycogen, structure 4 (glycogenin-1,6-{2[1,4-Glc], [1,4-Glc]})",,"glycogen, structure 4 (glycogenin-1,6-{2[1,4-Glc], [1,4-Glc]})",,,,,2016-11-22T15:11:50Z,,399,,,,,,glygn4,,,http://vmh.uni.lu/_api/metabolites/399/?format=pcsv
andrstrnglc,,,0,C25H38O8,CHEBI:28832,,"Human Metabolome Database (HMDB): Androsterone glucuronide (ADT-G) is one of the major circulating C19-steroid metabolites in humans. Human and monkey are unique in having high levels of circulating ADT-G. Furthermore, the plasma levels of these glucuronide derivatives reflect the peripheral tissue conversion of adrenal and gonadal precursor C19-steroids to active androgens in various pathophysiological conditions. Identification and characterization of human UDP-glucuronosyltransferase 2B (UGT2Bs) demonstrated the major role that these enzymes play in androgen conjugation, with UGT2B15 and UGT2B17 (EC 2.4.1.17) being the major androsterone-conjugating isoforms. Exaggerated androsterone metabolism, is observed in hyper-androgenic as well as in some normo-androgenic women with acne and androsterone glucuronide could be a marker in differentiating acne and hirsutism in hyperandrogenic women. Present data shows that the most practical and probably only valid means of assessing androgenic activity in women is to measure ADT-G, the metabolite that accounts for 93% of the total androgen glucuronide derivatives. (PMID: 12943709, 12445184, 16621522).",,androsterone 3-glucosiduronic acid,,HMDB02829,"InChI=1S/C25H38O8/c1-24-9-7-13(32-23-20(29)18(27)19(28)21(33-23)22(30)31)11-12(24)3-4-14-15-5-6-17(26)25(15,2)10-8-16(14)24/h12-16,18-21,23,27-29H,3-11H2,1-2H3,(H,30,31)/t12-,13+,14-,15-,16-,18-,19-,20+,21-,23+,24-,25-/m0/s1",C11135,2016-12-05T15:48:04Z,,400,,,,,,andrstrnglc,,"3a-Hydroxy-5a-androstan-17-one glucuronide, 5a-Androstan-3a-ol-17-one glucuronide, Androsterone 3-glucuronide, Androsterone glucosiduronate, Androsterone glucuronoside, Androsterone monoglucosiduronate, b-D-17-Oxo-5a-androstan-3a-yl  Glucopyranosiduronic acid",http://vmh.uni.lu/_api/metabolites/400/?format=pcsv
andrstrn,,,0,C19H30O2,CHEBI:16032,,"Human Metabolome Database (HMDB): Androsterone is an inactive breakdown metabolite of testosterone, the product of a reaction mediated by the enzyme oxidative 17beta-hydroxysteroid dehydrogenase (EC 1.1.1.51, 17beta-HSD). Androsterone is also can be metabolized from other adrenal androgens such as dehydroepiandrosterone, dihydrotestosterone or androstenedione, and is considered an inactive end product; however, it can be a physiological effector in its own right. Androsterone might be converted back to dihydrotestosterone. Humans (and other primates) are unique among mammals in having high levels of circulating androsterone glucuronide, a process that is the major role uridine-diphospho-glucuronosyltransferase (EC 2.4.1.17, UGT) enzymes for glucuronidation of steroid metabolism in humans. Conjugation of androsterone is a pathway found in all vertebrates and is widely recognized that the liver is a major site of glucuronidation; however it is now clear that extrahepatic tissues are also involved in the conjugation of compounds to which these tissues are exposed. High levels of androsterone glucuronide found in the human prostate, breast cyst fluid and ovary follicular fluid suggest that glucuronidation of 5alpha-reduced C19 steroids occurs in these tissues as well. In doping control, the ratio of androsterone/etiocholanone provides valuable information that allows the assignment of a urine specimen to a particular person or the identification of urine samples with identical steroid profiles; this is particularly important to detect attempts of urine manipulation including urine alteration and substitution. (PMID: 9188497, 17017935, 14643063, 12943709, 9699884, 17260133).",,androsterone,,HMDB00031,"InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12-,13+,14-,15-,16-,18-,19-/m0/s1",C00523,2016-12-05T15:48:04Z,,401,,,,,5879,andrstrn,,"(3alpha,5alpha)-3-hydroxy-Androstan-17-one, (3R,5S,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one, 3-alpha-Hydroxy-17-androstanone, 3-alpha-Hydroxy-5-alpha-androstan-17-one, 3-alpha-Hydroxy-5-alpha-androstane-17-one, 3-alpha-Hydroxy-5alpha-Androstan-17-one, 3-alpha-Hydroxyetioallocholan-17-one, 3-Epihydroxyetioallocholan-17-one, 3-Hydroxy-(3-alpha,5-alpha)-Androstan-17-one, 3-Hydroxyandrostan-17-one, 3a-Hydroxyetioallocholan-17-one, 3alpha-Hydroxy-17-androstanone, 3alpha-Hydroxy-5alpha-androstan-17-one, 3alpha-Hydroxyetioallocholan-17-one, 5-alpha-Androstan-3-alpha-ol-17-one, 5-alpha-Androstane-3alpha-ol-17-one, 5-alpha-Androsterone, 5a-Androstan-3a-ol-17-one, 5a-Androstane-3a-ol-17-one, 5a-Androsterone, 5alpha-Androstane-3alpha-ol-17-one, 5alpha-Androsterone, Androkinine, Androstanon-3-alpha-ol-17-one, Androsterone, Androtine, Atromide ICI, cis-Androsterone",http://vmh.uni.lu/_api/metabolites/401/?format=pcsv
antipyrene,,,0,C11H12N2O,CHEBI:31225,,antipyrine,,antipyrine,,,"InChI=1S/C11H12N2O/c1-9-8-11(14)13(12(9)2)10-6-4-3-5-7-10/h3-8H,1-2H3",C13244,2016-11-22T15:11:50Z,,402,,,,,2206,antipyrene,,,http://vmh.uni.lu/_api/metabolites/402/?format=pcsv
2aobut,,,0,C4H7NO3,CHEBI:17844,,Human Metabolome Database (HMDB): L-2-Amino-3-oxobutanoic acid or L-2-amino acetic acid is involved in glycine/serine metabolism and is a breakdown product from glycine. It spontaneously decomposes to aminoacetone. Delta-aminolevuliinate synthase is the enzyme that catalyzes the interconversion between glycine and L-2-amino-3-oxobutanoic acid. Glycine C-acetyltransferase is also capable of catalyzing this reaction.,,L-2-amino-3-oxobutanoic acid,,HMDB06454,"InChI=1S/C4H7NO3/c1-2(6)3(5)4(7)8/h3H,5H2,1H3,(H,7,8)/t3-/m0/s1",C03508,2016-12-05T15:48:04Z,,403,,,,,440033,2aobut,,"(2S)-2-amino-3-oxobutanoate, (2S)-2-amino-3-oxobutanoic acid, (S)-2-Amino-3-oxobutanoate, (S)-2-Amino-3-oxobutanoic acid, 2-Amino-3-oxobutanoate, 2-Amino-3-oxobutanoic acid, L-2-Amino acetic acid, L-2-Amino-3-oxobutanoate, L-2-Amino-3-oxobutanoic acid, L-2-Amino-acetoacetate",http://vmh.uni.lu/_api/metabolites/403/?format=pcsv
ap4a,,,-4,C20H24N10O19P4,CHEBI:17422,,"P(1),P(4)-bis(5'-adenosyl) tetraphosphate(4-)",,"P(1),P(4)-bis(5'-adenosyl) tetraphosphate(4-)",,,"InChI=1S/C20H28N10O19P4/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(45-19)1-43-50(35,36)47-52(39,40)49-53(41,42)48-51(37,38)44-2-8-12(32)14(34)20(46-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H,41,42)(H2,21,23,25)(H2,22,24,26)/p-4/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1",C01260,2016-11-22T15:11:50Z,,404,,,,,,ap4a,,,http://vmh.uni.lu/_api/metabolites/404/?format=pcsv
ala_B,,,0,C3H7NO2,CHEBI:16958,,"Human Metabolome Database (HMDB): Beta-alanine is the only naturally occurring beta-amino acid - the amino group is at the &#946;-position from the carboxylate group. It is formed in vivo by the degradation of dihydrouracil and carnosine. It is a component of the naturally occurring peptides carnosine and anserine and also of pantothenic acid (Vitamin B-5) which itself is a component of coenzyme A. Under normal conditions, beta-alanine is metabolized into acetic acid. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing gamma-aminobutyric acid. A rare genetic disorder, hyper-beta-alaninemia, has been reported.",,beta-alanine,,HMDB00056,"InChI=1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6)",C00099,2016-12-05T15:48:04Z,,405,,,,,,ala_B,,"2-Carboxyethylamine, 3-Amino-Propanoate, 3-Amino-Propanoic acid, 3-Aminopropanoate, 3-Aminopropanoic acid, 3-Aminopropionate, 3-Aminopropionic acid, Abufene, B-Alanine, b-Aminopropanoate, b-Aminopropanoic acid, b-Aminopropionate, b-Aminopropionic acid, beta Alanine, beta-Alanine, beta-Aminopropanoate, beta-Aminopropanoic acid, beta-Aminopropionate, beta-Aminopropionic acid, Omega-Aminopropionate, Omega-Aminopropionic acid",http://vmh.uni.lu/_api/metabolites/405/?format=pcsv
apnnox,,,0,C10H16O,CHEBI:29060,,"Human Metabolome Database (HMDB): Alpha-pinene oxide is cheap monoterpene, which is important compound for the fragnance industry. Biocatalytic method is used to convert monoterpenes into terpenoids. The biotransformation of alpha-pinene oxide using resting cells of Pseudomonas fluorescens NCIMB 11671 produces isonovalal (cis-2-methyl-5-isopropylhexa-2,5-dienal), which is a fragrance. However, this biotransformation has technical problems including the following: alpha-pinene oxide undergoes autoxidation in water and light; it is hydrophobic and relatively toxic to the biocatalyst; and it suffers from product inhibition. the influence of other terpene byproducts on the flux of alpha-pinene oxide was investigated and found to decrease the flux into the organic phase by up to 10%. (PMID: 16321051).",,alpha-pinene oxide,,HMDB03667,"InChI=1S/C10H16O/c1-9(2)6-4-7(9)10(3)8(5-6)11-10/h6-8H,4-5H2,1-3H3",C02759,2016-12-05T15:48:04Z,,406,,,,,91508,apnnox,,"2,3-Epoxy-pinane, 2,3-Epoxypinane, 2-Pinene oxide, alpha-Pinene 2,3-oxide, alpha-Pinene epoxide, alpha-Pinene oxide, alpha-Pinene-oxide, Pinene oxide",http://vmh.uni.lu/_api/metabolites/406/?format=pcsv
apoC,,,0,XH,,,Apocarboxlase (no lys residue),,Apocarboxlase (no lys residue),,,,,2016-11-22T15:11:50Z,,407,,,,,,apoC,,,http://vmh.uni.lu/_api/metabolites/407/?format=pcsv
lys_L,,,1,C6H15N2O2,CHEBI:18019,,"Human Metabolome Database (HMDB): L-lysine is an essential amino acid. Normal requirements for lysine have been found to be about 8 g per day or 12 mg/kg in adults. Children and infants need more- 44 mg/kg per day for an eleven to-twelve-year old, and 97 mg/kg per day for three-to six-month old. Lysine is highly concentrated in muscle compared to most other amino acids. Lysine is high in foods such as wheat germ, cottage cheese and chicken. Of meat products, wild game and pork have the highest concentration of lysine. Fruits and vegetables contain little lysine, except avocados. Normal lysine metabolism is dependent upon many nutrients including niacin, vitamin B6, riboflavin, vitamin C, glutamic acid and iron. Excess arginine antagonizes lysine. Several inborn errors of lysine metabolism are known. Most are marked by mental retardation with occasional diverse symptoms such as absence of secondary sex characteristics, undescended testes, abnormal facial structure, anemia, obesity, enlarged liver and spleen, and eye muscle imbalance. Lysine also may be a useful adjunct in the treatment of osteoporosis. Although high protein diets result in loss of large amounts of calcium in urine, so does lysine deficiency. Lysine may be an adjunct therapy because it reduces calcium losses in urine. Lysine deficiency also may result in immunodeficiency. Requirements for this amino acid are probably increased by stress. Lysine toxicity has not occurred with oral doses in humans. Lysine dosages are presently too small and may fail to reach the concentrations necessary to prove potential therapeutic applications. Lysine metabolites, amino caproic acid and carnitine have already shown their therapeutic potential. Thirty grams daily of amino caproic acid has been used as an initial daily dose in treating blood clotting disorders, indicating that the proper doses of lysine, its precursor, have yet to be used in medicine. Low lysine levels have been found in patients with Parkinson's, hypothyroidism, kidney disease, asthma and depression. The exact significance of these levels is unclear, yet lysine therapy can normalize the level and has been associated with improvement of some patients with these conditions. Abnormally elevated hydroxylysines have been found in virtually all chronic degenerative diseases and coumadin therapy. The levels of this stress marker may be improved by high doses of vitamin C. Lysine is particularly useful in therapy for marasmus (wasting) and herpes simplex. It stops the growth of herpes simplex in culture, and has helped to reduce the number and occurrence of cold sores in clinical studies. Dosing has not been adequately studied, but beneficial clinical effects occur in doses ranging from 100 mg to 4 g a day. Higher doses may also be useful, and toxicity has not been reported in doses as high as 8 g per day. Diets high in lysine and low in arginine can be useful in the prevention and treatment of herpes. Some researchers think herpes simplex virus is involved in many other diseases related to cranial nerves such as migraines, Bell's palsy and Meniere's disease. Herpes blister fluid will produce fatal encephalitis in the rabbit. (http://www.dcnutrition.com).",,L-lysinium(1+),,HMDB00182,"InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/p+1/t5-/m0/s1",C00047,2016-12-05T15:48:04Z,,408,,,,,5962,lys_L,,"(+)-S-Lysine, (S)-2,6-diamino-Hexanoate, (S)-2,6-diamino-Hexanoic acid, (S)-2,6-Diaminohexanoate, (S)-2,6-Diaminohexanoic acid, (S)-a,e-Diaminocaproate, (S)-a,e-Diaminocaproic acid, (S)-Lysine, 2,6-Diaminohexanoate, 2,6-Diaminohexanoic acid, 6-Amino-Aminutrin, 6-Amino-L-Norleucine, a-Lysine, alpha-Lysine, Aminutrin, h-Lys-oh, L-(+)-Lysine, L-2,6-Diainohexanoate, L-2,6-Diainohexanoic acid, L-2,6-Diaminocaproate, L-2,6-Diaminocaproic acid, L-Lys, Lys, Lysine, Lysine acid",http://vmh.uni.lu/_api/metabolites/408/?format=pcsv
apoC_Lys,,,0,C6H13N2OX,,,Apocarboxylase (Lys residue),,Apocarboxylase (Lys residue),,,,,2016-11-22T15:11:50Z,,409,,,,,,apoC_Lys,,,http://vmh.uni.lu/_api/metabolites/409/?format=pcsv
apoC_Lys_btn,,,0,C16H27N4O3SX,,,Holocarboxylase (biotin covalent bound to Lys residue of apoC),,Holocarboxylase (biotin covalent bound to Lys residue of apoC),,,,,2016-11-22T15:11:50Z,,410,,,,,,apoC_Lys_btn,,,http://vmh.uni.lu/_api/metabolites/410/?format=pcsv
biocyt,,,0,C16H28N4O4S,CHEBI:27870,,Biocytin,,Biocytin,,,"InChI=1/C16H28N4O4S/c17-10(15(22)23)5-3-4-8-18-13(21)7-2-1-6-12-14-11(9-25-12)19-16(24)20-14/h10-12,14H,1-9,17H2,(H,18,21)(H,22,23)(H2,19,20,24)/t10-,11-,12-,14-/m0/s1",C05552,2016-11-22T15:11:50Z,,411,,,,,83814,biocyt,,,http://vmh.uni.lu/_api/metabolites/411/?format=pcsv
appnn,,,0,C10H16,CHEBI:28261,,"Human Metabolome Database (HMDB): &#945;-Pinene is an organic compound of the terpene class, one of two isomers of pinene. It is an alkene and it contains a reactive four-membered ring. It is found in the oils of many species of many coniferous trees, notably the pine. It is also found in the essential oil of rosemary (Rosmarinus officinalis). Both enantiomers are known in nature; 1S,5S- or (&#8722;)-&#945;-pinene is more common in European pines, whereas the 1R,5R- or (+)-&#945;-isomer is more common in North America. The racemic mixture is present in some oils such as eucalyptus oil. The four-membered ring in &#945;-pinene 1 makes it a reactive hydrocarbon, prone to skeletal rearrangements such as the Wagner-Meerwein rearrangement. For example, attempts to perform hydration or hydrogen halide addition with the alkene functionality typically lead to rearranged products. of under acidic conditions. With concentrated sulfuric acid and ethanol the major products are terpineol 2 and its ethyl ether 3, while glacial acetic acid gives the corresponding acetate ester 4. With dilute acids, terpin hydrate 5 becomes the major product. With one molar equivalent of anhydrous HCl, the simple addition product 6a can be formed at low temperature in the presence of ether, but it is very unstable. At normal temperatures, or if no ether is present, the major product is bornyl chloride 6b, along with a small amount of fenchyl chloride 6c. For many years 6b (also called ""artificial camphor"") was referred to as ""pinene hydrochloride"", until it was confirmed as identical with bornyl chloride made from camphene. If more HCl is used, achiral 7 (dipentene hydrochloride) is the major product along with some 6b. Nitrosyl chloride followed by base leads to the oxime 8 which can be reduced to ""pinylamine"" 9. Both 8 and 9 are stable compounds containing an intact four-membered ring, and these compounds helped greatly in identifying this important component of the pinene skeleton. (Wikipedia).",,(+)-alpha-pinene,,HMDB06525,"InChI=1S/C10H16/c1-7-4-5-8-6-9(7)10(8,2)3/h4,8-9H,5-6H2,1-3H3/t8-,9-/m1/s1",C09880,2016-12-05T15:48:04Z,,412,,,,,82227,appnn,,"(+)-alpha-Pinene, (+)-Pin-2(3)-ene, (1R)-2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene, (1R,5R)-2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene, 1R-(+)-a-Pinene, 1R-(+)-alpha-Pinene, 1R-a-Pinene, 1R-alpha-Pinene, 2,6,6-Trimethyl-Bicyclo(3.1.1)hept-2-ene, 2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene, alpha-Pinene(dextro)",http://vmh.uni.lu/_api/metabolites/412/?format=pcsv
aprut,,,1,C6H15N2O,CHEBI:17768,,"Human Metabolome Database (HMDB): N-Acetylputrescine is a polyamine commonly occurring excreted in normal human urine (PMID 7775374). N-Acetylputrescine is the most abundant of all polyamines both in normal individuals and in patients with leukemia (PMID 9464484). N-Acetylputrescine is the N-acetylated form of the naturally occurring polyamine called putrescine. The N-acetylation is mediated by the enzyme diamine N-acetyltransferase. Putrescine is related to cadaverine (another polyamine). Both are produced by the breakdown of amino acids in living and dead organisms and both are toxic in large doses. Putrescine and cadaverine are largely responsible for the foul odor of putrefying flesh, but also contribute to the odor of such processes as bad breath and bacterial vaginosis. Putrescine is also found in semen. Putrescine attacks s-adenosyl methionine and converts it to spermidine. Spermidine in turn attacks another s-adenosyl methionine and converts it to spermine. Putrescine is synthesized in small quantities by healthy living cells by the action of ornithine decarboxylase.",,N-acetylputrescinium,,HMDB02064,"InChI=1S/C6H14N2O/c1-6(9)8-5-3-2-4-7/h2-5,7H2,1H3,(H,8,9)/p+1",C02714,2016-12-05T15:48:04Z,,413,,,,,,aprut,,"Acetylputrescine, Monoacetylputrescine, N-(4-Aminobutyl)acetamide",http://vmh.uni.lu/_api/metabolites/413/?format=pcsv
n4abutn,,,0,C6H11NO2,CHEBI:7386,,"Human Metabolome Database (HMDB): N4-Acetylaminobutanal is an intermediate of the urea cycle and metabolism of amino groups, the product of the enzyme monoamine oxidase A [EC:1.4.3.4] and the substrate of the enzyme aldehyde dehydrogenase 2 family (mitochondrial) [EC:1.2.1.3].",,4-acetamidobutanal,,HMDB04226,"InChI=1S/C6H11NO2/c1-6(9)7-4-2-3-5-8/h5H,2-4H2,1H3,(H,7,9)",C05936,2016-12-05T15:48:04Z,,414,,,,,440850,n4abutn,,,http://vmh.uni.lu/_api/metabolites/414/?format=pcsv
aqcobal,,,0,C62H93CoN13O15P,CHEBI:15852,,Aquacob(III)alamin,,Aquacob(III)alamin,,,"InChI=1S/C62H90N13O14P.Co.H2O/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;1H2/q;+3;/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;;/m1../s1",C00992,2016-11-22T15:11:50Z,,415,,,,,,aqcobal,,,http://vmh.uni.lu/_api/metabolites/415/?format=pcsv
arab_L,,,0,C5H10O5,CHEBI:17535,,"Human Metabolome Database (HMDB): L-Arabinose is a pentose with a sweet taste and one of the most abundant components released by complete hydrolysis of non-starch polysaccharides (NSP) of vegetable origin. However, NSPs are complicated compounds from the point of view of both physical structure and chemical composition, and they include cellulose, hemi-cellulose, pectin and oligosaccharides. It is well recognized that NSPs are resistant to the digestive enzymes and pass to the hind-gut where microbial degradation takes place. When L-Arabinose is ingested in a digestible form, it is absorbed from the intestinal tract but at a lower rate than glucose. A portion of the ingested L-Arabinose is excreted in the urine. Although widely present in nature, L-Arabinose is rarely used, and its physiological effects in vivo have received little attention. L-Arabinose selectively inhibits intestinal sucrase activity in a noncompetitive manner and suppresses the plasma glucose increase due to sucrose ingestion. Because the intestinal absorption of sucrose is inhibited in the presence of L-Arabinose, the absorption of sucrose should be reduced by arabinose ingestion. Most of the studies reported so far on the absorption and utilization of L-Arabinose relate to omnivore animal species other than humans. In a rare case of two autistic brothers that were not associated with any known metabolic disease, it was found the median value for their urine samples was 179 umol/mmol creatinine of L-Arabinose, nearly six times greater than normal children. (PMID: 11238761, 8931641, 1390604, 7628083).",,L-arabinose,,HMDB00646,,C00259,2016-12-05T15:48:04Z,,416,,,,,,arab_L,,"Arabinose, L-(+)-Arabinose, L-Arabinopyranose",http://vmh.uni.lu/_api/metabolites/416/?format=pcsv
arachcoa,,,-4,C41H70N7O17P3S,CHEBI:15527,,"Human Metabolome Database (HMDB): Eicosanoyl-CoA is an intermediate metabolite in the synthesis of phosphatidic acid, a substrate of lysophosphatidic acid acyltransferase with high specificity as an acyl donor. Cells and membranes of mammalian cells synthesize their glycerophospholipids and triglycerides to maintain the cellular integrity and to provide energy for cellular functions. The phospholipids are synthesized de novo in cells through an evolutionary conserved process involving serial acylations of glycerol-3-phosphate. Several isoforms of the enzyme 1-acylglycerol-3-phosphate-O-acyltransferase (EC 2.3.1.51, AGPAT) acylate lysophosphatidic acid at the sn-2 position to produce phosphatidic acid. Bile acid-CoA:amino acid N-acyltransferase (EC 2.3.1.65, BACAT) catalyzes the conjugation of bile acids to glycine and taurine for excretion into bile and can utilize Eicosanoyl-CoA as an acyl donor as well; this may play important roles in protection against toxicity by accumulation of unconjugated bile acids and non-esterified very long-chain fatty acids. (PMID: 17535882, 12810727).",,arachidyl coenzyme A,,HMDB04258,"InChI=1S/C41H74N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-32(50)69-25-24-43-31(49)22-23-44-39(53)36(52)41(2,3)27-62-68(59,60)65-67(57,58)61-26-30-35(64-66(54,55)56)34(51)40(63-30)48-29-47-33-37(42)45-28-46-38(33)48/h28-30,34-36,40,51-52H,4-27H2,1-3H3,(H,43,49)(H,44,53)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/t30-,34-,35-,36+,40-/m1/s1",C02041,2016-12-05T15:48:04Z,,417,,,,icosanoyl-CoA,16061151,arachcoa,,"Arachidinoyl-CoA, Arachidinoyl-Coenzyme A, Arachidoyl coenzyme A, Arachidoyl-CoA, Arachidoyl-Coenzyme A, Arachidyl CoA, Arachidyl coenzyme A, Eicosanethioate, Eicosanethioic acid, Eicosanethioic acid S-ester with coenzyme A, Eicosanoyl coenzyme A, Eicosyl-coenzyme A, Icosanoyl-coa, S-Eicosanoate, S-Eicosanoate CoA, S-Eicosanoate Coenzyme A, S-Eicosanoic acid",http://vmh.uni.lu/_api/metabolites/417/?format=pcsv
arachcrn,,,0,C27H53NO4,,,arachidyl carnitine,,arachidyl carnitine,,,"InChI=1/C27H53NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-27(31)32-25(23-26(29)30)24-28(2,3)4/h25H,5-24H2,1-4H3",,2016-11-22T15:11:50Z,,418,,,,,53477833,arachcrn,,,http://vmh.uni.lu/_api/metabolites/418/?format=pcsv
arachdcoa,,,-4,C41H62N7O17P3S,CHEBI:15514,,"Human Metabolome Database (HMDB): Arachidonyl-CoA is an intermediate in Biosynthesis of unsaturated fatty acids. Arachidonyl-CoA is produced from 8,11,14-Eicosatrienoyl-CoA via the enzyme fatty acid desaturase 1 (EC 1.14.19.-). It is then converted to Arachidonic acid via the enzymepalmitoyl-CoA hydrolase (EC 3.1.2.2).",,arachidonoyl-CoA(4-),,HMDB06523,"InChI=1S/C41H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-32(50)69-25-24-43-31(49)22-23-44-39(53)36(52)41(2,3)27-62-68(59,60)65-67(57,58)61-26-30-35(64-66(54,55)56)34(51)40(63-30)48-29-47-33-37(42)45-28-46-38(33)48/h8-9,11-12,14-15,17-18,28-30,34-36,40,51-52H,4-7,10,13,16,19-27H2,1-3H3,(H,43,49)(H,44,53)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/p-4/b9-8-,12-11-,15-14-,18-17-/t30-,34-,35-,36+,40-/m1/s1",C02249,2016-12-05T15:48:04Z,,419,,,,arachidonoyl-CoA,16061152,arachdcoa,,"(5Z,8Z,11Z,14Z)-Icosatetraenoyl-CoA, (5Z,8Z,11Z,14Z)-Icosatetraenoyl-Coenzyme A, Arachidonoyl-CoA, Arachidonoyl-Coenzyme A, Arachidonyl-CoA, Arachidonyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/419/?format=pcsv
arach,,,-1,C20H39O2,CHEBI:28822,,Human Metabolome Database (HMDB): Arachidic acid also called eicosanoic acid is a saturated fatty acid found in peanut oil. It can be formed by the hydrogenation of arachidonic acid. It is practically insoluble in water and stable under ordinary conditions -- Wikipedia.,,arachidate,,HMDB02212,"InChI=1S/C20H40O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h2-19H2,1H3,(H,21,22)/p-1",C06425,2016-12-05T15:48:04Z,,420,,,,,10467,arach,,"Arachate, Arachic acid, Arachidate, Arachidic acid, Eicosanoate, Eicosanoic acid, Icosanoate, Icosanoic acid, N-Eicosanoate, N-Eicosanoic acid",http://vmh.uni.lu/_api/metabolites/420/?format=pcsv
arg_L,,,1,C6H15N4O2,CHEBI:16467,,"Human Metabolome Database (HMDB): Arginine is an essential amino acid that is physiologically active in the L-form. In mammals, arginine is formally classified as a semiessential or conditionally essential amino acid, depending on the developmental stage and health status of the individual. Infants are unable to effectively synthesize arginine, making it nutritionally essential for infants. Adults, however, are able to synthesize arginine in the urea cycle. Arginine can be considered to be a basic amino acid as the part of the side chain nearest to the backbone is long, carbon-containing and hydrophobic, whereas the end of the side chain is a complex guanidinium group. With a pKa of 12.48, the guanidinium group is positively charged in neutral, acidic and even most basic environments. Because of the conjugation between the double bond and the nitrogen lone pairs, the positive charge is delocalized. This group is able to form multiple H-bonds. L-arginine is an amino acid that has numerous functions in the body. It helps dispose of ammonia, is used to make compounds such as nitric oxide, creatine, L-glutamate, L-proline, and it can be converted to glucose and glycogen if needed. In large doses, L-arginine also stimulates the release of hormones growth hormone and prolactin. Arginine is a known inducer of mTOR (mammalian target of rapamycin) and is responsible for inducing protein synthesis through the mTOR pathway. mTOR inhibition by rapamycin partially reduces arginine-induced protein synthesis PMID: 20841502. Catabolic disease states such as sepsis, injury, and cancer cause an increase in arginine utilization, which can exceed normal body production, leading to arginine depletion. Arginine also activates AMP kinase (AMPK) which then stimulates skeletal muscle fatty acid oxidation and muscle glucose uptake, thereby increasing insulin secretion by pancreatic beta-cells. PMID: 21311355 Arginine is found in plant and animal proteins, such as dairy products, meat, poultry, fish, and nuts. The ratio of L-arginine to lysine is also important - soy and other plant proteins have more L-arginine than animal sources of protein.",,L-argininium(1+),,HMDB00517,"InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/p+1/t4-/m0/s1",C00062,2016-12-05T15:48:04Z,,421,,,,L-Arg,6322,arg_L,,"(S)-2-amino-5-[(aminoiminomethyl)amino]-Pentanoate, (S)-2-amino-5-[(aminoiminomethyl)amino]-Pentanoic acid, (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoate, (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid, 2-Amino-5-guanidinovalerate, 2-Amino-5-guanidinovaleric acid, 5-[(Aminoiminomethyl)amino]-L-Norvaline, Arginine, L-(+)-Arginine, L-a-Amino-D-guanidinovalerate, L-a-Amino-D-guanidinovaleric acid, L-alpha-Amino-delta-guanidinovalerate, L-alpha-Amino-delta-guanidinovaleric acid, N5-(aminoiminomethyl)-L-Ornithine",http://vmh.uni.lu/_api/metabolites/421/?format=pcsv
argsuc,,,-1,C10H17N4O6,CHEBI:15682,,"Human Metabolome Database (HMDB): Arginosuccinic acid is a basic amino acid. Some cells synthesize it from citrulline, aspartic acid and use it as a precursor for arginine in the urea cycle or Citrulline-NO cycle. The enzyme that catalyzes the reaction is argininosuccinate synthetase. Argininosuccinic acid is a precursor to fumarate in the citric acid cycle via argininosuccinate lyase. Defects in the arginosuccinate lyase enzyme can lead to arginosuccinate lyase deficiency. Argininosuccinate (ASA) lyase deficiency results in defective cleavage of ASA. This leads to an accumulation of ASA in cells and an excessive excretion of ASA in urine (arginosuccinic aciduria). In virtually all respects, this disorder shares the characteristics of other urea cycle defects. The most important characteristic of ASA lyase deficiency is its propensity to cause hyperammonemia in affected individuals. ASA in affected individuals is excreted by the kidney at a rate practically equivalent to the glomerular filtration rate (GFR). Whether ASA itself causes a degree of toxicity due to hepatocellular accumulation is unknown; such an effect could help explain hyperammonemia development in affected individuals. Regardless, the name of the disease is derived from the rapid clearance of ASA in urine, although elevated levels of ASA can be found in plasma. ASA lyase deficiency is associated with high mortality and morbidity rates. Symptoms of ASA lyase deficiency include anorexia, irritability rapid breathing, lethargy and vomiting. Extreme symptoms include coma and cerebral edema.",,N(omega)-(L-Arginino)succinate,,HMDB00052,"InChI=1S/C10H18N4O6/c11-5(8(17)18)2-1-3-13-10(12)14-6(9(19)20)4-7(15)16/h5-6H,1-4,11H2,(H,15,16)(H,17,18)(H,19,20)(H3,12,13,14)/p-1/t5-,6?/m0/s1",C03406,2016-12-05T15:48:04Z,,422,,,,,16950,argsuc,,"2-(N(Omega)-L-arginine)succinate, 2-(N(Omega)-L-arginine)succinic acid, 2-(N(Omega)-L-arginino)succinate, 2-(N(Omega)-L-arginino)succinic acid, 2-(Nw-L-arginino)butanedioate, 2-(Nw-L-arginino)butanedioic acid, Argininosuccinate, Argininosuccinic acid, Arginosuccinate, Arginosuccinic acid, ASA, L-Argininosuccinate, L-Argininosuccinic acid, L-Arginosuccinate, L-Arginosuccinic acid, N(Omega)-(L-arginino)succinate, N(Omega)-(L-arginino)succinic acid, N-(((4-Amino-4-carboxybutyl)amino)iminomethyl)-L-Aspartate, N-(((4-Amino-4-carboxybutyl)amino)iminomethyl)-L-Aspartic acid, N-(L-Arginino) succinate, N-(L-Arginino) succinic acid, N-(L-Arginino)succinate, N-(L-Arginino)succinic acid, N-[(4-Amino-4-carboxybutyl)amidino]-L-Aspartate, N-[(4-Amino-4-carboxybutyl)amidino]-L-Aspartic acid, N-[[(4-Amino-4-carboxybutyl)amino]iminomethyl]-L-Aspartate, N-[[(4-Amino-4-carboxybutyl)amino]iminomethyl]-L-Aspartic acid",http://vmh.uni.lu/_api/metabolites/422/?format=pcsv
citr_L,,,0,C6H13N3O3,CHEBI:16349,,"Human Metabolome Database (HMDB): Citrulline is an amino acid made from ornithine and carbamoyl phosphate in one of the central reactions in the urea cycle. It is also produced from arginine as a by-product of the reaction catalyzed by NOS family (NOS; EC 1.14.13.39). In this reaction arginine is first oxidized into N-hydroxyl-arginine, which is then further oxidized to citrulline concomitant with the release of nitric oxide. EC 1.14.13.39). Citrulline's name is derived from citrullus, the Latin word for watermelon, from which it was first isolated.",,L-citrulline,,HMDB00904,"InChI=1S/C6H13N3O3/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)/t4-/m0/s1",C00327,2016-12-05T15:48:04Z,,423,,,,,9750,citr_L,,"(2S)-2-amino-5-(carbamoylamino)pentanoate, (2S)-2-amino-5-(carbamoylamino)pentanoic acid, (S)-2-amino-5-(aminocarbonyl)aminopentanoate, (S)-2-amino-5-(aminocarbonyl)aminopentanoic acid, (S)-2-Amino-5-ureidopentanoate, (S)-2-Amino-5-ureidopentanoic acid, 2-Amino-5-uredovalerate, 2-Amino-5-uredovaleric acid, 2-Amino-5-ureidovalerate, 2-Amino-5-ureidovaleric acid, A-Amino-D-ureidovalerate, A-Amino-D-ureidovaleric acid, alpha-Amino-delta-ureidovalerate, alpha-Amino-delta-ureidovaleric acid, alpha-Amino-gamma-ureidovalerate, alpha-Amino-gamma-ureidovaleric acid, Amino-ureidovalerate, Amino-ureidovaleric acid, CIR, CIT, Cytrulline, D-Ureidonorvaline, delta-Ureidonorvaline, DL-citrulline, Gammaureidonorvaline, H-Cit-oh, L(+)-2-Amino-5-ureidovalerate, L(+)-2-Amino-5-ureidovaleric acid, L(+)-Citrulline, L-2-Amino-5-ureido-valerate, L-2-Amino-5-ureido-valeric acid, L-2-Amino-5-ureidovalerate, L-2-Amino-5-ureidovaleric acid, L-Citrulline, L-Cytrulline, L-N5-carbamoyl-Ornithine, N()-Carbamylornithine, N(5)-(Aminocarbonyl)-DL-Ornithine, N(delta)-Carbamylornithine, N-Carbamylornithine, N5-(Aminocarbonyl)-L-ornithine, N5-(aminocarbonyl)-Ornithine, N5-(Aminocarbonyl)ornithine, N5-Carbamoyl-L-ornithine, N5-carbamoylornithine, N5-carbamylornithine, N<SUP>5</SUP>-(aminocarbonyl)ornithine, ND-carbamylornithine, Ndelta-carbamy-ornithine, Ndelta-carbamylornithine, Ngamma-carbamylornithine, Sitrulline, Ureidonorvaline, Ureidovalerate, Ureidovaleric acid",http://vmh.uni.lu/_api/metabolites/423/?format=pcsv
sgalside_hs,,,-1,C24H45NO10SFULLRCO,,,sulfatide galactocerebroside,,sulfatide galactocerebroside,,,,,2016-11-22T15:11:50Z,,424,,,,,,sgalside_hs,,,http://vmh.uni.lu/_api/metabolites/424/?format=pcsv
galside_hs,,,0,C24H46NO7FULLRCO,CHEBI:12947,,D-galactosyl-N-acylsphingosine,,D-galactosyl-N-acylsphingosine,,,,,2016-11-22T15:11:51Z,,425,,,,,,galside_hs,,,http://vmh.uni.lu/_api/metabolites/425/?format=pcsv
so4,,,-2,O4S,CHEBI:16189,,"Human Metabolome Database (HMDB): The sulfate ion is a polyatomic anion with the empirical formula SO42- and a molecular mass of 96.06 daltons; it consists of one central sulfur atom surrounded by four equivalent oxygen atoms in a tetrahedral arrangement. The sulfate ion carries a negative two charge and is the conjugate base of the hydrogen sulfate ion, HSO4-, which is the conjugate base of H2SO4, sulfuric acid. In inorganic chemistry, a sulfate (IUPAC-recommended spelling; also sulphate in British English) is a salt of sulfuric acid. Sulfate aerosols can act as cloud condensation nuclei and this leads to greater numbers of smaller droplets of water. Lots of smaller droplets can diffuse light more efficiently than just a few larger droplets.",,sulfate,,HMDB01448,"InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",C00059,2016-12-05T15:48:04Z,,426,,,,,1118,so4,,"Sulfate (ion 2-), Sulfate anion, Sulfate anion(2-), Sulfate dianion, Sulfate ion, Sulfate ion (SO42-), Sulfate(2-), Sulfuric acid ion(2-), Sulphate",http://vmh.uni.lu/_api/metabolites/426/?format=pcsv
Rtotalcoa,,,-4,CO2FULLRC21H31N7O15P3S,,,R total Coenzyme A,,R total Coenzyme A,,,,,2016-11-22T15:11:51Z,,427,,,,,,Rtotalcoa,,,http://vmh.uni.lu/_api/metabolites/427/?format=pcsv
Rtotal3coa,,,-4,CO2FULLR3C21H31N7O15P3S,,,R total 3 Coenzyme A,,R total 3 Coenzyme A,,,,,2016-11-22T15:11:51Z,,428,,,,,,Rtotal3coa,,,http://vmh.uni.lu/_api/metabolites/428/?format=pcsv
Rtotal3,,,-1,CO2FULLR3,,,R total 3 position,,R total 3 position,,,,,2016-11-22T15:11:51Z,,429,,,,,,Rtotal3,,,http://vmh.uni.lu/_api/metabolites/429/?format=pcsv
R1coa_hs,,,-4,XCO2C21H31N7O15P3S,,,R group 1 Coenzyme A,,R group 1 Coenzyme A,,,,,2016-11-22T15:11:51Z,,430,,,,,,R1coa_hs,,,http://vmh.uni.lu/_api/metabolites/430/?format=pcsv
hdcoa,,,-4,C37H60N7O17P3S,CHEBI:53152,,"Human Metabolome Database (HMDB): Palmitoleyl coenzyme A is a monounsaturated fatty acid, the product of palmitoyl-CoA from a reaction catalyzed by stearoyl-CoA desaturase (EC 1.14.99.5, SCD) in the endoplasmic reticulum, an enzyme that catalyzes the delta9-cis desaturation of saturated fatty acyl-CoAs. These monounsaturated fatty acids are used as substrates for the synthesis of triglycerides, wax esters, cholesteryl esters and membrane phospholipids. The saturated to monounsaturated fatty acid ratio affects membrane phospholipid composition and alteration in this ratio has been implicated in a variety of disease states including cardiovascular disease, obesity, diabetes, neurological disease, skin disorders and cancer. Thus, the expression of SCD is of physiological importance in normal and disease states. Unsaturated fatty acids are the most abundant form of stored fat in the human body and are vital for all living organisms. In addition to their role as an energy source, they are integral constituents of cell membranes, playing a role in membrane fluidity, cell signaling, and membrane integrity. Numerous beneficial physiologic effects have been attributed to unsaturated fatty acids, including protection from obesity, diabetes, cancer, and atherosclerosis. (PMID: 12538075, 16020546).",,Hexadecenoyl-CoA (n-C16:1CoA),,HMDB06532,,,2016-12-05T15:48:04Z,,431,,,,,,hdcoa,,"(Z)-S-9-hexadecenoate, (Z)-S-9-hexadecenoate CoA, (Z)-S-9-hexadecenoate Coenzyme A, (Z)-S-9-hexadecenoic acid, (Z)-thio-9-Hexadecenoate, (Z)-thio-9-Hexadecenoic acid, (Z)-thio-9-Hexadecenoic acid S-ester with coenzyme A, cis-9-Hexadecenoyl-coenzyme A, Palmitoleoyl coenzyme A, Palmitoleoyl-CoA, Palmitoleoyl-Coenzyme A, Palmitoleyl coenzyme A, Palmitoleyl-CoA, Palmitoleyl-Coenzyme A, S-(9Z)-9-Hexadecenoate, S-(9Z)-9-Hexadecenoate CoA, S-(9Z)-9-Hexadecenoate Coenzyme A, S-(9Z)-9-Hexadecenoic acid, S-cis-9-Hexadecenoate, S-cis-9-Hexadecenoate CoA, S-cis-9-Hexadecenoate Coenzyme A, S-cis-9-Hexadecenoic acid, S-Palmitoleate CoA, S-Palmitoleate Coenzyme A",http://vmh.uni.lu/_api/metabolites/431/?format=pcsv
lnlncacoa,,,-4,C39H60N7O17P3S,CHEBI:51985,,Human Metabolome Database (HMDB): Alpha-Linolenoyl-CoA is an intermediate in Biosynthesis of unsaturated fatty acids. alpha-Linolenoyl-CoA is converted. from Linoleoyl-CoA via the enzyme fatty acid desaturase (EC 1.14.19.-). It is then converted to alpha-Linolenic acid via the enzyme palmitoyl-CoA hydrolase(EC 3.1.2.2).,,alpha-Linolenoyl-CoA,,HMDB06290,"InChI=1S/C39H64N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h5-6,8-9,11-12,26-28,32-34,38,49-50H,4,7,10,13-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/b6-5-,9-8-,12-11-/t28-,32-,33-,34+,38-/m1/s1",C16162,2016-12-05T15:48:04Z,,432,,,,,53477815,lnlncacoa,,"(9Z,12Z,15Z)-Octadecatrienoyl-CoA, (9Z,12Z,15Z)-Octadecatrienoyl-Coenzyme A, alpha-Linolenoyl-CoA, alpha-Linolenoyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/432/?format=pcsv
R2coa_hs,,,-4,XCO2C21H31N7O15P3S,,,R group 2 Coenzyme A,,R group 2 Coenzyme A,,,,,2016-11-22T15:11:51Z,,433,,,,,,R2coa_hs,,,http://vmh.uni.lu/_api/metabolites/433/?format=pcsv
lnlncgcoa,,,-4,C39H60N7O17P3S,CHEBI:15508,,"Human Metabolome Database (HMDB): Gamma-linolenoyl-CoA is the product of a chemical reaction that involves linoleoyl-CoA desaturase which acts as a catalyst. In enzymology, linoleoyl-CoA desaturase (EC 1.14.19.3) is an enzyme that catalyzes the chemical reaction. linoleoyl-CoA + AH2 + O2 gamma-linolenoyl-CoA + A + 2 H2O. The 3 substrates of this enzyme are linoleoyl-CoA, AH2, and O2, whereas its 3 products are gamma-linolenoyl-CoA, A, and H2O. (Wikipedia).",,gamma-linolenoyl-CoA(4-),,HMDB06368,"InChI=1S/C39H64N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h8-9,11-12,14-15,26-28,32-34,38,49-50H,4-7,10,13,16-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/p-4/b9-8-,12-11-,15-14-/t28-,32-,33-,34+,38-/m1/s1",C03035,2016-12-05T15:48:04Z,,434,,,,,11966132,lnlncgcoa,,"gamma-Linolenoyl-CoA, gamma-Linolenoyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/434/?format=pcsv
strdnccoa,,,-4,C39H58N7O17P3S,CHEBI:63545,,stearidonyl coenzyme A,,stearidonyl coenzyme A,,,"InChI=1/C39H62N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h5-6,8-9,11-12,14-15,26-28,32-34,38,49-50H,4,7,10,13,16-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/b6-5-,9-8-,12-11-,15-14-/t28-,32-,33?,34+,38-/m1/s1",C16163,2016-11-22T15:11:51Z,,435,,,,,23724640,strdnccoa,,,http://vmh.uni.lu/_api/metabolites/435/?format=pcsv
dlnlcgcoa,,,-4,C41H64N7O17P3S,CHEBI:27979,,"Human Metabolome Database (HMDB): <p>8Z,11Z,14Z-eicosatrienoyl-CoA participates in the biosynthesis of unsaturated fatty acids. 8Z,11Z,14Z-eicosatrienoyl-CoA is converted from (8Z,11Z,14Z)-Icosatrienoic acid via palmitoyl-CoA hydrolase [EC:3.1.2.2].</p> <p>Unsaturated fatty acids are of similar form, except that one or more alkenyl functional groups exist along the chain, with each alkene substituting a single-bonded ""-CH2-CH2-"" part of the chain with a double-bonded ""-CH=CH-"" portion (that is, a carbon double-bonded to another carbon). The differences in geometry between the various types of unsaturated fatty acids, as well as between saturated and unsaturated fatty acids, play an important role in biological processes, and in the construction of biological structures (such as cell membranes). (Wikipedia)</p>.",,dihomo-gamma-linolenyl coenzyme A,,HMDB03947,"InChI=1S/C41H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-32(50)69-25-24-43-31(49)22-23-44-39(53)36(52)41(2,3)27-62-68(59,60)65-67(57,58)61-26-30-35(64-66(54,55)56)34(51)40(63-30)48-29-47-33-37(42)45-28-46-38(33)48/h8-9,11-12,14-15,28-30,34-36,40,51-52H,4-7,10,13,16-27H2,1-3H3,(H,43,49)(H,44,53)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/b9-8-,12-11-,15-14-/t30-,34-,35-,36+,40-/m1/s1",C03595,2016-12-05T15:48:04Z,,436,,,,,5280609,dlnlcgcoa,,"(8Z,11Z,14Z)-Eicosatrienoyl-CoA, (8Z,11Z,14Z)-Eicosatrienoyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/436/?format=pcsv
tmndnccoa,,,-4,C41H60N7O17P3S,,,timnodonyl coenzyme A,,timnodonyl coenzyme A,,,"InChI=1/C41H64N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-32(50)69-25-24-43-31(49)22-23-44-39(53)36(52)41(2,3)27-62-68(59,60)65-67(57,58)61-26-30-35(64-66(54,55)56)34(51)40(63-30)48-29-47-33-37(42)45-28-46-38(33)48/h5-6,8-9,11-12,14-15,17-18,28-30,34-36,40,51-52H,4,7,10,13,16,19-27H2,1-3H3,(H,43,49)(H,44,53)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/b6-5-,9-8-,12-11-,15-14-,18-17-/t30-,34-,35?,36+,40-/m1/s1",,2016-11-22T15:11:51Z,,437,,,,,52922050,tmndnccoa,,,http://vmh.uni.lu/_api/metabolites/437/?format=pcsv
lnlccoa,,,-4,C39H62N7O17P3S,CHEBI:15530,,"Human Metabolome Database (HMDB): Linoleoyl-CoA is the acyl-CoA of linoleic acid found in the human body. It binds to and results in decreased activity of Glutathione S-transferase1. It has been proposed that inhibition of mitochondrial adenine nucleotide translocator by long chain acyl-CoA underlies the mechanism associating obesity and type 2 diabetes. Unsaturated fatty acids play an important role in the prevention of human diseases such as diabetes, obesity, cancer, and neurodegeneration. Their oxidation in vivo by acyl-CoA dehydrogenases (ACADs) catalyze the first step of each cycle of mitochondrial fatty acid {beta}-oxidation; ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates. (PMID: 17184976, 16020546).",,linoleic coenzyme A,,HMDB01064,"InChI=1/C39H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h8-9,11-12,26-28,32-34,38,49-50H,4-7,10,13-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/b9-8+,12-11+",C02050,2016-12-05T15:48:04Z,,438,,,,linoleoyl-CoA,5280482,lnlccoa,,"(9Z,12Z)-Octadecadienoyl-CoA, (9Z,12Z)-Octadecadienoyl-Coenzyme A, Linoleoyl-CoA, Linoleoyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/438/?format=pcsv
clpndcoa,,,-4,C43H64N7O17P3S,CHEBI:63541,,clupanodonyl CoA,,clupanodonyl CoA,,HMDB06267,"InChI=1/C43H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-34(52)71-27-26-45-33(51)24-25-46-41(55)38(54)43(2,3)29-64-70(61,62)67-69(59,60)63-28-32-37(66-68(56,57)58)36(53)42(65-32)50-31-49-35-39(44)47-30-48-40(35)50/h5-6,8-9,11-12,14-15,17-18,30-32,36-38,42,53-54H,4,7,10,13,16,19-29H2,1-3H3,(H,45,51)(H,46,55)(H,59,60)(H,61,62)(H2,44,47,48)(H2,56,57,58)/p-4/b6-5-,9-8-,12-11-,15-14-,18-17-/t32-,36+,37+,38?,42-/m0/s1",C16166,2016-11-22T16:06:40Z,,439,,,,,53477812,clpndcoa,,"7,10,13,16,19-All-cis-docosapentaenoyl-CoA, 7,10,13,16,19-All-cis-docosapentaenoyl-Coenzyme A, 7Z,10Z,13Z,16Z,19Z-Docosapentaenoyl-CoA, 7Z,10Z,13Z,16Z,19Z-Docosapentaenoyl-Coenzyme A, All-cis-7,10,13,16,19-docosapentaenoyl-CoA, All-cis-7,10,13,16,19-docosapentaenoyl-Coenzyme A, cis-7,10,13,16,19-Docosapentanenoyl CoA, cis-7,10,13,16,19-Docosapentanenoyl Coenzyme A, Docosa-7,10,13,16,19-all-cis-pentaenoyl-CoA, Docosa-7,10,13,16,19-all-cis-pentaenoyl-Coenzyme A, DPA (20:5w-3) CoA, DPA (20:5w-3) Coenzyme A",http://vmh.uni.lu/_api/metabolites/439/?format=pcsv
dcsptn1coa,,,-4,C43H64N7O17P3S,,,"docosa-4,7,10,13,16-pentaenoyl coenzyme A",,"docosa-4,7,10,13,16-pentaenoyl coenzyme A",,,"InChI=1/C43H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-34(52)71-27-26-45-33(51)24-25-46-41(55)38(54)43(2,3)29-64-70(61,62)67-69(59,60)63-28-32-37(66-68(56,57)58)36(53)42(65-32)50-31-49-35-39(44)47-30-48-40(35)50/h8-9,11-12,14-15,17-18,20-21,30-32,36-38,42,53-54H,4-7,10,13,16,19,22-29H2,1-3H3,(H,45,51)(H,46,55)(H,59,60)(H,61,62)(H2,44,47,48)(H2,56,57,58)/b9-8-,12-11-,15-14-,18-17-,21-20-/t32-,36-,37?,38+,42-/m1/s1",C16173,2016-11-22T15:11:51Z,,440,,,,,23724650,dcsptn1coa,,,http://vmh.uni.lu/_api/metabolites/440/?format=pcsv
c226coa,,,-4,C43H62N7O17P3S,CHEBI:65132,,cervonyl coenzyme A,,cervonyl coenzyme A,,,"InChI=1/C43H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-34(52)71-27-26-45-33(51)24-25-46-41(55)38(54)43(2,3)29-64-70(61,62)67-69(59,60)63-28-32-37(66-68(56,57)58)36(53)42(65-32)50-31-49-35-39(44)47-30-48-40(35)50/h5-6,8-9,11-12,14-15,17-18,20-21,30-32,36-38,42,53-54H,4,7,10,13,16,19,22-29H2,1-3H3,(H,45,51)(H,46,55)(H,59,60)(H,61,62)(H2,44,47,48)(H2,56,57,58)/b6-5-,9-8-,12-11-,15-14-,18-17-,21-20-/t32-,36-,37-,38?,42-/m1/s1",C16169,2016-11-22T15:11:51Z,,441,,,,,,c226coa,,,http://vmh.uni.lu/_api/metabolites/441/?format=pcsv
stcoa,,,-4,C39H66N7O17P3S,CHEBI:15541,,"Human Metabolome Database (HMDB): Stearoyl-CoA is a long-chain acyl CoA ester that acts as an intermediate metabolite in the biosynthesis of monounsaturated fatty acids; a critical committed step in the reaction is the introduction of the cis-configuration double bond into acyl-CoAs (between carbons 9 and 10). This oxidative reaction is catalyzed by the iron-containing, microsomal enzyme, stearoyl-CoA desaturase (SCD, EC 1.14.19.1). NADH supplies the reducing equivalents for the reaction, the flavoprotein is cytochrome b5-reductase and the electron carrier is the heme protein cytochrome b5. Stearoyl-CoA is converted into oleoyl-CoA and then used as a major substrate for the synthesis of various kinds of lipids including phospholipids, triglycerides, cholesteryl esters and wax esters. Oleic acid is the preferred substrate for acyl-CoA cholesterol acyltransferase (ACAT, EC 2.3.1.26) and diacylglycerol acyltransferase (DGAT, EC 2.3.1.20), the enzymes responsible for cholesteryl esters and triglycerides synthesis, respectively. In addition oleate is the major monounsaturated fatty acid in human adipose tissue and in the phospholipid of the red-blood-cell membrane. In the biosynthesis of sphinganine, stearoyl-CoA proceeds through the acyl-CoA + serine -> 3-keto-sphinganine -> sphinganine pathway, with the key enzyme being acyl-CoA serine acyltransferase (EC 2.3.1.50) to yield C20-(3-ketosphinganine) long-chain base. There is growing recognition that acyl-CoA esters could act as signaling molecules in cellular metabolism. (PMID: 12538075, 10998569, Prostaglandins Leukot Essent Fatty Acids. 2003 Feb;68(2):113-21.).",,Stearoyl-CoA (n-C18:0CoA),,HMDB01114,"InChI=1S/C39H70N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h26-28,32-34,38,49-50H,4-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/p-4/t28-,32-,33-,34+,38-/m1/s1",C00412,2016-12-05T15:48:04Z,,442,,,,stearoyl-CoA,439229,stcoa,,"Octadecanoyl-CoA, Octadecanoyl-coenzyme A, S-Octadecanoate, S-Octadecanoate CoA, S-Octadecanoate Coenzyme A, S-Octadecanoic acid, S-Stearate CoA, S-Stearate Coenzyme A, S-Stearoylcoenzyme A, Stearoyl coenzyme A, Stearoyl coenzyme A ester, Stearoyl-CoA, Stearoyl-coenzyme A, Stearyl coenzyme A, Stearyl-CoA, Stearyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/442/?format=pcsv
R3coa_hs,,,-4,XCO2C21H31N7O15P3S,,,R group 3 Coenzyme A,,R group 3 Coenzyme A,,,,,2016-11-22T15:11:51Z,,443,,,,,,,,,http://vmh.uni.lu/_api/metabolites/443/?format=pcsv
odecoa,,,-4,C39H64N7O17P3S,CHEBI:15534,,Human Metabolome Database (HMDB): Oleoyl-CoA is a substrate for Acyl-CoA desaturase and Protein FAM34A.,,Octadecenoyl-CoA (n-C18:1CoA),,HMDB01322,"InChI=1S/C39H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h11-12,26-28,32-34,38,49-50H,4-10,13-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/p-4/b12-11-/t28-,32-,33-,34+,38-/m1/s1",C00510,2016-12-05T15:48:04Z,,444,,,,,92160,odecoa,,"Octadecenoyl-CoA (n-C18:1CoA), Oleoyl-Coa",http://vmh.uni.lu/_api/metabolites/444/?format=pcsv
vacccoa,,,-4,C39H64N7O17P3S,,,vaccenyl coenzyme A,,vaccenyl coenzyme A,,,"InChI=1/C39H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h9-10,26-28,32-34,38,49-50H,4-8,11-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/b10-9+/t28-,32-,33?,34+,38-/m1/s1",,2016-11-22T15:12:44Z,,445,,,,,53477847,vacccoa,,,http://vmh.uni.lu/_api/metabolites/445/?format=pcsv
lneldccoa,,,-4,C39H62N7O17P3S,,,linoelaidyl coenzyme A,,linoelaidyl coenzyme A,,,,,2016-11-22T15:11:51Z,,446,,,,,,lneldccoa,,,http://vmh.uni.lu/_api/metabolites/446/?format=pcsv
R4coa_hs,,,-4,XCO2C21H31N7O15P3S,,,R group 4 Coenzyme A,,R group 4 Coenzyme A,,,,,2016-11-22T15:11:51Z,,447,,,,,,,,,http://vmh.uni.lu/_api/metabolites/447/?format=pcsv
nrvnccoa,,,-4,C45H76N7O17P3S,,,nervonyl coenzyme A,,nervonyl coenzyme A,,,"InChI=1/C45H80N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h11-12,32-34,38-40,44,55-56H,4-10,13-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/b12-11-/t34-,38-,39-,40?,44-/m1/s1",C16532,2016-11-22T15:11:51Z,,448,,,,,24892792,nrvnccoa,,,http://vmh.uni.lu/_api/metabolites/448/?format=pcsv
od2coa,,,-4,C39H64N7O17P3S,CHEBI:50570,,Human Metabolome Database (HMDB): trans-Octadec-2-enoyl-CoA is an intermediate in Biosynthesis of unsaturated fatty acids. trans-Octadec-2-enoyl-CoA is produced from 3-Hydroxyoctadecanoyl-CoA and then converted to Stearoyl-CoA via enzymatic reaction.,,trans-Octadec-2-enoyl-CoA,,HMDB06529,"InChI=1S/C39H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h18-19,26-28,32-34,38,49-50H,4-17,20-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/p-4/b19-18+/t28-,32-,33-,34+,38-/m1/s1",C16218,2016-12-05T15:48:04Z,,449,,,,trans-2-octadecenoyl-CoA,53477850,od2coa,,"(2E)-Octadecenoyl-CoA, (2E)-Octadecenoyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/449/?format=pcsv
lgnccoa,,,-4,C45H78N7O17P3S,53477849,,Human Metabolome Database (HMDB): Tetracosanoyl-CoA is an intermediate in the biosynthesis of unsaturated fatty acids. Tetracosanoyl-CoA is converted from Palmitoyl-CoA in multiple steps. It is then converted to lignoceric acid via a thiol-ester hydrolase (E 3.1.2.-).,,lignocericyl coenzyme A,,HMDB06526,"InChI=1/C45H82N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h32-34,38-40,44,55-56H,4-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/t34-,38?,39-,40+,44-/m1/s1",C16529,2016-12-05T15:48:04Z,,450,,,,,53477849,,,"Lignoceroyl-CoA, Lignoceroyl-Coenzyme A, S-Tetracosanoate, S-Tetracosanoate CoA, S-Tetracosanoate Coenzyme A, S-Tetracosanoic acid, Tetracosanoyl-coenzyme A",http://vmh.uni.lu/_api/metabolites/450/?format=pcsv
R5coa_hs,,,-4,XCO2C21H31N7O15P3S,,,R group 5 Coenzyme A,,R group 5 Coenzyme A,,,,,2016-11-22T15:11:51Z,,451,,,,,,,,,http://vmh.uni.lu/_api/metabolites/451/?format=pcsv
hexccoa,,,-4,C47H82N7O17P3S,,,Hexacosanoyl-CoA (n-C26:0CoA),,Hexacosanoyl-CoA (n-C26:0CoA),,,"InChI=1/C47H86N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27-38(56)75-31-30-49-37(55)28-29-50-45(59)42(58)47(2,3)33-68-74(65,66)71-73(63,64)67-32-36-41(70-72(60,61)62)40(57)46(69-36)54-35-53-39-43(48)51-34-52-44(39)54/h34-36,40-42,46,57-58H,4-33H2,1-3H3,(H,49,55)(H,50,59)(H,63,64)(H,65,66)(H2,48,51,52)(H2,60,61,62)/p-4/t36-,40-,41-,42+,46-/m1/s1",,2016-11-22T15:11:51Z,,452,,,,,25246198,hexccoa,,,http://vmh.uni.lu/_api/metabolites/452/?format=pcsv
eicostetcoa,,,-4,C41H62N7O17P3S,,,eicosatetranoyl coenzyme A,,eicosatetranoyl coenzyme A,,,"InChI=1/C41H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-32(50)69-25-24-43-31(49)22-23-44-39(53)36(52)41(2,3)27-62-68(59,60)65-67(57,58)61-26-30-35(64-66(54,55)56)34(51)40(63-30)48-29-47-33-37(42)45-28-46-38(33)48/h5-6,8-9,11-12,14-15,28-30,34-36,40,51-52H,4,7,10,13,16-27H2,1-3H3,(H,43,49)(H,44,53)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/b6-5-,9-8-,12-11-,15-14-/t30-,34-,35-,36?,40-/m1/s1",C16164,2016-11-22T15:11:51Z,,453,,,,,23724641,eicostetcoa,,,http://vmh.uni.lu/_api/metabolites/453/?format=pcsv
tetpent6coa,,,-4,C45H68N7O17P3S,CHEBI:63546,,"tetracosapentaenoyl coenzyme A, n-6",,"tetracosapentaenoyl coenzyme A, n-6",,,"InChI=1/C45H72N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h8-9,11-12,14-15,17-18,20-21,32-34,38-40,44,55-56H,4-7,10,13,16,19,22-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/b9-8-,12-11-,15-14-,18-17-,21-20-/t34-,38-,39-,40?,44-/m1/s1",C16172,2016-11-22T15:11:51Z,,454,,,,,23724649,tetpent6coa,,,http://vmh.uni.lu/_api/metabolites/454/?format=pcsv
tetpent3coa,,,-4,C45H68N7O17P3S,CHEBI:63543,,"tetracosapentaenoyl coenzyme A, n-3",,"tetracosapentaenoyl coenzyme A, n-3",,,"InChI=1/C45H72N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h5-6,8-9,11-12,14-15,17-18,32-34,38-40,44,55-56H,4,7,10,13,16,19-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/b6-5-,9-8-,12-11-,15-14-,18-17-/t34-,38-,39-,40?,44-/m1/s1",C16167,2016-11-22T15:11:51Z,,455,,,,,23724644,tetpent3coa,,,http://vmh.uni.lu/_api/metabolites/455/?format=pcsv
tettet6coa,,,-4,C45H70N7O17P3S,CHEBI:63548,,"Human Metabolome Database (HMDB): (9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA is an intermediate in the biosynthesis of unsaturated fatty acids. (9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA is the 1st to last step in the synthesis of (6Z,9Z,12Z,15Z,18Z)-Tetracosapentaenoyl-CoA and is converted from (7Z,10Z,13Z,16Z)-Docosatetraenoyl-CoA via the enzyme 3-oxoacyl-[acyl-carrier protein] reductase (EC 1.1.1.100) in multisteps.",,tetracosatetraenoyl coenzyme A,,HMDB06516,"InChI=1/C45H74N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h8-9,11-12,14-15,17-18,32-34,38-40,44,55-56H,4-7,10,13,16,19-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/b9-8-,12-11-,15-14-,18-17-/t34-,38-,39?,40+,44-/m1/s1",C16171,2016-12-05T15:48:04Z,,456,,,,,53477846,tettet6coa,,"(9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA, (9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-Coenzyme A, Etracosatetraenoate, Etracosatetraenoatel CoA, Etracosatetraenoatel Coenzyme A, Etracosatetraenoic acid, Tetracosatetraenoate, Tetracosatetraenoatel coenzyme A, Tetracosatetraenoic acid, Tetracosatetraenoyl coenzyme A",http://vmh.uni.lu/_api/metabolites/456/?format=pcsv
tethex3coa,,,-4,C45H66N7O17P3S,,,tetracosahexaenoyl coenzyme A,,tetracosahexaenoyl coenzyme A,,,"InChI=1/C45H70N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h5-6,8-9,11-12,14-15,17-18,20-21,32-34,38-40,44,55-56H,4,7,10,13,16,19,22-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/b6-5-,9-8-,12-11-,15-14-,18-17-,21-20-/t34-,38?,39-,40+,44-/m1/s1",C16168,2016-11-22T15:11:51Z,,457,,,,,53477806,tethex3coa,,,http://vmh.uni.lu/_api/metabolites/457/?format=pcsv
R6coa_hs,,,-4,XCO2C21H31N7O15P3S,,,R group 6 Coenzyme A,,R group 6 Coenzyme A,,,,,2016-11-22T15:11:51Z,,458,,,,,,,,,http://vmh.uni.lu/_api/metabolites/458/?format=pcsv
crm_hs,,,0,C18H36NO2FULLRCO,,,N-acylsphingosine,,N-acylsphingosine,,,,,2016-11-22T15:11:51Z,,459,,,,,,crm_hs,,,http://vmh.uni.lu/_api/metabolites/459/?format=pcsv
sphings,,,1,C18H38NO2,CHEBI:16393,,"Human Metabolome Database (HMDB): Sphingosine is a 18-carbon amino alcohol with a long unsaturated hydrocarbon chain. Sphingosine and its derivative sphinganine are the major bases of the sphingolipids in mammals. (Dorland, 28th ed.). Sphingosine can be phosphorylated in vivo via two kinases, sphingosine kinase type 1 and sphingosine kinase type 2. This leads to the formation of sphingosine-1-phosphate, a potent signaling lipid.(Wikipedia).",,sphingosine(1+),,HMDB00252,"InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h14-15,17-18,20-21H,2-13,16,19H2,1H3/p+1/b15-14+/t17-,18+/m0/s1",C00319,2016-12-05T15:48:04Z,,460,,,,,31270,sphings,,"(-)-D-erythro-Sphingosine, (2S,3R)-Sphingosine, (2S,3R,4E)-2-Amino-4-octadecene-1,3-diol, (4E)-Sphingenine, 4-Sphingenine, 4-trans-Sphingenine, [R-[R*,S*-(E)]]-2-amino-4-Octadecene-1,3-diol",http://vmh.uni.lu/_api/metabolites/460/?format=pcsv
ascb_L,,,-1,C6H7O6,CHEBI:29073,,"Human Metabolome Database (HMDB): Ascorbic acid is found naturally in citrus fruits and many vegetables and is an essential nutrient in human diets. It is necessary to maintain connective tissue and bone. The biologically active form of ascorbic acid is vitamin C. Vitamin C is a water soluble vitamin. Primates (including humans) and a few other species in all divisions of the animal kingdom, notably the guinea pig, have lost the ability to synthesize ascorbic acid and must obtain it in their food. Vitamin C functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant. [PubChem] Ascorbic acid is an electron donor for enzymes involved in collagen hydroxylation, biosynthesis of carnitine and norepinephrine, tyrosine metabolism, and amidation of peptide hormones. Ascrobic acid (vitamin C) deficiency causes scurvy. The amount of vitamin C necessary to prevent scurvy may not be adequate to maintain optimal health. The ability of vitamin C to donate electrons also makes it a potent water-soluble antioxidant that readily scavenges free radicals such as molecular oxygen, superoxide, hydroxyl radical, and hypochlorous acid. In this setting, several mechanisms could account for a link between vitamin C and heart disease. One is the relation between LDL oxidation and vitamins C and E. Vitamin C in vitro can recycle vitamin E, which can donate electrons to prevent LDL oxidation in vitro. As the lipid-phase vitamin E is oxidized, it can be regenerated by aqueous vitamin C. Other possibilities are that vitamin C could decrease cholesterol by mechanisms not well characterized, or could improve vasodilatation and vascular reactivity, perhaps by decreasing the interactions of nitric oxide with oxidants. (PMID: 10799361).",,L-ascorbate,,HMDB00044,"InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/p-1/t2-,5+/m0/s1",C00072,2016-12-05T15:48:04Z,,461,,,,,,ascb_L,,"(+)-ascorbate, (+)-ascorbic acid, (+)-Sodium L-ascorbate , 3-Keto-L-gulofuranolactone, 3-Oxo-L-gulofuranolactone, Adenex, Allercorb, Antiscorbic vitamin, Antiscorbutic vitamin, Arco-cee, Ascoltin, Ascor-B.I.D., Ascorb, Ascorbajen, Ascorbate, Ascorbic acid, Ascorbicab, Ascorbicap, Ascorbicin, Ascorbin, Ascorbutina, Ascorin, Ascorteal, Ascorvit, C-Level, C-Long, C-Quin, C-Span, C-Vimin, Cantan, Cantaxin, Catavin C, Ce lent, Ce-mi-lin, Ce-vi-sol, Cebicure, Cebid, Cebion, Cebione, Cecon, Cee-caps TD, Cee-vite, Cegiolan, Ceglion, Ceklin, Celaskon, Celin, Cell C, Cemagyl, Cemill, Cenetone, Cenolate, Cereon, Cergona, Cescorbat, Cetamid, Cetane, Cetane-caps TC, Cetane-caps TD, Cetebe, Cetemican, Cevalin, Cevatine, Cevex, Cevi-bid, Cevimin, Cevital, Cevitamate, Cevitamic acid, Cevitamin, Cevitan, Cevitex, Cewin, Chewcee, Ciamin, Cipca, Citriscorb, Citrovit, Colascor, Concemin, Davitamon C, Dora-C-500, Duoscorb, Ferrous ascorbate, gamma-Lactone L-threo-Hex-2-enonate, gamma-Lactone L-threo-Hex-2-enonic acid, HiCee, Hybrin, Ido-C, Juvamine, Kangbingfeng, Kyselina askorbova, L(+)-Ascorbate, L(+)-Ascorbic acid, L-(+)-Ascorbate, L-(+)-Ascorbic acid, L-3-Ketothreohexuronic acid lactone, L-Ascorbate, L-Ascorbic acid, L-Lyxoascorbate, L-Lyxoascorbic acid, L-Threo-ascorbic acid, L-Xyloascorbate, L-Xyloascorbic acid, Laroscorbine, Lemascorb, Liqui-cee, Meri-c, Natrascorb, Natrascorb injectable, Planavit C, Proscorbin, Redoxon, Ribena, Ronotec 100, Rontex 100, Roscorbic, Rovimix C, Scorbacid, Scorbu C, Scorbu-C, Secorbate, Sodascorbate, Suncoat VC 40, Testascorbic, VASC, Vicelat, Vicin, Vicomin C, Viforcit, Viscorin, Viscorin 100M, Vitace, Vitacee, Vitacimin, Vitacin, Vitamin C, Vitamisin, Vitascorbol, Xitix",http://vmh.uni.lu/_api/metabolites/461/?format=pcsv
o2s,,,-1,O2,CHEBI:18421,,"Human Metabolome Database (HMDB): Superoxide is the anionic form O2. It is important as the product of the one-electron reduction of dioxygen (oxygen gas), which occurs widely in nature. With one unpaired electron, the superoxide ion is a free radical. It is also paramagnetic. The biological toxicity of superoxide is due to its capacity to inactivate iron-sulfur cluster containing enzymes (which are critical in a wide variety of metabolic pathways), thereby liberating free iron in the cell, which can undergo fenton-chemistry and generate the highly reactive hydroxyl radical. In its HO2 form, superoxide can also initiate lipid peroxidation of polyunsaturated fatty acids. It also reacts with carbonyl compounds and halogenated carbons to create toxic peroxy radicals. As such, superoxide is a main cause of oxidative stress. Highly reactive compounds produced when oxygen is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to Methemoglobin. Because superoxide is toxic, nearly all organisms living in the presence of oxygen contain isoforms of the superoxide scavenging enzyme, superoxide dismutase, or SOD. SOD is an extremely efficient enzyme; it catalyzes the neutralization of superoxide nearly as fast as the two can diffuse together spontaneously in solution. Genetic inactivation (""knockout"") of SOD produces deleterious phenotypes in organisms ranging from bacteria to mice. The latter species dies around 21 days after birth if the mitochondrial variant of SOD (Mn-SOD) is inactivated, and suffers from multiple pathologies, including reduced lifespan, liver cancer, muscle atrophy, cataracts and female infertility when the cytoplasmic (Cu, Zn -SOD) variant is inactivated. With one unpaired electron, the superoxide ion is a free radical and therefore paramagnetic. In living organisms, superoxide dismutase protects the cell from the deleterious effects of superoxides.",,superoxide,,HMDB02168,InChI=1S/HO2/c1-2/h1H/p-1,C00704,2016-12-05T15:48:04Z,,462,,,,superoxide,5359597,o2s,,"Dioxidanidyl, Dioxide(1-), Hyperoxid, Superoxide, Superoxide anion, Superoxide radical, Superoxide radical anion",http://vmh.uni.lu/_api/metabolites/462/?format=pcsv
dhdascb,,,0,C6H6O6,CHEBI:17242,,"Human Metabolome Database (HMDB): Dehydroascorbic acid is the oxidized form of vitamin C. Reduced Vitamin C concentrations in the brain exceed those in blood by 10 fold. Dehydroascorbic acid readily enters the brain and is retained in the brain tissue in the form of ascorbic acid (ascorbic acid is not able to cross the blood-brain barrier). Therefore, transport of dehydroascorbic acid by the Glucose Transporter 1 (GLUT1, Glucose transporters are integral membrane glycoproteins involved in transporting glucose into most cells. GLUT1 is a major glucose transporter in the mammalian blood-brain barrier. It is present at high levels in primate erythrocytes and brain endothelial cells.) is a mechanism by which the brain acquires vitamin C. (OMIM 138140).",,dehydroascorbide(1-),,HMDB01264,"InChI=1S/C6H6O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-8H,1H2",C00425,2016-12-05T15:48:04Z,,463,,,,,5780,dhdascb,,"1-Dehydroascorbate, 1-Dehydroascorbic acid, Dehydro-L-ascorbate, Dehydro-L-ascorbic acid, Dehydroascorbate, DHAA, L-Dehydroascorbate, L-Dehydroascorbic acid, L-Threo-2,3-Hexodiulosonic acid gamma-lactone, L-Threo-hexo-2,3-diulosono-1,4-lactone, Oxidized ascorbate, Oxidized ascorbic acid, Oxidized vitamin C",http://vmh.uni.lu/_api/metabolites/463/?format=pcsv
Asn_X_Ser_Thr,,,0,XH,,,protein-linked asparagine residue (N-glycosylation site),,protein-linked asparagine residue (N-glycosylation site),,,,,2016-11-22T15:11:51Z,,464,,,,,,Asn_X_Ser_Thr,,,http://vmh.uni.lu/_api/metabolites/464/?format=pcsv
cbp,,,-2,CH2NO5P,CHEBI:17672,,Carbamoyl phosphate,,Carbamoyl phosphate,,,"InChI=1S/CH4NO5P/c2-1(3)7-8(4,5)6/h(H2,2,3)(H2,4,5,6)/p-2",C00169,2016-11-22T15:11:51Z,,465,,,,,278,cbp,,,http://vmh.uni.lu/_api/metabolites/465/?format=pcsv
cbasp,,,-2,C5H6N2O5,CHEBI:15859,,N-Carbamoyl-L-aspartate,,N-Carbamoyl-L-aspartate,,,"InChI=1S/C5H8N2O5/c6-5(12)7-2(4(10)11)1-3(8)9/h2H,1H2,(H,8,9)(H,10,11)(H3,6,7,12)/p-2/t2-/m0/s1",C00438,2016-11-22T15:11:51Z,,466,,,,,93072,cbasp,,,http://vmh.uni.lu/_api/metabolites/466/?format=pcsv
asp_D,,,-1,C4H6NO4,CHEBI:17364,,D-aspartate(1-),,D-aspartate(1-),,,"InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/p-1/t2-/m1/s1",C00402,2016-11-22T15:11:51Z,,467,,,,,83887,asp_D,,,http://vmh.uni.lu/_api/metabolites/467/?format=pcsv
k,,,1,K,CHEBI:29103,,"Human Metabolome Database (HMDB): Potassium is an essential electrolyte. Potassium balance is crucial for regulating the excitability of nerves and muscles and so critical for regulating contractility of cardiac muscle. Although the most important changes seen in the presence of deranged potassium are cardiac, smooth muscle is also affected with increasing muscle weakness, a feature of both hyperkalaemia and hypokalaemia. Physiologically, it exists as an ion in the body. Potassium (K+) is a positively charged electrolyte, cation, which is present throughout the body in both intracellular and extracellular fluids. The majority of body potassium, >90%, are intracellular. It moves freely from intracellular fluid (ICF) to extracellular fluid (ECF) and vice versa when adenosine triphosphate increases the permeability of the cell membrane. It is mainly replaced inside or outside the cells by another cation, sodium (Na+). The movement of potassium into or out of the cells is linked to certain body hormones and also to certain physiological states. Standard laboratory tests measure ECF potassium. Potassium enters the body rapidly during food ingestion. Insulin is produced when a meal is eaten; this causes the temporary movement of potassium from ECF to ICF. Over the ensuing hours, the kidneys excrete the ingested potassium and homeostasis is returned. In the critically ill patient, suffering from hyperkalaemia, this mechanism can be manipulated beneficially by administering high concentration (50%) intravenous glucose. Insulin can be added to the glucose, but glucose alone will stimulate insulin production and cause movement of potassium from ECF to ICF. The stimulation of alpha receptors causes increased movement of potassium from ICF to ECF. A noradrenaline infusion can elevate serum potassium levels. An adrenaline infusion, or elevated adrenaline levels, can lower serum potassium levels. Metabolic acidosis causes a rise in extracellular potassium levels. In this situation, excess of hydrogen ions (H+) are exchanged for intracellular potassium ions, probably as a result of the cellular response to a falling blood pH. Metabolic alkalosis causes the opposite effect, with potassium moving into the cells. (PMID: 17883675).",,potassium,,HMDB00586,InChI=1S/K/q+1,C00238,2016-12-05T15:48:04Z,,468,,,,K+,813,k,,"K+, Kalium, Potassium, Potassium (ion), Potassium (K+), Potassium cation, Potassium ion, Potassium ion (K+), Potassium ion (K1+), Potassium ion(+), Potassium ion(1+), Potassium monocation, Potassium(+), Potassium(1+), Potassium(1+) ion, Potassium(I) cation",http://vmh.uni.lu/_api/metabolites/468/?format=pcsv
Nacasp,,,-2,C6H7NO5,CHEBI:16953,,"Human Metabolome Database (HMDB): N-Acetylaspartic acid is a derivative of aspartic acid. It is the second most concentrated molecule in the brain after the amino acid glutamate. It is synthesized in neurons from the amino acid aspartate and acetyl coenzyme A. The various functions served by N-acetylaspartic acid are still under investigation, but the primary proposed functions include:. 1) A neuronal osmolyte that is involved in fluid balance in the brain 2) A source of acetate for lipid and myelin synthesis in oligodendrocytes, the glial cells that myelinate neuronal axons 3) A precursor for the synthesis of the important neuronal dipeptide N-acetylaspartylglutamate 4)N-Acetylaspartic acid may also be involved in energy production from the amino acid glutamate in neuronal mitochondria.",,N-acetyl-L-aspartate(2-),,HMDB00812,"InChI=1S/C6H9NO5/c1-3(8)7-4(6(11)12)2-5(9)10/h4H,2H2,1H3,(H,7,8)(H,9,10)(H,11,12)/p-2/t4-/m0/s1",C01042,2016-12-05T15:48:04Z,,469,,,,,65065,Nacasp,,"(2S)-2-acetamidobutanedioate, (2S)-2-acetamidobutanedioic acid, (S)-2-(acetylamino)butanedioate, (S)-2-(acetylamino)butanedioic acid, (S)-2-(acetylamino)succinic acid, Acetyl-L-aspartate, Acetyl-L-aspartic acid, Acetylaspartate, Acetylaspartic acid, L-N-Acetylaspartate, L-N-Acetylaspartic acid, N-Acetyl-L-aspartate, N-Acetyl-L-aspartic acid, N-Acetyl-S-aspartate, N-Acetyl-S-aspartic acid, N-Acetylaspartate, N-Acetylaspartic acid, NAA",http://vmh.uni.lu/_api/metabolites/469/?format=pcsv
avite1,,,0,C29H50O2,CHEBI:18145,,"Human Metabolome Database (HMDB): Alpha-tocopherol is traditionally recognized as the most active form of vitamin E in humans, and is a powerful biological antioxidant. The measurement of ""vitamin E"" activity in international units (IU) was based on fertility enhancement by the prevention of spontaneous abortions in pregnant rats relative to alpha tocopherol. Natural vitamin E exists in eight different forms or isomers, four tocopherols and four tocotrienols. In foods, the most abundant sources of vitamin E are vegetable oils such as palm oil, sunflower, corn, soybean and olive oil. Nuts, sunflower seeds, and wheat germ are also good sources. --Wikipedia.",,(+)-alpha-tocopherol,,HMDB01893,"InChI=1S/C29H50O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h20-22,30H,9-19H2,1-8H3/t21-,22-,29-/m1/s1",C02477,2016-12-05T15:48:04Z,,470,,,,,14985,avite1,,"(+)-a-Tocopherol, (+)-alpha-Tocopherol, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol, (2R,4'R,8'R)-a-Tocopherol, (2R,4'R,8'R)-alpha-Tocopherol, (R,R,R)-a-Tocopherol, (R,R,R)-alpha-Tocopherol, 5,7,8-Trimethyltocol, a-D-Tocopherol, a-Tocopherol, alpha-delta-Tocopherol, alpha-Tocopherol, D-alpha-Tocopherol, delta-alpha-Tocopherol, Denamone, Eprolin, Phytogermin, Phytogermine, RRR-alpha-tocopherol, RRR-alpha-tocopheryl, Vitamin E, Vitamin Ea",http://vmh.uni.lu/_api/metabolites/470/?format=pcsv
avite2,,,0,C29H44O2,CHEBI:33270,,"Human Metabolome Database (HMDB): Alpha-Tocotrienol is found in the blood plasma and all lipoprotein subfractions. Compared to tocopherols, alpha-tocotrienols are poorly studied. Its presence in the blood plasma at nanomolar concentrations is thought to help to prevent stroke-related neurodegeneration. (PMID: 16771695 ). alpha-tocotrienol has been found to have vitamin E activity.",,alpha-tocotrienol,,HMDB06327,"InChI=1S/C29H44O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h12,14,16,30H,9-11,13,15,17-19H2,1-8H3/b21-14+,22-16+/t29-/m1/s1",C14153,2016-12-05T15:48:04Z,,471,,,,,5282347,avite2,,"(2R,3'E,7'E)-alpha-Tocotrienol, (R)-alpha-tocotrienol, alpha-Tocotrienol, D-alpha-Tocotrienol, delta-alpha-Tocotrienol, Zeta1-tocopherol",http://vmh.uni.lu/_api/metabolites/471/?format=pcsv
gbside_hs,,,0,C44H79N2O22FULLRCO,CHEBI:18259,,globoside,,globoside,,,,,2016-11-22T15:11:51Z,,472,,,,,,gbside_hs,,,http://vmh.uni.lu/_api/metabolites/472/?format=pcsv
ga2_hs,,,0,C38H69N2O17FULLRCO,CHEBI:27731,,GA2,,GA2,,,,,2016-11-22T15:11:51Z,,473,,,,,,ga2_hs,,,http://vmh.uni.lu/_api/metabolites/473/?format=pcsv
ga1_hs,,,0,C44H79N2O22FULLRCO,,,gibberellin A1(1-),,gibberellin A1(1-),,,,,2016-11-22T15:11:51Z,,474,,,,,,ga1_hs,,,http://vmh.uni.lu/_api/metabolites/474/?format=pcsv
gm2_hs,,,-1,C49H85N3O25FULLRCO,CHEBI:51013,,"Human Metabolome Database (HMDB): Ganglioside GM2 (d18:1/12:0) is a glycosphingolipid (ceramide and oligosaccharide)or oligoglycosylceramide with one or more sialic acids (i.e. n-acetylneuraminic acid) linked on the sugar chain. It is a component the cell plasma membrane which modulates cell signal transduction events. Gangliosides have been found to be highly important in immunology. Ganglioside GM2 carries a net-negative charge at pH 7.0 and is acidic. Gangliosides can amount to 6% of the weight of lipids from brain, but they are found at low levels in all animal tissues. G(M2) Ganglioside accumulates due to a deficiency of hexosaminidase A or B (beta-N-acetylhexosaminidase), or GM2 activator protein, resulting in Gangliosidoses. Gangliosidoses include heredity metabolic disorders that include Tay-Sachs disease and Sandhoff disease. Gangliosides GM2 is especially common in the nervous tissue of the brain. In the United States, about 1 in 27 to 1 in 30 Ashkenazi Jews is a recessive carrier. French Canadians and the Cajun community of Louisiana have an occurrence similar to the Ashkenazi Jews.Gangliosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Gangliosides are very similar to globosides except that they also contain N-acetyl neuraminic acid (NANA) in varying amounts. The specific names for the gangliosides provide information about their structure. The letter G refers to ganglioside, and the subscripts M, D, T and Q indicate that the molecule contains mono-, di-, tri and quatra-sialic acid. The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide. In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands for GalGlc-ceramide. Deficiencies in lysosomal enzymes that degrade the carbohydrate portions of various gangliosides are responsible for a number of lysosomal storage diseases such as Tay-Sachs disease, Sandhoff disease, and GM1 gangliosidosis. The carbohydrate portion of the ganglioside GM1 is the site of attachment of cholera toxin, the protein secreted by Vibrio cholerae.",,N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-acetylneuraminosyl-(2->3)]-beta-D-galactosyl-beta-D-glucosyl-(1<->1)-ceramide anion,,HMDB04936,,,2016-12-05T15:48:04Z,,475,,,,,,gm2_hs,,"GalNAc-beta1->4(Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer, Ganglioside GM2, II3NeuAcGgOse3Cer, N-Acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine, N-Acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide, N-Acetyl-delta-galactosaminyl-(N-acetylneuraminyl)-delta-galactosyl-1,4-beta-delta-glucosyl-N-acylsphingosine, N-Acetyl-delta-galactosaminyl-(N-acetylneuraminyl)-delta-galactosyl-delta-glucosylceramide, N-Acetyl-Ganglioside GM2, N-Acetylganglioside GM2, NeuAc-GM2, Tay-Sachs ganglioside",http://vmh.uni.lu/_api/metabolites/475/?format=pcsv
gm1_hs,,,-1,C55H95N3O30FULLRCO,CHEBI:18216,,ganglioside GM1,,ganglioside GM1,,HMDB00117,,,2016-11-22T15:11:51Z,,476,,,,,,gm1_hs,,,http://vmh.uni.lu/_api/metabolites/476/?format=pcsv
gd2_hs,,,-2,C60H101N4O33FULLRCO,CHEBI:28648,,GD2,,GD2,,,,,2016-11-22T15:11:51Z,,477,,,,,,gd2_hs,,,http://vmh.uni.lu/_api/metabolites/477/?format=pcsv
gd1b_hs,,,-2,C66H111N4O38FULLRCO,CHEBI:28175,,GD1b,,GD1b,,,,,2016-11-22T15:11:51Z,,478,,,,,,gd1b_hs,,,http://vmh.uni.lu/_api/metabolites/478/?format=pcsv
gt2_hs,,,-3,C71H117N5O41FULLRCO,,,GT2,,GT2,,,,,2016-11-22T15:11:51Z,,479,,,,,,gt2_hs,,,http://vmh.uni.lu/_api/metabolites/479/?format=pcsv
gt1c_hs,,,-3,C77H127N5O46FULLRCO,,,GT1c,,GT1c,,,,,2016-11-22T15:11:51Z,,480,,,,,,gt1c_hs,,,http://vmh.uni.lu/_api/metabolites/480/?format=pcsv
galgbside_hs,,,0,C50H89N2O27FULLRCO,,,galactosylgloboside,,galactosylgloboside,,,,,2016-11-22T15:11:51Z,,481,,,,,,galgbside_hs,,,http://vmh.uni.lu/_api/metabolites/481/?format=pcsv
acglcgalgluside_hs,,,0,C38H69N2O17FULLRCO,CHEBI:17103,,N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide,,N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide,,,,,2016-11-22T15:11:51Z,,482,,,,,,acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/482/?format=pcsv
galacglcgalgluside_hs,,,0,C44H79N2O22FULLRCO,CHEBI:17292,,Lc4Cer,,Lc4Cer,,,,,2016-11-22T15:11:52Z,,483,,,,,,galacglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/483/?format=pcsv
gal14acglcgalgluside_hs,,,0,C44H79N2O22FULLRCO,,,Lactoneotetraosylceramide,,Lactoneotetraosylceramide,,,,,2016-11-22T15:11:52Z,,484,,,,,,gal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/484/?format=pcsv
acglcgal14acglcgalgluside_hs,,,0,C52H92N3O27FULLRCO,CHEBI:16297,,nLc5Cer,,nLc5Cer,,,,,2016-11-22T15:11:52Z,,485,,,,,,acglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/485/?format=pcsv
galacglcgal14acglcgalgluside_hs,,,0,C58H102N3O32FULLRCO,,,i-antigen,,i-antigen,,,,,2016-11-22T15:11:52Z,,486,,,,,,galacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/486/?format=pcsv
acglc13galacglcgal14acglcgalgluside_hs,,,0,C66H115N4O37FULLRCO,,,nLc7Cer,,nLc7Cer,,,,,2016-11-22T15:11:52Z,,487,,,,,,acglc13galacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/487/?format=pcsv
galacgalfuc12gal14acglcgalgluside_hs,,,0,C64H112N3O36FULLRCO,,,(Gal)3 (GalNAc)1 (Glc)1 (GlcNAc)1 (LFuc)1 (Cer)1,,(Gal)3 (GalNAc)1 (Glc)1 (GlcNAc)1 (LFuc)1 (Cer)1,,,,,2016-11-22T15:11:52Z,,488,,,,,,galacgalfuc12gal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/488/?format=pcsv
galacgalfucgalacglcgal14acglcgalgluside_hs,,,0,C78H135N4O46FULLRCO,,,(Gal)4 (GalNAc)1 (Glc)1 (GlcNAc)2 (LFuc)1 (Cer)1,,(Gal)4 (GalNAc)1 (Glc)1 (GlcNAc)2 (LFuc)1 (Cer)1,,,,,2016-11-22T15:11:52Z,,489,,,,,,galacgalfucgalacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/489/?format=pcsv
acglcgalacglcgal14acglcgalgluside_hs,,,0,C66H115N4O37FULLRCO,,,(Gal)3 (Glc)1 (GlcNAc)3 (Cer)1,,(Gal)3 (Glc)1 (GlcNAc)3 (Cer)1,,,,,2016-11-22T15:11:52Z,,490,,,,,,acglcgalacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/490/?format=pcsv
galacglcgalacglcgal14acglcgalgluside_hs,,,0,C72H125N4O42FULLRCO,,,I-antigen,,I-antigen,,,,,2016-11-22T15:11:52Z,,491,,,,,,galacglcgalacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/491/?format=pcsv
galacglc13galacglcgal14acglcgalgluside_hs,,,0,C72H125N4O42FULLRCO,,,nLc8Cer,,nLc8Cer,,,,,2016-11-22T15:11:52Z,,492,,,,,,galacglc13galacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/492/?format=pcsv
galthcrm_hs,,,0,C42H76NO22FULLRCO,,,Gal-Gal-Gal-Glc-Cer,,Gal-Gal-Gal-Glc-Cer,,,,,2016-11-22T15:11:52Z,,493,,,,,,galthcrm_hs,,,http://vmh.uni.lu/_api/metabolites/493/?format=pcsv
galgalthcrm_hs,,,0,C48H86NO27FULLRCO,,,Gal-Gal-Gal-Gal-Glc-Cer,,Gal-Gal-Gal-Gal-Glc-Cer,,,,,2016-11-22T15:11:52Z,,494,,,,,,galgalthcrm_hs,,,http://vmh.uni.lu/_api/metabolites/494/?format=pcsv
galgalgalthcrm_hs,,,0,C54H96NO32FULLRCO,,,Gal-Gal-Gal-Gal-Gal-Glc-Cer,,Gal-Gal-Gal-Gal-Gal-Glc-Cer,,,,,2016-11-22T15:11:52Z,,495,,,,,,galgalgalthcrm_hs,,,http://vmh.uni.lu/_api/metabolites/495/?format=pcsv
acglcgalgbside_hs,,,0,C58H102N3O32FULLRCO,,,GlcNAc-Gal globoside,,GlcNAc-Gal globoside,,,,,2016-11-22T15:11:52Z,,496,,,,,,acglcgalgbside_hs,,,http://vmh.uni.lu/_api/metabolites/496/?format=pcsv
galacglcgalgbside_hs,,,0,C64H112N3O37FULLRCO,,,Gal-GlcNAc-Gal globoside,,Gal-GlcNAc-Gal globoside,,,,,2016-11-22T15:11:52Z,,497,,,,,,galacglcgalgbside_hs,,,http://vmh.uni.lu/_api/metabolites/497/?format=pcsv
gm2a_hs,,,-1,C49H85N3O25FULLRCO,,,GM2alpha,,GM2alpha,,,,,2016-11-22T15:11:52Z,,498,,,,,,gm2a_hs,,,http://vmh.uni.lu/_api/metabolites/498/?format=pcsv
gm1a_hs,,,-1,C55H95N3O30FULLRCO,,,GM1alpha,,GM1alpha,,,,,2016-11-22T15:11:52Z,,499,,,,,,gm1a_hs,,,http://vmh.uni.lu/_api/metabolites/499/?format=pcsv
gluside_hs,,,0,C24H46NO7FULLRCO,,,D-glucosyl-N-acylsphingosine,,D-glucosyl-N-acylsphingosine,,,,,2016-11-22T15:11:52Z,,500,,,,,,gluside_hs,,,http://vmh.uni.lu/_api/metabolites/500/?format=pcsv
cholcoa,,,-4,C45H70N7O20P3S,CHEBI:15519,,Human Metabolome Database (HMDB): Choloyl-CoA is an intermediate metabolite in the Bile acid biosynthesis (KEGG). The conjugation of bile acids to glycine and taurine for excretion into bile occurs via a reaction catalyzed by the enzyme Bile acid-CoA:amino acid N-acyltransferase (BACAT) catalyzes.,,choloyl-CoA(4-),,HMDB01374,"InChI=1S/C45H74N7O20P3S/c1-23(26-7-8-27-34-28(18-31(55)45(26,27)5)44(4)12-10-25(53)16-24(44)17-29(34)54)6-9-33(57)76-15-14-47-32(56)11-13-48-41(60)38(59)43(2,3)20-69-75(66,67)72-74(64,65)68-19-30-37(71-73(61,62)63)36(58)42(70-30)52-22-51-35-39(46)49-21-50-40(35)52/h21-31,34,36-38,42,53-55,58-59H,6-20H2,1-5H3,(H,47,56)(H,48,60)(H,64,65)(H,66,67)(H2,46,49,50)(H2,61,62,63)/p-4/t23-,24+,25-,26-,27+,28+,29-,30-,31+,34+,36-,37-,38+,42-,44+,45-/m1/s1",C01794,2016-12-05T15:48:04Z,,501,,,,,439573,cholcoa,,"7-alpha-12-alpha-Dihydroxy-3-oxo-5-beta-cholyl-Coa, Choloyl-CoA, Choloyl-Coenzyme A, Cholyl-CoA, Cholyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/501/?format=pcsv
gchola,,,0,C26H43NO6,CHEBI:17687,,"Human Metabolome Database (HMDB): Glycocholic acid is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895 ). More specifically, glycocholic acid or cholylglycine, is a crystalline bile acid involved in the emulsification of fats. It occurs as a sodium salt in the bile of mammals. Its anion is called glycocholate. As the glycine conjugate of cholic acid, this compound acts as a detergent to solubilize fats for absorption and is itself absorbed. (PubChem). Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487 , 16037564 , 12576301 , 11907135 ).",,glycocholate,,HMDB00138,"InChI=1S/C26H43NO6/c1-14(4-7-22(31)27-13-23(32)33)17-5-6-18-24-19(12-21(30)26(17,18)3)25(2)9-8-16(28)10-15(25)11-20(24)29/h14-21,24,28-30H,4-13H2,1-3H3,(H,27,31)(H,32,33)/t14-,15+,16-,17-,18+,19+,20-,21+,24+,25+,26-/m1/s1",C01921,2016-12-05T15:48:04Z,,502,,,,,10140,gchola,,"3a,7a,12a-Trihydroxy-5b-cholan-24-oylglycine, 3a,7a,12a-Trihydroxy-5b-cholanic acid-24-glycine, 3a,7a,12a-Trihydroxy-N-(carboxymethyl)-5b-cholan-24-amide, Cholylglycine, Glycine cholate, Glycocholate, Glycocholic acid, Glycoreductodehydrocholic acid, Glycylcholate, Glycylcholic acid, N-(Carboxymethyl)-3a,7a,12a-trihydroxy-5b-Cholan-24-amide, N-Choloyl-Glycine, N-Choloylglycine",http://vmh.uni.lu/_api/metabolites/502/?format=pcsv
taur,,,0,C2H7NO3S,CHEBI:15891,,"Human Metabolome Database (HMDB): Taurine is a sulfur amino acid like methionine, cystine, cysteine and homocysteine. It is a lesser-known amino acid because it is not incorporated into the structural building blocks of protein. Yet taurine is an essential amino acid in pre-term and newborn infants of humans and many other species. Adults can synthesize their own taurine, yet are probably dependent in part on dietary taurine. Taurine is abundant in the brain, heart, breast, gallbladder and kidney and has important roles in health and disease in these organs. Taurine has many diverse biological functions serving as a neurotransmitter in the brain, a stabilizer of cell membranes and a facilitator in the transport of ions such as sodium, potassium, calcium and magnesium. Taurine is highly concentrated in animal and fish protein, which are good sources of dietary taurine. It can be synthesized by the body from cysteine when vitamin B6 is present. Deficiency of taurine occurs in premature infants and neonates fed formula milk, and in various disease states. Inborn errors of taurine metabolism have been described. OMIM 168605, an unusual neuropsychiatric disorder inherited in an autosomal dominant fashion through 3 generations of a family. Symptoms began late in the fifth decade in 6 affected persons and death occurred after 4 to 6 years. The earliest and most prominent symptom was mental depression not responsive to antidepressant drugs or electroconvulsive therapy. Sleep disturbances, exhaustion and marked weight loss were features. Parkinsonism developed later, and respiratory failure occurred terminally. OMIM 145350 describes congestive cardiomyopathy and markedly elevated urinary taurine levels (about 5 times normal). Other family members had late or holosystolic mitral valve prolapse and elevated urinary taurine values (about 2.5 times normal). In 2 with mitral valve prolapse, congestive cardiomyopathy eventually developed while the amounts of urinary taurine doubled. Taurine, after GABA, is the second most important inhibitory neurotransmitter in the brain. Its inhibitory effect is one source of taurine's anticonvulsant and antianxiety properties. It also lowers glutamic acid in the brain, and preliminary clinical trials suggest taurine may be useful in some forms of epilepsy. Taurine in the brain is usually associated with zinc or manganese. The amino acids alanine and glutamic acid, as well as pantothenic acid, inhibit taurine metabolism while vitamins A and B6, zinc and manganese help build taurine. Cysteine and B6 are the nutrients most directly involved in taurine synthesis. Taurine levels have been found to decrease significantly in many depressed patients. One reason that the findings are not entirely clear is because taurine is often elevated in the blood of epileptics who need it. It is often difficult to distinguish compensatory changes in human biochemistry from true metabolic or deficiency disease. Low levels of taurine are found in retinitis pigmentosa. Taurine deficiency in experimental animals produces degeneration of light-sensitive cells. Therapeutic applications of taurine to eye disease are likely to be forthcoming. Taurine has many important metabolic roles. Supplements can stimulate prolactin and insulin release. The parathyroid gland makes a peptide hormone called glutataurine (glutamic acid-taurine), which further demonstrates taurine's role in endocrinology. Taurine increases bilirubin and cholesterol excretion in bile, critical to normal gallbladder function. It seems to inhibit the effect of morphine and potentiates the effects of opiate antagonists. Low plasma taurine levels have been found in a variety of conditions, i.e., depression, hypertension, hypothyroidism, gout, institutionalized patients, infertility, obesity, kidney failure and others. (http://www.dcnutrition.com/AminoAcids/).",,Taurine,,HMDB00251,"InChI=1S/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6)",C00245,2016-12-05T15:48:04Z,,503,,,,,1123,taur,,"1-Aminoethane-2-sulfonate, 1-Aminoethane-2-sulfonic acid, 2-Aminoethanesulfonate, 2-Aminoethanesulfonic acid, 2-Aminoethylsulfonate, 2-Aminoethylsulfonic acid, 2-Sulfoethylamine, Aminoethylsulfonate, Aminoethylsulfonic acid, b-Aminoethylsulfonate, b-Aminoethylsulfonic acid, beta-Aminoethylsulfonate, beta-Aminoethylsulfonic acid, Taurine",http://vmh.uni.lu/_api/metabolites/503/?format=pcsv
tchola,,,0,C26H45NO7S,CHEBI:28865,,taurocholate,,taurocholate,,,"InChI=1S/C26H45NO7S/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34)/t15-,16+,17-,18-,19+,20+,21-,22+,24+,25+,26-/m1/s1",,2016-11-22T15:11:52Z,,504,,,,,440567,tchola,,,http://vmh.uni.lu/_api/metabolites/504/?format=pcsv
dgcholcoa,,,-4,C45H70N7O19P3S,,,Chenodeoxyglycocholoyl-CoA,,Chenodeoxyglycocholoyl-CoA,,,"InChI=1/C45H74N7O19P3S/c1-24(27-7-8-28-34-29(11-14-45(27,28)5)44(4)13-10-26(53)18-25(44)19-30(34)54)6-9-33(56)75-17-16-47-32(55)12-15-48-41(59)38(58)43(2,3)21-68-74(65,66)71-73(63,64)67-20-31-37(70-72(60,61)62)36(57)42(69-31)52-23-51-35-39(46)49-22-50-40(35)52/h22-31,34,36-38,42,53-54,57-58H,6-21H2,1-5H3,(H,47,55)(H,48,59)(H,63,64)(H,65,66)(H2,46,49,50)(H2,60,61,62)/t24?,25-,26+,27?,28?,29?,30+,31+,34?,36+,37+,38?,42+,44-,45+/m0/s1",C05461,2016-11-22T15:11:52Z,,505,,,,,440685,dgcholcoa,,,http://vmh.uni.lu/_api/metabolites/505/?format=pcsv
dgchol,,,0,C26H43NO5,CHEBI:36274,,"Human Metabolome Database (HMDB): Chenodeoxycholic acid glycine conjugate is an acyl glycine and a bile acid-glycine conugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). This compound usually exists as the sodium salt and acts as a detergent to solubilize fats for absorption and is itself absorbed. It is a cholagogue and choleretic.",,glycochenodeoxycholate,,HMDB00637,"InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21-,24+,25+,26-/m1/s1",C05466,2016-12-05T15:48:04Z,,506,,,,,,dgchol,,"(23R)-Hydroxychenodeoxycholylglycine, 12-Deoxycholylglycine, 12-Desoxycholylglycine, 3a,7a-Dihydroxy-N-(carboxymethyl)-5b-cholan-24-amide, Chenodeoxycholic acid glycine conjugate, Chenodeoxycholylglycine, Glycine chenodeoxycholate, Glycochenodeoxycholate, Glycochenodeoxycholic acid, Glycylchenodeoxycholate, Glycylchenodeoxycholic acid, N-(3a,7a-Dihydroxy-5b-cholan-24-oyl)-Glycine, N-(Carboxymethyl)-3a,7a-dihydroxy-5b-Cholan-24-amide",http://vmh.uni.lu/_api/metabolites/506/?format=pcsv
dcholcoa,,,-4,C45H70N7O19P3S,CHEBI:28701,,chenodeoxycholoyl coenzyme a,,chenodeoxycholoyl coenzyme a,,HMDB02325,"InChI=1S/C45H74N7O19P3S/c1-24(27-7-8-28-34-29(11-14-45(27,28)5)44(4)13-10-26(53)18-25(44)19-30(34)54)6-9-33(56)75-17-16-47-32(55)12-15-48-41(59)38(58)43(2,3)21-68-74(65,66)71-73(63,64)67-20-31-37(70-72(60,61)62)36(57)42(69-31)52-23-51-35-39(46)49-22-50-40(35)52/h22-31,34,36-38,42,53-54,57-58H,6-21H2,1-5H3,(H,47,55)(H,48,59)(H,63,64)(H,65,66)(H2,46,49,50)(H2,60,61,62)/p-4/t24-,25+,26-,27-,28+,29+,30-,31-,34+,36-,37-,38+,42-,44+,45-/m1/s1",C05337,2016-11-22T15:11:52Z,,507,,,,,11953854,dcholcoa,,,http://vmh.uni.lu/_api/metabolites/507/?format=pcsv
btn,,,-1,C10H15N2O3S,CHEBI:15956,,"Human Metabolome Database (HMDB): Biotin is an enzyme co-factor present in minute amounts in every living cell. Biotin is also known as vitamin H or B7 or coenzyme R. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk. Biotin has been recognized as an essential nutrient. Our biotin requirement is fulfilled in part through diet, through endogenous reutilization of biotin and perhaps through capture of biotin generated in the intestinal flora. The utilization of biotin for covalent attachment to carboxylases and its reutilization through the release of carboxylase biotin after proteolytic degradation constitutes the 'biotin cycle'. Biotin deficiency is associated with neurological manifestations, skin rash, hair loss and metabolic disturbances that are thought to relate to the various carboxylase deficiencies (metabolic ketoacidosis with lactic acidosis). It has also been suggested that biotin deficiency is associated with protein malnutrition, and that marginal biotin deficiency in pregnant women may be teratogenic. Biotin acts as a carboxyl carrier in carboxylation reactions. There are four biotin-dependent carboxylases in mammals: those of propionyl-CoA (PCC), 3-methylcrotonyl-CoA (MCC), pyruvate (PC) and acetyl-CoA carboxylases (isoforms ACC-1 and ACC-2). All but ACC-2 are mitochondrial enzymes. The biotin moiety is covalently bound to the epsilon amino group of a Lysine residue in each of these carboxylases in a domain 60-80 amino acids long. The domain is structurally similar among carboxylases from bacteria to mammals. There are four biotin-dependent carboxylases in mammals: those of propionyl-CoA (PCC), 3-methylcrotonyl-CoA (MCC), pyruvate (PC) and acetyl-CoA carboxylases (isoforms ACC-1 and ACC-2). All but ACC-2 are mitochondrial enzymes. The biotin moiety is covalently bound to the epsilon amino group of a Lys residue in each of these carboxylases in a domain 60-80 amino acids long. The domain is structurally similar among carboxylases from bacteria to mammals. Evidence is emerging that biotin participates in processes other than classical carboxylation reactions. Specifically, novel roles for biotin in cell signaling, gene expression, and chromatin structure have been identified in recent years. Human cells accumulate biotin by using both the sodium-dependent multivitamin transporter and monocarboxylate transporter 1. These transporters and other biotin-binding proteins partition biotin to compartments involved in biotin signaling: cytoplasm, mitochondria, and nuclei. The activity of cell signals such as biotinyl-AMP, Sp1 and Sp3, nuclear factor (NF)-kappaB, and receptor tyrosine kinases depends on biotin supply. Consistent with a role for biotin and its catabolites in modulating these cell signals, greater than 2000 biotin-dependent genes have been identified in various human tissues. Many biotin-dependent gene products play roles in signal transduction and localize to the cell nucleus, consistent with a role for biotin in cell signaling. Posttranscriptional events related to ribosomal activity and protein folding may further contribute to effects of biotin on gene expression. Finally, research has shown that biotinidase and holocarboxylase synthetase mediate covalent binding of biotin to histones (DNA-binding proteins), affecting chromatin structure; at least seven biotinylation sites have been identified in human histones. Biotinylation of histones appears to play a role in cell proliferation, gene silencing, and the cellular response to DNA repair. Roles for biotin in cell signaling and chromatin structure are consistent with the notion that biotin has a unique significance in cell biology. (PMID: 15992684, 16011464).",,Biotin,,HMDB00030,"InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/p-1/t6-,7-,9-/m0/s1",C00120,2016-12-05T15:48:04Z,,508,,,,biotin,171548,btn,,"(+)-Biotin, (+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valerate, (+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid, (3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valerate, (3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid, -(+)-biotin, 1swk, 1swn, 1swr, 5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoate, 5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid, Biodermatin, Bioepiderm, Bios h, Bios II, Biotin, cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valerate, cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid, cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid, cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid, Coenzyme R, D(+)-Biotin, D-(+)-Biotin, D-Biotin, D-Biotin factor S, delta-(+)-Biotin, delta-Biotin, delta-Biotin factor S, Factor S, Factor S (vitamin), Hexahydro-2-oxo-1H-thieno(3,4-D)imidazole-4-pentanoate, Hexahydro-2-oxo-1H-thieno(3,4-D)imidazole-4-pentanoic acid, Hexahydro-2-oxo-[3aS-(3aa,4b,6aa)]-1H-Thieno[3,4-D]imidazole-4-pentanoate, Hexahydro-2-oxo-[3aS-(3aa,4b,6aa)]-1H-Thieno[3,4-D]imidazole-4-pentanoic acid, Hexahydro-2-oxo-[3as-(3alpha,4beta,6alpha)]-1H-Thieno[3,4-D]imidazole-4-pentanoate, Hexahydro-2-oxo-[3as-(3alpha,4beta,6alpha)]-1H-Thieno[3,4-D]imidazole-4-pentanoic acid, Lutavit H2, Meribin, Rovimix H 2, Vitamin B7, Vitamin H, Vitamin-h",http://vmh.uni.lu/_api/metabolites/508/?format=pcsv
btamp,,,-1,C20H27N7O9PS,CHEBI:3110,,Biotinyl-5'-AMP,,Biotinyl-5'-AMP,,,"InChI=1S/C20H28N7O9PS/c21-17-14-18(23-7-22-17)27(8-24-14)19-16(30)15(29)10(35-19)5-34-37(32,33)36-12(28)4-2-1-3-11-13-9(6-38-11)25-20(31)26-13/h7-11,13,15-16,19,29-30H,1-6H2,(H,32,33)(H2,21,22,23)(H2,25,26,31)/p-1/t9-,10+,11-,13-,15+,16+,19+/m0/s1",C05921,2016-11-22T15:11:52Z,,509,,,,,5326875,btamp,,,http://vmh.uni.lu/_api/metabolites/509/?format=pcsv
4tmeabutn,,,0,C7H15NO2,CHEBI:16244,,4-(trimethylammonio)butanoate,,4-(trimethylammonio)butanoate,,,"InChI=1S/C7H15NO2/c1-8(2,3)6-4-5-7(9)10/h4-6H2,1-3H3",C01181,2016-11-22T15:11:52Z,,510,,,,,,4tmeabutn,,,http://vmh.uni.lu/_api/metabolites/510/?format=pcsv
succ,,,-2,C4H4O4,CHEBI:15741,,"Human Metabolome Database (HMDB): Succinic acid is a dicarboxylic acid. The anion, succinate, is a component of the citric acid cycle capable of donating electrons to the electron transfer chain. Succinate dehydrogenase (SDH) plays an important role in the mitochondria, being both part of the respiratory chain and the Krebs cycle. SDH with a covalently attached FAD prosthetic group, binds enzyme substrates (succinate and fumarate) and physiological regulators (oxaloacetate and ATP). Oxidizing succinate links SDH to the fast-cycling Krebs cycle portion where it participates in the breakdown of acetyl-CoA throughout the whole Krebs cycle. The succinate can readily be imported into the mitochondrial matrix by the n-butylmalonate- (or phenylsuccinate-) sensitive dicarboxylate carrier in exchange with inorganic phosphate or another organic acid, e. g. malate. (PMID 16143825) Mutations in the four genes encoding the subunits of the mitochondrial respiratory chain succinate dehydrogenase are associated with a wide spectrum of clinical presentations (i.e.: Huntington's disease. (PMID 11803021).",,Succinate,,HMDB00254,"InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8)/p-2",C00042,2016-12-05T15:48:04Z,,511,,,,succinic acid,1110,succ,,"1,2-Ethanedicarboxylate, 1,2-Ethanedicarboxylic acid, 1,4-Butanedioate, 1,4-Butanedioic acid, Amber acid, Asuccin, Dihydrofumarate, Dihydrofumaric acid, Katasuccin, Succinate, Wormwood acid",http://vmh.uni.lu/_api/metabolites/511/?format=pcsv
caro,,,0,C40H56,,,beta-carotene,,beta-carotene,,,"InChI=1S/C40H56/c1-31(19-13-21-33(3)25-27-37-35(5)23-15-29-39(37,7)8)17-11-12-18-32(2)20-14-22-34(4)26-28-38-36(6)24-16-30-40(38,9)10/h11-14,17-22,25-28H,15-16,23-24,29-30H2,1-10H3/b12-11+,19-13+,20-14+,27-25+,28-26+,31-17+,32-18+,33-21+,34-22+",C02094,2016-11-22T15:11:52Z,,512,,,,,,caro,,,http://vmh.uni.lu/_api/metabolites/512/?format=pcsv
retinal,,,0,C20H28O,CHEBI:17898,,"Human Metabolome Database (HMDB): Retinal is a carotenoid constituent of visual pigments. It is the oxidized form of retinol which functions as the active component of the visual cycle. It is bound to the protein opsin forming the complex rhodopsin. When stimulated by visible light, the retinal component of the rhodopsin complex undergoes isomerization at the 11-position of the double bond to the cis-form; this is reversed in ""dark"" reactions to return to the native trans-configuration.",,retinal,,HMDB01358,"InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3",C00376,2016-12-05T15:48:04Z,,513,,,,,638015,retinal,,"3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-Nonatetraenal, All-E-Retinal, All-epsilon-Retinal, All-trans-Retinal, All-trans-Retinaldehyde, All-trans-retinene, All-trans-Vitamin A aldehyde, alpha-Retinene, Axerophthal, E-Retinal, epsilon-Retinal, Retinal, Retinaldehyde, Retinene, Retinene 1, trans-Retinal, trans-Vitamin A aldehyde, Vitamin A aldehyde, Vitamin A1 aldehyde",http://vmh.uni.lu/_api/metabolites/513/?format=pcsv
bdg2hc,,,0,C15H18O8,CHEBI:62223,,cis-beta-D-Glucosyl-2-hydroxycinnamate,,cis-beta-D-Glucosyl-2-hydroxycinnamate,,,"InChI=1/C15H18O8/c16-7-10-12(19)13(20)14(21)15(23-10)22-9-4-2-1-3-8(9)5-6-11(17)18/h1-6,10,12-16,19-21H,7H2,(H,17,18)/b6-5-/t10-,12-,13+,14-,15-/m1/s1",C05839,2016-11-22T15:11:52Z,,514,,,,,5316113,,,,http://vmh.uni.lu/_api/metabolites/514/?format=pcsv
2coum,,,-1,C9H7O3,CHEBI:47921,,cis-2-coumarate,,cis-2-coumarate,,,"InChI=1S/C9H8O3/c10-8-4-2-1-3-7(8)5-6-9(11)12/h1-6,10H,(H,11,12)/p-1/b6-5-",C05838,2016-11-22T15:11:52Z,,515,,,,,5280841,,,,http://vmh.uni.lu/_api/metabolites/515/?format=pcsv
bhb,,,-1,C4H7O3,CHEBI:10983,,"Human Metabolome Database (HMDB): (R)-3-Hydroxybutyric acid is a butyric acid substituted with a hydroxyl group in the beta or 3 position. 3-hydroxybutyric acid, or beta-hydroxybutyrate, is involved in the synthesis and degradation of ketone bodies. Like the other ketone bodies (acetoacetate and acetone), levels of beta-hydroxybutyrate are raised in the blood and urine in ketosis. Beta-hydroxybutyrate is a typical partial-degradation product of branched-chain amino acids (primarily valine) released from muscle for hepatic and renal gluconeogenesis This acid is metabolized by 3-hydroxybutyrate dehydrogenase (catalyzes the oxidation of D-3-hydroxybutyrate to form acetoacetate, using NAD+ as an electron acceptor). The enzyme functions in nervous tissues and muscles, enabling the use of circulating hydroxybutyrate as a fuel. In the liver mitochondrial matrix, the enzyme can also catalyze the reverse reaction, a step in ketogenesis. 3-Hydroxybutyric acid is a chiral compound having two enantiomers, D-3-hydroxybutyric acid and L-3-hydroxybutyric acid. In humans, beta-hydroxybutyrate is synthesized in the liver from acetyl-CoA, and can be used as an energy source by the brain when blood glucose is low. It can also be used for the synthesis of biodegradable plastics (Wikipedia).",,(R)-3-hydroxybutyrate,,HMDB00011,"InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/p-1/t3-/m1/s1",C01089,2016-12-05T15:48:04Z,,516,,,,(R)-3-hydroxybutyrate,,bhb,,"(R)-(-)-b-Hydroxybutyrate, (R)-(-)-b-Hydroxybutyric acid, (R)-(-)-beta-Hydroxybutyrate, (R)-(-)-beta-Hydroxybutyric acid, (R)-3-Hydroxybutanoate, (R)-3-Hydroxybutanoic acid, (R)-3-Hydroxybutyrate, 3-D-Hydroxybutyrate, 3-D-Hydroxybutyric acid, 3-delta-Hydroxybutyrate, 3-delta-Hydroxybutyric acid, BHIB, D-(-)-3-Hydroxybutyrate, D-3-Hydroxybutyrate, D-3-Hydroxybutyric acid, D-beta-Hydroxybutyrate, delta-(-)-3-Hydroxybutyrate, delta-3-Hydroxybutyrate, delta-3-Hydroxybutyric acid, delta-beta-Hydroxybutyrate",http://vmh.uni.lu/_api/metabolites/516/?format=pcsv
chito2pdol_L,,,-20,C1240H2028N20O170P20,,,"N,N'-Diacetylchitobiosyldiphosphodolichol, human liver homolog",,"N,N'-Diacetylchitobiosyldiphosphodolichol, human liver homolog",,,,,2016-11-22T15:11:52Z,,517,,,,,,chito2pdol_L,,,http://vmh.uni.lu/_api/metabolites/517/?format=pcsv
gdpmann,,,-2,C16H23N5O16P2,CHEBI:15820,,GDP-alpha-D-mannose(2-),,GDP-alpha-D-mannose(2-),,,"InChI=1S/C16H25N5O16P2/c17-16-19-12-6(13(28)20-16)18-3-21(12)14-10(26)8(24)5(34-14)2-33-38(29,30)37-39(31,32)36-15-11(27)9(25)7(23)4(1-22)35-15/h3-5,7-11,14-15,22-27H,1-2H2,(H,29,30)(H,31,32)(H3,17,19,20,28)/p-2/t4-,5-,7-,8-,9+,10-,11+,14-,15-/m1/s1",C00096,2016-11-22T15:11:52Z,,518,,,,,18396,gdpmann,,,http://vmh.uni.lu/_api/metabolites/518/?format=pcsv
mpdol_L,,,-20,C1300H2128N20O220P20,CHEBI:18396,,"beta-D-Mannosyldiacetylchitobiosyldiphosphodolichol, human liver homolog",,"beta-D-Mannosyldiacetylchitobiosyldiphosphodolichol, human liver homolog",,,,,2016-11-22T15:11:52Z,,519,,,,,,mpdol_L,,,http://vmh.uni.lu/_api/metabolites/519/?format=pcsv
chito2pdol_U,,,-20,C1185H1940N20O170P20,,,"N,N'-Diacetylchitobiosyldiphosphodolichol, human uterine homolog",,"N,N'-Diacetylchitobiosyldiphosphodolichol, human uterine homolog",,,,,2016-11-22T15:11:52Z,,520,,,,,,chito2pdol_U,,,http://vmh.uni.lu/_api/metabolites/520/?format=pcsv
mpdol_U,,,-20,C1245H2040N20O220P20,,,"beta-D-Mannosyldiacetylchitobiosyldiphosphodolichol, human uterine homolog",,"beta-D-Mannosyldiacetylchitobiosyldiphosphodolichol, human uterine homolog",,,,,2016-11-22T15:11:52Z,,521,,,,,,mpdol_U,,,http://vmh.uni.lu/_api/metabolites/521/?format=pcsv
betald,,,1,C5H12NO,CHEBI:15710,,betaine aldehyde,,betaine aldehyde,,,"InChI=1S/C5H12NO/c1-6(2,3)4-5-7/h5H,4H2,1-3H3/q+1",C00576,2016-11-22T15:11:52Z,,522,,,,,249,betald,,,http://vmh.uni.lu/_api/metabolites/522/?format=pcsv
glyb,,,0,C5H11NO2,CHEBI:17750,,"Human Metabolome Database (HMDB): Betaine, (or N,N,N-trimethylglycine) was named after its discovery in sugar beet (Beta vulgaris) in the 19th century. It is a small N-trimethylated amino acid, existing in zwitterionic form at neutral pH. It is now often called glycine betaine to distinguish it from other betaines that are widely distributed in microorganisms, plants and animals.  Many naturally occurring betaines serve as organic osmolytes, substances synthesized or taken up from the environment by cells for protection against osmotic stress, drought, high salinity or high temperature. Intracellular accumulation of betaines permits water retention in cells, thus protecting from the effects of dehydration (Wikipedia). Betaine functions as a methyl donor in that it carries and donates methyl functional groups to facilitate necessary chemical processes. In particular it methylates homocysteine to methionine, also producing N,N-dimethylglycine. The donation of methyl groups is important to proper liver function, cellular replication, and detoxification reactions. Betaine also plays a role in the manufacture of carnitine and serves to protect the kidneys from damage. Betaine comes from either the diet or by the oxidation of choline. Betaine insufficiency is associated with the metabolic syndrome, lipid disorders and diabetes, and may have a role in vascular and other diseases (PMID: 20346934). Betaine is important in development, from the pre-implantation embryo to infancy. Betaine is also widely regarded as an anti-oxidant.  Betaine has been shown to have an inhibitory effect on NO release in activated microglial cells and may be an effective therapeutic component to control neurological disorders (PMID: 22801281).  As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. (From Martindale, The Extra Pharmacopoeia, 30th Ed, p1341).



 ",,glycine betaine,,HMDB00043,"InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3",C00719,2016-12-05T15:48:04Z,,523,,,,,247,glyb,,"(Carboxymethyl)trimethylammonium hydroxide inner salt, (Trimethylammonio)acetate, 1-Carboxy-N,N,N-trimethyl-Methanaminium, 1-Carboxy-N,N,N-trimethyl-Methanaminium hydroxide, 1-Carboxy-N,N,N-trimethylmethanaminium inner salt, a-Earleine, Abromine, alpha-Earleine, Aminocoat, Betafin, Betafin BCR, Betafin BP, Betaine, Cystadane, Ektasolve EE, FinnStim, Glycine betaine, Glycocoll betaine, Glycylbetaine, Greenstim, Loramine AMB 13, Loramine AMB-13, Lycine, N,N,N-Trimethylglycine, Oxyneurine, Rubrine C, Trimethylaminoacetate, Trimethylaminoacetic acid, Trimethylbetaine Glycine, Trimethylglycine, Trimethylglycocoll",http://vmh.uni.lu/_api/metabolites/523/?format=pcsv
dmgly,,,0,C4H9NO2,CHEBI:17724,,"Human Metabolome Database (HMDB): Dimethylglycine (DMG) is an amino acid derivative found in the cells of all plants and animals and can be obtained in the diet in small amounts from grains and meat. The human body produces DMG when metabolizing choline into Glycine. Dimethylglycine that is not metabolized in the liver is transported by the circulatory system to body tissue. Dimethylglycine was popular with Russian athletes and cosmonauts owing to its reputed ability to increase endurance and reduce fatigue. DMG is also a byproduct of homocysteine metabolism. Homocysteine and betaine are converted to methionine and N, N-dimethylglycine by betaine-homocysteine methyltransferase.",,"N,N-dimethylglycine",,HMDB00092,"InChI=1S/C4H9NO2/c1-5(2)3-4(6)7/h3H2,1-2H3,(H,6,7)",C01026,2016-12-05T15:48:04Z,,524,,,,,673,dmgly,,"(Dimethylamino)acetate, (Dimethylamino)acetic acid, 2-(Dimethylamino)acetate, 2-(Dimethylamino)acetic acid, Dimethylglycine, N,N-Dimethylaminoacetate, N,N-Dimethylaminoacetic acid, N,N-Dimethylglycine, N-Methylsarcosine N,N-dimethyl-Glycine",http://vmh.uni.lu/_api/metabolites/524/?format=pcsv
met_L,,,0,C5H11NO2S,CHEBI:16643,,"Human Metabolome Database (HMDB): Methionine is a dietary indispensable amino acid required for normal growth and development of humans, other mammals, and avian species. In addition to being a substrate for protein synthesis, it is an intermediate in transmethylation reactions, serving as the major methyl group donor in vivo, including the methyl groups for DNA and RNA intermediates. Methionine is a methyl acceptor for 5-methyltetrahydrofolate-homocysteine methyl transferase (methionine synthase), the only reaction that allows for the recycling of this form of folate, and is also a methyl acceptor for the catabolism of betaine. Methionine is also required for synthesis of cysteine. Methionine is accepted as the metabolic precursor for cysteine. Only the sulfur atom from methionine is transferred to cysteine; the carbon skeleton of cysteine is donated by serine. (PMID 16702340). The adequacy range of dietary requirements of specific amino acids in disease states is difficult to determine. Requirements may not be similar in disease with regard to protein synthesis. Requirements for this purpose can be assessed only when such a function can be measured and related to clinical outcome. There is apparent consensus concerning normal sulfur amino acid (SAA) requirements. WHO recommendations amount to 13 mg/kg per 24 h in healthy adults. This amount is roughly doubled in artificial nutrition regimens. In disease or after trauma, requirements may be altered for methionine, cysteine, and taurine. Although in specific cases of congenital enzyme deficiency, prematurity, or diminished liver function, hypermethionemia or hyperhomocysteinemia may occur, SAA supplementation can be considered safe in amounts exceeding 2-3 times the minimal recommended daily intake. Apart from some very specific indications (e.g., acetaminophen poisoning) the usefulness of SAA supplementation is not yet established.(PMID 16702341). Methionine is known to exacerbate psychopathological symptoms in schizophrenic patients, there is no evidence of similar effects in healthy subjects. The role of methionine as a precursor of homocysteine is the most notable cause for concern. A ""loading dose"" of methionine (0.1 g/kg) has been given, and the resultant acute increase in plasma homocysteine has been used as an index of the susceptibility to cardiovascular disease. Although this procedure results in vascular dysfunction, this is acute and unlikely to result in permanent damage. However, a 10-fold larger dose, given mistakenly, resulted in death. Longer-term studies in adults have indicated no adverse consequences of moderate fluctuations in dietary methionine intake, but intakes higher than 5 times normal resulted in elevated homocysteine levels. These effects of methionine on homocysteine and vascular function are moderated by supplements of vitamins B-6, B-12, C, and folic acid. In infants, methionine intakes of 2 to 5 times normal resulted in impaired growth and extremely high plasma methionine levels, but no adverse long-term consequences were observed. (PMID 16702346).",,L-methionine,,HMDB00696,"InChI=1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1",C00073,2016-12-05T15:48:04Z,,525,,,,,6137,met_L,,"(2S)-2-amino-4-(methylsulfanyl)butanoate, (2S)-2-amino-4-(methylsulfanyl)butanoic acid, (L)-methionine, (S)-(+)-methionine, (S)-2-amino-4-(methylthio)-Butanoate, (S)-2-amino-4-(methylthio)-Butanoic acid, (S)-2-Amino-4-(methylthio)butanoate, (S)-2-Amino-4-(methylthio)butanoic acid, (S)-2-amino-4-(methylthio)butyric acid, (S)-methionine, 2-Amino-4-(methylthio)butyrate, 2-Amino-4-(methylthio)butyric acid, 2-Amino-4-methylthiobutanoate, 2-Amino-4-methylthiobutanoic acid, A-Amino-g-methylmercaptobutyrate, A-Amino-g-methylmercaptobutyric acid, Acimethin, alpha-Amino-alpha-aminobutyric acid, alpha-Amino-gamma-methylmercaptobutyrate, alpha-Amino-gamma-methylmercaptobutyric acid, Cymethion, G-Methylthio-a-aminobutyrate, G-Methylthio-a-aminobutyric acid, gamma-Methylthio-alpha-aminobutyrate, gamma-Methylthio-alpha-aminobutyric acid, H-Met-h, H-Met-oh, L(-)-Amino-alpha-amino-alpha-aminobutyric acid, L(-)-Amino-gamma-methylthiobutyric acid, L-(-)-Methionine, L-2-Amino-4-(methylthio)butyric acid, L-2-Amino-4-methylthiobutyric acid, L-a-Amino-g-methylthiobutyrate, L-a-Amino-g-methylthiobutyric acid, L-alpha-Amino-gamma-methylmercaptobutyric acid, L-alpha-Amino-gamma-methylthiobutyrate, L-alpha-Amino-gamma-methylthiobutyric acid, L-gamma-Methylthio-alpha-aminobutyric acid, L-Methionin, L-Methionine, L-Methioninum, Liquimeth, Mepron, MET, Methilanin, Methionine, Methioninum, Metionina, Neo-methidin, Poly-L-methionine, Polymethionine, S-Methionine, S-Methyl-L-homocysteine, Toxin WAR",http://vmh.uni.lu/_api/metabolites/525/?format=pcsv
bildglcur,,,-2,C45H50N4O18,CHEBI:18392,,bis(beta-glucosyluronate)bilirubin,,bis(beta-glucosyluronate)bilirubin,,,"InChI=1S/C45H52N4O18/c1-7-20-19(6)40(58)49-27(20)14-25-18(5)23(10-12-31(51)65-45-37(57)33(53)35(55)39(67-45)43(62)63)29(47-25)15-28-22(17(4)24(46-28)13-26-16(3)21(8-2)41(59)48-26)9-11-30(50)64-44-36(56)32(52)34(54)38(66-44)42(60)61/h7-8,13-14,32-39,44-47,52-57H,1-2,9-12,15H2,3-6H3,(H,48,59)(H,49,58)(H,60,61)(H,62,63)/p-2/b26-13+,27-14+/t32-,33-,34-,35-,36+,37+,38-,39-,44+,45+/m0/s1",C05787,2016-11-22T15:11:52Z,,526,,,,,,bildglcur,,,http://vmh.uni.lu/_api/metabolites/526/?format=pcsv
bilglcur,,,0,C39H44N4O12,CHEBI:16427,,mono(glucosyluronic acid)bilirubin(2-),,mono(glucosyluronic acid)bilirubin(2-),,,"InChI=1S/C39H44N4O12/c1-7-20-19(6)36(50)43-27(20)14-25-18(5)23(10-12-31(46)54-39-34(49)32(47)33(48)35(55-39)38(52)53)29(41-25)15-28-22(9-11-30(44)45)17(4)24(40-28)13-26-16(3)21(8-2)37(51)42-26/h7-8,13-14,32-35,39-41,47-49H,1-2,9-12,15H2,3-6H3,(H,42,51)(H,43,50)(H,44,45)(H,52,53)/b26-13+,27-14+/t32-,33-,34+,35-,39+/m0/s1",,2016-11-22T15:11:52Z,,527,,,,,,bilglcur,,,http://vmh.uni.lu/_api/metabolites/527/?format=pcsv
biliverd,,,-2,C33H32N4O6,CHEBI:17033,,biliverdin(2-),,biliverdin(2-),,,"InChI=1S/C33H34N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-15,35H,1-2,9-12H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/p-2/b26-13-,27-14-,28-15-",C00500,2016-11-22T15:11:52Z,,528,,,,,,biliverd,,,http://vmh.uni.lu/_api/metabolites/528/?format=pcsv
bilirub,,,-2,C33H34N4O6,CHEBI:16990,,"Human Metabolome Database (HMDB): Bilirubin is a bile pigment that is a degradation product of heme. In particular, bilirubin is a yellow breakdown product of normal heme catabolism. Its levels are elevated in certain diseases and it is responsible for the yellow color of bruises. Bilirubin is an excretion product, and the body does not control levels. Bilirubin levels reflect the balance between production and excretion. Thus, there is no ""normal"" level of bilirubin. Bilirubin consists of an open chain of four pyrroles (tetrapyrrole); by contrast, the heme molecule is a closed ring of four pyrroles, called porphyrin. -- Wikipedia.",,bilirubin(2-),,HMDB00054,"InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/p-2/b26-13-,27-14-",C00486,2016-12-05T15:48:04Z,,529,,,,,,bilirub,,"(4Z,15Z)-Bilirubin IXa, (Z,Z)-Bilirubin IXa, 1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionate, 1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionic acid, 2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoate, 2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoic acid, 3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate, 3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid, 3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene, 3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate, 3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid, 3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate, 3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid, Bilirubin, Bilirubin IX-alpha, Cholerythrin, Hematoidin",http://vmh.uni.lu/_api/metabolites/529/?format=pcsv
dolmanp_L,,,-10,C1140H1868O90P10,CHEBI:15809,,"Dolichyl phosphate D-mannose, human liver homolog",,"Dolichyl phosphate D-mannose, human liver homolog",,,,,2016-11-22T15:11:52Z,,530,,,,,,dolmanp_L,,,http://vmh.uni.lu/_api/metabolites/530/?format=pcsv
memgacpail_hs,,,0,C45H84N2O27P2FULLRCO2FULLR2CO2,,,"(mannosyl),(phosphoethanolaminyl)-mannosyl-glucosylaminyl-acylphosphatidylinositol (B)",,"(mannosyl),(phosphoethanolaminyl)-mannosyl-glucosylaminyl-acylphosphatidylinositol (B)",,,,,2016-11-22T15:11:52Z,,531,,,,,,memgacpail_hs,,,http://vmh.uni.lu/_api/metabolites/531/?format=pcsv
dolp_L,,,-20,C1080H1758O40P10,CHEBI:16214,,dolichyl phosphate(2-),,dolichyl phosphate(2-),,,,,2016-11-22T15:11:52Z,,532,,,,,,dolp_L,,,http://vmh.uni.lu/_api/metabolites/532/?format=pcsv
m2emgacpail_hs,,,0,C51H94N2O32P2FULLRCO2FULLR2CO2,,,"(dimannosyl),(phosphoethanolaminyl)-mannosyl-glucosylaminyl-acylphosphatidylinositol (H6)",,"(dimannosyl),(phosphoethanolaminyl)-mannosyl-glucosylaminyl-acylphosphatidylinositol (H6)",,,,,2016-11-22T15:11:52Z,,533,,,,,,m2emgacpail_hs,,,http://vmh.uni.lu/_api/metabolites/533/?format=pcsv
dolmanp_U,,,-10,C1085H1780O90P10,,,"Dolichyl phosphate D-mannose, human uterine homolog",,"Dolichyl phosphate D-mannose, human uterine homolog",,,,,2016-11-22T15:11:52Z,,534,,,,,,dolmanp_U,,,http://vmh.uni.lu/_api/metabolites/534/?format=pcsv
dolp_U,,,-20,C1025H1670O40P10,,,dolichyl phosphate(2-),,dolichyl phosphate(2-),,,,,2016-11-22T15:11:52Z,,535,,,,,,dolp_U,,,http://vmh.uni.lu/_api/metabolites/535/?format=pcsv
3uib,,,-1,C5H9N2O3,CHEBI:1670,,Human Metabolome Database (HMDB): Beta-ureidoisobutyrate (betaUIB) is increased in the urine of patients with beta-ureidopropionase deficiency [EC 3.5.1.6] (PMID: 12271438). Ureidoisobutyric acid can be used to predict patient's individual phenotypes of enzyme deficiencies in pyrimidine metabolism when associated with a risk for severe toxicity against the antineoplastic agent 5-fluorouracil (PMID: 12798197).,,3-Ureidoisobutyrate,,HMDB02031,"InChI=1S/C5H10N2O3/c1-3(4(8)9)2-7-5(6)10/h3H,2H2,1H3,(H,8,9)(H3,6,7,10)",C05100,2016-12-05T15:48:04Z,,536,,,,,,3uib,,"3-Carbamoylamino-2-methylpropanoate, 3-Carbamoylamino-2-methylpropanoic acid, 3-Ureidoisobutyrate, 3-Ureidoisobutyric acid, beta-Uba, beta-Ureidoisobutyrate, beta-Ureidoisobutyric acid, DL-beta-Ureidoisobutyrate, DL-beta-Ureidoisobutyric acid, N-Carbamyl-amino isobutyrate, N-Carbamyl-b-aminoisobutyric acid, N-Carbamyl-beta-aminoisobutyric acid",http://vmh.uni.lu/_api/metabolites/536/?format=pcsv
3aib_D,,,0,C4H9NO2,CHEBI:16320,,D-3-Amino-isobutanoate,,D-3-Amino-isobutanoate,,,"InChI=1/C4H9NO2/c1-3(2-5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m1/s1",C01205,2016-11-22T15:11:53Z,,537,,,,,5459822,3aib_D,,,http://vmh.uni.lu/_api/metabolites/537/?format=pcsv
but,,,-1,C4H7O2,CHEBI:30772,,"Human Metabolome Database (HMDB): Butyric acid, a four-carbon fatty acid, is formed in the human colon by bacterial fermentation of carbohydrates (including dietary fiber), and putatively suppresses colorectal cancer (CRC). Butyrate has diverse and apparently paradoxical effects on cellular proliferation, apoptosis and differentiation that may be either pro-neoplastic or anti-neoplastic, depending upon factors such as the level of exposure, availability of other metabolic substrate and the intracellular milieu. In humans, the relationship between luminal butyrate exposure and CRC has been examined only indirectly in case-control studies, by measuring fecal butyrate concentrations, although this may not accurately reflect effective butyrate exposure during carcinogenesis. Perhaps not surprisingly, results of these investigations have been mutually contradictory. The direct effect of butyrate on tumorigenesis has been assessed in a no. of in vivo animal models, which have also yielded conflicting results. In part, this may be explained by methodology: differences in the amount and route of butyrate administration, which are likely to significantly influence delivery of butyrate to the distal colon. (PMID: 16460475) Butyric acid is a carboxylic acid found in rancid butter, parmesan cheese, and vomit, and has an unpleasant odor and acrid taste, with a sweetish aftertaste (similar to ether). Butyric acid is a fatty acid occurring in the form of esters in animal fats and plant oils. Interestingly, low-molecular-weight esters of butyric acid, such as methyl butyrate, have mostly pleasant aromas or tastes. As a consequence, they find use as food and perfume additives. Butyrate is produced as end-product of a fermentation process solely performed by obligate anaerobic bacteria.",,butyrate,,HMDB00039,"InChI=1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6)/p-1",C00246,2016-12-05T15:48:04Z,,538,,,,,264,but,,"1-Butanoate, 1-Butanoic acid, 1-Butyrate, 1-Butyric acid, 1-Propanecarboxylate, 1-Propanecarboxylic acid, Butanate, Butanic acid, Butanoate, Butanoic acid, Buttersaeure, Butyrate, Butyric acid, Ethylacetate, Ethylacetic acid, Honey robber, Kyselina maselna, N-Butanoate, N-Butanoic acid, N-Butyrate, N-Butyric acid, Propanecarboxylate, Propanecarboxylic acid, Propylformate, Propylformic acid",http://vmh.uni.lu/_api/metabolites/538/?format=pcsv
bvite,,,0,C28H48O2,,,beta-tocopherol,,beta-tocopherol,,,"InChI=1S/C28H48O2/c1-20(2)11-8-12-21(3)13-9-14-22(4)15-10-17-28(7)18-16-25-24(6)26(29)19-23(5)27(25)30-28/h19-22,29H,8-18H2,1-7H3/t21-,22-,28-/m1/s1",C14152,2016-11-22T15:11:53Z,,539,,,,,,bvite,,,http://vmh.uni.lu/_api/metabolites/539/?format=pcsv
bz,,,-1,C7H5O2,CHEBI:30746,,benzoate,,benzoate,,,"InChI=1S/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9)/p-1",C00180,2016-11-22T15:11:53Z,,540,,,,,,bz,,,http://vmh.uni.lu/_api/metabolites/540/?format=pcsv
44mctr,,,0,C29H46O,CHEBI:17813,,"Human Metabolome Database (HMDB): 4,4-Dimethylcholesta-8,14,24-trienol is a product of the enzyme delta14-sterol reductase [EC 1.3.1.70] (KEGG). It is involved in the biosynthesis of steroids and is involved in the conversion of lanosterol to zymosterol. In particular, lanosterol 14-alpha-demethylase, catalyzes the C-14 demethylation of lanosterol to form 4,4-Dimethylcholesta-8,14,24-trienol in the ergosterol biosynthesis pathway. It is thought to be a meiosis activating sterol.",,"4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol",,HMDB01023,"InChI=1S/C29H46O/c1-19(2)9-8-10-20(3)22-12-13-23-21-11-14-25-27(4,5)26(30)16-18-29(25,7)24(21)15-17-28(22,23)6/h9,13,20,22,25-26,30H,8,10-12,14-18H2,1-7H3/t20-,22-,25+,26+,28-,29-/m1/s1",C11455,2016-12-05T15:48:04Z,,541,,,,,443212,44mctr,,"(3beta,5alpha)-4,4-dimethyl-Cholesta-8,14,24-trien-3-ol, (3beta,5alpha)-4,4-Dimethylcholesta-8,14,24-trien-3-ol, 4,4'-Dimethyl cholesta-8,14,24-triene-3-beta-ol, 4,4-Dimechol-8,14,24-trienol, 4,4-Dimethyl-5-alpha-cholesta-8,14,24-trien-3-beta-ol, 4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3-ol, 4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol, 4,4-Dimethyl-cholesta-8,14,24-trienol, 4,4-Dimethylcholesta-8,14,24-trienol, FF-MAS, Follicular fluid meiosis activating sterol",http://vmh.uni.lu/_api/metabolites/541/?format=pcsv
44mzym,,,0,C29H48O,CHEBI:18364,,14-demethyllanosterol,,14-demethyllanosterol,,,"InChI=1S/C29H48O/c1-19(2)9-8-10-20(3)22-12-13-23-21-11-14-25-27(4,5)26(30)16-18-29(25,7)24(21)15-17-28(22,23)6/h9,20,22-23,25-26,30H,8,10-18H2,1-7H3/t20-,22-,23+,25+,26+,28-,29-/m1/s1",C05108,2016-11-22T15:11:53Z,,542,,,,,,44mzym,,,http://vmh.uni.lu/_api/metabolites/542/?format=pcsv
pmtcrn,,,0,C23H45NO4,CHEBI:17490,,"Human Metabolome Database (HMDB): L-Palmitoylcarnitine is a long-chain acyl fatty acid derivative ester of carnitine which facilitates the transfer of long-chain fatty acids from cytoplasm into mitochondria during the oxidation of fatty acids. L-palmitoylcarnitine, due to its amphipatic character is, like detergents, a surface-active molecule and by changing the membrane fluidity and surface charge can change activity of several enzymes and transporters localized in the membrane. L-palmitoylcarnitine has been also reported to change the activity of certain proteins. On the contrary to carnitine, palmitoylcarnitine was shown to stimulate the activity of caspases 3, 7 and 8 and the level of this long-chain acylcarnitine increased during apoptosis. Palmitoylcarnitine was also reported to diminish completely binding of phorbol esters, the protein kinase C activators and to decrease the autophosphorylation of the enzyme. Apart from these isoform nonspecific phenomena, palmitoylcarnitine was also shown to be responsible for retardation in cytoplasm of protein kinase C isoforms &#946; and &#948; and, in the case of the latter one, to decrease its interaction with GAP-43. Some of the physico-chemical properties of palmitoylcarnitine may help to explain the need for coenzyme A-carnitine-coenzyme A acyl exchange during mitochondrial fatty acid import. The amphiphilic character of palmitoylcarnitine may also explain its proposed involvement in the pathogenesis of myocardial ischemia. L-Palmitoylcarnitine accumulates in ischemic myocardium and potentially contribute to myocardial damage through alterations in membrane molecular dynamics , one mechanism through which could play an important role in ischemic injury. Palmitoylcarnitine is characteristically elevated in carnitine palmitoyltransferase II deficiency, late-onset (OMIM 255110). (PMID 2540838, 15363641, 8706815).",,L-palmitoylcarnitine,,HMDB00222,"InChI=1S/C23H45NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(27)28-21(19-22(25)26)20-24(2,3)4/h21H,5-20H2,1-4H3/t21-/m0/s1",C02990,2016-12-05T15:48:04Z,,543,,,,L-palmitoylcarnitine,11953816,pmtcrn,,"(+)-palmitoylcarnitine, (3S)-3-hexadecanoyloxy-4-(trimethylammonio)butanoate, (3S)-3-hexadecanoyloxy-4-(trimethylammonio)butanoic acid, (3S)-3-palmitoyloxy-4-(trimethylammonio)butanoate, (3S)-3-palmitoyloxy-4-(trimethylammonio)butanoic acid, 3-Carboxy-N,N,N-trimethyl-2-[(1-oxohexadecyl)oxy]-1-Propanaminium, D-Palmitylcarnitine, Hexadecanoyl-L-carnitine, Hexadecenoyl carnitine, L(-)-Palmitylcarnitine, L-Carnitine palmitoyl ester, L-Palmitoyl-L-carnitine, Palmitoyl D-carnitine, Palmitoyl-(-)-carnitine, Palmitoyl-L-carnitine, Palmityl-L-carnitine",http://vmh.uni.lu/_api/metabolites/543/?format=pcsv
hdcecrn,,,0,C23H43NO4,,,Hexadecenoyl carnitine,,Hexadecenoyl carnitine,,,"InChI=1/C23H45NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(27)28-21(19-22(25)26)20-24(2,3)4/h21H,5-20H2,1-4H3/t21-/m1/s1",C02990,2016-11-22T15:11:53Z,,544,,,,,11953816,hdcecrn,,,http://vmh.uni.lu/_api/metabolites/544/?format=pcsv
hdd2crn,,,0,C23H43NO4,,,trans-Hexadec-2-enoyl carnitine,,trans-Hexadec-2-enoyl carnitine,,,"InChI=1/C23H43NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(27)28-21(19-22(25)26)20-24(2,3)4/h17-18,21H,5-16,19-20H2,1-4H3/b18-17+",,2016-11-22T15:11:53Z,,545,,,,,53477817,hdd2crn,,,http://vmh.uni.lu/_api/metabolites/545/?format=pcsv
stcrn,,,0,C25H49NO4,,,stearoylcarnitine,,stearoylcarnitine,,,"InChI=1/C25H49NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(21-24(27)28)22-26(2,3)4/h23H,5-22H2,1-4H3",,2016-11-22T15:11:53Z,,546,,,,,6426855,stcrn,,,http://vmh.uni.lu/_api/metabolites/546/?format=pcsv
odecrn,,,0,C25H47NO4,,,octadecenoyl carnitine,,octadecenoyl carnitine,,,,,2016-11-22T15:11:53Z,,547,,,,,,odecrn,,,http://vmh.uni.lu/_api/metabolites/547/?format=pcsv
arachdcrn,,,0,C27H45NO4,,,C20:4 carnitine,,C20:4 carnitine,,,,,2016-11-22T15:11:53Z,,548,,,,,,arachdcrn,,,http://vmh.uni.lu/_api/metabolites/548/?format=pcsv
c226crn,,,0,C29H45NO4,,,cervonyl carnitine,,cervonyl carnitine,,,"InChI=1/C29H45NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-29(33)34-27(25-28(31)32)26-30(2,3)4/h6-7,9-10,12-13,15-16,18-19,21-22,27H,5,8,11,14,17,20,23-26H2,1-4H3/b7-6+,10-9+,13-12+,16-15+,19-18+,22-21+",,2016-11-22T15:11:53Z,,549,,,,,,c226crn,,,http://vmh.uni.lu/_api/metabolites/549/?format=pcsv
c2m26dcoa,,,-4,C31H46N7O17P3S,,,"Human Metabolome Database (HMDB): cis-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA is an intermediate in Limonene and pinene degradation. cis-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA is the. 4th to last step in the synthesis of 3-Isopropylbut-3-enoic acid and is converted from cis-2-Methyl-5-isopropylhexa-2,5-dienoic acid via the enzyme (E6.2.1.-). It is then converted to 3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA via the enzyme paaG (E4.2.1.17).",,"cis-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA",,HMDB06540,"InChI=1/C31H50N7O17P3S/c1-17(2)18(3)7-8-19(4)30(43)59-12-11-33-21(39)9-10-34-28(42)25(41)31(5,6)14-52-58(49,50)55-57(47,48)51-13-20-24(54-56(44,45)46)23(40)29(53-20)38-16-37-22-26(32)35-15-36-27(22)38/h8,15-17,20,23-25,29,40-41H,3,7,9-14H2,1-2,4-6H3,(H,33,39)(H,34,42)(H,47,48)(H,49,50)(H2,32,35,36)(H2,44,45,46)/b19-8+/t20-,23?,24-,25+,29-/m1/s1",C11946,2016-12-05T15:48:04Z,,550,,,,,11953968,,,,http://vmh.uni.lu/_api/metabolites/550/?format=pcsv
3h26dm5coa,,,-4,C31H48N7O18P3S,,,"Human Metabolome Database (HMDB): 3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA is a metabolite of limonene and pinene degradation, the byproduct of the enzyme (3S)-3-hydroxyacyl-CoA hydrolyase (EC 4.2.1.17). Limonnene is a naturally occurring monoterpene chemical which is the major component in oil of orange; pinene is a monoterpene abundant in conifers of the Cupressaceae family (Juniper). (PMID: 17192005).",,"3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA",,HMDB04601,"InChI=1/C31H52N7O18P3S/c1-16(2)17(3)11-19(39)18(4)30(44)60-10-9-33-21(40)7-8-34-28(43)25(42)31(5,6)13-53-59(50,51)56-58(48,49)52-12-20-24(55-57(45,46)47)23(41)29(54-20)38-15-37-22-26(32)35-14-36-27(22)38/h14-16,18-20,23-25,29,39,41-42H,3,7-13H2,1-2,4-6H3,(H,33,40)(H,34,43)(H,48,49)(H,50,51)(H2,32,35,36)(H2,45,46,47)/t18?,19?,20-,23-,24-,25+,29-/m1/s1",C11947,2016-12-05T15:48:04Z,,551,,,,,9543313,,,"S-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 3-hydroxy-2,6-dimethyl-5-methylideneheptanethioate, S-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 3-hydroxy-2,6-dimethyl-5-methylideneheptanethioic acid",http://vmh.uni.lu/_api/metabolites/551/?format=pcsv
4mzym_int1,,,0,C29H46O3,,,4-Methylzymosterol intermediate 1,,4-Methylzymosterol intermediate 1,,,"InChI=1/C29H46O3/c1-18(2)8-7-9-19(3)21-11-12-22-20-10-13-24-28(5,23(20)14-16-27(21,22)4)17-15-25(30)29(24,6)26(31)32/h8,19,21-22,24-25,30H,7,9-17H2,1-6H3,(H,31,32)/t19-,21?,22?,24?,25-,27+,28+,29-/m0/s1",C15808,2016-11-22T15:11:53Z,,552,,,,,,4mzym_int1,,,http://vmh.uni.lu/_api/metabolites/552/?format=pcsv
4mzym_int2,,,0,C28H44O,CHEBI:50593,,4-Methylzymosterol intermediate 2,,4-Methylzymosterol intermediate 2,,,"InChI=1/C28H44O/c1-18(2)8-7-9-19(3)22-12-13-24-21-10-11-23-20(4)26(29)15-17-28(23,6)25(21)14-16-27(22,24)5/h8,19-20,22-24H,7,9-17H2,1-6H3/t19-,20?,22?,23?,24?,27-,28+/m1/s1",C15816,2016-11-22T15:11:53Z,,553,,,,,,4mzym_int2,,,http://vmh.uni.lu/_api/metabolites/553/?format=pcsv
zym_int2,,,0,C27H42O,,,zymosterol intermediate 2,,zymosterol intermediate 2,,,"InChI=1S/C27H42O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,19-20,23-24H,6,8-17H2,1-5H3/t19-,20+,23-,24+,26+,27-/m1/s1",C05437,2016-11-22T15:11:53Z,,554,,,,,22298942,zym_int2,,,http://vmh.uni.lu/_api/metabolites/554/?format=pcsv
zymst,,,0,C27H44O,CHEBI:18252,,zymosterol,,zymosterol,,,"InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,19-21,23-24,28H,6,8-17H2,1-5H3/t19-,20+,21+,23-,24+,26+,27-/m1/s1",C05437,2016-11-22T15:11:53Z,,555,,,,,92746,zymst,,,http://vmh.uni.lu/_api/metabolites/555/?format=pcsv
ca2,,,2,Ca,CHEBI:29108,,"Human Metabolome Database (HMDB): Calcium is essential for the normal growth and maintenance of bones and teeth, and calcium requirements must be met throughout life. Requirements are greatest during periods of growth, such as childhood, during pregnancy and when breast-feeding. Long-term calcium deficiency can lead to osteoporosis, in which the bone deteriorates and there is an increased risk of fractures. Adults need between 1,000 and 1,300 mg of calcium in their daily diet. Calcium is essential for living organisms, particularly in cell physiology, and is the most common metal in many animals. Physiologically, it exists as an ion in the body. Calcium combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Calcium is an important component of a healthy diet. A deficit can affect bone and tooth formation, while overretention can cause kidney stones. Vitamin D is needed to absorb calcium. Dairy products, such as milk and cheese, are a well-known source of calcium. However, some individuals are allergic to dairy products and even more people, particularly those of non-European descent, are lactose-intolerant, leaving them unable to consume dairy products. Fortunately, many other good sources of calcium exist. These include: seaweeds such as kelp, wakame and hijiki; nuts and seeds (like almonds and sesame); beans; amaranth; collard greens; okra; rutabaga; broccoli; kale; and fortified products such as orange juice and soy milk. Calcium has also been found to assist in the production of lymphatic fluids.",,calcium(2+),,HMDB00464,InChI=1S/Ca/q+2,C00076,2016-12-05T15:48:04Z,,556,,,,Ca2+,,,,"Ca, Calcium element",http://vmh.uni.lu/_api/metabolites/556/?format=pcsv
carveol,,,0,C10H16O,CHEBI:15389,,(-)-trans-carveol,,(-)-trans-carveol,,,"InChI=1S/C10H16O/c1-7(2)9-5-4-8(3)10(11)6-9/h4,9-11H,1,5-6H2,2-3H3/t9-,10+/m1/s1",C00964,2016-11-22T15:11:53Z,,557,,,,,,carveol,,,http://vmh.uni.lu/_api/metabolites/557/?format=pcsv
cbl2,,,0,C62H92CoN13O14P,CHEBI:16304,,Cob(II)alamin,,Cob(II)alamin,,,"InChI=1S/C62H90N13O14P.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);/q;+2/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;/m1./s1",C00541,2016-11-22T15:11:53Z,,558,,,,,,cbl2,,,http://vmh.uni.lu/_api/metabolites/558/?format=pcsv
cbl1,,,-1,C62H88CoN13O14P,CHEBI:15982,,Cob(I)alamin,,Cob(I)alamin,,,"InChI=1S/C62H90N13O14P.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);/q;+1/p-1/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;/m1./s1",C00853,2016-11-22T15:11:53Z,,559,,,,,,,,,http://vmh.uni.lu/_api/metabolites/559/?format=pcsv
adocbl,,,0,C72H100CoN18O17P,CHEBI:8408,,Adenosylcobalamin,,Adenosylcobalamin,,,"InChI=1S/C62H90N13O14P.C10H12N5O3.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;1-4-6(16)7(17)10(18-4)15-3-14-5-8(11)12-2-13-9(5)15;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);2-4,6-7,10,16-17H,1H2,(H2,11,12,13);/q;;+2/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;4-,6-,7-,10-;/m11./s1",C00194,2016-11-22T15:11:53Z,,560,,,,,,,,,http://vmh.uni.lu/_api/metabolites/560/?format=pcsv
pppi,,,-4,HO10P3,CHEBI:18036,,"Human Metabolome Database (HMDB): Triphosphate is a triphosphate is salt or ester containing three phosphate groups. It is the ionic form of triphosphoric acid, a condensed form of phosphoric acid. Triphosphate is an intermediate in the biosynthesis of Folate, the metabolism of Purine, the metabolism of Porphyrin and chlorophyll, the metabolism of Pyrimidine and the metabolism of Thiamine. It is a substrate for Transforming protein p21/H-Ras-1, Bis(5'-adenosyl)-triphosphatase, Ectonucleoside triphosphate diphosphohydrolase 5, Ectonucleoside triphosphate diphosphohydrolase 2, DNA polymerase gamma subunit 1, DNA nucleotidylexotransferase, Inosine triphosphate pyrophosphatase, Cob(I)yrinic acid a,c-diamide adenosyltransferase (mitochondrial), Ectonucleoside triphosphate diphosphohydrolase 1, Ectonucleoside triphosphate diphosphohydrolase 3, Hypothetical protein FLJ13970, Deoxyuridine 5'-triphosphate nucleotidohydrolase (mitochondrial), Thiamine-triphosphatase, DNA-directed RNA polymerase III 32 kDa polypeptide, Ectonucleoside triphosphate diphosphohydrolase 4, 6-pyruvoyl tetrahydrobiopterin synthase and Ectonucleoside triphosphate diphosphohydrolase 6.",,triphosphate(5-),,HMDB03379,"InChI=1S/H5O10P3/c1-11(2,3)9-13(7,8)10-12(4,5)6/h(H,7,8)(H2,1,2,3)(H2,4,5,6)/p-4",C00536,2016-12-05T15:48:04Z,,561,,,,,3440921,pppi,,"Bis(tetraoxidophosphato)dioxidophosphate(5-), Catena-triphosphate, Inorganic triphosphate, Triphoshoric acid, Triphosphate(5-), Tripolyphosphate",http://vmh.uni.lu/_api/metabolites/561/?format=pcsv
g6p,,,-2,C6H11O9P,CHEBI:4170,,D-Glucose 6-phosphate,,D-Glucose 6-phosphate,,,"1/C5H11/c1-3-5-4-2/h1,3-5H2,2H3",C00092,2016-11-22T15:11:53Z,,562,,,,,5958,g6p,,,http://vmh.uni.lu/_api/metabolites/562/?format=pcsv
prostg1,,,-1,C20H31O5,CHEBI:15548,,"Human Metabolome Database (HMDB): (13E)-11a-Hydroxy-9,15-dioxoprost-13-enoic acid is a substrate for Carbonyl reductase 1.Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,15-dehydro-prostaglandin E1(1-),,HMDB01320,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,16-17,19,23H,2-11,14H2,1H3,(H,24,25)/p-1/b13-12+/t16-,17-,19-/m1/s1",C04654,2016-12-05T15:48:04Z,,563,,,,,440424,,,"(11a,13E)-11-hydroxy-9,15-dioxoprost-13-en-1-oate, (11a,13E)-11-hydroxy-9,15-dioxoprost-13-en-1-oic acid, (11alpha,13E)-11-hydroxy-9,15-dioxoprost-13-en-1-oate, (11alpha,13E)-11-hydroxy-9,15-dioxoprost-13-en-1-oic acid, (13E)-11-alpha-hydroxy-9,15-dioxoprost-13-enoate, (13E)-11-alpha-hydroxy-9,15-dioxoprost-13-enoic acid, (13E)-11alpha-hydroxy-9,15-dioxoprost-13-en-1-oate, (13E)-11alpha-hydroxy-9,15-dioxoprost-13-en-1-oic acid, (13E)-11alpha-Hydroxy-9,15-dioxoprost-13-enoate, (13E)-11alpha-Hydroxy-9,15-dioxoprost-13-enoic acid, 1-Hydroxy-9,15-dioxo-(11a,13E)-Prost-13-en-1-oate, 1-Hydroxy-9,15-dioxo-(11a,13E)-Prost-13-en-1-oic acid, 15-Keto PGE1, 15-Keto-PGE, 15-Keto-PGE1, 15-Keto-PGE1-alpha, 15-Keto-Prostaglandin E1, 15-Ketoprostaglandin E, 15-Ketoprostaglandin E1, 15-Oxo-PGE1, 15-Oxoprostaglandin E1, 3-Hydroxy-5-oxo-2-(3-oxo-1-octenyl)-Cyclopentaneheptanoate, 3-Hydroxy-5-oxo-2-(3-oxo-1-octenyl)-Cyclopentaneheptanoic acid, 9,15-Dioxo-11R-hydroxy-13E-prostaenoate, 9,15-Dioxo-11R-hydroxy-13E-prostaenoic acid",http://vmh.uni.lu/_api/metabolites/563/?format=pcsv
prostge1,,,-1,C20H33O5,CHEBI:15544,,"Human Metabolome Database (HMDB): Prostaglandin E1 (PGE1) is a potent endogenous vasodilator agent that increases peripheral blood flow. It inhibits platelet aggregation and has many other biological effects such as bronchodilation, mediation of inflammation, and various protective functions.The protective action of PGE1 has been shown on both experimental animal models of liver injury and patients with fulminant viral hepatitis. PGE1-treated cirrhotic rats had less hepatosplenomegaly, lower serum alanine aminotransferase levels, and portal pressures and higher arterial pressure than placebo-treated cirrhotic rats. Mechanisms of hepatic cytopotection of PGE1: inhibitory effects on T-cell mediated cytotoxicity, enhance DNA synthesis of injured liver after partial hepatectomy by stimulating cyclic AMP production and increasing ATP level in hepatic tissue, and could accelerate the recovery of mitochondrial respiratory functio n after reperfusion, stabilization of membrane microviscosity.PGE1 is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). (PMID: 11819590, 16986207)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,prostaglandin E1(1-),,HMDB01442,"InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/p-1/b13-12+/t15-,16+,17+,19+/m0/s1",C04741,2016-12-05T15:48:04Z,,564,,,,,5280723,,,"(+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate, (+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid, (-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate, (-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid, (-)-Prostaglandin E1, (13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoate, (13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoic acid, (13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoate, (13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoic acid, (13e)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate, (13e)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoic acid, 11,15-Dihydroxy-9-oxoprost-13-en-1-oate, 11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid, 11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (ACD/Name 4.0), 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate, 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid, Alprostadil, Alprostadil Prostoglandin E1, Alprostadil(usan), Befar, Befar (TN), Caverject, EDEX, L-Prostaglandin E1, MUSE, PGE1, Prink, Prink (TN), Prostaglandin E1, Prostin VR",http://vmh.uni.lu/_api/metabolites/564/?format=pcsv
prostge2,,,-1,C20H31O5,CHEBI:15551,,"Human Metabolome Database (HMDB): The naturally occurring prostaglandin E2 (PGE2) is known in medicine as dinoprostone. It has important effects in labour and also stimulates osteoblasts to release factors which stimulate bone resorption by osteoclasts (a type of bone cell that removes bone tissue by removing the bone's mineralized matrix). PGE2 is also the prostaglandin that ultimately induces fever. PGE2 has been shown to increase vasodilation and cAMP production, to enhance the effects of bradykinin and histamine, induction of uterine contractions and of platelet aggregation. PGE2 is also responsible for maintaining the open passageway of the fetal ductus arteriosus; decreasing T-cell proliferation and lymphocyte migration and activating the secretion of IL-1&#945; and IL-2. PGE2 exhibits both pro- and anti-inflammatory effects, particularly on dendritic cells (DC). Depending on the nature of maturation signals, PGE2 has different and sometimes opposite effects on DC biology. PGE2 exerts an inhibitory action, reducing the maturation of DC and their ability to present antigen. PGE2 has also been shown to stimulate DC and promote IL-12 production when given in combination with TNF-alpha. PGE2 is an environmentally bioactive substance. Its action is prolonged and sustained by other factors especially IL-10. It modulates the activities of professional DC by acting on their differentiation, maturation and their ability to secrete cytokines. PGE2 is a potent inducer of IL-10 in bone marrow-derived DC (BM-DC), and PGE2-induced IL-10 is a key regulator of the BM-DC pro-inflammatory phenotype (PMID: 16978535). Dinoprostone is a naturally occurring prostaglandin E2 (PGE2) and the most common and most biologically active of the mammalian prostaglandins. It has important effects in labour and also stimulates osteoblasts to release factors which stimulate bone resorption by osteoclasts (a type of bone cell that removes bone tissue by removing the bone's mineralized matrix). PGE2 has been shown to increase vasodilation and cAMP production, to enhance the effects of bradykinin and histamine, to induce uterine contractions and to activate platelet aggregation. PGE2 is also responsible for maintaining the open passageway of the fetal ductus arteriosus; decreasing T-cell proliferation and lymphocyte migration and activating the secretion of IL-1alpha and IL-2. PGE2 exhibits both pro- and anti-inflammatory effects, particularly on dendritic cells (DC). Depending on the nature of maturation signals, PGE2 has different and sometimes opposite effects on DC biology. PGE2 exerts an inhibitory action, reducing the maturation of DC and their ability to present antigen. PGE2 has also been shown to stimulate DC and promote IL-12 production when given in combination with TNF-alpha. PGE2 is an environmentally bioactive substance. Its action is prolonged and sustained by other factors especially IL-10. It modulates the activities of professional DC by acting on their differentiation, maturation and their ability to secrete cytokines. PGE2 is a potent inducer of IL-10 in bone marrow-derived DC (BM-DC), and PGE2-induced IL-10 is a key regulator of the BM-DC pro-inflammatory phenotype (PMID: 16978535). Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,prostaglandin E2(1-),,HMDB01220,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/p-1/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",C00584,2016-12-05T15:48:05Z,,565,,,,prostaglandin E2,5280360,prostge2,,"(-)-Prostaglandin E2, (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate, (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid, (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate, (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid, (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoate, (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoic acid, 5-trans-PGE2, Dinoprostone, Dinoprostonum, Glandin, L-Prostaglandin E2, Minprositin E2, Minprostin E2, PGE2, Prepidil, Prostaglandin E, Prostaglandin E2, Prostaglandin E2alpha, Prostarmon E, Prostin, Prostin E2",http://vmh.uni.lu/_api/metabolites/565/?format=pcsv
prostgf2,,,-1,C20H33O5,CHEBI:15553,,"Human Metabolome Database (HMDB): Prostaglandin F2a (PGF2) is one of the earliest discovered and most common prostaglandins. It is actively biosynthesized in various organs of mammals and exhibits a variety of biological activities, including contraction of pulmonary arteries. It is used in medicine to induce labor and as an abortifacient. PGF2a binds to the Prostaglandin F2 receptor (PTGFR) which is a member of the G-protein coupled receptor family. PGF2-alpha mediates luteolysis. Luteolysis is the structural and functional degradation of the corpus luteum (CL) that occurs at the end of the luteal phase of both the estrous and menstrual cycles in the absence of pregnancy. PGF2 may also be involved in modulating intraocular pressure and smooth muscle contraction in the uterus and gastrointestinal tract sphincters. PGF2 is mainly synthesized directly from PGH2 by PGH2 9,11-endoperoxide reductase. A small amount of PGF2 is also produced from PGE2 by PGE2 9-ketoreductase. A PGF2 epimer has been reported to exhibit various biological activities, and its levels are increased in bronchoalveolar lavage fluid, plasma, and urine in patients with mastocytosis and bronchial asthma. PGF2 is synthesized from PGD2 by PGD2 11-ketoreductase. (PMID: 16475787). Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,prostaglandin F2alpha(1-),,HMDB01139,"InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/p-1/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1",C00639,2016-12-05T15:48:05Z,,566,,,,prostaglandin F2 alpha,11081,prostgf2,,"(+)-Prostaglandin F2a, (5Z,13E)-(15S)-9-alpha,11-alpha,15-trihydroxyprosta-5,13-dienoate, (5Z,13E)-(15S)-9-alpha,11-alpha,15-trihydroxyprosta-5,13-dienoic acid, (5Z,13E,15S)-9a,11a,15-trihydroxyprosta-5,13-dien-1-oate, (5Z,13E,15S)-9a,11a,15-trihydroxyprosta-5,13-dien-1-oic acid, (5Z,9a,11a,13E,15S)-9,11,15-trihydroxy-Prosta-5,13-dien-1-oate, (5Z,9a,11a,13E,15S)-9,11,15-trihydroxy-Prosta-5,13-dien-1-oic acid, (9alpha,11alpha,15)-trihydroxyprosta-(5Z,13E)-dien-1-oate, (9alpha,11alpha,15)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid, 7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoate, 7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-Heptenoic acid, 9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-oate, 9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-oic acid, 9,11,15-Trihydroxyprosta-5Z,13E-dien-1-oate, 9,11,15-Trihydroxyprosta-5Z,13E-dien-1-oic acid, 9a,11a,15(S)-Trihydroxy-5-cis-13-trans-prostadienoate, 9a,11a,15(S)-Trihydroxy-5-cis-13-trans-prostadienoic acid, 9a,11a-PGF2, 9a,11a-PGF2a, Amoglandin, Cyclosin, Dinifertin, Dinoprost, Enzaprost, Enzaprost F, F2a Isoprostane, Glandin N, L-PGF2-alpha, L-Prostaglandin F2-alpha, Panacelan, PGF2a, Prostaglandin F2, Prostaglandin F2a, Prostamate, Prostarmon F, Prostin F 2 alpha, Protamodin",http://vmh.uni.lu/_api/metabolites/566/?format=pcsv
cca_d3,,,-1,C22H33O4,,,Calcitroic acid (D3),,Calcitroic acid (D3),,,"InChI=1/C23H34O4/c1-14(11-22(26)27)19-8-9-20-16(5-4-10-23(19,20)3)6-7-17-12-18(24)13-21(25)15(17)2/h6-7,14,18-21,24-25H,2,4-5,8-13H2,1,3H3,(H,26,27)/b16-6+,17-7+/t14?,18-,19-,20+,21+,23-/m1/s1",,2016-11-22T15:11:53Z,,567,,,,,,,,,http://vmh.uni.lu/_api/metabolites/567/?format=pcsv
cdpdag_hs,,,-2,C12H17N3O11P2FULLRCO2FULLR2CO2,,,CDP-diacylglycerol(2-),,CDP-diacylglycerol(2-),,,,,2016-11-22T15:11:53Z,,568,,,,,,cdpdag_hs,,,http://vmh.uni.lu/_api/metabolites/568/?format=pcsv
inost,,,0,C6H12O6,CHEBI:17268,,"Human Metabolome Database (HMDB): Inositol is a cyclic polyalcohol that plays an important role as a second messenger in a cell, in the form of inositol phosphates. It is found in many foods, particularly in cereals with high bran content. It is an isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed., p1379) Inositol phospholipids are important in signal transduction.",,myo-inositol,,HMDB00211,"InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H/t1-,2-,3-,4+,5-,6-",C00137,2016-12-05T15:48:05Z,,569,,,,,892,inost,,"cis-1,2,3,5-trans-4,6-Cyclohexanehexol, i-Inositol, Iso-Inositol, Meat sugar, Meso-Inositol, MI, Myo-Inositol, Myoinosite, Myoinositol, Phaseomannite, Rat antispectacled eye factor",http://vmh.uni.lu/_api/metabolites/569/?format=pcsv
pail_hs,,,-1,C9H16O9PFULLRCO2FULLR2CO2,,,1-phosphatidyl-1D-myo-inositol(1-),,1-phosphatidyl-1D-myo-inositol(1-),,,,,2016-11-22T15:11:53Z,,570,,,,,,pail_hs,,,http://vmh.uni.lu/_api/metabolites/570/?format=pcsv
ctp,,,-4,C9H12N3O14P3,CHEBI:17677,,CTP,,CTP,,,"InChI=1S/C9H16N3O14P3/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H2,10,11,15)(H2,16,17,18)/p-4/t4-,6-,7-,8-/m1/s1",C00063,2016-11-22T15:11:53Z,,571,,,,,6176,ctp,,,http://vmh.uni.lu/_api/metabolites/571/?format=pcsv
dag_hs,,,0,C3H6OFULLRCO2FULLR2CO2,,,diglyceride,,diglyceride,,,,,2016-11-22T15:11:53Z,,572,,,,,,dag_hs,,,http://vmh.uni.lu/_api/metabolites/572/?format=pcsv
pchol_hs,,,0,C8H18NO4PFULLRCO2FULLR2CO2,,,Phosphatidylcholine,,Phosphatidylcholine,,,,,2016-11-22T15:11:53Z,,573,,,,,,pchol_hs,,,http://vmh.uni.lu/_api/metabolites/573/?format=pcsv
pe_hs,,,0,C5H12NO4PFULLRCO2FULLR2CO2,,,phosphatidylethanolamine,,phosphatidylethanolamine,,,,,2016-11-22T15:11:53Z,,574,,,,,,pe_hs,,,http://vmh.uni.lu/_api/metabolites/574/?format=pcsv
crmp_hs,,,-2,C18H35NO5PFULLRCO,,,ceramide 1-phosphate(2-),,ceramide 1-phosphate(2-),,,,,2016-11-22T15:11:53Z,,575,,,,,,crmp_hs,,,http://vmh.uni.lu/_api/metabolites/575/?format=pcsv
chsterol,,,0,C27H46O,CHEBI:16113,,"Human Metabolome Database (HMDB): Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The name originates from the Greek chole- (bile) and stereos (solid), and the chemical suffix -ol for an alcohol, as researchers first identified cholesterol (C27H45OH) in solid form in gallstones in 1784. Cholesterol is transported throughout the body via lipoprotein particles. The largest lipoproteins, which primarily transport fats from the intestinal mucosa to the liver, are called chylomicrons. They carry mostly triglyceride fats and cholesterol (that are from food and especially internal cholesterol secreted by the liver into the bile). In the liver, chylomicron particles give up triglycerides and some cholesterol, and are converted into low-density lipoprotein (LDL) particles, which carry triglycerides and cholesterol on to other body cells. In healthy individuals the LDL particles are large and relatively few in number. In contrast, large numbers of small LDL particles are strongly associated with promoting atheromatous disease within the arteries. (Lack of information on LDL particle number and size is one of the major problems of conventional lipid tests.). In conditions with elevated concentrations of oxidized LDL particles, especially small LDL particles, cholesterol promotes atheroma plaque deposits in the walls of arteries, a condition known as atherosclerosis, which is a major contributor to coronary heart disease and other forms of cardiovascular disease. (In contrast, HDL particles have been the only identified mechanism by which cholesterol can be removed from atheroma. Increased concentrations of large HDL particles, not total HDL particles, correlate with lower rates of atheroma progressions, even regression.). There is a world-wide trend to believe that lower total cholesterol levels tend to correlate with lower atherosclerosis event rates (though many studies refute this idea). Due to this reason, cholesterol has become a very large focus for scientific researchers trying to determine the proper amount of cholesterol needed in a healthy diet. However, the primary association of atherosclerosis with cholesterol has always been specifically with cholesterol transport patterns, not total cholesterol per se. For example, total cholesterol can be low, yet made up primarily of small LDL and small HDL particles and atheroma growth rates are high. In contrast, however, if LDL particle number is low (mostly large particles) and a large percentage of the HDL particles are large (HDL is actively reverse transporting cholesterol), then atheroma growth rates are usually low, even negative, for any given total cholesterol concentration. These effects are further complicated by the relative concentration of asymmetric dimethylarginin (ADMA) in the endothelium, since ADMA down-regulates production of nitric oxide, a relaxant of the endothelium. Thus, high levels of ADMA, associated with high oxidized levels of LDL pose a heightened risk factor for vascular disease. -- Wikipedia.",,cholesterol,,HMDB00067,"InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1",C00187,2016-12-05T15:48:05Z,,576,,,,cholesterol,5997,chsterol,,"(+)-ent-Cholesterol, (-)-Cholesterol, (20bFH)-cholest-5-en-3b-ol, (3b)-cholest-5-en-3-ol, (3beta)-Cholest-5-en-3-ol, 20-Epi-cholesterol, 20-Iso-cholesterol, 20bFH-cholest-5-en-3b-ol, 3beta-Hydroxycholest-5-ene, 5-Cholesten-3B-ol, 5-Cholesten-3beta-ol, 5:6-Cholesten-3-ol, 5:6-Cholesten-3beta-ol, Cholest-5-en-3-ol, Cholest-5-en-3b-ol, Cholest-5-en-3beta-ol, Cholesterin, Cholesterine, Cholesterol, Cholesterol base H, Cholesteryl alcohol, Cholestrin, Cholestrol, Cordulan, Dastar, Dusoline, Dusoran, Dythol, Epicholesterin, Epicholesterol, Fancol CH, Hydrocerin, Kathro, Lanol, Liquid crystal CN/9, Nimco cholesterol base H, Nimco cholesterol base No. 712, Super hartolan, Tegolan",http://vmh.uni.lu/_api/metabolites/576/?format=pcsv
xol25oh,,,0,C27H46O2,,,25-hydroxycholesterol,,25-hydroxycholesterol,,,"InChI=1S/C27H46O2/c1-18(7-6-14-25(2,3)29)22-10-11-23-21-9-8-19-17-20(28)12-15-26(19,4)24(21)13-16-27(22,23)5/h8,18,20-24,28-29H,6-7,9-17H2,1-5H3/t18-,20+,21+,22-,23+,24+,26+,27-/m1/s1",C15519,2016-11-22T15:11:53Z,,577,,,,,65094,xol25oh,,,http://vmh.uni.lu/_api/metabolites/577/?format=pcsv
cholp,,,-1,C5H13NO4P,CHEBI:18132,,"Human Metabolome Database (HMDB): Phosphorylcholine is a small haptenic molecule, is found in a wide variety of organisms. Human hepatic tumors undergo an elevation in the concentration of phosphorylcholine as the principal metabolic change is observed (PMID: 11076016). Phosphorylcholine is the precursor metabolite of choline in the glycine, serine and threonine metabolism pathways (KEGG, map00260) and in intermediate between choline and cytidine-diphosphate choline in the glycerophospholipid metabolism pathway (KEGG, map00564).",,choline phosphate(1-),,HMDB01565,"InChI=1S/C5H14NO4P/c1-6(2,3)4-5-10-11(7,8)9/h4-5H2,1-3H3,(H-,7,8,9)/p-1",C00588,2016-12-05T15:48:05Z,,578,,,,,,cholp,,"Choline phosphate, N-Trimethyl-2-aminoethylphosphonate, O-Phosphocholine, Phosphocholine, Phosphoryl-choline",http://vmh.uni.lu/_api/metabolites/578/?format=pcsv
cholate,,,-1,C24H39O5,CHEBI:16359,,"Human Metabolome Database (HMDB): Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",,Cholate,,HMDB00619,"InChI=1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/p-1/t13-,14+,15-,16-,17+,18+,19-,20+,22+,23+,24-/m1/s1",C00695,2016-12-05T15:48:05Z,,579,,,,,221493,cholate,,"17b-[1-Methyl-3-carboxypropyl]etiocholane-3a,7a,12a-triol, 3a,7a,12a-Trihydroxy-5b-cholan-24-oate, 3a,7a,12a-Trihydroxy-5b-cholan-24-oic acid, 3a,7a,12a-Trihydroxy-5b-cholanate, 3a,7a,12a-Trihydroxy-5b-cholanic acid, 3a,7a,12a-Trihydroxy-5b-cholanoate, 3a,7a,12a-Trihydroxy-5b-cholanoic acid, 3a,7a,12a-Trihydroxy-b-cholanate, 3a,7a,12a-Trihydroxy-b-cholanic acid, 3a,7a,12a-Trihydroxy-beta-cholanate, 3a,7a,12a-Trihydroxy-beta-cholanic acid, 3a,7a,12a-Trihydroxycholanate, 3a,7a,12a-Trihydroxycholanic acid, 5b-Cholanic acid-3a,7a,12a-triol, 5b-Cholate, 5b-Cholic acid, Cholalate, Cholalic acid, Cholalin, Cholate, Cholic acid, Colalin",http://vmh.uni.lu/_api/metabolites/579/?format=pcsv
chsterols,,,-1,C27H45O4S,CHEBI:41321,,"Human Metabolome Database (HMDB): Cholesterol sulfate is a sterol sulfate in human plasma. It is a component of cell membrane and has a regulatory function. It has a stabilizing function on the membrane, supports platelet adhesion and involves in signal transduction. (PMID 12730293).",,cholesterol sulfate,,HMDB00653,"InChI=1S/C27H46O4S/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(31-32(28,29)30)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25H,6-8,10-17H2,1-5H3,(H,28,29,30)/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1",C18043,2016-12-05T15:48:05Z,,580,,,,,65076,chsterols,,"5-Cholesten-3b-yl sulfate, 5-Cholesten-3b-yl sulphate, Cholest-5-en-3b-ol sulfate, Cholest-5-en-3b-ol sulphate, Cholesterol 3-sulfate, Cholesterol 3-sulphate, Cholesterol hydrogen sulfate, Cholesterol hydrogen sulphate, Cholesterol sulfate, Cholesterol sulphate, Cholesteryl sulfate, Cholesteryl sulphate",http://vmh.uni.lu/_api/metabolites/580/?format=pcsv
chtn,,,0,C24H41N3O16,,,chitin,,chitin,,,,,2016-11-22T15:11:53Z,,581,,,,,,chtn,,,http://vmh.uni.lu/_api/metabolites/581/?format=pcsv
itaccoa,,,-5,C26H35N7O19P3S,CHEBI:15528,,"Human Metabolome Database (HMDB): Itaconyl-CoA is an intermediate metabolite in the degradation pathway of itaconic acid, an unsaturated dicarbonic organic acid. Citramalyl coenzyme A (CoA) is found to be the intermediate in the conversion of itaconyl-Co-A to acetyl-CoA and pyruvate, catalyzed by methylglutaconase. Methylglutaconase catalyzes the interconversion of itaconyl-, mesaconyl-, and citramalyl-CoA. In liver mitochondria, methylglutaconase converts itaconate to pyruvate and acetyl coenzyme A. In this metabolic process, itaconate is first activated to itaconyl-CoA by a succinate activating enzyme, and a CoA derivative is cleaved to acetyl-CoA and pyruvate. (PMID: 13783048, 11548996).",,itaconyl-CoA(5-),,HMDB03377,"InChI=1S/C26H40N7O19P3S/c1-13(25(39)40)8-16(35)56-7-6-28-15(34)4-5-29-23(38)20(37)26(2,3)10-49-55(46,47)52-54(44,45)48-9-14-19(51-53(41,42)43)18(36)24(50-14)33-12-32-17-21(27)30-11-31-22(17)33/h11-12,14,18-20,24,36-37H,1,4-10H2,2-3H3,(H,28,34)(H,29,38)(H,39,40)(H,44,45)(H,46,47)(H2,27,30,31)(H2,41,42,43)/p-5/t14-,18-,19-,20+,24-/m1/s1",C00531,2016-12-05T15:48:05Z,,582,,,,,,itaccoa,,"Itaconoyl CoA, Itaconoyl coenzyme A, S-(1-Hydrogen methylenesuccinate) CoA, S-(1-Hydrogen methylenesuccinate) Coenzyme A, S-3-Methylenesuccinate CoA, S-3-Methylenesuccinate Coenzyme A, S-Itaconate CoA, S-Itaconate Coenzyme A",http://vmh.uni.lu/_api/metabolites/582/?format=pcsv
citmcoa_L,,,-5,C26H37N7O20P3S,CHEBI:36882,,Human Metabolome Database (HMDB): L-Citramalyl-CoA is an intermediate in C5-Branched dibasic acid metabolism. L-Citramalyl-CoA is the 3rd to last step in the synthesis of (R)-Acetoin and is converted from L-Citramalate via the enzyme citramalate CoA-transferase (EC 2.8.3.7). It is then converted to Pyruvate via the enzyme citramalate-CoA lyase (EC 4.1.3.25).,,(3S)-citramalyl-CoA(5-),,HMDB06345,"InChI=1S/C26H42N7O20P3S/c1-25(2,19(37)22(38)29-5-4-14(34)28-6-7-57-15(35)8-26(3,41)24(39)40)10-50-56(47,48)53-55(45,46)49-9-13-18(52-54(42,43)44)17(36)23(51-13)33-12-32-16-20(27)30-11-31-21(16)33/h11-13,17-19,23,36-37,41H,4-10H2,1-3H3,(H,28,34)(H,29,38)(H,39,40)(H,45,46)(H,47,48)(H2,27,30,31)(H2,42,43,44)/p-5/t13-,17-,18-,19+,23-,26+/m1/s1",C01011,2016-12-05T15:48:05Z,,583,,,,,,citmcoa_L,,"(3S)-Citramalyl-CoA, (3S)-Citramalyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/583/?format=pcsv
creat,,,0,C4H9N3O2,CHEBI:16919,,"Human Metabolome Database (HMDB): Creatine is an amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as creatinine in the urine. Creatine functions as part of the cell's energy shuttle. The high energy phosphate group of ATP is transferred to creatine to form phosphocreatine in the following reaction: Cr + ATP <-> PCr + ADP. This reaction is reversibly catalyzed by creatine kinase. In the human body creatine is synthesized mainly in the liver by the use of parts from three different amino acids - arginine, glycine, and methionine. 95% of it is later stored in the skeletal muscles, with the rest in the brain, heart, testes.",,creatine,,HMDB00064,"InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)",C00300,2016-12-05T15:48:05Z,,584,,,,,,creat,,"((amino(imino)methyl)(methyl)amino)acetate, ((amino(imino)methyl)(methyl)amino)acetic acid, (alpha-Methylguanido)acetate, (alpha-Methylguanido)acetic acid, Cosmocair C 100, Creatin, Creatine, Creatine hydrate, Kreatin, Krebiozon, Methylguanidoacetate, Methylguanidoacetic acid, N-(Aminoiminomethyl)-N-Methyl-Glycine, N-Methyl-N-guanylglycine, Phosphagen, [[Amino(imino)methyl](methyl)amino]acetate, [[Amino(imino)methyl](methyl)amino]acetic acid",http://vmh.uni.lu/_api/metabolites/584/?format=pcsv
pcreat,,,-1,C4H9N3O5P,CHEBI:58092,,N-phosphocreatinate(2-),,N-phosphocreatinate(2-),,,"InChI=1S/C4H10N3O5P/c1-7(2-3(8)9)4(5)6-13(10,11)12/h2H2,1H3,(H,8,9)(H4,5,6,10,11,12)/p-2",C02305,2016-11-22T15:11:53Z,,585,,,,,9548602,pcreat,,,http://vmh.uni.lu/_api/metabolites/585/?format=pcsv
cl,,,-1,Cl,CHEBI:17996,,"Human Metabolome Database (HMDB): Under standard conditions, chlorine exists as a diatomic molecule. Chlorine is a highly toxic, pale yellow-green gas that has a specific strong smell. In nature, chlorine is most abundant as a chloride ion. Physiologically, this it. exists as an ion in the body. The chloride ion is an essential anion that the body needs for many critical functions. It also helps keep the body's acid-base balance. The amount of chloride in the blood is carefully controlled by the kidneys. Chloride ions have important physiological roles. For instance, in the central nervous system, the inhibitory action of glycine and some of the action of GABA relies on the entry of Cl- into specific neurons. Also, the chloride-bicarbonate exchanger biological transport protein relies on the chloride ion to increase the blood's capacity of carbon dioxide, in the form of the bicarbonate ion. Chloride-transporting proteins (CLC) play fundamental roles in many tissues in the plasma membrane as well as in intracellular membranes. CLC proteins form a gene family that comprises nine members in mammals, at least four of which are involved in human genetic diseases. GABA(A) receptors are pentameric complexes that function as ligand-gated chloride ion channels. WNK kinases are a family of serine-threonine kinases that have been shown to play an essential role in the regulation of electrolyte homeostasis, and they are found in diverse epithelia throughout the body that are involved in chloride ion flux. Cystic fibrosis (CF) is caused by alterations in the CF transmembrane conductance regulator (CFTCR) gene that result in deranged sodium and chloride ion transport channels. (PMID: 17539703, 17729441, 17562499, 15300163) (For a complete review see Evans, Richard B. Chlorine: state of the art. Lung (2005), 183(3), 151-167. PMID: 16078037).",,Chloride,,HMDB00492,InChI=1S/ClH/h1H/p-1,C00698,2016-12-05T15:48:05Z,,586,,,,Cl-,312,cl,,"Bertholite, Chloor, Chlor, Chlore, Chloride, Chloride ion, Chlorine, Chlorine gas, Cl, Cl2, Diatomic chlorine, Dichlorine, Molecular chlorine",http://vmh.uni.lu/_api/metabolites/586/?format=pcsv
for,,,-1,CH1O2,CHEBI:30751,,"Human Metabolome Database (HMDB): Formic acid is the simplest carboxylic acid. Formate is an intermediate in normal metabolism. It takes part in the metabolism of one-carbon compounds and its carbon may appear in methyl groups undergoing transmethylation. It is eventually oxidized to carbon dioxide. Formate is typically produced as a byproduct in the production of acetate. It is responsible for both metabolic acidosis and disrupting mitochondrial electron transport and energy production by inhibiting cytochrome oxidase activity, the terminal electron acceptor of the electron transport chain. Cell death from cytochrome oxidase inhibition by formate is believed to result partly from depletion of ATP, reducing energy concentrations so that essential cell functions cannot be maintained. Furthermore, inhibition of cytochrome oxidase by formate may also cause cell death by increased production of cytotoxic reactive oxygen species (ROS) secondary to the blockade of the electron transport chain. In nature, formic acid is found in the stings and bites of many insects of the order Hymenoptera, including bees and ants. The principal use of formic acid is as a preservative and antibacterial agent in livestock feed. When sprayed on fresh hay or other silage, it arrests certain decay processes and causes the feed to retain its nutritive value longer.",,Formate,,HMDB00142,"InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)/p-1",C00058,2016-12-05T15:48:05Z,,587,,,,,284,for,,"Add-F, Ameisensaure, Aminate, Aminic acid, Bilorin, Collo-Bueglatt, Collo-Didax, Formate, Formira, Formisoton, Formylate, Formylic acid, Hydrogen carboxylate, Hydrogen carboxylic acid, Methanoate, Methanoic acid, Methanoic acid monomer, Myrmicyl, Sodium Formate , Sybest, Wonderbond Hardener M 600L",http://vmh.uni.lu/_api/metabolites/587/?format=pcsv
i,,,-1,I,CHEBI:16382,,iodide,,iodide,,,InChI=1S/HI/h1H/p-1,C00708,2016-11-22T15:11:53Z,,588,,,,,,i,,,http://vmh.uni.lu/_api/metabolites/588/?format=pcsv
oxa,,,-2,C2O4,CHEBI:16995,,oxalate(2-),,oxalate(2-),,,"InChI=1S/C2H2O4/c3-1(4)2(5)6/h(H,3,4)(H,5,6)/p-2",C00209,2016-11-22T15:11:53Z,,589,,,,,971,oxa,,,http://vmh.uni.lu/_api/metabolites/589/?format=pcsv
clpndcrn,,,0,C29H47NO4,,,clupanodonyl carnitine,,clupanodonyl carnitine,,,"InChI=1/C29H47NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-29(33)34-27(25-28(31)32)26-30(2,3)4/h6-7,10-11,13-14,17-18,21-22,27H,5,8-9,12,15-16,19-20,23-26H2,1-4H3/b7-6+,11-10+,14-13+,18-17+,22-21+",,2016-11-22T15:11:53Z,,590,,,,,,clpndcrn,,,http://vmh.uni.lu/_api/metabolites/590/?format=pcsv
clpnd,,,-1,C22H33O2,CHEBI:53488,,"Human Metabolome Database (HMDB): Docosapentaenoic acid (also known as clupanodonic acid) is an essential omega-3 fatty acid (EFA) which is prevalent in fish oils. Docosapentaenoic acid, commonly called DPA, is an intermediary between eicosapentaenoic acid (EPA, 20:5 &#969;-3) and docosahexaenoic acid (DHA, 22:6 &#969;-3). Seal oil is a rich source. There are three functions of docosapentaenoic acid. The most important is as part of phospholipids in all animal cellular membranes: a deficiency of docosapentaenoic acid leads to faulty membranes being formed. A second is in the transport and oxidation of cholesterol: clupanodonic acid tends to lower plasma cholesterol. A third function is as a precursor of prostanoids which are only formed from docosapentaenoic acid. Deficiency of this in experimental animals causes lesions mainly attributable to faulty cellular membranes: sudden failure of growth, lesions of skin and kidney and connective tissue, erythrocyte fragility, impaired fertility, uncoupling of oxidation and phosphorylation. In man pure deficiency of docosapentaenoic acid has been studied particularly in persons fed intravenously. A relative deficiency (that is, a low ratio in the body of docosapentaenoic to long-chain saturated fatty acids and isomers of docosapentaenoate) is common on Western diets and plays an important part in the causation of atherosclerosis, coronary thrombosis, multiple sclerosis, the triopathy of diabetes mellitus, hypertension and certain forms of malignant disease. Various factors affect the dietary requirement of docosapentaenoic acid. (PMID: 6469703).",,clupanodonic acid,,HMDB06528,"InChI=1S/C22H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15-",C16513,2016-12-05T15:48:05Z,,591,,,,,,clpnd,,"(7Z,10Z,13Z,16Z,19Z)-Docosa 7,10,13,16,19-pentaenoate, (7Z,10Z,13Z,16Z,19Z)-Docosa 7,10,13,16,19-pentaenoic acid, 7,10,13,16,19-Docosapentaenoate, 7,10,13,16,19-Docosapentaenoic acid, Clupanodonate, Clupanodonic acid, Docosapentaenoate, Docosapentaenoic acid, DPA",http://vmh.uni.lu/_api/metabolites/591/?format=pcsv
pglyc_hs,,,-1,C6H12O6PFULLRCO2FULLR2CO2,,,phosphatidylglycerol(1-),,phosphatidylglycerol(1-),,,,,2016-11-22T15:11:54Z,,592,,,,,,pglyc_hs,,,http://vmh.uni.lu/_api/metabolites/592/?format=pcsv
clpn_hs,,,-2,C9H16O9P2FULLRCO2FULLR2CO2FULLRCO2FULLR2CO2,,,cardiolipin,,cardiolipin,,,,,2016-11-22T15:11:54Z,,593,,,,,,clpn_hs,,,http://vmh.uni.lu/_api/metabolites/593/?format=pcsv
cmpacna,,,-2,C20H29N4O16P,CHEBI:16556,,CMP-N-acetyl-beta-neuraminate(2-),,CMP-N-acetyl-beta-neuraminate(2-),,,"InChI=1S/C20H31N4O16P/c1-7(26)22-12-8(27)4-20(18(32)33,39-16(12)13(29)9(28)5-25)40-41(35,36)37-6-10-14(30)15(31)17(38-10)24-3-2-11(21)23-19(24)34/h2-3,8-10,12-17,25,27-31H,4-6H2,1H3,(H,22,26)(H,32,33)(H,35,36)(H2,21,23,34)/p-2/t8-,9+,10+,12+,13+,14+,15+,16+,17+,20+/m0/s1",C00128,2016-11-22T15:11:54Z,,594,,,,,,cmpacna,,,http://vmh.uni.lu/_api/metabolites/594/?format=pcsv
coke,,,0,C17H21NO4,CHEBI:27958,,cocaine(1+),,cocaine(1+),,,"InChI=1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15+/m0/s1",C01416,2016-11-22T15:11:54Z,,595,,,,,446220,coke,,,http://vmh.uni.lu/_api/metabolites/595/?format=pcsv
egme,,,0,C10H17NO3,CHEBI:31529,,ecgoninium methyl ester(1+),,ecgoninium methyl ester(1+),,,"InChI=1S/C10H17NO3/c1-11-6-3-4-7(11)9(8(12)5-6)10(13)14-2/h6-9,12H,3-5H2,1-2H3/t6-,7+,8-,9+/m0/s1",C12448,2016-11-22T15:11:54Z,,596,,,,,,egme,,,http://vmh.uni.lu/_api/metabolites/596/?format=pcsv
2dpmhobq,,,0,C58H88O4,,,"2-decaprenyl-5-hydroxy-6-methoxy-3-methyl-1,4-benzoquinone",,"2-decaprenyl-5-hydroxy-6-methoxy-3-methyl-1,4-benzoquinone",,,"InChI=1S/C58H88O4/c1-43(2)23-14-24-44(3)25-15-26-45(4)27-16-28-46(5)29-17-30-47(6)31-18-32-48(7)33-19-34-49(8)35-20-36-50(9)37-21-38-51(10)39-22-40-52(11)41-42-54-53(12)55(59)57(61)58(62-13)56(54)60/h23,25,27,29,31,33,35,37,39,41,61H,14-22,24,26,28,30,32,34,36,38,40,42H2,1-13H3/b44-25+,45-27+,46-29+,47-31+,48-33+,49-35+,50-37+,51-39+,52-41+",,2016-11-22T15:11:54Z,,597,,,,,,2dpmhobq,,,http://vmh.uni.lu/_api/metabolites/597/?format=pcsv
q10,,,0,C59H90O4,CHEBI:16389,,ubiquinone-10,,ubiquinone-10,,,"InChI=1S/C59H90O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61/h24,26,28,30,32,34,36,38,40,42H,15-23,25,27,29,31,33,35,37,39,41,43H2,1-14H3/b45-26+,46-28+,47-30+,48-32+,49-34+,50-36+,51-38+,52-40+,53-42+",C11378,2016-11-22T15:11:54Z,,598,,,,ubiquinone,5281915,q10,,,http://vmh.uni.lu/_api/metabolites/598/?format=pcsv
2dp6mobq,,,0,C57H86O3,,,"2-decaprenyl-6-methoxy-1,4-benzoquinone",,"2-decaprenyl-6-methoxy-1,4-benzoquinone",,,"InChI=1S/C57H86O3/c1-44(2)22-13-23-45(3)24-14-25-46(4)26-15-27-47(5)28-16-29-48(6)30-17-31-49(7)32-18-33-50(8)34-19-35-51(9)36-20-37-52(10)38-21-39-53(11)40-41-54-42-55(58)43-56(60-12)57(54)59/h22,24,26,28,30,32,34,36,38,40,42-43H,13-21,23,25,27,29,31,33,35,37,39,41H2,1-12H3/b45-24+,46-26+,47-28+,48-30+,49-32+,50-34+,51-36+,52-38+,53-40+",,2016-11-22T15:11:54Z,,599,,,,,,2dp6mobq,,,http://vmh.uni.lu/_api/metabolites/599/?format=pcsv
2dp6mobq_me,,,0,C58H88O3,,,"2-decaprenyl-6-methoxy-3-methyl-1,4-benzoquinone",,"2-decaprenyl-6-methoxy-3-methyl-1,4-benzoquinone",,,"InChI=1S/C58H88O3/c1-44(2)23-14-24-45(3)25-15-26-46(4)27-16-28-47(5)29-17-30-48(6)31-18-32-49(7)33-19-34-50(8)35-20-36-51(9)37-21-38-52(10)39-22-40-53(11)41-42-55-54(12)56(59)43-57(61-13)58(55)60/h23,25,27,29,31,33,35,37,39,41,43H,14-22,24,26,28,30,32,34,36,38,40,42H2,1-13H3/b45-25+,46-27+,47-29+,48-31+,49-33+,50-35+,51-37+,52-39+,53-41+",,2016-11-22T15:11:54Z,,600,,,,,,2dp6mobq_me,,,http://vmh.uni.lu/_api/metabolites/600/?format=pcsv
2dp6mep,,,0,C57H88O2,CHEBI:50774,,2-Decaprenyl-6-methoxyphenol,,2-Decaprenyl-6-methoxyphenol,,,"InChI=1S/C57H88O2/c1-45(2)23-13-24-46(3)25-14-26-47(4)27-15-28-48(5)29-16-30-49(6)31-17-32-50(7)33-18-34-51(8)35-19-36-52(9)37-20-38-53(10)39-21-40-54(11)43-44-55-41-22-42-56(59-12)57(55)58/h22-23,25,27,29,31,33,35,37,39,41-43,58H,13-21,24,26,28,30,32,34,36,38,40,44H2,1-12H3/b46-25+,47-27+,48-29+,49-31+,50-33+,51-35+,52-37+,53-39+,54-43+",,2016-11-22T15:11:54Z,,601,,,,,,2dp6mep,,,http://vmh.uni.lu/_api/metabolites/601/?format=pcsv
Tn_antigen,,,0,C8H14NO5X,,,Tn antigen,,Tn antigen,,,,C04383,2016-11-22T15:11:54Z,,602,,,,,,Tn_antigen,,,http://vmh.uni.lu/_api/metabolites/602/?format=pcsv
core3,,,0,C16H27N2O10X,CHEBI:16250,,Core 3,,Core 3,,,,,2016-11-22T15:11:54Z,,603,,,,,,core3,,,http://vmh.uni.lu/_api/metabolites/603/?format=pcsv
core4,,,0,C24H40N3O15X,CHEBI:16478,,Core 4,,Core 4,,,,,2016-11-22T15:11:54Z,,604,,,,,,core4,,,http://vmh.uni.lu/_api/metabolites/604/?format=pcsv
core5,,,0,C16H27N2O10X,,,Core 5,,Core 5,,,,,2016-11-22T15:11:54Z,,605,,,,,,core5,,,http://vmh.uni.lu/_api/metabolites/605/?format=pcsv
core6,,,0,C16H27N2O10X,,,Core 6,,Core 6,,,,,2016-11-22T15:11:54Z,,606,,,,,,core6,,,http://vmh.uni.lu/_api/metabolites/606/?format=pcsv
core7,,,0,C16H27N2O10X,,,Core 7,,Core 7,,,,,2016-11-22T15:11:54Z,,607,,,,,,core7,,,http://vmh.uni.lu/_api/metabolites/607/?format=pcsv
core8,,,0,C14H24NO10X,,,Core 8,,Core 8,,,,,2016-11-22T15:11:54Z,,608,,,,,,core8,,,http://vmh.uni.lu/_api/metabolites/608/?format=pcsv
co,,,0,CO,CHEBI:17245,,carbon monoxide,,carbon monoxide,,,InChI=1S/CO/c1-2,C00237,2016-11-22T15:11:54Z,,609,,,,,281,co,,,http://vmh.uni.lu/_api/metabolites/609/?format=pcsv
T4hcinnm,,,-1,C9H7O3,CHEBI:32373,,trans-4-coumarate,,trans-4-coumarate,,,"InChI=1S/C9H8O3/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-6,10H,(H,11,12)/p-1/b6-3+",C00811,2016-11-22T15:11:54Z,,610,,,,,637542,T4hcinnm,,,http://vmh.uni.lu/_api/metabolites/610/?format=pcsv
coumarin,,,0,C9H6O2,CHEBI:28794,,"Human Metabolome Database (HMDB): Coumarin is a chemical compound/poison found in many plants, notably in high concentration in the tonka bean, woodruff, and bison grass. It has a sweet scent, readily recognised as the scent of newly-mown hay. It has clinical value as the precursor for several anticoagulants, notably warfarin. --Wikipedia. Coumarins, as a class, are comprised of numerous naturally occurring benzo-alpha-pyrone compounds with important and diverse physiological activities. The parent compound, coumarin, occurs naturally in many plants, natural spices, and foods such as tonka bean, cassia (bastard cinnamon or Chinese cinnamon), cinnamon, melilot (sweet clover), green tea, peppermint, celery, bilberry, lavender, honey (derived both from sweet clover and lavender), and carrots, as well as in beer, tobacco, wine, and other foodstuffs. Coumarin concentrations in these plants, spices, and foods range from <1 mg/kg in celery, 7000 mg/kg in cinnamon, and up to 87,000 mg/kg in cassia. An estimate of human exposure to coumarin from the diet has been calculated to be 0.02 mg/kg/day. Coumarin is used as an additive in perfumes and fragranced consumer products at concentrations ranging from <0.5% to 6.4% in fine fragrances to <0.01% in detergents. An estimate for systemic exposure of humans from the use of fragranced cosmetic products is 0.04 mg/kg BW/day, assuming complete dermal penetration. The use of coumarin as a food additive was banned by the FDA in 1954 based on reports of hepatotoxicity in rats. Due to its potential hepatotoxic effects in humans, the European Commission restricted coumarin from naturals as a direct food additive to 2 mg/kg food/day, with exceptions granting higher levels for alcoholic beverages, caramel, chewing gum, and certain 'traditional foods'. In addition to human exposure to coumarin from dietary sources and consumer products, coumarin is also used clinically as an antineoplastic and for the treatment of lymphedema and venous insufficiency. Exposure ranges from 11 mg/day for consumption of natural food ingredients to 7 g/day following clinical administration. Although adverse effects in humans following coumarin exposure are rare, and only associated with clinical doses, recent evidence indicates coumarin causes liver tumors in rats and mice and Clara cell toxicity and lung tumors in mice. The multiple effects as well as the ongoing human exposure to coumarin have resulted in a significant research effort focused on understanding the mechanism of coumarin induced toxicity/carcinogenicity and its human relevance. These investigations have revealed significant species differences in coumarin metabolism and toxicity such that the mechanism of coumarin induced effects in rodents, and the relevance of these findings for the safety assessment of coumarin exposure in humans are now better understood. In October 2004, the European Food Safety Authority (EFSA, 2004) reviewed coumarin to establish a tolerable daily intake (TDI) in foods. EFSA issued an opinion indicating that coumarin is not genotoxic, and that a threshold approach to safety assessment was most appropriate. EFSA recommended a TDI of 0 to 0.1 mg/kg BW/day. Including dietary contributions, the total human exposure is estimated to be 0.06 mg/kg/day. As a pharmaceutical, coumarin has been used in diverse applications with a wide variety of dosing regimens. Unlike coumadin and other coumarin derivatives, coumarin has no anti-coagulant activity. However, at low doses (typically 7 to 10 mg/day), coumarin has been used as a 'venotonic' to promote vein health and small venule blood flow. Additionally, coumarin has been used clinically in the treatment of high-protein lymphedema of various etiologies. (PMID: 16203076).",,coumarin,,HMDB01218,InChI=1S/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6H,C05851,2016-12-05T15:48:05Z,,611,,,,,323,coumarin,,"1, 2-Benzopyrone, 2-Oxo-1,2-benzopyran, 2-Oxo-2H-1-Benzopyran, 2H-1-Benzopyran-2-one, 2H-Benzo[b]pyran-2-one, 2H-Chromen-2-one, 2H-Chromen-2-one (ACD/Name 4.0), 5,6-Benzo-2-pyrone, Benzo-a-pyrone, Benzo-alpha-pyrone, cis-O-Coumarinic acid lactone, Coumarin, Coumarine, Coumarinic anhydride, Cumarin, Kumarin, O-Hydroxycinnamic acid lactone, O-Hydroxycinnamic lactone, O-Hydroxyzimtsaure-lacton, Rattex, Tonka bean camphor, {2H-Benzo[b]pyran-2-one}",http://vmh.uni.lu/_api/metabolites/611/?format=pcsv
ntm2amep,,,-1,C5H13NO3P,CHEBI:7347,,N-Trimethyl-2-aminoethylphosphonate,,N-Trimethyl-2-aminoethylphosphonate,,,"InChI=1/C5H14NO3P/c1-6(2,3)4-5-10(7,8)9/h4-5H2,1-3H3,(H-,7,8,9)/p+1",C06459,2016-11-22T15:11:54Z,,612,,,,,151927,,,,http://vmh.uni.lu/_api/metabolites/612/?format=pcsv
cmpntm2amep,,,-1,C14H25N4O10P2,,,CMP-N-trimethyl-2-aminoethylphosphonate,,CMP-N-trimethyl-2-aminoethylphosphonate,,,"InChI=1/C14H26N4O10P2/c1-18(2,3)6-7-29(22,23)28-30(24,25)26-8-9-11(19)12(20)13(27-9)17-5-4-10(15)16-14(17)21/h4-5,9,11-13,19-20H,6-8H2,1-3H3,(H3-,15,16,21,22,23,24,25)/p+1/t9-,11-,12-,13-/m1/s1",C05674,2016-11-22T15:11:54Z,,613,,,,,440755,,,,http://vmh.uni.lu/_api/metabolites/613/?format=pcsv
cpppg3,,,-4,C36H40N4O8,CHEBI:15439,,Human Metabolome Database (HMDB): Coproporphyrinogen III oxidase is deficient in hereditary coproporphyria. These persons usually have enhanced excretion even in a subclinical state of the disease.(PubMed ID 14605502 ).,,Coproporphyrinogen III,,HMDB01261,"InChI=1S/C36H44N4O8/c1-17-21(5-9-33(41)42)29-14-27-19(3)22(6-10-34(43)44)30(39-27)15-28-20(4)24(8-12-36(47)48)32(40-28)16-31-23(7-11-35(45)46)18(2)26(38-31)13-25(17)37-29/h37-40H,5-16H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)/p-4",C03263,2016-12-05T15:48:05Z,,614,,,,,321,cpppg3,,"3,8,13,17-Tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrapropanoate, 3,8,13,17-Tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrapropanoic acid, 5,10,15,20,22,24-Hexahydro-3,8,13,17-tetramethyl-2,7,12,18-Porphinetetrapropionate, 5,10,15,20,22,24-Hexahydro-3,8,13,17-tetramethyl-2,7,12,18-Porphinetetrapropionic acid, 5,10,15,20,22,24-Hexahydro-3,8,13,17-tetramethyl-21H,23H-Porphine-2,7,12,18-tetrapropanoate, 5,10,15,20,22,24-Hexahydro-3,8,13,17-tetramethyl-21H,23H-Porphine-2,7,12,18-tetrapropanoic acid, Coproporphyrinogen, Coproporphyrinogen III, Coproporphyrinogen-III",http://vmh.uni.lu/_api/metabolites/614/?format=pcsv
pppg9,,,-2,C34H38N4O4,CHEBI:15435,,Protoporphyrinogen IX,,Protoporphyrinogen IX,,,"InChI=1S/C34H40N4O4/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25/h7-8,35-38H,1-2,9-16H2,3-6H3,(H,39,40)(H,41,42)/p-2",C01079,2016-11-22T15:11:54Z,,615,,,,,121893,pppg9,,,http://vmh.uni.lu/_api/metabolites/615/?format=pcsv
pcrn,,,0,C10H19NO4,CHEBI:28867,,"Human Metabolome Database (HMDB): Propionylcarnitine is present in high abundance in the urine of patients with Methylmalonyl-CoA mutase (MUT) deficiency, (together with Methylmalonic acid). MUT is a mitochondrial enzyme that catalyzes the isomerization of methylmalonyl-CoA to succinyl-CoA (OMIM 609058 ).",,propionyl-carnitine,,HMDB00824,"InChI=1/C10H19NO4/c1-5-10(14)15-8(6-9(12)13)7-11(2,3)4/h8H,5-7H2,1-4H3",C03017,2016-12-05T15:48:05Z,,616,,,,,107738,pcrn,,"(+/-)-Propionylcarnitine chloride, (3-carboxy-2-hydroxypropyl)trimethyl-hydroxide Ammonium inner salt, 3-Carboxy-N,N,N-trimethyl-2-(1-oxopropoxy)-1-propanaminium inner salt, L-Propionylcarnitine, O-Propanoylcarnitine, O-Propionylcarnitine, Propionyl carnitine, Propionyl-carnitine, Propionyl-L-carnitine",http://vmh.uni.lu/_api/metabolites/616/?format=pcsv
dmnoncrn,,,0,C18H37NO4,,,"4,8-dimethylnonanoyl carnitine",,"4,8-dimethylnonanoyl carnitine",,,"InChI=1/C18H35NO4/c1-14(2)8-7-9-15(3)10-11-18(22)23-16(12-17(20)21)13-19(4,5)6/h14-16H,7-13H2,1-6H3",,2016-11-22T15:11:54Z,,617,,,,,,dmnoncrn,,,http://vmh.uni.lu/_api/metabolites/617/?format=pcsv
crtn,,,0,C4H7N3O,CHEBI:16737,,"Human Metabolome Database (HMDB): Creatinine or creatine anhydride, is a breakdown product of creatine phosphate in muscle. The loss of water molecule from creatine results in the formation of creatinine. Creatinine is transferred to the kidneys by blood plasma, whereupon it is eliminated from the body by glomerular filtration and partial tubular excretion. Creatinine is usually produced at a fairly constant rate by the body. Measuring serum creatinine is a simple test and it is the most commonly used indicator of renal function. A rise in blood creatinine levels is observed only with marked damage to functioning nephrons; therefore this test is not suitable for detecting early kidney disease. The typical reference range for women is considered about 45-90 umol/l, for men 60-110 umol/l. Creatine and creatinine are metabolized in the kidneys, muscle, liver and pancreas.",,creatinine,,HMDB00562,"InChI=1S/C4H7N3O/c1-7-2-3(8)6-4(7)5/h2H2,1H3,(H2,5,6,8)",C00791,2016-12-05T15:48:05Z,,618,,,,,,crtn,,"1-Methylglycocyamidine, 1-Methylhydantoin-2-imide, 2-Amino-1-methyl-1,5-dihydroimidazol-4-one, 2-Amino-1-methylimidazolin-4-one, Creatine anhydride, Creatinine",http://vmh.uni.lu/_api/metabolites/618/?format=pcsv
crtsl,,,0,C21H30O5,CHEBI:17650,,"Human Metabolome Database (HMDB): Cortisol is a corticosteroid hormone produced by the adrenal cortex that is involved in the response to stress; The main glucocorticoid secreted by the adrenal cortex. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. As an oral or injectable drug, cortisol is also known as hydrocortisone. It is used as an immunosuppressive drug, given by injection in the treatment of severe allergic reactions such as anaphylaxis and angioedema, in place of prednisolone in patients who need steroid treatment but cannot take oral medication, and peri-operatively in patients on long-term steroid treatment to prevent an Addisonian crisis. Cortisol or Hydrocortisone is a corticosteroid hormone produced by the adrenal cortex that is involved in the response to stress. It increases blood pressure, blood sugar levels, may cause infertility in women, and suppresses the immune system. Its synthetic counterpart (hydrocortisone) is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortisol is synthesized from pregnenolone. The amount of cortisol present in the serum undergoes diurnal variation, with the highest levels present in the early morning, and lower levels in the evening, several hours after the onset of sleep. Cortisol is a corticosteroid hormone produced by the adrenal cortex that is involved in the response to stress; it increases blood pressure, blood sugar levels, may cause infertility in women, and suppresses the immune system. Synthetic cortisol, also known as hydrocortisone, is used as a drug mainly to fight allergies and inflammation; it increases blood pressure, blood sugar levels, may cause infertility in women, and suppresses the immune system. Synthetic cortisol, also known as hydrocortisone, is used as a drug mainly to fight allergies and inflammation.",,cortisol,,HMDB00063,"InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",C00735,2016-12-05T15:48:05Z,,619,,,,,5754,crtsl,,"11-beta-Hydrocortisone, 11-beta-Hydroxycortisone, 11-Hydrocortisone, 11a-Hydroxycorticosterone, 11alpha-Hydroxycorticosterone, 11b,17,21-Trihydroxyprogesterone, 11b-Hydrocortisone, 11b-Hydroxycortisone, 11beta,17,21-Trihydroxyprogesterone, 11beta-Hydrocortisone, 11beta-Hydroxycortisone, 17-Hydroxycorticosterone, 17a-Hydroxycorticosterone, 17alpha-Hydroxycorticosterone, 4-Pregnene-11alpha,21-triol 3,20-dione, 4-Pregnene-11b,17a,21-triol-3,20-dione, Acticort, Aeroseb HC, Aeroseb-HC, Ala-Cort, Ala-Scalp, Alacort, Algicirtis, Alphaderm, Amberin, Anflam, Anti-inflammatory hormone, Aquacort, Aquanil HC, Barseb HC, Basan-Corti, CaldeCORT Spray, Cetacort, Chronocort, Clear aid, Cleiton, Cobadex, Compound F, Cor-Tar-Quin, Cort-Dome, Cort-Quin, Cortanal, Cortenema, Cortesal, Corticreme, Cortifan, Cortifoam, Cortiment, Cortisol alcohol, Cortisolonum, Cortisporin, Cortisporin Otico, Cortispray, Cortizol, Cortolotion, Cortonema, Cortoxide, Cremesone, Cremicort-H, Cutisol, Delacort, Derm-Aid, Dermil, Dermolate, Dihydrocostisone, Dioderm, Dome-cort, Domolene-HC, Drotic, Ef corlin, Efcorbin, Efcortelan, Efcortelin, Eldercort, Epicort, Epiderm H, Esiderm H, Evacort, Ficortril, Fiocortril, Foille Insetti, Genacort, Gyno-Cortisone, H-Cort, HC, Heb Cort, Heb-Cort, Hidalone, Hidro-Colisona, Hidrocortisona, Hycort, Hycortol, Hycortole, Hydracort, Hydrasson, Hydro-Adreson, Hydro-colisona, Hydrocort, Hydrocortal, Hydrocorticosterone, Hydrocortisone, Hydrocortisone alcohol, Hydrocortisone base, Hydrocortisone free alcohol, Hydrocortisonum, Hydrocortistab, Hydrocortisyl, Hydrocortone, Hydroskin, Hydroxycortisone, Hysone, Hytisone, Hytone, Hytone lotion, Idrocortisone, Incortin-H, Incortin-hydrogen, Kendall'S compound F, Komed HC, Kyypakkaus, Lacticare HC, Lacticare-HC, Lactisona, Lubricort, Maintasone, Medicort, Meusicort, Mildison, Milliderm, Neo-Cort-Dome, Neosporin-H Ear, Nutracort, Nystaform-HC, Optef, Otalgine, Otic-Neo-Cort-Dome, Otobiotic, Otocort, Otosone-F, Pediotic Suspension, Penecort, Permicort, Polcort H, Preparation H Hydrocortisone Cream, Prepcort, Prestwick_265, Prevex HC, Proctocort, Proctofoam, Protocort, Racet, Rectoid, Reichstein'S substance M, Remederm HC, Sanatison, Scalpicin Capilar, Schericur, Scheroson F, Sigmacort, Signef, Stiefcorcil, Synacort, Systral Hydrocort, Tarcortin, Timocort, Topicort, Transderma H, Traumaide, Uniderm, Vioform-Hydrocortisone, VoSol HC, Vytone, Zenoxone",http://vmh.uni.lu/_api/metabolites/619/?format=pcsv
crtstrn,,,0,C21H30O4,CHEBI:101161,,corticosterone,,corticosterone,,,"InChI=1S/C21H30O4/c1-20-8-7-13(23)9-12(20)3-4-14-15-5-6-16(18(25)11-22)21(15,2)10-17(24)19(14)20/h9,14-17,19,22,24H,3-8,10-11H2,1-2H3/t14-,15-,16+,17-,19+,20-,21-/m0/s1",C02140,2016-11-22T15:11:54Z,,620,,,,,,crtstrn,,,http://vmh.uni.lu/_api/metabolites/620/?format=pcsv
crvnc,,,-1,C22H31O2,CHEBI:28125,,"Human Metabolome Database (HMDB): Docosahexaenoic acid (DHA) is an omega-3 essential fatty acid. Chemically, DHA is a carboxylic acid with a 22-carbon chain and six cis double bonds with the first double bond is located at the third carbon from the omega end. DHA is most often found in fish oil. It is a major fatty acid in sperm and brain phospholipids, especially in the retina. Dietary DHA can reduce the level of blood triglycerides in humans, which may reduce the risk of heart disease. (wikipedia).",,"cervonic acid, C22:6 n-3",,HMDB02183,,C06429,2016-12-05T15:48:05Z,,621,,,,,,crvnc,,"4,7,10,13,16,19-Docosahexaenoate, 4,7,10,13,16,19-Docosahexaenoic acid, All-Z-Docosahexaenoate, All-Z-Docosahexaenoic acid, Cervonate, Cervonic acid, cis-4,7,10,13,16,19-Docosahexanoate, cis-4,7,10,13,16,19-Docosahexanoic acid, Doconexent, Doconexento, Doconexentum, Docosahexaenoate, Docosahexaenoic acid, Doxonexent",http://vmh.uni.lu/_api/metabolites/621/?format=pcsv
cspg_a,,,-5,C45H66N2O45S3X,,,chondroitin sulfate A (GalNAc4S-GlcA) proteoglycan,,chondroitin sulfate A (GalNAc4S-GlcA) proteoglycan,,,,,2016-11-22T15:11:54Z,,622,,,,,,cspg_a,,,http://vmh.uni.lu/_api/metabolites/622/?format=pcsv
Ser_Gly_Ala_X_Gly,,,0,XH,,,protein-linked serine residue (glycosaminoglycan attachment site),,protein-linked serine residue (glycosaminoglycan attachment site),,,,,2016-11-22T15:11:54Z,,623,,,,,,Ser_Gly_Ala_X_Gly,,,http://vmh.uni.lu/_api/metabolites/623/?format=pcsv
cs_a,,,-5,C45H67N2O46S3,,,"chondroitin sulfate A (GalNAc4S-GlcA), free chain",,"chondroitin sulfate A (GalNAc4S-GlcA), free chain",,,,,2016-11-22T15:11:55Z,,624,,,,,,cs_a,,,http://vmh.uni.lu/_api/metabolites/624/?format=pcsv
cspg_b,,,-6,C45H65N2O48S4X,,,chondroitin sulfate B / dermatan sulfate (IdoA2S-GalNAc4S) proteoglycan,,chondroitin sulfate B / dermatan sulfate (IdoA2S-GalNAc4S) proteoglycan,,,,,2016-11-22T15:11:55Z,,625,,,,,,cspg_b,,,http://vmh.uni.lu/_api/metabolites/625/?format=pcsv
cs_b,,,-6,C45H66N2O49S4,,,"chondroitin sulfate B / dermatan sulfate (IdoA2S-GalNAc4S), free chain",,"chondroitin sulfate B / dermatan sulfate (IdoA2S-GalNAc4S), free chain",,,,,2016-11-22T15:11:55Z,,626,,,,,,cs_b,,,http://vmh.uni.lu/_api/metabolites/626/?format=pcsv
cspg_c,,,-5,C45H66N2O45S3X,,,chondroitin sulfate C (GalNAc6S-GlcA) proteoglycan,,chondroitin sulfate C (GalNAc6S-GlcA) proteoglycan,,,,,2016-11-22T15:11:55Z,,627,,,,,,cspg_c,,,http://vmh.uni.lu/_api/metabolites/627/?format=pcsv
cs_c,,,-5,C45H67N2O46S3,,,"chondroitin sulfate C (GalNAc6S-GlcA), free chain",,"chondroitin sulfate C (GalNAc6S-GlcA), free chain",,,,,2016-11-22T15:11:55Z,,628,,,,,,cs_c,,,http://vmh.uni.lu/_api/metabolites/628/?format=pcsv
cspg_d,,,-7,C45H64N2O51S5X,,,chondroitin sulfate D (GlcNAc6S-GlcA2S) proteoglycan,,chondroitin sulfate D (GlcNAc6S-GlcA2S) proteoglycan,,,,,2016-11-22T15:11:55Z,,629,,,,,,cspg_d,,,http://vmh.uni.lu/_api/metabolites/629/?format=pcsv
cs_d,,,-7,C45H65N2O52S5,,,"chondroitin sulfate D (GlcNAc6S-GlcA2S), free chain",,"chondroitin sulfate D (GlcNAc6S-GlcA2S), free chain",,,,,2016-11-22T15:11:55Z,,630,,,,,,cs_d,,,http://vmh.uni.lu/_api/metabolites/630/?format=pcsv
cspg_e,,,-8,C45H63N2O54S6X,,,"chondroitin sulfate E (GalNAc4,6diS-GlcA) proteoglycan",,"chondroitin sulfate E (GalNAc4,6diS-GlcA) proteoglycan",,,,,2016-11-22T15:11:55Z,,631,,,,,,cspg_e,,,http://vmh.uni.lu/_api/metabolites/631/?format=pcsv
cs_e,,,-8,C45H64N2O55S6,,,"chondroitin sulfate E (GalNAc4,6diS-GlcA), free chain",,"chondroitin sulfate E (GalNAc4,6diS-GlcA), free chain",,,,,2016-11-22T15:11:55Z,,632,,,,,,cs_e,,,http://vmh.uni.lu/_api/metabolites/632/?format=pcsv
dmnoncoa,,,-4,C32H54N7O17P3S,,,"4,8 dimethylnonanoyl-CoA",,"4,8 dimethylnonanoyl-CoA",,,"InChI=1/C32H56N7O17P3S/c1-19(2)7-6-8-20(3)9-10-23(41)60-14-13-34-22(40)11-12-35-30(44)27(43)32(4,5)16-53-59(50,51)56-58(48,49)52-15-21-26(55-57(45,46)47)25(42)31(54-21)39-18-38-24-28(33)36-17-37-29(24)39/h17-21,25-27,31,42-43H,6-16H2,1-5H3,(H,34,40)(H,35,44)(H,48,49)(H,50,51)(H2,33,36,37)(H2,45,46,47)/t20?,21-,25-,26-,27?,31-/m1/s1",,2016-11-22T15:11:55Z,,633,,,,,,dmnoncoa,,,http://vmh.uni.lu/_api/metabolites/633/?format=pcsv
csn,,,0,C4H5N3O,CHEBI:16040,,Human Metabolome Database (HMDB): Cytosine is a pyrimidine base that is a fundamental unit of nucleic acids. The deamination of cytosine alone is apparent and the nucleotide of cytosine is the prime mutagenic nucleotide in leukaemia and cancer.,,cytosine,,HMDB00630,"InChI=1S/C4H5N3O/c5-3-1-2-6-4(8)7-3/h1-2H,(H3,5,6,7,8)",C00380,2016-12-05T15:48:05Z,,634,,,,,597,csn,,"4-Amino-2(1H)-pyrimidinone, 4-Amino-2-hydroxypyrimidine, 4-Amino-2-oxo-1,2-dihydropyrimidine, 4-Aminouracil, Cytosine, Cytosinimine",http://vmh.uni.lu/_api/metabolites/634/?format=pcsv
ura,,,0,C4H4N2O2,CHEBI:17568,,"Human Metabolome Database (HMDB): Uracil is a common naturally occurring pyrimidine found in RNA, it base pairs with adenine and is replaced by thymine in DNA. Methylation of uracil produces thymine. Uracil's use in the body is to help carry out the synthesis of many enzymes necessary for cell function through bonding with riboses and phosphates. Uracil serves as allosteric regulator and coenzyme for many important biochemical reactions. UDP and UTP regulate CPSase II activity in animals. UDP-glucose regulates the conversion of glucose to galactose in the liver and other tissues in the process of carbohydrate metabolism. Uracil is also involved in the biosynthesis of polysaccharides and the transportation of sugars containing aldehydes.",,uracil,,HMDB00300,"InChI=1S/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8)",C00106,2016-12-05T15:48:05Z,,635,,,,,1174,ura,,"2,4-Dihydroxypyrimidine, 2,4-Dioxopyrimidine, 2,4-Pyrimidinediol, 2,4-Pyrimidinedione, Hybar X, Pirod, Pyrod, Uracil",http://vmh.uni.lu/_api/metabolites/635/?format=pcsv
utp,,,-4,C9H11N2O15P3,CHEBI:15713,,"Human Metabolome Database (HMDB): Uridine 5'-(tetrahydrogen triphosphate). A uracil nucleotide containing three phosphate groups esterified to the sugar moiety. Uridine triphosphate has the role of a source of energy or an activator of substrates in metabolic reactions, like that of adenosine triphosphate, but more specific. When Uridine triphosphate activates a substrate, UDP-substrate is usually formed and inorganic phosphate is released. (Wikipedia).",,UTP,,HMDB00285,"InChI=1S/C9H15N2O15P3/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H,10,12,15)(H2,16,17,18)/p-4/t4-,6-,7-,8-/m1/s1",C00075,2016-12-05T15:48:05Z,,636,,,,,6133,utp,,"5'-UTP, Uridine 5'-triphosphate, Uridine mono(tetrahydrogen triphosphate), Uridine triphosphate, Uteplex, UTP",http://vmh.uni.lu/_api/metabolites/636/?format=pcsv
cyan,,,0,CHN,CHEBI:18407,,hydrogen cyanide,,hydrogen cyanide,,,InChI=1S/CHN/c1-2/h1H,C01326,2016-11-22T15:11:55Z,,637,,,,,768,cyan,,,http://vmh.uni.lu/_api/metabolites/637/?format=pcsv
focytC,,,2,C42H54FeN8O6S2,CHEBI:16928,,Ferrocytochrome C,,Ferrocytochrome C,,,,,2016-11-22T15:11:55Z,,638,,,,,,focytC,,,http://vmh.uni.lu/_api/metabolites/638/?format=pcsv
ficytC,,,3,C42H54FeN8O6S2,CHEBI:15991,,Ferricytochrome c,,Ferricytochrome c,,,,,2016-11-22T15:11:55Z,,639,,,,,,ficytC,,,http://vmh.uni.lu/_api/metabolites/639/?format=pcsv
q10h2,,,0,C59H92O4,CHEBI:17976,,Ubiquinol-10,,Ubiquinol-10,,,"InChI=1/C59H92O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61/h24,26,28,30,32,34,36,38,40,42,60-61H,15-23,25,27,29,31,33,35,37,39,41,43H2,1-14H3/b45-26+,46-28+,47-30+,48-32+,49-34+,50-36+,51-38+,52-40+,53-42+",C00390,2016-11-22T15:11:55Z,,640,,,,ubiquinol,9962735,q10h2,,,http://vmh.uni.lu/_api/metabolites/640/?format=pcsv
Lcystin,,,0,C6H12N2O4S2,CHEBI:16283,,"Human Metabolome Database (HMDB): Cystine is an oxidized dimeric form of cysteine. It is formed by linking two cysteine residues via a disulfide bond (cys-S-S-cys) between the -SH groups. Cystine is found in high concentrations in the cells of the immune system, skeletal and connective tissues, skin, digestive enzymes, and in hair. Hair and skin are 10-14% cystine. Cystine is the preferred form of cysteine for the synthesis of glutathione in cells involved in the immune function including macrophages and astrocytes. Lymphocytes and neurons prefer cysteine for glutathione production. Optimizing glutathione levels in macrophages and astrocytes with cystine allows these cells to provide cysteine to lymphocytes and neurons directly upon demand. (http://en.wikipedia.org/wiki/Cystine).",,L-cystine,,HMDB00192,"InChI=1S/C6H12N2O4S2/c7-3(5(9)10)1-13-14-2-4(8)6(11)12/h3-4H,1-2,7-8H2,(H,9,10)(H,11,12)/t3-,4-/m0/s1",C00491,2016-12-05T15:48:05Z,,641,,,,cysteine,,Lcystin,,"(-)-Cystine, (R-(R*,R*))-3,3'-Dithiobis, 2-Amino-3-(2-amino-2-carboxy-ethyl)disulfanyl-propanoate, 2-Amino-3-(2-amino-2-carboxy-ethyl)disulfanyl-propanoic acid, 2-Amino-3-[(2-amino-2-carboxyethyl)dithio]propanoate, 2-Amino-3-[(2-amino-2-carboxyethyl)dithio]propanoic acid, 3,3'-Dithiobis, 3,3'-Dithiobis-L-Alanine, 3,3'-Dithiobis[2-amino-[R-(R*,R*)]-Propanoate, 3,3'-Dithiobis[2-amino-[R-(R*,R*)]-Propanoic acid, 3,3'-Dithiodialanine, b,b'-Diamino-b,b'-dicarboxydiethyl disulfide, b,b'-Dithiodialanine, beta,beta'-Dithiobisalanine, beta,beta'-Dithiodialanine, Bis(b-amino-b-carboxyethyl) disulfide, Bis(b-amino-beta-carboxyethyl) disulfide, Cysteine disulfide, Cystin, Cystine, Cystine acid, D(+)-3,3'-Dithiobis(2-aminopropanoate, D(+)-3,3'-Dithiobis(2-aminopropanoic acid, Dicysteine, Gelucystine, L-(-)-Cystine, L-Cysteine disulfide, L-Cystin, L-Cystine, Oxidized L-cysteine, [R-(R*,R*)]-3,3'-Dithiobis",http://vmh.uni.lu/_api/metabolites/641/?format=pcsv
gthrd,,,-1,C10H16N3O6S,CHEBI:16856,,"Human Metabolome Database (HMDB): Glutathione is a compound synthesized from cysteine, perhaps the most important member of the body's toxic waste disposal team. Like cysteine, glutathione contains the crucial thiol (-SH) group that makes it an effective antioxidant. There are virtually no living organisms on this planet-animal or plant whose cells don't contain some glutathione. Scientists have speculated that glutathione was essential to the very development of life on earth. glutathione has many roles; in none does it act alone. It is a coenzyme in various enzymatic reactions. The most important of these are redox reactions, in which the thiol grouping on the cysteine portion of cell membranes protects against peroxidation; and conjugation reactions, in which glutathione (especially in the liver) binds with toxic chemicals in order to detoxify them. glutathione is also important in red and white blood cell formation and throughout the immune system. glutathione's clinical uses include the prevention of oxygen toxicity in hyperbaric oxygen therapy, treatment of lead and other heavy metal poisoning, lowering of the toxicity of chemotherapy and radiation in cancer treatments, and reversal of cataracts. (http://www.dcnutrition.com/AminoAcids/) glutathione participates in leukotriene synthesis and is a cofactor for the enzyme glutathione peroxidase. It is also important as a hydrophilic molecule that is added to lipophilic toxins and waste in the liver during biotransformation before they can become part of the bile. glutathione is also needed for the detoxification of methylglyoxal, a toxin produced as a by-product of metabolism. This detoxification reaction is carried out by the glyoxalase system. Glyoxalase I (EC 4.4.1.5) catalyzes the conversion of methylglyoxal and reduced glutathione to S-D-Lactoyl-glutathione. Glyoxalase II (EC 3.1.2.6) catalyzes the hydrolysis of S-D-Lactoyl-glutathione to glutathione and D-lactate. GSH is known as a substrate in both conjugation reactions and reduction reactions, catalyzed by glutathione S-transferase enzymes in cytosol, microsomes, and mitochondria. However, it is also capable of participating in non-enzymatic conjugation with some chemicals, as in the case of n-acetyl-p-benzoquinone imine (NAPQI), the reactive cytochrome P450-reactive metabolite formed by acetaminophen, that becomes toxic when GSH is depleted by an overdose (of acetaminophen). glutathione in this capacity binds to NAPQI as a suicide substrate and in the process detoxifies it, taking the place of cellular protein thiol groups which would otherwise be covalently modified; when all GSH has been spent, NAPQI begins to react with the cellular proteins, killing the cells in the process. The preferred treatment for an overdose of this painkiller is the administration (usually in atomized form) of N-acetylcysteine, which is used by cells to replace spent GSSG and renew the usable GSH pool. (http://en.wikipedia.org/wiki/glutathione).",,Reduced glutathione,,HMDB00125,"InChI=1S/C10H17N3O6S/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19)/p-1/t5-,6-/m0/s1",C00051,2016-12-05T15:48:05Z,,642,,,,glutathione,124886,gthrd,,"5-L-Glutamyl-L-cysteinylglycine, Agifutol S, Bakezyme RX, Copren, Deltathione, gamma-Glutamylcysteinylglycine, gamma-L-Glutamyl-L-cysteinyl-glycine, gamma-L-Glutamyl-L-cysteinylglycine, Glutathion, Glutathione, Glutathione red, Glutathione reduced, Glutathione-SH, Glutatiol, Glutatione, Glutide, Glutinal, GSH, Isethion, L-g-Glutamyl-L-cysteinyl-glycine, L-gamma-Glutamyl-L-cysteinyl-glycine, L-gamma-Glutamyl-L-cysteinylglycine, L-Glutamyl-L-cysteinylglycine, L-Glutathione, L-Glutathione reduce, Ledac, Neuthion, Red. glutathione, Reduced glutathione, Tathion, Tathione, Triptide",http://vmh.uni.lu/_api/metabolites/642/?format=pcsv
gthox,,,-2,C20H30N6O12S2,CHEBI:17858,,"Human Metabolome Database (HMDB): Oxidized glutathione is a glutathione dimer formed by a disulfide bond between the cysteine sulfhydryl side chains during the course of being oxidized. glutathione participates in leukotriene synthesis and is a cofactor for the enzyme glutathione peroxidase. It is also important as a hydrophilic molecule that is added to lipophilic toxins and waste in the liver during biotransformation before they can become part of the bile. glutathione is also needed for the detoxification of methylglyoxal, a toxin produced as a by-product of metabolism. This detoxification reaction is carried out by the glyoxalase system. Glyoxalase I (EC 4.4.1.5) catalyzes the conversion of methylglyoxal and reduced glutathione to S-D-Lactoyl-glutathione. Glyoxalase II (EC 3.1.2.6) catalyzes the hydrolysis of S-D-Lactoyl-glutathione to glutathione and D-lactate.",,Oxidized glutathione,,HMDB03337,"InChI=1S/C20H32N6O12S2/c21-9(19(35)36)1-3-13(27)25-11(17(33)23-5-15(29)30)7-39-40-8-12(18(34)24-6-16(31)32)26-14(28)4-2-10(22)20(37)38/h9-12H,1-8,21-22H2,(H,23,33)(H,24,34)(H,25,27)(H,26,28)(H,29,30)(H,31,32)(H,35,36)(H,37,38)/p-2/t9-,10-,11-,12-/m0/s1",C00127,2016-12-05T15:48:05Z,,643,,,,glutathione disulfide,65359,gthox,,"(2S)-2-azaniumyl-4-{[(1R)-2-{[(2R)-2-[(4S)-4-azaniumyl-4-carboxylatobutanamido]-2-[(carboxylatomethyl)carbamoyl]ethyl]disulfanyl}-1-[(carboxylatomethyl)carbamoyl]ethyl]carbamoyl}butanoate, Glutathione disulfide, GSSG, L(-)-Glutathione(oxidized), Oxiglutatione",http://vmh.uni.lu/_api/metabolites/643/?format=pcsv
thcys,,,0,C3H7NO2S2,CHEBI:28839,,"Human Metabolome Database (HMDB): The reactive species in the phosphofructokinase modulation system could be considered thiocysteine (R-S-S-) or cystine trisulfide (R-S-S-S-R) produced from cystine in the presence of gamma-Cystathionase (CST, EC 4.4.1.1). The desulfuration reaction of cystine in vivo produces thiocysteine containing a bound sulfur atom. Persulfide generated from L-cysteine inactivates tyrosine aminotransferase. Thiocysteine is the reactive (unstable) intermediate of thiocystine which functions as a persulfide in transferring its sulfane sulfur to thiophilic acceptors. Thiocystine conversion to unstable thiocysteine is accelerated by sulfhydryl compounds, or reagents that cleave sulfur-sulfur bonds to yield sulfhydryl groups. Thiocystine is proposed as the storage form of sulfane sulfur in biological systems. Liver cytosols contain factors that produce an inhibitor of tyrosine aminotransferase in 3 steps: initial oxidation of cysteine to form cystine; desulfurization of cystine catalyzed by cystathionase to form the persulfide, thiocysteine; and reaction of thiocysteine (or products of its decomposition) with proteins to form protein-bound sulfane. (PMID: 2903161, 454618, 7287665).",,3-disulfanyl-L-alanine,,HMDB03585,"InChI=1S/C3H7NO2S2/c4-2(1-8-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1",C01962,2016-12-05T15:48:05Z,,644,,,,,165331,thcys,,"3-(Thiosulfeno)-Alanine, 3-disulfanyl-L-alanine",http://vmh.uni.lu/_api/metabolites/644/?format=pcsv
mercppyr,,,-1,C3H3O3S,CHEBI:16208,,3-mercaptopyruvate,,3-mercaptopyruvate,,,"InChI=1S/C3H4O3S/c4-2(1-7)3(5)6/h7H,1H2,(H,5,6)/p-1",C00957,2016-11-22T15:11:56Z,,645,,,,,,mercppyr,,,http://vmh.uni.lu/_api/metabolites/645/?format=pcsv
cyst_L,,,0,C7H14N2O4S,CHEBI:17482,,"Human Metabolome Database (HMDB): Cystathionine is a dipeptide formed by serine and homocysteine. Cystathioninuria is a prominent manifestation of vitamin-B6 deficiency. The transsulfuration of methionine yields homocysteine, which combines with serine to form cystathionine, the proximate precursor of cysteine through the enzymatic activity of cystathionase. In conditions in which cystathionine gamma-synthase or cystathionase is deficient, for example, there is cystathioninuria. Although cystathionine has not been detected in normal human serum or plasma by most conventional methods, gas chromatographic/mass spectrometric methodology detected a mean concentration of cystathionine in normal human serum of 140 nM, with a range of 65 to 301 nM.567 Cystathionine concentrations in CSF have been 10, 1, and 0.5 uM, and ""not detected."" Only traces (i.e., <1 uM) of cystathionine are present in normal CSF.587. gamma-Cystathionase deficiency provided the first instance in which, in a human, the major biochemical abnormality due to a defined enzyme defect was clearly shown to be alleviated by administration of large doses of pyridoxine. The response in gamma-cystathionase-deficient patients is not attributable to correction of a preexisting deficiency of this vitamin. (OMMBID, Chap. 88).",,L-cystathionine,,HMDB00099,"InChI=1S/C7H14N2O4S/c8-4(6(10)11)1-2-14-3-5(9)7(12)13/h4-5H,1-3,8-9H2,(H,10,11)(H,12,13)/t4-,5-/m0/s1",C02291,2016-12-05T15:48:05Z,,646,,,,,439258,cyst_L,,"(R)-S-(2-amino-2-carboxyethyl)-L-Homocysteine, Cystathionine, L-(+)-Cystathionine, S-[(2R)-2-Amino-2-carboxyethyl]-L-Homocysteine, [R-(R*,S*)]-2-amino-4-[(2-amino-2-carboxyethyl)thio]-Butanoate, [R-(R*,S*)]-2-amino-4-[(2-amino-2-carboxyethyl)thio]-Butanoic acid",http://vmh.uni.lu/_api/metabolites/646/?format=pcsv
cytd,,,0,C9H13N3O5,CHEBI:17562,,"Human Metabolome Database (HMDB): Cytidine is a nucleoside that is composed of the base cytosine linked to the five-carbon sugar D-ribose. Cytidine is a pyrimidine that besides being incorporated into nucleic acids, can serve as substrate for the salvage pathway of pyrimidine nucleotide synthesis; as precursor of the cytidine triphosphate (CTP) needed in the phosphatidylcholine (PC) and phosphatidylethanolamine (PE) biosynthetic pathway. These variations probably reflect the species differences in cytidine deaminase, the enzyme that converts cytidine to uridine in the body. The transports of cytidine into the brain's extracellular fluid, and then into neurons and glia, are essential prerequisites for cytidine to be utilized in brain. An efficient mechanism mediating the brain uptake of circulating cytidine has not yet been demonstrated. The biosynthesis of PC, the most abundant phosphatide in the brain, via the Kennedy pathway requires phosphocholine and cytidine triphosphate (CTP), a cytidine nucleotide, which is involved in the rate-limiting step. The enzyme that converts CTP to endogenous CDP-choline (CTP: phosphocholine cytidylyltransferase) is unsaturated at physiological brain CTP levels. APOBEC is a family of enzymes has been discovered with the ability to deaminate cytidines on RNA or DNA. The human apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G (APOBEC3G, or hA3G) protein, provides cells with an intracellular antiretroviral activity that is associated with the hypermutation of viral DNA through cytidine deamination. Indeed, hA3G belongs to a family of vertebrate proteins that contain one or two copies of a signature sequence motif unique to cytidine deaminases (CTDAs). (PMID: 16769123, 15780864, 16720547).",,Cytidine,,HMDB00089,"InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7-,8-/m1/s1",C00475,2016-12-05T15:48:05Z,,647,,,,,6175,cytd,,"1-(b-D-Ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine, 1-(b-delta-Ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine, 1-b-D-Ribofuranosylcytosine, 1-b-D-Ribosyl-Cytosine, 1-beta-D-Ribofuranosyl-Cytosine, 1-beta-D-Ribofuranosylcytosine, 1-beta-delta-Ribofuranosyl-Cytosine, 1-beta-delta-Ribofuranosylcytosine, 1-beta-delta-Ribosyl-Cytosine, 1beta-D-Ribofuranosylcytosine, 1beta-delta-Ribofuranosylcytosine, 1beta-Ribofuranosylcytosine, 4-Amino-1-b-D-ribofuranosyl-2(1H)-pyrimidinone, 4-Amino-1-beta-delta-ribofuranosyl-2(1H)-pyrimidinone, Cytidine, Cytosine riboside, Cytosine-1b-D-Ribofuranoside, Cytosine-1b-delta-Ribofuranoside, Cytosine-1beta-D-Ribofuranoside, Cytosine-1beta-delta-Ribofuranoside",http://vmh.uni.lu/_api/metabolites/647/?format=pcsv
uri,,,0,C9H12N2O6,CHEBI:16704,,Human Metabolome Database (HMDB): Uridine is a molecule (known as a nucleoside) that is formed when uracil is attached to a ribose ring (also known as a ribofuranose) via a b-N1-glycosidic bond. (Wikipedia).,,Uridine,,HMDB00296,"InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7-,8-/m1/s1",C00299,2016-12-05T15:48:05Z,,648,,,,,6029,uri,,"1-b-D-Ribofuranosyl-2,4(1H,3H)-pyrimidinedione, 1-b-D-Ribofuranosyluracil, 1-beta-delta-Ribofuranosyl-2,4(1H,3H)-pyrimidinedione, 1-beta-delta-Ribofuranosyluracil, b-D-Ribofuranoside 2,4(1H,3H)-pyrimidinedione-1, b-Uridine, beta-delta-Ribofuranoside 2,4(1H,3H)-pyrimidinedione-1, beta-Uridine, Uridin",http://vmh.uni.lu/_api/metabolites/648/?format=pcsv
cdp,,,-3,C9H12N3O11P2,CHEBI:17239,,CDP,,CDP,,,"InChI=1S/C9H15N3O11P2/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H2,10,11,15)(H2,16,17,18)/p-3/t4-,6-,7-,8-/m1/s1",C00112,2016-11-22T15:11:56Z,,649,,,,,6132,cdp,,,http://vmh.uni.lu/_api/metabolites/649/?format=pcsv
dgtp,,,-4,C10H12N5O13P3,CHEBI:16497,,"Human Metabolome Database (HMDB): Under normal physiologic conditions, deoxyguanosine (dGuo) undergoes phosphorolysis by purine nucleoside phosphorylase (PNP, EC 2.4.2.1, an enzyme involved in the recycling of nucleosides and deoxynucleosides in cellular remodeling). However, when PNP is inhibited, deoxycytidine kinase (dCK, EC 2.7.1.74) shunts unmetabolized dGuo into deoxyguanosine triphosphate (dGTP), which accumulates and blocks DNA synthesis. Deficiency of purine nucleoside phosphorylase results in defective T-cell immunity. A correlation between the degree of T cell inhibition and the level of dCK activity is observed. (PMID: 11287638, 402573).",,dGTP,,HMDB01440,"InChI=1S/C10H16N5O13P3/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(26-6)2-25-30(21,22)28-31(23,24)27-29(18,19)20/h3-6,16H,1-2H2,(H,21,22)(H,23,24)(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1",C00286,2016-12-05T15:48:05Z,,650,,,,,65103,dgtp,," Deoxyguanosine 5'-triphosphate, 2'-Deoxyguanosine 5'-triphosphate, 2'-Deoxyguanosine triphosphate, Deoxyguanosine triphosphate",http://vmh.uni.lu/_api/metabolites/650/?format=pcsv
dgdp,,,-3,C10H12N5O10P2,CHEBI:28862,,"Human Metabolome Database (HMDB): dGDP is a derivative of the common nucleic acid GTP, or guanosine triphosphate, in which the -OH (hydroxyl) group on the 2' carbon on the nucleotide's pentose has been removed (hence the deoxy- part of the name). Additionally, the diphosphate of the name indicates that one of the phosphoryl groups of GTP has been removed, most likely by hydrolysis (Wikipedia).",,dGDP,,HMDB00960,"InChI=1S/C10H15N5O10P2/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(24-6)2-23-27(21,22)25-26(18,19)20/h3-6,16H,1-2H2,(H,21,22)(H2,18,19,20)(H3,11,13,14,17)/p-3/t4-,5+,6+/m0/s1",C00361,2016-12-05T15:48:05Z,,651,,,,,439220,dgdp,,"2'-Deoxy-GDP, 2'-Deoxyguanosine-5'-diphosphate, 5'-dGDP, Deoxyguanosine 5'-diphosphate, Deoxyguanosine diphosphate, Deoxyguanosine-diphosphate, dGDP",http://vmh.uni.lu/_api/metabolites/651/?format=pcsv
dcmp,,,-2,C9H12N3O7P,CHEBI:15918,,dCMP,,dCMP,,,"InChI=1S/C9H14N3O7P/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(19-8)4-18-20(15,16)17/h1-2,5-6,8,13H,3-4H2,(H2,10,11,14)(H2,15,16,17)/p-2/t5-,6+,8+/m0/s1",C00239,2016-11-22T15:11:56Z,,652,,,,,13945,dcmp,,,http://vmh.uni.lu/_api/metabolites/652/?format=pcsv
dcdp,,,-3,C9H12N3O10P2,,,dCDP,,dCDP,,,"InChI=1S/C9H15N3O10P2/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(21-8)4-20-24(18,19)22-23(15,16)17/h1-2,5-6,8,13H,3-4H2,(H,18,19)(H2,10,11,14)(H2,15,16,17)/p-3/t5-,6+,8+/m0/s1",C00705,2016-11-22T15:11:56Z,,653,,,,,150855,dcdp,,,http://vmh.uni.lu/_api/metabolites/653/?format=pcsv
dctp,,,-4,C9H12N3O13P3,CHEBI:16311,,dCTP,,dCTP,,,"InChI=1S/C9H16N3O13P3/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(23-8)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,5-6,8,13H,3-4H2,(H,18,19)(H,20,21)(H2,10,11,14)(H2,15,16,17)/t5-,6+,8+/m0/s1",C00458,2016-11-22T15:11:56Z,,654,,,,,65091,dctp,,,http://vmh.uni.lu/_api/metabolites/654/?format=pcsv
dad_2,,,0,C10H13N5O3,CHEBI:17256,,Human Metabolome Database (HMDB): Deoxyadenosine is a derivative of nucleoside adenosine. It is comprised of adenine attached to a deoxyribose moiety via a N9-glycosidic bond. Deoxyribose differs from ribose by the absence of oxygen in the 3' position of its ribose ring. Deoxyadenosine is a critical component of DNA.,,2-deoxyadenosine,,HMDB00101,"InChI=1S/C10H13N5O3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7/h3-7,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,7+/m0/s1",C00559,2016-12-05T15:48:05Z,,655,,,,,13730,dad_2,,"1-(6-Amino-9H-purin-9-yl)-1,2-dideoxy-b-D-Ribofuranose, 1-(6-Amino-9H-purin-9-yl)-1,2-dideoxy-beta-D-Ribofuranose, 1-(6-Amino-9H-purin-9-yl)-1,2-dideoxy-beta-delta-Ribofuranose, 2'-Deoxyadenosine, 2-Deoxyadenosine, 9-(2-Deoxy-b-D-erythro-pentofuranosyl)-9H-Purin-6-amine, 9-(2-Deoxy-b-D-erythro-pentofuranosyl)adenine, 9-(2-Deoxy-b-D-ribofuranosyl)-9H-Purin-6-amine, 9-(2-Deoxy-beta-D-erythro-pentofuranosyl)-9H-Purin-6-amine, 9-(2-Deoxy-beta-D-erythro-pentofuranosyl)adenine, 9-(2-Deoxy-beta-D-ribofuranosyl)-9H-Purin-6-amine, 9-(2-Deoxy-beta-delta-erythro-pentofuranosyl)-9H-Purin-6-amine, 9-(2-Deoxy-beta-delta-erythro-pentofuranosyl)adenine, 9-(2-Deoxy-beta-delta-ribofuranosyl)-9H-Purin-6-amine, Adenine deoxyribonucleoside, Adenine deoxyribose, Adenine-9 2-deoxy-b-D-erythro-Pentofuranoside, Adenine-9 2-deoxy-beta-D-erythro-Pentofuranoside, Adenine-9 2-deoxy-beta-delta-erythro-Pentofuranoside, Adenyldeoxyriboside, DA, Deoxyadenosine, Desoxyadenosine",http://vmh.uni.lu/_api/metabolites/655/?format=pcsv
din,,,0,C10H12N4O4,CHEBI:28997,,"Human Metabolome Database (HMDB): Deoxyinosine is a nucleoside that is formed when hypoxanthine is attached to a deoxyribose ring (also known as a ribofuranose) via a beta-N9-glycosidic bond. Deoxyinosine is found in DNA while Inosine is found in RNA. Inosine is a nucleic acid important for RNA editing. Adenosine deaminase (ADA) catalyzes the conversion of adenosine and deoxyadenosine to inosine and deoxyinosine, respectively. ADA-deficient individuals suffer from severe combined immunodeficiency (SCID) and are unable to produce significant numbers of mature T or B lymphocytes. This occurs as a consequence of the accumulation of ADA substrates or their metabolites. Inosine is also an intermediate in a chain of purine nucleotides reactions required for muscle movements.",,Deoxyinosine,,HMDB00071,"InChI=1S/C10H12N4O4/c15-2-6-5(16)1-7(18-6)14-4-13-8-9(14)11-3-12-10(8)17/h3-7,15-16H,1-2H2,(H,11,12,17)/t5-,6+,7+/m0/s1",C05512,2016-12-05T15:48:05Z,,656,,,,,65058,din,,"2'-Deoxyinosine, 2-Deoxy-Inosine, 9-(2-Deoxy-b-D-erythro-pentofuranosyl)-1,9-dihydro-6H-purin-6-one, 9-(2-Deoxy-b-D-erythro-pentofuranosyl)-Hypoxanthine, 9-(2-Deoxy-beta-D-erythro-pentofuranosyl)-Hypoxanthine, 9-(2-Deoxy-beta-delta-erythro-pentofuranosyl)-1,9-dihydro-6H-purin-6-one, 9-(2-Deoxy-beta-delta-erythro-pentofuranosyl)-Hypoxanthine, D-Ino, delta-Ino, Deoxyinosine",http://vmh.uni.lu/_api/metabolites/656/?format=pcsv
arg_D,,,1,C6H15N4O2,CHEBI:15816,,Human Metabolome Database (HMDB): D-Arginine is an essential amino acid that is physiologically active in the L-form.,,D-argininium(1+),,HMDB03416,"InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/p+1/t4-/m1/s1",C00792,2016-12-05T15:48:05Z,,657,,,,,,,,"D-2-Amino-5-guanidinovalerate, D-2-Amino-5-guanidinovaleric acid",http://vmh.uni.lu/_api/metabolites/657/?format=pcsv
5g2oxpt,,,0,C6H11N3O3,CHEBI:28116,,"Human Metabolome Database (HMDB): 2-Oxoarginine is a guanidino compound metabolite of arginine catabolism. 2-Oxoarginine levels are increased in patients with argininemia (OMIM:207800). Argininemia, characterized by arginase deficiency (EC 3.5.3.1, catalyzes the last step of the urea cycle) is an autosomal recessive inborn error of metabolism caused by a defect in the final step in the urea cycle, the hydrolysis of arginine to urea and ornithine. Accumulation of arginine metabolites (such as guanidino compounds) especially 2-oxoarginine, may produce the central nervous system damage in argininemia. (PMID: 3433275, 1588833, 1690873, 819629).",,5-guanidino-2-oxopentanoic acid,,HMDB04225,"InChI=1S/C6H11N3O3/c7-6(8)9-3-1-2-4(10)5(11)12/h1-3H2,(H,11,12)(H4,7,8,9)",C03771,2016-12-05T15:48:05Z,,658,,,,,,,,"2-Oxo-5-guanidinovaleric acid, 5-(Diaminomethylideneamino)-2-oxopentanoate, 5-(Diaminomethylideneamino)-2-oxopentanoic acid, 5-Guanidino-2-oxovaleric acid, a-Keto-D-Guanidinovaleric acid, alpha-Keto-delta-Guanidinovaleric acid, D-Guanidino-a-oxovaleric acid, D-Guanido-a-ketovaleric acid, delta-Guanidino-alpha-oxovaleric acid, delta-Guanido-alpha-ketovaleric acid",http://vmh.uni.lu/_api/metabolites/658/?format=pcsv
23doguln,,,-1,C6H7O7,CHEBI:15622,,"Human Metabolome Database (HMDB): 2,3-Diketo-L-gulonate is an intermediate in Ascorbate and aldarate metabolism. 2,3-Diketo-L-gulonate is produced from Dehydroascorbate and then converted to L-Xylonate via the enzyme Lyases (EC 4.1.1.-).",,"(4R,5S)-4,5,6-trihydroxy-2,3-dioxohexanoate",,HMDB06511,"InChI=1S/C6H8O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-3,7-9H,1H2,(H,12,13)/p-1/t2-,3+/m0/s1",C04575,2016-12-05T15:48:05Z,,659,,,,,440390,23doguln,,"(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate, (4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoic acid, 2,3-Diketo-L gulonic acid, 2,3-Diketo-L-gulonate, 2,3-Diketogulonic acid, Diketogulonic acid, L-Threo-2,3-hexodiulosonic acid, L-Threo-hexo-2,3-diulosonic acid",http://vmh.uni.lu/_api/metabolites/659/?format=pcsv
dd2coa,,,-4,C33H52N7O17P3S,CHEBI:15471,,trans-Dodec-2-enoyl-CoA,,trans-Dodec-2-enoyl-CoA,,,"InChI=1S/C33H56N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-24(42)61-17-16-35-23(41)14-15-36-31(45)28(44)33(2,3)19-54-60(51,52)57-59(49,50)53-18-22-27(56-58(46,47)48)26(43)32(55-22)40-21-39-25-29(34)37-20-38-30(25)40/h12-13,20-22,26-28,32,43-44H,4-11,14-19H2,1-3H3,(H,35,41)(H,36,45)(H,49,50)(H,51,52)(H2,34,37,38)(H2,46,47,48)/p-4/b13-12+/t22-,26-,27-,28+,32-/m1/s1",C03221,2016-11-22T15:11:56Z,,660,,,,trans-dodec-2-enoyl-CoA,45266564,dd2coa,,,http://vmh.uni.lu/_api/metabolites/660/?format=pcsv
dd3coa,,,-4,C33H52N7O17P3S,CHEBI:27989,,cis-dodec-3-enoyl-CoA(4-),,cis-dodec-3-enoyl-CoA(4-),,,"InChI=1S/C33H56N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-24(42)61-17-16-35-23(41)14-15-36-31(45)28(44)33(2,3)19-54-60(51,52)57-59(49,50)53-18-22-27(56-58(46,47)48)26(43)32(55-22)40-21-39-25-29(34)37-20-38-30(25)40/h11-12,20-22,26-28,32,43-44H,4-10,13-19H2,1-3H3,(H,35,41)(H,36,45)(H,49,50)(H,51,52)(H2,34,37,38)(H2,46,47,48)/p-4/b12-11-/t22-,26-,27-,28+,32-/m1/s1",C02944,2016-11-22T15:11:56Z,,661,,,,,16061154,dd3coa,,,http://vmh.uni.lu/_api/metabolites/661/?format=pcsv
dcyt,,,0,C9H13N3O4,CHEBI:15698,,"Human Metabolome Database (HMDB): One of the principal nucleosides of DNA composed of cytosine and deoxyribose. A nucleoside consists of only a pentose sugar linked to a purine or pyrimidine base, without a phosphate group. When N1 is linked to the C1 of deoxyribose, deoxynucleosides and nucleotides are formed from cytosine and deoxyribose; deoxycytidine monophosphate (dCMP), deoxycytidine diphosphate (dCDP), deoxycytidine triphosphate (dCTP). CTP is the source of the cytidine in RNA (ribonucleic acid) and deoxycytidine triphosphate (dCTP) is the source of the deoxycytidine in DNA (deoxyribonucleic acid).",,Deoxycytidine,,HMDB00014,"InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1",C00881,2016-12-05T15:48:05Z,,662,,,,,13711,dcyt,,"1-(2-Deoxy-b-D-ribofuranosyl)cytosine, 1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-Cytosine, 1-(2-Deoxy-beta-D-ribofuranosyl)cytosine, 1-(2-Deoxy-beta-delta-erythro-pentofuranosyl)-Cytosine, 1-(2-Deoxy-beta-delta-ribofuranosyl)cytosine, 2'-Deoxycytidine, 2-Deoxy-Cytidine, 4-Amino-1-(2-deoxy-b-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone, 4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone, 4-Amino-1-(2-deoxy-beta-delta-erythro-pentofuranosyl)-2(1H)-pyrimidinone, Cytosine deoxyribonucleoside, Cytosine deoxyriboside, Deoxy-Cytidine, Deoxyribose cytidine, Desoxycytidine",http://vmh.uni.lu/_api/metabolites/662/?format=pcsv
dump,,,-2,C9H11N2O8P,CHEBI:17622,,"Human Metabolome Database (HMDB): dUMP is formed by the reduction of ribonucleotides to deoxyribonucleotides by ribonucleoside diphosphate reductase [EC 1.17.4.1]. dUMP by the action of by thymidylate synthetase [EC 2.1.1.45] produces dTMP (5,10-Methylene-5,6,7,8-tetrahydrofolate is a cofactor for the reaction). The nuclear form of uracil-DNA glycosylase (UNG2), that its major role is to remove misincorporated dUMP residues (cells deficient in removal of misincorporated dUMP accumulate uracil residues). (PMID 11554311).",,dUMP,,HMDB01409,"InChI=1S/C9H13N2O8P/c12-5-3-8(11-2-1-7(13)10-9(11)14)19-6(5)4-18-20(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,10,13,14)(H2,15,16,17)/p-2/t5-,6+,8+/m0/s1",C00365,2016-12-05T15:48:05Z,,663,,,,,65063,dump,,"2'-Deoxy-5'-uridylate, 2'-Deoxy-5'-uridylic acid, 2'-Deoxyuridine 5'-monophosphate, 2'-Deoxyuridine 5'-phosphate, 2'-Deoxyuridylate, 2'-Deoxyuridylic acid, Deoxy-UMP, Deoxyuridine 5'-monophosphate, Deoxyuridine 5'-phosphate, Deoxyuridine monophosphate, Deoxyuridylate, Deoxyuridylic acid",http://vmh.uni.lu/_api/metabolites/663/?format=pcsv
dcsptn1crn,,,0,C29H47NO4,,,"docosa-4,7,10,13,16-pentaenoyl carnitine",,"docosa-4,7,10,13,16-pentaenoyl carnitine",,,"InChI=1/C29H47NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-29(33)34-27(25-28(31)32)26-30(2,3)4/h9-10,12-13,15-16,18-19,21-22,27H,5-8,11,14,17,20,23-26H2,1-4H3/b10-9+,13-12+,16-15+,19-18+,22-21+",,2016-11-22T15:11:56Z,,664,,,,,,dcsptn1crn,,,http://vmh.uni.lu/_api/metabolites/664/?format=pcsv
dcsptn1,,,-1,C22H33O2,CHEBI:65136,,"docosa-4,7,10,13,16-pentaenoic acid",,"docosa-4,7,10,13,16-pentaenoic acid",,HMDB13123,"InChI=1/C22H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h6-7,9-10,12-13,15-16,18-19H,2-5,8,11,14,17,20-21H2,1H3,(H,23,24)/b7-6-,10-9-,13-12-,16-15-,19-18-",,2016-11-22T15:11:56Z,,665,,,,,159656,dcsptn1,,,http://vmh.uni.lu/_api/metabolites/665/?format=pcsv
L_dpchrm,,,-1,C9H6NO4,CHEBI:15772,,"Human Metabolome Database (HMDB): The non-decarboxylative tautomerization of L-dopachrome to 5,6-dihydroxyindole-2-carboxylic acid in the melanin biosynthetic pathway is catalyzed by Tyrosinase-related protein-2, a melanocyte-specific enzyme. (PMID 11095412).",,L-dopachromate,,HMDB01430,"InChI=1S/C9H7NO4/c11-7-2-4-1-6(9(13)14)10-5(4)3-8(7)12/h2-3,6,10H,1H2,(H,13,14)/p-1/t6-/m0/s1",C01693,2016-12-05T15:48:05Z,,666,,,,L-dopachrome,5459802,L_dpchrm,,"2-L-Carboxy-2,3-dihydroindole-5,6-quinone, L-Dopachrome",http://vmh.uni.lu/_api/metabolites/666/?format=pcsv
56dihindlcrbxlt,,,-1,C9H6NO4,CHEBI:16875,,"Human Metabolome Database (HMDB): 5,6-Dihydroxyindole-2-carboxylic acid is an intermediate in the metabolism of Tyrosine. It is a substrate for Dopachrome tautomerase.",,"5,6-dihydroxyindole-2-carboxylate",,HMDB01253,"InChI=1S/C9H7NO4/c11-7-2-4-1-6(9(13)14)10-5(4)3-8(7)12/h1-3,10-12H,(H,13,14)/p-1",C04185,2016-12-05T15:48:05Z,,667,,,,,,56dihindlcrbxlt,,"5,6-Dhica, 5,6-Dihydroxy-1H-indole-2-carboxylate, 5,6-Dihydroxy-1H-indole-2-carboxylic acid, 5,6-Dihydroxy-2-indolecarboxylate, 5,6-Dihydroxy-2-indolecarboxylic acid, 5,6-Dihydroxy-2-indolylcarboxylate, 5,6-Dihydroxy-2-indolylcarboxylic acid, 5,6-Dihydroxyindole-2-carboxylate, DHI2C, DHICA",http://vmh.uni.lu/_api/metabolites/667/?format=pcsv
duri,,,0,C9H12N2O5,CHEBI:16450,,"Human Metabolome Database (HMDB): 2'-Deoxyuridine is a naturally occurring nucleoside. It is similar in chemical structure to uridine, but without the 2'-hydroxyl group. It is considered to be an antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemia due to vitamin B12 and folate deficiencies.",,Deoxyuridine,,HMDB00012,"InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1",C00526,2016-12-05T15:48:05Z,,668,,,,,13712,duri,,"1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-2,4(1H,3H)-Pyrimidinedione, 1-(2-Deoxy-beta-D-ribofuranosyl)-2,4(1H,3H)-Pyrimidinedione, 1-(2-Deoxy-beta-delta-erythro-pentofuranosyl)-2,4(1H,3H)-Pyrimidinedione, 1-(2-Deoxy-beta-delta-ribofuranosyl)-2,4(1H,3H)-Pyrimidinedione, 1-(2-Deoxy-D-erythro-pentofuranosyl)uracil, 1-(2-Deoxy-delta-erythro-pentofuranosyl)uracil, 2'-Deoxyuridine, 2'-Desoxyuridine, Deoxyribose uracil, Desoxyuridine, Uracil deoxyriboside, Uracil desoxyuridine",http://vmh.uni.lu/_api/metabolites/668/?format=pcsv
4h2oglt,,,-2,C5H4O6,CHEBI:30923,,4-hydroxy-2-oxoglutarate(2-),,4-hydroxy-2-oxoglutarate(2-),,,"InChI=1S/C5H6O6/c6-2(4(8)9)1-3(7)5(10)11/h2,6H,1H2,(H,8,9)(H,10,11)/p-2",C01127,2016-11-22T15:11:56Z,,669,,,,,599,4h2oglt,,,http://vmh.uni.lu/_api/metabolites/669/?format=pcsv
debrisoquine,,,1,C10H14N3,CHEBI:34665,,"Human Metabolome Database (HMDB): Debrisoquine is an adrenergic neuron-blocking drug. Genetic and environmental factors are determinants of the interindividual and interethnic variability in drug metabolism. Thus, interethnic differences in debrisoquine hydroxylation polymorphism (Cytochrome p450, subfamily IID, polypeptide 6, CYP2D6) might be partly responsible for the variation in haloperidol disposition between races. The influence of tobacco, ethanol, caffeine, gender, and oral contraceptive use on the debrisoquine metabolic ratio (MR) has been analyzed in panels of healthy volunteers. About 5-10% of European white population has a genetically determinant defect of the CYP2D6, one of the enzymes of cytochrome P-450. This defect leads to the impaired metabolism of many drugs including various psychopharmacological agents. The measurement of the hydroxylation of debrisoquine is a laboratory test which allows identifying such an individual. Patients who show an impaired hydroxylation of debrisoquine usually demonstrate severe side effects and poor outcome of psychopharmacotherapy. In practice, knowledge of a patient's debrisoquine metabolic phenotype is an advantage when prescribing tricyclic antidepressants and neuroleptics, as the drug concentration will be considerably higher in slow metabolisers than in the average patient. (PMID: 8839686, 1738265, 7878155).",,debrisoquine,,HMDB06543,"InChI=1S/C10H13N3/c11-10(12)13-6-5-8-3-1-2-4-9(8)7-13/h1-4H,5-7H2,(H3,11,12)",C13650,2016-12-05T15:48:05Z,,670,,,,,2966,debrisoquine,,"3,4-Dihydro-2(1H)-isoquinolinecarboximidamide, Debrisoquin sulfate, Debrisoquin sulphate",http://vmh.uni.lu/_api/metabolites/670/?format=pcsv
decdp,,,-3,C50H81O7P2,,,all trans Decaprenyl diphosphate,,all trans Decaprenyl diphosphate,,,"InChI=1/C50H90O7P2/c1-41(2)21-31-53-58(51,54-32-22-42(3)4)57-59(52,35-25-45(9)10,36-26-46(11)12,37-27-47(13)14,38-28-48(15)16,39-29-49(17)18,40-30-50(19)20,55-33-23-43(5)6)56-34-24-44(7)8/h21-30H,31-40H2,1-20H3",,2016-11-22T15:11:56Z,,671,,,,,,decdp,,,http://vmh.uni.lu/_api/metabolites/671/?format=pcsv
dedoldp_L,,,-30,C1080H1738O70P20,,,"Dehydrodolichol diphosphate, human liver homolog",,"Dehydrodolichol diphosphate, human liver homolog",,,,C05859,2016-11-22T15:11:56Z,,672,,,,,,dedoldp_L,,,http://vmh.uni.lu/_api/metabolites/672/?format=pcsv
dedolp_L,,,-20,C1080H1738O40P10,,,"Dehydrodolichol phosphate, human liver homolog",,"Dehydrodolichol phosphate, human liver homolog",,,,,2016-11-22T15:11:56Z,,673,,,,,,dedolp_L,,,http://vmh.uni.lu/_api/metabolites/673/?format=pcsv
dedoldp_U,,,-30,C1025H1650O70P20,,,"Dehydrodolichol diphosphate, human uterine homolog",,"Dehydrodolichol diphosphate, human uterine homolog",,,,C05859,2016-11-22T15:11:56Z,,674,,,,,,dedoldp_U,,,http://vmh.uni.lu/_api/metabolites/674/?format=pcsv
dedolp_U,,,-20,C1025H1650O40P10,,,"Dehydrodolichol phosphate, human uterine homolog",,"Dehydrodolichol phosphate, human uterine homolog",,,,,2016-11-22T15:11:56Z,,675,,,,,,dedolp_U,,,http://vmh.uni.lu/_api/metabolites/675/?format=pcsv
dedol_L,,,0,C1080H1748O10,,,"Dehydrodolichol, human liver homolog",,"Dehydrodolichol, human liver homolog",,,,,2016-11-22T15:11:56Z,,676,,,,,,dedol_L,,,http://vmh.uni.lu/_api/metabolites/676/?format=pcsv
dedol_U,,,0,C1025H1660O10,,,"Dehydrodolichol, human uterine homolog",,"Dehydrodolichol, human uterine homolog",,,,,2016-11-22T15:11:56Z,,677,,,,,,dedol_U,,,http://vmh.uni.lu/_api/metabolites/677/?format=pcsv
dolichol_L,,,0,C1080H1768O10,CHEBI:16091,,"Dolichol, human liver homolog",,"Dolichol, human liver homolog",,,,,2016-11-22T15:11:56Z,,678,,,,,,dolichol_L,,,http://vmh.uni.lu/_api/metabolites/678/?format=pcsv
dolichol_U,,,0,C1025H1680O10,,,"Dolichol, human uterine homolog",,"Dolichol, human uterine homolog",,,,,2016-11-22T15:11:56Z,,679,,,,,,dolichol_U,,,http://vmh.uni.lu/_api/metabolites/679/?format=pcsv
tag_hs,,,0,C3H5FULLRCO2FULLR2CO2FULLR3CO2,,,triglyceride,,triglyceride,,,,,2016-11-22T15:11:56Z,,680,,,,,,tag_hs,,,http://vmh.uni.lu/_api/metabolites/680/?format=pcsv
dgmp,,,-2,C10H12N5O7P,CHEBI:16192,,dGMP,,dGMP,,,"InChI=1S/C10H14N5O7P/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(22-6)2-21-23(18,19)20/h3-6,16H,1-2H2,(H2,18,19,20)(H3,11,13,14,17)/p-2/t4-,5+,6+/m0/s1",C00362,2016-11-22T15:11:56Z,,681,,,,,65059,dgmp,,,http://vmh.uni.lu/_api/metabolites/681/?format=pcsv
dgsn,,,0,C10H13N5O4,CHEBI:17172,,"Human Metabolome Database (HMDB): Deoxyguanosine is a nucleoside consisting of the base guanine and the sugar deoxyribose. It is like guanosine, but with one oxygen atom removed. It is a nucleoside component of DNA. Deoxyguanosine can be converted to 8-hydroxy-deoxyguanosine (8-OHdG) due to hydroxyl radical attack at the C8 of guanine. 8-OHdG is a sensitive marker of the DNA damage This damage, if left unrepaired, has been proposed to contribute to mutagenicity and cancer promotion.",,Deoxyguanosine,,HMDB00085,"InChI=1S/C10H13N5O4/c11-10-13-8-7(9(18)14-10)12-3-15(8)6-1-4(17)5(2-16)19-6/h3-6,16-17H,1-2H2,(H3,11,13,14,18)/t4-,5+,6+/m0/s1",C00330,2016-12-05T15:48:05Z,,682,,,,,187790,dgsn,,"2'-Deoxy-Guanosine, 2'-Deoxyguanosine, 2-Deoxyguanosine, 9-(2-Deoxy-b-D-erythro-pentofuranosyl)-Guanine, 9-(2-Deoxy-b-D-erythro-pentofuranosyl)guanine, 9-(2-Deoxy-beta-delta-erythro-pentofuranosyl)-Guanine, 9-(2-Deoxy-beta-delta-erythro-pentofuranosyl)guanine, Deoxyguanosine, Desoxyguanosine, Guanine deoxy nucleoside, Guanine deoxyriboside",http://vmh.uni.lu/_api/metabolites/682/?format=pcsv
3dhguln,,,-1,C6H9O7,CHEBI:16142,,"Human Metabolome Database (HMDB): 3-Dehydro-L-gulonate is an intermediate in Ascorbate and aldarate metabolism. 3-Dehydro-L-gulonate is the 4th to last step in the synthesis of D-Xylulose 5-phosphate and is converted from 2,3-Diketo-L-gulonate via the enzyme 3-dehydro-L-gulonate 2-dehydrogenase (EC 1.1.1.130). It is then converted to 3-Dehydro-L-gulonate 6-phosphate via the enzyme L-xylulokinase (EC 2.7.1.53).",,3-dehydro-L-gulonate,,HMDB06334,"InChI=1S/C6H10O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-3,5,7-9,11H,1H2,(H,12,13)/p-1/t2-,3+,5-/m0/s1",C00618,2016-12-05T15:48:05Z,,683,,,,,,3dhguln,,"3-Dehydro-L-gulonic acid, L-Xylo-hex-3-ulosonic acid",http://vmh.uni.lu/_api/metabolites/683/?format=pcsv
dhcholestanate,,,-1,C27H45O4,CHEBI:48467,,"Human Metabolome Database (HMDB): 3a,7a-Dihydroxycoprostanic acid is a bile acid excreted in small amounts in the urine of healthy subjects (PMID 864325). 3a,7a-Dihydroxycoprostanic acid is the precursor to chenodeoxycholic acid. A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues.",,"3alpha,7alpha-Dihydroxy-5beta-cholestanate",,HMDB00359,"InChI=1S/C27H46O4/c1-16(6-5-7-17(2)25(30)31)20-8-9-21-24-22(11-13-27(20,21)4)26(3)12-10-19(28)14-18(26)15-23(24)29/h16-24,28-29H,5-15H2,1-4H3,(H,30,31)/t16-,17?,18+,19-,20-,21+,22+,23-,24+,26+,27-/m1/s1",C04554,2016-12-05T15:48:05Z,,684,,,,,53477686,dhcholestanate,,"3a,7a-Dihydroxy-5b-cholestan-26-oate, 3a,7a-Dihydroxy-5b-cholestan-26-oic acid, 3a,7a-Dihydroxy-5b-cholestanoate, 3a,7a-Dihydroxy-5b-cholestanoic acid, 3a,7a-Dihydroxycoprostanate, 3a,7a-Dihydroxycoprostanic acid, 3a,7a-Hydroxy-5b-cholestan-26-oate, 3a,7a-Hydroxy-5b-cholestan-26-oic acid, 3alpha,7alpha-Dihydroxy-5beta-cholestan-26-oate, 3alpha,7alpha-Dihydroxy-5beta-cholestan-26-oic acid, 3alpha,7alpha-Dihydroxy-5beta-cholestanate, 3alpha,7alpha-dihydroxy-5beta-cholestanic acid, 3alpha,7alpha-Dihydroxy-5beta-cholestanoate, 3alpha,7alpha-dihydroxy-5beta-cholestanoic acid",http://vmh.uni.lu/_api/metabolites/684/?format=pcsv
zymstnl,,,0,C27H46O,CHEBI:16608,,"Human Metabolome Database (HMDB): 5a-Cholest-8-en-3b-ol is a normal human metabolite and an intermediate of cholesterol synthesis. The concentrations of zymostenol are higher, both in serum and bile of patients with cerebrotendinous xanthomatosis, compared to controls or in patients with cerebrotendinous xanthomatosis treated with chenodeoxycholic acid. Kidney transplant recipients had lower serum zymostenol when compared to controls. During consumption of plant stanol ester spread by hypercholesterolemic children, plant sterols in the plasma decrease and cholesterol precursor sterols such as zymostenol increase. (PMID: 15736111, 16709621, 16477216, 12756385).",,5alpha-cholest-8-en-3beta-ol,,HMDB06841,"InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h18-21,23-24,28H,6-17H2,1-5H3/t19-,20+,21+,23-,24+,26+,27-/m1/s1",C03845,2016-12-05T15:48:05Z,,685,,,,,101770,zymstnl,,"(3beta,5alpha)Cholestenol, 3beta-hydroxy-8(9)-cholestene, 3beta-hydroxycholest-8(9)-ene, 5-alpha-Cholest-8-en-3-beta-ol, 5alpha-Cholest-8(9)-en-3beta-ol, 5alpha-cholest-8-en-3beta-ol, Cholest-8(9)-en-3beta-ol, Cholesta-8(9)-en-3beta-ol, delta(8)-Cholestenol",http://vmh.uni.lu/_api/metabolites/685/?format=pcsv
chlstol,,,0,C27H44O,CHEBI:16290,,"5alpha-cholesta-7,24-dien-3beta-ol",,"5alpha-cholesta-7,24-dien-3beta-ol",,,"InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,10,19-21,23-25,28H,6,8-9,11-17H2,1-5H3/t19-,20+,21+,23-,24+,25+,26+,27-/m1/s1",C05439,2016-11-22T15:11:56Z,,686,,,,,,chlstol,,,http://vmh.uni.lu/_api/metabolites/686/?format=pcsv
lthstrl,,,0,C27H46O,CHEBI:17168,,"Human Metabolome Database (HMDB): Lathosterol is a a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. It is used as an indicator of whole-body cholesterol synthesis (PMID 14511438). Plasma lathosterol levels are significantly elevated in patients with bile acid malabsorption (PMID: 8777839). Lathosterol oxidase (EC 1.14.21.6) is an enzyme that catalyzes the chemical reaction 5alpha-cholest-7-en-3beta-ol + NAD(P)H + H+ + O2 cholesta-5,7-dien-3beta-ol + NAD(P)+ + 2 H2O.",,5alpha-cholest-7-en-3beta-ol,,HMDB01170,"InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h10,18-21,23-25,28H,6-9,11-17H2,1-5H3/t19-,20+,21+,23-,24+,25+,26+,27-/m1/s1",C01189,2016-12-05T15:48:05Z,,687,,,,,65728,lthstrl,,"(3beta)-Cholest-7-en-3-ol, (3beta,5alpha)-Cholest-7-en-3-ol, (3beta,alpha)-Cholest-7-en-3-ol, (7)-Cholestenol, 3b-Hydroxy-5-cholestene, 3beta-Hydroxy-5alpha-cholest-7-ene, 5-a-Cholest-7-en-3-beta-ol, 5-alpha-Cholest-7-en-3-beta-ol, 5alpha-cholest-7-en-3beta-ol, 7-Cholesten-3-beta-ol, 7-Cholestenol, 7-Cholesterol, Cholest-7-en-3-ol, Cholest-7-en-3beta-ol, Cholest-7-en-ol, Cholesterol - synthetic, Cholesterol extra pure, Cholesterol gr, Cholesterol Pharma, Cholesterol,NF Grade, delta(7)-Cholestenol, DELTA7-Cholesten-3beta-ol, DELTA7-Cholestenol, gamma-Cholestenol, gamma-Cholesterol, Lathosterol",http://vmh.uni.lu/_api/metabolites/687/?format=pcsv
dsmsterol,,,0,C27H44O,CHEBI:17737,,"Human Metabolome Database (HMDB): Desmosterol is an intermediate in the synthesis of cholesterol. Desmosterolosis is a rare autosomal recessive inborn errors of cholesterol synthesis that is caused by defective activity of desmosterol reductase which results in an accumulation of demosterol (DHCR24, EC 1.3.1.72), combines a severe osteosclerotic skeletal dysplasia and includes 2-3 toe syndactyly with Smith-Lemli-Opitz syndrome (SLOS; the biochemical block in SLOS results in decreased cholesterol levels and increased 7-dehydrocholesterol levels). Desmosterolosis is caused by mutation of the 24-dehydrocholesterol reductase gene (DHCR24). Many of the malformations in SLOS and desmosterolosis are consistent with impaired hedgehog function. The hedgehog proteins include Sonic hedgehog (SHH), which plays a major role in midline patterning and limb development. Desmosterolosis, caused by defective activity of desmosterol reductase, combines a severe osteosclerotic skeletal dysplasia. 7-dehydrocholesterol reductase (DHCR7, EC 1.3.1.21) reduces the C7-C8 double bond in the sterol B ring to form cholesterol or desmosterol depending upon the precursor. Desmosterol can be converted to cholesterol by DHCR24. Therefore, SLOS and Desmosterolosis patients invariably have elevated levels of cholesterol precursor's 7-dehydrocholesterol (and its spontaneous isomer 8-dehydrocholesterol) and absent desmosterol. (PMID: 14631207, 16207203).",,desmosterol,,HMDB02719,"InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,9,19,21-25,28H,6,8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1",C01802,2016-12-05T15:48:05Z,,688,,,,,439577,dsmsterol,,"24-Dehydrocholesterol, 3beta-cholesta-5,24-dien-3-ol, Cholest-5,24-dien-3beta-ol, Cholesta-5,24-dien-3-ol, Cholesta-5,24-dien-3b-ol, Cholesta-5,24-dien-3beta-ol, Desmosterol",http://vmh.uni.lu/_api/metabolites/688/?format=pcsv
ddsmsterol,,,0,C27H42O,CHEBI:27910,,"Human Metabolome Database (HMDB): 7-Dehydrodesmosterol is a sterol intermediate in the biosynthesis of steroids. 7-Dehydrodesmosterol is a substrate of the enzyme 24-dehydrocholesterol reductase (EC:1.3.1.72), an important enzyme in the biosynthesis of Cholesterol. Cholesterol is synthesized from either Lathosterol, 7-Dehydrocholesterol, Desmosterol or Cholestenol by the enzyme 3beta-hydroxysterol delta7 reductase (EC 1.3.1.21, Dhcr7). The Smith-Lemli-Opitz syndrome (SLOS, OMIM 270400) is caused by a genetic defect in cholesterol biosynthesis; mutations in the enzyme 3beta-hydroxysterol delta7 reductase lead to a failure of cholesterol synthesis, with an accumulation of precursor sterols, such as 7-Dehydrodesmosterol. SLOS results in craniofacial, limb as well as major organ defects, including the brain. In individuals with this syndrome, mental retardation, as well as other CNS dysfunction, is almost 100% prevalent. (PMID: 15862627, 17197219).",,7-dehydrodesmosterol,,HMDB03896,"InChI=1S/C27H42O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,9-10,19,21,23-25,28H,6,8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1",C05107,2016-12-05T15:48:05Z,,689,,,,,,ddsmsterol,,"24-Dehydroprovitamin D3, Cholesta-5,7,24-trien-3beta-ol",http://vmh.uni.lu/_api/metabolites/689/?format=pcsv
dhcrm_hs,,,0,C18H38NO2FULLRCO,,,dihydroceramide,,dihydroceramide,,,,,2016-11-22T15:11:56Z,,690,,,,,,dhcrm_hs,,,http://vmh.uni.lu/_api/metabolites/690/?format=pcsv
3dpdhb_me,,,-1,C58H87O4,,,3-Decaprenyl-4-hydroxy-5-methoxybenzoate,,3-Decaprenyl-4-hydroxy-5-methoxybenzoate,,,"InChI=1S/C58H88O4/c1-44(2)22-13-23-45(3)24-14-25-46(4)26-15-27-47(5)28-16-29-48(6)30-17-31-49(7)32-18-33-50(8)34-19-35-51(9)36-20-37-52(10)38-21-39-53(11)40-41-54-42-55(58(60)61)43-56(62-12)57(54)59/h22,24,26,28,30,32,34,36,38,40,42-43,59H,13-21,23,25,27,29,31,33,35,37,39,41H2,1-12H3,(H,60,61)/p-1/b45-24+,46-26+,47-28+,48-30+,49-32+,50-34+,51-36+,52-38+,53-40+",,2016-11-22T15:11:56Z,,691,,,,,,3dpdhb_me,,,http://vmh.uni.lu/_api/metabolites/691/?format=pcsv
dheas,,,-1,C19H27O5S,CHEBI:16814,,"Human Metabolome Database (HMDB): Dehydroepiandrosterone sulfate or DHEAS is the sulfated form of dehydroepiandrosterone (DHEA). This sulfation is reversibly catalyzed by sulfotransferase 2A1 (SULT2A1) primarily in the adrenals, the liver, and small intestine. In the blood, most DHEA is found as DHEAS with levels that are about 300 times higher than those of free DHEA. Orally-ingested DHEA is converted to its sulfate when passing through intestines and liver. Whereas DHEA levels naturally reach their peak in the early morning hours, DHEAS levels show no diurnal variation. From a practical point of view, measurement of DHEAS is preferable to DHEA, as levels are more stable. DHEA (from which DHEAS comes from) is a natural steroid prohormone produced from cholesterol by the adrenal glands, the gonads, adipose tissue, brain and in the skin (by an autocrine mechanism). DHEA is the precursor of androstenedione, which can undergo further conversion to produce the androgen testosterone and the estrogens estrone and estradiol. DHEA is also a potent sigma-1 agonist. DHEAS can serve as a precursor for testosterone; androstenedione; estradiol; and estrone. 

Serum dehydroepiandrosterone sulfate is a classic marker for adrenarche and, subsequently, for the individual hormonal milieu (PMID 10599744). Dehydroepiandrosterone sulfate is an endogenously produced sex steroid that has been hypothesized to have anti aging effects (PMID 16960027). It also has been inversely associated with development of atherosclerosis (PMID 8956025).",,3beta-hydroxyandrost-5-en-17-one 3-sulfate(1-),,HMDB01032,"InChI=1S/C19H28O5S/c1-18-9-7-13(24-25(21,22)23)11-12(18)3-4-14-15-5-6-17(20)19(15,2)10-8-16(14)18/h3,13-16H,4-11H2,1-2H3,(H,21,22,23)/p-1/t13-,14-,15-,16-,18-,19-/m0/s1",C04555,2016-12-05T15:48:05Z,,692,,,,,,dheas,,"(3beta)-3-(sulfooxy)-Androst-5-en-17-one, 17-Oxoandrost-5-en-3-yl hydrogen sulfate, 17-Oxoandrost-5-en-3-yl hydrogen sulphate, 17-Oxoandrost-5-en-3b-yl hydrogen sulfate, 17-Oxoandrost-5-en-3b-yl hydrogen sulphate, 17-Oxoandrost-5-en-3beta-yl hydrogen sulfate, 17-Oxoandrost-5-en-3beta-yl hydrogen sulphate, 3-b-Hydroxyandrost-5-en-17-one 3-sulfate, 3-b-Hydroxyandrost-5-en-17-one 3-sulphate, 3-beta-Hydroxyandrost-5-en-17-one 3-sulfate, 3-beta-Hydroxyandrost-5-en-17-one 3-sulphate, 3b-Hydroxy-Androst-5-en-17-one hydrogen sulfate, 3b-Hydroxy-Androst-5-en-17-one hydrogen sulphate, 3b-Hydroxyandrost-5-en-17-one 3-sulfate, 3b-Hydroxyandrost-5-en-17-one 3-sulphate, 3beta-hydroxy-Androst-5-en-17-one hydrogen sulfate, 3beta-hydroxy-Androst-5-en-17-one hydrogen sulphate, 3beta-hydroxyandrost-5-en-17-one 3-sulfate, 3beta-hydroxyandrost-5-en-17-one 3-sulphate, Dehydroepiandrosterone sulfate, Dehydroepiandrosterone sulphate, Dehydroepiandrosterone-3-sulfate, Dehydroepiandrosterone-3-sulphate, Dehydroisoandrosterone sulfate, Dehydroisoandrosterone sulphate, DHEA sulfate, DHEA sulphate, DHEAS, Formylisoglutamic acid, Prasterone sulfate, Prasterone sulphate, Prasterone-3-sulfate, Prasterone-3-sulphate",http://vmh.uni.lu/_api/metabolites/692/?format=pcsv
dhea,,,0,C19H28O2,CHEBI:28689,,"Human Metabolome Database (HMDB): Dehydroepiandrosterone (DHEA) is a natural steroid hormone produced from cholesterol by the adrenal glands. DHEA is also produced in the gonads, adipose tissue and the brain. DHEA is structurally similar to, and is a precursor of, androstenedione, testosterone, estradiol, estrone and estrogen. It is the most abundant hormone in the human body. Most of DHEA is sulfated (dehydroepiandrosterone sulfate- DEHAS) before secretion. DHEAS is the sulfated version of DHEA; - this conversion is reversibly catalyzed by sulfotransferase (SULT2A1) primarily in the adrenals, the liver, and small intestines. In blood, most DHEA is found as DHEAS with levels that are about 300 times higher than free DHEA. Blood measurements of DHEAS/DHEA are useful to detect excess adrenal activity as seen in adrenal cancer or hyperplasia, including certain forms of congenital adrenal hyperplasia. Women with polycystic ovary syndrome tend to have normal or mildly elevated levels of DHEAS.",,3beta-hydroxyandrost-5-en-17-one,,HMDB00077,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14-,15-,16-,18-,19-/m0/s1",C01227,2016-12-05T15:48:05Z,,693,,,,,5881,dhea,,"(+)-Dehydroisoandrosterone, (3-beta)-3-Hydroxyandrost-5-en-17-one, (3beta)-3-hydroxy-Androst-5-en-17-one, (3beta,16alpha)-3,16-dihydroxy-androst-5-en-17-one, 17-Chetovis, 17-Hormoforin, 3-beta-Hydroxy-5-androsten-17-one, 3-beta-Hydroxyandrost-5-en-17-one, 3b-Hydroxy-D5-androsten-17-one, 3b-Hydroxyandrost-5-en-17-one, 3beta-hydroxy-5-androsten-17-one, 3beta-hydroxy-Androst-5-en-17-one, 3beta-Hydroxy-D5-androsten-17-one, 3beta-Hydroxyandrost-5-en-17-one, 5,6-Dehydroisoandrosterone, 5,6-Didehydroisoandrosterone, 5-Androsten-3-beta-ol-17-one, 5-Androsten-3b-ol-17-one, 5-Androsten-3beta-ol-17-one, 5-Dehydro-Epiandrosterone, 5-Dehydroepiandrosterone, Andrestenol, Androst-5-ene-3b-ol-17-one, Androst-5-ene-3beta-ol-17-one, Androsten-3beta-ol-17-one, Androstenolone, Astenile, D5-Androsten-3b-ol-17-one, D5-Androsten-3beta-ol-17-one, Deandros, Dehydro-epi-androsterone, Dehydroepiandrosterone, Dehydroisoandrosterone, Diandron, Diandrone, Hydroxyandrostenone, Prasterona, Prasterone, Prasteronum, Prestara, Psicosterone, trans-Dehydroandrosterone",http://vmh.uni.lu/_api/metabolites/693/?format=pcsv
dhf,,,-2,C19H19N7O6,CHEBI:15633,,"7,8-Dihydrofolate",,"7,8-Dihydrofolate",,,"InChI=1S/C19H21N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,12,21H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/p-2/t12-/m0/s1",C00415,2016-11-22T15:11:56Z,,694,,,,,98792,dhf,,,http://vmh.uni.lu/_api/metabolites/694/?format=pcsv
dhor_S,,,-1,C5H5N2O4,CHEBI:17025,,(S)-dihydroorotate,,(S)-dihydroorotate,,,"InChI=1S/C5H6N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h2H,1H2,(H,9,10)(H2,6,7,8,11)/p-1/t2-/m0/s1",C00337,2016-11-22T15:11:56Z,,695,,,,,,dhor_S,,,http://vmh.uni.lu/_api/metabolites/695/?format=pcsv
orot,,,-1,C5H3N2O4,CHEBI:16742,,"Human Metabolome Database (HMDB): Orotic acid is a minor dietary constituent. Indeed, until it was realized that it could be synthesized by humans, orotic acid was known as vitamin B-13. The richest dietary sources are cow's milk and other dairy products as well as root vegetables such as carrots and beets. Dietary intake probably contributes to a basal rate of orotic acid excretion in urine because fasting decreases excretion by ~50%. However, it is now apparent that most urinary orotic acid is synthesized in the body, where it arises as an intermediate in the pathway for the synthesis of pyrimidine nucleotides. Orotic acid is converted to UMP by UMP synthase, a multifunctional protein with both orotate phosphoribosyltransferase and orotidylate decarboxylase activity. The most frequently observed inborn error of pyrimidine nucleotide synthesis is a mutation of the multifunctional protein UMP synthase. This disorder prevents the conversion of orotic acid to UMP and thus to other pyrimidines. As a result, plasma orotic acid accumulates to high concentrations, and increased quantities appear in the urine. Indeed, urinary orotic acid is so markedly increased in individuals harboring a mutation in UMP synthase that orotic acid crystals can form in the urine. The urinary concentration of orotic acid in homozygotes can be of the order of millimoles per millimole creatinine. By comparison, the urinary level in unaffected individuals is ~ 1 umol/mmol creatinine. (PMID: 17513443).",,Orotate,,HMDB00226,"InChI=1S/C5H4N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)/p-1",C00295,2016-12-05T15:48:05Z,,696,,,,,967,orot,,"1,2,3,6-Tetrahydro-2,6-dioxo-4-pyrimidecarboxylic acid, 1,2,3,6-Tetrahydro-2,6-dioxo-4-Pyrimidinecarboxylic acid, 1,2,3,6-Tetrahydro-2,6-dioxopyrimidin-4-carbonsaeure, 2,6-Dihydroxy-4-pyrimidinecarboxylic acid, 2,6-Dihydroxypyrimidine-4-carboxylic acid, 2,6-Dioxo-1,2,3,6-tetrahydro-pyrimidine-4-carboxylic acid, 2,6-Dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid, 6-Carboxy-2,4-dihydroxypyrimidine, 6-Carboxyuracil, 6-Uracilcarboxylic acid, Acide orotique, Acido orotico, Acidum oroticum, Animal galactose factor, Lactinium, Molkensaeure, ORO, Orodin, Oropur, Orotate, Orotic acid, Orotonin, Orotonsan, Orotsaeure, Orotsaure, Oroturic, Orotyl, Uracil-6-carbosaeure, Uracil-6-carboxylate, Uracil-6-carboxylic acid, Vitamin B13, Whey factor",http://vmh.uni.lu/_api/metabolites/696/?format=pcsv
56dura,,,0,C4H6N2O2,CHEBI:15901,,"Human Metabolome Database (HMDB): Dihydrouracil is an intermediate breakdown product of uracil. Dihydropyrimidine dehydrogenase catalyzes the reduction of uracil to 5, 6-dihydrouracil then dihydropyrimidinase hydrolyzes 5, 6-dihydrouracil to N-carbamyl-b-alanine. Finally, beta-ureidopropionase catalyzes the conversion of N-carbamyl-b-alanine to beta-alanine. Patients with dihydropyrimidinase deficiency (DPYS; also called 5, 6-dihydropyrimidine amidohydrolase, or DHP; EC 3.5.2.2) exhibit highly increased concentrations of 5, 6-dihydrouracil in urine. The direct measurement of the activity of DHP in patients had been hampered by the fact that the enzyme is expressed almost exclusively in liver tissue. Various neurological abnormalities have been described in this group of patients. (OMIM 222748).",,"5,6-dihydrouracil",,HMDB00076,"InChI=1S/C4H6N2O2/c7-3-1-2-5-4(8)6-3/h1-2H2,(H2,5,6,7,8)",C00429,2016-12-05T15:48:05Z,,697,,,,,649,56dura,,"5,6-Dihydro-2,4(1H,3H)-pyrimidinedione, 5,6-Dihydro-2,4-dihydroxypyrimidine, 5,6-Dihydrouracil, Dihydro-2,4(1H,3H)-pyrimidinedione, Dihydro-pyrimidine-2,4-dione, Dihydrouracil, Dihydrouracile, Hydrouracil",http://vmh.uni.lu/_api/metabolites/697/?format=pcsv
cala,,,-1,C4H7N2O3,CHEBI:18261,,Human Metabolome Database (HMDB): Ureidopropionic acid is an intermediate in the metabolism of uracil. More specifically it is a breakdown product of dihydrouracil and is produced by the enzyme dihydropyrimidase. It is further decomposed to beta-alanine via the enzyme beta-ureidopropionase. Ureidopropionic acid is essentially a urea derivative of beta-alanine. High levels of Ureidopropionic acid are found in individuals with beta-ureidopropionase (UP) deficiency [PMID: 11675655]. Enzyme deficiencies in pyrimidine metabolism are associated with a risk for severe toxicity against the antineoplastic agent 5-fluorouracil.,,N-carbamoyl-beta-alaninate,,HMDB00026,"InChI=1S/C4H8N2O3/c5-4(9)6-2-1-3(7)8/h1-2H2,(H,7,8)(H3,5,6,9)/p-1",C02642,2016-12-05T15:48:05Z,,698,,,,,,cala,,"3-(Carbamoylamino)propanoate, 3-(Carbamoylamino)propanoic acid, 3-Ureido-propionate, 3-Ureidopropanoate, 3-Ureidopropanoic acid, 3-Ureidopropionate, 3-Ureidopropionic acid, beta-Ureidopropionate, beta-Ureidopropionic acid, Carbamoyl-b-Ala-OH, Carbamoyl-beta-Ala-OH, N-(Aminocarbonyl)-'b-Alanine, N-(Aminocarbonyl)-b-alanine, N-(Aminocarbonyl)-beta-Alanine, N-Carbamoyl-b-alanine, N-Carbamoyl-beta-alanine, N-Carbamyl-b-alanine, N-Carbamyl-beta-alanine, Ureidopropionate, Ureidopropionic acid",http://vmh.uni.lu/_api/metabolites/698/?format=pcsv
56dthm,,,0,C5H8N2O2,CHEBI:27468,,"Human Metabolome Database (HMDB): Dihydrothymine is an intermediate breakdown product of thymine. Dihydropyrimidine dehydrogenase catalyzes the reduction of thymine to 5, 6-dihydrothymine then dihydropyrimidinase hydrolyzes 5, 6-dihydrothymine to N-carbamyl-b-alanine. Finally, beta-ureidopropionase catalyzes the conversion of N-carbamyl-b-alanine to beta-alanine. Patients with dihydropyrimidinase deficiency exhibit highly increased concentrations of 5, 6-dihydrouracil and 5, 6-dihydrothymine and moderately increased concentrations of uracil and thymine can be detected in urine.",,"5,6-dihydrothymine",,HMDB00079,"InChI=1S/C5H8N2O2/c1-3-2-6-5(9)7-4(3)8/h3H,2H2,1H3,(H2,6,7,8,9)",C00906,2016-12-05T15:48:05Z,,699,,,,,93556,56dthm,,"5,6-Dihydro-5-methyluracil, 5,6-Dihydrothymine, 5-Methyl-5,6-dihydrouracil, 5-Methyl-Hydrouracil, 5-Methyldihydropyrimidine-2,4(1H,3H)-dione, Dihydro-5-methyl-2,4(1H,3H)-Pyrimidinedione, Dihydrothymine",http://vmh.uni.lu/_api/metabolites/699/?format=pcsv
dhbpt,,,0,C9H13N5O3,,,"6,7-dihydrobiopterin",,"6,7-dihydrobiopterin",,,"InChI=1S/C9H13N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,15-16H,2H2,1H3,(H3,10,11,13,14,17)",C02953,2016-11-22T15:11:56Z,,700,,,,,1879,dhbpt,,,http://vmh.uni.lu/_api/metabolites/700/?format=pcsv
thbpt,,,0,C9H15N5O3,CHEBI:15372,,"5,6,7,8-tetrahydrobiopterin",,"5,6,7,8-tetrahydrobiopterin",,,"InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)",C00272,2016-11-22T15:11:56Z,,701,,,,,1125,thbpt,,,http://vmh.uni.lu/_api/metabolites/701/?format=pcsv
mlthf,,,-2,C20H21N7O6,CHEBI:1989,,"5,10-Methylenetetrahydrofolate",,"5,10-Methylenetetrahydrofolate",,,"InChI=1S/C20H23N7O6/c21-20-24-16-15(18(31)25-20)27-9-26(8-12(27)7-22-16)11-3-1-10(2-4-11)17(30)23-13(19(32)33)5-6-14(28)29/h1-4,12-13H,5-9H2,(H,23,30)(H,28,29)(H,32,33)(H4,21,22,24,25,31)/p-2/t12-,13+/m1/s1",C00143,2016-11-22T15:11:57Z,,702,,,,,439175,mlthf,,,http://vmh.uni.lu/_api/metabolites/702/?format=pcsv
didp,,,-3,C10H11N4O10P2,CHEBI:28823,,dIDP,,dIDP,,,"InChI=1S/C10H14N4O10P2/c15-5-1-7(14-4-13-8-9(14)11-3-12-10(8)16)23-6(5)2-22-26(20,21)24-25(17,18)19/h3-7,15H,1-2H2,(H,20,21)(H,11,12,16)(H2,17,18,19)/p-3/t5-,6+,7+/m0/s1",C01344,2016-11-22T15:11:57Z,,703,,,,,439488,didp,,,http://vmh.uni.lu/_api/metabolites/703/?format=pcsv
digalsgalside_hs,,,-1,C30H55NO15SFULLRCO,,,Digalactosylceramidesulfate,,Digalactosylceramidesulfate,,,,C06127,2016-11-22T15:11:57Z,,704,,,,,,digalsgalside_hs,,,http://vmh.uni.lu/_api/metabolites/704/?format=pcsv
digalside_hs,,,0,C30H56NO12FULLRCO,,,Digalactosylceramide,,Digalactosylceramide,,,,C06126,2016-11-22T15:11:57Z,,705,,,,,,digalside_hs,,,http://vmh.uni.lu/_api/metabolites/705/?format=pcsv
ditp,,,-4,C10H11N4O13P3,CHEBI:28807,,dITP(4-),,dITP(4-),,,"InChI=1S/C10H15N4O13P3/c15-5-1-7(14-4-13-8-9(14)11-3-12-10(8)16)25-6(5)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h3-7,15H,1-2H2,(H,20,21)(H,22,23)(H,11,12,16)(H2,17,18,19)/p-4/t5-,6+,7+/m0/s1",C01345,2016-11-22T15:11:57Z,,706,,,,,146302,ditp,,,http://vmh.uni.lu/_api/metabolites/706/?format=pcsv
dkmpp,,,-2,C6H9O6PS,CHEBI:50604,,"2,3-diketo-5-methylthio-1-phosphopentane",,"2,3-diketo-5-methylthio-1-phosphopentane",,,"InChI=1S/C6H11O6PS/c1-14-3-2-5(7)6(8)4-12-13(9,10)11/h2-4H2,1H3,(H2,9,10,11)/p-2",C15650,2016-11-22T15:11:57Z,,707,,,,,561,dkmpp,,,http://vmh.uni.lu/_api/metabolites/707/?format=pcsv
2kmb,,,-1,C5H7O3S,CHEBI:33574,,2-keto-4-methylthiobutyrate,,2-keto-4-methylthiobutyrate,,,"InChI=1S/C5H8O3S/c1-9-3-2-4(6)5(7)8/h2-3H2,1H3,(H,7,8)/p-1",C01180,2016-11-22T15:11:57Z,,708,,,,,,2kmb,,,http://vmh.uni.lu/_api/metabolites/708/?format=pcsv
lac_D,,,-1,C3H5O3,CHEBI:42111,,(R)-lactate,,(R)-lactate,,,"InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/p-1/t2-/m1/s1",C00256,2016-11-22T15:11:57Z,,709,,,,,61503,lac_D,,,http://vmh.uni.lu/_api/metabolites/709/?format=pcsv
dlnlcgcrn,,,0,C27H47NO4,,,dihomo-gamma-linolenyl carnitine,,dihomo-gamma-linolenyl carnitine,,,,,2016-11-22T15:11:57Z,,710,,,,,,dlnlcgcrn,,,http://vmh.uni.lu/_api/metabolites/710/?format=pcsv
dlnlcg,,,-1,C20H33O2,CHEBI:53486,,"Human Metabolome Database (HMDB): 8,11,14-Eicosatrienoic acid is a 20-carbon-chain omega-6 fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid (5,8,11,14-eicosatetraenoic acid) only at position 5. 8,11,14-Eicosatrienoic acid is also known as Dihomo-gamma-linolenic acid (DGLA). In physiological literature, it is given the name 20:3(n-6). DGLA is the elongation product of the 18 carbon gamma-linolenic acid (GLA). DGLA can be converted into prostaglandin E1 (PGE1). PGE1 inhibits platelet aggregation and also exerts a vasodilatory effect. DGLA competes with arachadonic acid for COX and lipoxygenase, inhibiting the production of arachadonic acid's eicosanoids.",,dihomo-gamma-linolenic acid (n-6),,HMDB02925,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/p-1/b7-6-,10-9-,13-12-",C03242,2016-12-05T15:48:05Z,,711,,,,,3011,dlnlcg,,"(8Z,11Z,14Z)-Icosatrienoate, (8Z,11Z,14Z)-Icosatrienoic acid, (Z,Z,Z)-8,11,14-Eicosatrienoate, (Z,Z,Z)-8,11,14-Eicosatrienoic acid, (Z,Z,Z)-8,11,14-Icosatrienoate, (Z,Z,Z)-8,11,14-Icosatrienoic acid, (Z,Z,Z)-icosatri-8,11,14-enoate, (Z,Z,Z)-icosatri-8,11,14-enoic acid, 8,11,14-All-cis-Eicosatrienoate, 8,11,14-All-cis-Eicosatrienoic acid, 8,11,14-Eicosatrienoate, 8,11,14-Eicosatrienoic acid, 8,11,14-Icosatrienoate, 8,11,14-Icosatrienoic acid, 8Z,11Z,14Z-Eicosatrienoate, 8Z,11Z,14Z-Eicosatrienoic acid, All-cis-8,11,14-Eicosatrienoate, All-cis-8,11,14-Eicosatrienoic acid, Bishomo-gamma-linolenate, Bishomo-gamma-linolenic acid, cis,cis,cis-8,11,14-Eicosatrienoate, cis,cis,cis-8,11,14-Eicosatrienoic acid, cis-8,11,14-Eicosatrienoate, cis-8,11,14-Eicosatrienoic acid, cis-8,cis-11,cis-14-Eicosatrienoate, cis-8,cis-11,cis-14-Eicosatrienoic acid, DGLA, Dihomo-gamma-linolenate, Dihomo-gamma-linolenic acid, Eicosatrienoate, Eicosatrienoic acid, gamma-Homolinolenate, gamma-Homolinolenic acid, Homo-gamma-linolenate",http://vmh.uni.lu/_api/metabolites/711/?format=pcsv
13_cis_oretn,,,-1,C20H27O3,,,13-cis-oxo-retinoic acid,,13-cis-oxo-retinoic acid,,,,,2016-11-22T15:11:57Z,,712,,,,,,13_cis_oretn,,,http://vmh.uni.lu/_api/metabolites/712/?format=pcsv
13_cis_retn,,,-1,C20H27O2,,,"Human Metabolome Database (HMDB): 13-cis-Retinoic acid is a topical dermatologic agent that is used in the treatment of acne vulgaris and several other skin diseases. The drug has teratogenic and other adverse effects. (PubChem). 13-cis-retinoic acid is also a naturally occurring retinoid that is present in the circulation. Although 13-cis-retinoic acid (isotretinoin) does not have the potent gene regulatory activity of other isomers, it is an effective pharmacologic agent for treating a variety of dermatologic conditions. (PMID: 11606944). The steric conversion of 13-cis-retinoic acid (13-cRA) to all-trans-retinoic acid (t-RA) has been proposed as an activation mechanism for the observed therapeutic and teratogenic activities of 13-cRA. (PMID: 9806904). 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. (PMID: 10951254).",,13-cis-retinoate,,HMDB06219,"InChI=1/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14-",D00348,2016-12-05T15:48:05Z,,713,,,,,5282379,13_cis_retn,,"(13-cis)-Retinoate, (13-cis)-Retinoic acid, 13-cis-Retinoate, 13-cis-Retinoic acid, 13-cis-Vitamin A acid, Accutane, Accutane (TN), Amnesteem, CIP-Isotretinoin, cis-Retinoate, cis-Retinoic acid, Claravis, Isotretinoin, Isotretinoin (USP), Isotretinoin [USAN:BAN:INN], Isotretinoine [INN-French], Isotretinoino [INN-Spanish], Isotretinoinum [INN-Latin], Isotrex, Neovitamin A acid, Retinoate, Retinoic acid, Roaccutan, Roaccutane, Roacutan, Sotret, Teriosal",http://vmh.uni.lu/_api/metabolites/713/?format=pcsv
dem2emgacpail_prot_hs,,,0,C37H70N3O34P3FULLRCO2FULLR2CO2X,,,"deacylated-(phosphoethanolaminyl-dimannosyl),(phosphoethanolaminyl)-mannosyl-glucosaminyl-acylphosphatidylinositol",,"deacylated-(phosphoethanolaminyl-dimannosyl),(phosphoethanolaminyl)-mannosyl-glucosaminyl-acylphosphatidylinositol",,,,,2016-11-22T15:11:57Z,,714,,,,,,dem2emgacpail_prot_hs,,,http://vmh.uni.lu/_api/metabolites/714/?format=pcsv
dgpi_prot_hs,,,0,C39H76N4O37P4FULLRCO2FULLR2CO2X,,,deacylated-glycophosphatidylinositol (GPI)-anchored protein,,deacylated-glycophosphatidylinositol (GPI)-anchored protein,,,,,2016-11-22T15:11:57Z,,715,,,,,,dgpi_prot_hs,,,http://vmh.uni.lu/_api/metabolites/715/?format=pcsv
dsT_antigen,,,-2,C36H56N3O26X,,,disialyl-T antigen,,disialyl-T antigen,,,,,2016-11-22T15:11:57Z,,716,,,,,,dsT_antigen,,,http://vmh.uni.lu/_api/metabolites/716/?format=pcsv
dttp,,,-4,C10H13N2O14P3,CHEBI:18077,,"Human Metabolome Database (HMDB): Thymidine triphosphate or TTP is one of the four nucleoside triphosphates that make up DNA. It can be used by DNA ligase to create overlapping ""sticky ends"" so that protruding ends of opened microbial plasmids maybe closed up.",,dTTP,,HMDB01342,"InChI=1S/C10H17N2O14P3/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(24-8)4-23-28(19,20)26-29(21,22)25-27(16,17)18/h3,6-8,13H,2,4H2,1H3,(H,19,20)(H,21,22)(H,11,14,15)(H2,16,17,18)/p-4/t6-,7+,8+/m0/s1",C00459,2016-12-05T15:48:05Z,,717,,,,,64968,dttp,,"2'-Deoxythymidine 5'-triphosphate, 2'-Deoxythymidine triphosphate, 5'-TTP, 5-Methyl-dUTP, Deoxy-TTP, Deoxythymidine 5'-triphosphate, Deoxythymidine triphosphate, dTTP, Thymidine 5'-triphosphate, Thymidine mono(tetrahydrogen triphosphate), Thymidine triphosphate, TTP",http://vmh.uni.lu/_api/metabolites/717/?format=pcsv
ethamp,,,-1,C2H7NO4P,CHEBI:17553,,"Human Metabolome Database (HMDB): Phosphoethanolamine (PE) is a phosphomonoester metabolite of the phospholipid metabolism. PE is a precursor of phospholipid synthesis and a product of phospholipid breakdown. Phosphomonoesters are present at much higher levels in brain than in other organs. In developing brain, phosphomonoesters are normally elevated during the period of neuritic proliferation. This also coincides with the occurrence of normal programmed cell death and synaptic pruning in developing brain. These findings are consistent with the role of phosphomonoesters in membrane biosynthesis. PE shows a strong structural similarity to the inhibitory neurotransmitter, GABA, and the GABAB receptor partial agonist, 3-amino-propylphosphonic acid. PE is a phosphomonoester which is decreased in post-mortem Alzheimer's disease (AD) brain. (PMID: 7791524, 8588821, 11566853).",,O-phosphonatoethanaminium(1-),,HMDB00224,"InChI=1S/C2H8NO4P/c3-1-2-7-8(4,5)6/h1-3H2,(H2,4,5,6)/p-1",C00346,2016-12-05T15:48:05Z,,718,,,,,1015,ethamp,,"2-Amino-Ethanol dihydrogen phosphate, 2-Amino-Ethanol dihydrogen phosphate (ester), 2-Amino-Ethanol phosphate, 2-Aminoethanol O-phosphate, 2-Aminoethyl dihydrogen phosphate, 2-Aminoethyl dihydrogen phosphate (ACD/Name 4.0), 2-Aminoethyl phosphate, Colamine acid phosphate, Colamine phosphate, Colamine phosphoric acid, Colaminephosphoric acid, Colaminphosphoric acid, EAP, Ethanolamine acid phosphate, Ethanolamine O-phosphate, Ethanolamine phosphate, Mono(2-aminoethyl) phosphate, Monoaminoethyl phosphate, O-Phosphocolamine, O-Phosphoethanolamine, O-Phosphorylethanolamine, OPE, PETN, Phosphoethanolamine, Phosphonoethanolamine, Phosphoric acid 2-aminoethyl phenyl ester, Phosphoryethanolamine, Phosphorylethanolamine",http://vmh.uni.lu/_api/metabolites/718/?format=pcsv
gpi_sig,,,0,Y,,,glycophosphatidylinositol (GPI) signal sequence (C-terminal peptide),,glycophosphatidylinositol (GPI) signal sequence (C-terminal peptide),,,,,2016-11-22T15:11:57Z,,719,,,,,,gpi_sig,,,http://vmh.uni.lu/_api/metabolites/719/?format=pcsv
hretn,,,-1,C20H27O3,,,"Human Metabolome Database (HMDB): 4-Hydroxyretinoic acid is an NADPH-dependent hydroxylation metabolite of retinoic acid in the microsomes, via the cytochrome P-450 system. Retinoic acid is an activated metabolite of retinol that supports the systemic functions of vitamin A in vivo. (PMID: 1538719, 1932598, 2851384).",,4 hydroxy retinoic acid,,HMDB06254,,C16677,2016-12-05T15:48:05Z,,720,,,,,6438629,hretn,,"4-Hydroxy-13-cis-retinoate, 4-Hydroxy-13-cis-retinoic acid, 4-Hydroxy-all-trans-retinoate, 4-Hydroxy-all-trans-retinoic acid, 4-Hydroxy-Retinoate, 4-Hydroxy-Retinoic acid, 4-OH-retinoate, 4-OH-retinoic acid, All-trans-4-hydroxyretinoate, All-trans-4-hydroxyretinoic acid, Rac-4-hydroxy-all-trans-retinoate, Rac-4-hydroxy-all-trans-retinoic acid",http://vmh.uni.lu/_api/metabolites/720/?format=pcsv
kdn,,,-1,C9H15O9,,,"Human Metabolome Database (HMDB): 3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid (KDN) is a sialic acid (Sia) that is ubiquitously expressed in vertebrates during normal development and tumorigenesis. Its expression is thought to be regulated by multiple biosynthetic steps catalyzed by several enzymes, including CMP-Sia synthetase. (PMID 11479279) Sialic acids are frequently the terminal sugars on secreted and cell surface glycoproteins and glycolipids, and their presence can have considerable influence on the biological properties of a cell. For example, the temporal appearance and disappearance of polysialic polymers has been intimately linked with the proper development of neural tissues during embryogenesis. In pathogenic diseases, including meningitis and gastric inflammation, particular microbes recognize cell surface sialic acids when invading host cells. Sialic acid residues can also mask recognition sites such as galactose residues on glycoproteins to prevent their in vivo removal by asialoglycoprotein receptors. In certain cancers, changes in sialic acid amounts, types, and linkages have been associated with tumorogenesis and cancer metastasis. (PMID 10749855).",,2-keto-3-deoxy-D-glycero-D-galactononic acid,,HMDB00425,"InChI=1/C9H16O9/c10-2-5(13)7(15)8(16)6(14)3(11)1-4(12)9(17)18/h3,5-8,10-11,13-16H,1-2H2,(H,17,18)/t3-,5-,6+,7+,8+/m0/s1",,2016-12-05T15:48:05Z,,721,,,,,,kdn,,"2-KDN, 2-Keto-3-deoxy-D-glycero-D-galacto-nononate, 2-Keto-3-deoxy-D-glycero-D-galacto-nononic acid, 2-Oxo-3-deoxy-D-glycero-galactononulosonate, 2-Oxo-3-deoxy-D-glycero-galactononulosonic acid, 3-Deoxy-D-glycero-D-galacto-2-nonulosonate, 3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid, 3-Deoxy-D-glycero-D-galacto-Nonulosonate, 3-Deoxy-D-glycero-D-galacto-Nonulosonic acid, 3-Deoxyglycero-galacto-nonulosonate, 3-Deoxyglycero-galacto-nonulosonic acid, 3-Deoxyglycerogalacto-2-nonulopyranosonate, 3-Deoxyglycerogalacto-2-nonulopyranosonic acid, Deoxy-kdn, KDN, Sialosonate, Sialosonic acid, SiaX",http://vmh.uni.lu/_api/metabolites/721/?format=pcsv
m3gacpail_prot_hs,,,0,X,,,,,,,,,,2016-11-22T15:11:57Z,,722,,,,,,,,,http://vmh.uni.lu/_api/metabolites/722/?format=pcsv
melanin,,,-1,C9H6NO4,,,Melanin,,Melanin,,,"InChI=1/C18H10N2O4/c1-5-13-9-7(3-19-13)12-10-8(11(9)17(23)15(5)21)4-20-14(10)6(2)16(22)18(12)24/h3-4,19-20H,1-2H3",,2016-11-22T15:11:57Z,,723,,,,,,melanin,,,http://vmh.uni.lu/_api/metabolites/723/?format=pcsv
mem2emgacpail_prot_hs,,,0,C59H110N3O40P3FULLRCO2FULLR2CO2X,,,"({[(mannosyl),(phosphoethanolaminyl)]-dimannosyl},{phosphoethanolaminyl})-mannosyl-glucosaminyl-acylphosphatidylinositol-Protein (M4B)",,"({[(mannosyl),(phosphoethanolaminyl)]-dimannosyl},{phosphoethanolaminyl})-mannosyl-glucosaminyl-acylphosphatidylinositol-Protein (M4B)",,,,,2016-11-22T15:11:57Z,,724,,,,,,mem2emgacpail_prot_hs,,,http://vmh.uni.lu/_api/metabolites/724/?format=pcsv
n5m2masn,,,0,C74H122N7O50X,,,((N-acetyl-D-glucosaminyl)5-(alpha-D-mannosyl)2-beta-D-mannosyl-diacetylchitobiosyl)-L-asparagine (protein),,((N-acetyl-D-glucosaminyl)5-(alpha-D-mannosyl)2-beta-D-mannosyl-diacetylchitobiosyl)-L-asparagine (protein),,,,,2016-11-22T15:11:57Z,,725,,,,,,n5m2masn,,,http://vmh.uni.lu/_api/metabolites/725/?format=pcsv
oretn,,,-1,C20H27O3,,,4-oxo-retinoic acid,,4-oxo-retinoic acid,,,"InChI=1/C20H26O3/c1-14(7-6-8-15(2)13-19(22)23)9-10-17-16(3)18(21)11-12-20(17,4)5/h6-10,13H,11-12H2,1-5H3,(H,22,23)/p-1",C16678,2016-11-22T15:11:57Z,,726,,,,,104857,oretn,,,http://vmh.uni.lu/_api/metabolites/726/?format=pcsv
Ser_Thr,,,0,XH,,,protein-linked serine or threonine residue (O-glycosylation site),,protein-linked serine or threonine residue (O-glycosylation site),,,,,2016-11-22T15:11:57Z,,727,,,,,,Ser_Thr,,,http://vmh.uni.lu/_api/metabolites/727/?format=pcsv
sprm,,,4,C10H30N4,CHEBI:15746,,"Human Metabolome Database (HMDB): Spermine is a biogenic polyamine formed from spermidine. It is found in a wide variety of organisms and tissues and is an essential growth factor in some bacteria. It is found as a polycation at all pH values. Spermine is associated with nucleic acids, particularly in viruses, and is thought to stabilize the helical structure.",,spermine(4+),,HMDB01256,"InChI=1S/C10H26N4/c11-5-3-9-13-7-1-2-8-14-10-4-6-12/h13-14H,1-12H2",C00750,2016-12-05T15:48:05Z,,728,,,,,1103,sprm,,"1,5,10,14-Tetraazatetradecane, 4,9-Diaza-1,12-dodecanediamine, 4,9-Diazadodecamethylenediamine, 4,9-Diazadodecane-1,12-diamine, Diaminopropyl-tetramethylenediamine, Diaminopropyltetramethylenediamine, Gerontine, Musculamine, N,N'-Bis(3-aminopropyl)-1,4-Butanediamine, N,N'-Bis(3-aminopropyl)-1,4-tetramethylenediamine, N,N'-Bis(3-aminopropyl)butane-1,4-diamine, N1,N4-bis(3-aminopropyl)-1,4-butanediamine, Neuridine, Spermin, Spermine, Spermine dihydrate, Spermine puriss, SPM",http://vmh.uni.lu/_api/metabolites/728/?format=pcsv
sTn_antigen,,,-1,C19H30N2O13X,,,sialyl-Tn antigen,,sialyl-Tn antigen,,,,,2016-11-22T15:11:57Z,,729,,,,,,sTn_antigen,,,http://vmh.uni.lu/_api/metabolites/729/?format=pcsv
yvite,,,0,C28H48O2,,,gamma-tocopherol,,gamma-tocopherol,,,"InChI=1S/C28H48O2/c1-20(2)11-8-12-21(3)13-9-14-22(4)15-10-17-28(7)18-16-25-19-26(29)23(5)24(6)27(25)30-28/h19-22,29H,8-18H2,1-7H3/t21-,22-,28-/m1/s1",C02483,2016-11-22T15:11:57Z,,730,,,,,92729,yvite,,,http://vmh.uni.lu/_api/metabolites/730/?format=pcsv
dmantipyrine,,,0,C10H10N2O,,,"Human Metabolome Database (HMDB): Demethylated antipyrine is a novel potent free radical scavenger that has been clinically used to reduce the neuronal damage following ischemic stroke. Demethylated antipyrine exerts neuroprotective effects by inhibiting endothelial injury and by ameliorating neuronal damage in brain ischemia. Demethylated antipyrine provides the desirable features of NOS: it increases eNOS (beneficial NOS for rescuing ischemic stroke) and decreases nNOS and iNOS (detrimental NOS). Post- reperfusion brain edema and hemorrhagic events induced by thrombolytic therapy may be reduced by demethylated antipyrine pretreatment. Increased productions of superoxide and NO in the brain after reperfusion and a concomitant surge in oxygen free radicals with increased NO during recirculation lead to formation of peroxynitrite, a super potent radical. Demethylated antipyrine, which inhibits oxidation and enhances NO production derived from increased eNOS expression, may improve and conserve cerebral blood flow without peroxynitrite generation during reperfusion. Clinical experience with demethylated antipyrine suggests that this drug has a wide therapeutic time window. Demethylated antipyrine can exert a wide range of inhibitory effects on water-soluble and lipid soluble peroxyl radical-induced peroxidation systems, and appears to display combined properties of both, vitamin C and E. Demethylated antipyrine can scavenge not only hydroxyl radicals but also other free radicals, although it has no major effect on superoxide anion radicals. Demethylated antipyrine apparently traps hydroxyl radicals and inhibits OH-dependent lipid peroxidation or tyrosine nitration induced by peroxynitrite (ONOO-). Lipid peroxidation starts with lipid radical (L) production after free radical-mediated extraction of proton from unsaturated fatty acid. Subsequently lipid peroxyl radical (LOO) is generated by addition of oxygen atom, and a further L is produced by LOO-mediated extraction of proton from another unsaturated fatty acid. Demethylated antipyrine can inhibit lipid peroxidation by scavenging not only hydroxyl radicals but also other free radicals including LOO. Under physiological conditions, 50% of demethylated antipyrine is present as an anion form, and electrons released from demethylated antipyrine anion exert radical scavenging. Subsequently, demethylated antipyrine radicals are generated. They react readily with oxygen atoms, and form peroxyl radical of demethylated antipyrine, and eventually 2-oxo-3-(phenylhydrazone)- butanoic acid (OPB). (PMID: 16834755, CNS Drug Rev. 2006 Spring;12(1):9-20.).",,demethylated antipyrine,,HMDB06240,"InChI=1/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-7,11H,1H3",C13008,2016-12-05T15:48:05Z,,731,,,,,,dmantipyrine,,"1-Phenyl-3-methyl-1H-4,5-dihydropyrazol-5-one, 1-Phenyl-3-methyl-2-pyrazolin-5-one, 1-Phenyl-3-methyl-5-oxopyrazole, 1-Phenyl-3-methyl-5-pyrazolinone, 1-Phenyl-3-methyl-5-pyrazolone, 2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one, 3-Methyl-1-phenyl-1H-pyrazol-5-one, 3-Methyl-1-phenyl-2-pyrazolin-5-one, 3-Methyl-1-phenyl-2-pyrazoline-5-one, 3-Methyl-1-phenyl-4,5-dihydropyrazol-5-one, 3-Methyl-1-phenyl-4,5-dihydropyrazole-5-one, 3-Methyl-1-phenyl-5-pyrazolone, 3-Methyl-1-phenylpyrazol-5(4H)-one, 3-Methyl-1-phenylpyrazolin-5-one, 5-Methyl-2-phenyl-2H-pyrazol-3(4H)-one, 5-Methyl-2-phenylpyrazol-3-one, Edarabone, Edaravone, Methylphenylpyrazolone, Norantipyrine, Norphenazone",http://vmh.uni.lu/_api/metabolites/731/?format=pcsv
dmpp,,,-3,C5H9O7P2,CHEBI:16057,,Human Metabolome Database (HMDB): Dimethylallyl pyrophosphate (or -diphosphate) (DMAPP) is an intermediate product of both mevalonic acid (MVA) pathway and DOXP/MEP pathway. It is an isomer of isopentenyl pyrophosphate (IPP) and exists in virtually all life forms. (wikipedia).,,Dimethylallyl diphosphate,,HMDB01120,"InChI=1S/C5H12O7P2/c1-5(2)3-4-11-14(9,10)12-13(6,7)8/h3H,4H2,1-2H3,(H,9,10)(H2,6,7,8)/p-3",C00235,2016-12-05T15:48:05Z,,732,,,,,647,dmpp,,"1,1-Dimethyl-4-phenylpiperazinium iodide, 2-Isopentenyl diphosphate, 3,3-Dimethylallyl pyrophosphate, 3-Methyl-2-Buten-1-ol pyrophosphate, 3-Methyl-2-Buten-1-ol trihydrogen pyrophosphate, 3-Methyl-2-butenyl pyrophosphate, 3-Methylbut-2-enyl pyrophosphate, delta-Prenyl diphosphate, Delta2-Isopentenyl diphosphate, Delta2-isopentenyl-diphosphate, Dimethylallyl diphosphate, Dimethylallyl pyrophosphate, Dimethylallyl-diphosphate, Dimethylallyl-PP, Dimethylallyl-PPi, Dimethylallyl-pyrophosphate, Dimethylallylpyrophosphate, Diphosphoric acid mono(3-methyl-2-butenyl) ester, DMAPP, DMPP, IPE, Prenyl diphosphate, Prenyl-diphosphate",http://vmh.uni.lu/_api/metabolites/732/?format=pcsv
ipdp,,,-3,C5H9O7P2,CHEBI:16584,,Isopentenyl diphosphate,,Isopentenyl diphosphate,,,"InChI=1S/C5H12O7P2/c1-5(2)3-4-11-14(9,10)12-13(6,7)8/h1,3-4H2,2H3,(H,9,10)(H2,6,7,8)/p-3",C00129,2016-11-22T15:11:57Z,,733,,,,,1195,ipdp,,,http://vmh.uni.lu/_api/metabolites/733/?format=pcsv
grdp,,,-3,C10H17O7P2,CHEBI:17211,,Geranyl diphosphate,,Geranyl diphosphate,,,"InChI=1S/C10H20O7P2/c1-9(2)5-4-6-10(3)7-8-16-19(14,15)17-18(11,12)13/h5,7H,4,6,8H2,1-3H3,(H,14,15)(H2,11,12,13)/p-3/b10-7+",C00341,2016-11-22T15:11:57Z,,734,,,,,445995,grdp,,,http://vmh.uni.lu/_api/metabolites/734/?format=pcsv
sarcs,,,0,C3H7NO2,CHEBI:15611,,"Human Metabolome Database (HMDB): Sarcosine is the N-methyl derivative of glycine. Sarcosine is metabolized to glycine by the enzyme sarcosine dehydrogenase, while glycine-N-methyl transferase generates sarcosine from glycine. Sarcosine is a natural amino acid found in muscles and other body tissues. In the laboratory it may be synthesized from chloroacetic acid and methylamine. Sarcosine is naturally found in the metabolism of choline to glycine. Sarcosine is sweet to the taste and dissolves in water. It is used in manufacturing biodegradable surfactants and toothpastes as well as in other applications. Sarcosine is ubiquitous in biological materials and is present in such foods as egg yolks, turkey, ham, vegetables, legumes, etc. Sarcosine is formed from dietary intake of choline and from the metabolism of methionine, and is rapidly degraded to glycine. Sarcosine has no known toxicity, as evidenced by the lack of phenotypic manifestations of sarcosinemia, an inborn error of sarcosine metabolism. Sarcosinemia can result from severe folate deficiency because of the folate requirement for the conversion of sarcosine to glycine (Wikipedia). Sarcosine has recently been identified as a biomarker for invasive prostate cancer. It was found to be greatly increased during prostate cancer progression to metastasis and could be detected in urine. Sarcosine levels were also increased in invasive prostate cancer cell lines relative to benign prostate epithelial cells.(PMID: 19212411).",,Sarcosine,,HMDB00271,"InChI=1S/C3H7NO2/c1-4-2-3(5)6/h4H,2H2,1H3,(H,5,6)",C00213,2016-12-05T15:48:05Z,,735,,,,,1088,sarcs,,"(methylamino)-Acetate, (methylamino)-Acetic acid, (Methylamino)acetate, (Methylamino)acetic acid, (Methylamino)ethanoate, (Methylamino)ethanoic acid, Methylglycine, N-Methyl-Glycine, N-Methylaminoacetate, N-Methylaminoacetic acid, N-Methylglycine, Sarcosin, Sarcosinate, Sarcosine, Sarcosinic acid",http://vmh.uni.lu/_api/metabolites/735/?format=pcsv
dmhptcoa,,,-4,C30H52N7O17P3S,,,"2,6 dimethylheptanoyl-CoA",,"2,6 dimethylheptanoyl-CoA",,,"InChI=1/C30H52N7O17P3S/c1-17(2)7-6-8-18(3)29(42)58-12-11-32-20(38)9-10-33-27(41)24(40)30(4,5)14-51-57(48,49)54-56(46,47)50-13-19-23(53-55(43,44)45)22(39)28(52-19)37-16-36-21-25(31)34-15-35-26(21)37/h15-19,22-24,28,39-40H,6-14H2,1-5H3,(H,32,38)(H,33,41)(H,46,47)(H,48,49)(H2,31,34,35)(H2,43,44,45)/p-4/t18-,19+,22-,23-,24?,28+/m0/s1",,2016-11-22T15:11:57Z,,736,,,,,,dmhptcoa,,,http://vmh.uni.lu/_api/metabolites/736/?format=pcsv
dmhptcrn,,,0,C16H35NO4,,,"Human Metabolome Database (HMDB): 2,6 dimethylheptanoyl carnitine is an acylcarnitine. Numerous disorders have been described that lead to disturbances in energy production and in intermediary metabolism in the organism which are characterized by the production and excretion of unusual acylcarnitines. A mutation in the gene coding for carnitine-acylcarnitine translocase or the OCTN2 transporter aetiologically causes a carnitine deficiency that results in poor intestinal absorption of dietary L-carnitine, its impaired reabsorption by the kidney and, consequently, in increased urinary loss of L-carnitine. Determination of the qualitative pattern of acylcarnitines can be of diagnostic and therapeutic importance. The betaine structure of carnitine requires special analytical procedures for recording. The ionic nature of L-carnitine causes a high water solubility which decreases with increasing chain length of the ester group in the acylcarnitines. Therefore, the distribution of L-carnitine and acylcarnitines in various organs is defined by their function and their physico-chemical properties as well. High performance liquid chromatography (HPLC) permits screening for free and total carnitine, as well as complete quantitative acylcarnitine determination, including the long-chain acylcarnitine profile. (PMID: 17508264, Monatshefte fuer Chemie (2005), 136(8), 1279-1291., Int J Mass Spectrom. 1999;188:39-52.).",,"2,6 dimethylheptanoyl carnitine",,HMDB06320,"InChI=1/C16H31NO4/c1-12(2)8-7-9-13(3)16(20)21-14(10-15(18)19)11-17(4,5)6/h12-14H,7-11H2,1-6H3",,2016-12-05T15:48:05Z,,737,,,,,53477823,dmhptcrn,,"2,6-Dimethylheptanoyl carnitine, Dimethyl heptanoyl carnitine",http://vmh.uni.lu/_api/metabolites/737/?format=pcsv
dnad,,,-2,C21H24N6O15P2,CHEBI:18304,,Deamino-NAD+,,Deamino-NAD+,,,"InChI=1S/C21H26N6O15P2/c22-17-12-18(24-7-23-17)27(8-25-12)20-16(31)14(29)11(41-20)6-39-44(36,37)42-43(34,35)38-5-10-13(28)15(30)19(40-10)26-3-1-2-9(4-26)21(32)33/h1-4,7-8,10-11,13-16,19-20,28-31H,5-6H2,(H4-,22,23,24,32,33,34,35,36,37)/p+1/t10-,11-,13-,14-,15-,16-,19-,20-/m1/s1",C00857,2016-11-22T15:11:57Z,,738,,,,,165491,dnad,,,http://vmh.uni.lu/_api/metabolites/738/?format=pcsv
dna,,,0,C10H17O8PR2,CHEBI:16991,,DNA,,DNA,,,,,2016-11-22T15:11:57Z,,739,,,,,,dna,,,http://vmh.uni.lu/_api/metabolites/739/?format=pcsv
dna5mtc,,,0,C11H19O8PR2,,,DNA 5-methylcytosine,,DNA 5-methylcytosine,,,,C02967,2016-11-22T15:11:57Z,,740,,,,,,dna5mtc,,,http://vmh.uni.lu/_api/metabolites/740/?format=pcsv
seasmet,,,1,C15H23N6O5Se,CHEBI:9066,,Se-Adenosylselenomethionine,,Se-Adenosylselenomethionine,,,"InChI=1/C15H22N6O5Se/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/p+1/t7?,8-,10-,11-,14-,27?/m1/s1",C05691,2016-11-22T15:11:57Z,,741,,,,,24892761,seasmet,,,http://vmh.uni.lu/_api/metabolites/741/?format=pcsv
seahcys,,,0,C14H20N6O5Se,,,Se-Adenosylselenohomocysteine,,Se-Adenosylselenohomocysteine,,,"InChI=1/C14H20N6O5Se/c15-6(14(23)24)1-2-26-3-7-9(21)10(22)13(25-7)20-5-19-8-11(16)17-4-18-12(8)20/h4-7,9-10,13,21-22H,1-3,15H2,(H,23,24)(H2,16,17,18)/t6?,7-,9-,10-,13+/m1/s1",C05692,2016-11-22T15:11:57Z,,742,,,,,16682731,seahcys,,,http://vmh.uni.lu/_api/metabolites/742/?format=pcsv
dtdp,,,-3,C10H13N2O11P2,CHEBI:18075,,Human Metabolome Database (HMDB): Is an intermediate in the Thymidylate kinase (EC 2.7.4.9; ATP:dTMP phosphotransferase) catalyzes the phosphorylation of dTMP (to form dTDP) in the dTTP synthesis pathway for DNA synthesis. (OMIM 188345 ),,dTDP,,HMDB01274,"InChI=1S/C10H16N2O11P2/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(22-8)4-21-25(19,20)23-24(16,17)18/h3,6-8,13H,2,4H2,1H3,(H,19,20)(H,11,14,15)(H2,16,17,18)/p-3/t6-,7+,8+/m0/s1",C00363,2016-12-05T15:48:05Z,,743,,,,,164628,dtdp,,"Deoxy-TDP, Deoxythymidine 5'-diphosphate, dTDP, TDP, Thymidine 5'-diphosphate, Thymidine 5'-pyrophosphate",http://vmh.uni.lu/_api/metabolites/743/?format=pcsv
dudp,,,-3,C9H11N2O11P2,CHEBI:28850,,dUDP,,dUDP,,,"InChI=1S/C9H14N2O11P2/c12-5-3-8(11-2-1-7(13)10-9(11)14)21-6(5)4-20-24(18,19)22-23(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,18,19)(H,10,13,14)(H2,15,16,17)/p-3/t5-,6+,8+/m0/s1",C01346,2016-11-22T15:11:57Z,,744,,,,,145729,dudp,,,http://vmh.uni.lu/_api/metabolites/744/?format=pcsv
dutp,,,-4,C9H11N2O14P3,CHEBI:17625,,"Human Metabolome Database (HMDB): Deoxyuridine triphosphate is an intermediate in the metabolism of Pyrimidine. It is a substrate for Inosine triphosphate pyrophosphatase, Deoxyuridine 5'-triphosphate nucleotidohydrolase (mitochondrial), Uridine-cytidine kinase 1, Nucleoside diphosphate kinase 3, Nucleoside diphosphate kinase B, Nucleoside diphosphate kinase 6, Nucleoside diphosphate kinase (mitochondrial), Nucleoside diphosphate kinase homolog 5, Nucleoside diphosphate kinase A and Nucleoside diphosphate kinase 7.",,dUTP,,HMDB01191,"InChI=1S/C9H15N2O14P3/c12-5-3-8(11-2-1-7(13)10-9(11)14)23-6(5)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,18,19)(H,20,21)(H,10,13,14)(H2,15,16,17)/t5-,6+,8+/m0/s1",C00460,2016-12-05T15:48:05Z,,745,,,,,65070,dutp,,"2'-Deoxyuridine 5'-triphosphate, 2'-Deoxyuridine-5'-triphosphorate, 2'-Deoxyuridine-5'-triphosphoric acid, 2'-Deoxyuridine-5'-triphosphoric acid = dUTP, Deoxy-UTP, Deoxyuridine triphosphate, Deoxyuridine-5'-Triphosphate, dUTP",http://vmh.uni.lu/_api/metabolites/745/?format=pcsv
lyxnt,,,-1,C5H9O6,,,L-lyxonate,,L-lyxonate,,,"InChI=1/C5H10O6/c6-1-2(7)3(8)4(9)5(10)11/h2-4,6-9H,1H2,(H,10,11)",C05412,2016-11-22T15:11:57Z,,746,,,,,644110,lyxnt,,,http://vmh.uni.lu/_api/metabolites/746/?format=pcsv
xylnt,,,-1,C5H9O6,CHEBI:48092,,L-xylonate,,L-xylonate,,,"InChI=1S/C5H10O6/c6-1-2(7)3(8)4(9)5(10)11/h2-4,6-9H,1H2,(H,10,11)/p-1/t2-,3+,4-/m0/s1",C05411,2016-11-22T15:11:57Z,,747,,,,,6971043,xylnt,,,http://vmh.uni.lu/_api/metabolites/747/?format=pcsv
thrnt,,,-1,C4H7O5,CHEBI:15908,,L-threonate,,L-threonate,,,"InChI=1S/C4H8O5/c5-1-2(6)3(7)4(8)9/h2-3,5-7H,1H2,(H,8,9)/p-1/t2-,3+/m0/s1",C01620,2016-11-22T15:11:57Z,,748,,,,,5460407,thrnt,,,http://vmh.uni.lu/_api/metabolites/748/?format=pcsv
eryth,,,0,C4H8O4,CHEBI:27913,,"Human Metabolome Database (HMDB): L-Erythrulose is an extremely reactive ketose, which rapidly glycates and crosslinks proteins, and therefore may mediate the(L-ascorbate) AsA-dependent modification of protein (ascorbylation) seen in vitro, and also proposed to occur in vivo in human lens during diabetic and age-onset cataract formation.(PMID: 10727845).",,L-erythrulose,,HMDB06293,"InChI=1S/C4H8O4/c5-1-3(7)4(8)2-6/h3,5-7H,1-2H2/t3-/m0/s1",C02045,2016-12-05T15:48:05Z,,749,,,,,5460032,eryth,,"(3S)-1,3,4-trihydroxybutan-2-one, L-Glycero-tetrulose",http://vmh.uni.lu/_api/metabolites/749/?format=pcsv
g3m8mpdol_L,,,-20,C1960H3228N20O770P20,,,"(alpha-D-Glucosyl)3-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,"(alpha-D-Glucosyl)3-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,,,,2016-11-22T15:11:57Z,,750,,,,,,g3m8mpdol_L,,,http://vmh.uni.lu/_api/metabolites/750/?format=pcsv
doldp_L,,,-30,C1080H1758O70P20,CHEBI:15750,,"Dolichol diphosphate, human liver homolog",,"Dolichol diphosphate, human liver homolog",,,,,2016-11-22T15:11:57Z,,751,,,,,,doldp_L,,,http://vmh.uni.lu/_api/metabolites/751/?format=pcsv
g3m8masn,,,0,C88H147N2O70X,,,(alpha-D-Glucosyl)3-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,(alpha-D-Glucosyl)3-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,,,C05873,2016-11-22T15:11:57Z,,752,,,,,,g3m8masn,,,http://vmh.uni.lu/_api/metabolites/752/?format=pcsv
g3m8mpdol_U,,,-20,C1905H3140N20O770P20,,,"(alpha-D-Glucosyl)3-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,"(alpha-D-Glucosyl)3-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,,,,2016-11-22T15:11:57Z,,753,,,,,,g3m8mpdol_U,,,http://vmh.uni.lu/_api/metabolites/753/?format=pcsv
doldp_U,,,-30,C1025H1670O70P20,,,"Dolichol diphosphate, human uterine homolog",,"Dolichol diphosphate, human uterine homolog",,,,,2016-11-22T15:11:57Z,,754,,,,,,doldp_U,,,http://vmh.uni.lu/_api/metabolites/754/?format=pcsv
dolglcp_L,,,-10,C1140H1868O90P10,CHEBI:15812,,"Dolichyl beta-D-glucosyl phosphate, human liver homolog",,"Dolichyl beta-D-glucosyl phosphate, human liver homolog",,,,,2016-11-22T15:11:57Z,,755,,,,,,dolglcp_L,,,http://vmh.uni.lu/_api/metabolites/755/?format=pcsv
dolglcp_U,,,-10,C1085H1780O90P10,,,"Dolichyl beta-D-glucosyl phosphate, human uterine homolog",,"Dolichyl beta-D-glucosyl phosphate, human uterine homolog",,,,,2016-11-22T15:11:58Z,,756,,,,,,dolglcp_U,,,http://vmh.uni.lu/_api/metabolites/756/?format=pcsv
m8mpdol_L,,,-20,C1780H2928N20O620P20,,,"(alpha-D-Mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,"(alpha-D-Mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,,,,2016-11-22T15:11:58Z,,757,,,,,,m8mpdol_L,,,http://vmh.uni.lu/_api/metabolites/757/?format=pcsv
g1m8mpdol_L,,,-20,C1840H3028N20O670P20,,,"alpha-D-Glucosyl-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,"alpha-D-Glucosyl-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,,,C05870,2016-11-22T15:11:58Z,,758,,,,,,g1m8mpdol_L,,,http://vmh.uni.lu/_api/metabolites/758/?format=pcsv
m8mpdol_U,,,-20,C1725H2840N20O620P20,,,"(alpha-D-Mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,"(alpha-D-Mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,,,,2016-11-22T15:11:58Z,,759,,,,,,m8mpdol_U,,,http://vmh.uni.lu/_api/metabolites/759/?format=pcsv
g1m8mpdol_U,,,-20,C1785H2940N20O670P20,,,"alpha-D-Glucosyl-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,"alpha-D-Glucosyl-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,,,,2016-11-22T15:11:58Z,,760,,,,,,g1m8mpdol_U,,,http://vmh.uni.lu/_api/metabolites/760/?format=pcsv
g2m8mpdol_L,,,-20,C1900H3128N20O720P20,,,"(alpha-D-Glucosyl)2-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,"(alpha-D-Glucosyl)2-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,,,,2016-11-22T15:11:58Z,,761,,,,,,g2m8mpdol_L,,,http://vmh.uni.lu/_api/metabolites/761/?format=pcsv
g2m8mpdol_U,,,-20,C1845H3040N20O720P20,,,"(alpha-D-Glucosyl)2-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,"(alpha-D-Glucosyl)2-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,,,,2016-11-22T15:11:58Z,,762,,,,,,g2m8mpdol_U,,,http://vmh.uni.lu/_api/metabolites/762/?format=pcsv
m4mpdol_L,,,-20,C1540H2528N20O420P20,CHEBI:37633,,"(alpha-D-Mannosyl)4-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,"(alpha-D-Mannosyl)4-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,,,,2016-11-22T15:11:58Z,,763,,,,,,m4mpdol_L,,,http://vmh.uni.lu/_api/metabolites/763/?format=pcsv
m5mpdol_L,,,-20,C1600H2628N20O470P20,,,"(alpha-D-Mannosyl)5-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,"(alpha-D-Mannosyl)5-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,,,,2016-11-22T15:11:58Z,,764,,,,,,m5mpdol_L,,,http://vmh.uni.lu/_api/metabolites/764/?format=pcsv
m4mpdol_U,,,-20,C1485H2440N20O420P20,,,"(alpha-D-Mannosyl)4-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,"(alpha-D-Mannosyl)4-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,,,,2016-11-22T15:11:58Z,,765,,,,,,m4mpdol_U,,,http://vmh.uni.lu/_api/metabolites/765/?format=pcsv
m5mpdol_U,,,-20,C1545H2540N20O470P20,,,"(alpha-D-Mannosyl)5-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,"(alpha-D-Mannosyl)5-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,,,,2016-11-22T15:11:58Z,,766,,,,,,m5mpdol_U,,,http://vmh.uni.lu/_api/metabolites/766/?format=pcsv
m6mpdol_L,,,-20,C1660H2728N20O520P20,,,"(alpha-D-Mannosyl)6-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,"(alpha-D-Mannosyl)6-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,,,,2016-11-22T15:11:58Z,,767,,,,,,m6mpdol_L,,,http://vmh.uni.lu/_api/metabolites/767/?format=pcsv
m6mpdol_U,,,-20,C1605H2640N20O520P20,,,"(alpha-D-Mannosyl)6-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,"(alpha-D-Mannosyl)6-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,,,,2016-11-22T15:11:58Z,,768,,,,,,m6mpdol_U,,,http://vmh.uni.lu/_api/metabolites/768/?format=pcsv
m7mpdol_L,,,-20,C1720H2828N20O570P20,,,"(alpha-D-Mannosyl)7-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,"(alpha-D-Mannosyl)7-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,,,,2016-11-22T15:11:58Z,,769,,,,,,m7mpdol_L,,,http://vmh.uni.lu/_api/metabolites/769/?format=pcsv
m7mpdol_U,,,-20,C1665H2740N20O570P20,,,"(alpha-D-Mannosyl)7-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,"(alpha-D-Mannosyl)7-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,,,,2016-11-22T15:11:58Z,,770,,,,,,m7mpdol_U,,,http://vmh.uni.lu/_api/metabolites/770/?format=pcsv
2c23dh56dhoxin,,,-1,C9H8NO4,,,"Human Metabolome Database (HMDB): Leucodopachrome is an indolic intermediate in the melanogenesis pathway, the non-enzymatically product of dopaquinone through cyclization in a reaction whose operation is determined by a pH greater than 4 (melanin synthesis in human pigment cell lysates is maximal at pH 6.8). Leucodopachrome participates in redox exchange with dopaquinone to give the eumelanin precursor dopachrome plus dopa. Dopaquinone (the quinone intermediate resulting from tyrosinase-mediated oxidation of tyrosine, monophenol dihydroxyphenylalanine:oxygen oxidoreductase, EC 1.14.18.1) could be a toxic metabolite in melanin biosynthesis. (PMID: 6807981, 1445949, 413870, 11461115, 11171088, 12755639).",,"2-Carboxy-2,3-dihydro-5,6-dihydroxyindole",,HMDB04067,"InChI=1/C9H9NO4/c11-7-2-4-1-6(9(13)14)10-5(4)3-8(7)12/h2-3,6,10-12H,1H2,(H,13,14)/t6-/m0/s1",C05604,2016-12-05T15:48:05Z,,771,,,,,161255,2c23dh56dhoxin,,"2,3-Dihydro-5,6-dihydroxyindole-2-carboxylate, 2-Carboxy-2,3-dihydro-5,6-dihydroxyindole, Cyclodopa",http://vmh.uni.lu/_api/metabolites/771/?format=pcsv
dopaqn,,,0,C9H9NO4,CHEBI:16852,,Human Metabolome Database (HMDB): Dopaquinone is a substrate of enzyme monophenol monooxygenase [EC 1.14.18.1] in tyrosine metabolism pathway (KEGG).,,L-dopaquinone,,HMDB01229,"InChI=1S/C9H9NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6H,3,10H2,(H,13,14)/t6-/m0/s1",C00822,2016-12-05T15:48:05Z,,772,,,,L-dopaquinone,439316,dopaqn,,O-Dopaquinone,http://vmh.uni.lu/_api/metabolites/772/?format=pcsv
dopasf,,,0,C8H11NO5S,CHEBI:37946,,dopamine 3-O-sulfate,,dopamine 3-O-sulfate,,,"InChI=1S/C8H11NO5S/c9-4-3-6-1-2-7(10)8(5-6)14-15(11,12)13/h1-2,5,10H,3-4,9H2,(H,11,12,13)",C13690,2016-11-22T15:11:58Z,,773,,,,,122136,dopasf,,,http://vmh.uni.lu/_api/metabolites/773/?format=pcsv
orn_D,,,1,C5H13N2O2,CHEBI:16176,,"Human Metabolome Database (HMDB): D-Ornithine is an amino acid produced in the urea cycle by the splitting off of urea from arginine. Ornithine is one of the products of the action of the enzyme arginase on L-arginine, creating urea. Therefore, ornithine is a central part of the urea cycle, which allows for the disposal of excess nitrogen.",,D-ornithinium(1+),,HMDB03374,"InChI=1S/C5H12N2O2/c6-3-1-2-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/p+1/t4-/m1/s1",C00515,2016-12-05T15:48:05Z,,774,,,,,71082,,,"(2R)-2,5-diaminopentanoate, (2R)-2,5-diaminopentanoic acid, (R)-ornithine, Ornithine",http://vmh.uni.lu/_api/metabolites/774/?format=pcsv
5a2opntn,,,0,C5H9NO3,CHEBI:49268,,"Human Metabolome Database (HMDB): 5-Amino-2-oxopentanoic acid is a breakdown product of D-proline. D-proline is first converted to 1-pyrroline-2-carboxylic acid via D-amino acid oxidase, which then spontaneously breaks down into 5-amino-2-oxopentanoic acid.",,5-amino-2-oxopentanoic acid,,HMDB06272,"InChI=1S/C5H9NO3/c6-3-1-2-4(7)5(8)9/h1-3,6H2,(H,8,9)",C01110,2016-12-05T15:48:05Z,,775,,,,,,,,"2-Oxo-5-amino-pentanoate, 2-Oxo-5-amino-pentanoic acid, 2-Oxo-5-aminopentanoate, 2-Oxo-5-aminopentanoic acid, 2-Oxo-5-aminovalerate, 5-Amino-2-oxopentanoate, 5-Amino-2-oxopentanoic acid, alpha-Keto-delta-aminopentanoate, alpha-Keto-delta-aminopentanoic acid",http://vmh.uni.lu/_api/metabolites/775/?format=pcsv
dpcoa,,,-2,C21H33N7O13P2S,CHEBI:15468,,Dephospho-CoA,,Dephospho-CoA,,,"InChI=1S/C21H35N7O13P2S/c1-21(2,16(32)19(33)24-4-3-12(29)23-5-6-44)8-39-43(36,37)41-42(34,35)38-7-11-14(30)15(31)20(40-11)28-10-27-13-17(22)25-9-26-18(13)28/h9-11,14-16,20,30-32,44H,3-8H2,1-2H3,(H,23,29)(H,24,33)(H,34,35)(H,36,37)(H2,22,25,26)/p-2/t11-,14-,15-,16+,20-/m1/s1",C00882,2016-11-22T15:11:58Z,,776,,,,,444485,dpcoa,,,http://vmh.uni.lu/_api/metabolites/776/?format=pcsv
23dpg,,,-5,C3H3O10P2,CHEBI:17720,,"2,3-bisphosphonato-D-glycerate(5-)",,"2,3-bisphosphonato-D-glycerate(5-)",,,"InChI=1S/C3H8O10P2/c4-3(5)2(13-15(9,10)11)1-12-14(6,7)8/h2H,1H2,(H,4,5)(H2,6,7,8)(H2,9,10,11)/p-5/t2-/m1/s1",C01159,2016-11-22T15:11:58Z,,777,,,,"2,3-bisphospho-D-glyceric acid",,23dpg,,,http://vmh.uni.lu/_api/metabolites/777/?format=pcsv
5dpmev,,,-4,C6H10O10P2,CHEBI:15899,,(R)-5-Diphosphomevalonate,,(R)-5-Diphosphomevalonate,,,"InChI=1S/C6H14O10P2/c1-6(9,4-5(7)8)2-3-15-18(13,14)16-17(10,11)12/h9H,2-4H2,1H3,(H,7,8)(H,13,14)(H2,10,11,12)/p-4/t6-/m1/s1",C01143,2016-11-22T15:11:58Z,,778,,,,,439418,5dpmev,,,http://vmh.uni.lu/_api/metabolites/778/?format=pcsv
frdp,,,-3,C15H25O7P2,CHEBI:17407,,Human Metabolome Database (HMDB): Farnesyl pyrophosphate is an intermediate in the HMG-CoA reductase pathway used by organisms in the biosynthesis of terpenes and terpenoids. -- Wikipedia.,,Farnesyl diphosphate,,HMDB00961,"InChI=1S/C15H28O7P2/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-21-24(19,20)22-23(16,17)18/h7,9,11H,5-6,8,10,12H2,1-4H3,(H,19,20)(H2,16,17,18)/p-3/b14-9+,15-11+",C00448,2016-12-05T15:48:05Z,,779,,,,,445713,frdp,,"(2E,6E)-Farnesyl diphosphate, (2E,6E)-Farnesyl pyrophosphate, (all-E)-Farnesyl diphosphate, (E,E)-Farnesyl diphosphate, (E,E)-Farnesyl pyrophosphate, 2-trans,6-trans-Farnesyl diphosphate, 2-trans,6-trans-Farnesyl pyrophosphate, All-trans-Farnesyl pyrophosphate, Farnesyl diphosphate, Farnesyl pyrophosphate, Farnesyl-PP, trans-Farnesyl pyrophosphate, trans-trans-Farnesyl diphosphate, trans-trans-Farnesyl pyrophosphate",http://vmh.uni.lu/_api/metabolites/779/?format=pcsv
pro_D,,,0,C5H9NO2,CHEBI:16313,,"Human Metabolome Database (HMDB): D-proline is an isomer of the naturally occurring amino acid, L-Proline. D-amino acids have been found in relatively high abundance in human plasma and saliva (PMID: 16480744). These amino acids may be of bacterial origin, but there is also evidence that they are endogenously produced through amino acid racemase activity. (PMID: 1426150).",,D-proline,,HMDB03411,"InChI=1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m1/s1",C00763,2016-12-05T15:48:05Z,,780,,,,,8988,,,"(2R)-pyrrolidine-2-carboxylate, (2R)-pyrrolidine-2-carboxylic acid, (R)-pyrrolidine-2-carboxylate, (R)-pyrrolidine-2-carboxylic acid, D-Prolin, D-Proline, R)-2-Carboxypyrrolidine , R-Proline",http://vmh.uni.lu/_api/metabolites/780/?format=pcsv
1p2cbxl,,,-1,C5H6NO2,CHEBI:17425,,Human Metabolome Database (HMDB): 1-Pyrroline-2-carboxylic acid is a terminal product of D-proline metabolism. Specifically D-proline is converted to 1-Pyrroline-2-carboxylic acid via D-amino acid oxidase. This spontaneously breaks down to 2-oxo-5-amino-valerate.,,1-pyrroline-2-carboxylate,,HMDB06875,"InChI=1S/C5H7NO2/c7-5(8)4-2-1-3-6-4/h1-3H2,(H,7,8)/p-1",C03564,2016-12-05T15:48:05Z,,781,,,,,440046,,,"1-Pyrroline-2-carboxylate, 3,4-Dihydro-2H-pyrrole-5-carboxylate, 3,4-Dihydro-2H-pyrrole-5-carboxylic acid, D1-Pyrroline 2-carboxylate, D1-Pyrroline 2-carboxylic acid, Delta1-Pyrroline 2-carboxylate, Delta1-Pyrroline 2-carboxylic acid",http://vmh.uni.lu/_api/metabolites/781/?format=pcsv
2dr5p,,,-2,C5H9O7P,CHEBI:16132,,2-deoxy-D-ribose 5-phosphate(2-),,2-deoxy-D-ribose 5-phosphate(2-),,,"InChI=1S/C5H11O7P/c6-2-1-4(7)5(8)3-12-13(9,10)11/h2,4-5,7-8H,1,3H2,(H2,9,10,11)/p-2/t4-,5+/m0/s1",C00673,2016-11-22T15:11:58Z,,782,,,,,45934311,2dr5p,,,http://vmh.uni.lu/_api/metabolites/782/?format=pcsv
g3p,,,-2,C3H5O6P,CHEBI:29052,,Glyceraldehyde 3-phosphate,,Glyceraldehyde 3-phosphate,,,"InChI=1S/C3H7O6P/c4-1-3(5)2-9-10(6,7)8/h1,3,5H,2H2,(H2,6,7,8)/p-2",C00661,2016-11-22T15:11:58Z,,783,,,,,729,g3p,,,http://vmh.uni.lu/_api/metabolites/783/?format=pcsv
dtmp,,,-2,C10H13N2O8P,CHEBI:17013,,"Human Metabolome Database (HMDB): 5-Thymidylic acid is a thymine nucleotide. Also known as thymidine monophosphate, and abbreviated TMP, is a nucleotide that is found in DNA. It is an ester of phosphoric acid with the nucleoside thymidine. TMP consists of a phosphate group, esterified to the the pentose sugar deoxyribose moiety, and the nucleobase thymine. In mammalian cells, thymidine deprivation induces chromosome aberrations such as chromatid breaks, chromatid interchanges, and chromosome fragmentation. (PMID 3888175).",,dTMP,,HMDB01227,"InChI=1S/C10H15N2O8P/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(20-8)4-19-21(16,17)18/h3,6-8,13H,2,4H2,1H3,(H,11,14,15)(H2,16,17,18)/p-2/t6-,7+,8+/m0/s1",C00364,2016-12-05T15:48:05Z,,784,,,,,9700,dtmp,,"2'-Deoxythymidine 5'-monophosphate, 5'-dTMP, 5'-Thymidylate, 5'-Thymidylic acid, 5'-TMP, 5-Methyl-dUMP, Deoxy TMP, Deoxyribosylthymine monophosphate, Deoxythymidine 5'-monophosphate, Deoxythymidine 5'-phosphate, Deoxythymidine monophosphate, Deoxythymidylate, Deoxythymidylic acid, Deoxythymydilate, Deoxythymydilic acid, dTMP, Thymidine 5'-monophosphate, Thymidine 5'-phosphate, Thymidine 5'-phosphorate, Thymidine 5'-phosphoric acid, Thymidine 5'MP, Thymidine mononucleotide, Thymidine monophosphate, Thymidine phosphate, Thymidine-5'-monophosphorate, Thymidine-5'-monophosphoric acid, Thymidylate, Thymidylic acid",http://vmh.uni.lu/_api/metabolites/784/?format=pcsv
thym,,,0,C5H6N2O2,CHEBI:17821,,"Human Metabolome Database (HMDB): One of the pyrimidine bases of living matter. Derivation: Hydrolysis of deoxyribonucleic acid, from methylcyanoacetylurea by catalytic reduction. Use: Biochemical research. (Hawley's Condensed Chemical Dictionary). Thymine is a pyrimidine nucleobase. As the name implies, thymine may be derived by methylation of uracil at the 5th carbon. Thymine is found in the nucleic acid DNA. In RNA thymine is replaced with uracil in most cases. In DNA, thymine binds to adenine via two hydrogen bonds to assist in stabilizing the nucleic acid structures.",,Thymine,,HMDB00262,"InChI=1S/C5H6N2O2/c1-3-2-6-5(9)7-4(3)8/h2H,1H3,(H2,6,7,8,9)",C00178,2016-12-05T15:48:05Z,,785,,,,,1135,thym,,"2,4-Dihydroxy-5-methylpyrimidine, 4-Hydroxy-5-methylpyrimidin-2(1H)-one, 5-Methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione, 5-Methyl-2,4(1H,3H)-pyrimidinedione, 5-Methyl-2,4-dihydroxypyrimidine, 5-Methylpyrimidine-2,4-dione, 5-Methyluracil, Thymine",http://vmh.uni.lu/_api/metabolites/785/?format=pcsv
eaflatoxin,,,0,C17H12O7,,,"aflatoxin B1 exo-8,9-epoxide",,"aflatoxin B1 exo-8,9-epoxide",,,"InChI=1S/C17H12O7/c1-20-7-4-8-11(12-14-17(23-14)24-16(12)21-8)13-10(7)5-2-3-6(18)9(5)15(19)22-13/h4,12,14,16-17H,2-3H2,1H3/t12-,14-,16+,17+/m1/s1",C19586,2016-11-22T15:11:58Z,,786,,,,,104756,eaflatoxin,,,http://vmh.uni.lu/_api/metabolites/786/?format=pcsv
ebastineoh,,,0,C32H39NO3,,,hydroxylated ebastine,,hydroxylated ebastine,,,,,2016-11-22T15:11:58Z,,787,,,,,,ebastineoh,,,http://vmh.uni.lu/_api/metabolites/787/?format=pcsv
ebastine,,,0,C32H39NO2,CHEBI:211060,,ebastine,,ebastine,,,"InChI=1S/C32H39NO2/c1-32(2,3)28-18-16-25(17-19-28)30(34)15-10-22-33-23-20-29(21-24-33)35-31(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-9,11-14,16-19,29,31H,10,15,20-24H2,1-3H3",,2016-11-22T15:11:58Z,,788,,,,,3191,ebastine,,,http://vmh.uni.lu/_api/metabolites/788/?format=pcsv
ecgon,,,-1,C9H14NO3,CHEBI:4743,,"Human Metabolome Database (HMDB): Ecgonine is an organic chemical and tropane alkaloid found naturally in coca leaves. It is has a close structural relation to cocaine: it is both a metabolite and a precursor, and as such, it is a controlled substance, as are all known substances which can be used as precursors to ecgonine itself. Structurally, ecgonine is a cycloheptane derivative with a nitrogen bridge. It is obtained by hydrolysis of cocaine with acids or alkalis, and crystallizes with one molecule of water, the crystals melting at 198-199oC. It is levorotary, and on warming with alkalis gives iso-ecgonine, which is dextrorotary. It is a tertiary base, and has the properties of an acid and an alcohol. It is the carboxylic acid corresponding to tropine, for it yields the same products on oxidation, and by treatment with phosphorus pentachloride is converted into anhydroecgonine, C9H13NO2, which, when heated to 280oC with hydrochloric acid, eliminates carbon dioxide and yields tropidine, C8H13N.(Wikipedia).",,ecgonine,,HMDB06548,"InChI=1/C9H15NO3/c1-10-5-2-3-6(10)8(9(12)13)7(11)4-5/h5-8,11H,2-4H2,1H3,(H,12,13)/t5?,6?,7-,8+/m0/s1",C10858,2016-12-05T15:48:05Z,,789,,,,,443003,ecgon,,"(2R,3S)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, 3-b-Hydroxy-2-b-tropanecarboxylic acid, 3-beta-Hydroxy-2-beta-tropanecarboxylic acid, Ekgonin, L-Ecgonine",http://vmh.uni.lu/_api/metabolites/789/?format=pcsv
pecgon,,,-1,C9H14NO3,,,pseudoecgonine,,pseudoecgonine,,,"InChI=1/C9H15NO3/c1-10-5-2-3-6(10)8(9(12)13)7(11)4-5/h5-8,11H,2-4H2,1H3,(H,12,13)/t5?,6?,7-,8-/m0/s1",C12449,2016-11-22T15:11:58Z,,790,,,,,443845,pecgon,,,http://vmh.uni.lu/_api/metabolites/790/?format=pcsv
3hbcoa,,,-4,C25H38N7O18P3S,CHEBI:15453,,(S)-3-hydroxybutanoyl-CoA(4-),,(S)-3-hydroxybutanoyl-CoA(4-),,,"InChI=1S/C25H42N7O18P3S/c1-13(33)8-16(35)54-7-6-27-15(34)4-5-28-23(38)20(37)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-19(49-51(39,40)41)18(36)24(48-14)32-12-31-17-21(26)29-11-30-22(17)32/h11-14,18-20,24,33,36-37H,4-10H2,1-3H3,(H,27,34)(H,28,38)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/p-4/t13-,14+,18+,19+,20-,24+/m0/s1",C03561,2016-11-22T15:11:58Z,,791,,,,(S)-3-hydroxybutanoyl-CoA,9543037,3hbcoa,,,http://vmh.uni.lu/_api/metabolites/791/?format=pcsv
3hmbcoa,,,-4,C26H40N7O18P3S,CHEBI:15449,,"(2S,3S)-3-hydroxy-2-methylbutanoyl-CoA(4-)",,"(2S,3S)-3-hydroxy-2-methylbutanoyl-CoA(4-)",,,"InChI=1S/C26H44N7O18P3S/c1-13(14(2)34)25(39)55-8-7-28-16(35)5-6-29-23(38)20(37)26(3,4)10-48-54(45,46)51-53(43,44)47-9-15-19(50-52(40,41)42)18(36)24(49-15)33-12-32-17-21(27)30-11-31-22(17)33/h11-15,18-20,24,34,36-37H,5-10H2,1-4H3,(H,28,35)(H,29,38)(H,43,44)(H,45,46)(H2,27,30,31)(H2,40,41,42)/p-4/t13-,14-,15+,18+,19+,20-,24+/m0/s1",C04405,2016-11-22T15:11:58Z,,792,,,,,11966220,3hmbcoa,,,http://vmh.uni.lu/_api/metabolites/792/?format=pcsv
eicostetcrn,,,0,C27H45NO4,,,Eicosatetranoyl carnitine,,Eicosatetranoyl carnitine,,,,,2016-11-22T15:11:58Z,,793,,,,,,eicostetcrn,,,http://vmh.uni.lu/_api/metabolites/793/?format=pcsv
eicostet,,,-1,C20H31O2,,,"Human Metabolome Database (HMDB): Cis-8,11,14,17-Eicosatetraenoic acid is an eicosanoid present in marine lipids, a minor n-3 polyunsaturated fatty acid (PUFA) which is a position isomer of 20:4n-6. n-3 PUFA contained in marine lipids appear to have a protective effect against coronary heart disease and thrombosis. Human platelets metabolize 8,11,14,17-eicosatetraenoic acid primarily into 12-hydroxy-8,10,14,17-eicosatetraenoic acid. The eicosanoids are a diverse family of molecules that have powerful effects on cell function. They are best known as intercellular messengers, having autocrine and paracrine effects following their secretion from the cells that synthesize them. The diversity of possible products that can be synthesized from eicosatrienoic acid is due, in part to the variety of enzymes that can act on it. Studies have placed many, but not all, of these enzymes at or inside the nucleus. In some cases, the nuclear import or export of eicosatrienoic acid-processing enzymes is highly regulated. Furthermore, nuclear receptors that are activated by specific eicosanoids are known to exist. Taken together, these findings indicate that the enzymatic conversion of eicosatrienoic acid to specific signaling molecules can occur in the nucleus, that it is regulated, and that the synthesized products may act within the nucleus. PMID: 3109494, 8142566, 16574479, 15896193, 10037447). Trans fatty acids are characteristically produced during industrial hydrogenation of plant oils.",,eicosatetranoic acid,,HMDB02177,,,2016-12-05T15:48:05Z,,794,,,,,11722594,eicostet,,"8, 11, 14, 17-Icosatetraenoate, 8, 11, 14, 17-Icosatetraenoic acid, 8,11,14,17-Eicosatetraenoate, 8,11,14,17-Eicosatetraenoic acid",http://vmh.uni.lu/_api/metabolites/794/?format=pcsv
elaidcrn,,,0,C25H47NO4,,,Elaidic carnitine,,Elaidic carnitine,,,"InChI=1/C25H47NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(21-24(27)28)22-26(2,3)4/h12-13,23H,5-11,14-22H2,1-4H3/b13-12+",,2016-11-22T15:11:58Z,,795,,,,,6441392,elaidcrn,,,http://vmh.uni.lu/_api/metabolites/795/?format=pcsv
elaid,,,-1,C18H33O2,CHEBI:27997,,"Human Metabolome Database (HMDB): Elaidic acid is the major trans fat found in hydrogenated vegetable oils and occurs in small amounts in caprine and bovine milk (very roughly 0.1 % of the fatty acids) [1] and some meats. It is the trans isomer of oleic acid. The name of the elaidinization reaction comes from elaidic acid. Elaidic acid increases CETP activity, which in turn raises VLDL and lowers HDL cholesterol. (Wiki).",,elaidate,,HMDB00573,"InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/p-1/b10-9+",C00712,2016-12-05T15:48:05Z,,796,,,,,445639,elaid,,"Elaidate, trans-9-Octadecenoic acid, trans-Oleic acid",http://vmh.uni.lu/_api/metabolites/796/?format=pcsv
s2l2n2m2m,,,-2,C84H136N6O62,,,de-Fuc form of PA6 (w/o peptide linkage),,de-Fuc form of PA6 (w/o peptide linkage),,,,,2016-11-22T15:11:58Z,,797,,,,,,s2l2n2m2m,,,http://vmh.uni.lu/_api/metabolites/797/?format=pcsv
s2l2n2m2mn,,,-2,C76H123N5O57,,,"de-Fuc, reducing GlcNAc removed form of PA6 (w/o peptide linkage)",,"de-Fuc, reducing GlcNAc removed form of PA6 (w/o peptide linkage)",,,,,2016-11-22T15:11:58Z,,798,,,,,,s2l2n2m2mn,,,http://vmh.uni.lu/_api/metabolites/798/?format=pcsv
n2m2nm,,,0,C58H97N5O41,,,n2m2nmasn (w/o peptide linkage),,n2m2nmasn (w/o peptide linkage),,,,,2016-11-22T15:11:58Z,,799,,,,,,n2m2nm,,,http://vmh.uni.lu/_api/metabolites/799/?format=pcsv
ksi_deg2,,,-13,C241H384N17O210S12,,,"keratan sulfate I, degradation product 2",,"keratan sulfate I, degradation product 2",,,,,2016-11-22T15:11:58Z,,800,,,,,,ksi_deg2,,,http://vmh.uni.lu/_api/metabolites/800/?format=pcsv
ksi_deg3,,,-13,C233H371N16O205S12,,,"keratan sulfate I, degradation product 3",,"keratan sulfate I, degradation product 3",,,,,2016-11-22T15:11:58Z,,801,,,,,,ksi_deg3,,,http://vmh.uni.lu/_api/metabolites/801/?format=pcsv
g1m8masn,,,0,C76H127N2O60X,,,(alpha-D-Glucosyl)-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,(alpha-D-Glucosyl)-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,,,C05875,2016-11-22T15:11:58Z,,802,,,,,,g1m8masn,,,http://vmh.uni.lu/_api/metabolites/802/?format=pcsv
glc1man,,,0,C12H22O11,,,"glucose-1,3-mannose oligosaccharide",,"glucose-1,3-mannose oligosaccharide",,,"InChI=1S/C12H22O11/c13-1-3-5(15)7(17)8(18)12(22-3)23-10-6(16)4(2-14)21-11(20)9(10)19/h3-20H,1-2H2/t3-,4-,5-,6-,7+,8-,9+,10+,11-,12-/m1/s1",C04147,2016-11-22T15:11:58Z,,803,,,,,440240,glc1man,,,http://vmh.uni.lu/_api/metabolites/803/?format=pcsv
m7masnA,,,0,C64H107N2O50X,,,"(alpha-D-mannosyl)7-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform A (protein)",,"(alpha-D-mannosyl)7-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform A (protein)",,,,,2016-11-22T15:11:58Z,,804,,,,,,m7masnA,,,http://vmh.uni.lu/_api/metabolites/804/?format=pcsv
g2m8masn,,,0,C82H137N2O65X,,,(alpha-D-Glucosyl)2-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,(alpha-D-Glucosyl)2-(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,,,C05874,2016-11-22T15:11:58Z,,805,,,,,,g2m8masn,,,http://vmh.uni.lu/_api/metabolites/805/?format=pcsv
glc2man,,,0,C18H32O16,,,"(2)[glucose-1,3]-mannose oligosaccharide",,"(2)[glucose-1,3]-mannose oligosaccharide",,,,,2016-11-22T15:11:58Z,,806,,,,,,glc2man,,,http://vmh.uni.lu/_api/metabolites/806/?format=pcsv
glc3man,,,0,C24H42O21,,,"glucose-1,2-(2)[glucose-1,3]-mannose oligosaccharide",,"glucose-1,2-(2)[glucose-1,3]-mannose oligosaccharide",,,,,2016-11-22T15:11:58Z,,807,,,,,,glc3man,,,http://vmh.uni.lu/_api/metabolites/807/?format=pcsv
g1m7masnC,,,0,C70H117N2O55X,,,"glucosyl-(alpha-D-mannosyl)7-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform C (protein)",,"glucosyl-(alpha-D-mannosyl)7-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform C (protein)",,,,,2016-11-22T15:11:58Z,,808,,,,,,g1m7masnC,,,http://vmh.uni.lu/_api/metabolites/808/?format=pcsv
m6masnC,,,0,C58H97N2O45X,,,(alpha-D-mannosyl)6-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,(alpha-D-mannosyl)6-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,,,,2016-11-22T15:11:58Z,,809,,,,,,m6masnC,,,http://vmh.uni.lu/_api/metabolites/809/?format=pcsv
g1m7masnB,,,0,C70H117N2O55X,,,"glucosyl-(alpha-D-mannosyl)7-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform B (protein)",,"glucosyl-(alpha-D-mannosyl)7-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform B (protein)",,,,,2016-11-22T15:11:58Z,,810,,,,,,g1m7masnB,,,http://vmh.uni.lu/_api/metabolites/810/?format=pcsv
m6masnB2,,,0,C58H97N2O45X,,,(alpha-D-mannosyl)6-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,(alpha-D-mannosyl)6-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,,,,2016-11-22T15:11:58Z,,811,,,,,,m6masnB2,,,http://vmh.uni.lu/_api/metabolites/811/?format=pcsv
g1m6masnB1,,,0,C64H107N2O50X,,,glucosyl-(alpha-D-mannosyl)6-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,glucosyl-(alpha-D-mannosyl)6-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,,,,2016-11-22T15:11:58Z,,812,,,,,,g1m6masnB1,,,http://vmh.uni.lu/_api/metabolites/812/?format=pcsv
m5masnB1,,,0,C52H87N2O40X,,,(alpha-D-mannosyl)5-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,(alpha-D-mannosyl)5-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,,,,2016-11-22T15:11:58Z,,813,,,,,,m5masnB1,,,http://vmh.uni.lu/_api/metabolites/813/?format=pcsv
2pg,,,-3,C3H4O7P,CHEBI:17835,,D-Glycerate 2-phosphate,,D-Glycerate 2-phosphate,,,"1/C3H7O7P/c4-1-2(3(5)6)10-11(7,8)9/h2,4H,1H2,(H,5,6)(H2,7,8,9)/t2-/m1/s1/f/h5,7-8H",C00631,2016-11-22T15:11:58Z,,814,,,,,439278,2pg,,,http://vmh.uni.lu/_api/metabolites/814/?format=pcsv
2ameph,,,-1,C2H7NO3P,CHEBI:15573,,Human Metabolome Database (HMDB): Ciliatine is an organophosphorus compound isolated from human and animal tissues.,,(2-Aminoethyl)phosphonate,,HMDB11747,"InChI=1S/C2H8NO3P/c3-1-2-7(4,5)6/h1-3H2,(H2,4,5,6)",C03557,2016-12-05T15:48:05Z,,815,,,,,339,,," beta-Aminoethylphosphonic acid, (2-Aminoethane)phosphonic acid, (2-aminoethyl)phosphonate, (2-Aminoethyl)phosphonic acid, 2-Aminoethylphosphonate, Aminoethylphosphonic acid, Ciliatine, Phosphonoethylamine",http://vmh.uni.lu/_api/metabolites/815/?format=pcsv
cmp2amep,,,-1,C11H19N4O10P2,,,CMP-2-aminoethylphosphonate,,CMP-2-aminoethylphosphonate,,,"InChI=1/C11H20N4O10P2/c12-2-4-26(19,20)25-27(21,22)23-5-6-8(16)9(17)10(24-6)15-3-1-7(13)14-11(15)18/h1,3,6,8-10,16-17H,2,4-5,12H2,(H,19,20)(H,21,22)(H2,13,14,18)/t6-,8-,9-,10-/m1/s1",C05673,2016-11-22T15:11:58Z,,816,,,,,440754,,,,http://vmh.uni.lu/_api/metabolites/816/?format=pcsv
estradiolglc,,,0,C24H32O8,CHEBI:36489,,Human Metabolome Database (HMDB): Estradiol gulcuronide is believed to play important roles in the mechanism of 17beta-estradiol(E2)-mediated tumor formation. Conjugation with glucuronic acid lowers tissue levels by facilitating excretion.The heterotropic activation by daidzein appears to be specific for the glucuronidation of E2 because daidzein did not affect the glucuronidation of the 2- and 4-hydroxy metabolites of E2. (PMID: 16598814).,,17beta-estradiol 3-glucosiduronic acid,,HMDB06224,"InChI=1S/C24H32O8/c1-24-9-8-14-13-5-3-12(10-11(13)2-4-15(14)16(24)6-7-17(24)25)31-23-20(28)18(26)19(27)21(32-23)22(29)30/h3,5,10,14-21,23,25-28H,2,4,6-9H2,1H3,(H,29,30)/t14-,15-,16+,17+,18+,19+,20-,21+,23-,24+/m1/s1",C05503,2016-12-05T15:48:05Z,,817,,,,,13783824,estradiolglc,,"17-b-Estradiol-3-glucuronide, 17-beta-Estradiol-3-glucuronide, 17beta-Estradiol 3-(beta-D-glucuronide), 17beta-Estradiol 3-(beta-delta-glucuronide), 17beta-estradiol 3-glucosiduronic acid, 17beta-estradiol 3-glucuronide, 17beta-estradiol-3-glucuronide, 17beta-hydroxyestra-1,3,5(10)-trien-3-yl beta-D-glucopyranosiduronic acid, 17beta-hydroxyestra-1,3,5(10)-trien-3-yl beta-delta-glucopyranosiduronic acid, beta-Estradiol 3-?-D-glucuronide, Estra-1,3,5(10)-triene-3,17beta-diol 3-D-glucuronide, Estra-1,3,5(10)-triene-3,17beta-diol 3-delta-glucuronide, Estradiol glucuronide, Estradiol-17-beta-3-glucuronide, Estradiol-17beta 3-glucuronide",http://vmh.uni.lu/_api/metabolites/817/?format=pcsv
estradiol,,,0,C18H24O2,CHEBI:16469,,"Human Metabolome Database (HMDB): Estradiol is the most potent form of mammalian estrogenic steroids. Estradiol is produced in the ovaries. The ovary requires both luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to produce sex steroids. LH stimulates the cells surrounding the follicle to produce progesterone and androgens. The androgens diffuse across the basement membrane to the granulosa cell layer, where, under the action of FSH, they are aromatized to estrogens, mainly estradiol. The ovary shows cyclical activity, unlike the testis that is maintained in a more or less constant state of activity. Hormone secretions vary according to the phase of the menstrual cycle. In the developing follicle LH receptors (LH-R) are only located on the thecal cells and FSH receptors (FSHR) on the granulosa cells. The dominant pre-ovulatory follicle develops LH-Rs on the granulosa cells prior to the LH surge. Thecal cells of the preovulatory follicle also develop the capacity to synthesize estradiol and this persists when the thecal cells become incorporated into the corpus luteum. After ovulation, the empty follicle is remodelled and plays an important role in the second half or luteal phase of the menstrual cycle. This phase is dominated by progesterone and, to a lesser extent, estradiol secretion by the corpus luteum. estradiol is also synthesized locally from cholesterol through testosterone in the hippocampus and acts rapidly to modulate neuronal synaptic plasticity. Localization of estrogen receptor alpha (ERalpha) in spines in addition to nuclei of principal neurons implies that synaptic ERalpha is responsible for rapid modulation of synaptic plasticity by endogenous estradiol. estradiol is a potent endogenous antioxidant which suppresses hepatic fibrosis in animal models, and attenuates induction of redox sensitive transcription factors, hepatocyte apoptosis and hepatic stellate cells activation by inhibiting a generation of reactive oxygen species in primary cultures. This suggests that the greater progression of hepatic fibrosis and hepatocellular carcinoma in men and postmenopausal women may be due, at least in part, to lower production of estradiol and a reduced response to the action of estradiol. estradiol has been reported to induce the production of interferon (INF)-gamma in lymphocytes, and augments an antigen-specific primary antibody response in human peripheral blood mononuclear cells. IFN-gamma is a potent cytokine with immunomodulatory and antiproliferative properties. Therefore, female subjects, particularly before menopause, may produce antibodies against hepatitis B virus e antigen and hepatitis B virus surface antigen at a higher frequency than males with chronic hepatitis B virus infection. The estradiol-Dihydrotestosterone model of prostate cancer (PC) proposes that the first step in the development of most PC and breast cancer (BC) occurs when aromatase converts testosterone to estradiol. (PMID: 17708600, 17678531, 17644764).",,estradiol,,HMDB00151,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",C00951,2016-12-05T15:48:05Z,,818,,,,,5757,estradiol,,"(+)-3,17b-Estradiol, (17b)-Estra-1,3,5(10)-triene-3,17-diol, 13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol, 17b-Estradiol, 17b-Oestradiol, 3,17-Epidihydroxyestratriene, 3,17b-Dihydroxyestra-1,3,5(10)-triene, 3,17b-Estradiol, Aerodiol, Agofollin, Altrad, Amnestrogen, Aquadiol, b-Estradiol, Bardiol, beta-Estradiol, Climaderm, Climara, Compudose, Corpagen, D-Estradiol, D-Oestradiol, delta-Estradiol, delta-Oestradiol, Dermestril, Dihydro-Theelin, Dihydrofollicular hormone, Dihydrofolliculin, Dihydromenformon, Dihydrotheelin, Dihydroxyestrin, Dimenformon, Diogyn, Diogynets, Divigel, Encore, Epiestriol 50, Estra-1,3,5(10)-triene-3,17b-diol, Estrace, Estraderm TTS, Estradiol, Estradiol-17-beta, Estradot, Estraldine, Estring Vaginal Ring, Estroclim, Estroclim 50, Estrogel, Estrogel HBF, Estrovite, Evorel, Femestral, Femogen, Follicyclin, Gelestra, Ginosedol, Gynergon, Gynoestryl, Lamdiol, Macrodiol, Menorest, Nordicol, Oesclim, Oestergon, Oestra-1,3,5(10)-triene-3,17b-diol, Oestradiol, Oestrogel, Oestroglandol, Ovahormon, Ovasterol, Ovastevol, Ovocyclin, Ovocylin, Perlatanol, Primofol, Profoliol, Profoliol B, Progynon, Progynon DH, Sandrena 1, Syndiol, Systen, Vivelle, Zumenon",http://vmh.uni.lu/_api/metabolites/818/?format=pcsv
estriolglc,,,0,C24H32O9,,,"Human Metabolome Database (HMDB): Estriol-16-glucuronide is a glucuronide derivative of the steroid estriol where the glucuronic acid is attached to the 16-hydroxyl group of Estriol. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Estriol (also known as oestriol) is one of the three main estrogens produced by the human body. It is only produced in significant amounts during pregnancy as it is made by the placenta.",,16-Glucuronide-estriol,,HMDB06766,"InChI=1/C24H32O9/c1-24-7-6-13-12-5-3-11(25)8-10(12)2-4-14(13)15(24)9-16(21(24)29)32-23-19(28)17(26)18(27)20(33-23)22(30)31/h3,5,8,13-21,23,25-29H,2,4,6-7,9H2,1H3,(H,30,31)/t13-,14-,15+,16-,17+,18+,19-,20+,21+,23-,24+/m1/s1",C05504,2016-12-05T15:48:05Z,,819,,,,,122281,,,"16-Glucuronide-Estriol, 16alpha,17beta-Estriol 16-(beta-D-glucuronide), 16alpha,17beta-Estriol 16-(beta-delta-glucuronide)",http://vmh.uni.lu/_api/metabolites/819/?format=pcsv
estriol,,,0,C18H24O3,CHEBI:27974,,"Human Metabolome Database (HMDB): Estriol is a metabolite of estrone metabolized via 16alpha-hydroxyestrone through the enzyme 16alpha-hydroxysteroid dehydrogenase (EC 1.1.1.147) or to 2- or 4-hydroxyestrone (catechol estrogens) by the action of catecho-O-methyltransferase (EC 2.1.1.6). The latter metabolites can be formed in the brain and may compete with receptors for catecholamines. Metabolites are conjugated with sulfate or glucuronide before excretion by the kidney. During pregnancy, estriol constitutes 60-70% of the total estrogens, increasing to 300-500-fold in relation to non-pregnant women. The late term human fetus produces relatively large amounts of 16 alphahydroxy DHEA, which serves the mother as a precursor of estriol. It has been shown that 90% of the precursors for the formation of estriol are of fetal origin. If abnormal maternal serum screening results, specifically low levels of unconjugated estriol in the second trimester are detected, a diagnosis of Smith-Lemli-Opitz syndrome (SLOS),or RSH is suspected. SLOS is an autosomal recessive disorder caused by mutations of the gene encoding 7-dehydrocholesterol reductase (EC 1.3.1.21, DHCR7). (PMID: 16202579, 16112271, 16097001).",,estriol,,HMDB00153,"InChI=1S/C18H24O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-16(20)17(18)21/h3,5,8,13-17,19-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1",C05141,2016-12-05T15:48:05Z,,820,,,,,5756,,," 16a,17b-Estriol, 13b-Methyl-1,3,5(10)-gonatriene-3,16a,17b-triol, 16-alpha,17-beta-Estriol, 16-alpha,17-beta-Oestriol, 16-alpha-Hydroxyestradiol, 16a-Estriol, 16a-Hydroxyestradiol, 16alpha,17beta-Estriol, 16alpha,17beta-Oestriol, 16alpha-Hydroxy-17beta-estradiol, 16alpha-Hydroxyestradiol, 16alpha-Hydroxyoestradiol, 3,16a,17b-Estriol, 3,16a,17b-Trihydroxyestra-1,3,5(10)-triene, 3,16alpha,17beta-Trihydroxy-1,3,5(10)-estratriene, 3,16alpha,17beta-Trihydroxyestra-1,3,5(10)-triene, Aacifemine, Colpogyn, Colpovister, Destriol, Deuslon A, Deuslon-A, Estra-1,3,5(10)-triene-3,16a,17b-triol, Estratriol, Estriel, Estriol, Follicular hormone hydrate, Gynasan, Hemostyptanon, Holin V, Hormomed, Incurin, Klimax E, Klimoral, Oekolp, Oestratriol, Oestriol, Oestriolum, Orestin, Orgastyptin, Ortho-Gynest, Ovesterin, Ovestin, Ovestinon, Ovestrion, Ovo-Vinces, Theelol, Tridestrin, Trihydroxyestrin, Triovex",http://vmh.uni.lu/_api/metabolites/820/?format=pcsv
estroneglc,,,0,C24H30O8,CHEBI:28919,,"Human Metabolome Database (HMDB): Estrone-glucuronide is the dominant metabolite of estradiol. Estrone glucuronide is formed by a UDP glucuronyltransferase (EC 2.4.1.17, UTP) reaction creating a much more water-soluble form of the hormone; glucuronides are the most abundant estrogen conjugates. Measurement of estrone-glucuronide is used as one reference method for determining ovulation (immunotubes are available for measuring urinary estrone glucuronide in conjunction with LH, one of the most advanced of ovulation prediction products). (PMID: 14742773, 1755456).",,estrone 3-glucosiduronic acid,,HMDB04483,,C11133,2016-12-05T15:48:05Z,,821,,,,,115255,estroneglc,,"Estrone 3-glucuronide, Estrone beta-D-glucuronide, Estrone beta-delta-glucuronide, Estrone-3-glucosiduronic acid",http://vmh.uni.lu/_api/metabolites/821/?format=pcsv
estrones,,,-1,C18H21O5S,CHEBI:17474,,estrone 3-sulfate(1-),,estrone 3-sulfate(1-),,,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/p-1/t14-,15-,16+,18+/m1/s1",C02538,2016-11-22T15:11:59Z,,822,,,,,3001028,estrones,,,http://vmh.uni.lu/_api/metabolites/822/?format=pcsv
estrone,,,0,C18H22O2,CHEBI:17263,,"Human Metabolome Database (HMDB): Estrone is a major mammalian estrogen. The conversion of the natural C19 steroids, testosterone and androstenedione into estrone is dependent on a complex key reaction catalyzed by the cytochrome P450 aromatase (EC 1.14.14.1, unspecific monooxygenase), which is expressed in many tissues of the adult human (e.g. ovary, fat tissue), but not in the liver. The ovaries after menopause continue to produce androstenedione and testosterone in significant amounts and these androgens are converted in fat, muscle, and skin into estrone. When women between the ages of 45 and 64 years have prophylactic oophorectomy (when hysterectomy is performed for benign disease to prevent the development of ovarian cancer), evidence suggests that oophorectomy increases the subsequent risk of coronary heart disease (CHD) and osteoporosis. Whereas 14,000 women die of ovarian cancer every year nearly 490,000 women die of heart disease and 48,000 women die within 1 year after hip fracture. Therefore, the decision to perform prophylactic oophorectomy should be approached with great caution for the majority of women who are at low risk of developing ovarian cancer. Steroid sulfatase (EC 3.1.6.2, STS) hydrolyzes steroid sulfates, such as estrone sulfate to estrone which can be converted to steroids with potent estrogenic properties, that is, estradiol; STS activity is much higher in breast tumors and high levels of STS mRNA expression in tumors are associated with a poor prognosis. The biological roles of estrogens in tumorigenesis are certainly different between the endometrium and breast, although both are considered ""estrogen-dependent tissues"". 17beta-hydroxysteroid dehydrogenases (EC 1.1.1.62, 17-HSDs) are enzymes involved in the formation of active sex steroids. estrone is interconverted by two enzymes 17-HSD types. Type 1 converts estrone to estradiol and Type 2 catalyzes the reverse reaction. (PMID: 17653961, 17513923, 17470679, 17464097).",,estrone,,HMDB00145,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",C00468,2016-12-05T15:48:05Z,,823,,,,,5870,estrone,,"(+)-Estrone, 1,3,5(10)-Estratrien-3-ol-17-one, 3-Hydroxy-17-keto-estra-1,3,5-triene, 3-Hydroxyestra-1,3,5(10)-trien-17-one, 3-Hydroxyestra-1,3,5(10)-triene-17-one, 3-Hydroxyoestra-1,3,5(10)-trien-17-one, D1,3,5(10)-Estratrien-3-ol-17-one",http://vmh.uni.lu/_api/metabolites/823/?format=pcsv
etfox,,,0,R,,,Electron transfer flavoprotein oxidized,,Electron transfer flavoprotein oxidized,,,,,2016-11-22T15:11:59Z,,824,,,,,,etfox,,,http://vmh.uni.lu/_api/metabolites/824/?format=pcsv
etfrd,,,0,RH2,,,Electron transfer flavoprotein reduced,,Electron transfer flavoprotein reduced,,,,,2016-11-22T15:11:59Z,,825,,,,,,etfrd,,,http://vmh.uni.lu/_api/metabolites/825/?format=pcsv
etha,,,1,C2H8NO,CHEBI:16000,,"Human Metabolome Database (HMDB): Ethanolamine is a viscous, hygroscopic amino alcohol with an ammoniacal odor. It is widely distributed in biological tissue and is a component of lecithin. It is used as a surfactant, fluorometric reagent, and to remove CO2 and H2S from natural gas and other gases.",,etha[c],,HMDB00149,"InChI=1S/C2H7NO/c3-1-2-4/h4H,1-3H2/p+1",C00189,2016-12-05T15:48:05Z,,826,,,,,700,etha,,"1-Amino-2-hydroxyethane, 2-Amino-1-ethanol, 2-Aminoethanol, 2-Aminoethyl alcohol, 2-Ethanolamine, 2-Hydroxyethanamine, 2-Hydroxyethylamine, Aethanolamin, Aminoethanol, b-Aminoethanol, b-Aminoethyl alcohol, b-Ethanolamine, b-Hydroxyethylamine, beta-Aminoethanol, beta-Aminoethyl alcohol, beta-Ethanolamine, beta-Hydroxyethylamine, Colamine, Envision Conditioner PDD 9020, eta, Ethanolamine, Ethylolamine, Glycinol, H-Glycinol, MEA, Monoaethanolamin, Monoethanolamine, Olamine",http://vmh.uni.lu/_api/metabolites/826/?format=pcsv
11_cis_retfa,,,0,C20H29OFULLR2CO,,,fatty acid 11-cis-retinol,,fatty acid 11-cis-retinol,,,,,2016-11-22T15:11:59Z,,827,,,,,,11_cis_retfa,,,http://vmh.uni.lu/_api/metabolites/827/?format=pcsv
13_cis_retnglc,,,-1,C26H35O8,,,13-cis-retinoyl glucuronide,,13-cis-retinoyl glucuronide,,,"InChI=1S/C26H36O8/c1-15(11-12-18-17(3)10-7-13-26(18,4)5)8-6-9-16(2)14-19(27)33-25-22(30)20(28)21(29)23(34-25)24(31)32/h6,8-9,11-12,14,20-23,25,28-30H,7,10,13H2,1-5H3,(H,31,32)/b9-6+,12-11+,15-8+,16-14+/t20-,21-,22+,23-,25+/m0/s1",C11061,2016-11-22T15:11:59Z,,828,,,,,5281877,13_cis_retnglc,,,http://vmh.uni.lu/_api/metabolites/828/?format=pcsv
1glyc_hs,,,-1,C6H13O7PFULLRCO2,,,1 acyl phosphoglycerol,,1 acyl phosphoglycerol,,,,,2016-11-22T15:11:59Z,,829,,,,,,1glyc_hs,,,http://vmh.uni.lu/_api/metabolites/829/?format=pcsv
9_cis_retfa,,,0,C20H29OFULLR2CO,,,fatty acid 9-cis-retinol,,fatty acid 9-cis-retinol,,,,,2016-11-22T15:11:59Z,,830,,,,,,9_cis_retfa,,,http://vmh.uni.lu/_api/metabolites/830/?format=pcsv
adprbp,,,-4,C15H20N5O17P3,CHEBI:37463,,ADP-D-ribose 2'-phosphate(4-),,ADP-D-ribose 2'-phosphate(4-),,,"InChI=1S/C15H24N5O17P3/c16-12-7-13(18-3-17-12)20(4-19-7)14-11(35-38(25,26)27)9(23)6(33-14)2-32-39(28,29)37-40(30,31)36-15-10(24)8(22)5(1-21)34-15/h3-6,8-11,14-15,21-24H,1-2H2,(H,28,29)(H,30,31)(H2,16,17,18)(H2,25,26,27)/p-4/t5-,6-,8-,9-,10-,11-,14-,15?/m1/s1",C03246,2016-11-22T15:11:59Z,,831,,,,,439957,adprbp,,,http://vmh.uni.lu/_api/metabolites/831/?format=pcsv
fe2,,,2,Fe,CHEBI:29033,,"Human Metabolome Database (HMDB): Iron is a chemical element with the symbol Fe and atomic number 26. Iron makes up 5% of the Earth's crust and is second in abundance to aluminium among the metals and fourth in abundance among the elements. Physiologically, it. exists as an ion in the body. Iron (as Fe2+, ferrous ion) is a necessary trace element used by all known living organisms. Iron-containing enzymes, usually containing heme prosthetic groups, participate in catalysis of oxidation reactions in biology, and in transport of a number of soluble gases. Iron is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Inorganic iron involved in redox reactions is also found in the iron-sulfur clusters of many enzymes, such as nitrogenase (involved in the synthesis of ammonia from nitrogen and hydrogen) and hydrogenase. A class of non-heme iron proteins is responsible for a wide range of functions such as ribonucleotide reductase (reduces ribose to deoxyribose; DNA biosynthesis) and purple acid phosphatase (hydrolysis of phosphate esters). When the body is fighting a bacterial infection, the body sequesters iron inside of cells (mostly stored in the storage molecule ferritin) so that it cannot be used by bacteria. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia. Humans experience iron toxicity above 20 milligrams of iron for every kilogram of weight, and 60 milligrams per kilogram is a lethal dose. Over-consumption of iron, often the result of children eating large quantities of ferrous sulfate tablets intended for adult consumption, is the most common toxicological cause of death in children under six. The DRI lists the Tolerable Upper Intake Level (UL) for adults as 45 mg/day. For children under fourteen years old the UL is 40 mg/day. Iron is a metal extracted from iron ore, and is almost never found in the free elemental state.",,Fe2+,,HMDB00692,InChI=1S/Fe/q+2,C14818,2016-12-05T15:48:05Z,,832,,,,Fe2+,27284,fe2,,"Armco iron, Carbonyl iron, FE, Ferrovac e, Hematite, Infed, Limonite, LOHA, Magnetite, Malleable iron, Metopirone, Metyrapone, Pzh2M, PZHO, Remko, Suy-B 2, Taconite, Venofer, Wrought iron",http://vmh.uni.lu/_api/metabolites/832/?format=pcsv
fe3,,,3,Fe,CHEBI:29034,,Fe3+,,Fe3+,,,InChI=1S/Fe/q+3,C14819,2016-11-22T15:11:59Z,,833,,,,Fe3+,29936,fe3,,,http://vmh.uni.lu/_api/metabolites/833/?format=pcsv
fol,,,-1,C19H18N7O6,CHEBI:27470,,"Human Metabolome Database (HMDB): Folic acid is a member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (poaceae). Folic acid, being biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase. These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylated tRNA, and generate and use formate. Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia.",,Folate,,HMDB00121,"InChI=1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1",C00504,2016-12-05T15:48:05Z,,834,,,,,6037,fol,,"Acifolic, Cytofol, Dosfolat B activ, Folacid, Folacin, Folate, Folbal, Folcidin, Foldine, Folettes, Foliamin, Folic acid, Folicet, Folipac, Folsan, Folsaure, Folsav, Folvite, Incafolic, Liver Lactobacillus casei factor, Millafol, N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid, N-Pteroyl-L-glutamic acid, N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid, N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid, PGA, PteGlu, Pteroyl-L-glutamate, Pteroyl-L-glutamic acid, Pteroyl-L-monoglutamate, Pteroyl-L-monoglutamic acid, Pteroylglutamate, Pteroylglutamic acid, Pteroylmonoglutamic acid, Vitamin Bc, Vitamin Be, Vitamin M",http://vmh.uni.lu/_api/metabolites/834/?format=pcsv
fru,,,0,C6H12O6,CHEBI:15824,,"Human Metabolome Database (HMDB): Fructose, or levulose, is a levorotatory monosaccharide and an isomer of glucose (C6H12O6). The chemical composition of fructose is (C6H12O6). Pure fructose has a sweet taste similar to cane sugar, but with a ""fruity"" aroma. Although fructose is a hexose (6 carbon sugar), it generally exists as a 5-member hemiketal ring (a furanose). This structure is responsible for the long metabolic pathway and high reactivity compared to glucose. Fructose is found in many foods and is one of the three most important blood sugars along with glucose and galactose. Honey; tree fruits; berries; melons; and some root vegetables, such as beets, sweet potatoes, parsnips and onions, contain fructose, usually in combination with sucrose and glucose. Fructose is also derived from the digestion of sucrose, a disaccharide consisting of glucose and fructose that is broken down by enzymes during digestion. Fructose is the sweetest naturally occurring sugar, estimated to be twice as sweet as sucrose. It is used as a preservative and an intravenous infusion in parenteral feeding. Fructose is a reducing sugar, as are all monosaccharides. The spontaneous addition of single sugar molecules to proteins, known as glycation, is a significant cause of damage in diabetics. Fructose appears to be as dangerous as glucose in this regard and so does not seem to be the answer for diabetes (McPherson et al, 1988). This may be an important contribution to senescence and many age-related chronic diseases (Levi & Werman 1998).",,D-Fructose,,HMDB00660,,C02336,2016-12-05T15:48:05Z,,835,,,,,439709,fru,,"beta-D-Arabino-hexulose, beta-D-Fructofuranose, beta-D-Fructose, beta-delta-Arabino-hexulose, beta-delta-Fructofuranose, beta-delta-Fructose, beta-Fruit sugar, beta-Levulose, D-(-)-Fructose, D-Fructose, delta-(-)-Fructose, delta-Fructose, FRU, Fructon, Fructose, Levulose",http://vmh.uni.lu/_api/metabolites/835/?format=pcsv
fuc13galacglcgal14acglcgalgluside_hs,,,0,C64H112N3O36FULLRCO,,,III3Fuc-nLc6Cer,,III3Fuc-nLc6Cer,,,,,2016-11-22T15:11:59Z,,836,,,,,,fuc13galacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/836/?format=pcsv
fuc14galacglcgalgluside_hs,,,0,C50H89N2O26FULLRCO,,,Lea glycolipid,,Lea glycolipid,,,,,2016-11-22T15:11:59Z,,837,,,,,,fuc14galacglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/837/?format=pcsv
fucacgalfucgalacglcgalgluside_hs,,,0,C64H112N3O35FULLRCO,,,(Gal)2 (GalNAc)1 (Glc)1 (GlcNAc)1 (LFuc)2 (Cer)1,,(Gal)2 (GalNAc)1 (Glc)1 (GlcNAc)1 (LFuc)2 (Cer)1,,,,,2016-11-22T15:11:59Z,,838,,,,,,fucacgalfucgalacglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/838/?format=pcsv
fucacngal14acglcgalgluside_hs,,,-1,C61H105N3O34FULLRCO,,,"IV3-a-NeuAc,III3-a-Fuc-nLc4Cer",,"IV3-a-NeuAc,III3-a-Fuc-nLc4Cer",,,,,2016-11-22T15:11:59Z,,839,,,,,,fucacngal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/839/?format=pcsv
fucacngalacglcgalgluside_hs,,,-1,C61H105N3O34FULLRCO,,,"IV3-a-Neu5Ac,III4-a-Fuc-Lc4Cer",,"IV3-a-Neu5Ac,III4-a-Fuc-Lc4Cer",,,,,2016-11-22T15:11:59Z,,840,,,,,,fucacngalacglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/840/?format=pcsv
fucfuc12gal14acglcgalgluside_hs,,,0,C56H99N2O30FULLRCO,,,Ley glycolipid,,Ley glycolipid,,,,,2016-11-22T15:11:59Z,,841,,,,,,fucfuc12gal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/841/?format=pcsv
fucfuc132galacglcgal14acglcgalgluside_hs,,,0,C70H122N3O40FULLRCO,,,"V3Fuc,III3Fuc-nLc6Cer",,"V3Fuc,III3Fuc-nLc6Cer",,,,,2016-11-22T15:11:59Z,,842,,,,,,fucfuc132galacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/842/?format=pcsv
fucfucfucgalacglc13galacglcgal14acglcgalgluside_hs,,,0,C90H155N4O54FULLRCO,,,(Gal)4 (Glc)1 (GlcNAc)3 (LFuc)3 (Cer)1,,(Gal)4 (Glc)1 (GlcNAc)3 (LFuc)3 (Cer)1,,,,,2016-11-22T15:11:59Z,,843,,,,,,fucfucfucgalacglc13galacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/843/?format=pcsv
fucfucfucgalacglcgal14acglcgalgluside_hs,,,0,C76H132N3O44FULLRCO,,,(Gal)3 (Glc)1 (GlcNAc)2 (LFuc)3 (Cer)1,,(Gal)3 (Glc)1 (GlcNAc)2 (LFuc)3 (Cer)1,,,,,2016-11-22T15:11:59Z,,844,,,,,,fucfucfucgalacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/844/?format=pcsv
fucfucgalacglcgalgluside_hs,,,0,C56H99N2O30FULLRCO,,,Leb glycolipid,,Leb glycolipid,,,,,2016-11-22T15:11:59Z,,845,,,,,,fucfucgalacglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/845/?format=pcsv
fucgal14acglcgalgluside_hs,,,0,C50H89N2O26FULLRCO,,,Lacto-N-fucopentaosyl III ceramide,,Lacto-N-fucopentaosyl III ceramide,,,,,2016-11-22T15:11:59Z,,846,,,,,,fucgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/846/?format=pcsv
fucgalfucgalacglcgalgluside_hs,,,0,C62H109N2O35FULLRCO,,,(Gal)3 (Glc)1 (GlcNAc)1 (LFuc)2 (Cer)1,,(Gal)3 (Glc)1 (GlcNAc)1 (LFuc)2 (Cer)1,,,,,2016-11-22T15:11:59Z,,847,,,,,,fucgalfucgalacglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/847/?format=pcsv
fucgalgbside_hs,,,0,C56H99N2O31FULLRCO,,,fucosyl galactosylgloboside,,fucosyl galactosylgloboside,,,,,2016-11-22T15:11:59Z,,848,,,,,,fucgalgbside_hs,,,http://vmh.uni.lu/_api/metabolites/848/?format=pcsv
fuc_L,,,0,C6H12O5,CHEBI:2181,,"Human Metabolome Database (HMDB): Fucose is a hexose deoxy sugar with the chemical formula C6H12O5. L-fucose (6-deoxy-L-galactose) is a monosaccharide that is a common component of many N- and O-linked glycans and glycolipids produced by mammalian cells. It is the fundamental sub-unit of the fucoidan polysaccharide. As a free sugar, L-fucose is normally found at very low levels in mammals. It is unique in that it is the only levorotatory sugar synthesized and utilized by mammals. Fucose polymers are synthesized by fucosyltransferases.  All fucosyltransferases utilize a nucleotide-activated form of fucose, GDP-fucose, as a fucose donor in the construction of fucosylated oligosaccharides. The ABO blood group antigens are among the most well known fucosylated glycans. The alpha-1->3 linked core fucose is a suspected carbohydrate antigen for IgE-mediated allergy. Two structural features distinguish fucose from other six-carbon sugars present in mammals: the lack of a hydroxyl group on the carbon at the 6-position (C-6) and the L-configuration. In fucose-containing glycan structures, fucosylated glycans, fucose can exist as a terminal modification or serve as an attachment point for adding other sugars. Fucose is metabolized by an enzyme called alpha-fucosidase. Fucose is secreted in urine when the liver is damaged.  Free L-fucose in serum and urine can be used as a marker for cancer, cirrhosis, alcoholic liver disease and gastric ulcers (PMID: 2311216) (PMID: 8488966). Elevated levels of serum fucose have been reported in breast cancer, ovarian cancer, lung cancer, liver cancer, diabetes and cardiovascular disease. It has been shown that feeding rats a diet high in L-fucose induces neuropathy similar to that seen in diabetics.
",,L-fucose,,HMDB00174,,C01019,2016-12-05T15:48:05Z,,849,,,,,17106,fuc_L,,"(-)-Fucose, (-)-L-Fucose, 6-Deoxy-beta-galactose, 6-Deoxy-D-galactopyranose, 6-Deoxy-delta-galactopyranose, 6-Deoxy-L-beta-galactose, 6-Deoxy-L-galactopyranose, 6-Deoxy-L-galactose, 6-Desoxygalactose, 6-Methyloxane-2,3,4,5-tetrol, 6-Methyltetrahydropyran-2,3,4,5-tetraol, D-Threo-Aldose, Fucose, Isodulcit, L-(-)-Fucose, L-Fucopyranose, L-Fucose, L-Galactomethylose, Rhodeose",http://vmh.uni.lu/_api/metabolites/849/?format=pcsv
gal,,,0,C6H12O6,CHEBI:4139,,"Human Metabolome Database (HMDB): D-Galactose is an aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. D-Galactose is an energy-providing nutrient and also a necessary basic substrate for the biosynthesis of many macromolecules in the body. Metabolic pathways for D-Galactose are important not only for the provision of these pathways but also for the prevention of D-Galactose and D-Galactose metabolite accumulation. The main source of D-Galactose is lactose in the milk of mammals, but it can also be found in some fruits and vegetables. Utilization of D-Galactose in all living cells is initiated by the phosphorylation of the hexose by the enzyme galactokinase (E.C. 2.7.1.6) (GALK) to form D-Galactose-1-phosphate. In the presence of D-Galactose-1-phosphate uridyltransferase (E.C. 2.7.7.12) (GALT) D-Galactose-1-phosphate is exchanged with glucose-1-phosphate in UDP-glucose to form UDP-galactose. Glucose-1-phosphate will then enter the glycolytic pathway for energy production. Deficiency of the enzyme GALT in galactosemic patients leads to the accumulation of D-Galactose-1-phosphate. Classic galactosemia-a term that denotes the presence of D-Galactose in the blood is the rare inborn error of D-Galactose metabolism, diagnosed by the deficiency of the second enzyme of the D-Galactose assimilation pathway, GALT, which, in turn, is caused by mutations at the GALT gene. (PMID: 15256214, 11020650, 10408771).",,D-Galactose,,HMDB00143,,C00984,2016-12-05T15:48:05Z,,850,,,,,439357,gal,,"(+)-Galactose, 5abp, 8abp, alpha D-Galactose, alpha-D-Galactopyranose, alpha-D-Galactose, D-(+)-Galactose, D-Galactose, D-Hexose, GAL, Galactose, Galactose (NF), GLA, GLC, Hexose",http://vmh.uni.lu/_api/metabolites/850/?format=pcsv
gam,,,1,C6H14NO5,CHEBI:47977,,D-Glucosamine,,D-Glucosamine,,,,C00329,2016-11-22T15:11:59Z,,851,,,,,439213,gam,,,http://vmh.uni.lu/_api/metabolites/851/?format=pcsv
gd1b2_hs,,,-2,C66H111N4O38FULLRCO,,,GD1beta,,GD1beta,,,,,2016-11-22T15:11:59Z,,852,,,,,,gd1b2_hs,,,http://vmh.uni.lu/_api/metabolites/852/?format=pcsv
gd1c_hs,,,-2,C66H111N4O38FULLRCO,,,GD1c,,GD1c,,,,,2016-11-22T15:11:59Z,,853,,,,,,gd1c_hs,,,http://vmh.uni.lu/_api/metabolites/853/?format=pcsv
gluala,,,-1,C8H13N2O5,,,"Human Metabolome Database (HMDB): 5-L-Glutamyl-L-alanine is a natural substrate of the enzyme 5-L-glutamyl)-L-amino acid 5-glutamyltransferase (cyclizing) (g-glutamylcyclotransferase, EC 2.3.2.2) in the glutathione metabolism pathway, which cleaves 5-L-Glutamyl-L-alanine, producing L-5-oxoproline. gamma-Glutamylcyclotransferase is widely distributed in both human and animal tissues where it catalyzes the scission of the y-peptide bonds of many different gamma-glutamyl-aminoacids and gamma-glutamyl-gamma-glutamyl-amino-acids. The latter are 'better' substrates of the enzyme than the corresponding gamma-glutamyl - amino-acids. (PMID: 2570694, 2893631).",,5-L-Glutamyl-L-alanine,,HMDB06248,"InChI=1/C8H14N2O5/c1-4(7(12)13)10-6(11)3-2-5(9)8(14)15/h4-5H,2-3,9H2,1H3,(H,10,11)(H,12,13)(H,14,15)/t4-,5-/m0/s1",C03740,2016-12-05T15:48:05Z,,854,,,,,440103,gluala,,"5-L-Glutamylalanine, g-Glu-Ala, g-Glutamylalanine, g-L-Glutamyl-L-alanine, gamma-Glu-Ala, gamma-Glutamylalanine, gamma-L-Glutamyl-L-alanine",http://vmh.uni.lu/_api/metabolites/854/?format=pcsv
glyc,,,0,C3H8O3,CHEBI:17754,,"Human Metabolome Database (HMDB): Glycerol is an important component of triglycerides (i.e. fats and oils) and of phospholipids. glycerol is a three-carbon substance that forms the backbone of fatty acids in fats. When the body uses stored fat as a source of energy, glycerol and fatty acids are released into the bloodstream. The glycerol component can be converted to glucose by the liver and provides energy for cellular metabolism.",,Glycerol,,HMDB00131,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",C00116,2016-12-05T15:48:05Z,,855,,,,glycerol,753,glyc,,"1,2,3-Trihydroxypropane, Bulbold, Cristal, E 422, Emery 916, Glyceol Opthalgan, Glycerin, Glycerine, Glyceritol, Glycerol, Glycyl alcohol, Glyrol, Glysanin, IFP, Incorporation factor, Mackstat H 66, Osmoglyn, Pricerine 9091, Propanetriol, RG-S, Trihydroxypropane, Tryhydroxypropane",http://vmh.uni.lu/_api/metabolites/855/?format=pcsv
glyc_S,,,0,C3H5O4,,,(S)-Glycerate,,(S)-Glycerate,,,"InChI=1S/C3H6O4/c4-1-2(5)3(6)7/h2,4-5H,1H2,(H,6,7)/p-1",,2016-11-22T15:11:59Z,,856,,,,,6326776,glyc_S,,,http://vmh.uni.lu/_api/metabolites/856/?format=pcsv
glygn5,,,0,C12H21O11X,,,"glycogen, structure 5 (glycogenin-2[1,4-Glc])",,"glycogen, structure 5 (glycogenin-2[1,4-Glc])",,,,,2016-11-22T15:11:59Z,,857,,,,,,glygn5,,,http://vmh.uni.lu/_api/metabolites/857/?format=pcsv
gmp,,,-2,C10H12N5O8P,CHEBI:17345,,GMP,,GMP,,,"InChI=1S/C10H14N5O8P/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18)/p-2/t3-,5-,6-,9-/m1/s1",C00144,2016-11-22T15:11:59Z,,858,,,,,6804,gmp,,,http://vmh.uni.lu/_api/metabolites/858/?format=pcsv
gp1c_hs,,,-5,C99H159N7O62FULLRCO,,,GP1c,,GP1c,,,,,2016-11-22T15:11:59Z,,859,,,,,,gp1c_hs,,,http://vmh.uni.lu/_api/metabolites/859/?format=pcsv
gp1calpha_hs,,,-5,C99H159N7O62FULLRCO,,,GP1c alpha,,GP1c alpha,,,,,2016-11-22T15:11:59Z,,860,,,,,,gp1calpha_hs,,,http://vmh.uni.lu/_api/metabolites/860/?format=pcsv
gq1b_hs,,,-4,C88H143N6O54FULLRCO,CHEBI:27515,,GQ1b,,GQ1b,,,,,2016-11-22T15:11:59Z,,861,,,,,,gq1b_hs,,,http://vmh.uni.lu/_api/metabolites/861/?format=pcsv
gq1balpha_hs,,,-4,C88H143N6O54FULLRCO,,,GQ1balpha,,GQ1balpha,,,,,2016-11-22T15:11:59Z,,862,,,,,,gq1balpha_hs,,,http://vmh.uni.lu/_api/metabolites/862/?format=pcsv
gsn,,,0,C10H13N5O5,CHEBI:16750,,"Human Metabolome Database (HMDB): Guanosine is a nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a beta-N9-glycosidic bond. Guanosine can be phosphorylated to become GMP (guanosine monophosphate), cGMP (cyclic guanosine monophosphate), GDP (guanosine diphosphate) and GTP (guanosine triphosphate). (Wikipedia). The nucleoside guanosine exert important neuroprotective and neuromodulator roles in the central nervous system, which may be related to inhibition of the glutamatergic neurotransmission activity. Guanosine is the specific extracellular guanine-based purines effector and indicate that its conversion occurs not only in the central nervous system but also peripherally. (PMID: 16325434).",,Guanosine,,HMDB00133,"InChI=1S/C10H13N5O5/c11-10-13-7-4(8(19)14-10)12-2-15(7)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5-,6-,9-/m1/s1",C00387,2016-12-05T15:48:05Z,,863,,,,,6802,gsn,,"2-Amino-1,9-dihydro-9-b-D-ribofuranosyl-6H-purin-6-one, 2-Amino-1,9-dihydro-9-beta-delta-ribofuranosyl-6H-purin-6-one, 2-Amino-Inosine, 9-b-D-Ribofuranosyl-Guanine, 9-beta-delta-Ribofuranosyl-Guanine, b-D-Ribofuranoside guanine-9, beta-delta-Ribofuranoside guanine-9, Guanosine, Ribonucleoside, Vernine",http://vmh.uni.lu/_api/metabolites/863/?format=pcsv
gt1a_hs,,,-3,C77H127N5O46FULLRCO,CHEBI:27691,,GT1a,,GT1a,,,,,2016-11-22T15:11:59Z,,864,,,,,,gt1a_hs,,,http://vmh.uni.lu/_api/metabolites/864/?format=pcsv
gua,,,0,C5H5N5O,CHEBI:16235,,"Human Metabolome Database (HMDB): Guanine is one of the five main nucleobases found in the nucleic acids DNA and RNA. Guanine is a derivative of purine, consisting of a fused pyrimidine-imidazole ring system with conjugated double bonds. Being unsaturated, the bicyclic molecule is planar. The guanine nucleoside is called guanosine. The first isolation of guanine was reported in 1844 from the excreta of sea birds, known as guano, which was used as a source of fertilizer. High affinity binding of guanine nucleotides and the ability to hydrolyze bound GTP to GDP are characteristics of an extended family of intracellular proteins. Guanine nucleotide-binding regulatory proteins may be involved in the activation of phospholipases C and A2 by hormones and other ligands. The binding of hormones to receptors that activate phospholipase C is decreased by guanine nucleotides and these hormones also stimulate a high-affinity GTPase activity in cell membranes. Effects of hormones on phospholipase C activity in cell-free preparations are dependent on the presence of guanine nucleotides. Hypoxanthine-guanine phosphoribosyltransferase (HPRT, EC 2.4.2.8) is a purine salvage enzyme that catalyses the conversion of hypoxanthine and guanine to their respective mononucleotides. Partial deficiency of this enzyme can result in the overproduction of uric acid leading to a severe form of gout, whilst a virtual absence of HPRT activity causes the Lesch-Nyhan syndrome which is characterised by hyperuricaemia, mental retardation, choreoathetosis and compulsive self-mutilation. Peroxynitrite induces DNA base damage predominantly at guanine (G) and 8-oxoguanine (8-oxoG) nucleobases via oxidation reactions. G and 8-oxoG are the most reactive bases toward Peroxynitrite and possibly the major contributors to peroxynitrite-derived genotoxic and mutagenic lesions. The neutral G radical, reacts with NO2 to yield 8-nitroguanine and 5-nitro-4-guanidinohydantoin. (PMID: 16352449, 2435586, 2838362, 1487231).",,Guanine,,HMDB00132,"InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",C00242,2016-12-05T15:48:05Z,,865,,,,,764,gua,,"2-Amino-1,7-dihydro-6H-Purin-6-one, 2-Amino-1,9-dihydro-6H-purin-6-one, 2-Amino-1,9-dihydro-purin-6-one, 2-Amino-3,7-dihydro-6H-purin-6-one, 2-Amino-6-hydroxy-1H-purine, 2-Amino-6-hydroxypurine, 2-Amino-6-purinol, 2-Amino-Hypoxanthine, 2-Aminohypoxanthine, 6-Hydroxy-2-aminopurine, C.I. Natural White 1, CI Natural white 1, Dew Pearl, GUA, Guanin, Guanine, Guanine enol, GUN, Mearlmaid, Mearlmaid AA, Natural pearl essence, Natural White 1, Naturon, Pathocidin, Pearl Essence, Stella Polaris",http://vmh.uni.lu/_api/metabolites/865/?format=pcsv
ha,,,-2,C28H40N2O22,CHEBI:16336,,hyaluronan,,hyaluronan,,,,,2016-11-22T15:11:59Z,,866,,,,,,ha,,,http://vmh.uni.lu/_api/metabolites/866/?format=pcsv
ha_pre1,,,-1,C14H20NO11,CHEBI:16126,,"hyaluronan biosynthesis, precursor 1",,"hyaluronan biosynthesis, precursor 1",,,"InChI=1S/C14H21NO11/c1-4(17)15-8-11(10(20)7(3-16)24-13(8)23)26-14-9(19)5(18)2-6(25-14)12(21)22/h2,5,7-11,13-14,16,18-20,23H,3H2,1H3,(H,15,17)(H,21,22)/t5-,7+,8+,9+,10+,11+,13+,14-/m0/s1",C04794,2016-11-22T15:11:59Z,,867,,,,,440484,ha_pre1,,,http://vmh.uni.lu/_api/metabolites/867/?format=pcsv
hcoumarin,,,0,C9H6O3,CHEBI:27510,,umbelliferone,,umbelliferone,,,"InChI=1S/C9H6O3/c10-7-3-1-6-2-4-9(11)12-8(6)5-7/h1-5,10H",C09315,2016-11-22T15:11:59Z,,868,,,,,5281426,hcoumarin,,,http://vmh.uni.lu/_api/metabolites/868/?format=pcsv
hdca,,,-1,C16H31O2,CHEBI:15756,,"Human Metabolome Database (HMDB): Palmitic acid, or hexadecanoic acid is one of the most common saturated fatty acids found in animals and plants, a saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.(wikipedia) Biological Source: Occurs in the form of esters (glycerides) in oils and fats of vegetable and animal origin. Usually obtained from palm oil. Widely distributed in plants Use/Importance:. Palmitic acid is used in determination of water hardness Biological Use/Importance: Active ingredient of *Levovist*TM, used in echo enhancement in sonographic Doppler B-mode imaging. Ultrasound contrast medium (Dictionary of Organic Compounds).",,Hexadecanoate (n-C16:0),,HMDB00220,"InChI=1S/C16H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H,17,18)/p-1",C00249,2016-12-05T15:48:05Z,,869,,,,,985,hdca,,"1-Hexyldecanoate, 1-Hexyldecanoic acid, 1-Pentadecanecarboxylic acid, C16 fatty acid, Cetylic acid, Edenor C16, Emersol 140, Emersol 143, Glycon P-45, Hexadecanoate, Hexadecanoic acid, Hexadecanoic acid palmitic acid, Hexadecoate, Hexadecoic acid, Hexadecylic acid, Hexaectylic acid, Hydrofol, Hydrofol acid 1690, Hystrene 8016, Hystrene 9016, Industrene 4516, Kortacid 1698, Loxiol EP 278, Lunac P 95, Lunac P 95KC, Lunac P 98, N-Hexadecanoate, N-Hexadecanoic acid, N-Hexadecoate, N-Hexadecoic acid, Palmitate, Palmitic acid, Palmitinate, Palmitinic acid, Palmitinsaeure, Palmitoate, Palmitoic acid, PAM, Pentadecanecarboxylate, Pentadecanecarboxylic acid, PLM, Prifac 2960, Prifrac 2960, Pristerene 4934, Univol U332",http://vmh.uni.lu/_api/metabolites/869/?format=pcsv
hdcea,,,-1,C16H29O2,CHEBI:28716,,"Human Metabolome Database (HMDB): fatty acids, Monounsaturated. Palmitoleic acid, or 9-hexadecenoic acid, is an unsaturated fatty acid that is a common constituent of the glycerides of human adipose tissue. Present in all tissues, generally found in higher concentrations in the liver. Macadamia oil (Macadamia integrifolia) and Sea Buckthorn oil (Hippophae rhamnoides) are botanical sources of palmitoleic acid, containing 22 and 40% respectively. -- Wikipedia.",,Hexadecenoate (n-C16:1),,HMDB03229,"InChI=1S/C16H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h7-8H,2-6,9-15H2,1H3,(H,17,18)/p-1/b8-7-",C08362,2016-12-05T15:48:05Z,,870,,,,,445638,hdcea,,"(Z)-9-Hexadecenoate, (Z)-9-Hexadecenoic acid, (Z)-Hexadec-9-enoate, (Z)-Hexadec-9-enoic acid, 9-cis-Hexadecenoate, 9-cis-Hexadecenoic acid, 9-Hexadecenoate, 9-Hexadecenoic acid, cis-9-Hexadecenoate, cis-9-Hexadecenoic acid, cis-9-Palmitoleic acid, cis-delta-9-Hexadecenoate, cis-delta-9-Hexadecenoic acid, cis-Palmitoleate, cis-Palmitoleic acid, Hexadecenoate, Hexadecenoic acid, Oleopalmitate, Oleopalmitic acid, Palmitoleate, Palmitoleic acid, Zoomerate, Zoomeric acid",http://vmh.uni.lu/_api/metabolites/870/?format=pcsv
hestratriol,,,0,C18H24O3,,,Human Metabolome Database (HMDB): 4-Hydroxyestradiol is an oncogenic catechol estrogen produced by metabolism of Estrogen.,,"4,17 dihydroxy estradiol",,HMDB05896,"InChI=1/C18H24O3/c1-18-9-8-11-10-4-6-15(19)17(21)13(10)3-2-12(11)14(18)5-7-16(18)20/h4,6,11-12,14,16,19-21H,2-3,5,7-9H2,1H3/t11?,12?,14?,16-,18-/m0/s1",C14209,2016-12-05T15:48:05Z,,871,,,,,44348689,hestratriol,,"1,3,5[10]-Estratriene-3,4,17beta-triol, 3,4,17beta-estriol, 3,4,17beta-trihydroxy-1,3,5[10]-estratriene, 4,17 dihydroxy estradiol, 4-Hydroxy-17beta-estradiol, 4-Hydroxy-estradiol, 4-Hydroxyestradiol, 4-Hydroxyestradiol-17 beta, 4-Hydroxyestradiol-17beta, 4-OH-Estradiol, 4OHE2",http://vmh.uni.lu/_api/metabolites/871/?format=pcsv
hexc,,,-1,C26H51O2,CHEBI:31009,,"Human Metabolome Database (HMDB): X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder biochemically characterized by the accumulation of very long chain fatty acids (VLCFA), particularly hexacosanoic acid (C(26:0)) and tetracosanoic acid (C(24:0)), in tissues and biological fluids. (PMID 16750542).",,cerotate,,HMDB02356,"InChI=1S/C26H52O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26(27)28/h2-25H2,1H3,(H,27,28)/p-1",,2016-12-05T15:48:05Z,,872,,,,,10469,hexc,,"Cerate, Ceratinate, Ceratinic acid, Ceric acid, Cerinate, Cerinic acid, Cerotic acid, Cerylate, Cerylic acid, Hexacosanoate, Hexacosanoate (N-C26:0), Hexacosanoic acid, N-Hexacosanoate, N-Hexacosanoic acid",http://vmh.uni.lu/_api/metabolites/872/?format=pcsv
his_L,,,0,C6H9N3O2,CHEBI:15971,,"Human Metabolome Database (HMDB): Histidine is an alpha-amino acid with an imidazole functional group. It is one of the 22 proteinogenic amino acids. Histidine was first isolated by German physician Albrecht Kossel in 1896. Histidine is an essential amino acid in humans and other mammals. It was initially thought that it was only essential for infants, but longer-term studies established that it is also essential for adults. Infants four to six months old require 33 mg/kg of histidine. It is not clear how adults make small amounts of histidine, and dietary sources probably account for most of the histidine in the body. Histidine is a precursor for histamine and carnosine biosynthesis. Inborn errors of histidine metabolism exist and are marked by increased histidine levels in the blood. Elevated blood histidine is accompanied by a wide range of symptoms, from mental and physical retardation to poor intellectual functioning, emotional instability, tremor, ataxia and psychosis. Histidine and other imidazole compounds have anti-oxidant, anti-inflammatory and anti-secretory properties (PMID: 9605177). The efficacy of L-histidine in protecting inflamed tissue is attributed to the capacity of the imidazole ring to scavenge reactive oxygen species (ROS) generated by cells during acute inflammatory response (PMID: 9605177). Histidine, when administered in therapeutic quantities is able to inhibit cytokines and growth factors involved in cell and tissue damage (US patent 6150392). Histidine in medical therapies has its most promising trials in rheumatoid arthritis where up to 4.5 g daily have been used effectively in severely affected patients. Arthritis patients have been found to have low serum histidine levels, apparently because of very rapid removal of histidine from their blood (PMID: 1079527). Other patients besides arthritis patients that have been found to be low in serum histidine are those with chronic renal failure. Urinary levels of histidine are reduced in pediatric patients with pneumonia. (PMID: 2084459). Asthma patients exhibit increased serum levels of histidine over normal controls (PMID: 23517038).  Serum histidine levels are lower and are negatively associated with inflammation and oxidative stress in obese women (PMID: 23361591).  Histidine supplementation has been shown to reduce insulin resistance, reduce BMI and fat mass and suppress inflammation and oxidative stress in obese women with metabolic syndrome.  Histidine appears to suppress pro-inflammatory cytokine expression, possibly via the NF-?B pathway, in adipocytes (PMID: 23361591). Low plasma concentrations of histidine are associated with protein-energy wasting, inflammation, oxidative stress, and greater mortality in chronic kidney disease patients (PMID: 18541578). Histidine may have many other possible functions because it is the precursor of the ubiquitous neurohormone-neurotransmitter histamine. Histidine increases histamine in the blood and probably in the brain. Low blood histamine with low serum histidine occurs in rheumatoid arthritis patients. Low blood histamine also occurs in some manic, schizophrenic, high copper and hyperactive groups of psychiatric patients. Histidine is a useful therapy in all patients with low histamine levels. (http://www.dcnutrition.com ).


",,L-histidine,,HMDB00177,"InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1",C00135,2016-12-05T15:48:05Z,,873,,,,,6274,his_L,,"(S)-1H-Imidazole-4-alanine, (S)-2-Amino-3-(4-imidazolyl)propionsaeure, (S)-4-(2-Amino-2-carboxyethyl)imidazole, (S)-a-Amino-1H-imidazole-4-propanoate, (S)-a-Amino-1H-imidazole-4-propanoic acid, (S)-alpha-Amino-1H-imidazole-4-propanoate, (S)-alpha-Amino-1H-imidazole-4-propanoic acid, (S)-alpha-Amino-1H-imidazole-4-propionate, (S)-alpha-Amino-1H-imidazole-4-propionic acid, (S)-Histidine, (S)1H-Imidazole-4-alanine, 3-(1H-Imidazol-4-yl)-L-Alanine, Amino-1H-imidazole-4-propanoate, Amino-1H-imidazole-4-propanoic acid, Amino-4-imidazoleproprionate, Amino-4-imidazoleproprionic acid, Glyoxaline-5-alanine, His, Histidine, L-(-)-Histidine",http://vmh.uni.lu/_api/metabolites/873/?format=pcsv
hista,,,1,C5H10N3,CHEBI:18295,,"Human Metabolome Database (HMDB): Histamine is an amine derived by enzymatic decarboxylation of histidine. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.",,histamium,,HMDB00870,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)/p+1",C00388,2016-12-05T15:48:05Z,,874,,,,,774,hista,,"1H-Imidazole-4-ethanamine, 2-(1H-Imidazol-4-yl)ethanamine, 2-(1H-Imidazol-4-yl)ethylamine, 2-(1H-Imidazol-5-yl)ethanamine, 2-(1H-Imidazol-5-yl)ethylamine, 2-(4-Imidazolyl)ethanamine, 2-(4-Imidazolyl)ethylamine, 2-Imidazol-4-yl-Ethylamine, 2-Imidazol-4-ylethylamine, 4-(2-Aminoethyl)-1H-imidazole, 4-(2-Aminoethyl)imidazole, 4-Imidazoleethylamine, 5-Imidazoleethylamine, b-Imidazolyl-4-ethylamine, beta-Aminoethylglyoxaline, beta-Aminoethylimidazole, beta-Aminothethylglyoxaline, beta-Imidazolyl-4-ethylamine, Eramin, Ergamine, Ergotidine, Free histamine, Histamine, HSM, L-Histamin base, L-Histamine, Theramine",http://vmh.uni.lu/_api/metabolites/874/?format=pcsv
hom_L,,,0,C4H9NO3,CHEBI:15699,,"Human Metabolome Database (HMDB): Homoserine is a more reactive variant of the amino acid serine. In this variant, the hydroxyl side chain contains an additional CH2 group which brings the hydroxyl group closer to its own carboxyl group, allowing it to chemically react to form a five-membered ring. This occurs at the point that amino acids normally join to their neighbours in a peptide bond. Homoserine is therefore unsuitable for forming proteins and has been eliminated from the repertoire of amino acids used by living things. Homoserine is the final product on the C-terminal end of the N-terminal fragment following a cyanogen bromide cleavage. (wikipedia).",,L-homoserine,,HMDB00719,"InChI=1S/C4H9NO3/c5-3(1-2-6)4(7)8/h3,6H,1-2,5H2,(H,7,8)/t3-/m0/s1",C00263,2016-12-05T15:48:05Z,,875,,,,,12647,hom_L,,"(S)-2-amino-4-hydroxy-Butanoate, (S)-2-amino-4-hydroxy-Butanoic acid, (S)-2-Amino-4-hydroxybutanoate, (S)-2-Amino-4-hydroxybutanoic acid, (S)-Homoserine, 2-Amino-4-hydroxy-Butyrate, 2-Amino-4-hydroxy-Butyric acid, 2-Amino-4-hydroxy-L-Butyrate, 2-Amino-4-hydroxy-L-Butyric acid, 2-Amino-4-hydroxybutanoate, 2-Amino-4-hydroxybutanoic acid, 2-Amino-4-hydroxybutyrate, 2-Amino-4-hydroxybutyric acid, Homoserine, L-Homoserine",http://vmh.uni.lu/_api/metabolites/875/?format=pcsv
hpdca,,,-1,C17H33O2,CHEBI:32365,,"Human Metabolome Database (HMDB): Heptadecanoic acid is a fatty acid of exogenous (primarily ruminant) origin. Many ""odd"" length long chain amino acids are derived from the consumption of dairy fats (milk and meat). Heptadecanoic acid constitutes 0.61% of milk fat and 0.83% of ruminant meat fat. The content of heptadecanoic acid in the subcutaneous adipose tissue of humans appears to be a good biological marker of long-term milk fat intake in free-living individuals in populations with high consumption of dairy products. (PMID 9701185).",,margarate,,HMDB02259,"InChI=1S/C17H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17(18)19/h2-16H2,1H3,(H,18,19)/p-1",,2016-12-05T15:48:05Z,,876,,,,,10465,hpdca,,"Heptadecanoate, Heptadecanoic acid, Margarate, Margaric acid, Margarinate, Margarinic acid, Margaroate, Margaroic acid, N-Heptadecanoate, N-Heptadecanoic acid, N-Heptadecoate, N-Heptadecoic acid, N-Heptadecylate, N-Heptadecylic acid, Normal-heptadecanoate, Normal-heptadecanoic acid",http://vmh.uni.lu/_api/metabolites/876/?format=pcsv
hspg,,,-13,C79H113N5O101S12X,,,heparan sulfate proteoglycan,,heparan sulfate proteoglycan,,,,,2016-11-22T15:11:59Z,,877,,,,,,hspg,,,http://vmh.uni.lu/_api/metabolites/877/?format=pcsv
htaxol,,,0,C47H31NO15,CHEBI:63859,,6 alpha hydroxy taxol/ 6 alpha hydroxy paclitaxel,,6 alpha hydroxy taxol/ 6 alpha hydroxy paclitaxel,,,,,2016-11-22T15:11:59Z,,878,,,,,,,,,http://vmh.uni.lu/_api/metabolites/878/?format=pcsv
hxan,,,0,C5H4N4O,CHEBI:17368,,Human Metabolome Database (HMDB): Hypoxanthine is a naturally occurring purine derivative and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway. Hypoxanthine is also a spontaneous deamination product of adenine. Lesch-Nyhan disease is caused by deficiency of the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase. (OMIN 308000).,,Hypoxanthine,,HMDB00157,"InChI=1S/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)",C00262,2016-12-05T15:48:05Z,,879,,,,,790,hxan,,"1,7-Dihydro-6H-purin-6-one, 1,7-Dihydro-6H-purine-6-one, 1H,7H-Hypoxanthine, 3H-Purin-6-ol, 4-Hydroxy-1H-purine, 6(1H)-Purinone, 6-Hydroxy-1H-purine, 6-Hydroxypurine, 6-Oxopurine, 7H-Purin-6-ol, 9H-Purin-6(1H)-one, 9H-Purin-6-ol, Hypoxanthine enol, Purin-6(1H)-one, Purin-6(3H)-one, Purin-6-ol, Purine-6-ol, Sarcine, Sarkin, Sarkine",http://vmh.uni.lu/_api/metabolites/879/?format=pcsv
ile_L,,,0,C6H13NO2,CHEBI:17191,,"Human Metabolome Database (HMDB): Branched chain amino acids (BCAA) are essential amino acids whose carbon structure is marked by a branch point. These three amino acids are critical to human life and are particularly involved in stress, energy and muscle metabolism. BCAA supplementation as therapy, both oral and intravenous, in human health and disease holds great promise. ""BCAA"" denotes valine, isoleucine and leucine which are branched chain essential amino acids. Despite their structural similarities, the branched amino acids have different metabolic routes, with valine going solely to carbohydrates, leucine solely to fats and isoleucine to both. The different metabolism accounts for different requirements for these essential amino acids in humans: 12 mg/kg, 14 mg/kg and 16 mg/kg of valine, leucine and isoleucine respectively. Furthermore, these amino acids have different deficiency symptoms. Valine deficiency is marked by neurological defects in the brain, while isoleucine deficiency is marked by muscle tremors. BCAA are decreased in patients with liver disease, such as hepatitis, hepatic coma, cirrhosis, extrahepatic biliary atresia or portacaval shunt; aromatic amino acids (AAA)-tyrosine, tryptophan and phenylalanine, as well as methionine-are increased in these conditions. Valine, in particular, has been established as a useful supplemental therapy to the ailing liver. All the BCAA probably compete with AAA for absorption into the brain. Supplemental BCAA with vitamin B6 and zinc help normalize the BCAA:AAA ratio. The BCAA are not without side effects. Leucine alone, for example, exacerbates pellagra and can cause psychosis in pellagra patients by increasing excretion of niacin in the urine. Leucine may lower brain serotonin and dopamine. A dose of 3 g of isoleucine added to the niacin regime has cleared leucine-aggravated psychosis in schizophrenic patients. Isoleucine may have potential as an antipsychotic treatment. Leucine is more highly concentrated in foods than other amino acids. A cup of milk contains 800 mg of leucine and only 500 mg of isoleucine and valine. A cup of wheat germ has about 1.6 g of leucine and 1 g of isoleucine and valine. The ratio evens out in eggs and cheese. One egg and an ounce of most cheeses each contain about 400 mg of leucine and 400 mg of valine and isoleucine. The ratio of leucine to other BCAA is greatest in pork, where leucine is 7 to 8 g and the other BCAA together are only 3 to 4 g. (http://www.dcnutrition.com).",,L-isoleucine,,HMDB00172,"InChI=1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1",C00407,2016-12-05T15:48:05Z,,880,,,,,6306,ile_L,,"(2S,3S)-2-amino-3-methyl-Pentanoate, (2S,3S)-2-amino-3-methyl-Pentanoic acid, (2S,3S)-2-Amino-3-methylpentanoate, (2S,3S)-2-Amino-3-methylpentanoic acid, (2S,3S)-a-Amino-b-methyl-N-valerate, (2S,3S)-a-Amino-b-methyl-N-valeric acid, (2S,3S)-a-Amino-b-methylvalerate, (2S,3S)-a-Amino-b-methylvaleric acid, (2S,3S)-alph-Amino-beta-methylvalerate, (2S,3S)-alph-Amino-beta-methylvaleric acid, (2S,3S)-alpha-Amino-beta-merthyl-N-valerate, (2S,3S)-alpha-Amino-beta-merthyl-N-valeric acid, (2S,3S)-alpha-Amino-beta-merthylvalerate, (2S,3S)-alpha-Amino-beta-merthylvaleric acid, (2S,3S)-alpha-Amino-beta-methyl-N-valerate, (2S,3S)-alpha-Amino-beta-methyl-N-valeric acid, (2S,3S)-alpha-Amino-beta-methylvalerate, (2S,3S)-alpha-Amino-beta-methylvaleric acid, (S)-Isoleucine, (S,S)-Isoleucine, 2-Amino-3-methylpentanoate, 2-Amino-3-methylpentanoic acid, 2-Amino-3-methylvalerate, 2-Amino-3-methylvaleric acid, 2S,3S-Isoleucine, Erythro-L-Isoleucine, Ile, Iso-leucine, Isoleucine, L-(+)-Isoleucine, L-Ile, [S-(R*,R*)]-2-Amino-3-methylpentanoate, [S-(R*,R*)]-2-Amino-3-methylpentanoic acid",http://vmh.uni.lu/_api/metabolites/880/?format=pcsv
ksi,,,-13,C247H393N17O213S12X,,,keratan sulfate I,,keratan sulfate I,,,,,2016-11-22T15:11:59Z,,881,,,,,,ksi,,,http://vmh.uni.lu/_api/metabolites/881/?format=pcsv
ksi_deg1,,,-13,C241H383N17O209S12X,,,"keratan sulfate I, degradation product 1",,"keratan sulfate I, degradation product 1",,,,,2016-11-22T15:12:00Z,,882,,,,,,ksi_deg1,,,http://vmh.uni.lu/_api/metabolites/882/?format=pcsv
ksii_core2,,,-4,C81H129N6O67S3X,,,keratan sulfate II (core 2-linked),,keratan sulfate II (core 2-linked),,,,,2016-11-22T15:12:00Z,,883,,,,,,ksii_core2,,,http://vmh.uni.lu/_api/metabolites/883/?format=pcsv
ksii_core4,,,-4,C89H142N7O72S3X,,,keratan sulfate II (core 4-linked),,keratan sulfate II (core 4-linked),,,,,2016-11-22T15:12:00Z,,884,,,,,,ksii_core4,,,http://vmh.uni.lu/_api/metabolites/884/?format=pcsv
lac_L,,,-1,C3H5O3,CHEBI:422,,"Human Metabolome Database (HMDB): Lactic acid plays a role in several biochemical processes and is produced in the muscles during intense activity. Lactate measurement in the critically ill has been traditionally used to stratify patients with poor outcome. However, plasma lactate levels are the result of a finely tuned interplay of factors that affect the balance between its production and its clearance. When the oxygen supply does not match its consumption, organisms such as man who are forced to produce ATP for their integrity adapt in many different ways up to the point when energy failure occurs. Lactate, being part of the adaptive response, may then be used to assess the severity of the supply/demand imbalance. In such a scenario, the time to intervention becomes relevant: early and effective treatment may allow the cell to revert to a normal state, as long as the oxygen machinery (i.e. mitochondria) is intact. Conversely, once the mitochondria are deranged, energy failure occurs even in the presence of normoxia. The lactate increase in critically ill patients may therefore be viewed as an early marker of a potentially reversible state. (PMID 16356243) A number of studies have demonstrated that malignant transformation is associated with an increase in glycolytic flux and in anaerobic and aerobic cellular lactate excretion. Using quantitative bioluminescence imaging in various primary carcinomas in patients (uterine cervix, head and neck, colorectal region) at first diagnosis of the disease, lactate concentrations in tumors in vivo could be relatively low or extremely high (up to 40 micromol/g) in different individual tumors or within the same lesion. In all tumor entities investigated, high molar concentrations of lactate were correlated with a high incidence of distant metastasis already in an early stage of the disease. Low lactate tumors (< median of approximately 8 micromol/g) were associated with both a longer overall and disease free survival compared to high lactate lesions (lactate > approximately 8 micromol/g). Lactate dehydrogenase was found to be upregulated in most of these tumors compared to surrounding normal tissue. (PMID 15279558).",,(S)-lactate,,HMDB00190,"InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/p-1/t2-/m0/s1",C00186,2016-12-05T15:48:05Z,,885,,,,,107689,lac_L,,"(+)-Lactate, (+)-Lactic acid, (alpha)-Lactate, (alpha)-Lactic acid, (S)-(+)-2-Hydroxypropanoate, (S)-(+)-2-Hydroxypropanoic acid, (S)-2-hydroxy-Propanoate, (S)-2-hydroxy-Propanoic acid, (S)-2-Hydroxypropanoate, (S)-2-Hydroxypropanoic acid, (S)-2-Hydroxypropionate, (S)-2-Hydroxypropionic acid, (S)-Lactate, (S)-Lactic acid, 1-Hydroxyethane 1-carboxylate, 1-Hydroxyethane 1-carboxylic acid, 1-Hydroxyethanecarboxylate, 1-Hydroxyethanecarboxylic acid, 2-Hydroxypropanoate, 2-Hydroxypropanoic acid, 2-Hydroxypropionate, a-Hydroxypropanoate, a-Hydroxypropanoic acid, a-Hydroxypropionate, a-Hydroxypropionic acid, alpha-Hydroxypropanoate, alpha-Hydroxypropanoic acid, alpha-Hydroxypropionate, alpha-Hydroxypropionic acid, L-(+)- Lactic acid, L-2-Hydroxypropanoate, L-2-Hydroxypropanoic acid, Lactate, Lactic acid, Milk acid, Sarcolactic acid",http://vmh.uni.lu/_api/metabolites/885/?format=pcsv
lcts,,,0,C12H22O11,CHEBI:36219,,"Human Metabolome Database (HMDB): alpha-Lactose is the major sugar present in milk and the main source of energy supplied to the newborn mammalian in its mother's milk. Lactose is also an important osmotic regulator of lactation. It is digested by the intestinal lactase (EC 3.2.1.108), an enzyme expressed in newborns. Its activity declines following weaning. As a result, adult mammals are normally lactose-intolerant and more than 75% of the human adult population suffers from lactase deficiency. Lactase deficiency is present in up to 80 percent of blacks and Latinos, and up to 100 percent of American Indians and Asians. Persons with lactose intolerance are unable to digest significant amounts of lactose. Common symptoms include abdominal pain and bloating, excessive flatus, and watery stool following the ingestion of foods containing lactose. A sizable number of adults believe they are lactose intolerant but do not actually have impaired lactose digestion, and some persons with lactase deficiency can tolerate moderate amounts of ingested lactose. A diagnosis of lactose intolerance can usually be made with a careful history supported by dietary manipulation. If necessary, diagnosis can be confirmed by using a breath hydrogen or lactose tolerance test. These mostly uncomfortable symptoms of lactose maldigestion are blamed for a variably dairy consumption. There is, however, emerging evidence that certain lactic acid-producing bacteria, which selectively consume prebiotics, may be beneficial against some lower intestinal diseases. Lactose maldigestion and lactose should perhaps be re-evaluated as a potential provider of such a prebiotic. Treatment consists primarily of avoiding lactose-containing foods. Lactase enzyme supplements may be helpful. The degree of lactose malabsorption varies greatly among patients with lactose intolerance, but most of them can ingest up to 350 mL of milk daily without symptoms. Lactose-intolerant patients must ensure adequate calcium intake. (PMID: 13130292, 12216958, 12197838, 12018807).",,Lactose,,HMDB00186,"InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5+,6+,7-,8-,9-,10-,11?,12+/m1/s1",C00243,2016-12-05T15:48:05Z,,886,,,,,440995,lcts,,"(+)-lactose, 1-beta-D-Galactopyranosyl-4-alpha-D-glucopyranose, 1-beta-delta-Galactopyranosyl-4-alpha-delta-glucopyranose, 4-O-Hexopyranosylhexose, a-Lactose, Aletobiose, alpha-Lactose, Anhydrous lactose, Dilactose, Fast-Flo Lactose, Flowlac 100, Galactinum, Glc-(4-1)Gal, Granulac 140M, Lactin, Lactin (carbohydrate), Lactobiose, Lactohale 300, Lactose, Lactose anhydride, Lactose Fast-flo, Milk sugar, Osmolactan, Pharmatosa DCL 21, Pharmatose 21, Pharmatose 325M, Pharmatose DCL 15, Prismalac, Respitose ML 003, Respitose SV 003, Saccharum lactin, Sachelac, Sorbalac 400, Sorbolac 400, Spherolac, Super-Tab, Tablettose, Tablettose 70, Tablettose 80, Zeparox EP",http://vmh.uni.lu/_api/metabolites/886/?format=pcsv
leuktrB4,,,-1,C20H31O4,CHEBI:15647,,"Human Metabolome Database (HMDB): Leukotriene B4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by b-oxidation from the w-carboxy position and after CoA ester formation. Other specific pathways of leukotriene metabolism include the 12-hydroxydehydrogenase/ 15-oxo-prostaglandin-13-reductase that form a series of conjugated diene metabolites that have been observed to be excreted into human urine. Metabolism of LTC4 occurs by sequential peptide cleavage reactions involving a gamma-glutamyl transpeptidase that forms LTD4 (leukotriene D4) and a membrane-bound dipeptidase that converts LTD4 into LTE4 (leukotriene E4) before w-oxidation. These metabolic transformations of the primary leukotrienes are critical for termination of their biological activity, and defects in expression of participating enzymes may be involved in specific genetic disease. The term leukotriene was coined to indicate the presence of three conjugated double bonds within the 20-carbon structure of arachidonic acid as well as the fact that these compounds were derived from leucocytes such as PMNNs or transformed mast cells. Interestingly, most of the cells known to express 5-LO are of myeloid origin, which includes neutrophils, eosinophils, mast cells, macrophages, basophils and monocytes. Leukotriene biosynthesis begins with the specific oxidation of arachidonic acid by a free radical mechanism as a consequence of interaction with 5-LO. The first enzymatic step involves the abstraction of a hydrogen atom from C-7 of arachidonate followed by the addition of molecular oxygen to form 5-HpETE (5-hydroperoxyeicosatetraenoic acid). A second enzymatic step is also catalysed by 5-LO and involves removal of a hydrogen atom from C-10, resulting in formation of the conjugated triene epoxide LTA4. LTA4 must then be released by 5-LO and encounter either LTA4-H (LTA4 hydrolase) or LTC4-S [LTC4 (leukotriene C4) synthase]. LTA4-H can stereospecifically add water to C-12 while retaining a specific double-bond geometry, leading to LTB4 [leukotriene B4, 5(S),12(R)-dihydroxy-6,8,10,14-(Z,E,E,Z)-eicosatetraenoic acid]. If LTA4 encounters LTC4-S, then the reactive epoxide is opened at C-6 by the thiol anion of glutathione to form the product LTC4 [5(S)-hydroxy-6(R)-S-glutathyionyl-7,9,11,14- (E,E,Z,Z)-eicosatetraenoic acid], essentially a glutathionyl adduct of oxidized arachidonic acid. Both of these terminal leukotrienes are biologically active in that specific GPCRs recognize these chemical structures and receptor recognition initiates complex intracellular signalling cascades. In order for these molecules to serve as lipid mediators, however, they must be released from the biosynthetic cell into the extracellular milieu so that they can encounter the corresponding GPCRs. Surprising features of this cascade include the recognition of the assembly of critical enzymes at the perinuclear region of the cell and even localization of 5-LO within the nucleus of some cells. Under some situations, the budding phagosome has been found to assemble these proteins. Non-enzymatic proteins such as FLAP are now known as critical partners of this protein-machine assembly. An unexpected pathway of leukotriene biosynthesis involves the transfer of the chemically reactive intermediate, LTA4, from the biosynthetic cell followed by conversion into LTB4 or LTC4 by other cells that do not express 5-LO. (PMID 17623009). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,leukotriene B4(1-),,HMDB01085,"InChI=1S/C20H32O4/c1-2-3-4-5-6-9-13-18(21)14-10-7-8-11-15-19(22)16-12-17-20(23)24/h6-11,14-15,18-19,21-22H,2-5,12-13,16-17H2,1H3,(H,23,24)/p-1/b8-7+,9-6-,14-10+,15-11-/t18-,19-/m1/s1",C02165,2016-12-05T15:48:05Z,,887,,,,,5280492,leuktrB4,,"(6z,8e,10e,14z)-(5S,12R)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate, (6z,8e,10e,14z)-(5S,12R)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid, 5,12-DiHETE, 5,12-Dihydroxy-6,10-trans -8,14-cis -eicosatetraenoate, 5,12-Dihydroxy-6,10-trans -8,14-cis -eicosatetraenoic acid, Leukotriene B4 ethanol solution",http://vmh.uni.lu/_api/metabolites/887/?format=pcsv
leuktrC4,,,-2,C30H45N3O9S,CHEBI:16978,,"Human Metabolome Database (HMDB): Leukotriene C4 (LTC4) is a cysteinyl leukotriene (CysLT), a family of potent inflammatory mediators. Eosinophils, one of the principal cell types recruited to and activated at sites of allergic inflammation, is capable of elaborating lipid mediators, including leukotrienes derived from the oxidative metabolism of arachidonic acid (AA). Potentially 'activated' eosinophils may elaborate greater quantities of LTC4, than normal eosinophils. These activated eosinophils thus are 'primed' for enhanced LTC4 generation in response to subsequent stimuli. Some recognized priming stimuli are chemoattractants (e.g., eotaxin, PAF) that may participate in the recruitment of eosinophils to sites of allergic inflammation. The mechanisms by which chemoattractants and other activating cytokines (e.g., interleukin (IL)-5) or extracellular matrix components (e.g., fibronectin) enhance eosinophil eicosanoid formation are pertinent to the functions of these eicosanoids as paracrine mediators of allergic inflammation. Some eosinophil-derived eicosanoids may be active in down-regulating inflammation. It is increasingly likely that eicosanoids synthesized within cells, including eosinophils, may have intracellular (e.g., intracrine) roles in regulating cell functions, in addition to the more recognized activities of eicosanoids as paracrine mediators of inflammation. Acting extracellularly, the cysteinyl leukotrienes (CysLTs) LTC4 and its extracellular derivatives, LTD4 and LTE4 are key paracrine mediators pertinent to asthma and allergic diseases. Based on their receptor-mediated capabilities, they can elicit bronchoconstriction, mucous hypersecretion, bronchial hyperresponsiveness, increased microvascular permeability, and additional eosinophil infiltration. Eosinophils are a major source of CysLTs and have been identified as the principal LTC4 synthase expressing cells in bronchial mucosal biopsies of asthmatic subjects. (PMID: 12895596)Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,leukotriene C4(2-),,HMDB01198,"InChI=1S/C30H47N3O9S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-25(24(34)15-14-17-27(36)37)43-21-23(29(40)32-20-28(38)39)33-26(35)19-18-22(31)30(41)42/h6-7,9-13,16,22-25,34H,2-5,8,14-15,17-21,31H2,1H3,(H,32,40)(H,33,35)(H,36,37)(H,38,39)(H,41,42)/p-2/b7-6-,10-9-,12-11+,16-13+/t22-,23-,24-,25+/m0/s1",C02166,2016-12-05T15:48:05Z,,888,,,,,5280493,leuktrC4,,"(R-(R*,S*-(E,E,Z,Z)))-N-(S-(1-(4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-N-L-gamma-glutamyl-L-cysteinyl)-Glycine, 5S,6R-Ltc, 5S-Hydroxy,6R-(S-glutathionyl),7E,9E,11Z,14Z-eicosatetraenoate, 5S-Hydroxy,6R-(S-glutathionyl),7E,9E,11Z,14Z-eicosatetraenoic acid, L-gamma-Glutamyl-S-[(1R,2E,4E,6Z,9Z)-1-[(1S)-4-carboxy-1-hydroxybutyl]-2,4,6,9-pentadecatetraenyl]-L-cysteinyl-glycine, Leucotriene C4, Leukotriene C, Leukotriene C1, Leukotriene C4, LTC, LTC4, [R-[R*,S*-(E,E,Z,Z)]]-N-[S-[1-(4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl]-N-L-gamma-glutamyl-L-cysteinyl]-Glycine 5S,6R-LTC4",http://vmh.uni.lu/_api/metabolites/888/?format=pcsv
leuktrD4,,,-1,C25H39N2O6S,CHEBI:28666,,Leukotriene D4,,Leukotriene D4,,,"InChI=1S/C25H40N2O6S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-22(21(28)15-14-17-23(29)30)34-19-20(26)25(33)27-18-24(31)32/h6-7,9-13,16,20-22,28H,2-5,8,14-15,17-19,26H2,1H3,(H,27,33)(H,29,30)(H,31,32)/p-1/b7-6-,10-9-,12-11+,16-13+/t20-,21-,22+/m0/s1",C05951,2016-11-22T15:12:00Z,,889,,,,,6435286,leuktrD4,,,http://vmh.uni.lu/_api/metabolites/889/?format=pcsv
leuktrE4,,,-1,C23H36NO5S,CHEBI:15650,,"Human Metabolome Database (HMDB): Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,leukotriene E4(1-),,HMDB02200,"InChI=1S/C23H37NO5S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-21(30-18-19(24)23(28)29)20(25)15-14-17-22(26)27/h6-7,9-13,16,19-21,25H,2-5,8,14-15,17-18,24H2,1H3,(H,26,27)(H,28,29)/p-1/b7-6-,10-9-,12-11+,16-13+/t19-,20-,21+/m0/s1",C05952,2016-12-05T15:48:05Z,,890,,,,,440857,leuktrE4,,"20-Hydroxy-leukotriene E4, 20-OH-Leukotriene E4, LTE4, [5S-[5R*,6S*(S*),7E,9E,11Z,14Z]]- 6-[(2-amino-2-carboxyethyl)thio]-5-hydroxy-7,9,11,14-Eicosatetraenoate, [5S-[5R*,6S*(S*),7E,9E,11Z,14Z]]- 6-[(2-amino-2-carboxyethyl)thio]-5-hydroxy-7,9,11,14-Eicosatetraenoic acid",http://vmh.uni.lu/_api/metabolites/890/?format=pcsv
leuktrF4,,,-2,C28H42N2O8S,CHEBI:27491,,leukotriene F4,,leukotriene F4,,,"InChI=1S/C28H44N2O8S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-24(23(31)15-14-17-26(33)34)39-20-22(28(37)38)30-25(32)19-18-21(29)27(35)36/h6-7,9-13,16,21-24,31H,2-5,8,14-15,17-20,29H2,1H3,(H,30,32)(H,33,34)(H,35,36)(H,37,38)/b7-6-,10-9-,12-11+,16-13+/t21-,22+,23+,24-/m1/s1",C06462,2016-11-22T15:12:00Z,,891,,,,,5280938,leuktrF4,,,http://vmh.uni.lu/_api/metabolites/891/?format=pcsv
leu_L,,,0,C6H13NO2,CHEBI:15603,,"Human Metabolome Database (HMDB): Branched chain amino acids (BCAA) are essential amino acids whose carbon structure is marked by a branch point. These three amino acids are critical to human life and are particularly involved in stress, energy and muscle metabolism. BCAA supplementation as therapy, both oral and intravenous, in human health and disease holds great promise. 'BCAA' denotes valine, isoleucine and leucine which are branched chain essential amino acids. Despite their structural similarities, the branched amino acids have different metabolic routes, with valine going solely to carbohydrates, leucine solely to fats and isoleucine to both. The different metabolism accounts for different requirements for these essential amino acids in humans: 12 mg/kg, 14 mg/kg and 16 mg/kg of valine, leucine and isoleucine respectively. Furthermore, these amino acids have different deficiency symptoms. Valine deficiency is marked by neurological defects in the brain, while isoleucine deficiency is marked by muscle tremors. Many types of inborn errors of BCAA metabolism exist, and are marked by various abnormalities. The most common form is the maple syrup urine disease, marked by a characteristic urinary odor. Other abnormalities are associated with a wide range of symptoms, such as mental retardation, ataxia, hypoglycemia, spinal muscle atrophy, rash, vomiting and excessive muscle movement. Most forms of BCAA metabolism errors are corrected by dietary restriction of BCAA and at least one form is correctable by supplementation with 10 mg of biotin daily. BCAA are useful because they are metabolized primarily by muscle. Stress state- e.g surgery, trauma, cirrhosis, infections, fever and starvation--require proportionately more BCAA than other amino acids and probably proportionately more leucine than either valine or isoleucine. BCAA and other amino acids are frequently fed intravenously (TPN) to malnourished surgical patients and in some cases of severe trauma. BCAA, particularly leucine, stimulate protein synthesis, increase reutilization of amino acids in many organs and reduce protein breakdown. Furthermore, leucine can be an important source of calories, and is superior as fuel to the ubiquitous intravenous glucose (dextrose). Leucine also stimulates insulin release, which in turn stimulates protein synthesis and inhibits protein breakdown. These effects are particularly useful in athletic training. BCAA should also replace the use of steroids as commonly used by weightlifters. Huntington's chorea and anorexic disorders both are characterized by low serum BCAA. These diseases, as well as forms of Parkinson's, may respond to BCAA therapy. BCAA, and particularly leucine, are among the amino acids most essential for muscle health. (http://www.dcnutrition.com).",,L-leucine,,HMDB00687,"InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1",C00123,2016-12-05T15:48:05Z,,892,,,,,6106,leu_L,,"(2S)-2-Amino-4-methylpentanoate, (2S)-2-Amino-4-methylpentanoic acid, (S)-(+)-Leucine, (S)-2-Amino-4-methylpentanoate, (S)-2-Amino-4-methylpentanoic acid, (S)-2-Amino-4-methylvalerate, (S)-2-Amino-4-methylvaleric acid, (S)-Leucine, 4-Methyl-L-Norvaline, L-(+)-Leucine, L-a-Aminoisocaproate, L-a-Aminoisocaproic acid, L-alpha-Aminoisocaproate, L-alpha-Aminoisocaproic acid, Leu, Leucine",http://vmh.uni.lu/_api/metabolites/892/?format=pcsv
lgnc,,,-1,C24H47O2,CHEBI:28866,,"Human Metabolome Database (HMDB): Lignoceric acid, also tetracosanoic acid, is a normal carboxylic acid, a very long chain fatty acid (VLCFA). Very long chain fatty acids (VLCFAs) are exclusively oxidized in peroxisomes and their levels are significantly increased in tissues of patients with peroxisomal disorders. (PMID 15565636).",,lignocerate,,HMDB02003,"InChI=1S/C24H48O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26/h2-23H2,1H3,(H,25,26)/p-1",C08320,2016-12-05T15:48:05Z,,893,,,,,11197,lgnc,,"Lignocerate, Lignoceric acid, N-Tetracosanoate, N-Tetracosanoic acid, Tetracosanoate, Tetracosanoic acid",http://vmh.uni.lu/_api/metabolites/893/?format=pcsv
limnen,,,0,C10H16,CHEBI:15384,,"Human Metabolome Database (HMDB): The monoterpene d-limonene is a naturally occurring chemical which is the major component in oil of orange. Currently, d-limonene is widely used as a flavor and fragrance and is listed to be generally recognized as safe in food by the Food and Drug Administration (21 CFR 182.60 in the Code of Federal Regulations, U.S.A.). Recently, however, d-limonene has been shown to cause a male rat-specific kidney toxicity referred to as hyaline droplet nephropathy. Furthermore, chronic exposure to d-limonene causes a significant incidence of renal tubular tumors exclusively in male rats. Although d-limonene is not carcinogenic in female rats or male and female mice given much higher dosages, the male rat-specific nephrocarcinogenicity of d-limonene may raise some concern regarding the safety of d-limonene for human consumption. A considerable body of scientific data has indicated that the renal toxicity of d-limonene results from the accumulation of a protein, alpha 2u-globulin, in male rat kidney proximal tubule lysosomes. This protein is synthesized exclusively by adult male rats. Other species, including humans, synthesize proteins that share significant homology with alpha 2u-globulin. However, none of these proteins, including the mouse equivalent of alpha 2u-globulin, can produce this toxicity, indicating a unique specificity for alpha 2u-globulin. With chronic exposure to d-limonene, the hyaline droplet nephropathy progresses and the kidney shows tubular cell necrosis, granular cast formation at the corticomedullary junction, and compensatory cell proliferation. Both d-limonene and cis-d-limonene-1,2-oxide (the major metabolite involved in this toxicity) are negative in vitro mutagenicity screens. Therefore, the toxicity-related renal cell proliferation is believed to be integrally involved in the carcinogenicity of d-limonene as persistent elevations in renal cell proliferation may increase fixation of spontaneously altered DNA or serve to promote spontaneously initiated cells. The scientific data base demonstrates that the tumorigenic activity of d-limonene in male rats is not relevant to humans. The three major lines of evidence supporting the human safety of d-limonene are (1) the male rat specificity of the nephrotoxicity and carcinogenicity; (2) the pivotal role that alpha 2u-globulin plays in the toxicity, as evidenced by the complete lack of toxicity in other species despite the presence of structurally similar proteins; and (3) the lack of genotoxicity of both d-limonene and d-limonene-1,2-oxide, supporting the concept of a nongenotoxic mechanism, namely, sustained renal cell proliferation. (PMID: 2024047).",,limonene,,HMDB03375,"InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,10H,1,5-7H2,2-3H3",C00521,2016-12-05T15:48:05Z,,894,,,,,439250,limnen,,"(-)-(4S)-Limonene, (-)-(S)-Limonene, (-)-Limonene, 4-Isopropenyl-1-methyl-1-cyclohexene, L-Limonene, Limonene",http://vmh.uni.lu/_api/metabolites/894/?format=pcsv
lipoate,,,0,C8H14O2S2,CHEBI:16494,,"Human Metabolome Database (HMDB): Lipoic acid is a vitamin-like antioxidant that acts as a free-radical scavenger. Alpha-lipoic acid is also known as thioctic acid. It is a naturally occurring compound that is synthesized by both plants and animals. Lipoic acid contains two thiol groups which may be either oxidized or reduced. The reduced form is known as dihydrolipoic acid (DHLA). Lipoic acid (Delta E= -0.288) is therefore capable of thiol-disulfide exchange, giving it antioxidant activity. Lipoate is a critical cofactor for aerobic metabolism, participating in the transfer of acyl or methylamine groups via the 2-Oxoacid dehydrogenase (2-OADH) or alpha-ketoglutarate dehydrogenase complex. This enzyme catalyzes the conversion of alpha-ketoglutarate to succinyl CoA. This activity results in the catabolism of the branched chain amino acids (leucine, isoleucine and valine). Lipoic acid also participates in the glycine cleavage system(GCV). The glycine cleavage system is a multi-enzyme complex that catalyzes the oxidation of glycine to form 5,10 methylene tetrahydrofolate, an important cofactor in nucleic acid synthesis. Since Lipoic acid is an essential cofactor for many enzyme complexes, it is essential for aerobic life as we know it. This system is used by many organisms and plays a crucial role in the photosynthetic carbon cycle. Lipoic acid was first postulated to be an effective antioxidant when it was found it prevented vitamin C and vitamin E deficiency. It is able to scavenge reactive oxygen species and reduce other metabolites, such as glutathione or vitamins, maintaining a healthy cellular redox state. Lipoic acid has been shown in cell culture experiments to increase cellular uptake of glucose by recruiting the glucose transporter GLUT4 to the cell membrane, suggesting its use in diabetes. Studies of rat aging have suggested that the use of L-carnitine and lipoic acid results in improved memory performance and delayed structural mitochondrial decay. As a result, it may be helpful for people with Alzheimer's disease or Parkinson's disease. -- Wikipedia.",,lipoate,,HMDB01451,"InChI=1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)",C16241,2016-12-05T15:48:05Z,,895,,,,,6112,lipoate,,"(+)-alpha-Lipoic acid, (R)-(+)-lipoic acid, (R)-1,2-Dithiolane-3-pentanoic acid, (R)-1,2-dithiolane-3-valeric acid, (R)-6,8-thioctic acid, alpha-Lipoic acid, Lipoic acid, R-LA, RLA, Thioctic acid, Thioctic acid d-form",http://vmh.uni.lu/_api/metabolites/895/?format=pcsv
lneldc,,,-1,C18H31O2,,,linoelaidic acid (all trans C18:2),,linoelaidic acid (all trans C18:2),,,"InChI=1/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6+,10-9+",,2016-11-22T15:12:00Z,,896,,,,,5282457,lneldc,,,http://vmh.uni.lu/_api/metabolites/896/?format=pcsv
lnlc,,,-1,C18H31O2,CHEBI:17351,,"Human Metabolome Database (HMDB): Linoleic acid is a doubly unsaturated fatty acid, also known as an omega-6 fatty acid, occurring widely in plant glycosides. In this particular polyunsaturated fatty acid (PUFA), the first double bond is located between the sixth and seventh carbon atom from the methyl end of the fatty acid (n-6). Linoleic acid is an essential fatty acid in human nutrition because it cannot be synthesized by humans. It is used in the biosynthesis of prostaglandins (via arachidonic acid) and cell membranes. (From Stedman, 26th ed).",,linoleate,,HMDB00673,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/p-1/b7-6-,10-9-",C01595,2016-12-05T15:48:05Z,,897,,,,,5280450,lnlc,,"(9Z,12Z)-9,12-Octadecadienoate, (9Z,12Z)-9,12-Octadecadienoic acid, (Z,Z)-9,12-Octadecadienoate, (Z,Z)-9,12-Octadecadienoic acid, 9-cis,12-cis-Linoleate, 9-cis,12-cis-Linoleic acid, 9Z,12Z-Linoleate, 9Z,12Z-Linoleic acid, 9Z,12Z-Octadecadienoate, 9Z,12Z-Octadecadienoic acid, All-cis-9,12-Octadecadienoate, All-cis-9,12-Octadecadienoic acid, cis,cis-Linoleate, cis,cis-Linoleic acid, cis-9,cis-12-Octadecadienoate, cis-9,cis-12-Octadecadienoic acid, cis-D9,12-Octadecadienoate, cis-D9,12-Octadecadienoic acid, Emersol 315, Extra Linoleic 90, Linolate, Linoleate, Linoleic acid, Linolic acid, Polylin 515, Unifac 6550",http://vmh.uni.lu/_api/metabolites/897/?format=pcsv
lnlnca,,,-1,C18H29O2,CHEBI:27432,,"Human Metabolome Database (HMDB): Alpha-linolenic acid (ALA) is a polyunsaturated fatty acid (PUFA). It is a member of the group of essential fatty acids called omega-3 fatty acids. Alpha-linolenic acid, in particular, is not synthesized by mammals and therefore is an essential dietary requirement for all mammals. Certain nuts (English walnuts) and vegetable oils (canola, soybean, flaxseed/linseed, olive) are particularly rich in alpha-linolenic acid (ALA). Omega-3 fatty acids get their name based on the location of one of their first double bond. In all omega-3 fatty acids, the first double bond is located between the third and fourth carbon atom counting from the methyl end of the fatty acid (n-3). Although humans and other mammals can synthesize saturated and some monounsaturated fatty acids from carbon groups in carbohydrates and proteins, they lack the enzymes necessary to insert a cis double bond at the n-6 or the n-3 position of a fatty acid. Omega-3 fatty acids like a-linolenic acid are important structural components of cell membranes. When incorporated into phospholipids, they affect cell membrane properties such as fluidity, flexibility, permeability and the activity of membrane bound enzymes. Omega-3 fatty acids can modulate the expression of a number of genes, including those involved with fatty acid metabolism and inflammation. Alpha linolenic acid and other omega 3 fatty acids may regulate gene expression by interacting with specific transcription factors, including peroxisome proliferator activated receptors (PPARs) and liver X receptors (LXRs).",,alpha-linolenate,,HMDB01388,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/p-1/b4-3-,7-6-,10-9-",C06427,2016-12-05T15:48:05Z,,898,,,,,5280934,lnlnca,,"(9,12,15)-linolenate, (9,12,15)-linolenic acid, (9Z,12Z,15Z)-Octadecatrienoate, (9Z,12Z,15Z)-Octadecatrienoic acid, (Z,Z,Z)-9,12,15-Octadecatrienoate, (Z,Z,Z)-9,12,15-Octadecatrienoic acid, 9,12,15-Octadecatrienoate, 9,12,15-Octadecatrienoic acid, 9-cis,12-cis,15-cis-Octadecatrienoate, 9-cis,12-cis,15-cis-Octadecatrienoic acid, a-Linolenate, a-Linolenic acid, All-cis-9,12,15-Octadecatrienoate, All-cis-9,12,15-Octadecatrienoic acid, alpha-Linolenate, alpha-Linolenic acid, cis,cis,cis-9,12,15-Octadecatrienoate, cis,cis,cis-9,12,15-Octadecatrienoic acid, cis-9,12,15-Octadecatrienoate, cis-9,12,15-Octadecatrienoic acid, Industrene 120, Linolenate, Linolenic acid",http://vmh.uni.lu/_api/metabolites/898/?format=pcsv
lnlncg,,,-1,C18H29O2,CHEBI:28661,,"Human Metabolome Database (HMDB): Gamma-Linolenic acid is an omega-6 fatty acid produced in the body as the delta 6-desaturase metabolite of linoleic acid. It is converted to dihomo-gamma-linolenic acid, a biosynthetic precursor of monoenoic prostaglandins such as PGE1. (From Merck Index, 11th ed) -- Pubchem.",,gamma-linolenate,,HMDB03073,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/p-1/b7-6-,10-9-,13-12-",C06426,2016-12-05T15:48:05Z,,899,,,,,5280933,lnlncg,,"(6,9,12)-linolenate, (6,9,12)-linolenic acid, (6Z,9Z,12Z)-Octadecatrienoate, (6Z,9Z,12Z)-Octadecatrienoic acid, (Z,Z,Z)-6,9,12-Octadecatrienoate, (Z,Z,Z)-6,9,12-Octadecatrienoic acid, 6(Z),9(Z),12(Z)-Octadecatrienoate, 6(Z),9(Z),12(Z)-Octadecatrienoic acid, 6,9,12-All-cis-Octadecatrienoate, 6,9,12-All-cis-Octadecatrienoic acid, 6,9,12-Octadecatrienoate, 6,9,12-Octadecatrienoic acid, 6Z,9Z,12Z-Octadecatrienoate, 6Z,9Z,12Z-Octadecatrienoic acid, All-cis-6,9,12-octadecatrienoate, All-cis-6,9,12-octadecatrienoic acid, cis-delta(6,9,12)-Octadecatrienoate, cis-delta(6,9,12)-Octadecatrienoic acid, gamma-Linolenate, gamma-Linolenic acid, gamma-Llnolenic acid, Ligla",http://vmh.uni.lu/_api/metabolites/899/?format=pcsv
lpchol_hs,,,0,C8H19NO5PFULLRCO2,,,lysophosphatidylcholine,,lysophosphatidylcholine,,,,,2016-11-22T15:12:00Z,,900,,,,,,lpchol_hs,,,http://vmh.uni.lu/_api/metabolites/900/?format=pcsv
mag_hs,,,0,C3H7O2FULLR2CO2,,,monoacylglycerol 2,,monoacylglycerol 2,,,,,2016-11-22T15:12:00Z,,901,,,,,,mag_hs,,,http://vmh.uni.lu/_api/metabolites/901/?format=pcsv
malt,,,0,C12H22O11,CHEBI:17306,,"Human Metabolome Database (HMDB): Maltose, or malt sugar, is a primary disaccharide in the human diet formed from two units of glucose joined with an alpha (1->4) linkage. It is the second member of an important biochemical series of glucose chains. The addition of another glucose unit yields maltotriose, Further additions will produce dextrins, also called maltodextrins, and eventually starch. Maltose can be broken down into two glucose molecules by hydrolysis in living organisms. At the surface of the small intestine, the brush border enzymes maltase, breaks down maltose. (PMID: 14522745).",,Maltose,,HMDB00163,"InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5-,6+,7-,8-,9-,10-,11?,12-/m1/s1",C00208,2016-12-05T15:48:05Z,,902,,,,,439186,malt,,"1-alpha-D-Glucopyranosyl-4-alpha-D-glucopyranose, 1-alpha-delta-Glucopyranosyl-4-alpha-delta-glucopyranose, 4-(alpha-D-Glucopyranosido)-alpha-glucopyranose, 4-(alpha-D-Glucosido)-D-glucose, 4-(alpha-delta-Glucopyranosido)-alpha-glucopyranose, 4-(alpha-delta-Glucosido)-delta-glucose, 4-O-a-D-Glucopyranosyl-D-glucose, 4-O-alpha-D-Glucopyranosyl-D-glucopyranose, 4-O-alpha-D-Glucopyranosyl-D-glucose, 4-O-alpha-delta-Glucopyranosyl-delta-glucopyranose, 4-O-alpha-delta-Glucopyranosyl-delta-glucose, Advantose 100, alpha-D-Glcp-(1->4)-D-Glcp, alpha-D-Glucopyranosyl-(1->4)-D-glucopyranose, alpha-D-Glucopyranosyl-(1->4)-D-glucose, alpha-delta-Glcp-(1->4)-delta-Glcp, alpha-delta-Glucopyranosyl-(1->4)-delta-glucopyranose, alpha-delta-Glucopyranosyl-(1->4)-delta-glucose, alpha-Malt sugar, Cextromaltose, D-(+)-Maltose, D-Maltose, delta-(+)-Maltose, delta-Maltose, Finetose, Finetose F, Madoros, Madoros (TN), Malt sugar, Maltobiose, Maltodiose, Maltos, Maltose, Maltose HH, Maltose HHH, Maltose solution, Malzzucker, Martos-10, Sunmalt, Sunmalt S",http://vmh.uni.lu/_api/metabolites/902/?format=pcsv
malttr,,,0,C18H32O16,CHEBI:27931,,"Human Metabolome Database (HMDB): Maltotriose is a common oligosaccharide metabolite found in human urine after maltose ingestion or infusion (PMID 6645121). Maltotriose is increased in Glycogen storage disease II (OMIM 232300) due to a mutation of the enzyme alpha-1,4-glucosidase (E.C. 3.2.1.20) (4286143).",,maltotriose,,HMDB01262,"InChI=1S/C18H32O16/c19-1-4-7(22)8(23)12(27)17(31-4)34-15-6(3-21)32-18(13(28)10(15)25)33-14-5(2-20)30-16(29)11(26)9(14)24/h4-29H,1-3H2/t4-,5-,6-,7-,8+,9-,10-,11-,12-,13-,14-,15-,16+,17-,18-/m1/s1",C01835,2016-12-05T15:48:05Z,,903,,,,,439586,malttr,,"4-O-(4-O-Hexopyranosylhexopyranosyl)hexose, Amylotriose, D-(+)-Maltotriose, delta-(+)-Maltotriose, Maltotriose, O-alpha-D-Glucopyranosyl-(1beta94)-O-alpha-D-glucopyranosyl-(1beta94)-O-alpha-D-glucose, O-alpha-delta-Glucopyranosyl-(1beta94)-O-alpha-delta-glucopyranosyl-(1beta94)-O-alpha-delta-glucose",http://vmh.uni.lu/_api/metabolites/903/?format=pcsv
mepi,,,1,C10H16NO3,,,"Human Metabolome Database (HMDB): Metanephrine is a metabolite of epinephrine created by action of catechol O-methyltransferase on epinephrine. Technically it is a product of epinephrine O-methylation. It is a commonly occurring, pharmacologically and physiologically inactive metabolite of epinephrine. The measurement of plasma free metanephrines is considered to be the best tool in the diagnosis of pheochromocytoma, a rare kind of adrenal medullary neoplasm. In adrenal chromaffin cells, leakage of norepinephrine and epinephrine from storage granules leads to substantial intracellular production of the O-methylated metabolite metanephrine. In fact, the adrenals constitute the single largest source out of any organ system including the liver for circulating metanephrine. In humans, about 93 percent of circulating metanephrine is derived from catecholamines metabolized within adrenal chromaffin cells. (PMID 15317907).",,Metanephrine,,HMDB04063,"InChI=1S/C10H15NO3/c1-11-6-9(13)7-3-4-8(12)10(5-7)14-2/h3-5,9,11-13H,6H2,1-2H3",C05588,2016-12-05T15:48:05Z,,904,,,,,21100,mepi,,"(+/-)-Metanephrine, 3-Methoxy-adrenaline, 3-Methoxyadrenaline, 3-O-Methyl-Adrenaline, 3-O-Methylepinephrine, 4-Hydroxy-3-methoxy-N-methylphenethanolamine, DL-3-O-Methyladrenaline, DL-Metanephrine, m-O-Methyladrenaline, Metadrenaline",http://vmh.uni.lu/_api/metabolites/904/?format=pcsv
mercplaccys,,,-1,C6H10O5S2N,,,"Human Metabolome Database (HMDB): 3-mercaptolactate-cysteine disulfide is a compound analog of cysteine excreted in the urine of patients affected by Mercaptolactate-cysteine disulfiduria (MCDU, OMIM 249650), the product of disorder of sulfur amino acid metabolism and a reduced activity of the enzyme mercaptopyruvate sulfurtransferase (MST, EC 2.8.1.2). Reduction of protein in the diet, addition of pyridoxine or of neomycin did not affect the urinary excretion of beta-mercaptolactate-cysteine disulfide of a mentally defective patient who was excreting this mixed disulfide. Addition of cysteine to the diet did increase the excretion of this disulfide (PMID: 3888441, 527218, 6945862, 5644041).",,3-mercaptolactate-cysteine disulfide,,HMDB06512,"InChI=1/C6H11NO5S2/c7-3(5(9)10)1-13-14-2-4(8)6(11)12/h3-4,8H,1-2,7H2,(H,9,10)(H,11,12)/t3-,4?/m0/s1",,2016-12-05T15:48:05Z,,905,,,,,193536,mercplaccys,,"3-((2-Carboxy-2-hydroxyethyl)dithio)-L-Alanine, beta-Mercaptolactate cysteine disulfide, Hcetc, S-(2-Hydroxy-2-carboxyethylthio)cysteine",http://vmh.uni.lu/_api/metabolites/905/?format=pcsv
n2m2nmasn,,,0,C58H96N5O40X,,,"N-Acetyl-beta-D-glucosaminyl-1,2-alpha-D-mannosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,2-alpha-D-mannosyl-1,6)-(N-acetyl-beta-D-glucosaminyl-1,4)-beta-D-mannosyl-1,4-N-acetyl-beta-D-glucosaminyl-R",,"N-Acetyl-beta-D-glucosaminyl-1,2-alpha-D-mannosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,2-alpha-D-mannosyl-1,6)-(N-acetyl-beta-D-glucosaminyl-1,4)-beta-D-mannosyl-1,4-N-acetyl-beta-D-glucosaminyl-R",,,,C04946,2016-11-22T15:12:00Z,,906,,,,,,n2m2nmasn,,,http://vmh.uni.lu/_api/metabolites/906/?format=pcsv
nac,,,-1,C6H4NO2,CHEBI:15940,,"Human Metabolome Database (HMDB): Nicotinic acid, also known as niacin or vitamin B3, is a water-soluble vitamin whose derivatives such as NADH, NAD, NAD+, and NADP play essential roles in energy metabolism in the living cell and DNA repair. The designation vitamin B3 also includes the amide form, nicotinamide or niacinamide. Severe lack of niacin causes the deficiency disease pellagra, whereas a mild deficiency slows down the metabolism decreasing cold tolerance. The recommended daily allowance of niacin is 2-12 mg a day for children, 14 mg a day for women, 16 mg a day for men, and 18 mg a day for pregnant or breast-feeding women. It is found in various animal and plant tissues and has pellagra-curative, vasodilating, and antilipemic properties. The liver can synthesize niacin from the essential amino acid tryptophan (see below), but the synthesis is extremely slow and requires vitamin B6; 60 mg of tryptophan are required to make one milligram of niacin. Bacteria in the gut may also perform the conversion but are inefficient.",,Nicotinate,,HMDB01488,,C00253,2016-12-05T15:48:05Z,,907,,,,,938,nac,,"3-Carboxylpyridine, 3-Carboxypyridine, 3-Pyridinecarboxylate, 3-Pyridinecarboxylic acid, 3-Pyridylcarboxylate, 3-Pyridylcarboxylic acid, Akotin, Apelagrin, Daskil, Efacin, Enduracin, Linic, Niac, Niacin, Niacine, Niacor, Nicacid, Nicamin, Nicangin, Nico-Span, Nicobid, Nicocap, Nicodelmine, Nicolar, Niconacid, Nicosan 3, Nicotinate, Nicotinic acid, Nicotinipca, Nicyl, Nyclin, Pellagrin, Pelonin, Slo-niacin, Wampocap",http://vmh.uni.lu/_api/metabolites/907/?format=pcsv
ncam,,,0,C6H6N2O,CHEBI:17154,,Nicotinamide,,Nicotinamide,,,,C00153,2016-11-22T15:12:00Z,,908,,,,nicotinamide,936,ncam,,,http://vmh.uni.lu/_api/metabolites/908/?format=pcsv
nifedipine,,,0,C17H18N2O6,CHEBI:7565,,nifedipine,,nifedipine,,,"InChI=1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-7-5-6-8-12(11)19(22)23/h5-8,15,18H,1-4H3",C07266,2016-11-22T15:12:00Z,,909,,,,,4485,nifedipine,,,http://vmh.uni.lu/_api/metabolites/909/?format=pcsv
no,,,0,NO,CHEBI:16480,,"Human Metabolome Database (HMDB): The biologically active molecule nitric oxide (NO) is a simple, membrane-permeable gas with unique chemistry. It is formed by the conversion of L-arginine to L-citrulline, with the release of NO. The enzymatic oxidation of L-arginine to L-citrulline takes place in the presence of oxygen and NADPH using flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), heme, thiol and tetrahydrobiopterin as cofactors. The enzyme responsible for the generation of NO is nitric oxide synthase (E.C. 1.7.99.7; NOS). Three NOS isoforms have been described and shown to be encoded on three distinct genes: Neuronal NOS (nNOS, NOS type I), inducible NOS (NOS type II) and endothelial NOS (eNOS, NOS type III). Two of them are constitutively expressed and dependent on the presence of calcium ions and calmodulin to function (nNOS and eNOS), while iNOS is considered non-constitutive and calcium-independent. However, experience has shown that constitutive expression of nNOS and eNOS is not as rigid as previously thought (i.e., either present or absent), but can be dynamically controlled during development and in response to injury. Functionally, NO may act as a hormone, neurotransmitter, paracrine messenger, mediator, cytoprotective and cytotoxic molecule. NO has multiple cellular molecular targets. It influences the activity of transcription factors, modulates upstream signaling cascades, mRNA stability and translation, and processes the primary gene products. In the brain, many processes are linked to NO. NO activates its receptor, soluble guanylate cyclase by binding to it. The stimulation of this enzyme leads to increased synthesis of the second messenger, cGMP, which in turn activates cGMP-dependent kinases in target cells. NO exerts strong influence on glutamatergic neurotransmission by directly interacting with the N-Methyl-d-Aspartate (NMDA) receptor. Neuronal NOS is connected to NMDA receptors (see below) and sharply increases NO production following activation of this receptor. Thus, the level of endogenously produced NO around NMDA synapses reflects the activity of glutamate-mediated neurotransmission. However, there is recent evidence showing that non-NMDA glutamate receptors (i.e., AMPA and type I metabotropic receptors) also contribute to NO generation. Besides its influence on glutamate, NO is known to have effects on the storage, uptake and/or release of most other neurotransmitters in the CNS (acetylcholine, dopamine, noradrenaline, GABA, and taurine and glycine, as well as of certain neuropeptides. Finally, since NO is a highly diffusible molecule, it may reach extrasynaptic receptors at target cell membranes at some distance from the place of NO synthesis. NO is thus capable of mediating both synaptic and nonsynaptic communication processes. NO is a potent vasodilator (a major endogenous regulator of vascular tone), and an important endothelium-dependent relaxing factor. NO is synthesized by NO synthases (NOS) and NOS are inhibited by asymmetrical dimethylarginine (ADMA). ADMA is metabolized by dimethylarginine dimethylaminohydrolase (DDAH) and excreted in the kidneys. Lower ADMA levels in pregnant women compared to non-pregnant controls suggest that ADMA has a role in vascular dilatation and blood pressure changes. Several studies show an increase in ADMA levels in pregnancies complicated with preeclampsia. Elevated ADMA levels in preeclampsia are seen before clinical symptoms have developed; these findings suggest that ADMA has a role in the pathogenesis of preeclampsia. In some pulmonary hypertensive states such as ARDS, the production of endogenous NO may be impaired. Nitric oxide inhalation selectively dilates the pulmonary circulation. Significant systemic vasodilation does not occur because NO is inactivated by rapidly binding to hemoglobin. In an injured lung with pulmonary hypertension, inhaled NO produces local vasodilation of well-ventilated lung units and may ""steal"" blood flow away from unventilated regions. This reduces intrapulmonary shunting and may improve systemic arterial oxygenation. Nitric oxide is a chemical mediator fundamental in the maintenance of adequate tissue perfusion and effective cardiovascular function. The use of nitrates is well established as pharmacological agents but it is only recently that it has been recognized that they act as a source of nitric oxide. (PMID: 16966108, 8752507, 17181668, 16005189).",,Nitric oxide,,HMDB03378,InChI=1S/NO/c1-2,C00533,2016-12-05T15:48:05Z,,910,,,,NO;nitric oxide;nitrite radical,145068,no,,"Mononitrogen monoxide, Nitric oxide, Nitrogen monoxide, Nitrogen oxide, Nitrogen protoxide, Nitrosyl hydride, Nitrosyl radical, Nitroxide radical, Nitroxyl",http://vmh.uni.lu/_api/metabolites/910/?format=pcsv
npthl,,,0,C10H8,CHEBI:16482,,naphthalene,,naphthalene,,,InChI=1S/C10H8/c1-2-6-10-8-4-3-7-9(10)5-1/h1-8H,C00829,2016-11-22T15:12:00Z,,911,,,,,931,npthl,,,http://vmh.uni.lu/_api/metabolites/911/?format=pcsv
nrpphrsf,,,0,C8H11NO6S,,,"Human Metabolome Database (HMDB): Plasma norepinephrine sulfate increases after sympathetic nervous system activation by an exhausting incremental exercise test and remain elevated up to 2 h after exercise. (PMID: 8330610). Human platelets contribute to the formation of plasma norepinephrine sulfate by norepinephrine uptake, intraplatelet sulfoconjugation and release of norepinephrine sulfate. (PMID: 7968241). Higher concentrations of norepinephrine sulfate in portal venous than arterial plasma indicate substantial production of norepinephrine by mesenteric organs. (PMID: 8627312). Intravenously infused norepinephrine is sulfoconjugated in humans, indicating that a major part of NE is sulfoconjugated in blood or at sites easily accessible from blood. (PMID: 12020748).",,Sulfate derivative of norepinephrine,,HMDB02062,"InChI=1/C8H11NO6S/c9-4-7(11)5-1-2-8(6(10)3-5)15-16(12,13)14/h1-3,7,10-11H,4,9H2,(H,12,13,14)/t7-/m0/s1",,2016-12-05T15:48:05Z,,912,,,,,123747,nrpphrsf,,"Noradrenaline sulfate, Noradrenaline sulfoconjugate, Noradrenaline sulphate, Norepinephrine-3-O-sulfate, Norepinephrine-3-O-sulphate, Norepinephrine-O-sulfate, Norepinephrine-O-sulphate",http://vmh.uni.lu/_api/metabolites/912/?format=pcsv
nrvnc,,,-1,C24H45O2,CHEBI:44247,,"Human Metabolome Database (HMDB): Nervonic acid is a long chain unsaturated fatty acid that is enriched in sphingomyelin. It consists of choline, sphingosine, phosphoric acid, and fatty acid. Nervonic acid may enhance the brain functions and prevent demyelination (Chemical Land21). Research shows that there is negative relationship between nervonic acid and obesity-related risk factors (PMID: 16394593). Demyelination in adrenoleukodystrophy (ALD) is associated with an accumulation of very long chain saturated fatty acids stemming from a genetic defect in the peroxisomal beta oxidation system responsible for the chain shortening of these fatty acids. Sphingolipids from post mortem ALD brain have decreased levels of nervonic acid, 24:1(n-9), and increased levels of stearic acid, 18:0. (PMID: 8072429).",,nervonate,,HMDB02368,"InChI=1S/C24H46O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26/h9-10H,2-8,11-23H2,1H3,(H,25,26)/p-1/b10-9-",C08323,2016-12-05T15:48:05Z,,913,,,,,5281120,nrvnc,,"(15Z)-tetracos-15-enoate, (15Z)-tetracos-15-enoic acid, (15Z)-Tetracosenoate, (15Z)-Tetracosenoic acid, (Z)-15-Tetracosenoate, (Z)-15-Tetracosenoic acid, 15-Tetracosenoate, 15-Tetracosenoic acid, 15Z-Tetracosenoate, 15Z-Tetracosenoic acid, cis-15-Teracosenoate, cis-15-Teracosenoic acid, cis-15-Tetracosenate, cis-15-Tetracosenic acid, cis-15-Tetracosenoate, cis-15-Tetracosenoic acid, cis-delta(15)-Tetracosenoate, cis-delta(15)-Tetracosenoic acid, cis-Selacholeate, cis-Selacholeic acid, Nervonate, Selacholeate, Selacholeic acid",http://vmh.uni.lu/_api/metabolites/913/?format=pcsv
oagd3_hs,,,-2,C54H90N3O29FULLRCO,,,9-O-Acetylated GD3,,9-O-Acetylated GD3,,,,,2016-11-22T15:12:00Z,,914,,,,,,oagd3_hs,,,http://vmh.uni.lu/_api/metabolites/914/?format=pcsv
oagt3_hs,,,-3,C65H106N4O37FULLRCO,,,9-O-Acetylated GT3,,9-O-Acetylated GT3,,,,,2016-11-22T15:12:00Z,,915,,,,,,oagt3_hs,,,http://vmh.uni.lu/_api/metabolites/915/?format=pcsv
ocdca,,,-1,C18H35O2,CHEBI:28842,,"Human Metabolome Database (HMDB): Stearic acid, also called octadecanoic acid, is one of the useful types of saturated fatty acids that comes from many animal and vegetable fats and oils. It is a waxy solid, and its chemical formula is CH3(CH2)16COOH. Its name comes from the Greek word stear, which means tallow. Its IUPAC name is octadecanoic acid. -- Wikipedia.",,octadecanoate (n-C18:0),,HMDB00827,"InChI=1S/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20)/p-1",C01530,2016-12-05T15:48:05Z,,916,,,,,3033836,ocdca,,"1-Heptadecanecarboxylate, 1-Heptadecanecarboxylic acid, N-Octadecanoate, N-Octadecanoic acid, Octadecanoate, Octadecanoic acid, Stearate, Stearex Beads, Stearic acid, Stearic acid Cherry, Stearophanate, Stearophanic acid",http://vmh.uni.lu/_api/metabolites/916/?format=pcsv
ocdcea,,,-1,C18H33O2,CHEBI:16196,,"Human Metabolome Database (HMDB): Oleic acid is an unsaturated fatty acid that is the most widely distributed and abundant fatty acid in nature. It is used commercially in the preparation of oleates and lotions, and as a pharmaceutical solvent. (Stedman, 26th ed) Biological Source: Major constituent of plant oils e.g. olive oil (about 80%), almond oil (about 80%) and many others, mainly as glyceride. Constituent of tall oil and present in fruits Use/Importance: Food additive. Oleic acid is used in manufacturing of surfactants, soaps, plasticizers. Emulsifying agent in foods and pharmaceuticals. Biological Use/Importance: Skin penetrant. Herbicide, insecticide, fungicide (Dictionary of Organic Compounds). Oleic acid is a fatty acid that occurs naturally in various animal and vegetable fats and oils. It is an odorless, colourless oil, although commercial samples may be yellowish. In chemical terms, oleic acid is classified as a monounsaturated omega-9 fatty acid. It has the formula CH3(CH2)7CH=CH(CH2)7COOH. The term ""oleic"" means related to, or derived from, oil or olive, the oil that is predominantly composed of oleic acid. (Wiki).",,octadecenoate (n-C18:1),,HMDB00207,"InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/p-1/b10-9-",C00712,2016-12-05T15:48:05Z,,917,,,,,5460221,ocdcea,,"(9Z)-9-Octadecenoate, (9Z)-9-Octadecenoic acid, (9Z)-Octadecenoate, (9Z)-Octadecenoic acid, (Z)-9-Octadecanoate, (Z)-9-Octadecanoic acid, (Z)-Octadec-9-enoate, (Z)-Octadec-9-enoic acid, 9,10-Octadecenoate, 9,10-Octadecenoic acid, 9-(Z)-Octadecenoate, 9-(Z)-Octadecenoic acid, 9-Octadecenoate, 9-Octadecenoic acid, Century cd fatty acid, cis-9-Octadecenoate, cis-9-Octadecenoic acid, cis-Octadec-9-enoate, cis-Octadec-9-enoic acid, cis-Oleate, cis-Oleic acid, Distoline, Emersol 210, Emersol 211, Emersol 213, Emersol 220 White Oleate, Emersol 220 White Oleic acid, Emersol 221 Low Titer White Oleate, Emersol 221 Low Titer White Oleic acid, Emersol 233ll, Emersol 6321, Emersol 6333 NF, Emersol 7021, Glycon ro, Glycon wo, Groco 2, Groco 4, Groco 5L, Groco 6, Industrene 104, Industrene 105, Industrene 205, Industrene 206, L'Acide oleique, Metaupon, Oelsauere, Oleate, Oleic acid extra pure, Oleinate, Oleinic acid, Pamolyn, Pamolyn 100, Pamolyn 100 FG, Pamolyn 100 FGK, Pamolyn 125, Priolene 6900, Red oil, Tego-oleic 130, Vopcolene 27, Wecoline OO, Z-9-Octadecenoate, Z-9-Octadecenoic acid",http://vmh.uni.lu/_api/metabolites/917/?format=pcsv
octa,,,-1,C8H15O2,CHEBI:28837,,Human Metabolome Database (HMDB): Caprylic acid is the common name for the eight-carbon straight chain fatty acid known by the systematic name octanoic acid. It is found naturally in coconuts and breast milk. It is an oily liquid with a slightly unpleasant rancid taste that is minimally soluble in water. Caprylic acid is used commercially in the production of esters used in perfumery and also in the manufacture of dyes. (wikipedia).,,octanoate (n-C8:0),,HMDB00482,"InChI=1S/C8H16O2/c1-2-3-4-5-6-7-8(9)10/h2-7H2,1H3,(H,9,10)/p-1",C06423,2016-12-05T15:48:05Z,,918,,,,,379,octa,,"1-Heptanecarboxylate, 1-Heptanecarboxylic acid, Caprylate, Caprylic acid, Emery 657, Kortacid 0899, Lunac 8-95, Lunac 8-98, N-Caprylate, N-Caprylic acid, N-Octanoate, N-Octanoic acid, N-Octoate, N-Octoic acid, N-Octylate, N-Octylic acid, Neo-Fat 8, Neo-Fat 8S, Octylate, Octylic acid, Prifac 2901",http://vmh.uni.lu/_api/metabolites/918/?format=pcsv
omeprazole,,,0,C17H19N3O3S,CHEBI:7772,,"Human Metabolome Database (HMDB): Omeprazole is a highly effective inhibitor of gastric acid secretion used in the therapy of stomach ulcers, dyspepsia, peptic ulcer disease , gastroesophageal reflux disease and Zollinger-Ellison syndrome. The drug inhibits the H(+)-K(+)-ATPase (H(+)-K(+)-exchanging ATPase) in the proton pump of Gastric Parietal Cells.--Pubchem. Omeprazole is one of the most widely prescribed drugs internationally and is available over the counter in some countries.",,omeprazole,,HMDB01913,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)",C07324,2016-12-05T15:48:05Z,,919,,,,,4594,omeprazole,,"( -)-Omeprazole, (-)-Omeprazole, (S)-(-)-Omeprazole, (S)-Omeprazole, 2,3,5-Trimethylpyridine/Omeprazole, Antra, Antra MUPS, Audazol, Aulcer, Belmazol, Ceprandal, Danlox, Demeprazol, Desec, Dizprazol, Dudencer, Elgam, Emeproton, Epirazole, Erbolin, Esomeprazole, Esomperazole, Exter, Gasec, Gastrimut, Gastroloc, Gibancer, Indurgan, Inhibitron, Inhipump, Lensor, Logastric, Lomac, Losec, Mepral, Miol, Miracid, Mopral, Morecon, Nexiam, Nexium, Nexium IV, Nilsec, Nopramin, Nuclosina, Ocid, Olexin, Omapren, Omebeta 20, Omed, Omegast, OMEP, Omepradex, Omepral, Omeprazol, Omeprazole, Omeprazole Pellets, Omeprazolum, Omeprazon, Omeprol, Omesek, Omez, Omezol, Omezolan, Omid, Omisec, Omizac, Ompanyt, OMZ, Ortanol, Osiren, Ozoken, Paprazol, Parizac, Pepticum, Pepticus, Peptilcer, Prazentol, Prazidec, Prazolit, Prestwick_808, Prilosec, Prilosec OTC, Procelac, Proclor, Prysma, Ramezol, Regulacid, Result, Sanamidol, Secrepina, Tedec Ulceral, Ulceral, Ulcesep, Ulcometion, Ulcozol, Ulcsep, Ulsen, Ultop, Ulzol, Victrix, Zefxon, Zegerid, Zepral, Zimor, Zoltum",http://vmh.uni.lu/_api/metabolites/919/?format=pcsv
onpthl,,,0,C10H8O,CHEBI:33998,,naphthalene epoxide,,naphthalene epoxide,,,"InChI=1/C10H8O/c1-2-4-8-7(3-1)5-6-9-10(8)11-9/h1-6,9-10H",,2016-11-22T15:12:00Z,,920,,,,,108063,onpthl,,,http://vmh.uni.lu/_api/metabolites/920/?format=pcsv
paf_hs,,,0,C11H23O4NPFULLRCO2,CHEBI:36707,,1-alkyl 2-acteylglycerol 3-phosphocholine,,1-alkyl 2-acteylglycerol 3-phosphocholine,,,,,2016-11-22T15:12:00Z,,921,,,,,,paf_hs,,,http://vmh.uni.lu/_api/metabolites/921/?format=pcsv
peplys,,,0,XH,,,Peptidyl-L-lysine,,Peptidyl-L-lysine,,,,C02188,2016-11-22T15:12:00Z,,922,,,,,,peplys,,,http://vmh.uni.lu/_api/metabolites/922/?format=pcsv
perillyl,,,0,C10H16O,CHEBI:15420,,"Human Metabolome Database (HMDB): Perillyl alcohol is a monoterpene isolated from the essential oils of lavendin, peppermint, spearmint, cherries, celery seeds, and several other plants. In animal studies it has been shown to regress pancreatic, mammary, and liver tumors, to exhibit possible application as a chemopreventative agent for colon, skin, and lung cancer, and as a chemotherapeutic agent for neuroblastoma, and prostate and colon cancer.(PMID: 9855569).",,perillyl alcohol,,HMDB03634,"InChI=1S/C10H16O/c1-8(2)10-5-3-9(7-11)4-6-10/h3,10-11H,1,4-7H2,2H3",C02452,2016-12-05T15:48:05Z,,923,,,,,10819,perillyl,,"(-)-Perillyl alcohol, (S)-(-)-Perillyl alcohol, 1,8-p-Menthadien-7-ol, 4-Isopropenyl-1-cyclohexene carbinol, 4-Isopropenyl-cyclohex-1-ene-1-methanol, 4-Isopropenylcyclohex-1-en-1-ylmethanol, Dihydrocuminic alcohol, Dihydrocuminyl alcohol, Hydrocumin alcohol, Iso-carveol, Isocarveol, p-Mentha-1,8-dien-7-ol, Para-mentha-1,8-dien-7-ol, Perill alcohol, Perilla alcohol, Perillic alcohol, Perillol",http://vmh.uni.lu/_api/metabolites/923/?format=pcsv
pheacgln,,,0,C13H16N2O4,CHEBI:17884,,"Human Metabolome Database (HMDB): Phenylacetylglutamine is a product formed by the conjugation of phenylacetate and glutamine. Technically it is the amino acid acetylation product of phenylacetate (or phenylbutyrate after beta-oxidation). Phenylacetylglutamine is a normal constituent of human urine, but other mammals including the dog, cat, rat, monkey, sheep and horse do not excrete this compound. Phenylacetyl CoA and glutamine react to form phenylacetyl glutamine and Coenzyme A. The enzyme (Glutamine N-acetyl transferase) that catalyzes this reaction has been purified from human liver mitochondria and shown to be a distinct polypeptide species from glycine-N-acyltransferase. Phenylacetylglutamine is a major nitrogenous metabolite that accumulates in uremia. (PMID: 2791363; PMID: 8972626). It has been shown that over 50% of urine phenylacetylglutamine may be derived from kidney conjugation of free plasma phenylacetic acid and/or from the kidney's preferential filtration of conjugated phenylacetic acid (PMID: 6420430). In enzymology, a glutamine N-phenylacetyltransferase (EC 2.3.1.14) is an enzyme that catalyzes the chemical reaction. phenylacetyl-CoA + L-glutamine CoA + alpha-N-phenylacetyl-L-glutamine. Thus, the two substrates of this enzyme are phenylacetyl-CoA and L-glutamine, whereas its two products are CoA and alpha-N-phenylacetyl-L-glutamine.(Wikipedia).",,(2S)-4-carbamoyl-2-(2-phenylacetamido)butanoate,,HMDB06344,"InChI=1S/C13H16N2O4/c14-11(16)7-6-10(13(18)19)15-12(17)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,14,16)(H,15,17)(H,18,19)/t10-/m0/s1",C04148,2016-12-05T15:48:05Z,,924,,,,,92258,pheacgln,,"alpha-N-Phenylacetyl-L-glutamine, L-N(Sup 2)-(Phenylacetyl)glutamine, N(2)-(Phenylacetyl)-L-glutamine, Phenylacetyl-L-glutamine, Phenylacetylglutamine",http://vmh.uni.lu/_api/metabolites/924/?format=pcsv
phe_L,,,0,C9H11NO2,CHEBI:17295,,"Human Metabolome Database (HMDB): Phenylalanine is an essential amino acid and the precursor for the amino acid tyrosine. Like tyrosine, it is the precursor of catecholamines in the body (tyramine, dopamine, epinephrine and norepinephrine). The psychotropic drugs (mescaline, morphine, codeine, and papaverine) also have phenylalanine as a constituent. Phenylalanine is a precursor of the neurotransmitters called catecholamines, which are adrenalin-like substances. Phenylalanine is highly concentrated in the human brain and plasma. Normal metabolism of phenylalanine requires biopterin, iron, niacin, vitamin B6, copper and vitamin C. An average adult ingests 5 g of phenylalanine per day and may optimally need up to 8 g daily. Phenylalanine is highly concentrated in high protein foods, such as meat, cottage cheese and wheat germ. A new dietary source of phenylalanine is artificial sweeteners containing aspartame. Aspartame appears to be nutritious except in hot beverages; however, it should be avoided by phenylketonurics and pregnant women. Phenylketonurics, who have a genetic error of phenylalanine metabolism, have elevated serum plasma levels of phenylalanine up to 400 times normal. Mild phenylketonuria can be an unsuspected cause of hyperactivity, learning problems, and other developmental problems in children. Phenylalanine can be an effective pain reliever. Its use in premenstrual syndrome and Parkinson's may enhance the effects of acupuncture and electric transcutaneous nerve stimulation (TENS). Phenylalanine and tyrosine, like L-dopa, produce a catecholamine effect. Phenylalanine is better absorbed than tyrosine and may cause fewer headaches. Low phenylalanine diets have been prescribed for certain cancers with mixed results. Some tumors use more phenylalanine (particularly melatonin-producing tumors called melanoma). One strategy is to exclude this amino acid from the diet, i.e., a Phenylketonuria (PKU) diet (compliance is a difficult issue; it is hard to quantify and is under-researched). The other strategy is just to increase phenylalanine's competing amino acids, i.e., tryptophan, valine, isoleucine and leucine, but not tyrosine. (http://www.dcnutrition.com).",,L-phenylalanine,,HMDB00159,"InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1",C00079,2016-12-05T15:48:05Z,,925,,,,L-phenylalanine,6140,phe_L,,"(-)-beta-Phenylalanine, (L)-Phenylalanine, (S)-(-)-Phenylalanine, (S)-2-amino-3-phenylpropanoate, (S)-2-amino-3-phenylpropanoic acid, (S)-2-Amino-3-phenylpropionate, (S)-2-Amino-3-phenylpropionic acid, (S)-alpha-Amino-benzenepropanoate, (S)-alpha-Amino-benzenepropanoic acid, (S)-alpha-Amino-beta-phenylpropionate, (S)-alpha-Amino-beta-phenylpropionic acid, (S)-alpha-Aminobenzenepropanoate, (S)-alpha-Aminobenzenepropanoic acid, (S)-alpha-Aminohydrocinnamate, (S)-alpha-Aminohydrocinnamic acid, (S)-Phenylalanine, 3-Phenyl-L-alanine, alpha-Aminohydrocinnamate, alpha-Aminohydrocinnamic acid, beta-Phenyl-alpha-alanine, beta-Phenyl-L-alanine, beta-Phenylalanine, L-2-Amino-3-phenylpropionate, L-2-Amino-3-phenylpropionic acid, Phe, Phenyl-Alanine, Phenylalamine, Phenylalanine",http://vmh.uni.lu/_api/metabolites/925/?format=pcsv
pheme,,,-2,C34H30FeN4O4,CHEBI:17627,,Protoheme,,Protoheme,,,"InChI=1S/C34H34N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);/q;+2/p-2/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-;",C00032,2016-11-22T15:12:00Z,,926,,,,,,pheme,,,http://vmh.uni.lu/_api/metabolites/926/?format=pcsv
phyQ,,,0,C31H46O2,CHEBI:18067,,"Human Metabolome Database (HMDB): Vitamin K1 or Phylloquinone is a polycyclic aromatic ketone, based on 1,4-naphthoquinone, with 2-methyl and 3-phytyl substituents. Vitamin K is a family of phylloquinones that contains a ring of 2-methyl-1,4-naphthoquinone and an isoprenoid side chain. Several forms of vitamin K have been identified: vitamin K 1 (vitamin K 1) derived from plants, vitamin K 2 (menaquinone) from bacteria, and synthetic naphthoquinone provitamins, vitamin K 3 (menadione). Vitamin K1 has only one double bond on the proximal isoprene unit. Vitamin K1 possesses the same type and degree of activity as does naturally-occurring vitamin K, which is necessary for the production via the liver of active prothrombin (factor II), proconvertin (factor VII), plasma thromboplastin component (factor IX), and Stuart factor (factor X). Rich sources of vitamin K 1 include green plants, algae, and photosynthetic bacteria. Vitamin K1 has antihemorrhagic and prothrombogenic activity. Vitamin K1 is a fat-soluble vitamin that is stable to air and moisture but decomposes in sunlight. It is found naturally in a wide variety of green plants.",,phylloquinone,,HMDB03555,"InChI=1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3/b25-20+/t23-,24-/m1/s1",C02059,2016-12-05T15:48:05Z,,927,,,,,5280483,phyQ,,"2',3'-trans-Vitamin K1, 2-Methyl-3-phythyl-1,4-naphthochinon, 2-Methyl-3-phytyl-1,4-naphthochinon, 2-Methyl-3-phytyl-1,4-naphthoquinone, 2-Methyl-3-phytyl-1,4-napthoquinone, 2-Methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl]naphthalene-1,4-dione, 3-Phytylmenadione, a-Phylloquinone, alpha-Phylloquinone, Antihemorrhagic vitamin, Aqua Mephyton, Aqua-Mephytin, Aquamephyton, Combinal K1, Fitomenadiona, Fitomenadione, K-Ject, Kativ N, Kephton, Kinadion, Konakion, Mephyton, Mono-Kay, Monodion, Phyllochinon, Phyllochinonum, Phylloquinone, Phythyl-menadion, Phytomenadione, Phytomenadionum, Phytonadione, Phytonadionum, Phytylmenadione, Synthex P, trans-Phylloquinone, Vitamin K1",http://vmh.uni.lu/_api/metabolites/927/?format=pcsv
phyt,,,-1,C20H39O2,CHEBI:16285,,"Human Metabolome Database (HMDB): Phytanic acid is a 20-carbon branched chain fatty acid, Phytanic acid is present in animal (primarily herbivores or omnivores) tissues where it may be derived from the chlorophyll in consumed plant material. Phytanic acid derives from the corresponding alcohol, phytol, and is ultimately oxidized into pristanic acid. In phytanic acid storage disease (Refsum disease) this lipid may comprise as much as 30% of the total fatty acids in plasma. These high levels in Refsum disease (a neurological disorder) are due to a phytanic acid alpha-hydroxylase deficiency.",,phytanate,,HMDB00801,"InChI=1S/C20H40O2/c1-16(2)9-6-10-17(3)11-7-12-18(4)13-8-14-19(5)15-20(21)22/h16-19H,6-15H2,1-5H3,(H,21,22)/p-1",C01607,2016-12-05T15:48:05Z,,928,,,,,26840,phyt,,"3,7,11,15-Tetramethyl-hexadecanoate, 3,7,11,15-Tetramethyl-hexadecanoic acid, 3,7,11,15-Tetramethyl-hexadecansaeure, 3,7,11,15-Tetramethylhexadecanoate, 3,7,11,15-Tetramethylhexadecanoic acid, 3,7,11,15-Tetramethylhexadecoanoate, 3,7,11,15-Tetramethylhexadecoanoic acid, Phytanate, Phytanoate, Phytanoic acid",http://vmh.uni.lu/_api/metabolites/928/?format=pcsv
pnto_R,,,-1,C9H16NO5,CHEBI:29032,,"Human Metabolome Database (HMDB): Pantothenic acid, also called vitamin B5, is a water-soluble vitamin required to sustain life. Pantothenic acid is needed to form coenzyme-A (CoA), and is thus critical in the metabolism and synthesis of carbohydrates, proteins, and fats. Its name is derived from the Greek pantothen meaning ""from everywhere"" and small quantities of pantothenic acid are found in nearly every food, with high amounts in whole grain cereals, legumes, eggs, meat, and royal jelly.",,(R)-Pantothenate,,HMDB00210,"InChI=1S/C9H17NO5/c1-9(2,5-11)7(14)8(15)10-4-3-6(12)13/h7,11,14H,3-5H2,1-2H3,(H,10,15)(H,12,13)/p-1",C00864,2016-12-05T15:48:05Z,,929,,,,,988,pnto_R,,"(+)-Pantothenate, (+)-Pantothenic acid, (D)-(+)-Pantothenate, (D)-(+)-Pantothenic acid, (R)-pantothenate, Chick antidermatitis factor, D(+)-N-(2,4-Dihydroxy-3,3-dimethylbutyryl)-b-alanine, D(+)-N-(2,4-Dihydroxy-3,3-dimethylbutyryl)-beta-alanine, D-Pantothenate, D-Pantothenic acid, delta-Pantothenate, delta-Pantothenic acid, Pantothenate, Vitamin B5",http://vmh.uni.lu/_api/metabolites/929/?format=pcsv
pro_L,,,0,C5H9NO2,CHEBI:17203,,"Human Metabolome Database (HMDB): L-Proline is one of the twenty amino acids used in living organisms as the building blocks of proteins. Proline is sometimes called an imino acid, although the IUPAC definition of an imine requires a carbon-nitrogen double bond. Proline is a non-essential amino acid that is synthesized from glutamic acid. It is an essential component of collagen and is important for proper functioning of joints and tendons.",,L-proline,,HMDB00162,"InChI=1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m0/s1",C00148,2016-12-05T15:48:05Z,,930,,,,,145742,pro_L,,"(-)-(S)-Proline, (-)-2-Pyrrolidinecarboxylate, (-)-2-Pyrrolidinecarboxylic acid, (-)-Proline, (S)-(-)-Proline, (S)-(-)-Pyrrolidine-2-carboxylate, (S)-(-)-Pyrrolidine-2-carboxylic acid, (S)-2-Carboxypyrrolidine, (S)-2-Pyrralidinecarboxylate, (S)-2-Pyrralidinecarboxylic acid, (S)-2-Pyrrolidinecarboxylate, (S)-2-Pyrrolidinecarboxylic acid, (S)-Proline, 2-Pyrrolidinecarboxylate, 2-Pyrrolidinecarboxylic acid, Proline",http://vmh.uni.lu/_api/metabolites/930/?format=pcsv
prostgd2,,,-1,C20H31O5,CHEBI:15555,,"Human Metabolome Database (HMDB): Prostaglandin D2 (or PGD2) is a prostaglandin that is actively produced in various organs such as the brain, spleen, thymus, bone marrow, uterus, ovary, oviduct, testis, prostate and epididymis, and is involved in many physiological events. PGD2 binds to the prostaglandin D2 receptor (PTGDR) which is a G-protein-coupled receptor. Its activity is mainly mediated by G-S proteins that stimulate adenylate cyclase resulting in an elevation of intracellular cAMP and Ca2+. PGD2 promotes sleep; regulates body temperature, olfactory function, hormone release, and nociception in the central nervous system; prevents platelet aggregation; and induces vasodilation and bronchoconstriction. PGD2 is also released from mast cells as an allergic and inflammatory mediator. Prostaglandin H2 is an unstable intermediate formed from PGG2 by the action of cyclooxygenase (COX) in the arachidonate cascade. In mammalian systems, it is efficiently converted into more stable arachidonate metabolites, such as PGD2, PGE2, PGF2a by the action of three groups of enzymes, PGD synthases (PGDS), PGE synthases and PGF synthases, respectively. PGDS catalyzes the isomerization of PGH2 to PGD2. Two types of PGD2 synthase are known. Lipocalin-type PGD synthase is present in cerebrospinal fluid, seminal plasma and may play an important role in male reproduction. Another PGD synthase, hematopoietic PGD synthase is present in the spleen, fallopian tube, endometrial gland cells, extravillous trophoblasts and villous trophoblasts, and perhaps plays an important role in female reproduction. Recent studies demonstrate that PGD2 is probably involved in multiple aspects of inflammation through its dual receptor systems, DP and CRTH2. (PMID: 12148545)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,prostaglandin D2(1-),,HMDB01403,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-18,21-22H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/p-1/b7-4-,13-12+/t15-,16+,17+,18-/m0/s1",C00696,2016-12-05T15:48:05Z,,931,,,,prostaglandin D2,448457,prostgd2,,"(5Z,13E)-(15S)-9,15-dihydroxy-11-oxoprosta-5,13-dienoate, (5Z,13E)-(15S)-9,15-dihydroxy-11-oxoprosta-5,13-dienoic acid, (5z,13e)-(15S)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate, (5z,13e)-(15S)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoic acid, (5Z,13E)-(15S)-9a,15-Dihydroxy-11-oxoprosta-5,13-dienoate, (5Z,13E)-(15S)-9a,15-Dihydroxy-11-oxoprosta-5,13-dienoic acid, (5Z,13E)-(15S)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate, (5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoic acid, (5Z,13E,15S)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate, (5Z,13E,15S)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoic acid, (5Z,13E,15S)-9a,15-dihydroxy-11-oxoprosta-5,13-dien-1-oate, (5Z,13E,15S)-9a,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acid, (5Z,9-alpha,13E,15S)-9,15-dihydroxy-11-oxo-Prosta-5,13-dien-1-oate, (5Z,9-alpha,13E,15S)-9,15-dihydroxy-11-oxo-Prosta-5,13-dien-1-oic acid, (5Z,9alpha,13E,15S)-9,15-dihydroxy-11-oxo-prosta-5,13-dien-1-oate, (5Z,9alpha,13E,15S)-9,15-dihydroxy-11-oxo-prosta-5,13-dien-1-oic acid, 11-Dehydroprostaglandin F2-alpha, 11-Dehydroprostaglandin F2alpha, 9S,15S-Dihydroxy-11-oxo-5Z,13E-prostadienoate, 9S,15S-Dihydroxy-11-oxo-5Z,13E-prostadienoic acid, PGD2, Prostaglandin d2",http://vmh.uni.lu/_api/metabolites/931/?format=pcsv
ps_hs,,,-1,C6H11NO6PFULLRCO2FULLR2CO2,,,phosphatidylserine,,phosphatidylserine,,,,,2016-11-22T15:12:00Z,,932,,,,,,ps_hs,,,http://vmh.uni.lu/_api/metabolites/932/?format=pcsv
ptdca,,,-1,C15H29O2,CHEBI:42504,,"Human Metabolome Database (HMDB): Pentadecanoic acid is a fatty acid of exogenous (primarily ruminant) origin. Many ""odd"" length long chain amino acids are derived from the consumption of dairy fats (milk and meat). Pentadecanoic acid constitutes 1.05% of milk fat and 0.43% of ruminant meat fat. The content of heptadecanoic acid in the subcutaneous adipose tissue of humans appears to be a good biological marker of long-term milk fat intake in free-living individuals in populations with high consumption of dairy products. (PMID 9701185; PMID 11238766).",,pentadecanoate,,HMDB00826,"InChI=1/C15H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15(16)17/h2-14H2,1H3,(H,16,17)",C16537,2016-12-05T15:48:05Z,,933,,,,,13849,ptdca,,"N-Pentadecanoate, N-Pentadecanoic acid, N-Pentadecylate, N-Pentadecylic acid, Pentadecanoate, Pentadecanoic acid, Pentadecyclate, Pentadecyclic acid",http://vmh.uni.lu/_api/metabolites/933/?format=pcsv
pydam,,,1,C8H13N2O2,CHEBI:16410,,Pyridoxamine,,Pyridoxamine,,,"InChI=1S/C8H12N2O2/c1-5-8(12)7(2-9)6(4-11)3-10-5/h3,11-12H,2,4,9H2,1H3/p+1",C00534,2016-11-22T15:12:00Z,,934,,,,,1052,pydam,,,http://vmh.uni.lu/_api/metabolites/934/?format=pcsv
pydx,,,0,C8H9NO3,CHEBI:17310,,Pyridoxal,,Pyridoxal,,,"InChI=1S/C8H9NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,4,10,12H,3H2,1H3",C00250,2016-11-22T15:12:00Z,,935,,,,,1050,pydx,,,http://vmh.uni.lu/_api/metabolites/935/?format=pcsv
pydxn,,,0,C8H11NO3,CHEBI:16709,,"Human Metabolome Database (HMDB): The 4-methanol form of vitamin B6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. Although pyridoxine and Vitamin B6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading (EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990). Pyridoxine is one of the compounds that can be called vitamin B6. Pyridoxine assists in the balancing of sodium and potassium as well as promoting red blood cell production. It is linked to cancer immunity and helps fight the formation of homocysteine. It has been suggested that Pyridoxine might help children with learning difficulties, and may also prevent dandruff, eczema, and psoriasis. In addition, pyridoxine can help balance hormonal changes in women and aid in immune system. Lack of pyridoxine may cause anemia, nerve damage, seizures, skin problems, and sores in the mouth. -- Wikipedia Deficiency, though rare because of widespread distribution in foods, leads to the development of peripheral neuritis in adults and affects the central nervous system in children (DOSE - 3rd edition).",,Pyridoxine,,HMDB00239,"InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3",C00314,2016-12-05T15:48:05Z,,936,,,,,1054,pydxn,,"2-Methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine, 2-Methyl-3-hydroxy-4,5-di(hydroxymethyl)pyridine, 2-Methyl-4,5-bis(hydroxymethyl)-3-hydroxypyridine, 3-Hydroxy-2-Picoline-4,5-dimethanol, 3-Hydroxy-4,5-dimethylol-alpha-picoline, 5-Hydroxy-6-methyl-3,4-pyridinedimethanol, Adermine, Gravidox, Hydoxin, Piridossina, Piridoxina, Pyridoxin, Pyridoxine, Pyridoxinum, Pyridoxol, Pyridoxolum",http://vmh.uni.lu/_api/metabolites/936/?format=pcsv
rbt,,,0,C5H12O5,CHEBI:15963,,"Human Metabolome Database (HMDB): Ribitol is a metabolic end product formed by the reduction of ribose in human fibroblasts and erythrocytes (pentitol, sugar alcohol, polyol). Export of ribitol across the cell membrane indicates that can be cleared from the body without metabolic conversion. (PMID 15234337). Several inborn errors of metabolism with abnormal polyol concentrations in body fluids are known to date. Most of these defects can be diagnosed by the assessment of urinary concentrations of polyols. (PMID 16435188). Ribitol is normally absent in Breast milk. (PMID 16456418).",,D-ribitol,,HMDB00508,"InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4+,5-",C00474,2016-12-05T15:48:05Z,,937,,,,,827,rbt,,"1,2,3,4,5-Pentanepentol, Adonit, Adonite, Adonitol, Pentitol, Ribitol",http://vmh.uni.lu/_api/metabolites/937/?format=pcsv
retfa,,,0,C20H29OFULLR2CO,,,fatty acid retinol,,fatty acid retinol,,,,,2016-11-22T15:12:00Z,,938,,,,,,retfa,,,http://vmh.uni.lu/_api/metabolites/938/?format=pcsv
retinol,,,0,C20H30O,,,"Human Metabolome Database (HMDB): Vitamin A (retinol) is a yellow fat-soluble, antioxidant vitamin important in vision and bone growth. It belongs to the family of chemical compounds known as retinoids. Retinol is ingested in a precursor form; animal sources (milk and eggs) contain retinyl esters, whereas plants (carrots, spinach) contain pro-vitamin A carotenoids. Hydrolysis of retinyl esters results in retinol while pro-vitamin A carotenoids can be cleaved to produce retinal. Retinal, also known as retinaldehyde, can be reversibly reduced to produce retinol or it can be irreversibly oxidized to produce retinoic acid. Retinol and derivatives of retinol that play an essential role in metabolic functioning of the retina, the growth of and differentiation of epithelial tissue, the growth of bone, reproduction, and the immune response. Dietary vitamin A is derived from a variety of carotenoids found in plants. It is enriched in the liver, egg yolks, and the fat component of dairy products.",,retinol,,HMDB00305,"InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3",C00473,2016-12-05T15:48:05Z,,939,,,,,445354,retinol,,"(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, All-trans-Retinol, b-Retinol, beta-Retinol, Retinol, trans-Retinol, Vitamin A1",http://vmh.uni.lu/_api/metabolites/939/?format=pcsv
retinol_9_cis,,,0,C20H30O,,,9-cis-retinol,,9-cis-retinol,,,"InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+",C16682,2016-11-22T15:12:00Z,,940,,,,,9947823,retinol_9_cis,,,http://vmh.uni.lu/_api/metabolites/940/?format=pcsv
retinol_cis_11,,,0,C20H30O,,,11-cis-retinol,,11-cis-retinol,,,"InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6-,12-11+,16-8+,17-13+",C00899,2016-11-22T15:12:01Z,,941,,,,,5280382,retinol_cis_11,,,http://vmh.uni.lu/_api/metabolites/941/?format=pcsv
retn,,,-1,C20H27O2,CHEBI:15367,,"Human Metabolome Database (HMDB): All-trans-retinoic acid is an isomer of retinoic acid, the oxidized form of Vitamin A. Retinoic acid functions in determining position along embryonic anterior/posterior axis in chordates. It acts through Hox genes, which ultimately controls anterior/posterior patterning in early developmental stages (PMID: 17495912). It is an important regulator of gene expression during growth and development, and in neoplasms. As a drug, all-trans-retinoic acid is known as tretinoin. Tretinoin is derived from maternal vitamin A and is essential for normal growth and embryonic development. An excess of tretinoin can be teratogenic. Tretinoin is used in the treatment of psoriasis; acne vulgaris; and several other skin diseases. It has also been approved for use in promyelocytic leukemia (leukemia, promyelocytic, acute).",,all-trans-retinoate,,HMDB01852,"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/p-1/b9-6+,12-11+,15-8+,16-14+",C00777,2016-12-05T15:48:05Z,,942,,,,,444795,retn,,"(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate, (all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid, 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate, 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid, Acide retinoique (French), All-(E)-Retinoate, All-(E)-Retinoic acid, All-trans-Retinoate, All-trans-Retinoic acid, All-trans-Tretinoin, All-trans-Vitamin A acid, All-trans-Vitamin A1 acid, beta-Retinoate, beta-Retinoic acid, Retinoate, Retinoic acid, trans-Retinoate, trans-Retinoic acid, Tretin M, Tretinoine (French), Vitamin A acid",http://vmh.uni.lu/_api/metabolites/942/?format=pcsv
retnglc,,,-1,C26H35O8,CHEBI:28870,,"Human Metabolome Database (HMDB): Retinoyl beta-glucuronide is a naturally occurring, biologically active metabolite of vitamin A. Although retinoyl beta-glucuronide is regarded as a detoxification product of retinoic acid, it plays several roles in the functions of vitamin A. It can serve as a source of retinoic acid, and it may be a vehicle for transport of retinoic acid to target tissues. Topically applied retinoyl beta-glucuronide is comparable in efficacy to retinoic acid in the treatment of acne in humans, without the same side effects. Retinoyl beta-glucuronide may or may not be teratogenic, depending on the mode of administration and the species in which it is used. It may be a valuable therapeutic compound for the treatment of skin disorders and certain types of cancers.",,retinoyl glucuronide,,HMDB03141,"InChI=1S/C26H36O8/c1-15(11-12-18-17(3)10-7-13-26(18,4)5)8-6-9-16(2)14-19(27)33-25-22(30)20(28)21(29)23(34-25)24(31)32/h6,8-9,11-12,14,20-23,25,28-30H,7,10,13H2,1-5H3,(H,31,32)/b9-6+,12-11+,15-8+,16-14+/t20-,21-,22+,23-,25+/m0/s1",C11061,2016-12-05T15:48:05Z,,943,,,,,5281877,retnglc,,"13-cis-Retinoate, 13-cis-Retinoic acid, 13-cis-Retinoic acid acyl beta-D-glucuronide, 13-cis-Retinoic acid acyl beta-delta-glucuronide, 13-cis-Retinoyl glucuronide, 13-cis-Retinoyl-beta-D-glucuronide, 13-cis-Retinoyl-beta-delta-glucuronide, 13-cis-Retinoyl-beta-glucuronide, 9-cis-Retinoyl-beta-D-glucuronide, 9-cis-Retinoyl-beta-delta-glucuronide, All-trans-Retinoyl-beta-D-glucuronide, All-trans-Retinoyl-beta-delta-glucuronide, All-trans-Retinoyl-beta-glucuronide, Glucuronide, Retinoate, Retinoic acid, Retinoic acid beta-D-glucuronide, Retinoic acid beta-delta-glucuronide, Retinoyl beta-glucuronide, Retinoyl glucuronide, Retinoyl-beta-glucuronide",http://vmh.uni.lu/_api/metabolites/943/?format=pcsv
rib_D,,,0,C5H10O5,CHEBI:47013,,"Human Metabolome Database (HMDB): D-ribose is commonly referred to simply as ribose, a five-carbon sugar found in all living cells. Ribose is not an essential nutrient because it can be synthesized by almost every tissue in the body from other substances, such as glucose. It is vital for life as a component of DNA, RNA, ATP, ADP, and AMP. In nature, small amounts of ribose can be found in ripe fruits and vegetables. Brewer's yeast, which has a high concentration of RNA, is another rich source of ribose. D-ribose is also a component of many so-called energy drinks and antiaging products available on the market today. Ribose is a structural component of ATP, which is the primary energy source for exercising muscle. The adenosine component is an adenine base attached to the five-carbon sugar ribose. ATP provides energy to working muscles by releasing a phosphate group, hence becoming ADP, which in turn may release a phosphate group, then becoming AMP. During intense muscular activity, the total amount of ATP available is quickly depleted. In an effort to correct this imbalance, AMP is broken down in the muscle and secreted from the cell. Once the breakdown products of AMP are released from the cell, the energy potential (TAN pool) of the muscle is reduced and ATP must then be reformed using ribose. Ribose helps restore the level of adenine nucleotides by bypassing the rate-limiting step in the de novo (oxidative pentose phosphate) pathway, which regenerates 5-phosphoribosyl-l-pyrophosphate (PRPP), the essential precursor for ATP. If ribose is not readily available to a cell, glucose may be converted to ribose. Ribose supplementation has been shown to increase the rate of ATP resynthesis following intense exercise. The use of ribose in men with severe coronary artery disease resulted in improved exercise tolerance. Hence, there is interest in the potential of ribose supplements to boost muscular performance in athletic activities. (PMID: 17618002, Curr Sports Med Rep. 2007 Jul;6(4):254-7.).",,D-ribose,,HMDB00283,,C00121,2016-12-05T15:48:05Z,,944,,,,,5779,rib_D,,"alpha-D-Ribose, alpha-D-Ribose-5, alpha-delta-Ribose, alpha-delta-Ribose-5, D-(-)-Ribose, D-Ribo-2,3,4,5-tetrahydroxyvaleraldehyde, D-Ribose, delta-(-)-Ribose, delta-Ribo-2,3,4,5-tetrahydroxyvaleraldehyde, delta-Ribose, Ribose",http://vmh.uni.lu/_api/metabolites/944/?format=pcsv
s2l2fn2m2masn,,,-2,C90H145N6O65X,,,PA6,,PA6,,,,,2016-11-22T15:12:01Z,,945,,,,,,s2l2fn2m2masn,,,http://vmh.uni.lu/_api/metabolites/945/?format=pcsv
s2l2n2m2masn,,,-2,C84H135N6O61X,,,de-Fuc form of PA6,,de-Fuc form of PA6,,,,,2016-11-22T15:12:01Z,,946,,,,,,s2l2n2m2masn,,,http://vmh.uni.lu/_api/metabolites/946/?format=pcsv
sel,,,-2,O4Se,CHEBI:18170,,selenate,,selenate,,,"InChI=1S/H2O4Se/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",C05697,2016-11-22T15:12:01Z,,947,,,,,1089,,,,http://vmh.uni.lu/_api/metabolites/947/?format=pcsv
ser_D,,,0,C3H7NO3,CHEBI:16523,,"Human Metabolome Database (HMDB): D-Serine is a non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from glycine or threonine. It is involved in the biosynthesis of purines, pyrimidines, and other amino acids. As a constituent (residue) of proteins, its side chain can undergo O-linked glycosylation. This might be important in explaining some of the devastating consequences of diabetes. It is one of three amino acid residues that are commonly phosphorylated by kinases during cell signalling in eukaryotes. Phosphorylated serine residues are often referred to as phosphoserine. Serine proteases are a common type of protease. Serine (IPA [sejin]), organic compound, one of the 20 amino acids commonly found in animal proteins. Only the L-stereoisomer appears in mammalian protein. It is not essential to the human diet, since it can be synthesized in the body from other metabolites, including glycine. Serine was first obtained from silk protein, a particularly rich source, in 1865. Its name is derived from the Latin for silk, sericum. Serine's structure was established in 1902.",,D-serine,,HMDB03406,"InChI=1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m1/s1",C00740,2016-12-05T15:48:05Z,,948,,,,,71077,ser_D,,"(2R)-2-amino-3-hydroxypropanoate, (2R)-2-amino-3-hydroxypropanoic acid, (R)-2-amino-3-hydroxypropanoate, (R)-2-amino-3-hydroxypropanoic acid, D-Serin, DL-Serine, DSN, Serine D-form",http://vmh.uni.lu/_api/metabolites/948/?format=pcsv
sl_L,,,-2,C3H4O6S,CHEBI:16712,,(S)-3-sulfonatolactate(2-),,(S)-3-sulfonatolactate(2-),,,"InChI=1S/C3H6O6S/c4-2(3(5)6)1-10(7,8)9/h2,4H,1H2,(H,5,6)(H,7,8,9)/p-2/t2-/m1/s1",C11499,2016-11-22T15:12:01Z,,949,,,,,443233,sl_L,,,http://vmh.uni.lu/_api/metabolites/949/?format=pcsv
spc_hs,,,1,C23H50N2O5P,,,sphingosylphosphorylcholine,,sphingosylphosphorylcholine,,,"InChI=1S/C23H49N2O5P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(26)22(24)21-30-31(27,28)29-20-19-25(2,3)4/h17-18,22-23,26H,5-16,19-21,24H2,1-4H3/b18-17+/t22-,23+/m1/s1",C03640,2016-11-22T15:12:01Z,,950,,,,,5311445,spc_hs,,,http://vmh.uni.lu/_api/metabolites/950/?format=pcsv
sph1p,,,-1,C18H39NO5P,CHEBI:16893,,"(2S,3R)-2-azaniumyl-3-hydroxyoctadecyl phosphate",,"(2S,3R)-2-azaniumyl-3-hydroxyoctadecyl phosphate",,,"InChI=1S/C18H40NO5P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(20)17(19)16-24-25(21,22)23/h17-18,20H,2-16,19H2,1H3,(H2,21,22,23)/p-1/t17-,18+/m0/s1",C01120,2016-11-22T15:12:01Z,,951,,,,,644260,sph1p,,,http://vmh.uni.lu/_api/metabolites/951/?format=pcsv
sphs1p,,,-1,C18H37NO5P,CHEBI:37550,,sphingosine 1-phosphate(1-),,sphingosine 1-phosphate(1-),,,"InChI=1S/C18H38NO5P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(20)17(19)16-24-25(21,22)23/h14-15,17-18,20H,2-13,16,19H2,1H3,(H2,21,22,23)/p-1/b15-14+/t17-,18+/m0/s1",C06124,2016-11-22T15:12:01Z,,952,,,,,5353956,sphs1p,,,http://vmh.uni.lu/_api/metabolites/952/?format=pcsv
strdnc,,,-1,C18H27O2,CHEBI:32389,,"Human Metabolome Database (HMDB): Stearidonic acid is found in dietary plant oils which are metabolized to longer-chain, more unsaturated (n-3) PUFA. These oils appear to possess hypotriglyceridemic properties typically associated with fish oils.(PMID: 15173404). Stearidonic acid may be used as a precursor to increase the EPA content of human lipids and that combinations of gamma-linolenic acid and stearidonic acid eicosapentaenoic acid can be used to manipulate the fatty acid compositions of lipid pools in subtle ways. Such effects may offer new strategies for manipulation of cell composition in order to influence cellular responses and functions in desirable ways. (PMID: 15120716).",,"stearidonic acid C18:4, n-3",,HMDB06547,"InChI=1/C18H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10,12-13H,2,5,8,11,14-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-,13-12-",C16300,2016-12-05T15:48:05Z,,953,,,,,163841,strdnc,,"6,9,12,15-Octadecatetraenoate, 6,9,12,15-Octadecatetraenoic acid, Stearidonic acid, Stearidonic acid C18:4",http://vmh.uni.lu/_api/metabolites/953/?format=pcsv
sucr,,,0,C12H22O11,CHEBI:17992,,"Human Metabolome Database (HMDB): Sucrose is a nonreducing disaccharide composed of glucose and fructose linked via their anomeric carbons. It is obtained commercially from sugarcane, sugar beet (beta vulgaris), and other plants and used extensively as a food and a sweetener. Sucrose is derived by crushing and extraction of sugarcane (Saccharum officinarum) with water or extraction of the sugar beet (Beta vulgaris) with water, evaporating, and purifying with lime, carbon, and various liquids. Sucrose is also obtainable from sorghum. Sucrose occurs in low percentages in honey and maple syrup. Sucrose is used as a sweetener in foods and soft drinks, in the manufacture of syrups, in invert sugar, confectionery, preserves and jams, demulcent, pharmaceutical products, and caramel. Sucrose is also a chemical intermediate for detergents, emulsifying agents, and other sucrose derivatives. Sucrose is wiidespread in seeds, leaves, fruits, flowers and roots of plants, where it functions as an energy store for metabolism and as a carbon source for biosynthesis. The annual world production of sucrose is in excess of 90 million tons mainly from the juice of sugar cane (20%) and sugar beet (17%). In addition to its use as a sweetner, sucrose is used in food products as a preservative, antioxidant, moisture control agent, stabilizer and thickening agent.",,Sucrose,,HMDB00258,"InChI=1S/C12H22O11/c13-1-4-6(16)8(18)9(19)11(21-4)23-12(3-15)10(20)7(17)5(2-14)22-12/h4-11,13-20H,1-3H2/t4-,5-,6-,7-,8+,9-,10+,11-,12+/m1/s1",C00089,2016-12-05T15:48:05Z,,954,,,,,5988,sucr,,"(+)-Sucrose, b -D-Fructofuranosyl a-D-glucopyranoside, D-(+)-Saccharose, D-(+)-Sucrose, D-Sucrose, Saccharose, Saccharum, Sucrose, Sugar, Table sugar, White sugar",http://vmh.uni.lu/_api/metabolites/954/?format=pcsv
tagat_D,,,0,C6H12O6,CHEBI:4249,,"Human Metabolome Database (HMDB): D-Tagatose, a rare natural hexoketose, is an isomer of d-galactose. D-Tagatose occurs naturally in Sterculia setigera gum, and it is also found in small quantities in various foods such as sterilized and powdered cow's milk, hot cocoa, and a variety of cheeses, yogurts, and other dairy products. It can be synthesized from D-galactose by isomerization under alkaline conditions in the presence of calcium. D-Tagatose have numerous health benefits, including promotion of weight loss, no glycemic effect, anti-plaque, non-cariogenic, anti-halitosis, prebiotic, and anti-biofilm properties, organ transplants, enhancement of flavor, improvement of pregnancy and fetal development, treatment of obesity, and reduction in symptoms associated with type 2 diabetes, hyperglycemia, anemia, and hemophilia. (PMID: 17492284).",,D-tagatose,,HMDB03418,,C00795,2016-12-05T15:48:05Z,,955,,,,,92092,tagat_D,,"D-Lyxo-2-Hexulose, D-Lyxo-hex-2-ulose, D-Tag, D-Tagatose, Lyxo-2-Hexulose, Lyxo-Hexulose, Tagatose",http://vmh.uni.lu/_api/metabolites/955/?format=pcsv
taxol,,,0,C47H31NO14,CHEBI:45863,,paclitaxel,,paclitaxel,,,"InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1",C07394,2016-11-22T15:12:01Z,,956,,,,,36314,,,,http://vmh.uni.lu/_api/metabolites/956/?format=pcsv
tcynt,,,-1,CNS,CHEBI:18022,,"Human Metabolome Database (HMDB): Thiocyanate is analogous to the cyanate ion, [OCN]-, wherein oxygen is replaced by sulfur. [SCN]- is one of the pseudohalogens, due to the similarity of its reactions to that of halide ions. Thiocyanate was formerly known as rhodanide (from a Greek word for rose) because of the red color of its complexes with iron. Thiocyanates are typically colorless. Cyanide ions can react with cystine to yield thicocyanate. This reaction occurs to a slight extent even in neutral solution, but is more pronounced in alkaline solutions of cystine. In addition to this non-enzymatic route, cyanide produced in vivo can be converted in part to thiocyanate by sulfur transferase systems. The thiocyanate ion can be oxidized at acid pH by hydrogen peroxide to generate sulfate and cyanide. The reaction is catalyzed by hemoglobin acting as a peroxidase.",,thiocyanate,,HMDB01453,InChI=1S/CHNS/c2-1-3/h3H/p-1,C01755,2016-12-05T15:48:05Z,,957,,,,,781,tcynt,," Rhodanide,  SCN, Ammonium rhodanate, Ammonium rhodanide, Ammonium sulfocyanate, HSCN, Hydrogen thiocyanate, Nitridosulfanidocarbon, Rhodanid, Silver thiocyanate agscn, Thallium thiocyanate, Thiocyanate ion, Thiocyanic acid, Thiocyanid, Weedazol TL",http://vmh.uni.lu/_api/metabolites/957/?format=pcsv
tdchola,,,0,C26H45NO6S,CHEBI:16525,,"Human Metabolome Database (HMDB): Taurochenodesoxycholic acid is a bile acid formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",,taurochenodeoxycholate,,HMDB00951,"InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22-,24+,25+,26-/m1/s1",C05465,2016-12-05T15:48:05Z,,958,,,,,387316,tdchola,,"12-Deoxycholyltaurine, 12-Desoxycholyltaurine, 3a,7a-Dihydroxy-N-(2-sulfoethyl)-5b-cholan-24-amide, Chenodeoxycholyltaurine, Chenyltaurine, N-(3a,7a-Dihydroxy-5b-cholan-24-oyl)-Taurine, Taurochenodeoxycholate, Taurochenodeoxycholic acid, Taurochenodesoxycholate, Taurochenodesoxycholic acid",http://vmh.uni.lu/_api/metabolites/958/?format=pcsv
tethex3,,,-1,C24H35O2,,,"Human Metabolome Database (HMDB): 6,9,12,15,18,21-Tetracosahexaenoic acid (24:6n-3) is one of the n-3 PUFA and is a very long chain fatty acid. Distribution of 24:6n-3 in marine organisms was investigated by several researchers. Takagi et al. reported relatively high contents of 24:6n-3 in sea lilies and brittle stars (4&#8211;10% of total fatty acids). High 24:6n-3 content was also found in marine coelenterates. In some edible fishes, 24:6n-3 was detected at significant levels (0&#8211;10% of total fatty acids).The existence of 24:6n-3 in mammalian tissues was reported with other very long chain fatty acids in the spermatozoa,the retina, and the brain. Voss et al. reported that 24:6n-3 is formed as an intermediate in the metabolic pathway from 20:5n-3 to 22:6n-3 in rat liver. Even though 24:6n-3 is a PUFA existing in fish and mammalian species, physiological functions of 24:6n-3 have not been studied. As functions to be studied, anti-inflammatory and antiallergic. effects of 24:6n-3 are noteworthy because these events are known to be closely related to the unsaturated fatty acid metabolism such as in the arachidonic acid cascade, and 20:5n-3 and 22:6n-3 were reported to suppress inflammatory actions by influencing arachidonic acid metabolism.s24:6n-3 could inhibit the antigen-stimulated production of LT-related compounds as well as other n-3 polyunsaturated fatty acids (PUFA) such as eicosapentaenoic. acid (20:5n-3) and docosahexaenoic acid (22:6n-3), which are major n-3 PUFA in fish oils; 24:6n-3 was also shown to reduce the histamine content in MC/9 cells at 25 uM (27% reduction from the control), and the effect was diminished with increase of the fatty acid concentration (up to 100 uM). These two n-3 PUFA, 20:5n-3 and 22:6n-3, also reduced the histamine content (16 and 20% reduction at 25 &#956;M, respectively), whereas arachidonic acid (20:4n-6) increased it (18% increase at 25 &#956;M). ",,"tetracosahexaenoic acid, n-3",,HMDB13025,"InChI=1/C24H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26/h3-4,6-7,9-10,12-13,15-18H,2,5,8,11,14,19-23H2,1H3,(H,25,26)/b4-3-,7-6-,10-9-,13-12-,16-15-,18-17-",,2016-12-05T15:48:05Z,,959,,,,,11792612,tethex3,,"6Z,9Z,12Z,15Z,18Z,21Z-Tetracosahexaenoate, 6Z,9Z,12Z,15Z,18Z,21Z-Tetracosahexaenoic acid, 6Z,9Z,12Z,15Z,18Z,21Z-Tetracosahexaenoic acid anion, All-cis-6,9,12,15,18,21-tetracosahexaenoate, All-cis-6,9,12,15,18,21-tetracosahexaenoic acid, C 24:6 (N-3), Nisinate, Nisinic acid anion",http://vmh.uni.lu/_api/metabolites/959/?format=pcsv
tetpent3,,,-1,C24H37O2,,,"tetracosapentaenoic acid, n-3",,"tetracosapentaenoic acid, n-3",,,"InChI=1/C24H38O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-23H2,1H3,(H,25,26)/b4-3-,7-6-,10-9-,13-12-,16-15-",,2016-11-22T15:12:01Z,,960,,,,,52921801,tetpent3,,,http://vmh.uni.lu/_api/metabolites/960/?format=pcsv
tetpent6,,,-1,C24H37O2,,,"tetracosapentaenoic acid, n-6",,"tetracosapentaenoic acid, n-6",,,"InChI=1/C24H38O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26/h6-7,9-10,12-13,15-16,18-19H,2-5,8,11,14,17,20-23H2,1H3,(H,25,26)/b7-6-,10-9-,13-12-,16-15-,19-18-",,2016-11-22T15:12:01Z,,961,,,,,14505435,tetpent6,,,http://vmh.uni.lu/_api/metabolites/961/?format=pcsv
tettet6,,,-1,C24H39O2,,,tetracosatetraenoic acid n-6,,tetracosatetraenoic acid n-6,,,"InChI=1/C24H40O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26/h16-23H,2-15H2,1H3,(H,25,26)/b17-16+,19-18+,21-20+,23-22+",,2016-11-22T15:12:01Z,,962,,,,,152972,tettet6,,,http://vmh.uni.lu/_api/metabolites/962/?format=pcsv
thm,,,1,C12H17N4OS,CHEBI:18385,,"Human Metabolome Database (HMDB): Thiamine or thiamin, also known as vitamin B1, is a colorless compound with the chemical formula C12H17N4OS. It is soluble in water and insoluble in alcohol. Thiamine decomposes if heated. Thiamine was first discovered by Umetaro Suzuki in Japan when researching how rice bran cured patients of Beriberi. Thiamine plays a key role in intracellular glucose metabolism and it is thought that thiamine inhibits the effect of glucose and insulin on arterial smooth muscle cell proliferation. thiamine plays an important role in helping the body convert carbohydrates and fat into energy. It is essential for normal growth and development and helps to maintain proper functioning of the heart and the nervous and digestive systems. Thiamine cannot be stored in the body; however, once absorbed, the vitamin is concentrated in muscle tissue.",,Thiamin,,HMDB00235,"InChI=1S/C12H17N4OS/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15)/q+1",C00378,2016-12-05T15:48:05Z,,963,,,,,1130,thm,,"Aneurin, Antiberiberi factor, Apate drops, Beatine, Bedome, Begiolan, Benerva, Bequin, Berin, Betalin S, Betaxin, Bethiazine, Beuion, Bevitex, Bevitine, Bewon, Biamine, Bithiamin, Biuno, Bivatin, Bivita, Cernevit-12, Clotiamina, Eskapen, Eskaphen, Hybee, Lixa-beta, Metabolin, Slowten, THD, Thiadoxine, Thiamin, Thiaminal, Thiaminium, Thiamol, Thiavit, Tiamidon, Tiaminal, Trophite, Vetalin S, VIB, Vinothiam, Vitamin B1, Vitaneuron",http://vmh.uni.lu/_api/metabolites/963/?format=pcsv
thmmp,,,-1,C12H16N4O4PS,CHEBI:9533,,"Human Metabolome Database (HMDB): Thiamine monophosphate is a thiamine derivative. It is a monophosphate ester of thiamine. Thiamine monophosphate (ThMP) is one of the five known natural thiamine phosphate derivatives. Thiamine (vitamin B1) is the transport form of the vitamin, while the phosphorylated derivatives are the active forms. There is no known physiological role of thiamine monophosphate.",,Thiamin monophosphate,,HMDB02666,"InChI=1S/C12H17N4O4PS/c1-8-11(3-4-20-21(17,18)19)22-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7H,3-4,6H2,1-2H3,(H3-,13,14,15,17,18,19)/p-1",C01081,2016-12-05T15:48:05Z,,964,,,,,3382778,thmmp,,"Aneurin-monophosphorsaeureester, Aneurine monophosphate, Monofosfotiamina, Monophosphoric ester of thiamine, Monophosphothiamine, Monophosphothiaminum, Phosphothiaminum, Thiamin dihydrogenphosphate, Thiamin monophosphate, Thiamin phosphate, Thiamine monophosphate, Thiamine monophosphate dihydrate, Thiamine phosphate, Tiamina monofosfato, TMP",http://vmh.uni.lu/_api/metabolites/964/?format=pcsv
thmtp,,,-3,C12H16N4O10P3S,CHEBI:9534,,thiamine(1+) triphosphate(4-),,thiamine(1+) triphosphate(4-),,,"InChI=1S/C12H19N4O10P3S/c1-8-11(30-7-16(8)6-10-5-14-9(2)15-12(10)13)3-4-24-28(20,21)26-29(22,23)25-27(17,18)19/h5,7H,3-4,6H2,1-2H3,(H5-,13,14,15,17,18,19,20,21,22,23)/p-3",C03028,2016-11-22T15:12:01Z,,965,,,,,511,thmtp,,,http://vmh.uni.lu/_api/metabolites/965/?format=pcsv
thymd,,,0,C10H14N2O5,CHEBI:17748,,"Human Metabolome Database (HMDB): Thymidine is non-toxic and is a naturally occurring compound that exists in all living organisms and DNA viruses. 25% of DNA is composed of thymidine. RNA does not have thymidine and has uridine instead. Thymidine is a chemical compound which is a pyrimidine nucleoside. Thymidine is the DNA base T, which pairs with adenosine in double stranded DNA.",,Thymidine,,HMDB00273,"InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m0/s1",C00214,2016-12-05T15:48:05Z,,966,,,,,5789,thymd,,"1-(2-Deoxy-b-D-erythro-pentofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione, 1-(2-Deoxy-beta-delta-erythro-pentofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione, 1-[4-Hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione, 2'-Deoxy-5-methyl-Uridine, 2'-Deoxythymidine, 5-Methyl-2'-deoxyuridine, 5-Methyldeoxyuridine, Deoxyribothymidine, Deoxythymidine, DT, DThyd, Thymidin, Thymidine, Thymine 2-desoxyriboside, Thymine deoxyriboside, Thymine-1 2-deoxy-b-D-Ribofuranoside, Thymine-1 2-deoxy-beta-delta-Ribofuranoside",http://vmh.uni.lu/_api/metabolites/966/?format=pcsv
thyox_L,,,0,C15H11I4NO4,CHEBI:18332,,"Human Metabolome Database (HMDB): The thyronamines function via some unknown mechanism to inhibit neuronal activity; this plays an important role in the hibernation cycles of mammals. One effect of administering the thyronamines is a severe drop in body temperature. Iodide is actively absorbed from the bloodstream and concentrated in the thyroid follicles. (If there is a deficiency of dietary iodine, the thyroid enlarges in an attempt to trap more iodine, resulting in goitre.) Via a reaction with the enzyme thyroperoxidase, iodine is covalently bound to tyrosine residues in the thyroglobulin molecules, forming monoiodotyrosine (MIT) and diiodotyrosine (DIT). Linking two moieties of DIT produces thyroxine. Combining one particle of MIT and one particle of DIT produces triiodothyronine. Both T3 and T4 are used to treat thyroid hormone deficiency (hypothyroidism). They are both absorbed well by the gut, so can be given orally. Levothyroxine, the most commonly used synthetic thyroxine form, is a stereoisomer of physiological thyroxine, which is metabolized more slowly and hence usually only needs once-daily administration. Natural desiccated thyroid hormones, which are derived from pig thyroid glands, are a ""natural"" hypothyroid treatment containing 20% T3 and traces of T2, T1 and calcitonin. this plays an important role in the hibernation cycles of mammals. One effect of administering the thyronamines is a severe drop in body temperature. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (monoiodotyrosine) and the coupling of iodotyrosines (diiodotyrosine) in the thyroglobulin. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form triiodothyronine which exerts a broad spectrum of stimulatory effects on cell metabolism. The thyronamines function via some unknown mechanism to inhibit neuronal activity.",,L-thyroxine,,HMDB00248,"InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1",C01829,2016-12-05T15:48:05Z,,967,,,,,5819,thyox_L,,"(-)-Thyroxine, 3,3',5,5''-Tetraiodo-L-thyronine, 3,3',5,5'-Tetraiodo-L-thyronine, 3,5,3',5'-Tetraiodo-L-Thyronine, 3,5,3',5'-Tetraiodothyronine, 3,5,3'5'-Tetraiodo-L-thyronine, D-Thyroxine, DL-Thyroxin, Henning, L-3,5,3',5'-Tetraiodothyronine, L-Thyroxin, L-Thyroxine, Laevothyroxinum, Levothroid, Levothyroxin, Levothyroxine, Levothyroxine sodium, Levothyroxinum, Levoxyl, Prestwick_548, Synthroid, T4, Tetraiodothyronine, Tetramet, THX, Thyratabs, Thyrax, Thyreoideum, Thyroxin, Thyroxinal, Thyroxine, Thyroxine I 125, Thyroxine iodine",http://vmh.uni.lu/_api/metabolites/967/?format=pcsv
tmndnc,,,-1,C20H29O2,CHEBI:28364,,"Human Metabolome Database (HMDB): Eicosapentaenoic acid (EPA or also icosapentaenoic acid) is an important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families. Eicosapentaenoic acid is an omega-3 fatty acid. In physiological literature, it is given the name 20:5(n-3). Its systematic chemical name is all-cis-5,8,11,14,17-icosapentaenoic acid. It also has the trivial name timnodonic acid. Chemically, EPA is a carboxylic acid with a 20-carbon chain and five cis double bonds; the first double bond is located at the third carbon from the omega end. Because of the presence of double bonds, EPS is a polyunsaturated fatty acid. Metabolically it acts as a precursor for prostaglandin-3 (which inhibits platelet aggregation), thromboxane-3 and leukotriene-5 groups. It is found in fish oils of cod liver, herring, mackerel, salmon, menhaden and sardine. It is also found in human breast milk. -- Wikipedia.",,"timnodonic acid C20:5, n-3",,HMDB01999,"InChI=1/C20H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-19H2,1H3,(H,21,22)/b4-3-,7-6-,10-9-,13-12-,16-15-",C06428,2016-12-05T15:48:05Z,,968,,,,,3209,tmndnc,,"(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate, (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid, 5,8,11,14,17-Eicosapentaenoate, 5,8,11,14,17-Eicosapentaenoic acid, 5,8,11,14,17-Icosapentaenoate, 5,8,11,14,17-Icosapentaenoic acid, 5Z,8Z,11Z,14Z,17Z-Eicosapentaenoate, 5Z,8Z,11Z,14Z,17Z-Eicosapentaenoic acid, All-cis-icosapentaenoate, All-cis-icosapentaenoic acid, cis-5,8,11,14,17-Eicosapentaenoate, cis-5,8,11,14,17-Eicosapentaenoic acid, Eicosapentaenoate, Eicosapentaenoic acid, EPA, Icosapent, Icosapentaenoate, Icosapentaenoic acid, Icosapento, Icosapentum, Timnodonate, Timnodonic acid",http://vmh.uni.lu/_api/metabolites/968/?format=pcsv
tolbutamide,,,0,C12H18N2O3S,CHEBI:27999,,tolbutamide,,tolbutamide,,,"InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)",C07148,2016-11-22T15:12:01Z,,969,,,,,5505,tolbutamide,,,http://vmh.uni.lu/_api/metabolites/969/?format=pcsv
tre,,,0,C12H22O11,CHEBI:16551,,Trehalose,,Trehalose,,,"InChI=1S/C12H22O11/c13-1-3-5(15)7(17)9(19)11(21-3)23-12-10(20)8(18)6(16)4(2-14)22-12/h3-20H,1-2H2/t3-,4-,5-,6-,7+,8+,9-,10-,11-,12-/m1/s1",C01083,2016-11-22T15:12:01Z,,970,,,,,7427,tre,,,http://vmh.uni.lu/_api/metabolites/970/?format=pcsv
triodthy,,,0,C15H12I3NO4,CHEBI:18258,,"Human Metabolome Database (HMDB): Liothyronine is a T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. Mildly toxic by ingestion. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx, I(-), and Cl(-). (Sax's Dangerous Properties of Industrial Materials).",,"3,3',5-triiodo-L-thyronine",,HMDB00265,"InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1",C02465,2016-12-05T15:48:05Z,,971,,,,,5920,triodthy,,"3,3',5'-Triiodo-L-thyronine, 3,3',5'-Triiodothyronine, 3,3',5-Triiodo-L-thyronine, 3,3',5-Triiodothyronine, 3,5,3'-Triiodothyronine, 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine, Cyronine, L-3,3',5-Triiodo-Thyronine, L-3,3',5-Triiodothyronine, L-3-[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]-Alanine, L-Liothyronine, L-T3, L-Triiodothyronine, Liothyronin, Liothyronine, O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-Tyrosine, T3, Tresitope, Triiodo-L-thyronine, Triiodothyronine",http://vmh.uni.lu/_api/metabolites/971/?format=pcsv
triodthysuf,,,-1,C15H11I3NO7S,CHEBI:35432,,Triiodothyronine sulfate,,Triiodothyronine sulfate,,,"InChI=1S/C15H12I3NO7S/c16-9-6-8(1-2-13(9)26-27(22,23)24)25-14-10(17)3-7(4-11(14)18)5-12(19)15(20)21/h1-4,6,12H,5,19H2,(H,20,21)(H,22,23,24)/t12-/m0/s1",,2016-11-22T15:12:01Z,,972,,,,,122196,triodthysuf,,,http://vmh.uni.lu/_api/metabolites/972/?format=pcsv
trp_L,,,0,C11H12N2O2,CHEBI:16828,,"Human Metabolome Database (HMDB): Tryptophan is an essential amino acid which is the precursor of serotonin. Serotonin is a brain neurotransmitter, platelet clotting factor and neurohormone found in organs throughout the body. Metabolism of tryptophan to serotonin requires nutrients such as vitamin B6, niacin and glutathione. Niacin is an important metabolite of tryptophan. High corn or other tryptophan-deficient diets can cause pellagra, which is a niacin-tryptophan deficiency disease with symptoms of dermatitis, diarrhea and dementia. Inborn errors of tryptophan metabolism exist where a tumor (carcinoid) makes excess serotonin. Hartnup's disease is a disease where tryptophan and other amino acids are not absorbed properly. Tryptophan supplements may be useful in each condition, in carcinoid replacing the over-metabolized nutrient and in Hartnup's supplementing a malabsorbed nutrient. Some disorders of excess tryptophan in the blood may contribute to mental retardation. Assessment of tryptophan deficiency is done through studying excretion of tryptophan metabolites in the urine or blood. Blood may be the most sensitive test because the amino acid tryptophan is transported in a unique way. Increased urination of tryptophan fragments correlates with increased tryptophan degradation, which occurs with oral contraception, depression, mental retardation, hypertension and anxiety states. The requirement for tryptophan and protein decreases with age. Adults' minimum daily requirement is 3 mg/kg/day or about 200 mg a day. This may be an underestimation, for there are 400 mg of tryptophan in just a cup of wheat germ. A cup of low fat cottage cheese contains 300 mg of tryptophan and chicken and turkey contain up to 600 mg per pound. (http://www.dcnutrition.com).",,L-tryptophan,,HMDB00929,"InChI=1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m0/s1",C00078,2016-12-05T15:48:05Z,,973,,,,,6305,trp_L,,"(-)-tryptophan, (2S)-2-amino-3-(1H-indol-3-yl)propanoate, (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid, (L)-tryptophan, (S)-1H-Indole-3-alanine, (S)-2-Amino-3-(3-indolyl)propionic acid, (S)-a-Amino-1H-indole-3-propanoate, (S)-a-Amino-1H-indole-3-propanoic acid, (S)-a-amino-b-indolepropionate, (S)-a-amino-b-indolepropionic acid, (S)-a-Aminoindole-3-propionate, (S)-a-Aminoindole-3-propionic acid, (S)-alpha-Amino-1H-indole-3-propanoate, (S)-alpha-Amino-1H-indole-3-propanoic acid, (S)-alpha-Amino-beta-(3-indolyl)-propionic acid, (S)-alpha-amino-beta-indolepropionate, (S)-alpha-amino-beta-indolepropionic acid, (S)-alpha-Aminoindole-3-propionate, (S)-alpha-Aminoindole-3-propionic acid, (S)-tryptophan, 1-beta-3-Indolylalanine, 1beta-3-Indolylalanine, 1H-Indole-3-Alanine, 2-Amino-3-indolylpropanoate, 2-Amino-3-indolylpropanoic acid, 3-(1H-Indol-3-yl)-L-Alanine, 3-Indol-3-ylalanine, alpha'-Amino-3-indolepropionic acid, alpha-Aminoindole-3-propionic acid, Ardeytropin, H-TRP-oh, Indole-3-alanine, Kalma, L-(-)-Tryptophan, L-alpha-Amino-3-indolepropionic acid, L-alpha-Aminoindole-3-propionic acid, L-b-3-Indolylalanine, L-beta-3-Indolylalanine, L-Tryptofan, L-Tryptophan, L-Tryptophane, Lopac-T-0254, Lyphan, Optimax, Pacitron, Sedanoct, Triptofano, Trofan, Tryptacin, Tryptan, Tryptophan, Tryptophane, Tryptophanum",http://vmh.uni.lu/_api/metabolites/973/?format=pcsv
tststerone,,,0,C19H28O2,CHEBI:17347,,"Human Metabolome Database (HMDB): Testosterone is the most important androgen in potency and quantity. Testosterone is synthesized and released by the Leydig cells that lie between the tubules and comprise less than 5% of the total testicular volume. testosterone diffuses into the seminiferous tubules where it is essential for maintaining spermatogenesis. Some binds to an androgen-binding protein (ABP) that is produced by the Sertoli cells and is homologous to the sex-hormone binding globulin that transports testosterone in the general circulation. The ABP carries testosterone in the testicular fluid where it maintains the activity of the accessory sex glands and may also help to retain testosterone within the tubule and bind excess free hormone. Some testosterone is converted to estradiol by Sertoli cell-derived aromatase enzyme. Leydig cell steroidogenesis is controlled primarily by luteinizing hormone with negative feedback of testosterone on the hypothalamic-pituitary axis. The requirement of spermatogenesis for high local concentrations of testosterone means that loss of androgen production is likely to be accompanied by loss of spermatogenesis. Indeed, if testicular androgen production is inhibited by the administration of exogenous androgens then spermatogenesis ceases. This is the basis of using exogenous testosterone as a male contraceptive. testosterone is converted to dihydrotestosterone by 5a-reductase type 2 (EC 1.3.1.22, SRD5A2), the androgen with the highest affinity for the androgen receptor. SRD5A2 deficiency illustrates the importance of dihydrotestosterone for external virilization, as individuals with this condition have normal male internal structures but their external genitalia are of female appearance. There is now clear evidence that the human fetal testis and also the fetal adrenal gland is capable of testosterone biosynthesis during the first trimester. Regardless of the source of androgen production, the target tissue responds by male sexual differentiation of the external genitalia by the end of the first trimester. It is clear that testicular damage may result in loss of testosterone production or the loss of spermatogenesis or both. Loss of androgen production results in hypogonadism, the symptoms of which reflect the functions of testosterone. Male hypogonadism is defined as failure of the testes to produce normal amounts of testosterone, combined with signs and symptoms of androgen deficiency. Systemic testosterone levels fall by about 1% each year in men. Therefore, with increasing longevity and the aging of the population, the number of older men with testosterone deficiency will increase substantially over the next several decades. Serum testosterone levels decrease progressively in aging men, but the rate and magnitude of decrease vary considerably. Approximately 1% of healthy young men have total serum testosterone levels below normal; in contrast, approximately 20% of healthy men over age 60 years have serum testosterone levels below normal. (PMID: 17904450, 17875487).",,testosterone,,HMDB00234,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",C00535,2016-12-05T15:48:05Z,,974,,,,,6013,tststerone,,"(+)-testosterone, (+-)-8-iso-testosterone, (+-)-retrotestosterone, (+-)-testosterone, (17b)-17-hydroxy-androst-4-en-3-one, 13-Iso-testosterone, 17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one, 17-Hydroxy-androst-4-en-3-one, 17-Hydroxy-D4-androsten-3-one, 17a-Hydroxy-(13a)-androst-4-en-3-one, 17a-Hydroxy-13a-androst-4-en-3-one, 17a-Hydroxy-14b-androst-4-en-3-one, 17a-Hydroxy-androst-4-en-3-one, 17b-Hydroxy-(10a)-androst-4-en-3-one, 17b-Hydroxy-(13a)-androst-4-en-3-one, 17b-Hydroxy-(8a)-androst-4-en-3-one, 17b-Hydroxy-(8a,10a)-androst-4-en-3-one, 17b-Hydroxy-(9b)-androst-4-en-3-one, 17b-Hydroxy-(9b,10a)-androst-4-en-3-one, 17b-Hydroxy-13a-androst-4-en-3-one, 17b-Hydroxy-8a-androst-4-en-3-one, 17b-Hydroxy-androst-4-en-3-on, 17b-Hydroxy-androst-4-en-3-one, 17b-Hydroxy-D4-androsten-3-one, 17b-Hydroxyandrost-4-en-3-one, 17b-Hydroxyandrost-4-ene-3-one, 17b-Testosterone, 4-Androsten-3-one-17b-ol, 8-Iso-testosterone, 9b,10a-Testosterone, 9b-Testosterone, Androderm, AndroGel, Androlin, Andronaq, Andropatch, Androst-4-en-17b-ol-3-one, Androst-4-ene-17b-ol-3-one, Andrusol, Cristerona T, D4-Androsten-17b-ol-3-one, Epitestosteron, Geno-cristaux Gremy, Homosteron, Homosterone, Lumitestosteron, Mertestate, Neotestis, Oreton, Orquisteron, Perandren, Percutacrine androgenique, Primotest, Primoteston, Rac-17b-hydroxy-(13a)androst-4-en-3-one, Rac-17b-hydroxy-(8a)-androst-4-en-3-one, Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one, Rac-17b-hydroxy-androst-4-en-3-one, Relibra, Retrotestosterone, Sustanon, Sustanone, Sustason 250, Synandrol F, Teslen, Testandrone, Testiculosterone, Testim, Testobase, Testoderm, Testogel, Testolent, Testolin, Testopropon, Testosteroid, Testosteron, Testoviron Schering, Testoviron T, Testro AQ, Testrone, Testryl, Tostrelle, Tostrex, Viatrel, Virormone, Virosterone",http://vmh.uni.lu/_api/metabolites/974/?format=pcsv
tststeroneglc,,,0,C25H36O8,CHEBI:28835,,"Human Metabolome Database (HMDB): Testosterone glucuronide is a natural human metabolite of testosterone. Testosterone is a steroid hormone from the androgen group. Testosterone is primarily secreted in the testes of males and the ovaries of females although small amounts are secreted by the adrenal glands. It is the principal male sex hormone and an anabolic steroid. In both males and females, it plays key roles in health and well-being. There is a sex difference in the median values of testosterone glucuronide in the amniotic fluid specimens 15-19 wk gestation between female (median 160 pM, range 64-465 pM) and male (median 817 pM, range 68-3707 pM). This difference, when used in conjunction with amniotic fluid unconjugated testosterone values, increase the predictive accuracy of fetal sexing from 95.4 to 98.9%. In human newborns and young infants, urinary testosterone sulfate is higher than glucuronide. The high sulfokinase activity in fetal and neonatal testes is more likely responsible for this phenomenon than an impaired glucuronizing capacity of the liver. Urinary excretion of testosterone glucuronide increases significantly during puberty. The level of testosterone glucuronide exceeds the level of unconjugated testosterone in human seminal plasma. Urinary testosterone glucuronide excretion is increased in women with virilizing adrenocortical tumors. Concentration of testosterone glucuronide in urine from women with breast tumor in urine samples is not different from patients with benign or malignant breast disease, either before or after the menopause. (PMID: 8327267, 3560942, 6246233, 871373, 133773, 947290).",,testosterone 3-glucosiduronic acid,,HMDB03193,"InChI=1S/C25H36O8/c1-24-9-7-13(26)11-12(24)3-4-14-15-5-6-17(25(15,2)10-8-16(14)24)32-23-20(29)18(27)19(28)21(33-23)22(30)31/h11,14-21,23,27-29H,3-10H2,1-2H3,(H,30,31)/t14-,15-,16-,17-,18-,19-,20+,21-,23+,24-,25-/m0/s1",C11134,2016-12-05T15:48:05Z,,975,,,,,108192,tststeroneglc,,"(17b)-3-oxoandrost-4-en-17-yl b-D-Glucopyranosiduronic acid, b-D-3-Oxoandrost-4-en-17b-yl Glucopyranosiduronic acid, b-D-Androstane glucopyranosiduronic acid, Epitestosterone glucuronide, Testosterone 17-glucosiduronate, Testosterone 17-glucuronide, Testosterone 17b-(b-D-glucuronide), Testosterone glucopyranuronoside, Testosterone glucosiduronide, Testosterone glucuronate, Testosterone glucuronoside, Testosterone-glucuronide",http://vmh.uni.lu/_api/metabolites/975/?format=pcsv
tststerones,,,-1,C19H27O5S,,,"Human Metabolome Database (HMDB): Testosterone is a predominantly male hormone, though females do produce certain amounts of it. The primary female hormone is estrogen and males also produce certain amounts of this hormone. testosterone causes the appearance of male traits (i.e deepening voice, pubic and facial hairs, muscular build, etc.). The keto group on C-17 is reduced to an alcohol to yield testosterone. Testosterone is a steroid hormone from the androgen group. testosterone is primarily secreted in the testes of males and the ovaries of females although small amounts are secreted by the adrenal glands. It is the principal male sex hormone and an anabolic steroid. In both males and females, it plays key roles in health and well-being. On average, the adult male body produces about twenty times the amount of testosterone that an adult female's body does. Free testosterone (T) is transported into the cytoplasm of target tissue cells, where it can bind to the androgen receptor, or can be reduced to 5-alpha -dihydrotestosterone (DHT) by the cytoplasmic enzyme 5-alpha-reductase(5-alpha-reduktas). DHT binds to the same androgen receptor even more strongly than T, so that its androgenic potency is about 2.5 times that of T. The T-receptor or DHT-receptor complex undergoes a structural change that allows it to move into the cell nucleus and bind directly to specific nucleotide sequences of the chromosomal DNA. The areas of binding are called hormone response elements (HREs), and influence transcriptional activity of certain genes, producing the androgen effects. It is important to note that if there is a too low amount of 5-alpha-reductase(5-alfa-reduktas), the body (of a human) will continue growing into a female with testicles.",,testosterone sulfate,,HMDB02833,"InChI=1/C19H28O5S/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(24-25(21,22)23)19(15,2)10-8-16(14)18/h11,14-17H,3-10H2,1-2H3,(H,21,22,23)/t14-,15-,16-,17-,18-,19-/m0/s1",,2016-12-05T15:48:05Z,,976,,,,,119207,tststerones,,"17-O-Sulfotestosterone, 17beta-(Sulfooxy)androst-4-en-3-one, Testosterone 17-sulfate, Testosterone 17-sulphate, Testosterone 17b-sulfate, Testosterone 17b-sulphate, Testosterone hydrogen sulfate, Testosterone hydrogen sulphate, Testosterone monosulfate, Testosterone monosulphate, Testosterone sulfate, Testosterone sulphate, Testosterone-17-sulfate, Testosterone-17-sulphate",http://vmh.uni.lu/_api/metabolites/976/?format=pcsv
tsul,,,-2,O3S2,CHEBI:16094,,"Human Metabolome Database (HMDB): Thiosulfate occurs naturally in hot springs and geysers, and is produced by certain biochemical processes. In the body, thiosulfate converts small amounts of cyanide ion into harmless products and plays a role in the biosynthesis of cysteine, a sulfur-containing amino acid that locks proteins into their correct three-dimensional shapes. Thiosulfate is not found in large quantities in nature. Solutions of thiosulfate break down into sulfur, sulfites, and sulfates when exposed to acids, light, metal ions, and bacteria. Thiosulfate is sometimes used as an antidote for cyanide poisoning. It reacts with cyanide to produce sulfite and thiocyanate ions: CN- + S2O32- SCN- + SO32- This reaction is catalyzed by an enzyme produced by cell mitochondria to neutralize small quantities of ingested cyanide (which occurs naturally in cassava root, lima beans, and almonds!). Thiosulfate is an intermediate in several biochemical pathways, including the synthesis of L-cysteine. Thiosulfate is manufactured by some cells by oxidation of elemental sulfur and by degradation of L-cysteine. Use: Photography (fixing agent to dissolve unchanged silver salts from exposed negatives), chrome tanning, removing chlorine in bleaching and papermaking, extraction of silver from its ores, dechlorination of water, mordant, reagent, bleaching, reducing agent in chrome dyeing, sequestrant in salt (up to 0.1%), antidote for cyanide poisoning. (Hawley's Condensed Chemical Dictionary) Source/Synthesis: Synthesis by dehydration of the pentahydrate at 105 degree. Alternatively formed by reaction of S2Cl2 with Na2O2 or by reduction of Na2S2O4 with sodium amalgam Use/Importance: Commercially available Biological Use/Importance: Cyanide antidote often administered with other antidotes, antifungal agent (ChemNetBase) Sodium thiosulfate is a common analytical reagent used in iodometric titration to analyze chlorine, bromine, and sulfide. Other uses are in bleaching paper pulp, bleaching straw, ivory, and bones, for removing chlorine from solutions, silver extraction from its ores, a mordant in dyeing and printing textiles, and as an antidote to cyanide poisoning. Another major application is in photography, where it is used as a fixer to dissolve unchanged silver salts from exposed negatives. (Handbook of Inorganic Chemicals).",,thiosulfate(2-),,HMDB00257,"InChI=1S/H2O3S2/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",C05529,2016-12-05T15:48:05Z,,977,,,,,1084,tsul,,"Hyposulfite, S-Hydril, Sodium hyposulfite, Sodium oxide sulfide (Na2S2O3), Sodium thiosulfate, Sodium thiosulfate (Na2S2O3), Sodium thiosulfate anhydrous, Sodium thiosulphate, Sodium thiosulphate (Na2S2O3), Sodium thiosulphate anhydrous, Sulfactol, Thiosulfate, Thiosulfate ion, Thiosulfuric acid, Thiosulfuric acid (H2S2O3), Thiosulphate, Thiosulphate ion",http://vmh.uni.lu/_api/metabolites/977/?format=pcsv
ttdca,,,-1,C14H27O2,CHEBI:28875,,"Human Metabolome Database (HMDB): Myristic acid is a saturated 14-carbon fatty acid occurring in most animal and vegetable fats, particularly butterfat and coconut, palm, and nutmeg oils. It is used to synthesize flavor and as an ingredient in soaps and cosmetics. (From Dorland, 28th ed). Myristic acid is also commonly added to a penultimate nitrogen terminus glycine in receptor-associated kinases to confer the membrane localisation of the enzyme. this is achieved by the myristic acid having a high enough hydrophobicity to become incorporated into the fatty acyl core of the phospholipid bilayer of the plasma membrane of the eukaryotic cell.(wikipedia).",,tetradecanoate (n-C14:0),,HMDB00806,"InChI=1S/C14H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2-13H2,1H3,(H,15,16)/p-1",C06424,2016-12-05T15:48:05Z,,978,,,,,11005,ttdca,,"1-Tridecanecarboxylate, 1-Tridecanecarboxylic acid, Crodacid, Myristate, Myristic acid, Myristic acid pure, Myristoate, Myristoic acid, N-Tetradecan-1-oate, N-Tetradecan-1-oic acid, N-Tetradecanoate, N-Tetradecanoic acid, Tetradecanoate, Tetradecanoic (Myristic) acid, Tetradecanoic acid",http://vmh.uni.lu/_api/metabolites/978/?format=pcsv
txa2,,,-1,C20H31O5,CHEBI:15627,,"Human Metabolome Database (HMDB): Thromboxane A2 is an unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS).Thromboxanes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,thromboxane A2(1-),,HMDB01452,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18-14-20(24-17)25-18)10-7-4-5-8-11-19(22)23/h4,7,12-13,15-18,20-21H,2-3,5-6,8-11,14H2,1H3,(H,22,23)/p-1/b7-4-,13-12+/t15-,16+,17+,18-,20+/m0/s1",C02198,2016-12-05T15:48:05Z,,979,,,,,5280497,txa2,,"(1S-(1alpha,3alpha,3R*),4beta(Z),5alpha)-7-(3-(3-hydroxy-1-octenyl)-2,6-dioxabicyclo(3.1.1)hept-4-yl)-5-Heptenoate, (1S-(1alpha,3alpha,3R*),4beta(Z),5alpha)-7-(3-(3-hydroxy-1-octenyl)-2,6-dioxabicyclo(3.1.1)hept-4-yl)-5-Heptenoic acid, (5Z)-7-[(1S,3R,4S,5S)-3-[(1E,3S)-3-hydroxy-1-octenyl]-2,6-dioxabicyclo[3.1.1]hept-4-yl]-5-Heptenoate, (5Z)-7-[(1S,3R,4S,5S)-3-[(1E,3S)-3-hydroxy-1-octenyl]-2,6-dioxabicyclo[3.1.1]hept-4-yl]-5-Heptenoic acid, (5Z,13E)-(15S)-9,11-epoxy-15-hydroxythromba-5,13-dienoate, (5Z,13E)-(15S)-9,11-epoxy-15-hydroxythromba-5,13-dienoic acid, (5Z,13E)-(15S)-9-alpha,11-alpha-Epoxy-15-hydroxythromboxa-5,13-dienoate, (5Z,13E)-(15S)-9-alpha,11-alpha-Epoxy-15-hydroxythromboxa-5,13-dienoic acid, (5Z,13E)-(15S)-9a,11a-epoxy-15-Hydroxythromboxa-5,13-dienoate, (5Z,13E)-(15S)-9a,11a-epoxy-15-Hydroxythromboxa-5,13-dienoic acid, (5Z,13E)-(15S)-9alpha,11alpha-epoxy-15-hydroxythromboxa-5,13-dienoate, (5Z,13E)-(15S)-9alpha,11alpha-epoxy-15-hydroxythromboxa-5,13-dienoic acid, (5Z,9alpha,11alpha,13E,15S)-9,11-epoxy-15-hydroxy-Thromboxa-5,13-dien-1-oate, (5Z,9alpha,11alpha,13E,15S)-9,11-epoxy-15-hydroxy-Thromboxa-5,13-dien-1-oic acid, (5Z,9alpha,11alpha,13E,15S)-9,11-Epoxy-15-hydroxythromboxa-5,13-dien-1-oate, (5Z,9alpha,11alpha,13E,15S)-9,11-Epoxy-15-hydroxythromboxa-5,13-dien-1-oic acid, 7-[3-(3-Hydroxy-1-octenyl)-2,6-dioxabicyclo[3.1.1]hept-4-yl]-[1S-[1alpha,3alpha(1E,3R*),4beta(Z),5alpha]]-5-Heptenoate, 7-[3-(3-Hydroxy-1-octenyl)-2,6-dioxabicyclo[3.1.1]hept-4-yl]-[1S-[1alpha,3alpha(1E,3R*),4beta(Z),5alpha]]-5-Heptenoic acid, 9S,11S-Epoxy,15S-hydroxy-thromboxa-5Z,13E-dien-1-oate, 9S,11S-Epoxy,15S-hydroxy-thromboxa-5Z,13E-dien-1-oic acid, Cid, Rabbit aorta contracting substance, RCS, TXA-2, TXA2",http://vmh.uni.lu/_api/metabolites/979/?format=pcsv
tymsf,,,0,C8H11NO4S,,,"Human Metabolome Database (HMDB): Tyramine-O-sulfate is a sulfate derivative of tyramine. Tyramine is formed from the decarboyxlation of tyrosine. Tyramine O-sulfate is found in the urine of patients following an oral load of tyramine with unipolar and bipolar major depressive episode. (PMID: 8432957, 2175186).",,Tyramine O-sulfate,,HMDB06409,"InChI=1/C8H11NO4S/c9-6-5-7-1-3-8(4-2-7)13-14(10,11)12/h1-4H,5-6,9H2,(H,10,11,12)",,2016-12-05T15:48:05Z,,980,,,,,153005,tymsf,,"4-(2-Aminoethyl)-Phenol(hydrogen sulfate) , 4-(2-Aminoethyl)-Phenol(hydrogen sulphate) ",http://vmh.uni.lu/_api/metabolites/980/?format=pcsv
Tyr_ggn,,,0,XOH,,,Tyr-194 of apo-glycogenin protein (primer for glycogen synthesis),,Tyr-194 of apo-glycogenin protein (primer for glycogen synthesis),,,,,2016-11-22T15:12:01Z,,981,,,,,,Tyr_ggn,,,http://vmh.uni.lu/_api/metabolites/981/?format=pcsv
tyr_L,,,0,C9H11NO3,CHEBI:17895,,"Human Metabolome Database (HMDB): Tyrosine is an essential amino acid that readily passes the blood-brain barrier. Once in the brain, it is a precursor for the neurotransmitters dopamine, norepinephrine and epinephrine, better known as adrenalin. These neurotransmitters are an important part of the body's sympathetic nervous system, and their concentrations in the body and brain are directly dependent upon dietary tyrosine. Tyrosine is not found in large concentrations throughout the body, probably because it is rapidly metabolized. Folic acid, copper and vitamin C are cofactor nutrients of these reactions. Tyrosine is also the precursor for hormones, thyroid, catecholestrogens and the major human pigment, melanin. Tyrosine is an important amino acid in many proteins, peptides and even enkephalins, the body's natural pain reliever. Valine and other branched amino acids, and possibly tryptophan and phenylalanine may reduce tyrosine absorption. A number of genetic errors of tyrosine metabolism occur. Most common is the increased amount of tyrosine in the blood of premature infants, which is marked by decreased motor activity, lethargy and poor feeding. Infection and intellectual deficits may occur. Vitamin C supplements reverse the disease. Some adults also develop elevated tyrosine in their blood. This indicates a need for more vitamin C. More tyrosine is needed under stress, and tyrosine supplements prevent the stress-induced depletion of norepinephrine and can cure biochemical depression. However, tyrosine may not be good for psychosis. Many antipsychotic medications apparently function by inhibiting tyrosine metabolism. L-dopa, which is directly used in Parkinson's, is made from tyrosine. Tyrosine, the nutrient, can be used as an adjunct in the treatment of Parkinson's. Peripheral metabolism of tyrosine necessitates large doses of tyrosine, however, compared to L-dopa. (http://www.dcnutrition.com).",,L-tyrosine,,HMDB00158,"InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1",C00082,2016-12-05T15:48:05Z,,982,,,,L-tyrosine,6057,tyr_L,,"(-)-a-Amino-p-hydroxyhydrocinnamate, (-)-a-Amino-p-hydroxyhydrocinnamic acid, (-)-alpha-Amino-p-hydroxyhydrocinnamate, (-)-alpha-Amino-p-hydroxyhydrocinnamic acid, (S)-(-)-Tyrosine, (S)-2-Amino-3-(p-hydroxyphenyl)propionate, (S)-2-Amino-3-(p-hydroxyphenyl)propionic acid, (S)-3-(p-Hydroxyphenyl)alanine, (S)-a-amino-4-hydroxy-Benzenepropanoate, (S)-a-amino-4-hydroxy-Benzenepropanoic acid, (S)-a-Amino-4-hydroxybenzenepropanoate, (S)-a-Amino-4-hydroxybenzenepropanoic acid, (S)-alpha-amino-4-hydroxy-Benzenepropanoate, (S)-alpha-amino-4-hydroxy-Benzenepropanoic acid, (S)-alpha-Amino-4-hydroxybenzenepropanoate, (S)-alpha-Amino-4-hydroxybenzenepropanoic acid, (S)-Tyrosine, 2-Amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-Propanoate, 2-Amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-Propanoic acid, 3-(4-Hydroxyphenyl)-L-alanine, 4-Hydroxy-L-Phenylalanine, Benzenepropanoate, Benzenepropanoic acid, L-p-Tyrosine, L-Tyrosine, p-Tyrosine, Tyr, Tyrosine",http://vmh.uni.lu/_api/metabolites/982/?format=pcsv
ump,,,-2,C9H11N2O9P,CHEBI:16695,,UMP,,UMP,,,"InChI=1S/C9H13N2O9P/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,10,12,15)(H2,16,17,18)/p-2/t4-,6-,7-,8-/m1/s1",C00105,2016-11-22T15:12:02Z,,983,,,,,6030,ump,,,http://vmh.uni.lu/_api/metabolites/983/?format=pcsv
urate,,,0,C5H4N4O3,CHEBI:17775,,"Human Metabolome Database (HMDB): Uric acid is a heterocyclic purine derivative that is the final oxidation product of purine metabolism. It is produced by the enzyme xanthine oxidase, which oxidizes oxypurines such as xanthine into uric acid. In most mammals, except humans and higher primates, the enzyme uricase further oxidizes uric acid to allantoin. Uric acid is also the end product of nitrogen metabolism in birds and reptiles. In such species, it is excreted in feces as a dry mass. Humans produce only small quantities of uric acid with excess accumulation leading to a type of arthritis known as gout. The loss of uricase in higher primates parallels the similar loss of the ability to synthesize ascorbic acid vitamin C. This may be because in higher primates uric acid partially replaces ascorbic acid.",,Urate,,HMDB00289,"InChI=1S/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H4,6,7,8,9,10,11,12)",C00366,2016-12-05T15:48:05Z,,984,,,,,1175,urate,,"1H-Purine-2,6,8-triol, 2,6,8-Trihydroxypurine, 2,6,8-Trioxopurine, 2,6,8-Trioxypurine, Lithate, Lithic acid, Purine-2,6,8(1H,3H,9H)-trione, Urate, Uric acid",http://vmh.uni.lu/_api/metabolites/984/?format=pcsv
vacc,,,-1,C18H33O2,CHEBI:50464,,"Human Metabolome Database (HMDB): Vaccenic acid is present in all tissues. Present in virtually all lipid classes at a low concentration, 18:1n7 is present at about 25% of the concentration of 18:1n9 in most phospholipids. A notable exception is the phospholipid cardiolipin, which often contains as much 18:1n7 as 18:1n9. --www.lipomics.com.",,trans-vaccenate,,HMDB03231,"InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h7-8H,2-6,9-17H2,1H3,(H,19,20)/p-1/b8-7+",C08367,2016-12-05T15:48:05Z,,985,,,,,5281127,vacc,,"(11Z)-Octadecenoate, (11Z)-Octadecenoic acid, (Z)-Octadec-11-enoate, (Z)-Octadec-11-enoic acid, 11-Octadecenoate, 11-Octadecenoic acid, 11Z-Octadecenoate, 11Z-Octadecenoic acid, trans-11-Octadecenoate, trans-11-Octadecenoic acid, Vaccenate",http://vmh.uni.lu/_api/metabolites/985/?format=pcsv
val_L,,,0,C5H11NO2,CHEBI:16414,,"Human Metabolome Database (HMDB): Valine (abbreviated as Val or V) is an -amino acid with the chemical formula HO2CCH(NH2)CH(CH3)2. It is named after the plant valerian. L-Valine is one of 20 proteinogenic amino acids. Its codons are GUU, GUC, GUA, and GUG. This essential amino acid is classified as nonpolar. Along with leucine and isoleucine, valine is a branched-chain amino acid. Branched chain amino acids (BCAA) are essential amino acids whose carbon structure is marked by a branch point. These three amino acids are critical to human life and are particularly involved in stress, energy and muscle metabolism. BCAA supplementation as therapy, both oral and intravenous, in human health and disease holds great promise. ""BCAA"" denotes valine, isoleucine and leucine which are branched chain essential amino acids. Despite their structural similarities, the branched amino acids have different metabolic routes, with valine going solely to carbohydrates, leucine solely to fats and isoleucine to both. The different metabolism accounts for different requirements for these essential amino acids in humans: 12 mg/kg, 14 mg/kg and 16 mg/kg of valine, leucine and isoleucine respectively. Furthermore, these amino acids have different deficiency symptoms. Valine deficiency is marked by neurological defects in the brain, while isoleucine deficiency is marked by muscle tremors. Many types of inborn errors of BCAA metabolism exist, and are marked by various abnormalities. The most common form is the maple syrup urine disease, marked by a characteristic urinary odor. Other abnormalities are associated with a wide range of symptoms, such as mental retardation, ataxia, hypoglycemia, spinal muscle atrophy, rash, vomiting and excessive muscle movement. Most forms of BCAA metabolism errors are corrected by dietary restriction of BCAA and at least one form is correctable by supplementation with 10 mg of biotin daily. BCAA are decreased in patients with liver disease, such as hepatitis, hepatic coma, cirrhosis, extrahepatic biliary atresia or portacaval shunt; aromatic amino acids (AAA)â€”tyrosine, tryptophan and phenylalanine, as well as methionineâ€”are increased in these conditions. Valine in particular, has been established as a useful supplemental therapy to the ailing liver. All the BCAA probably compete with AAA for absorption into the brain. Supplemental BCAA with vitamin B6 and zinc help normalize the BCAA:AAA ratio. (http://www.dcnutrition.com). In sickle-cell disease, valine substitutes for the hydrophilic amino acid glutamic acid in hemoglobin. Because valine is hydrophobic, the hemoglobin does not fold correctly. Valine is an essential amino acid, hence it must be ingested, usually as a component of proteins.",,L-valine,,HMDB00883,"InChI=1S/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8)/t4-/m0/s1",C00183,2016-12-05T15:48:05Z,,986,,,,,6287,val_L,,"(2S)-2-Amino-3-methylbutanoate, (2S)-2-Amino-3-methylbutanoic acid, (S)-2-amino-3-methyl-Butanoate, (S)-2-amino-3-methyl-Butanoic acid, (S)-2-Amino-3-methylbutanoate, (S)-2-Amino-3-methylbutanoic acid, (S)-2-Amino-3-methylbutyrate, (S)-2-Amino-3-methylbutyric acid, (S)-a-Amino-b-methylbutyrate, (S)-a-Amino-b-methylbutyric acid, (S)-alpha-Amino-beta-methylbutyrate, (S)-alpha-Amino-beta-methylbutyric acid, (S)-Valine, 2-Amino-3-methylbutanoate, 2-Amino-3-methylbutanoic acid, 2-Amino-3-methylbutyrate, 2-Amino-3-methylbutyric acid, L-(+)-a-Aminoisovalerate, L-(+)-a-Aminoisovaleric acid, L-(+)-alpha-Aminoisovalerate, L-(+)-alpha-Aminoisovaleric acid, L-a-Amino-b-methylbutyrate, L-a-Amino-b-methylbutyric acid, L-alpha-Amino-beta-methylbutyrate, L-alpha-Amino-beta-methylbutyric acid, L-Valine, Valine",http://vmh.uni.lu/_api/metabolites/986/?format=pcsv
vitd2,,,0,C28H44O,CHEBI:28934,,"Human Metabolome Database (HMDB): Ergocalciferol is a form of Vitamin D, also called vitamin D2. It is created from viosterol, which in turn is created when ultraviolet light activates ergosterol. Ergocalciferol is used in the treatment of hypcalcemia and in dialysis-dependent renal failure. Ergoalcifediol is a fat soluble steroid hormone precursor of vitamin D that contributes to the maintenance of normal levels of calcium and phosphorus in the bloodstream. Vitamin D2 is the form of vitamin D most commonly added to foods and nutritional supplements. Vitamin D2 must be transformed (hydroxylated) into one of two active forms via the liver or kidney. Once transformed, it binds to the vitamin D receptor that then leads to a variety of regulatory roles.",,vitamin D2,,HMDB00900,"InChI=1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1",C05441,2016-12-05T15:48:05Z,,987,,,,,5280793,vitd2,,"(+)-Vitamin D2, (5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol, 22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol, 4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol, 9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol, beta-Ol, Buco-D, Calciferol, Calciferon 2, Condacaps, Condocaps, Condol, Crtron, Crystallina, D-Arthin, D-Tracetten, Daral, Davitamon D, Davitin, De-rat concentrate, Decaps, Dee-Osterol, Dee-Ron, Dee-Ronal, Dee-Roual, delta-Arthin, delta-Tracetten, Deltalin, Deratol, Detalup, Diactol, Divit urto, Doral, Drisdol, Ercalciol, Ergocalciferol, Ergocalciferol oil, Ergorone, Ergosterol activated, Ergosterol irradiated, Ertron, Fortodyl, Geltabs, Hi-Deratol, Infron, Irradiated ergosta-5,7,22-trien-3beta-ol, Metadee, Mina D2, Mulsiferol, Mykostin, Novovitamin-D, Oleovitamin D, Oleovitamin D2, Osteil, Ostelin, Radiostol, Radstein, Radsterin, Rodine C, Shock-ferol, Shock-ferol sterogyl, Sterogyl, Synthetic Vitamin D, Uvesterol D, Uvesterol-D, Vio D, Vio-D, Viostdrol, Viosterol, Viosterol in Oil, Vitamin D2, Vitavel-D",http://vmh.uni.lu/_api/metabolites/987/?format=pcsv
vitd3,,,0,C27H44O,CHEBI:28940,,"Human Metabolome Database (HMDB): Vitamin D3 is a steroid hormone that has long been known for its important role in regulating body levels of calcium and phosphorus, in mineralization of bone, and for the assimilation of Vitamin A. It is structurally similar to steroids such as testosterone, cholesterol, and cortisol (though vitamin D3 itself is a secosteroid).",,calciol,,HMDB00876,"InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1",C05443,2016-12-05T15:48:05Z,,988,,,,,10883523,vitd3,,"(+)-Vitamin D3, (3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol, (5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol, 3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol, 9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol, 9,10-Secocholesta-5,7,10(19)-trien-3-ol, 9,10-Secocholesta-5,7,10-trien-3-ol, Arachitol, Calciol, CC, Cholecalciferol, Cholecalciferol D3, Colecalciferol, D3-Vigantol, Delsterol, Deparal, Devaron, Ebivit, FeraCol, Granuvit D3, Micro-dee, Oleovitamin D3, Provitina, Quintox, Ricketon, Trivitan, Vi-De3, VidDe-3-hydrosol, Videkhol, Vigantol, Vigorsan, Vitinc Dan-Dee-3",http://vmh.uni.lu/_api/metabolites/988/?format=pcsv
whddca,,,-1,C12H23O3,CHEBI:39567,,"Human Metabolome Database (HMDB): 12-hydroxydodecanoic acid is the substrate of the human glutathione-dependent formaldehyde dehydrogenase (EC1.1.1.1). The enzyme that catalyzes the conversion of alcohols to aldehydes is a zinc-containing dimeric enzyme responsible for the oxidation of long-chain alcohols and omega-hydroxy fatty acids. (OMIM). The human glutathione-dependent formaldehyde dehydrogenase is unique among the structurally studied members of the alcohol dehydrogenase family in that it follows a random bi kinetic mechanism forming a binary complex, and a ternary complex with NAD+. (PMID 12196016).",,omega hydroxy dodecanoate (n-C12:0),,HMDB02059,"InChI=1/C12H24O3/c13-11-9-7-5-3-1-2-4-6-8-10-12(14)15/h13H,1-11H2,(H,14,15)",C08317,2016-12-05T15:48:05Z,,989,,,,,79034,whddca,,"12-Hydroxydodecanoate, 12-Hydroxydodecanoic acid, 12-Hydroxylaurate, 12-Hydroxylauric acid, Omega hydroxy dodecanoate, Omega hydroxy dodecanoic acid, Omega-Hydroxydodecanoate, Omega-Hydroxydodecanoic acid",http://vmh.uni.lu/_api/metabolites/989/?format=pcsv
whhdca,,,-1,C16H31O3,,,"Human Metabolome Database (HMDB): 16-Hydroxy hexadecanoic acid (or 16-hydroxypalmitic acid) is a hydroxylated fatty acid where the terminal (omega) carbon has been hydroxylated. In animal tissues, a family of enzymes termed cytochromes P450s are involved in fatty acid oxidation, hydroxylating with high specificity at the energetically unfavorable terminal (omega) or omega-1 carbons. Hydroxy fatty acids primarily come from consumption of plant products (vegetables or fruits) or from cowâ€™s milk. Omega hydroxy fatty acids are found in the structure of suberin, a lipid polyester present in plant cell walls, and of cutin, a lipid polyester which is a component of the plant cuticle. These apoplastic structures are important plant-environment interfaces that act as barriers limiting water and nutrient loss and protecting plants from radiation and pathogens. 16-hydroxypalmitic acid and 18-hydroxy stearic acid are particularly abundant in cutin in the plant cuticle. 16-hydroxypalmitic acid has been proposed as a biomarker of beer consumption.",,omega hydroxy hexadecanoate (n-C16:0),,HMDB06294,"InChI=1/C16H32O3/c17-15-13-11-9-7-5-3-1-2-4-6-8-10-12-14-16(18)19/h17H,1-15H2,(H,18,19)/p-1",C18218,2016-12-05T15:48:05Z,,990,,,,,7058075,whhdca,,"16-Hydoxy hexadecanoate, 16-Hydoxy hexadecanoic acid, Hydroxy hexadecanoate, Hydroxy hexadecanoic acid, Juniperic acid, Omega hydroxy hexadecanoate, Omega hydroxy hexadecanoate (N-C16:0), Omega hydroxy hexadecanoic acid, Omega-hydroxy hexadecanoate, Omega-hydroxy hexadecanoic acid, w-Hydroxy hexadecanoate, w-Hydroxy hexadecanoic acid",http://vmh.uni.lu/_api/metabolites/990/?format=pcsv
whtststerone,,,0,C19H28O3,,,w hydroxy testosterone,,w hydroxy testosterone,,,"InChI=1/C19H28O3/c1-18-8-7-16-14(15(18)4-5-17(18)22)3-2-12-10-13(21)6-9-19(12,16)11-20/h10,14-17,20,22H,2-9,11H2,1H3/t14-,15?,16-,17-,18-,19+/m0/s1",C05294,2016-11-22T15:12:02Z,,991,,,,,16395893,whtststerone,,,http://vmh.uni.lu/_api/metabolites/991/?format=pcsv
whttdca,,,-1,C14H27O3,,,omega hydroxy tetradecanoate (n-C14:0),,omega hydroxy tetradecanoate (n-C14:0),,,,,2016-11-22T15:12:02Z,,992,,,,,,whttdca,,,http://vmh.uni.lu/_api/metabolites/992/?format=pcsv
xolest_hs,,,0,C27H45XCO2,,,cholesterol ester,,cholesterol ester,,,,,2016-11-22T15:12:02Z,,993,,,,,,xolest_hs,,,http://vmh.uni.lu/_api/metabolites/993/?format=pcsv
xolest2_hs,,,0,C27H45FULLR2CO2,,,cholesterol ester,,cholesterol ester,,,,,2016-11-22T15:12:02Z,,994,,,,,,xolest2_hs,,,http://vmh.uni.lu/_api/metabolites/994/?format=pcsv
xoltri24,,,0,C27H46O3,,,"(24S)-7alpha,24-dihydroxycholesterol",,"(24S)-7alpha,24-dihydroxycholesterol",,,"InChI=1S/C27H46O3/c1-16(2)23(29)9-6-17(3)20-7-8-21-25-22(11-13-27(20,21)5)26(4)12-10-19(28)14-18(26)15-24(25)30/h15-17,19-25,28-30H,6-14H2,1-5H3/t17-,19+,20-,21+,22+,23+,24-,25+,26+,27-/m1/s1",C15518,2016-11-22T15:12:02Z,,995,,,,,11954196,xoltri24,,,http://vmh.uni.lu/_api/metabolites/995/?format=pcsv
xoltri25,,,0,C27H46O3,,,"7alpha,25-dihydroxycholesterol",,"7alpha,25-dihydroxycholesterol",,,"InChI=1S/C27H46O3/c1-17(7-6-12-25(2,3)30)20-8-9-21-24-22(11-14-27(20,21)5)26(4)13-10-19(28)15-18(26)16-23(24)29/h16-17,19-24,28-30H,6-15H2,1-5H3/t17-,19+,20-,21+,22+,23-,24+,26+,27-/m1/s1",C15520,2016-11-22T15:12:02Z,,996,,,,,11954197,xoltri25,,,http://vmh.uni.lu/_api/metabolites/996/?format=pcsv
xoltri27,,,0,C27H46O3,CHEBI:18431,,"Human Metabolome Database (HMDB): 7-a,27-dihydroxycholesterol is an intermediate in bile acid biosynthesis. The enzyme 27-Hydroxycholesterol 7alpha-monooxygenase [EC:1.14.13.60] catalyzes the production of this metabolite from 27-hydroxycholesterol. This enzyme reaction is irreversible and occurs in the endoplasmic reticulum.",,"7alpha,26-dihydroxycholesterol",,HMDB06281,"InChI=1S/C27H46O3/c1-17(16-28)6-5-7-18(2)21-8-9-22-25-23(11-13-27(21,22)4)26(3)12-10-20(29)14-19(26)15-24(25)30/h15,17-18,20-25,28-30H,5-14,16H2,1-4H3/t17?,18-,20+,21-,22+,23+,24-,25+,26+,27-/m1/s1",C06341,2016-12-05T15:48:05Z,,997,,,,,440985,xoltri27,,"5-Cholestene-3beta,7alpha,26-triol, 7-alpha,27-Dihydroxycholesterol, 7alpha,26-dihydroxycholesterol, 7alpha,27-Dihydroxycholesterol, Cholest-5-ene-3,7,27-triol, Cholest-5-ene-3- b,7-a,27-triol, Cholest-5-ene-3-b,7-a,27-triol, Cholest-5-ene-3-beta,7-alpha,27-triol, Cholest-5-ene-3beta,7alpha,26-triol, Cholest-5-ene-3beta,7alpha,27-triol",http://vmh.uni.lu/_api/metabolites/997/?format=pcsv
xyl_D,,,0,C5H10O5,CHEBI:15936,,aldehydo-D-xylose,,aldehydo-D-xylose,,,"InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4+,5+/m0/s1",,2016-11-22T15:12:02Z,,998,,,,,644160,xyl_D,,,http://vmh.uni.lu/_api/metabolites/998/?format=pcsv
xylt,,,0,C5H12O5,CHEBI:17151,,"Human Metabolome Database (HMDB): Xylitol is a five-carbon sugar alcohol that is obtained through the diet. It is not endogenously produced by humans. Xylitol is used as a diabetic sweetener which is roughly as sweet as sucrose with 33% fewer calories. Xylitol is naturally found in many fruits (strawberries, plums, raspberries) and vegetables (e.g. cauliflower). Because of fruit and vegetable consumption the human body naturally processes 15 grams of xylitol per day. Xylitol can be produced industrially starting from primary matters rich in xylan which is hydrolyzed to obtain xylose. It is extracted from hemicelluloses present in the corn raids, the almond hulls or the barks of birch (or of the by-products of wood: shavings hard, paper pulp). Of all polyols, it is the one that has the sweetest flavor (it borders that of saccharose). It gives a strong refreshing impression, making xylitol an ingredient of choice for the sugarless chewing gum industry. In addition to his use in confectionery, it is used in the pharmaceutical industry for certain mouthwashes and toothpastes and in cosmetics (creams, soaps, etc.). Xylitol is produced starting from xylose, the isomaltose, by enzymatic transposition of the saccharose (sugar). Xylitol is not metabolized by cariogenic (cavity-causing) bacteria and gum chewing stimulates the flow of saliva; as a result, chewing xylitol gum may prevent dental caries. Chewing xylitol gum for 4 to 14 days reduces the amount of dental plaque. The reduction in the amount of plaque following xylitol gum chewing within 2 weeks may be a transient phenomenon. Chewing xylitol gum for 6 months reduced mutans streptococci levels in saliva and plaque in adults. (PMID: 17426399 , 15964535 ).  Studies have also shown xylitol chewing gum can help prevent acute otitis media (ear aches and infections) as the act of chewing and swallowing assists with the disposal of earwax and clearing the middle ear, while the presence of xylitol prevents the growth of bacteria in the eustachian tubes. Xylitol is well established as a life-threatening toxin to dogs. The number of reported cases of xylitol toxicosis in dogs has significantly increased since the first reports in 2002. Dogs that have ingested foods containing xylitol (greater than 100 milligrams of xylitol consumed per kilogram of bodyweight) have presented with low blood sugar (hypoglycemia), which can be life-threatening.



 ",,xylitol,,HMDB02917,"InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4+,5+",C00379,2016-12-05T15:48:05Z,,999,,,,,6912,xylt,,"D-Xylitol, Eutrit, Fluorette, Klinit, Kylit, Meso-xylitol, Wood sugar alcohol, Xylisorb, Xylisorb 300, Xylisorb 700, Xylit, Xylitab 100, Xylitab 300, Xylitab DC, Xylite, Xylite (sugar), Xylitol, Xylitol C, Xyliton, Xylo-Pentitol",http://vmh.uni.lu/_api/metabolites/999/?format=pcsv
f1a,,,0,C22H37N2O15X,,,F1alpha,,F1alpha,,,,,2016-11-22T15:12:02Z,,1000,,,,,,f1a,,,http://vmh.uni.lu/_api/metabolites/1000/?format=pcsv
fuc1p_L,,,-2,C6H11O8P,CHEBI:28319,,L-Fucose 1-phosphate,,L-Fucose 1-phosphate,,,"InChI=1S/C6H13O8P/c1-2-3(7)4(8)5(9)6(13-2)14-15(10,11)12/h2-9H,1H3,(H2,10,11,12)/t2-,3+,4+,5-,6?/m0/s1",C02985,2016-11-22T15:12:02Z,,1001,,,,,439871,fuc1p_L,,,http://vmh.uni.lu/_api/metabolites/1001/?format=pcsv
gdpfuc,,,-2,C16H23N5O15P2,CHEBI:17009,,GDP-L-fucose(2-),,GDP-L-fucose(2-),,,"InChI=1S/C16H25N5O15P2/c1-4-7(22)9(24)11(26)15(33-4)35-38(30,31)36-37(28,29)32-2-5-8(23)10(25)14(34-5)21-3-18-6-12(21)19-16(17)20-13(6)27/h3-5,7-11,14-15,22-26H,2H2,1H3,(H,28,29)(H,30,31)(H3,17,19,20,27)/p-2/t4-,5+,7+,8+,9+,10+,11-,14+,15?/m0/s1",C00325,2016-11-22T15:12:02Z,,1002,,,,,439211,gdpfuc,,,http://vmh.uni.lu/_api/metabolites/1002/?format=pcsv
n2m2masn,,,0,C50H83N4O35X,,,((N-acetyl-D-glucosaminyl)2-(alpha-D-mannosyl)2-beta-D-mannosyl-diacetylchitobiosyl)-L-asparagine (protein),,((N-acetyl-D-glucosaminyl)2-(alpha-D-mannosyl)2-beta-D-mannosyl-diacetylchitobiosyl)-L-asparagine (protein),,,,C11530,2016-11-22T15:12:02Z,,1003,,,,,,n2m2masn,,,http://vmh.uni.lu/_api/metabolites/1003/?format=pcsv
fn2m2masn,,,0,C56H93N4O39X,CHEBI:32984,,"N4-{N-Acetyl-beta-D-glucosaminyl-(1,2)-alpha-D-mannosyl-(1,3)-[N-acetyl-beta-D-glucosaminyl-(1,2)-alpha-D-mannosyl-(1,6)]-beta-D-mannosyl-(1,4)-N-acetyl-beta-D-glucosaminyl-(1,4)-[alpha-L-fucosyl-(1,6)]-N-acetyl-beta-D-glucosaminyl}asparagine",,"N4-{N-Acetyl-beta-D-glucosaminyl-(1,2)-alpha-D-mannosyl-(1,3)-[N-acetyl-beta-D-glucosaminyl-(1,2)-alpha-D-mannosyl-(1,6)]-beta-D-mannosyl-(1,4)-N-acetyl-beta-D-glucosaminyl-(1,4)-[alpha-L-fucosyl-(1,6)]-N-acetyl-beta-D-glucosaminyl}asparagine",,,,,2016-11-22T15:12:02Z,,1004,,,,,,fn2m2masn,,,http://vmh.uni.lu/_api/metabolites/1004/?format=pcsv
ddcaACP,,,-1,C23H43N2O8PRS,,,Dodecanoyl-ACP (n-C12:0ACP),,Dodecanoyl-ACP (n-C12:0ACP),,,,,2016-11-22T15:12:02Z,,1005,,,,,,ddcaACP,,,http://vmh.uni.lu/_api/metabolites/1005/?format=pcsv
ddca,,,-1,C12H23O2,CHEBI:30805,,"Human Metabolome Database (HMDB): Lauric acid, or dodecanoic acid is the main fatty acid in coconut oil and in palm kernel oil, and is believed to have antimicrobial properties. It is a white, powdery solid with a faint odor of bay oil. Lauric acid, although slightly irritating to mucous membranes, has a very low toxicity and so is used in many soaps and shampoos.",,laurate,,HMDB00638,"InChI=1S/C12H24O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2-11H2,1H3,(H,13,14)/p-1",C02679,2016-12-05T15:48:05Z,,1006,,,,,3893,ddca,,"1-Undecanecarboxylate, 1-Undecanecarboxylic acid, ABL, Aliphat No. 4, Dodecanoate, Dodecanoic acid, Dodecylate, Dodecylic acid, Edenor C 1298-100, Emery 651, Hystrene 9512, Kortacid 1299, Laurate, Lauric acid, Laurostearate, Laurostearic acid, Lunac L 70, Lunac L 98, N-Dodecanoate, N-Dodecanoic acid, Neo-Fat 12, Neo-Fat 12-43, Nissan NAA 122, Philacid 1200, Prifac 2920, Univol U 314, Vulvate, Vulvic acid",http://vmh.uni.lu/_api/metabolites/1006/?format=pcsv
myrsACP,,,-1,C25H47N2O8PRS,,,Myristoyl-ACP (n-C14:0ACP),,Myristoyl-ACP (n-C14:0ACP),,,,,2016-11-22T15:12:02Z,,1007,,,,,,myrsACP,,,http://vmh.uni.lu/_api/metabolites/1007/?format=pcsv
tdeACP,,,-1,C25H45N2O8PRS,,,cis-tetradec-7-enoyl-[acyl-carrier protein] (n-C14:1),,cis-tetradec-7-enoyl-[acyl-carrier protein] (n-C14:1),,,,,2016-11-22T15:12:02Z,,1008,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1008/?format=pcsv
ttdcea,,,-1,C14H25O2,,,tetradecenoate (n-C14:1),,tetradecenoate (n-C14:1),,,"InChI=1/C14H26O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h5-6H,2-4,7-13H2,1H3,(H,15,16)/b6-5-",C08322,2016-11-22T15:12:02Z,,1009,,,,,68344,,,,http://vmh.uni.lu/_api/metabolites/1009/?format=pcsv
palmACP,,,-1,C27H51N2O8PRS,,,Palmitoyl-ACP (n-C16:0ACP),,Palmitoyl-ACP (n-C16:0ACP),,,,,2016-11-22T15:12:02Z,,1010,,,,,,palmACP,,,http://vmh.uni.lu/_api/metabolites/1010/?format=pcsv
hdeACP,,,-1,C27H49N2O8PRS,,,cis-hexadec-9-enoyl-[acyl-carrier protein] (n-C16:1),,cis-hexadec-9-enoyl-[acyl-carrier protein] (n-C16:1),,,,,2016-11-22T15:12:02Z,,1011,,,,,,hdeACP,,,http://vmh.uni.lu/_api/metabolites/1011/?format=pcsv
ocdcaACP,,,-1,C29H55N2O8PRS,,,Octadecanoyl-ACP (n-C18:0ACP),,Octadecanoyl-ACP (n-C18:0ACP),,,,,2016-11-22T15:12:02Z,,1012,,,,,,ocdcaACP,,,http://vmh.uni.lu/_api/metabolites/1012/?format=pcsv
octeACP,,,-1,C29H53N2O8PRS,,,cis-octadec-11-enoyl-[acyl-carrier protein] (n-C18:1),,cis-octadec-11-enoyl-[acyl-carrier protein] (n-C18:1),,,,,2016-11-22T15:12:02Z,,1013,,,,,,octeACP,,,http://vmh.uni.lu/_api/metabolites/1013/?format=pcsv
lnlcACP,,,-1,C29H51N2O8PRS,,,linoleic acid ACP (all cis),,linoleic acid ACP (all cis),,,,C16160,2016-11-22T15:12:02Z,,1014,,,,,,lnlcACP,,,http://vmh.uni.lu/_api/metabolites/1014/?format=pcsv
lneldcACP,,,-1,C29H51N2O8PRS,,,linoelaidic acid ACP (all trans),,linoelaidic acid ACP (all trans),,,,,2016-11-22T15:12:02Z,,1015,,,,,,lneldcACP,,,http://vmh.uni.lu/_api/metabolites/1015/?format=pcsv
ocdcyaACP,,,-1,C29H51N2O8PRS,,,Octadecynoyl-ACP (n-C18:2ACP),,Octadecynoyl-ACP (n-C18:2ACP),,,,,2016-11-22T15:12:02Z,,1016,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1016/?format=pcsv
ocdcya,,,-1,C18H31O2,,,octadecadienoate (n-C18:2),,octadecadienoate (n-C18:2),,,,,2016-11-22T15:12:02Z,,1017,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1017/?format=pcsv
ptdcacoa,,,-4,C36H60N7O17P3S,,,pentadecanoyl Coenzyme A,,pentadecanoyl Coenzyme A,,,"InChI=1/C36H64N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-27(45)64-20-19-38-26(44)17-18-39-34(48)31(47)36(2,3)22-57-63(54,55)60-62(52,53)56-21-25-30(59-61(49,50)51)29(46)35(58-25)43-24-42-28-32(37)40-23-41-33(28)43/h23-25,29-31,35,46-47H,4-22H2,1-3H3,(H,38,44)(H,39,48)(H,52,53)(H,54,55)(H2,37,40,41)(H2,49,50,51)/p-4/t25-,29-,30-,31+,35-/m0/s1",,2016-11-22T15:12:02Z,,1018,,,,,,ptdcacoa,,,http://vmh.uni.lu/_api/metabolites/1018/?format=pcsv
hpdcacoa,,,-4,C38H64N7O17P3S,,,heptadecanoyl coa,,heptadecanoyl coa,,,"InChI=1/C38H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-29(47)66-22-21-40-28(46)19-20-41-36(50)33(49)38(2,3)24-59-65(56,57)62-64(54,55)58-23-27-32(61-63(51,52)53)31(48)37(60-27)45-26-44-30-34(39)42-25-43-35(30)45/h25-27,31-33,37,48-49H,4-24H2,1-3H3,(H,40,46)(H,41,50)(H,54,55)(H,56,57)(H2,39,42,43)(H2,51,52,53)/t27-,31-,32-,33+,37-/m1/s1",,2016-11-22T15:12:02Z,,1019,,,,,3082004,hpdcacoa,,,http://vmh.uni.lu/_api/metabolites/1019/?format=pcsv
pristcoa,,,-4,C40H68N7O17P3S,CHEBI:64039,,pristanoyl coa,,pristanoyl coa,,,"InChI=1/C40H72N7O17P3S/c1-25(2)11-8-12-26(3)13-9-14-27(4)15-10-16-28(5)39(52)68-20-19-42-30(48)17-18-43-37(51)34(50)40(6,7)22-61-67(58,59)64-66(56,57)60-21-29-33(63-65(53,54)55)32(49)38(62-29)47-24-46-31-35(41)44-23-45-36(31)47/h23-29,32-34,38,49-50H,8-22H2,1-7H3,(H,42,48)(H,43,51)(H,56,57)(H,58,59)(H2,41,44,45)(H2,53,54,55)/t26?,27?,28?,29-,32-,33-,34+,38-/m1/s1/f/h42-43,53-54,56,58H,41H2",,2016-11-22T15:12:02Z,,1020,,,,,25137904,pristcoa,,,http://vmh.uni.lu/_api/metabolites/1020/?format=pcsv
phytcoa,,,-4,C41H70N7O17P3S,CHEBI:15538,,phytanoyl-CoA(4-),,phytanoyl-CoA(4-),,,"InChI=1S/C41H74N7O17P3S/c1-26(2)11-8-12-27(3)13-9-14-28(4)15-10-16-29(5)21-32(50)69-20-19-43-31(49)17-18-44-39(53)36(52)41(6,7)23-62-68(59,60)65-67(57,58)61-22-30-35(64-66(54,55)56)34(51)40(63-30)48-25-47-33-37(42)45-24-46-38(33)48/h24-30,34-36,40,51-52H,8-23H2,1-7H3,(H,43,49)(H,44,53)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/p-4/t27?,28?,29?,30-,34-,35-,36+,40-/m1/s1",C02060,2016-11-22T15:12:02Z,,1021,,,,,439640,phytcoa,,,http://vmh.uni.lu/_api/metabolites/1021/?format=pcsv
Sfglutth,,,-1,C11H16N3O7S,CHEBI:16225,,S-formylglutathionate(1-),,S-formylglutathionate(1-),,,"InChI=1S/C11H17N3O7S/c12-6(11(20)21)1-2-8(16)14-7(4-22-5-15)10(19)13-3-9(17)18/h5-7H,1-4,12H2,(H,13,19)(H,14,16)(H,17,18)(H,20,21)/p-1/t6-,7-/m0/s1",C01031,2016-11-22T15:12:02Z,,1022,,,,,189122,,,,http://vmh.uni.lu/_api/metabolites/1022/?format=pcsv
fdp,,,-4,C6H10O12P2,CHEBI:16905,,"D-Fructose 1,6-bisphosphate",,"D-Fructose 1,6-bisphosphate",,,"InChI=1S/C6H14O12P2/c7-3(1-17-19(11,12)13)5(9)6(10)4(8)2-18-20(14,15)16/h3,5-7,9-10H,1-2H2,(H2,11,12,13)(H2,14,15,16)/t3-,5-,6-/m1/s1",C00354,2016-11-22T15:12:02Z,,1023,,,,,172313,fdp,,,http://vmh.uni.lu/_api/metabolites/1023/?format=pcsv
f1p,,,-2,C6H11O9P,CHEBI:18105,,D-Fructose 1-phosphate,,D-Fructose 1-phosphate,,,"InChI=1S/C6H13O9P/c7-1-3(8)5(10)6(11)4(9)2-15-16(12,13)14/h3,5-8,10-11H,1-2H2,(H2,12,13,14)/t3-,5-,6-/m1/s1",C01094,2016-11-22T15:12:02Z,,1024,,,,,10400369,f1p,,,http://vmh.uni.lu/_api/metabolites/1024/?format=pcsv
glyald,,,0,C3H6O3,CHEBI:17378,,"Human Metabolome Database (HMDB): Glyceraldehyde is a triose monosaccharide with chemical formula C3H6O3. It is the simplest of all common aldoses. It is a sweet colorless crystalline solid that is an intermediate compound in carbohydrate metabolism. The word comes from combining glycerine and aldehyde, as glyceraldehyde is merely glycerine with one hydroxide changed to an aldehyde.",,D-Glyceraldehyde,,HMDB01051,"InChI=1S/C3H6O3/c4-1-3(6)2-5/h1,3,5-6H,2H2/t3-/m0/s1",C02154,2016-12-05T15:48:05Z,,1025,,,,,79014,glyald,,"(+/-)-2,3-dihydroxy-Propanal, (+/-)-Glyceraldehyde, 2,3-Dihydroxypropanal, 2,3-Dihydroxypropionaldehyde, alpha,beta-Dihydroxypropionaldehyde, D-(+)-Glyceraldehyde, D-2,3-Dihydroxypropanal, D-2,3-Dihydroxypropionaldehyde, D-Aldotriose, D-Glyceraldehyde, D-Glycerose, delta-(+)-Glyceraldehyde, delta-2,3-Dihydroxypropanal, delta-2,3-Dihydroxypropionaldehyde, delta-Aldotriose, delta-Glyceraldehyde, delta-Glycerose, Dihydroxypropionaldehyde, DL-Glyceraldehyde, Glyceraldehyde, Glyceric aldehyde, Glycerinaldehyde, Glycerinformal, Glycerose",http://vmh.uni.lu/_api/metabolites/1025/?format=pcsv
xu1p_D,,,-2,C5H9O8P,,,"Human Metabolome Database (HMDB): D-xylulose-1-phosphate is produced in the hepatocytes and is the product of fructokinase (Ketohexokinase, EC 2.7.1.3) phosphorylation of D-xylulose. The cleavage of D-xylulose-1-phosphateglycolaldehyde by aldolase (fructose-bisphosphate aldolase, EC 4.1.2.13) produces glycolaldehyde which is an oxalate precursor. The distribution of both enzymes in human tissues indicates that this reaction sequence occurs mainly in the liver, to a lesser extent in the kidney, and very little in heart, brain and muscle. The kinetic properties of fructokinase show that this enzyme can phosphorylate D-xylulose as readily as D-fructose. (PMID: 6458298, 13898172, 6284103, 2996495).",,D-Xylulose 1-phosphate,,HMDB06534,"InChI=1/C5H11O8P/c6-1-3(7)5(9)4(8)2-13-14(10,11)12/h3,5-7,9H,1-2H2,(H2,10,11,12)/t3-,5-/m1/s1",,2016-12-05T15:48:05Z,,1026,,,,,14844436,xu1p_D,,"1-(Dihydrogen phosphate) D-threo-Pentulose, 1-Phosphate-D-threo-Pentulose",http://vmh.uni.lu/_api/metabolites/1026/?format=pcsv
gcald,,,0,C2H4O2,CHEBI:17071,,"Human Metabolome Database (HMDB): Glycolaldehyde (HOCH2-CH=O, IUPAC name 2-hydroxyethanal) is a type of diose (2-carbon monosaccharide). Glycolaldehyde is readily converted to acetyl coenzyme A. It has an aldehyde and a hydroxyl group. However, it is not actually a sugar, because there is only one hydroxyl group. Glycolaldehyde is formed from many sources, including the amino acid glycine and from purone catabolism. It can form by action of ketolase on fructose 1,6-bisphosphate in an alternate glycolysis pathway. This compound is transferred by thiamin pyrophosphate during the pentose phosphate shunt.",,glycolaldehyde,,HMDB03344,"InChI=1S/C2H4O2/c3-1-2-4/h1,4H,2H2",C00266,2016-12-05T15:48:05Z,,1027,,,,,756,gcald,," Glycolaldehyde, 2-Hydroxyacetaldehyde, 2-Hydroxyethanal, 2-OH-acetaldehyde, 2-Oxoethanol, Diose, Glycolic aldehyde, Glycollaldehyde, Hydroxyacetaldehyde, Hydroxyethanal, Methylol formaldehyde, Methylolformaldehyde, Monomethylolformaldehyde",http://vmh.uni.lu/_api/metabolites/1027/?format=pcsv
tag1p_D,,,-2,C6H11O9P,,,D-Tagatose 1-phosphate,,D-Tagatose 1-phosphate,,,"InChI=1/C6H13O9P/c7-1-3(8)5(10)6(11)4(9)2-15-16(12,13)14/h3,5-8,10-11H,1-2H2,(H2,12,13,14)/t3-,5+,6-/m1/s1",,2016-11-22T15:12:02Z,,1028,,,,,6101730,tag1p_D,,,http://vmh.uni.lu/_api/metabolites/1028/?format=pcsv
f6p,,,-2,C6H11O9P,CHEBI:15946,,D-Fructose 6-phosphate,,D-Fructose 6-phosphate,,,"InChI=1S/C6H13O9P/c7-1-3(8)5(10)6(11)4(9)2-15-16(12,13)14/h4-7,9-11H,1-2H2,(H2,12,13,14)/p-2/t4-,5-,6-/m1/s1",C00085,2016-11-22T15:12:02Z,,1029,,,,,69507,f6p,,,http://vmh.uni.lu/_api/metabolites/1029/?format=pcsv
f26bp,,,-4,C6H10O12P2,CHEBI:28602,,"beta-D-fructofuranose 2,6-bisphosphate(4-)",,"beta-D-fructofuranose 2,6-bisphosphate(4-)",,,"InChI=1S/C6H14O12P2/c7-2-6(18-20(13,14)15)5(9)4(8)3(17-6)1-16-19(10,11)12/h3-5,7-9H,1-2H2,(H2,10,11,12)(H2,13,14,15)/p-4/t3-,4-,5+,6+/m1/s1",C00665,2016-11-22T15:12:02Z,,1030,,,,,105021,f26bp,,,http://vmh.uni.lu/_api/metabolites/1030/?format=pcsv
ppp9,,,-2,C34H32N4O4,CHEBI:15430,,Protoporphyrin,,Protoporphyrin,,,"InChI=1S/C34H34N4O4/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42)/p-2/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-",C02191,2016-11-22T15:12:02Z,,1031,,,,,,ppp9,,,http://vmh.uni.lu/_api/metabolites/1031/?format=pcsv
formcoa,,,-4,C22H32N7O17P3S,CHEBI:15522,,"Human Metabolome Database (HMDB): Formyl-CoA is formed during the alpha-oxidation process in liver peroxisomes, as a result of the alpha-oxidation of 3-methyl-substituted fatty acids. The amount of formyl-CoA formed constitutes 2 - 5% of the total formate. The formyl-CoA formed is not due to activation of formate - until now presumed to be the primary end-product of alpha-oxidation - but is rather than formate the end-product of alpha-oxidation. The cleavage of 2-hydroxy-3-methylhexadecanoyl-CoA to 2-methylpentadecanal and formate (formyl-CoA) is probably due to the presence of a specific lyase. (PMID: 9276483, 9166898).",,formyl-CoA(4-),,HMDB03419,"InChI=1S/C22H36N7O17P3S/c1-22(2,17(33)20(34)25-4-3-13(31)24-5-6-50-11-30)8-43-49(40,41)46-48(38,39)42-7-12-16(45-47(35,36)37)15(32)21(44-12)29-10-28-14-18(23)26-9-27-19(14)29/h9-12,15-17,21,32-33H,3-8H2,1-2H3,(H,24,31)(H,25,34)(H,38,39)(H,40,41)(H2,23,26,27)(H2,35,36,37)/p-4/t12-,15-,16-,17+,21-/m1/s1",C00798,2016-12-05T15:48:05Z,,1032,,,,,439313,formcoa,,Formyl coenzyme A,http://vmh.uni.lu/_api/metabolites/1032/?format=pcsv
Lfmkynr,,,0,C11H12N2O4,CHEBI:30249,,N-formyl-L-kynurenine,,N-formyl-L-kynurenine,,,"InChI=1S/C11H12N2O4/c12-8(11(16)17)5-10(15)7-3-1-2-4-9(7)13-6-14/h1-4,6,8H,5,12H2,(H,13,14)(H,16,17)/t8-/m0/s1",C02700,2016-11-22T15:12:02Z,,1033,,,,,910,Lfmkynr,,,http://vmh.uni.lu/_api/metabolites/1033/?format=pcsv
Lkynr,,,0,C10H12N2O3,CHEBI:16946,,"Human Metabolome Database (HMDB): Kynurenine is a metabolite of the amino acid tryptophan used in the production of niacin. L-kynurenine is a central compound of the pathway of tryptophan metabolism pathway since it can change to the neuroprotective agent kynurenic acid or to the neurotoxic agent quinolinic acid. The break-up of these endogenous compounds' balance can be observable in many disorders. It can occur in neurodegenerative disorders, such as Parkinson's disease, Huntington's and Alzheimer's disease, in stroke, in epilepsy, in multiple sclerosis, in amyotrophic lateral sclerosis, and in mental failures, such as schizophrenia and depression.",,L-kynurenine,,HMDB00684,"InChI=1S/C10H12N2O3/c11-7-4-2-1-3-6(7)9(13)5-8(12)10(14)15/h1-4,8H,5,11-12H2,(H,14,15)/t8-/m0/s1",C00328,2016-12-05T15:48:05Z,,1034,,,,,161166,Lkynr,,"(alphaS)-alpha,2-diamino-3-hydroxy-gamma-oxo-Benzenebutanoate, (alphaS)-alpha,2-diamino-3-hydroxy-gamma-oxo-Benzenebutanoic acid, (S)-alpha,2-diamino-3-hydroxy-gamma-oxo-Benzenebutanoate, (S)-alpha,2-diamino-3-hydroxy-gamma-oxo-Benzenebutanoic acid, 3-(3-Hydroxyanthraniloyl)-L-alanine, 3-Anthraniloyl-Alanine, 3-Anthraniloyl-L-alanine, 3-Anthraniloylalanine, 3-Hydroxy-L-kynurenine, alpha,2-Diamino-gamma-oxo-Benzenebutanoate, alpha,2-Diamino-gamma-oxo-Benzenebutanoic acid, Dl-Kynurenine, DL-Kynureninefree base, Kynurenin, Kynurenine, Quinurenine",http://vmh.uni.lu/_api/metabolites/1034/?format=pcsv
ggdp,,,-3,C20H33O7P2,,,"2-trans,6-trans,10-trans-geranylgeranyl diphosphate(3-)",,"2-trans,6-trans,10-trans-geranylgeranyl diphosphate(3-)",,,"InChI=1S/C20H36O7P2/c1-17(2)9-6-10-18(3)11-7-12-19(4)13-8-14-20(5)15-16-26-29(24,25)27-28(21,22)23/h9,11,13,15H,6-8,10,12,14,16H2,1-5H3,(H,24,25)(H2,21,22,23)/p-3/b18-11+,19-13+,20-15+",C00353,2016-11-22T15:12:02Z,,1035,,,,,735,ggdp,,,http://vmh.uni.lu/_api/metabolites/1035/?format=pcsv
ttc_ggdp,,,-3,C20H33O7P2,,,"trans,trans,cis-Geranylgeranyl diphosphate",,"trans,trans,cis-Geranylgeranyl diphosphate",,,"InChI=1S/C20H36O7P2/c1-17(2)9-6-10-18(3)11-7-12-19(4)13-8-14-20(5)15-16-26-29(24,25)27-28(21,22)23/h9,11,13,15H,6-8,10,12,14,16H2,1-5H3,(H,24,25)(H2,21,22,23)/p-3/b18-11+,19-13+,20-15-",C11356,2016-11-22T15:12:02Z,,1036,,,,,5281909,ttc_ggdp,,,http://vmh.uni.lu/_api/metabolites/1036/?format=pcsv
5forthf,,,-2,C20H22N8O6,CHEBI:15639,,5-Formiminotetrahydrofolate,,5-Formiminotetrahydrofolate,,,"InChI=1S/C20H24N8O6/c21-9-28-12(8-24-16-15(28)18(32)27-20(22)26-16)7-23-11-3-1-10(2-4-11)17(31)25-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,21,23H,5-8H2,(H,25,31)(H,29,30)(H,33,34)(H4,22,24,26,27,32)/p-2/t12-,13-/m0/s1",C00664,2016-11-22T15:12:02Z,,1037,,,,,530,5forthf,,,http://vmh.uni.lu/_api/metabolites/1037/?format=pcsv
methf,,,-1,C20H20N7O6,CHEBI:15638,,"5,10-Methenyltetrahydrofolate",,"5,10-Methenyltetrahydrofolate",,,"InChI=1S/C20H21N7O6/c21-20-24-16-15(18(31)25-20)27-9-26(8-12(27)7-22-16)11-3-1-10(2-4-11)17(30)23-13(19(32)33)5-6-14(28)29/h1-4,9,12-13H,5-8H2,(H6-,21,22,23,24,25,28,29,30,31,32,33)/p-1/t12-,13+/m1/s1",C00445,2016-11-22T15:12:02Z,,1038,,,,,644350,methf,,,http://vmh.uni.lu/_api/metabolites/1038/?format=pcsv
4fumacac,,,-2,C8H6O6,CHEBI:30907,,4-fumarylacetoacetate(2-),,4-fumarylacetoacetate(2-),,,"InChI=1S/C8H8O6/c9-5(1-2-7(11)12)3-6(10)4-8(13)14/h1-2H,3-4H2,(H,11,12)(H,13,14)/p-2/b2-1+",C01061,2016-11-22T15:12:02Z,,1039,,,,,5280398,4fumacac,,,http://vmh.uni.lu/_api/metabolites/1039/?format=pcsv
acngalacglcgalgluside_hs,,,-1,C55H95N3O30FULLRCO,,,(Gal)3 (Glc)1 (GlcNAc)1 (Cer)1,,(Gal)3 (Glc)1 (GlcNAc)1 (Cer)1,,,,,2016-11-22T15:12:02Z,,1040,,,,,,acngalacglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/1040/?format=pcsv
fucgalacglc13galacglcgal14acglcgalgluside_hs,,,0,C78H135N4O46FULLRCO,,,(Gal)4 (Glc)1 (GlcNAc)3 (LFuc)1 (Cer)1,,(Gal)4 (Glc)1 (GlcNAc)3 (LFuc)1 (Cer)1,,,,,2016-11-22T15:12:02Z,,1041,,,,,,fucgalacglc13galacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/1041/?format=pcsv
fucfucgalacglc13galacglcgal14acglcgalgluside_hs,,,0,C84H145N4O50FULLRCO,,,(Gal)4 (Glc)1 (GlcNAc)3 (LFuc)2 (Cer)1,,(Gal)4 (Glc)1 (GlcNAc)3 (LFuc)2 (Cer)1,,,,,2016-11-22T15:12:02Z,,1042,,,,,,fucfucgalacglc13galacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/1042/?format=pcsv
acngal14acglcgalgluside_hs,,,-1,C55H95N3O30FULLRCO,CHEBI:36528,,Sialyl-3-paragloboside,,Sialyl-3-paragloboside,,,,,2016-11-22T15:12:02Z,,1043,,,,,,acngal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/1043/?format=pcsv
fucfucgalacglcgal14acglcgalgluside_hs,,,0,C70H122N3O40FULLRCO,,,(Gal)3 (Glc)1 (GlcNAc)2 (LFuc)2 (Cer)1,,(Gal)3 (Glc)1 (GlcNAc)2 (LFuc)2 (Cer)1,,,,,2016-11-22T15:12:02Z,,1044,,,,,,fucfucgalacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/1044/?format=pcsv
fuc132galacglcgal14acglcgalgluside_hs,,,0,C64H112N3O36FULLRCO,,,V3Fuc-nLc6Cer,,V3Fuc-nLc6Cer,,,,,2016-11-22T15:12:02Z,,1045,,,,,,fuc132galacglcgal14acglcgalgluside_hs,,,http://vmh.uni.lu/_api/metabolites/1045/?format=pcsv
m2mpdol_L,,,-20,C1420H2328N20O320P20,,,"(alpha-D-mannosyl)2-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,"(alpha-D-mannosyl)2-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human liver homolog",,,,,2016-11-22T15:12:02Z,,1046,,,,,,m2mpdol_L,,,http://vmh.uni.lu/_api/metabolites/1046/?format=pcsv
m3mpdol_L,,,-20,C1480H2428N20O370P20,,,"(alpha-D-mannosyl)3-beta-D-mannosyl-diacetylchitodiphosphodolichol, human liver homolog",,"(alpha-D-mannosyl)3-beta-D-mannosyl-diacetylchitodiphosphodolichol, human liver homolog",,,,,2016-11-22T15:12:02Z,,1047,,,,,,m3mpdol_L,,,http://vmh.uni.lu/_api/metabolites/1047/?format=pcsv
m2mpdol_U,,,-20,C1365H2240N20O320P20,,,"(alpha-D-mannosyl)2-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,"(alpha-D-mannosyl)2-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, human uterine homolog",,,,,2016-11-22T15:12:02Z,,1048,,,,,,m2mpdol_U,,,http://vmh.uni.lu/_api/metabolites/1048/?format=pcsv
m3mpdol_U,,,-20,C1425H2340N20O370P20,,,"(alpha-D-mannosyl)3-beta-D-mannosyl-diacetylchitodiphosphodolichol, human uterine homolog",,"(alpha-D-mannosyl)3-beta-D-mannosyl-diacetylchitodiphosphodolichol, human uterine homolog",,,,,2016-11-22T15:12:03Z,,1049,,,,,,m3mpdol_U,,,http://vmh.uni.lu/_api/metabolites/1049/?format=pcsv
m1mpdol_L,,,-20,C1360H2228N20O270P20,CHEBI:28067,,"alpha-D-mannosyl-beta-D-mannosyl-diacylchitobiosyldiphosphodolichol, human liver homolog",,"alpha-D-mannosyl-beta-D-mannosyl-diacylchitobiosyldiphosphodolichol, human liver homolog",,,,,2016-11-22T15:12:03Z,,1050,,,,,,m1mpdol_L,,,http://vmh.uni.lu/_api/metabolites/1050/?format=pcsv
m1mpdol_U,,,-20,C1305H2140N20O270P20,,,"alpha-D-mannosyl-beta-D-mannosyl-diacylchitobiosyldiphosphodolichol, human uterine homolog",,"alpha-D-mannosyl-beta-D-mannosyl-diacylchitobiosyldiphosphodolichol, human uterine homolog",,,,,2016-11-22T15:12:03Z,,1051,,,,,,m1mpdol_U,,,http://vmh.uni.lu/_api/metabolites/1051/?format=pcsv
ksi_pre14,,,-5,C143H230N10O114S4X,,,"keratan sulfate I biosynthesis, precursor 14",,"keratan sulfate I biosynthesis, precursor 14",,,,,2016-11-22T15:12:03Z,,1052,,,,,,ksi_pre14,,,http://vmh.uni.lu/_api/metabolites/1052/?format=pcsv
ksi_pre17,,,-6,C157H252N11O127S5X,,,"keratan sulfate I biosynthesis, precursor 17",,"keratan sulfate I biosynthesis, precursor 17",,,,,2016-11-22T15:12:03Z,,1053,,,,,,ksi_pre17,,,http://vmh.uni.lu/_api/metabolites/1053/?format=pcsv
ksi_pre20,,,-7,C171H274N12O140S6X,,,"keratan sulfate I biosynthesis, precursor 20",,"keratan sulfate I biosynthesis, precursor 20",,,,,2016-11-22T15:12:03Z,,1054,,,,,,ksi_pre20,,,http://vmh.uni.lu/_api/metabolites/1054/?format=pcsv
ksi_pre23,,,-8,C185H296N13O153S7X,,,"keratan sulfate I biosynthesis, precursor 23",,"keratan sulfate I biosynthesis, precursor 23",,,,,2016-11-22T15:12:03Z,,1055,,,,,,ksi_pre23,,,http://vmh.uni.lu/_api/metabolites/1055/?format=pcsv
ksi_pre26,,,-9,C199H318N14O166S8X,,,"keratan sulfate I biosynthesis, precursor 26",,"keratan sulfate I biosynthesis, precursor 26",,,,,2016-11-22T15:12:03Z,,1056,,,,,,ksi_pre26,,,http://vmh.uni.lu/_api/metabolites/1056/?format=pcsv
ksi_pre29,,,-10,C213H340N15O179S9X,,,"keratan sulfate I biosynthesis, precursor 29",,"keratan sulfate I biosynthesis, precursor 29",,,,,2016-11-22T15:12:03Z,,1057,,,,,,ksi_pre29,,,http://vmh.uni.lu/_api/metabolites/1057/?format=pcsv
ksi_pre32,,,-11,C227H362N16O192S10X,,,"keratan sulfate I biosynthesis, precursor 32",,"keratan sulfate I biosynthesis, precursor 32",,,,,2016-11-22T15:12:03Z,,1058,,,,,,ksi_pre32,,,http://vmh.uni.lu/_api/metabolites/1058/?format=pcsv
ksi_pre35,,,-12,C241H384N17O205S11X,,,"keratan sulfate I biosynthesis, precursor 35",,"keratan sulfate I biosynthesis, precursor 35",,,,,2016-11-22T15:12:03Z,,1059,,,,,,ksi_pre35,,,http://vmh.uni.lu/_api/metabolites/1059/?format=pcsv
ksi_pre36,,,-12,C247H394N17O210S11X,,,"keratan sulfate I biosynthesis, precursor 36",,"keratan sulfate I biosynthesis, precursor 36",,,,,2016-11-22T15:12:03Z,,1060,,,,,,ksi_pre36,,,http://vmh.uni.lu/_api/metabolites/1060/?format=pcsv
ksii_core4_pre1,,,0,C36H60N3O25X,,,"keratan sulfate II biosynthesis, precursor 1",,"keratan sulfate II biosynthesis, precursor 1",,,,,2016-11-22T15:12:03Z,,1061,,,,,,ksii_core4_pre1,,,http://vmh.uni.lu/_api/metabolites/1061/?format=pcsv
ksii_core4_pre6,,,-2,C69H111N6O51SX,,,"keratan sulfate II biosynthesis, precursor 6",,"keratan sulfate II biosynthesis, precursor 6",,,,,2016-11-22T15:12:03Z,,1062,,,,,,ksii_core4_pre6,,,http://vmh.uni.lu/_api/metabolites/1062/?format=pcsv
ksii_core4_pre9,,,-3,C83H133N7O64S2X,,,"keratan sulfate II biosynthesis, precursor 9",,"keratan sulfate II biosynthesis, precursor 9",,,,,2016-11-22T15:12:03Z,,1063,,,,,,ksii_core4_pre9,,,http://vmh.uni.lu/_api/metabolites/1063/?format=pcsv
ksii_core4_pre10,,,-3,C89H143N7O69S2X,,,"keratan sulfate II biosynthesis, precursor 10",,"keratan sulfate II biosynthesis, precursor 10",,,,,2016-11-22T15:12:03Z,,1064,,,,,,ksii_core4_pre10,,,http://vmh.uni.lu/_api/metabolites/1064/?format=pcsv
ksii_core2_pre1,,,-1,C33H53N3O23X,,,"keratan sulfate II biosynthesis, precursor 1",,"keratan sulfate II biosynthesis, precursor 1",,,,,2016-11-22T15:12:03Z,,1065,,,,,,ksii_core2_pre1,,,http://vmh.uni.lu/_api/metabolites/1065/?format=pcsv
ksii_core2_pre6,,,-2,C61H98N5O46SX,,,"keratan sulfate II biosynthesis, precursor 6",,"keratan sulfate II biosynthesis, precursor 6",,,,,2016-11-22T15:12:03Z,,1066,,,,,,ksii_core2_pre6,,,http://vmh.uni.lu/_api/metabolites/1066/?format=pcsv
ksii_core2_pre9,,,-3,C75H120N6O59S2X,,,"keratan sulfate II biosynthesis, precursor 9",,"keratan sulfate II biosynthesis, precursor 9",,,,,2016-11-22T15:12:03Z,,1067,,,,,,ksii_core2_pre9,,,http://vmh.uni.lu/_api/metabolites/1067/?format=pcsv
ksii_core2_pre10,,,-3,C81H130N6O64S2X,,,"keratan sulfate II biosynthesis, precursor 10",,"keratan sulfate II biosynthesis, precursor 10",,,,,2016-11-22T15:12:03Z,,1068,,,,,,ksii_core2_pre10,,,http://vmh.uni.lu/_api/metabolites/1068/?format=pcsv
ksi_pre5,,,-2,C101H164N7O75SX,,,"keratan sulfate I biosynthesis, precursor 5",,"keratan sulfate I biosynthesis, precursor 5",,,,,2016-11-22T15:12:03Z,,1069,,,,,,ksi_pre5,,,http://vmh.uni.lu/_api/metabolites/1069/?format=pcsv
ksi_pre8,,,-3,C115H186N8O88S2X,,,"keratan sulfate I biosynthesis, precursor 8",,"keratan sulfate I biosynthesis, precursor 8",,,,,2016-11-22T15:12:03Z,,1070,,,,,,ksi_pre8,,,http://vmh.uni.lu/_api/metabolites/1070/?format=pcsv
ksi_pre11,,,-4,C129H208N9O101S3X,,,"keratan sulfate I biosynthesis, precursor 11",,"keratan sulfate I biosynthesis, precursor 11",,,,,2016-11-22T15:12:03Z,,1071,,,,,,ksi_pre11,,,http://vmh.uni.lu/_api/metabolites/1071/?format=pcsv
l2fn2m2masn,,,0,C68H113N4O49X,,,"{[galactosyl-(1,4)-N-Acetyl-glucosaminyl-(1,2)-mannosyl-(1,3)-],[N-acetyl-glucosaminyl-(1,2)-mannosyl-(1,6)-]mannosyl-(1,4)-N-acetyl-glucosaminyl-(1,4)-[fucosyl-(1,6)]-N-acetyl-glucosaminyl}asparagine",,"{[galactosyl-(1,4)-N-Acetyl-glucosaminyl-(1,2)-mannosyl-(1,3)-],[N-acetyl-glucosaminyl-(1,2)-mannosyl-(1,6)-]mannosyl-(1,4)-N-acetyl-glucosaminyl-(1,4)-[fucosyl-(1,6)]-N-acetyl-glucosaminyl}asparagine",,,,,2016-11-22T15:12:03Z,,1072,,,,,,l2fn2m2masn,,,http://vmh.uni.lu/_api/metabolites/1072/?format=pcsv
dtdpglu,,,-2,C16H24N2O16P2,CHEBI:15700,,dTDP-glucose(2-),,dTDP-glucose(2-),,,"InChI=1S/C16H26N2O16P2/c1-6-3-18(16(25)17-14(6)24)10-2-7(20)9(31-10)5-30-35(26,27)34-36(28,29)33-15-13(23)12(22)11(21)8(4-19)32-15/h3,7-13,15,19-23H,2,4-5H2,1H3,(H,26,27)(H,28,29)(H,17,24,25)/p-2/t7-,8+,9+,10+,11+,12-,13+,15+/m0/s1",C00842,2016-11-22T15:12:03Z,,1073,,,,,443210,dtdpglu,,,http://vmh.uni.lu/_api/metabolites/1073/?format=pcsv
glyc3p,,,-2,C3H7O6P,CHEBI:15978,,Glycerol 3-phosphate,,Glycerol 3-phosphate,,,"InChI=1S/C3H9O6P/c4-1-3(5)2-9-10(6,7)8/h3-5H,1-2H2,(H2,6,7,8)/p-2/t3-/m1/s1",C00093,2016-11-22T15:12:03Z,,1074,,,,sn-glycerol 3-phosphate,439162,glyc3p,,,http://vmh.uni.lu/_api/metabolites/1074/?format=pcsv
glu5sa,,,0,C5H9NO3,CHEBI:17232,,L-Glutamate 5-semialdehyde,,L-Glutamate 5-semialdehyde,,,"InChI=1S/C5H9NO3/c6-4(5(8)9)2-1-3-7/h3-4H,1-2,6H2,(H,8,9)/t4-/m0/s1",C01165,2016-11-22T15:12:03Z,,1075,,,,,193305,glu5sa,,,http://vmh.uni.lu/_api/metabolites/1075/?format=pcsv
1pyr5c,,,-1,C5H6NO2,CHEBI:371,,1-Pyrroline-5-carboxylate,,1-Pyrroline-5-carboxylate,,,"InChI=1S/C5H7NO2/c7-5(8)4-2-1-3-6-4/h3-4H,1-2H2,(H,7,8)/p-1",C04322,2016-11-22T15:12:03Z,,1076,,,,,1196,1pyr5c,,,http://vmh.uni.lu/_api/metabolites/1076/?format=pcsv
glu5p,,,-2,C5H8NO7P,CHEBI:17798,,L-Glutamate 5-phosphate,,L-Glutamate 5-phosphate,,,"InChI=1S/C5H10NO7P/c6-3(5(8)9)1-2-4(7)13-14(10,11)12/h3H,1-2,6H2,(H,8,9)(H2,10,11,12)/p-2/t3-/m0/s1",C03287,2016-11-22T15:12:03Z,,1077,,,,,193475,glu5p,,,http://vmh.uni.lu/_api/metabolites/1077/?format=pcsv
6pgl,,,-2,C6H9O9P,CHEBI:16938,,"6-phospho-D-glucono-1,5-lactone",,"6-phospho-D-glucono-1,5-lactone",,,"InChI=1S/C6H11O9P/c7-3-2(1-14-16(11,12)13)15-6(10)5(9)4(3)8/h2-5,7-9H,1H2,(H2,11,12,13)/p-2/t2-,3-,4+,5-/m1/s1",C01236,2016-11-22T15:12:03Z,,1078,,,,"6-O-phosphono-D-glucono-1,5-lactone",439452,6pgl,,,http://vmh.uni.lu/_api/metabolites/1078/?format=pcsv
gudac,,,0,C3H7N3O2,CHEBI:16344,,"Human Metabolome Database (HMDB): Guanidoacetic acid is a metabolite in the Urea cycle and metabolism of amino groups, and in the metabolic pathways of several amino acids. This includes glycine, serine, threonine, arginine and proline metabolism. Guanidinoacetic acid is also a precursor of creatine, an essential substrate for muscle energy metabolism.",,guanidinoacetic acid,,HMDB00128,"InChI=1S/C3H7N3O2/c4-3(5)6-1-2(7)8/h1H2,(H,7,8)(H4,4,5,6)",C00581,2016-12-05T15:48:05Z,,1079,,,,,763,gudac,,"(carboxymethyl)-Guanidine, 2-[[Amino(imino)methyl]amino]acetate, 2-[[Amino(imino)methyl]amino]acetic acid, a-Guanidinoacetate, a-Guanidinoacetic acid, alpha-Guanidinoacetate, alpha-Guanidinoacetic acid, b-Guanidinoacetate, b-Guanidinoacetic acid, beta-Guanidinoacetate, beta-Guanidinoacetic acid, Betacyamine, Betasyamine, Glycocyamine, Guanidineacetate, Guanidineacetic acid, Guanidinoacetate, Guanidinoacetic acid, Guanidoacetate, Guanidoacetic acid, Guanidylacetate, Guanidylacetic acid, Guanyl glycine, N-Amidino-Glycine, N-Amidinoglycine, [(aminoiminomethyl)amino]-Acetate, [(aminoiminomethyl)amino]-Acetic acid",http://vmh.uni.lu/_api/metabolites/1079/?format=pcsv
gacpail_hs,,,0,C31H58NO14PFULLRCO2FULLR2CO2,,,glucosaminyl-acylphosphatidylinositol,,glucosaminyl-acylphosphatidylinositol,,,,,2016-11-22T15:12:03Z,,1080,,,,,,gacpail_hs,,,http://vmh.uni.lu/_api/metabolites/1080/?format=pcsv
ksi_deg26,,,-4,C110H179N7O93S4,,,"keratan sulfate I, degradation product 26",,"keratan sulfate I, degradation product 26",,,,,2016-11-22T15:12:03Z,,1081,,,,,,ksi_deg26,,,http://vmh.uni.lu/_api/metabolites/1081/?format=pcsv
ksi_deg27,,,-4,C104H169N7O88S4,,,"keratan sulfate I, degradation product 27",,"keratan sulfate I, degradation product 27",,,,,2016-11-22T15:12:03Z,,1082,,,,,,ksi_deg27,,,http://vmh.uni.lu/_api/metabolites/1082/?format=pcsv
ksi_deg29,,,-3,C96H157N6O80S3,,,"keratan sulfate I, degradation product 29",,"keratan sulfate I, degradation product 29",,,,,2016-11-22T15:12:03Z,,1083,,,,,,ksi_deg29,,,http://vmh.uni.lu/_api/metabolites/1083/?format=pcsv
ksi_deg30,,,-3,C90H147N6O75S3,,,"keratan sulfate I, degradation product 30",,"keratan sulfate I, degradation product 30",,,,,2016-11-22T15:12:03Z,,1084,,,,,,ksi_deg30,,,http://vmh.uni.lu/_api/metabolites/1084/?format=pcsv
ksi_deg32,,,-2,C82H135N5O67S2,,,"keratan sulfate I, degradation product 32",,"keratan sulfate I, degradation product 32",,,,,2016-11-22T15:12:03Z,,1085,,,,,,ksi_deg32,,,http://vmh.uni.lu/_api/metabolites/1085/?format=pcsv
ksi_deg33,,,-2,C76H125N5O62S2,,,"keratan sulfate I, degradation product 33",,"keratan sulfate I, degradation product 33",,,,,2016-11-22T15:12:03Z,,1086,,,,,,ksi_deg33,,,http://vmh.uni.lu/_api/metabolites/1086/?format=pcsv
ksi_deg35,,,-1,C68H113N4O54S1,,,"keratan sulfate I, degradation product 35",,"keratan sulfate I, degradation product 35",,,,,2016-11-22T15:12:03Z,,1087,,,,,,ksi_deg35,,,http://vmh.uni.lu/_api/metabolites/1087/?format=pcsv
ksi_deg36,,,-1,C62H103N4O49S1,,,"keratan sulfate I, degradation product 36",,"keratan sulfate I, degradation product 36",,,,,2016-11-22T15:12:03Z,,1088,,,,,,ksi_deg36,,,http://vmh.uni.lu/_api/metabolites/1088/?format=pcsv
ksi_deg38,,,0,C54H91N3O41,,,"keratan sulfate I, degradation product 38",,"keratan sulfate I, degradation product 38",,,,,2016-11-22T15:12:03Z,,1089,,,,,,ksi_deg38,,,http://vmh.uni.lu/_api/metabolites/1089/?format=pcsv
ksi_deg39,,,0,C48H81N3O36,,,"keratan sulfate I, degradation product 39",,"keratan sulfate I, degradation product 39",,,,,2016-11-22T15:12:03Z,,1090,,,,,,ksi_deg39,,,http://vmh.uni.lu/_api/metabolites/1090/?format=pcsv
ksi_deg40,,,0,C40H68N2O31,,,"keratan sulfate I, degradation product 40",,"keratan sulfate I, degradation product 40",,,,,2016-11-22T15:12:03Z,,1091,,,,,,ksi_deg40,,,http://vmh.uni.lu/_api/metabolites/1091/?format=pcsv
ksi_deg41,,,0,C34H58N2O26,,,"keratan sulfate I, degradation product 41",,"keratan sulfate I, degradation product 41",,,,,2016-11-22T15:12:03Z,,1092,,,,,,ksi_deg41,,,http://vmh.uni.lu/_api/metabolites/1092/?format=pcsv
ksii_core2_deg2,,,-2,C70H114N5O56S2X,,,"keratan sulfate II (core 2-linked), degradation product 2",,"keratan sulfate II (core 2-linked), degradation product 2",,,,,2016-11-22T15:12:03Z,,1093,,,,,,ksii_core2_deg2,,,http://vmh.uni.lu/_api/metabolites/1093/?format=pcsv
ksii_core2_deg3,,,-2,C58H94N5O46S2X,,,"keratan sulfate II (core 2-linked), degradation product 3",,"keratan sulfate II (core 2-linked), degradation product 3",,,,,2016-11-22T15:12:03Z,,1094,,,,,,ksii_core2_deg3,,,http://vmh.uni.lu/_api/metabolites/1094/?format=pcsv
ksii_core2_deg5,,,-1,C50H82N4O38SX,,,"keratan sulfate II (core 2-linked), degradation product 5",,"keratan sulfate II (core 2-linked), degradation product 5",,,,,2016-11-22T15:12:03Z,,1095,,,,,,ksii_core2_deg5,,,http://vmh.uni.lu/_api/metabolites/1095/?format=pcsv
ksii_core2_deg6,,,-1,C44H72N4O33SX,,,"keratan sulfate II (core 2-linked), degradation product 6",,"keratan sulfate II (core 2-linked), degradation product 6",,,,,2016-11-22T15:12:03Z,,1096,,,,,,ksii_core2_deg6,,,http://vmh.uni.lu/_api/metabolites/1096/?format=pcsv
ksii_core2_deg8,,,0,C36H60N3O25X,,,"keratan sulfate II (core 2-linked), degradation product 8",,"keratan sulfate II (core 2-linked), degradation product 8",,,,,2016-11-22T15:12:03Z,,1097,,,,,,ksii_core2_deg8,,,http://vmh.uni.lu/_api/metabolites/1097/?format=pcsv
ksii_core2_deg9,,,0,C30H50N3O20X,,,"keratan sulfate II (core 2-linked), degradation product 9",,"keratan sulfate II (core 2-linked), degradation product 9",,,,,2016-11-22T15:12:03Z,,1098,,,,,,ksii_core2_deg9,,,http://vmh.uni.lu/_api/metabolites/1098/?format=pcsv
l2n2m2mn,,,0,C54H91N3O41,,,"de-Fuc, reducing GlcNAc removed, de-Sia form of PA6 (w/o peptide linkage)",,"de-Fuc, reducing GlcNAc removed, de-Sia form of PA6 (w/o peptide linkage)",,,,,2016-11-22T15:12:03Z,,1099,,,,,,l2n2m2mn,,,http://vmh.uni.lu/_api/metabolites/1099/?format=pcsv
ksii_core4_deg2,,,-2,C78H127N6O61S2X,,,"keratan sulfate II (core 4-linked), degradation product 2",,"keratan sulfate II (core 4-linked), degradation product 2",,,,,2016-11-22T15:12:03Z,,1100,,,,,,ksii_core4_deg2,,,http://vmh.uni.lu/_api/metabolites/1100/?format=pcsv
ksii_core4_deg3,,,-2,C66H107N6O51S2X,,,"keratan sulfate II (core 4-linked), degradation product 3",,"keratan sulfate II (core 4-linked), degradation product 3",,,,,2016-11-22T15:12:03Z,,1101,,,,,,ksii_core4_deg3,,,http://vmh.uni.lu/_api/metabolites/1101/?format=pcsv
ksi_deg5,,,-11,C222H356N15O194S11,,,"keratan sulfate I, degradation product 5",,"keratan sulfate I, degradation product 5",,,,,2016-11-22T15:12:03Z,,1102,,,,,,ksi_deg5,,,http://vmh.uni.lu/_api/metabolites/1102/?format=pcsv
ksi_deg6,,,-11,C210H336N15O184S11,,,"keratan sulfate I, degradation product 6",,"keratan sulfate I, degradation product 6",,,,,2016-11-22T15:12:03Z,,1103,,,,,,ksi_deg6,,,http://vmh.uni.lu/_api/metabolites/1103/?format=pcsv
ksi_deg8,,,-10,C194H311N13O171S10,,,"keratan sulfate I, degradation product 8",,"keratan sulfate I, degradation product 8",,,,,2016-11-22T15:12:03Z,,1104,,,,,,ksi_deg8,,,http://vmh.uni.lu/_api/metabolites/1104/?format=pcsv
ksi_deg9,,,-10,C188H301N13O166S10,,,"keratan sulfate I, degradation product 9",,"keratan sulfate I, degradation product 9",,,,,2016-11-22T15:12:03Z,,1105,,,,,,ksi_deg9,,,http://vmh.uni.lu/_api/metabolites/1105/?format=pcsv
ksi_deg11,,,-9,C180H289N12O158S9,,,"keratan sulfate I, degradation product 11",,"keratan sulfate I, degradation product 11",,,,,2016-11-22T15:12:03Z,,1106,,,,,,ksi_deg11,,,http://vmh.uni.lu/_api/metabolites/1106/?format=pcsv
ksi_deg12,,,-9,C174H279N12O153S9,,,"keratan sulfate I, degradation product 12",,"keratan sulfate I, degradation product 12",,,,,2016-11-22T15:12:03Z,,1107,,,,,,ksi_deg12,,,http://vmh.uni.lu/_api/metabolites/1107/?format=pcsv
ksi_deg14,,,-8,C166H267N11O145S8,,,"keratan sulfate I, degradation product 14",,"keratan sulfate I, degradation product 14",,,,,2016-11-22T15:12:03Z,,1108,,,,,,ksi_deg14,,,http://vmh.uni.lu/_api/metabolites/1108/?format=pcsv
ksi_deg15,,,-8,C160H257N11O140S8,,,"keratan sulfate I, degradation product 15",,"keratan sulfate I, degradation product 15",,,,,2016-11-22T15:12:03Z,,1109,,,,,,ksi_deg15,,,http://vmh.uni.lu/_api/metabolites/1109/?format=pcsv
ksi_deg17,,,-7,C152H245N10O132S7,,,"keratan sulfate I, degradation product 17",,"keratan sulfate I, degradation product 17",,,,,2016-11-22T15:12:03Z,,1110,,,,,,ksi_deg17,,,http://vmh.uni.lu/_api/metabolites/1110/?format=pcsv
ksi_deg18,,,-7,C146H235N10O127S7,,,"keratan sulfate I, degradation product 18",,"keratan sulfate I, degradation product 18",,,,,2016-11-22T15:12:03Z,,1111,,,,,,ksi_deg18,,,http://vmh.uni.lu/_api/metabolites/1111/?format=pcsv
ksi_deg20,,,-6,C138H223N9O119S6,,,"keratan sulfate I, degradation product 20",,"keratan sulfate I, degradation product 20",,,,,2016-11-22T15:12:03Z,,1112,,,,,,ksi_deg20,,,http://vmh.uni.lu/_api/metabolites/1112/?format=pcsv
ksi_deg21,,,-6,C132H213N9O114S6,,,"keratan sulfate I, degradation product 21",,"keratan sulfate I, degradation product 21",,,,,2016-11-22T15:12:03Z,,1113,,,,,,ksi_deg21,,,http://vmh.uni.lu/_api/metabolites/1113/?format=pcsv
ksi_deg23,,,-5,C124H201N8O106S5,,,"keratan sulfate I, degradation product 23",,"keratan sulfate I, degradation product 23",,,,,2016-11-22T15:12:04Z,,1114,,,,,,ksi_deg23,,,http://vmh.uni.lu/_api/metabolites/1114/?format=pcsv
ksi_deg24,,,-5,C118H191N8O101S5,,,"keratan sulfate I, degradation product 24",,"keratan sulfate I, degradation product 24",,,,,2016-11-22T15:12:04Z,,1115,,,,,,ksi_deg24,,,http://vmh.uni.lu/_api/metabolites/1115/?format=pcsv
gm3_hs,,,-1,C41H72N2O20FULLRCO,CHEBI:15681,,alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide(1-),,alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide(1-),,,,,2016-11-22T15:12:04Z,,1116,,,,,,gm3_hs,,,http://vmh.uni.lu/_api/metabolites/1116/?format=pcsv
gd3_hs,,,-2,C52H88N3O28FULLRCO,CHEBI:28424,,GD3,,GD3,,,,,2016-11-22T15:12:04Z,,1117,,,,,,gd3_hs,,,http://vmh.uni.lu/_api/metabolites/1117/?format=pcsv
gt3_hs,,,-3,C63H104N4O36FULLRCO,CHEBI:28541,,GT3,,GT3,,,,,2016-11-22T15:12:04Z,,1118,,,,,,gt3_hs,,,http://vmh.uni.lu/_api/metabolites/1118/?format=pcsv
gal1p,,,-2,C6H11O9P,,,"(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl phosphate",,"(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl phosphate",,,"InChI=1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/p-2/t2-,3+,4+,5-,6-/m1/s1",C00446,2016-11-22T15:12:04Z,,1119,,,,,123912,gal1p,,,http://vmh.uni.lu/_api/metabolites/1119/?format=pcsv
cs_hs_linkage,,,-1,C23H36O20X,,,chondroitin sulfate/heparan sulfate linkage region (GlcA-(Gal)2-Xyl-L-Ser (protein)),,chondroitin sulfate/heparan sulfate linkage region (GlcA-(Gal)2-Xyl-L-Ser (protein)),,,,,2016-11-22T15:12:04Z,,1120,,,,,,cs_hs_linkage,,,http://vmh.uni.lu/_api/metabolites/1120/?format=pcsv
cs_pre,,,-1,C31H49NO25X,,,chondroitin sulfate precursor (GalNAc-GlcA-(Gal)2-Xyl-L-Ser (protein)),,chondroitin sulfate precursor (GalNAc-GlcA-(Gal)2-Xyl-L-Ser (protein)),,,,C04893,2016-11-22T15:12:04Z,,1121,,,,,,cs_pre,,,http://vmh.uni.lu/_api/metabolites/1121/?format=pcsv
cs_a_b_pre2,,,-4,C37H54NO37S2X,,,"chondroitin sulfate A (GalNAc4S-GlcA) and B (IdoA2S-GalNAc4S), precursor 2",,"chondroitin sulfate A (GalNAc4S-GlcA) and B (IdoA2S-GalNAc4S), precursor 2",,,,,2016-11-22T15:12:04Z,,1122,,,,,,cs_a_b_pre2,,,http://vmh.uni.lu/_api/metabolites/1122/?format=pcsv
cs_a_b_pre3,,,-4,C45H67N2O42S2X,,,"chondroitin sulfate A (GalNAc4S-GlcA) and B (IdoA2S-GalNAc4S), precursor 3",,"chondroitin sulfate A (GalNAc4S-GlcA) and B (IdoA2S-GalNAc4S), precursor 3",,,,,2016-11-22T15:12:04Z,,1123,,,,,,cs_a_b_pre3,,,http://vmh.uni.lu/_api/metabolites/1123/?format=pcsv
cs_c_pre2,,,-4,C37H54NO37S2X,,,"chondroitin sulfate C (GalNAc6S-GlcA), precursor 2",,"chondroitin sulfate C (GalNAc6S-GlcA), precursor 2",,,,,2016-11-22T15:12:04Z,,1124,,,,,,cs_c_pre2,,,http://vmh.uni.lu/_api/metabolites/1124/?format=pcsv
cs_c_pre3,,,-4,C45H67N2O42S2X,,,"chondroitin sulfate C (GalNAc6S-GlcA), precursor 3",,"chondroitin sulfate C (GalNAc6S-GlcA), precursor 3",,,,,2016-11-22T15:12:04Z,,1125,,,,,,cs_c_pre3,,,http://vmh.uni.lu/_api/metabolites/1125/?format=pcsv
cs_d_pre3,,,-5,C37H53NO40S3X,,,"chondroitin sulfate D (GlcNAc6S-GlcA2S), precursor 3",,"chondroitin sulfate D (GlcNAc6S-GlcA2S), precursor 3",,,,,2016-11-22T15:12:04Z,,1126,,,,,,cs_d_pre3,,,http://vmh.uni.lu/_api/metabolites/1126/?format=pcsv
cs_d_pre4,,,-5,C45H66N2O45S3X,,,"chondroitin sulfate D (GlcNAc6S-GlcA2S), precursor 4",,"chondroitin sulfate D (GlcNAc6S-GlcA2S), precursor 4",,,,,2016-11-22T15:12:04Z,,1127,,,,,,cs_d_pre4,,,http://vmh.uni.lu/_api/metabolites/1127/?format=pcsv
cs_e_pre3,,,-6,C37H52NO43S4X,,,"chondroitin sulfate E (GalNAc4,6diS-GlcA), precursor 3",,"chondroitin sulfate E (GalNAc4,6diS-GlcA), precursor 3",,,,,2016-11-22T15:12:04Z,,1128,,,,,,cs_e_pre3,,,http://vmh.uni.lu/_api/metabolites/1128/?format=pcsv
cs_e_pre4,,,-6,C45H65N2O48S4X,,,"chondroitin sulfate E (GalNAc4,6diS-GlcA), precursor 4",,"chondroitin sulfate E (GalNAc4,6diS-GlcA), precursor 4",,,,,2016-11-22T15:12:04Z,,1129,,,,,,cs_e_pre4,,,http://vmh.uni.lu/_api/metabolites/1129/?format=pcsv
galt,,,0,C6H14O6,CHEBI:16813,,Human Metabolome Database (HMDB): Galactitol is a naturally occurring product of plants obtained following reduction of galactose. It appears as a white crystalline powder with a slight sweet taste. It may form in excess in the lens of the eye in galactosemias a deficiency of galactokinase.,,galactitol,,HMDB00107,"InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4+,5+,6-",C01697,2016-12-05T15:48:05Z,,1130,,,,,11850,galt,,"Ambap5938, D-Dulcitol, Dulcite, Dulcitol, Dulcose, Euonymit, Galactitol, Hexitol, Melampyrin, Melampyrit, Melampyrite, Melampyrum, Meso-galactitol",http://vmh.uni.lu/_api/metabolites/1130/?format=pcsv
lxser,,,0,C11H19O9X,,,Gal-Xyl-L-Ser (protein),,Gal-Xyl-L-Ser (protein),,,,C01287,2016-11-22T15:12:04Z,,1131,,,,,,lxser,,,http://vmh.uni.lu/_api/metabolites/1131/?format=pcsv
l2xser,,,0,C17H29O14X,,,(Gal)2-Xyl-L-Ser (protein),,(Gal)2-Xyl-L-Ser (protein),,,,C04825,2016-11-22T15:12:04Z,,1132,,,,,,l2xser,,,http://vmh.uni.lu/_api/metabolites/1132/?format=pcsv
xser,,,0,C5H9O4X,,,Xyl-L-Ser (protein),,Xyl-L-Ser (protein),,,,C03424,2016-11-22T15:12:04Z,,1133,,,,,,xser,,,http://vmh.uni.lu/_api/metabolites/1133/?format=pcsv
udpg,,,-2,C15H22N2O17P2,CHEBI:18066,,UDPglucose,,UDPglucose,,,"InChI=1S/C15H24N2O17P2/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25)/p-2/t5-,6-,8-,9-,10+,11-,12-,13-,14?/m1/s1",C00029,2016-11-22T15:12:04Z,,1134,,,,,53477679,udpg,,,http://vmh.uni.lu/_api/metabolites/1134/?format=pcsv
gar,,,-1,C7H14N2O8P,CHEBI:18349,,N1-(5-Phospho-D-ribosyl)glycinamide,,N1-(5-Phospho-D-ribosyl)glycinamide,,,"InChI=1S/C7H15N2O8P/c8-1-4(10)9-7-6(12)5(11)3(17-7)2-16-18(13,14)15/h3,5-7,11-12H,1-2,8H2,(H,9,10)(H2,13,14,15)/p-1/t3-,5-,6-,7?/m1/s1",C03838,2016-11-22T15:12:04Z,,1135,,,,,160913,gar,,,http://vmh.uni.lu/_api/metabolites/1135/?format=pcsv
fgam,,,-2,C8H13N2O9P,CHEBI:18272,,N2-Formyl-N1-(5-phospho-D-ribosyl)glycinamide,,N2-Formyl-N1-(5-phospho-D-ribosyl)glycinamide,,,"InChI=1S/C8H15N2O9P/c11-3-9-1-5(12)10-8-7(14)6(13)4(19-8)2-18-20(15,16)17/h3-4,6-8,13-14H,1-2H2,(H,9,11)(H,10,12)(H2,15,16,17)/p-2/t4-,6-,7-,8?/m1/s1",C04376,2016-11-22T15:12:04Z,,1136,,,,,130805,fgam,,,http://vmh.uni.lu/_api/metabolites/1136/?format=pcsv
glyclt,,,-1,C2H3O3,CHEBI:17497,,"Human Metabolome Database (HMDB): Glycolic acid (or hydroxyacetic acid) is the smallest alpha-hydroxy acid (AHA). In its pure form, glycolic acid is a colorless crystalline solid. Due to its excellent capability to penetrate skin, glycolic acid finds applications in skin care products, most often as a chemical peel. Glycolic acid is also used for tattoo removal.",,glycolate,,HMDB00115,"InChI=1S/C2H4O3/c3-1-2(4)5/h3H,1H2,(H,4,5)/p-1",C00160,2016-12-05T15:48:05Z,,1137,,,,,757,glyclt,,"2-Hydroxyacetate, 2-Hydroxyacetic acid, a-Hydroxyacetate, a-Hydroxyacetic acid, alpha-Hydroxyacetate, alpha-Hydroxyacetic acid, Glycocide, Glycolate, Glycolic acid, Glycollate, Glycollic acid, GlyPure, GlyPure 70, Hydroxyacetate, Hydroxyacetic acid, Hydroxyethanoate, Hydroxyethanoic acid, Sodium glycolate",http://vmh.uni.lu/_api/metabolites/1137/?format=pcsv
lpam,,,0,C8H15NOS2,,,lipoamide,,lipoamide,,,"InChI=1S/C8H15NOS2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H2,9,10)",C00248,2016-11-22T15:12:04Z,,1138,,,,,863,lpam,,,http://vmh.uni.lu/_api/metabolites/1138/?format=pcsv
alpam,,,1,C9H21N2OS2,CHEBI:50622,,"Human Metabolome Database (HMDB): S-aminomethyldihydrolipoamide is an intermediate in the glycine, serine, threonine metabolism pathway. The enzyme glycine dehydrogenase (decarboxylating) [EC:1.4.4.2] catalyzes the production and consumption of this metabolite in the mitochondria (reversible reaction).",,S-aminomethyldihydrolipoamide,,HMDB06239,"InChI=1/C9H20N2OS2/c10-7-14-6-5-8(13)3-1-2-4-9(11)12/h8,13H,1-7,10H2,(H2,11,12)",,2016-12-05T15:48:05Z,,1139,,,,,24906333,alpam,,8-[(Aminomethyl)sulfanyl]-6-sulfanyloctanamide,http://vmh.uni.lu/_api/metabolites/1139/?format=pcsv
dhlam,,,0,C8H17NOS2,CHEBI:17694,,"Human Metabolome Database (HMDB): Dihydrolipoamide is an intermediate in glycolysis/gluconeogenesis, citrate cycle (TCA cycle), alanine, aspartate and pyruvate metabolism, and valine, leucine and isoleucine degradation (KEGG ID C00579). It is converted to lipoamide via the enzyme dihydrolipoamide dehydrogenase [EC:1.8.1.4]. Dihydrolipoamide is also a substrate of enzyme Acyltransferases [EC 2.3.1.-]. (KEGG).",,dihydrolipoamide,,HMDB00985,"InChI=1S/C8H17NOS2/c9-8(10)4-2-1-3-7(12)5-6-11/h7,11-12H,1-6H2,(H2,9,10)",C00579,2016-12-05T15:48:05Z,,1140,,,,,663,dhlam,,"6,8-Bis-sulfanyloctanamide, 6,8-Dimercapto-Octanamide, 6,8-Dimercaptooctanamide, 6,8-Disulfanyloctanamide, Dihydrolipoamide, Dihydrothioctamide",http://vmh.uni.lu/_api/metabolites/1140/?format=pcsv
lpro,,,0,S2X,CHEBI:15804,,Lipoylprotein,,Lipoylprotein,,,,,2016-11-22T15:12:04Z,,1141,,,,,,lpro,,,http://vmh.uni.lu/_api/metabolites/1141/?format=pcsv
alpro,,,1,CH6NS2X,CHEBI:16882,,S-Aminomethyldihydrolipoylprotein,,S-Aminomethyldihydrolipoylprotein,,,,,2016-11-22T15:12:04Z,,1142,,,,,,alpro,,,http://vmh.uni.lu/_api/metabolites/1142/?format=pcsv
dhlpro,,,0,H2S2X,CHEBI:16194,,Dihydrolipolprotein,,Dihydrolipolprotein,,,,,2016-11-22T15:12:04Z,,1143,,,,,,dhlpro,,,http://vmh.uni.lu/_api/metabolites/1143/?format=pcsv
gdpddman,,,-2,C16H21N5O15P2,CHEBI:16955,,GDP-4-dehydro-6-deoxy-alpha-D-mannose(2-),,GDP-4-dehydro-6-deoxy-alpha-D-mannose(2-),,,"InChI=1S/C16H23N5O15P2/c1-4-7(22)9(24)11(26)15(33-4)35-38(30,31)36-37(28,29)32-2-5-8(23)10(25)14(34-5)21-3-18-6-12(21)19-16(17)20-13(6)27/h3-5,8-11,14-15,23-26H,2H2,1H3,(H,28,29)(H,30,31)(H3,17,19,20,27)/p-2/t4-,5-,8-,9+,10-,11+,14-,15-/m1/s1",C01222,2016-11-22T15:12:04Z,,1144,,,,,439446,gdpddman,,,http://vmh.uni.lu/_api/metabolites/1144/?format=pcsv
5oxpro,,,-1,C5H6NO3,CHEBI:16010,,"Human Metabolome Database (HMDB): Pyroglutamic acid is a cyclized derivative of L-glutamic acid. It is an uncommon amino acid derivative in which the free amino group of glutamic acid cyclizes to form a lactam. It is formed nonenzymatically from glutamate, glutamine, and gamma-glutamylated peptides, but it can also be produced by the action of gamma-glutamylcyclotransferase on an L-amino acid. Elevated blood levels may be associated with problems of glutamine or glutathione metabolism. This compound is found in substantial amounts in brain tissue and other tissue in bound form, especially skin. Also present in plant tissues. It is sold, over the counter, as a ""smart drug"" for improving blood circulation in the brain.",,5-oxoprolinate,,HMDB00267,"InChI=1S/C5H7NO3/c7-4-2-1-3(6-4)5(8)9/h3H,1-2H2,(H,6,7)(H,8,9)/p-1",C01879,2016-12-05T15:48:05Z,,1145,,,,,7405,5oxpro,,"(-)-2-Pyrrolidone-5-carboxylate, (-)-2-Pyrrolidone-5-carboxylic acid, (-)-Pyroglutamate, (-)-Pyroglutamic acid, (5S)-2-Oxopyrrolidine-5-carboxylate, (5S)-2-Oxopyrrolidine-5-carboxylic acid, (S)-(-)-2-Pyrrolidone-5-carboxylate, (S)-(-)-2-Pyrrolidone-5-carboxylic acid, (S)-(-)-g-Butyrolactam-g-carboxylate, (S)-(-)-g-Butyrolactam-g-carboxylic acid, (S)-(-)-gamma-Butyrolactam-gamma-carboxylate, (S)-(-)-gamma-Butyrolactam-gamma-carboxylic acid, (S)-2-Pyrrolidone-5-carboxylate, (S)-2-Pyrrolidone-5-carboxylic acid, (S)-5-Oxo-2-pyrrolidinecarboxylate, (S)-5-Oxo-2-pyrrolidinecarboxylic acid, (S)-Pyroglutamate, (S)-Pyroglutamic acid, 2-L-Pyrrolidone-5-carboxylate, 2-L-Pyrrolidone-5-carboxylic acid, 2-Oxopyrrolidine-5(S)-carboxylate, 2-Oxopyrrolidine-5(S)-carboxylic acid, 2-Pyrrolidinone-5-carboxylate, 2-Pyrrolidinone-5-carboxylic acid, 5-Carboxy-2-pyrrolidinone, 5-L-Oxoproline, 5-Oxo-L-proline, 5-Oxoproline, 5-Pyrrolidinone-2-carboxylate, 5-Pyrrolidinone-2-carboxylic acid, Ajidew A 100, Glutimate, Glutimic acid, Glutiminate, Glutiminic acid, L-2-Pyrrolidone-5-carboxylate, L-2-Pyrrolidone-5-carboxylic acid, L-5-Carboxy-2-pyrrolidinone, L-5-Oxo-2-pyrrolidinecarboxylate, L-5-Oxo-2-pyrrolidinecarboxylic acid, L-5-Oxoproline, L-Glutamic acid g-lactam, L-Glutimate, L-Glutimic acid, L-Glutiminate, L-Glutiminic acid, L-Pyroglutamate, L-Pyroglutamic acid, L-Pyrrolidinonecarboxylate, L-Pyrrolidinonecarboxylic acid, L-Pyrrolidonecarboxylate, L-Pyrrolidonecarboxylic acid, Oxoproline, Oxopyrrolidinecarboxylate, Oxopyrrolidinecarboxylic acid, Pidolate, Pidolic acid, Pidolidone, Pyroglutamate, Pyroglutamic acid, Pyrrolidinonecarboxylate, Pyrrolidinonecarboxylic acid, Pyrrolidone-5-carboxylate, Pyrrolidone-5-carboxylic acid, Pyrrolidonecarboxylic acid",http://vmh.uni.lu/_api/metabolites/1145/?format=pcsv
ggn,,,0,C48H81O41X,,,"primed glycogenin (glycogenin-8[1,4-Glc])",,"primed glycogenin (glycogenin-8[1,4-Glc])",,,,,2016-11-22T15:12:04Z,,1146,,,,,,ggn,,,http://vmh.uni.lu/_api/metabolites/1146/?format=pcsv
3htmelys,,,0,C9H20N2O3,CHEBI:57515,,"3-Hydroxy-N6,N6,N6-trimethyl-L-lysine",,"3-Hydroxy-N6,N6,N6-trimethyl-L-lysine",,,"InChI=1S/C9H20N2O3/c1-11(2,3)6-4-5-7(12)8(10)9(13)14/h7-8,12H,4-6,10H2,1-3H3/p+1/t7?,8-/m0/s1",C01259,2016-11-22T15:12:04Z,,1147,,,,,439460,3htmelys,,,http://vmh.uni.lu/_api/metabolites/1147/?format=pcsv
4tmeabut,,,1,C7H16NO,CHEBI:18020,,4-trimethylammoniobutanal,,4-trimethylammoniobutanal,,,"InChI=1S/C7H16NO/c1-8(2,3)6-4-5-7-9/h7H,4-6H2,1-3H3/q+1",C01149,2016-11-22T15:12:04Z,,1148,,,,,133,4tmeabut,,,http://vmh.uni.lu/_api/metabolites/1148/?format=pcsv
glac,,,0,C6H8O6,CHEBI:18268,,"Human Metabolome Database (HMDB): D-glucurono-6,3-lactone participates in ascorbate and aldarate metabolism. D-glucurono-6,3-lactone is produced by the reaction between D-glucaric acid and the enzyme, aldehyde dehydrogenase (NAD+) [EC: 1.2.1.3].",,"D-glucurono-6,3-lactone",,HMDB06355,"InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h1-5,8-10H/t2-,3+,4-,5+/m0/s1",C02670,2016-12-05T15:48:05Z,,1149,,,,,92283,glac,,"D-Glucurone, D-Glucuronic acid, D-Glucuronic acid lactone (van), D-Glucurono-3,6-lactone, D-Glucuronolactone, Dicurone, Glucofuranurono-6,3-lactone, Glucoxy, Glucurolactone, Glucuron, Glucurone, Glucuronic acid lactone, Glucuronolactone (van), Glucuronosan, Gluronsan, Glycurone, Guronsan (van), Reulatt S.S.",http://vmh.uni.lu/_api/metabolites/1149/?format=pcsv
glcr,,,-2,C6H8O8,CHEBI:16002,,Human Metabolome Database (HMDB): Glucaric acid is a sugar acid derived from D-glucose in which both the aldehydic carbon atom and the carbon atom bearing the primary hydroxyl group are oxidized to carboxylic acid groups.,,D-glucarate(2-),,HMDB00663,"InChI=1S/C6H10O8/c7-1(3(9)5(11)12)2(8)4(10)6(13)14/h1-4,7-10H,(H,11,12)(H,13,14)/p-2/t1-,2-,3-,4+/m0/s1",C00818,2016-12-05T15:48:05Z,,1150,,,,,33037,glcr,,"(2R,3S,4S,5S)-2,3,4,5-tetrahydroxyhexanedioate, (2R,3S,4S,5S)-2,3,4,5-tetrahydroxyhexanedioic acid, D-(+)-Saccharate, D-(+)-Saccharic acid, D-Glucarate, D-Glucaric acid, D-Glucosaccharate, D-Glucosaccharic acid, D-Saccharate, D-Saccharic acid, D-Tetrahydroxyadipate, D-Tetrahydroxyadipic acid, DL-glucaric acid, GKR, Glucarate, Glucosaccharic acid, L-Gularate, L-Gularic acid, Saccharic acid, Tetrahydroxyadipic acid",http://vmh.uni.lu/_api/metabolites/1150/?format=pcsv
glygn1,,,0,C66H111O56X,,,"glycogen, structure 1 (glycogenin-11[1,4-Glc])",,"glycogen, structure 1 (glycogenin-11[1,4-Glc])",,,,,2016-11-22T15:12:04Z,,1151,,,,,,glygn1,,,http://vmh.uni.lu/_api/metabolites/1151/?format=pcsv
hs_deg9,,,-10,C61H87N3O76S8,,,"heparan sulfate, degradation product 9",,"heparan sulfate, degradation product 9",,,,,2016-11-22T15:12:04Z,,1152,,,,,,hs_deg9,,,http://vmh.uni.lu/_api/metabolites/1152/?format=pcsv
glcur,,,-1,C6H9O7,CHEBI:4178,,"Human Metabolome Database (HMDB): Glucuronic acid is a carboxylic acid that has the structure of a glucose molecule that has had its sixth carbon atom (of six total) oxidized. The salts of glucuronic acid are known as glucuronates. Glucuronic acid is highly soluble in water. In humans, glucuronic acid is often linked to toxic or poisonous substances to allow for subsequent elimination, and to hormones to allow for easier transport. These linkages involve O-glycosidic bonds. The process is known as glucuronidation, and the resulting substances are known as glucuronides (or glucuronosides). Glucuronidation uses UDP-glucuronic acid (glucuronic acid linked via a glycosidic bond to uridine diphosphate) as an intermediate. UDP-glucuronic acid is formed in the liver of all animals.",,D-glucuronate,,HMDB00127,,C00191,2016-12-05T15:48:05Z,,1153,,,,,444791,glcur,,"alpha-D-Glucopyranuronic acid, alpha-D-Glucuronic acid, alpha-delta-Glucopyranuronic acid, alpha-delta-Glucuronic acid, D-(+)-Glucuronate, D-(+)-Glucuronic acid, D-Glucuronate, delta-(+)-Glucuronate, delta-(+)-Glucuronic acid, delta-Glucuronate, GCU, Glucosiduronate, Glucosiduronic acid, Glucuronate, Glucuronic acid",http://vmh.uni.lu/_api/metabolites/1153/?format=pcsv
hs_deg10,,,-9,C55H80N3O70S8,,,"heparan sulfate, degradation product 10",,"heparan sulfate, degradation product 10",,,,,2016-11-22T15:12:04Z,,1154,,,,,,hs_deg10,,,http://vmh.uni.lu/_api/metabolites/1154/?format=pcsv
cs_a_deg2,,,-4,C37H55NO38S2,,,"chondroitin sulfate A (GalNAc4S-GlcA), degradation product 2",,"chondroitin sulfate A (GalNAc4S-GlcA), degradation product 2",,,,,2016-11-22T15:12:04Z,,1155,,,,,,cs_a_deg2,,,http://vmh.uni.lu/_api/metabolites/1155/?format=pcsv
cs_a_deg3,,,-3,C31H48NO32S2,,,"chondroitin sulfate A (GalNAc4S-GlcA), degradation product 3",,"chondroitin sulfate A (GalNAc4S-GlcA), degradation product 3",,,,,2016-11-22T15:12:04Z,,1156,,,,,,cs_a_deg3,,,http://vmh.uni.lu/_api/metabolites/1156/?format=pcsv
cs_c_deg2,,,-4,C37H55NO38S2,,,"chondroitin sulfate C (GalNAc6S-GlcA), degradation product 2",,"chondroitin sulfate C (GalNAc6S-GlcA), degradation product 2",,,,,2016-11-22T15:12:04Z,,1157,,,,,,cs_c_deg2,,,http://vmh.uni.lu/_api/metabolites/1157/?format=pcsv
cs_c_deg3,,,-3,C31H48NO32S2,,,"chondroitin sulfate C (GalNAc6S-GlcA), degradation product 3",,"chondroitin sulfate C (GalNAc6S-GlcA), degradation product 3",,,,,2016-11-22T15:12:04Z,,1158,,,,,,cs_c_deg3,,,http://vmh.uni.lu/_api/metabolites/1158/?format=pcsv
cs_d_deg3,,,-5,C37H54NO41S3,,,"chondroitin sulfate D (GlcNAc6S-GlcA2S), degradation product 3",,"chondroitin sulfate D (GlcNAc6S-GlcA2S), degradation product 3",,,,,2016-11-22T15:12:04Z,,1159,,,,,,cs_d_deg3,,,http://vmh.uni.lu/_api/metabolites/1159/?format=pcsv
cs_d_deg4,,,-4,C31H47NO35S3,,,"chondroitin sulfate D (GlcNAc6S-GlcA2S), degradation product 4",,"chondroitin sulfate D (GlcNAc6S-GlcA2S), degradation product 4",,,,,2016-11-22T15:12:04Z,,1160,,,,,,cs_d_deg4,,,http://vmh.uni.lu/_api/metabolites/1160/?format=pcsv
cs_e_deg3,,,-6,C37H53NO44S4,,,"chondroitin sulfate E (GalNAc4,6diS-GlcA), degradation product 3",,"chondroitin sulfate E (GalNAc4,6diS-GlcA), degradation product 3",,,,,2016-11-22T15:12:04Z,,1161,,,,,,cs_e_deg3,,,http://vmh.uni.lu/_api/metabolites/1161/?format=pcsv
cs_e_deg4,,,-5,C31H46NO38S4,,,"chondroitin sulfate E (GalNAc4,6diS-GlcA), degradation product 4",,"chondroitin sulfate E (GalNAc4,6diS-GlcA), degradation product 4",,,,,2016-11-22T15:12:04Z,,1162,,,,,,cs_e_deg4,,,http://vmh.uni.lu/_api/metabolites/1162/?format=pcsv
ha_deg1,,,-1,C22H33N2O16,,,hyaluronan degradation product 1,,hyaluronan degradation product 1,,,,,2016-11-22T15:12:04Z,,1163,,,,,,ha_deg1,,,http://vmh.uni.lu/_api/metabolites/1163/?format=pcsv
cs_b_pre4,,,-4,C45H67N2O42S2X,,,"chondroitin sulfate B (IdoA2S-GalNAc4S), precursor 4",,"chondroitin sulfate B (IdoA2S-GalNAc4S), precursor 4",,,,,2016-11-22T15:12:04Z,,1164,,,,,,cs_b_pre4,,,http://vmh.uni.lu/_api/metabolites/1164/?format=pcsv
hs_pre10,,,-5,C79H121N5O77S4X,,,(GlcN2S-GlcA)4-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,(GlcN2S-GlcA)4-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,,,,2016-11-22T15:12:04Z,,1165,,,,,,hs_pre10,,,http://vmh.uni.lu/_api/metabolites/1165/?format=pcsv
hs_pre11,,,-5,C79H121N5O77S4X,,,(GlcN2S-IdoA-GlcN2S-GlcA)2-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,(GlcN2S-IdoA-GlcN2S-GlcA)2-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,,,,2016-11-22T15:12:04Z,,1166,,,,,,hs_pre11,,,http://vmh.uni.lu/_api/metabolites/1166/?format=pcsv
cs_a_b_e_pre1,,,-3,C31H47NO31S2X,,,"chondroitin sulfate A (GalNAc4S-GlcA), B (IdoA2S-GalNAc4S), and E (GalNAc4,6diS-GlcA), precursor 1",,"chondroitin sulfate A (GalNAc4S-GlcA), B (IdoA2S-GalNAc4S), and E (GalNAc4,6diS-GlcA), precursor 1",,,,,2016-11-22T15:12:04Z,,1167,,,,,,cs_a_b_e_pre1,,,http://vmh.uni.lu/_api/metabolites/1167/?format=pcsv
udpglcur,,,-3,C15H19N2O18P2,CHEBI:17200,,"Human Metabolome Database (HMDB): Uridine diphosphate glucuronic acid is a nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP Iduronic acid, which donates Iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones. The transfer of glucuronic acid from UDP-alpha-D-glucuronic acid onto a terminal galactose residue is done by beta1,3-glucuronosyltransferases, responsible for the completion of the protein-glycosaminoglycan linkage region of proteoglycans and of the HNK1 epitope of glycoproteins and glycolipids. In humans the enzyme galactose-beta-1,3-glucuronosyltransferase I completes the synthesis of the common linker region of glycosaminoglycans (GAGs) by transferring glucuronic acid (GlcA) onto the terminal galactose of the glycopeptide primer of proteoglycans. The GAG chains of proteoglycans regulate major biological processes such as cell proliferation and recognition, extracellular matrix deposition, and morphogenesis. (PMID: 16815917).",,UDP-D-glucuronate,,HMDB00935,"InChI=1S/C15H22N2O18P2/c18-5-1-2-17(15(26)16-5)12-9(22)6(19)4(32-12)3-31-36(27,28)35-37(29,30)34-14-10(23)7(20)8(21)11(33-14)13(24)25/h1-2,4,6-12,14,19-23H,3H2,(H,24,25)(H,27,28)(H,29,30)(H,16,18,26)/p-3/t4-,6-,7+,8+,9-,10-,11+,12-,14-/m1/s1",C00167,2016-12-05T15:48:05Z,,1168,,,,,17473,udpglcur,,"a-D-Glucopyranuronic acid 1->5'-ester with uridine 5'-(trihydrogen pyrophosphate), a-D-Glucopyranuronic acid ester with uridine 5'-pyrophosphate, alpha-D-Glucopyranuronic acid 1-P'-ester with uridine 5'-(trihydrogen diphosphate), alpha-delta-Glucopyranuronic acid 1->5'-ester with uridine 5'-(trihydrogen pyrophosphate), alpha-delta-Glucopyranuronic acid 1-P'-ester with uridine 5'-(trihydrogen diphosphate), alpha-delta-Glucopyranuronic acid ester with uridine 5'-pyrophosphate, Glucopyranuronic acid 1-ester with uridine 5'-pyrophosphate, UDP Glucuronate, UDP Glucuronic acid, UDP-alpha-D-Glucuronate, UDP-alpha-delta-Glucuronate, UDP-D-Glucuronate, UDP-D-Glucuronic acid, UDP-delta-Glucuronate, UDP-delta-Glucuronic acid, UDP-GlcUA, UDP-Glucuronate, UDP-Glucuronic acid, UDPGA, UDPglucuronate, UGA, Uridine 5'-diphospho-a-D-glucuronate, Uridine 5'-diphospho-a-D-glucuronic acid, Uridine 5'-diphospho-alpha-delta-glucuronate, Uridine 5'-diphospho-alpha-delta-glucuronic acid, Uridine 5'-diphospho-glucuronic acid, Uridine 5'-diphosphoglucuronate, Uridine 5'-diphosphoglucuronic acid, Uridine 5'-[3-(D-glucopyranosyloxyuronic acid) dihydrogen diphosphate], Uridine diphosphate glucuronate, Uridine diphosphate glucuronic acid, Uridine diphosphate-glucuronate, Uridine diphospho-D-glucuronate, Uridine diphospho-D-glucuronic acid, Uridine diphospho-delta-glucuronate, Uridine diphospho-delta-glucuronic acid, Uridine diphosphoglucuronate, Uridine diphosphoglucuronic acid, Uridine pyrophosphoglucuronate, Uridine pyrophosphoglucuronic acid, Uridinediphosphoglucuronic acid",http://vmh.uni.lu/_api/metabolites/1168/?format=pcsv
cs_c_d_e_pre1,,,-3,C31H47NO31S2X,,,"chondroitin sulfate C (GalNAc6S-GlcA) and D (GlcNAc6S-GlcA2S), precursor 1",,"chondroitin sulfate C (GalNAc6S-GlcA) and D (GlcNAc6S-GlcA2S), precursor 1",,,,,2016-11-22T15:12:04Z,,1169,,,,,,cs_c_d_e_pre1,,,http://vmh.uni.lu/_api/metabolites/1169/?format=pcsv
cs_d_pre2,,,-4,C31H46NO34S3X,,,chondroitin sulfate D (GlcNAc6S-GlcA2S) precursor 2,,chondroitin sulfate D (GlcNAc6S-GlcA2S) precursor 2,,,,,2016-11-22T15:12:04Z,,1170,,,,,,cs_d_pre2,,,http://vmh.uni.lu/_api/metabolites/1170/?format=pcsv
cs_e_pre2,,,-5,C31H45NO37S4X,,,"chondroitin sulfate E (GalNAc4,6diS-GlcA), precursor 2",,"chondroitin sulfate E (GalNAc4,6diS-GlcA), precursor 2",,,,,2016-11-22T15:12:04Z,,1171,,,,,,cs_e_pre2,,,http://vmh.uni.lu/_api/metabolites/1171/?format=pcsv
hs_pre1,,,-1,C31H49NO25X,,,"heparan sulfate, precursor 1",,"heparan sulfate, precursor 1",,,,,2016-11-22T15:12:04Z,,1172,,,,,,hs_pre1,,,http://vmh.uni.lu/_api/metabolites/1172/?format=pcsv
hs_pre2,,,-2,C37H56NO31X,,,"heparan sulfate, precursor 2",,"heparan sulfate, precursor 2",,,,,2016-11-22T15:12:04Z,,1173,,,,,,hs_pre2,,,http://vmh.uni.lu/_api/metabolites/1173/?format=pcsv
hs_pre3,,,-2,C45H69N2O36X,,,GlcNAc-GlcA-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,GlcNAc-GlcA-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,,,,2016-11-22T15:12:04Z,,1174,,,,,,hs_pre3,,,http://vmh.uni.lu/_api/metabolites/1174/?format=pcsv
hs_pre4,,,-3,C51H76N2O42X,,,GlcA-GlcNAc-GlcA-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,GlcA-GlcNAc-GlcA-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,,,,2016-11-22T15:12:04Z,,1175,,,,,,hs_pre4,,,http://vmh.uni.lu/_api/metabolites/1175/?format=pcsv
hs_pre5,,,-3,C59H89N3O47X,,,(GlcNAc-GlcA)2-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,(GlcNAc-GlcA)2-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,,,,2016-11-22T15:12:05Z,,1176,,,,,,hs_pre5,,,http://vmh.uni.lu/_api/metabolites/1176/?format=pcsv
hs_pre6,,,-4,C65H96N3O53X,,,GlcA-(GlcNAc-GlcA)2-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,GlcA-(GlcNAc-GlcA)2-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,,,,2016-11-22T15:12:05Z,,1177,,,,,,hs_pre6,,,http://vmh.uni.lu/_api/metabolites/1177/?format=pcsv
hs_pre7,,,-4,C73H109N4O58X,,,(GlcNAc-GlcA)3-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,(GlcNAc-GlcA)3-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,,,,2016-11-22T15:12:05Z,,1178,,,,,,hs_pre7,,,http://vmh.uni.lu/_api/metabolites/1178/?format=pcsv
hs_pre8,,,-5,C79H116N4O64X,,,GlcA-(GlcNAc-GlcA)3-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,GlcA-(GlcNAc-GlcA)3-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,,,,2016-11-22T15:12:05Z,,1179,,,,,,hs_pre8,,,http://vmh.uni.lu/_api/metabolites/1179/?format=pcsv
hs_deg3,,,-12,C81H117N5O97S10,,,"heparan sulfate, degradation product 3",,"heparan sulfate, degradation product 3",,,,,2016-11-22T15:12:05Z,,1180,,,,,,hs_deg3,,,http://vmh.uni.lu/_api/metabolites/1180/?format=pcsv
hs_deg4,,,-12,C73H104N4O92S10,,,"heparan sulfate, degradation product 4",,"heparan sulfate, degradation product 4",,,,,2016-11-22T15:12:05Z,,1181,,,,,,hs_deg4,,,http://vmh.uni.lu/_api/metabolites/1181/?format=pcsv
hs_deg8,,,-10,C69H100N4O81S8,,,"heparan sulfate, degradation product 8",,"heparan sulfate, degradation product 8",,,,,2016-11-22T15:12:05Z,,1182,,,,,,hs_deg8,,,http://vmh.uni.lu/_api/metabolites/1182/?format=pcsv
hs_deg14,,,-7,C57H84N3O62S5,,,"heparan sulfate, degradation product 14",,"heparan sulfate, degradation product 14",,,,,2016-11-22T15:12:05Z,,1183,,,,,,hs_deg14,,,http://vmh.uni.lu/_api/metabolites/1183/?format=pcsv
hs_deg15,,,-7,C49H71N2O57S5,,,"heparan sulfate, degradation product 15",,"heparan sulfate, degradation product 15",,,,,2016-11-22T15:12:05Z,,1184,,,,,,hs_deg15,,,http://vmh.uni.lu/_api/metabolites/1184/?format=pcsv
hs_deg20,,,-4,C45H68N2O43S2,,,"heparan sulfate, degradation product 20",,"heparan sulfate, degradation product 20",,,,,2016-11-22T15:12:05Z,,1185,,,,,,hs_deg20,,,http://vmh.uni.lu/_api/metabolites/1185/?format=pcsv
hs_deg21,,,-4,C37H55NO38S2,,,"IdoA2S-beta-1,4-GlcNAc(3S)-alpha-1,4-GlcA-beta-1,3-Gal-beta-1,3-Gal-beta-1,4-Xylose",,"IdoA2S-beta-1,4-GlcNAc(3S)-alpha-1,4-GlcA-beta-1,3-Gal-beta-1,3-Gal-beta-1,4-Xylose",,,,,2016-11-22T15:12:05Z,,1186,,,,,,hs_deg21,,,http://vmh.uni.lu/_api/metabolites/1186/?format=pcsv
hs_deg24,,,-1,C31H50NO26,,,GlcNAc-GlcA-(Gal)2-Xyl,,GlcNAc-GlcA-(Gal)2-Xyl,,,,,2016-11-22T15:12:05Z,,1187,,,,,,hs_deg24,,,http://vmh.uni.lu/_api/metabolites/1187/?format=pcsv
hs_deg25,,,-1,C23H37O21,,,"GlcA-beta-1,3-Gal-beta-1,3-Gal-beta-1,4-Xylose",,"GlcA-beta-1,3-Gal-beta-1,3-Gal-beta-1,4-Xylose",,,,,2016-11-22T15:12:05Z,,1188,,,,,,hs_deg25,,,http://vmh.uni.lu/_api/metabolites/1188/?format=pcsv
hs_pre9,,,-5,C87H129N5O69X,,,(GlcNAc-GlcA)4-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,(GlcNAc-GlcA)4-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,,,,2016-11-22T15:12:05Z,,1189,,,,,,hs_pre9,,,http://vmh.uni.lu/_api/metabolites/1189/?format=pcsv
naglc2p_L,,,-20,C1160H1898N10O120P20,,,"N-Acetyl-D-glucosaminyldiphosphodolichol, human liver homolog",,"N-Acetyl-D-glucosaminyldiphosphodolichol, human liver homolog",,,,,2016-11-22T15:12:05Z,,1190,,,,,,naglc2p_L,,,http://vmh.uni.lu/_api/metabolites/1190/?format=pcsv
naglc2p_U,,,-20,C1105H1810N10O120P20,,,"N-Acetyl-D-glucosaminyldiphosphodolichol, human uterine homolog",,"N-Acetyl-D-glucosaminyldiphosphodolichol, human uterine homolog",,,,,2016-11-22T15:12:05Z,,1191,,,,,,naglc2p_U,,,http://vmh.uni.lu/_api/metabolites/1191/?format=pcsv
dxtrn,,,0,C48H81O41X,,,"phosphorylase-limit dextrin (glycogenin-1,6{4[1,4-Glc], 4[1,4-Glc]})",,"phosphorylase-limit dextrin (glycogenin-1,6{4[1,4-Glc], 4[1,4-Glc]})",,,,,2016-11-22T15:12:05Z,,1192,,,,,,dxtrn,,,http://vmh.uni.lu/_api/metabolites/1192/?format=pcsv
glygn3,,,0,C42H71O36X,,,"glycogen, structure 3 (glycogenin-7[1,4-Glc])",,"glycogen, structure 3 (glycogenin-7[1,4-Glc])",,,,,2016-11-22T15:12:05Z,,1193,,,,,,glygn3,,,http://vmh.uni.lu/_api/metabolites/1193/?format=pcsv
guln,,,-1,C6H11O7,CHEBI:13115,,Human Metabolome Database (HMDB): Reduction product of glucuronic acid; oxidation product of l-gulose.,,L-gulonate,,HMDB03290,"InChI=1S/C6H12O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-5,7-11H,1H2,(H,12,13)/p-1/t2-,3+,4-,5-/m0/s1",C00800,2016-12-05T15:48:05Z,,1194,,,,,152304,guln,,"D-Gulonate, D-Gulonic acid, Gulonate, L-Gulonate, L-Gulonic acid",http://vmh.uni.lu/_api/metabolites/1194/?format=pcsv
gullac,,,0,C6H10O6,CHEBI:17587,,"Human Metabolome Database (HMDB): L-Gulonolactone (also known as reduced ascorbic acid, RAA) is the substrate of the enzyme L-gulono-1,4-lactone oxidoreductase (EC 1.1.3.8), which catalyzes the last step of the biosynthesis of L-ascorbic acid (vitamin C) in plants and animals. The enzyme L-Gulono-1,4-lactone oxidase is missing in scurvy-prone, vitamin C-deficient animals, such as humans. L-Gulonolactone is present in human blood and has been used as one of the markers to compare changes in exercise-induced oxidative stress. (PMID: 16956367, 16494601).",,"L-gulono-1,4-lactone",,HMDB03466,"InChI=1S/C6H10O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2-5,7-10H,1H2/t2-,3+,4-,5+/m0/s1",C01040,2016-12-05T15:48:05Z,,1195,,,,,439373,gullac,,"gamma-Gulonolactone, L-(+)-Gulono-1,4-lactone, L-Gulonic acid gamma-lactone, L-Gulono-1,4-lactone, L-Gulono-gamma-lactone, Reduced ascorbate, Reduced ascorbic acid",http://vmh.uni.lu/_api/metabolites/1195/?format=pcsv
glucys,,,-1,C8H13N2O5S,CHEBI:17515,,Human Metabolome Database (HMDB): G-Glutamylcysteine is a product of enzyme glutamate-cysteine ligase [EC 6.3.2.2] and a substrate of enzyme glutathione synthase [EC 6.3.2.3] in glutamate metabolism pathway (KEGG).,,gamma-L-Glutamyl-L-cysteine,,HMDB01049,"InChI=1S/C8H14N2O5S/c9-4(7(12)13)1-2-6(11)10-5(3-16)8(14)15/h4-5,16H,1-3,9H2,(H,10,11)(H,12,13)(H,14,15)/p-1/t4-,5-/m0/s1",C00669,2016-12-05T15:48:05Z,,1196,,,,yGluCys,123938,glucys,,"(Des-Gly)-Glutathione, 3GC, 5-L-Glutamyl-L-cysteine, 5-L-Glutamylcysteine, g-Glutamylcysteine, g-L-Glutamyl-L-cysteine, gamma-Glu-cys, gamma-Glutamylcysteine, gamma-L-Glutamyl-L-cysteine, H-gamma-Glu-Cys-OH, H-Glu(Cys-OH)-OH, L-g-Glutamyl-L-cysteine, L-gamma-Glutamyl-L-cysteine, L-gamma-Glutamylcysteine, N-(1-Carboxy-2-mercaptoethyl)-L-Glutamine, N-L-gamma-Glutamyl-L-Cysteine, XN-L-g-glutamyl-Glutamine, XN-L-gamma-glutamyl-Glutamine",http://vmh.uni.lu/_api/metabolites/1196/?format=pcsv
forglu,,,-2,C6H8N2O4,CHEBI:7274,,Human Metabolome Database (HMDB): Measurement of this acid in the urine after oral administration of histidine provides the basis for the diagnostic test of folic acid deficiency and of megaloblastic anemia of pregnancy.,,N-Formimidoyl-L-glutamate,,HMDB00854,"InChI=1S/C6H10N2O4/c7-3-8-4(6(11)12)1-2-5(9)10/h3-4H,1-2H2,(H2,7,8)(H,9,10)(H,11,12)/p-2/t4-/m0/s1",C00439,2016-12-05T15:48:05Z,,1197,,,,,439233,forglu,,"Formimino-glu, Formimino-L-glutamate, Formimino-L-glutamic acid, Formiminoglutamate, N-(Iminomethyl)-L-glutamic acid, N-Formimidoyl-Glutamic acid, N-Formimidoyl-L-glutamate, N-Formimidoyl-L-glutamic acid, N-Formimino-glutamate, N-Formimino-L-glutamate, N-Formimino-L-glutamic acid",http://vmh.uni.lu/_api/metabolites/1197/?format=pcsv
pram,,,-1,C5H11NO7P,CHEBI:37737,,5-Phospho-beta-D-ribosylamine,,5-Phospho-beta-D-ribosylamine,,,"InChI=1S/C5H12NO7P/c6-5-4(8)3(7)2(13-5)1-12-14(9,10)11/h2-5,7-8H,1,6H2,(H2,9,10,11)/p-1/t2-,3-,4-,5-/m1/s1",C03090,2016-11-22T15:12:05Z,,1198,,,,,439905,pram,,,http://vmh.uni.lu/_api/metabolites/1198/?format=pcsv
glyc_R,,,-1,C3H5O4,CHEBI:32398,,"Human Metabolome Database (HMDB): Glyceric acid is a colorless syrupy acid, obtained from oxidation of glycerol. It is a compound that is secreted excessively in the urine by patients suffering from D-glyceric aciduria and D-glycerate anemia. Deficiency of human glycerate kinase leads to D-glycerate acidemia/D-glyceric aciduria. Symptoms of the disease include progressive neurological impairment, hypotonia, seizures, failure to thrive and metabolic acidosis.",,D-glycerate,,HMDB00139,"InChI=1S/C3H6O4/c4-1-2(5)3(6)7/h2,4-5H,1H2,(H,6,7)/p-1/t2-/m1/s1",C00258,2016-12-05T15:48:05Z,,1199,,,,,439194,glyc_R,,"(R)-glycerate, a,b-Hydroxypropionate, a,b-Hydroxypropionic acid, D-Glycerate, D-Glyceric acid, Glycerate, Glyceric acid",http://vmh.uni.lu/_api/metabolites/1199/?format=pcsv
lgt_S,,,-1,C13H20N3O8S,CHEBI:15694,,(R)-S-lactoylglutathionate(1-),,(R)-S-lactoylglutathionate(1-),,,"InChI=1S/C13H21N3O8S/c1-6(17)13(24)25-5-8(11(21)15-4-10(19)20)16-9(18)3-2-7(14)12(22)23/h6-8,17H,2-5,14H2,1H3,(H,15,21)(H,16,18)(H,19,20)(H,22,23)/p-1/t6-,7+,8+/m1/s1",C03451,2016-11-22T15:12:05Z,,1200,,,,,440018,lgt_S,,,http://vmh.uni.lu/_api/metabolites/1200/?format=pcsv
xmp,,,-2,C10H11N4O9P,CHEBI:15652,,Xanthosine 5'-phosphate,,Xanthosine 5'-phosphate,,,"InChI=1S/C10H13N4O9P/c15-5-3(1-22-24(19,20)21)23-9(6(5)16)14-2-11-4-7(14)12-10(18)13-8(4)17/h2-3,5-6,9,15-16H,1H2,(H2,19,20,21)(H2,12,13,17,18)/p-2/t3-,5-,6-,9-/m1/s1",C00655,2016-11-22T15:12:05Z,,1201,,,,,73323,xmp,,,http://vmh.uni.lu/_api/metabolites/1201/?format=pcsv
6pgc,,,-3,C6H10O10P,CHEBI:48928,,Human Metabolome Database (HMDB): Intermediate in the Pentose phosphate pathway (KEGG).,,6-Phospho-D-gluconate,,HMDB01316,"InChI=1S/C6H13O10P/c7-2(1-16-17(13,14)15)3(8)4(9)5(10)6(11)12/h2-5,7-10H,1H2,(H,11,12)(H2,13,14,15)/p-3/t2-,3-,4+,5-/m1/s1",C00345,2016-12-05T15:48:05Z,,1202,,,,6-Phosphogluconate,91493,6pgc,,"6-O-Phosphono-D-gluconic acid, 6-p-Gluconate, 6-Phospho-D-gluconate, 6-Phospho-D-gluconic acid, 6-Phosphogluconate, 6-Phosphogluconic acid, D-Gluconic acid 6-(dihydrogen phosphate), D-Gluconic acid 6-phosphate, Gluconic acid-6-phosphate",http://vmh.uni.lu/_api/metabolites/1202/?format=pcsv
ru5p_D,,,-2,C5H9O8P,CHEBI:17363,,D-ribulose 5-phosphate(2-),,D-ribulose 5-phosphate(2-),,,"InChI=1S/C5H11O8P/c6-1-3(7)5(9)4(8)2-13-14(10,11)12/h4-6,8-9H,1-2H2,(H2,10,11,12)/p-2/t4-,5+/m1/s1",C00199,2016-11-22T15:12:05Z,,1203,,,,,439184,ru5p_D,,,http://vmh.uni.lu/_api/metabolites/1203/?format=pcsv
g3pc,,,0,C8H20NO6P,CHEBI:16870,,"Human Metabolome Database (HMDB): Glycerophosphorylcholine (GPC) is a choline derivative and one of the two major forms of choline storage (along with phosphocholine) in the cytosol. Glycerophosphorylcholine is also one of the four major organic osmolytes in renal medullary cells, changing their intracellular osmolyte concentration in parallel with extracellular tonicity during cellular osmoadaptation. As an osmolyte, Glycerophosphorylcholine counteracts the effects of urea on enzymes and other macromolecules. Kidneys (especially medullar cells), which are exposed under normal physiological conditions to widely fluctuating extracellular solute concentrations, respond to hypertonic stress by accumulating the organic osmolytes glycerophosphorylcholine (GPC), betaine, myo-inositol, sorbitol and free amino acids. Increased intracellular contents of these osmolytes are achieved by a combination of increased uptake (myo-inositol and betaine) and synthesis (sorbitol, GPC), decreased degradation (GPC) and reduced osmolyte release. GPC is formed in the breakdown of phosphatidylcholine (PtC). This pathway is active in many body tissues, including mammary tissue.",,sn-Glycero-3-phosphocholine,,HMDB00086,"InChI=1S/C8H20NO6P/c1-9(2,3)4-5-14-16(12,13)15-7-8(11)6-10/h8,10-11H,4-7H2,1-3H3/p+1/t8-/m1/s1",C00670,2016-12-05T15:48:05Z,,1204,,,,,439285,g3pc,,"2-[[(2,3-Dihydroxypropoxy)hydroxyphosphinyl]oxy]-N,N,N-trimethyl-Ethanaminium inner salt, a-Glycerophosphorylcholine, a-Glycerylphosphorylcholine, alpha-Glycerophosphorylcholine, alpha-Glycerylphosphorylcholine, Choline Alfoscerate, Choline glycerophosphate, Glycerol 3-phosphocholine, Glycerol phosphorylcholine, Glycerol-3-phosphatidylcholine, Glycerophosphatidylcholine, Glycerophosphocholine, Glycerophosphorylcholine, GPC, GPCho, Hydrogen glycerophosphate Choline, L-alpha-Glycerophosphocholine, L-alpha-Glycerophosphorylcholine, L-alpha-Glycerylphosphorylcholine, L-Choline hydroxide 2,3-dihydroxypropyl hydrogen phosphate inner salt, Sn-Glycero-3-phosphocholine",http://vmh.uni.lu/_api/metabolites/1204/?format=pcsv
em2emgacpail_prot_hs,,,0,C53H100N3O35P3FULLRCO2FULLR2CO2X,,,"(phosphoethanolaminyl-dimannosyl),(phosphoethanolaminyl)-mannosyl-glucosaminyl-acylphosphatidylinositol",,"(phosphoethanolaminyl-dimannosyl),(phosphoethanolaminyl)-mannosyl-glucosaminyl-acylphosphatidylinositol",,,,,2016-11-22T15:12:05Z,,1205,,,,,,em2emgacpail_prot_hs,,,http://vmh.uni.lu/_api/metabolites/1205/?format=pcsv
gpi_prot_hs,,,0,C55H106N4O38P4FULLRCO2FULLR2CO2X,,,"{[(Prot-PE-Man),(PE)-Man],[PE]}-Man-GlcN-acylPI",,"{[(Prot-PE-Man),(PE)-Man],[PE]}-Man-GlcN-acylPI",,,,,2016-11-22T15:12:05Z,,1206,,,,,,gpi_prot_hs,,,http://vmh.uni.lu/_api/metabolites/1206/?format=pcsv
mgacpail_hs,,,0,C37H68NO19PFULLRCO2FULLR2CO2,,,mannosyl-glucosaminyl-acylphosphatidylinositiol (H2),,mannosyl-glucosaminyl-acylphosphatidylinositiol (H2),,,,,2016-11-22T15:12:05Z,,1207,,,,,,mgacpail_hs,,,http://vmh.uni.lu/_api/metabolites/1207/?format=pcsv
ahdt,,,-4,C9H12N5O13P3,CHEBI:18372,,"7,8-dihydroneopterin 3'-triphosphate(4-)",,"7,8-dihydroneopterin 3'-triphosphate(4-)",,,"InChI=1S/C9H16N5O13P3/c10-9-13-7-5(8(17)14-9)12-3(1-11-7)6(16)4(15)2-25-29(21,22)27-30(23,24)26-28(18,19)20/h4,6,15-16H,1-2H2,(H,21,22)(H,23,24)(H2,18,19,20)(H4,10,11,13,14,17)/p-4/t4-,6+/m1/s1",C04895,2016-11-22T15:12:05Z,,1208,,,,DHNTP,121885,ahdt,,,http://vmh.uni.lu/_api/metabolites/1208/?format=pcsv
xan,,,0,C5H4N4O2,CHEBI:17712,,"Human Metabolome Database (HMDB): Xanthine is a purine base found in most body tissues and fluids, certain plants, and some urinary calculi. It is an intermediate in the degradation of adenosine monophosphate to uric acid, being formed by oxidation of hypoxanthine. The methylated xanthine compounds caffeine, theobromine, and theophylline and their derivatives are used in medicine for their bronchodilator effects. (Dorland, 28th ed.).",,Xanthine,,HMDB00292,"InChI=1S/C5H4N4O2/c10-4-2-3(7-1-6-2)8-5(11)9-4/h1H,(H3,6,7,8,9,10,11)",C00385,2016-12-05T15:48:05Z,,1209,,,,,1188,xan,,"1H-Purine-2,6-diol, 2,6(1,3)-Purinedion, 2,6-Dihydroxypurine, 2,6-Dioxopurine, 3,7-Dihydro-1H-purine-2,6-dione, 3,7-Dihydropurine-2,6-dione, 9H-Purine-2,6(1H,3H)-dione, 9H-Purine-2,6-diol, Dioxopurine, Isoxanthine, Pseudoxanthine, Purine-2,6(1H,3H)-dione, Purine-2,6-diol, Xanthic oxide, Xanthin, Xanthine",http://vmh.uni.lu/_api/metabolites/1209/?format=pcsv
glcur1p,,,-3,C6H8O10P,CHEBI:28547,,"Human Metabolome Database (HMDB): D-Glucuronic acid 1-phosphate is an end product of the UDP-glucuronic acid pathway. Formation of free glucuronic acid from UDP-glucuronic acid can be considered as the first step in the synthesis of vitamin C, a pathway that occurs in most vertebrates, although not in guinea pigs and primates, including humans. Free glucuronic acid can also be converted to pentose phosphate intermediates via the 'pentose pathway'. The latter is interrupted in subjects with pentosuria, who have a deficiency in l-xylulose reductase (EC 1.1.1.10, an enzyme that belongs to the short-chain dehydrogenase/reductase family) and excrete abnormal amounts of l-xylulose. Some xenobiotics stimulate the formation of vitamin C in animals and enhance the excretion of l-xylulose in humans with pentosuria and have shown that aminopyrine, metyrapone and other xenobiotics cause an almost instantaneous increase in the conversion of UDP-glucuronic acid to glucuronic acid. It is usually stated that glucuronic acid formation from UDP-glucuronic acid is the result of two successive reactions comprising the hydrolysis of UDP-glucuronic acid to glucuronic acid 1-phosphate and UMP by nucleotide pyrophosphatase (E-NPP3, EC 3.6.1.9), followed by dephosphorylation of glucuronic acid 1-phosphate. Glucuronidation is responsible for conjugating potentially toxic lipophilic compounds with glucuronic acid, thereby producing molecules with greater aqueous solubility that is excreted more readily into urine and bile. The rate at which any compound may be glucuronidated depends on the concentration and activity of the UDP-glucuronosyltransferases as well as the concentration of the cofactor UDP-glucuronic acid. UDP-glucuronic acid is formed after oxidation of UDP-glucose by UDP-glucose dehydrogenase (UGDH, EC 1.1.1.22) with NAD as the electron acceptor. UDP-glucuronic acid may then be either used as the glucuronic acid donor for xenobiotic conjugation reactions by UDPglucuronosyltransferases (GlcAT-P, EC 2.4.1.17), or degraded to D-glucuronic acid 1-phosphate after the phosphodiester bond is cleaved by E-NPP3. E-NPP3 is the same enzyme that further reduces D-Glucuronic acid 1-phosphate to free D-glucuronic acid. Decreases in UDP-glucuronic acid concentration may be due to reduced availability of UDP-glucose or decreased UGDH activity or to increased activities of GlcAT-P or E-NPP3. Exposure to volatile anesthetics reduces hepatic UDP-glucuronic acid concentrations, and alters the rate of conjugation of compounds such as acetaminophen, bilirubin, diethylstilbestrol, iopanoic acid and valproic acid in a non-sex-dependent fashion in experimental mice. The depletion of UDP-glucuronic acid by anesthetics is caused by altered activity of microsomal E-NPP3. (PMID: 2167093, 16689937, 1276).",,D-Glucuronate 1-phosphate,,HMDB03976,"InChI=1S/C6H11O10P/c7-1-2(8)4(5(10)11)15-6(3(1)9)16-17(12,13)14/h1-4,6-9H,(H,10,11)(H2,12,13,14)/p-1/t1-,2-,3+,4-,6?/m0/s1",C05385,2016-12-05T15:48:05Z,,1210,,,,,440650,glcur1p,,"1-O-Phosphono-D-glucopyranuronic acid, 1-O-Phosphono-delta-glucopyranuronic acid, 1-Phospho-a-D-glucuronate, 1-Phospho-alpha-delta-glucuronate, a-D-Glucopyranuronic acid 1-phosphate, a-D-Glucuronic acid 1-phosphate, alpha-D-Glucuronate 1-phosphate, alpha-D-Glucuronic acid 1-phosphate, alpha-delta-Glucopyranuronic acid 1-phosphate, alpha-delta-Glucuronate 1-phosphate, alpha-delta-Glucuronic acid 1-phosphate, D-Glucuronate 1-phosphate, D-Glucuronate-1-P, D-Glucuronate-1-phosphate, D-Glucuronic acid 1-phosphate, delta-Glucuronate 1-phosphate, delta-Glucuronate-1-P, delta-Glucuronate-1-phosphate, delta-Glucuronic acid 1-phosphate, Glucuronate-1-P, Glucuronate-1-phosphate, Glucuronic acid 1-phosphate",http://vmh.uni.lu/_api/metabolites/1210/?format=pcsv
emgacpail_hs,,,0,C39H74N2O22P2FULLRCO2FULLR2CO2,,,phosphoethanolaminyl-mannosyl-glucosylaminyl-acylphosphatidylinositol (H5),,phosphoethanolaminyl-mannosyl-glucosylaminyl-acylphosphatidylinositol (H5),,,,,2016-11-22T15:12:05Z,,1211,,,,,,emgacpail_hs,,,http://vmh.uni.lu/_api/metabolites/1211/?format=pcsv
m2gacpail_hs,,,0,C43H78NO24PFULLRCO2FULLR2CO2,,,dimannosyl-glucosaminyl-acylphosphatidylinositol (H3),,dimannosyl-glucosaminyl-acylphosphatidylinositol (H3),,,,,2016-11-22T15:12:05Z,,1212,,,,,,m2gacpail_hs,,,http://vmh.uni.lu/_api/metabolites/1212/?format=pcsv
m3gacpail_hs,,,0,C49H88NO29PFULLRCO2FULLR2CO2,,,trimannosyl-glucosaminyl-acylphosphatidylinositol (H4),,trimannosyl-glucosaminyl-acylphosphatidylinositol (H4),,,,,2016-11-22T15:12:05Z,,1213,,,,,,m3gacpail_hs,,,http://vmh.uni.lu/_api/metabolites/1213/?format=pcsv
em3gacpail_hs,,,0,C51H94N2O32P2FULLRCO2FULLR2CO2,,,phosphoethanolaminyl-trimannosyl-glucosaminyl-acylphosphatidylinositol (H6'),,phosphoethanolaminyl-trimannosyl-glucosaminyl-acylphosphatidylinositol (H6'),,,,,2016-11-22T15:12:05Z,,1214,,,,,,em3gacpail_hs,,,http://vmh.uni.lu/_api/metabolites/1214/?format=pcsv
emem2gacpail_hs,,,0,C53H100N3O35P3FULLRCO2FULLR2CO2,,,"(phosphoethanolaminyl-mannosyl),(phosphoethanolaminyl)-dimannosyl-glucosaminyl-acylphosphatidylinositol (H7')",,"(phosphoethanolaminyl-mannosyl),(phosphoethanolaminyl)-dimannosyl-glucosaminyl-acylphosphatidylinositol (H7')",,,,,2016-11-22T15:12:05Z,,1215,,,,,,emem2gacpail_hs,,,http://vmh.uni.lu/_api/metabolites/1215/?format=pcsv
em2emgacpail_hs,,,0,C53H100N3O35P3FULLRCO2FULLR2CO2,,,"(phosphoethanolaminyl-dimannosyl),(phosphoethanolaminyl)-mannosyl-glucosaminyl-acylphosphatidylinositol (H7)",,"(phosphoethanolaminyl-dimannosyl),(phosphoethanolaminyl)-mannosyl-glucosaminyl-acylphosphatidylinositol (H7)",,,,,2016-11-22T15:12:05Z,,1216,,,,,,em2emgacpail_hs,,,http://vmh.uni.lu/_api/metabolites/1216/?format=pcsv
m3emgacpail_hs,,,0,C57H104N2O37P2FULLRCO2FULLR2CO2,,,"(trimannosyl),(phosphoethanolaminyl)-mannosyl-glucosaminyl-acylphosphatidylinositol (M4C)",,"(trimannosyl),(phosphoethanolaminyl)-mannosyl-glucosaminyl-acylphosphatidylinositol (M4C)",,,,,2016-11-22T15:12:05Z,,1217,,,,,,m3emgacpail_hs,,,http://vmh.uni.lu/_api/metabolites/1217/?format=pcsv
gpi_hs,,,0,C55H106N4O38P4FULLRCO2FULLR2CO2,,,"{[PE-Man-],[PE-]Man},{PE-}Man-GlcN-acylPI",,"{[PE-Man-],[PE-]Man},{PE-}Man-GlcN-acylPI",,,,,2016-11-22T15:12:05Z,,1218,,,,,,gpi_hs,,,http://vmh.uni.lu/_api/metabolites/1218/?format=pcsv
mem2emgacpail_hs,,,0,C59H110N3O40P3FULLRCO2FULLR2CO2,,,"({[(mannosyl),(phosphoethanolaminyl)]-dimannosyl},{phosphoethanolaminyl})-mannosyl-glucosaminyl-acylphosphatidylinositol (M4B)",,"({[(mannosyl),(phosphoethanolaminyl)]-dimannosyl},{phosphoethanolaminyl})-mannosyl-glucosaminyl-acylphosphatidylinositol (M4B)",,,,,2016-11-22T15:12:05Z,,1219,,,,,,mem2emgacpail_hs,,,http://vmh.uni.lu/_api/metabolites/1219/?format=pcsv
pre_prot,,,0,XY,,,glycophosphatidylinositol (GPI)-anchored protein precursor,,glycophosphatidylinositol (GPI)-anchored protein precursor,,,,,2016-11-22T15:12:05Z,,1220,,,,,,pre_prot,,,http://vmh.uni.lu/_api/metabolites/1220/?format=pcsv
hexccrn,,,0,C33H65NO4,,,hexacosanoyl carnitine,,hexacosanoyl carnitine,,,"InChI=1/C33H65NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27-28-33(37)38-31(29-32(35)36)30-34(2,3)4/h31H,5-30H2,1-4H3",,2016-11-22T15:12:05Z,,1221,,,,,53477828,hexccrn,,,http://vmh.uni.lu/_api/metabolites/1221/?format=pcsv
4mlacac,,,-2,C8H6O6,CHEBI:47904,,4-maleylacetoacetate,,4-maleylacetoacetate,,,"InChI=1S/C8H8O6/c9-5(1-2-7(11)12)3-6(10)4-8(13)14/h1-2H,3-4H2,(H,11,12)(H,13,14)/p-2/b2-1-",C01036,2016-11-22T15:12:05Z,,1222,,,,,5280393,4mlacac,,,http://vmh.uni.lu/_api/metabolites/1222/?format=pcsv
urcan,,,-1,C6H5N2O2,CHEBI:30817,,"Human Metabolome Database (HMDB): Urocanic acid is a breakdown (deamination) product of histidine. In the liver, urocanic acid is an intermediate in the conversion of histidine to glutamic acid, whereas in the epidermis, it accumulates and may be both a UV protectant and an immunoregulator. Urocanic acid (UA) exists as a trans isomer (t-UA, approximately 30 mg/cm2) in the uppermost layer of the skin (stratum corneum). t-UA is formed as the cells of the second layer of skin become metabolically inactive. During this process, proteins and membranes degrade, histidine is released, and histidase (histidine ammonia lyase) catalyzes the deamination of histidine to form t-UA. t-UA accumulates in the epidermis until removal by either the monthly skin renewal cycle or sweat. Upon absorption of UV light, the naturally occurring t-UA isomerizes to its cis form, c-UA. Because DNA lesions (e.g., pyrimidine dimers) in the lower epidermis can result from UV-B absorption, initial research proposed that t-UA acted as a natural sunscreen absorbing UV-B in the stratum corneum before the damaging rays could penetrate into lower epidermal zones. Researchers have found that c-UA also suppresses contact hypersensitivity and delayed hypersensitivity, reduces the Langerhans cell count in the epidermis, prolongs skin-graft survival time, and affects natural killer cell activity.",,Urocanate,,HMDB00301,"InChI=1S/C6H6N2O2/c9-6(10)2-1-5-3-7-4-8-5/h1-4H,(H,7,8)(H,9,10)/p-1/b2-1+",C00785,2016-12-05T15:48:05Z,,1223,,,,,736715,urcan,,"3-(1H-Imidazol-4-yl)-2-propenoate, 3-(1H-Imidazol-4-yl)-2-propenoic acid, 3-(1H-Imidazol-4-yl)acrylate, 3-(1H-Imidazol-4-yl)acrylic acid, 3-(4-Imidazolyl)acrylate, 3-(4-Imidazolyl)acrylic acid, 5-Imidazoleacrylate, 5-Imidazoleacrylic acid, Imidazole-4-acrylate, Imidazole-4-acrylic acid, Imidazoleacrylic acid, Urocanate, Urocanic acid",http://vmh.uni.lu/_api/metabolites/1223/?format=pcsv
im4act,,,0,C5H6N2O,CHEBI:27398,,"Human Metabolome Database (HMDB): Imidazole-4-acetaldehyde is a naturally occurring aldehyde metabolite of histamine formed by the action of histaminase (E.C. 1.4.3.6), and can be synthesized by oxidation of histidine. Aldehyde dehydrogenase (EC 1.2.1.3) is the only enzyme in the human liver capable of catalyzing dehydrogenation of aldehydes arising via monoamine, diamine, and plasma amine oxidases. NAD-linked dehydrogenation of short chain aliphatic aldehydes has been found in virtually every organ of the mammalian body. Imidazole-4-acetaldehyde is a good substrate for all aldehyde dehydrogenase isozymes. Experimentally, the prebiotic formation of histidine has been accomplished by the reaction of erythrose with formamidine followed by a Strecker synthesis. Imidazole-4-acetaldehyde could have been converted to histidine on the primitive earth by a Strecker synthesis, and several prebiotic reactions could convert imidazole-4-glycol and imidazole-4-ethanol to imidazole-4-acetaldehyde. (PMID: 2071588, 2957640, 11536478).",,imidazole-4-acetaldehyde,,HMDB03905,"InChI=1S/C5H6N2O/c8-2-1-5-3-6-4-7-5/h2-4H,1H2,(H,6,7)",C05130,2016-12-05T15:48:05Z,,1224,,,,,150841,im4act,,"1H-Imidazole-4-acetaldehyde, 1H-Imidazole-5-acetaldehyde, 4-Imidazolylacetaldehyde, Imidazole acetaldehyde, Imidazole-4(or 5)-acetaldehyde",http://vmh.uni.lu/_api/metabolites/1224/?format=pcsv
ppbng,,,-1,C10H13N2O4,CHEBI:17381,,"Human Metabolome Database (HMDB): Porphobilinogen is a pyrrole involved in porphyrin metabolism. -- Wikipedia; It consists of a pyrrole ring with acetyl, propionyl, and aminomethyl side chains; It is a key monopyrrolic intermediate in porphyrin, chlorophyll and vitamin B12 biosynthesis. Porphobilinogen is generated by the enzyme ALA dehydratase by combining two molecules of dALA together, and converted into hydroxymethyl bilane by the enzyme porphobilinogen deaminase. 4 molecules of porphobilinogen are condensed to form one molecule of uroporphyrinogen III, which is then converted successively to coproporphyrinogen III, protoporphyrin IX, and heme. Porphobilinogen is produced in excess and excreted in the urine in acute intermittent porphyria and several other porphyrias.",,Porphobilinogen,,HMDB00245,"InChI=1S/C10H14N2O4/c11-4-8-7(3-10(15)16)6(5-12-8)1-2-9(13)14/h5,12H,1-4,11H2,(H,13,14)(H,15,16)/p-1",C00931,2016-12-05T15:48:05Z,,1225,,,,,1021,ppbng,,"5-(Aminomethyl)-4-(carboxymethyl)-Pyrrole-3-propionate, 5-(Aminomethyl)-4-(carboxymethyl)-Pyrrole-3-propionic acid, PBG, Porphobilinogen",http://vmh.uni.lu/_api/metabolites/1225/?format=pcsv
hmbil,,,-8,C40H38N4O17,CHEBI:16645,,Hydroxymethylbilane,,Hydroxymethylbilane,,,"InChI=1S/C40H46N4O17/c45-17-32-25(12-40(60)61)21(4-8-36(52)53)29(44-32)15-31-24(11-39(58)59)20(3-7-35(50)51)28(43-31)14-30-23(10-38(56)57)19(2-6-34(48)49)27(42-30)13-26-22(9-37(54)55)18(16-41-26)1-5-33(46)47/h16,41-45H,1-15,17H2,(H,46,47)(H,48,49)(H,50,51)(H,52,53)(H,54,55)(H,56,57)(H,58,59)(H,60,61)/p-8",C01024,2016-11-22T15:12:05Z,,1226,,,,,788,hmbil,,,http://vmh.uni.lu/_api/metabolites/1226/?format=pcsv
hmgcoa,,,-5,C27H39N7O20P3S,CHEBI:15467,,Hydroxymethylglutaryl-CoA,,Hydroxymethylglutaryl-CoA,,,"InChI=1S/C27H44N7O20P3S/c1-26(2,21(40)24(41)30-5-4-15(35)29-6-7-58-17(38)9-27(3,42)8-16(36)37)11-51-57(48,49)54-56(46,47)50-10-14-20(53-55(43,44)45)19(39)25(52-14)34-13-33-18-22(28)31-12-32-23(18)34/h12-14,19-21,25,39-40,42H,4-11H2,1-3H3,(H,29,35)(H,30,41)(H,36,37)(H,46,47)(H,48,49)(H2,28,31,32)(H2,43,44,45)/p-5/t14-,19-,20-,21+,25-,27+/m1/s1",C00356,2016-11-22T15:12:05Z,,1227,,,,(3S)-3-hydroxy-3-methylglutaryl-CoA,439218,hmgcoa,,,http://vmh.uni.lu/_api/metabolites/1227/?format=pcsv
mev_R,,,-1,C6H11O4,CHEBI:17710,,"Human Metabolome Database (HMDB): Mevalonic acid is a key organic compound in biochemistry. It is a precursor in the biosynthetic pathway, known as the HMG-CoA reductase pathway, that produces terpenes and steroids. Mevalonate is produced by NADPH from 3-hydroxy-3-methylglutaryl CoA via reduction. This reaction occurs in the cytosol. It is the committed step in cholesterol synthesis, -- Wikipedia The production of mevalonic acid (MVA) by the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, is the rate-limiting step in the biosynthesis of cholesterol. (Jemal et. al, Rapid Communications in Mass Spectrometry, 2003, 17:1715) Plasma concentrations and urinary excretion of MVA are decreased by HMG-CoA reductase inhibitor drugs such as pravastatin, simvastatin and atorvastatin. Naoumova RP, Marais AD, Mountney J, Firth JC, Rendell NB, Taylor GW, Thompson GR. Atherosclerosis 1996; 119: 203.",,(R)-mevalonate,,HMDB00227,"InChI=1S/C6H12O4/c1-6(10,2-3-7)4-5(8)9/h7,10H,2-4H2,1H3,(H,8,9)/p-1/t6-/m1/s1",C00418,2016-12-05T15:48:06Z,,1228,,,,,439230,mev_R,,"(3RS)-Mevalonate, (3RS)-Mevalonic acid, 2,4-Dideoxy-3-C-methylpentonate, 2,4-Dideoxy-3-C-methylpentonic acid, 3,5-Dihydroxy-3-methyl-Valerate, 3,5-Dihydroxy-3-methyl-Valeric acid, 3,5-Dihydroxy-3-methylpentanoate, 3,5-Dihydroxy-3-methylpentanoic acid, 3,5-Dihydroxy-3-methylvalerate, 3,5-Dihydroxy-3-methylvaleric acid, b,D-Dihydroxy-b-methylvalerate, b,D-Dihydroxy-b-methylvaleric acid, b,D-Dihydroxy-beta-methylvalerate, b,D-Dihydroxy-beta-methylvaleric acid, DL-Mevalonate, DL-Mevalonic acid, Hiochic acid, Mevalonate, Mevalonic acid, MK 91, MVA, MVS, RS-Mevalonate, RS-Mevalonic acid",http://vmh.uni.lu/_api/metabolites/1228/?format=pcsv
phyt2ohcoa,,,-4,C41H70N7O18P3S,,,2-hydroxyphytanoyl-CoA(4-),,2-hydroxyphytanoyl-CoA(4-),,,"InChI=1S/C41H74N7O18P3S/c1-25(2)11-8-12-26(3)13-9-14-27(4)15-10-16-28(5)32(50)40(54)70-20-19-43-30(49)17-18-44-38(53)35(52)41(6,7)22-63-69(60,61)66-68(58,59)62-21-29-34(65-67(55,56)57)33(51)39(64-29)48-24-47-31-36(42)45-23-46-37(31)48/h23-29,32-35,39,50-52H,8-22H2,1-7H3,(H,43,49)(H,44,53)(H,58,59)(H,60,61)(H2,42,45,46)(H2,55,56,57)/p-4/t26?,27?,28?,29-,32?,33-,34-,35+,39-/m1/s1",C07343,2016-11-22T15:12:05Z,,1229,,,,,11966142,phyt2ohcoa,,,http://vmh.uni.lu/_api/metabolites/1229/?format=pcsv
hpdcacrn,,,0,C24H47NO4,,,"Human Metabolome Database (HMDB): Heptadecanoyl carnitine is an acylcarnitine. Numerous disorders have been described that lead to disturbances in energy production and in intermediary metabolism in the organism which are characterized by the production and excretion of unusual acylcarnitines. A mutation in the gene coding for carnitine-acylcarnitine translocase or the OCTN2 transporter aetiologically causes a carnitine deficiency that results in poor intestinal absorption of dietary L-carnitine, its impaired reabsorption by the kidney and, consequently, in increased urinary loss of L-carnitine. Determination of the qualitative pattern of acylcarnitines can be of diagnostic and therapeutic importance. The betaine structure of carnitine requires special analytical procedures for recording. The ionic nature of L-carnitine causes a high water solubility which decreases with increasing chain length of the ester group in the acylcarnitines. Therefore, the distribution of L-carnitine and acylcarnitines in various organs is defined by their function and their physico-chemical properties as well. High performance liquid chromatography (HPLC) permits screening for free and total carnitine, as well as complete quantitative acylcarnitine determination, including the long-chain acylcarnitine profile. (PMID: 17508264, Monatshefte fuer Chemie (2005), 136(8), 1279-1291., Int J Mass Spectrom. 1999;188:39-52.).",,heptadecanoyl carnitine,,HMDB06210,"InChI=1/C24H47NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-24(28)29-22(20-23(26)27)21-25(2,3)4/h22H,5-21H2,1-4H3",,2016-12-05T15:48:06Z,,1230,,,,,53477803,hpdcacrn,,"3-Carboxy-N,N,N-trimethyl-2-[(1-oxoheptadecyl)oxy]-1-Propanaminium inner salt, Carnitine heptadecanoate, Carnitine heptadecanoic acid, Heptadecanoate, Heptadecanoate carnitine, Heptadecanoic acid, Heptadecanoyl acid carnitine, Heptadecanoyl carnitine, Heptadecanoylcarnitine",http://vmh.uni.lu/_api/metabolites/1230/?format=pcsv
hpyr,,,-1,C3H3O4,CHEBI:30841,,3-hydroxypyruvate,,3-hydroxypyruvate,,,"InChI=1S/C3H4O4/c4-1-2(5)3(6)7/h4H,1H2,(H,6,7)/p-1",C00168,2016-11-22T15:12:05Z,,1231,,,,,964,hpyr,,,http://vmh.uni.lu/_api/metabolites/1231/?format=pcsv
hs_deg1,,,-12,C79H115N5O99S11,,,"heparan sulfate, degradation product 1",,"heparan sulfate, degradation product 1",,,,,2016-11-22T15:12:05Z,,1232,,,,,,hs_deg1,,,http://vmh.uni.lu/_api/metabolites/1232/?format=pcsv
hs_deg2,,,-11,C79H116N5O96S10,,,"heparan sulfate, degradation product 2",,"heparan sulfate, degradation product 2",,,,,2016-11-22T15:12:05Z,,1233,,,,,,hs_deg2,,,http://vmh.uni.lu/_api/metabolites/1233/?format=pcsv
hs_deg6,,,-10,C67H98N4O83S9,,,"heparan sulfate, degradation product 6",,"heparan sulfate, degradation product 6",,,,,2016-11-22T15:12:05Z,,1234,,,,,,hs_deg6,,,http://vmh.uni.lu/_api/metabolites/1234/?format=pcsv
hs_deg7,,,-9,C67H99N4O80S8,,,"heparan sulfate, degradation product 7",,"heparan sulfate, degradation product 7",,,,,2016-11-22T15:12:05Z,,1235,,,,,,hs_deg7,,,http://vmh.uni.lu/_api/metabolites/1235/?format=pcsv
hs_deg12,,,-7,C55H82N3O64S6,,,"heparan sulfate, degradation product 12",,"heparan sulfate, degradation product 12",,,,,2016-11-22T15:12:05Z,,1236,,,,,,hs_deg12,,,http://vmh.uni.lu/_api/metabolites/1236/?format=pcsv
hs_deg13,,,-6,C55H83N3O61S5,,,"heparan sulfate, degradation product 13",,"heparan sulfate, degradation product 13",,,,,2016-11-22T15:12:05Z,,1237,,,,,,hs_deg13,,,http://vmh.uni.lu/_api/metabolites/1237/?format=pcsv
hs_deg18,,,-4,C43H66N2O45S3,,,"heparan sulfate, degradation product 18",,"heparan sulfate, degradation product 18",,,,,2016-11-22T15:12:05Z,,1238,,,,,,hs_deg18,,,http://vmh.uni.lu/_api/metabolites/1238/?format=pcsv
hs_deg19,,,-3,C43H67N2O42S2,,,"heparan sulfate, degradation product 19",,"heparan sulfate, degradation product 19",,,,,2016-11-22T15:12:05Z,,1239,,,,,,hs_deg19,,,http://vmh.uni.lu/_api/metabolites/1239/?format=pcsv
cortsn,,,0,C21H28O5,,,cortisone,,cortisone,,,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-15,18,22,26H,3-8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1",C00762,2016-11-22T15:12:05Z,,1240,,,,,222786,cortsn,,,http://vmh.uni.lu/_api/metabolites/1240/?format=pcsv
andrstndn,,,0,C19H26O2,CHEBI:16422,,"Human Metabolome Database (HMDB): Androstenedione is a delta-4 19-carbon steroid that is produced not only in the testis, but also in the ovary and the adrenal cortex. Depending on the tissue type, androstenedione can serve as a precursor to testosterone as well as estrone and estradiol. It is the common precursor of male and female sex hormones. Some androstenedione is also secreted into the plasma, and may be converted in peripheral tissues to testosterone and estrogens. Androstenedione originates either from the conversion of dehydroepiandrosterone or from 17-hydroxyprogesterone. It is further converted to either testosterone or estrone. The production of adrenal androstenedione is governed by ACTH, while production of gonadal androstenedione is under control by gonadotropins.",,"androst-4-ene-3,17-dione",,HMDB00053,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",C00280,2016-12-05T15:48:06Z,,1241,,,,,6128,andrstndn,,"(4)-Androsten-3,17-dione, 17-Ketotestosterone, 3,17-Dioxoandrost-4-ene, 4-Androsten-3,17-dione, 4-Androstene-3,17-dione, 4-Androstenedione, Androst-4-ene-3,17-dione, Androstendione, Androstenedione, D4-Androstene-3,17-dione, Delta4-androstenedione, Fecundin, [4-14C]-androstenedione, [4-14C]androst-4-ene-3,17-dione",http://vmh.uni.lu/_api/metabolites/1241/?format=pcsv
cholcoaone,,,-4,C48H74N7O21P3S,CHEBI:27379,,"Human Metabolome Database (HMDB): 3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA is an intermediate in bile acid synthesis. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",,"3alpha,7alpha,12alpha-trihydroxy-24-oxo-5beta-cholestan-26-oyl-CoA(4-)",,HMDB06891,"InChI=1S/C48H78N7O21P3S/c1-24(28-8-9-29-36-30(19-34(59)48(28,29)6)47(5)13-11-27(56)17-26(47)18-32(36)58)7-10-31(57)25(2)45(64)80-16-15-50-35(60)12-14-51-43(63)40(62)46(3,4)21-73-79(70,71)76-78(68,69)72-20-33-39(75-77(65,66)67)38(61)44(74-33)55-23-54-37-41(49)52-22-53-42(37)55/h22-30,32-34,36,38-40,44,56,58-59,61-62H,7-21H2,1-6H3,(H,50,60)(H,51,63)(H,68,69)(H,70,71)(H2,49,52,53)(H2,65,66,67)/p-4/t24-,25?,26+,27-,28-,29+,30+,32-,33-,34+,36+,38-,39-,40+,44-,47+,48-/m1/s1",C05467,2016-12-05T15:48:06Z,,1242,,,,,25195379,cholcoaone,,"(24R,25R)-3-alpha,7-alpha,12-alpha,24-tetrahydroxy-5-beta-cholestan-26-oyl-CoA, (24R,25R)-3-alpha,7-alpha,12-alpha,24-tetrahydroxy-5-beta-cholestan-26-oyl-Coenzyme A, 24-Oxo-25(R)-trihydroxycoprostanoyl-CoA, 24-Oxo-25(R)-trihydroxycoprostanoyl-Coenzyme A, 25(R)-24-Oxo-3alpha,7alpha,12alpha-trihydroxycoprostanoyl-CoA, 25(R)-24-Oxo-3alpha,7alpha,12alpha-trihydroxycoprostanoyl-Coenzyme A, 25(R)-3alpha,7alpha,12alpha-trihydroxy-24-oxo-5beta-cholestanoyl-CoA, 25(R)-3alpha,7alpha,12alpha-trihydroxy-24-oxo-5beta-cholestanoyl-Coenzyme A, 25(R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-24-on-26-oyl-CoA, 25(R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-24-on-26-oyl-Coenzyme A, 25(R)-5beta-cholestane-3alpha,7alpha,12alpha-triol-24-on-26-oyl-CoA, 25(R)-5beta-cholestane-3alpha,7alpha,12alpha-triol-24-on-26-oyl-Coenzyme A, 3-alpha,7-alpha,12-alpha,24-Tetrahydroxy-5-beta-cholestan-26-oyl-CoA, 3-alpha,7-alpha,12-alpha,24-Tetrahydroxy-5-beta-cholestan-26-oyl-Coenzyme A, 3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-beta-cholestanoyl-CoA, 3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-beta-cholestanoyl-Coenzyme A, 3a,7a,12a-Trihydroxy-5b-24-oxocholestanoyl-CoA, 3a,7a,12a-Trihydroxy-5b-24-oxocholestanoyl-Coenzyme A, 3alpha,7alpha,12alpha-Trihydroxy-24-oxo-5beta-cholestanoyl-CoA, 3alpha,7alpha,12alpha-Trihydroxy-24-oxo-5beta-cholestanoyl-Coenzyme A, 3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA, 3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-Coenzyme A, R-TrHOCCoA, R-TrHOCCoenzyme A",http://vmh.uni.lu/_api/metabolites/1242/?format=pcsv
eandrstrn,,,0,C19H28O3,CHEBI:27771,,"Human Metabolome Database (HMDB): 16a-Hydroxydehydroisoandrosterone is a metabolite present during pregnancy with increased concentrations as it progresses (PMID 6461703). A reduced level of 16a-Hydroxydehydroisoandrosterone is observed in cases of Placental sulfatase deficiency (PSD), a rare disorder with low estrogen production due to placental enzymatic deficiency. (PMID 2150812).",,16alpha-hydroxydehydroepiandrosterone,,HMDB00352,"InChI=1S/C19H28O3/c1-18-7-5-12(20)9-11(18)3-4-13-14(18)6-8-19(2)15(13)10-16(21)17(19)22/h3,12-16,20-21H,4-10H2,1-2H3/t12-,13+,14-,15-,16+,18-,19-/m0/s1",C05139,2016-12-05T15:48:06Z,,1243,,,,,102030,eandrstrn,,"16 alpha-Hydroxy-dehydroepiandrosterone, 16-Hydroxydehydroandrosterone, 16-Hydroxydehydroepiandrosterone, 16a-Hydroxy-DHEA, 16a-Hydroxydehydroandrosterone, 16a-Hydroxydehydroepiandrosterone, 16a-Hydroxydehydroisoandrosterone, 3b,16a-Dihydroxy-Androst-5-en-17-one, 3b,16a-Dihydroxyandrost-5-en-17-one, Androst-5-ene-3b-16a-diol-17-one",http://vmh.uni.lu/_api/metabolites/1243/?format=pcsv
andrstandn,,,0,C19H28O2,,,Human Metabolome Database (HMDB): Androstanedione is a steroid metabolite and a procursor of both testosterone and estrone. It is a product of enzyme 3alpha-hydroxysteroid dehydrogenase [EC 1.1.1.50] in pathway Androgen and estrogen metabolism (KEGG).,,"5alpha-androstane-3,17-dione",,HMDB00899,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-16H,3-11H2,1-2H3/t12-,14-,15-,16-,18-,19-/m0/s1",C00674,2016-12-05T15:48:06Z,,1244,,,,,222865,andrstandn,,"(5a)-Androstane-3,17-dione, 5-alpha-Androstane-3,17-dione, 5a-Androsta-3,17-dione, 5a-Androstan-3,17-dione, 5a-Androstane-3, 17-dione, 5a-Androstane-3,17-dione, 5a-Androstanedione, 5alpha-Androstane-3,17-dione, Androstane-3,17-dione, Androstane-3,7-dione, Androstanedione",http://vmh.uni.lu/_api/metabolites/1244/?format=pcsv
prgnlone,,,0,C21H32O2,CHEBI:16581,,"Human Metabolome Database (HMDB): Pregnenolone is a derivative of cholesterol, the product of Cytochrome P450 side-chain cleavage (EC 1.14.15.6, CYP11A1); this reaction consists of three consecutive monooxygenations; a 22-hydroxylation, 20-hydroxylation and the cleavage of the C20-C22 bond, yielding pregnenolone. Pregnenolone is the precursor to gonadal steroid hormones and the adrenal corticosteroids. This reaction occurs in steroid hormone-producing tissues such as the adrenal cortex, corpus luteum and placenta. The most notable difference between the placenta and other steroidogenic tissues is that electron supply to CYP11A1 limits the rate at which cholesterol is converted to pregnenolone in the placenta. The limiting component for electron delivery to CYP11A1 is the concentration of adrenodoxin reductase in the mitochondrial matrix which is insufficient to maintain the adrenodoxin pool in a fully reduced state. Pregnenolone is also a neurosteroid, and is produced in the spinal cord; CYP11A1 is the key enzyme catalyzing the conversion of cholesterol into pregnenolone, the rate-limiting step in the biosynthesis of all classes of steroids, and has been localized in sensory networks of the spinal cord dorsal horn. In the adrenal glomerulosa cell angiotensin II, one of the major physiological regulators of mineralocorticoid synthesis, appears to affect most of the cholesterol transfer to the mitochondrial outer membrane and transport to the inner membrane steps and thus to exerts a powerful control over the use of cholesterol for aldosterone production. (PMID: 17222962, 15823613, 16632873, 15134809).",,pregnenolone,,HMDB00253,"InChI=1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17+,18-,19-,20-,21+/m0/s1",C01953,2016-12-05T15:48:06Z,,1245,,,,,8955,prgnlone,,"(3b)-3-hydroxy-Pregn-5-en-20-one, 3-Hydroxypregn-5-en-20-one, 3b-Hydroxypregn-5-en-20-one, 3beta-Hydroxypregn-5-en-20-one, 5-Pregnen-3b-ol-20-one, 5-Pregnen-3beta-ol-20-one, Natolone, Pregn-5-en-3b-ol-20-one, Pregn-5-ene-3b-ol-20-one, Pregnetan, Pregneton, Pregnolon, Prenolon, Regnosone, Skinostelon",http://vmh.uni.lu/_api/metabolites/1245/?format=pcsv
17ahprgnlone,,,0,C21H32O3,CHEBI:28750,,"Human Metabolome Database (HMDB): 17a-Hydroxypregnenolone is a 21-carbon steroid that is converted from pregnenolone by cytochrome P450 17alpha hydroxylase/C17,20 lyase (CYP17, EC 1.14.99.9). 17a-Hydroxypregnenolone is an intermediate in the delta-5 pathway of biosynthesis of gonadal steroid hormones and the adrenal corticosteroids. The first, rate-limiting and hormonally regulated step in the biosynthesis of all steroid hormones is the conversion of cholesterol to pregnenolone. The conversion of cholesterol to pregnenolone is accomplished by the cleavage of the cholesterol side chain, catalyzed by a mitochondrial cytochrome P450 enzyme termed P450scc where scc designates Side Chain Cleavage. All steroid hormones are made from the pregnenolone produced by P450scc; thus, the presence or absence of each of the activities of CYP17 directs this pregnenolone towards its final metabolic pathway. While all cytochrome P450 enzymes can catalyze multiple reactions on a single active site, CYP17 is the only one described to date in which these multiple activities are differentially regulated by a physiologic process. 17a-Hydroxypregnenolone is converted to dehydroepiandrosterone by the 17,20 lyase activity of CYP17. The ratio of the 17,20 lyase to 17 alpha-hydroxylase activity of CYP17 determines the ratio of C21 to C19 steroids produced. This ratio is regulated post-translationally by at least three factors: the abundance of the electron-donating protein P450 oxidoreductase, the presence of cytochrome b5, and the serine phosphorylation of CYP17. (PMID: 12573809).",,17alpha-hydroxypregnenolone,,HMDB00363,"InChI=1S/C21H32O3/c1-13(22)21(24)11-8-18-16-5-4-14-12-15(23)6-9-19(14,2)17(16)7-10-20(18,21)3/h4,15-18,23-24H,5-12H2,1-3H3/t15-,16+,17-,18-,19-,20-,21-/m0/s1",C05138,2016-12-05T15:48:06Z,,1246,,,,,91451,17ahprgnlone,,"17-Hydroxy-D5-pregnenolone, 17-Hydroxypregnenolone, 17-OH-pregnenolone, 17a-Hydroxypregnolone, 17alpha-Hydroxypregnanolone , 17alpha-hydroxypregnenolone, 3b,17-Dihydroxy-5-pregnen-20-one, 3b,17-Dihydroxy-Pregn-5-en-20-one, 3b,17a-Dihydroxypregn-5-en-20-one, 5-Pregnen-3b,17a-diol-20-one",http://vmh.uni.lu/_api/metabolites/1246/?format=pcsv
17ahprgstrn,,,0,C21H30O3,CHEBI:17252,,"Human Metabolome Database (HMDB): It serves as an intermediate in the biosynthesis of hydrocortisone and gonadal steroid hormones. It is derived from progesterone via 17-hydroxylase, a P450c17 enzyme, or from 17-hydroxypregnenolone via 3&#946;-hydroxysteroid dehydrogenase/&#916;5-4 isomerase. 17-Hydroxyprogesterone is a natural progestin and in pregnancy increases in the third trimester primarily due to fetal adrenal production. This hormone is primarily produced in the adrenal glands and to some degree in the gonads, specifically the corpus luteum of the ovary. Normal levels are 3-90 ng/dl in children, and in women, 15-70 ng/dl prior to ovulation, and 35-290 ng/dl during the luteal phase. Measurements of levels of 17-hydroxyprogesterone are useful in the evaluation of patients with suspected congenital adrenal hyperplasia as the typical enzymes that are defective, namely 21-hydroxylase and 11&#946;-hydroxylase, lead to a build-up of 17OHP. In contrast, the rare patient with 17&#945;-hydroxylase deficiency will have very low or undetectable levels of 17OHP. 17OHP levels can also be used to measure contribution of progestational activity of the corpus luteum during pregnancy as progesterone but not 17OHP is also contributed by the placenta.",,17alpha-hydroxyprogesterone,,HMDB00374,"InChI=1S/C21H30O3/c1-13(22)21(24)11-8-18-16-5-4-14-12-15(23)6-9-19(14,2)17(16)7-10-20(18,21)3/h12,16-18,24H,4-11H2,1-3H3/t16-,17+,18+,19+,20+,21+/m1/s1",C01176,2016-12-05T15:48:06Z,,1247,,,,,6238,17ahprgstrn,,"17-alpha-Hydroxyprogesterone, 17-Hydroxypregn-4-ene-3,20-dione, 17-Hydroxyprogesterone, 17-OH Progesterone, 17-OHP, 17a-Hydroxypregn-4-ene-3,20-dione, 17a-Hydroxyprogesterone, 17alpha-hydroxyprogesterone, D4-Pregnen-17a-ol-3,20-dione, Gestageno, Gestageno Gador, Hydroxyprogesterone, Pregn-4-en-17a-ol-3,20-dione, Prodix, Prodox",http://vmh.uni.lu/_api/metabolites/1247/?format=pcsv
xol7a,,,0,C27H46O2,CHEBI:17500,,20-hydroxycholesterol,,20-hydroxycholesterol,,,"InChI=1S/C27H46O2/c1-18(2)7-6-14-27(5,29)24-11-10-22-21-9-8-19-17-20(28)12-15-25(19,3)23(21)13-16-26(22,24)4/h8,18,20-24,28-29H,6-7,9-17H2,1-5H3/t20-,21-,22-,23-,24-,25-,26-,27-/m0/s1",C05500,2016-11-22T15:12:06Z,,1248,,,,,121935,xol7a,,,http://vmh.uni.lu/_api/metabolites/1248/?format=pcsv
hs,,,-13,C79H114N5O102S12,CHEBI:28815,,"heparan sulfate, free chain",,"heparan sulfate, free chain",,,,,2016-11-22T15:12:06Z,,1249,,,,,,hs,,,http://vmh.uni.lu/_api/metabolites/1249/?format=pcsv
pyam5p,,,-1,C8H12N2O5P,CHEBI:18335,,Pyridoxamine 5'-phosphate,,Pyridoxamine 5'-phosphate,,,"InChI=1S/C8H13N2O5P/c1-5-8(11)7(2-9)6(3-10-5)4-15-16(12,13)14/h3,11H,2,4,9H2,1H3,(H2,12,13,14)/p-1",C00647,2016-11-22T15:12:06Z,,1250,,,,,1053,pyam5p,,,http://vmh.uni.lu/_api/metabolites/1250/?format=pcsv
3ityr_L,,,0,C9H10INO3,CHEBI:27847,,3-iodo-L-tyrosine,,3-iodo-L-tyrosine,,,"InChI=1S/C9H10INO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1",C02515,2016-11-22T15:12:06Z,,1251,,,,,439744,3ityr_L,,,http://vmh.uni.lu/_api/metabolites/1251/?format=pcsv
iodine,,,0,I2,CHEBI:17606,,"Human Metabolome Database (HMDB): Iodine is an essential trace element. Chemically, iodine is the least reactive of the halogens, and the most electropositive halogen after astatine. However, iodine does not occur in the free state in nature. As with all other halogens , when freed from its compounds iodine forms diatomic molecules (I2). Iodine and its compounds are primarily used in medicine, photography, and dyes. Iodine is required for the production of thyroid hormones, which are essential for normal brain development, and the fetus, newborn, and young child are particularly vulnerable to iodine deficiency. Physiologically, iodine exists as an ion in the body. The iodine requirement increases during pregnancy and recommended intakes are in the range of 220-250 microg/day. Monitoring iodine status during pregnancy is a challenge. New recommendations from World Health Organization suggest that a median urinary iodine concentration >250 microg/L and <500 microg/L indicates adequate iodine intake in pregnancy. Based on this range, it appears that many pregnant women in have inadequate intakes. Thyroid-stimulating hormone concentration in the newborn is a sensitive indicator of mild iodine deficiency in late pregnancy. The potential adverse effects of mild iodine deficiency during pregnancy are uncertain. Controlled trials of iodine supplementation in mildly iodine-deficient pregnant women suggest beneficial effects on maternal and newborn serum thyroglobulin and thyroid volume, but no effects on maternal and newborn total or free thyroid hormone concentrations. There are no long-term data on the effect of iodine supplementation on birth outcomes or infant development. New data from well-controlled studies indicate that iodine repletion in moderately iodine-deficient school-age children has clear benefits: it improves cognitive and motor function; it also increases concentrations of insulin-like growth factor 1 and insulin-like growth factor-binding protein 3, and improves somatic growth. (PMID: 17956157).",,Iodine,,HMDB00675,,C01382,2016-12-05T15:48:06Z,,1252,,,,,807,iodine,,"I2, Iode, Iodine-molecule, Iodio, Iodum, Jod, Jood, Tincture iodine",http://vmh.uni.lu/_api/metabolites/1252/?format=pcsv
35diotyr,,,0,C9H9I2NO3,CHEBI:15768,,"3,5-diiodo-L-tyrosine",,"3,5-diiodo-L-tyrosine",,,"InChI=1S/C9H9I2NO3/c10-5-1-4(2-6(11)8(5)13)3-7(12)9(14)15/h1-2,7,13H,3,12H2,(H,14,15)/t7-/m0/s1",C01060,2016-11-22T15:12:06Z,,1253,,,,,9305,35diotyr,,,http://vmh.uni.lu/_api/metabolites/1253/?format=pcsv
hs_deg5,,,-11,C67H97N4O86S10,,,"heparan sulfate, degradation product 5",,"heparan sulfate, degradation product 5",,,,,2016-11-22T15:12:06Z,,1254,,,,,,hs_deg5,,,http://vmh.uni.lu/_api/metabolites/1254/?format=pcsv
idour,,,-1,C6H9O7,CHEBI:28481,,L-iduronate,,L-iduronate,,,"InChI=1S/C6H10O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h1-5,8-11H,(H,12,13)/p-1/t2-,3+,4-,5+/m0/s1",C06472,2016-11-22T15:12:06Z,,1255,,,,,18845,idour,,,http://vmh.uni.lu/_api/metabolites/1255/?format=pcsv
hs_deg16,,,-6,C49H72N2O54S4,,,"heparan sulfate, degradation product 16",,"heparan sulfate, degradation product 16",,,,,2016-11-22T15:12:06Z,,1256,,,,,,hs_deg16,,,http://vmh.uni.lu/_api/metabolites/1256/?format=pcsv
hs_deg17,,,-5,C43H65N2O48S4,,,"heparan sulfate, degradation product 17",,"heparan sulfate, degradation product 17",,,,,2016-11-22T15:12:06Z,,1257,,,,,,hs_deg17,,,http://vmh.uni.lu/_api/metabolites/1257/?format=pcsv
hs_deg22,,,-3,C37H56NO35S,,,"IdoA-beta-1,4-GlcNAc(3S)-alpha-1,4-GlcA-beta-1,3-Gal-beta-1,3-Gal-beta-1,4-Xylose",,"IdoA-beta-1,4-GlcNAc(3S)-alpha-1,4-GlcA-beta-1,3-Gal-beta-1,3-Gal-beta-1,4-Xylose",,,,,2016-11-22T15:12:06Z,,1258,,,,,,hs_deg22,,,http://vmh.uni.lu/_api/metabolites/1258/?format=pcsv
hs_deg23,,,-2,C31H49NO29S,,,"GlcNAc(3S)-alpha-1,4-GlcA-beta-1,3-Gal-beta-1,3-Gal-beta-1,4-Xylose",,"GlcNAc(3S)-alpha-1,4-GlcA-beta-1,3-Gal-beta-1,3-Gal-beta-1,4-Xylose",,,,,2016-11-22T15:12:06Z,,1259,,,,,,hs_deg23,,,http://vmh.uni.lu/_api/metabolites/1259/?format=pcsv
cs_b_deg3,,,-4,C37H55NO38S2,,,"chondroitin sulfate B / dermatan sulfate (IdoA2S-GalNAc4S), degradation product 3",,"chondroitin sulfate B / dermatan sulfate (IdoA2S-GalNAc4S), degradation product 3",,,,,2016-11-22T15:12:06Z,,1260,,,,,,cs_b_deg3,,,http://vmh.uni.lu/_api/metabolites/1260/?format=pcsv
im4ac,,,-1,C5H5N2O2,CHEBI:16974,,Human Metabolome Database (HMDB): Imidazoleacetic acid is a metabolite product of Histamine metabolism. It is present in normal urine and increased in histidinemic patients. (PMID 6530403).,,imidazol-4-ylacetate,,HMDB02024,"InChI=1S/C5H6N2O2/c8-5(9)1-4-2-6-3-7-4/h2-3H,1H2,(H,6,7)(H,8,9)/p-1",C02835,2016-12-05T15:48:06Z,,1261,,,,,96215,im4ac,,"1H-Imidazol-4-ylacetic acid, 1H-Imidazole-4-acetic acid, 4(5)-Imidazoleacetate, 4-Imidazoleacetate, 4-Imidazoleacetic acid, IAA, IMAC, Imidazol-4-ylacetic acid, Imidazole acetate, Imidazole-4-acetate, Imidazole-4-acetic acid, Imidazolyl-4-acetic acid, IZC, Lopac-I-0375",http://vmh.uni.lu/_api/metabolites/1261/?format=pcsv
itacon,,,-2,C5H4O4,CHEBI:17240,,"Human Metabolome Database (HMDB): Itaconic acid is an intermediate in the C5-Branched dibasic acid metabolism, a substrate for the enzyme Succinate-CoA ligase (ADP-forming) (EC:6.2.1.5)(Kegg).",,itaconate(2-),,HMDB02092,"InChI=1S/C5H6O4/c1-3(5(8)9)2-4(6)7/h1-2H2,(H,6,7)(H,8,9)/p-2",C00490,2016-12-05T15:48:06Z,,1262,,,,,811,itacon,,"  Methylenebutanedioate, 2-Hydroxy-3-Naphthoyl-2-Naphthylamine, 2-Methylenesuccinate, 2-Methylenesuccinic acid, 2-Propene-1,2-dicarboxylate, 2-Propene-1,2-dicarboxylic acid, Itaconate, Methylenebutanedioic acid, Methylenesuccinate, Methylenesuccinic acid, Propylenedicarboxylate, Propylenedicarboxylic acid",http://vmh.uni.lu/_api/metabolites/1262/?format=pcsv
4izp,,,-1,C6H7N2O3,,,4-Imidazolone-5-propanoate,,4-Imidazolone-5-propanoate,,,"InChI=1S/C6H7N2O3/c9-5(10)2-1-4-6(11)8-3-7-4/h3H,1-2H2,(H,9,10)(H,7,8,11)/q-1/p-1",C03680,2016-11-22T15:12:06Z,,1263,,,,,128,4izp,,,http://vmh.uni.lu/_api/metabolites/1263/?format=pcsv
xylu_D,,,0,C5H10O5,CHEBI:17140,,"Human Metabolome Database (HMDB): D-xylulose is a monosaccharide containing five carbon atoms. D-xylulose is converted from xylitol by the enzyme NAD+-linked xylitol dehydrogenase (EC 1.1.1.9) in the glucuronate pathway, the most important xylitol-handling metabolic pathway in mammals. This activity has been described in human erythrocytes. Most likely, D-xylulose (as well as D-arabinose or D-ribulose) is a precursor of the pentiol D-arabitol, since pentitols are derived from their corresponding pentose phosphate precursors via pentoses. This pathway can play a role in inherited metabolic disorders underlying the accumulation of pentitols e.g., ribose 5-phosphate isomerase deficiency and transaldolase deficiency. Although pentitols are present in all living organisms, knowledge concerning their metabolism is limited. (PMID: 15234337, Mol Genet Metab. 2004 Jul;82(3):231-7.).",,D-xylulose,,HMDB01644,"InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h3,5-8,10H,1-2H2/t3-,5+/m1/s1",C00310,2016-12-05T15:48:06Z,,1264,,,,,5289590,xylu_D,,"D-Threo-Pentulose, D-Xylulose, Xylulose",http://vmh.uni.lu/_api/metabolites/1264/?format=pcsv
anth,,,-1,C7H6NO2,CHEBI:30754,,Human Metabolome Database (HMDB): 2-Aminobenzoic acid is an organic compound. It is a substrate of enzyme anthranilate hydroxylase [EC 1.14.13.35] in benzoate degradation via hydroxylation pathway (KEGG).,,anthranilate,,HMDB01123,"InChI=1S/C7H7NO2/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,8H2,(H,9,10)/p-1",C00108,2016-12-05T15:48:06Z,,1265,,,,,227,anth,,"1-Amino-2-carboxybenzene, 2-Amino-Benzoate, 2-Amino-Benzoic acid, 2-Aminobenzoate, 2-Aminobenzoic acid, 2-Aminophenylacetate, 2-Aminophenylacetic acid, 2-Carboxyaniline, Anthranate, Anthranic acid, Anthranilate, Anthranilic acid, Anthranilic acid gr, Carboxyaniline, H-2-Abz-OH, Kyselina anthranilova, Kyselina O-aminobenzoova, O-Amino-Benzoate, O-Amino-Benzoic acid, O-Aminobenzoate, O-Aminobenzoic acid, O-Anthranilate, O-Anthranilic acid, O-Carboxyaniline, Ortho-amidobenzoate, Ortho-amidobenzoic acid, Ortho-aminobenzoate, Ortho-aminobenzoic acid, Vitamin L, Vitamin L1",http://vmh.uni.lu/_api/metabolites/1265/?format=pcsv
4aphdob,,,-1,C10H8NO4,CHEBI:17442,,"Human Metabolome Database (HMDB): 4-(2-Aminophenyl)-2,4-dioxobutanoic acid is a substrate for Kynurenine/alpha-aminoadipate aminotransferase mitochondrial.",,"4-(2-aminophenyl)-2,4-dioxobutanoate",,HMDB00978,"InChI=1S/C10H9NO4/c11-7-4-2-1-3-6(7)8(12)5-9(13)10(14)15/h1-4H,5,11H2,(H,14,15)/p-1",C01252,2016-12-05T15:48:06Z,,1266,,,,,472,4aphdob,,"4-(2-Aminophenyl)-2,4-dioxo-butanoate, 4-(2-Aminophenyl)-2,4-dioxo-butanoic acid, 4-(2-Aminophenyl)-2,4-dioxobutanoate, 4-(2-Aminophenyl)-2,4-dioxobutanoic acid",http://vmh.uni.lu/_api/metabolites/1266/?format=pcsv
kynate,,,-1,C10H6NO3,CHEBI:18344,,"Human Metabolome Database (HMDB): Kynurenic acid (KYNA) is a well-known endogenous antagonist of the glutamate ionotropic excitatory amino acid receptors N-methyl-D-aspartate (NMDA), alphaamino-3-hydroxy-5-methylisoxazole-4-propionic acid and kainate receptors and of the nicotine cholinergic subtype alpha 7 receptors. KYNA neuroprotective and anticonvulsive activities have been demonstrated in animal models of neurodegenerative diseases. Because of KYNA's neuromodulatory character, its involvement has been speculatively linked to the pathogenesis of a number of neurological conditions including those in the ageing process. Different patterns of abnormalities in various stages of KYNA metabolism in the CNS have been reported in Alzheimer's disease, Parkinson's disease and Huntington's disease. In HIV-1-infected patients and in patients with Lyme neuroborreliosis a marked rise of KYNA metabolism was seen. In the ageing process KYNA metabolism in the CNS of rats shows a characteristic pattern of changes throughout the life span. A marked increase of the KYNA content in the CNS occurs before the birth, followed by a dramatic decline on the day of birth. A low activity was seen during ontogenesis, and a slow and progressive enhancement occurs during maturation and ageing. This remarkable profile of KYNA metabolism alterations in the mammalian brain has been suggested to result from the development of the organisation of neuronal connections and synaptic plasticity, development of receptor recognition sites, maturation and ageing. There is significant evidence that KYNA can improve cognition and memory, but it has also been demonstrated that it interferes with working memory. Impairment of cognitive function in various neurodegenerative disorders is accompanied by profound reduction and/or elevation of KYNA metabolism. The view that enhancement of CNS KYNA levels could underlie cognitive decline is supported by the increased KYNA metabolism in Alzheimer's disease, by the increased KYNA metabolism in down's syndrome and the enhancement of KYNA function during the early stage of Huntington's disease. Kynurenic acid is the only endogenous N-methyl-D-aspartate (NMDA) receptor antagonist identified up to now, that mediates glutamatergic hypofunction. Schizophrenia is a disorder of dopaminergic neurotransmission, but modulation of the dopaminergic system by glutamatergic neurotransmission seems to play a key role. Despite the NMDA receptor antagonism, kynurenic acid also blocks, in lower doses, the nicotinergic acetycholine receptor, i.e., increased kynurenic acid levels can explain psychotic symptoms and cognitive deterioration. Kynurenic acid levels are described to be higher in the cerebrospinal fluid (CSF) and in critical central nervous system (CNS) regions of schizophrenics as compared to controls. (PMID: 17062375, 16088227).",,kynurenate,,HMDB00715,"InChI=1S/C10H7NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-5H,(H,11,12)(H,13,14)/p-1",C01717,2016-12-05T15:48:06Z,,1267,,,,,3845,kynate,,"2-Carboxy-4-hydroxyquinoline, 4-Hydroxy-2-Quinolinecarboxylic acid, 4-Hydroxy-Quinaldate, 4-Hydroxy-Quinaldic acid, 4-Hydroxyquinaldate, 4-Hydroxyquinaldic acid, 4-Hydroxyquinaldinate, 4-Hydroxyquinaldinic acid, 4-Hydroxyquinoline-2-carboxylate, 4-Hydroxyquinoline-2-carboxylic acid, Kynurenate, Kynurenic acid, Quinurenic acid",http://vmh.uni.lu/_api/metabolites/1267/?format=pcsv
3spyr,,,-2,C3H2O6S,CHEBI:16894,,"Human Metabolome Database (HMDB): 3-Sulfopyruvic acid is the product of the transamination of cysteinesulfonate in a reaction catalyzed by aspartate aminotransferase. 3-sulfopyruvic acid is stable and is reduced by malate dehydrogenase to beta-sulfolactate, which is excreted in the urine. Cysteinesulfonate, 3-sulfopyruvic acid, and beta-sulfolactate are reversibly interconverted in vivo. (PMID: 3346220).",,3-sulfonatopyruvate(2-),,HMDB04045,"InChI=1S/C3H4O6S/c4-2(3(5)6)1-10(7,8)9/h1H2,(H,5,6)(H,7,8,9)/p-2",C05528,2016-12-05T15:48:06Z,,1268,,,,,440717,3spyr,,"2-Carboxy-2-oxoethanesulfonic acid, 2-Oxo-3-sulfo-Propanoate, 2-Oxo-3-sulfo-Propanoic acid, 2-Oxo-3-sulfopropanoate, 2-Oxo-3-sulfopropanoic acid, 3-Sulfopyruvate, beta-Sulfopyruvic acid, Sulfopyruvate",http://vmh.uni.lu/_api/metabolites/1268/?format=pcsv
nformanth,,,-1,C8H6NO3,CHEBI:36575,,N-formylanthranilate,,N-formylanthranilate,,,"InChI=1S/C8H7NO3/c10-5-9-7-4-2-1-3-6(7)8(11)12/h1-5H,(H,9,10)(H,11,12)/p-1",C05653,2016-11-22T15:12:06Z,,1269,,,,,101399,nformanth,,,http://vmh.uni.lu/_api/metabolites/1269/?format=pcsv
lgnccrn,,,0,C31H61NO4,,,lignoceryl carnitine,,lignoceryl carnitine,,,,,2016-11-22T15:12:06Z,,1270,,,,,,lgnccrn,,,http://vmh.uni.lu/_api/metabolites/1270/?format=pcsv
cs_a_deg5,,,-2,C23H36O24S,,,"chondroitin sulfate A (GalNAc4S-GlcA), degradation product 5",,"chondroitin sulfate A (GalNAc4S-GlcA), degradation product 5",,,,,2016-11-22T15:12:06Z,,1271,,,,,,cs_a_deg5,,,http://vmh.uni.lu/_api/metabolites/1271/?format=pcsv
cs_c_deg5,,,-2,C23H36O24S,,,"chondroitin sulfate C (GalNAc6S-GlcA), degradation product 5",,"chondroitin sulfate C (GalNAc6S-GlcA), degradation product 5",,,,,2016-11-22T15:12:06Z,,1272,,,,,,cs_c_deg5,,,http://vmh.uni.lu/_api/metabolites/1272/?format=pcsv
cs_e_deg7,,,-3,C23H35O27S2,,,"chondroitin sulfate E (GalNAc4,6diS-GlcA), degradation product 7",,"chondroitin sulfate E (GalNAc4,6diS-GlcA), degradation product 7",,,,,2016-11-22T15:12:06Z,,1273,,,,,,cs_e_deg7,,,http://vmh.uni.lu/_api/metabolites/1273/?format=pcsv
lneldccrn,,,0,C25H45NO4,,,Linoelaidyl carnitine,,Linoelaidyl carnitine,,,"InChI=1/C25H45NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(21-24(27)28)22-26(2,3)4/h9-10,12-13,23H,5-8,11,14-22H2,1-4H3/b10-9+,13-12+",,2016-11-22T15:12:06Z,,1274,,,,,53477834,lneldccrn,,,http://vmh.uni.lu/_api/metabolites/1274/?format=pcsv
lnlccrn,,,0,C25H45NO4,,,Linoleyl carnitine,,Linoleyl carnitine,,,"InChI=1/C25H45NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(21-24(27)28)22-26(2,3)4/h9-10,12-13,23H,5-8,11,14-22H2,1-4H3/b10-9-,13-12-/t23-/m1/s1",,2016-11-22T15:12:06Z,,1275,,,,,6450015,lnlccrn,,,http://vmh.uni.lu/_api/metabolites/1275/?format=pcsv
lnlncacrn,,,0,C25H43NO4,,,alpha-linolenyl carnitine,,alpha-linolenyl carnitine,,,"InChI=1/C25H43NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(26(2,3)4)21-22-24(27)28/h6-7,9-10,12-13,23H,5,8,11,14-22H2,1-4H3/b7-6-,10-9-,13-12-/t23-/m0/s1",,2016-11-22T15:12:06Z,,1276,,,,,53477821,lnlncacrn,,,http://vmh.uni.lu/_api/metabolites/1276/?format=pcsv
lnlncgcrn,,,0,C25H43NO4,,,gamma-linolenyl carnitine,,gamma-linolenyl carnitine,,,"InChI=1/C25H43NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(26(2,3)4)21-22-24(27)28/h9-10,12-13,15-16,23H,5-8,11,14,17-22H2,1-4H3/b10-9-,13-12-,16-15-/t23-/m0/s1",,2016-11-22T15:12:06Z,,1277,,,,,53477819,lnlncgcrn,,,http://vmh.uni.lu/_api/metabolites/1277/?format=pcsv
lanost,,,0,C30H50O,CHEBI:16521,,"Human Metabolome Database (HMDB): Lanosterol is a tetracyclic triterpenoid which is the compound from which all steroids are derived. Lanosterol is biochemically synthesized starting from acetyl-CoA by the HMG-CoA reductase pathway. The critical step is the enzymatic conversion of the acyclic terpene squalene to the polycylic lanosterol via 2,3-squalene oxide.(wikipedia).",,lanosterol,,HMDB01251,"InChI=1S/C30H50O/c1-20(2)10-9-11-21(3)22-14-18-30(8)24-12-13-25-27(4,5)26(31)16-17-28(25,6)23(24)15-19-29(22,30)7/h10,21-22,25-26,31H,9,11-19H2,1-8H3/t21-,22-,25+,26+,28-,29-,30+/m1/s1",C01724,2016-12-05T15:48:06Z,,1278,,,,,246983,lanost,,"(3 beta)-Lanosta-8,24-dien-3-ol, (3alpha)-4,4,14-trimethyl-Cholesta-8,24-dien-3-ol, (3beta)-Lanosta-8,24-dien-3-ol, (3beta,5alpha)-4,4,14-trimethyl-Cholesta-8,24-dien-3-ol, 4,4',14alpha-Trimethyl-5alpha-cholesta-8,24-dien-3beta-ol, Botalan base 138, Lanosta-8,24-dien-3-ol, Lanosta-8,24-dien-3beta-ol, Lanosta-8,24-dienol, Lanosterin, Lanosterol, Lanster",http://vmh.uni.lu/_api/metabolites/1278/?format=pcsv
Ssq23epx,,,0,C30H50O,CHEBI:15441,,"(S)-2,3-epoxysqualene",,"(S)-2,3-epoxysqualene",,,"InChI=1S/C30H50O/c1-24(2)14-11-17-27(5)20-12-18-25(3)15-9-10-16-26(4)19-13-21-28(6)22-23-29-30(7,8)31-29/h14-16,20-21,29H,9-13,17-19,22-23H2,1-8H3/b25-15+,26-16+,27-20+,28-21+/t29-/m0/s1",C01054,2016-11-22T15:12:06Z,,1279,,,,,53477723,Ssq23epx,,,http://vmh.uni.lu/_api/metabolites/1279/?format=pcsv
thp2c,,,-1,C6H8NO2,CHEBI:16987,,"Human Metabolome Database (HMDB): (S)-2,3,4,5-Tetrahydropiperidine-2-carboxylate is a cyclic intermediate in lysine degradation. L-Lysine is an essential amino acid that is a necessary building block for all protein in the body and It plays a major role in calcium absorption; building muscle protein; recovering from surgery or sports injuries; and the body's production of hormones, enzymes, and antibodies. In lysine degradation pathway, (S)-2,3,4,5-Tetrahydropiperidine-2-carboxylate is a substrate for L-aminoadipate-semialdehyde dehydrogenase (amaA) and can be formed by spontaneous cyclization of 2-aminoadipate-6-semialdehyde.",,1-piperideine-6-carboxylate,,HMDB12130,"InChI=1S/C6H9NO2/c8-6(9)5-3-1-2-4-7-5/h4-5H,1-3H2,(H,8,9)/p-1",,2016-12-05T15:48:06Z,,1280,,,,,45266761,thp2c,,"1,6-Didehydropiperidine-2-carboxylate, 2,3,4,5- Tetrahydropyridine-2-carboxylate , Delta1-piperideine-6-carboxylate, Delta6-piperideine-2-carboxylate",http://vmh.uni.lu/_api/metabolites/1280/?format=pcsv
pd3,,,0,C27H44O,,,Human Metabolome Database (HMDB): Previtamin D3 is an intermediate in the production of Vitamin D.,,Previtamin D3,,HMDB06500,"InChI=1/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h10,12-13,19,21,24-26,28H,6-9,11,14-18H2,1-5H3/b13-12-/t21-,24+,25-,26?,27-/m1/s1",C07711,2016-12-05T15:48:06Z,,1281,,,,,11199982,pd3,,"(3beta,6Z)-9,10-Secocholesta-5(10),6,8-trien-3-ol, (6Z)-(3S)-9,10-seco-5(10),6,8-cholestatrien-3-ol, Previtamin D(3), Previtamin D_3 / precholecalciferol / (6Z)-tacalciol",http://vmh.uni.lu/_api/metabolites/1281/?format=pcsv
lum3,,,0,C27H44O,,,"Human Metabolome Database (HMDB): Lumisterol 3 is a normal human secosterooid metabolite from the class of vitamin D3 photoisomer derivatives. It is synthesized from 7-Dehydrocholesterol in the epidermis in response to ultraviolet irradiation. When human skin is exposed to ultraviolet radiation, epidermal 7-dehydrocholesterol is converted to previtamin D, and during prolonged exposure, the synthesis of previtamin D3 reaches a plateau at about 10 to 15 percent of the original 7-dehydrocholesterol content, and previtamin D3 is photoisomerized to two biologically inert isomers and lumisterol 3 is one of them (the other one being lumisterol 3). Therefore, lumisterol 3 is a metabolite to chronic exposure to sunlight. Lumisterol 3, as well as other photoisomers of vitamin D3 and previtamin D3 has been demonstrated to have inhibited keratinocyte proliferation. Thus, sunlight provides vitamin D3 photoproducts that may act directly to regulate epidermal proliferation and differentiation under physiologic conditions. (PMID 6256855, 10876100).",,Lumisterol 3,,HMDB06505,"InChI=1/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9-10,18-19,21,23-25,28H,6-8,11-17H2,1-5H3/t19-,21+,23-,24+,25-,26-,27-/m1/s1",,2016-12-05T15:48:06Z,,1282,,,,,111049,lum3,,"(3b,9b,10a)-Cholesta-5,7-dien-3-ol, 9b,10a-Cholesta-5,7-dien-3b-ol, 9beta,10alpha-Cholesta-5,7-dien-3beta-ol",http://vmh.uni.lu/_api/metabolites/1282/?format=pcsv
trypta,,,1,C10H13N2,CHEBI:16765,,"Human Metabolome Database (HMDB): Tryptamine is a monoamine compound that is common precursor molecule to many hormones and neurotransmitters. Biosynthesis generally proceeds from the amino acid tryptophan, with tryptamine in turn acting as a precursor for other compounds. Substitutions to the tryptamine molecule give rise to a group of compounds collectively known as tryptamines. The most well-known tryptamines are serotonin, an important neurotransmitter, and melatonin, a hormone involved in regulating the sleep-wake cycle.",,tryptaminium,,HMDB00303,"InChI=1S/C10H12N2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6,11H2/p+1",C00398,2016-12-05T15:48:06Z,,1283,,,,,1150,trypta,,"(3-Indolyl)ethylamine, 1H-Indole-3-ethanamine, 2-(1H-Indol-3-yl)ethanamine, 2-(1H-Indol-3-yl)ethylamine, 2-(3-Indolyl)ethylamine, 2-Indol-3-yl-aethylamin, 2-Indol-3-yl-ethylamine, 3-(2-Aminoethyl)-1H-indole, 3-(2-Aminoethyl)indole, 3-Indoleethanamine, 3-Indoleethylamine, Tryptamin, Tryptamine",http://vmh.uni.lu/_api/metabolites/1283/?format=pcsv
Nmelys,,,1,CXH4,,,Histone N6-methyl-L-lysine,,Histone N6-methyl-L-lysine,,,,C03702,2016-11-22T15:12:07Z,,1284,,,,,,Nmelys,,,http://vmh.uni.lu/_api/metabolites/1284/?format=pcsv
Ndmelys,,,2,C2H7X,,,"Protein N6,N6-dimethyl-L-lysine",,"Protein N6,N6-dimethyl-L-lysine",,,,C05545,2016-11-22T15:12:07Z,,1285,,,,,,Ndmelys,,,http://vmh.uni.lu/_api/metabolites/1285/?format=pcsv
Ntmelys,,,3,C3H10X,,,"Protein N6,N6,N6-trimethyl-L-lysine",,"Protein N6,N6,N6-trimethyl-L-lysine",,,,C05546,2016-11-22T15:12:07Z,,1286,,,,,,Ntmelys,,,http://vmh.uni.lu/_api/metabolites/1286/?format=pcsv
6a2ohxnt,,,0,C6H11NO3,CHEBI:17534,,"Human Metabolome Database (HMDB): 2-Keto-6-aminocaproate is an intermediate in lysine degradation and can be formed from L-lysine. L-Lysine is an essential amino-acid that is a necessary building block for all protein in the body. L-Lysine plays a major role in calcium absorption; building muscle protein; recovering from surgery or sports injuries; and the body's production of hormones, enzymes, and antibodies. L-Lysine can be converted to 2-keto-6-aminocaproate via the enzyme L-lysine alpha-oxidase. 2-Keto-6-aminocaproate can spontaneously decarboxylate to 5-aminovalerate in the presence of the reaction product, hydrogen peroxide. It can also be spontaneously converted in solution to its cyclic form delta-piperideine-2-carboxylate. This has been demonstrated in vitro in the presence of catalase, which splits hydrogen peroxide.",,6-amino-2-oxohexanoic acid,,HMDB12151,"InChI=1S/C6H11NO3/c7-4-2-1-3-5(8)6(9)10/h1-4,7H2,(H,9,10)",C03239,2016-12-05T15:48:06Z,,1287,,,,,439954,6a2ohxnt,,"2-Keto-6-amino-caproate, 2-Keto-6-amino-caproic acid, 2-Oxo-6-aminocaproate, 2-Oxo-6-aminocaproic acid, 2-Oxo-6-aminohexanoate, 2-Oxo-6-aminohexanoic acid, 6-Amino-2-oxohexanoate, 6-Amino-2-oxohexanoic acid, alpha-Keto-epsilon-aminocaproate, alpha-Keto-epsilon-aminocaproic acid, alpha-Keto-epsilon-aminohexanoate, alpha-Keto-epsilon-aminohexanoic acid, alpha-Ketolysine",http://vmh.uni.lu/_api/metabolites/1287/?format=pcsv
nm4masn,,,0,C54H90N3O40X,,,(N-acetyl-D-glucosaminyl-(alpha-D-mannosyl)4-beta-D-mannosyl-diacetylchitobiosyl)-L-asparagine (protein),,(N-acetyl-D-glucosaminyl-(alpha-D-mannosyl)4-beta-D-mannosyl-diacetylchitobiosyl)-L-asparagine (protein),,,,C05882,2016-11-22T15:12:07Z,,1288,,,,,,nm4masn,,,http://vmh.uni.lu/_api/metabolites/1288/?format=pcsv
nm2masn,,,0,C42H70N3O30X,,,(N-acetyl-D-glucosaminyl-(alpha-D-mannosyl)2-beta-D-mannosyl-diacetylchitobiosyl)-L-asparagine (protein),,(N-acetyl-D-glucosaminyl-(alpha-D-mannosyl)2-beta-D-mannosyl-diacetylchitobiosyl)-L-asparagine (protein),,,,C05884,2016-11-22T15:12:07Z,,1289,,,,,,nm2masn,,,http://vmh.uni.lu/_api/metabolites/1289/?format=pcsv
m4masn,,,0,C46H77N2O35X,,,(alpha-D-mannosyl)4-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,(alpha-D-mannosyl)4-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,,,C05881,2016-11-22T15:12:07Z,,1290,,,,,,m4masn,,,http://vmh.uni.lu/_api/metabolites/1290/?format=pcsv
n3m2masn,,,0,C58H96N5O40X,,,((N-acetyl-D-glucosaminyl)3-(alpha-D-mannosyl)2-beta-D-mannosyl-diacetylchitobiosyl)-L-asparagine (protein),,((N-acetyl-D-glucosaminyl)3-(alpha-D-mannosyl)2-beta-D-mannosyl-diacetylchitobiosyl)-L-asparagine (protein),,,,,2016-11-22T15:12:07Z,,1291,,,,,,n3m2masn,,,http://vmh.uni.lu/_api/metabolites/1291/?format=pcsv
n4m2masn,,,0,C66H109N6O45X,,,((N-acetyl-D-glucosaminyl)4-(alpha-D-mannosyl)2-beta-D-mannosyl-diacetylchitobiosyl)-L-asparagine (protein),,((N-acetyl-D-glucosaminyl)4-(alpha-D-mannosyl)2-beta-D-mannosyl-diacetylchitobiosyl)-L-asparagine (protein),,,,,2016-11-22T15:12:07Z,,1292,,,,,,n4m2masn,,,http://vmh.uni.lu/_api/metabolites/1292/?format=pcsv
m7masnB,,,0,C64H107N2O50X,,,"(alpha-D-mannosyl)7-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform B (protein)",,"(alpha-D-mannosyl)7-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform B (protein)",,,,,2016-11-22T15:12:07Z,,1293,,,,,,m7masnB,,,http://vmh.uni.lu/_api/metabolites/1293/?format=pcsv
m8masn,,,0,C70H117N2O55X,,,(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,(alpha-D-mannosyl)8-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,,,C05876,2016-11-22T15:12:07Z,,1294,,,,,,m8masn,,,http://vmh.uni.lu/_api/metabolites/1294/?format=pcsv
3mldz,,,0,C6H8N2O,CHEBI:28104,,1-methylimidazole-4-acetaldehyde,,1-methylimidazole-4-acetaldehyde,,,"InChI=1S/C6H8N2O/c1-8-4-6(2-3-9)7-5-8/h3-5H,2H2,1H3",C05827,2016-11-22T15:12:07Z,,1295,,,,,193545,3mldz,,,http://vmh.uni.lu/_api/metabolites/1295/?format=pcsv
normete_L,,,1,C9H14NO3,,,Human Metabolome Database (HMDB): Normetanephrine is a methylated metabolite of norepinephrine that is excreted in the urine and found in certain tissues. It is a marker for tumors.,,L-Normetanephrine,,HMDB00819,"InChI=1/C9H13NO3/c1-13-9-4-6(8(12)5-10)2-3-7(9)11/h2-4,8,11-12H,5,10H2,1H3",C05589,2016-12-05T15:48:06Z,,1296,,,,,1237,normete_L,,"(+/-)-alpha-(aminomethyl)-4-hydroxy-3-methoxy-Benzenemethanol, (+/-)-Normetanephrine, 3-Methoxy-Noradrenaline, 3-O-Methyl-Noradrenaline, 4-(2-Amino-1-hydroxyethyl)-2-methoxyphenol, alpha-(Aminomethyl)-4-hydroxy-3-methoxy-Benzenemethanol, Dl-N-Normetanephrine, Dl-Normetanephrine, L-Normetanephrine, m-O-Methylnorepinephrine, N111, Normetadrenaline, O-Methylnoradrenaline",http://vmh.uni.lu/_api/metabolites/1296/?format=pcsv
3mgcoa,,,-5,C27H37N7O19P3S,CHEBI:15488,,trans-3-methylglutaconyl-CoA(5-),,trans-3-methylglutaconyl-CoA(5-),,,"InChI=1S/C27H42N7O19P3S/c1-14(8-17(36)37)9-18(38)57-7-6-29-16(35)4-5-30-25(41)22(40)27(2,3)11-50-56(47,48)53-55(45,46)49-10-15-21(52-54(42,43)44)20(39)26(51-15)34-13-33-19-23(28)31-12-32-24(19)34/h8,12-13,15,20-22,26,39-40H,4-7,9-11H2,1-3H3,(H,29,35)(H,30,41)(H,36,37)(H,45,46)(H,47,48)(H2,28,31,32)(H2,42,43,44)/p-5/b14-8+/t15-,20-,21-,22+,26-/m1/s1",C03231,2016-11-22T15:12:07Z,,1297,,,,,5462214,3mgcoa,,,http://vmh.uni.lu/_api/metabolites/1297/?format=pcsv
mercplac,,,-1,C3H5O3S,CHEBI:28580,,3-Mercaptolactate,,3-Mercaptolactate,,,"InChI=1/C3H6O3S/c4-2(1-7)3(5)6/h2,4,7H,1H2,(H,5,6)",C05823,2016-11-22T15:12:07Z,,1298,,,,,160645,mercplac,,,http://vmh.uni.lu/_api/metabolites/1298/?format=pcsv
malACP,,,-2,C14H22N2O10PRS,,,Malonyl-[acyl-carrier protein],,Malonyl-[acyl-carrier protein],,,,,2016-11-22T15:12:07Z,,1299,,,,,,malACP,,,http://vmh.uni.lu/_api/metabolites/1299/?format=pcsv
5mdru1p,,,-2,C6H11O7PS,CHEBI:28096,,5-Methylthio-5-deoxy-D-ribulose 1-phosphate,,5-Methylthio-5-deoxy-D-ribulose 1-phosphate,,,"InChI=1S/C6H13O7PS/c1-15-3-5(8)6(9)4(7)2-13-14(10,11)12/h5-6,8-9H,2-3H2,1H3,(H2,10,11,12)/p-2/t5-,6+/m1/s1",C04582,2016-11-22T15:12:07Z,,1300,,,,,174549,5mdru1p,,,http://vmh.uni.lu/_api/metabolites/1300/?format=pcsv
mescon,,,-2,C5H4O4,CHEBI:16600,,"Human Metabolome Database (HMDB): Mesaconic acid is one of several isomeric carboxylic acids obtained from citric acid. Is used as a fire retardant, recent studies revealed this acid is a competitive inhibitor of fumarate reduction.",,Mesaconate,,HMDB00749,"InChI=1S/C5H6O4/c1-3(5(8)9)2-4(6)7/h2H,1H3,(H,6,7)(H,8,9)/p-2/b3-2+",C01732,2016-12-05T15:48:06Z,,1301,,,,,638129,mescon,,"(2E)-2-Methyl-2-butenedioate, (2E)-2-Methyl-2-butenedioic acid, (E)-Citraconate, (E)-Citraconic acid, 2-Methylfumarate, 2-Methylfumaric acid, Citronate, Citronic acid, Mesaconate, Methylfumarate, Methylfumaric acid, trans-1-Propene-1,2-dicarboxylate, trans-1-Propene-1,2-dicarboxylic acid, trans-2-Methyl-2-butenedioate, trans-2-Methyl-2-butenedioic acid",http://vmh.uni.lu/_api/metabolites/1301/?format=pcsv
mescoa,,,-5,C26H35N7O19P3S,CHEBI:27969,,Mesaconyl-CoA,,Mesaconyl-CoA,,,"InChI=1S/C26H40N7O19P3S/c1-13(8-16(35)36)25(40)56-7-6-28-15(34)4-5-29-23(39)20(38)26(2,3)10-49-55(46,47)52-54(44,45)48-9-14-19(51-53(41,42)43)18(37)24(50-14)33-12-32-17-21(27)30-11-31-22(17)33/h8,11-12,14,18-20,24,37-38H,4-7,9-10H2,1-3H3,(H,28,34)(H,29,39)(H,35,36)(H,44,45)(H,46,47)(H2,27,30,31)(H2,41,42,43)/b13-8+/t14-,18-,19-,20+,24-/m1/s1",C06028,2016-11-22T15:12:07Z,,1302,,,,,5280895,mescoa,,,http://vmh.uni.lu/_api/metabolites/1302/?format=pcsv
fna5moxam,,,0,C13H16N2O4,,,"Human Metabolome Database (HMDB): Acetyl-N-formyl-5-methoxykynurenamine (AFMK) results from the oxidative cleavage of the pyrrole ring during melatonin oxidation by myeloperoxidase (MPO), a superoxide anion (O)-dependent reaction. AFMK is also expected to be formed from oxidation catalyzed by the unspecific enzyme indoleamine-2,3-dioxygenase (IDO), found in a variety of cell types including monocyte/macrophage lineages. MPO- and IDO-catalyzed melatonin oxidation has the requirement of O in common, a species formed in large amounts in inflammatory conditions. The non-enzymatic formation of AFMK can also be expected by its direct reaction with highly reactive oxygen species, such as hydroxyl radical and singlet oxygen. Thus, we assume that AFMK is a product formed in a route of melatonin metabolism, especially active in inflammation. As AFMK is biologically more active on leukocytes than melatonin, the metabolizing of melatonin to AFMK at inflammatory sites possibly plays a role in immunomodulation. AFMK is found in the CSF of patients with meningitis, and in some samples at a remarkably high concentration, with AFMK found in some patients exceeding the concentration of melatonin normally found in serum. (PMID: 16150112).",,Formyl-N-acetyl-5-methoxykynurenamine,,HMDB04259,"InChI=1/C13H16N2O4/c1-9(17)14-6-5-13(18)11-7-10(19-2)3-4-12(11)15-8-16/h3-4,7-8H,5-6H2,1-2H3,(H,14,17)(H,15,16)",C05642,2016-12-05T15:48:06Z,,1303,,,,,171161,fna5moxam,,"AFMK, Formyl-N-acetyl-5-methoxykynurenamine, N-Acetyl-N-formyl-5-methoxykynurenamine, N-[3-(2-Formamido-5-methoxy-phenyl)-3-oxo-propyl]acetamide",http://vmh.uni.lu/_api/metabolites/1303/?format=pcsv
6hoxmelatn,,,0,C13H16N2O3,,,Human Metabolome Database (HMDB): Melatonin is a hormone that is metabolized by cytochrome P450 (CYP) 1A2 to its main primary metabolite 6-hydroxymelatonin. (PMID 11452239).,,6-Hydroxymelatonin,,HMDB04081,"InChI=1/C13H16N2O3/c1-8(16)14-4-3-9-7-15-11-6-12(17)13(18-2)5-10(9)11/h5-7,15,17H,3-4H2,1-2H3,(H,14,16)",C05643,2016-12-05T15:48:06Z,,1304,,,,,1864,6hoxmelatn,,Lopac-H-0627,http://vmh.uni.lu/_api/metabolites/1304/?format=pcsv
5pmev,,,-3,C6H10O7P,CHEBI:17436,,(R)-5-phosphonatomevalonate(3-),,(R)-5-phosphonatomevalonate(3-),,,"InChI=1S/C6H13O7P/c1-6(9,4-5(7)8)2-3-13-14(10,11)12/h9H,2-4H2,1H3,(H,7,8)(H2,10,11,12)/p-3/t6-/m1/s1",C01107,2016-11-22T15:12:07Z,,1305,,,,,439400,5pmev,,,http://vmh.uni.lu/_api/metabolites/1305/?format=pcsv
mhista,,,1,C6H12N3,CHEBI:29009,,Human Metabolome Database (HMDB): 1-Methylhistamine is a histamine metabolite. It is a product of histamine 1-methyltransferase [EC 2.1.1.8] in the pathway histidine metabolism (KEGG).,,N(tele)-methylhistaminium,,HMDB00898,"InChI=1S/C6H11N3/c1-9-4-6(2-3-7)8-5-9/h4-5H,2-3,7H2,1H3/p+1",C05127,2016-12-05T15:48:06Z,,1306,,,,,3614,mhista,,"1-Methyl-1H-imidazole-4-ethanamine, 1-Methyl-4-(2-aminoethyl)imidazole, 1-Methyl-4-(b-aminoethyl)imidazole, 1-Methyl-4-(beta-aminoethyl)imidazole, 1-Methyl-4-histamine, 1-Methylhistamine, 2-(1-Methyl-1H-imidazol-4-yl)ethanamine, 2-(1-Methyl-1H-imidazol-4-yl)ethylamine, 4-(2-Aminoethyl)-1-methyl-Imidazole, 4-(2-Aminoethyl)-1-methylimidazole, H137, Methylhistamine, N( 1)-Methylhistamine, N(T)-Methylhistamine, N-Methylhistamine, N-Tele-Methylhistamine, N-Telle-methylhistamine, N1-Methylhistamine, NT-methylhistamine, Ntau-Methylhistamine, Tele-methylhistamine",http://vmh.uni.lu/_api/metabolites/1306/?format=pcsv
mi13456p,,,-10,C6H7O21P5,CHEBI:16322,,"myo-inositol 1,3,4,5,6-pentakisphosphate(10-)",,"myo-inositol 1,3,4,5,6-pentakisphosphate(10-)",,,"InChI=1S/C6H17O21P5/c7-1-2(23-28(8,9)10)4(25-30(14,15)16)6(27-32(20,21)22)5(26-31(17,18)19)3(1)24-29(11,12)13/h1-7H,(H2,8,9,10)(H2,11,12,13)(H2,14,15,16)(H2,17,18,19)(H2,20,21,22)/p-10/t1-,2+,3-,4-,5+,6+",C01284,2016-11-22T15:12:07Z,,1307,,,,,,mi13456p,,,http://vmh.uni.lu/_api/metabolites/1307/?format=pcsv
minohp,,,-12,C6H6O24P6,CHEBI:17401,,myo-inositol hexakisphosphate(12-),,myo-inositol hexakisphosphate(12-),,,"InChI=1S/C6H18O24P6/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24)/p-12/t1-,2-,3-,4+,5-,6-",C01204,2016-11-22T15:12:07Z,,1308,,,,,890,minohp,,,http://vmh.uni.lu/_api/metabolites/1308/?format=pcsv
mi1345p,,,-8,C6H8O18P4,CHEBI:16783,,,,"1D-myo-inositol 1,3,4,5-tetrakisphosphate",,HMDB01059,"InChI=1S/C6H16O18P4/c7-1-3(21-25(9,10)11)2(8)5(23-27(15,16)17)6(24-28(18,19)20)4(1)22-26(12,13)14/h1-8H,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20)/p-8/t1-,2-,3-,4+,5-,6-/m0/s1",C01272,2016-12-19T16:23:35Z,,1309,,,,,107758,mi1345p,,,http://vmh.uni.lu/_api/metabolites/1309/?format=pcsv
mi134p,,,-6,C6H9O15P3,CHEBI:18228,,"1D-myo-inositol 1,3,4-trisphosphate(6-)",,"1D-myo-inositol 1,3,4-trisphosphate(6-)",,,"InChI=1S/C6H15O15P3/c7-1-2(8)5(20-23(13,14)15)6(21-24(16,17)18)3(9)4(1)19-22(10,11)12/h1-9H,(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)/p-6/t1-,2-,3+,4+,5+,6+/m1/s1",C01243,2016-11-22T15:12:07Z,,1310,,,,,439455,mi134p,,,http://vmh.uni.lu/_api/metabolites/1310/?format=pcsv
mi1346p,,,-8,C6H8O18P4,CHEBI:16155,,"myo-inositol 1,3,4,6-tetrakisphosphate(8-)",,"myo-inositol 1,3,4,6-tetrakisphosphate(8-)",,,"InChI=1S/C6H16O18P4/c7-1-3(21-25(9,10)11)5(23-27(15,16)17)2(8)6(24-28(18,19)20)4(1)22-26(12,13)14/h1-8H,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20)/p-8/t1-,2+,3-,4+,5-,6+",C04477,2016-11-22T15:12:07Z,,1311,,,,,,mi1346p,,,http://vmh.uni.lu/_api/metabolites/1311/?format=pcsv
mi13p,,,-4,C6H10O12P2,CHEBI:18225,,"1D-myo-Inositol 1,3-bisphosphate",,"1D-myo-Inositol 1,3-bisphosphate",,,"InChI=1S/C6H14O12P2/c7-1-2(8)5(17-19(11,12)13)4(10)6(3(1)9)18-20(14,15)16/h1-10H,(H2,11,12,13)(H2,14,15,16)/t1-,2-,3+,4+,5+,6-",C04062,2016-11-22T15:12:07Z,,1312,,,,,,mi13p,,,http://vmh.uni.lu/_api/metabolites/1312/?format=pcsv
mi34p,,,-4,C6H10O12P2,CHEBI:28858,,"Human Metabolome Database (HMDB): 1D-myo-Inositol 3,4-bisphosphate is an intermediate in inositol phosphate metabolism. 1D-myo-Inositol 3,4-bisphosphate is converted from 1D-myo-inositol-3-phosphate via inositol polyphosphate-4-phosphatase [EC:3.1.3.66].",,"1D-myo-Inositol 3,4-bisphosphate",,HMDB06235,"InChI=1S/C6H14O12P2/c7-1-2(8)4(10)6(18-20(14,15)16)5(3(1)9)17-19(11,12)13/h1-10H,(H2,11,12,13)(H2,14,15,16)/t1-,2-,3-,4+,5-,6-/m0/s1",C04063,2016-12-05T15:48:06Z,,1313,,,,,440211,mi34p,,"1D-Myo-inositol 3,4-bis(dihydrogen phosphate), D-Myo-Inositol 3,4-bisphosphate, Inositol 3,4-bisphosphate",http://vmh.uni.lu/_api/metabolites/1313/?format=pcsv
mi1p_D,,,-2,C6H11O9P,CHEBI:18297,,1D-myo-inositol 1-phosphate(2-),,1D-myo-inositol 1-phosphate(2-),,,"InChI=1S/C6H13O9P/c7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h1-11H,(H2,12,13,14)/p-2/t1-,2-,3+,4-,5-,6-/m1/s1",C01177,2016-11-22T15:12:07Z,,1314,,,,,,mi1p_D,,,http://vmh.uni.lu/_api/metabolites/1314/?format=pcsv
mi1456p,,,-8,C6H8O18P4,CHEBI:16067,,"1D-myo-inositol 1,4,5,6-tetrakisphosphate(8-)",,"1D-myo-inositol 1,4,5,6-tetrakisphosphate(8-)",,,"InChI=1S/C6H16O18P4/c7-1-2(8)4(22-26(12,13)14)6(24-28(18,19)20)5(23-27(15,16)17)3(1)21-25(9,10)11/h1-8H,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20)/p-8/t1-,2+,3-,4-,5+,6+/m1/s1",C11555,2016-11-22T15:12:07Z,,1315,,,,,443266,mi1456p,,,http://vmh.uni.lu/_api/metabolites/1315/?format=pcsv
mi145p,,,-6,C6H9O15P3,CHEBI:16595,,"1D-myo-inositol 1,4,5-trisphosphate(6-)",,"1D-myo-inositol 1,4,5-trisphosphate(6-)",,,"InChI=1S/C6H15O15P3/c7-1-2(8)5(20-23(13,14)15)6(21-24(16,17)18)3(9)4(1)19-22(10,11)12/h1-9H,(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)/p-6/t1-,2+,3+,4-,5-,6-/m1/s1",C01245,2016-11-22T15:12:07Z,,1316,,,,IP3 ,439456,mi145p,,,http://vmh.uni.lu/_api/metabolites/1316/?format=pcsv
mi14p,,,-4,C6H10O12P2,CHEBI:17816,,"(1R,2R,3R,4R,5R,6S)-2,3,5,6-tetrahydroxy-4-(phosphonatooxy)cyclohexyl phosphate",,"(1R,2R,3R,4R,5R,6S)-2,3,5,6-tetrahydroxy-4-(phosphonatooxy)cyclohexyl phosphate",,,"InChI=1S/C6H14O12P2/c7-1-2(8)6(18-20(14,15)16)4(10)3(9)5(1)17-19(11,12)13/h1-10H,(H2,11,12,13)(H2,14,15,16)/p-4/t1-,2-,3-,4+,5+,6+/m1/s1",C01220,2016-11-22T15:12:07Z,,1317,,,,,,mi14p,,,http://vmh.uni.lu/_api/metabolites/1317/?format=pcsv
mi4p_D,,,-2,C6H11O9P,CHEBI:18384,,1D-myo-inositol 4-phosphate(2-),,1D-myo-inositol 4-phosphate(2-),,,"InChI=1S/C6H13O9P/c7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h1-11H,(H2,12,13,14)/p-2/t1-,2-,3-,4+,5-,6-/m0/s1",C03546,2016-11-22T15:12:07Z,,1318,,,,,,mi4p_D,,,http://vmh.uni.lu/_api/metabolites/1318/?format=pcsv
mi3456p,,,-8,C6H8O18P4,CHEBI:15844,,"1D-myo-inositol 3,4,5,6-tetrakisphosphate(8-)",,"1D-myo-inositol 3,4,5,6-tetrakisphosphate(8-)",,,"InChI=1S/C6H16O18P4/c7-1-2(8)4(22-26(12,13)14)6(24-28(18,19)20)5(23-27(15,16)17)3(1)21-25(9,10)11/h1-8H,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20)/p-8/t1-,2+,3-,4-,5+,6+/m0/s1",C04520,2016-11-22T15:12:07Z,,1319,,,,,121920,mi3456p,,,http://vmh.uni.lu/_api/metabolites/1319/?format=pcsv
mi3p_D,,,-2,C6H11O9P,CHEBI:18169,,1D-myo-inositol 3-phosphate(2-),,1D-myo-inositol 3-phosphate(2-),,,"InChI=1S/C6H13O9P/c7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h1-11H,(H2,12,13,14)/p-2/t1-,2-,3+,4-,5-,6-/m0/s1",C04006,2016-11-22T15:12:07Z,,1320,,,,,440194,mi3p_D,,,http://vmh.uni.lu/_api/metabolites/1320/?format=pcsv
2mcacn,,,-3,C7H5O6,,,"(Z)-but-2-ene-1,2,3-tricarboxylate",,"(Z)-but-2-ene-1,2,3-tricarboxylate",,,"InChI=1S/C7H8O6/c1-3(6(10)11)4(7(12)13)2-5(8)9/h2H2,1H3,(H,8,9)(H,10,11)(H,12,13)/p-3/b4-3-",C04225,2016-11-22T15:12:07Z,,1321,,,,,3080625,,,,http://vmh.uni.lu/_api/metabolites/1321/?format=pcsv
micit,,,-3,C7H7O7,,,"(2S,3R)-3-hydroxybutane-1,2,3-tricarboxylate",,"(2S,3R)-3-hydroxybutane-1,2,3-tricarboxylate",,,"InChI=1S/C7H10O7/c1-7(14,6(12)13)3(5(10)11)2-4(8)9/h3,14H,2H2,1H3,(H,8,9)(H,10,11)(H,12,13)/p-3/t3-,7-/m1/s1",C04593,2016-11-22T15:12:07Z,,1322,,,,,5459784,,,,http://vmh.uni.lu/_api/metabolites/1322/?format=pcsv
m5masnC,,,0,C52H87N2O40X,,,(alpha-D-mannosyl)5-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,(alpha-D-mannosyl)5-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,,,,2016-11-22T15:12:07Z,,1323,,,,,,m5masnC,,,http://vmh.uni.lu/_api/metabolites/1323/?format=pcsv
m5masnB2,,,0,C52H87N2O40X,,,(alpha-D-mannosyl)5-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,(alpha-D-mannosyl)5-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,,,,2016-11-22T15:12:07Z,,1324,,,,,,m5masnB2,,,http://vmh.uni.lu/_api/metabolites/1324/?format=pcsv
m6masnA,,,0,C58H97N2O45X,,,(alpha-D-mannosyl)6-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,(alpha-D-mannosyl)6-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,,,,2016-11-22T15:12:07Z,,1325,,,,,,m6masnA,,,http://vmh.uni.lu/_api/metabolites/1325/?format=pcsv
m6masnB1,,,0,C58H97N2O45X,,,(alpha-D-mannosyl)6-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,(alpha-D-mannosyl)6-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine (protein),,,,,2016-11-22T15:12:07Z,,1326,,,,,,m6masnB1,,,http://vmh.uni.lu/_api/metabolites/1326/?format=pcsv
m7masnC,,,0,C64H107N2O50X,,,"(alpha-D-mannosyl)7-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform C (protein)",,"(alpha-D-mannosyl)7-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform C (protein)",,,,,2016-11-22T15:12:07Z,,1327,,,,,,m7masnC,,,http://vmh.uni.lu/_api/metabolites/1327/?format=pcsv
mmcoa_S,,,-5,C25H35N7O19P3S,CHEBI:15466,,(S)-methylmalonyl-CoA(5-),,(S)-methylmalonyl-CoA(5-),,,"InChI=1S/C25H40N7O19P3S/c1-12(23(37)38)24(39)55-7-6-27-14(33)4-5-28-21(36)18(35)25(2,3)9-48-54(45,46)51-53(43,44)47-8-13-17(50-52(40,41)42)16(34)22(49-13)32-11-31-15-19(26)29-10-30-20(15)32/h10-13,16-18,22,34-35H,4-9H2,1-3H3,(H,27,33)(H,28,36)(H,37,38)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/p-5/t12-,13+,16+,17+,18-,22+/m0/s1",C00683,2016-11-22T15:12:07Z,,1328,,,,(S)-methylmalonyl-CoA,21252287,mmcoa_S,,,http://vmh.uni.lu/_api/metabolites/1328/?format=pcsv
mmcoa_R,,,-5,C25H35N7O19P3S,CHEBI:15465,,(R)-methylmalonyl-CoA(5-),,(R)-methylmalonyl-CoA(5-),,,"InChI=1S/C25H40N7O19P3S/c1-12(23(37)38)24(39)55-7-6-27-14(33)4-5-28-21(36)18(35)25(2,3)9-48-54(45,46)51-53(43,44)47-8-13-17(50-52(40,41)42)16(34)22(49-13)32-11-31-15-19(26)29-10-30-20(15)32/h10-13,16-18,22,34-35H,4-9H2,1-3H3,(H,27,33)(H,28,36)(H,37,38)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/p-5/t12-,13-,16-,17-,18+,22-/m1/s1",C00683,2016-11-22T15:12:07Z,,1329,,,,(R)-methylmalonyl-CoA,439291,mmcoa_R,,,http://vmh.uni.lu/_api/metabolites/1329/?format=pcsv
5mta,,,0,C11H15N5O3S,CHEBI:17509,,"Human Metabolome Database (HMDB): 5'-Methylthioadenosine (MTA) is a naturally occurring sulfur-containing nucleoside present in all mammalian tissues. It is produced from S-adenosylmethionine mainly through the polyamine biosynthetic pathway, where it behaves as a powerful inhibitory product. MTA is metabolized solely by MTA-phosphorylase, to yield 5-methylthioribose-1-phosphate and adenine, a crucial step in the methionine and purine salvage pathways, respectively. Evidence suggests that MTA can affect cellular processes in many ways. For instance, MTA has been shown to influence regulation of gene expression, proliferation, differentiation and apoptosis (PMID 15313459). 5-Methylthioadenosine can be found in human urine. Elevated excretion appears in children with severe combined immunodeficiency syndrome (PMID 3987052).",,5-Methylthioadenosine,,HMDB01173,"InChI=1S/C11H15N5O3S/c1-20-2-5-7(17)8(18)11(19-5)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1",C00170,2016-12-05T15:48:06Z,,1330,,,,,439176,5mta,,"1-(6-Amino-9H-purin-9-yl)-1-deoxy-5-S-methyl-5-thio-beta-D-Ribofuranose, 1-(6-Amino-9H-purin-9-yl)-1-deoxy-5-S-methyl-5-thio-beta-delta-Ribofuranose, 5'-(Methylthio)-5'-deoxyadenosine, 5'-(Methylthio)adenosine, 5'-Deoxy-5'-(methylthio)adenosine, 5'-Methylthioadenosine, 5'-S-Methyl-5'-thio-Adenosine, 5'-S-Methyl-5'-thioadenosine, 5-Methylthioadenosine, Methylthioadenosine, MTA, S-Methyl-5'-thioadenosine, S-Methyl-5-thioadenosine, Thiomethyladenosine",http://vmh.uni.lu/_api/metabolites/1330/?format=pcsv
5mdr1p,,,-2,C6H11O7PS,,,5-Methylthio-5-deoxy-D-ribose 1-phosphate,,5-Methylthio-5-deoxy-D-ribose 1-phosphate,,,"InChI=1S/C6H13O7PS/c1-15-2-3-4(7)5(8)6(12-3)13-14(9,10)11/h3-8H,2H2,1H3,(H2,9,10,11)/p-2/t3-,4-,5-,6-/m1/s1",C04188,2016-11-22T15:12:08Z,,1331,,,,,53477720,5mdr1p,,,http://vmh.uni.lu/_api/metabolites/1331/?format=pcsv
4aabutn,,,-1,C6H10NO3,CHEBI:17645,,"Human Metabolome Database (HMDB): 4-Acetamidobutanoic acid is a GABA derivative, product of the Urea cycle and metabolism of amino groups, the product of NAD-linked aldehyde dehydrogenase (EC 1.2.1.3) (KEGG).",,4-acetamidobutanoate,,HMDB03681,"InChI=1S/C6H11NO3/c1-5(8)7-4-2-3-6(9)10/h2-4H2,1H3,(H,7,8)(H,9,10)/p-1",C02946,2016-12-05T15:48:06Z,,1332,,,,,18189,4aabutn,,"4-(Acetylamino)butanoate, 4-(Acetylamino)butanoic acid, 4-Acetamidobutyric acid, N-Acetyl-4-aminobutanoate, N-Acetyl-4-aminobutanoic acid, N-Acetyl-4-aminobutyric acid, N-Acetyl-GABA, N-Acetyl-gamma-amino-N-butyric acid, N-Acetyl-gamma-aminobutyrate, N4-Acetylaminobutanoate, N4-Acetylaminobutanoic acid",http://vmh.uni.lu/_api/metabolites/1332/?format=pcsv
ksi_deg7,,,-10,C210H337N15O181S10,,,"keratan sulfate I, degradation product 7",,"keratan sulfate I, degradation product 7",,,,,2016-11-22T15:12:08Z,,1333,,,,,,ksi_deg7,,,http://vmh.uni.lu/_api/metabolites/1333/?format=pcsv
ksi_deg10,,,-9,C188H302N13O163S9,,,"keratan sulfate I, degradation product 10",,"keratan sulfate I, degradation product 10",,,,,2016-11-22T15:12:08Z,,1334,,,,,,ksi_deg10,,,http://vmh.uni.lu/_api/metabolites/1334/?format=pcsv
ksi_deg13,,,-8,C174H280N12O150S8,,,"keratan sulfate I, degradation product 13",,"keratan sulfate I, degradation product 13",,,,,2016-11-22T15:12:08Z,,1335,,,,,,ksi_deg13,,,http://vmh.uni.lu/_api/metabolites/1335/?format=pcsv
ksi_deg16,,,-7,C160H258N11O137S7,,,"keratan sulfate I, degradation product 16",,"keratan sulfate I, degradation product 16",,,,,2016-11-22T15:12:08Z,,1336,,,,,,ksi_deg16,,,http://vmh.uni.lu/_api/metabolites/1336/?format=pcsv
ksi_deg19,,,-6,C146H236N10O124S6,,,"keratan sulfate I, degradation product 19",,"keratan sulfate I, degradation product 19",,,,,2016-11-22T15:12:08Z,,1337,,,,,,ksi_deg19,,,http://vmh.uni.lu/_api/metabolites/1337/?format=pcsv
ksi_deg22,,,-5,C132H214N9O111S5,,,"keratan sulfate I, degradation product 22",,"keratan sulfate I, degradation product 22",,,,,2016-11-22T15:12:08Z,,1338,,,,,,ksi_deg22,,,http://vmh.uni.lu/_api/metabolites/1338/?format=pcsv
ksi_deg25,,,-4,C118H192N8O98S4,,,"keratan sulfate I, degradation product 25",,"keratan sulfate I, degradation product 25",,,,,2016-11-22T15:12:08Z,,1339,,,,,,ksi_deg25,,,http://vmh.uni.lu/_api/metabolites/1339/?format=pcsv
ksi_deg28,,,-3,C104H170N7O85S3,,,"keratan sulfate I, degradation product 28",,"keratan sulfate I, degradation product 28",,,,,2016-11-22T15:12:08Z,,1340,,,,,,ksi_deg28,,,http://vmh.uni.lu/_api/metabolites/1340/?format=pcsv
ksi_deg31,,,-2,C90H148N6O72S2,,,"keratan sulfate I, degradation product 31",,"keratan sulfate I, degradation product 31",,,,,2016-11-22T15:12:08Z,,1341,,,,,,ksi_deg31,,,http://vmh.uni.lu/_api/metabolites/1341/?format=pcsv
ksi_deg34,,,-1,C76H126N5O59S1,,,"keratan sulfate I, degradation product 34",,"keratan sulfate I, degradation product 34",,,,,2016-11-22T15:12:08Z,,1342,,,,,,ksi_deg34,,,http://vmh.uni.lu/_api/metabolites/1342/?format=pcsv
cs_a_deg1,,,-4,C45H68N2O43S2,,,"chondroitin sulfate A (GalNAc4S-GlcA), degradation product 1",,"chondroitin sulfate A (GalNAc4S-GlcA), degradation product 1",,,,,2016-11-22T15:12:08Z,,1343,,,,,,cs_a_deg1,,,http://vmh.uni.lu/_api/metabolites/1343/?format=pcsv
ksi_deg37,,,0,C62H104N4O46,,,"keratan sulfate I, degradation product 37",,"keratan sulfate I, degradation product 37",,,,,2016-11-22T15:12:08Z,,1344,,,,,,ksi_deg37,,,http://vmh.uni.lu/_api/metabolites/1344/?format=pcsv
ksii_core2_deg4,,,-1,C58H95N5O43SX,,,"keratan sulfate II (core 2-linked), degradation product 4",,"keratan sulfate II (core 2-linked), degradation product 4",,,,,2016-11-22T15:12:08Z,,1345,,,,,,ksii_core2_deg4,,,http://vmh.uni.lu/_api/metabolites/1345/?format=pcsv
ksii_core2_deg7,,,0,C44H73N4O30X,,,"keratan sulfate II (core 2-linked), degradation product 7",,"keratan sulfate II (core 2-linked), degradation product 7",,,,,2016-11-22T15:12:08Z,,1346,,,,,,ksii_core2_deg7,,,http://vmh.uni.lu/_api/metabolites/1346/?format=pcsv
ksii_core4_deg4,,,-1,C66H108N6O48SX,,,"keratan sulfate II (core 4-linked), degradation product 4",,"keratan sulfate II (core 4-linked), degradation product 4",,,,,2016-11-22T15:12:08Z,,1347,,,,,,ksii_core4_deg4,,,http://vmh.uni.lu/_api/metabolites/1347/?format=pcsv
cs_a_deg4,,,-2,C31H49NO29S,,,"chondroitin sulfate A (GalNAc4S-GlcA), degradation product 4",,"chondroitin sulfate A (GalNAc4S-GlcA), degradation product 4",,,,,2016-11-22T15:12:08Z,,1348,,,,,,cs_a_deg4,,,http://vmh.uni.lu/_api/metabolites/1348/?format=pcsv
cs_b_deg1,,,-5,C45H67N2O46S3,,,"chondroitin sulfate B / dermatan sulfate (IdoA2S-GalNAc4S), degradation product 1",,"chondroitin sulfate B / dermatan sulfate (IdoA2S-GalNAc4S), degradation product 1",,,,,2016-11-22T15:12:08Z,,1349,,,,,,cs_b_deg1,,,http://vmh.uni.lu/_api/metabolites/1349/?format=pcsv
cs_b_deg2,,,-5,C37H54NO41S3,,,"chondroitin sulfate B / dermatan sulfate (IdoA2S-GalNAc4S), degradation product 2",,"chondroitin sulfate B / dermatan sulfate (IdoA2S-GalNAc4S), degradation product 2",,,,,2016-11-22T15:12:08Z,,1350,,,,,,cs_b_deg2,,,http://vmh.uni.lu/_api/metabolites/1350/?format=pcsv
cs_c_deg1,,,-4,C45H68N2O43S2,,,"chondroitin sulfate C (GalNAc6S-GlcA), degradation product 1",,"chondroitin sulfate C (GalNAc6S-GlcA), degradation product 1",,,,,2016-11-22T15:12:08Z,,1351,,,,,,cs_c_deg1,,,http://vmh.uni.lu/_api/metabolites/1351/?format=pcsv
cs_c_deg4,,,-2,C31H49NO29S,,,"chondroitin sulfate C (GalNAc6S-GlcA), degradation product 4",,"chondroitin sulfate C (GalNAc6S-GlcA), degradation product 4",,,,,2016-11-22T15:12:08Z,,1352,,,,,,cs_c_deg4,,,http://vmh.uni.lu/_api/metabolites/1352/?format=pcsv
cs_d_deg1,,,-6,C45H66N2O49S4,,,"chondroitin sulfate D (GlcNAc6S-GlcA2S), degradation product 1",,"chondroitin sulfate D (GlcNAc6S-GlcA2S), degradation product 1",,,,,2016-11-22T15:12:08Z,,1353,,,,,,cs_d_deg1,,,http://vmh.uni.lu/_api/metabolites/1353/?format=pcsv
cs_d_deg2,,,-6,C37H53NO44S4,,,"chondroitin sulfate D (GlcNAc6S-GlcA2S), degradation product 2",,"chondroitin sulfate D (GlcNAc6S-GlcA2S), degradation product 2",,,,,2016-11-22T15:12:08Z,,1354,,,,,,cs_d_deg2,,,http://vmh.uni.lu/_api/metabolites/1354/?format=pcsv
cs_d_deg5,,,-3,C31H48NO32S2,,,"chondroitin sulfate D (GlcNAc6S-GlcA2S), degradation product 5",,"chondroitin sulfate D (GlcNAc6S-GlcA2S), degradation product 5",,,,,2016-11-22T15:12:08Z,,1355,,,,,,cs_d_deg5,,,http://vmh.uni.lu/_api/metabolites/1355/?format=pcsv
cs_d_deg6,,,-3,C23H35O27S2,,,"chondroitin sulfate D (GlcNAc6S-GlcA2S), degradation product 6",,"chondroitin sulfate D (GlcNAc6S-GlcA2S), degradation product 6",,,,,2016-11-22T15:12:08Z,,1356,,,,,,cs_d_deg6,,,http://vmh.uni.lu/_api/metabolites/1356/?format=pcsv
cs_e_deg2,,,-6,C45H66N2O49S4,,,"chondroitin sulfate E (GalNAc4,6diS-GlcA), degradation product 2",,"chondroitin sulfate E (GalNAc4,6diS-GlcA), degradation product 2",,,,,2016-11-22T15:12:08Z,,1357,,,,,,cs_e_deg2,,,http://vmh.uni.lu/_api/metabolites/1357/?format=pcsv
cs_e_deg6,,,-3,C31H48NO32S2,,,"chondroitin sulfate E (GalNAc4,6diS-GlcA), degradation product 6",,"chondroitin sulfate E (GalNAc4,6diS-GlcA), degradation product 6",,,,,2016-11-22T15:12:08Z,,1358,,,,,,cs_e_deg6,,,http://vmh.uni.lu/_api/metabolites/1358/?format=pcsv
carn,,,0,C9H14N4O3,CHEBI:15727,,"Human Metabolome Database (HMDB): Carnosine (beta-alanyl-L-histidine) is found exclusively in animal tissues. It is a dipeptide of the amino acids beta-alanine and histidine. Carnosine has the potential to suppress many of the biochemical changes (e.g., protein oxidation, glycation, AGE formation, and cross-linking) that accompany aging and associated pathologies (PMID 16804013). It is highly concentrated in muscle and brain tissues. Some autistics patients take it as a dietary supplement, and attribute an improvement in their condition to it. Supplemental carnosine may increase corticosterone levels. This may explain the ""hyperactivity"" seen in autistic subjects at higher doses. Carnosine also exhibits some antioxidant effects. The antioxidant mechanism of carnosine is attributed to its chelating effect against metal ions, superoxide dismutase (SOD)-like activity, ROS and free radicals scavenging ability (PMID 16406688).",,carnosine,,HMDB00033,"InChI=1S/C9H14N4O3/c10-2-1-8(14)13-7(9(15)16)3-6-4-11-5-12-6/h4-5,7H,1-3,10H2,(H,11,12)(H,13,14)(H,15,16)/t7-/m0/s1",C00386,2016-12-05T15:48:06Z,,1359,,,,,439224,carn,,"b-Alanyl-L-histidine, b-Alanylhistidine, beta-Alanyl-L-histidine, beta-Alanylhistidine, Carnosine, Ignotine, Karnozin, Karnozzn, L-Carnosine, N-(3-Aminopropanoyl)histidine, N-(b-Alanyl)-L-histidine, N-b-Alanyl-L-Histidine, N-beta-Alanyl-L-Histidine, Sevitin",http://vmh.uni.lu/_api/metabolites/1359/?format=pcsv
nicrns,,,0,C11H13NO6,,,Nicotinate D-ribonucleoside,,Nicotinate D-ribonucleoside,,,"InChI=1S/C11H13NO6/c13-5-7-8(14)9(15)10(18-7)12-3-1-2-6(4-12)11(16)17/h1-4,7-10,13-15H,5H2/t7-,8-,9-,10-/m1/s1",C05841,2016-11-22T15:12:08Z,,1360,,,,,161234,nicrns,,,http://vmh.uni.lu/_api/metabolites/1360/?format=pcsv
nicrnt,,,-2,C11H12NO9P,CHEBI:15763,,Nicotinate D-ribonucleotide,,Nicotinate D-ribonucleotide,,,"InChI=1S/C11H14NO9P/c13-8-7(5-20-22(17,18)19)21-10(9(8)14)12-3-1-2-6(4-12)11(15)16/h1-4,7-10,13-14H,5H2,(H2-,15,16,17,18,19)/p-2/t7-,8-,9-,10-/m1/s1",C01185,2016-11-22T15:12:08Z,,1361,,,,,53477721,nicrnt,,,http://vmh.uni.lu/_api/metabolites/1361/?format=pcsv
nmn,,,-1,C11H14N2O8P,CHEBI:16171,,"Human Metabolome Database (HMDB): Nicotinamide ribotide (NMN) is an important intermediate metabolite in the nicotinate and nicotinamide metabolism pathway. Mammals predominantly use nicotinamide rather than nicotinic acid as a precursor for NAD biosynthesis. Instead of the deamidation to nicotinic acid, nicotinamide is directly converted to NMN by nicotinamide phosphoribosyltransferase (NAMPT, EC 2.4.2.12). The enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT, EC 2.7.7.1), which is a member of the nucleotidyltransferase alpha/beta-phosphodiesterase superfamily, catalyzes the reaction NMN + ATP <=> Nicotinamide adenine dinucleotide (NAD) + PPi, representing the final step in the biosynthesis of NAD. NAD is a molecule that plays a fundamental role as a cofactor in cellular redox reactions. Thus NMN is an important metabolite for the maintenance of normal NAD biosynthesis. Circulating NMN levels may play an important role in regulating cell function in physiological and pathophysiological conditions. (PMID: 15078171, 17983582).",,NMN,,HMDB00229,"InChI=1S/C11H15N2O8P/c12-10(16)6-2-1-3-13(4-6)11-9(15)8(14)7(21-11)5-20-22(17,18)19/h1-4,7-9,11,14-15H,5H2,(H3-,12,16,17,18,19)/p-1/t7-,8-,9-,11-/m1/s1",C00455,2016-12-05T15:48:06Z,,1362,,,,,14180,nmn,,"3-(Aminocarbonyl)-1-(5-O-phosphono-b-D-ribofuranosyl)-Pyridinium hydroxide inner salt, 3-(Aminocarbonyl)-1-(5-O-phosphono-b-D-ribofuranosyl)-Pyridinium inner salt, 3-(Aminocarbonyl)-1-(5-O-phosphono-beta-delta-ribofuranosyl)-Pyridinium hydroxide inner salt, 3-(Aminocarbonyl)-1-(5-O-phosphono-beta-delta-ribofuranosyl)-Pyridinium inner salt, 3-Carbamoyl-1-b-D-ribofuranosylpyridinium hydroxide 5'-phosphate inner salt, 3-Carbamoyl-1-beta-delta-ribofuranosylpyridinium hydroxide 5'-phosphate inner salt, b-D-NMN, b-NMN, beta-delta-NMN, beta-NMN, Nicotinamide D-ribonucleotide, Nicotinamide mononucleotide, Nicotinamide ribonucleoside 5'-phosphate, Nicotinamide ribonucleotide, NMN",http://vmh.uni.lu/_api/metabolites/1362/?format=pcsv
nmptrc,,,2,C5H16N2,CHEBI:17166,,"Human Metabolome Database (HMDB): N-Methylputrescine is a byproduct of putrescine (a diamine), via methylation by putrescine N-methyltransferase (PMT; EC 2.1.1.53). N-methylputrescine is able to affect protein synthesis to a small extent in stimulated H-35 hepatoma cells, being an inhibitor of cellular insulin-induced ornithine decarboxylase activity. (PMID: 2051998). Putrescine is related to cadaverine (another polyamine). Both are produced by the breakdown of amino acids in living and dead organisms and both are toxic in large doses. Putrescine and cadaverine are largely responsible for the foul odor of putrefying flesh, but also contribute to the odor of such processes as bad breath and bacterial vaginosis. Putrescine is also found in semen. Putrescine attacks s-adenosyl methionine and converts it to spermidine. Spermidine in turn attacks another s-adenosyl methionine and converts it to spermine. Putrescine is synthesized in small quantities by healthy living cells by the action of ornithine decarboxylase.",,N-methylputrescinium(2+),,HMDB03661,"InChI=1S/C5H14N2/c1-7-5-3-2-4-6/h7H,2-6H2,1H3/p+2",C02723,2016-12-05T15:48:06Z,,1363,,,,,439791,,,"1-Amino-4-methylaminobutane, N-Methyl-1,4-Butanediamine, N-Methyl-1,4-diaminobutane, N-Methylbutane-1,4-diamine, N1-methyl-1,4-Butanediamine",http://vmh.uni.lu/_api/metabolites/1363/?format=pcsv
1mpyr,,,1,C5H10N,CHEBI:27435,,1-methylpyrrolinium,,1-methylpyrrolinium,,,"InChI=1S/C5H10N/c1-6-4-2-3-5-6/h4H,2-3,5H2,1H3/q+1",C06178,2016-11-22T15:12:08Z,,1364,,,,,440932,,,,http://vmh.uni.lu/_api/metabolites/1364/?format=pcsv
nwharg,,,1,C6H15N4O3,CHEBI:7101,,N-(omega)-Hydroxyarginine,,N-(omega)-Hydroxyarginine,,,"InChI=1S/C6H14N4O3/c7-4(5(11)12)2-1-3-9-6(8)10-13/h4,13H,1-3,7H2,(H,11,12)(H3,8,9,10)",C05933,2016-11-22T15:12:08Z,,1365,,,,,440849,nwharg,,,http://vmh.uni.lu/_api/metabolites/1365/?format=pcsv
r1p,,,-2,C5H9O8P,CHEBI:35425,,alpha-D-Ribose 1-phosphate,,alpha-D-Ribose 1-phosphate,,,"InChI=1S/C5H11O8P/c6-1-2-3(7)4(8)5(12-2)13-14(9,10)11/h2-8H,1H2,(H2,9,10,11)/p-2/t2-,3-,4-,5-/m1/s1",C00620,2016-11-22T15:12:08Z,,1366,,,,,439236,r1p,,,http://vmh.uni.lu/_api/metabolites/1366/?format=pcsv
nrvnccrn,,,0,C31H59NO4,,,Nervonyl carnitine,,Nervonyl carnitine,,,"InChI=1/C31H59NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-31(35)36-29(27-30(33)34)28-32(2,3)4/h12-13,29H,5-11,14-28H2,1-4H3/t29-/m0/s1",,2016-11-22T15:12:08Z,,1367,,,,,,nrvnccrn,,,http://vmh.uni.lu/_api/metabolites/1367/?format=pcsv
sT_antigen,,,-1,C25H40N2O18X,CHEBI:16565,,sialyl-T antigen,,sialyl-T antigen,,,,,2016-11-22T15:12:08Z,,1368,,,,,,sT_antigen,,,http://vmh.uni.lu/_api/metabolites/1368/?format=pcsv
xtsn,,,0,C10H12N4O6,CHEBI:18107,,"Human Metabolome Database (HMDB): Biological Source: Xanthosine is produced by guanine-free mutants of bacteria e.g. Bacillus subtilis, Aerobacter aerogenes. Also reported from seeds of Trifolium alexandrinum Physical Description: Prismatic cryst. (H2O) (Chemnetbase) The deamination product of guanosine. Xanthosine monophosphate is an intermediate in purine metabolism, formed from IMP, and forming GMP.(Wikipedia). Xanthylic acid can be used in quantitative measurements of the Inosine monophosphate dehydrogenase enzyme activities in purine metabolism, as recommended to ensure optimal thiopurine therapy for children with acute lymphoblastic leukaemia (ALL). (PMID: 16725387).",,xanthosine,,HMDB00299,"InChI=1S/C10H12N4O6/c15-1-3-5(16)6(17)9(20-3)14-2-11-4-7(14)12-10(19)13-8(4)18/h2-3,5-6,9,15-17H,1H2,(H2,12,13,18,19)/t3-,5-,6-,9-/m1/s1",C01762,2016-12-05T15:48:06Z,,1369,,,,,64959,xtsn,,"3,9-Dihydro-9-b-D-ribofuranosyl-1H-purine-2,6-dione, 3,9-Dihydro-9-beta-delta-ribofuranosyl-1H-purine-2,6-dione, 3,9-Dihydro-9-D-ribofuranosyl-1H-purine-2,6-dione, 3,9-Dihydro-9-delta-ribofuranosyl-1H-purine-2,6-dione, 9-b-D-Ribofuranosylxanthine, 9-beta-delta-Ribofuranosylxanthine, 9-D-Ribofuranosylxanthine, 9-delta-Ribofuranosylxanthine, Xanthosine",http://vmh.uni.lu/_api/metabolites/1369/?format=pcsv
dimp,,,-2,C10H11N4O7P,CHEBI:28806,,2'-deoxyinosine 5'-phosphate(2-),,2'-deoxyinosine 5'-phosphate(2-),,,"InChI=1S/C10H13N4O7P/c15-5-1-7(21-6(5)2-20-22(17,18)19)14-4-13-8-9(14)11-3-12-10(8)16/h3-7,15H,1-2H2,(H,11,12,16)(H2,17,18,19)/p-2/t5-,6+,7+/m0/s1",C06196,2016-11-22T15:12:08Z,,1370,,,,,91531,dimp,,,http://vmh.uni.lu/_api/metabolites/1370/?format=pcsv
xtp,,,-4,C10H11N4O15P3,,,"Human Metabolome Database (HMDB): Xanthosine 5-triphosphate (XTP) is a Guanosine triphosphate (GTP) analogue. The base of XTP, xanthine, bears a keto group instead of an amino group at C2 of the purine rings. XTP can substitute for GTP in supporting receptor-mediated adenylyl cyclase activation. XTP competitively inhibits the binding of GTP to the guanine nucleotide-binding site of retinal G-protein, transducin (TD). These suggests that GTP, ITP, and XTP are differential signal sorters and signal amplifiers at the G-protein level. G-proteins mediate signal transfer from receptors to effector systems. (PMID: 9337071). Xanthosine 5-triphosphate is an intermediate of the Purine metabolism pathway, a substrate of the enzymes dinucleoside tetraphosphatase (EC 3.6.1.17 ) and nucleoside-triphosphate pyrophosphatase (EC 3.6.1.19). (KEGG).",,XTP,,HMDB00293,"InChI=1/C10H15N4O15P3/c15-5-3(1-26-31(22,23)29-32(24,25)28-30(19,20)21)27-9(6(5)16)14-2-11-4-7(14)12-10(18)13-8(4)17/h2-3,5-6,9,15-16H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H2,12,13,17,18)/t3-,5-,6-,9-/m1/s1",C00700,2016-12-05T15:48:06Z,,1371,,,,,439296,xtp,,"5'-XTP, Xanthosine 5'-triphosphate, Xanthosine mono(tetrahydrogen triphosphate), Xanthosine triphosphate, XTP",http://vmh.uni.lu/_api/metabolites/1371/?format=pcsv
orot5p,,,-3,C10H10N2O11P,CHEBI:15842,,Orotidine 5'-phosphate,,Orotidine 5'-phosphate,,,"InChI=1S/C10H13N2O11P/c13-5-1-3(9(16)17)12(10(18)11-5)8-7(15)6(14)4(23-8)2-22-24(19,20)21/h1,4,6-8,14-15H,2H2,(H,16,17)(H,11,13,18)(H2,19,20,21)/p-3/t4-,6-,7-,8-/m1/s1",C01103,2016-11-22T15:12:08Z,,1372,,,,,160617,orot5p,,,http://vmh.uni.lu/_api/metabolites/1372/?format=pcsv
xoltetrol,,,0,C27H48O4,CHEBI:17278,,"Human Metabolome Database (HMDB): 27-Deoxy-5b-cyprinol is an intermediate in Bile acid synthesis pathway, in a sequence of reactions catalyzed by sterol 27-hydroxylase (CYP27) in the oxidation of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,27-tetrol into 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid (PMID: 8496170). 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol 3-glucuronide, a metabolite of 27-Deoxy-5b-cyprinol, is the major bile alcohol component in serum from cerebrotendinous xanthomatosis patients (PMID: 7920441).",,"5beta-cholestane-3alpha,7alpha,12alpha,26-tetrol",,HMDB01231,"InChI=1S/C27H48O4/c1-16(15-28)6-5-7-17(2)20-8-9-21-25-22(14-24(31)27(20,21)4)26(3)11-10-19(29)12-18(26)13-23(25)30/h16-25,28-31H,5-15H2,1-4H3/t16?,17-,18+,19-,20-,21+,22+,23-,24+,25+,26+,27-/m1/s1",C05446,2016-12-05T15:48:06Z,,1373,,,,,193321,xoltetrol,,"(25R)-5-beta-cholestane-3-alpha,7-alpha,12-alpha,26-tetraol, 3a,7a,12a,26-Tetrahydroxy-5b-cholestane, 5-b-Cholestane-3a-7-tetraol, 5-beta-Cholestane-3-alpha-7-alpha-12-alpha-26-tetraol, 5-beta-Cholestane-3a-7-tetraol, 5b-Cholestane-3a,7a,12a,26-tetrol, 5beta-cholestane-3alpha,7alpha,12alpha,27-tetraol, 5beta-cholestane-3alpha,7alpha,12alpha,27-tetrol, 5beta-cholestane-3alpha,7alpha,12alpha,27alpha-tetrol",http://vmh.uni.lu/_api/metabolites/1373/?format=pcsv
thcholst,,,0,C27H46O4,CHEBI:48940,,"3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-al",,"3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-al",,,"InChI=1S/C27H46O4/c1-16(15-28)6-5-7-17(2)20-8-9-21-25-22(14-24(31)27(20,21)4)26(3)11-10-19(29)12-18(26)13-23(25)30/h15-25,29-31H,5-14H2,1-4H3/t16?,17-,18+,19-,20-,21+,22+,23-,24+,25+,26+,27-/m1/s1",C01301,2016-11-22T15:12:08Z,,1374,,,,,439479,thcholst,,,http://vmh.uni.lu/_api/metabolites/1374/?format=pcsv
thcholstoic,,,-1,C27H45O5,CHEBI:48043,,"Human Metabolome Database (HMDB): 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues.",,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoate",,HMDB03873,"InChI=1S/C27H46O5/c1-15(6-5-7-16(2)25(31)32)19-8-9-20-24-21(14-23(30)27(19,20)4)26(3)11-10-18(28)12-17(26)13-22(24)29/h15-24,28-30H,5-14H2,1-4H3,(H,31,32)/t15-,16?,17+,18-,19-,20+,21+,22-,23+,24+,26+,27-/m1/s1",C04722,2016-12-05T15:48:06Z,,1375,,,,,23657849,thcholstoic,,"(25R)-3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestan-26-oate, (25R)-3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestan-26-oic acid, 3-alpha,7-alpha,12-alpha-Trihydroxy-5-beta-cholestanate, 3a,7a,12a-Trihydroxy-5b-cholestanoate, 3a,7a,12a-Trihydroxy-5b-cholestanoic acid, 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoate, 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoic acid",http://vmh.uni.lu/_api/metabolites/1375/?format=pcsv
xol7ah3,,,0,C27H48O3,CHEBI:28540,,"Human Metabolome Database (HMDB): 3 alpha,7 alpha,26-Trihydroxy-5beta-cholestane is found in the primary bile acid biosynthesis pathway. 3 alpha,7 alpha,26-Trihydroxy-5beta-cholestane is produced from 3 alpha,7 alpha-Dihydroxy-5beta-cholestane through the action of CYP27A (E1.14.13.15). 3 alpha,7 alpha,26-Trihydroxy-5beta-cholestane is then converted to 3 alpha,7 alpha-Dihydroxy-5beta-cholestan-26-al by CYP27A (E1.14.13.15).",,"5beta-cholestane-3alpha,7alpha,26-triol",,HMDB12455,"InChI=1S/C27H48O3/c1-17(16-28)6-5-7-18(2)21-8-9-22-25-23(11-13-27(21,22)4)26(3)12-10-20(29)14-19(26)15-24(25)30/h17-25,28-30H,5-16H2,1-4H3/t17?,18-,19+,20-,21-,22+,23+,24-,25+,26+,27-/m1/s1",C05444,2016-12-05T15:48:06Z,,1376,,,,,3082089,xol7ah3,,"(25R)-5beta-cholestane-3alpha,7alpha,26-triol, (3alpha,5beta,7alpha)-Cholestane-3,7,26-triol, 3alpha,7alpha,26-Trihydroxy-5beta-cholestane, 5 beta-Cholestane-3 alpha,7 alpha,26-triol, 5beta-cholestan-3alpha,7alpha,26-triol, 5beta-Cholestane-3alpha,7alpha,26-triol, Cholestane-3,7,26-triol",http://vmh.uni.lu/_api/metabolites/1376/?format=pcsv
xol7ah2al,,,0,C27H46O3,CHEBI:27428,,"Human Metabolome Database (HMDB): 3alpha,7alpha-Dihydroxy-5beta-cholestan-26-al is an intermediate involved in bile acid biosynthesis, specifically in the synthesis of chenodeoxyglycocholate and lithocholate. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",,"3alpha,7alpha-dihydroxy-5beta-cholestan-26-al",,HMDB06894,"InChI=1S/C27H46O3/c1-17(16-28)6-5-7-18(2)21-8-9-22-25-23(11-13-27(21,22)4)26(3)12-10-20(29)14-19(26)15-24(25)30/h16-25,29-30H,5-15H2,1-4H3/t17?,18-,19+,20-,21-,22+,23+,24-,25+,26+,27-/m1/s1",C05445,2016-12-05T15:48:06Z,,1377,,,,,5460041,xol7ah2al,,"3alpha,7alpha-dihydroxy-5beta-cholestan-27-al, 5beta-cholestan-27-al-3alpha,7alpha-diol, 5beta-cholestane-3alpha,7alpha-diol-27-al",http://vmh.uni.lu/_api/metabolites/1377/?format=pcsv
xol27oh,,,0,C27H46O2,CHEBI:17703,,"Human Metabolome Database (HMDB): 27-hydroxycholesterol is an oxygenated derivative of cholesterol and a major oxysterol in circulation. 27-hydroxycholesterol is the product of the enzyme sterol 27-hydroxylase. The enzyme is critical for degradation of the steroid side-chain and a genetic deficiency of the enzyme leads to reduced formation of bile acids in humans. There is a correlation between 27-hydroxycholesterol and cholesterol in the circulation, and females have lower levels of 27-hydroxycholesterol than males. A strong correlation is observed between circulating levels of 27-hydroxycholesterol and cholesterol, in both healthy subjects and subjects with hypercholesterolemia and documented atherosclerosis. 27-hydroxycholesterol is metabolized by an oxysterol 7a-hydroxylase in the liver, and changes in the activity of this enzyme may lead to accumulation of 27-hydroxycholesterol in the circulation. It has been reported that patients with a genetic deficiency of oxysterol 7a-hydroxylase in the liver had markedly increased levels of 27-hydroxycholesterol in the circulation. Under normal conditions, however, and in the absence of liver or kidney disease, changes in the levels of 27-hydroxycholesterol in the circulation are likely to be caused by changes in the rate of synthesis of these steroids rather than by the rate of metabolism. Three possible explanations for the high concentrations of 27-hydroxycholesterol found in the circulation of the three subjects with atherosclerosis could be: 1) Increased expression of sterol 27-hydroxylase owing to a genetic factor or some other factor completely unrelated to atherosclerosis. 2) The extrahepatic sterol 27-hydroxylase may be up-regulated by circulating factors (e.g. cytokines) that are directly or indirectly related to the development of atherosclerosis. 3) The high amounts of cholesterol accumulating in macrophages in some patients with atherosclerosis may result in increased flux of 27-hydroxycholesterol from the macrophages to the circulation. Since there is a close relation between levels of cholesterol and 27-hydroxycholesterol in the circulation, the possibility must be considered that the flux of 27-hydroxycholesterol into the brain may be part of the yet unexplained link between hypercholesterolemia and Alzheimer's disease. 27-hydroxysterol is the most dominant oxysterol in human ateromas where it may reflect a mechanism for eliminating excessive cholesterol and thus have a protective role. Hypercholesterolemia and chronic low-grade immunological activation are pivotal in the development of atherosclerosis. However, the interconnections between these two factors are not well known. The CD40 system, as measured by the plasma level of soluble CD40 (sCD40), is associated with cholesterol metabolism in hypercholesterolemic patients. When combined, a decreased cholesterol synthesis rate and increased levels of 27-hydroxycholesterol may be a consequence of high levels of cellular cholesterol and, therefore, be related to sCD40. However, sCD40 had no significant correlation with total plasma cholesterol. This suggests that the cellular cholesterol synthesis rate and 27-hydroxycholesterol production are more importantly linked with the plasma levels of sCD40 than total cholesterol. (PMID: 16081359, 17012138, 11504730, 9144161).",,26-hydroxycholesterol,,HMDB02103,"InChI=1S/C27H46O2/c1-18(17-28)6-5-7-19(2)23-10-11-24-22-9-8-20-16-21(29)12-14-26(20,3)25(22)13-15-27(23,24)4/h8,18-19,21-25,28-29H,5-7,9-17H2,1-4H3/t18?,19-,21+,22+,23-,24+,25+,26+,27-/m1/s1",C15610,2016-12-05T15:48:06Z,,1378,,,,,99470,xol27oh,,"(25R)-26-Hydroxycholesterol, (25R)-Cholest-5-ene-3b,26-diol, (25R)-Cholest-5-ene-3beta,26-diol, (3-beta)-cholest-5-ene-3,26-diol, (3b,25R)-Cholest-5-ene-3,26-diol, (3beta,25R)-Cholest-5-ene-3,26,diol, 26-Hydroxycholesterol(25R), Cholest-(25R)-5-en-3beta,26-diol, Cholest-5-ene-3-b,27-diol, Cholest-5-ene-3-beta,26-diol, Cholest-5-ene-3-beta,27-diol, Cholest-5-ene-3beta,26-diol, Cholest-5-ene-3beta,27-diol",http://vmh.uni.lu/_api/metabolites/1378/?format=pcsv
xol24oh,,,0,C27H46O2,,,"Human Metabolome Database (HMDB): 24-Hydroxycholesterol (24OHC) is almost exclusively formed in the brain. The enzymatic conversion of CNS cholesterol to 24OHC, which readily crosses the blood-brain barrier, is the major pathway for brain cholesterol elimination and brain cholesterol homeostasis maintenance. The enzyme mediating this conversion has been characterized at the molecular level as cholesterol 24-hydroxylase (EC 1.14.13.98, CYP46) and is mainly located in neurons. Like other oxysterols, 24OHC is efficiently converted into normal bile acids or excreted in bile in its sulfated and glucuronidated form. Levels of 24OHC in the circulation decrease with age in infants and children. In adults, however, the levels appear to be stable. There is accumulating evidence pointing toward a potentially important link between cholesterol, beta-amyloid, and Alzheimer's disease. Patients with active demyelinating diseases had increased levels of 24OHC in cerebrospinal fluid (CSF). Patients with Alzheimer's disease have slightly increased levels of 24OHC in CSF. Patients with multiple sclerosis have a tendency to have higher levels of 24OHC during active periods. (PMID: 15061359, 14574622).",,(24S)-24-hydroxycholesterol,,HMDB01419,"InChI=1S/C27H46O2/c1-17(2)25(29)11-6-18(3)22-9-10-23-21-8-7-19-16-20(28)12-14-26(19,4)24(21)13-15-27(22,23)5/h7,17-18,20-25,28-29H,6,8-16H2,1-5H3/t18-,20+,21+,22-,23+,24+,25+,26+,27-/m1/s1",C13550,2016-12-05T15:48:06Z,,1379,,,,,121948,xol24oh,,"(24S)-24-Hydroxycholesterol, (24S)-cholest-5-ene-3b,24-diol, (24S)-cholest-5-ene-3beta,24-diol, 24(S)-Hydroxycholesterol, 24-Hydroxycholesterol, 24S-Cholest-5-ene-3b,24-diol, 24S-Hydroxycholesterol, Cerebrosterin, Cerebrosterol, Cholest-5-en-3b,24S-diol, Cholest-5-en-3beta,24S-diol, Cholest-5-ene-3,24-diol, Cholest-5-ene-3b,24b-diol",http://vmh.uni.lu/_api/metabolites/1379/?format=pcsv
hnifedipine,,,0,C17H18N2O7,,,hydroxy nifedipine,,hydroxy nifedipine,,,,,2016-11-22T15:12:08Z,,1380,,,,,,hnifedipine,,,http://vmh.uni.lu/_api/metabolites/1380/?format=pcsv
12harachd,,,-1,C20H31O3,,,"Human Metabolome Database (HMDB): 12-hydroxyeicosatetraenoic acid (12-HETE) is an eicosanoid, a 5-lipoxygenase metabolite of arachidonic acid. 5-Lipoxygenase (LO)-derived leukotrienes are involved in inflammatory glomerular injury. LO product 12-HETE is associated with pathogenesis of hypertension, and may mediate angiotensin II and TGFbeta induced mesengial cell abnormality in diabetic nephropathy. 12-HETE is markedly elevated in the psoriatic lesions. 12-HETE is a vasoconstrictor eicosanoid that contribute to high blood pressure in (renovascular) hypertension and pregnancy-induced hypertension. A significant percentage of patients suffering from a selective increase in plasma LDL cholesterol (type IIa hyperlipoproteinaemia) exhibits increased platelet reactivity. This includes enhanced platelet responsiveness against a variety of platelet-stimulating agents ex vivo and enhanced arachidonic acid metabolism associated with increased generation of arachidonic acid metabolites such as 12-HETE, and secretion of platelet-storage products. (PMID: 7562532, 12480795, 17361113, 8498970,1333255, 2119633). 12-HETE is a highly selective ligand used to label mu-opioid receptors in both membranes and tissue sections. The 12-s-HETE analog has been reported to augment tumour cell metastatic potential through activation of protein kinase c. 12-HETE can be formed either in the 12-S or 12-R configuration. It has a diversity of biological actions and is generated by a number of tissues including the renal glomerulus and the vasculature. 12-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. 12-HETE is a neuromodulator that is synthesized during ischemia. Its neuronal effects include attenuation of calcium influx and glutamate release as well as inhibition of AMPA receptor (AMPA-R) activation.",,12 hydroxy arachidonic acid,,HMDB06111,"InChI=1/C20H32O3/c1-2-3-4-5-10-13-16-19(21)17-14-11-8-6-7-9-12-15-18-20(22)23/h7-11,13-14,17,19,21H,2-6,12,15-16,18H2,1H3,(H,22,23)/b9-7+,11-8-,13-10-,17-14-",,2016-12-05T15:48:06Z,,1381,,,,,5312983,12harachd,,"(E,Z,Z,Z)-12-hydroxy-5,8,10,14-Eicosatetraenoate, (E,Z,Z,Z)-12-hydroxy-5,8,10,14-Eicosatetraenoic acid, 12-HETE, 12-Hydroxy-5,8,10,14-eicosatetraenoate, 12-Hydroxy-5,8,10,14-eicosatetraenoic acid, 12-Hydroxy-5E,8Z,10Z,14Z-eicosatetraenoate, 12-Hydroxy-5E,8Z,10Z,14Z-eicosatetraenoic acid, 12-Hydroxyeicosatetraenoate, 12-Hydroxyeicosatetraenoic acid",http://vmh.uni.lu/_api/metabolites/1381/?format=pcsv
wharachd,,,-1,C20H31O3,CHEBI:34306,,w-hydroxyl arachidonic acid,,w-hydroxyl arachidonic acid,,,"InChI=1/C20H32O3/c21-19-17-15-13-11-9-7-5-3-1-2-4-6-8-10-12-14-16-18-20(22)23/h4,6,8,10,12,14,16,18,21H,1-3,5,7,9,11,13,15,17,19H2,(H,22,23)/b6-4+,10-8+,14-12+,18-16+",C14748,2016-11-22T15:12:08Z,,1382,,,,,5283157,wharachd,,,http://vmh.uni.lu/_api/metabolites/1382/?format=pcsv
leuktrB4woh,,,-1,C20H31O5,CHEBI:15646,,"Human Metabolome Database (HMDB): 20-hydroxy- Leukotriene B4 (20-OH-LTB4) is an omega-hydroxylated metabolite of leukotriene B4 in human neutrophils. Elevated urinary concentrations of 20-OH-LTB4 and LTB4 are found in patients with Sjogren-Larsson syndrome (SLS, OMIM 270220), an autosomal recessively inherited neurocutaneous disorder caused by a deficiency of the microsomal enzyme fatty aldehyde dehydrogenase (FALDH), which as an essential role in LTB4 metabolism. Preterm birth seems to be one of the features of the syndrome. The reason for the preterm birth is unclear. It is hypothesized that it relates to the defective LTB4 degradation in SLS. The pathological urinary excretion of LTB4 and 20-OH-LTB4 is a biochemical marker for SLS. Surprisingly, 20-OH-LTB4 concentrations are normal in CSF. Leukotriene B4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. Other specific pathways of leukotriene metabolism include the 12-hydroxydehydrogenase/ 15-oxo-prostaglandin-13-reductase that form a series of conjugated diene metabolites that have been observed to be excreted into human urine. Metabolism of LTC4 occurs by sequential peptide cleavage reactions involving a gamma-glutamyl transpeptidase that forms LTD4 (leukotriene D4) and a membrane-bound dipeptidase that converts LTD4 into LTE4 (leukotriene E4) before w-oxidation. These metabolic transformations of the primary leukotrienes are critical for termination of their biological activity, and defects in expression of participating enzymes may be involved in specific genetic disease. (PMID: 12709426, 9799565, 11408337, 17623009). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,w-hydroxyl leukotriene B4,,HMDB01509,"InChI=1/C20H32O5/c21-17-10-6-2-1-3-7-12-18(22)13-8-4-5-9-14-19(23)15-11-16-20(24)25/h3-5,7-9,13-14,18-19,21-23H,1-2,6,10-12,15-17H2,(H,24,25)/b5-4+,7-3-,13-8+,14-9-/t18-,19-/m1/s1",C04853,2016-12-05T15:48:06Z,,1383,,,,,440514,leuktrB4woh,,"(5S,12R)-5,12,20-Trihydroxy-(6Z,8E,10E,14Z)-eicosatetraenoate, (5S,12R)-5,12,20-Trihydroxy-(6Z,8E,10E,14Z)-eicosatetraenoic acid, (5S,6Z,8E,10E,12R,14Z)-5,12,20-trihydroxyicosa-6,8,10,14-tetraenoate, (5S,6Z,8E,10E,12R,14Z)-5,12,20-trihydroxyicosa-6,8,10,14-tetraenoic acid, (6Z,8E,10E,14Z)-(5S,12R)-5,12,20-Trihydroxyeicosa-6,8,10,14-tetraenoate, (6Z,8E,10E,14Z)-(5S,12R)-5,12,20-Trihydroxyeicosa-6,8,10,14-tetraenoic acid, (6Z,8E,10E,14Z)-(5S,12R)-5,12,20-Trihydroxyicosa-6,8,10,14-tetraenoate, (6Z,8E,10E,14Z)-(5S,12R)-5,12,20-Trihydroxyicosa-6,8,10,14-tetraenoic acid, 20-Hydroxy LTB4, 20-Hydroxy-leukotriene B4, 20-Hydroxy-LTB4, 20-Hydroxyleukotriene B4, 20-OH-5S,12S-dihydroxy-6,10-trans-8,14-cis-eicosatetraenoate, 20-OH-5S,12S-dihydroxy-6,10-trans-8,14-cis-eicosatetraenoic acid, 20-OH-Leukotriene B4, 20-OH-LTB4, 5,12,20-THETE, 5,12,20-TriHETE, 5S,12R,20-Trihydroxy-6Z,8E,10E,14Z-eicosatetraenoate, 5S,12R,20-Trihydroxy-6Z,8E,10E,14Z-eicosatetraenoic acid, Omega-Hydroxy-LTB4, w-Hydroxy-LTB4, [S-[R*,S*-(E,Z,E,Z)]]-5,12,20-trihydroxy-6,8,10,14-Eicosatetraenoate, [S-[R*,S*-(E,Z,E,Z)]]-5,12,20-trihydroxy-6,8,10,14-Eicosatetraenoic acid",http://vmh.uni.lu/_api/metabolites/1383/?format=pcsv
18harachd,,,-1,C20H31O3,,,"Human Metabolome Database (HMDB): (18R)-Hydroxyarachidonate is a substrate for CYP4F8 or leukotriene-B4 20-monooxygenase (EC 1.14.13.30). This enzyme hydroxylates arachdonic acid (20:4n-6) to (18R)-hydroxyarachidonate in the endoplasmic reticulum. This reaction is irreversible. CYP4F8 is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and functions as a 19-hydroxylase of prostaglandins in seminal vesicles. In particular, CYP4F8 catalyzes the 2-hydroxylation of PGH1 and PGH2, which will lead to biosynthesis of the two main PGs of human seminal fluid, (19R)-hydroxy-PGE1 and (19R)-hydroxy-PGE2 (PMID: 10791960). 18-Hydroxyarachidonic acid is an intermediate in eicosanoid metabolism.",,18 hydroxy arachidonic acid,,HMDB06245,"InChI=1/C20H32O3/c1-2-19(21)17-15-13-11-9-7-5-3-4-6-8-10-12-14-16-18-20(22)23/h4-7,10-13,19,21H,2-3,8-9,14-18H2,1H3,(H,22,23)/b6-4-,7-5-,12-10-,13-11-/t19-/m1/s1",,2016-12-05T15:48:06Z,,1384,,,,,11141754,18harachd,,"(18R)-Hydroxyarachidonate, (18R)-Hydroxyarachidonic acid, 18(R)-Hydroxyeicosatetraenoate, 18(R)-Hydroxyeicosatetraenoic acid, 18-HETE, 18-Hydroxyarachidonate, 18-Hydroxyarachidonic acid, 18-Hydroxyeicosatetraenoate, 18-Hydroxyeicosatetraenoic acid, Omega-Hydroxyarachidonic acid, w-Hydroxyarachidonic acid",http://vmh.uni.lu/_api/metabolites/1384/?format=pcsv
leuktrB4wcooh,,,-2,C20H28O6,,,"Human Metabolome Database (HMDB): 20-Carboxyleukotriene B4 is an omega-oxidized metabolite of leukotriene B4 (LTB4). Neutrophil microsomes are known to oxidize 20-hydroxy-LTB4 (20-OH-LTB4) to its 20-oxo and 20-carboxy derivatives in the presence of NADPH. This activity has been ascribed to LTB4 omega-hydroxylase (cytochrome P-450LTB omega). Leukotriene B4 release from polymorphonuclear granulocytes of severely burned patients was reduced as compared to healthy donor cells. This decrease is due to an enhanced conversion of LTB4 into the 20-hydroxy- and 20-carboxy-metabolites and further to a decreased LTB4-synthesis. LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. Other specific pathways of leukotriene metabolism include the 12-hydroxydehydrogenase/ 15-oxo-prostaglandin-13-reductase that form a series of conjugated diene metabolites that have been observed to be excreted into human urine. Metabolism of LTC4 occurs by sequential peptide cleavage reactions involving a gamma-glutamyl transpeptidase that forms LTD4 (leukotriene D4) and a membrane-bound dipeptidase that converts LTD4 into LTE4 (leukotriene E4) before w-oxidation. These metabolic transformations of the primary leukotrienes are critical for termination of their biological activity, and defects in expression of participating enzymes may be involved in specific genetic disease. (PMID 17623009, 7633595, 2155225, 3039534)Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,w-carboxy leukotriene B4,,HMDB06059,"InChI=1/C20H30O6/c21-17(11-6-2-1-3-9-15-19(23)24)12-7-4-5-8-13-18(22)14-10-16-20(25)26/h2,4-8,12-13,17-18,21-22H,1,3,9-11,14-16H2,(H,23,24)(H,25,26)/b5-4+,6-2-,12-7+,13-8-/t17-,18-/m1/s1",C05950,2016-12-05T15:48:06Z,,1385,,,,,5280877,leuktrB4wcooh,,"(5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenedioate, (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenedioic acid, (S-(R*,S*-(E,Z,E,Z)))-5,12-dihydroxy-6,8,10,14-Eicosatetraenedioate, (S-(R*,S*-(E,Z,E,Z)))-5,12-dihydroxy-6,8,10,14-Eicosatetraenedioic acid, 20-Carboxy-leukotriene- B4, 20-Carboxy-LTB4, 20-Carboxyleukotriene B4, 20-COOH-Leukotriene B4, 20-COOH-LTB4, 20-Hydroxy-20-oxo-leukotriene B4, 5(S),12(R)-Dihydroxy-20-carboxy-6,8,10,14-eicosatetraenoate, 5(S),12(R)-Dihydroxy-20-carboxy-6,8,10,14-eicosatetraenoic acid, 5,12-Dihydroxy-delta5,8,11,14-eicosapolyendioate, 5,12-Dihydroxy-delta5,8,11,14-eicosapolyendioic acid, 5S,12R-Dihydroxy-6Z,8E,10E,14Z-eicosatetraene-1,20-dioate, 5S,12R-Dihydroxy-6Z,8E,10E,14Z-eicosatetraene-1,20-dioic acid",http://vmh.uni.lu/_api/metabolites/1385/?format=pcsv
20ahchsterol,,,0,C27H46O2,CHEBI:1296,,"Human Metabolome Database (HMDB): 20 alpha-hydroxycholesterol participates in C21-Steroid hormone metabolism. 20 alpha-hydroxycholesterol is produced by the reaction between cholesterol and the enzyme, cholesterol monooxygenase (side-chain-cleaving) [EC:1.14.15.6].",,20-hydroxycholesterol,,HMDB06283,"InChI=1S/C27H46O2/c1-18(2)7-6-14-27(5,29)24-11-10-22-21-9-8-19-17-20(28)12-15-25(19,3)23(21)13-16-26(22,24)4/h8,18,20-24,28-29H,6-7,9-17H2,1-5H3/t20-,21-,22-,23-,24-,25-,26-,27-/m0/s1",C05500,2016-12-05T15:48:06Z,,1386,,,,,121935,20ahchsterol,,"(3beta,20R)-cholest-5-ene-3,20-diol, 20-Hydroxycholesterol, 20alpha-hydroxy cholesterol, 20alpha-Hydroxycholesterol",http://vmh.uni.lu/_api/metabolites/1386/?format=pcsv
pac,,,-1,C8H7O2,CHEBI:30745,,"Human Metabolome Database (HMDB): Phenyl acetate (or phenylacetate) is a carboxylic acid ester that has been found in the biofluids of patients with nephritis and/or hepatitis as well as patients with phenylketonuria (PKU). Excess phenylalanine in the body can be disposed of through a transamination process leading to the production of phenylpyruvate. The phenylpyruvate can be further metabolized into a number of products. Decarboxylation of phenylpyruvate gives phenylacetate, while a reduction reaction gives phenyllactate. The phenylacetate can be further conjugated with glutamine to give phenylacetyl glutamine. All of these metabolites can be detected in serum and urine of PKU patients. Phenyl acetate is also produced endogenously as the metabolite of 2-Phenylethylamine, which is mainly metabolized by monoamine oxidase to form phenyl acetate. 2-phenylethylamine is an ""endogenous amphetamine"" which may modulate central adrenergic functions, and the urinary phenyl acetate levels have been postulated as a marker for depression. (PMID: 17978765, 476920, 6857245). Phenylacetate is also found in essential oils, e.g. neroli, rose oil, free and as esters' and in many fruits. As a result it is used as a perfumery and flavoring ingredient.",,phenylacetate,,HMDB00209,"InChI=1S/C8H8O2/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)/p-1",C07086,2016-12-05T15:48:06Z,,1387,,,,,999,pac,,"2-Phenylacetate, 2-Phenylacetic acid, 2-Phenylethanoate, 2-Phenylethanoic acid, a-Toluate, a-Toluic acid, alpha-Toluate, alpha-Toluic acid, Benzeneacetate, Benzeneacetic acid, Benzylformate, Benzylformic acid, Omega-Phenylacetate, Omega-Phenylacetic acid, Phenylacetate, Phenylacetic acid, Phenylethanoate, Phenylethanoic acid, w-Phenylacetate, w-Phenylacetic acid",http://vmh.uni.lu/_api/metabolites/1387/?format=pcsv
phaccoa,,,-4,C29H38N7O17P3S,CHEBI:15537,,"Human Metabolome Database (HMDB): Phenylacetyl-CoA was found to be a very potent inhibitor of choline acetyltransferase, competitive for acetyl-CoA with Ki of 3.1 X 10(-7)M. Phenylacetate exerts its neurotoxic action through its metabolic product, phenylacetyl-CoA, which could severely decrease the availability of acetyl-CoA (PMID: 6142928).",,phenylacetyl-CoA(4-),,HMDB06503,"InChI=1S/C29H42N7O17P3S/c1-29(2,24(40)27(41)32-9-8-19(37)31-10-11-57-20(38)12-17-6-4-3-5-7-17)14-50-56(47,48)53-55(45,46)49-13-18-23(52-54(42,43)44)22(39)28(51-18)36-16-35-21-25(30)33-15-34-26(21)36/h3-7,15-16,18,22-24,28,39-40H,8-14H2,1-2H3,(H,31,37)(H,32,41)(H,45,46)(H,47,48)(H2,30,33,34)(H2,42,43,44)/p-4/t18-,22-,23-,24+,28-/m1/s1",C00582,2016-12-05T15:48:06Z,,1388,,,,,165620,phaccoa,,,http://vmh.uni.lu/_api/metabolites/1388/?format=pcsv
pail45p_hs,,,-5,C9H14O15P3FULLRCO2FULLR2CO2,CHEBI:28910,,"phosphatidylinositol 4,5-bisphosphate",,"phosphatidylinositol 4,5-bisphosphate",,,,,2016-11-22T15:12:09Z,,1389,,,,,,pail45p_hs,,,http://vmh.uni.lu/_api/metabolites/1389/?format=pcsv
pail4p_hs,,,-3,C9H15O12P2FULLRCO2FULLR2CO2,CHEBI:17526,,1-phosphatidyl-1D-myo-inositol 4-phosphate(3-),,1-phosphatidyl-1D-myo-inositol 4-phosphate(3-),,,,,2016-11-22T15:12:09Z,,1390,,,,,,pail4p_hs,,,http://vmh.uni.lu/_api/metabolites/1390/?format=pcsv
pan4p,,,-2,C11H21N2O7PS,CHEBI:16858,,Pantetheine 4'-phosphate,,Pantetheine 4'-phosphate,,,"InChI=1S/C11H23N2O7PS/c1-11(2,7-20-21(17,18)19)9(15)10(16)13-4-3-8(14)12-5-6-22/h9,15,22H,3-7H2,1-2H3,(H,12,14)(H,13,16)(H2,17,18,19)/p-2",C01134,2016-11-22T15:12:09Z,,1391,,,,,987,pan4p,,,http://vmh.uni.lu/_api/metabolites/1391/?format=pcsv
ptth,,,0,C11H22N2O4S,CHEBI:16753,,Human Metabolome Database (HMDB): Palmityl-CoA is a fatty acid coenzyme derivative which plays a key role in fatty acid oxidation and biosynthesis.,,pantetheine,,HMDB01338,"InChI=1S/C11H22N2O4S/c1-11(2,7-14)9(16)10(17)13-4-3-8(15)12-5-6-18/h9,14,16,18H,3-7H2,1-2H3,(H,12,15)(H,13,17)/t9-/m0/s1",C00831,2016-12-05T15:48:06Z,,1392,,,,,439322,ptth,,"Hexadecanoyl CoA, Hexadecanoyl Coenzyme A, Palmitoyl CoA, Palmitoyl coenzyme a, Palmitoyl-CoA, Palmitoyl-Coenzyme A, Palmityl-CoA, Palmityl-Coenzyme A, S-Hexadecanoate, S-Hexadecanoate CoA, S-Hexadecanoate Coenzyme A, S-Hexadecanoic acid, S-Palmitoylcoenzyme a",http://vmh.uni.lu/_api/metabolites/1392/?format=pcsv
am6sa,,,0,C6H7NO3,CHEBI:15745,,"Human Metabolome Database (HMDB): 2-aminomuconic semialdehyde is an intermediate in the oxidative metabolism of tryptophan in mammals, and takes place via the kynurenine pathway, which is also used for NAD biosynthesis in all eukaryotic organisms. 2-Aminomuconic semialdehyde is reported to be unstable and spontaneously converted to picolinic acid (regarded as metabolically inert and is excreted in the urine as a glycine conjugate), and enzymatically converted to 2-aminomuconic acid through the action of 2-aminomuconic semialdehyde dehydrogenase. (PMID: 10510494, 16267312, 14275129).",,2-aminomuconate 6-semialdehyde(1-),,HMDB01280,"InChI=1S/C6H7NO3/c7-5(6(9)10)3-1-2-4-8/h1-4H,7H2,(H,9,10)/b2-1-,5-3+",C03824,2016-12-05T15:48:06Z,,1393,,,,,5280625,am6sa,,"2-Aminomuconate 6-semialdehyde, 2-Aminomuconate semialdehyde, 2-Aminomuconic semialdehyde",http://vmh.uni.lu/_api/metabolites/1393/?format=pcsv
pcollglys,,,1,C7H14N3O2R2,,,Procollagen L-lysine,,Procollagen L-lysine,,,,C03020,2016-11-22T15:12:09Z,,1394,,,,,,pcollglys,,,http://vmh.uni.lu/_api/metabolites/1394/?format=pcsv
pcollg5hlys,,,0,C6H14N2O3,CHEBI:18040,,"Human Metabolome Database (HMDB): 5-Hydroxylysine is a hydroxylated derivative of the amino acid lysine that is present in certain collagens. Hydroxylysine is an amino acid and is most widely known as a component of collagen. A standard amino acid with the R' group consisting of an amino terminated butyl hydrocarbon chain, with a hydroxyl group on the carbon atom before the amino group.",,erythro-5-hydroxy-L-lysinium(1+),,HMDB00450,"InChI=1S/C6H14N2O3/c7-3-4(9)1-2-5(8)6(10)11/h4-5,9H,1-3,7-8H2,(H,10,11)/t4-,5+/m1/s1",C16741,2016-12-05T15:48:06Z,,1395,,,,,3032849,pcollg5hlys,,"(2S,5R)-2,6-diamino-5-hydroxyhexanoate, (2S,5R)-2,6-diamino-5-hydroxyhexanoic acid, (2S,5R)-5-hydroxylysine, (5R)-5-hydroxy-L-lysine, 5-Hydroxy-L-lysine, 5-Hydroxy-Lysine, alpha,epsilon-Diamino-delta-hydroxycaproate, alpha,epsilon-Diamino-delta-hydroxycaproic acid, D-Hydroxy-L-lysine, D-Hydroxylysine, delta-DL-hydroxylysine, delta-Hydroxy-L-lysine, delta-Hydroxylysine, Erythro-5-hydroxy-L-lysine, Hydroxy-Lysine, Hydroxylysine, L-D-Hydroxylysine, L-delta-Hydroxylysine, L-Normal-5-hydroxylysine, Procollagen 5-hydroxy-L-lysine, Procollagen L-erythro-5-hydroxy-L-lysine",http://vmh.uni.lu/_api/metabolites/1395/?format=pcsv
pdx5p,,,-2,C8H10NO6P,CHEBI:28803,,Pyridoxine 5'-phosphate,,Pyridoxine 5'-phosphate,,,"InChI=1S/C8H12NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2,10-11H,3-4H2,1H3,(H2,12,13,14)/p-2",C00627,2016-11-22T15:12:09Z,,1396,,,,,1055,pdx5p,,,http://vmh.uni.lu/_api/metabolites/1396/?format=pcsv
pydx5p,,,-2,C8H8NO6P,CHEBI:18405,,"Human Metabolome Database (HMDB): This is the active form of vitamin B6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (pyridoxamine). -- Pubchem; Pyridoxal-phosphate (PLP, pyridoxal-5'-phosphate) is a cofactor of many enzymatic reactions. It is the active form of vitamin B6 which comprises three natural organic compounds, pyridoxal, pyridoxamine and pyridoxine. -- Wikipedia.",,Pyridoxal 5'-phosphate,,HMDB01491,"InChI=1S/C8H10NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2-3,11H,4H2,1H3,(H2,12,13,14)/p-2",C00018,2016-12-05T15:48:06Z,,1397,,,,,1051,pydx5p,,"Apolon B6, Biosechs, Codecarboxylase, Coenzyme B6, Hairoxal, Hexermin-P, Hi-Pyridoxin, Hiadelon, Himitan, PAL-P, Phosphopyridoxal, Phosphopyridoxal coenzyme, Pidopidon, Piodel, PLP, Pydoxal, Pyridoxal 5'-phosphate, Pyridoxal 5-phosphate, Pyridoxal P, Pyridoxal phosphate, Pyridoxal-P, Pyridoxyl phosphate, Pyromijin, Sechvitan, Vitahexin-P, Vitazechs",http://vmh.uni.lu/_api/metabolites/1397/?format=pcsv
peamn,,,1,C8H12N,CHEBI:18397,,2-phenylethanaminium,,2-phenylethanaminium,,,"InChI=1S/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H2/p+1",C05332,2016-11-22T15:12:09Z,,1398,,,,,1001,peamn,,,http://vmh.uni.lu/_api/metabolites/1398/?format=pcsv
pacald,,,0,C8H8O,CHEBI:16424,,phenylacetaldehyde,,phenylacetaldehyde,,,"InChI=1S/C8H8O/c9-7-6-8-4-2-1-3-5-8/h1-5,7H,6H2",C00601,2016-11-22T15:12:09Z,,1399,,,,,998,pacald,,,http://vmh.uni.lu/_api/metabolites/1399/?format=pcsv
pecgoncoa,,,-3,C30H46N8O18P3S,,,Pseudoecgonyl-CoA,,Pseudoecgonyl-CoA,,,"InChI=1/C30H49N8O18P3S/c1-30(2,24(42)27(43)33-7-6-19(40)32-8-9-60-29(44)20-16-5-4-15(37(16)3)10-17(20)39)12-53-59(50,51)56-58(48,49)52-11-18-23(55-57(45,46)47)22(41)28(54-18)38-14-36-21-25(31)34-13-35-26(21)38/h13-18,20,22-24,28,39,41-42H,4-12H2,1-3H3,(H,32,40)(H,33,43)(H,48,49)(H,50,51)(H2,31,34,35)(H2,45,46,47)/t15?,16?,17-,18+,20-,22+,23+,24?,28+/m0/s1",C12450,2016-11-22T15:12:09Z,,1400,,,,,443846,pecgoncoa,,,http://vmh.uni.lu/_api/metabolites/1400/?format=pcsv
3php,,,-3,C3H2O7P,CHEBI:30933,,3-phosphonatooxypyruvate(3-),,3-phosphonatooxypyruvate(3-),,,"InChI=1S/C3H5O7P/c4-2(3(5)6)1-10-11(7,8)9/h1H2,(H,5,6)(H2,7,8,9)/p-3",C03232,2016-11-22T15:12:09Z,,1401,,,,,105,3php,,,http://vmh.uni.lu/_api/metabolites/1401/?format=pcsv
prostgh2,,,-1,C20H31O5,CHEBI:15554,,"Human Metabolome Database (HMDB): Prostaglandin H2 (PGH2) is the first intermediate in the biosynthesis of all prostaglandins. Prostaglandins are synthesized from arachidonic acid by the enzyme COX-1 and COX-2, which are also called PGH synthase 1 and 2. These enzymes generate a reactive intermediate PGH2 which has a reasonably long half-life (90-100 s) but is highly lipophilic. PGH2 is converted into the biologically active prostaglandins by prostaglandin isomerases, yielding PGE2, PGD2, and PGF2, or by thromboxane synthase to make TxA2 or by prostacyclin synthase to make PGI2. Most nonsteroidal anti-inflammatory drugs such as aspirin and indomethacin inhibit both PGH synthase 1 and 2. A key feature for eicosanoid transcellular biosynthesis is the export of PGH2 or LTA4 from the donor cell as well as the uptake of these reactive intermediates by the acceptor cell. Very little is known about either process despite the demonstrated importance of both events. In cells, PGH2 rearranges nonenzymatically to LGs even in the presence of enzymes that use PGH2 as a substrate. When platelets form Thromboxane A2 (TXA2) from endogenous arachidonic acid (AA), PGH2 reaches concentrations very similar to those of TXA2 and high enough to produce strong platelet activation. Therefore, platelet activation by TXA2 appears to go along with an activation by PGH2. The agonism of PGH2 is limited by the formation of inhibitory prostaglandins, especially PGD2 at higher concentrations. That is why thromboxane synthase inhibitors in PRP and at a physiological HSA concentration do not augment platelet activation. (PMID: 2798452, 15650407, 16968946)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,prostaglandin H2(1-),,HMDB01381,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18-14-19(17)25-24-18)10-7-4-5-8-11-20(22)23/h4,7,12-13,15-19,21H,2-3,5-6,8-11,14H2,1H3,(H,22,23)/p-1/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1",C00427,2016-12-05T15:48:06Z,,1402,,,,prostaglandin H2,445049,prostgh2,,"(15S)Hydroxy-9alpha,11alpha-(epoxymethano)prosta-5,13-dienoate, (15S)Hydroxy-9alpha,11alpha-(epoxymethano)prosta-5,13-dienoic acid, (5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]hept-5-yl}hept-5-enoate, (5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]hept-5-yl}hept-5-enoic acid, (5Z,13E)-(15S)-9,11-epidioxy-15-hydroxyprosta-5,13-dienoate, (5Z,13E)-(15S)-9,11-epidioxy-15-hydroxyprosta-5,13-dienoic acid, (5Z,13E)-(15S)-9-alpha,11-alpha-epidioxy-15-hydroxyprosta-5,13-dienoate, (5Z,13E)-(15S)-9-alpha,11-alpha-epidioxy-15-hydroxyprosta-5,13-dienoic acid, (5Z,13E)-(15S)-9alpha,11alpha-Epidioxy-15-hydroxyprosta-5,13-dienoate, (5Z,13E)-(15S)-9alpha,11alpha-Epidioxy-15-hydroxyprosta-5,13-dienoic acid, (5Z,13E,15S)-9-alpha,11-alpha-epidioxy-15-hydroxyprosta-5,13-dienoate, (5Z,13E,15S)-9-alpha,11-alpha-epidioxy-15-hydroxyprosta-5,13-dienoic acid, (5Z,13E,15S)-9a,11a-epidioxy-15-hydroxyprosta-5,13-dienoate, (5Z,13E,15S)-9a,11a-epidioxy-15-hydroxyprosta-5,13-dienoic acid, (5Z,9a,11a,13E,15S)-9,11-epidioxy-15-hydroxyprosta-5,13-dien-1-oate, (5Z,9a,11a,13E,15S)-9,11-epidioxy-15-hydroxyprosta-5,13-dien-1-oic acid, (5Z,9alpha,11alpha,13E,15S)-9,11-epidioxy-15-hydroxy-Prosta-5,13-dien-1-oate, (5Z,9alpha,11alpha,13E,15S)-9,11-epidioxy-15-hydroxy-Prosta-5,13-dien-1-oic acid, 15-Hydroxy-9alpha,11alpha-peroxidoprosta-5,13-dienoate, 15-Hydroxy-9alpha,11alpha-peroxidoprosta-5,13-dienoic acid, 9,11-Epoxymethano-pgh2, 9S,11R-Epidioxy-15S-hydroxy-5Z,13E-prostadienoate, 9S,11R-Epidioxy-15S-hydroxy-5Z,13E-prostadienoic acid, Endoperoxide H2, PGH2, Prostaglandin R2, Prostaglandin-H2",http://vmh.uni.lu/_api/metabolites/1402/?format=pcsv
prostgi2,,,-1,C20H31O5,CHEBI:15552,,"Human Metabolome Database (HMDB): Prostaglandin I2 or prostacyclin (or PGI2) is a member of the family of lipid molecules known as eicosanoids. It is produced in endothelial cells from prostaglandin H2 (PGH2) by the action of the enzyme prostacyclin synthase. It is a powerful vasodilator and inhibits platelet aggregation. Prostaglandin I2 is the main prostaglandin synthesized by the blood vessel wall. This suggests that it may play an important role in limiting platelet-mediated thrombosis. In particular, prostacyclin (PGI2) chiefly prevents formation of the platelet plug involved in primary hemostasis (a part of blood clot formation). The sodium salt (known as epoprostenol) has been used to treat primary pulmonary hypertension. Prostacyclin (PGI2) is released by healthy endothelial cells and performs its function through a paracrine signaling cascade that involves G protein-coupled receptors on nearby platelets and endothelial cells. The platelet Gs protein-coupled receptor (prostacyclin receptor) is activated when it binds to PGI2. This activation, in turn, signals adenylyl cyclase to produce cAMP. cAMP goes on to inhibit any undue platelet activation (in order to promote circulation) and also counteracts any increase in cytosolic calcium levels which would result from thromboxane A2 (TXA2) binding (leading to platelet activation and subsequent coagulation). PGI2 also binds to endothelial prostacyclin receptors and in the same manner raise cAMP levels in the cytosol. This cAMP then goes on to activate protein kinase A (PKA). PKA then continues the cascade by inhibiting myosin light-chain kinase which leads to smooth muscle relaxation and vasodilation. Notably, PGI2 and TXA2 work as antagonists. PGI2 is stable in basic buffers (pH=8), but it is rapidly hydrolyzed to 6-keto PGF1alpha in neutral or acidic solutions. The half-life is short both in vivo and in vitro, ranging from 30 seconds to a few minutes. PGI2 is administered by continuous infusion in humans for the treatment of idiopathic pulmonary hypertension.Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,prostaglandin I2(1-),,HMDB01335,"InChI=1S/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/p-1/b11-10+,15-8-/t14-,16+,17+,18+,19-/m0/s1",C01312,2016-12-05T15:48:06Z,,1403,,,,,5282411,prostgi2,,"(5Z,13E)-(15S)-6,9-alpha-epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoate, (5Z,13E)-(15S)-6,9-alpha-epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoic acid, (5Z,13E)-(15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dienoate, (5Z,13E)-(15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dienoic acid, (5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate, (5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoic acid, (5Z,13E,15S)-6,9a-epoxy-11a,15-dihydroxyprosta-5,13-dienoate, (5Z,13E,15S)-6,9a-epoxy-11a,15-dihydroxyprosta-5,13-dienoic acid, (5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oate, (5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid, (5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oate, (5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid, Epoprostenol, PGI2, PGX, Prostacyclin, Prostacycline, Prostaglandin I2, Prostaglandin X, Vasocyclin",http://vmh.uni.lu/_api/metabolites/1403/?format=pcsv
2pglyc,,,-3,C2H2O6P,CHEBI:17150,,2-phosphonatoglycolate(3-),,2-phosphonatoglycolate(3-),,,"InChI=1S/C2H5O6P/c3-2(4)1-8-9(5,6)7/h1H2,(H,3,4)(H2,5,6,7)/p-3",C00988,2016-11-22T15:12:09Z,,1404,,,,,529,2pglyc,,,http://vmh.uni.lu/_api/metabolites/1404/?format=pcsv
pgp_hs,,,-3,C6H11O9P2FULLRCO2FULLR2CO2,,,phosphatidyl glycerol phosphate,,phosphatidyl glycerol phosphate,,,,,2016-11-22T15:12:09Z,,1405,,,,,,pgp_hs,,,http://vmh.uni.lu/_api/metabolites/1405/?format=pcsv
1p3h5c,,,-1,C5H6NO3,CHEBI:6151,,L-1-Pyrroline-3-hydroxy-5-carboxylate,,L-1-Pyrroline-3-hydroxy-5-carboxylate,,,"InChI=1S/C5H7NO3/c7-3-1-4(5(8)9)6-2-3/h2-4,7H,1H2,(H,8,9)/p-1/t3-,4+/m1/s1",C04281,2016-11-22T15:12:09Z,,1406,,,,,11966267,1p3h5c,,,http://vmh.uni.lu/_api/metabolites/1406/?format=pcsv
phpyr,,,-1,C9H7O3,CHEBI:30851,,"Human Metabolome Database (HMDB): Phenylpyruvic acid is a keto-acid that is an intermediate or catabolic byproduct of phenylalanine metabolism. It has a slight honey-like odor. Levels of phenylpyruvate are normally very low in blood or urine. High levels of phenylpyruvic acid can be found in the urine of individuals with phenylketonuria (PKU). PKU is due to lack of the enzyme phenylalanine hydroxylase (PAH), so that phenylalanine is converted not to tyrosine but to phenylpyruvic acid. In particular, excessive phenylalanine can be metabolized into phenylketones through, a transaminase pathway route involving glutamate. Metabolites of this transamination reaction include phenylacetate, phenylpyruvate and phenethylamine. In persons with PKU, dietary phenylalanine either accumulates in the body or some of it is converted to phenylpyruvic acid. Individuals with PKU tend to excrete large quantities of phenylpyruvate, phenylacetate and phenyllactate, along with phenylalanine, in their urine. If untreated, mental retardation effects and microcephaly are evident by the first year along with other symptoms which include: unusual irritability, epileptic seizures and skin lesions. Hyperactivity, EEG abnormalities and seizures, and severe learning disabilities are major clinical problems later in life. A ""musty or mousy"" odor of skin, hair, sweat and urine (due to phenylacetate accumulation); and a tendency to hypopigmentation and eczema are also observed. The neural-development effects of PKU are primarily due to the disruption of neurotransmitter synthesis. In particular, phenylalanine is a large, neutral amino acid which moves across the blood-brain barrier (BBB) via the large neutral amino acid transporter (LNAAT). Excessive phenylalanine in the blood saturates the transporter. Thus, excessive levels of phenylalanine significantly decrease the levels of other LNAAs in the brain. But since these amino acids are required for protein and neurotransmitter synthesis, phenylalanine accumulation disrupts brain development, leading to mental retardation.",,keto-phenylpyruvate,,HMDB00205,"InChI=1S/C9H8O3/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,11,12)/p-1",C00166,2016-12-05T15:48:06Z,,1407,,,,,997,phpyr,,"2-Oxo-3-phenylpropanoate, 2-Oxo-3-phenylpropanoic acid, 3-Phenyl-2-oxopropanoate, 3-Phenyl-2-oxopropanoic acid, 3-Phenylpyruvate, 3-Phenylpyruvic acid, alpha-Ketohydrocinnamate, alpha-Ketohydrocinnamic acid, b-Phenylpyruvate, b-Phenylpyruvic acid, beta-Phenylpyruvate, beta-Phenylpyruvic acid, Keto-Phenylpyruvate, Phenylpyroracemate, Phenylpyroracemic acid, Phenylpyruvate",http://vmh.uni.lu/_api/metabolites/1407/?format=pcsv
thbpt4acam,,,0,C9H15N5O4,CHEBI:15374,,"Human Metabolome Database (HMDB): Tetrahydrobiopterin (BH4) is essential to catalyze the conversion of phenylalanine to tyrosine by phenylalanine hydroxylase. During this physiological reaction, the oxidation of BH4 creates 4a-hydroxytetrahydropterin intermediates and hydrogen peroxide is formed. The hydrogen peroxide and the hydroxytetrahydropterin can both derive from alternate routes of breakdown of a common precursor, the corresponding 4a-hydroperoxytetrahydropterin. (PMID 8323303).",,4a-hydroxytetrahydrobiopterin,,HMDB02281,"InChI=1S/C9H15N5O4/c1-3(15)5(16)4-2-11-6-9(18,14-4)7(17)13-8(10)12-6/h3-5,14-16,18H,2H2,1H3,(H3,10,11,12,13,17)",C15522,2016-12-05T15:48:06Z,,1408,,,,4a-hydroxytetrahydrobiopterin,129803,thbpt4acam,,"(6R)-6-(L-erythro-1,2-Dihydroxypropyl)-5,6,7,8-tetrahydro-4a-hydroxypterin, 2-Amino-6-(1,2-dihydroxypropyl)-4a-hydroxy-5,6,7,8-tetrahydropteridin-4(4aH)-one, 2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-4a-hydroxy-4(4aH)-Pteridinone, 2-Amino-6-[(1R,2S)-1,2-dihydroxypropyl]-4a-hydroxy-1,5,6,7-tetrahydropteridin-4-one, 4a-Hydroxy-5,6,7,8-tetrahydrobiopterin, 4a-Hydroxytetrahydrobiopterin, 4alpha-Hydroxytetrahydrobiopterin",http://vmh.uni.lu/_api/metabolites/1408/?format=pcsv
pail345p_hs,,,-7,C9H13O18P4FULLRCO2FULLR2CO2,CHEBI:16618,,"1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate(7-)",,"1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate(7-)",,,,,2016-11-22T15:12:09Z,,1409,,,,,,pail345p_hs,,,http://vmh.uni.lu/_api/metabolites/1409/?format=pcsv
pail34p_hs,,,-5,C9H14O15P3FULLRCO2FULLR2CO2,CHEBI:16152,,"1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate(5-)",,"1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate(5-)",,,,,2016-11-22T15:12:09Z,,1410,,,,,,pail34p_hs,,,http://vmh.uni.lu/_api/metabolites/1410/?format=pcsv
pail3p_hs,,,-3,C9H15O12P2FULLRCO2FULLR2CO2,CHEBI:17283,,1-phosphatidyl-1D-myo-inositol 3-phosphate(3-),,1-phosphatidyl-1D-myo-inositol 3-phosphate(3-),,,,,2016-11-22T15:12:09Z,,1411,,,,,,pail3p_hs,,,http://vmh.uni.lu/_api/metabolites/1411/?format=pcsv
pail35p_hs,,,-5,C9H14O15P3FULLRCO2FULLR2CO2,,,"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate(5-)",,"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate(5-)",,,,,2016-11-22T15:12:09Z,,1412,,,,,,pail35p_hs,,,http://vmh.uni.lu/_api/metabolites/1412/?format=pcsv
pail5p_hs,,,-3,C9H15O12P2FULLRCO2FULLR2CO2,CHEBI:16500,,1-phosphatidyl-1D-myo-inositol 5-phosphate(3-),,1-phosphatidyl-1D-myo-inositol 5-phosphate(3-),,,,,2016-11-22T15:12:09Z,,1413,,,,,,pail5p_hs,,,http://vmh.uni.lu/_api/metabolites/1413/?format=pcsv
pepslys,,,0,X,,,peptide sans lysine,,peptide sans lysine,,,,,2016-11-22T15:12:09Z,,1414,,,,,,pepslys,,,http://vmh.uni.lu/_api/metabolites/1414/?format=pcsv
tmlys,,,0,C9H20N2O2,CHEBI:17311,,"Human Metabolome Database (HMDB): N6,N6,N6-Trimethyl-L-lysine is a methylated derivative of the amino acid lysine. It is a component of histone proteins, a precursor of carnitine and a coenzyme of fatty acid oxidation. N6,N6,N6-Trimethyl-L-lysine residues are found in a number of proteins and are generated by the action of S-adenosyl-L-methionine on exposed lysine residues. When trimethyllysine is released from cognate proteins via proteolysis, it serves as a precursor for carnitine biosynthesis. Mitochondrial 6-N-trimethyllysine dioxygenase converts 6-N-trimethyllysine to 3-hydroxy-6-N-trimethyllysine as the first step for carnitine biosynthesis. Because the subsequent carnitine biosynthesis enzymes are cytosolic, 3-hydroxy-6-N-trimethyllysine must be transported out of the mitochondria by a putative mitochondrial 6-N-trimethyllysine/3-hydroxy-6-N-trimethyllysine transporter system. Plasma -N-trimethyllysine concentrations are significantly lower in systemic carnitine deficiency patients compared to normal individuals, but no significant difference in urinary -N-trimethyllysine excretion is seen between the two groups.",,"N6,N6,N6-Trimethyl-L-lysine",,HMDB01325,"InChI=1S/C9H20N2O2/c1-11(2,3)7-5-4-6-8(10)9(12)13/h8H,4-7,10H2,1-3H3/p+1/t8-/m0/s1",C03793,2016-12-05T15:48:06Z,,1415,,,,,440120,tmlys,,"(S)-2-amino-6-(trimethylammonio)hexanoate, (S)-2-amino-6-(trimethylammonio)hexanoic acid, delta-Trimethyllysine, epsilon-N-Trimethyl-L-lysine, epsilon-Trimethyl-L-lysine, N(6),N(6),N(6)-Trimethyl-L-lysine, N6,N6,N6-trimethyl-L-lysine, S)-5-Amino-5-carboxy-N,N,N-trimethyl-1-pentanaminium, Trimethyllysine",http://vmh.uni.lu/_api/metabolites/1415/?format=pcsv
ppmi12346p,,,-13,C6H6O27P7,CHEBI:30164,,5-Diphosphoinositol pentakisphosphate,,5-Diphosphoinositol pentakisphosphate,,,"InChI=1S/C6H19O27P7/c7-34(8,9)27-1-2(28-35(10,11)12)4(30-37(16,17)18)6(32-40(25,26)33-39(22,23)24)5(31-38(19,20)21)3(1)29-36(13,14)15/h1-6H,(H,25,26)(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24)/p-13/t1-,2+,3-,4-,5+,6+",C11526,2016-11-22T15:12:09Z,,1416,,,,,,ppmi12346p,,,http://vmh.uni.lu/_api/metabolites/1416/?format=pcsv
ppmi1346p,,,-11,C6H7O24P6,,,Diphosphoinositol tetrakisphosphate,,Diphosphoinositol tetrakisphosphate,,,"InChI=1/C6H18O24P6/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24)",C01204,2016-11-22T15:12:09Z,,1417,,,,,890,ppmi1346p,,,http://vmh.uni.lu/_api/metabolites/1417/?format=pcsv
rnam,,,1,C11H15N2O5,CHEBI:15927,,N-Ribosylnicotinamide,,N-Ribosylnicotinamide,,,"InChI=1S/C11H14N2O5/c12-10(17)6-2-1-3-13(4-6)11-9(16)8(15)7(5-14)18-11/h1-4,7-9,11,14-16H,5H2,(H-,12,17)/p+1/t7-,8-,9-,11-/m1/s1",C03150,2016-11-22T15:12:09Z,,1418,,,,,439924,rnam,,,http://vmh.uni.lu/_api/metabolites/1418/?format=pcsv
cysam,,,1,C2H8NS,CHEBI:17141,,cysteaminium,,cysteaminium,,,"InChI=1S/C2H7NS/c3-1-2-4/h4H,1-3H2/p+1",C01678,2016-11-22T15:12:09Z,,1419,,,,,6058,cysam,,,http://vmh.uni.lu/_api/metabolites/1419/?format=pcsv
4ppan,,,-3,C9H15NO8P,CHEBI:15905,,D-4'-Phosphopantothenate,,D-4'-Phosphopantothenate,,,"InChI=1S/C9H18NO8P/c1-9(2,5-18-19(15,16)17)7(13)8(14)10-4-3-6(11)12/h7,13H,3-5H2,1-2H3,(H,10,14)(H,11,12)(H2,15,16,17)/p-3/t7-/m0/s1",C03492,2016-11-22T15:12:09Z,,1420,,,,,41635,4ppan,,,http://vmh.uni.lu/_api/metabolites/1420/?format=pcsv
4ppcys,,,-3,C12H20N2O9PS,CHEBI:15769,,N-((R)-4-Phosphopantothenoyl)-L-cysteine,,N-((R)-4-Phosphopantothenoyl)-L-cysteine,,,"InChI=1S/C12H23N2O9PS/c1-12(2,6-23-24(20,21)22)9(16)10(17)13-4-3-8(15)14-7(5-25)11(18)19/h7,9,16,25H,3-6H2,1-2H3,(H,13,17)(H,14,15)(H,18,19)(H2,20,21,22)/p-3/t7-,9-/m0/s1",C04352,2016-11-22T15:12:09Z,,1421,,,,,440304,4ppcys,,,http://vmh.uni.lu/_api/metabolites/1421/?format=pcsv
prpncoa,,,-4,C24H34N7O17P3S,CHEBI:15513,,acryloyl-CoA(4-),,acryloyl-CoA(4-),,,"InChI=1S/C24H38N7O17P3S/c1-4-15(33)52-8-7-26-14(32)5-6-27-22(36)19(35)24(2,3)10-45-51(42,43)48-50(40,41)44-9-13-18(47-49(37,38)39)17(34)23(46-13)31-12-30-16-20(25)28-11-29-21(16)31/h4,11-13,17-19,23,34-35H,1,5-10H2,2-3H3,(H,26,32)(H,27,36)(H,40,41)(H,42,43)(H2,25,28,29)(H2,37,38,39)/p-4/t13-,17-,18-,19+,23-/m1/s1",C00894,2016-11-22T15:12:09Z,,1422,,,,,439340,prpncoa,,,http://vmh.uni.lu/_api/metabolites/1422/?format=pcsv
2hyoxplac,,,-1,C8H7O3,CHEBI:28478,,Human Metabolome Database (HMDB): ortho-Hydroxyphenylacetic acid is a substrate of the enzyme oxidoreductases [EC 1.14.13.-] in the pathway styrene degradation. (KEGG).,,2-Hydroxyphenylacetate,,HMDB00669,"InChI=1/C8H8O3/c9-7-4-2-1-3-6(7)5-8(10)11/h1-4,9H,5H2,(H,10,11)",C05852,2016-12-05T15:48:06Z,,1423,,,,,11970,2hyoxplac,,"(2-Hydroxyphenyl)acetate, (2-Hydroxyphenyl)acetic acid, (O-hydroxyphenyl)-Acetate, (O-hydroxyphenyl)-Acetic acid, (O-Hydroxyphenyl)acetate, (O-Hydroxyphenyl)acetic acid, 2-HPAA, 2-Hydroxybenzeneacetate, 2-Hydroxybenzeneacetic acid, 2-Hydroxyphenylacetic acid, Hydroxyphenylacetate, Hydroxyphenylacetic acid, O-Hydroxyphenylacetic acid",http://vmh.uni.lu/_api/metabolites/1423/?format=pcsv
fpram,,,-1,C8H15N3O8P,CHEBI:18413,,2-(Formamido)-N1-(5-phospho-D-ribosyl)acetamidine,,2-(Formamido)-N1-(5-phospho-D-ribosyl)acetamidine,,,"InChI=1S/C8H16N3O8P/c9-5(1-10-3-12)11-8-7(14)6(13)4(19-8)2-18-20(15,16)17/h3-4,6-8,13-14H,1-2H2,(H2,9,11)(H,10,12)(H2,15,16,17)/p-1/t4-,6-,7-,8?/m1/s1",C04640,2016-11-22T15:12:09Z,,1424,,,,,,fpram,,,http://vmh.uni.lu/_api/metabolites/1424/?format=pcsv
prgnlones,,,-1,C21H31O5S,CHEBI:35420,,"Human Metabolome Database (HMDB): Pregnenolone sulfate, a neurosteroid, is a metabolite of Pregnenolone. It is found in the brain and central nervous system.",,pregnenolone sulfate,,HMDB00774,"InChI=1S/C21H32O5S/c1-13(22)17-6-7-18-16-5-4-14-12-15(26-27(23,24)25)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19H,5-12H2,1-3H3,(H,23,24,25)/t15-,16-,17+,18-,19-,20-,21+/m0/s1",C18044,2016-12-05T15:48:06Z,,1425,,,,,20845972,prgnlones,,"5-Pregnen-3b-sulfate-20-one, 5-Pregnen-3b-sulphate-20-one, Pregn-5-en-20-on-3b-yl sulfurate, Pregn-5-en-20-on-3b-yl sulfuric acid, Pregn-5-en-20-one-3b-yl sulfate, Pregn-5-en-20-one-3b-yl sulphate, Pregnenolone 3-sulfate, Pregnenolone 3-sulphate, Pregnenolone 3b-sulfate, Pregnenolone 3b-sulphate, Pregnenolone hydrogen sulfate, Pregnenolone hydrogen sulphate, Pregnenolone monosulfate, Pregnenolone monosulphate, Pregnenolone sulfate, Pregnenolone sulphate",http://vmh.uni.lu/_api/metabolites/1425/?format=pcsv
4hpro_LT,,,0,C5H9NO3,CHEBI:18095,,"Human Metabolome Database (HMDB): 4-Hydroxyproline (or hydroxyproline or Hyp) is a major component of the protein collagen. Hydroxyproline is produced by hydroxylation of the amino acid proline and is, therefore, a post-translationally modified amino acid. Hydroxyproline and proline play key roles for collagen stability. In particular, they permit the sharp twisting of the collagen helix. Hydroxyproline is found in few proteins other than collagen. The only other mammalian protein which includes hydroxyproline is elastin. For this reason, hydroxyproline content has been used as an indicator to determine collagen and/or gelatin amount in tissue or biological samples.  Increased serum and urine levels of hydroxyproline have been found in Paget's disease (PMID: 436278). Hydroxyproline (Hyp) content in biological fluids is used as a parameter of collagen catabolism, especially bone resorption or tissue degradation. Bedridden and elderly individuals show significantly elevated serum levels of hydroxyproline in comparison to normal, active individuals (PMID: 10706420). Elevated levels of urinary hydroxyproline are also indicative of muscle damage (PMID: 21988268). Increased reactive oxygen species (ROS) are also known to accelerate collagen degradation. Hydroxyproline levels increase in cases of depression and stress (PMID: 21483218).",,trans-4-hydroxy-L-proline,,HMDB00725,"InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4+/m1/s1",C01157,2016-12-05T15:48:06Z,,1426,,,,,5810,4hpro_LT,,"(2S,4R)-4-hydroxy-2-pyrrolidinecarboxylic acid, (2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid, (4R)-4-hydroxy-L-proline, 4-Hydroxy-2-pyrrolidinecarboxylic acid, 4-Hydroxy-L-proline, 4-L-Hydroxyproline, delta-Hydroxyproline, Hydroxiproline, Hydroxy-L-proline, Hydroxy-proline, Hydroxyproline, L-4-Hydroxyproline, L-Hydroxyproline, L-Threo-4-hydroxyproline, LS-hydroxyproline, Oxaceprol, trans-4-Hydroxy-L-proline, trans-4-Hydroxyproline, Trans-hydroxyproline, Trans-L-hydroxyproline",http://vmh.uni.lu/_api/metabolites/1426/?format=pcsv
pser_L,,,-2,C3H6NO6P,CHEBI:15811,,"Human Metabolome Database (HMDB): The phosphoric acid ester of serine. As a constituent (residue) of proteins, its side chain can undergo O-linked glycosylation. This might be important in explaining some of the devastating consequences of diabetes. It is one of three amino acid residues that are commonly phosphorylated by kinases during cell signalling in eukaryotes. Phosphorylated serine residues are often referred to as phosphoserine. Serine proteases are a common type of protease. Serine, organic compound, one of the 20 amino acids commonly found in animal proteins. Only the L-stereoisomer appears in mammalian protein. It is not essential to the human diet, since it can be synthesized in the body from other metabolites, including glycine. Serine was first obtained from silk protein, a particularly rich source, in 1865. Its name is derived from the Latin for silk, sericum. Serine's structure was established in 1902.",,O-Phospho-L-serine,,HMDB00272,"InChI=1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/t2-/m0/s1",C01005,2016-12-05T15:48:06Z,,1427,,,,,68841,pser_L,,"3-O-Phosphoserine, Dexfosfoserine, Fosforina, L-3-Phosphoserine, L-O-Phosphoserine, L-O-Serine phosphate, L-Phosphoserine, L-Serine dihydrogen phosphate (ester), L-Serine phosphate, L-Serinephosphorate, L-Serinephosphoric acid, L-Seryl phosphate",http://vmh.uni.lu/_api/metabolites/1427/?format=pcsv
ptdcacrn,,,0,C22H43NO4,,,pendtadenoyl carnitine,,pendtadenoyl carnitine,,,,,2016-11-22T15:12:09Z,,1428,,,,,,ptdcacrn,,,http://vmh.uni.lu/_api/metabolites/1428/?format=pcsv
6pthp,,,0,C9H11N5O3,CHEBI:17804,,"6-pyruvoyl-5,6,7,8-tetrahydropterin",,"6-pyruvoyl-5,6,7,8-tetrahydropterin",,,"InChI=1S/C9H11N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h4,12H,2H2,1H3,(H4,10,11,13,14,17)",C03684,2016-11-22T15:12:09Z,,1429,,,,PTHP,128973,6pthp,,,http://vmh.uni.lu/_api/metabolites/1429/?format=pcsv
pylald,,,0,C10H14O,CHEBI:15421,,"Human Metabolome Database (HMDB): Perillaldehyde, or perilla aldehyde, is a natural organic compound found most abundantly in the perennial herb perilla, but also in a wide variety of other plants and essential oils. It is a monoterpenoid containing an aldehyde functional group.",,perillyl aldehyde,,HMDB03647,"InChI=1S/C10H14O/c1-8(2)10-5-3-9(7-11)4-6-10/h3,7,10H,1,4-6H2,2H3",C02576,2016-12-05T15:48:06Z,,1430,,,,,16441,,,"(-)-Perillaldehyde, 1,8-p-Menthadien-7-al, 1-Perillaldehyde, 4-Isopropenylcyclohex-1-enecarbaldehyde, Dihydrocuminyl aldehyde, DL-perillaldehyde(for perfumery), FEMA No. 3557, L-Perillaldehyde, p-Mentha-1,8-dien-7-al, p-Mentha-1,8-dien-7-al (natural), Para-Mentha-1,8-dien-7-al, Perilla aldehyde, Perillal, Perillaldehyde, Perillic aldehyde, Perillylaldehyde",http://vmh.uni.lu/_api/metabolites/1430/?format=pcsv
peracd,,,-1,C10H13O2,CHEBI:36999,,Human Metabolome Database (HMDB): Perillic acid is an intermediate in the Limonene and pinene degradation pathway. (KEGG). Its measurement in urine is used to monitor cancer patients receiving oral Limonene (a farnesyl transferase inhibitor that has shown antitumor properties)(PubMed ID 8723738 ).,,Perillic acid,,HMDB04586,"InChI=1S/C10H14O2/c1-7(2)8-3-5-9(6-4-8)10(11)12/h5,8H,1,3-4,6H2,2H3,(H,11,12)/p-1",C11924,2016-12-05T15:48:06Z,,1431,,,,,1256,,,Perillate,http://vmh.uni.lu/_api/metabolites/1431/?format=pcsv
quln,,,-2,C7H3NO4,CHEBI:16675,,"Human Metabolome Database (HMDB): Quinolinic acid is a metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS. Quinolinic acid (QUIN) is a product of tryptophan metabolism that can act as an endogenous brain excitotoxin when released by activated macrophages. (Valle et. al, Brain 127:1047 (2004)).",,quinolinate(2-),,HMDB00232,"InChI=1S/C7H5NO4/c9-6(10)4-2-1-3-8-5(4)7(11)12/h1-3H,(H,9,10)(H,11,12)/p-2",C03722,2016-12-05T15:48:06Z,,1432,,,,,1066,quln,,"2,3-Pyridinedicarboxylate, 2,3-Pyridinedicarboxylic acid, 3,4-Pyridinedicarboxylic acid, Pyridin-2,3-dicarbonsaeure, Pyridine-2,3-carboxylate, Pyridine-2,3-dicarboxylate, Pyridine-2,3-dicarboxylic acid, Pyridine-3,4-dicarboxylic acid, Quinolinate, Quinolinic acid",http://vmh.uni.lu/_api/metabolites/1432/?format=pcsv
retinal_cis_13,,,0,C20H28O,CHEBI:45487,,"Human Metabolome Database (HMDB): 13-cis-Retinal is a naturally occurring retinoid. Retinoids are vitamin A analogs that have profound biological activities. Several retinoids have been reported to have antiinflammatory activity in certain animal models of arthritis, such as adjuvant-induced and streptococcal cell wall-induced arthritis in rats. Some retinoids also have been shown to possess antiinftammatory activity in man by their ability to modulate inflammatory diseases of the skin. It has been reported, for example, that retinoid treatment can inhibit neutrophil accumulation in cutaneous disorders such as psoriasis. (PMID: 2123476).",,13-cis-retinal,,HMDB06220,"InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13-",C00376,2016-12-05T15:48:06Z,,1433,,,,,6436079,retinal_cis_13,,"13-cis-Retinal, 13-cis-Retinaldehyde, 13Z-Retinal, cis-13-Retinal, Neoretinene a, Neovitamin A aldehyde",http://vmh.uni.lu/_api/metabolites/1433/?format=pcsv
retinal_11_cis,,,0,C20H28O,CHEBI:16066,,"Human Metabolome Database (HMDB): Vitamin A (all-trans retinol) is converted in the retina to the 11-cis-isomer of retinaldehyde or 11-cis-retinal. 11-cis-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-cis-retinal, while attached to opsin in rhodopsin is isomerized to all-trans-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-trans-retinal is then released from opsin and reduced to all-trans-retinol. All-trans-retinol is isomerized to 11-cis-retinol in the dark, and then oxidized to 11-cis-retinal. 11-cis-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to resynthesize 11-cis retinal rapidly (http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/vit_0260.shtml).",,11-cis-retinal,,HMDB02152,"InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6-,12-11+,16-8+,17-13+",C02110,2016-12-05T15:48:06Z,,1434,,,,,5280490,retinal_11_cis,,"11-cis-Retinal, cis-11-Retinal",http://vmh.uni.lu/_api/metabolites/1434/?format=pcsv
retinal_cis_9,,,0,C20H28O,,,all-trans-retinal,,all-trans-retinal,,,"InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+",C00376,2016-11-22T15:12:09Z,,1435,,,,,638015,retinal_cis_9,,,http://vmh.uni.lu/_api/metabolites/1435/?format=pcsv
rbl_D,,,0,C5H10O5,CHEBI:17173,,"Human Metabolome Database (HMDB): Ribulose is a ketopentose - a monosaccharide containing five carbon atoms, and including a ketone functional group. D-ribulose is an intermediate in the fungal pathway for D-arabitol production. As the 1,5-bisphosphate, it combines with CO2 at the start of the photosynthetic process in green plants (carbon dioxide trap); d-ribulose is the epimer of d-xylulose. (Wikipedia).",,D-ribulose,,HMDB00621,"InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h3,5-8,10H,1-2H2/t3-,5-/m1/s1",C00309,2016-12-05T15:48:06Z,,1436,,,,,151261,rbl_D,,"D(-)-Ribulose, D-Adonose, D-Arabinulose, D-Araboketose, D-Erythro-2-Keptopentose, D-Erythro-Pentulose, D-Erythropentulose, D-Ribosone, D-Ribulose",http://vmh.uni.lu/_api/metabolites/1436/?format=pcsv
retinol_cis_13,,,0,C20H30O,,,13-cis-retinol,,13-cis-retinol,,,"InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13-",C19962,2016-11-22T15:12:09Z,,1437,,,,,9904001,retinol_cis_13,,,http://vmh.uni.lu/_api/metabolites/1437/?format=pcsv
retncoa,,,-4,C41H58N7O17P3S,,,"Human Metabolome Database (HMDB): Retinoyl coenzyme A is an intermediate in vitamin A metabolism. The formation of retinoyl-CoA from retinoic acid, as the first step of retinoylation (acylation of proteins by retinoic acid in cells), required ATP, CoA and MgCl2.",,retinoyl CoA,,HMDB06508,"InChI=1/C41H62N7O17P3S/c1-25(13-14-28-27(3)12-9-16-40(28,4)5)10-8-11-26(2)20-31(50)69-19-18-43-30(49)15-17-44-38(53)35(52)41(6,7)22-62-68(59,60)65-67(57,58)61-21-29-34(64-66(54,55)56)33(51)39(63-29)48-24-47-32-36(42)45-23-46-37(32)48/h8,10-11,13-14,20,23-24,29,33-35,39,51-52H,9,12,15-19,21-22H2,1-7H3,(H,43,49)(H,44,53)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/b11-8+,14-13+,25-10+,26-20+/t29-,33-,34-,35?,39-/m1/s1",,2016-12-05T15:48:06Z,,1438,,,,,14232703,retncoa,,"Acyl-CoA-retinol acyltransferase, Acyl-CoA-retinol acyltransferase., Acyl-Coenzyme A-retinol acyltransferase, Acyl-Coenzyme A-retinol acyltransferase., Retinol acyltransferase, Retinol fatty-acyltransferase, Retinol O-acyltransferase, Retinoyl coenzyme A",http://vmh.uni.lu/_api/metabolites/1438/?format=pcsv
trdrd,,,0,XH2,CHEBI:15967,,Reduced thioredoxin,,Reduced thioredoxin,,,,C00342,2016-11-22T15:12:09Z,,1439,,,,,,trdrd,,,http://vmh.uni.lu/_api/metabolites/1439/?format=pcsv
trdox,,,0,X,CHEBI:18191,,Oxidized thioredoxin,,Oxidized thioredoxin,,,,C00343,2016-11-22T15:12:09Z,,1440,,,,,,trdox,,,http://vmh.uni.lu/_api/metabolites/1440/?format=pcsv
xu5p_D,,,-2,C5H9O8P,CHEBI:16332,,D-xylulose 5-phosphate(2-),,D-xylulose 5-phosphate(2-),,,"InChI=1S/C5H11O8P/c6-1-3(7)5(9)4(8)2-13-14(10,11)12/h4-6,8-9H,1-2H2,(H2,10,11,12)/p-2/t4-,5-/m1/s1",C00231,2016-11-22T15:12:09Z,,1441,,,,,439190,xu5p_D,,,http://vmh.uni.lu/_api/metabolites/1441/?format=pcsv
Rtotal2crn,,,0,CO2FULLR2C7H14NO2,,,R total 2 carnitine,,R total 2 carnitine,,,,,2016-11-22T15:12:09Z,,1442,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1442/?format=pcsv
Rtotal3crn,,,0,CO2FULLR3C7H14NO2,,,R total 3 carnitine,,R total 3 carnitine,,,,,2016-11-22T15:12:09Z,,1443,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1443/?format=pcsv
Rtotalcrn,,,0,CO2FULLRC7H14NO2,,,R total carnitine,,R total carnitine,,,,,2016-11-22T15:12:09Z,,1444,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1444/?format=pcsv
cs_d_pre5,,,-6,C45H65N2O48S4X,,,"chondroitin sulfate D (GlcNAc6S-GlcA2S), precursor 5",,"chondroitin sulfate D (GlcNAc6S-GlcA2S), precursor 5",,,,,2016-11-22T15:12:09Z,,1445,,,,,,cs_d_pre5,,,http://vmh.uni.lu/_api/metabolites/1445/?format=pcsv
cs_b_pre5,,,-5,C45H66N2O45S3X,,,"chondroitin sulfate B (IdoA2S-GalNAc4s), precursor 5",,"chondroitin sulfate B (IdoA2S-GalNAc4s), precursor 5",,,,,2016-11-22T15:12:09Z,,1446,,,,,,cs_b_pre5,,,http://vmh.uni.lu/_api/metabolites/1446/?format=pcsv
hs_pre12,,,-7,C79H119N5O83S6X,,,GlcN2S-IdoA-GlcN2S-GlcA2S-GlcN2S-IdoA2S-GlcN2S-GlcA-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,GlcN2S-IdoA-GlcN2S-GlcA2S-GlcN2S-IdoA2S-GlcN2S-GlcA-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein),,,,,2016-11-22T15:12:10Z,,1447,,,,,,hs_pre12,,,http://vmh.uni.lu/_api/metabolites/1447/?format=pcsv
hs_pre13,,,-10,C79H116N5O92S9X,,,"GlcN2S-IdoA-GlcN2,6diS-GlcA2S-GlcN2,6diS-IdoA2S-GlcN2,6diS-GlcA-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein)",,"GlcN2S-IdoA-GlcN2,6diS-GlcA2S-GlcN2,6diS-IdoA2S-GlcN2,6diS-GlcA-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein)",,,,,2016-11-22T15:12:10Z,,1448,,,,,,hs_pre13,,,http://vmh.uni.lu/_api/metabolites/1448/?format=pcsv
hs_pre14,,,-11,C79H115N5O95S10X,,,"heparan sulfate, precursor 14",,"heparan sulfate, precursor 14",,,,,2016-11-22T15:12:10Z,,1449,,,,,,hs_pre14,,,http://vmh.uni.lu/_api/metabolites/1449/?format=pcsv
hs_pre15,,,-12,C79H114N5O98S11X,,,"heparan sulfate, precursor 15",,"heparan sulfate, precursor 15",,,,,2016-11-22T15:12:10Z,,1450,,,,,,hs_pre15,,,http://vmh.uni.lu/_api/metabolites/1450/?format=pcsv
hs_deg11,,,-8,C55H81N3O67S7,,,"heparan sulfate, degradation product 11",,"heparan sulfate, degradation product 11",,,,,2016-11-22T15:12:10Z,,1451,,,,,,hs_deg11,,,http://vmh.uni.lu/_api/metabolites/1451/?format=pcsv
cs_e_pre5a,,,-7,C45H64N2O51S5X,,,"chondroitin sulfate E (GalNAc4,6diS-GlcA), precursor 5a",,"chondroitin sulfate E (GalNAc4,6diS-GlcA), precursor 5a",,,,,2016-11-22T15:12:10Z,,1452,,,,,,cs_e_pre5a,,,http://vmh.uni.lu/_api/metabolites/1452/?format=pcsv
cs_e_pre5b,,,-7,C45H64N2O51S5X,,,"chondroitin sulfate E (GalNAc4,6diS-GlcA), precursor 5b",,"chondroitin sulfate E (GalNAc4,6diS-GlcA), precursor 5b",,,,,2016-11-22T15:12:10Z,,1453,,,,,,cs_e_pre5b,,,http://vmh.uni.lu/_api/metabolites/1453/?format=pcsv
cs_e_deg1,,,-7,C45H65N2O52S5,,,"chondroitin sulfate E (GalNAc4,6diS-GlcA), degradation product 1",,"chondroitin sulfate E (GalNAc4,6diS-GlcA), degradation product 1",,,,,2016-11-22T15:12:10Z,,1454,,,,,,cs_e_deg1,,,http://vmh.uni.lu/_api/metabolites/1454/?format=pcsv
cs_e_deg5,,,-4,C31H47NO35S3,,,"chondroitin sulfate E (GalNAc4,6diS-GlcA), degradation product 5",,"chondroitin sulfate E (GalNAc4,6diS-GlcA), degradation product 5",,,,,2016-11-22T15:12:10Z,,1455,,,,,,cs_e_deg5,,,http://vmh.uni.lu/_api/metabolites/1455/?format=pcsv
ksi_deg4,,,-12,C222H355N15O197S12,,,"keratan sulfate I, degradation product 4",,"keratan sulfate I, degradation product 4",,,,,2016-11-22T15:12:10Z,,1456,,,,,,ksi_deg4,,,http://vmh.uni.lu/_api/metabolites/1456/?format=pcsv
ksii_core2_deg1,,,-3,C70H113N5O59S3X,,,"keratan sulfate II (core 2-linked), degradation product 1",,"keratan sulfate II (core 2-linked), degradation product 1",,,,,2016-11-22T15:12:10Z,,1457,,,,,,ksii_core2_deg1,,,http://vmh.uni.lu/_api/metabolites/1457/?format=pcsv
ksii_core4_deg1,,,-3,C78H126N6O64S3X,,,"keratan sulfate II (core 4-linked), degradation product 1",,"keratan sulfate II (core 4-linked), degradation product 1",,,,,2016-11-22T15:12:10Z,,1458,,,,,,ksii_core4_deg1,,,http://vmh.uni.lu/_api/metabolites/1458/?format=pcsv
saccrp_L,,,-1,C11H19N2O6,CHEBI:16927,,L-saccharopinate(1-),,L-saccharopinate(1-),,,"InChI=1S/C11H20N2O6/c12-7(10(16)17)3-1-2-6-13-8(11(18)19)4-5-9(14)15/h7-8,13H,1-6,12H2,(H,14,15)(H,16,17)(H,18,19)/p-1/t7-,8-/m0/s1",C00449,2016-11-22T15:12:10Z,,1459,,,,,160556,saccrp_L,,,http://vmh.uni.lu/_api/metabolites/1459/?format=pcsv
sbt_D,,,0,C6H14O6,CHEBI:17924,,"Human Metabolome Database (HMDB): Sorbitol is a polyhydric alcohol with about half the sweetness of sucrose. Sorbitol occurs naturally and is also produced synthetically from glucose. It was formerly used as a diuretic and may still be used as a laxative and in irrigating solutions for some surgical procedures. It is also used in many manufacturing processes, as a pharmaceutical aid, and in several research applications. Ascorbic acid fermentation; in solution form for moisture-conditioning of cosmetic creams and lotions, toothpaste, tobacco, gelatin; bodying agent for paper, textiles, and liquid pharmaceuticals; softener for candy; sugar crystallization inhibitor; surfactants; urethane resins and rigid foams; plasticizer, stabilizer for vinyl resins; food additive (sweetener, humectant, emulsifier, thickener, anticaking agent); dietary supplement. (Hawley's Condensed Chemical Dictionary) Biological Source: Occurs widely in plants ranging from algae to the higher orders. Fruits of the plant family Rosaceae, which include apples, pears, cherries, apricots, contain appreciable amounts. Rich sources are the fruits of the Sorbus and Crataegus species Use/Importance: Used for manufacturing of sorbose, propylene glycol, ascorbic acid, resins, plasticizers and as antifreeze mixtures with glycerol or glycol. Tablet diluent, sweetening agent and humectant, other food uses. Sorbitol is used in photometric determination of Ru(VI) and Ru(VIII); in acid-base titration of borate (Dictionary of Organic Compounds).",,D-glucitol,,HMDB00247,"InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4+,5-,6-/m1/s1",C00794,2016-12-05T15:48:06Z,,1460,,,,,5780,sbt_D,,"(-)-Sorbitol, D-Glucitol, D-Sorbitol, D-Sorbol, Diakarmon, Esasorb, Foodol D 70, Glucarine, Glucitol, Karion, Karion instant, Kyowa Powder 50M, L-Gulitol, Multitol, Neosorb, Neosorb 20/60DC, Neosorb 70/02, Neosorb 70/70, Neosorb P 20/60, Neosorb P 60, Neosorb P 60W, Nivitin, Resulax, Sionit, Sionit K, Sionite, Sionon, Siosan, Sorbex M, Sorbex R, Sorbex Rp, Sorbex S, Sorbex X, Sorbilande, Sorbilax, Sorbit, Sorbit D 70, Sorbit D-Powder, Sorbit DP, Sorbit DP 50, Sorbit Kyowa Powder 50M, Sorbit L 70, Sorbit S, Sorbit T 70, Sorbit W 70, Sorbit W-Powder, Sorbit W-Powder 50, Sorbit WP, Sorbite, Sorbitol F, Sorbitol FK, Sorbitol FP, Sorbitol S, Sorbitol syrup C, Sorbitur, Sorbo, Sorbogem 712, Sorbol, Sorbostyl",http://vmh.uni.lu/_api/metabolites/1460/?format=pcsv
selhcys,,,0,C4H9NO2Se,CHEBI:9068,,"Human Metabolome Database (HMDB): Selenohomocysteine is the precursor of selenocysteine, which is synthesized by catalysis of cystathionine beta-synthase (EC 4.2.1.22) and cystathionine gamma-lyase (EC 4.4.1.1), in mammalian systems (both enzymes require pyridoxal phosphate). Selenohomocysteine (lactone) has been found to be a competitive and irreversible inhibitor of lysyl oxidase; this may relate to the development of connective tissue defects seen in homocystinuria. L-Selenohomocysteine also can serve as a substituent donor in the beta-replacement reaction to yield selenocystathionine. (PMID: 10609891, 9405445, 6456763, 3338973).",,Selenohomocysteine,,HMDB04119,"InChI=1S/C4H9NO2Se/c1-8-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)",C05698,2016-12-05T15:48:06Z,,1461,,,,,440763,selhcys,,"2-Amino-4-selanyl-butanoate, 2-Amino-4-selanyl-butanoic acid, Se-selenocysteine",http://vmh.uni.lu/_api/metabolites/1461/?format=pcsv
dtt,,,0,C4H10O2S2,CHEBI:18320,,"1,4-dithiothreitol",,"1,4-dithiothreitol",,,"InChI=1S/C4H10O2S2/c5-3(1-7)4(6)2-8/h3-8H,1-2H2",C00265,2016-11-22T15:12:10Z,,1462,,,,,439196,dtt,,,http://vmh.uni.lu/_api/metabolites/1462/?format=pcsv
selcys,,,0,C3H7NO2Se,CHEBI:16633,,selenocysteine,,selenocysteine,,,"InChI=1S/C3H7NO2Se/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)",C05688,2016-11-22T15:12:10Z,,1463,,,,,25076,selcys,,,http://vmh.uni.lu/_api/metabolites/1463/?format=pcsv
dttOX,,,0,C4H8O2S2,CHEBI:16912,,"trans-1,2-dithiane-4,5-diol",,"trans-1,2-dithiane-4,5-diol",,,,C01119,2016-11-22T15:12:10Z,,1464,,,,,439407,dttOX,,,http://vmh.uni.lu/_api/metabolites/1464/?format=pcsv
seln,,,-1,HSe,CHEBI:16503,,Selenide,,Selenide,,,InChI=1S/Se/q-2,C01528,2016-11-22T15:12:10Z,,1465,,,,,533,seln,,,http://vmh.uni.lu/_api/metabolites/1465/?format=pcsv
selcyst,,,0,C7H14N2O4Se,CHEBI:27760,,Selenocystathionine,,Selenocystathionine,,,"InChI=1/C7H14N2O4Se/c8-4(6(10)11)1-2-14-3-5(9)7(12)13/h4-5H,1-3,8-9H2,(H,10,11)(H,12,13)",C05699,2016-11-22T15:12:10Z,,1466,,,,,98223,selcyst,,,http://vmh.uni.lu/_api/metabolites/1466/?format=pcsv
selmeth,,,0,C5H11NO2Se,CHEBI:30021,,"Human Metabolome Database (HMDB): Selenomethionine is an amino acid containing selenium that cannot be synthesized by higher animals, but can be obtained from plant material. Selenomethionine is the major seleno-compound in cereal grains (wheat grain, maize and rice), soybeans and enriched yeast. Seleno-compounds present in plants may have a profound effect upon the health of animals and human subjects. It is now known that the total Se content cannot be used as an indication of its efficacy, but knowledge of individual selenocompounds is necessary to fully assess the significance. Thus, speciation of the seleno-compounds has moved to the forefront. Since animals and man are dependent upon plants for their nutritional requirements, this makes the types of seleno-compounds in plants even more critical. Se enters the food chain through incorporation into plant proteins, mostly as selenocysteine and selenomethionine at normal Se levels. There are two possible pathways for the catabolism of selenomethionine. One is the transsulfuration pathway via selenocystathionine to produce selenocysteine, which in turn is degraded to H2Se by the enzyme b-lyase. The other pathway is the transamination-decarboxylation pathway. It was estimated that 90% of methionine is metabolized through this pathway and thus could be also the major route for selenomethionine catabolism. (PMID: 14748935, Br J Nutr. 2004 Jan;91(1):11-28.).",,selenomethionine,,HMDB03966,"InChI=1S/C5H11NO2Se/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)",C05335,2016-12-05T15:48:06Z,,1467,,,,,15103,selmeth,,"(+-)-Selenomethionine, (2S)-2-amino-4-(methylseleno)butanoate, (2S)-2-amino-4-(methylseleno)butanoic acid, (S)-2-amino-4-(methylseleno)-Butanoate, (S)-2-amino-4-(methylseleno)-Butanoic acid, (S)-2-Amino-4-(methylseleno)butanoate, (S)-2-Amino-4-(methylseleno)butanoic acid, (S)-2-Amino-4-(methylseleno)butyric acid, 2-Amino-4-(methylseleno)butanoate, 2-Amino-4-(methylseleno)butanoic acid, 2-Amino-4-(methylselenyl)butyrate, 2-Amino-4-(methylselenyl)butyric acid, DL-Selenomethionine, L(+)-Selenomethionine, L-2-Amino-4-(methylselenyl)-Butyric acid, L-Selenomethionine, L-Selenomethioninum, MSE, Selenium methionine, Selenium-L-methionine, Seleno-D,L-methionine, Seleno-DL-methionine, Seleno-L-methionine, Selenomethionine Se 75, SeMet, Sethotope",http://vmh.uni.lu/_api/metabolites/1467/?format=pcsv
selnp,,,-1,H2O3PSe,CHEBI:16144,,Selenophosphate,,Selenophosphate,,,"InChI=1S/H3O3PSe/c1-4(2,3)5/h(H3,1,2,3,5)/p-3",C05172,2016-11-22T15:12:10Z,,1468,,,,,1092,selnp,,,http://vmh.uni.lu/_api/metabolites/1468/?format=pcsv
hxdcal,,,0,C16H32O,CHEBI:17600,,hexadecanal,,hexadecanal,,,"InChI=1S/C16H32O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h16H,2-15H2,1H3",C00517,2016-11-22T15:12:10Z,,1469,,,,,984,hxdcal,,,http://vmh.uni.lu/_api/metabolites/1469/?format=pcsv
acngalgbside_hs,,,-1,C61H105N3O35FULLRCO,,,sialyl galactosylgloboside,,sialyl galactosylgloboside,,,,,2016-11-22T15:12:10Z,,1470,,,,,,acngalgbside_hs,,,http://vmh.uni.lu/_api/metabolites/1470/?format=pcsv
sphmyln_hs,,,0,C23H48N2O5PFULLRCO,,,sphingomyelin betaine,,sphingomyelin betaine,,,,,2016-11-22T15:12:10Z,,1471,,,,,,sphmyln_hs,,,http://vmh.uni.lu/_api/metabolites/1471/?format=pcsv
spmd,,,3,C7H22N3,CHEBI:16610,,"Human Metabolome Database (HMDB): Spermidine is a polyamine formed from putrescine. It is found in almost all tissues in association with nucleic acids. It is found as a cation at all pH values, and is thought to help stabilize some membranes and nucleic acid structures. It is a precursor of spermine.",,Spermidine,,HMDB01257,"InChI=1S/C7H19N3/c8-4-1-2-6-10-7-3-5-9/h10H,1-9H2/p+3",C00315,2016-12-05T15:48:06Z,,1472,,,,,1102,spmd,,"1,5,10-Triazadecane, 1,8-Diamino-4-azaoctane, 4-Azaoctamethylenediamine, 4-Azaoctane-1,8-diamine, Aminopropylbutandiamine, N-(3-Aminopropyl)-1,4-butane-diamine, N-(3-Aminopropyl)-1,4-butanediamine, N-(3-Aminopropyl)-1,4-diamino-butane, N-(3-Aminopropyl)-1,4-diaminobutane, N-(3-Aminopropyl)-4-aminobutylamine, N-(4-Aminobutyl)-1,3-diaminopropane, N-(gamma-Aminopropyl)tetramethylenediamine, SPD, Spermidin, Spermidine",http://vmh.uni.lu/_api/metabolites/1472/?format=pcsv
sql,,,0,C30H50,CHEBI:15440,,squalene,,squalene,,,"InChI=1S/C30H50/c1-25(2)15-11-19-29(7)23-13-21-27(5)17-9-10-18-28(6)22-14-24-30(8)20-12-16-26(3)4/h15-18,23-24H,9-14,19-22H2,1-8H3/b27-17+,28-18+,29-23+,30-24+",C00751,2016-11-22T15:12:10Z,,1473,,,,,11975273,sql,,,http://vmh.uni.lu/_api/metabolites/1473/?format=pcsv
f5hoxkyn,,,1,C10H13N2O3,,,Formyl-5-hydroxykynurenamine,,Formyl-5-hydroxykynurenamine,,,"InChI=1/C10H12N2O3/c11-4-3-10(15)8-5-7(14)1-2-9(8)12-6-13/h1-2,5-6,14H,3-4,11H2,(H,12,13)",C05647,2016-11-22T15:12:10Z,,1474,,,,,440743,f5hoxkyn,,,http://vmh.uni.lu/_api/metabolites/1474/?format=pcsv
nmthsrtn,,,1,C11H15N2O,CHEBI:48294,,N-Methylserotonin,,N-Methylserotonin,,,"InChI=1S/C11H14N2O/c1-12-5-4-8-7-13-11-3-2-9(14)6-10(8)11/h2-3,6-7,12-14H,4-5H2,1H3",C06212,2016-11-22T15:12:10Z,,1475,,,,,150885,nmthsrtn,,,http://vmh.uni.lu/_api/metabolites/1475/?format=pcsv
gm1b_hs,,,-1,C55H95N3O30FULLRCO,,,GM1b,,GM1b,,,,,2016-11-22T15:12:10Z,,1476,,,,,,gm1b_hs,,,http://vmh.uni.lu/_api/metabolites/1476/?format=pcsv
gd1a_hs,,,-2,C66H111N4O38FULLRCO,CHEBI:18163,,N-acetylneuraminosyl-D-galactosyl-N-acetyl-D-galactosaminyl-(N-acetylneuraminosyl)-D-galactosyl-D-glucosylceramide dianion,,N-acetylneuraminosyl-D-galactosyl-N-acetyl-D-galactosaminyl-(N-acetylneuraminosyl)-D-galactosyl-D-glucosylceramide dianion,,,,,2016-11-22T15:12:10Z,,1477,,,,,,gd1a_hs,,,http://vmh.uni.lu/_api/metabolites/1477/?format=pcsv
gt1b_hs,,,-3,C77H127N5O46FULLRCO,CHEBI:28058,,GT1b,,GT1b,,,,,2016-11-22T15:12:10Z,,1478,,,,,,gt1b_hs,,,http://vmh.uni.lu/_api/metabolites/1478/?format=pcsv
gt1alpha_hs,,,-3,C77H127N5O46FULLRCO,,,GT1aalpha,,GT1aalpha,,,,,2016-11-22T15:12:10Z,,1479,,,,,,gt1alpha_hs,,,http://vmh.uni.lu/_api/metabolites/1479/?format=pcsv
gq1c_hs,,,-4,C88H143N6O54FULLRCO,,,GQ1c,,GQ1c,,,,,2016-11-22T15:12:10Z,,1480,,,,,,gq1c_hs,,,http://vmh.uni.lu/_api/metabolites/1480/?format=pcsv
strdnccrn,,,0,C25H41NO4,,,stearidonyl carnitine,,stearidonyl carnitine,,,"InChI=1/C25H41NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(21-24(27)28)22-26(2,3)4/h6-7,9-10,13-14,17-18,23H,5,8,11-12,15-16,19-22H2,1-4H3/b7-6-,10-9-,14-13-,18-17-",,2016-11-22T15:12:10Z,,1481,,,,,53477835,strdnccrn,,,http://vmh.uni.lu/_api/metabolites/1481/?format=pcsv
t2m26dcoa,,,-4,C31H46N7O17P3S,,,"Human Metabolome Database (HMDB): trans-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA is an intermediate in Limonene and pinene degradation. trans-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA is the. 4th to last step in the synthesis of 3-Isopropylbut-3-enoic acid and is converted from trans-2-Methyl-5-isopropylhexa-2,5-dienoic acid via the enzyme (E6.2.1.-). It is then converted to 3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA via the enzyme paaG (E4.2.1.17).",,"trans-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA",,HMDB06530,"InChI=1/C31H50N7O17P3S/c1-17(2)18(3)7-8-19(4)30(43)59-12-11-33-21(39)9-10-34-28(42)25(41)31(5,6)14-52-58(49,50)55-57(47,48)51-13-20-24(54-56(44,45)46)23(40)29(53-20)38-16-37-22-26(32)35-15-36-27(22)38/h8,15-17,20,23-25,29,40-41H,3,7,9-14H2,1-2,4-6H3,(H,33,39)(H,34,42)(H,47,48)(H,49,50)(H2,32,35,36)(H2,44,45,46)/b19-8-/t20-,23-,24?,25+,29-/m1/s1",C11945,2016-12-05T15:48:06Z,,1482,,,,,53477851,,,,http://vmh.uni.lu/_api/metabolites/1482/?format=pcsv
34dhcinm,,,-1,C9H7O4,CHEBI:16433,,"Human Metabolome Database (HMDB): 3,4-Dihydroxy-trans-cinnamate is a polyphenol present in normal human urine positively correlated to coffee consumption and influenced by the dietary intake of diverse types of food. (PMID:16870009).",,trans-caffeate,,HMDB03501,"InChI=1S/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/p-1/b4-2+",C01197,2016-12-05T15:48:06Z,,1483,,,,,689043,,,"3,4-Dihydroxy-trans-cinnamic acid, trans-Caffeate",http://vmh.uni.lu/_api/metabolites/1483/?format=pcsv
s7p,,,-2,C7H13O10P,CHEBI:15721,,Sedoheptulose 7-phosphate,,Sedoheptulose 7-phosphate,,,"InChI=1S/C7H15O10P/c8-1-3(9)5(11)7(13)6(12)4(10)2-17-18(14,15)16/h4-8,10-13H,1-2H2,(H2,14,15,16)/p-2/t4-,5-,6-,7+/m1/s1",C05382,2016-11-22T15:12:10Z,,1484,,,,,22833559,s7p,,,http://vmh.uni.lu/_api/metabolites/1484/?format=pcsv
e4p,,,-2,C4H7O7P,CHEBI:48153,,D-Erythrose 4-phosphate,,D-Erythrose 4-phosphate,,,"InChI=1S/C4H9O7P/c5-1-3(6)4(7)2-11-12(8,9)10/h1,3-4,6-7H,2H2,(H2,8,9,10)/p-2/t3-,4+/m0/s1",C00279,2016-11-22T15:12:10Z,,1485,,,,,122357,e4p,,,http://vmh.uni.lu/_api/metabolites/1485/?format=pcsv
thmpp,,,-2,C12H16N4O7P2S,CHEBI:9532,,"Human Metabolome Database (HMDB): Thiamine pyrophosphate is the active form of thiamine, and it serves as a cofactor for several enzymes involved primarily in carbohydrate catabolism. The enzymes are important in the biosynthesis of a number of cell constituents, including neurotransmitters, and for the production of reducing equivalents used in oxidant stress defenses and in biosyntheses and for synthesis of pentoses used as nucleic acid precursors. The chemical structure of TPP is that of an aromatic methylaminopyrimidine ring, linked via a methylene bridge to a methylthiazolium ring with a pyrophosphate group attached to a hydroxyethyl side chain. In non-enzymatic model studies it has been demonstrated that the thiazolium ring can catalyse reactions which are similar to those of TPP-dependent enzymes but several orders of magnitude slower. Using infrared and NMR spectrophotometry it has been shown that the dissociation of the proton from C2 of the thiazolium ring is necessary for catalysis; the abstraction of the proton leads to the formation of a carbanion (ylid) with the potential for a nucleophilic attack on the carbonyl group of the substrate. In all TPP-dependent enzymes the abstraction of the proton from the C2 atom is the first step in catalysis, which is followed by a nucleophilic attack of this carbanion on the substrate. Subsequent cleavage of a C-C bond releases the first product with formation of a second carbanion (2-greek small letter alpha-carbanion or enamine). The formation of this 2-greek small letter alpha-carbanion is the second feature of TPP catalysis common to all TPP-dependent enzymes. Depending on the enzyme and the substrate(s), the reaction intermediates and products differ. Methyl-branched fatty acids, as phytanic acid, undergo peroxisomal beta-oxidation in which they are shortened by 1 carbon atom. This process includes four steps: activation, 2-hydroxylation, thiamine pyrophosphate dependent cleavage and aldehyde dehydrogenation. In the third step, 2-hydroxy-3-methylacyl-CoA is cleaved in the peroxisomal matrix by 2-hydroxyphytanoyl-CoA lyase (2-HPCL), which uses thiamine pyrophosphate (TPP) as cofactor. The thiamine pyrophosphate dependence of the third step is unique in peroxisomal mammalian enzymology. Human pathology due to a deficient alpha-oxidation is mostly linked to mutations in the gene coding for the second enzyme of the sequence, phytanoyl-CoA hydroxylase (EC 1.14.11.18). (PMID: 12694175, 11899071, 9924800).",,Thiamine diphosphate,,HMDB01372,"InChI=1S/C12H18N4O7P2S/c1-8-11(3-4-22-25(20,21)23-24(17,18)19)26-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7H,3-4,6H2,1-2H3,(H4-,13,14,15,17,18,19,20,21)",C00068,2016-12-05T15:48:06Z,,1486,,,,thiamine(1+) diphosphate,1132,thmpp,,"Thaimine pyrophosphate, Thiamin diphosphate, Thiamin pyrophosphate, Thiamin-PPi, Thiamine diphosphate, Thiamine pyrophosphate, Thiamine-PPi, Thiamine-pyrophosphate, ThPP, TPP",http://vmh.uni.lu/_api/metabolites/1486/?format=pcsv
dtdp4d6dg,,,-2,C16H22N2O15P2,CHEBI:57649,,"Human Metabolome Database (HMDB): 4,6-Dideoxy-4-oxo-dTDP-D-glucose is a product of the enzyme TDP-glucose 4,6-dehydratase [EC:4.2.1.46] in the Nucleotide sugars metabolism (KEGG).",,dTDP-4-dehydro-6-deoxy-alpha-D-glucose(2-),,HMDB01399,"InChI=1S/C16H24N2O15P2/c1-6-4-18(16(24)17-14(6)23)10-3-8(19)9(31-10)5-29-34(25,26)33-35(27,28)32-15-13(22)12(21)11(20)7(2)30-15/h4,7-10,12-13,15,19,21-22H,3,5H2,1-2H3,(H,25,26)(H,27,28)(H,17,23,24)/p-2/t7-,8+,9-,10-,12+,13-,15-/m1/s1",C11907,2016-12-05T15:48:06Z,,1487,,,,,439292,dtdp4d6dg,,"4,6-Dideoxy-4-oxo-dTDP-D-glucose, dTDP-4-Dehydro-6-deoxy-D-glucose, dTDP-4-Dehydro-6-deoxy-L-mannose, dTDP-4-Dehydro-L-rhamnose, dTDP-4-Oxo-6-deoxy-D-glucose, dTDP-4-Oxo-6-deoxy-L-mannose, dTDP-4-Oxo-L-rhamnose, TDP-4-Keto-6-deoxy-D-glucose, TDP-4-Oxo-6-deoxy-D-glucose",http://vmh.uni.lu/_api/metabolites/1487/?format=pcsv
dtdp4d6dm,,,-2,C16H22N2O15P2,CHEBI:15744,,dTDP-4-dehydro-6-deoxy-L-mannose(2-),,dTDP-4-dehydro-6-deoxy-L-mannose(2-),,,"InChI=1S/C16H24N2O15P2/c1-6-4-18(16(24)17-14(6)23)10-3-8(19)9(31-10)5-29-34(25,26)33-35(27,28)32-15-13(22)12(21)11(20)7(2)30-15/h4,7-10,12-13,15,19,21-22H,3,5H2,1-2H3,(H,25,26)(H,27,28)(H,17,23,24)/p-2/t7-,8-,9+,10+,12+,13+,15?/m0/s1",C11907,2016-11-22T15:12:10Z,,1488,,,,,439293,dtdp4d6dm,,,http://vmh.uni.lu/_api/metabolites/1488/?format=pcsv
dtdprmn,,,-2,C16H24N2O15P2,CHEBI:15774,,"Human Metabolome Database (HMDB): Deoxythymidine diphosphate (dTDP)-l-rhamnose is the precursor of l-rhamnose, a saccharide required for the virulence of some pathogenic bacteria. In gram negative bacteria such as Salmonella enterica, Vibrio cholerae or Escherichia coli 075:K5, l-rhamnose is an important residue in the O-antigen of lipopolysaccharides, which are essential for resistance to serum killing and for colonization. In gram positive bacteria, such as streptococci, the capsule is a recognized virulence factor, for example, l-rhamnose is known to be present in the capsule of Streptococcus suis, a causative agent of meningitis in humans. In Streptococcus mutans, l-rhamnose containing polysaccharides have been implicated in tooth surface colonization and adherence to kidney, muscle and heart tissues. In mycobacteria, l-rhamnose is fundamental to the structural integrity of the cell wall since it connects the inner peptidoglycan layer to the arabinogalactan polysaccharides. dTDP-l-rhamnose is synthesized from glucose-1-phosphate and deoxythymidine triphosphate (dTTP) via a pathway involving four distinct enzymes. Whereas common sugars such as glucose, fructose and mannose are all D-configured, bacteria commonly utilize the L-configured carbohydrates in pharmacologically active compounds and in their cell-wall structures. The bacterial cell wall is unique to bacteria; neither the cell wall nor the enzymes and chemical intermediates in its formation have analogues in humans. The enzymes involved in dTDP-l-rhamnose synthesis are potential targets for the design of new therapeutic agents. (PMID: 10802738, 12773151).",,dTDP-L-rhamnose,,HMDB06354,"InChI=1S/C16H26N2O15P2/c1-6-4-18(16(24)17-14(6)23)10-3-8(19)9(31-10)5-29-34(25,26)33-35(27,28)32-15-13(22)12(21)11(20)7(2)30-15/h4,7-13,15,19-22H,3,5H2,1-2H3,(H,25,26)(H,27,28)(H,17,23,24)/t7-,8-,9+,10+,11-,12+,13+,15?/m0/s1",C03319,2016-12-05T15:48:06Z,,1489,,,,,439975,dtdprmn,,"dTDP-6-Deoxy-L-mannose, dTDP-L-Rhamnose, Thymidine diphosphate rhamnose, Thymidine diphosphate-L-rhamnose",http://vmh.uni.lu/_api/metabolites/1489/?format=pcsv
tetpent3crn,,,0,C31H51NO4,,,tetracosapentaenoyl carnitine,,tetracosapentaenoyl carnitine,,,,,2016-11-22T15:12:10Z,,1490,,,,,,tetpent3crn,,,http://vmh.uni.lu/_api/metabolites/1490/?format=pcsv
tetpent6crn,,,0,C31H51NO4,,,tetracosapentaenoyl carnitine,,tetracosapentaenoyl carnitine,,,,,2016-11-22T15:12:10Z,,1491,,,,,,tetpent6crn,,,http://vmh.uni.lu/_api/metabolites/1491/?format=pcsv
tettet6crn,,,0,C31H53NO4,,,Tetracosatetraenoyl carnitine,,Tetracosatetraenoyl carnitine,,,"InChI=1/C31H53NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-31(35)36-29(27-30(33)34)28-32(2,3)4/h9-10,12-13,15-16,18-19,29H,5-8,11,14,17,20-28H2,1-4H3/t29-/m0/s1",,2016-11-22T15:12:10Z,,1492,,,,,,tettet6crn,,,http://vmh.uni.lu/_api/metabolites/1492/?format=pcsv
phom,,,-2,C4H8NO6P,CHEBI:15961,,O-phosphonato-L-homoserine(2-),,O-phosphonato-L-homoserine(2-),,,"InChI=1S/C4H10NO6P/c5-3(4(6)7)1-2-11-12(8,9)10/h3H,1-2,5H2,(H,6,7)(H2,8,9,10)/p-2/t3-/m0/s1",C01102,2016-11-22T15:12:10Z,,1493,,,,,151187,phom,,,http://vmh.uni.lu/_api/metabolites/1493/?format=pcsv
tmndnccrn,,,0,C27H43NO4,,,Timnodonyl carnitine,,Timnodonyl carnitine,,,,,2016-11-22T15:12:10Z,,1494,,,,,,tmndnccrn,,,http://vmh.uni.lu/_api/metabolites/1494/?format=pcsv
ts3,,,0,C27H44O,,,"Human Metabolome Database (HMDB): Tachysterol 3 is a normal human secosterooid metabolite from the class of vitamin D3 photoisomer derivatives. It is synthesized from 7-Dehydrocholesterol in the epidermis in response to ultraviolet irradiation. When human skin is exposed to ultraviolet radiation, epidermal 7-dehydrocholesterol is converted to previtamin D, and during prolonged exposure, the synthesis of previtamin D3 reaches a plateau at about 10 to 15 percent of the original 7-dehydrocholesterol content, and previtamin D3 is photoisomerized to two biologically inert isomers and tachysterol 3 is one of them (the other one being lumisterol 3). Therefore, tachysterol is a metabolite to chronic exposure to sunlight. Tachysterol 3, as well as other photoisomers of vitamin D3 and previtamin D3 has been demonstrated to have inhibited keratinocyte proliferation. Thus, sunlight provides vitamin D3 photoproducts that may act directly to regulate epidermal proliferation and differentiation under physiologic conditions. (PMID 6256855, 10876100).",,Tachysterol 3,,HMDB06560,"InChI=1/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h10,12-13,19,21,24-26,28H,6-9,11,14-18H2,1-5H3/b13-12+/t21-,24+,25-,26+,27-/m1/s1",C07711,2016-12-05T15:48:06Z,,1495,,,,,5281058,ts3,,"(3b,6E)-9,10-Secocholesta-5(10),6,8-trien-3-ol, (6E)-(3S)-9,10-seco-5(10),6,8-cholestatrien-3-ol, Tachysterol_3",http://vmh.uni.lu/_api/metabolites/1495/?format=pcsv
ttdcrn,,,0,C21H41NO4,,,tetradecanoyl carnitine,,tetradecanoyl carnitine,,,"InChI=1/C21H41NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-21(25)26-19(17-20(23)24)18-22(2,3)4/h19H,5-18H2,1-4H3/t19-/m1/s1",,2016-11-22T15:12:10Z,,1496,,,,,53477791,ttdcrn,,,http://vmh.uni.lu/_api/metabolites/1496/?format=pcsv
tym,,,1,C8H12NO,CHEBI:15760,,"Human Metabolome Database (HMDB): Tyramine is a monoamine compound derived from the amino acid tyrosine. Tyramine is metabolized by the enzyme monoamine oxidase. In foods, it is often produced by the decarboxylation of tyrosine during fermentation or decay. Foods containing considerable amounts of tyramine include fish, chocolate, alcoholic beverages, cheese, soy sauce, sauerkraut, and processed meat. A large dietary intake of tyramine can cause an increase in systolic blood pressure of 30 mmHg or more. Tyramine acts as a neurotransmitter via a G protein-coupled receptor with high affinity for tyramine called TA1. The TA1 receptor is found in the brain as well as peripheral tissues including the kidney. An indirect sympathomimetic, Tyramine can also serve as a substrate for adrenergic uptake systems and monoamine oxidase so it prolongs the actions of adrenergic transmitters. It also provokes transmitter release from adrenergic terminals.",,tyraminium,,HMDB00306,"InChI=1S/C8H11NO/c9-6-5-7-1-3-8(10)4-2-7/h1-4,10H,5-6,9H2/p+1",C00483,2016-12-05T15:48:06Z,,1497,,,,,5610,tym,,"2-(4'-Hydroxyphenyl)ethylamine, 2-(4-Hydroxyphenyl)ethylamine, 2-(p-Hydroxyphenyl)ethylamine, 4- (2-Aminoethyl)-Phenol, 4-(2-Aminoethyl)-Phenol, 4-(2-Aminoethyl)-phenol(thyramin), 4-(2-Aminoethyl)phenol, 4-Hydroxy-b-phenylethylamine, 4-Hydroxy-Benzeneethanamine, 4-Hydroxy-beta-phenylethylamine, 4-Hydroxyphenethylamine, 4-Hydroxyphenylethylamine, a-(4-Hydroxyphenyl)-b-aminoethane, alpha-(4-Hydroxyphenyl)-beta-aminoethane, alpha.-(4-Hydroxyphenyl)-beta-aminoethane, b-(4-Hydroxyphenyl)ethylamine, beta-(4-Hydroxyphenyl)ethylamine, p-(2-Aminoethyl)-Phenol, p-(2-Aminoethyl)phenol, P-beta-Aminoethylphenol, P-Hydroxy-b-phenethylamine, P-Hydroxy-b-phenylethylamine, P-Hydroxy-beta-phenethylamine, P-Hydroxy-beta-phenylethylamine, P-Hydroxyphenethylamine, P-Hydroxyphenylethylamine, P-Tyramine, Systogene, Tenosin-wirkstoff, Tocosine, Tyramin, Tyramine base, Tyrosamine, Uteramine",http://vmh.uni.lu/_api/metabolites/1497/?format=pcsv
udpxyl,,,-2,C14H20N2O16P2,CHEBI:16082,,UDP-alpha-D-xylose(2-),,UDP-alpha-D-xylose(2-),,,"InChI=1S/C14H22N2O16P2/c17-5-3-28-13(11(22)8(5)19)31-34(26,27)32-33(24,25)29-4-6-9(20)10(21)12(30-6)16-2-1-7(18)15-14(16)23/h1-2,5-6,8-13,17,19-22H,3-4H2,(H,24,25)(H,26,27)(H,15,18,23)/p-2/t5-,6-,8+,9-,10-,11-,12-,13-/m1/s1",C00190,2016-11-22T15:12:10Z,,1498,,,,,439179,udpxyl,,,http://vmh.uni.lu/_api/metabolites/1498/?format=pcsv
ahandrostan,,,0,C19H30O2,CHEBI:28195,,"Human Metabolome Database (HMDB): Etiocholanolone is the 5-beta-reduced isomer of androsterone. Etiocholanolone is a major metabolite of testosterone and androstenedione in many mammalian species including humans. It is excreted in the urine and is androgenically inactive. Classified a ketosteroid, it causes fever (it is a pyrogen), immunostimulation and leukocytosis. The pyrogenic effect of Etiocholanolone has been shown to be due to the release of interleukin-1 (IL-1) from the leukocytes that are mobilized in response to its production or injection. Etiocholanolone has anticonvulsant activity and may be an endogenous modulator of seizure susceptibility. Significantly increased values of etiocholanolone (along with testoterone and androsterone) an be detected in the urine of men with androgenic alopecia (male pattern baldness).",,3alpha-hydroxy-5beta-androstan-17-one,,HMDB00490,"InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12-,13-,14+,15+,16+,18+,19+/m1/s1",C04373,2016-12-05T15:48:06Z,,1499,,,,,5880,,,"3a-Etiocholanolone, 3a-Hydroxy-5b-androstane-17-one, 3alpha-Hydroxy-5beta-androstan-17-one, 3alpha-Hydroxyetiocholan-17-one, 5 beta Androsterone, 5-Isoandrosterone, 5b-Androstan-3a-ol-17-one, 5b-Androstane-3a-ol-17-one, 5b-Androsterone, a-Etiocholanolone, Aetiocholanolone, alpha-Etiocholanolone",http://vmh.uni.lu/_api/metabolites/1499/?format=pcsv
uppg3,,,-8,C40H36N4O16,CHEBI:15437,,"Human Metabolome Database (HMDB): Uroporphyrinogens are porphyrinogen variants in which each pyrrole ring has one acetate side chain and one propionate side chain; it is formed by condensation 4 four molecules of porphobilinogen. 4 isomers are possible but only 2 commoly are found, types I and III. Uroporphyrinogen III is a functional intermediate in heme biosynthesis while Uroporphyrinogen I is produced in an abortive side reaction.",,Uroporphyrinogen III,,HMDB01086,"InChI=1S/C40H44N4O16/c45-33(46)5-1-17-21(9-37(53)54)29-14-27-19(3-7-35(49)50)22(10-38(55)56)30(43-27)15-28-20(4-8-36(51)52)24(12-40(59)60)32(44-28)16-31-23(11-39(57)58)18(2-6-34(47)48)26(42-31)13-25(17)41-29/h41-44H,1-16H2,(H,45,46)(H,47,48)(H,49,50)(H,51,52)(H,53,54)(H,55,56)(H,57,58)(H,59,60)/p-8",C01051,2016-12-05T15:48:06Z,,1500,,,,,1179,uppg3,,"3,8,13,17-Tetrakis(carboxymethyl)-5,10,15,20,22,24-hexahydro-2,7,12,18-Porphinetetrapropionate, 3,8,13,17-Tetrakis(carboxymethyl)-5,10,15,20,22,24-hexahydro-2,7,12,18-Porphinetetrapropionic acid, 3,8,13,17-Tetrakis(carboxymethyl)-5,10,15,20,22,24-hexahydro-21H,23H-Porphine-2,7,12,18-tetrapropanoate, 3,8,13,17-Tetrakis(carboxymethyl)-5,10,15,20,22,24-hexahydro-21H,23H-Porphine-2,7,12,18-tetrapropanoic acid, 3,8,13,17-Tetrakis(carboxymethyl)-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrapropanoate, 3,8,13,17-Tetrakis(carboxymethyl)-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrapropanoic acid, Urogen III, Uroporphyrinogen III, Uroporphyrinogen-III",http://vmh.uni.lu/_api/metabolites/1500/?format=pcsv
vacccrn,,,0,C25H47NO4,,,Vaccenyl carnitine,,Vaccenyl carnitine,,,"InChI=1/C25H47NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(26(2,3)4)21-22-24(27)28/h10-11,23H,5-9,12-22H2,1-4H3/b11-10+/t23-/m0/s1",,2016-11-22T15:12:45Z,,1501,,,,,53477830,vacccrn,,,http://vmh.uni.lu/_api/metabolites/1501/?format=pcsv
HC00229,,,0,C12H22O11,CHEBI:28189,,Isomaltose,,Isomaltose,,,"InChI=1S/C12H22O11/c13-1-4(15)7(17)8(18)5(16)3-22-12-11(21)10(20)9(19)6(2-14)23-12/h1,4-12,14-21H,2-3H2/t4-,5+,6+,7+,8+,9+,10-,11+,12-/m0/s1",C00252,2016-11-22T15:12:10Z,,1502,,,,,5460022,HC00229,,,http://vmh.uni.lu/_api/metabolites/1502/?format=pcsv
HC00250,,,-1,HS,CHEBI:16136,,hydrosulfide,,hydrosulfide,,,InChI=1S/H2S/h1H2/p-1,C00283,2016-11-22T15:12:10Z,,1503,,,,,402,HC00250,,,http://vmh.uni.lu/_api/metabolites/1503/?format=pcsv
HC01104,,,-2,C6H4NO6P,CHEBI:17440,,4-nitrophenyl phosphate(2-),,4-nitrophenyl phosphate(2-),,,"InChI=1S/C6H6NO6P/c8-7(9)5-1-3-6(4-2-5)13-14(10,11)12/h1-4H,(H2,10,11,12)/p-2",C03360,2016-11-22T15:12:10Z,,1504,,,,,378,HC01104,,,http://vmh.uni.lu/_api/metabolites/1504/?format=pcsv
HC01361,,,0,C9H13N5O4,CHEBI:17001,,Dihydroneopterin,,Dihydroneopterin,,,"InChI=1S/C9H13N5O4/c10-9-13-7-5(8(18)14-9)12-3(1-11-7)6(17)4(16)2-15/h4,6,15-17H,1-2H2,(H4,10,11,13,14,18)/t4-,6+/m1/s1",C04874,2016-11-22T15:12:10Z,,1505,,,,,65074,,,,http://vmh.uni.lu/_api/metabolites/1505/?format=pcsv
HC01440,,,0,C6H10O6,CHEBI:27453,,3-Keto-beta-D-galactose,,3-Keto-beta-D-galactose,,,"InChI=1S/C6H10O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-3,5-8,10-11H,1H2/t2-,3+,5-,6-/m1/s1",C05394,2016-11-22T15:12:10Z,,1506,,,,,440653,,,,http://vmh.uni.lu/_api/metabolites/1506/?format=pcsv
HC01441,,,0,,,,Lactose-6P,,Lactose-6P,,,,,2016-11-22T15:12:11Z,,1507,,,,,,HC01441,,,http://vmh.uni.lu/_api/metabolites/1507/?format=pcsv
HC01444,,,0,C9H18O8,CHEBI:15754,,Galactosylglycerol,,Galactosylglycerol,,,"InChI=1S/C9H18O8/c10-1-4(12)3-16-9-8(15)7(14)6(13)5(2-11)17-9/h4-15H,1-3H2/t4-,5-,6+,7+,8-,9-/m1/s1",C05401,2016-11-22T15:12:11Z,,1508,,,,,16048618,HC01444,,,http://vmh.uni.lu/_api/metabolites/1508/?format=pcsv
HC01446,,,0,,,,3-Ketolactose,,3-Ketolactose,,,,,2016-11-22T15:12:11Z,,1509,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1509/?format=pcsv
HC01577,,,0,C9H12N3O5,,,Human Metabolome Database (HMDB): This compound belongs to the family of N-acyl-Alpha Amino Acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). ,,gamma-Glutamyl-beta-cyanoalanine,,HMDB60478,,,2016-12-05T15:48:06Z,,1510,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1510/?format=pcsv
HC01609,,,-8,C40H36N4O16,CHEBI:28766,,UroporphyrinogenI,,UroporphyrinogenI,,,"InChI=1S/C40H44N4O16/c45-33(46)5-1-17-21(9-37(53)54)29-14-26-19(3-7-35(49)50)23(11-39(57)58)31(43-26)16-28-20(4-8-36(51)52)24(12-40(59)60)32(44-28)15-27-18(2-6-34(47)48)22(10-38(55)56)30(42-27)13-25(17)41-29/h41-44H,1-16H2,(H,45,46)(H,47,48)(H,49,50)(H,51,52)(H,53,54)(H,55,56)(H,57,58)(H,59,60)/p-8",C05766,2016-11-22T15:12:11Z,,1511,,,,,440775,,,,http://vmh.uni.lu/_api/metabolites/1511/?format=pcsv
HC01610,,,-4,C36H40N4O8,440776,,Human Metabolome Database (HMDB): Formed by Uroporphyrinogen decarboxylase from Uroporphyrinogen I by decarboxylation of 4 acetates.,,CoproporphyrinogenI,,HMDB02158,"InChI=1S/C36H44N4O8/c1-17-21(5-9-33(41)42)29-14-26-19(3)23(7-11-35(45)46)31(39-26)16-28-20(4)24(8-12-36(47)48)32(40-28)15-27-18(2)22(6-10-34(43)44)30(38-27)13-25(17)37-29/h37-40H,5-16H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)/p-4",C05768,2016-12-05T15:48:06Z,,1512,,,,,440776,,,"3,8,13,18-Tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,17-tetrapropanoate, 3,8,13,18-Tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,17-tetrapropanoic acid",http://vmh.uni.lu/_api/metabolites/1512/?format=pcsv
HC01700,,,0,C8H13N3O3,,,gamma-Glutamyl-3-aminopropiononitrile,,gamma-Glutamyl-3-aminopropiononitrile,,,,,2016-11-22T15:12:11Z,,1513,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1513/?format=pcsv
HC02160,,,0,,CHEBI:51013,,"Human Metabolome Database (HMDB): Ganglioside GM2 (d18:1/12:0) is a glycosphingolipid (ceramide and oligosaccharide)or oligoglycosylceramide with one or more sialic acids (i.e. n-acetylneuraminic acid) linked on the sugar chain. It is a component the cell plasma membrane which modulates cell signal transduction events. Gangliosides have been found to be highly important in immunology. Ganglioside GM2 carries a net-negative charge at pH 7.0 and is acidic. Gangliosides can amount to 6% of the weight of lipids from brain, but they are found at low levels in all animal tissues. G(M2) Ganglioside accumulates due to a deficiency of hexosaminidase A or B (beta-N-acetylhexosaminidase), or GM2 activator protein, resulting in Gangliosidoses. Gangliosidoses include heredity metabolic disorders that include Tay-Sachs disease and Sandhoff disease. Gangliosides GM2 is especially common in the nervous tissue of the brain. In the United States, about 1 in 27 to 1 in 30 Ashkenazi Jews is a recessive carrier. French Canadians and the Cajun community of Louisiana have an occurrence similar to the Ashkenazi Jews.Gangliosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Gangliosides are very similar to globosides except that they also contain N-acetyl neuraminic acid (NANA) in varying amounts. The specific names for the gangliosides provide information about their structure. The letter G refers to ganglioside, and the subscripts M, D, T and Q indicate that the molecule contains mono-, di-, tri and quatra-sialic acid. The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide. In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands for GalGlc-ceramide. Deficiencies in lysosomal enzymes that degrade the carbohydrate portions of various gangliosides are responsible for a number of lysosomal storage diseases such as Tay-Sachs disease, Sandhoff disease, and GM1 gangliosidosis. The carbohydrate portion of the ganglioside GM1 is the site of attachment of cholera toxin, the protein secreted by Vibrio cholerae.",,GM2-pool,,HMDB04936,,,2016-12-05T15:48:06Z,,1514,,,,,,,,"GalNAc-beta1->4(Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer, Ganglioside GM2, II3NeuAcGgOse3Cer, N-Acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine, N-Acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide, N-Acetyl-delta-galactosaminyl-(N-acetylneuraminyl)-delta-galactosyl-1,4-beta-delta-glucosyl-N-acylsphingosine, N-Acetyl-delta-galactosaminyl-(N-acetylneuraminyl)-delta-galactosyl-delta-glucosylceramide, N-Acetyl-Ganglioside GM2, N-Acetylganglioside GM2, NeuAc-GM2, Tay-Sachs ganglioside",http://vmh.uni.lu/_api/metabolites/1514/?format=pcsv
HC02161,,,0,,CHEBI:18216,,GM1-pool,,GM1-pool,,HMDB00117,,,2016-11-22T15:12:11Z,,1515,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1515/?format=pcsv
HC02119,,,0,,,,Adenosylmethioninamine-potential,,Adenosylmethioninamine-potential,,,,,2016-11-22T15:12:11Z,,1516,,,,,,HC02119,,,http://vmh.uni.lu/_api/metabolites/1516/?format=pcsv
HC00822,,,0,C16H28N2O11,,,Chitobiose,,Chitobiose,,,"InChI=1S/C16H28N2O11/c1-5(21)17-9-13(25)14(8(4-20)27-15(9)26)29-16-10(18-6(2)22)12(24)11(23)7(3-19)28-16/h7-16,19-20,23-26H,3-4H2,1-2H3,(H,17,21)(H,18,22)/t7-,8-,9-,10-,11-,12-,13-,14-,15?,16+/m1/s1",C01674,2016-11-22T15:12:11Z,,1517,,,,,439544,HC00822,,,http://vmh.uni.lu/_api/metabolites/1517/?format=pcsv
HC00617,,,0,,CHEBI:18097,,Ferricytochrome b5,,Ferricytochrome b5,,,,,2016-11-22T15:12:11Z,,1518,,,,,,HC00617,,,http://vmh.uni.lu/_api/metabolites/1518/?format=pcsv
HC00619,,,0,,,,Ferrocytochrome b5,,Ferrocytochrome b5,,,,C00999,2016-11-22T15:12:11Z,,1519,,,,,,HC00619,,,http://vmh.uni.lu/_api/metabolites/1519/?format=pcsv
HC01672,,,-1,C12H15N5O8P,CHEBI:37666,,Acetyl adenylate,,Acetyl adenylate,,,"InChI=1S/C12H16N5O8P/c1-5(18)25-26(21,22)23-2-6-8(19)9(20)12(24-6)17-4-16-7-10(13)14-3-15-11(7)17/h3-4,6,8-9,12,19-20H,2H2,1H3,(H,21,22)(H2,13,14,15)/t6-,8-,9-,12-/m1/s1",C05993,2016-11-22T15:12:11Z,,1520,,,,,440867,HC01672,,,http://vmh.uni.lu/_api/metabolites/1520/?format=pcsv
HC01434,,,-3,C6H3O7,CHEBI:7815,,oxalatosuccinate(3-),,oxalatosuccinate(3-),,,"InChI=1S/C6H6O7/c7-3(8)1-2(5(10)11)4(9)6(12)13/h2H,1H2,(H,7,8)(H,10,11)(H,12,13)/p-3",C05379,2016-11-22T15:12:11Z,,1521,,,,,972,HC01434,,,http://vmh.uni.lu/_api/metabolites/1521/?format=pcsv
HC00591,,,-1,C5H6NO4,CHEBI:30882,,2-oxoglutaramate,,2-oxoglutaramate,,,"InChI=1S/C5H7NO4/c6-4(8)2-1-3(7)5(9)10/h1-2H2,(H2,6,8)(H,9,10)/p-1",C00940,2016-11-22T15:12:11Z,,1522,,,,,48,HC00591,,,http://vmh.uni.lu/_api/metabolites/1522/?format=pcsv
HC01651,,,0,C10H14N5O15P3,,,Formamidopyrimidine nucleoside triphosphate,,Formamidopyrimidine nucleoside triphosphate,,,,,2016-11-22T15:12:11Z,,1523,,,,,,HC01651,,,http://vmh.uni.lu/_api/metabolites/1523/?format=pcsv
HC01435,,,-3,C16H21N4O10P2S,CHEBI:1463,,3-Carboxy-1-hydroxypropyl-ThPP,,3-Carboxy-1-hydroxypropyl-ThPP,,,"InChI=1S/C16H24N4O10P2S/c1-9-13(5-6-29-32(27,28)30-31(24,25)26)33-16(12(21)3-4-14(22)23)20(9)8-11-7-18-10(2)19-15(11)17/h7,12,21H,3-6,8H2,1-2H3,(H5-,17,18,19,22,23,24,25,26,27,28)/p+1",C05381,2016-11-22T15:12:11Z,,1524,,,,,440649,HC01435,,,http://vmh.uni.lu/_api/metabolites/1524/?format=pcsv
HC01118,,,-3,C30H49O7P2,CHEBI:15442,,presqualene diphosphate(3-),,presqualene diphosphate(3-),,,"InChI=1S/C30H52O7P2/c1-23(2)13-9-15-25(5)17-11-18-27(7)21-28-29(22-36-39(34,35)37-38(31,32)33)30(28,8)20-12-19-26(6)16-10-14-24(3)4/h13-14,17,19,21,28-29H,9-12,15-16,18,20,22H2,1-8H3,(H,34,35)(H2,31,32,33)/p-3/b25-17+,26-19+,27-21+/t28-,29-,30-/m0/s1",,2016-11-22T15:12:11Z,,1525,,,,,,HC01118,,,http://vmh.uni.lu/_api/metabolites/1525/?format=pcsv
HC01496,,,-1,C6H8NO5,,,2-Amino-3-oxoadipate,,2-Amino-3-oxoadipate,,,"InChI=1S/C6H9NO5/c7-5(6(11)12)3(8)1-2-4(9)10/h5H,1-2,7H2,(H,9,10)(H,11,12)",C05520,2016-11-22T15:12:11Z,,1526,,,,,440714,HC01496,,,http://vmh.uni.lu/_api/metabolites/1526/?format=pcsv
HC01668,,,0,C13H18N5O8P,,,Propinol adenylate,,Propinol adenylate,,,,,2016-11-22T15:12:11Z,,1527,,,,,,HC01668,,,http://vmh.uni.lu/_api/metabolites/1527/?format=pcsv
HC01111,,,-2,C6H11O9P,439995,,Human Metabolome Database (HMDB): Galactose 1-phosphate is an intermediate in the Galactose metabolism. and Nucleotide sugars metabolism pathways (KEGG). Galactose-1-phosphate is an intermediate in the intraconversion of glucose and galactose. It is formed from galactose by galactokinase. (Wikipeida).,,Galactose-1P,,HMDB00645,"InChI=1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/t2-,3+,4+,5-,6?/m1/s1",C00446,2016-12-05T15:48:06Z,,1528,,,,,439995,,,"1-(Dihydrogen phosphate) Galactitol, 1-Phosphate a-D-Galactopyranose, a-D-1-(Dihydrogen phosphate) Galactopyranose, a-D-Galactopyranosyl phosphate, a-D-Galactose 1-phosphate, a-D-Galactosyl phosphate, alpha-D-1-(Dihydrogen phosphate) Galactopyranose, alpha-D-Galactopyranosyl phosphate, alpha-D-Galactose 1-phosphate, alpha-D-Galactosyl phosphate, D-Galactose 1-phosphate, Galactopyranose 1-phosphate, Galactose 1-phosphate",http://vmh.uni.lu/_api/metabolites/1528/?format=pcsv
HC01162,,,-2,C20H29N4O17P,CHEBI:18098,,"(2R,4S,5R,6R)-2-[({[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphinato)oxy]-4-hydroxy-5-(2-hydroxyacetamido)-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate",,"(2R,4S,5R,6R)-2-[({[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphinato)oxy]-4-hydroxy-5-(2-hydroxyacetamido)-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate",,,"InChI=1S/C20H31N4O17P/c21-10-1-2-24(19(35)22-10)17-15(32)14(31)9(39-17)6-38-42(36,37)41-20(18(33)34)3-7(27)12(23-11(29)5-26)16(40-20)13(30)8(28)4-25/h1-2,7-9,12-17,25-28,30-32H,3-6H2,(H,23,29)(H,33,34)(H,36,37)(H2,21,22,35)/p-2/t7-,8+,9+,12+,13+,14+,15+,16+,17+,20+/m0/s1",C03691,2016-11-22T15:12:11Z,,1529,,,,,656501,HC01162,,,http://vmh.uni.lu/_api/metabolites/1529/?format=pcsv
HC01408,,,-4,C27H40N7O18P3S,CHEBI:27648,,3-Oxohexanoyl-CoA,,3-Oxohexanoyl-CoA,,,"InChI=1S/C27H44N7O18P3S/c1-4-5-15(35)10-18(37)56-9-8-29-17(36)6-7-30-25(40)22(39)27(2,3)12-49-55(46,47)52-54(44,45)48-11-16-21(51-53(41,42)43)20(38)26(50-16)34-14-33-19-23(28)31-13-32-24(19)34/h13-14,16,20-22,26,38-39H,4-12H2,1-3H3,(H,29,36)(H,30,40)(H,44,45)(H,46,47)(H2,28,31,32)(H2,41,42,43)/p-4/t16-,20-,21-,22+,26-/m1/s1",C05269,2016-11-22T15:12:11Z,,1530,,,,3-oxohexanoyl-CoA,3082152,HC01408,,,http://vmh.uni.lu/_api/metabolites/1530/?format=pcsv
HC00342,,,-3,C6H3O6,CHEBI:32805,,cis-aconitate(3-),,cis-aconitate(3-),,,"InChI=1S/C6H6O6/c7-4(8)1-3(6(11)12)2-5(9)10/h1H,2H2,(H,7,8)(H,9,10)(H,11,12)/p-3/b3-1-",,2016-11-22T15:12:11Z,,1531,,,,,309,HC00342,,,http://vmh.uni.lu/_api/metabolites/1531/?format=pcsv
HC01161,,,0,,,,Apo-ACP,,Apo-ACP,,,,,2016-11-22T15:12:11Z,,1532,,,,,,HC01161,,,http://vmh.uni.lu/_api/metabolites/1532/?format=pcsv
HC00682,,,0,C10H19NO2S2,CHEBI:16807,,S-Acetyldihydrolipoamide,,S-Acetyldihydrolipoamide,,,"InChI=1S/C10H19NO2S2/c1-8(12)15-9(6-7-14)4-2-3-5-10(11)13/h9,14H,2-7H2,1H3,(H2,11,13)",C01136,2016-11-22T15:12:11Z,,1533,,,,,1076,HC00682,,,http://vmh.uni.lu/_api/metabolites/1533/?format=pcsv
HC00695,,,-1,C12H20NO4S2,CHEBI:17432,,S-Succinyldihydrolipoamide,,S-Succinyldihydrolipoamide,,,"InChI=1S/C12H21NO4S2/c13-10(14)4-2-1-3-9(18)7-8-19-12(17)6-5-11(15)16/h9,18H,1-8H2,(H2,13,14)(H,15,16)",C01169,2016-11-22T15:12:11Z,,1534,,,,,11953795,HC00695,,,http://vmh.uni.lu/_api/metabolites/1534/?format=pcsv
2mpdhl,,,0,C12H23NO2S2,CHEBI:17577,,S-(2-Methylpropanoyl)-dihydrolipoamide,,S-(2-Methylpropanoyl)-dihydrolipoamide,,,"InChI=1S/C12H23NO2S2/c1-9(2)12(15)17-8-7-10(16)5-3-4-6-11(13)14/h9-10,16H,3-8H2,1-2H3,(H2,13,14)",C04424,2016-11-22T15:12:11Z,,1535,,,,,11953835,2mpdhl,,,http://vmh.uni.lu/_api/metabolites/1535/?format=pcsv
HC01377,,,0,C13H25NO2S2,CHEBI:27462,,S-(3-Methylbutanoyl)-dihydrolipoamide,,S-(3-Methylbutanoyl)-dihydrolipoamide,,,"InChI=1S/C13H25NO2S2/c1-10(2)9-13(16)18-8-7-11(17)5-3-4-6-12(14)15/h10-11,17H,3-9H2,1-2H3,(H2,14,15)",C05119,2016-11-22T15:12:11Z,,1536,,,,,440566,HC01377,,,http://vmh.uni.lu/_api/metabolites/1536/?format=pcsv
HC01115,,,-1,C11H18NO10,CHEBI:29025,,NeuNGc,,NeuNGc,,,"InChI=1S/C11H19NO10/c13-2-5(16)8(18)9-7(12-6(17)3-14)4(15)1-11(21,22-9)10(19)20/h4-5,7-9,13-16,18,21H,1-3H2,(H,12,17)(H,19,20)/p-1/t4-,5+,7+,8+,9+,11?/m0/s1",C03410,2016-11-22T15:12:11Z,,1537,,,,,440001,HC01115,,,http://vmh.uni.lu/_api/metabolites/1537/?format=pcsv
HC01254,,,0,C9H13N5O3,CHEBI:17248,,"6-Lactoyl-5,6,7,8-tetrahydropterin",,"6-Lactoyl-5,6,7,8-tetrahydropterin",,,"InChI=1S/C9H13N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,12,15H,2H2,1H3,(H4,10,11,13,14,17)",C04244,2016-11-22T15:12:11Z,,1538,,,,,169508,HC01254,,,http://vmh.uni.lu/_api/metabolites/1538/?format=pcsv
HC00361,,,-4,C7H12O13P2,CHEBI:17969,,"sedoheptulose 1,7-bisphosphate(4-)",,"sedoheptulose 1,7-bisphosphate(4-)",,,"InChI=1S/C7H16O13P2/c8-3(1-19-21(13,14)15)5(10)7(12)6(11)4(9)2-20-22(16,17)18/h3,5-8,10-12H,1-2H2,(H2,13,14,15)(H2,16,17,18)/p-4/t3-,5-,6-,7-/m1/s1",C00447,2016-11-22T15:12:11Z,,1539,,,,,164735,HC00361,,,http://vmh.uni.lu/_api/metabolites/1539/?format=pcsv
HC10859,,,0,,,,"Human Metabolome Database (HMDB): Malonylcarnitine is a metabolite that accumulates with specific disruption of fatty-acid oxidation caused by impaired entry of long-chain acylcarnitine esters into the mitochondria and failure of the mitochondrial respiratory chain at complex 11 and malonyl-CoA decarboxylase (EC 4.1.1.9) deficiency (OMIM 248360). Malonylcarnitine has also been found to accumulate in some newborns with medium-chain acyl-CoA dehydrogenase (EC 1.3.99.3) deficiency (OMIM 201450). (PMID 11558490, 15303003, 12651823).",,Malonyl-Carnitin,,HMDB02095,,,2016-12-05T15:48:06Z,,1540,,,,,,HC10859,,"2-[(2-Carboxyacetyl)oxy]-4-hydroxy-N,N,N-trimethyl-4-oxo-1-Butanaminium  inner salt, 3-Carboxy-2-[(carboxyacetyl)oxy]-N,N,N-trimethyl-1-Propanaminium  inner salt, Malonyl-L-carnitine",http://vmh.uni.lu/_api/metabolites/1540/?format=pcsv
HC10855,,,0,,,,linoleic-Carnitine,,linoleic-Carnitine,,,,,2016-11-16T10:44:55Z,,1541,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1541/?format=pcsv
HC10852,,,-4,C37H60N7O17P3S,,,palmitoleyl-CoA(4-),,palmitoleyl-CoA(4-),,,"InChI=1S/C37H64N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-28(46)65-21-20-39-27(45)18-19-40-35(49)32(48)37(2,3)23-58-64(55,56)61-63(53,54)57-22-26-31(60-62(50,51)52)30(47)36(59-26)44-25-43-29-33(38)41-24-42-34(29)44/h9-10,24-26,30-32,36,47-48H,4-8,11-23H2,1-3H3,(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,38,41,42)(H2,50,51,52)/p-4/b10-9-/t26-,30-,31-,32+,36-/m1/s1",,2016-11-16T10:44:55Z,,1542,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1542/?format=pcsv
HC10854,,,0,,,,palmitoleoyl-Carnitine,,palmitoleoyl-Carnitine,,,,,2016-11-16T10:44:55Z,,1543,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1543/?format=pcsv
HC01712,,,-1,C13H22NO4S2,CHEBI:28391,,S-Glutaryldihydrolipoamide,,S-Glutaryldihydrolipoamide,,,"InChI=1S/C13H23NO4S2/c14-11(15)5-2-1-4-10(19)8-9-20-13(18)7-3-6-12(16)17/h10,19H,1-9H2,(H2,14,15)(H,16,17)",C06157,2016-11-22T15:12:11Z,,1544,,,,,11953879,HC01712,,,http://vmh.uni.lu/_api/metabolites/1544/?format=pcsv
HC00576,,,0,,,,Homocarnosine,,Homocarnosine,,,,,2016-11-22T15:12:11Z,,1545,,,,,,HC00576,,,http://vmh.uni.lu/_api/metabolites/1545/?format=pcsv
HC00718,,,-1,C3H9NO4P,CHEBI:16463,,N-methylethanolaminium phosphate(1-),,N-methylethanolaminium phosphate(1-),,,"InChI=1S/C3H10NO4P/c1-4-2-3-8-9(5,6)7/h4H,2-3H2,1H3,(H2,5,6,7)/p-1",C01210,2016-11-22T15:12:11Z,,1546,,,,,439436,HC00718,,,http://vmh.uni.lu/_api/metabolites/1546/?format=pcsv
HC01522,,,0,C7H6O3,,,Gentisate aldehyde,,Gentisate aldehyde,,,"InChI=1S/C7H6O3/c8-4-5-3-6(9)1-2-7(5)10/h1-4,9-10H",C05585,2016-11-22T15:12:11Z,,1547,,,,,70949,,,,http://vmh.uni.lu/_api/metabolites/1547/?format=pcsv
HC00460,,,-1,C7H5O4,CHEBI:17189,,"Human Metabolome Database (HMDB): Gentisic acid is a dihydroxybenzoic acid. It is a crystalline powder that forms monoclinic prism in water solution. Gentisic acid is an active metabolite of salicylic acid degradation. There is an increasing amount of evidence indicating that gentisic acid has a broad spectrum of biological activity, such as anti-inflammatory, antirheumatic and antioxidant properties. Gentisic acid is also a byproduct of tyrosine and benzoate metabolism.",,"2,5-dihydroxybenzoate",,HMDB00152,"InChI=1S/C7H6O4/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,8-9H,(H,10,11)/p-1",C00628,2016-12-05T15:48:06Z,,1548,,,,,3469,,,"2,5-Dihydroxybenzoate, 2,5-Dihydroxybenzoic acid, 2,5-Dioxybenzoate, 2,5-Dioxybenzoic acid, 3,6-Dihydroxybenzoate, 3,6-Dihydroxybenzoic acid, 5-Hydroxy-Salicylate, 5-Hydroxy-Salicylic acid, 5-Hydroxysalicylate, 5-Hydroxysalicylic acid, Carboxyhydroquinone, Dihydroxybenzoicacid, Gensigen, Gensigon, Gentisate, Gentisic acid, Gentisinate, Gentisinic acid, Hydroquinonecarboxylate, Hydroquinonecarboxylic acid",http://vmh.uni.lu/_api/metabolites/1548/?format=pcsv
HC00900,,,-2,C4H4O4,CHEBI:30860,,Human Metabolome Database (HMDB): Methylmalonic acid is a malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA.,,Methylmalonate,,HMDB00202,"InChI=1S/C4H6O4/c1-2(3(5)6)4(7)8/h2H,1H3,(H,5,6)(H,7,8)",C02170,2016-12-05T15:48:06Z,,1549,,,,,487,HC00900,,"1,1-Ethanedicarboxylate, 1,1-Ethanedicarboxylic acid, 2-Methylmalonate, 2-Methylmalonic acid, Isosuccinate, Isosuccinic acid, Methyl-Malonate, Methyl-Malonic acid, Methyl-Propanedioate, Methyl-Propanedioic acid, Methylmalonate, Methylmalonic acid, Methylpropanedioate, Methylpropanedioic acid",http://vmh.uni.lu/_api/metabolites/1549/?format=pcsv
HC01231,,,-1,C12H21N2O6S,,,N-[(R)-pantothenoyl]-L-cysteinate,,N-[(R)-pantothenoyl]-L-cysteinate,,,"InChI=1S/C12H22N2O6S/c1-12(2,6-15)9(17)10(18)13-4-3-8(16)14-7(5-21)11(19)20/h7,9,15,17,21H,3-6H2,1-2H3,(H,13,18)(H,14,16)(H,19,20)/p-1/t7-,9-/m0/s1",C04079,2016-11-22T15:12:11Z,,1550,,,,,440217,HC01231,,,http://vmh.uni.lu/_api/metabolites/1550/?format=pcsv
HC01501,,,-1,HO3S2,CHEBI:16094,,hydroxidodioxidosulfidosulfate(1-),,hydroxidodioxidosulfidosulfate(1-),,,"InChI=1S/H2O3S2/c1-5(2,3)4/h(H2,1,2,3,4)/p-1",C05529,2016-11-22T15:12:11Z,,1551,,,,,24478,HC01501,,,http://vmh.uni.lu/_api/metabolites/1551/?format=pcsv
HC00832,,,0,C6H12O5,CHEBI:17617,,L-Fuculose,,L-Fuculose,,,"InChI=1S/C6H12O5/c1-3(8)5(10)6(11)4(9)2-7/h3,5-8,10-11H,2H2,1H3/t3-,5+,6-/m0/s1",C01721,2016-11-22T15:12:11Z,,1552,,,,,6857362,HC00832,,,http://vmh.uni.lu/_api/metabolites/1552/?format=pcsv
HC01376,,,0,C13H25NO2S2,CHEBI:28692,,S-(2-Methylbutanoyl)-dihydrolipoamide,,S-(2-Methylbutanoyl)-dihydrolipoamide,,,"InChI=1S/C13H25NO2S2/c1-3-10(2)13(16)18-9-8-11(17)6-4-5-7-12(14)15/h10-11,17H,3-9H2,1-2H3,(H2,14,15)",C05118,2016-11-22T15:12:11Z,,1553,,,,,440565,HC01376,,,http://vmh.uni.lu/_api/metabolites/1553/?format=pcsv
HC00664,,,-2,C6H11O9P,CHEBI:4251,,D-tagatofuranose 6-phosphate(2-),,D-tagatofuranose 6-phosphate(2-),,,"InChI=1S/C6H13O9P/c7-2-6(10)5(9)4(8)3(15-6)1-14-16(11,12)13/h3-5,7-10H,1-2H2,(H2,11,12,13)/p-2/t3-,4+,5+,6?/m1/s1",C01097,2016-11-22T15:12:11Z,,1554,,,,,439396,,,,http://vmh.uni.lu/_api/metabolites/1554/?format=pcsv
HC01180,,,-4,C6H10O12P2,CHEBI:4250,,"D-tagatofuranose 1,6-bisphosphate(4-)",,"D-tagatofuranose 1,6-bisphosphate(4-)",,,"InChI=1S/C6H14O12P2/c7-4-3(1-16-19(10,11)12)18-6(9,5(4)8)2-17-20(13,14)15/h3-5,7-9H,1-2H2,(H2,10,11,12)(H2,13,14,15)/p-4/t3-,4+,5+,6?/m1/s1",C03785,2016-11-22T15:12:11Z,,1555,,,,,440117,,,,http://vmh.uni.lu/_api/metabolites/1555/?format=pcsv
HC01415,,,-4,C29H44N7O17P3S,CHEBI:27537,,(2E)-Octenoyl-CoA,,(2E)-Octenoyl-CoA,,,"InChI=1S/C29H48N7O17P3S/c1-4-5-6-7-8-9-20(38)57-13-12-31-19(37)10-11-32-27(41)24(40)29(2,3)15-50-56(47,48)53-55(45,46)49-14-18-23(52-54(42,43)44)22(39)28(51-18)36-17-35-21-25(30)33-16-34-26(21)36/h8-9,16-18,22-24,28,39-40H,4-7,10-15H2,1-3H3,(H,31,37)(H,32,41)(H,45,46)(H,47,48)(H2,30,33,34)(H2,42,43,44)/p-4/b9-8+/t18-,22-,23-,24+,28-/m1/s1",C05276,2016-11-22T15:12:11Z,,1556,,,,trans-oct-2-enoyl-CoA,46173358,HC01415,,,http://vmh.uni.lu/_api/metabolites/1556/?format=pcsv
HC01007,,,0,C15H29NO4,439824,,"Human Metabolome Database (HMDB): L-Octanoylcarnitine is the physiologically active form of octanoylcarnitine. (PMID 11274033). Octanoylcarnitine is detected in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. MCAD is characterized by intolerance to prolonged fasting, recurrent episodes of hypoglycemic coma with medium-chain dicarboxylic aciduria, impaired ketogenesis, and low plasma and tissue carnitine levels. (OMIM 201450).",,L-Octanoylcarnitine,,HMDB00791,"InChI=1S/C15H29NO4/c1-5-6-7-8-9-10-15(19)20-13(11-14(17)18)12-16(2,3)4/h13H,5-12H2,1-4H3/t13-/m0/s1",C02838,2016-12-05T15:48:06Z,,1557,,,,,439824,,,"(-)-Octanoylcarnitine, L-Carnitine octanoyl ester, L-O-Octanoylcarnitine, L-Octanoylcarnitine, Octanoate, Octanoic acid, Octanoic acid ester with L-(3-carboxy-2-hydroxypropyl)trimethylammonium hydroxide inner salt, Octanoyl-L-carnitine, Octanoylcarnitine",http://vmh.uni.lu/_api/metabolites/1557/?format=pcsv
C02470,,,-1,C10H6NO4,,,Human Metabolome Database (HMDB): Xanthurenic acid is a metabolite from tryptophan catabolism. It is a substrate of the enzyme methyltransferases [EC 2.1.1.-] in pathway tryptophan metabolism (KEGG).,,Xanthurenic acid,,HMDB00881,"InChI=1/C10H7NO4/c12-7-3-1-2-5-8(13)4-6(10(14)15)11-9(5)7/h1-4,12H,(H,11,13)(H,14,15)",C02470,2016-12-05T15:48:06Z,,1558,,,,,5699,C02470,,"4,8-Dihydroxy-2-quinolinecarboxylate, 4,8-Dihydroxy-2-quinolinecarboxylic acid, 4,8-Dihydroxy-Quinaldate, 4,8-Dihydroxy-Quinaldic acid, 4,8-Dihydroxyquinaldate, 4,8-Dihydroxyquinaldic acid, 4,8-Dihydroxyquinaldinate, 4,8-Dihydroxyquinaldinic acid, 4,8-Dihydroxyquinoline-2-carboxylate, 4,8-Dihydroxyquinoline-2-carboxylic acid, 4-Oxoxanthurenic acid, 8-Hydroxykynurenate, 8-Hydroxykynurenic acid, Oxoxanthurenate, Xanthurate, Xanthurenate, Xanthuric acid",http://vmh.uni.lu/_api/metabolites/1558/?format=pcsv
HC00955,,,0,C4H6N2O2,CHEBI:16934,,L-3-Cyanoalanine,,L-3-Cyanoalanine,,,"InChI=1S/C4H6N2O2/c5-2-1-3(6)4(7)8/h3H,1,6H2,(H,7,8)/t3-/m0/s1",C02512,2016-11-22T15:12:11Z,,1559,,,,,439742,,,,http://vmh.uni.lu/_api/metabolites/1559/?format=pcsv
C02528,,,-1,C24H39O4,CHEBI:16755,,"Human Metabolome Database (HMDB): Chenodeoxycholic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135). Usually conjugated with either glycine or taurine. It acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. It is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones.",,chenodeoxycholate,,HMDB00518,"InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/p-1/t14-,15+,16-,17-,18+,19+,20-,22+,23+,24-/m1/s1",C02528,2016-12-05T15:48:06Z,,1560,,,,,10133,C02528,,"(+)-chenodeoxycholate, (+)-chenodeoxycholic acid, (3a,5b,7a)-3,7-dihydroxy-cholan-24-oate, (3a,5b,7a)-3,7-dihydroxy-cholan-24-oic acid, 3a,7a-Dihydroxy-5b,14a,17b-cholanate, 3a,7a-Dihydroxy-5b,14a,17b-cholanic acid, 3a,7a-Dihydroxy-5b-cholan-24-oate, 3a,7a-Dihydroxy-5b-cholan-24-oic acid, 3a,7a-Dihydroxy-5b-cholanate, 3a,7a-Dihydroxy-5b-cholanic acid, 7a-Hydroxy-desoxycholsaeure, Chenodeoxycholate, Chenodesoxycholsaeure",http://vmh.uni.lu/_api/metabolites/1560/?format=pcsv
HC01412,,,-4,C35H56N7O17P3S,CHEBI:27721,,trans-tetradec-2-enoyl-CoA(4-),,trans-tetradec-2-enoyl-CoA(4-),,,"InChI=1S/C35H60N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-26(44)63-19-18-37-25(43)16-17-38-33(47)30(46)35(2,3)21-56-62(53,54)59-61(51,52)55-20-24-29(58-60(48,49)50)28(45)34(57-24)42-23-41-27-31(36)39-22-40-32(27)42/h14-15,22-24,28-30,34,45-46H,4-13,16-21H2,1-3H3,(H,37,43)(H,38,47)(H,51,52)(H,53,54)(H2,36,39,40)(H2,48,49,50)/p-4/b15-14+/t24-,28-,29-,30+,34-/m1/s1",,2016-11-22T15:12:11Z,,1561,,,,trans-tetradec-2-enoyl-CoA,,HC01412,,,http://vmh.uni.lu/_api/metabolites/1561/?format=pcsv
HC01401,,,-4,C33H54N7O18P3S,11966173,,Human Metabolome Database (HMDB): (S)-3-Hydroxydodecanoyl-CoA is a human metabolite involved in the fatty acid elongation in mitochondria pathway. The enzyme long-chain-3-hydroxyacyl-CoA dehydrogenase catalyzes the conversion of 3-Oxododecanoyl-CoA to (S)-3-Hydroxydodecanoyl-CoA.,,(S)-3-Hydroxydodecanoyl-CoA,,HMDB03936,"InChI=1S/C33H58N7O18P3S/c1-4-5-6-7-8-9-10-11-21(41)16-24(43)62-15-14-35-23(42)12-13-36-31(46)28(45)33(2,3)18-55-61(52,53)58-60(50,51)54-17-22-27(57-59(47,48)49)26(44)32(56-22)40-20-39-25-29(34)37-19-38-30(25)40/h19-22,26-28,32,41,44-45H,4-18H2,1-3H3,(H,35,42)(H,36,46)(H,50,51)(H,52,53)(H2,34,37,38)(H2,47,48,49)/p-4/t21-,22+,26+,27+,28-,32+/m0/s1",C05262,2016-12-05T15:48:06Z,,1562,,,,,11966173,,,"(S)-3-hydroxydodecanoyl-coenzyme A, (S)-3-hydroxylauroyl-CoA, (S)-3-hydroxylauroyl-coenzyme A",http://vmh.uni.lu/_api/metabolites/1562/?format=pcsv
HC01223,,,-4,C25H38N7O18P3S,CHEBI:15481,,3-hydroxy-2-methylpropanoyl-CoA(4-),,3-hydroxy-2-methylpropanoyl-CoA(4-),,,"InChI=1S/C25H42N7O18P3S/c1-13(8-33)24(38)54-7-6-27-15(34)4-5-28-22(37)19(36)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-18(49-51(39,40)41)17(35)23(48-14)32-12-31-16-20(26)29-11-30-21(16)32/h11-14,17-19,23,33,35-36H,4-10H2,1-3H3,(H,27,34)(H,28,37)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/p-4/t13?,14-,17-,18-,19+,23-/m1/s1",,2016-11-22T15:12:11Z,,1563,,,,,45259165,HC01223,,,http://vmh.uni.lu/_api/metabolites/1563/?format=pcsv
HC01587,,,0,,,,Acetoacetyl-ACP,,Acetoacetyl-ACP,,,,C05744,2016-11-22T15:12:11Z,,1564,,,,,,HC01587,,,http://vmh.uni.lu/_api/metabolites/1564/?format=pcsv
HC01321,,,0,,,,(R)-3-Hydroxybutanoyl-ACP,,(R)-3-Hydroxybutanoyl-ACP,,,,C04618,2016-11-22T15:12:11Z,,1565,,,,,,HC01321,,,http://vmh.uni.lu/_api/metabolites/1565/?format=pcsv
HC01255,,,0,,,,But-2-enoyl-ACP,,But-2-enoyl-ACP,,,,C04246,2016-11-22T15:12:11Z,,1566,,,,,,HC01255,,,http://vmh.uni.lu/_api/metabolites/1566/?format=pcsv
HC01588,,,0,,,,Butyryl-ACP,,Butyryl-ACP,,,,C05745,2016-11-22T15:12:11Z,,1567,,,,,,HC01588,,,http://vmh.uni.lu/_api/metabolites/1567/?format=pcsv
HC01322,,,0,,,,(R)-3-Hydroxydecanoyl-ACP,,(R)-3-Hydroxydecanoyl-ACP,,,,C04619,2016-11-22T15:12:11Z,,1568,,,,,,HC01322,,,http://vmh.uni.lu/_api/metabolites/1568/?format=pcsv
HC01596,,,0,,,,3-Oxodecanoyl-ACP,,3-Oxodecanoyl-ACP,,,,C05753,2016-11-22T15:12:11Z,,1569,,,,,,HC01596,,,http://vmh.uni.lu/_api/metabolites/1569/?format=pcsv
HC01597,,,0,,,,(2E)-Decenoyl-ACP,,(2E)-Decenoyl-ACP,,,,C05754,2016-11-22T15:12:11Z,,1570,,,,,,HC01597,,,http://vmh.uni.lu/_api/metabolites/1570/?format=pcsv
HC01323,,,0,,,,(R)-3-Hydroxyoctanoyl-ACP,,(R)-3-Hydroxyoctanoyl-ACP,,,,C04620,2016-11-22T15:12:11Z,,1571,,,,,,HC01323,,,http://vmh.uni.lu/_api/metabolites/1571/?format=pcsv
HC01593,,,0,,,,3-Oxooctanoyl-ACP,,3-Oxooctanoyl-ACP,,,,C05750,2016-11-22T15:12:11Z,,1572,,,,,,HC01593,,,http://vmh.uni.lu/_api/metabolites/1572/?format=pcsv
HC01594,,,0,,,,(2E)-Octenoyl-ACP,,(2E)-Octenoyl-ACP,,,,C05751,2016-11-22T15:12:11Z,,1573,,,,,,HC01594,,,http://vmh.uni.lu/_api/metabolites/1573/?format=pcsv
HC01326,,,0,,,,(R)-3-Hydroxypalmitoyl-ACP,,(R)-3-Hydroxypalmitoyl-ACP,,,,C04633,2016-11-22T15:12:12Z,,1574,,,,,,HC01326,,,http://vmh.uni.lu/_api/metabolites/1574/?format=pcsv
HC01605,,,0,,,,3-Oxohexadecanoyl-ACP,,3-Oxohexadecanoyl-ACP,,,,C05762,2016-11-22T15:12:12Z,,1575,,,,,,HC01605,,,http://vmh.uni.lu/_api/metabolites/1575/?format=pcsv
HC01606,,,0,,,,(2E)-Hexadecenoyl-ACP,,(2E)-Hexadecenoyl-ACP,,,,C05763,2016-11-22T15:12:12Z,,1576,,,,,,HC01606,,,http://vmh.uni.lu/_api/metabolites/1576/?format=pcsv
HC01602,,,0,,,,3-Oxotetradecanoyl-ACP,,3-Oxotetradecanoyl-ACP,,,,C05759,2016-11-22T15:12:12Z,,1577,,,,,,HC01602,,,http://vmh.uni.lu/_api/metabolites/1577/?format=pcsv
HC01603,,,0,,,,(2E)-Tetradecenoyl-ACP,,(2E)-Tetradecenoyl-ACP,,,,C05760,2016-11-22T15:12:12Z,,1578,,,,,,HC01603,,,http://vmh.uni.lu/_api/metabolites/1578/?format=pcsv
HC01710,,,0,C9H14N5O14P3,,,"2,5-Diamino-6-(5-triphosphoryl-3,4-trihydroxy-2-oxopentyl)- amino-4-oxopyrimidine",,"2,5-Diamino-6-(5-triphosphoryl-3,4-trihydroxy-2-oxopentyl)- amino-4-oxopyrimidine",,,,,2016-11-22T15:12:12Z,,1579,,,,,,HC01710,,,http://vmh.uni.lu/_api/metabolites/1579/?format=pcsv
HC01601,,,0,,,,(2E)-Dodecenoyl-ACP,,(2E)-Dodecenoyl-ACP,,,,C05758,2016-11-22T15:12:12Z,,1580,,,,,,HC01601,,,http://vmh.uni.lu/_api/metabolites/1580/?format=pcsv
HC01397,,,-4,C37H62N7O18P3S,CHEBI:27402,,(S)-3-Hydroxyhexadecanoyl-CoA,,(S)-3-Hydroxyhexadecanoyl-CoA,,,"InChI=1S/C37H66N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-25(45)20-28(47)66-19-18-39-27(46)16-17-40-35(50)32(49)37(2,3)22-59-65(56,57)62-64(54,55)58-21-26-31(61-63(51,52)53)30(48)36(60-26)44-24-43-29-33(38)41-23-42-34(29)44/h23-26,30-32,36,45,48-49H,4-22H2,1-3H3,(H,39,46)(H,40,50)(H,54,55)(H,56,57)(H2,38,41,42)(H2,51,52,53)/p-4/t25-,26+,30+,31+,32-,36+/m0/s1",C05258,2016-11-22T15:12:12Z,,1581,,,,(S)-3-hydroxypalmitoyl-CoA,11966179,HC01397,,,http://vmh.uni.lu/_api/metabolites/1581/?format=pcsv
HC01399,,,-4,C35H58N7O18P3S,11966177,,Human Metabolome Database (HMDB): (S)-3-Hydroxytetradecanoyl-CoA is an intermediate in Fatty acid elongation in mitochondria. (S)-3-Hydroxytetradecanoyl-CoA is the 7th to last step in the synthesis of Hexadecanoic acid and is converted from 3-Oxotetradecanoyl-CoA via the enzyme long-chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211). It is then converted to trans-Tetradec-2-enoyl-CoA via the enzyme enoyl-CoA hydratase (EC 4.2.1.17).,,(S)-3-Hydroxytetradecanoyl-CoA,,HMDB03934,"InChI=1S/C35H62N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-23(43)18-26(45)64-17-16-37-25(44)14-15-38-33(48)30(47)35(2,3)20-57-63(54,55)60-62(52,53)56-19-24-29(59-61(49,50)51)28(46)34(58-24)42-22-41-27-31(36)39-21-40-32(27)42/h21-24,28-30,34,43,46-47H,4-20H2,1-3H3,(H,37,44)(H,38,48)(H,52,53)(H,54,55)(H2,36,39,40)(H2,49,50,51)/p-4/t23-,24+,28+,29+,30-,34+/m0/s1",C05260,2016-12-05T15:48:06Z,,1582,,,,,11966177,,,"(S)-3-Hydroxytetradecanoyl-CoA., (S)-3-Hydroxytetradecanoyl-Coenzyme A.",http://vmh.uni.lu/_api/metabolites/1582/?format=pcsv
HC01403,,,-4,C31H50N7O18P3S,16061159,,"Human Metabolome Database (HMDB): (S)-Hydroxydecanoyl-CoA has a role in the synthesis and oxidation of fatty acids. It is involved in fatty acid elongation in mitochondria. In this pathway 3-Oxodecanoyl-CoA is acted upon by two enzymes, 3-hydroxyacyl-CoA dehydrogenase and long-chain-3-hydroxyacyl-CoA dehydrogenase to produce (S)-Hydroxydecanoyl-CoA. Since coenzyme A is chemically a thiol, it can react with carboxylic acids to form thioesters, thus functioning as an acyl group carrier. It assists in transferring fatty acids from the cytoplasm to mitochondria. A molecule of coenzyme A carrying an acetyl group is also referred to as acetyl-CoA. When it is not attached to an acyl group it is usually referred to as CoASH or HSCoA.",,(S)-Hydroxydecanoyl-CoA,,HMDB03938,"InChI=1S/C31H54N7O18P3S/c1-4-5-6-7-8-9-19(39)14-22(41)60-13-12-33-21(40)10-11-34-29(44)26(43)31(2,3)16-53-59(50,51)56-58(48,49)52-15-20-25(55-57(45,46)47)24(42)30(54-20)38-18-37-23-27(32)35-17-36-28(23)38/h17-20,24-26,30,39,42-43H,4-16H2,1-3H3,(H,33,40)(H,34,44)(H,48,49)(H,50,51)(H2,32,35,36)(H2,45,46,47)/p-4/t19-,20+,24+,25+,26-,30+/m0/s1",C05264,2016-12-05T15:48:06Z,,1583,,,,,16061159,,,"(S)-3-Hydroxydecanoyl-CoA, (S)-3-Hydroxydecanoyl-Coenzyme A, 3-Hydroxydecanoyl-CoA, 3-Hydroxydecanoyl-Coenzyme A, 3S-Hydroxy-decanoyl-CoA, 3S-Hydroxy-decanoyl-Coenzyme A, b-Hydroxydecanoyl coenzyme A, beta-Hydroxydecanoyl coenzyme A, DL-b-Hydroxydecanoyl coenzyme A, DL-beta-Hydroxydecanoyl coenzyme A, S-(3-Hydroxydecanoate, S-(3-Hydroxydecanoate) CoA, S-(3-Hydroxydecanoate) Coenzyme A, S-(3-Hydroxydecanoate)CoA, S-(3-Hydroxydecanoate)Coenzyme A, S-(3-Hydroxydecanoic acid",http://vmh.uni.lu/_api/metabolites/1583/?format=pcsv
dc2coa,,,-4,C31H48N7O17P3S,CHEBI:10723,,trans-Dec-2-enoyl-CoA,,trans-Dec-2-enoyl-CoA,,,"InChI=1S/C31H52N7O17P3S/c1-4-5-6-7-8-9-10-11-22(40)59-15-14-33-21(39)12-13-34-29(43)26(42)31(2,3)17-52-58(49,50)55-57(47,48)51-16-20-25(54-56(44,45)46)24(41)30(53-20)38-19-37-23-27(32)35-18-36-28(23)38/h10-11,18-20,24-26,30,41-42H,4-9,12-17H2,1-3H3,(H,33,39)(H,34,43)(H,47,48)(H,49,50)(H2,32,35,36)(H2,44,45,46)/p-4/b11-10+/t20-,24-,25-,26+,30-/m1/s1",C05275,2016-11-22T15:12:12Z,,1584,,,,trans-dec-2-enoyl-CoA,24883423,dc2coa,,,http://vmh.uni.lu/_api/metabolites/1584/?format=pcsv
HC01414,,,-4,C31H48N7O17P3S,,,trans-dec-2-enoyl-CoA(4-),,trans-dec-2-enoyl-CoA(4-),,,"InChI=1S/C31H52N7O17P3S/c1-4-5-6-7-8-9-10-11-22(40)59-15-14-33-21(39)12-13-34-29(43)26(42)31(2,3)17-52-58(49,50)55-57(47,48)51-16-20-25(54-56(44,45)46)24(41)30(53-20)38-19-37-23-27(32)35-18-36-28(23)38/h10-11,18-20,24-26,30,41-42H,4-9,12-17H2,1-3H3,(H,33,39)(H,34,43)(H,47,48)(H,49,50)(H2,32,35,36)(H2,44,45,46)/p-4/b11-10+/t20-,24-,25-,26+,30-/m1/s1",,2016-11-16T10:44:55Z,,1585,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1585/?format=pcsv
HC01405,,,-4,C29H46N7O18P3S,CHEBI:28632,,(S)-Hydroxyoctanoyl-CoA,,(S)-Hydroxyoctanoyl-CoA,,,"InChI=1S/C29H50N7O18P3S/c1-4-5-6-7-17(37)12-20(39)58-11-10-31-19(38)8-9-32-27(42)24(41)29(2,3)14-51-57(48,49)54-56(46,47)50-13-18-23(53-55(43,44)45)22(40)28(52-18)36-16-35-21-25(30)33-15-34-26(21)36/h15-18,22-24,28,37,40-41H,4-14H2,1-3H3,(H,31,38)(H,32,42)(H,46,47)(H,48,49)(H2,30,33,34)(H2,43,44,45)/p-4/t17-,18+,22+,23+,24-,28+/m0/s1",C05266,2016-11-22T15:12:12Z,,1586,,,,(S)-3-hydroxyoctanoyl-CoA,11966216,,,,http://vmh.uni.lu/_api/metabolites/1586/?format=pcsv
HC01406,,,-4,C29H44N7O18P3S,CHEBI:28264,,3-Oxooctanoyl-CoA,,3-Oxooctanoyl-CoA,,,"InChI=1S/C29H48N7O18P3S/c1-4-5-6-7-17(37)12-20(39)58-11-10-31-19(38)8-9-32-27(42)24(41)29(2,3)14-51-57(48,49)54-56(46,47)50-13-18-23(53-55(43,44)45)22(40)28(52-18)36-16-35-21-25(30)33-15-34-26(21)36/h15-16,18,22-24,28,40-41H,4-14H2,1-3H3,(H,31,38)(H,32,42)(H,46,47)(H,48,49)(H2,30,33,34)(H2,43,44,45)/p-4/t18-,22-,23-,24+,28-/m1/s1",C05267,2016-11-22T15:12:12Z,,1587,,,,3-oxooctanoyl-CoA,11966162,HC01406,,,http://vmh.uni.lu/_api/metabolites/1587/?format=pcsv
HC01409,,,-4,C27H42N7O17P3S,449118,,Human Metabolome Database (HMDB): Fatty acid coenzyme A derivative that can be involved in the biosynthesis and oxidation of fatty acids as well as in ceramide formation.,,Hexanoyl-CoA,,HMDB02845,"InChI=1S/C27H46N7O17P3S/c1-4-5-6-7-18(36)55-11-10-29-17(35)8-9-30-25(39)22(38)27(2,3)13-48-54(45,46)51-53(43,44)47-12-16-21(50-52(40,41)42)20(37)26(49-16)34-15-33-19-23(28)31-14-32-24(19)34/h14-16,20-22,26,37-38H,4-13H2,1-3H3,(H,29,35)(H,30,39)(H,43,44)(H,45,46)(H2,28,31,32)(H2,40,41,42)/p-4/t16-,20-,21-,22+,26-/m1/s1",C05270,2016-12-05T15:48:06Z,,1588,,,,,449118,,,"6-Carboxyhexanoyl-CoA, 6-Carboxyhexanoyl-Coenzyme A, Caproyl-CoA, Caproyl-Coenzyme A, Hexanoyl-coenzyme A, Pimeloyl-CoA, Pimeloyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/1588/?format=pcsv
HC01407,,,-4,C27H42N7O18P3S,CHEBI:28276,,(S)-Hydroxyhexanoyl-CoA,,(S)-Hydroxyhexanoyl-CoA,,,"InChI=1S/C27H46N7O18P3S/c1-4-5-15(35)10-18(37)56-9-8-29-17(36)6-7-30-25(40)22(39)27(2,3)12-49-55(46,47)52-54(44,45)48-11-16-21(51-53(41,42)43)20(38)26(50-16)34-14-33-19-23(28)31-13-32-24(19)34/h13-16,20-22,26,35,38-39H,4-12H2,1-3H3,(H,29,36)(H,30,40)(H,44,45)(H,46,47)(H2,28,31,32)(H2,41,42,43)/p-4/t15-,16+,20+,21+,22-,26+/m0/s1",C05268,2016-11-22T15:12:12Z,,1589,,,,(S)-3-hydroxyhexanoyl-CoA,11966160,HC01407,,,http://vmh.uni.lu/_api/metabolites/1589/?format=pcsv
HC01410,,,-4,C27H40N7O17P3S,11966204,,"Human Metabolome Database (HMDB): trans-Hexenoyl-CoA is an intermediate in fatty acid metabolism. Beta-oxidation occurs in both mitochondria and peroxisomes. Mitochondria catalyze the beta-oxidation of the bulk of short-, medium-, and long-chain fatty acids derived from diet, and this pathway constitutes the major process by which fatty acids are oxidized to generate energy. Peroxisomes are involved in the beta-oxidation chain shortening of long-chain and very-long-chain fatty acyl-coenzyme (CoAs), long-chain dicarboxylyl-CoAs, the CoA esters of eicosanoids, 2-methyl-branched fatty acyl-CoAs, and the CoA esters of the bile acid intermediates di- and trihydroxycoprostanoic acids, and in the process they generate H2O2. Long-chain and very-long-chain fatty acids (VLCFAs) are also metabolized by the cytochrome P450 CYP4A omega-oxidation system to dicarboxylic acids that serve as substrates for peroxisomal beta-oxidation. The peroxisomal beta-oxidation system consists of (a) a classical peroxisome proliferator-inducible pathway capable of catalyzing straight-chain acyl-CoAs by fatty acyl-CoA oxidase, L-bifunctional protein, and thiolase, and (b) a second noninducible pathway catalyzing the oxidation of 2-methyl-branched fatty acyl-CoAs by branched-chain acyl-CoA oxidase (pristanoyl-CoA oxidase/trihydroxycoprostanoyl-CoA oxidase), D-bifunctional protein, and sterol carrier protein (SCP)x.  trans-Hexenoyl-CoA is the substrate of the enzymes enoyl-coenzyme A reductase, acyl-CoA oxidase [EC 1.3.99.2-1.3.3.6], acyl-CoA dehydrogenase, long-chain-acyl-CoA dehydrogenase [EC 1.3.99.3-1.3.99.13], and Oxidoreductases [EC 1.3.99.-]; trans-Hexenoyl-CoA is an intermediate in fatty acid elongation in mitochondria, being the substrate of the enzymes enoyl-CoA hydratase and long-chain-enoyl-CoA hydratase [EC 4.2.1.17-4.2.1.74]. (PMID: 11375435).",,(2E)-Hexenoyl-CoA,,HMDB03944,"InChI=1S/C27H44N7O17P3S/c1-4-5-6-7-18(36)55-11-10-29-17(35)8-9-30-25(39)22(38)27(2,3)13-48-54(45,46)51-53(43,44)47-12-16-21(50-52(40,41)42)20(37)26(49-16)34-15-33-19-23(28)31-14-32-24(19)34/h6-7,14-16,20-22,26,37-38H,4-5,8-13H2,1-3H3,(H,29,35)(H,30,39)(H,43,44)(H,45,46)(H2,28,31,32)(H2,40,41,42)/p-4/b7-6+/t16-,20-,21-,22+,26-/m1/s1",C05271,2016-12-05T15:48:06Z,,1590,,,,,11966204,,,"(2E)-Hexenoyl-CoA, (2E)-Hexenoyl-Coenzyme A, trans-2,3-Dehydrohexanoyl-CoA, trans-2,3-Dehydrohexanoyl-Coenzyme A, trans-Hex-2-enoyl-CoA, trans-Hex-2-enoyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/1590/?format=pcsv
HC01459,,,-4,C48H76N7O21P3S,CHEBI:52050,,"3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestanoyl-CoA",,"3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestanoyl-CoA",,,"InChI=1S/C48H80N7O21P3S/c1-24(28-8-9-29-36-30(19-34(59)48(28,29)6)47(5)13-11-27(56)17-26(47)18-32(36)58)7-10-31(57)25(2)45(64)80-16-15-50-35(60)12-14-51-43(63)40(62)46(3,4)21-73-79(70,71)76-78(68,69)72-20-33-39(75-77(65,66)67)38(61)44(74-33)55-23-54-37-41(49)52-22-53-42(37)55/h22-34,36,38-40,44,56-59,61-62H,7-21H2,1-6H3,(H,50,60)(H,51,63)(H,68,69)(H,70,71)(H2,49,52,53)(H2,65,66,67)/t24-,25?,26+,27-,28-,29+,30+,31?,32-,33-,34+,36+,38-,39-,40+,44-,47+,48-/m1/s1",C05450,2016-11-22T15:12:12Z,,1591,,,,,46224537,HC01459,,,http://vmh.uni.lu/_api/metabolites/1591/?format=pcsv
HC01589,,,0,,,,3-Oxohexanoyl-ACP,,3-Oxohexanoyl-ACP,,,,C05746,2016-11-22T15:12:12Z,,1592,,,,,,HC01589,,,http://vmh.uni.lu/_api/metabolites/1592/?format=pcsv
HC01590,,,0,,,,D-3-Hydroxyhexanoyl-ACP,,D-3-Hydroxyhexanoyl-ACP,,,,C05747,2016-11-22T15:12:12Z,,1593,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1593/?format=pcsv
HC01591,,,0,,,,(2E)-Hexenoyl-ACP,,(2E)-Hexenoyl-ACP,,,,C05748,2016-11-22T15:12:12Z,,1594,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1594/?format=pcsv
HC01592,,,0,,,,Hexanoyl-ACP,,Hexanoyl-ACP,,,,C05749,2016-11-22T15:12:12Z,,1595,,,,,,HC01592,,,http://vmh.uni.lu/_api/metabolites/1595/?format=pcsv
HC01595,,,0,C8H15ORS,,,Octanoyl-ACP,,Octanoyl-ACP,,,,,2016-11-22T15:12:12Z,,1596,,,,,,HC01595,,,http://vmh.uni.lu/_api/metabolites/1596/?format=pcsv
HC01598,,,0,C10H19ORS,,,Decanoyl-ACP,,Decanoyl-ACP,,,,,2016-11-22T15:12:12Z,,1597,,,,,,HC01598,,,http://vmh.uni.lu/_api/metabolites/1597/?format=pcsv
HC01599,,,0,,,,3-Oxododecanoyl-ACP,,3-Oxododecanoyl-ACP,,,,C05756,2016-11-22T15:12:12Z,,1598,,,,,,HC01599,,,http://vmh.uni.lu/_api/metabolites/1598/?format=pcsv
HC01600,,,0,,,,D-3-Hydroxydodecanoyl-ACP,,D-3-Hydroxydodecanoyl-ACP,,,,C05757,2016-11-22T15:12:12Z,,1599,,,,,,HC01600,,,http://vmh.uni.lu/_api/metabolites/1599/?format=pcsv
HC01652,,,-4,C9H14N5O14P3,,,"2,5-Diaminopyrimidine nucleoside triphosphate",,"2,5-Diaminopyrimidine nucleoside triphosphate",,,"InChI=1S/C9H18N5O14P3/c10-3-6(13-9(11)14-7(3)17)12-8-5(16)4(15)2(26-8)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2,4-5,8,15-16H,1,10H2,(H,21,22)(H,23,24)(H2,18,19,20)(H4,11,12,13,14,17)/t2-,4-,5-,8-/m1/s1",C05923,2016-11-22T15:12:12Z,,1600,,,,,440841,HC01652,,,http://vmh.uni.lu/_api/metabolites/1600/?format=pcsv
HC02228,,,0,,,,Hexadecenal,,Hexadecenal,,,,,2016-11-22T15:12:12Z,,1601,,,,,,HC02228,,,http://vmh.uni.lu/_api/metabolites/1601/?format=pcsv
HC01842,,,-2,C4H10NO4P,CHEBI:31997,,Phosphodimethylethanolamine,,Phosphodimethylethanolamine,,,"InChI=1S/C4H12NO4P/c1-5(2)3-4-9-10(6,7)8/h3-4H2,1-2H3,(H2,6,7,8)",C13482,2016-11-22T15:12:12Z,,1602,,,,,151438,HC01842,,,http://vmh.uni.lu/_api/metabolites/1602/?format=pcsv
HC01797,,,0,,,,Activated_methyl_group,,Activated_methyl_group,,,,C10905,2016-11-22T15:12:12Z,,1603,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1603/?format=pcsv
HC00001,,,0,,,,Albumin,,Albumin,,,,,2016-11-22T15:12:12Z,,1604,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1604/?format=pcsv
HC00002,,,0,,,,Antichymotrypsin,,Antichymotrypsin,,,,,2016-11-22T15:12:12Z,,1605,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1605/?format=pcsv
HC00003,,,0,,,,Antitrypsin,,Antitrypsin,,,,,2016-11-22T15:12:12Z,,1606,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1606/?format=pcsv
HC00004,,,0,,,,ApoA1,,ApoA1,,,,,2016-11-22T15:12:12Z,,1607,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1607/?format=pcsv
HC00319,,,-2,C3H2O4,CHEBI:30794,,"Human Metabolome Database (HMDB): Malonic acid (IUPAC systematic name: propanedioic acid) is a dicarboxylic acid with structure CH2(COOH)2. The ionised form of malonic acid, as well as its esters and salts, are known as malonates. For example, diethyl malonate is malonic acid's ethyl ester. The name originates from Latin malum, meaning apple. Malonic acid is the archetypal example of a competitive inhibitor: it acts against succinate dehydrogenase (complex II) in the respiratory electron transport chain.",,Malonate,,HMDB00691,"InChI=1S/C3H4O4/c4-2(5)1-3(6)7/h1H2,(H,4,5)(H,6,7)",C00383,2016-12-05T15:48:06Z,,1608,,,,,867,,,"alpha,Omega-dicarboxylic acid, Carboxyacetic acid, Dicarboxylate, Dicarboxylic acid, Dicarboxymethane, Kyselina malonova, Kyselina malonova [czech], Malonate, Malonate dicarboxylic acid, Malonic acid, Metahnedicarboxylic acid, Methanedicarbonic acid, Methanedicarboxylic acid, Propanedioate, Propanedioic acid, Propanedioic acid dithallium salt, Propanediolic acid, Thallium malonate",http://vmh.uni.lu/_api/metabolites/1608/?format=pcsv
HC01787,,,0,,,,Lepidimoide,,Lepidimoide,,,,,2016-11-22T15:12:12Z,,1609,,,,,,HC01787,,,http://vmh.uni.lu/_api/metabolites/1609/?format=pcsv
HC01852,,,0,,,,Fibrinogen,,Fibrinogen,,,,C00393,2016-11-22T15:12:12Z,,1610,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1610/?format=pcsv
HC01939,,,0,,,,Haptoglobin,,Haptoglobin,,,,,2016-11-22T15:12:12Z,,1611,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1611/?format=pcsv
HC01942,,,0,,,,Plasminogen,,Plasminogen,,,,,2016-11-22T15:12:12Z,,1612,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1612/?format=pcsv
HC01943,,,0,,,,Prothrombin,,Prothrombin,,,,,2016-11-22T15:12:12Z,,1613,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1613/?format=pcsv
HC01944,,,0,,,,ApoTransferin,,ApoTransferin,,,,C05780,2016-11-22T15:12:12Z,,1614,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1614/?format=pcsv
HC00005,,,0,,,,ApoB100,,ApoB100,,,,,2016-11-22T15:12:12Z,,1615,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1615/?format=pcsv
HC02222,,,0,,,,mitoApo-ACP,,mitoApo-ACP,,,,,2016-11-22T15:12:12Z,,1616,,,,,,HC02222,,,http://vmh.uni.lu/_api/metabolites/1616/?format=pcsv
HC00006,,,0,,,,ApoC1,,ApoC1,,,,,2016-11-22T15:12:12Z,,1617,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1617/?format=pcsv
HC00007,,,0,,,,ApoC2,,ApoC2,,,,,2016-11-22T15:12:13Z,,1618,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1618/?format=pcsv
HC00008,,,0,,,,ApoC3,,ApoC3,,,,,2016-11-22T15:12:13Z,,1619,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1619/?format=pcsv
HC00009,,,0,,,,ApoE,,ApoE,,,,,2016-11-22T15:12:13Z,,1620,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1620/?format=pcsv
HC02108,,,0,,,,4alpha-Methylzymosterol-4-carboxylate,,4alpha-Methylzymosterol-4-carboxylate,,,,,2016-11-16T10:44:55Z,,1621,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1621/?format=pcsv
HC02109,,,0,C28H44O,24906328,,Human Metabolome Database (HMDB): 3-Keto-4-methylzymosterol is an intermediate in the biosynthesis of steroids (KEGG:C15816). It is the 8th to last step in the synthesis of vitamin D2 and is converted from 4-methtylzymosterol-carboxylate via the enzyme sterol-4alpha-carboxylate 3-dehydrogenase (decarboxylating) (EC:1.1.1.170). It is then converted to 4-methylzymosterol via the enzyme 3-keto steroid reductase (EC:1.1.1.270).,,3-Keto-4-methylzymosterol,,HMDB06838,"InChI=1S/C28H44O/c1-18(2)8-7-9-19(3)22-12-13-24-21-10-11-23-20(4)26(29)15-17-28(23,6)25(21)14-16-27(22,24)5/h8,19-20,22-24H,7,9-17H2,1-6H3/t19-,20?,22-,23+,24+,27-,28+/m1/s1",C15816,2016-12-05T15:48:06Z,,1622,,,,,24906328,,,"(5a)-4-methylcholesta-8,24-dien-3-one, (5alpha)-4-methylcholesta-8,24-dien-3-one, 3-Dehydro-4-methylzymosterol, 3-Keto-4-methylzymosterol, 4-Methyl-5a-cholesta-8,24-dien-3-one, 4-Methyl-5alpha-cholesta-8,24-dien-3-one",http://vmh.uni.lu/_api/metabolites/1622/?format=pcsv
HC02110,,,0,C28H46O,,,4alpha-Methylzymosterol,,4alpha-Methylzymosterol,,,"InChI=1S/C28H46O/c1-18(2)8-7-9-19(3)22-12-13-24-21-10-11-23-20(4)26(29)15-17-28(23,6)25(21)14-16-27(22,24)5/h8,19-20,22-24,26,29H,7,9-17H2,1-6H3/t19-,20+,22-,23+,24+,26+,27-,28+/m1/s1",C05103,2016-11-22T15:12:13Z,,1623,,,,,22212495,HC02110,,,http://vmh.uni.lu/_api/metabolites/1623/?format=pcsv
HC02020,,,0,C43H76O2,CHEBI:3663,,Cholesterol-ester-palm,,Cholesterol-ester-palm,,,"InChI=1S/C43H76O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-23-41(44)45-36-28-30-42(5)35(32-36)24-25-37-39-27-26-38(34(4)22-20-21-33(2)3)43(39,6)31-29-40(37)42/h24,33-34,36-40H,7-23,25-32H2,1-6H3/t34-,36+,37+,38-,39+,40+,42+,43-/m1/s1",C11251,2016-11-22T15:12:13Z,,1624,,,,,246520,HC02020,,,http://vmh.uni.lu/_api/metabolites/1624/?format=pcsv
HC02021,,,0,,,,Cholesterol-ester-palmn,,Cholesterol-ester-palmn,,,,,2016-11-22T15:12:13Z,,1625,,,,,,HC02021,,,http://vmh.uni.lu/_api/metabolites/1625/?format=pcsv
HC02022,,,0,,,,Cholesterol-ester-stea,,Cholesterol-ester-stea,,,,,2016-11-22T15:12:13Z,,1626,,,,,,HC02022,,,http://vmh.uni.lu/_api/metabolites/1626/?format=pcsv
HC02023,,,0,C45H78O2,CHEBI:46898,,Cholesterol-ester-ol,,Cholesterol-ester-ol,,,"InChI=1S/C45H78O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-43(46)47-38-30-32-44(5)37(34-38)26-27-39-41-29-28-40(36(4)24-22-23-35(2)3)45(41,6)33-31-42(39)44/h14-15,26,35-36,38-42H,7-13,16-25,27-34H2,1-6H3/b15-14-/t36-,38+,39+,40-,41+,42+,44+,45-/m1/s1",,2016-11-22T15:12:13Z,,1627,,,,,644119,HC02023,,,http://vmh.uni.lu/_api/metabolites/1627/?format=pcsv
HC02024,,,0,C45H76O2,CHEBI:41509,,Cholesterol-ester-lin,,Cholesterol-ester-lin,,,"InChI=1S/C45H76O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-43(46)47-38-30-32-44(5)37(34-38)26-27-39-41-29-28-40(36(4)24-22-23-35(2)3)45(41,6)33-31-42(39)44/h11-12,14-15,26,35-36,38-42H,7-10,13,16-25,27-34H2,1-6H3/b12-11-,15-14-/t36-,38+,39+,40-,41+,42+,44+,45-/m1/s1",,2016-11-22T15:12:13Z,,1628,,,,,92819,HC02024,,,http://vmh.uni.lu/_api/metabolites/1628/?format=pcsv
HC02025,,,0,,,,Cholesterol-ester-ala,,Cholesterol-ester-ala,,,,,2016-11-22T15:12:13Z,,1629,,,,,,HC02025,,,http://vmh.uni.lu/_api/metabolites/1629/?format=pcsv
HC02026,,,0,,,,Cholesterol-ester-gla,,Cholesterol-ester-gla,,,,,2016-11-22T15:12:13Z,,1630,,,,,,HC02026,,,http://vmh.uni.lu/_api/metabolites/1630/?format=pcsv
HC02027,,,0,,,,Cholesterol-ester-arach,,Cholesterol-ester-arach,,,,,2016-11-22T15:12:13Z,,1631,,,,,,HC02027,,,http://vmh.uni.lu/_api/metabolites/1631/?format=pcsv
HC02029,,,0,,,,1-Acylglycerol-3P-palm,,1-Acylglycerol-3P-palm,,,,,2016-11-22T15:12:13Z,,1632,,,,,,HC02029,,,http://vmh.uni.lu/_api/metabolites/1632/?format=pcsv
HC02030,,,0,,,,1-Acylglycerol-3P-palmn,,1-Acylglycerol-3P-palmn,,,,,2016-11-22T15:12:13Z,,1633,,,,,,HC02030,,,http://vmh.uni.lu/_api/metabolites/1633/?format=pcsv
HC02031,,,0,,,,1-Acylglycerol-3P-stea,,1-Acylglycerol-3P-stea,,,,,2016-11-22T15:12:13Z,,1634,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1634/?format=pcsv
HC02032,,,0,,,,1-Acylglycerol-3P-ol,,1-Acylglycerol-3P-ol,,,,,2016-11-22T15:12:13Z,,1635,,,,,,HC02032,,,http://vmh.uni.lu/_api/metabolites/1635/?format=pcsv
HC02033,,,0,,,,1-Acylglycerol-3P-lin,,1-Acylglycerol-3P-lin,,,,,2016-11-22T15:12:13Z,,1636,,,,,,HC02033,,,http://vmh.uni.lu/_api/metabolites/1636/?format=pcsv
HC02036,,,0,,,,1-Acylglycerol-3P-arach,,1-Acylglycerol-3P-arach,,,,,2016-11-22T15:12:13Z,,1637,,,,,,HC02036,,,http://vmh.uni.lu/_api/metabolites/1637/?format=pcsv
HC02097,,,0,X,,,3-Oxostearoyl-ACP,,3-Oxostearoyl-ACP,,,,C16219,2016-11-22T15:12:13Z,,1638,,,,,,HC02097,,,http://vmh.uni.lu/_api/metabolites/1638/?format=pcsv
HC02098,,,0,X,,,3-Hydroxystearoyl-ACP,,3-Hydroxystearoyl-ACP,,,,C16220,2016-11-22T15:12:13Z,,1639,,,,,,HC02098,,,http://vmh.uni.lu/_api/metabolites/1639/?format=pcsv
HC02099,,,0,X,,,(2E)-Octadecenoyl-ACP,,(2E)-Octadecenoyl-ACP,,,,C16221,2016-11-22T15:12:13Z,,1640,,,,,,HC02099,,,http://vmh.uni.lu/_api/metabolites/1640/?format=pcsv
HC01988,,,0,,,,Stearoyl-ACP,,Stearoyl-ACP,,,,C04088,2016-11-22T15:12:13Z,,1641,,,,,,HC01988,,,http://vmh.uni.lu/_api/metabolites/1641/?format=pcsv
HC02111,,,0,,,,ATP-energy,,ATP-energy,,,,,2016-11-22T15:12:13Z,,1642,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1642/?format=pcsv
HC02112,,,0,,,,NADH-redox-potential,,NADH-redox-potential,,,,,2016-11-22T15:12:13Z,,1643,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1643/?format=pcsv
HC02113,,,0,,,,NADPH-redox-potential,,NADPH-redox-potential,,,,,2016-11-22T15:12:13Z,,1644,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1644/?format=pcsv
HC02114,,,0,,,,FADH-redox-potential,,FADH-redox-potential,,,,,2016-11-22T15:12:13Z,,1645,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1645/?format=pcsv
HC02115,,,0,,,,Proton-gradient,,Proton-gradient,,,,,2016-11-22T15:12:13Z,,1646,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1646/?format=pcsv
HC02116,,,0,,,,activated-sulphur,,activated-sulphur,,,,,2016-11-22T15:12:13Z,,1647,,,,,,HC02116,,,http://vmh.uni.lu/_api/metabolites/1647/?format=pcsv
HC02100,,,-1,C20H33O2,5280581,,"Human Metabolome Database (HMDB): 8,11,14-Eicosatrienoic acid is a 20-carbon-chain omega-6 fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid (5,8,11,14-eicosatetraenoic acid) only at position 5. 8,11,14-Eicosatrienoic acid is also known as Dihomo-gamma-linolenic acid (DGLA). In physiological literature, it is given the name 20:3(n-6). DGLA is the elongation product of the 18 carbon gamma-linolenic acid (GLA). DGLA can be converted into prostaglandin E1 (PGE1). PGE1 inhibits platelet aggregation and also exerts a vasodilatory effect. DGLA competes with arachadonic acid for COX and lipoxygenase, inhibiting the production of arachadonic acid's eicosanoids.",,Dihomo-gamma-linolenate,,HMDB02925,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/p-1/b7-6-,10-9-,13-12-",C03242,2016-12-05T15:48:06Z,,1648,,,,,5280581,,,"(8Z,11Z,14Z)-Icosatrienoate, (8Z,11Z,14Z)-Icosatrienoic acid, (Z,Z,Z)-8,11,14-Eicosatrienoate, (Z,Z,Z)-8,11,14-Eicosatrienoic acid, (Z,Z,Z)-8,11,14-Icosatrienoate, (Z,Z,Z)-8,11,14-Icosatrienoic acid, (Z,Z,Z)-icosatri-8,11,14-enoate, (Z,Z,Z)-icosatri-8,11,14-enoic acid, 8,11,14-All-cis-Eicosatrienoate, 8,11,14-All-cis-Eicosatrienoic acid, 8,11,14-Eicosatrienoate, 8,11,14-Eicosatrienoic acid, 8,11,14-Icosatrienoate, 8,11,14-Icosatrienoic acid, 8Z,11Z,14Z-Eicosatrienoate, 8Z,11Z,14Z-Eicosatrienoic acid, All-cis-8,11,14-Eicosatrienoate, All-cis-8,11,14-Eicosatrienoic acid, Bishomo-gamma-linolenate, Bishomo-gamma-linolenic acid, cis,cis,cis-8,11,14-Eicosatrienoate, cis,cis,cis-8,11,14-Eicosatrienoic acid, cis-8,11,14-Eicosatrienoate, cis-8,11,14-Eicosatrienoic acid, cis-8,cis-11,cis-14-Eicosatrienoate, cis-8,cis-11,cis-14-Eicosatrienoic acid, DGLA, Dihomo-gamma-linolenate, Dihomo-gamma-linolenic acid, Eicosatrienoate, Eicosatrienoic acid, gamma-Homolinolenate, gamma-Homolinolenic acid, Homo-gamma-linolenate",http://vmh.uni.lu/_api/metabolites/1648/?format=pcsv
HC02121,,,-1,C11H18N3O7S,CHEBI:48926,,S-(hydroxymethyl)glutathione(1-),,S-(hydroxymethyl)glutathione(1-),,,"InChI=1S/C11H19N3O7S/c12-6(11(20)21)1-2-8(16)14-7(4-22-5-15)10(19)13-3-9(17)18/h6-7,15H,1-5,12H2,(H,13,19)(H,14,16)(H,17,18)(H,20,21)/p-1/t6-,7-/m0/s1",C14180,2016-11-22T15:12:13Z,,1649,,,,,447123,,,,http://vmh.uni.lu/_api/metabolites/1649/?format=pcsv
HC02129,,,0,,,,THF-hexaglutamate,,THF-hexaglutamate,,,,,2016-11-22T15:12:13Z,,1650,,,,,,HC02129,,,http://vmh.uni.lu/_api/metabolites/1650/?format=pcsv
HC02136,,,0,,,,Glycogenin-G7G1,,Glycogenin-G7G1,,,,,2016-11-22T15:12:13Z,,1651,,,,,,HC02136,,,http://vmh.uni.lu/_api/metabolites/1651/?format=pcsv
HC02147,,,0,,,,L-Oleoylcarnitine,,L-Oleoylcarnitine,,,,,2016-11-16T10:44:55Z,,1652,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1652/?format=pcsv
HC02149,,,0,C10H19NO4,107738,,"Human Metabolome Database (HMDB): Propionylcarnitine is present in high abundance in the urine of patients with Methylmalonyl-CoA mutase (MUT) deficiency, (together with Methylmalonic acid). MUT is a mitochondrial enzyme that catalyzes the isomerization of methylmalonyl-CoA to succinyl-CoA (OMIM 609058 ).",,O-Propanoylcarnitine,,HMDB00824,"InChI=1S/C10H19NO4/c1-5-10(14)15-8(6-9(12)13)7-11(2,3)4/h8H,5-7H2,1-4H3",C03017,2016-12-05T15:48:06Z,,1653,,,,,107738,,,"(+/-)-Propionylcarnitine chloride, (3-carboxy-2-hydroxypropyl)trimethyl-hydroxide Ammonium inner salt, 3-Carboxy-N,N,N-trimethyl-2-(1-oxopropoxy)-1-propanaminium inner salt, L-Propionylcarnitine, O-Propanoylcarnitine, O-Propionylcarnitine, Propionyl carnitine, Propionyl-carnitine, Propionyl-L-carnitine",http://vmh.uni.lu/_api/metabolites/1653/?format=pcsv
HC02150,,,0,,,,O-Butanoylcarnitine,,O-Butanoylcarnitine,,,,,2016-11-16T10:44:55Z,,1654,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1654/?format=pcsv
HC02223,,,0,,,,mitoACP,,mitoACP,,,,,2016-11-22T15:12:13Z,,1655,,,,,,HC02223,,,http://vmh.uni.lu/_api/metabolites/1655/?format=pcsv
HC10856,,,0,,,,"trans,cis-octadeca-2,9-dienoyl-CoA",,"trans,cis-octadeca-2,9-dienoyl-CoA",,,,,2016-11-22T15:12:13Z,,1656,,,,,,HC10856,,,http://vmh.uni.lu/_api/metabolites/1656/?format=pcsv
HC10857,,,0,,,,(S)-3-hydroxyoleyleoyl-CoA,,(S)-3-hydroxyoleyleoyl-CoA,,,,,2016-11-22T15:12:13Z,,1657,,,,,,HC10857,,,http://vmh.uni.lu/_api/metabolites/1657/?format=pcsv
HC10858,,,0,,,,3-oxooleoyl-CoA,,3-oxooleoyl-CoA,,,,,2016-11-22T15:12:13Z,,1658,,,,,,HC10858,,,http://vmh.uni.lu/_api/metabolites/1658/?format=pcsv
HC02192,,,-1,C26H44NO5S,CHEBI:36259,,"Human Metabolome Database (HMDB): Lithocholyltaurine is a bile salt formed in the liver from lithocholic acid conjugation with taurine, usually as the sodium salt. It solubilizes fats for absorption and is itself absorbed. Lithocholic acid, a hydrophobic secondary bile acid, is well known to cause intrahepatic cholestasis. There have been extensive studies on the mechanisms of lithocholate-induced cholestasis in animals. Lithocholate diminishes both the bile acid-dependent and independent bile flow. In humans, elevated levels of lithocholic acid are found in patients with chronic cholestatic liver disease. Lithocholyltaurine impairs both the bile canalicular contractions and the canalicular bile secretion, possibly by acting directly on the canalicular membranes in lithocholyltaurine-induced cholestasis. Lithocholyltaurine induce acute cholestasis-associated with retrieval of the bile salt export pump. The bile salt export pump (BSEP) of hepatocyte secretes conjugated bile salts across the canalicular membrane in an ATP-dependent manner. Hepatic retention of bile acids may lead to liver injury by hepatocyte apoptosis and eventually deterioration of cholestatic liver diseases. One mechanism of induced apoptosis by lithocholyltaurine is the induction of transcriptional activity of AP-1 (activation protein-1). (PMID: 16981261, 15763547, 16332456, 18164257).",,taurolithocholate,,HMDB00722,"InChI=1S/C26H45NO5S/c1-17(4-9-24(29)27-14-15-33(30,31)32)21-7-8-22-20-6-5-18-16-19(28)10-12-25(18,2)23(20)11-13-26(21,22)3/h17-23,28H,4-16H2,1-3H3,(H,27,29)(H,30,31,32)/p-1/t17-,18-,19-,20+,21-,22+,23+,25+,26-/m1/s1",C02592,2016-12-05T15:48:06Z,,1659,,,,,439763,HC02192,,"2-[(3alpha-hydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonic acid, 2-[[(3a,5b)-3-Hydroxy-24-oxocholan-24-yl]amino]-Ethanesulfonate, 2-[[(3a,5b)-3-Hydroxy-24-oxocholan-24-yl]amino]-Ethanesulfonic acid, 3a-Hydroxy-5b-cholanoyltaurine, 3a-Hydroxy-N-(2-sulfoethyl)-5b-cholan-24-amide, Cholane ethanesulfonic acid deriv., Lithocholic acid taurine conjugate, Lithocholic acid taurine conjugic acid, N-(3a-Hydroxy-5b-cholan-24-oyl)-Taurine, Taurolithocholate, Taurolithocholic acid",http://vmh.uni.lu/_api/metabolites/1659/?format=pcsv
HC02193,,,-1,C26H42NO4,CHEBI:37998,,glycolithocholate,,glycolithocholate,,,"InChI=1S/C26H43NO4/c1-16(4-9-23(29)27-15-24(30)31)20-7-8-21-19-6-5-17-14-18(28)10-12-25(17,2)22(19)11-13-26(20,21)3/h16-22,28H,4-15H2,1-3H3,(H,27,29)(H,30,31)/p-1/t16-,17-,18-,19+,20-,21+,22+,25+,26-/m1/s1",C15557,2016-11-22T15:12:13Z,,1660,,,,,115245,HC02193,,,http://vmh.uni.lu/_api/metabolites/1660/?format=pcsv
HC02195,,,0,,,,tauroursodeoxycholate,,tauroursodeoxycholate,,,,,2016-11-22T15:12:13Z,,1661,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1661/?format=pcsv
HC02196,,,0,,,,"Human Metabolome Database (HMDB): Glycoursodeoxycholic acid is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",,glycoursodeoxycholate,,HMDB00708,,,2016-12-05T15:48:06Z,,1662,,,,,,,,"3a,7b-Dihydroxy-5b-cholanoylglycine, Glycoursodeoxycholate, Glycoursodeoxycholic acid, Glycylursodeoxycholate, Glycylursodeoxycholic acid, N-(3a,7b-Dihydroxy-5b-cholan-24-oyl)glycine, N-[(3a,5b,7b)-3,7-Dihydroxy-24-oxocholan-24-yl]glycine, Ursodeoxycholylglycine",http://vmh.uni.lu/_api/metabolites/1662/?format=pcsv
HC02220,,,0,,,,sulfochenodeoxycholate,,sulfochenodeoxycholate,,,,,2016-11-22T15:12:13Z,,1663,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1663/?format=pcsv
HC02154,,,0,,,,GM4-pool,,GM4-pool,,,,,2016-11-22T15:12:13Z,,1664,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1664/?format=pcsv
HC02175,,,-1,C10H19O2,2969,,"Human Metabolome Database (HMDB): Capric acid is a member of the series of fatty acids found in oils and animal fats. The names of Caproic, Caprylic, and Capric acids are all derived from the word caper (Latin: 'goat'). These are colorless light yellowish transparent oily liquids with unconfortable smells. These are used in organic synthesis, manufacture of perfume, medicine, lubricating grease, rubber and dye.(ChemicalLAND21).",,caprate,,HMDB00511,"InChI=1S/C10H20O2/c1-2-3-4-5-6-7-8-9-10(11)12/h2-9H2,1H3,(H,11,12)/p-1",C01571,2016-12-05T15:48:06Z,,1665,,,,,2969,,,"1-Nonanecarboxylate, 1-Nonanecarboxylic acid, Caprate, Capric acid, Caprinate, Caprinic acid, Caprynate, Caprynic acid, Decoate, Decoic acid, Decylate, Decylic acid, Emery 659, Lunac 10-95, Lunac 10-98, N-Caprate, N-Capric acid, N-Decanoate, N-Decanoic acid, N-Decoate, N-Decoic acid, N-Decylate, N-Decylic acid, Prifac 2906, Prifac 296",http://vmh.uni.lu/_api/metabolites/1665/?format=pcsv
HC02176,,,-1,C12H23O2,3893,,"Human Metabolome Database (HMDB): Lauric acid, or dodecanoic acid is the main fatty acid in coconut oil and in palm kernel oil, and is believed to have antimicrobial properties. It is a white, powdery solid with a faint odor of bay oil. Lauric acid, although slightly irritating to mucous membranes, has a very low toxicity and so is used in many soaps and shampoos.",,laurate,,HMDB00638,"InChI=1S/C12H24O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2-11H2,1H3,(H,13,14)/p-1",C02679,2016-12-05T15:48:06Z,,1666,,,,,3893,,,"1-Undecanecarboxylate, 1-Undecanecarboxylic acid, ABL, Aliphat No. 4, Dodecanoate, Dodecanoic acid, Dodecylate, Dodecylic acid, Edenor C 1298-100, Emery 651, Hystrene 9512, Kortacid 1299, Laurate, Lauric acid, Laurostearate, Laurostearic acid, Lunac L 70, Lunac L 98, N-Dodecanoate, N-Dodecanoic acid, Neo-Fat 12, Neo-Fat 12-43, Nissan NAA 122, Philacid 1200, Prifac 2920, Univol U 314, Vulvate, Vulvic acid",http://vmh.uni.lu/_api/metabolites/1666/?format=pcsv
HC02199,,,0,,,,glutathionyl-leuc4,,glutathionyl-leuc4,,,,,2016-11-22T15:12:13Z,,1667,,,,,,HC02199,,,http://vmh.uni.lu/_api/metabolites/1667/?format=pcsv
HC02200,,,0,,,,S-glutathionyl-2-4-dinitrobenzene,,S-glutathionyl-2-4-dinitrobenzene,,,,,2016-11-22T15:12:13Z,,1668,,,,,,HC02200,,,http://vmh.uni.lu/_api/metabolites/1668/?format=pcsv
HC02201,,,0,,,,S-glutathionyl-ethacrynic-acid,,S-glutathionyl-ethacrynic-acid,,,,,2016-11-22T15:12:13Z,,1669,,,,,,HC02201,,,http://vmh.uni.lu/_api/metabolites/1669/?format=pcsv
HC02172,,,2,Zn,CHEBI:29105,,"Human Metabolome Database (HMDB): Zinc is an essential element, necessary for sustaining all life.Physiologically, it exists as an ion in the body. It is estimated that 3000 of the hundreds of thousands of proteins in the human body contain zinc prosthetic groups. In addition, there are over a dozen types of cells in the human body that secrete zinc ions, and the roles of these secreted zinc signals in medicine and health are now being actively studied. Intriguingly, brain cells in the mammalian forebrain are one type of cell that secretes zinc, along with its other neuronal messenger substances. Cells in the salivary gland, prostate, immune system and intestine are other types that secrete zinc. Obtaining a sufficient zinc intake during pregnancy and in young children is a problem, especially among those who cannot afford a good and varied diet. Brain development is stunted by zinc deficiency in utero and in youth. Zinc is an activator of certain enzymes, such as carbonic anhydrase. Carbonic anhydrase is important in the transport of carbon dioxide in vertebrate blood. Even though zinc is an essential requirement for a healthy body, too much zinc can be harmful. Excessive absorption of zinc can also suppress copper and iron absorption. The free zinc ion in solution is highly toxic to plants, invertebrates, and even vertebrate fish. The Free Ion Activity Model (FIAM) is well-established in the literature, and shows that just micromolar amounts of the free ion kills some organisms.",,Zinc,,HMDB01303,InChI=1S/Zn/q+2,C00038,2016-12-05T15:48:06Z,,1670,,,,Zn2+,32051,,,"Zinc, Zinc ion",http://vmh.uni.lu/_api/metabolites/1670/?format=pcsv
HC02191,,,-1,C24H39O3,CHEBI:16325,,"Human Metabolome Database (HMDB): Lithocholic acid is a bile acid formed from chenodeoxycholate by bacterial action, usually conjugated with glycine or taurine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as cholagogue and choleretic. A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",,lithocholate,,HMDB00761,"InChI=1S/C24H40O3/c1-15(4-9-22(26)27)19-7-8-20-18-6-5-16-14-17(25)10-12-23(16,2)21(18)11-13-24(19,20)3/h15-21,25H,4-14H2,1-3H3,(H,26,27)/p-1/t15-,16-,17-,18+,19-,20+,21+,23+,24-/m1/s1",C03990,2016-12-05T15:48:06Z,,1671,,,,,9903,HC02191,,"(3a,5b)-3-hydroxy-cholan-24-oate, (3a,5b)-3-hydroxy-cholan-24-oic acid, 3a-Hydroxy-5b-cholan-24-oate, 3a-Hydroxy-5b-cholan-24-oic acid, Lithocholate",http://vmh.uni.lu/_api/metabolites/1671/?format=pcsv
HC02194,,,0,,CHEBI:9907,,ursodeoxycholate,,ursodeoxycholate,,,,,2016-11-22T15:12:13Z,,1672,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1672/?format=pcsv
HC02197,,,-2,C26H41NO7S,,,sulfoglycolithocholate(2-),,sulfoglycolithocholate(2-),,,"InChI=1S/C26H43NO7S/c1-16(4-9-23(28)27-15-24(29)30)20-7-8-21-19-6-5-17-14-18(34-35(31,32)33)10-12-25(17,2)22(19)11-13-26(20,21)3/h16-22H,4-15H2,1-3H3,(H,27,28)(H,29,30)(H,31,32,33)/p-2/t16-,17-,18-,19+,20-,21+,22+,25+,26-/m1/s1",,2016-11-22T15:12:13Z,,1673,,,,,72222,,,,http://vmh.uni.lu/_api/metabolites/1673/?format=pcsv
HC02198,,,-2,C26H43NO8S2,CHEBI:17864,,"2-[(4R)-4-[(1S,2S,5R,7R,10R,11S,14R,15R)-2,15-dimethyl-5-(sulfonatooxy)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]ethane-1-sulfonate",,"2-[(4R)-4-[(1S,2S,5R,7R,10R,11S,14R,15R)-2,15-dimethyl-5-(sulfonatooxy)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]ethane-1-sulfonate",,,"InChI=1S/C26H45NO8S2/c1-17(4-9-24(28)27-14-15-36(29,30)31)21-7-8-22-20-6-5-18-16-19(35-37(32,33)34)10-12-25(18,2)23(20)11-13-26(21,22)3/h17-23H,4-16H2,1-3H3,(H,27,28)(H,29,30,31)(H,32,33,34)/p-2/t17-,18-,19-,20+,21-,22+,23+,25+,26-/m1/s1",C03642,2016-11-22T15:12:13Z,,1674,,,,,440071,,,,http://vmh.uni.lu/_api/metabolites/1674/?format=pcsv
HC02187,,,0,C15H12I3NO4,CHEBI:28774,,reverse-triiodthyronine,,reverse-triiodthyronine,,,"InChI=1S/C15H12I3NO4/c16-9-3-7(4-12(19)15(21)22)1-2-13(9)23-8-5-10(17)14(20)11(18)6-8/h1-3,5-6,12,20H,4,19H2,(H,21,22)",,2016-11-22T15:12:13Z,,1675,,,,,22069,,,,http://vmh.uni.lu/_api/metabolites/1675/?format=pcsv
HC02180,,,-1,C20H33O6,CHEBI:28728,,thromboxane-b2,,thromboxane-b2,,,"InChI=1S/C20H34O6/c1-2-3-6-9-15(21)12-13-18-16(17(22)14-20(25)26-18)10-7-4-5-8-11-19(23)24/h4,7,12-13,15-18,20-22,25H,2-3,5-6,8-11,14H2,1H3,(H,23,24)/b7-4-,13-12+/t15-,16-,17-,18+,20?/m0/s1",,2016-11-22T15:12:13Z,,1676,,,,,41063,,,,http://vmh.uni.lu/_api/metabolites/1676/?format=pcsv
HC02179,,,-1,C20H31O3,123803,,20-hydroxy-arachidonate,,20-hydroxy-arachidonate,,,"InChI=1S/C20H32O3/c21-19-17-15-13-11-9-7-5-3-1-2-4-6-8-10-12-14-16-18-20(22)23/h1,3-4,6-7,9-10,12,21H,2,5,8,11,13-19H2,(H,22,23)/b3-1-,6-4-,9-7-,12-10-",,2016-11-16T10:44:56Z,,1677,,,,,123803,,,,http://vmh.uni.lu/_api/metabolites/1677/?format=pcsv
HC02202,,,-1,C20H31O4,CHEBI:15545,,"Human Metabolome Database (HMDB): Prostaglandin A1 (PGA1, a prostaglandin characterized by a cyclopentenone structure) has a fundamental structure common to punaglandin and clavulone, the antitumor eicosanoids discovered in marine organisms such as corals. It is well established that PGA1, which exert potent antiviral activity in several DNA and RNA virus models, induce heat shock protein (hsp)70 syntheses through cycloheximide sensitive activation of heat shock transcription factor. Antitumor prostaglandins are actively incorporated through cell membrane and control gene expression. P53 (protein 53, is a transcription factor that regulates the cell cycle and functions as a tumor suppressor) independent expression of p21 (also known as cyclin-dependent kinase inhibitor 1A or CDKN1A, is a human gene on chromosome 6 (location 6p21.2), that encodes a cyclin-dependent kinase) and gadd 45 (growth arrest and DNA-damage-inducible, alpha 45, a major breast cancer (BRCA1) target is the DNA damage-responsive gene GADD45) activation of peroxisome proliferative activated receptor gamma (PPARgamma) are involved in antitumor mechanism of these prostaglandins. At the low concentration, these prostaglandins exhibit physiological or pathological activity such as osteoblast calcification, promotion of colon cancer cell proliferation. One of the mechanisms of anti-cancer activity of prostaglandins, has been believed to be that these prostaglandins might have p53 like effect in cells lacking p53. (PMID: 7988663, 11104898)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,prostaglandin A1(1-),,HMDB02656,"InChI=1S/C20H32O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h12-18,21H,2-11H2,1H3,(H,23,24)/p-1/b14-12+/t16-,17-,18+/m0/s1",,2016-12-05T15:48:06Z,,1678,,,,,26487,,,"(13E,15S)-15-hydroxy-9-oxo-Prosta-10,13-dien-1-oate, (13E,15S)-15-hydroxy-9-oxo-Prosta-10,13-dien-1-oic acid, 15-Hydroxy-9-oxoprosta-10,13-dienoate, 15-Hydroxy-9-oxoprosta-10,13-dienoic acid, 15a-Hydroxy-9-ketoprosta-10,13-dienoate, 15a-Hydroxy-9-ketoprosta-10,13-dienoic acid, 15a-Hydroxy-9-oxo-10,13E-prostadienoate, 15a-Hydroxy-9-oxo-10,13E-prostadienoic acid, 2-(3-Hydroxy-1-octenyl)-5-oxo-3- cyclopentene-1-heptanoate, 2-(3-Hydroxy-1-octenyl)-5-oxo-3- cyclopentene-1-heptanoic acid, 2-(3-Hydroxy-1-octenyl)-5-oxo-3-Cyclopentene-1-heptanoate, 2-(3-Hydroxy-1-octenyl)-5-oxo-3-Cyclopentene-1-heptanoic acid, PGA1, Prostaglandin A1, Prostaglandin E1-217",http://vmh.uni.lu/_api/metabolites/1678/?format=pcsv
HC02203,,,-1,C20H29O4,CHEBI:27820,,"Human Metabolome Database (HMDB): Produced by the seminal vessicals: Prostaglandins are a group of lipid compounds that are derived enzymatically from fattyacids. Technically a hormone, the prostanoid class of fatty acid derivatives is a subclass of eicosanoids. Prostaglandin A is a cyclopentenone and is an endogenous metabolite derived from arachidonic acid. Exhibits potent cellular anti-proliferative activity in vivo and in vitro. Excess PGA2 causes an accumulation in both S and G2/M, and a marked decrease in G1. As well there is an increase in DNA content preceeding the G0/G1 peak (indicative of apoptic body formation) mediated by changes in expression levels of Bax and Bcl-2. Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,prostaglandin-a2,,HMDB02752,"InChI=1S/C20H30O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h4,7,12-18,21H,2-3,5-6,8-11H2,1H3,(H,23,24)/b7-4-,14-12+/t16-,17-,18+/m0/s1",,2016-12-05T15:48:06Z,,1679,,,,,99022,HC02203,,"(+)-Prostaglandin A2, 15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoate, 15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoic acid, 15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostenoate, 15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostenoic acid, 15(S)-Prostaglandin A2, 15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylate, 15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylic acid, 15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoate, 15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic acid, Prostaglandin A2",http://vmh.uni.lu/_api/metabolites/1679/?format=pcsv
HC02204,,,-1,C20H31O4,CHEBI:27624,,"Human Metabolome Database (HMDB): Prostaglandin B1 (PGB1) is a metabolite of PGE1. PGE1 is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). PGB1does not inhibit phospholipase activity, but oligomers of PGB1 (PGBx) extracted from human neutrophils inhibit human phospholipases A2 in vitro and in situ in a dose-dependent manner; these oligomers inhibit arachidonic acid mobilization in human neutrophils and endothelial cells. One mechanism for the pharmacological effects of PGBx may be inhibition of cell-associated and extracellular phospholipase A2. PGB1 has the ability to enhance peripheral vascular resistance and elevate blood pressure. The effect is not central in origin and apparently is not the result of changes in cholinergic or alpha-adrenoceptor sensitivity or changes in vascular smooth muscle susceptibility per se. PGB1 blocks S-phase DNA synthesis; inhibition of DNA synthesis does not appear to require elevated levels of cAMP. (PMID: 7667505, 1477202, 2129000, 2597672, 6635328). Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,prostaglandin-b1,,HMDB02982,"InChI=1S/C20H32O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h12,14,17,21H,2-11,13,15H2,1H3,(H,23,24)/b14-12+/t17-/m0/s1",C00959,2016-12-05T15:48:06Z,,1680,,,,,114675,,,"(13E,15S)-15-hydroxy-9-oxoprosta-8(12),13-dien-1-oate, (13E,15S)-15-hydroxy-9-oxoprosta-8(12),13-dien-1-oic acid, 9-Oxo-15S-hydroxy-8(12),13E-prostadienoate, 9-Oxo-15S-hydroxy-8(12),13E-prostadienoic acid, PGB1, Prostaglandin-B1",http://vmh.uni.lu/_api/metabolites/1680/?format=pcsv
HC02205,,,-1,C20H29O4,CHEBI:28099,,"Human Metabolome Database (HMDB): Prostaglandin B2 (PGB2) is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207). Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,prostaglandin-b2,,HMDB04236,"InChI=1S/C20H30O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h4,7,12,14,17,21H,2-3,5-6,8-11,13,15H2,1H3,(H,23,24)/b7-4-,14-12+/t17-/m0/s1",,2016-12-05T15:48:06Z,,1681,,,,,114674,HC02205,,PGB2,http://vmh.uni.lu/_api/metabolites/1681/?format=pcsv
HC02206,,,-1,C20H31O4,CHEBI:15546,,prostaglandin C1(1-),,prostaglandin C1(1-),,,"InChI=1S/C20H32O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h12-14,17-18,21H,2-11,15H2,1H3,(H,23,24)/p-1/b14-12+/t17-,18+/m0/s1",,2016-11-22T15:12:13Z,,1682,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1682/?format=pcsv
HC02207,,,-1,C20H29O4,CHEBI:27555,,prostaglandin-c2,,prostaglandin-c2,,,"InChI=1S/C20H30O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h4,7,12-14,17-18,21H,2-3,5-6,8-11,15H2,1H3,(H,23,24)/b7-4-,14-12+/t17-,18+/m0/s1",,2016-11-22T15:12:13Z,,1683,,,,,440858,HC02207,,,http://vmh.uni.lu/_api/metabolites/1683/?format=pcsv
HC02208,,,-1,C20H33O5,CHEBI:27696,,prostaglandin-d1,,prostaglandin-d1,,,"InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-18,21-22H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,18-/m0/s1",,2016-11-22T15:12:13Z,,1684,,,,,205449,,,,http://vmh.uni.lu/_api/metabolites/1684/?format=pcsv
HC02210,,,-1,C20H29O5,CHEBI:34939,,prostaglandin-d3,,prostaglandin-d3,,,"InChI=1S/C20H30O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h3-4,6-7,12-13,15-18,21-22H,2,5,8-11,14H2,1H3,(H,24,25)/b6-3-,7-4-,13-12+/t15-,16+,17+,18-/m0/s1",,2016-11-22T15:12:13Z,,1685,,,,,656745,,,,http://vmh.uni.lu/_api/metabolites/1685/?format=pcsv
HC02213,,,-1,C20H29O5,CHEBI:28031,,"Human Metabolome Database (HMDB): Prostaglandin E3 is from the cyclooxygenase metabolism of eicosapentaenoic acid.Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,prostaglandin-e3,,HMDB02664,"InChI=1S/C20H30O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h3-4,6-7,12-13,15-17,19,21,23H,2,5,8-11,14H2,1H3,(H,24,25)/b6-3-,7-4-,13-12+/t15-,16+,17+,19+/m0/s1",,2016-12-05T15:48:06Z,,1686,,,,,123733,,,"(-)-prostaglandin E3, 7-[3-Hydroxy-2-(3-hydroxy-1,5-octadienyl)-5-oxocyclopentyl]-5-Heptenoate, 7-[3-Hydroxy-2-(3-hydroxy-1,5-octadienyl)-5-oxocyclopentyl]-5-Heptenoic acid, 7-[3-Hydroxy-2-(3-hydroxy-1,5-octadienyl)-5-oxocyclopentyl]-5-Heptenoic acid stereoisomer, PGE3, Prostaglandin E3",http://vmh.uni.lu/_api/metabolites/1686/?format=pcsv
HC02214,,,-1,C20H35O5,CHEBI:28852,,prostaglandin-f1alpha,,prostaglandin-f1alpha,,,"InChI=1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-19,21-23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,18-,19+/m0/s1",,2016-11-22T15:12:13Z,,1687,,,,,105061,,,,http://vmh.uni.lu/_api/metabolites/1687/?format=pcsv
HC02216,,,-1,C20H33O5,CHEBI:28922,,prostaglandin-f2beta,,prostaglandin-f2beta,,,"InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18+,19+/m0/s1",,2016-11-22T15:12:13Z,,1688,,,,,439702,,,,http://vmh.uni.lu/_api/metabolites/1688/?format=pcsv
HC02217,,,-1,C20H31O6,CHEBI:27647,,prostaglandin-g2,,prostaglandin-g2,,,"InChI=1S/C20H32O6/c1-2-3-6-9-15(24-23)12-13-17-16(18-14-19(17)26-25-18)10-7-4-5-8-11-20(21)22/h4,7,12-13,15-19,23H,2-3,5-6,8-11,14H2,1H3,(H,21,22)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1",,2016-11-22T15:12:14Z,,1689,,,,prostaglandin G2,,,,,http://vmh.uni.lu/_api/metabolites/1689/?format=pcsv
no2,,,-1,NO2,CHEBI:16301,,"Human Metabolome Database (HMDB): Nitrite is a nitrite compound is either a salt or an ester of nitrous acid. Sodium nitrite is used for the curing of meat because it prevents bacterial growth and, in a reaction with the meat's myoglobin, gives the product a desirable dark red color. Nitrite can be reduced to nitric oxide or ammonia by many species of bacteria. Under hypoxic conditions, nitrite may release nitric oxide, which causes potent vasodilation. Several mechanisms for nitrite conversion to NO have been described including enzymatic reduction by xanthine oxidoreductase, the mitochondria, and NO synthase (NOS), as well as nonenzymatic acidic disproportionation. -- Wikipedia.",,Nitrite,,HMDB02786,"InChI=1S/HNO2/c2-1-3/h(H,2,3)/p-1",C00088,2016-12-05T15:48:06Z,,1690,,,,nitrite,24529,no2,,"Nitrite, Nitrite anion, Nitrite ion, Nitrogen dioxide, Nitrogen dioxide ion, Nitrogen peroxide ion",http://vmh.uni.lu/_api/metabolites/1690/?format=pcsv
C01241,,,0,C8H14NO8PR2,CHEBI:15958,,Phosphatidyl-N-methylethanolamine,,Phosphatidyl-N-methylethanolamine,,,,,2016-11-22T15:12:14Z,,1691,,,,,,C01241,,,http://vmh.uni.lu/_api/metabolites/1691/?format=pcsv
C04308,,,-1,C9H15NO8PR2,,,Phosphatidyl-N-dimethylethanolamine,,Phosphatidyl-N-dimethylethanolamine,,,,,2016-11-22T15:12:14Z,,1692,,,,,,C04308,,,http://vmh.uni.lu/_api/metabolites/1692/?format=pcsv
glcn,,,-1,C6H11O7,CHEBI:4157,,"Human Metabolome Database (HMDB): Gluconic acid occurs naturally in fruit, honey and wine and is used as a food additive, an acidity regulator. It is also used in cleaning products where it helps cleaning up mineral deposits. It is a strong chelating agent, especially in alkaline solution. It chelates the anions of calcium, iron, aluminium, copper, and other heavy metals. Glucono delta lactone is a cyclic ester of D-gluconic acid.",,D-gluconate,,HMDB00625,"InChI=1S/C6H12O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-5,7-11H,1H2,(H,12,13)/p-1/t2-,3-,4+,5-/m1/s1",C00257,2016-12-05T15:48:06Z,,1693,,,,,10690,glcn,,"2,3,4,5,6-Pentahydroxy-hexanoate, 2,3,4,5,6-Pentahydroxy-hexanoic acid, 2,3,4,5,6-Pentahydroxyhexanoate, 2,3,4,5,6-Pentahydroxyhexanoic acid, D-Gluco-hexonic acid, D-Gluconate, D-Gluconic acid, D-Gluconsaeure, D-Glukonsaeure, Dextronate, Dextronic acid, GCO, Glosanto, Gluconate, Gluconic acid, Glycogenate, Glycogenic acid, Glyconate, Glyconic acid, Hexonic acid, Maltonate, Maltonic acid, Pentahydroxycaproate, Pentahydroxycaproic acid",http://vmh.uni.lu/_api/metabolites/1693/?format=pcsv
CE2421,,,-4,C39H62N7O18P3S,,,(3S)-3-hydroxylinoleoyl-CoA,,(3S)-3-hydroxylinoleoyl-CoA,,,,,2016-11-22T15:12:14Z,,1694,,,,,53481430,CE2421,,,http://vmh.uni.lu/_api/metabolites/1694/?format=pcsv
CE0713,,,-4,C39H60N7O18P3S,,,3-oxolinoleoyl-CoA,,3-oxolinoleoyl-CoA,,,,,2016-11-22T15:12:14Z,,1695,,,,,,CE0713,,,http://vmh.uni.lu/_api/metabolites/1695/?format=pcsv
C10164,,,-1,C6H4NO2,CHEBI:28747,,"Human Metabolome Database (HMDB): Picolinic acid is a metabolite of the tryptophan catabolism. Picolinic acid is produced under inflammatory conditions and a costimulus with interferon-gamma (IFNgamma) of macrophage (Mphi) effector functions, is a selective inducer of the Mphi inflammatory protein-1alpha (MIP-1alpha) and -1beta (MIPs), two chemokines/cytokines involved in the elicitation of the inflammatory reactions and in the development of the Th1 responses. IFNgamma and picolinic acid have reciprocal effects on the production of MIPs chemokines and the expression of their receptor. The concerted action of IFNgamma and picolinic acid on MIP-1alpha/beta chemokine/receptor system is likely to be of pathophysiological significance and to represent an important regulatory mechanism for leukocyte recruitment and distribution into damaged tissues during inflammatory responses. Picolinic acid has an effect on the production of L-arginine-derived reactive nitrogen intermediates in macrophages, by augmenting IFN-gamma-induced NO2- production, and acts synergistically with IFN-gamma in activating macrophages. Children with acrodermatitis enteropathica (AE) are treated with oral zinc dipicolinate (zinc-PA). The concentration of picolinic acid in the plasma of asymptomatic children with AE was significantly less than that of normal children. However, oral treatment with PA alone is ineffective. The results support the hypothesis that the genetic defect in AE is in the tryptophan pathway, although the role of PA in zinc metabolism remains to be defined. (PMID: 15206716, 8473748, 1701787, 6694049).",,Picolinic acid,,HMDB02243,"InChI=1S/C6H5NO2/c8-6(9)5-3-1-2-4-7-5/h1-4H,(H,8,9)",C10164,2016-12-05T15:48:06Z,,1696,,,,,1018,C10164,,"2-Carboxypyridine, 2-Methoxy-5-aminopyridine, 2-Picolinic acid, 2-Pyridinecarboxylic acid, 4,5-Dehydropipecolic acid, 5-Amino-2-fluoropyridine, 5-Amino-2-methoxypyridine, 5-Amino-2-Pyridinecarboxylic acid, 5-Aminopicolinic acid, 5-Aminopyridine-2-carboxylic acid, 6-Methoxy-pyridin-3-ylamine, a-Pyridinecarboxylic acid, Acide picolique, alpha-Picolinic acid, alpha-Pyridinecarboxylic acid, L-Baikiain, O-Pyridinecarboxylic acid, Phenyl-(2-pyridyl)acetonitrile, Picolinate, PLA, Pyridine-2-carboxylic acid, Pyridine-carboxylique-2, Pyridinecarboxylic acid-(2)",http://vmh.uni.lu/_api/metabolites/1696/?format=pcsv
CE2251,,,-4,C41H68N7O18P3S,,,3-oxoeicosanoyl-CoA,,3-oxoeicosanoyl-CoA,,,"InChI=1S/C41H72N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-29(49)24-32(51)70-23-22-43-31(50)20-21-44-39(54)36(53)41(2,3)26-63-69(60,61)66-68(58,59)62-25-30-35(65-67(55,56)57)34(52)40(64-30)48-28-47-33-37(42)45-27-46-38(33)48/h27-28,30,34-36,40,52-53H,4-26H2,1-3H3,(H,43,50)(H,44,54)(H,58,59)(H,60,61)(H2,42,45,46)(H2,55,56,57)/p-4/t30-,34-,35-,36+,40-/m1/s1",,2016-11-22T15:12:14Z,,1697,,,,,25229571,CE2251,,,http://vmh.uni.lu/_api/metabolites/1697/?format=pcsv
CE2247,,,-4,C41H70N7O18P3S,,,3-hydroxyeicosanoyl-CoA,,3-hydroxyeicosanoyl-CoA,,,"InChI=1S/C41H74N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-29(49)24-32(51)70-23-22-43-31(50)20-21-44-39(54)36(53)41(2,3)26-63-69(60,61)66-68(58,59)62-25-30-35(65-67(55,56)57)34(52)40(64-30)48-28-47-33-37(42)45-27-46-38(33)48/h27-30,34-36,40,49,52-53H,4-26H2,1-3H3,(H,43,50)(H,44,54)(H,58,59)(H,60,61)(H2,42,45,46)(H2,55,56,57)/p-4/t29?,30-,34-,35-,36+,40-/m1/s1",,2016-11-22T15:12:14Z,,1698,,,,,25229587,CE2247,,,http://vmh.uni.lu/_api/metabolites/1698/?format=pcsv
CE2243,,,-4,C41H68N7O17P3S,,,trans-eicos-2-enoyl-CoA,,trans-eicos-2-enoyl-CoA,,,,,2016-11-22T15:12:14Z,,1699,,,,,,CE2243,,,http://vmh.uni.lu/_api/metabolites/1699/?format=pcsv
CE2250,,,-4,C43H72N7O18P3S,,,3-oxodocosanoyl-CoA,,3-oxodocosanoyl-CoA,,,"InChI=1S/C43H76N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-31(51)26-34(53)72-25-24-45-33(52)22-23-46-41(56)38(55)43(2,3)28-65-71(62,63)68-70(60,61)64-27-32-37(67-69(57,58)59)36(54)42(66-32)50-30-49-35-39(44)47-29-48-40(35)50/h29-30,32,36-38,42,54-55H,4-28H2,1-3H3,(H,45,52)(H,46,56)(H,60,61)(H,62,63)(H2,44,47,48)(H2,57,58,59)/p-4/t32-,36-,37-,38+,42-/m1/s1",,2016-11-22T15:12:14Z,,1700,,,,,25229584,CE2250,,,http://vmh.uni.lu/_api/metabolites/1700/?format=pcsv
CE2246,,,-4,C43H74N7O18P3S,,,3-hydroxydocosanoyl-CoA,,3-hydroxydocosanoyl-CoA,,,"InChI=1S/C43H78N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-31(51)26-34(53)72-25-24-45-33(52)22-23-46-41(56)38(55)43(2,3)28-65-71(62,63)68-70(60,61)64-27-32-37(67-69(57,58)59)36(54)42(66-32)50-30-49-35-39(44)47-29-48-40(35)50/h29-32,36-38,42,51,54-55H,4-28H2,1-3H3,(H,45,52)(H,46,56)(H,60,61)(H,62,63)(H2,44,47,48)(H2,57,58,59)/p-4/t31?,32-,36-,37-,38+,42-/m1/s1",,2016-11-22T15:12:14Z,,1701,,,,,25229586,CE2246,,,http://vmh.uni.lu/_api/metabolites/1701/?format=pcsv
CE2242,,,-4,C43H72N7O17P3S,,,trans-docos-2-enoyl-CoA,,trans-docos-2-enoyl-CoA,,,,,2016-11-22T15:12:14Z,,1702,,,,,,CE2242,,,http://vmh.uni.lu/_api/metabolites/1702/?format=pcsv
CE2254,,,-4,C43H74N7O17P3S,168166,,"Human Metabolome Database (HMDB): Docosanoyl-CoA is an acyl-CoA with the C-22 fatty acid Acyl chain moiety. Acyl-CoA (or formyl-CoA) is a coenzyme involved in the metabolism of fatty acids. It is a temporary compound formed when coenzyme A (CoA) attaches to the end of a long-chain fatty acid, inside living cells. The CoA is then removed from the chain, carrying two carbons from the chain with it, forming acetyl-CoA. This is then used in the citric acid cycle to start a chain of reactions, eventually forming many adenosine triphosphates. To be oxidatively degraded, a fatty acid must first be activated in a two-step reaction catalyzed by acyl-CoA synthetase. First, the fatty acid displaces the diphosphate group of ATP, then coenzyme A (HSCoA) displaces the AMP group to form an Acyl-CoA. The acyladenylate product of the first step has a large free energy of hydrolysis and conserves the free energy of the cleaved phosphoanhydride bond in ATP. The second step, transfer of the acyl group to CoA (the same molecule that carries acetyl groups as acetyl-CoA), conserves free energy in the formation of a thioester bond. Consequently, the overall reaction Fatty acid + CoA + ATP <=> Acyl-CoA + AMP + PPi has a free energy change near zero. Subsequent hydrolysis of the product PPi (by the enzyme inorganic pyrophosphatase) is highly exergonic, and this reaction makes the formation of acyl-CoA spontaneous and irreversible. Fatty acids are activated in the cytosol, but oxidation occurs in the mitochondria. Because there is no transport protein for CoA adducts, acyl groups must enter the mitochondria via a shuttle system involving the small molecule carnitine.",,docosanoyl-CoA,,HMDB12930,,C16528,2016-12-05T15:48:06Z,,1703,,,,,168166,,,"Behenoyl-CoA, Behenoyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/1703/?format=pcsv
CE2253,,,-4,C45H76N7O18P3S,,,3-oxotetracosanoyl-CoA,,3-oxotetracosanoyl-CoA,,,"InChI=1S/C45H80N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-33(53)28-36(55)74-27-26-47-35(54)24-25-48-43(58)40(57)45(2,3)30-67-73(64,65)70-72(62,63)66-29-34-39(69-71(59,60)61)38(56)44(68-34)52-32-51-37-41(46)49-31-50-42(37)52/h31-32,34,38-40,44,56-57H,4-30H2,1-3H3,(H,47,54)(H,48,58)(H,62,63)(H,64,65)(H2,46,49,50)(H2,59,60,61)/t34-,38-,39-,40+,44-/m1/s1",,2016-11-22T15:12:14Z,,1704,,,,,25229583,CE2253,,,http://vmh.uni.lu/_api/metabolites/1704/?format=pcsv
CE2249,,,-4,C45H78N7O18P3S,,,3-hydroxytetracosanoyl-CoA,,3-hydroxytetracosanoyl-CoA,,,"InChI=1S/C45H82N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-33(53)28-36(55)74-27-26-47-35(54)24-25-48-43(58)40(57)45(2,3)30-67-73(64,65)70-72(62,63)66-29-34-39(69-71(59,60)61)38(56)44(68-34)52-32-51-37-41(46)49-31-50-42(37)52/h31-34,38-40,44,53,56-57H,4-30H2,1-3H3,(H,47,54)(H,48,58)(H,62,63)(H,64,65)(H2,46,49,50)(H2,59,60,61)/p-4/t33?,34-,38-,39-,40+,44-/m1/s1",,2016-11-22T15:12:14Z,,1705,,,,,25229585,CE2249,,,http://vmh.uni.lu/_api/metabolites/1705/?format=pcsv
CE2245,,,-4,C45H76N7O17P3S,,,trans-tetracos-2-enoyl-CoA,,trans-tetracos-2-enoyl-CoA,,,,,2016-11-22T15:12:14Z,,1706,,,,,,CE2245,,,http://vmh.uni.lu/_api/metabolites/1706/?format=pcsv
CE2257,,,-4,C45H78N7O17P3S,3082227,,Human Metabolome Database (HMDB): Tetracosanoyl-CoA is an intermediate in the biosynthesis of unsaturated fatty acids. Tetracosanoyl-CoA is converted from Palmitoyl-CoA in multiple steps. It is then converted to lignoceric acid via a thiol-ester hydrolase (E 3.1.2.-).,,tetracosanoyl-CoA,,HMDB06526,"InChI=1S/C45H82N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h32-34,38-40,44,55-56H,4-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/p-4/t34-,38-,39-,40+,44-/m1/s1",C16529,2016-12-05T15:48:06Z,,1707,,,,,3082227,,,"Lignoceroyl-CoA, Lignoceroyl-Coenzyme A, S-Tetracosanoate, S-Tetracosanoate CoA, S-Tetracosanoate Coenzyme A, S-Tetracosanoic acid, Tetracosanoyl-coenzyme A",http://vmh.uni.lu/_api/metabolites/1707/?format=pcsv
C08281,,,-1,C22H43O2,8215,,"Human Metabolome Database (HMDB): Behenic acid, also docosanoic acid, is a normal carboxylic acid, a fatty acid with formula C21H43COOH. -- Wikipedia; It is an important constituent of the behen oil extracted from the seeds of the Ben-oil tree, and it is so named from the Persian month Bahman when the roots of this tree were harvested. -- Wikipedia.",,behenate,,HMDB00944,"InChI=1S/C22H44O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h2-21H2,1H3,(H,23,24)/p-1",C08281,2016-12-05T15:48:06Z,,1708,,,,,8215,,,"1-Docosanoate, 1-Docosanoic acid, B 95, Behenate, Behenic acid, Edenor C 22-85R, EXL 5, Glycon B 70, Hydrofol 2022-55, Hydrofol acid 560, N-Docosanoate, N-Docosanoic acid, Prifac 2987",http://vmh.uni.lu/_api/metabolites/1708/?format=pcsv
CE2248,,,-4,C39H66N7O18P3S,,,3-hydroxyoctadecanoyl-CoA,,3-hydroxyoctadecanoyl-CoA,,,"InChI=1S/C39H70N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-27(47)22-30(49)68-21-20-41-29(48)18-19-42-37(52)34(51)39(2,3)24-61-67(58,59)64-66(56,57)60-23-28-33(63-65(53,54)55)32(50)38(62-28)46-26-45-31-35(40)43-25-44-36(31)46/h25-28,32-34,38,47,50-51H,4-24H2,1-3H3,(H,41,48)(H,42,52)(H,56,57)(H,58,59)(H2,40,43,44)(H2,53,54,55)/p-4/t27?,28-,32-,33-,34+,38-/m1/s1",C16217,2016-11-22T15:12:14Z,,1709,,,,,24906329,,,,http://vmh.uni.lu/_api/metabolites/1709/?format=pcsv
CE1935,,,3,C10H26N3O,,,spermine monoaldehyde,,spermine monoaldehyde,,,,,2016-11-22T15:12:14Z,,1710,,,,,,CE1935,,,http://vmh.uni.lu/_api/metabolites/1710/?format=pcsv
CE1940,,,2,C7H18N2O,,,spermidine monoaldehyde 2,,spermidine monoaldehyde 2,,,,,2016-11-22T15:12:14Z,,1711,,,,,19913541,CE1940,,,http://vmh.uni.lu/_api/metabolites/1711/?format=pcsv
CE1943,,,1,C7H14NO2,,,spermidine dialdehyde,,spermidine dialdehyde,,,,,2016-11-22T15:12:14Z,,1712,,,,,,CE1943,,,http://vmh.uni.lu/_api/metabolites/1712/?format=pcsv
CE1944,,,1,C4H8N,CHEBI:19092,,1-pyrrolinium,,1-pyrrolinium,,,"InChI=1S/C4H7N/c1-2-4-5-3-1/h3H,1-2,4H2/p+1",C15668,2016-11-22T15:12:14Z,,1713,,,,,79803,CE1944,,,http://vmh.uni.lu/_api/metabolites/1713/?format=pcsv
CE2011,,,0,CHNOS,,,hypothiocyanite,,hypothiocyanite,,,,,2016-11-22T15:12:14Z,,1714,,,,,124985,CE2011,,,http://vmh.uni.lu/_api/metabolites/1714/?format=pcsv
CE1936,,,2,C10H22N2O2,,,spermine dialdehyde,,spermine dialdehyde,,,,,2016-11-22T15:12:14Z,,1715,,,,,217390,CE1936,,,http://vmh.uni.lu/_api/metabolites/1715/?format=pcsv
CE1939,,,2,C7H18N2O,,,spermidine monoaldehyde 1,,spermidine monoaldehyde 1,,,,,2016-11-22T15:12:14Z,,1716,,,,,145925,CE1939,,,http://vmh.uni.lu/_api/metabolites/1716/?format=pcsv
CE2705,,,0,C9H13N5O3,,,Human Metabolome Database (HMDB): Dihydrobiopterin (BH2) is an oxidation product of tetrahydrobiopterin. Tetrahydrobiopterin is a natural occurring cofactor of the aromatic amino acid hydroxylase and is involved in the synthesis of tyrosine and the neurotransmitters dopamine and serotonin. Tetrahydrobiopterin is also essential for nitric oxide synthase catalyzed oxidation of L-arginine to L-citrulline and nitric oxide.,,quinonoid dihydrobiopterin,,HMDB00038,,C02953,2016-12-05T15:48:06Z,,1717,,,,,252,CE2705,,"(6R)-6-(L-erythro-1,2-Dihydroxypropyl)-7,8-dihydro-6H-pterin, (S-(R*,S*))-2-amino-6-(1,2-dihydroxypropyl)-7,8-dihydro-4(1H)-Pteridinone, 2-Amino-6-((1R,2S)-1,2-dihydroxypropyl)-7,8-dihydro-4(1H)-Pteridinone, 2-Amino-6-(1,2-dihydroxypropyl)-7,8-dihydro-4(1H)-Pteridinone, 6,7-Dihydrobiopterin, 7,8-Dihydro-L-biopterin, 7,8-Dihydrobiopterin, BH2, Dihydrobiopterin, L-Erythro-1-(2-amino-7,8-dihydro-4-hydroxy-6-pteridinyl)-1,2-Propanediol, L-Erythro-7,8-Dihydrobiopterin, L-Erythro-Dihydrobiopterin, L-Erythro-q-Dihydrobiopterin, Quinoid-dihydrobiopterin, Quinonoid dihydrobiopterin",http://vmh.uni.lu/_api/metabolites/1717/?format=pcsv
CE1787,,,1,C12H25N2O7,,,1-deoxy-1-(N6-lysino)-D-fructose,,1-deoxy-1-(N6-lysino)-D-fructose,,,,,2016-11-22T15:12:14Z,,1718,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1718/?format=pcsv
CE2846,,,-1,C12H24N2O10P,,,fructoselysine 3-phosphate,,fructoselysine 3-phosphate,,,,,2016-11-22T15:12:14Z,,1719,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1719/?format=pcsv
CE2847,,,0,C8H15NO7,CHEBI:24108,,fructoseglycine,,fructoseglycine,,,"InChI=1S/C8H15NO7/c10-3-5(12)8(16)7(15)4(11)1-9-2-6(13)14/h5,7-10,12,15-16H,1-3H2,(H,13,14)/t5-,7-,8-/m1/s1",,2016-11-22T15:12:14Z,,1720,,,,,3081391,,,,http://vmh.uni.lu/_api/metabolites/1720/?format=pcsv
CE2848,,,-2,C8H14NO10P,,,fructoseglycine ketone 3-phosphate,,fructoseglycine ketone 3-phosphate,,,,,2016-11-22T15:12:14Z,,1721,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1721/?format=pcsv
CE2870,,,-1,C15H12I2NO7S,,,"3,3'-diiodo-L-thyronine 4'-O-sulfate",,"3,3'-diiodo-L-thyronine 4'-O-sulfate",,,,,2016-11-22T15:12:14Z,,1722,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1722/?format=pcsv
CE2866,,,0,C15H13I2NO4,,,"3,3'-diiodo-L-thyronine",,"3,3'-diiodo-L-thyronine",,,"InChI=1S/C15H13I2NO4/c16-10-7-9(2-3-13(10)19)22-14-4-1-8(5-11(14)17)6-12(18)15(20)21/h1-5,7,12,19H,6,18H2,(H,20,21)/t12-/m0/s1",,2016-11-22T15:12:14Z,,1723,,,,,107564,,,,http://vmh.uni.lu/_api/metabolites/1723/?format=pcsv
maltttr,,,0,C24H42O21,,,Maltotetraose,,Maltotetraose,,,"InChI=1/C24H42O21/c25-1-5-9(29)10(30)15(35)22(40-5)44-19-7(3-27)42-24(17(37)12(19)32)45-20-8(4-28)41-23(16(36)13(20)33)43-18-6(2-26)39-21(38)14(34)11(18)31/h5-38H,1-4H2/t5-,6-,7-,8-,9-,10+,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21u,22-,23-,24-/m1/s1",C02052,2016-11-22T15:12:14Z,,1724,,,,,439639,maltttr,,,http://vmh.uni.lu/_api/metabolites/1724/?format=pcsv
CE2873,,,-1,C15H12I2NO7S,,,"3',5'-diiodo-L-thyronine 4'-O-sulfate",,"3',5'-diiodo-L-thyronine 4'-O-sulfate",,,"InChI=1/C15H13I2NO7S/c16-11-6-10(7-12(17)14(11)25-26(21,22)23)24-9-3-1-8(2-4-9)5-13(18)15(19)20/h1-4,6-7,13H,5,18H2,(H,19,20)(H,21,22,23)/p-1/t13-/m1/s1",,2016-11-22T15:12:14Z,,1725,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1725/?format=pcsv
CE2872,,,0,C15H13I2NO4,,,"3',5'-diiodo-L-thyronine",,"3',5'-diiodo-L-thyronine",,,"InChI=1/C15H13I2NO4/c16-11-6-10(7-12(17)14(11)19)22-9-3-1-8(2-4-9)5-13(18)15(20)21/h1-4,6-7,13,19H,5,18H2,(H,20,21)/t13-/m1/s1",,2016-11-22T15:12:14Z,,1726,,,,,67894139,,,,http://vmh.uni.lu/_api/metabolites/1726/?format=pcsv
CE2875,,,-1,C15H13INO7S,,,3'-monoiodo-L-thyronine 4'-O-sulfate,,3'-monoiodo-L-thyronine 4'-O-sulfate,,,"InChI=1/C15H14INO7S/c16-12-8-11(5-6-14(12)24-25(20,21)22)23-10-3-1-9(2-4-10)7-13(17)15(18)19/h1-6,8,13H,7,17H2,(H,18,19)(H,20,21,22)/p-1/t13-/m1/s1",,2016-11-22T15:12:14Z,,1727,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1727/?format=pcsv
CE2874,,,0,C15H14INO4,,,3'-monoiodo-L-thyronine,,3'-monoiodo-L-thyronine,,,"InChI=1/C15H14INO4/c16-12-8-11(5-6-14(12)18)21-10-3-1-9(2-4-10)7-13(17)15(19)20/h1-6,8,13,18H,7,17H2,(H,19,20)/t13-/m1/s1",,2016-11-22T15:12:14Z,,1728,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1728/?format=pcsv
CE2876,,,-1,C21H20I2NO10,,,"3',5'-diiodo-L-thyronine-beta-D-glucuronoside",,"3',5'-diiodo-L-thyronine-beta-D-glucuronoside",,,"InChI=1/C21H21I2NO10/c22-11-6-10(32-9-3-1-8(2-4-9)5-13(24)19(28)29)7-12(23)17(11)33-21-16(27)14(25)15(26)18(34-21)20(30)31/h1-4,6-7,13-16,18,21,25-27H,5,24H2,(H,28,29)(H,30,31)/p-1/t13-,14+,15-,16+,18+,21?/m1/s1",,2016-11-22T15:12:14Z,,1729,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1729/?format=pcsv
CE2877,,,-1,C21H18I4NO10,,,"3,5,3',5'-tetraiodo-L-thyronine-beta-D-glucuronoside",,"3,5,3',5'-tetraiodo-L-thyronine-beta-D-glucuronoside",,,"InChI=1/C21H19I4NO10/c22-8-1-6(3-12(26)19(30)31)2-9(23)16(8)34-7-4-10(24)17(11(25)5-7)35-21-15(29)13(27)14(28)18(36-21)20(32)33/h1-2,4-5,12-15,18,21,27-29H,3,26H2,(H,30,31)(H,32,33)/p-1/t12-,13+,14-,15+,18+,21?/m1/s1",,2016-11-22T15:12:14Z,,1730,,,,,,CE2877,,,http://vmh.uni.lu/_api/metabolites/1730/?format=pcsv
CE2754,,,0,C15H12I3NO4,CHEBI:28774,,"3,3',5' - triiodothyronine",,"3,3',5' - triiodothyronine",,,,,2016-11-22T15:12:14Z,,1731,,,,,53393659,,,,http://vmh.uni.lu/_api/metabolites/1731/?format=pcsv
CE2878,,,-1,C21H19I3NO10,,,"3,3',5'-triiodo-L-thyronine-beta-D-glucuronoside",,"3,3',5'-triiodo-L-thyronine-beta-D-glucuronoside",,,,,2016-11-22T15:12:14Z,,1732,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1732/?format=pcsv
CE2879,,,-1,C21H19I3NO10,,,"3,5,3'-triiodo-L-thyronine-beta-D-glucuronoside",,"3,5,3'-triiodo-L-thyronine-beta-D-glucuronoside",,,,,2016-11-22T15:12:14Z,,1733,,,,,,CE2879,,,http://vmh.uni.lu/_api/metabolites/1733/?format=pcsv
CE2880,,,-1,C21H20I2NO10,,,"3,3'-diiodo-L-thyronine-beta-D-glucuronoside",,"3,3'-diiodo-L-thyronine-beta-D-glucuronoside",,,,,2016-11-22T15:12:14Z,,1734,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1734/?format=pcsv
CE2881,,,-1,C14H7I4O4,,,"3,5,3',5'-tetraiodothyroacetate",,"3,5,3',5'-tetraiodothyroacetate",,,,,2016-11-22T15:12:14Z,,1735,,,,,65552,,,,http://vmh.uni.lu/_api/metabolites/1735/?format=pcsv
CE2885,,,-2,C20H14I4O10,,,"3,5,3',5'-tetraiodothyroacetate-beta-D-glucuronoside",,"3,5,3',5'-tetraiodothyroacetate-beta-D-glucuronoside",,,,,2016-11-22T15:12:14Z,,1736,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1736/?format=pcsv
CE2882,,,-1,C14H8I3O4,,,"3,3',5'-triiodothyroacetate",,"3,3',5'-triiodothyroacetate",,,,,2016-11-22T15:12:14Z,,1737,,,,,22660069,,,,http://vmh.uni.lu/_api/metabolites/1737/?format=pcsv
CE2886,,,-2,C20H15I3O10,,,"3,3',5'-triiodothyroacetate-beta-D-glucuronoside",,"3,3',5'-triiodothyroacetate-beta-D-glucuronoside",,,,,2016-11-22T15:12:14Z,,1738,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1738/?format=pcsv
maltpt,,,0,C30H52O26,,,maltopentaose,,maltopentaose,,,,,2016-11-22T15:12:14Z,,1739,,,,,13489094,maltpt,,,http://vmh.uni.lu/_api/metabolites/1739/?format=pcsv
CE2883,,,-1,C14H8I3O4,,,"3,5,3'-triiodothyroacetate",,"3,5,3'-triiodothyroacetate",,,,,2016-11-22T15:12:14Z,,1740,,,,,5803,,,,http://vmh.uni.lu/_api/metabolites/1740/?format=pcsv
CE2887,,,-2,C20H15I3O10,,,"3,5,3'-triiodothyroacetate-beta-D-glucuronoside",,"3,5,3'-triiodothyroacetate-beta-D-glucuronoside",,,,,2016-11-22T15:12:14Z,,1741,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1741/?format=pcsv
CE2884,,,-1,C14H9I2O4,,,"3',5'-diiodothyroacetate",,"3',5'-diiodothyroacetate",,,,,2016-11-22T15:12:14Z,,1742,,,,,4532725,,,,http://vmh.uni.lu/_api/metabolites/1742/?format=pcsv
CE2888,,,-2,C20H16I2O10,,,"3',5'-diiodothyroacetate-beta-D-glucuronoside",,"3',5'-diiodothyroacetate-beta-D-glucuronoside",,,,,2016-11-22T15:12:14Z,,1743,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1743/?format=pcsv
malthx,,,0,C36H62O31,,,Maltohexaose,,Maltohexaose,,,"InChI=1/C36H62O31/c37-1-7-13(43)14(44)21(51)32(58-7)64-27-9(3-39)60-34(23(53)16(27)46)66-29-11(5-41)62-36(25(55)18(29)48)67-30-12(6-42)61-35(24(54)19(30)49)65-28-10(4-40)59-33(22(52)17(28)47)63-26-8(2-38)57-31(56)20(50)15(26)45/h7-56H,1-6H2/t7-,8-,9-,10-,11-,12-,13-,14+,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31?,32-,33-,34-,35-,36-/m1/s1",C01936,2016-11-22T15:12:14Z,,1744,,,,,439606,malthx,,,http://vmh.uni.lu/_api/metabolites/1744/?format=pcsv
CE2915,,,-1,C44H60N7O11,,,beta-casomorphin,,beta-casomorphin,,,"InChI=1/C44H61N7O11/c1-5-26(4)37(44(61)62)49-40(57)34-14-10-22-51(34)43(60)31(19-20-35(53)54)46-41(58)36(25(2)3)48-38(55)32(24-27-11-7-6-8-12-27)47-39(56)33-13-9-21-50(33)42(59)30(45)23-28-15-17-29(52)18-16-28/h6-8,11-12,15-18,25-26,30-34,36-37,52H,5,9-10,13-14,19-24,45H2,1-4H3,(H,46,58)(H,47,56)(H,48,55)(H,49,57)(H,53,54)(H,61,62)/p-1/t26-,30-,31+,32+,33-,34+,36-,37-/m1/s1",,2016-11-22T15:12:14Z,,1745,,,,,4424653,,,,http://vmh.uni.lu/_api/metabolites/1745/?format=pcsv
CE4722,,,-1,C38H49N6O10,,,beta-casomorphin (1-6),,beta-casomorphin (1-6),,,"InChI=1/C38H50N6O10/c1-22(2)32(35(50)40-27(16-17-31(46)47)37(52)44-19-7-11-30(44)38(53)54)42-33(48)28(21-23-8-4-3-5-9-23)41-34(49)29-10-6-18-43(29)36(51)26(39)20-24-12-14-25(45)15-13-24/h3-5,8-9,12-15,22,26-30,32,45H,6-7,10-11,16-21,39H2,1-2H3,(H,40,50)(H,41,49)(H,42,48)(H,46,47)(H,53,54)/p-1/t26-,27+,28+,29-,30+,32-/m1/s1",,2016-11-22T15:12:14Z,,1746,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1746/?format=pcsv
CE2916,,,-1,C35H51N6O10,,,neocasomorphin,,neocasomorphin,,,"InChI=1/C35H52N6O10/c1-5-20(4)29(35(50)51)39-31(46)26-9-7-17-41(26)34(49)24(14-15-27(43)44)37-32(47)28(19(2)3)38-30(45)25-8-6-16-40(25)33(48)23(36)18-21-10-12-22(42)13-11-21/h10-13,19-20,23-26,28-29,42H,5-9,14-18,36H2,1-4H3,(H,37,47)(H,38,45)(H,39,46)(H,43,44)(H,50,51)/p-1/t20-,23+,24+,25+,26+,28-,29-/m0/s1",,2016-11-22T15:12:14Z,,1747,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1747/?format=pcsv
CE4723,,,-1,C29H40N5O9,,,neocasomorphin (1-5),,neocasomorphin (1-5),,,"InChI=1/C29H41N5O9/c1-16(2)24(26(39)31-20(11-12-23(36)37)28(41)34-14-4-6-22(34)29(42)43)32-25(38)21-5-3-13-33(21)27(40)19(30)15-17-7-9-18(35)10-8-17/h7-10,16,19-22,24,35H,3-6,11-15,30H2,1-2H3,(H,31,39)(H,32,38)(H,36,37)(H,42,43)/p-1/t19-,20-,21-,22-,24+/m1/s1",,2016-11-22T15:12:14Z,,1748,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1748/?format=pcsv
CE2917,,,3,C69H114N23O16S,,,apelin-13,,apelin-13,,,"InChI=1/C69H111N23O16S/c1-39(2)32-47(86-58(98)44(17-9-26-78-68(73)74)83-63(103)52-20-12-29-91(52)65(105)45(18-10-27-79-69(75)76)84-56(96)42(71)22-23-54(72)94)59(99)89-50(37-93)61(101)87-48(34-41-35-77-38-81-41)60(100)82-43(16-7-8-25-70)57(97)80-36-55(95)90-28-11-19-51(90)62(102)85-46(24-31-109-3)66(106)92-30-13-21-53(92)64(104)88-49(67(107)108)33-40-14-5-4-6-15-40/h4-6,14-15,35,38-39,42-53,93H,7-13,16-34,36-37,70-71H2,1-3H3,(H2,72,94)(H,77,81)(H,80,97)(H,82,100)(H,83,103)(H,84,96)(H,85,102)(H,86,98)(H,87,101)(H,88,104)(H,89,99)(H,107,108)(H4,73,74,78)(H4,75,76,79)/p+3/t42-,43-,44-,45+,46-,47+,48+,49+,50-,51+,52+,53-/m1/s1",,2016-11-22T15:12:14Z,,1749,,,,,53481538,,,,http://vmh.uni.lu/_api/metabolites/1749/?format=pcsv
CE4724,,,3,C60H105N22O15S,,,apelin (1-12),,apelin (1-12),,,"InChI=1/C60H102N22O15S/c1-33(2)27-40(77-50(88)37(12-6-21-69-59(64)65)74-55(93)44-15-9-24-81(44)56(94)38(13-7-22-70-60(66)67)75-48(86)35(62)17-18-46(63)84)51(89)79-42(31-83)53(91)78-41(28-34-29-68-32-72-34)52(90)73-36(11-4-5-20-61)49(87)71-30-47(85)80-23-8-14-43(80)54(92)76-39(19-26-98-3)57(95)82-25-10-16-45(82)58(96)97/h29,32-33,35-45,83H,4-28,30-31,61-62H2,1-3H3,(H2,63,84)(H,68,72)(H,71,87)(H,73,90)(H,74,93)(H,75,86)(H,76,92)(H,77,88)(H,78,91)(H,79,89)(H,96,97)(H4,64,65,69)(H4,66,67,70)/p+3/t35-,36-,37-,38+,39-,40+,41+,42-,43+,44+,45-/m1/s1",,2016-11-22T15:12:14Z,,1750,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1750/?format=pcsv
malthp,,,0,C42H72O36,,,maltoheptaose,,maltoheptaose,,,"InChI=1/C42H72O36/c43-1-8-15(50)16(51)24(59)37(67-8)74-31-10(3-45)69-39(26(61)18(31)53)76-33-12(5-47)71-41(28(63)20(33)55)78-35-14(7-49)72-42(29(64)22(35)57)77-34-13(6-48)70-40(27(62)21(34)56)75-32-11(4-46)68-38(25(60)19(32)54)73-30-9(2-44)66-36(65)23(58)17(30)52/h8-65H,1-7H2/t8-,9-,10-,11-,12-,13-,14-,15+,16+,17-,18-,19-,20-,21-,22-,23+,24+,25+,26+,27+,28+,29+,30+,31+,32+,33+,34+,35+,36u,37+,38+,39+,40+,41+,42+/m1/s1",,2016-11-22T15:12:14Z,,1751,,,,,,malthp,,,http://vmh.uni.lu/_api/metabolites/1751/?format=pcsv
CE2839,,,0,C60H102O51,,,maltodecaose,,maltodecaose,,,"InChI=1/C60H102O51/c61-1-11-21(71)22(72)33(83)52(94-11)104-43-13(3-63)96-54(35(85)24(43)74)106-45-15(5-65)98-56(37(87)26(45)76)108-47-17(7-67)100-58(39(89)28(47)78)110-49-19(9-69)102-60(41(91)30(49)80)111-50-20(10-70)101-59(40(90)31(50)81)109-48-18(8-68)99-57(38(88)29(48)79)107-46-16(6-66)97-55(36(86)27(46)77)105-44-14(4-64)95-53(34(84)25(44)75)103-42-12(2-62)93-51(92)32(82)23(42)73/h11-92H,1-10H2/t11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21+,22+,23-,24-,25-,26-,27-,28-,29-,30-,31-,32+,33+,34+,35+,36+,37+,38+,39+,40+,41+,42+,43+,44+,45+,46+,47+,48+,49+,50+,51u,52+,53+,54+,55+,56+,57+,58+,59+,60+/m1/s1",,2016-11-22T15:12:14Z,,1752,,,,,53481573,,,,http://vmh.uni.lu/_api/metabolites/1752/?format=pcsv
CE2838,,,0,C54H92O46,,,maltononaose,,maltononaose,,,"InChI=1/C54H92O46/c55-1-10-19(64)20(65)30(75)47(85-10)94-39-12(3-57)87-49(32(77)22(39)67)96-41-14(5-59)89-51(34(79)24(41)69)98-43-16(7-61)91-53(36(81)26(43)71)100-45-18(9-63)92-54(37(82)28(45)73)99-44-17(8-62)90-52(35(80)27(44)72)97-42-15(6-60)88-50(33(78)25(42)70)95-40-13(4-58)86-48(31(76)23(40)68)93-38-11(2-56)84-46(83)29(74)21(38)66/h10-83H,1-9H2/t10-,11-,12-,13-,14-,15-,16-,17-,18-,19+,20+,21-,22-,23-,24-,25-,26-,27-,28-,29+,30+,31+,32+,33+,34+,35+,36+,37+,38+,39+,40+,41+,42+,43+,44+,45+,46u,47+,48+,49+,50+,51+,52+,53+,54+/m1/s1",,2016-11-22T15:12:14Z,,1753,,,,,3081402,,,,http://vmh.uni.lu/_api/metabolites/1753/?format=pcsv
CE1950,,,0,CH2NO2S,,,cyanosulfurous acid anion,,cyanosulfurous acid anion,,,InChI=1/CHNO2S/c2-1-5(3)4/h3H/q-1,,2016-11-22T15:12:14Z,,1754,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1754/?format=pcsv
cynt,,,-1,CNO,,,Cyanate,,Cyanate,,,InChI=1S/CHNO/c2-1-3/h3H/p-1,C01417,2016-11-22T15:12:15Z,,1755,,,,,540,,,,http://vmh.uni.lu/_api/metabolites/1755/?format=pcsv
C01836,,,1,C78H122N21O20,CHEBI:7542,,Neurotensin,,Neurotensin,,,"InChI=1S/C78H121N21O20/c1-7-43(6)63(73(115)96-57(76(118)119)37-42(4)5)97-70(112)55(39-45-21-25-47(101)26-22-45)95-72(114)59-18-13-35-99(59)75(117)52(16-11-33-86-78(83)84)90-64(106)48(15-10-32-85-77(81)82)89-71(113)58-17-12-34-98(58)74(116)51(14-8-9-31-79)91-69(111)56(40-60(80)102)94-66(108)50(28-30-62(104)105)88-68(110)54(38-44-19-23-46(100)24-20-44)93-67(109)53(36-41(2)3)92-65(107)49-27-29-61(103)87-49/h19-26,41-43,48-59,63,100-101H,7-18,27-40,79H2,1-6H3,(H2,80,102)(H,87,103)(H,88,110)(H,89,113)(H,90,106)(H,91,111)(H,92,107)(H,93,109)(H,94,108)(H,95,114)(H,96,115)(H,97,112)(H,104,105)(H,118,119)(H4,81,82,85)(H4,83,84,86)",,2016-11-22T15:12:15Z,,1756,,,,,25078013,,,,http://vmh.uni.lu/_api/metabolites/1756/?format=pcsv
CE2862,,,1,C57H91N18O16,,,neurotensin 1-10,,neurotensin 1-10,,,,,2016-11-22T15:12:15Z,,1757,,,,,53481584,,,,http://vmh.uni.lu/_api/metabolites/1757/?format=pcsv
CE2863,,,0,C21H33N3O5,,,neurotensin 11-13,,neurotensin 11-13,,,,,2016-11-22T15:12:15Z,,1758,,,,,53481585,,,,http://vmh.uni.lu/_api/metabolites/1758/?format=pcsv
CE2858,,,2,C46H74N14O10,,,dynorphin A 1-8,,dynorphin A 1-8,,,,,2016-11-22T15:12:15Z,,1759,,,,,53481552,,,,http://vmh.uni.lu/_api/metabolites/1759/?format=pcsv
CE2751,,,0,C28H37N5O7,,,dynorphin A (1-5),,dynorphin A (1-5),,,,,2016-11-22T15:12:15Z,,1760,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1760/?format=pcsv
CE2890,,,2,C18H39N9O4,,,dynorphin A (6-8),,dynorphin A (6-8),,,,,2016-11-22T15:12:15Z,,1761,,,,,53481551,,,,http://vmh.uni.lu/_api/metabolites/1761/?format=pcsv
CE2891,,,3,C74H118N21O17,,,dynorphin B,,dynorphin B,,,"InChI=1S/C74H115N21O17/c1-40(2)34-53(91-68(107)54(36-44-18-10-8-11-19-44)86-58(100)39-84-57(99)38-85-62(101)48(76)35-46-25-27-47(97)28-26-46)67(106)89-51(24-17-33-83-74(80)81)63(102)87-50(23-16-32-82-73(78)79)64(103)90-52(29-30-56(77)98)65(104)92-55(37-45-20-12-9-13-21-45)69(108)88-49(22-14-15-31-75)66(105)93-59(41(3)4)70(109)94-60(42(5)6)71(110)95-61(43(7)96)72(111)112/h8-13,18-21,25-28,40-43,48-55,59-61,96-97H,14-17,22-24,29-39,75-76H2,1-7H3,(H2,77,98)(H,84,99)(H,85,101)(H,86,100)(H,87,102)(H,88,108)(H,89,106)(H,90,103)(H,91,107)(H,92,104)(H,93,105)(H,94,109)(H,95,110)(H,111,112)(H4,78,79,82)(H4,80,81,83)/t43-,48+,49+,50+,51+,52+,53+,54+,55+,59+,60+,61+/m1/s1",,2016-11-22T15:12:15Z,,1762,,,,,25075991,,,,http://vmh.uni.lu/_api/metabolites/1762/?format=pcsv
CE4753,,,1,C20H40N5O6,,,dynorphin B (10-13),,dynorphin B (10-13),,,,,2016-11-22T15:12:15Z,,1763,,,,,53481556,,,,http://vmh.uni.lu/_api/metabolites/1763/?format=pcsv
CE4754,,,2,C26H45N11O6,,,dynorphin B (6-9),,dynorphin B (6-9),,,,,2016-11-22T15:12:15Z,,1764,,,,,53481557,,,,http://vmh.uni.lu/_api/metabolites/1764/?format=pcsv
CE0737,,,-1,C3H3O2,,,"Human Metabolome Database (HMDB): Malondialdehyde (MDA) is the dialdehyde of malonic acid and a biomarker of oxidative damage to lipids caused by smoking. Oxidized lipids are able to produce MDA as a decomposition product. The mechanism is thought to involve formation of prostaglandin-like endoperoxides from polyunsaturated fatty acids with two or more double bonds. An alternative mechanism is based on successive hydroperoxide formation and &#946;-cleavage of polyunsaturated fatty acids. MDA is then directly formed by &#946;-scission of a 3-hydroperoxyaldehyde or by reaction between acrolein and hydroxyl radicals. While oxidation of polyunsaturated fatty acids is the major source of MDA in vivo, other minor sources exists such as byproducts of free radical generation by ionizing radiation and of the biosynthesis of prostaglandins. Aldehydes are generally reactive species capable of forming adducts and complexes in biological systems and MDA is no exception although the main species at physiological pH is the enolate ion which is of relative low reactivity. Consistent evidence is available for the reaction between MDA and cellular macromolecules such as proteins, RNA and DNA. MDA reacts with DNA to form adducts to deoxyguanosine and deoxyadenosine which may be mutagenic and these can be quantified in several human tissues. Oxidative stress is an imbalance between oxidants and antioxidants on a cellular or individual level. Oxidative damage is one result of such an imbalance and includes oxidative modification of cellular macromolecules, induction of cell death by apoptosis or necrosis, as well as structural tissue damage. Chemically speaking, oxidants are compounds capable of oxidizing target molecules. This can take place in three ways: abstraction of hydrogen, abstraction of electrons or addition of oxygen. All cells living under aerobic conditions are continuously exposed to a large numbers of oxidants derived from various endogenous and exogenous sources. The endogenous sources of oxidants are several and include the respiratory chain in the mitochondria, immune reactions, enzymes such as xanthine oxidase and nitric oxide synthase and transition metal mediated oxidation. Various exogenous sources of ROS also contribute directly or indirectly to the total oxidant load. These include effects of ionizing and non-ionizing radiation, air pollution and natural toxic gases such as ozone, and chemicals and toxins including oxidizing disinfectants. A poor diet containing inadequate amounts of nutrients may also indirectly result in oxidative stress by impairing cellular defense mechanisms. The cellular macromolecules, in particular lipids, proteins and DNA, are natural targets of oxidation. Oxidants are capable of initiating lipid oxidation by abstraction of an allylic proton from a polyunsaturated fatty acid. This process, by multiple stages leading to the formation of lipid hydroperoxides, is a known contributor to the development of atherosclerosis. (PMID: 17336279).",,malonic dialdehyde,,HMDB06112,"InChI=1/C3H4O2/c4-2-1-3-5/h2-3H,1H2",C19440,2016-12-05T15:48:06Z,,1765,,,,,10964,CE0737,,"1,3-Propanedial, 1,3-Propanedialdehyde, 1,3-Propanedione, Malonaldehyde, Malonic aldehyde, Malonic dialdehyde, Malonodialdehyde, Malonyldialdehyde, MDD, Propanedial",http://vmh.uni.lu/_api/metabolites/1765/?format=pcsv
CE1243,,,-1,C17H27O3,,,12S-HHT,,12S-HHT,,,"InChI=1/C17H28O3/c1-2-3-10-13-16(18)14-11-8-6-4-5-7-9-12-15-17(19)20/h5-8,11,14,16,18H,2-4,9-10,12-13,15H2,1H3,(H,19,20)/p-1/b7-5-,8-6+,14-11+/t16-/m0/s1",,2016-11-22T15:12:15Z,,1766,,,,,182416,CE1243,,,http://vmh.uni.lu/_api/metabolites/1766/?format=pcsv
CE1352,,,-1,C21H31O6S,,,17alpha-hydroxypregnenolone sulfate,,17alpha-hydroxypregnenolone sulfate,,,,,2016-11-22T15:12:15Z,,1767,,,,,152971,CE1352,,,http://vmh.uni.lu/_api/metabolites/1767/?format=pcsv
N1aspmd,,,2,C9H23N3O,CHEBI:17927,,"Human Metabolome Database (HMDB): N1-Acetylspermidine is a polyamine. In many organisms, polyamines originate from L-ornithine and methionine. Ornithine decarboxylase (EC 4.1.1.17), a key enzyme in polyamine metabolism, decarboxylates L-ornithine to yield putrescine which is then converted to higher polyamines spermidine and spermine by successive addition of aminopropyl groups derived from decarboxylated S-adenosylmethionine. Aliphatic polyamines occur ubiquitously in organisms and have important functions in the stabilization of cell membranes, biosynthesis of informing molecules, cell growth and differentiation, as well as adaptation to osmotic, ionic, pH and thermal stress. These cationic substances are implicated in multiple functions, therefore it is not surprising that intracellular levels of polyamines are regulated by different mechanisms. The inhibition of polyamine metabolism has important pharmacological and therapeutic implications for the control of physiological processes, reproduction, cancer and parasitic diseases. Recent reports have suggested the idea that parasites with an high turnover of Ornithine Decarboxilase (ODC) are resistant to Difluoromethyl ornithine (DFMO, the irreversible inhibitor of ornithine decarboxylase) because they always contain a fraction of newly synthesized and active enzyme, therefore not DFMO inhibited, sufficient to produce small amounts of putrescine rapidly converted into spermidine, which can support protozoan proliferation. DFMO has proved to be curative in trypanosomiasis, coccidiosis, and certain other protozoan infections. (PMID: 15490259).",,N(1)-acetylspermidinium(2+),,HMDB01276,"InChI=1S/C9H21N3O/c1-9(13)12-8-4-7-11-6-3-2-5-10/h11H,2-8,10H2,1H3,(H,12,13)/p+2",C00612,2016-12-05T15:48:06Z,,1768,,,,,496,N1aspmd,,"1-N-Acetylspermidine, An N-acetylspermidine, N(1)-Acetylspermidine, N-(3-((4-Aminobutyl)amino)propyl)-Acetamide, N-(3-((4-Aminobutyl)amino)propyl)acetamide, N-Acetylspermidine, N1-Acetylspermidine",http://vmh.uni.lu/_api/metabolites/1768/?format=pcsv
n8aspmd,,,2,C9H23N3O,,,N(8)-acetylspermidinium(2+),,N(8)-acetylspermidinium(2+),,,"InChI=1S/C9H21N3O/c1-9(13)12-8-3-2-6-11-7-4-5-10/h11H,2-8,10H2,1H3,(H,12,13)/p+2",C01029,2016-11-22T15:12:15Z,,1769,,,,,123689,n8aspmd,,,http://vmh.uni.lu/_api/metabolites/1769/?format=pcsv
CE1059,,,1,C11H24N3O2,,,"N1,N8-diacetylspermidine",,"N1,N8-diacetylspermidine",,,,,2016-11-22T15:12:15Z,,1770,,,,,389613,CE1059,,,http://vmh.uni.lu/_api/metabolites/1770/?format=pcsv
N1sprm,,,3,C12H31N4O,CHEBI:17312,,Human Metabolome Database (HMDB): N1-Acetylspermine is a polyamine that has been postulated to be an intermediate in the conversion of spermine to spermidine.,,N(1)-acetylsperminium(3+),,HMDB01186,"InChI=1S/C12H28N4O/c1-12(17)16-11-5-10-15-8-3-2-7-14-9-4-6-13/h14-15H,2-11,13H2,1H3,(H,16,17)/p+3",C02567,2016-12-05T15:48:06Z,,1771,,,,,916,N1sprm,,"N'-Acetylspermine, N'-Monoacetylspermine, N(1)-Acetylspermine, N-(3-((4-((3-Aminopropyl)amino)butyl)amino)propyl)-Acetamide, N-Acetylspermine, N1-Acetylspermine",http://vmh.uni.lu/_api/metabolites/1771/?format=pcsv
C03413,,,2,C14H32N4O2,CHEBI:28101,,"Human Metabolome Database (HMDB): N1,N12-Diacetylspermine is a polyamine commonly occurring in normal human urine (PMID 7775374). It has been reported that urinary N1,N12-Diacetylspermine can be used as a marker to efficiently detect colorectal and breast cancers at early stages (PMID 15837752).",,"N(1),N(12)-diacetylsperminium(2+)",,HMDB02172,"InChI=1S/C14H30N4O2/c1-13(19)17-11-5-9-15-7-3-4-8-16-10-6-12-18-14(2)20/h15-16H,3-12H2,1-2H3,(H,17,19)(H,18,20)/p+2",C03413,2016-12-05T15:48:06Z,,1772,,,,,132680,C03413,,,http://vmh.uni.lu/_api/metabolites/1772/?format=pcsv
CE2028,,,-1,C5H9O3,,,"Human Metabolome Database (HMDB): 3-Hydroxyisovaleric acid is a normal human metabolite excreted in the urine. Elevated levels of this compound are found in several inherited disorders such as Dihydrolipoamide dehydrogenase Deficiency, 3-Methylcrotonyl-CoA carboxylase 1 deficiency, 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency (3-hydroxy-3-methylglutaryl -CoA lyase Deficiency, Biotinidase deficiency multiple carboxylase deficiency late-onset , Late onset multiple carboxylase deficiency, HolMcarboxylase synthetase deficiency, 3-Methylcrotonyl-CoA carboxylase 2 deficiency. 3-Hydroxyisovaleric acid is also elevated in smokers, in subjects undergoing long-term anticonvulsant therapy with carbamazepine and/or phenytoin. These levels are elevated due to impairment of renal reclamation of biotin. Levels may also be increased from prolonged consumption of raw egg-whites (PMID: 16895887, 9523856, 15447901, 9176832)(OMIM: 210210, 253270, 600529, 253260, 246450, 210200, 238331).",,beta-hydroxy-beta-methylbutyrate,,HMDB00754,,,2016-12-05T15:48:06Z,,1773,,,,,69362,CE2028,,"3-Hydroxy-3-methyl-Butanoate, 3-Hydroxy-3-methyl-Butanoic acid, 3-Hydroxy-3-methyl-Butyric acid, 3-Hydroxy-3-methylbutanoate, 3-Hydroxy-3-methylbutanoic acid, 3-Hydroxy-3-methylbutyrate, 3-Hydroxy-3-methylbutyric acid, 3-Hydroxy-isovaleric acid, 3-Hydroxyisovalerate, 3-Hydroxyisovaleric acid, 3-OH-isovaleric acid, B-Hydroxy-b-methylbutyrate, B-Hydroxy-b-methylbutyric acid, B-Hydroxyisovalerate, B-Hydroxyisovaleric acid, beta-Hydroxy-beta-methylbutyrate, beta-Hydroxy-beta-methylbutyric acid, beta-Hydroxyisovalerate, beta-Hydroxyisovaleric acid",http://vmh.uni.lu/_api/metabolites/1773/?format=pcsv
CE2201,,,0,C27H44O3,,,"Human Metabolome Database (HMDB): 23S,25-dihydroxyvitamin D3 (23S,25-(OH)2D3) is a circulating metabolite of vitamin D3 during vitamin D excess. During hypocalcemia or hypovitaminosis D, 25-OH-D3 is 1alpha-hydroxylated, primarily in kidney, to produce 1,25-(OH)2D3. 1,25-(OH)2D3 is a hormonally active form of vitamin D3 that enhances intestinal calcium transport and promotes mobilization of calcium from bone. In states of vitamin D excess, other pathways of 25-OH-D3 metabolism emerge as alternatives to 1-and 24-hydroxylation. Recently, 25-hydroxyvitamin D3-26,23-lactone (lactone) was identified as a major plasma metabolite in animals receiving large doses of vitamin D. Although the function of the lactone is not known, its 5-fold greater potency of binding to the plasma vitamin D carrier protein, relative to 25-OH-D3, suggests that it may, perhaps indirectly, contribute to vitamin D toxicity. This indicates the existence of an alternate route to lactone formation through a new 25-OH-D3 metabolite, 23,25-(OH)2D3. (PMID: 6286629).",,"23S,25-dihydroxyvitamin D3",,HMDB06720,"InChI=1/C27H44O3/c1-18-8-11-22(28)16-21(18)10-9-20-7-6-14-27(5)24(12-13-25(20)27)19(2)15-23(29)17-26(3,4)30/h9-10,19,22-25,28-30H,1,6-8,11-17H2,2-5H3/b20-9+,21-10-/t19-,22-,23?,24-,25?,27-/m1/s1",,2016-12-05T15:48:06Z,,1774,,,,,13072270,CE2201,,"(3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,23,25-triol, 23,25-Dihydroxycholecalciferol, 23,25-Dihydroxyvitamin D3, 23S,25-Dihydroxyvitamin D, 23S,25-Dihydroxyvitamin D3",http://vmh.uni.lu/_api/metabolites/1774/?format=pcsv
CE2202,,,0,C27H44O4,,,"23S,25,26-trihydroxyvitamin D3",,"23S,25,26-trihydroxyvitamin D3",,,"InChI=1S/C27H44O4/c1-18-7-10-22(29)15-21(18)9-8-20-6-5-13-27(4)24(11-12-25(20)27)19(2)14-23(30)16-26(3,31)17-28/h8-9,19,22-25,28-31H,1,5-7,10-17H2,2-4H3/b20-8+,21-9-/t19-,22+,23+,24-,25+,26?,27-/m1/s1",,2016-11-22T15:12:15Z,,1775,,,,,17756748,CE2202,,,http://vmh.uni.lu/_api/metabolites/1775/?format=pcsv
CE2203,,,0,C27H42O4,,,"25-hydroxyvitamin D3-26,23-lactol",,"25-hydroxyvitamin D3-26,23-lactol",,,"InChI=1/C27H42O4/c1-17-7-10-21(28)15-20(17)9-8-19-6-5-13-26(3)23(11-12-24(19)26)18(2)14-22-16-27(4,30)25(29)31-22/h8-9,18,21-25,28-30H,1,5-7,10-16H2,2-4H3/b19-8+,20-9-/t18-,21-,22-,23-,24+,25u,26?,27?/m1/s1",,2016-11-22T15:12:15Z,,1776,,,,,,CE2203,,,http://vmh.uni.lu/_api/metabolites/1776/?format=pcsv
CE2204,,,0,C27H40O4,,,"25-hydroxyvitamin D3-26,23-lactone",,"25-hydroxyvitamin D3-26,23-lactone",,,"InChI=1/C27H40O4/c1-17-7-10-21(28)15-20(17)9-8-19-6-5-13-26(3)23(11-12-24(19)26)18(2)14-22-16-27(4,30)25(29)31-22/h8-9,18,21-24,28,30H,1,5-7,10-16H2,2-4H3/b19-8+,20-9-/t18-,21-,22-,23-,24+,26?,27?/m1/s1",,2016-11-22T15:12:15Z,,1777,,,,,,CE2204,,,http://vmh.uni.lu/_api/metabolites/1777/?format=pcsv
C01507,,,0,C6H14O6,CHEBI:18202,,L-Iditol,,L-Iditol,,HMDB01363,"InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4-,5+,6+/m0/s1",C01507,2016-11-22T15:12:15Z,,1778,,,,,5460044,,,,http://vmh.uni.lu/_api/metabolites/1778/?format=pcsv
srb_L,,,0,C6H12O6,CHEBI:17266,,Human Metabolome Database (HMDB): Sorbose is a ketose belonging to the group of sugars known as monosaccharides. The commercial production of vitamin C (ascorbic acid) often begins with sorbose.,,L-Sorbose,,HMDB01266,"InChI=1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3,5-9,11-12H,1-2H2/t3-,5+,6+/m0/s1",C08356,2016-12-05T15:48:06Z,,1779,,,,,441484,,,"alpha-L-Sorbopyranose, Hex-2-ulose, L(-) Sorbose for biochemistry, L(-)-Sorbose, L-(-)-Sorbose, L-(-)-Sorbose 99%, L-1,3,4,5,6-Pentahydroxyhexan-2-one, L-Sorbinose, L-Sorbose, L-Xylo-2-Hexulose, L-Xylo-hexulose, Sorbin, Sorbinose, Sorbose, Xylo-Hexulose",http://vmh.uni.lu/_api/metabolites/1779/?format=pcsv
CE5101,,,-3,C11H15O16P2R2,CHEBI:16500,,1-phosphatidyl-1D-myo-inositol 5-phosphate(3-),,1-phosphatidyl-1D-myo-inositol 5-phosphate(3-),,,,,2016-11-22T15:12:15Z,,1780,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1780/?format=pcsv
CE0469,,,-1,C8H13N2O5,,,gama-L-glutamyl-L-alanine,,gama-L-glutamyl-L-alanine,,,,,2016-11-22T15:12:15Z,,1781,,,,,11183554,CE0469,,,http://vmh.uni.lu/_api/metabolites/1781/?format=pcsv
C03693,,,-4,C6H10O12P2,,,"D-Mannose 1,6-bisphosphate",,"D-Mannose 1,6-bisphosphate",,,"InChI=1/C6H14O12P2/c7-3-2(1-16-19(10,11)12)17-6(5(9)4(3)8)18-20(13,14)15/h2-9H,1H2,(H2,10,11,12)(H2,13,14,15)/t2-,3-,4+,5+,6+/m1/s1",C03693,2016-11-22T15:12:15Z,,1782,,,,,3036654,C03693,,,http://vmh.uni.lu/_api/metabolites/1782/?format=pcsv
CE2434,,,-4,C39H60N7O17P3S,,,"trans,cis,cis-2,9,12-octadecatrienoyl-CoA",,"trans,cis,cis-2,9,12-octadecatrienoyl-CoA",,,,,2016-11-22T15:12:15Z,,1783,,,,,,CE2434,,,http://vmh.uni.lu/_api/metabolites/1783/?format=pcsv
CE0849,,,-4,C37H58N7O17P3S,,,"cis,cis-palmito-7,10-dienoyl-CoA",,"cis,cis-palmito-7,10-dienoyl-CoA",,,,,2016-11-22T15:12:15Z,,1784,,,,,,CE0849,,,http://vmh.uni.lu/_api/metabolites/1784/?format=pcsv
CE2433,,,-4,C37H56N7O17P3S,,,"trans,cis,cis-2,7,10-hexadecatrienoyl-CoA",,"trans,cis,cis-2,7,10-hexadecatrienoyl-CoA",,,,,2016-11-22T15:12:15Z,,1785,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1785/?format=pcsv
CE0785,,,-4,C35H54N7O17P3S,,,"cis,cis-myristo-5,8-dienoyl-CoA",,"cis,cis-myristo-5,8-dienoyl-CoA",,,,,2016-11-22T15:12:15Z,,1786,,,,,21252281,CE0785,,,http://vmh.uni.lu/_api/metabolites/1786/?format=pcsv
CE2432,,,-4,C35H52N7O17P3S,,,"trans-2-cis,cis-5,8-tetradecatrienoyl-CoA",,"trans-2-cis,cis-5,8-tetradecatrienoyl-CoA",,,,,2016-11-22T15:12:15Z,,1787,,,,,,CE2432,,,http://vmh.uni.lu/_api/metabolites/1787/?format=pcsv
CE2431,,,-4,C31H48N7O17P3S,6443609,,"Human Metabolome Database (HMDB): cis-4-Decenoyl-CoA is an intermediate of linoleic acid catabolism, degraded by a mitochondrial 4-enoyl-CoA reductase. (PMID: 729581). There are two 2,4-dienoyl-CoA reductases (formerly called 4-enoyl-CoA reductase) in liver, one in mitochondria and another one in peroxisomes. Isolated peroxisomes metabolize 4-cis-decenoyl-CoA via the 2,4-dienoyl-CoA reductase pathway. (PMID: 7263650).",,cis-deca-4-enoyl-CoA,,HMDB02145,,,2016-12-05T15:48:06Z,,1788,,,,,6443609,,,"4Z-Decaenoyl-CoA, 4Z-Decaenoyl-Coenzyme A, cis-Deca-4-enoyl-CoA, cis-Deca-4-enoyl-Coenzime A, cis-Deca-4-enoyl-Coenzyme A, Deca-4Z-enoyl-CoA, Deca-4Z-enoyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/1788/?format=pcsv
CE2435,,,-4,C31H46N7O17P3S,,,"trans,cis-deca-2,4-dienoyl-CoA",,"trans,cis-deca-2,4-dienoyl-CoA",,,,,2016-11-16T10:44:56Z,,1789,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1789/?format=pcsv
C05279,,,-4,C33H50N7O17P3S,CHEBI:28387,,"Human Metabolome Database (HMDB): trans,cis-Lauro-2,6-dienoyl-CoA participates in fatty acid metabolism. trans,cis-Lauro-2,6-dienoyl-CoA is converted from cis,cis-3,6-Dodecadienoyl-CoA via dodecenoyl-CoA delta-isomerase [EC:5.3.3.8] and vice-versa. Fatty acid degradation is the process in which fatty acids are broken down, resulting in release of energy. It includes three major steps:Activation and transport into mitochondria, &#946;-oxidation and Electron transport chain. Fatty acids are transported across the outer mitochondrial membrane by carnitine-palmitoyl transferase I (CPT-I), and then couriered across the inner mitochondrial membrane by carnitine[1]. Once inside the mitochondrial matrix, fatty acyl-carnitine reacts with coenzyme A to release the fatty acid and produce acetyl-CoA. CPT-I is believed to be the rate limiting step in fatty acid oxidation. Once inside the mitochondrial matrix, fatty acids undergo &#946;-oxidation. During this process, two-carbon molecules acetyl-CoA are repeatedly cleaved from the fatty acid. Acetyl-CoA can then enter the TCA cycle, which produces NADH and FADH. NADH and FADH are subsequently used in the electron transport chain to produce ATP, the energy currency of the cell. (Wikipedia).",,"trans,cis-Lauro-2,6-dienoyl-CoA",,HMDB11123,"InChI=1S/C33H54N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-24(42)61-17-16-35-23(41)14-15-36-31(45)28(44)33(2,3)19-54-60(51,52)57-59(49,50)53-18-22-27(56-58(46,47)48)26(43)32(55-22)40-21-39-25-29(34)37-20-38-30(25)40/h8-9,12-13,20-22,26-28,32,43-44H,4-7,10-11,14-19H2,1-3H3,(H,35,41)(H,36,45)(H,49,50)(H,51,52)(H2,34,37,38)(H2,46,47,48)/b9-8-,13-12+/t22-,26-,27-,28+,32-/m1/s1",C05279,2016-12-05T15:48:06Z,,1790,,,,"(2-trans,6-cis)-dodeca-2,6-dienoyl-CoA",53480665,,,,http://vmh.uni.lu/_api/metabolites/1790/?format=pcsv
CE2420,,,-4,C33H52N7O18P3S,,,(3S)-3-hydroxydodec-cis-6-enoyl-CoA,,(3S)-3-hydroxydodec-cis-6-enoyl-CoA,,,,,2016-11-22T15:12:15Z,,1791,,,,,53481428,CE2420,,,http://vmh.uni.lu/_api/metabolites/1791/?format=pcsv
CE2417,,,-4,C35H54N7O18P3S,,,"3(S)-hydroxy-5Z,8Z-tetradecadienoyl-CoA",,"3(S)-hydroxy-5Z,8Z-tetradecadienoyl-CoA",,,,,2016-11-22T15:12:15Z,,1792,,,,,,CE2417,,,http://vmh.uni.lu/_api/metabolites/1792/?format=pcsv
CE2418,,,-4,C37H58N7O18P3S,,,"(3S)-3-hydroxy-cis,cis-palmito-7,10-dienoyl-CoA",,"(3S)-3-hydroxy-cis,cis-palmito-7,10-dienoyl-CoA",,,,,2016-11-22T15:12:15Z,,1793,,,,,53481423,CE2418,,,http://vmh.uni.lu/_api/metabolites/1793/?format=pcsv
CE2422,,,-4,C37H56N7O18P3S,,,"3-oxo-cis,cis-7,10-hexadecadienoyl-CoA",,"3-oxo-cis,cis-7,10-hexadecadienoyl-CoA",,,,,2016-11-22T15:12:15Z,,1794,,,,,,CE2422,,,http://vmh.uni.lu/_api/metabolites/1794/?format=pcsv
CE2424,,,-4,C35H52N7O18P3S,,,"3-oxo-cis,cis-5,8-tetradecadienoyl-CoA",,"3-oxo-cis,cis-5,8-tetradecadienoyl-CoA",,,,,2016-11-22T15:12:15Z,,1795,,,,,,CE2424,,,http://vmh.uni.lu/_api/metabolites/1795/?format=pcsv
CE0693,,,-4,C33H50N7O18P3S,,,3-oxolaur-6-cis-enoyl-CoA,,3-oxolaur-6-cis-enoyl-CoA,,,,,2016-11-22T15:12:15Z,,1796,,,,,,CE0693,,,http://vmh.uni.lu/_api/metabolites/1796/?format=pcsv
C05280,,,-4,C33H50N7O17P3S,CHEBI:28002,,"Human Metabolome Database (HMDB): cis,cis-3,6-Dodecadienoyl-CoA is an intermediate in Fatty acid metabolism. cis,cis-3,6-Dodecadienoyl-CoA is produced from trans,cis-Lauro-2,6-dienoyl-CoA via the enzyme dodecenoyl-CoA delta-isomerase (EC 5.3.3.8).",,"cis,cis-3,6-Dodecadienoyl-CoA",,HMDB03952,"InChI=1S/C33H54N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-24(42)61-17-16-35-23(41)14-15-36-31(45)28(44)33(2,3)19-54-60(51,52)57-59(49,50)53-18-22-27(56-58(46,47)48)26(43)32(55-22)40-21-39-25-29(34)37-20-38-30(25)40/h8-9,11-12,20-22,26-28,32,43-44H,4-7,10,13-19H2,1-3H3,(H,35,41)(H,36,45)(H,49,50)(H,51,52)(H2,34,37,38)(H2,46,47,48)/b9-8-,12-11-/t22-,26-,27-,28+,32-/m1/s1",C05280,2016-12-05T15:48:06Z,,1797,,,,"cis,cis-dodeca-3,6-dienoyl-CoA",5280771,C05280,,"cis,cis-3,6-Dodecadienoyl-coenzyme A, cis,cis-Dodeca-3,6-dienoyl-CoA, cis,cis-Dodeca-3,6-dienoyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/1797/?format=pcsv
CE4788,,,0,C5H9NO2,,,acetamidopropanal,,acetamidopropanal,,,,C18170,2016-11-22T15:12:15Z,,1798,,,,,5460495,CE4788,,,http://vmh.uni.lu/_api/metabolites/1798/?format=pcsv
CE2180,,,0,C18H22O3,,,"Human Metabolome Database (HMDB): 4-Hydroxyestrone is metabolite originating from 17beta-estradiol, and is reported as carcinogenic and have ability to initiate cancer.",,4-hydroxyestrone,,HMDB05895,"InChI=1/C18H22O3/c1-18-9-8-11-10-4-6-15(19)17(21)13(10)3-2-12(11)14(18)5-7-16(18)20/h4,6,11-12,14,19,21H,2-3,5,7-9H2,1H3/t11?,12?,14?,18-/m1/s1",,2016-12-05T15:48:06Z,,1799,,,,,53477797,CE2180,,"1,3,5(10)-Estratriene-3,4-diol-17-one, 3,4-Dihydroxy-1,3,5(10)-estratrien-17-one, 3,4-Dihydroxy-estra-1,3,5(10)-trien-17-one, 3,4-Dihydroxyestra-1,3,5(10)-trien-17-one, 4-Hydroxy catechol estrogen, 4OHEs, Estra-1,3,5(10)-triene-3,4-diol-17-one",http://vmh.uni.lu/_api/metabolites/1799/?format=pcsv
C05298,,,0,C18H22O3,CHEBI:1156,,"Human Metabolome Database (HMDB): Estrone (also oestrone) is an estrogenic hormone secreted by the ovary. Its molecular formula is C18H22O2. estrone has a melting point of 254.5 degrees Celsius. estrone is one of the three estrogens, which also include estriol and estradiol. estrone is the least prevalent of the three hormones, estradiol being prevalent almost always in a female body, estriol being prevalent primarily during pregnancy. estrone sulfate is relevant to health and disease due to its conversion to estrone sulfate, a long-lived derivative of estrone. estrone sulfate acts as a pool of estrone which can be converted as needed to the more active estradiol.",,2-Hydroxyestrone,,HMDB00343,"InChI=1S/C18H22O3/c1-18-7-6-11-12(14(18)4-5-17(18)21)3-2-10-8-15(19)16(20)9-13(10)11/h8-9,11-12,14,19-20H,2-7H2,1H3/t11-,12+,14-,18-/m0/s1",C05298,2016-12-05T15:48:06Z,,1800,,,,,440623,C05298,,"2,3-Dihydroxyestra-1,3,5(10)-trien-17-one, 2-Hydroxyestrone, 2-OHE1, Catecholestrone",http://vmh.uni.lu/_api/metabolites/1800/?format=pcsv
C05301,,,0,C18H24O3,CHEBI:28744,,"Human Metabolome Database (HMDB): 2-Hydroxyestradiol is generated from estradiol by a Cytochrome P450. 2-Hydroxyestradiol binds, with a low affinity, to estrogen receptors. It inhbits catechol-O-methyltransferase (COMT) activity. Inactivity of COMT blocks inactivation of catechol hormones and catecholamine neutransmitters. 2-Hydroxyestradiol is also reported to inhibit angiongensis and tumor cell growth (PMID: 9472688).",,2-Hydroxyestradiol-17beta,,HMDB00338,"InChI=1S/C18H24O3/c1-18-7-6-11-12(14(18)4-5-17(18)21)3-2-10-8-15(19)16(20)9-13(10)11/h8-9,11-12,14,17,19-21H,2-7H2,1H3/t11-,12+,14-,17-,18-/m0/s1",C05301,2016-12-05T15:48:06Z,,1801,,,,,247304,C05301,,"(17b)-Estra-1,3, 5(10)-triene-2,3,17-triol, (17beta)- Estra-1,3, 5 (10)-triene-2,3,17-triol, (17beta)-Estra-1,3,5(10)-triene-2,3,17-triol, 1,3,5(10)-Estratriene-2,3,17Beta-triol, 17beta-2-Hydroxyestradiol, 2,3,17b-Trihydroxyestra-1,3,5(10)-triene, 2-Hydroxy-17beta-estradiol, 2-Hydroxy-estradiol, 2-Hydroxyestradiol, 2-OH-Estradiol, ECS, Estra-1,3,5 (10)-triene-2,3,17.beta.-triol, Estra-1,3,5(10)-triene-2,3,17-beta-triol, Estra-1,3,5(10)-triene-2,3,17-triol (ACD/Name 4.0), Estra-1,3,5(10)-triene-2,3,17b-triol, Estra-1,3,5(10)-triene-2,3,17beta-triol",http://vmh.uni.lu/_api/metabolites/1801/?format=pcsv
CE2183,,,0,C19H26O3,,,2-hydroxy-3-methoxy-17beta-estradiol,,2-hydroxy-3-methoxy-17beta-estradiol,,,,,2016-11-22T15:12:15Z,,1802,,,,,,CE2183,,,http://vmh.uni.lu/_api/metabolites/1802/?format=pcsv
CE2179,,,0,C18H24O3,44348689,,Human Metabolome Database (HMDB): 4-Hydroxyestradiol is an oncogenic catechol estrogen produced by metabolism of Estrogen.,,4-hydroxy-17beta-estradiol,,HMDB05896,"InChI=1/C18H24O3/c1-18-9-8-11-10-4-6-15(19)17(21)13(10)3-2-12(11)14(18)5-7-16(18)20/h4,6,11-12,14,16,19-21H,2-3,5,7-9H2,1H3/t11?,12?,14?,16-,18-/m0/s1",C14209,2016-12-05T15:48:06Z,,1803,,,,,44348689,,,"1,3,5[10]-Estratriene-3,4,17beta-triol, 3,4,17beta-estriol, 3,4,17beta-trihydroxy-1,3,5[10]-estratriene, 4,17 dihydroxy estradiol, 4-Hydroxy-17beta-estradiol, 4-Hydroxy-estradiol, 4-Hydroxyestradiol, 4-Hydroxyestradiol-17 beta, 4-Hydroxyestradiol-17beta, 4-OH-Estradiol, 4OHE2",http://vmh.uni.lu/_api/metabolites/1803/?format=pcsv
CE2186,,,0,C19H26O3,,,4-methoxy-17beta-estradiol,,4-methoxy-17beta-estradiol,,,"InChI=1/C19H26O3/c1-19-10-9-12-11-5-7-16(20)18(22-2)14(11)4-3-13(12)15(19)6-8-17(19)21/h5,7,12-13,15,17,20-21H,3-4,6,8-10H2,1-2H3/t12-,13-,15+,17-,19-/m0/s1",C05302,2016-11-22T15:12:15Z,,1804,,,,,29983092,CE2186,,,http://vmh.uni.lu/_api/metabolites/1804/?format=pcsv
CE2189,,,0,C19H24O3,,,4-methoxyestrone,,4-methoxyestrone,,,"InChI=1/C19H24O3/c1-19-10-9-12-11-5-7-16(20)18(22-2)14(11)4-3-13(12)15(19)6-8-17(19)21/h5,7,12-13,15,20H,3-4,6,8-10H2,1-2H3/t12-,13-,15+,19-/m1/s1",,2016-11-22T15:12:15Z,,1805,,,,,194066,CE2189,,,http://vmh.uni.lu/_api/metabolites/1805/?format=pcsv
C05299,,,0,C19H24O3,CHEBI:1189,,Human Metabolome Database (HMDB): 2-methoxyestrone is a steroid derivative that is a byproduct of estrone and 2-hydroxyestrone metabolism. It is part of the androgen and estrogen metabolic pathway. The acid ionization constant (pKa) of 2-methoxyestrone is 10.81 (PMID: 516114). 2-Methoxyestrone can be metabolized to a sulfated derivative (2-Methoxyestrone 3-sulfate) via steroid sulfotransferase (EC 2.8.2.15). It can also be glucuronidated to 2-Methoxyestrone 3-glucuronide by UDP glucuronosyltransferase (EC 2.4.1.17).,,2-Methoxyestrone,,HMDB00010,"InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,20H,3-8H2,1-2H3/t12-,13+,15-,19-/m0/s1",C05299,2016-12-05T15:48:06Z,,1806,,,,,440624,C05299,,"2-(8S,9S,13S,14S)-3-Hydroxy-2-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one, 2-Hydroxyestrone 2-methyl ether, 2-Methoxy-17-oxoestra-1,3,5(10)-trien-3-ol, 2-Methoxy-3-hydroxyestra-1,3,5(10)-trien-17-one, 3-Hydroxy-2-methoxy-Estra-1,3,5(10)-trien-17-one, 3-Hydroxy-2-methoxyestra-1,3,5(10)-trien-17-one, Methoxy-Estrone",http://vmh.uni.lu/_api/metabolites/1806/?format=pcsv
CE2184,,,0,C19H24O3,,,"Human Metabolome Database (HMDB): 2-Hydroxy-3-methoxyestrone is obtained after methylation of 2-Hydroxyestrone and is generally found in the urine as an excretion product. 2-hydroxyestrone is the result of the hydroxylation of estrone E1. The hydroxylation process helps to clear out E1 from the body. This is critical because higher lifetime exposure to estrogen has been found to increase cancer risks to the reproductive system, especially to the breast. However, 2-hydroxyestrone has a weak estrogenic activity and breast cancer risks are quite low in women with high urinary excretion of 2-hydroxyestrone. 2-Hydroxy-3-methoxyestrone levels in urine could be an indicator to help assess the risk factors for development of breast cancers.",,2-hydroxy-3-methoxyestrone,,HMDB11195,"InChI=1/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-17(22-2)16(20)10-14(11)12/h9-10,12-13,15,20H,3-8H2,1-2H3/t12?,13?,15?,19-/m1/s1",,2016-12-05T15:48:06Z,,1807,,,,,53480676,CE2184,,,http://vmh.uni.lu/_api/metabolites/1807/?format=pcsv
CE5250,,,0,C18H22O3,,,"17beta-estradiol-2,3-quinone",,"17beta-estradiol-2,3-quinone",,,"InChI=1/C18H22O3/c1-18-7-6-11-12(14(18)4-5-17(18)21)3-2-10-8-15(19)16(20)9-13(10)11/h8-9,11-12,14,17,21H,2-7H2,1H3/t11-,12+,14-,17+,18+/m1/s1",,2016-11-22T15:12:15Z,,1808,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1808/?format=pcsv
CE5239,,,-1,C28H38N3O9S,,,2-hydroxy-17beta-estradiol-4-S-glutathione,,2-hydroxy-17beta-estradiol-4-S-glutathione,,,"InChI=1/C28H39N3O9S/c1-28-9-8-13-14(17(28)4-6-21(28)33)2-3-15-16(13)10-20(32)24(37)25(15)41-12-19(26(38)30-11-23(35)36)31-22(34)7-5-18(29)27(39)40/h10,13-14,17-19,21,32-33,37H,2-9,11-12,29H2,1H3,(H,30,38)(H,31,34)(H,35,36)(H,39,40)/p-1/t13-,14+,17-,18+,19+,21+,28+/m1/s1",,2016-11-22T15:12:15Z,,1809,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1809/?format=pcsv
CE4888,,,0,C8H7NO2,,,"Human Metabolome Database (HMDB): 5,6-Dihydroxyindole is a substrate for Tyrosinase.",,dopaminochrome,,HMDB04058,"InChI=1/C8H7NO2/c10-7-3-5-1-2-9-6(5)4-8(7)11/h1-4,9-11H",C05578,2016-12-05T15:48:06Z,,1810,,,,,114683,,,"Aminochrome, DHI, Dopaminochrome",http://vmh.uni.lu/_api/metabolites/1810/?format=pcsv
CE5277,,,0,C8H8NO2,,,aminochrome o-semiquinone,,aminochrome o-semiquinone,,,"InChI=1/C8H8NO2/c10-7-3-5-1-2-9-6(5)4-8(7)11/h3-4,9,11H,1-2H2",,2016-11-22T15:12:15Z,,1811,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1811/?format=pcsv
CE5278,,,-2,C9H6NO4,,,dopachrome o-semiquinone,,dopachrome o-semiquinone,,,"InChI=1/C9H8NO4/c11-7-2-4-1-6(9(13)14)10-5(4)3-8(7)12/h2-3,6,10,12H,1H2,(H,13,14)/p-1/t6-/m1/s1",,2016-11-22T15:12:15Z,,1812,,,,,53481550,CE5278,,,http://vmh.uni.lu/_api/metabolites/1812/?format=pcsv
CE5256,,,0,C18H20O3,,,"estrone-2,3-semiquinone",,"estrone-2,3-semiquinone",,,,,2016-11-22T15:12:15Z,,1813,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1813/?format=pcsv
CE5252,,,0,C18H20O3,,,"estrone-2,3-quinone",,"estrone-2,3-quinone",,,"InChI=1/C18H20O3/c1-18-7-6-11-12(14(18)4-5-17(18)21)3-2-10-8-15(19)16(20)9-13(10)11/h8-9,11-12,14H,2-7H2,1H3/t11-,12+,14-,18+/m0/s1",,2016-11-22T15:12:15Z,,1814,,,,,148381,,,,http://vmh.uni.lu/_api/metabolites/1814/?format=pcsv
CE5255,,,0,C18H20O3,,,"estrone-3,4-semiquinone",,"estrone-3,4-semiquinone",,,,,2016-11-22T15:12:15Z,,1815,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1815/?format=pcsv
CE5251,,,0,C18H20O3,,,"estrone-3,4-quinone",,"estrone-3,4-quinone",,,"InChI=1/C18H20O3/c1-18-9-8-11-10-4-6-15(19)17(21)13(10)3-2-12(11)14(18)5-7-16(18)20/h4,6,11-12,14H,2-3,5,7-9H2,1H3/t11-,12-,14+,18-/m1/s1",,2016-11-22T15:12:15Z,,1816,,,,,114862,,,,http://vmh.uni.lu/_api/metabolites/1816/?format=pcsv
CE5254,,,0,C18H22O3,,,"17beta-estradiol-2,3-semiquinone",,"17beta-estradiol-2,3-semiquinone",,,,,2016-11-22T15:12:15Z,,1817,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1817/?format=pcsv
CE5253,,,0,C18H22O3,,,"17beta-estradiol-3,4-semiquinone",,"17beta-estradiol-3,4-semiquinone",,,,,2016-11-22T15:12:15Z,,1818,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1818/?format=pcsv
CE5249,,,0,C18H22O3,,,"17beta-estradiol-3,4-quinone",,"17beta-estradiol-3,4-quinone",,,"InChI=1/C18H22O3/c1-18-9-8-11-10-4-6-15(19)17(21)13(10)3-2-12(11)14(18)5-7-16(18)20/h4,6,11-12,14,16,20H,2-3,5,7-9H2,1H3/t11-,12-,14+,16-,18-/m0/s1",,2016-11-22T15:12:15Z,,1819,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1819/?format=pcsv
CE5236,,,0,C9H13N5O3,,,O2'-4a-cyclic-tetrahydrobiopterin,,O2'-4a-cyclic-tetrahydrobiopterin,,,"InChI=1/C9H13N5O3/c1-3-5(15)4-2-11-6-9(14-4,17-3)7(16)13-8(10)12-6/h3-5,14-15H,2H2,1H3,(H3,10,11,12,13,16)/p+1/t3-,4u,5+,9u/m0/s1",,2016-11-22T15:12:15Z,,1820,,,,,53481588,CE5236,,,http://vmh.uni.lu/_api/metabolites/1820/?format=pcsv
CE1918,,,0,C10H11NO2,,,"Human Metabolome Database (HMDB): 5-Hydroxytryptophol is a relatively minor metabolite of serotonin that is excreted primarily as the glucuronide conjugate in human urine. 5-Hydroxytryptophol becomes more important quantitatively during alcohol intoxication, when a shift in the metabolism of serotonin occurs from 5-hydroxyindole acetic acid toward increased (15-fold higher) formation of 5-hydroxytryptophol due to the inhibition of aldehyde dehydrogenase by ethanol-derived acetaldehyde. Urinary excretion of 5-hydroxytryptophol has also been shown to be markedly increased for several hours following intake of foods rich in serotonin, such as bananas. Wide interspecies variation has been reported in the metabolism serotonin to 5-hydroxytryptophol; 5-Hydroxytryptophol makes up 35% of the excreted serotonin metabolites in the rat on average and 10 to 20% in several other species. Human UDP-glucuronosyltransferase 1A6 (UGT1A6) plays a predominant role in the glucuronidation of 5-hydroxytryptophol by human liver microsomes. (PMID 15258112).",,5-hydroxytryptophol,,HMDB01855,"InChI=1/C10H11NO2/c12-4-3-7-6-11-10-2-1-8(13)5-9(7)10/h1-2,5-6,11-13H,3-4H2",,2016-12-05T15:48:06Z,,1821,,,,,9061,,,"5-HTOL, 5-Hydroxy-1H-indole-3-ethanol, 5-Hydroxy-1H-Indole-3-ethanol(9CI), 5-Hydroxy-3-indole, 5-Hydroxy-3-indoleacetic acid, 5-Hydroxy-indole-acetic acid, 5-Hydroxyindoacetic acid, 5-Hydroxyindol, 5-Hydroxyindolacetate, 5-Hydroxyindolacetic acid, 5-Hydroxyindole-3-ethanol, 5-Hydroxyindole-acetic acid, 5-Hydroxytryptophol, Hydroxyindoleacetic acid, Hydroxytryptophol",http://vmh.uni.lu/_api/metabolites/1821/?format=pcsv
CE0233,,,0,C27H48O3,,,"5beta-cholestane-3alpha,7alpha,27-triol",,"5beta-cholestane-3alpha,7alpha,27-triol",,,"InChI=1/C27H48O3/c1-17(7-6-12-25(2,3)30)20-8-9-21-24-22(11-14-27(20,21)5)26(4)13-10-19(28)15-18(26)16-23(24)29/h17-24,28-30H,6-16H2,1-5H3/t17-,18-,19+,20-,21-,22-,23+,24-,26?,27-/m1/s1",,2016-11-22T15:12:15Z,,1822,,,,,,CE0233,,,http://vmh.uni.lu/_api/metabolites/1822/?format=pcsv
CE1272,,,0,C27H48O4,,,"Human Metabolome Database (HMDB): Cholestane-3,7,12,25-tetrol is an intermediate in the bile acid biosynthetic pathways accumulating (together with other 25-hydroxylated bile alcohols intermediates and cholestanol) in Cerebrotendinous xanthomatosis (CTX, a rare recessively inherited lipid storage disease characterized by a markedly reduced production of chenodeoxycholic acid) (PMID 11181760).",,"5beta-cholestane-3alpha,7alpha,12alpha,25-tetrol",,HMDB00655,"InChI=1/C27H48O4/c1-16(7-6-11-25(2,3)31)19-8-9-20-24-21(15-23(30)27(19,20)5)26(4)12-10-18(28)13-17(26)14-22(24)29/h16-24,28-31H,6-15H2,1-5H3/t16-,17?,18?,19-,20+,21+,22+,23?,24+,26+,27-/m1/s1",,2016-12-05T15:48:06Z,,1823,,,,,53477712,CE1272,,"5beta-Cholestane-3alpha,7alpha,12alpha,25-tetrol, 5beta-Cholestane-3beta,7alpha,12alpha,25-tetrol",http://vmh.uni.lu/_api/metabolites/1823/?format=pcsv
CE1273,,,0,C27H48O5,,,"Human Metabolome Database (HMDB): Cholestane-3,7,12,24,25-pentol is the major bile alcohol identified in urine from healthy humans, both in children and adults. Bile alcohols have been found to be present as minor components in the bile and urine in healthy subjects. Bile alcohols are end products for cholesterol elimination as well as major biliary constituents; in mammals, cholesterol is metabolized by additional enzymes that ultimately transform it to bile acids. Bile alcohols are preferentially excreted as glucuronides into the urine, which constitute about 10% of total bile acids. The excretion of glucuronidated bile alcohols in urine is suggested to reflect an alternative metabolism of intermediates in the normal biosynthesis of bile acids. Patients with the rare inherited sterol storage disease, cerebrotendinous xanthomatosis, accumulation bile alcohols in bile and feces.(PMID: 6726087, 6548247, 11718684).",,"5beta-cholestane-3alpha,7alpha,12alpha,24S,25-pentol",,HMDB02208,"InChI=1/C27H48O5/c1-15(6-9-22(30)25(2,3)32)18-7-8-19-24-20(14-23(31)27(18,19)5)26(4)11-10-17(28)12-16(26)13-21(24)29/h15-24,28-32H,6-14H2,1-5H3/t15-,16+,17-,18-,19+,20+,21?,22+,23+,24+,26+,27-/m1/s1",,2016-12-05T15:48:06Z,,1824,,,,,6453659,CE1273,,"3alpha,7alpha,12alpha,24S,25-pentahydroxy-5beta-cholestane, 5-beta-Cholestane-3alpha,7alpha,12alpha,24beta,25-pentol, 5beta-Cholestane-3alpha,7alpha,12alpha,24S,25-pentol",http://vmh.uni.lu/_api/metabolites/1824/?format=pcsv
CE1277,,,0,C27H48O5,,,"5beta-cholestane-3alpha,7alpha,12alpha,23,25-pentol",,"5beta-cholestane-3alpha,7alpha,12alpha,23,25-pentol",,,"InChI=1/C27H48O5/c1-15(10-18(29)14-25(2,3)32)19-6-7-20-24-21(13-23(31)27(19,20)5)26(4)9-8-17(28)11-16(26)12-22(24)30/h15-24,28-32H,6-14H2,1-5H3/t15-,16-,17+,18u,19-,20-,21-,22+,23-,24-,26?,27-/m1/s1",,2016-11-22T15:12:16Z,,1825,,,,,5284212,CE1277,,,http://vmh.uni.lu/_api/metabolites/1825/?format=pcsv
CE1279,,,0,C27H48O5,,,"Human Metabolome Database (HMDB): 5b-Cholestane-3a,7a,12a,24,25-pentol has been found excreted in the urine from a patient with sitosterolemia as glycine- and taurine-conjugated bile acids (PMID 7896564).",,"5beta-cholestane-3alpha,7alpha,12alpha,24R,25-pentol",,HMDB00556,"InChI=1/C27H48O5/c1-15(6-9-22(30)25(2,3)32)18-7-8-19-24-20(14-23(31)27(18,19)5)26(4)11-10-17(28)12-16(26)13-21(24)29/h15-24,28-32H,6-14H2,1-5H3/t15-,16?,17-,18-,19+,20+,21-,22?,23+,24+,26+,27-/m1/s1",,2016-12-05T15:48:06Z,,1826,,,,,21252253,CE1279,,"3a,7a,12a,24,25-Pentahydroxycoprostane, 3alpha,7alpha,12alpha,24R,25-pentahydroxy-5beta-cholestane, 5beta-cholestane-3alpha,7alpha,12alpha,24R,25-pentol",http://vmh.uni.lu/_api/metabolites/1826/?format=pcsv
CE1278,,,0,C27H48O5,,,"Human Metabolome Database (HMDB): 5b-Cholestane-3a,7a,12a,25,26-pentol is a bile alcohol. Bile alcohols have been found to be present as minor components in the bile and urine in healthy subjects. Bile alcohols are end products for cholesterol elimination as well as major biliary constituents; in mammals, cholesterol is metabolized by additional enzymes that ultimately transform it to bile acids. Bile alcohols are preferentially excreted as glucuronides into the urine, which constitute about 10% of total bile acids. Large amounts of bile alcohols have been found to be excreted into the bile and urine in patients with cerebrotendinous xanthomatosis (CTX), a rare inherited lipid storage disease. (PMID: 11718684).",,"5beta-cholestane-3alpha,7alpha,12alpha,25,27-pentol",,HMDB02180,"InChI=1/C27H48O5/c1-16(6-5-10-25(2,32)15-28)19-7-8-20-24-21(14-23(31)27(19,20)4)26(3)11-9-18(29)12-17(26)13-22(24)30/h16-24,28-32H,5-15H2,1-4H3/t16-,17+,18-,19-,20+,21+,22?,23+,24+,25?,26+,27-/m1/s1",,2016-12-05T15:48:06Z,,1827,,,,,5284194,CE1278,,"3alpha,7alpha,12alpha,25,27-pentahydroxy-5beta-cholestane, 5beta-Cholestane-3alpha,7alpha,12alpha,25,26-pentol, 5?-Cholestane-3?,7?,12?,25,26-pentol",http://vmh.uni.lu/_api/metabolites/1827/?format=pcsv
CE5242,,,-1,C28H36N3O9S,,,2-hydroxyestrone-1-S-glutathione,,2-hydroxyestrone-1-S-glutathione,,,"InChI=1/C28H37N3O9S/c1-28-9-8-15-14(16(28)4-6-20(28)33)3-2-13-10-19(32)24(37)25(23(13)15)41-12-18(26(38)30-11-22(35)36)31-21(34)7-5-17(29)27(39)40/h10,14-18,32,37H,2-9,11-12,29H2,1H3,(H,30,38)(H,31,34)(H,35,36)(H,39,40)/p-1/t14-,15+,16+,17-,18-,28-/m1/s1",,2016-11-22T15:12:16Z,,1828,,,,,53481501,,,,http://vmh.uni.lu/_api/metabolites/1828/?format=pcsv
CE5243,,,-1,C28H38N3O9S,,,4-hydroxy-17beta-estradiol-2-S-glutathione,,4-hydroxy-17beta-estradiol-2-S-glutathione,,,"InChI=1/C28H39N3O9S/c1-28-9-8-13-14(17(28)4-6-21(28)32)2-3-15-16(13)10-20(25(37)24(15)36)41-12-19(26(38)30-11-23(34)35)31-22(33)7-5-18(29)27(39)40/h10,13-14,17-19,21,32,36-37H,2-9,11-12,29H2,1H3,(H,30,38)(H,31,33)(H,34,35)(H,39,40)/p-1/t13-,14+,17-,18+,19+,21+,28+/m1/s1",,2016-11-22T15:12:16Z,,1829,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1829/?format=pcsv
CE5244,,,-1,C28H36N3O9S,,,4-hydroxyestrone-2-S-glutathione,,4-hydroxyestrone-2-S-glutathione,,,"InChI=1/C28H37N3O9S/c1-28-9-8-13-14(17(28)4-6-21(28)32)2-3-15-16(13)10-20(25(37)24(15)36)41-12-19(26(38)30-11-23(34)35)31-22(33)7-5-18(29)27(39)40/h10,13-14,17-19,36-37H,2-9,11-12,29H2,1H3,(H,30,38)(H,31,33)(H,34,35)(H,39,40)/p-1/t13-,14+,17-,18+,19+,28+/m0/s1",,2016-11-22T15:12:16Z,,1830,,,,,53481521,,,,http://vmh.uni.lu/_api/metabolites/1830/?format=pcsv
CE4990,,,-1,C20H29O4,,,12-oxo-leukotriene B4,,12-oxo-leukotriene B4,,,"InChI=1/C20H30O4/c1-2-3-4-5-6-9-13-18(21)14-10-7-8-11-15-19(22)16-12-17-20(23)24/h6-11,14-15,19,22H,2-5,12-13,16-17H2,1H3,(H,23,24)/p-1/b8-7+,9-6-,14-10+,15-11-/t19-/m0/s1",C05949,2016-11-22T15:12:16Z,,1831,,,,,5280876,CE4990,,,http://vmh.uni.lu/_api/metabolites/1831/?format=pcsv
CE5531,,,-2,C30H45N3O10S,,,12-oxo-c-LTB3,,12-oxo-c-LTB3,,,"InChI=1/C30H47N3O10S/c1-2-3-4-5-6-8-12-21(34)13-9-7-10-15-25(24(35)14-11-16-27(37)38)44-20-23(29(41)32-19-28(39)40)33-26(36)18-17-22(31)30(42)43/h6-10,15,22-25,35H,2-5,11-14,16-20,31H2,1H3,(H,32,41)(H,33,36)(H,37,38)(H,39,40)(H,42,43)/p-2/b8-6-,9-7+,15-10+/t22-,23-,24-,25+/m1/s1",,2016-11-22T15:12:16Z,,1832,,,,,,CE5531,,,http://vmh.uni.lu/_api/metabolites/1832/?format=pcsv
CE4993,,,-2,C30H47N3O10S,,,"10,11-dihydro-12R-hydroxy-leukotriene C4",,"10,11-dihydro-12R-hydroxy-leukotriene C4",,,"InChI=1/C30H49N3O10S/c1-2-3-4-5-6-8-12-21(34)13-9-7-10-15-25(24(35)14-11-16-27(37)38)44-20-23(29(41)32-19-28(39)40)33-26(36)18-17-22(31)30(42)43/h6-10,15,21-25,34-35H,2-5,11-14,16-20,31H2,1H3,(H,32,41)(H,33,36)(H,37,38)(H,39,40)(H,42,43)/p-2/b8-6-,9-7+,15-10+/t21-,22+,23-,24-,25+/m0/s1",,2016-11-22T15:12:16Z,,1833,,,,,,CE4993,,,http://vmh.uni.lu/_api/metabolites/1833/?format=pcsv
CE1298,,,0,C27H44O2,,,3beta-hydroxy-5-cholestenal,,3beta-hydroxy-5-cholestenal,,,"InChI=1/C27H44O2/c1-18(17-28)6-5-7-19(2)23-10-11-24-22-9-8-20-16-21(29)12-14-26(20,3)25(22)13-15-27(23,24)4/h8,17-19,21-25,29H,5-7,9-16H2,1-4H3/t18u,19-,21+,22-,23-,24-,25-,26+,27-/m1/s1",,2016-11-22T15:12:16Z,,1834,,,,,,CE1298,,,http://vmh.uni.lu/_api/metabolites/1834/?format=pcsv
CE1292,,,-1,C27H43O3,,,3beta-hydroxy-5-cholestene-27-oate,,3beta-hydroxy-5-cholestene-27-oate,,,"InChI=1/C27H44O3/c1-17(6-5-7-18(2)25(29)30)22-10-11-23-21-9-8-19-16-20(28)12-14-26(19,3)24(21)13-15-27(22,23)4/h8,17-18,20-24,28H,5-7,9-16H2,1-4H3,(H,29,30)/p-1/t17-,18u,20+,21-,22-,23-,24-,26+,27-/m0/s1",,2016-11-22T15:12:16Z,,1835,,,,,,CE1292,,,http://vmh.uni.lu/_api/metabolites/1835/?format=pcsv
CE3038,,,-1,C27H43O4,,,"3beta,7alpha-dihydroxy-5-cholestenoate",,"3beta,7alpha-dihydroxy-5-cholestenoate",,,"InChI=1/C27H44O4/c1-16(6-5-7-17(2)25(30)31)20-8-9-21-24-22(11-13-27(20,21)4)26(3)12-10-19(28)14-18(26)15-23(24)29/h15-17,19-24,28-29H,5-14H2,1-4H3,(H,30,31)/p-1/t16-,17u,19+,20-,21-,22-,23+,24-,26+,27-/m0/s1",C17335,2016-11-22T15:12:16Z,,1836,,,,,3081084,CE3038,,,http://vmh.uni.lu/_api/metabolites/1836/?format=pcsv
CE2345,,,-1,C27H41O4,,,7alpha-hydroxy-3-oxo-4-cholestenoic acid anion,,7alpha-hydroxy-3-oxo-4-cholestenoic acid anion,,,"InChI=1/C27H42O4/c1-16(6-5-7-17(2)25(30)31)20-8-9-21-24-22(11-13-27(20,21)4)26(3)12-10-19(28)14-18(26)15-23(24)29/h14,16-17,20-24,29H,5-13,15H2,1-4H3,(H,30,31)/p-1/t16-,17?,20-,21-,22-,23+,24-,26+,27-/m0/s1",,2016-11-22T15:12:16Z,,1837,,,,,,CE2345,,,http://vmh.uni.lu/_api/metabolites/1837/?format=pcsv
CE1589,,,-4,C45H70N7O19P3S,CHEBI:58810,,deoxycholoyl-CoA,,deoxycholoyl-CoA,,,"InChI=1S/C45H74N7O19P3S/c1-24(28-9-10-29-27-8-7-25-18-26(53)12-14-44(25,4)30(27)19-32(54)45(28,29)5)6-11-34(56)75-17-16-47-33(55)13-15-48-41(59)38(58)43(2,3)21-68-74(65,66)71-73(63,64)67-20-31-37(70-72(60,61)62)36(57)42(69-31)52-23-51-35-39(46)49-22-50-40(35)52/h22-32,36-38,42,53-54,57-58H,6-21H2,1-5H3,(H,47,55)(H,48,59)(H,63,64)(H,65,66)(H2,46,49,50)(H2,60,61,62)/p-4/t24-,25-,26-,27+,28-,29+,30+,31-,32+,36-,37-,38+,42-,44+,45-/m1/s1",C15560,2016-11-22T15:12:16Z,,1838,,,,,24820763,CE1589,,,http://vmh.uni.lu/_api/metabolites/1838/?format=pcsv
C05463,,,-1,C26H44NO6S,2733768,,"Human Metabolome Database (HMDB): Taurodeoxycholic acid is a bile salt formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",,taurodeoxycholate,,HMDB00896,"InChI=1S/C26H45NO6S/c1-16(4-9-24(30)27-12-13-34(31,32)33)20-7-8-21-19-6-5-17-14-18(28)10-11-25(17,2)22(19)15-23(29)26(20,21)3/h16-23,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/p-1/t16-,17-,18-,19+,20-,21+,22+,23+,25+,26-/m1/s1",C05463,2016-12-05T15:48:06Z,,1839,,,,,2733768,,,"Deoxycholyltaurine, Deoxytaurocholate, Deoxytaurocholic acid, N-(3a,12a-Dihydroxy-5b-cholan-24-oyl)-Taurine, Sodium taurodeoxycholate, Sodium taurodeoxylate, Taurodeoxycholic acid, Taurodeoxycholic acid sodium salt, Taurodeoxycholic acid sodium salt hydrate, Taurodesoxycholate, Taurodesoxycholic acid, Tudcabil",http://vmh.uni.lu/_api/metabolites/1839/?format=pcsv
23cump,,,-1,C9H10N2O8P,,,"2',3'-cyclic UMP(1-)",,"2',3'-cyclic UMP(1-)",,,"InChI=1S/C9H11N2O8P/c12-3-4-6-7(19-20(15,16)18-6)8(17-4)11-2-1-5(13)10-9(11)14/h1-2,4,6-8,12H,3H2,(H,15,16)(H,10,13,14)/p-1/t4-,6-,7-,8-/m1/s1",C02355,2016-11-22T15:12:16Z,,1840,,,,,439715,,,,http://vmh.uni.lu/_api/metabolites/1840/?format=pcsv
3ump,,,-2,C9H11N2O9P,CHEBI:28895,,3'-UMP(2-),,3'-UMP(2-),,,"InChI=1S/C9H13N2O9P/c12-3-4-7(20-21(16,17)18)6(14)8(19-4)11-2-1-5(13)10-9(11)15/h1-2,4,6-8,12,14H,3H2,(H,10,13,15)(H2,16,17,18)/p-2/t4-,6-,7-,8-/m1/s1",C01368,2016-11-22T15:12:16Z,,1841,,,,,101543,,,,http://vmh.uni.lu/_api/metabolites/1841/?format=pcsv
CE5586,,,3,C7H20N3,,,"N-[(E)-4-ammoniobutylidene]propane-1,3-diaminium",,"N-[(E)-4-ammoniobutylidene]propane-1,3-diaminium",,,"InChI=1S/C7H17N3/c8-4-1-2-6-10-7-3-5-9/h6H,1-5,7-9H2/p+3/b10-6+",,2016-11-22T15:12:16Z,,1842,,,,,23657850,CE5586,,,http://vmh.uni.lu/_api/metabolites/1842/?format=pcsv
CE5588,,,2,C10H25N3O2,,,deoxyhypusine,,deoxyhypusine,,,"InChI=1S/C10H23N3O2/c11-6-2-4-8-13-7-3-1-5-9(12)10(14)15/h9,13H,1-8,11-12H2,(H,14,15)/t9-/m0/s1",,2016-11-22T15:12:16Z,,1843,,,,,122083,CE5588,,,http://vmh.uni.lu/_api/metabolites/1843/?format=pcsv
CE1617,,,-1,C20H27O2,,,9-cis-retinoate,,9-cis-retinoate,,,,C15493,2016-11-22T15:12:16Z,,1844,,,,,449171,CE1617,,,http://vmh.uni.lu/_api/metabolites/1844/?format=pcsv
CE5591,,,0,C20H28O2,,,4-OH-13-cis-retinal,,4-OH-13-cis-retinal,,,,,2016-11-22T15:12:16Z,,1845,,,,,,CE5591,,,http://vmh.uni.lu/_api/metabolites/1845/?format=pcsv
CE5592,,,0,C20H28O2,,,4-OH-9-cis-retinal,,4-OH-9-cis-retinal,,,,,2016-11-22T15:12:16Z,,1846,,,,,,CE5592,,,http://vmh.uni.lu/_api/metabolites/1846/?format=pcsv
CE5593,,,0,C20H28O2,,,4-OH-retinal,,4-OH-retinal,,,,,2016-11-22T15:12:16Z,,1847,,,,,14015984,CE5593,,,http://vmh.uni.lu/_api/metabolites/1847/?format=pcsv
CE5594,,,-1,C20H27O2,,,"9,13-cis-retinoate",,"9,13-cis-retinoate",,,,C00777,2016-11-22T15:12:16Z,,1848,,,,,6419708,CE5594,,,http://vmh.uni.lu/_api/metabolites/1848/?format=pcsv
CE1261,,,0,C12H16N2O6S,,,5-S-cysteinyldopa,,5-S-cysteinyldopa,,,,,2016-11-22T15:12:16Z,,1849,,,,,10663203,CE1261,,,http://vmh.uni.lu/_api/metabolites/1849/?format=pcsv
CE5026,,,-1,C19H25N4O10S,,,5-S-glutathionyl-L-DOPA,,5-S-glutathionyl-L-DOPA,,,,,2016-11-22T15:12:16Z,,1850,,,,,,CE5026,,,http://vmh.uni.lu/_api/metabolites/1850/?format=pcsv
CE1262,,,0,C12H14N2O6S,,,5-(S-L-cysteinyl)-dopaquinone,,5-(S-L-cysteinyl)-dopaquinone,,,,,2016-11-22T15:12:16Z,,1851,,,,,,CE1262,,,http://vmh.uni.lu/_api/metabolites/1851/?format=pcsv
C09642,,,1,C10H14NO2,,,"Human Metabolome Database (HMDB): Salsolinol is an endogenous catechol isoquinoline detected in humans. Salsolinol was detected in urine of parkinsonian patients administered with L-DOPA. This finding stimulated the studies on Salsolinol derivatives in the brain, and gave new aspects of the endogenous alkaloids, which had been considered to occur only in plants. In normal non-alcoholic subjects and alcoholics, Salsolinol and O-methylated Salsolinol were found in urine, cerebrospinal fluid and brains. Salsolinol has an asymmetric center at first position and exists as (R)- and (S)enantiomer. The (R)enantiomer of Salsolinol is predominant in urine from healthy volunteers. Only the (R)enantiomers of Salsolinol and N-methylated Salsolinol occur in the human brain, cerebrospinal fluid (CSF) and intraventricular fluid (IVF), and the (S)enantiomers were not detected. (R)salsolinol synthase catalyzes the enantio-selective synthesis of (R)Salsolinol and 1-carboxyl(R)Salsolinol from dopamine with acetaldehyde or pyruvic acid. The N-methylation of (R)salsolinol into N-methylsalsolinol (NMSal) is catalyzed by two N-methyltransferases with different optimum pH, at pH 7.0 and 8.4. NM(R)Salsolinol is enzymatically oxidized into 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion (DMDHIQ+) by an oxidase sensitive to semicarbaside and also non-enzymatically by autoxidation. NM(R)Salsolinol and its precursor, dopamine, were found to occur selectively in the nigro-striatum, whereas (R)Salsolinol distributes uniformly among the brain regions. (PMID 14697894).",,(-)-Salsolinol,,HMDB05199,InChI=Not Available,C09642,2016-12-05T15:48:06Z,,1852,,,,,91588,C09642,,"(+)-(R)-Salsolinol, (+)-Salsolinol, (R)-(+)-Salsolinol, (R)-Salsolinol , 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline",http://vmh.uni.lu/_api/metabolites/1852/?format=pcsv
CE5626,,,0,C11H13NO4,,,salsolinol 1-carboxylate,,salsolinol 1-carboxylate,,,"InChI=1/C11H13NO4/c1-11(10(15)16)7-5-9(14)8(13)4-6(7)2-3-12-11/h4-5,12-14H,2-3H2,1H3,(H,15,16)/p-1",,2016-11-22T15:12:16Z,,1853,,,,,100185,CE5626,,,http://vmh.uni.lu/_api/metabolites/1853/?format=pcsv
CE5627,,,0,C12H15NO4,,,salsoline-1-carboxylate,,salsoline-1-carboxylate,,,"InChI=1/C12H15NO4/c1-12(11(15)16)8-6-10(17-2)9(14)5-7(8)3-4-13-12/h5-6,13-14H,3-4H2,1-2H3,(H,15,16)/p-1",,2016-11-22T15:12:16Z,,1854,,,,,320322,CE5627,,,http://vmh.uni.lu/_api/metabolites/1854/?format=pcsv
CE5629,,,0,C10H11NO2,,,"1,2-dehydrosalsolinol",,"1,2-dehydrosalsolinol",,,"InChI=1/C10H11NO2/c1-6-8-5-10(13)9(12)4-7(8)2-3-11-6/h4-5,12-13H,2-3H2,1H3",,2016-11-22T15:12:16Z,,1855,,,,,,CE5629,,,http://vmh.uni.lu/_api/metabolites/1855/?format=pcsv
C09640,,,1,C11H16NO2,,,(-)-Salsoline,,(-)-Salsoline,,,"InChI=1/C11H15NO2/c1-7-9-6-11(14-2)10(13)5-8(9)3-4-12-7/h5-7,12-13H,3-4H2,1-2H3/t7-/m0/s1",C09640,2016-11-22T15:12:16Z,,1856,,,,,442356,C09640,,,http://vmh.uni.lu/_api/metabolites/1856/?format=pcsv
CE4890,,,1,C11H16NO2,,,"Human Metabolome Database (HMDB): 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline is an endogenous amine in parkinsonian and normal human brain. (PMID 2049084). Endogenous isoquinolines with and without catechol structure have been proposed to be neurotoxins specific for dopamine neurons. (PMID 9085193).",,N-methylsalsolinol,,HMDB03892,"InChI=1/C11H15NO2/c1-7-9-6-11(14)10(13)5-8(9)3-4-12(7)2/h5-7,13-14H,3-4H2,1-2H3/t7-/m0/s1",,2016-12-05T15:48:06Z,,1857,,,,,124148,CE4890,,"(S)-N-Methylsalsolinol, 1,2-Ddtiq, 1,2-Dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-Methyl-(S)-salsolinol, N-Methylsalsolinol",http://vmh.uni.lu/_api/metabolites/1857/?format=pcsv
C06350,,,1,C16H18NO4,CHEBI:28770,,"(R,S)-Norlaudanosoline",,"(R,S)-Norlaudanosoline",,,"InChI=1S/C16H17NO4/c18-13-2-1-9(6-14(13)19)5-12-11-8-16(21)15(20)7-10(11)3-4-17-12/h1-2,6-8,12,17-21H,3-5H2",C06350,2016-11-22T15:12:16Z,,1858,,,,,18519,C06350,,,http://vmh.uni.lu/_api/metabolites/1858/?format=pcsv
CE1401,,,1,C4H8NOS,,,homocysteine thiolactone,,homocysteine thiolactone,,,"InChI=1S/C4H7NOS/c5-3-1-2-7-4(3)6/h3H,1-2,5H2/t3-/m0/s1",,2016-11-22T15:12:16Z,,1859,,,,,134505,CE1401,,,http://vmh.uni.lu/_api/metabolites/1859/?format=pcsv
CE1761,,,0,C20H30O2,,,4-hydroxyvitamin A1,,4-hydroxyvitamin A1,,,,,2016-11-22T15:12:16Z,,1860,,,,,4363341,CE1761,,,http://vmh.uni.lu/_api/metabolites/1860/?format=pcsv
CE5653,,,-1,C20H25O3,,,4-oxo-9-cis-retinoate,,4-oxo-9-cis-retinoate,,,,,2016-11-22T15:12:16Z,,1861,,,,,54518673,CE5653,,,http://vmh.uni.lu/_api/metabolites/1861/?format=pcsv
CE5654,,,-1,C20H25O3,,,4-oxo-13-cis-retinoate,,4-oxo-13-cis-retinoate,,,,,2016-11-22T15:12:16Z,,1862,,,,,9995780,CE5654,,,http://vmh.uni.lu/_api/metabolites/1862/?format=pcsv
CE2957,,,-1,C20H27O3,,,18-hydroxy-all-trans-retinoate,,18-hydroxy-all-trans-retinoate,,,,C16679,2016-11-22T15:12:16Z,,1863,,,,,6506224,CE2957,,,http://vmh.uni.lu/_api/metabolites/1863/?format=pcsv
CE5656,,,-1,C18H25N5O8PS2,,,lipoyl-AMP(1-),,lipoyl-AMP(1-),,,"InChI=1S/C18H26N5O8PS2/c19-16-13-17(21-8-20-16)23(9-22-13)18-15(26)14(25)11(30-18)7-29-32(27,28)31-12(24)4-2-1-3-10-5-6-33-34-10/h8-11,14-15,18,25-26H,1-7H2,(H,27,28)(H2,19,20,21)/p-1/t10?,11-,14-,15-,18-/m1/s1",C16238,2016-11-22T15:12:16Z,,1864,,,,,23724672,,,,http://vmh.uni.lu/_api/metabolites/1864/?format=pcsv
CE2566,,,-1,C20H29O4,,,"5(S),6(S)-epoxy-15(R)-hydroxyeicosatetraenoate",,"5(S),6(S)-epoxy-15(R)-hydroxyeicosatetraenoate",,,,,2016-11-22T15:12:16Z,,1865,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1865/?format=pcsv
CE2568,,,-1,C20H31O5,,,15-epi-lipoxin A4,,15-epi-lipoxin A4,,,,,2016-11-22T15:12:16Z,,1866,,,,,3934,,,,http://vmh.uni.lu/_api/metabolites/1866/?format=pcsv
CE5661,,,-1,C20H29O5,,,15-oxo-lipoxin A4,,15-oxo-lipoxin A4,,,,,2016-11-22T15:12:16Z,,1867,,,,,53481477,,,,http://vmh.uni.lu/_api/metabolites/1867/?format=pcsv
CE5662,,,-1,C20H31O5,,,"13,14-dihydro-15-oxo-lipoxin A4",,"13,14-dihydro-15-oxo-lipoxin A4",,,,,2016-11-22T15:12:16Z,,1868,,,,,53481470,,,,http://vmh.uni.lu/_api/metabolites/1868/?format=pcsv
CE2569,,,-1,C20H31O5,,,15-epi-lipoxin B4,,15-epi-lipoxin B4,,,,,2016-11-22T15:12:16Z,,1869,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1869/?format=pcsv
C11695,,,0,C22H37NO2,CHEBI:2700,,"Human Metabolome Database (HMDB): Anandamide is a highly potent endogenous agonist of the cannabinoid CB1 and CB2 receptors. CB1 receptors are predominantly found in the central nervous system (CNS) where they mainly mediate the psychotropic effects of Tetrahydrocannabinol (THC) and endocannabinoids, whereas the expression of the CB2 receptor is thought to be restricted to cells of the immune system. It was suggested that AEA might inhibit tumor cell proliferation or induce apoptosis independently of CB1 and CB2 receptors, via interaction with the type 1 vanilloid receptor (VR1). VR1 is an ion channel expressed almost exclusively by sensory neurons, activated by pH, noxious heat (>48 degree centigrade) and plant toxins and is thought to play an important role in nociception. Cervical cancer cells are sensitive to AEA-induced apoptosis via VR1 that is aberrantly expressed in vitro and in vivo while CB1 and CB2 receptors play a protective role. (PMID 15047233). Novel prostaglandins (prostaglandin glycerol esters and prostaglandin ethanolamides) are COX-2 oxidative metabolites of endogenous cannabinoids (such as Anandamide). Recent evidence suggests that these new types of prostaglandins are likely novel signaling mediators involved in synaptic transmission and plasticity. (PMID 16957004).",,Anandamide,,HMDB04080,"InChI=1S/C22H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23-20-21-24/h6-7,9-10,12-13,15-16,24H,2-5,8,11,14,17-21H2,1H3,(H,23,25)/b7-6-,10-9-,13-12-,16-15-",C11695,2016-12-05T15:48:06Z,,1870,,,,,5281969,C11695,,"5,8,11,14-Eicosatetraenoylethanolamide, AEA, Anandamide, Anandamide (20.4, N-6), Anandamide(20:4, N-6), Arachidonic acid N-(hydroxyethyl)amide, Arachidonylethanolamide, N-(2-Hydroxyethyl)-5,8,11,14-Eicosatetraenamide (all-Z), N-(2-Hydroxyethyl)anachidonamide, N-(5Z,8Z,11Z,14Z-Eicosatetraenoyl)-ethanolamine, N-(5Z,8Z,11Z,14Z-Icosatetraenoyl)-ethanolamide, N-Arachidonoyl ethanolamine, N-Arachidonoyl-2-hydroxyethylamide",http://vmh.uni.lu/_api/metabolites/1870/?format=pcsv
CE5698,,,-1,C12H11N2O5S,,,"1,4-benzothiazine-o-quinonimine",,"1,4-benzothiazine-o-quinonimine",,,,,2016-11-22T15:12:16Z,,1871,,,,,53481441,CE5698,,,http://vmh.uni.lu/_api/metabolites/1871/?format=pcsv
CE5272,,,-1,C12H13N2O5S,,,"3,4-dihydro-1,4-benzothiazine-3-carboxylate",,"3,4-dihydro-1,4-benzothiazine-3-carboxylate",,,,,2016-11-22T15:12:16Z,,1872,,,,,,CE5272,,,http://vmh.uni.lu/_api/metabolites/1872/?format=pcsv
CE1264,,,0,,,,benzothiazine,,benzothiazine,,,,,2016-11-22T15:12:16Z,,1873,,,,,,CE1264,,,http://vmh.uni.lu/_api/metabolites/1873/?format=pcsv
CE5274,,,0,C11H14N2O4S,,,"3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine",,"3,5-dihydroxy-3,4-dihydro-1,4-benzothiazine",,,,,2016-11-22T15:12:16Z,,1874,,,,,,CE5274,,,http://vmh.uni.lu/_api/metabolites/1874/?format=pcsv
C02712,,,-1,C7H12NO3S,,,"Human Metabolome Database (HMDB): N-acetyl-L-methionine is nutritionally and metabolically equivalent to L-methionine. Methionine is a dietary indispensable amino acid required for normal growth and development of humans, other mammals, and avian species. In addition to being a substrate for protein synthesis, it is an intermediate in transmethylation reactions, serving as the major methyl group donor in vivo, including the methyl groups for DNA and RNA intermediates. Methionine is a methyl acceptor for 5-methyltetrahydrofolate-homocysteine methyl transferase (methionine synthase), the only reaction that allows for the recycling of this form of folate, and is also a methyl acceptor for the catabolism of betaine. Methionine is also required for synthesis of cysteine. Methionine is accepted as the metabolic precursor for cysteine. Only the sulfur atom from methionine is transferred to cysteine; the carbon skeleton of cysteine is donated by serine. (PMID 16702340). The adequacy range of dietary requirements of specific amino acids in disease states is difficult to determine. Requirements may not be similar in disease with regard to protein synthesis. Requirements for this purpose can be assessed only when such a function can be measured and related to clinical outcome. There is apparent consensus concerning normal sulfur amino acid (SAA) requirements. WHO recommendations amount to 13 mg/kg per 24 h in healthy adults. This amount is roughly doubled in artificial nutrition regimens. In disease or after trauma, requirements may be altered for methionine, cysteine, and taurine. Although in specific cases of congenital enzyme deficiency, prematurity, or diminished liver function, hypermethionemia or hyperhomocysteinemia may occur, SAA supplementation can be considered safe in amounts exceeding 2-3 times the minimal recommended daily intake. Apart from some very specific indications (e.g., acetaminophen poisoning) the usefulness of SAA supplementation is not yet established.(PMID 16702341). Methionine is known to exacerbate psychopathological symptoms in schizophrenic patients, there is no evidence of similar effects in healthy subjects. The role of methionine as a precursor of homocysteine is the most notable cause for concern. A ""loading dose"" of methionine (0.1 g/kg) has been given, and the resultant acute increase in plasma homocysteine has been used as an index of the susceptibility to cardiovascular disease. Although this procedure results in vascular dysfunction, this is acute and unlikely to result in permanent damage. However, a 10-fold larger dose, given mistakenly, resulted in death. Longer-term studies in adults have indicated no adverse consequences of moderate fluctuations in dietary methionine intake, but intakes higher than 5 times normal resulted in elevated homocysteine levels. These effects of methionine on homocysteine and vascular function are moderated by supplements of vitamins B-6, B-12, C, and folic acid. In infants, methionine intakes of 2 to 5 times normal resulted in impaired growth and extremely high plasma methionine levels, but no adverse long-term consequences were observed. (PMID 16702346).",,N-Acetylmethionine,,HMDB11745,"InChI=1/C7H13NO3S/c1-5(9)8-6(7(10)11)3-4-12-2/h6H,3-4H2,1-2H3,(H,8,9)(H,10,11)",C02712,2016-12-05T15:48:06Z,,1875,,,,,6180,C02712,,"Acetyl-L-methionine, Acetylmethionin, Acetylmethionine, DL-N-acetylmethionine, L-(N-Acetyl)methionine, L-N-Acetyl-Methionine, Methionamine, Methionin, N-Acetyl(methyl)homocysteine, N-Acetyl-L-methionine, N-Acetyl-Methionine, N-Acetyl-S-methylhomocysteine, N-Acetylmethionine, Thiomedon",http://vmh.uni.lu/_api/metabolites/1875/?format=pcsv
CE1554,,,-1,C5H8NO3,,,N-acetyl-L-alanine,,N-acetyl-L-alanine,,,"InChI=1/C5H9NO3/c1-3(5(8)9)6-4(2)7/h3H,1-2H3,(H,6,7)(H,8,9)/p-1/t3-/m1/s1",,2016-11-22T15:12:16Z,,1876,,,,,132213,CE1554,,,http://vmh.uni.lu/_api/metabolites/1876/?format=pcsv
CE1556,,,-1,C6H9N2O4,,,N-acetyl-L-asparagine,,N-acetyl-L-asparagine,,,"InChI=1/C6H10N2O4/c1-3(9)8-4(6(11)12)2-5(7)10/h4H,2H2,1H3,(H2,7,10)(H,8,9)(H,11,12)/p-1/t4-/m0/s1",,2016-11-22T15:12:16Z,,1877,,,,,99715,CE1556,,,http://vmh.uni.lu/_api/metabolites/1877/?format=pcsv
C02356,,,0,C4H9NO2,CHEBI:35619,,Human Metabolome Database (HMDB): A-Aminobutyric acid is an isomer of the amino acid aminobutyric acid. It is a key intermediate in the biosynthesis of ophthalmic acid or ophthalmate.,,(S)-2-Aminobutanoate,,HMDB00452,"InChI=1S/C4H9NO2/c1-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1",C02356,2016-12-05T15:48:06Z,,1878,,,,,80283,C02356,,"(+)-2-Aminobutanoate, (+)-2-Aminobutanoic acid, (+)-2-Aminobutyric acid, (+)-alpha-Aminobutyric acid, (-)-2-Aminobutyric acid, (2S)-2-aminobutanoate, (2S)-2-aminobutanoic acid, (S)-(+)-alpha-Aminobutyric acid, (S)-2-amino-Butanoate, (S)-2-amino-Butanoic acid, (S)-2-Aminobutanoate, (S)-2-Aminobutanoic acid, (S)-2-Aminobutyric acid, 2-Aminobutanoate, 2-Aminobutanoic acid, 2-Aminobutyrate, 2S-Amino-butanoate, 2S-Amino-butanoic acid, alpha-Aminobutyric acid, L-(+)-2-Aminobutyric acid, L-2-Amino-N-butyric acid, L-2-Aminobuttersaeure, L-2-Aminobutyric acid, L-a-Aminobutyric acid, L-alpha-Amino-N-butyric acid, L-alpha-Aminobutyrate, L-alpha-Aminobutyric acid, L-Butyrine, L-Ethylglycine, S-Butyrine",http://vmh.uni.lu/_api/metabolites/1878/?format=pcsv
CE1661,,,-1,C9H15N2O5,,,gama-L-glutamyl-L-alpha-aminobutyrate,,gama-L-glutamyl-L-alpha-aminobutyrate,,,,,2016-11-22T15:12:16Z,,1879,,,,,,CE1661,,,http://vmh.uni.lu/_api/metabolites/1879/?format=pcsv
CE1665,,,-2,C15H22N4O9S,,,gama-glutamylglutathione,,gama-glutamylglutathione,,,,,2016-11-22T15:12:16Z,,1880,,,,,,CE1665,,,http://vmh.uni.lu/_api/metabolites/1880/?format=pcsv
CE2565,,,-1,C20H31O3,,,"15(R)-Hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoate",,"15(R)-Hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoate",,,,,2016-11-22T15:12:16Z,,1881,,,,,3246888,,,,http://vmh.uni.lu/_api/metabolites/1881/?format=pcsv
CE1957,,,-2,C8H5NO5,,,4-hydroxy-3-nitrophenylacetate,,4-hydroxy-3-nitrophenylacetate,,,,,2016-11-22T15:12:16Z,,1882,,,,,447364,CE1957,,,http://vmh.uni.lu/_api/metabolites/1882/?format=pcsv
C13856,,,0,C23H38O4,CHEBI:52392,,"Human Metabolome Database (HMDB): 2-Arachidonoylglycerol (2-AG) is a unique molecular species of monoacylglycerol isolated in 1995 from rat brain and canine gut as an endogenous ligand for the cannabinoid receptors. 2-AG is rapidly formed from arachidonic acid-containing phospholipids through increased phospholipid metabolism, such as enhanced inositol phospholipid turnover, in various tissues and cells upon stimulation. 2-AG binds to the cannabinoid receptors (CB1 and CB2) and exhibits a variety of cannabimimetic activities in vitro and in vivo. 2-Arachidonylglycerol is an endogenous cannabinoid (endocannabinoid). Endocannabinoids are a class of fatty acid derivatives defined by their ability to interact with the specific cannabinoid receptors that were originally identified as the targets of Delta9-tetrahydocannabinol (Delta9-THC), the psychoactive component of cannabis. Endocannabinoids have been implicated in a growing number of important physiological and behavioral events. Endocannabinoids are amides, esters and ethers of long chain polyunsaturated fatty acids, which act as new lipidic mediators. 2-AG is one of the main endogenous agonists of cannabinoid receptors, able to mimic several pharmacological effects of (-)-Delta9-tetrahydrocannabinol (THC), the active principle of Cannabis sativa preparations like hashish and marijuana. The activity of AEA and 2-AG at their receptors is limited by cellular uptake through an anandamide membrane transporter (AMT), followed by intracellular degradation. A fatty acid amide hydrolase (FAAH) is the main AEA hydrolase, whereas a monoacylglycerol lipase (MAGL) is critical in degrading 2-AG. (PMID: 16515464, 16278487, 16678907). 

2-Arachidonoylglycerol, or MG(0:0/20:4(5Z,8Z,11Z,14Z)/0:0), is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed 'alpha-monoacylglycerols', while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well.",,2-Arachidonoylglycerol,,HMDB04666,"InChI=1S/C23H38O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23(26)27-22(20-24)21-25/h6-7,9-10,12-13,15-16,22,24-25H,2-5,8,11,14,17-21H2,1H3/b7-6-,10-9-,13-12-,16-15-",C13856,2016-12-05T15:48:06Z,,1883,,,,,1541,C13856,,"(5Z,8Z,11Z,14Z)-2-hydroxy-1-(hydroxymethyl)ethyl ester 5,8,11,14-Eicosatetraenoate, (5Z,8Z,11Z,14Z)-2-hydroxy-1-(hydroxymethyl)ethyl ester 5,8,11,14-Eicosatetraenoic acid, (all-Z)-2-hydroxy-1-(hydroxymethyl)ethyl ester 5,8,11,14-Eicosatetraenoate, (all-Z)-2-hydroxy-1-(hydroxymethyl)ethyl ester 5,8,11,14-Eicosatetraenoic acid, 1-Monoacylglyceride, 1-Monoacylglycerol, 2-(5Z,8Z,11Z,14Z-Eicosatetraenoyl)-rac-glycerol, 2-AG, 2-Arachidonoyl-glycerol, 2-Arachidonyl glycerol, 2-Monoarachidonoylglycerolbeta-monoacylglycerol, b-Monoacylglycerol, beta-Monoacylglycerol, MAG(0:0/20:4), MAG(0:0/20:4n6), MAG(0:0/20:4w6), MAG(20:4), MG(0:0/20:4(5Z,8Z,11Z,14Z)/0:0), MG(0:0/20:4), MG(0:0/20:4n6), MG(0:0/20:4w6), MG(20:4)",http://vmh.uni.lu/_api/metabolites/1883/?format=pcsv
CE5700,,,0,C23H38O6,,,12-hydroperoxyeicosatetraenoate glyceryl ester,,12-hydroperoxyeicosatetraenoate glyceryl ester,,,,,2016-11-22T15:12:16Z,,1884,,,,,,CE5700,,,http://vmh.uni.lu/_api/metabolites/1884/?format=pcsv
CE3481,,,-2,C23H37O7P,,,1-lyso-2-arachidonoyl-phosphatidate,,1-lyso-2-arachidonoyl-phosphatidate,,,,,2016-11-22T15:12:16Z,,1885,,,,,53481443,CE3481,,,http://vmh.uni.lu/_api/metabolites/1885/?format=pcsv
CE5726,,,0,C23H38O7,,,Prostaglandin PGE2 1-glyceryl ester,,Prostaglandin PGE2 1-glyceryl ester,,,,,2016-11-22T15:12:16Z,,1886,,,,,52193688,CE5726,,,http://vmh.uni.lu/_api/metabolites/1886/?format=pcsv
CE5727,,,0,C23H38O7,,,Prostaglandin PGE2 3-glyceryl ester,,Prostaglandin PGE2 3-glyceryl ester,,,,,2016-11-22T15:12:16Z,,1887,,,,,,CE5727,,,http://vmh.uni.lu/_api/metabolites/1887/?format=pcsv
CE4980,,,0,C23H38O7,,,Prostaglandin PGE2 glyceryl ester,,Prostaglandin PGE2 glyceryl ester,,,,,2016-11-22T15:12:17Z,,1888,,,,,53481593,,,,http://vmh.uni.lu/_api/metabolites/1888/?format=pcsv
CE5730,,,0,C23H36O6,,,Prostaglandin PGB2 glyceryl ester,,Prostaglandin PGB2 glyceryl ester,,,,,2016-11-22T15:12:17Z,,1889,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1889/?format=pcsv
C05953,,,-1,C20H29O4,22833602,,"Human Metabolome Database (HMDB): Produced by the seminal vessicals: Prostaglandins are a group of lipid compounds that are derived enzymatically from fattyacids. Technically a hormone, the prostanoid class of fatty acid derivatives is a subclass of eicosanoids. Prostaglandin A is a cyclopentenone and is an endogenous metabolite derived from arachidonic acid. Exhibits potent cellular anti-proliferative activity in vivo and in vitro. Excess PGA2 causes an accumulation in both S and G2/M, and a marked decrease in G1. As well there is an increase in DNA content preceeding the G0/G1 peak (indicative of apoptic body formation) mediated by changes in expression levels of Bax and Bcl-2. Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,Prostaglandin A2,,HMDB02752,"InChI=1S/C20H30O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h4,7,12-18,21H,2-3,5-6,8-11H2,1H3,(H,23,24)/b7-4-,14-12+/t16-,17-,18+/m0/s1",C05953,2016-12-05T15:48:06Z,,1890,,,,,22833602,,,"(+)-Prostaglandin A2, 15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoate, 15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoic acid, 15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostenoate, 15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostenoic acid, 15(S)-Prostaglandin A2, 15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylate, 15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylic acid, 15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoate, 15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic acid, Prostaglandin A2",http://vmh.uni.lu/_api/metabolites/1890/?format=pcsv
C05957,,,-1,C20H29O4,CHEBI:27485,,"Human Metabolome Database (HMDB): Prostaglandin J2 (PGJ2) is an endogenous product of inflammation in humans. It induces neuronal death and the accumulation of ubiquitinated proteins into distinct aggregates. It may play a role in neurodegenerative disorders inducing a chain of events that culminates in neuronal cell death. An altered expression of enzymes in PGJ2 synthesis may represent a novel pathogenic mechanism in human obesity. The peroxisome proliferator-activated receptor gamma (PPAR&#947;) has a fundamental role in glucose homeostasis and adipocyte differentiation. Besides linoleate, linolenate and arachidonate, the most notable PPAR ligand is 15-deoxy-delta12-14-prostaglandin J2, a natural derivative of prostaglandin D2 and PGJ2. It is therefore plausible that the production of 15d-PGJ2 within adipose tissue may act as an endogenous mediator of adipocyte differentiation. PGJ2 disrupts the cytoskeleton in neuronal cells. This cyclopentenone prostaglandin triggered endoplasmic reticulum (ER) collapse and the redistribution of ER proteins, such as calnexin and catechol-O-methyltransferase, into a large centrosomal aggregate containing ubiquitinated proteins and alpha-synuclein. The PGJ2-dependent cytoskeletal rearrangement paralleled the development of the large centrosomal aggregate. Supporting a mechanism by which, upon PGJ2 treatment, cytoskeleton/ER collapse coincides with the relocation of ER proteins, other potentially neighboring proteins, and ubiquitinated proteins into centrosomal aggregates. Development of these large perinuclear aggregates is associated with disruption of the microtubule/ER network. This aberrant protein deposition, triggered by a product of inflammation, may be common to other compounds that disrupt microtubules and induce protein aggregation, such as MPP+ and rotenone, found to be associated with neurodegeneration. Many neurodegenerative disorders, such as Parkinson disease, exhibit inclusion bodies containing ubiquitinated proteins. Concentrations of PGJ2 in biofluids have not been established, since this prostaglandin is further metabolized into delta12-PGJ2, and 15-deoxy-delta12,14-PGJ2. (PMID: 16737963, 16842938, 16774923)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,Prostaglandin J2,,HMDB02710,"InChI=1S/C20H30O4/c1-2-3-6-10-17(21)13-14-18-16(12-15-19(18)22)9-7-4-5-8-11-20(23)24/h4,7,12-18,21H,2-3,5-6,8-11H2,1H3,(H,23,24)/b7-4-,14-13+/t16-,17-,18+/m0/s1",C05957,2016-12-05T15:48:06Z,,1891,,,,,5280884,C05957,,"11-Oxo-15S-hydroxy-5Z,8Z,13E-prostatrienoate, 11-Oxo-15S-hydroxy-5Z,8Z,13E-prostatrienoic acid, 9-Deoxy-delta-9-pgd2, 9-Deoxy-delta-9-prostaglandin D2, PGJ2",http://vmh.uni.lu/_api/metabolites/1891/?format=pcsv
CE4877,,,-1,C20H27O3,,,15-deoxy-prostaglandin J2,,15-deoxy-prostaglandin J2,,,,C14717,2016-11-22T15:12:17Z,,1892,,,,,404025,,,,http://vmh.uni.lu/_api/metabolites/1892/?format=pcsv
CE2065,,,-1,C11H15N4O4,,,acetylcarnosine,,acetylcarnosine,,,,,2016-11-22T15:12:17Z,,1893,,,,,10221026,CE2065,,,http://vmh.uni.lu/_api/metabolites/1893/?format=pcsv
CE2026,,,-1,C7H10NO3,,,3-methylcrotonoylglycine,,3-methylcrotonoylglycine,,,,,2016-11-22T15:12:17Z,,1894,,,,,169485,CE2026,,,http://vmh.uni.lu/_api/metabolites/1894/?format=pcsv
C04483,,,-1,C24H39O4,222528,,"Human Metabolome Database (HMDB): Deoxycholic acid is a bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",,deoxycholate,,HMDB00626,"InChI=1S/C24H40O4/c1-14(4-9-22(27)28)18-7-8-19-17-6-5-15-12-16(25)10-11-23(15,2)20(17)13-21(26)24(18,19)3/h14-21,25-26H,4-13H2,1-3H3,(H,27,28)/p-1/t14-,15-,16-,17+,18-,19+,20+,21+,23+,24-/m1/s1",C04483,2016-12-05T15:48:06Z,,1895,,,,,222528,,,"5b-Cholanic acid-3a,12a-diol, 5b-Deoxycholate, 5b-Deoxycholic acid, 7-Deoxycholate, 7-Deoxycholic acid, Cholerebic, Cholorebic, Degalol, Deoxy-Cholate, Deoxy-Cholic acid, Deoxycholatate, Deoxycholate, Deoxycholatic acid, Deoxycholic acid",http://vmh.uni.lu/_api/metabolites/1895/?format=pcsv
CE2020,,,-1,C22H34NO3,,,N-arachidonoylglycinate,,N-arachidonoylglycinate,,,"InChI=1S/C22H35NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21(24)23-20-22(25)26/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-20H2,1H3,(H,23,24)(H,25,26)/p-1/b7-6-,10-9-,13-12-,16-15-",,2016-11-22T15:12:17Z,,1896,,,,,4345,CE2020,,,http://vmh.uni.lu/_api/metabolites/1896/?format=pcsv
CE2176,,,0,C10H13NO4,,,"Human Metabolome Database (HMDB): 3-Methoxytyrosine is one of the main biochemical markers for Aromatic L-amino acid decarboxylase (AADC, EC 4.1.1.28) deficiency, an inborn error of metabolism that affects serotonin and dopamine biosynthesis. Patients are usually detected in infancy due to developmental delay, hypotonia, and extrapyramidal movements. Diagnosis is based on an abnormal neurotransmitter metabolite profile in CSF and reduced AADC activity in plasma. 3-methoxytyrosine is elevated in CSF, plasma, and urine. (PMID 1357595, 1281049, 16288991).",,3-O-methyldopa,,HMDB01434,"InChI=1/C10H13NO4/c1-15-9-5-6(2-3-8(9)12)4-7(11)10(13)14/h2-3,5,7,12H,4,11H2,1H3,(H,13,14)",,2016-12-05T15:48:06Z,,1897,,,,,1670,CE2176,,"3-Methoxy-tyrosine, 3-Methoxytyrosine, 3-O-Methyldopa, L-3-Methoxy tyrosine, L-3-Methoxytyrosine, L-4-Hydroxy-3-methoxyphenylalanine, Vanilalanine",http://vmh.uni.lu/_api/metabolites/1897/?format=pcsv
C02442,,,1,C9H14NO,CHEBI:17458,,"Human Metabolome Database (HMDB): N-methyltyramine (NMT) is a phenolic amine. NMT is a potent stimulant of gastrin release present in alcoholic beverages produced by alcoholic fermentation, but not by distillation (i.e.: beer.). NMT is well absorbed in the small intestine, especially in the duodenum and jejunum. NMT is metabolized in the liver (the site of first-pass metabolism), but not in the small-intestinal mucosa. NMT is occasionally present in the stools of children and infants. Satisfactory results have been obtained in treating infective shock with injection of natural Fructus Aurantii immaturus (nat-FAI); the anti-shock effective compositions in FAI have been proved to be synephrine and NMT. (PMID: 10772638, 2570680).",,N-methyltyraminium,,HMDB03633,"InChI=1S/C9H13NO/c1-10-7-6-8-2-4-9(11)5-3-8/h2-5,10-11H,6-7H2,1H3/p+1",C02442,2016-12-05T15:48:06Z,,1898,,,,,9727,C02442,,"4-(2-(Methylamino)ethyl)-Phenol, 4-(2-Methylaminoethyl)phenol, 4-Hydroxy-N-methylphenethylamine, 4-[2-(Methylamino)ethyl]-Phenol, 4-[2-(Methylamino)ethyl]phenol, Methyl tyramine, Methyl-4-tyramine, N-Methyl-p-tyramine, NMT, p-(2-(Methylamino)ethyl)phenol, p-(2-Methylaminoethyl)phenol, p-[2-(Methylamino)ethyl]-Phenol, {p-[2-(Methylamino)ethyl]phenol}",http://vmh.uni.lu/_api/metabolites/1898/?format=pcsv
bgly,,,-1,C9H8NO3,CHEBI:18089,,"Human Metabolome Database (HMDB): Hippuric acid is an acyl glycine formed by the conjugation of benzoic aicd with glycine. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine < -- > CoA + N-acylglycine. Hippuric acid is a normal component of urine and is typically increased with increased consumption of phenolic compounds (tea, wine, fruit juices). These phenols are converted to benzoic acid which is then converted to hippuric acid and excreted in the urine. Hippuric acid is the most frequently used biomarker in the biological monitoring of occupational exposure to toluene. This product of solvent biotransformation may be also found in the urine of individuals who have not been exposed to the solvent. A smaller fraction of the absorbed toluene is oxidized to aromatic compounds including ortho-cresol, which is not found significantly in the urine of nonexposed individuals. The concentration of hippuric acid in the urine of individuals exposed to a low toluene concentration does not differ from that of individuals not exposed to the solvent. This has led to the conclusion that hippuric acid should not be utilized in the biological monitoring of occupational exposure to low levels of toluene in the air. Protein-bound organic acids such as hippuric acid are markedly accumulated in uremic plasma and produce defective protein binding of drugs. (PMID: 9120876, 8734460).",,N-benzoylglycinate,,HMDB00714,"InChI=1S/C9H9NO3/c11-8(12)6-10-9(13)7-4-2-1-3-5-7/h1-5H,6H2,(H,10,13)(H,11,12)/p-1",C01586,2016-12-05T15:48:06Z,,1899,,,,,464,,,"(benzoylamino)-Acetate, (benzoylamino)-Acetic acid, 2-Benzamidoacetate, 2-Benzamidoacetic acid, Benzamidoacetate, Benzamidoacetic acid, Benzoylglycine, Hippurate, N-Benzoylglycine, Phenylcarbonylaminoacetate, Phenylcarbonylaminoacetic acid",http://vmh.uni.lu/_api/metabolites/1899/?format=pcsv
CE2934,,,-1,C10H10NO3,,,o-methylhippurate,,o-methylhippurate,,,,,2016-11-22T15:12:17Z,,1900,,,,,91637,,,,http://vmh.uni.lu/_api/metabolites/1900/?format=pcsv
CE2152,,,1,C11H13N2,,,"1,2,3,4-tetrahydro-beta-carboline",,"1,2,3,4-tetrahydro-beta-carboline",,,,,2016-11-22T15:12:17Z,,1901,,,,,107838,,,,http://vmh.uni.lu/_api/metabolites/1901/?format=pcsv
CE2153,,,1,C11H13N2O,,,"6-hydroxy-1,2,3,4-tetrahydro-beta-carboline",,"6-hydroxy-1,2,3,4-tetrahydro-beta-carboline",,,,,2016-11-22T15:12:17Z,,1902,,,,,159959,CE2153,,,http://vmh.uni.lu/_api/metabolites/1902/?format=pcsv
CE2172,,,1,C9H12NO2,,,"Human Metabolome Database (HMDB): Norsalsolinol is a putative metabolic neuromodulators that hs been found to be present in both rat and human brains. It modulates dopaminergic transmission and have been shown to be associated with neurotoxicity within cells and diseases such as alcoholism and Parkinsonism. Norsalsolinol can be synthesized in vivo non-enzymatically by condensation of dopamine with formaldehyde, the oxidized metabolite of methanol.",,"6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline",,HMDB06044,"InChI=1/C9H11NO2/c11-8-3-6-1-2-10-5-7(6)4-9(8)12/h3-4,10-12H,1-2,5H2",,2016-12-05T15:48:06Z,,1903,,,,,36937,CE2172,,"1,2,3,4-Tetrahydro-6,7-isoquinolinediol, 6,7-Dihydroxy-1,2,3,4-tetrahydroisoquinoline, 6,7-Dihydroxytetrahydroisoquinoline, Tetrahydro-6,7-Isoquinolinediol",http://vmh.uni.lu/_api/metabolites/1903/?format=pcsv
CE2173,,,0,C10H13NO3,,,"N-methyl-4,6,7-trihydroxy-1,2,3,4-tetrahydroisoquinoline",,"N-methyl-4,6,7-trihydroxy-1,2,3,4-tetrahydroisoquinoline",,,"InChI=1/C10H13NO3/c1-11-4-6-2-8(12)9(13)3-7(6)10(14)5-11/h2-3,10,12-14H,4-5H2,1H3",,2016-11-22T15:12:17Z,,1904,,,,,157875,CE2173,,,http://vmh.uni.lu/_api/metabolites/1904/?format=pcsv
CE2174,,,1,C9H12NO3,,,"4,6,7-trihydroxy-1,2,3,4-tetrahydroisoquinoline",,"4,6,7-trihydroxy-1,2,3,4-tetrahydroisoquinoline",,,"InChI=1/C9H11NO3/c11-7-1-5-3-10-4-9(13)6(5)2-8(7)12/h1-2,9-13H,3-4H2",,2016-11-22T15:12:17Z,,1905,,,,,3016280,CE2174,,,http://vmh.uni.lu/_api/metabolites/1905/?format=pcsv
CE2122,,,0,C11H11NO2,,,methyl indole-3-acetate,,methyl indole-3-acetate,,,"InChI=1/C11H11NO2/c1-14-11(13)6-8-7-12-10-5-3-2-4-9(8)10/h2-5,7,12H,6H2,1H3",,2016-11-22T15:12:17Z,,1906,,,,,74706,CE2122,,,http://vmh.uni.lu/_api/metabolites/1906/?format=pcsv
CE5747,,,1,C42H58NO,,,N-retinylidene-N-retinylethanolamine,,N-retinylidene-N-retinylethanolamine,,,"InChI=1/C42H58NO/c1-32(20-22-39-35(4)17-12-25-41(39,6)7)14-10-16-34(3)30-38-31-37(24-27-43(38)28-29-44)19-11-15-33(2)21-23-40-36(5)18-13-26-42(40,8)9/h10-11,14-16,19-24,27,30-31,44H,12-13,17-18,25-26,28-29H2,1-9H3/q+1/b16-10+,19-11+,22-20+,23-21+,32-14+,33-15+,34-30+",,2016-11-22T15:12:17Z,,1907,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1907/?format=pcsv
CE5752,,,1,C42H58NO,,,iso-A2E(13-cis),,iso-A2E(13-cis),,,"InChI=1/C42H58NO/c1-32(20-22-39-35(4)17-12-25-41(39,6)7)14-10-16-34(3)30-38-31-37(24-27-43(38)28-29-44)19-11-15-33(2)21-23-40-36(5)18-13-26-42(40,8)9/h10-11,14-16,19-24,27,30-31,44H,12-13,17-18,25-26,28-29H2,1-9H3/q+1/b16-10+,19-11+,22-20+,23-21+,32-14+,33-15+,34-30-",,2016-11-22T15:12:17Z,,1908,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1908/?format=pcsv
CE5753,,,1,C42H58NO,,,iso-A2E(11-cis),,iso-A2E(11-cis),,,"InChI=1/C42H58NO/c1-32(20-22-39-35(4)17-12-25-41(39,6)7)14-10-16-34(3)30-38-31-37(24-27-43(38)28-29-44)19-11-15-33(2)21-23-40-36(5)18-13-26-42(40,8)9/h10-11,14-16,19-24,27,30-31,44H,12-13,17-18,25-26,28-29H2,1-9H3/q+1/b16-10+,19-11-,22-20+,23-21+,32-14+,33-15+,34-30+",,2016-11-22T15:12:17Z,,1909,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1909/?format=pcsv
CE5754,,,1,C42H58NO,,,iso-A2E(9-cis),,iso-A2E(9-cis),,,"InChI=1/C42H58NO/c1-32(20-22-39-35(4)17-12-25-41(39,6)7)14-10-16-34(3)30-38-31-37(24-27-43(38)28-29-44)19-11-15-33(2)21-23-40-36(5)18-13-26-42(40,8)9/h10-11,14-16,19-24,27,30-31,44H,12-13,17-18,25-26,28-29H2,1-9H3/q+1/b16-10+,19-11+,22-20+,23-21+,32-14+,33-15-,34-30+",,2016-11-22T15:12:17Z,,1910,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1910/?format=pcsv
CE5755,,,1,C42H58NO,,,"iso-A2E(9,13-di-cis)",,"iso-A2E(9,13-di-cis)",,,"InChI=1/C42H58NO/c1-32(20-22-39-35(4)17-12-25-41(39,6)7)14-10-16-34(3)30-38-31-37(24-27-43(38)28-29-44)19-11-15-33(2)21-23-40-36(5)18-13-26-42(40,8)9/h10-11,14-16,19-24,27,30-31,44H,12-13,17-18,25-26,28-29H2,1-9H3/q+1/b16-10+,19-11+,22-20+,23-21+,32-14+,33-15-,34-30-",,2016-11-22T15:12:17Z,,1911,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1911/?format=pcsv
CE2953,,,-1,C20H27O3,,,"rac-5,6-epoxy-retinoate",,"rac-5,6-epoxy-retinoate",,,"InChI=1/C20H28O3/c1-15(8-6-9-16(2)14-17(21)22)10-13-20-18(3,4)11-7-12-19(20,5)23-20/h6,8-10,13-14H,7,11-12H2,1-5H3,(H,21,22)/p-1/b9-6+,13-10+,15-8+,16-14+",,2016-11-22T15:12:17Z,,1912,,,,,536537,,,,http://vmh.uni.lu/_api/metabolites/1912/?format=pcsv
CE2958,,,-1,C26H35O9,,,"rac-5,6-epoxy-retinoyl-beta-D-glucuronide",,"rac-5,6-epoxy-retinoyl-beta-D-glucuronide",,,"InChI=1/C26H36O9/c1-15(10-13-26-24(3,4)11-7-12-25(26,5)35-26)8-6-9-16(2)14-17(27)33-23-20(30)18(28)19(29)21(34-23)22(31)32/h6,8-10,13-14,18-21,23,28-30H,7,11-12H2,1-5H3,(H,31,32)/p-1/b9-6+,13-10+,15-8+,16-14+/t18-,19+,20-,21-,23?,25?,26?/m1/s1",,2016-11-22T15:12:17Z,,1913,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1913/?format=pcsv
CE2959,,,-1,C26H35O8,,,"Human Metabolome Database (HMDB): Retinoyl beta-glucuronide is a naturally occurring, biologically active metabolite of vitamin A. Although retinoyl beta-glucuronide is regarded as a detoxification product of retinoic acid, it plays several roles in the functions of vitamin A. It can serve as a source of retinoic acid, and it may be a vehicle for transport of retinoic acid to target tissues. Topically applied retinoyl beta-glucuronide is comparable in efficacy to retinoic acid in the treatment of acne in humans, without the same side effects. Retinoyl beta-glucuronide may or may not be teratogenic, depending on the mode of administration and the species in which it is used. It may be a valuable therapeutic compound for the treatment of skin disorders and certain types of cancers.",,13-cis-retinoyl-beta-D-glucuronide,,HMDB03141,"InChI=1/C26H36O8/c1-15(11-12-18-17(3)10-7-13-26(18,4)5)8-6-9-16(2)14-19(27)33-25-22(30)20(28)21(29)23(34-25)24(31)32/h6,8-9,11-12,14,20-23,25,28-30H,7,10,13H2,1-5H3,(H,31,32)/p-1/b9-6+,12-11+,15-8+,16-14-/t20-,21+,22-,23-,25?/m1/s1",C11061,2016-12-05T15:48:06Z,,1914,,,,,,,,"13-cis-Retinoate, 13-cis-Retinoic acid, 13-cis-Retinoic acid acyl beta-D-glucuronide, 13-cis-Retinoic acid acyl beta-delta-glucuronide, 13-cis-Retinoyl glucuronide, 13-cis-Retinoyl-beta-D-glucuronide, 13-cis-Retinoyl-beta-delta-glucuronide, 13-cis-Retinoyl-beta-glucuronide, 9-cis-Retinoyl-beta-D-glucuronide, 9-cis-Retinoyl-beta-delta-glucuronide, All-trans-Retinoyl-beta-D-glucuronide, All-trans-Retinoyl-beta-delta-glucuronide, All-trans-Retinoyl-beta-glucuronide, Glucuronide, Retinoate, Retinoic acid, Retinoic acid beta-D-glucuronide, Retinoic acid beta-delta-glucuronide, Retinoyl beta-glucuronide, Retinoyl glucuronide, Retinoyl-beta-glucuronide",http://vmh.uni.lu/_api/metabolites/1914/?format=pcsv
CE2961,,,0,C22H32O3,,,4-hydroxy-all-trans-retinyl acetate,,4-hydroxy-all-trans-retinyl acetate,,,"InChI=1/C22H32O3/c1-16(8-7-9-17(2)13-15-25-19(4)23)10-11-20-18(3)21(24)12-14-22(20,5)6/h7-11,13,21,24H,12,14-15H2,1-6H3/b9-7+,11-10+,16-8+,17-13+",,2016-11-22T15:12:17Z,,1915,,,,,54359871,,,,http://vmh.uni.lu/_api/metabolites/1915/?format=pcsv
CE2962,,,-1,C28H39O9,,,rac-4-hydroxy-4-O-(beta-D-glucuronide)-all-trans-retinyl acetate,,rac-4-hydroxy-4-O-(beta-D-glucuronide)-all-trans-retinyl acetate,,,"InChI=1/C28H40O9/c1-16(8-7-9-17(2)13-15-35-19(4)29)10-11-20-18(3)21(12-14-28(20,5)6)36-27-24(32)22(30)23(31)25(37-27)26(33)34/h7-11,13,21-25,27,30-32H,12,14-15H2,1-6H3,(H,33,34)/p-1/b9-7+,11-10+,16-8+,17-13+/t21u,22-,23+,24-,25-,27?/m1/s1",,2016-11-22T15:12:17Z,,1916,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1916/?format=pcsv
CE5756,,,-1,C26H35O8,,,9-cis-retinoyl-beta-D-glucuronide,,9-cis-retinoyl-beta-D-glucuronide,,,"InChI=1/C26H36O8/c1-15(11-12-18-17(3)10-7-13-26(18,4)5)8-6-9-16(2)14-19(27)33-25-22(30)20(28)21(29)23(34-25)24(31)32/h6,8-9,11-12,14,20-23,25,28-30H,7,10,13H2,1-5H3,(H,31,32)/p-1/b9-6+,12-11+,15-8-,16-14+/t20-,21+,22-,23-,25?/m1/s1",C11061,2016-11-22T15:12:17Z,,1917,,,,,5281877,CE5756,,,http://vmh.uni.lu/_api/metabolites/1917/?format=pcsv
CE5757,,,-1,C26H33O9,,,4-oxo-9-cis-retinoyl-beta-glucuronide,,4-oxo-9-cis-retinoyl-beta-glucuronide,,,"InChI=1/C26H34O9/c1-14(9-11-17-16(3)10-12-18(27)26(17,4)5)7-6-8-15(2)13-19(28)34-25-22(31)20(29)21(30)23(35-25)24(32)33/h6-9,11,13,20-23,25,29-31H,10,12H2,1-5H3,(H,32,33)/p-1/b8-6+,11-9+,14-7-,15-13+/t20-,21+,22-,23-,25?/m1/s1",,2016-11-22T15:12:17Z,,1918,,,,,,CE5757,,,http://vmh.uni.lu/_api/metabolites/1918/?format=pcsv
CE1162,,,0,C20H28O,,,vitamin A2,,vitamin A2,,,"InChI=1/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6-13,21H,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+",,2016-11-22T15:12:17Z,,1919,,,,,65722,,,,http://vmh.uni.lu/_api/metabolites/1919/?format=pcsv
CE2955,,,-1,C20H25O2,,,"all-trans-3,4-didehydroretinoate",,"all-trans-3,4-didehydroretinoate",,,"InChI=1/C20H26O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6-12,14H,13H2,1-5H3,(H,21,22)/p-1/b9-6+,12-11+,15-8+,16-14+",,2016-11-22T15:12:17Z,,1920,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1920/?format=pcsv
C03681,,,0,C21H32O2,CHEBI:28952,,"Human Metabolome Database (HMDB): 5a-Pregnane-3,20-dione is a biologically active 5-alpha-reduced metabolite of plasma progesterone. It is the immediate precursor of 5-alpha-pregnan-3-alpha-ol-20-one (allopregnanolone), a neuroactive steroid that binds with GABA(A) receptor.",,"5alpha-Pregnane-3,20-dione",,HMDB03759,"InChI=1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14,16-19H,4-12H2,1-3H3/t14-,16-,17+,18-,19-,20-,21+/m0/s1",C03681,2016-12-05T15:48:06Z,,1921,,,,,92810,,,"3,20-Allopregnanedione, 3,20-Dioxo-5a-pregnane, 3,20-Dioxo-5alpha-pregnane, 5-alpha-Dihydroprogesterone, 5-alpha-Pregnane-3,20-dione, 5a-Dihydroprogesterone, 5a-Pregnan-3,20-dione, 5a-Pregnane-3,20-dione, 5alpha-Dihydroprogesterone, 5alpha-pregnan-3,20-dione, 5alpha-Pregnane-3,20-dione, 5b-Pregnane-3,20-dione, 5beta-Pregnane-3,20-dione, Allopregnan-3,20-dione, Pregnane-3,20-dione",http://vmh.uni.lu/_api/metabolites/1921/?format=pcsv
CE2211,,,0,C21H34O2,CHEBI:32924,,"Human Metabolome Database (HMDB): Allopregnanolone is a neuroactive metabolite of progesterone and a barbiturate-like modulator of central gamma-aminobutyric acid receptors that modify a range of behaviors, including the stress response. is a steroid created in the body when progesterone, the female sex hormone, is metabolized. Typically, THP (allopregnanolone) is released in the brain in response to stress, and quiets the neural system within 30 minutes of escalation. This steroid hormone has recently been found to be responsible for the extreme mood swings found in teenagers. In adults and pre-pubescent chlidren THP normally helps soothe the activity of brain cells by binding to GABA receptors that inhibit accelerating electrical activity. However, in pubescent teenagers THP actually becomes a GABA receptor antagonist. GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the brain with most sedatives (tranquilizers, anesthetics and alcohol) acting on the GABA receptor.",,allopregnanolone,,HMDB01449,"InChI=1S/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15+,16-,17+,18-,19-,20-,21+/m0/s1",C13712,2016-12-05T15:48:06Z,,1922,,,,,92786,,,"(+)-3a-Hydroxy-5a-pregnan-20-one, (3a)-Allopregnanolone, 3-a-Tetrahydroprogesterone, 3-alpha-Tetrahydroprogesterone, 3a,5a-Pregnanolone, 3a,5a-Tetrahydroprogesterone, 3a,5a-THP, 3a-Hydroxy-5a-dihydroprogesterone, 3a-Hydroxy-5a-pregnan-20-one, 3a-Hydroxy-5a-pregnane-20-one, 5a-Pregnan-3a-ol-20-one, 5a-Pregnane-3a-ol-20-one, Allopregnan-3a-ol-20-one, Allotetrahydroprogesterone",http://vmh.uni.lu/_api/metabolites/1922/?format=pcsv
CE5072,,,0,C21H34O3,,,"Human Metabolome Database (HMDB): The neurosteroid allotetrahydrodeoxycorticosterone (THDOC) is an allosteric modulator of the GABA(A) receptor. Although the role of THDOC within the brain is undefined, recent studies indicate that stress induces THDOC to levels that can activate GABA(A) receptors. These results might have significant implications for human stress-sensitive conditions such as epilepsy, post-traumatic stress disorder and depression. (PMID 12628349).",,21-hydroxyallopregnanolone,,HMDB00879,,C13713,2016-12-05T15:48:06Z,,1923,,,,,101771,,,"3alpha,21-Dihydroxy-5beta-pregnan-20-one, 5-alpha-THDOC, Allotetrahydrodeoxycorticosterone, Deoxycorticosterone-21-aminopropane, Tetrahydro-11-deoxycorticosterone, Tetrahydrodeoxycorticosterone",http://vmh.uni.lu/_api/metabolites/1923/?format=pcsv
CE5082,,,-1,C9H15N2O5S,,,N-acetyl-L-cystathionine,,N-acetyl-L-cystathionine,,,,,2016-11-22T15:12:17Z,,1924,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1924/?format=pcsv
CE5775,,,1,C42H58NO,,,iso-A2E(9'-cis),,iso-A2E(9'-cis),,,,,2016-11-22T15:12:17Z,,1925,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1925/?format=pcsv
CE5776,,,1,C42H58NO,,,iso-A2E(11'-cis),,iso-A2E(11'-cis),,,,,2016-11-22T15:12:17Z,,1926,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1926/?format=pcsv
CE1293,,,0,C27H44O2,,,27alpha-hydroxy-7-dehydrocholesterol,,27alpha-hydroxy-7-dehydrocholesterol,,,,,2016-11-22T15:12:17Z,,1927,,,,,,CE1293,,,http://vmh.uni.lu/_api/metabolites/1927/?format=pcsv
CE1297,,,0,C27H44O,,,8-dehydrocholesterol,,8-dehydrocholesterol,,,"InChI=1/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21,23-24,28H,6-8,10-17H2,1-5H3/t19-,21+,23-,24+,26+,27-/m1/s1",,2016-11-22T15:12:17Z,,1928,,,,,129846,,,,http://vmh.uni.lu/_api/metabolites/1928/?format=pcsv
CE1294,,,0,C27H44O2,,,27alpha-hydroxy-8-dehydrocholesterol,,27alpha-hydroxy-8-dehydrocholesterol,,,"InChI=1/C27H44O2/c1-18(17-28)6-5-7-19(2)23-10-11-24-22-9-8-20-16-21(29)12-14-26(20,3)25(22)13-15-27(23,24)4/h8,18-19,21,23-24,28-29H,5-7,9-17H2,1-4H3/t18u,19-,21+,23-,24-,26+,27-/m1/s1",,2016-11-22T15:12:17Z,,1929,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1929/?format=pcsv
CE1310,,,-1,C5H8NO3S,,,N-acetyl-L-cysteine,,N-acetyl-L-cysteine,,,"InChI=1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1",C06809,2016-11-22T15:12:17Z,,1930,,,,,12035,CE1310,,,http://vmh.uni.lu/_api/metabolites/1930/?format=pcsv
C05300,,,0,C18H22O3,CHEBI:776,,"Human Metabolome Database (HMDB): Estrone (also oestrone) is an estrogenic hormone secreted by the ovary. Its molecular formula is C18H22O2. estrone has a melting point of 254.5 degrees Celsius. estrone is one of the three estrogens, which also include estriol and estradiol. estrone is the least prevalent of the three hormones, estradiol being prevalent almost always in a female body, estriol being prevalent primarily during pregnancy. estrone sulfate is relevant to health and disease due to its conversion to estrone sulfate, a long-lived derivative of estrone. estrone sulfate acts as a pool of estrone which can be converted as needed to the more active estradiol.",,16alpha-Hydroxyestrone,,HMDB00335,"InChI=1S/C18H22O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-16(20)17(18)21/h3,5,8,13-16,19-20H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,18+/m1/s1",C05300,2016-12-05T15:48:06Z,,1931,,,,,115116,C05300,,"16 alpha-Hydroxyestrone, 16a-Hydroxyestrone, 3,16a-Dihydroxy-1,3,5(10)-estratrien-17-one, 3,16a-Dihydroxy-Estra-1,3,5(10)-trien-17-one, Estra-1,3,5(10)-triene-3,16a-diol-17-one",http://vmh.uni.lu/_api/metabolites/1931/?format=pcsv
CE2963,,,-1,C20H27O3,,,"5,6-epoxy-13-cis-retinoate",,"5,6-epoxy-13-cis-retinoate",,,,,2016-11-22T15:12:17Z,,1932,,,,,536537,CE2963,,,http://vmh.uni.lu/_api/metabolites/1932/?format=pcsv
CE2964,,,-1,C20H27O3,,,"5,8-epoxy-13-cis-retinoate",,"5,8-epoxy-13-cis-retinoate",,,,,2016-11-22T15:12:17Z,,1933,,,,,92945,CE2964,,,http://vmh.uni.lu/_api/metabolites/1933/?format=pcsv
CE5932,,,0,C20H30O2,,,"13,14-epoxy-retinol",,"13,14-epoxy-retinol",,,,,2016-11-22T15:12:17Z,,1934,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1934/?format=pcsv
CE5013,,,0,C20H30O2,,,"14-hydroxy-4,14-retro-retinol",,"14-hydroxy-4,14-retro-retinol",,,,,2016-11-22T15:12:17Z,,1935,,,,,6449967,,,,http://vmh.uni.lu/_api/metabolites/1935/?format=pcsv
CE5014,,,0,C20H28,,,anhydroretinol,,anhydroretinol,,,,,2016-11-22T15:12:17Z,,1936,,,,,5287678,CE5014,,,http://vmh.uni.lu/_api/metabolites/1936/?format=pcsv
CE3136,,,-1,C20H27O3,,,"9-cis-4-oxo-13,14-dihydro-retinoate",,"9-cis-4-oxo-13,14-dihydro-retinoate",,,,,2016-11-22T15:12:17Z,,1937,,,,,,CE3136,,,http://vmh.uni.lu/_api/metabolites/1937/?format=pcsv
CE5782,,,2,C76H106N18O19S2,,,somatostatin,,somatostatin,,,,,2016-11-22T15:12:17Z,,1938,,,,,44291156,,,,http://vmh.uni.lu/_api/metabolites/1938/?format=pcsv
CE5783,,,2,C72H100N16O17S2,,,Somatostatin fragment 3-14,,Somatostatin fragment 3-14,,,,,2016-11-22T15:12:17Z,,1939,,,,,53481604,,,,http://vmh.uni.lu/_api/metabolites/1939/?format=pcsv
CE5786,,,2,C56H87N17O11,,,kinetensin,,kinetensin,,,,,2016-11-22T15:12:17Z,,1940,,,,,147043,,,,http://vmh.uni.lu/_api/metabolites/1940/?format=pcsv
CE5788,,,2,C41H67N15O9,,,kinetensin 1-7,,kinetensin 1-7,,,,,2016-11-22T15:12:17Z,,1941,,,,,53481565,,,,http://vmh.uni.lu/_api/metabolites/1941/?format=pcsv
CE5789,,,2,C50H76N16O10,,,kinetensin 1-8,,kinetensin 1-8,,,,,2016-11-22T15:12:17Z,,1942,,,,,53481566,,,,http://vmh.uni.lu/_api/metabolites/1942/?format=pcsv
CE5794,,,1,C52H74N15O12S,,,neuromedin B,,neuromedin B,,,,,2016-11-22T15:12:17Z,,1943,,,,,53481579,,,,http://vmh.uni.lu/_api/metabolites/1943/?format=pcsv
CE5795,,,0,C12H22N4O5,,,neuromedin B (1-3),,neuromedin B (1-3),,,,,2016-11-22T15:12:17Z,,1944,,,,,53481577,,,,http://vmh.uni.lu/_api/metabolites/1944/?format=pcsv
CE5796,,,1,C40H54N11O8S,,,neuromedin B (4-10),,neuromedin B (4-10),,,,,2016-11-22T15:12:17Z,,1945,,,,,53481578,,,,http://vmh.uni.lu/_api/metabolites/1945/?format=pcsv
CE5797,,,0,C32H51N5O7,,,neuromedin N,,neuromedin N,,,,,2016-11-22T15:12:17Z,,1946,,,,,53481583,,,,http://vmh.uni.lu/_api/metabolites/1946/?format=pcsv
CE5798,,,0,C26H40N4O6,,,neuromedin N (1-4),,neuromedin N (1-4),,,,,2016-11-22T15:12:17Z,,1947,,,,,53481582,,,,http://vmh.uni.lu/_api/metabolites/1947/?format=pcsv
CE5456,,,-1,C6H11O3,,,(R)-2-hydroxy-4-methylpentanoate,,(R)-2-hydroxy-4-methylpentanoate,,,"InChI=1S/C6H12O3/c1-4(2)3-5(7)6(8)9/h4-5,7H,3H2,1-2H3,(H,8,9)/p-1/t5-/m1/s1",C03264,2016-11-22T15:12:17Z,,1948,,,,,439960,CE5456,,,http://vmh.uni.lu/_api/metabolites/1948/?format=pcsv
CE5276,,,1,C8H10NO2,,,dopamine o-quinone,,dopamine o-quinone,,,"InChI=1/C8H9NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5H,3-4,9H2/p+1",C17755,2016-11-22T15:12:17Z,,1949,,,,,162602,CE5276,,,http://vmh.uni.lu/_api/metabolites/1949/?format=pcsv
CE5025,,,0,C18H26N4O8S,,,5-S-glutathionyl-dopamine,,5-S-glutathionyl-dopamine,,,,,2016-11-22T15:12:17Z,,1950,,,,,,CE5025,,,http://vmh.uni.lu/_api/metabolites/1950/?format=pcsv
CE5787,,,1,C15H31N6O4,,,kinetensin 1-3,,kinetensin 1-3,,,,,2016-11-22T15:12:17Z,,1951,,,,,53481564,,,,http://vmh.uni.lu/_api/metabolites/1951/?format=pcsv
CE5791,,,1,C35H47N10O7,,,kinetensin 4-8,,kinetensin 4-8,,,,,2016-11-22T15:12:17Z,,1952,,,,,53481568,,,,http://vmh.uni.lu/_api/metabolites/1952/?format=pcsv
C03958,,,0,C16H22N6O4,CHEBI:35940,,Thyrotropin releasing hormone,,Thyrotropin releasing hormone,,HMDB05763,"InChI=1S/C16H22N6O4/c17-14(24)12-2-1-5-22(12)16(26)11(6-9-7-18-8-19-9)21-15(25)10-3-4-13(23)20-10/h7-8,10-12H,1-6H2,(H2,17,24)(H,18,19)(H,20,23)(H,21,25)/t10-,11-,12-/m0/s1",C03958,2016-11-22T15:12:17Z,,1953,,,,,638678,C03958,,,http://vmh.uni.lu/_api/metabolites/1953/?format=pcsv
CE5820,,,1,C11H18N5O2,,,histidyl-prolinamide,,histidyl-prolinamide,,,,,2016-11-22T15:12:17Z,,1954,,,,,,CE5820,,,http://vmh.uni.lu/_api/metabolites/1954/?format=pcsv
CE5241,,,-1,C28H38N3O9S,,,2-hydroxy-17beta-estradiol-1-S-glutathione,,2-hydroxy-17beta-estradiol-1-S-glutathione,,,,,2016-11-22T15:12:17Z,,1955,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1955/?format=pcsv
CE5240,,,-1,C28H36N3O9S,,,2-hydroxyestrone-4-S-glutathione,,2-hydroxyestrone-4-S-glutathione,,,,,2016-11-22T15:12:18Z,,1956,,,,,53481502,,,,http://vmh.uni.lu/_api/metabolites/1956/?format=pcsv
CE5021,,,0,C29H52O3,,,alpha-tocopheryl hydroquinone,,alpha-tocopheryl hydroquinone,,,,,2016-11-22T15:12:18Z,,1957,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1957/?format=pcsv
CE5022,,,0,C29H50O3,,,alpha-tocopheryl quinone,,alpha-tocopheryl quinone,,,,,2016-11-22T15:12:18Z,,1958,,,,,24205,,,,http://vmh.uni.lu/_api/metabolites/1958/?format=pcsv
CE2072,,,1,C7H17N2O2,,,"Human Metabolome Database (HMDB): Putreanine is a new amino acid isolated from mammalian and bird brain.Its structure represents a condensation of putrescine and b-alanine and is therefore named putreanine.This amino acid can be synthesized by condensation of 4-phthalimino-1-bromobutane and ethyl b-alaninate followed by add hydrolysis.It was only detected in the central nervous system of mammalian and avian organisms. Its concentration was highest in caudal regions of the brain, and the white matter of the cerebral and cerebellar cortices and the spinal cord contained more than grey matter of the corresponding areas. Putreanine appears in the brain of rats 2 weeks after birth and subsequently its concentration increases for several months.The concentration of this amino acid in mammalian brain is roughly 50 mmoles per g, which is comparable to the concentrations of branched amino acids, aromatic amino acids, histidine, and ornithine in the same tissue.[PMID:5350953].",,putreanine,,HMDB06078,"InChI=1/C7H16N2O2/c8-4-1-2-5-9-6-3-7(10)11/h9H,1-6,8H2,(H,10,11)/p+1",,2016-12-05T15:48:06Z,,1959,,,,,53477800,CE2072,,"N-(2-Carboxyethyl)putrescine, N-(4-Aminobutyl)-3-aminopropionic acid, N-(4-Aminobutyl)-beta-Alanine",http://vmh.uni.lu/_api/metabolites/1959/?format=pcsv
CE1941,,,1,C7H17N2O2,,,"Human Metabolome Database (HMDB): Isoputreanine is urinary metabolite of spermidine, which is predominantly excreted as the monoacetyl conjugate of N-(3-aminopropyl)pyrrolidin-2-one, the acetylated &gamma;-lactam form of isoputreanine.",,isoputreanine,,HMDB06009,"InChI=1/C7H16N2O2/c8-4-2-6-9-5-1-3-7(10)11/h9H,1-6,8H2,(H,10,11)",,2016-12-05T15:48:06Z,,1960,,,,,171763,CE1941,,"4-((3-Aminopropyl)amino)-Butanoate, 4-((3-Aminopropyl)amino)-Butanoic acid, IPu, N-(3-Aminopropyl)-4-aminobutanoate, N-(3-Aminopropyl)-4-aminobutanoic acid, N-(3-Aminopropyl)-4-aminobutyrate, N-(3-Aminopropyl)-4-aminobutyric acid, N-(4-Carboxybutyl)-1,3-diaminopropane, N-(4-Carboxybutyl)-1,3-propanediamine",http://vmh.uni.lu/_api/metabolites/1960/?format=pcsv
CE1937,,,2,C10H25N3O2,,,spermic acid 1,,spermic acid 1,,,"InChI=1/C10H23N3O2/c11-5-3-8-12-6-1-2-7-13-9-4-10(14)15/h12-13H,1-9,11H2,(H,14,15)/p+2",,2016-11-22T15:12:18Z,,1961,,,,,125245,CE1937,,,http://vmh.uni.lu/_api/metabolites/1961/?format=pcsv
CE2576,,,0,C9H16O3,,,4-hydroperoxy-2-nonenal,,4-hydroperoxy-2-nonenal,,,"InChI=1/C9H16O3/c1-2-3-4-6-9(12-11)7-5-8-10/h5,7-9,11H,2-4,6H2,1H3/b7-5+",,2016-11-22T15:12:18Z,,1962,,,,,55189,,,,http://vmh.uni.lu/_api/metabolites/1962/?format=pcsv
CE2577,,,0,C9H14O2,CHEBI:58972,,4-oxo-2-nonenal,,4-oxo-2-nonenal,,,"InChI=1S/C9H14O2/c1-2-3-4-6-9(11)7-5-8-10/h5,7-8H,2-4,6H2,1H3/b7-5+",,2016-11-22T15:12:18Z,,1963,,,,,216297,,,,http://vmh.uni.lu/_api/metabolites/1963/?format=pcsv
CE4936,,,-2,C25H37NO6S,,,N-acetyl-leukotriene E4,,N-acetyl-leukotriene E4,,,"InChI=1/C25H39NO6S/c1-3-4-5-6-7-8-9-10-11-12-13-14-17-23(22(28)16-15-18-24(29)30)33-19-21(25(31)32)26-20(2)27/h7-8,10-14,17,21-23,28H,3-6,9,15-16,18-19H2,1-2H3,(H,26,27)(H,29,30)(H,31,32)/p-2/b8-7-,11-10-,13-12+,17-14+/t21-,22-,23+/m1/s1",C11361,2016-11-22T15:12:18Z,,1964,,,,,53477792,CE4936,,,http://vmh.uni.lu/_api/metabolites/1964/?format=pcsv
CE5835,,,0,C29H50O3,,,8alpha-hydroxytocopherone,,8alpha-hydroxytocopherone,,,,,2016-11-22T15:12:18Z,,1965,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1965/?format=pcsv
CE5837,,,0,C29H50O5,,,"7,8-epoxy-8alpha-hydroperoxytocopherone",,"7,8-epoxy-8alpha-hydroperoxytocopherone",,,,,2016-11-22T15:12:18Z,,1966,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1966/?format=pcsv
CE5838,,,0,C29H50O4,,,"5,6-epoxy-alpha-tocopheryl quinone",,"5,6-epoxy-alpha-tocopheryl quinone",,,,,2016-11-22T15:12:18Z,,1967,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1967/?format=pcsv
CE5839,,,0,C29H50O5,,,"4alpha,5-epoxy-8alpha-hydroperoxytocopherone",,"4alpha,5-epoxy-8alpha-hydroperoxytocopherone",,,,,2016-11-22T15:12:18Z,,1968,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1968/?format=pcsv
CE5840,,,0,C29H50O4,,,"2,3-epoxy-alpha-tocopheryl quinone",,"2,3-epoxy-alpha-tocopheryl quinone",,,,,2016-11-22T15:12:18Z,,1969,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1969/?format=pcsv
CE1924,,,0,C28H48O2,,,(+)-gama-tocopherol,,(+)-gama-tocopherol,,,,,2016-11-16T10:44:56Z,,1970,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1970/?format=pcsv
CE5655,,,0,C28H48O3,,,13'-hydroxy-gama-tocopherol,,13'-hydroxy-gama-tocopherol,,,,,2016-11-22T15:12:18Z,,1971,,,,,53481467,,,,http://vmh.uni.lu/_api/metabolites/1971/?format=pcsv
CE5842,,,0,C29H50O3,,,13'-hydroxy-alpha-tocopherol,,13'-hydroxy-alpha-tocopherol,,,,,2016-11-22T15:12:18Z,,1972,,,,,53481465,CE5842,,,http://vmh.uni.lu/_api/metabolites/1972/?format=pcsv
CE5843,,,-1,C29H47O4,,,13'-carboxy-alpha-tocopherol,,13'-carboxy-alpha-tocopherol,,,,,2016-11-22T15:12:18Z,,1973,,,,,53481461,CE5843,,,http://vmh.uni.lu/_api/metabolites/1973/?format=pcsv
CE2196,,,1,C11H16NO2,,,"(R)-1,2-dimethyl-5,6-dihydroxy-tetrahydroisoquinoline",,"(R)-1,2-dimethyl-5,6-dihydroxy-tetrahydroisoquinoline",,,,,2016-11-22T15:12:18Z,,1974,,,,,53481438,CE2196,,,http://vmh.uni.lu/_api/metabolites/1974/?format=pcsv
C05302,,,0,C19H26O3,CHEBI:28955,,"Human Metabolome Database (HMDB): 2-Methoxyestradiol (2ME2) is a drug that prevents the formation of new blood vessels that tumors need in order to grow (angiogenesis). It is derived from estrogen, although it binds poorly to known estrogen receptors, and belongs to the family of drugs called angiogenesis inhibitors. It has undergone Phase 1 clinical trials against breast cancers. Preclinical models also suggest that 2ME2 could also be effective against inflammatory diseases such as rheumatoid arthritis. The CAS name for 2ME2 is (17 beta)-2-methoxyestra-1,3,5(10)-triene-3,17-diol. It also acts as a vasodilator.",,2-Methoxyestradiol-17beta,,HMDB00405,"InChI=1S/C19H26O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,18,20-21H,3-8H2,1-2H3/t12-,13+,15-,18-,19-/m0/s1",C05302,2016-12-05T15:48:06Z,,1975,,,,,66414,C05302,,2-Methoxyestradiol,http://vmh.uni.lu/_api/metabolites/1975/?format=pcsv
CE4898,,,-1,C28H45O4,,,13'-carboxy-gama-tocopherol,,13'-carboxy-gama-tocopherol,,,,,2016-11-22T15:12:18Z,,1976,,,,,53481463,,,,http://vmh.uni.lu/_api/metabolites/1976/?format=pcsv
CE1925,,,-1,C16H21O4,,,3'-carboxy-alpha-chromanol,,3'-carboxy-alpha-chromanol,,,,,2016-11-22T15:12:18Z,,1977,,,,,9943542,,,,http://vmh.uni.lu/_api/metabolites/1977/?format=pcsv
CE5853,,,-1,C22H29O10,,,alpha-CEHC-glucuronide,,alpha-CEHC-glucuronide,,,,,2016-11-22T15:12:18Z,,1978,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1978/?format=pcsv
CE1926,,,-1,C15H19O4,,,gama-carboxyethyl-hydroxychroman,,gama-carboxyethyl-hydroxychroman,,,,,2016-11-22T15:12:18Z,,1979,,,,,133098,,,,http://vmh.uni.lu/_api/metabolites/1979/?format=pcsv
CE5854,,,-1,C21H27O10,,,gama-CEHC-glucuronide,,gama-CEHC-glucuronide,,,,,2016-11-22T15:12:18Z,,1980,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1980/?format=pcsv
C05109,,,0,C30H52O,CHEBI:28113,,"Human Metabolome Database (HMDB): 24,25-Dihydrolanosterol is involved in the biosynthesis of steriods. 24,25-Dihydrolanosterol is reversibly converted to lanosterol by delta24-sterol reductase [EC:1.3.1.72].",,"24,25-Dihydrolanosterol",,HMDB06839,"InChI=1S/C30H52O/c1-20(2)10-9-11-21(3)22-14-18-30(8)24-12-13-25-27(4,5)26(31)16-17-28(25,6)23(24)15-19-29(22,30)7/h20-22,25-26,31H,9-19H2,1-8H3/t21-,22-,25+,26+,28-,29-,30+/m1/s1",C05109,2016-12-05T15:48:06Z,,1981,,,,,440560,,,,http://vmh.uni.lu/_api/metabolites/1981/?format=pcsv
CE2321,,,0,C27H42O,440558,,"Human Metabolome Database (HMDB): 7-Dehydrodesmosterol is a sterol intermediate in the biosynthesis of steroids. 7-Dehydrodesmosterol is a substrate of the enzyme 24-dehydrocholesterol reductase (EC:1.3.1.72), an important enzyme in the biosynthesis of Cholesterol. Cholesterol is synthesized from either Lathosterol, 7-Dehydrocholesterol, Desmosterol or Cholestenol by the enzyme 3beta-hydroxysterol delta7 reductase (EC 1.3.1.21, Dhcr7). The Smith-Lemli-Opitz syndrome (SLOS, OMIM 270400) is caused by a genetic defect in cholesterol biosynthesis; mutations in the enzyme 3beta-hydroxysterol delta7 reductase lead to a failure of cholesterol synthesis, with an accumulation of precursor sterols, such as 7-Dehydrodesmosterol. SLOS results in craniofacial, limb as well as major organ defects, including the brain. In individuals with this syndrome, mental retardation, as well as other CNS dysfunction, is almost 100% prevalent. (PMID: 15862627, 17197219).",,"cholesta-5,7,24-trien-3beta-ol",,HMDB03896,"InChI=1/C27H42O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,9-10,19,21,23-25,28H,6,8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1",C05107,2016-12-05T15:48:06Z,,1982,,,,,440558,,,"24-Dehydroprovitamin D3, Cholesta-5,7,24-trien-3beta-ol",http://vmh.uni.lu/_api/metabolites/1982/?format=pcsv
CE4968,,,-1,C7H12NO3,,,"Human Metabolome Database (HMDB): Isovalerylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:. acyl-CoA + glycine < -- > CoA + N-acylglycine. Isovalerylglycine is a byproduct of the catabolism of the aminoacid leucine. Accumulation of isovalerylglycine occurs in Isovaleric Acidemia (IVA). IVA (OMIM/ McKusick 243500) is an autosomal recessive disorder caused by mutations in the isovaleryl-CoA dehydrogenase (EC 1.3.99.10) gene. The deficiency of this enzyme in the metabolism of leucine leads to the accumulation of a series of isovaleryl-CoA metabolites, such as isovalerylglycine (IVG). It is very important to caution for false positive results when screening for isovaleric acidemia by tandem mass spectrometry based on dried blood-spot levels of C5-acylcarnitines, including isovalerylcarnitine and its isomer, pivaloylcarnitine; pivaloylcarnitine is derived from pivalate-generating antibiotics, and has caused many false-positive results. (PMID: 17850781).",,isovalerylglycine,,HMDB00678,,,2016-12-05T15:48:06Z,,1983,,,,,546304,CE4968,,"2-(3-Methylbutanoylamino)ethanoate, 2-(3-Methylbutanoylamino)ethanoic acid, 3-Methylbutyrylglycine, Isovalerylglycine, N-Isovaleroylglycine, N-Isovaleryl-glycine, [(3-methylbutanoyl)amino]acetate, [(3-methylbutanoyl)amino]acetic acid",http://vmh.uni.lu/_api/metabolites/1983/?format=pcsv
CE4970,,,-1,C7H12NO3,,,"Human Metabolome Database (HMDB): 2-Methylbutyrylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:. acyl-CoA + glycine < -- > CoA + N-acylglycine. The isolated excretion of high levels of 2-methylbutyrylglycine (2-MBG) is the hallmark of short/branched-chain acyl-CoA dehydrogenase deficiency or SBCADD (PMID:15615815). The disorder is also called 2-methylbutyryl-CoA dehydrogenase deficiency (PMID: 17883863) and has been associated with autism and mental retardation. SBCADD is a recently described autosomal recessive disorder caused by a defect in the degradation pathway of L- isoleucine leading to increased urinary excretion of 2-methylbutyryl glycine. The enzymatic defect results from disruption of the SBCAD gene. Deficiency of SBCAD leads to accumulation of its substrate, 2-methylbutyryl-CoA within the mitochondrion. This substance is transesterified with glycine by the mitochondrial enzyme acyl-CoA glycine-N-acyltransferase (glycine-N-acylase) to form 2-methylbutyryl glycine. Affected patients can be divided into two categories. The first category consists of infants detected by newborn screening programmes. These infants are treated with diet and remain without clinical symptoms. In the second category affected patients are diagnosed because they presented clinically with seizures and psychomotor delay and have increased urinary excretion of 2-methylbutyryl glycine (PMID: 17883863). 2-methylbutyrylglycine has also been found in the urine of patients with propionyl-CoA carboxylase deficiency after consuming isoleucine. (PMID: 630060). 2-methylbutyrylglycine is also elevated in the urine of patients with glutaric aciduria II and ethylmalonic encephalopathy.",,2-methylbutyrylglycine,,HMDB00339,,,2016-12-05T15:48:06Z,,1984,,,,,193872,CE4970,,"(2-methyl-butyrylamino)-acetate, (2-methyl-butyrylamino)-acetic acid, 2-MBG, 2-methylbutyryl glycine, 2-Methylbutyrylglycine, a-Methylbutyrylglycine, alpha-Methylbutyrylglycine, N-(2-Methylbutyryl)glycine, N-Sec-Valerylglycine",http://vmh.uni.lu/_api/metabolites/1984/?format=pcsv
CE4969,,,-1,C6H10NO3,,,"Human Metabolome Database (HMDB): Isobutyrylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:acyl-CoA + glycine < -- > CoA + N-acylglycineIsobutyrylglycine is identified in large amount in urine of patients with isobutyryl-CoA dehydrogenase deficiency. Isobutyryl-CoA dehydrogenase deficiency is a disorder caused by the deficiency of isobutyryl-CoA dehydrogenase that is involved in the catabolism of the branched-chain amino acid valine (PMID 15505379).",,isobutyrylglycine,,HMDB00730,,,2016-12-05T15:48:06Z,,1985,,,,,10855600,CE4969,,,http://vmh.uni.lu/_api/metabolites/1985/?format=pcsv
CE5860,,,0,C12H16N2O3,,,N-acetyl-5-methoxykynuramine,,N-acetyl-5-methoxykynuramine,,,,,2016-11-22T15:12:18Z,,1986,,,,,390658,CE5860,,,http://vmh.uni.lu/_api/metabolites/1986/?format=pcsv
CE2095,,,0,C16H22N2O9,,,3-hydroxykynurenine-O-beta-D-glucoside,,3-hydroxykynurenine-O-beta-D-glucoside,,,,,2016-11-22T15:12:18Z,,1987,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1987/?format=pcsv
CE3086,,,-1,C16H20NO9,,,4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-glucoside,,4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-glucoside,,,,,2016-11-22T15:12:18Z,,1988,,,,,10948689,,,,http://vmh.uni.lu/_api/metabolites/1988/?format=pcsv
CE3092,,,-1,C26H36N5O14S,,,glutathionyl-3-hydroxykynurenine glucoside,,glutathionyl-3-hydroxykynurenine glucoside,,,,,2016-11-22T15:12:18Z,,1989,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1989/?format=pcsv
CE5829,,,0,C18H34N4O6,,,5-HT-moduline,,5-HT-moduline,,,,,2016-11-22T15:12:18Z,,1990,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1990/?format=pcsv
CE5865,,,0,C9H18N2O4,,,L-leucyl-L-serine,,L-leucyl-L-serine,,,,,2016-11-22T15:12:18Z,,1991,,,,,40489070,,,,http://vmh.uni.lu/_api/metabolites/1991/?format=pcsv
CE5866,,,0,C9H18N2O3,,,L-alanyl-L-leucine,,L-alanyl-L-leucine,,,,,2016-11-22T15:12:18Z,,1992,,,,,6992388,,,,http://vmh.uni.lu/_api/metabolites/1992/?format=pcsv
CE5867,,,-1,C20H32N5O9,,,N-acetyl-seryl-aspartyl-lysyl-proline,,N-acetyl-seryl-aspartyl-lysyl-proline,,,,,2016-11-22T15:12:18Z,,1993,,,,,14181658,,,,http://vmh.uni.lu/_api/metabolites/1993/?format=pcsv
CE5868,,,-2,C9H12N2O7,,,N-acetyl-seryl-aspartate,,N-acetyl-seryl-aspartate,,,,,2016-11-22T15:12:18Z,,1994,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1994/?format=pcsv
CE5869,,,1,C11H22N3O3,,,lysyl-proline,,lysyl-proline,,,,,2016-11-22T15:12:18Z,,1995,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1995/?format=pcsv
CE5016,,,0,C20H32O3,,,"13,14-dihydroxy-retinol",,"13,14-dihydroxy-retinol",,,,,2016-11-22T15:12:18Z,,1996,,,,,,,,,http://vmh.uni.lu/_api/metabolites/1996/?format=pcsv
CE5875,,,-5,C27H37N7O19P3S,,,2-methylglutaconyl-CoA,,2-methylglutaconyl-CoA,,,,,2016-11-22T15:12:18Z,,1997,,,,,,CE5875,,,http://vmh.uni.lu/_api/metabolites/1997/?format=pcsv
CE5068,,,-2,C6H6O4,,,2-methylglutaconic acid,,2-methylglutaconic acid,,,,,2016-11-22T15:12:18Z,,1998,,,,,193896,CE5068,,,http://vmh.uni.lu/_api/metabolites/1998/?format=pcsv
CE2102,,,0,C14H26N2O3S2,,,lipoyllysine,,lipoyllysine,,,,,2016-11-22T15:12:18Z,,1999,,,,,53481572,,,,http://vmh.uni.lu/_api/metabolites/1999/?format=pcsv
C06948,,,0,C16ClH13N2O,,,Diazepam,,Diazepam,,,"InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",C06948,2016-11-22T15:12:18Z,,2000,,,,,3016,,,,http://vmh.uni.lu/_api/metabolites/2000/?format=pcsv
C07486,,,0,C15ClH11N2O,,,Nordazepam,,Nordazepam,,,"InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",C07486,2016-11-22T15:12:18Z,,2001,,,,,2997,,,,http://vmh.uni.lu/_api/metabolites/2001/?format=pcsv
CE3140,,,0,C17H22N2O7,,,"1-(1,2,3,4,5-pentahydroxypent-1-yl)-1,2,3,4-tetrahydro-beta-carboline-3-carboxylate",,"1-(1,2,3,4,5-pentahydroxypent-1-yl)-1,2,3,4-tetrahydro-beta-carboline-3-carboxylate",,,,,2016-11-22T15:12:18Z,,2002,,,,,21125948,CE3140,,,http://vmh.uni.lu/_api/metabolites/2002/?format=pcsv
CE3087,,,0,C11H8N2,CHEBI:109895,,beta-carboline,,beta-carboline,,,"InChI=1S/C11H8N2/c1-2-4-10-8(3-1)9-5-6-12-7-11(9)13-10/h1-7,13H",C20157,2016-11-22T15:12:18Z,,2003,,,,,64961,,,,http://vmh.uni.lu/_api/metabolites/2003/?format=pcsv
C09209,,,0,C12H10N2,CHEBI:5623,,Harman,,Harman,,,"InChI=1/C12H10N2/c1-8-12-10(6-7-13-8)9-4-2-3-5-11(9)14-12/h2-7,14H,1H3",C09209,2016-11-22T15:12:18Z,,2004,,,,,5281404,,,,http://vmh.uni.lu/_api/metabolites/2004/?format=pcsv
C06453,,,-1,C63CoH91N13O14P,,,Methylcobalamin,,Methylcobalamin,,,"InChI=1S/C62H90N13O14P.CH3.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);1H3;/q;;+1/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;;/m1../s1",C06453,2016-11-22T15:12:18Z,,2005,,,,,,C06453,,,http://vmh.uni.lu/_api/metabolites/2005/?format=pcsv
CE4633,,,0,ClHO,,,hypochlorous acid,,hypochlorous acid,,,InChI=1S/ClHO/c1-2/h2H,C19697,2016-11-22T15:12:18Z,,2006,,,,,24341,,,,http://vmh.uni.lu/_api/metabolites/2006/?format=pcsv
CE4881,,,0,ClNO2,,,nitryl chloride,,nitryl chloride,,,,,2016-11-22T15:12:18Z,,2007,,,,,13932711,,,,http://vmh.uni.lu/_api/metabolites/2007/?format=pcsv
CE5536,,,0,C9H9NO3,,,adrenochrome,,adrenochrome,,,,,2016-11-22T15:12:18Z,,2008,,,,,5898,CE5536,,,http://vmh.uni.lu/_api/metabolites/2008/?format=pcsv
CE5541,,,-1,C9H9NO3,,,adrenochrome o-semiquinone,,adrenochrome o-semiquinone,,,,,2016-11-22T15:12:18Z,,2009,,,,,10313383,CE5541,,,http://vmh.uni.lu/_api/metabolites/2009/?format=pcsv
CE5538,,,0,C8H7NO3,,,noradrenochrome,,noradrenochrome,,,"InChI=1/C8H7NO3/c10-6-1-4-5(2-7(6)11)9-3-8(4)12/h1,8,12H,2-3H2",,2016-11-22T15:12:18Z,,2010,,,,,10176277,,,,http://vmh.uni.lu/_api/metabolites/2010/?format=pcsv
CE5542,,,-1,C8H7NO3,,,noradrenochrome o-semiquinone,,noradrenochrome o-semiquinone,,,,,2016-11-22T15:12:18Z,,2011,,,,,53481587,,,,http://vmh.uni.lu/_api/metabolites/2011/?format=pcsv
CE5546,,,-1,C19H25N4O9S,,,5-S-glutathionyl-adrenochrome hydroquinone,,5-S-glutathionyl-adrenochrome hydroquinone,,,,,2016-11-22T15:12:18Z,,2012,,,,,,CE5546,,,http://vmh.uni.lu/_api/metabolites/2012/?format=pcsv
CE5547,,,-1,C18H23N4O9S,,,5-S-glutathionyl-noradrenochrome hydroquinone,,5-S-glutathionyl-noradrenochrome hydroquinone,,,,,2016-11-22T15:12:18Z,,2013,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2013/?format=pcsv
CE5544,,,-2,C19H22N4O10S,,,5-S-glutathionyl-dopachrome hydroquinone,,5-S-glutathionyl-dopachrome hydroquinone,,,,,2016-11-22T15:12:18Z,,2014,,,,,,CE5544,,,http://vmh.uni.lu/_api/metabolites/2014/?format=pcsv
CE5545,,,-1,C18H23N4O8S,,,5-S-glutathionyl-aminochrome reduced,,5-S-glutathionyl-aminochrome reduced,,,"InChI=1/C18H24N4O8S/c19-9(18(29)30)1-2-13(24)22-11(17(28)21-6-14(25)26)7-31-16-8-3-4-20-10(8)5-12(23)15(16)27/h5,9,11,20,23,27H,1-4,6-7,19H2,(H,21,28)(H,22,24)(H,25,26)(H,29,30)/p-1/t9-,11+/m1/s1",,2016-11-22T15:12:18Z,,2015,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2015/?format=pcsv
CE5665,,,0,C8H9NO2,,,leukoaminochrome,,leukoaminochrome,,,"InChI=1/C8H9NO2/c10-7-3-5-1-2-9-6(5)4-8(7)11/h3-4,9-11H,1-2H2",C17756,2016-11-22T15:12:18Z,,2016,,,,,147311,,,,http://vmh.uni.lu/_api/metabolites/2016/?format=pcsv
CE5643,,,-1,NO3,CHEBI:25941,,"Human Metabolome Database (HMDB): Peroxynitrite is a potent oxidant synthesized by the cell during its normal metabolism. The peroxynitrite anion (ONOO-) is a reactive species produced in the reaction between the superoxide anion (O2*-) and nitric oxide (*NO). Peroxynitrite (ONOO-) is a strong oxidation and nitration agent, which damages DNA, proteins and other cellular structures. ONOO- is involved in several pathological conditions such as inflammation, arteriosclerosis, and neurodegenerative and cardiovascular disorders. ONOO- inhibits different steps of blood platelet activation and causes the depletion of platelet thiols. (PMID 15647782).",,peroxynitrite,,HMDB02179,InChI=1S/HNO3/c2-1-4-3/h3H/p-1,C16845,2016-12-05T15:48:06Z,,2017,,,,peroxynitrite,123349,,," Peroxonitrite, (-)Oxoperoxonitrate, (1-)oxidoperoxidonitrate, Azoperoxoite, Pernitrite, Peroxynitrate, Peroxynitrite, Peroxynitrosyl (NO3)",http://vmh.uni.lu/_api/metabolites/2017/?format=pcsv
CE6000,,,-1,CNO5,,,nitrosoperoxycarbonate,,nitrosoperoxycarbonate,,,,,2016-11-22T15:12:18Z,,2018,,,,,53356678,,,,http://vmh.uni.lu/_api/metabolites/2018/?format=pcsv
CE6205,,,0,C11H13NO2,,,"Human Metabolome Database (HMDB): 5-Methoxytryptophol is synthesized by the pineal gland. Daily rhythms in pineal methoxyindole metabolism have been described in rodents and humans (5-Methoxytryptophol levels are coincident with serotonin levels in rodents pineal) and 5-Methoxytryptophol at its highest during the daylight hours and fall markedly soon after the onset of darkness, coincident with increases in the levels of pineal melatonin and the activities of pineal serotonin-N-acetyltransferase (EC 2.3.1.87, SNAT) and hydroxyindole-O-methyltransferase (EC 2.1.1.4, HIOMT). The fact that the levels of 5-methoxytryptophol and melatonin vary in parallel suggests that the major factor generating the methoxyindole rhythms is not SNAT activity, but perhaps a change in the availability (for metabolism) of ""stored"" serotonin. When the onset of darkness is delayed by 12 hours, human 5-methoxytryptophol (and melatonin) rhythms usually require 3 or 4 days to adjust to the new lighting regimen. Environmental factors, other than light, that activate the sympathetic nervous system or cause epinephrine to be secreted from the adrenal medulla (e.g., the stress of immobilization; insulin-induced hypoglycemia) can override the inhibitory effects of light and accelerate melatonin synthesis. Rhythms in 5-methoxytryptophol (and melatonin) synthesis apparently persist among animals placed in environments of continuous darkness; the source of the cyclic signal (mediated by the pineal sympathetic nerves) has not yet been identified. Preliminary evidence suggests that levels of a peptide hormone, arginine vasotocin, in rat pineal and sera also exhibit daily rhythms and are increased by norepinephrine. The circadian rhythm of melatonin secretion is generated in the suprachiasmatic nucleus. Sleep disruption, nightly restlessness, sundowning, and other circadian disturbances are frequently seen in Alzheimer's disease patients. Changes in the suprachiasmatic nucleus and pineal gland are thought to be the biological basis for these behavioral disturbances. (PMID 288858, 2245336).",,5-methoxytryptophol,,HMDB01896,"InChI=1/C11H13NO2/c1-14-9-2-3-11-10(6-9)8(4-5-13)7-12-11/h2-3,6-7,12-13H,4-5H2,1H3",,2016-12-05T15:48:06Z,,2019,,,,,12835,,,"5-Methoxy-1H-indole-3-ethanol, 5-Methoxyindole-3-ethanol, 5-Methoxytryptophol, Methoxytryptophol",http://vmh.uni.lu/_api/metabolites/2019/?format=pcsv
CE6252,,,0,C5H3N4O3,,,urate radical,,urate radical,,,"InChI=1/C5H3N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H3,7,8,9,10,11,12)/p-1",,2016-11-22T15:12:18Z,,2020,,,,,,CE6252,,,http://vmh.uni.lu/_api/metabolites/2020/?format=pcsv
CE2949,,,-2,C10H5NO4,,,oxoxanthurenate,,oxoxanthurenate,,,"InChI=1/C10H7NO4/c12-7-3-1-2-5-8(13)4-6(10(14)15)11-9(5)7/h1-3,12H,4H2,(H,14,15)/p-1",,2016-11-22T15:12:18Z,,2021,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2021/?format=pcsv
CE2947,,,-1,C16H16NO9,,,xanthurenate-8-O-beta-D-glucoside,,xanthurenate-8-O-beta-D-glucoside,,,"InChI=1/C16H17NO9/c18-5-10-12(20)13(21)14(22)16(26-10)25-9-3-1-2-6-8(19)4-7(15(23)24)17-11(6)9/h1-4,10,12-14,16,18,20-22H,5H2,(H,17,19)(H,23,24)/p-1/t10-,12+,13+,14+,16-/m0/s1",,2016-11-22T15:12:18Z,,2022,,,,,53481609,,,,http://vmh.uni.lu/_api/metabolites/2022/?format=pcsv
CE5982,,,0,C13H17N2O3,,,melatonin radical,,melatonin radical,,,"InChI=1/C13H17N2O3/c1-9(16)14-6-5-13(17)8-15-12-4-3-10(18-2)7-11(12)13/h3-4,7-8,15,17H,5-6H2,1-2H3,(H,14,16)",,2016-11-22T15:12:18Z,,2023,,,,,,CE5982,,,http://vmh.uni.lu/_api/metabolites/2023/?format=pcsv
C01041,,,-1,C6H6O6,CHEBI:16504,,monodehydroascorbate(1-),,monodehydroascorbate(1-),,,"InChI=1S/C6H7O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-8,10H,1H2/t2?,5-/m1/s1",,2016-11-22T15:12:18Z,,2024,,,,,439374,C01041,,,http://vmh.uni.lu/_api/metabolites/2024/?format=pcsv
CE2615,,,0,C11H11N5O,,,"2-hydroxyamino-3,8-dimethylimidazo[4,5-f]quinoxaline",,"2-hydroxyamino-3,8-dimethylimidazo[4,5-f]quinoxaline",,,,,2016-11-22T15:12:18Z,,2025,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2025/?format=pcsv
CE2616,,,-1,C17H18N5O7,,,"2-hydroxyamino-MeIQx-N2-(beta-1-glucosiduronyl)-2-hydroxyamino-3,8-dimethylimidazo[4,5-f]quinoxaline",,"2-hydroxyamino-MeIQx-N2-(beta-1-glucosiduronyl)-2-hydroxyamino-3,8-dimethylimidazo[4,5-f]quinoxaline",,,,,2016-11-22T15:12:18Z,,2026,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2026/?format=pcsv
CE5166,,,-4,C48H76N7O20P3S,CHEBI:37643,,25(S)-trihydroxycoprostanoyl-CoA,,25(S)-trihydroxycoprostanoyl-CoA,,,,C05448,2016-11-22T15:12:18Z,,2027,,,,,15942872,CE5166,,,http://vmh.uni.lu/_api/metabolites/2027/?format=pcsv
CE5165,,,-4,C48H76N7O20P3S,,,25(R)-trihydroxycoprostanoyl-CoA,,25(R)-trihydroxycoprostanoyl-CoA,,,,,2016-11-16T10:44:57Z,,2028,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2028/?format=pcsv
CE4872,,,0,C27H46O4,CHEBI:48940,,"3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-27-al",,"3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-27-al",,,,,2016-11-22T15:12:19Z,,2029,,,,,,CE4872,,,http://vmh.uni.lu/_api/metabolites/2029/?format=pcsv
CE5530,,,0,C27H46O3,CHEBI:18431,,"Human Metabolome Database (HMDB): 7-a,27-dihydroxycholesterol is an intermediate in bile acid biosynthesis. The enzyme 27-Hydroxycholesterol 7alpha-monooxygenase [EC:1.14.13.60] catalyzes the production of this metabolite from 27-hydroxycholesterol. This enzyme reaction is irreversible and occurs in the endoplasmic reticulum.",,"7alpha,27-dihydroxycholesterol",,HMDB06281,"InChI=1S/C27H46O3/c1-17(16-28)6-5-7-18(2)21-8-9-22-25-23(11-13-27(21,22)4)26(3)12-10-20(29)14-19(26)15-24(25)30/h15,17-18,20-25,28-30H,5-14,16H2,1-4H3/t17?,18-,20+,21-,22+,23+,24-,25+,26+,27-/m1/s1",C06341,2016-12-05T15:48:06Z,,2030,,,,,440985,CE5530,,"5-Cholestene-3beta,7alpha,26-triol, 7-alpha,27-Dihydroxycholesterol, 7alpha,26-dihydroxycholesterol, 7alpha,27-Dihydroxycholesterol, Cholest-5-ene-3,7,27-triol, Cholest-5-ene-3- b,7-a,27-triol, Cholest-5-ene-3-b,7-a,27-triol, Cholest-5-ene-3-beta,7-alpha,27-triol, Cholest-5-ene-3beta,7alpha,26-triol, Cholest-5-ene-3beta,7alpha,27-triol",http://vmh.uni.lu/_api/metabolites/2030/?format=pcsv
CE1274,,,0,C27H46O5,,,"3alpha,7alpha,12alpha,25-tetrahydroxy-5beta-cholestane-24-one",,"3alpha,7alpha,12alpha,25-tetrahydroxy-5beta-cholestane-24-one",,,"InChI=1/C27H46O5/c1-15(6-9-22(30)25(2,3)32)18-7-8-19-24-20(14-23(31)27(18,19)5)26(4)11-10-17(28)12-16(26)13-21(24)29/h15-21,23-24,28-29,31-32H,6-14H2,1-5H3/t15-,16-,17+,18-,19-,20-,21+,23-,24-,26?,27-/m1/s1",,2016-11-22T15:12:19Z,,2031,,,,,,CE1274,,,http://vmh.uni.lu/_api/metabolites/2031/?format=pcsv
C03990,,,-1,C24H39O3,9903,,"Human Metabolome Database (HMDB): Lithocholic acid is a bile acid formed from chenodeoxycholate by bacterial action, usually conjugated with glycine or taurine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as cholagogue and choleretic. A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",,lithocholate,,HMDB00761,"InChI=1S/C24H40O3/c1-15(4-9-22(26)27)19-7-8-20-18-6-5-16-14-17(25)10-12-23(16,2)21(18)11-13-24(19,20)3/h15-21,25H,4-14H2,1-3H3,(H,26,27)/p-1/t15-,16-,17-,18+,19-,20+,21+,23+,24-/m1/s1",C03990,2016-12-05T15:48:06Z,,2032,,,,,9903,,,"(3a,5b)-3-hydroxy-cholan-24-oate, (3a,5b)-3-hydroxy-cholan-24-oic acid, 3a-Hydroxy-5b-cholan-24-oate, 3a-Hydroxy-5b-cholan-24-oic acid, Lithocholate",http://vmh.uni.lu/_api/metabolites/2032/?format=pcsv
C02592,,,-1,C26H44NO5S,439763,,"Human Metabolome Database (HMDB): Lithocholyltaurine is a bile salt formed in the liver from lithocholic acid conjugation with taurine, usually as the sodium salt. It solubilizes fats for absorption and is itself absorbed. Lithocholic acid, a hydrophobic secondary bile acid, is well known to cause intrahepatic cholestasis. There have been extensive studies on the mechanisms of lithocholate-induced cholestasis in animals. Lithocholate diminishes both the bile acid-dependent and independent bile flow. In humans, elevated levels of lithocholic acid are found in patients with chronic cholestatic liver disease. Lithocholyltaurine impairs both the bile canalicular contractions and the canalicular bile secretion, possibly by acting directly on the canalicular membranes in lithocholyltaurine-induced cholestasis. Lithocholyltaurine induce acute cholestasis-associated with retrieval of the bile salt export pump. The bile salt export pump (BSEP) of hepatocyte secretes conjugated bile salts across the canalicular membrane in an ATP-dependent manner. Hepatic retention of bile acids may lead to liver injury by hepatocyte apoptosis and eventually deterioration of cholestatic liver diseases. One mechanism of induced apoptosis by lithocholyltaurine is the induction of transcriptional activity of AP-1 (activation protein-1). (PMID: 16981261, 15763547, 16332456, 18164257).",,Taurolithocholate,,HMDB00722,"InChI=1S/C26H45NO5S/c1-17(4-9-24(29)27-14-15-33(30,31)32)21-7-8-22-20-6-5-18-16-19(28)10-12-25(18,2)23(20)11-13-26(21,22)3/h17-23,28H,4-16H2,1-3H3,(H,27,29)(H,30,31,32)/p-1/t17-,18-,19-,20+,21-,22+,23+,25+,26-/m1/s1",C02592,2016-12-05T15:48:06Z,,2033,,,,,439763,,,"2-[(3alpha-hydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonic acid, 2-[[(3a,5b)-3-Hydroxy-24-oxocholan-24-yl]amino]-Ethanesulfonate, 2-[[(3a,5b)-3-Hydroxy-24-oxocholan-24-yl]amino]-Ethanesulfonic acid, 3a-Hydroxy-5b-cholanoyltaurine, 3a-Hydroxy-N-(2-sulfoethyl)-5b-cholan-24-amide, Cholane ethanesulfonic acid deriv., Lithocholic acid taurine conjugate, Lithocholic acid taurine conjugic acid, N-(3a-Hydroxy-5b-cholan-24-oyl)-Taurine, Taurolithocholate, Taurolithocholic acid",http://vmh.uni.lu/_api/metabolites/2033/?format=pcsv
CE5560,,,-1,C26H42NO4,115245,,"Human Metabolome Database (HMDB): Lithocholic acid glycine conjugate is an acyl glycine and a bile acid-glycine conjugate. is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",,glycolithocholate,,HMDB00698,"InChI=1S/C26H43NO4/c1-16(4-9-23(29)27-15-24(30)31)20-7-8-21-19-6-5-17-14-18(28)10-12-25(17,2)22(19)11-13-26(20,21)3/h16-22,28H,4-15H2,1-3H3,(H,27,29)(H,30,31)/p-1/t16-,17-,18-,19+,20-,21+,22+,25+,26-/m1/s1",C15557,2016-12-05T15:48:06Z,,2034,,,,,115245,,,"3a-Hydroxy-5b-cholanic acid glycine ester, 3a-Hydroxy-5b-cholanoylglycine, 3a-Hydroxy-N-(carboxymethyl)-5b-cholan-24-amide, 3alpha-hydroxy-5beta-cholan-24-oate, 3alpha-hydroxy-5beta-cholan-24-oic acid, 3alpha-hydroxy-5beta-cholan-24-oic acid N-(carboxymethyl)amide, Glycolithocholate, Glycolithocholic acid, Lithocholic acid glycine conjugate, Lithocholic acid glycine conjugic acid, Lithocholoyglycine, Lithocholylglycine, N-(3a-Hydroxy-5b-cholan-24-oyl)-Glycine, N-(3a-Hydroxy-5b-cholanoyl)glycine, N-(Carboxymethyl)-3a-hydroxy-5b-Cholan-24-amide",http://vmh.uni.lu/_api/metabolites/2034/?format=pcsv
C01290,,,0,C31H56NO13R,CHEBI:17950,,"beta-D-Galactosyl-1,4-beta-D-glucosylceramide",,"beta-D-Galactosyl-1,4-beta-D-glucosylceramide",,HMDB00173,,,2016-11-22T15:12:19Z,,2035,,,,,,C01290,,,http://vmh.uni.lu/_api/metabolites/2035/?format=pcsv
CE7047,,,0,C28H47O2,,,gama-tocopheroxyl radical,,gama-tocopheroxyl radical,,,,,2016-11-22T15:12:19Z,,2036,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2036/?format=pcsv
CE5986,,,0,C28H47NO4,,,5-nitro-gama-tocopherol,,5-nitro-gama-tocopherol,,,,,2016-11-22T15:12:19Z,,2037,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2037/?format=pcsv
C01747,,,1,C24H48NO7,CHEBI:16874,,Human Metabolome Database (HMDB): Galactosylsphingosine is an intermediate in the biosynthesis of cerebrosides. It is formed by reaction of sphingosine with UDP-galactose and then itself reacts with fatty acid-Coenzyme A to form the cerebroside.,,psychosine(1+),,HMDB00648,"InChI=1S/C24H47NO7/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(27)18(25)17-31-24-23(30)22(29)21(28)20(16-26)32-24/h14-15,18-24,26-30H,2-13,16-17,25H2,1H3/p+1/b15-14+/t18-,19+,20+,21-,22-,23+,24+/m0/s1",C01747,2016-12-05T15:48:06Z,,2038,,,,,22833541,C01747,,"(E)-DL-erythro-b-D-2-amino-3-hydroxy-4-octadecenyl Galactopyranoside, (E)-DL-erythro-beta-delta-2-amino-3-hydroxy-4-octadecenyl Galactopyranoside, 2-Amino-3-hydroxy-4-octadecenyl Galactopyranoside, Erythro-Psychosine, Galactosylsphingosine, Psychosine, Sphingosine galactoside, [R-[R*,S*-(E)]]-2-amino-3-hydroxy-4-octadecenyl b-D-Galactopyranoside, [R-[R*,S*-(E)]]-2-amino-3-hydroxy-4-octadecenyl b-delta-Galactopyranoside",http://vmh.uni.lu/_api/metabolites/2038/?format=pcsv
C02744,,,0,C24H47NO10S,CHEBI:17507,,Psychosine sulfate,,Psychosine sulfate,,,"InChI=1S/C24H47NO10S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(26)18(25)16-33-24-23(29)22(28)21(27)20(35-24)17-34-36(30,31)32/h14-15,18-24,26-29H,2-13,16-17,25H2,1H3,(H,30,31,32)/b15-14+/t18-,19+,20+,21-,22-,23+,24+/m0/s1",C02744,2016-11-22T15:12:19Z,,2039,,,,,5280538,,,,http://vmh.uni.lu/_api/metabolites/2039/?format=pcsv
C03405,,,0,,,,Lactosylceramide sulfate,,Lactosylceramide sulfate,,,,C03405,2016-11-22T15:12:19Z,,2040,,,,,,C03405,,,http://vmh.uni.lu/_api/metabolites/2040/?format=pcsv
CE2119,,,0,C13H16N2O3,,,cyclic 3-hydroxymelatonin,,cyclic 3-hydroxymelatonin,,,"InChI=1/C13H16N2O3/c1-8(16)15-6-5-13(17)10-7-9(18-2)3-4-11(10)14-12(13)15/h3-4,7,12,14,17H,5-6H2,1-2H3",,2016-11-22T15:12:19Z,,2041,,,,,,CE2119,,,http://vmh.uni.lu/_api/metabolites/2041/?format=pcsv
CE5125,,,-4,C40H68N7O17P3S,CHEBI:64039,,(2S)-pristanoyl-CoA,,(2S)-pristanoyl-CoA,,,"InChI=1/C40H72N7O17P3S/c1-25(2)11-8-12-26(3)13-9-14-27(4)15-10-16-28(5)39(52)68-20-19-42-30(48)17-18-43-37(51)34(50)40(6,7)22-61-67(58,59)64-66(56,57)60-21-29-33(63-65(53,54)55)32(49)38(62-29)47-24-46-31-35(41)44-23-45-36(31)47/h23-29,32-34,38,49-50H,8-22H2,1-7H3,(H,42,48)(H,43,51)(H,56,57)(H,58,59)(H2,41,44,45)(H2,53,54,55)/p-4/t26-,27-,28-,29-,32+,33+,34u,38-/m0/s1",,2016-11-22T15:12:19Z,,2042,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2042/?format=pcsv
CE5126,,,-4,C40H68N7O17P3S,CHEBI:20067,,(2R)-pristanoyl-CoA,,(2R)-pristanoyl-CoA,,,"InChI=1/C40H72N7O17P3S/c1-25(2)11-8-12-26(3)13-9-14-27(4)15-10-16-28(5)39(52)68-20-19-42-30(48)17-18-43-37(51)34(50)40(6,7)22-61-67(58,59)64-66(56,57)60-21-29-33(63-65(53,54)55)32(49)38(62-29)47-24-46-31-35(41)44-23-45-36(31)47/h23-29,32-34,38,49-50H,8-22H2,1-7H3,(H,42,48)(H,43,51)(H,56,57)(H,58,59)(H2,41,44,45)(H2,53,54,55)/p-4/t26-,27-,28-,29-,32+,33+,34u,38-/m0/s1",,2016-11-22T15:12:19Z,,2043,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2043/?format=pcsv
C05284,,,0,C19H26O3,CHEBI:27967,,"Human Metabolome Database (HMDB): 11beta-Hydroxyandrost-4-ene-3,17-dione is an intermediate in adrenosterone production. 11beta-Hydroxyandrost-4-ene-3,17-dione is produced from androst-4-ene-3,17-dione, a reaction catalyzed by the enzyme cytochrome P450 B [EC:1.14.15.4]. 11beta-Hydroxyandrost-4-ene-3,17-dione is then converted into adrenosterone by the enzyme 11beta-hydroxysteroid dehydrogenase [EC:1.1.1.146].",,"11beta-Hydroxyandrost-4-ene-3,17-dione",,HMDB06773,"InChI=1S/C19H26O3/c1-18-8-7-12(20)9-11(18)3-4-13-14-5-6-16(22)19(14,2)10-15(21)17(13)18/h9,13-15,17,21H,3-8,10H2,1-2H3/t13-,14-,15-,17+,18-,19-/m0/s1",C05284,2016-12-05T15:48:06Z,,2044,,,,,94141,C05284,,"11beta-Hydroxyandrost-4-ene-3,17-dione, 4-Androsten-11beta-ol-3,17-dione, Androst-4-ene-3,17-dione-11beta-ol",http://vmh.uni.lu/_api/metabolites/2044/?format=pcsv
CE3075,,,-2,C6H13O9P,,,sorbitol 3-phosphate,,sorbitol 3-phosphate,,,,,2016-11-22T15:12:19Z,,2045,,,,,129544,CE3075,,,http://vmh.uni.lu/_api/metabolites/2045/?format=pcsv
alltn,,,0,C4H6N4O3,CHEBI:15676,,"Human Metabolome Database (HMDB): Allantoin is a diureide of glyoxylic acid with the chemical formula C4H6N4O3. It is also called 5-ureidohydantoin, glyoxyldiureide, and 5-ureidohydantoin. It is a product of oxidation of uric acid. It is a product of purine metabolism in most mammals except higher apes, and it is present in their urine. In humans, uric acid is excreted instead of allantoin. The presence of allantoin in the urine can be an indication of microbial overgrowth or it can be created via non-enzymatic means through high levels of reactive oxygen species. In this regard Allantoin is sometimes used as a marker of oxidative stress. Allantoin can be isolated from cow urine or as a botanical extract of the comfrey plant. It has long been used for its healing, soothing, and anti-irritating properties. Allantoin helps to heal wounds and skin irritations and stimulates the growth of healthy tissue. Allantoin can be found in anti-acne products, sun care products, and clarifying lotions because of its ability to help heal minor wounds and promote healthy skin. Allantoin is frequently present in toothpaste, mouthwash, and other oral hygiene products as well as shampoos, lipsticks, various cosmetic lotions and creams and other cosmetic and pharmaceutical products.",,Allantoin,,HMDB00462,"InChI=1S/C4H6N4O3/c5-3(10)6-1-2(9)8-4(11)7-1/h1H,(H3,5,6,10)(H2,7,8,9,11)",C01551,2016-12-05T15:48:06Z,,2046,,,,,204,,,"(S)-allantoin, 2,5-Dioxo-4-imidazolidinyl-urea, 4-Ureido-2,5-Imidazolidinedione, 5-Ureido-Hydantoin, 5-Ureidohydantoin, 5-Ureidohydrantoin, Alantan, Allantoin, Allantol, Alloxantin, AVC/Dienestrolcream, Cordianine, D00121, Fancol TOIN, Glyoxyldiureid, Glyoxyldiureide, Glyoxylic diureide, N-(2,5-Dioxo-4-imidazolidinyl)urea, Psoralon, Sebical, Septalan",http://vmh.uni.lu/_api/metabolites/2046/?format=pcsv
alltt,,,-1,C4H7N4O4,CHEBI:30837,,"Human Metabolome Database (HMDB): Allantoic acid is the END product of Allantoicase [EC:3.5.3.4], an enzyme involved in uric acid degradation (Purine metabolism). Although it is commonly accepted that allantoicase is lost in mammals, it has been identified in mice and humans. (PMID 11852104). A crystalline, transparent, colorless substance found in the allantoic liquid of the fetal calf; -- formerly called allantoic acid and amniotic acid.",,allantoate,,HMDB01209,"InChI=1S/C4H8N4O4/c5-3(11)7-1(2(9)10)8-4(6)12/h1H,(H,9,10)(H3,5,7,11)(H3,6,8,12)/p-1",C00499,2016-12-05T15:48:06Z,,2047,,,,,203,,,"Allantoate, Allantoic acid, Diureidoacetate, Diureidoacetic acid",http://vmh.uni.lu/_api/metabolites/2047/?format=pcsv
CE0328,,,-1,C22H31O2,CHEBI:28125,,"Human Metabolome Database (HMDB): Docosahexaenoic acid (DHA) is an omega-3 essential fatty acid. Chemically, DHA is a carboxylic acid with a 22-carbon chain and six cis double bonds with the first double bond is located at the third carbon from the omega end. DHA is most often found in fish oil. It is a major fatty acid in sperm and brain phospholipids, especially in the retina. Dietary DHA can reduce the level of blood triglycerides in humans, which may reduce the risk of heart disease. (wikipedia).",,docosahexaenoate,,HMDB02183,,C06429,2016-12-05T15:48:06Z,,2048,,,,,3144,,,"4,7,10,13,16,19-Docosahexaenoate, 4,7,10,13,16,19-Docosahexaenoic acid, All-Z-Docosahexaenoate, All-Z-Docosahexaenoic acid, Cervonate, Cervonic acid, cis-4,7,10,13,16,19-Docosahexanoate, cis-4,7,10,13,16,19-Docosahexanoic acid, Doconexent, Doconexento, Doconexentum, Docosahexaenoate, Docosahexaenoic acid, Doxonexent",http://vmh.uni.lu/_api/metabolites/2048/?format=pcsv
CE6423,,,-1,C22H30O4,,,11-peroxy-docosahexaenoate,,11-peroxy-docosahexaenoate,,,,,2016-11-22T15:12:19Z,,2049,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2049/?format=pcsv
CE6426,,,-1,C22H30O4,,,7-peroxy-docosahexaenoate,,7-peroxy-docosahexaenoate,,,,,2016-11-22T15:12:19Z,,2050,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2050/?format=pcsv
CE6429,,,-1,C22H30O4,,,14-peroxy-docosahexaenoate,,14-peroxy-docosahexaenoate,,,,,2016-11-22T15:12:19Z,,2051,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2051/?format=pcsv
CE6435,,,-1,C22H30O4,,,17-peroxy-docosahexaenoate,,17-peroxy-docosahexaenoate,,,,,2016-11-22T15:12:19Z,,2052,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2052/?format=pcsv
CE6432,,,-1,C22H30O4,,,10-peroxy-docosahexaenoate,,10-peroxy-docosahexaenoate,,,,,2016-11-22T15:12:19Z,,2053,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2053/?format=pcsv
CE6438,,,-1,C22H30O4,,,16-peroxy-docosahexaenoate,,16-peroxy-docosahexaenoate,,,,,2016-11-22T15:12:19Z,,2054,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2054/?format=pcsv
CE6420,,,-1,C22H30O4,,,8-peroxy-docosahexaenoate,,8-peroxy-docosahexaenoate,,,,,2016-11-22T15:12:19Z,,2055,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2055/?format=pcsv
CE6444,,,-1,C22H31O6,,,4-hydroperoxy-H4-neuroprostane,,4-hydroperoxy-H4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2056,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2056/?format=pcsv
CE6445,,,-1,C22H31O6,,,7-hydroperoxy-H4-neuroprostane,,7-hydroperoxy-H4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2057,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2057/?format=pcsv
CE6447,,,-1,C22H31O6,,,10-hydroperoxy-H4-neuroprostane,,10-hydroperoxy-H4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2058,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2058/?format=pcsv
CE6446,,,-1,C22H31O6,,,11-hydroperoxy-H4-neuroprostane,,11-hydroperoxy-H4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2059,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2059/?format=pcsv
CE6448,,,-1,C22H31O6,,,14-hydroperoxy-H4-neuroprostane,,14-hydroperoxy-H4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2060,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2060/?format=pcsv
CE6449,,,-1,C22H31O6,,,13-hydroperoxy-H4-neuroprostane,,13-hydroperoxy-H4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2061,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2061/?format=pcsv
CE6451,,,-1,C22H31O6,,,20-hydroperoxy-H4-neuroprostane,,20-hydroperoxy-H4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2062,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2062/?format=pcsv
CE6450,,,-1,C22H31O6,,,17-hydroperoxy-H4-neuroprostane,,17-hydroperoxy-H4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2063,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2063/?format=pcsv
CE6453,,,-1,C22H31O5,,,4-hydroxy-D4-neuroprostane,,4-hydroxy-D4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2064,,,,,53481519,,,,http://vmh.uni.lu/_api/metabolites/2064/?format=pcsv
CE6452,,,-1,C22H31O5,,,4-hydroxy-E4-neuroprostane,,4-hydroxy-E4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2065,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2065/?format=pcsv
CE6454,,,-1,C22H31O5,,,7-hydroxy-E4-neuroprostane,,7-hydroxy-E4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2066,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2066/?format=pcsv
CE6455,,,-1,C22H31O5,,,7-hydroxy-D4-neuroprostane,,7-hydroxy-D4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2067,,,,,53481533,,,,http://vmh.uni.lu/_api/metabolites/2067/?format=pcsv
CE6456,,,-1,C22H31O5,,,11-hydroxy-E4-neuroprostane,,11-hydroxy-E4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2068,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2068/?format=pcsv
CE6457,,,-1,C22H31O5,,,11-hydroxy-D4-neuroprostane,,11-hydroxy-D4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2069,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2069/?format=pcsv
CE6458,,,-1,C22H31O5,,,10-hydroxy-E4-neuroprostane,,10-hydroxy-E4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2070,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2070/?format=pcsv
CE6459,,,-1,C22H31O5,,,10-hydroxy-D4-neuroprostane,,10-hydroxy-D4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2071,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2071/?format=pcsv
CE6460,,,-1,C22H31O5,,,14-hydroxy-E4-neuroprostane,,14-hydroxy-E4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2072,,,,,53481475,,,,http://vmh.uni.lu/_api/metabolites/2072/?format=pcsv
CE6461,,,-1,C22H31O5,,,14-hydroxy-D4-neuroprostane,,14-hydroxy-D4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2073,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2073/?format=pcsv
CE6462,,,-1,C22H31O5,,,13-hydroxy-E4-neuroprostane,,13-hydroxy-E4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2074,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2074/?format=pcsv
CE6463,,,-1,C22H31O5,,,13-hydroxy-D4-neuroprostane,,13-hydroxy-D4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2075,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2075/?format=pcsv
CE6464,,,-1,C22H31O5,,,17-hydroxy-E4-neuroprostane,,17-hydroxy-E4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2076,,,,,53481484,,,,http://vmh.uni.lu/_api/metabolites/2076/?format=pcsv
CE6465,,,-1,C22H31O5,,,17-hydroxy-D4-neuroprostane,,17-hydroxy-D4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2077,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2077/?format=pcsv
CE6467,,,-1,C22H31O5,,,20-hydroxy-D4-neuroprostane,,20-hydroxy-D4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2078,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2078/?format=pcsv
CE6466,,,-1,C22H31O5,,,20-hydroxy-E4-neuroprostane,,20-hydroxy-E4-neuroprostane,,,,,2016-11-22T15:12:19Z,,2079,,,,,53481510,,,,http://vmh.uni.lu/_api/metabolites/2079/?format=pcsv
CE0074,,,0,C4H2N2O4,,,"Human Metabolome Database (HMDB): Alloxan or mesoxalylurea is an organic compound based on a pyrimidine heterocyclic skeleton. This compound has a high affinity for water and therefore exists as the monohydrate. The compound was discovered by Justus von Liebig and Friedrich Wohler following the discovery of urea in 1828 and is one of the oldest named organic compounds that exist. The name is derived from allantoin, a product of uric acid excreted by the fetus into the allantois and oxaluric acid derived from oxalic acid and urea, found in urine. The original recipe for Alloxan was by oxidation of uric acid by nitric acid. Alloxan is a strong oxidizing agent and it forms a hemiacetal with its reduced reaction product dialuric acid (in which a carbonyl group is reduced to a hydroxyl group) which is called alloxantin. -- Wikipedia; Alloxane is a raw material for the production of the purple dye Murexide. Carl Wilhelm Scheele discovered the dye in 1776. Murexide is the product of the complex in-situ multistep reaction of alloxantin and gaseous ammonia. Murexide results from the condensation of the unisolated intermdiate uramil with alloxan, liberated during the course of the reaction. Scheele sourced uric acid from human calculi (such as kidney stones) and called the compound lithic acid. William Prout investigated the compound in 1818 and he used boa constrictor excrement with up to 90% ammonium acid urate. Liebig and Wohler in the nineteenth century coined the name murexide for the dye after the Trunculus Murex which is the source of the Tyrian purple of antiquity. Primo Levi in his world famous novel The Periodic Table in chapter Nitrogen considers pythons as a source for alloxane on behalf of a lipstick producer but he is turned down by the director of the Turin zoo because the zoo already has lucrative contracts with cosmetics companies (his attempts with chicken dung end in misery). -- Wikipedia.",,alloxan,,HMDB02818,"InChI=1/C4H2N2O4/c7-1-2(8)5-4(10)6-3(1)9/h(H2,5,6,8,9,10)",,2016-12-05T15:48:06Z,,2080,,,,,5781,CE0074,,"2,4,5,6(1H,3H)-Pyrimidinetetrone, 2,4,5,6-Pyrimidintetron, 2,4,5,6-Pyrimidintetrone, 2,4,5,6-Tetraoxohexahydropyrimidine, 5-Oxo-barbiturate, 5-Oxo-barbituric acid, Alloxan, Alloxan 7169, Alloxan tetrahydrat, Alloxane, Mesoxalyl-Urea, Mesoxalylcarbamide, Mesoxalylurea, Pyrimidinetetrone",http://vmh.uni.lu/_api/metabolites/2080/?format=pcsv
CE7122,,,0,C29H43O2,,,alpha-tocotrienoxyl radical,,alpha-tocotrienoxyl radical,,,"InChI=1/C29H43O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h12,14,16H,9-11,13,15,17-19H2,1-8H3/b21-14+,22-16+",,2016-11-22T15:12:19Z,,2081,,,,,,CE7122,,,http://vmh.uni.lu/_api/metabolites/2081/?format=pcsv
C02147,,,-1,C8H15O2S2,CHEBI:18047,,"Human Metabolome Database (HMDB): Dihydrolipoic acid is an organic compound that is the reduced form of lipoic acid. This carboxylic acid features a pair of thiol groups. It is optically active but only the R-enantiomer is biochemically significant. The lipoic acid/dihydrolipoic acid pair participate in a variety of biochemical transformations.( from Wiki). Inside the cell, alpha lipoic acid is readily reduced or broken down to dihydrolipoic acid. Dihydrolipoic acid is even more potent than alpha lipoic acid, neutralizing free radicals, preventing them from causing harm. It directly destroys damaging superoxide radicals, hydroperoxy radicals and hydroxyl radicals. It has been shown in vitro that dihydrolipoate (DL-6,8-dithioloctanoic acid) has antioxidant activity against microsomal lipid peroxidation.Dihydrolipoate is tested for its neuroprotective activity using models of hypoxic and excitotoxic neuronal damage in vitro and rodent models of cerebral ischemia in vivo. Dihydrolipoate, similarly to dimethylthiourea, is able to protect neurons against ischemic damage by diminishing the accumulation of reactive oxygen species within the cerebral tissue.(PMID: 1345759).",,dihydrolipoate,,HMDB12210,"InChI=1S/C8H16O2S2/c9-8(10)4-2-1-3-7(12)5-6-11/h7,11-12H,1-6H2,(H,9,10)/p-1",C02147,2016-12-05T15:48:06Z,,2082,,,,,421,C02147,,"6,8-Bis-sulfanyloctanoate, 6,8-Bis-sulfanyloctanoic acid, 6,8-Dihydrothioctic acid, 6,8-Dimercapto-Octanoate, 6,8-Dimercapto-Octanoic acid, 6,8-Dimercaptooctanoate, 6,8-Dimercaptooctanoic acid, 6,8-Disulfanyloctanoate, 6,8-Disulfanyloctanoic acid, D,L-Dihydrolipoate, D,L-Dihydrolipoic acid, DHLA, Dihydro-a-lipoate, Dihydro-a-lipoic acid, Dihydro-alpha-lipoate, Dihydro-alpha-lipoic acid, Dihydro-DL-alpha-lipoate, Dihydro-DL-alpha-lipoic acid, Dihydro-Lipoate, Dihydro-Lipoic acid, Dihydro-Thioctic acid, Dihydro-Thiocytic acid, Dihydrolipoate, Dihydrolipoic acid, Dihydrothioctic acid, Dl-Dihydro-a-6-thioctic acid, Dl-Dihydro-alpha-6-thioctic acid, Reduced DL-6,8-Thioctic acid, Reduced Lipoate, Reduced Lipoic acid, Reduced thioctic acid",http://vmh.uni.lu/_api/metabolites/2082/?format=pcsv
CE2592,,,-4,C37H60N7O18P3S,,,(S)-3-hydroxypalmitoleoyl-CoA,,(S)-3-hydroxypalmitoleoyl-CoA,,,,,2016-11-22T15:12:19Z,,2083,,,,,53481439,CE2592,,,http://vmh.uni.lu/_api/metabolites/2083/?format=pcsv
CE0853,,,-4,C37H58N7O18P3S,,,3-oxopalmitoleoyl-CoA,,3-oxopalmitoleoyl-CoA,,,,C05259,2016-11-22T15:12:19Z,,2084,,,,,440601,CE0853,,,http://vmh.uni.lu/_api/metabolites/2084/?format=pcsv
CE1102,,,-4,C35H56N7O18P3S,,,cis-(3S)-hydroxytetradec-7-enoyl-CoA,,cis-(3S)-hydroxytetradec-7-enoyl-CoA,,,,,2016-11-22T15:12:19Z,,2085,,,,,,CE1102,,,http://vmh.uni.lu/_api/metabolites/2085/?format=pcsv
CE0782,,,-4,C35H54N7O18P3S,,,3-oxomyrist-7-enoyl-CoA,,3-oxomyrist-7-enoyl-CoA,,,,,2016-11-22T15:12:19Z,,2086,,,,,,CE0782,,,http://vmh.uni.lu/_api/metabolites/2086/?format=pcsv
CE2597,,,-4,C33H52N7O18P3S,,,3(S)-3-hydroxydodecen-(5Z)-oyl-CoA,,3(S)-3-hydroxydodecen-(5Z)-oyl-CoA,,,,,2016-11-22T15:12:19Z,,2087,,,,,53481515,CE2597,,,http://vmh.uni.lu/_api/metabolites/2087/?format=pcsv
CE0692,,,-4,C33H50N7O18P3S,,,3-oxolaur-cis-5-enoyl-CoA,,3-oxolaur-cis-5-enoyl-CoA,,,,,2016-11-22T15:12:19Z,,2088,,,,,,CE0692,,,http://vmh.uni.lu/_api/metabolites/2088/?format=pcsv
C03372,,,-2,C4H4O7PR,CHEBI:15835,,1-acylglycerone 3-phosphate(2-),,1-acylglycerone 3-phosphate(2-),,,,,2016-11-22T15:12:19Z,,2089,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2089/?format=pcsv
1ddecg3p,,,-2,C15H29O7P1,57970,,1-acyl-sn-glycerol 3-phosphate(2-),,1-acyl-sn-glycerol 3-phosphate(2-),,,,,2016-11-22T15:12:29Z,,2090,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2090/?format=pcsv
CE0852,,,-4,C37H60N7O17P3S,,,palmitoleyl-CoA(4-),,palmitoleyl-CoA(4-),,,"InChI=1S/C37H64N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-28(46)65-21-20-39-27(45)18-19-40-35(49)32(48)37(2,3)23-58-64(55,56)61-63(53,54)57-22-26-31(60-62(50,51)52)30(47)36(59-26)44-25-43-29-33(38)41-24-42-34(29)44/h9-10,24-26,30-32,36,47-48H,4-8,11-23H2,1-3H3,(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,38,41,42)(H2,50,51,52)/p-4/b10-9-/t26-,30-,31-,32+,36-/m1/s1",,2016-11-16T10:44:57Z,,2091,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2091/?format=pcsv
CE2591,,,-4,C37H58N7O17P3S,,,"trans,cis-hexadeca-2,9-dienoyl-CoA",,"trans,cis-hexadeca-2,9-dienoyl-CoA",,,"InChI=1/C37H62N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-28(46)65-21-20-39-27(45)18-19-40-35(49)32(48)37(2,3)23-58-64(55,56)61-63(53,54)57-22-26-31(60-62(50,51)52)30(47)36(59-26)44-25-43-29-33(38)41-24-42-34(29)44/h9-10,16-17,24-26,30-32,36,47-48H,4-8,11-15,18-23H2,1-3H3,(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,38,41,42)(H2,50,51,52)/p-4/b10-9-,17-16+/t26-,30+,31+,32u,36-/m0/s1",,2016-11-22T15:12:19Z,,2092,,,,,,CE2591,,,http://vmh.uni.lu/_api/metabolites/2092/?format=pcsv
CE0784,,,-4,C35H56N7O17P3S,,,cis-myrist-7-enoyl-CoA,,cis-myrist-7-enoyl-CoA,,,,,2016-11-22T15:12:19Z,,2093,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2093/?format=pcsv
CE2594,,,-4,C35H54N7O17P3S,,,"trans,cis-myristo-2,7-dienoyl-CoA",,"trans,cis-myristo-2,7-dienoyl-CoA",,,,,2016-11-22T15:12:19Z,,2094,,,,,,CE2594,,,http://vmh.uni.lu/_api/metabolites/2094/?format=pcsv
CE2596,,,-4,C33H50N7O17P3S,,,"trans,cis-dodeca-2,5-dienoyl-CoA",,"trans,cis-dodeca-2,5-dienoyl-CoA",,,,,2016-11-22T15:12:19Z,,2095,,,,,,CE2596,,,http://vmh.uni.lu/_api/metabolites/2095/?format=pcsv
CE0695,,,-4,C33H52N7O17P3S,,,cis-laur-5-enoyl-CoA,,cis-laur-5-enoyl-CoA,,,,,2016-11-22T15:12:19Z,,2096,,,,,,CE0695,,,http://vmh.uni.lu/_api/metabolites/2096/?format=pcsv
CE0955,,,-1,C20H33O6,,,"Human Metabolome Database (HMDB): 6-keto-Prostaglandin F1a is the physiologically active and stable metabolite of prostacyclin. (A prostaglandin found in nearly all mammalian tissue that is a powerful vasodilator and inhibits platelet aggregation; it is biosynthesized enzymatically from prostaglandin endoperoxides in human vascular tissue; the sodium salt has been also used to treat primary pulmonary hypertension (Hypertension, Pulmonary). A delayed and prolonged increase in 6-keto-PGF1 alpha is reported in animals with septic shock, i.e., those with fecal peritonitis or cecal ligation. 6-keto-Prostaglandin F1a plasma levels has been found increased in patients with epidemic hemorrhagic fever, in patients with acute obstructive suppurative cholangitis, in patients with gynecologic cancer and has significant correlation with the level of high density lipoprotein cholesterol in plasma. (PMID 1976492, 2298410, 2379443, 2111556)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,6-oxo-prostaglandin F1alpha,,HMDB02886,"InChI=1S/C20H34O6/c1-2-3-4-7-14(21)10-11-16-17(19(24)13-18(16)23)12-15(22)8-5-6-9-20(25)26/h10-11,14,16-19,21,23-24H,2-9,12-13H2,1H3,(H,25,26)/b11-10+/t14-,16+,17+,18+,19-/m0/s1",C05961,2016-12-05T15:48:06Z,,2097,,,,,440860,CE0955,,"6-Keto-PGF1a, 6-Keto-PGF1alpha, 6-Keto-prostaglandin F1a, 6-Keto-prostaglandin F1alpha, 6-Ketoprostaglandin F1 alpha, 6-Ketoprostaglandin F1alpha, 6-Oxo-9S,11R,15S-trihydroxy-13E-prostenoate, 6-Oxo-9S,11R,15S-trihydroxy-13E-prostenoic acid, 6-Oxo-PGF1a, 6-Oxo-PGF1alpha, 6-Oxo-prostaglandin F1alpha, 6-Oxoprostaglandin F1a, 6-Oxoprostaglandin F1alpha",http://vmh.uni.lu/_api/metabolites/2097/?format=pcsv
CE5132,,,-5,C11H14O19P3R2,,,"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate(5-)",,"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate(5-)",,,,,2016-11-16T10:44:57Z,,2098,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2098/?format=pcsv
CE2206,,,0,C27H42O4,,,"24-oxo-1alpha,25-dihydroxyvitamin D3",,"24-oxo-1alpha,25-dihydroxyvitamin D3",,,"InChI=1S/C27H42O4/c1-17(8-13-25(30)26(3,4)31)22-11-12-23-19(7-6-14-27(22,23)5)9-10-20-15-21(28)16-24(29)18(20)2/h9-10,17,21-24,28-29,31H,2,6-8,11-16H2,1,3-5H3/b19-9+,20-10-/t17-,21-,22-,23+,24+,27-/m1/s1",,2016-11-22T15:12:19Z,,2099,,,,,5283703,,,,http://vmh.uni.lu/_api/metabolites/2099/?format=pcsv
CE2207,,,0,C27H42O5,,,"24-oxo-1alpha,23,25-trihydroxyvitamin D3",,"24-oxo-1alpha,23,25-trihydroxyvitamin D3",,,"InChI=1S/C27H42O5/c1-16(13-24(30)25(31)26(3,4)32)21-10-11-22-18(7-6-12-27(21,22)5)8-9-19-14-20(28)15-23(29)17(19)2/h8-9,16,20-24,28-30,32H,2,6-7,10-15H2,1,3-5H3/b18-8+,19-9-/t16-,20-,21-,22+,23+,24?,27-/m1/s1",,2016-11-22T15:12:19Z,,2100,,,,,10478755,,,,http://vmh.uni.lu/_api/metabolites/2100/?format=pcsv
C03968,,,-2,C3H6O6PR,,,1-alkyl-sn-glycerol 3-phosphate(1-),,1-alkyl-sn-glycerol 3-phosphate(1-),,,,,2016-11-22T15:12:19Z,,2101,,,,,,C03968,,,http://vmh.uni.lu/_api/metabolites/2101/?format=pcsv
CE4795,,,-4,C41H60N7O17P3S,,,"2-trans-cis,cis,cis,cis-4,8,11,14-eicosapentaenoyl-CoA",,"2-trans-cis,cis,cis,cis-4,8,11,14-eicosapentaenoyl-CoA",,,,,2016-11-22T15:12:19Z,,2102,,,,,,CE4795,,,http://vmh.uni.lu/_api/metabolites/2102/?format=pcsv
CE5114,,,-4,C41H62N7O17P3S,,,"trans-2-cis,cis,cis-8,11,14-eicosatetraenoyl-CoA",,"trans-2-cis,cis,cis-8,11,14-eicosatetraenoyl-CoA",,,,,2016-11-22T15:12:19Z,,2103,,,,,,CE5114,,,http://vmh.uni.lu/_api/metabolites/2103/?format=pcsv
CE4791,,,-4,C41H64N7O18P3S,,,3(S)-hydroxy-dihomo-gama-linolenoyl-CoA,,3(S)-hydroxy-dihomo-gama-linolenoyl-CoA,,,,,2016-11-22T15:12:19Z,,2104,,,,,,CE4791,,,http://vmh.uni.lu/_api/metabolites/2104/?format=pcsv
CE4793,,,-4,C41H62N7O18P3S,,,3-oxo-dihomo-gama-linolenoyl-CoA,,3-oxo-dihomo-gama-linolenoyl-CoA,,,,,2016-11-22T15:12:20Z,,2105,,,,,,CE4793,,,http://vmh.uni.lu/_api/metabolites/2105/?format=pcsv
CE2439,,,-4,C39H58N7O18P3S,,,"3-oxo-6Z,9Z,12Z-octadecatrienoyl-CoA",,"3-oxo-6Z,9Z,12Z-octadecatrienoyl-CoA",,,,,2016-11-22T15:12:20Z,,2106,,,,,,CE2439,,,http://vmh.uni.lu/_api/metabolites/2106/?format=pcsv
CE2440,,,-4,C37H56N7O17P3S,,,"4Z,7Z,10Z-hexadecatrienoyl-CoA",,"4Z,7Z,10Z-hexadecatrienoyl-CoA",,,,,2016-11-22T15:12:20Z,,2107,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2107/?format=pcsv
CE2437,,,-4,C39H58N7O17P3S,,,"2E,6Z,9Z,12Z-octadecatetraenoyl-CoA",,"2E,6Z,9Z,12Z-octadecatetraenoyl-CoA",,,,,2016-11-22T15:12:20Z,,2108,,,,,,CE2437,,,http://vmh.uni.lu/_api/metabolites/2108/?format=pcsv
CE2438,,,-4,C39H60N7O18P3S,,,"3(S)-hydroxy-6Z,9Z,12Z-octadecatrienoyl-CoA",,"3(S)-hydroxy-6Z,9Z,12Z-octadecatrienoyl-CoA",,,,,2016-11-22T15:12:20Z,,2109,,,,,,CE2438,,,http://vmh.uni.lu/_api/metabolites/2109/?format=pcsv
CE2442,,,-4,C37H56N7O17P3S,,,"3Z,7Z,10Z-hexadecatrienoyl-CoA",,"3Z,7Z,10Z-hexadecatrienoyl-CoA",,,,,2016-11-22T15:12:20Z,,2110,,,,,,CE2442,,,http://vmh.uni.lu/_api/metabolites/2110/?format=pcsv
CE2441,,,-4,C37H54N7O17P3S,,,"2E,4Z,7Z,10Z-hexadecatetraenoyl-CoA",,"2E,4Z,7Z,10Z-hexadecatetraenoyl-CoA",,,,,2016-11-22T15:12:20Z,,2111,,,,,,CE2441,,,http://vmh.uni.lu/_api/metabolites/2111/?format=pcsv
CE5115,,,-4,C41H60N7O17P3S,,,"trans-3-cis-5,8,11,14-eicosapentaenoyl-CoA",,"trans-3-cis-5,8,11,14-eicosapentaenoyl-CoA",,,,,2016-11-22T15:12:20Z,,2112,,,,,,CE5115,,,http://vmh.uni.lu/_api/metabolites/2112/?format=pcsv
CE5116,,,-4,C41H62N7O17P3S,,,"trans-3-cis-8,11,14-eicosatetraenoyl-CoA",,"trans-3-cis-8,11,14-eicosatetraenoyl-CoA",,,,,2016-11-22T15:12:20Z,,2113,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2113/?format=pcsv
CE5117,,,-4,C35H52N7O17P3S,,,"(3E,5Z,8Z)-tetradecatrienoyl-CoA",,"(3E,5Z,8Z)-tetradecatrienoyl-CoA",,,,,2016-11-22T15:12:20Z,,2114,,,,,53481421,CE5117,,,http://vmh.uni.lu/_api/metabolites/2114/?format=pcsv
CE5118,,,-4,C35H52N7O17P3S,,,"trans-2-cis,cis-4,8-tetradecatrienoyl-CoA",,"trans-2-cis,cis-4,8-tetradecatrienoyl-CoA",,,,,2016-11-22T15:12:20Z,,2115,,,,,,CE5118,,,http://vmh.uni.lu/_api/metabolites/2115/?format=pcsv
CE5119,,,-4,C35H54N7O17P3S,,,trans-3-cis-8-tetradecadienoyl-CoA,,trans-3-cis-8-tetradecadienoyl-CoA,,,,,2016-11-22T15:12:20Z,,2116,,,,,,CE5119,,,http://vmh.uni.lu/_api/metabolites/2116/?format=pcsv
CE5120,,,-4,C35H54N7O17P3S,,,trans-2-cis-8-tetradecadienoyl-CoA,,trans-2-cis-8-tetradecadienoyl-CoA,,,,,2016-11-22T15:12:20Z,,2117,,,,,,CE5120,,,http://vmh.uni.lu/_api/metabolites/2117/?format=pcsv
CE4790,,,-4,C35H56N7O18P3S,,,(3S)-3-hydroxy-cis-8-tetradecenoyl-CoA,,(3S)-3-hydroxy-cis-8-tetradecenoyl-CoA,,,,,2016-11-22T15:12:20Z,,2118,,,,,53481425,CE4790,,,http://vmh.uni.lu/_api/metabolites/2118/?format=pcsv
CE4792,,,-4,C35H54N7O18P3S,,,3-oxo-cis-8-tetradecenoyl-CoA,,3-oxo-cis-8-tetradecenoyl-CoA,,,,,2016-11-22T15:12:20Z,,2119,,,,,,CE4792,,,http://vmh.uni.lu/_api/metabolites/2119/?format=pcsv
CE4794,,,-4,C33H52N7O17P3S,,,cis-6-dodecenoyl-CoA,,cis-6-dodecenoyl-CoA,,,,,2016-11-22T15:12:20Z,,2120,,,,,,CE4794,,,http://vmh.uni.lu/_api/metabolites/2120/?format=pcsv
C04853,,,-1,C20H31O5,5280745,,"Human Metabolome Database (HMDB): 20-hydroxy- Leukotriene B4 (20-OH-LTB4) is an omega-hydroxylated metabolite of leukotriene B4 in human neutrophils. Elevated urinary concentrations of 20-OH-LTB4 and LTB4 are found in patients with Sjogren-Larsson syndrome (SLS, OMIM 270220), an autosomal recessively inherited neurocutaneous disorder caused by a deficiency of the microsomal enzyme fatty aldehyde dehydrogenase (FALDH), which as an essential role in LTB4 metabolism. Preterm birth seems to be one of the features of the syndrome. The reason for the preterm birth is unclear. It is hypothesized that it relates to the defective LTB4 degradation in SLS. The pathological urinary excretion of LTB4 and 20-OH-LTB4 is a biochemical marker for SLS. Surprisingly, 20-OH-LTB4 concentrations are normal in CSF. Leukotriene B4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. Other specific pathways of leukotriene metabolism include the 12-hydroxydehydrogenase/ 15-oxo-prostaglandin-13-reductase that form a series of conjugated diene metabolites that have been observed to be excreted into human urine. Metabolism of LTC4 occurs by sequential peptide cleavage reactions involving a gamma-glutamyl transpeptidase that forms LTD4 (leukotriene D4) and a membrane-bound dipeptidase that converts LTD4 into LTE4 (leukotriene E4) before w-oxidation. These metabolic transformations of the primary leukotrienes are critical for termination of their biological activity, and defects in expression of participating enzymes may be involved in specific genetic disease. (PMID: 12709426, 9799565, 11408337, 17623009). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,20-hydroxy-leukotriene B4(1-),,HMDB01509,"InChI=1S/C20H32O5/c21-17-10-6-2-1-3-7-12-18(22)13-8-4-5-9-14-19(23)15-11-16-20(24)25/h3-5,7-9,13-14,18-19,21-23H,1-2,6,10-12,15-17H2,(H,24,25)/p-1/b5-4+,7-3-,13-8+,14-9-/t18-,19-/m1/s1",C04853,2016-12-05T15:48:06Z,,2121,,,,,5280745,,,"(5S,12R)-5,12,20-Trihydroxy-(6Z,8E,10E,14Z)-eicosatetraenoate, (5S,12R)-5,12,20-Trihydroxy-(6Z,8E,10E,14Z)-eicosatetraenoic acid, (5S,6Z,8E,10E,12R,14Z)-5,12,20-trihydroxyicosa-6,8,10,14-tetraenoate, (5S,6Z,8E,10E,12R,14Z)-5,12,20-trihydroxyicosa-6,8,10,14-tetraenoic acid, (6Z,8E,10E,14Z)-(5S,12R)-5,12,20-Trihydroxyeicosa-6,8,10,14-tetraenoate, (6Z,8E,10E,14Z)-(5S,12R)-5,12,20-Trihydroxyeicosa-6,8,10,14-tetraenoic acid, (6Z,8E,10E,14Z)-(5S,12R)-5,12,20-Trihydroxyicosa-6,8,10,14-tetraenoate, (6Z,8E,10E,14Z)-(5S,12R)-5,12,20-Trihydroxyicosa-6,8,10,14-tetraenoic acid, 20-Hydroxy LTB4, 20-Hydroxy-leukotriene B4, 20-Hydroxy-LTB4, 20-Hydroxyleukotriene B4, 20-OH-5S,12S-dihydroxy-6,10-trans-8,14-cis-eicosatetraenoate, 20-OH-5S,12S-dihydroxy-6,10-trans-8,14-cis-eicosatetraenoic acid, 20-OH-Leukotriene B4, 20-OH-LTB4, 5,12,20-THETE, 5,12,20-TriHETE, 5S,12R,20-Trihydroxy-6Z,8E,10E,14Z-eicosatetraenoate, 5S,12R,20-Trihydroxy-6Z,8E,10E,14Z-eicosatetraenoic acid, Omega-Hydroxy-LTB4, w-Hydroxy-LTB4, [S-[R*,S*-(E,Z,E,Z)]]-5,12,20-trihydroxy-6,8,10,14-Eicosatetraenoate, [S-[R*,S*-(E,Z,E,Z)]]-5,12,20-trihydroxy-6,8,10,14-Eicosatetraenoic acid",http://vmh.uni.lu/_api/metabolites/2121/?format=pcsv
CE2053,,,-1,C20H29O5,,,20-oxo-leukotriene B4,,20-oxo-leukotriene B4,,,"InChI=1/C20H30O5/c21-17-10-6-2-1-3-7-12-18(22)13-8-4-5-9-14-19(23)15-11-16-20(24)25/h3-5,7-9,13-14,17-19,22-23H,1-2,6,10-12,15-16H2,(H,24,25)/p-1/b5-4+,7-3-,13-8+,14-9-/t18-,19-/m1/s1",,2016-11-22T15:12:20Z,,2122,,,,,3081088,CE2053,,,http://vmh.uni.lu/_api/metabolites/2122/?format=pcsv
CE2054,,,-2,C20H28O6,,,20-carboxy-leukotriene-B4,,20-carboxy-leukotriene-B4,,,"InChI=1/C20H30O6/c21-17(11-6-2-1-3-9-15-19(23)24)12-7-4-5-8-13-18(22)14-10-16-20(25)26/h2,4-8,12-13,17-18,21-22H,1,3,9-11,14-16H2,(H,23,24)(H,25,26)/p-2/b5-4+,6-2-,12-7+,13-8-/t17-,18-/m0/s1",,2016-11-16T10:44:57Z,,2123,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2123/?format=pcsv
CE2056,,,-1,C20H31O6,,,20-dihydroxyleukotriene B4,,20-dihydroxyleukotriene B4,,,,,2016-11-22T15:12:20Z,,2124,,,,,53481509,,,,http://vmh.uni.lu/_api/metabolites/2124/?format=pcsv
CE3554,,,-1,C20H31O7,,,20-trihydroxy-leukotriene-B4,,20-trihydroxy-leukotriene-B4,,,,,2016-11-22T15:12:20Z,,2125,,,,,53481513,,,,http://vmh.uni.lu/_api/metabolites/2125/?format=pcsv
CE5138,,,-1,C20H29O5,,,12-oxo-20-hydroxy-leukotriene B4,,12-oxo-20-hydroxy-leukotriene B4,,,"InChI=1/C20H30O5/c21-17-10-6-2-1-3-7-12-18(22)13-8-4-5-9-14-19(23)15-11-16-20(24)25/h3-5,7-9,13-14,19,21,23H,1-2,6,10-12,15-17H2,(H,24,25)/p-1/b5-4+,7-3-,13-8+,14-9-/t19-/m0/s1",,2016-11-22T15:12:20Z,,2126,,,,,53481459,CE5138,,,http://vmh.uni.lu/_api/metabolites/2126/?format=pcsv
CE5139,,,-1,C20H29O6,,,12-oxo-20-dihydroxy-leukotriene B4,,12-oxo-20-dihydroxy-leukotriene B4,,,,,2016-11-22T15:12:20Z,,2127,,,,,53481458,CE5139,,,http://vmh.uni.lu/_api/metabolites/2127/?format=pcsv
CE5140,,,-1,C20H29O7,,,12-oxo-20-trihydroxy-leukotriene B4,,12-oxo-20-trihydroxy-leukotriene B4,,,,,2016-11-22T15:12:20Z,,2128,,,,,53481460,CE5140,,,http://vmh.uni.lu/_api/metabolites/2128/?format=pcsv
CE5141,,,-1,C20H27O5,,,"12,20-dioxo-leukotriene B4",,"12,20-dioxo-leukotriene B4",,,"InChI=1/C20H28O5/c21-17-10-6-2-1-3-7-12-18(22)13-8-4-5-9-14-19(23)15-11-16-20(24)25/h3-5,7-9,13-14,17,19,23H,1-2,6,10-12,15-16H2,(H,24,25)/p-1/b5-4+,7-3-,13-8+,14-9-/t19-/m1/s1",,2016-11-22T15:12:20Z,,2129,,,,,,CE5141,,,http://vmh.uni.lu/_api/metabolites/2129/?format=pcsv
CE5525,,,-2,C20H26O6,,,12-oxo-20-carboxy-leukotriene B4,,12-oxo-20-carboxy-leukotriene B4,,,,,2016-11-22T15:12:20Z,,2130,,,,,53481457,CE5525,,,http://vmh.uni.lu/_api/metabolites/2130/?format=pcsv
CE2567,,,-1,C20H29O4,,,"5(S),6(S)-epoxy-15(S)-hydroxy-7E,9E,11Z,13E-eicosatetraenoic acid anion",,"5(S),6(S)-epoxy-15(S)-hydroxy-7E,9E,11Z,13E-eicosatetraenoic acid anion",,,"InChI=1/C20H30O4/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18-19(24-18)15-11-16-20(22)23/h4-7,9-10,13-14,17-19,21H,2-3,8,11-12,15-16H2,1H3,(H,22,23)/p-1/b6-4-,7-5+,13-9+,14-10+/t17-,18?,19-/m0/s1",,2016-11-22T15:12:20Z,,2131,,,,,,CE2567,,,http://vmh.uni.lu/_api/metabolites/2131/?format=pcsv
CE7172,,,-1,C20H31O4,,,"14,15-DiHETE",,"14,15-DiHETE",,,,,2016-11-22T15:12:20Z,,2132,,,,,188277,CE7172,,,http://vmh.uni.lu/_api/metabolites/2132/?format=pcsv
C06315,,,-1,C20H31O5,CHEBI:6499,,"Human Metabolome Database (HMDB): Lipoxins (LXs) and aspirin-triggered Lipoxin (ATL) are trihydroxytetraene-containing eicosanoids generated from arachidonic acid that are distinct in structure, formation, and function from the many other proinflammatory lipid-derived mediators. These endogenous eicosanoids have now emerged as founding members of the first class of lipid/chemical mediators involved in the resolution of the inflammatory response. Lipoxin A4 (LXA4), ATL, and their metabolic stable analogs elicit cellular responses and regulate leukocyte trafficking in vivo by activating the specific receptor, ALX. Many of the eicosanoids derived from arachidonic acid (AA2), including prostaglandins (PGs) and leukotrienes (LTs), play important roles as local mediators exerting a wide range of actions relevant in immune hypersensitivity and inflammation. However, recent observations indicate that other agents derived from the lipoxygenase (LO) pathways are formed and play a key role in initiating the resolution of acute inflammation. This phenomenon is an active process that is governed by specific lipid mediators and involves a series of well-orchestrated temporal events. Thus, potent locally released mediators serve as checkpoint controllers of inflammation. In addition to the well-appreciated ability of aspirin to inhibit PGs, aspirin also acetylates cyclooxygenase (COX)-2, triggering the formation of a 15-epimeric form of lipoxins, termed aspirin-triggered LXA4 (ATL). These eicosanoids (i.e., LXA4 and ATL) with a unique trihydroxytetraene structure function as 'stop signals' in inflammation and actively participate in dampening host responses to bring the inflammation to a close, namely, resolution. LXA4 and ATL elicit the multicellular responses via a specific G protein-coupled receptor (GPCR) termed ALX that has been identified in human. (PMID: 16968948, 11478982).",,Lipoxin B4,,HMDB05082,"InChI=1S/C20H32O5/c1-2-3-8-14-18(22)19(23)15-10-7-5-4-6-9-12-17(21)13-11-16-20(24)25/h4-7,9-10,12,15,17-19,21-23H,2-3,8,11,13-14,16H2,1H3,(H,24,25)/p-1/b6-4-,7-5+,12-9+,15-10+/t17-,18+,19-/m1/s1",C06315,2016-12-05T15:48:06Z,,2133,,,,,5280915,C06315,,"(5S,6E,8Z,10E,12E,14R,15S)-5,14,15-trihydroxyicosa-6,8,10,12-tetraenoate, (5S,6E,8Z,10E,12E,14R,15S)-5,14,15-trihydroxyicosa-6,8,10,12-tetraenoic acid, (6E,8Z,10E,12E)-(5S,14R,15S)-Trihydroxyicosa-6,8,10,12-tetraenoate, (6E,8Z,10E,12E)-(5S,14R,15S)-Trihydroxyicosa-6,8,10,12-tetraenoic acid, 15-Epi-lipoxin B4, 15-Epi-LXB(4), 5S,14R,15S-Trihydroxy-6E,8Z,10E,12E-Eicosatetraenoate, 5S,14R,15S-Trihydroxy-6E,8Z,10E,12E-Eicosatetraenoic acid, LXB4",http://vmh.uni.lu/_api/metabolites/2133/?format=pcsv
C01264,,,-2,C5H8O7PR,,,1-alkyl-2-acetyl-sn-glycerol 3-phosphate(2-),,1-alkyl-2-acetyl-sn-glycerol 3-phosphate(2-),,,,,2016-11-22T15:12:20Z,,2134,,,,,,C01264,,,http://vmh.uni.lu/_api/metabolites/2134/?format=pcsv
C06314,,,-1,C20H31O5,CHEBI:6498,,"Human Metabolome Database (HMDB): Lipoxin A4 (LXA4) was first identified in 1984 by Serhan and colleagues as 5-lipoxygenase interaction product of activated leukocytes. Endogenous transcellular biosynthesis of LXA4 occurs via interaction of leukocytes with epithelium, endothelium or platelets. Lipoxins (LXs) or the lipoxygenase interaction products are generated from arachidonic acid via sequential actions of lipoxygenases and subsequent reactions to give specific trihydroxytetraene-containing eicosanoids. These unique structures are formed during cell-cell interactions and appear to act at both temporal and spatially distinct sites from other eicosanoids produced during the course of inflammatory responses and to stimulate natural resolution. Lipoxin A4 (LXA4) and lipoxin B4 (LXB4) are positional isomers that each possesses potent cellular and in vivo actions. These LX structures are conserved across species. The results of numerous studies reviewed in this work now confirm that they are the first recognized eicosanoid chemical mediators that display both potent anti-inflammatory and pro-resolving actions in vivo in disease models that include rabbit, rat, and mouse systems. LXs act at specific GPCRs as agonists to regulate cellular responses of interest in inflammation and resolution. Aspirin has a direct impact in the LX circuit by triggering the biosynthesis of endogenous epimers of LX, termed the aspirin-triggered 15-epi-LX, that share the potent anti-inflammatory actions of LX. (PMID: 16005201, 16613568).",,Lipoxin A4,,HMDB04385,"InChI=1S/C20H32O5/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18(22)19(23)15-11-16-20(24)25/h4-7,9-10,13-14,17-19,21-23H,2-3,8,11-12,15-16H2,1H3,(H,24,25)/p-1/b6-4-,7-5+,13-9+,14-10+/t17-,18+,19-/m0/s1",C06314,2016-12-05T15:48:06Z,,2135,,,,,5280914,C06314,,"(7E,9E,11Z,13E)-(5S,6R,15S)-5,6,15-Trihydroxyicosa-7,9,11,13-tetraenoate, (7E,9E,11Z,13E)-(5S,6R,15S)-5,6,15-Trihydroxyicosa-7,9,11,13-tetraenoic acid, 5S,6R,15S-Trihydroxy-7E,9E,11Z,13E-eicosatetraenoate, 5S,6R,15S-Trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid, 5S,6R-LipoxinA4, 5S,6S-Lipoxin A4, LXA4",http://vmh.uni.lu/_api/metabolites/2135/?format=pcsv
C03820,,,0,C5H9O4R,CHEBI:16291,,1-Alkyl-2-acetyl-sn-glycerol,,1-Alkyl-2-acetyl-sn-glycerol,,,,,2016-11-22T15:12:20Z,,2136,,,,,,C03820,,,http://vmh.uni.lu/_api/metabolites/2136/?format=pcsv
cpppg1,,,-4,C36H40N4O8,CHEBI:28607,,Human Metabolome Database (HMDB): Formed by Uroporphyrinogen decarboxylase from Uroporphyrinogen I by decarboxylation of 4 acetates.,,Coproporphyrinogen I,,HMDB02158,"InChI=1S/C36H44N4O8/c1-17-21(5-9-33(41)42)29-14-26-19(3)23(7-11-35(45)46)31(39-26)16-28-20(4)24(8-12-36(47)48)32(40-28)15-27-18(2)22(6-10-34(43)44)30(38-27)13-25(17)37-29/h37-40H,5-16H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)/p-4",C05768,2016-12-05T15:48:06Z,,2137,,,,,440776,,,"3,8,13,18-Tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,17-tetrapropanoate, 3,8,13,18-Tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,17-tetrapropanoic acid",http://vmh.uni.lu/_api/metabolites/2137/?format=pcsv
C05769,,,-4,C36H34N4O8,CHEBI:28421,,"Human Metabolome Database (HMDB): Coproporphyrin I is a porphyrin metabolite arising from heme synthesis. Porphyrins are pigments found in both animal and plant life. Coproporphyrin I is a tetrapyrrole dead-end product from the spontaneous oxidation of the methylene bridges of coproporphynogen, arising from heme synthesis and secreted in feces and urine. Increased levels of coproporphyrins can indicate congenital erythropoietic porphyria or sideroblastic anaemia. Porphyria is a pathological state characterised by abnormalities of porphyrin metabolism and results in the excretion of large quantities of porphyrins in the urine and in extreme sensitivity to light. A large number of factors are capable of increasing porphyrin excretion, owing to different and multiple causes and etiologies: 1) the main site of the chronic hepatic porphyria disease process concentrates on the liver, 2) a functional and morphologic liver injury is almost regularly associated with this chronic porphyria, 3) the toxic form due to occupational and environmental exposure takes mainly a subclinical course. Hepatic factors includes disturbance in coproporphyrinogen metabolism, which results from inhibition of coproporphyrinogen oxidase as well as from the rapid loss from, and diminished utilization of coproporphyrinogen in the hepatocytes, which may also explain why coproporphyrin, its autoxidation product, predominates physiologically in the urine; decreased biliary excretion of coproporphyrin leading to a compensatory urinary excretion, so that the coproporphyrin ring isomer ratio (1:III) becomes a sensitive index for impaired liver function and intrahepatic cholestasis; and disturbed activity of hepatic uroporphyrinogen decarboxylase. In itself, secondary coproporphyrinuria is not associated with porphyria symptoms of a hepatologic-gastroenterologic, neurologic, or dermatologic order, even though coproporphyrinuria can occur with such symptoms. (PMID: 3327428).",,Coproporphyrin I,,HMDB00643,"InChI=1S/C36H38N4O8/c1-17-21(5-9-33(41)42)29-14-26-19(3)23(7-11-35(45)46)31(39-26)16-28-20(4)24(8-12-36(47)48)32(40-28)15-27-18(2)22(6-10-34(43)44)30(38-27)13-25(17)37-29/h13-16,37,40H,5-12H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)/b25-13-,26-14-,27-15-,28-16-,29-14-,30-13-,31-16-,32-15-",C05769,2016-12-05T15:48:06Z,,2138,,,,,,,,"3,8,13,18-Tetramethyl-2,7,12,17-Porphinetetrapropionate, 3,8,13,18-Tetramethyl-2,7,12,17-Porphinetetrapropionic acid, 3,8,13,18-Tetramethyl-21H,23H-porphine-2,7,12,17-tetrapropionate, 3,8,13,18-Tetramethyl-21H,23H-porphine-2,7,12,17-tetrapropionic acid",http://vmh.uni.lu/_api/metabolites/2138/?format=pcsv
C05770,,,-4,C36H34N4O8,CHEBI:27609,,"Human Metabolome Database (HMDB): Coproporphyrin III is a porphyrin metabolite arising from heme synthesis. Porphyrins are pigments found in both animal and plant life. Coproporphyrin III is a tetrapyrrole dead-end product from the spontaneous oxidation of the methylene bridges of coproporphynogen, arising from heme synthesis and secreted in feces and urine. Increased levels of coproporphyrins can indicate congenital erythropoietic porphyria or sideroblastic anaemia. Porphyria is a pathological state characterised by abnormalities of porphyrin metabolism and results in the excretion of large quantities of porphyrins in the urine and in extreme sensitivity to light. A large number of factors are capable of increasing porphyrin excretion, owing to different and multiple causes and etiologies: 1) the main site of the chronic hepatic porphyria disease process concentrates on the liver, 2) a functional and morphologic liver injury is almost regularly associated with this chronic porphyria, 3) the toxic form due to occupational and environmental exposure takes mainly a subclinical course. Hepatic factors includes disturbance in coproporphyrinogen metabolism, which results from inhibition of coproporphyrinogen oxidase as well as from the rapid loss from, and diminished utilization of coproporphyrinogen in the hepatocytes, which may also explain why coproporphyrin, its autoxidation product, predominates physiologically in the urine; decreased biliary excretion of coproporphyrin leading to a compensatory urinary excretion, so that the coproporphyrin ring isomer ratio (1:III) becomes a sensitive index for impaired liver function and intrahepatic cholestasis; and disturbed activity of hepatic uroporphyrinogen decarboxylase. In itself, secondary coproporphyrinuria is not associated with porphyria symptoms of a hepatologic-gastroenterologic, neurologic, or dermatologic order, even though coproporphyrinuria can occur with such symptoms. (PMID: 3327428).",,Coproporphyrin III,,HMDB00570,"InChI=1S/C36H38N4O8/c1-17-21(5-9-33(41)42)29-14-27-19(3)22(6-10-34(43)44)30(39-27)15-28-20(4)24(8-12-36(47)48)32(40-28)16-31-23(7-11-35(45)46)18(2)26(38-31)13-25(17)37-29/h13-16,37,40H,5-12H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-",C05770,2016-12-05T15:48:06Z,,2139,,,,,,C05770,,,http://vmh.uni.lu/_api/metabolites/2139/?format=pcsv
C02469,,,-8,C40H30N4O16,CHEBI:15436,,"Human Metabolome Database (HMDB): Uroporphyrin is the porphyrin produced by oxidation of the methylene bridges in uroporphyrinogen. They have four acetic acid and four propionic acid side chains attached to the pyrrole rings. Uroporphyrinogen I and III are formed from polypyrryl methane in the presence of uroporphyrinogen III cosynthetase and uroporphyrin I synthetase, respectively. They can yield uroporphyrins by autooxidation or coproporphyrinogens by decarboxylation. Excessive amounts of uroporphyrin I are excreted in congenital erythropoietic porphyria, and both types I and III are excreted in porphyria cutanea tarda. Uroporphyrin I and III are the most common isomers.",,Uroporphyrin III,,HMDB00916,"InChI=1S/C40H38N4O16/c45-33(46)5-1-17-21(9-37(53)54)29-14-27-19(3-7-35(49)50)22(10-38(55)56)30(43-27)15-28-20(4-8-36(51)52)24(12-40(59)60)32(44-28)16-31-23(11-39(57)58)18(2-6-34(47)48)26(42-31)13-25(17)41-29/h13-16,41,44H,1-12H2,(H,45,46)(H,47,48)(H,49,50)(H,51,52)(H,53,54)(H,55,56)(H,57,58)(H,59,60)/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-",C02469,2016-12-05T15:48:06Z,,2140,,,,,,C02469,,"3,8,13,17-Tetrakis(carboxymethyl)porphyrin-2,7,12,18-tetrapropanoate, 3,8,13,17-Tetrakis(carboxymethyl)porphyrin-2,7,12,18-tetrapropanoic acid, 3,8,13,17-Tetramethyl-2,7,12,18-Porphinetetrapropionate, 3,8,13,17-Tetramethyl-2,7,12,18-Porphinetetrapropionic acid, Coproporphyrin III, Uroporphyrin III",http://vmh.uni.lu/_api/metabolites/2140/?format=pcsv
CE5122,,,-4,C41H70N7O17P3S,CHEBI:15538,,3(S)-phytanoyl-CoA,,3(S)-phytanoyl-CoA,,,,,2016-11-22T15:12:20Z,,2141,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2141/?format=pcsv
CE5123,,,-4,C41H70N7O18P3S,,,3(S)-2-hydroxyphytanoyl-CoA,,3(S)-2-hydroxyphytanoyl-CoA,,,,C07343,2016-11-22T15:12:20Z,,2142,,,,,441263,,,,http://vmh.uni.lu/_api/metabolites/2142/?format=pcsv
CE2416,,,-1,C19H37O2,,,"(2R,6S,10S)-pristanate",,"(2R,6S,10S)-pristanate",,,,,2016-11-22T15:12:20Z,,2143,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2143/?format=pcsv
CE2414,,,-1,C20H39O2,CHEBI:16285,,"Human Metabolome Database (HMDB): Phytanic acid is a 20-carbon branched chain fatty acid, Phytanic acid is present in animal (primarily herbivores or omnivores) tissues where it may be derived from the chlorophyll in consumed plant material. Phytanic acid derives from the corresponding alcohol, phytol, and is ultimately oxidized into pristanic acid. In phytanic acid storage disease (Refsum disease) this lipid may comprise as much as 30% of the total fatty acids in plasma. These high levels in Refsum disease (a neurological disorder) are due to a phytanic acid alpha-hydroxylase deficiency.",,"(3S,7R,11R)-phytanate",,HMDB00801,,,2016-12-05T15:48:06Z,,2144,,,,,,,,"3,7,11,15-Tetramethyl-hexadecanoate, 3,7,11,15-Tetramethyl-hexadecanoic acid, 3,7,11,15-Tetramethyl-hexadecansaeure, 3,7,11,15-Tetramethylhexadecanoate, 3,7,11,15-Tetramethylhexadecanoic acid, 3,7,11,15-Tetramethylhexadecoanoate, 3,7,11,15-Tetramethylhexadecoanoic acid, Phytanate, Phytanoate, Phytanoic acid",http://vmh.uni.lu/_api/metabolites/2144/?format=pcsv
CE0932,,,-1,C19H37O2,20849056,,pristanate,,pristanate,,,,,2016-11-16T10:44:57Z,,2145,,,,,20849056,,,,http://vmh.uni.lu/_api/metabolites/2145/?format=pcsv
CE2038,,,-4,C40H66N7O17P3S,,,"trans-2,3-dehydropristanoyl-CoA",,"trans-2,3-dehydropristanoyl-CoA",,,,,2016-11-22T15:12:20Z,,2146,,,,,56927963,,,,http://vmh.uni.lu/_api/metabolites/2146/?format=pcsv
CE5934,,,-4,C40H68N7O18P3S,,,3(R)-hydroxy-pristanoyl-CoA,,3(R)-hydroxy-pristanoyl-CoA,,,,,2016-11-22T15:12:20Z,,2147,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2147/?format=pcsv
C07297,,,-4,C40H66N7O18P3S,CHEBI:15371,,"Human Metabolome Database (HMDB): (R) Pristanoyl-CoA is converted by alpha-methylacyl-CoA racemase (E.C. 5.1.99.4) (S) pristanoyl-CoA, which is then degraded via peroxisomal beta-oxidation. Deficiency in this enzyme results in neuropathy, hypogonadism of adult onset; and in infant, defective bile acid synthesis has been observed. Pristanoyl-CoA is the substrate of propionyl-CoA C(2)-trimethyltridecanoyltransferase (E.C.2.3.1.154). It is the substrate of peroxisomal pristanoyl-CoA oxidase (E.C.1.3.3.6). A genetic disorder called Zellweger syndrome (OMIM: 214100), also known as neonatal adrenoleukodystrophy, NALD) is the result of a lack of pristanoyl-CoA oxidase, and the subsequent accumulation of phytanic acid and pristanic acid.",,3-oxopristanoyl-CoA(4-),,HMDB02057,"InChI=1S/C40H70N7O18P3S/c1-24(2)10-8-11-25(3)12-9-13-26(4)14-15-28(48)27(5)39(53)69-19-18-42-30(49)16-17-43-37(52)34(51)40(6,7)21-62-68(59,60)65-67(57,58)61-20-29-33(64-66(54,55)56)32(50)38(63-29)47-23-46-31-35(41)44-22-45-36(31)47/h22-27,29,32-34,38,50-51H,8-21H2,1-7H3,(H,42,49)(H,43,52)(H,57,58)(H,59,60)(H2,41,44,45)(H2,54,55,56)/p-4/t25?,26?,27?,29-,32-,33-,34+,38-/m1/s1",C07297,2016-12-05T15:48:06Z,,2148,,,,,441253,,,"3-Oxopristanoyl-CoA, 3-Oxopristanoyl-Coenzyme A, Pristanoyl CoA, Pristanoyl Coenzyme A",http://vmh.uni.lu/_api/metabolites/2148/?format=pcsv
CE5935,,,-4,C35H58N7O17P3S,,,"(2S,6R,10R)-trimethyl-hendecanoyl-CoA",,"(2S,6R,10R)-trimethyl-hendecanoyl-CoA",,,,,2016-11-22T15:12:20Z,,2149,,,,,53481419,CE5935,,,http://vmh.uni.lu/_api/metabolites/2149/?format=pcsv
CE5936,,,-4,C35H58N7O17P3S,,,"(2R,6R,10R)-trimethyl-hendecanoyl-CoA",,"(2R,6R,10R)-trimethyl-hendecanoyl-CoA",,,,,2016-11-22T15:12:20Z,,2150,,,,,,CE5936,,,http://vmh.uni.lu/_api/metabolites/2150/?format=pcsv
C07296,,,-4,C37H62N7O17P3S,11966114,,"4,8,12-trimethyltridecanoyl-CoA(4-)",,"4,8,12-trimethyltridecanoyl-CoA(4-)",,,"InChI=1S/C37H66N7O17P3S/c1-23(2)9-7-10-24(3)11-8-12-25(4)13-14-28(46)65-18-17-39-27(45)15-16-40-35(49)32(48)37(5,6)20-58-64(55,56)61-63(53,54)57-19-26-31(60-62(50,51)52)30(47)36(59-26)44-22-43-29-33(38)41-21-42-34(29)44/h21-26,30-32,36,47-48H,7-20H2,1-6H3,(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,38,41,42)(H2,50,51,52)/p-4/t24?,25?,26-,30-,31-,32+,36-/m1/s1",,2016-11-16T10:44:57Z,,2151,,,,,11966114,,,,http://vmh.uni.lu/_api/metabolites/2151/?format=pcsv
CE5938,,,-4,C37H60N7O17P3S,,,"(4R,8R,12R)-trimethyl-2E-tridecenoyl-CoA",,"(4R,8R,12R)-trimethyl-2E-tridecenoyl-CoA",,,"InChI=1/C37H64N7O17P3S/c1-23(2)9-7-10-24(3)11-8-12-25(4)13-14-28(46)65-18-17-39-27(45)15-16-40-35(49)32(48)37(5,6)20-58-64(55,56)61-63(53,54)57-19-26-31(60-62(50,51)52)30(47)36(59-26)44-22-43-29-33(38)41-21-42-34(29)44/h13-14,21-26,30-32,36,47-48H,7-12,15-20H2,1-6H3,(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,38,41,42)(H2,50,51,52)/p-4/b14-13+/t24-,25-,26-,30+,31+,32u,36-/m0/s1",,2016-11-22T15:12:20Z,,2152,,,,,53481434,CE5938,,,http://vmh.uni.lu/_api/metabolites/2152/?format=pcsv
CE5940,,,-4,C37H62N7O18P3S,,,"3(R)-hydroxy-(4R,8R,12R)-trimethyl-tridecanoyl-CoA",,"3(R)-hydroxy-(4R,8R,12R)-trimethyl-tridecanoyl-CoA",,,,,2016-11-22T15:12:20Z,,2153,,,,,,CE5940,,,http://vmh.uni.lu/_api/metabolites/2153/?format=pcsv
CE5939,,,-4,C37H60N7O18P3S,,,"3-oxo-(4R,8R,12R)-trimethyl-tridecanoyl-CoA",,"3-oxo-(4R,8R,12R)-trimethyl-tridecanoyl-CoA",,,,,2016-11-22T15:12:20Z,,2154,,,,,,CE5939,,,http://vmh.uni.lu/_api/metabolites/2154/?format=pcsv
CE5941,,,-4,C35H56N7O17P3S,,,"(2S,6R,10R)-trimethyl-2E-hendecenoyl-CoA",,"(2S,6R,10R)-trimethyl-2E-hendecenoyl-CoA",,,,,2016-11-22T15:12:20Z,,2155,,,,,53481417,CE5941,,,http://vmh.uni.lu/_api/metabolites/2155/?format=pcsv
CE5942,,,-4,C35H56N7O18P3S,,,"3-oxo-(2S,6R,10R)-trimethyl-hendecanoyl-CoA",,"3-oxo-(2S,6R,10R)-trimethyl-hendecanoyl-CoA",,,,,2016-11-22T15:12:20Z,,2156,,,,,,CE5942,,,http://vmh.uni.lu/_api/metabolites/2156/?format=pcsv
CE4805,,,-4,C32H52N7O17P3S,,,"4(R),8-dimethyl-nonanoyl-CoA",,"4(R),8-dimethyl-nonanoyl-CoA",,,,,2016-11-22T15:12:20Z,,2157,,,,,,CE4805,,,http://vmh.uni.lu/_api/metabolites/2157/?format=pcsv
CE5943,,,-4,C35H58N7O18P3S,,,"3(R)-hydroxy-(2S,6R,10)-trimethyl-hendecanoyl-CoA",,"3(R)-hydroxy-(2S,6R,10)-trimethyl-hendecanoyl-CoA",,,,,2016-11-22T15:12:20Z,,2158,,,,,,CE5943,,,http://vmh.uni.lu/_api/metabolites/2158/?format=pcsv
CE4812,,,-4,C41H60N7O17P3S,,,"eicosa-2E,8Z,11Z,14Z,17Z-pentaenoyl-CoA",,"eicosa-2E,8Z,11Z,14Z,17Z-pentaenoyl-CoA",,,,,2016-11-22T15:12:20Z,,2159,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2159/?format=pcsv
CE4814,,,-4,C41H62N7O17P3S,,,"(8Z,11Z,14Z,17Z)-eicosatetraenoyl-CoA",,"(8Z,11Z,14Z,17Z)-eicosatetraenoyl-CoA",,,,,2016-11-16T10:44:57Z,,2160,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2160/?format=pcsv
CE2209,,,0,C19H32O2,CHEBI:36713,,"Human Metabolome Database (HMDB): Dihydroandrosterone is a major metabolite of testosterone. Dihydroandrosterone is the main steroid produced by the immature ovary; at puberty the synthesis of steroids shifts toward 4-ene-3-oxo steroids. testosterone 5a-reduced metabolites, including dihydrotestosterone are produced in the anterior pituitary and the central nervous system. Anabolic androgen steroid (AAS) are one of primary performance-enhancing substances abused by athletes. To defeat doping controls, athletes changed to take endogenous androgens from the application of synthetic AAS. testosterone was one candidate of endogenous androgens abused in sports. testosterone and its relevant steroids in urine is detected and monitored with GC/MS. The abuse of anabolic-androgenic steroids (AS) is a growing problem; however, the effects and mechanisms underlying their addictive effects are not well understood. (PMID: 17112575, 6243214, 491593, 491592).",,"5alpha-androstane-3alpha,17beta-diol",,HMDB00554,"InChI=1S/C19H32O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-17,20-21H,3-11H2,1-2H3/t12-,13+,14-,15-,16-,17-,18-,19-/m0/s1",,2016-12-05T15:48:06Z,,2161,,,,,15818,CE2209,," Adiol,  Etiocholane-3a,17b-diol, 3a,17b-Dihydroxy-5a-androstane, 3a,5a-Tetrahydrotestosterone, 3alpha,17beta-Dihydroxy-5alpha-androstane, 5a-Androstane-3a,17b-diol, 5alpha-Androstane-3alpha,17beta-androstanediol, 5alpha-Androstane-3alpha,17beta-diol, Androstane-3a,17b-diol, Etiocholane-3alpha,17beta-diol, Hombreol",http://vmh.uni.lu/_api/metabolites/2161/?format=pcsv
CE4815,,,-4,C39H58N7O17P3S,56928001,,"Human Metabolome Database (HMDB): Stearidonyl CoA or (6Z,9Z,12Z,15Z)-Octadecatetraenoyl-CoA is an intermediate in the biosynthesis of unsaturated fatty acids. (6Z,9Z,12Z,15Z)-Octadecatetraenoyl-CoA is generated from (9Z,12Z,15Z)-Octadecatrienoyl-CoA via the enzyme fatty acid desaturase 2(EC 1.14.19.-).",,stearidonoyl-CoA,,HMDB06519,,C16163,2016-12-05T15:48:06Z,,2162,,,,,56928001,,,"(6Z,9Z,12Z,15Z)-Octadecatetraenoyl-CoA, (6Z,9Z,12Z,15Z)-Octadecatetraenoyl-Coenzyme A, Stearidonoyl coenzyme A, Stearidonoyl-CoA, Stearidonoyl-Coenzyme A, Stearidonyl coenzyme A",http://vmh.uni.lu/_api/metabolites/2162/?format=pcsv
CE4811,,,-4,C41H60N7O18P3S,,,"3-keto-eicosa-8,11,14,17-all-cis-tetraenoyl-CoA",,"3-keto-eicosa-8,11,14,17-all-cis-tetraenoyl-CoA",,,,,2016-11-22T15:12:20Z,,2163,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2163/?format=pcsv
C04295,,,0,C19H30O2,CHEBI:2710,,"Human Metabolome Database (HMDB): 5-Androstenediol is a direct metabolite of the most abundant steroid produced by the human adrenal cortex, dehydroepiandrosterone (DHEA). 5-Androstenediol is less androgenic than 4-androstenediol, and stimulates the immune system. When administered to rats in vivo, 5-androstenediol has approximately 1/70 the androgenicity of DHEA, 1/185 the androgenicity of androstenedione, and 1/475 the androgenicity of testosterone (Wikipedia). Because it induces production of white blood cells and platelets, 5-androstenediol is being developed as a radiation countermeasure as Neumune (HE2100). An intermediate in testosterone biosynthesis, found in the testis or the adrenal glands. 5-Androstenediol, derived from dehydroepiandrosterone by the reduction of the 17-keto group (17-hydroxysteroid dehydrogenases), is converted to testosterone by the oxidation of the 3-beta hydroxyl group to a 3-keto group (3-fydroxysteroid dehydrogenase).",,"Androst-5-ene-3beta,17beta-diol",,HMDB03818,"InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-17,20-21H,4-11H2,1-2H3/t13-,14-,15-,16-,17-,18-,19-/m0/s1",C04295,2016-12-05T15:48:06Z,,2164,,,,,10634,C04295,,"3beta,17beta-Dihydroxy-5-androstene, 3beta,17beta-Dihydroxyandrost-5-ene, 5-Androstenediol, Androst-5-ene-3,17-diol, Androst-5-ene-3b,17b-diol, Androst-5-ene-3beta,17beta-diol, Androst-5-enediol, Androstenediol, b,17b-Diol, delta(Sup 5)-Androstenediol, delta-5-Androstenediol, Delta5-Androstenediol, Hermaphrodiol, Tetrabol",http://vmh.uni.lu/_api/metabolites/2164/?format=pcsv
CE4810,,,-4,C41H62N7O18P3S,,,"3(S)-hydroxy-all-cis-8,11,14,17-eicosatetraenoyl-CoA",,"3(S)-hydroxy-all-cis-8,11,14,17-eicosatetraenoyl-CoA",,,,,2016-11-22T15:12:20Z,,2165,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2165/?format=pcsv
CE4821,,,-4,C43H62N7O17P3S,,,"2-trans-7,10,13,16,19-all-cis-docosahexaenoyl-CoA",,"2-trans-7,10,13,16,19-all-cis-docosahexaenoyl-CoA",,,"InChI=1/C43H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-34(52)71-27-26-45-33(51)24-25-46-41(55)38(54)43(2,3)29-64-70(61,62)67-69(59,60)63-28-32-37(66-68(56,57)58)36(53)42(65-32)50-31-49-35-39(44)47-30-48-40(35)50/h5-6,8-9,11-12,14-15,17-18,22-23,30-32,36-38,42,53-54H,4,7,10,13,16,19-21,24-29H2,1-3H3,(H,45,51)(H,46,55)(H,59,60)(H,61,62)(H2,44,47,48)(H2,56,57,58)/p-4/b6-5-,9-8-,12-11-,15-14-,18-17-,23-22+/t32-,36+,37+,38u,42-/m0/s1",,2016-11-22T15:12:20Z,,2166,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2166/?format=pcsv
CE4822,,,-4,C43H64N7O17P3S,53477812,,"docosa-7,10,13,16,19-all-cis-pentaenoyl-CoA",,"docosa-7,10,13,16,19-all-cis-pentaenoyl-CoA",,HMDB06267,"InChI=1/C43H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-34(52)71-27-26-45-33(51)24-25-46-41(55)38(54)43(2,3)29-64-70(61,62)67-69(59,60)63-28-32-37(66-68(56,57)58)36(53)42(65-32)50-31-49-35-39(44)47-30-48-40(35)50/h5-6,8-9,11-12,14-15,17-18,30-32,36-38,42,53-54H,4,7,10,13,16,19-29H2,1-3H3,(H,45,51)(H,46,55)(H,59,60)(H,61,62)(H2,44,47,48)(H2,56,57,58)/p-4/b6-5-,9-8-,12-11-,15-14-,18-17-/t32-,36+,37+,38?,42-/m0/s1",,2016-11-22T16:06:40Z,,2167,,,,,53477812,,,"7,10,13,16,19-All-cis-docosapentaenoyl-CoA, 7,10,13,16,19-All-cis-docosapentaenoyl-Coenzyme A, 7Z,10Z,13Z,16Z,19Z-Docosapentaenoyl-CoA, 7Z,10Z,13Z,16Z,19Z-Docosapentaenoyl-Coenzyme A, All-cis-7,10,13,16,19-docosapentaenoyl-CoA, All-cis-7,10,13,16,19-docosapentaenoyl-Coenzyme A, cis-7,10,13,16,19-Docosapentanenoyl CoA, cis-7,10,13,16,19-Docosapentanenoyl Coenzyme A, Docosa-7,10,13,16,19-all-cis-pentaenoyl-CoA, Docosa-7,10,13,16,19-all-cis-pentaenoyl-Coenzyme A, DPA (20:5w-3) CoA, DPA (20:5w-3) Coenzyme A",http://vmh.uni.lu/_api/metabolites/2167/?format=pcsv
CE4813,,,-4,C41H60N7O17P3S,,,"eicosa-5,8,11,14,17-all-cis-pentaenoyl-CoA",,"eicosa-5,8,11,14,17-all-cis-pentaenoyl-CoA",,,"InChI=1/C41H64N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-32(50)69-25-24-43-31(49)22-23-44-39(53)36(52)41(2,3)27-62-68(59,60)65-67(57,58)61-26-30-35(64-66(54,55)56)34(51)40(63-30)48-29-47-33-37(42)45-28-46-38(33)48/h5-6,8-9,11-12,14-15,17-18,28-30,34-36,40,51-52H,4,7,10,13,16,19-27H2,1-3H3,(H,43,49)(H,44,53)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/p-4/b6-5-,9-8-,12-11-,15-14-,18-17-/t30-,34+,35+,36u,40-/m0/s1",,2016-11-16T10:44:57Z,,2168,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2168/?format=pcsv
CE4819,,,-4,C43H62N7O18P3S,,,"3-oxo-docosa-7,10,13,16,19-all-cis-pentaenoyl-CoA",,"3-oxo-docosa-7,10,13,16,19-all-cis-pentaenoyl-CoA",,,"InChI=1/C43H66N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-31(51)26-34(53)72-25-24-45-33(52)22-23-46-41(56)38(55)43(2,3)28-65-71(62,63)68-70(60,61)64-27-32-37(67-69(57,58)59)36(54)42(66-32)50-30-49-35-39(44)47-29-48-40(35)50/h5-6,8-9,11-12,14-15,17-18,29-30,32,36-38,42,54-55H,4,7,10,13,16,19-28H2,1-3H3,(H,45,52)(H,46,56)(H,60,61)(H,62,63)(H2,44,47,48)(H2,57,58,59)/p-4/b6-5-,9-8-,12-11-,15-14-,18-17-/t32-,36+,37+,38u,42-/m0/s1",,2016-11-22T15:12:20Z,,2169,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2169/?format=pcsv
CE4817,,,-4,C43H64N7O18P3S,,,"3(S)-hydroxy-docosa-7,10,13,16,19-all-cis-pentaenoyl-CoA",,"3(S)-hydroxy-docosa-7,10,13,16,19-all-cis-pentaenoyl-CoA",,,"InChI=1/C43H68N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-31(51)26-34(53)72-25-24-45-33(52)22-23-46-41(56)38(55)43(2,3)28-65-71(62,63)68-70(60,61)64-27-32-37(67-69(57,58)59)36(54)42(66-32)50-30-49-35-39(44)47-29-48-40(35)50/h5-6,8-9,11-12,14-15,17-18,29-32,36-38,42,51,54-55H,4,7,10,13,16,19-28H2,1-3H3,(H,45,52)(H,46,56)(H,60,61)(H,62,63)(H2,44,47,48)(H2,57,58,59)/p-4/b6-5-,9-8-,12-11-,15-14-,18-17-/t31-,32-,36+,37+,38u,42-/m0/s1",,2016-11-22T15:12:20Z,,2170,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2170/?format=pcsv
CE4816,,,-4,C45H66N7O17P3S,,,"2-trans-9,12,15,18,21-all-cis-tetracosahexaenoyl-CoA",,"2-trans-9,12,15,18,21-all-cis-tetracosahexaenoyl-CoA",,,"InChI=1/C45H70N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h5-6,8-9,11-12,14-15,17-18,24-25,32-34,38-40,44,55-56H,4,7,10,13,16,19-23,26-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/p-4/b6-5-,9-8-,12-11-,15-14-,18-17-,25-24+/t34-,38+,39+,40u,44-/m0/s1",,2016-11-22T15:12:20Z,,2171,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2171/?format=pcsv
CE4824,,,-4,C45H68N7O17P3S,CHEBI:63543,,"tetracosa-9,12,15,18,21-all-cis-pentaenoyl-CoA",,"tetracosa-9,12,15,18,21-all-cis-pentaenoyl-CoA",,,"InChI=1/C45H72N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h5-6,8-9,11-12,14-15,17-18,32-34,38-40,44,55-56H,4,7,10,13,16,19-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/p-4/b6-5-,9-8-,12-11-,15-14-,18-17-/t34-,38+,39+,40u,44-/m0/s1",,2016-11-22T15:12:20Z,,2172,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2172/?format=pcsv
CE4820,,,-4,C45H66N7O18P3S,,,"3-oxo-all-cis-6,9,12,15,18-tetracosapentaenoyl-CoA",,"3-oxo-all-cis-6,9,12,15,18-tetracosapentaenoyl-CoA",,,"InChI=1/C45H70N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-33(53)28-36(55)74-27-26-47-35(54)24-25-48-43(58)40(57)45(2,3)30-67-73(64,65)70-72(62,63)66-29-34-39(69-71(59,60)61)38(56)44(68-34)52-32-51-37-41(46)49-31-50-42(37)52/h5-6,8-9,11-12,14-15,17-18,31-32,34,38-40,44,56-57H,4,7,10,13,16,19-30H2,1-3H3,(H,47,54)(H,48,58)(H,62,63)(H,64,65)(H2,46,49,50)(H2,59,60,61)/p-4/b6-5-,9-8-,12-11-,15-14-,18-17-/t34-,38+,39+,40u,44-/m0/s1",,2016-11-22T15:12:20Z,,2173,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2173/?format=pcsv
CE4818,,,-4,C45H68N7O18P3S,,,"3(S)-hydroxy-tetracosa-9,12,15,18,21-all-cis-pentaenoyl-CoA",,"3(S)-hydroxy-tetracosa-9,12,15,18,21-all-cis-pentaenoyl-CoA",,,"InChI=1/C45H72N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-33(53)28-36(55)74-27-26-47-35(54)24-25-48-43(58)40(57)45(2,3)30-67-73(64,65)70-72(62,63)66-29-34-39(69-71(59,60)61)38(56)44(68-34)52-32-51-37-41(46)49-31-50-42(37)52/h5-6,8-9,11-12,14-15,17-18,31-34,38-40,44,53,56-57H,4,7,10,13,16,19-30H2,1-3H3,(H,47,54)(H,48,58)(H,62,63)(H,64,65)(H2,46,49,50)(H2,59,60,61)/p-4/b6-5-,9-8-,12-11-,15-14-,18-17-/t33-,34-,38+,39+,40u,44-/m0/s1",,2016-11-22T15:12:20Z,,2174,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2174/?format=pcsv
CE2540,,,-1,C20H29O2,3209,,"Human Metabolome Database (HMDB): Eicosapentaenoic acid (EPA or also icosapentaenoic acid) is an important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families. Eicosapentaenoic acid is an omega-3 fatty acid. In physiological literature, it is given the name 20:5(n-3). Its systematic chemical name is all-cis-5,8,11,14,17-icosapentaenoic acid. It also has the trivial name timnodonic acid. Chemically, EPA is a carboxylic acid with a 20-carbon chain and five cis double bonds; the first double bond is located at the third carbon from the omega end. Because of the presence of double bonds, EPS is a polyunsaturated fatty acid. Metabolically it acts as a precursor for prostaglandin-3 (which inhibits platelet aggregation), thromboxane-3 and leukotriene-5 groups. It is found in fish oils of cod liver, herring, mackerel, salmon, menhaden and sardine. It is also found in human breast milk. -- Wikipedia.",,timnodonate,,HMDB01999,,C06428,2016-12-05T15:48:06Z,,2175,,,,,3209,,,"(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate, (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid, 5,8,11,14,17-Eicosapentaenoate, 5,8,11,14,17-Eicosapentaenoic acid, 5,8,11,14,17-Icosapentaenoate, 5,8,11,14,17-Icosapentaenoic acid, 5Z,8Z,11Z,14Z,17Z-Eicosapentaenoate, 5Z,8Z,11Z,14Z,17Z-Eicosapentaenoic acid, All-cis-icosapentaenoate, All-cis-icosapentaenoic acid, cis-5,8,11,14,17-Eicosapentaenoate, cis-5,8,11,14,17-Eicosapentaenoic acid, Eicosapentaenoate, Eicosapentaenoic acid, EPA, Icosapent, Icosapentaenoate, Icosapentaenoic acid, Icosapento, Icosapentum, Timnodonate, Timnodonic acid",http://vmh.uni.lu/_api/metabolites/2175/?format=pcsv
CE2313,,,0,C29H48O,,,"4,4-dimethylcholesta-8(9),14-dien-3beta-ol",,"4,4-dimethylcholesta-8(9),14-dien-3beta-ol",,,"InChI=1/C29H48O/c1-19(2)9-8-10-20(3)22-12-13-23-21-11-14-25-27(4,5)26(30)16-18-29(25,7)24(21)15-17-28(22,23)6/h13,19-20,22,25-26,30H,8-12,14-18H2,1-7H3/t20-,22-,25-,26+,28-,29-/m0/s1",,2016-11-22T15:12:20Z,,2176,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2176/?format=pcsv
CE2314,,,0,C29H50O,,,"Human Metabolome Database (HMDB): 4,4-Dimethyl-5alpha-cholesta-8-en-3beta-ol is involved in the biosynthesis of steriods. 4,4-Dimethyl-5alpha-cholesta-8-en-3beta-ol is reversibly converted into 14-Demethyllanosterol by delta24-sterol reductase [EC:1.3.1.72].",,"4,4-dimethylcholesta-8(9)-en-3beta-ol",,HMDB06840,"InChI=1/C29H50O/c1-19(2)9-8-10-20(3)22-12-13-23-21-11-14-25-27(4,5)26(30)16-18-29(25,7)24(21)15-17-28(22,23)6/h19-20,22-23,25-26,30H,8-18H2,1-7H3/t20-,22-,23?,25+,26+,28-,29-/m1/s1",C15915,2016-12-05T15:48:06Z,,2177,,,,,23724604,,,"3beta-hydroxy-4,4-dimethyl-8(9)-cholestene, 3beta-hydroxy-4,4-dimethylcholest-8(9)-ene, 4,4-Dimethyl-3beta-hydroxy-8(9)-cholestene, 4,4-Dimethyl-3beta-hydroxycholest-8(9)-ene, 4,4-Dimethyl-5alpha-cholesta-8-en-3beta-ol, 4,4-Dimethylcholest-8(9)-en-3beta-ol, 4,4-Dimethylcholesta-8(9)-en-3beta-ol",http://vmh.uni.lu/_api/metabolites/2177/?format=pcsv
CE2315,,,0,C27H46O,101770,,"Human Metabolome Database (HMDB): 5a-Cholest-8-en-3b-ol is a normal human metabolite and an intermediate of cholesterol synthesis. The concentrations of zymostenol are higher, both in serum and bile of patients with cerebrotendinous xanthomatosis, compared to controls or in patients with cerebrotendinous xanthomatosis treated with chenodeoxycholic acid. Kidney transplant recipients had lower serum zymostenol when compared to controls. During consumption of plant stanol ester spread by hypercholesterolemic children, plant sterols in the plasma decrease and cholesterol precursor sterols such as zymostenol increase. (PMID: 15736111, 16709621, 16477216, 12756385).",,cholesta-8(9)-en-3beta-ol,,HMDB06841,"InChI=1/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h18-21,23-24,28H,6-17H2,1-5H3/t19-,20+,21+,23-,24+,26+,27-/m1/s1",C03845,2016-12-05T15:48:06Z,,2178,,,,,101770,,,"(3beta,5alpha)Cholestenol, 3beta-hydroxy-8(9)-cholestene, 3beta-hydroxycholest-8(9)-ene, 5-alpha-Cholest-8-en-3-beta-ol, 5alpha-Cholest-8(9)-en-3beta-ol, 5alpha-cholest-8-en-3beta-ol, Cholest-8(9)-en-3beta-ol, Cholesta-8(9)-en-3beta-ol, delta(8)-Cholestenol",http://vmh.uni.lu/_api/metabolites/2178/?format=pcsv
CE4826,,,-4,C45H64N7O18P3S,,,"3-oxo-all-cis-6,9,12,15,18,21-tetracosahexaenoyl-CoA",,"3-oxo-all-cis-6,9,12,15,18,21-tetracosahexaenoyl-CoA",,,,,2016-11-22T15:12:20Z,,2179,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2179/?format=pcsv
CE4827,,,-4,C43H62N7O17P3S,CHEBI:65132,,"docosa-4,7,10,13,16,19-all-cis-hexaenoyl-CoA",,"docosa-4,7,10,13,16,19-all-cis-hexaenoyl-CoA",,,"InChI=1/C43H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-34(52)71-27-26-45-33(51)24-25-46-41(55)38(54)43(2,3)29-64-70(61,62)67-69(59,60)63-28-32-37(66-68(56,57)58)36(53)42(65-32)50-31-49-35-39(44)47-30-48-40(35)50/h5-6,8-9,11-12,14-15,17-18,20-21,30-32,36-38,42,53-54H,4,7,10,13,16,19,22-29H2,1-3H3,(H,45,51)(H,46,55)(H,59,60)(H,61,62)(H2,44,47,48)(H2,56,57,58)/p-4/b6-5-,9-8-,12-11-,15-14-,18-17-,21-20-/t32-,36+,37+,38u,42-/m0/s1",,2016-11-22T15:12:20Z,,2180,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2180/?format=pcsv
CE4828,,,-4,C45H64N7O17P3S,,,"trans-2-all-cis-6,9,12,15,18,21-tetracosaheptaenoyl-CoA",,"trans-2-all-cis-6,9,12,15,18,21-tetracosaheptaenoyl-CoA",,HMDB06260,"InChI=1/C45H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h5-6,8-9,11-12,14-15,17-18,20-21,24-25,32-34,38-40,44,55-56H,4,7,10,13,16,19,22-23,26-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/p-4/b6-5+,9-8-,12-11-,15-14-,18-17-,21-20-,25-24+/t34-,38+,39+,40?,44-/m0/s1",C16374,2016-11-22T16:03:31Z,,2181,,,,,53477810,,,"2E,6Z,9Z,12Z,15Z,18Z,21Z-Tetracosaheptaenoyl-CoA, 2E,6Z,9Z,12Z,15Z,18Z,21Z-Tetracosaheptaenoyl-Coenzyme A, TChpCoA, TChpCoenzyme A",http://vmh.uni.lu/_api/metabolites/2181/?format=pcsv
CE4825,,,-4,C45H66N7O18P3S,,,"(3S)-hydroxy-tetracosa-6,9,12,15,18,21-all-cis-hexaenoyl-CoA",,"(3S)-hydroxy-tetracosa-6,9,12,15,18,21-all-cis-hexaenoyl-CoA",,,"InChI=1/C45H70N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-33(53)28-36(55)74-27-26-47-35(54)24-25-48-43(58)40(57)45(2,3)30-67-73(64,65)70-72(62,63)66-29-34-39(69-71(59,60)61)38(56)44(68-34)52-32-51-37-41(46)49-31-50-42(37)52/h5-6,8-9,11-12,14-15,17-18,20-21,31-34,38-40,44,53,56-57H,4,7,10,13,16,19,22-30H2,1-3H3,(H,47,54)(H,48,58)(H,62,63)(H,64,65)(H2,46,49,50)(H2,59,60,61)/p-4/b6-5-,9-8-,12-11-,15-14-,18-17-,21-20-/t33-,34-,38+,39+,40u,44-/m0/s1",,2016-11-22T15:12:20Z,,2182,,,,,53481432,,,,http://vmh.uni.lu/_api/metabolites/2182/?format=pcsv
CE6027,,,0,C23H34O3,,,"24,25,26,27-tetranor-23-oxo-hydroxyvitamin D3",,"24,25,26,27-tetranor-23-oxo-hydroxyvitamin D3",,,"InChI=1/C23H34O3/c1-15(10-12-24)20-8-9-21-17(5-4-11-23(20,21)3)6-7-18-13-19(25)14-22(26)16(18)2/h6-7,12,15,19-22,25-26H,2,4-5,8-11,13-14H2,1,3H3/b17-6+,18-7-/t15-,19+,20-,21+,22+,23?/m0/s1",,2016-11-22T15:12:20Z,,2183,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2183/?format=pcsv
CE5079,,,-1,C23H33O4,,,"1alpha-hydroxy-23-carboxy-24,25,26,27-tetranorvitamin D3",,"1alpha-hydroxy-23-carboxy-24,25,26,27-tetranorvitamin D3",,,"InChI=1/C23H34O4/c1-14(11-22(26)27)19-8-9-20-16(5-4-10-23(19,20)3)6-7-17-12-18(24)13-21(25)15(17)2/h6-7,14,18-21,24-25H,2,4-5,8-13H2,1,3H3,(H,26,27)/p-1/b16-6+,17-7-/t14-,18+,19-,20+,21+,23?/m1/s1",,2016-11-16T10:44:57Z,,2184,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2184/?format=pcsv
CE4823,,,-4,C45H66N7O17P3S,,,"tetracosa-6,9,12,15,18,21-all-cis-hexaenoyl-CoA",,"tetracosa-6,9,12,15,18,21-all-cis-hexaenoyl-CoA",,,"InChI=1/C45H70N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h5-6,8-9,11-12,14-15,17-18,20-21,32-34,38-40,44,55-56H,4,7,10,13,16,19,22-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/p-4/b6-5-,9-8-,12-11-,15-14-,18-17-,21-20-/t34-,38+,39+,40u,44-/m0/s1",,2016-11-16T10:44:57Z,,2185,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2185/?format=pcsv
CE4786,,,-1,C24H35O2,53481586,,"Human Metabolome Database (HMDB): 6,9,12,15,18,21-Tetracosahexaenoic acid (24:6n-3) is one of the n-3 PUFA and is a very long chain fatty acid. Distribution of 24:6n-3 in marine organisms was investigated by several researchers. Takagi et al. reported relatively high contents of 24:6n-3 in sea lilies and brittle stars (4&#8211;10% of total fatty acids). High 24:6n-3 content was also found in marine coelenterates. In some edible fishes, 24:6n-3 was detected at significant levels (0&#8211;10% of total fatty acids).The existence of 24:6n-3 in mammalian tissues was reported with other very long chain fatty acids in the spermatozoa,the retina, and the brain. Voss et al. reported that 24:6n-3 is formed as an intermediate in the metabolic pathway from 20:5n-3 to 22:6n-3 in rat liver. Even though 24:6n-3 is a PUFA existing in fish and mammalian species, physiological functions of 24:6n-3 have not been studied. As functions to be studied, anti-inflammatory and antiallergic. effects of 24:6n-3 are noteworthy because these events are known to be closely related to the unsaturated fatty acid metabolism such as in the arachidonic acid cascade, and 20:5n-3 and 22:6n-3 were reported to suppress inflammatory actions by influencing arachidonic acid metabolism.s24:6n-3 could inhibit the antigen-stimulated production of LT-related compounds as well as other n-3 polyunsaturated fatty acids (PUFA) such as eicosapentaenoic. acid (20:5n-3) and docosahexaenoic acid (22:6n-3), which are major n-3 PUFA in fish oils; 24:6n-3 was also shown to reduce the histamine content in MC/9 cells at 25 uM (27% reduction from the control), and the effect was diminished with increase of the fatty acid concentration (up to 100 uM). These two n-3 PUFA, 20:5n-3 and 22:6n-3, also reduced the histamine content (16 and 20% reduction at 25 &#956;M, respectively), whereas arachidonic acid (20:4n-6) increased it (18% increase at 25 &#956;M). ",,nisinate,,HMDB13025,"InChI=1/C24H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-23H2,1H3,(H,25,26)/p-1/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-",,2016-12-05T15:48:06Z,,2186,,,,,53481586,,,"6Z,9Z,12Z,15Z,18Z,21Z-Tetracosahexaenoate, 6Z,9Z,12Z,15Z,18Z,21Z-Tetracosahexaenoic acid, 6Z,9Z,12Z,15Z,18Z,21Z-Tetracosahexaenoic acid anion, All-cis-6,9,12,15,18,21-tetracosahexaenoate, All-cis-6,9,12,15,18,21-tetracosahexaenoic acid, C 24:6 (N-3), Nisinate, Nisinic acid anion",http://vmh.uni.lu/_api/metabolites/2186/?format=pcsv
CE4829,,,-4,C43H64N7O17P3S,,,adrenoyl-CoA,,adrenoyl-CoA,,,"InChI=1/C43H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-34(52)71-27-26-45-33(51)24-25-46-41(55)38(54)43(2,3)29-64-70(61,62)67-69(59,60)63-28-32-37(66-68(56,57)58)36(53)42(65-32)50-31-49-35-39(44)47-30-48-40(35)50/h8-9,11-12,14-15,17-18,20-21,30-32,36-38,42,53-54H,4-7,10,13,16,19,22-29H2,1-3H3,(H,45,51)(H,46,55)(H,59,60)(H,61,62)(H2,44,47,48)(H2,56,57,58)/p-4/b9-8-,12-11-,15-14-,18-17-,21-20-/t32-,36+,37+,38u,42-/m0/s1",,2016-11-16T10:44:57Z,,2187,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2187/?format=pcsv
CE4830,,,-4,C45H68N7O17P3S,,,"2-trans-9,12,15,18-all-cis-tetracosapentaenoyl-CoA",,"2-trans-9,12,15,18-all-cis-tetracosapentaenoyl-CoA",,,"InChI=1/C45H72N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h8-9,11-12,14-15,17-18,24-25,32-34,38-40,44,55-56H,4-7,10,13,16,19-23,26-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/p-4/b9-8-,12-11-,15-14-,18-17-,25-24+/t34-,38+,39+,40u,44-/m0/s1",,2016-11-22T15:12:20Z,,2188,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2188/?format=pcsv
CE4837,,,-4,C45H70N7O17P3S,CHEBI:63548,,"Human Metabolome Database (HMDB): (9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA is an intermediate in the biosynthesis of unsaturated fatty acids. (9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA is the 1st to last step in the synthesis of (6Z,9Z,12Z,15Z,18Z)-Tetracosapentaenoyl-CoA and is converted from (7Z,10Z,13Z,16Z)-Docosatetraenoyl-CoA via the enzyme 3-oxoacyl-[acyl-carrier protein] reductase (EC 1.1.1.100) in multisteps.",,"tetracosa-9,12,15,18-all-cis-tetraenoyl-CoA",,HMDB06516,"InChI=1/C45H74N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h8-9,11-12,14-15,17-18,32-34,38-40,44,55-56H,4-7,10,13,16,19-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/p-4/b9-8-,12-11-,15-14-,18-17-/t34-,38+,39+,40u,44-/m0/s1",,2016-12-05T15:48:06Z,,2189,,,,,,,,"(9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA, (9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-Coenzyme A, Etracosatetraenoate, Etracosatetraenoatel CoA, Etracosatetraenoatel Coenzyme A, Etracosatetraenoic acid, Tetracosatetraenoate, Tetracosatetraenoatel coenzyme A, Tetracosatetraenoic acid, Tetracosatetraenoyl coenzyme A",http://vmh.uni.lu/_api/metabolites/2189/?format=pcsv
CE4833,,,-4,C43H64N7O18P3S,,,"3-oxo-docosa-7,10,13,16-all-cis-tetraenoyl-CoA",,"3-oxo-docosa-7,10,13,16-all-cis-tetraenoyl-CoA",,,"InChI=1/C43H68N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-31(51)26-34(53)72-25-24-45-33(52)22-23-46-41(56)38(55)43(2,3)28-65-71(62,63)68-70(60,61)64-27-32-37(67-69(57,58)59)36(54)42(66-32)50-30-49-35-39(44)47-29-48-40(35)50/h8-9,11-12,14-15,17-18,29-30,32,36-38,42,54-55H,4-7,10,13,16,19-28H2,1-3H3,(H,45,52)(H,46,56)(H,60,61)(H,62,63)(H2,44,47,48)(H2,57,58,59)/p-4/b9-8-,12-11-,15-14-,18-17-/t32-,36+,37+,38u,42-/m0/s1",,2016-11-22T15:12:21Z,,2190,,,,,,CE4833,,,http://vmh.uni.lu/_api/metabolites/2190/?format=pcsv
CE4831,,,-4,C43H66N7O18P3S,,,"3(S)-hydroxy-docosa-7,10,13,16-all-cis-tetraenoyl-CoA",,"3(S)-hydroxy-docosa-7,10,13,16-all-cis-tetraenoyl-CoA",,,"InChI=1/C43H70N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-31(51)26-34(53)72-25-24-45-33(52)22-23-46-41(56)38(55)43(2,3)28-65-71(62,63)68-70(60,61)64-27-32-37(67-69(57,58)59)36(54)42(66-32)50-30-49-35-39(44)47-29-48-40(35)50/h8-9,11-12,14-15,17-18,29-32,36-38,42,51,54-55H,4-7,10,13,16,19-28H2,1-3H3,(H,45,52)(H,46,56)(H,60,61)(H,62,63)(H2,44,47,48)(H2,57,58,59)/p-4/b9-8-,12-11-,15-14-,18-17-/t31-,32-,36+,37+,38u,42-/m0/s1",,2016-11-22T15:12:21Z,,2191,,,,,,CE4831,,,http://vmh.uni.lu/_api/metabolites/2191/?format=pcsv
CE4835,,,-4,C43H64N7O17P3S,,,"2E,7Z,10Z,13Z,16Z-docosapentaenoyl-CoA",,"2E,7Z,10Z,13Z,16Z-docosapentaenoyl-CoA",,,"InChI=1/C43H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-34(52)71-27-26-45-33(51)24-25-46-41(55)38(54)43(2,3)29-64-70(61,62)67-69(59,60)63-28-32-37(66-68(56,57)58)36(53)42(65-32)50-31-49-35-39(44)47-30-48-40(35)50/h8-9,11-12,14-15,17-18,22-23,30-32,36-38,42,53-54H,4-7,10,13,16,19-21,24-29H2,1-3H3,(H,45,51)(H,46,55)(H,59,60)(H,61,62)(H2,44,47,48)(H2,56,57,58)/p-4/b9-8-,12-11-,15-14-,18-17-,23-22+/t32-,36+,37+,38u,42-/m0/s1",,2016-11-22T15:12:21Z,,2192,,,,,,CE4835,,,http://vmh.uni.lu/_api/metabolites/2192/?format=pcsv
CE4834,,,-4,C45H68N7O18P3S,,,"3-oxo-tetracosa-9,12,15,18-all-cis-tetraenoyl-CoA",,"3-oxo-tetracosa-9,12,15,18-all-cis-tetraenoyl-CoA",,,"InChI=1/C45H72N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-33(53)28-36(55)74-27-26-47-35(54)24-25-48-43(58)40(57)45(2,3)30-67-73(64,65)70-72(62,63)66-29-34-39(69-71(59,60)61)38(56)44(68-34)52-32-51-37-41(46)49-31-50-42(37)52/h8-9,11-12,14-15,17-18,31-32,34,38-40,44,56-57H,4-7,10,13,16,19-30H2,1-3H3,(H,47,54)(H,48,58)(H,62,63)(H,64,65)(H2,46,49,50)(H2,59,60,61)/p-4/b9-8-,12-11-,15-14-,18-17-/t34-,38+,39+,40u,44-/m0/s1",,2016-11-22T15:12:21Z,,2193,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2193/?format=pcsv
CE4849,,,-4,C45H70N7O18P3S,,,"3(S)-hydroxy-tetracosa-12,15,18,21-all-cis-tetraenoyl-CoA",,"3(S)-hydroxy-tetracosa-12,15,18,21-all-cis-tetraenoyl-CoA",,,"InChI=1/C45H74N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-33(53)28-36(55)74-27-26-47-35(54)24-25-48-43(58)40(57)45(2,3)30-67-73(64,65)70-72(62,63)66-29-34-39(69-71(59,60)61)38(56)44(68-34)52-32-51-37-41(46)49-31-50-42(37)52/h5-6,8-9,11-12,14-15,31-34,38-40,44,53,56-57H,4,7,10,13,16-30H2,1-3H3,(H,47,54)(H,48,58)(H,62,63)(H,64,65)(H2,46,49,50)(H2,59,60,61)/p-4/b6-5-,9-8-,12-11-,15-14-/t33-,34-,38+,39+,40u,44-/m0/s1",,2016-11-22T15:12:21Z,,2194,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2194/?format=pcsv
CE4832,,,-4,C45H68N7O18P3S,,,"3(S)-hydroxy-tetracosa-6,9,12,15,18-all-cis-pentaenoyl-CoA",,"3(S)-hydroxy-tetracosa-6,9,12,15,18-all-cis-pentaenoyl-CoA",,,"InChI=1/C45H72N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-33(53)28-36(55)74-27-26-47-35(54)24-25-48-43(58)40(57)45(2,3)30-67-73(64,65)70-72(62,63)66-29-34-39(69-71(59,60)61)38(56)44(68-34)52-32-51-37-41(46)49-31-50-42(37)52/h8-9,11-12,14-15,17-18,20-21,31-34,38-40,44,53,56-57H,4-7,10,13,16,19,22-30H2,1-3H3,(H,47,54)(H,48,58)(H,62,63)(H,64,65)(H2,46,49,50)(H2,59,60,61)/p-4/b9-8-,12-11-,15-14-,18-17-,21-20-/t33-,34-,38+,39+,40u,44-/m0/s1",,2016-11-22T15:12:21Z,,2195,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2195/?format=pcsv
CE4836,,,-4,C45H68N7O17P3S,,,"tetracosa-6,9,12,15,18-all-cis-pentaenoyl-CoA",,"tetracosa-6,9,12,15,18-all-cis-pentaenoyl-CoA",,,"InChI=1/C45H72N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h8-9,11-12,14-15,17-18,20-21,32-34,38-40,44,55-56H,4-7,10,13,16,19,22-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/p-4/b9-8-,12-11-,15-14-,18-17-,21-20-/t34-,38+,39+,40u,44-/m0/s1",,2016-11-16T10:44:57Z,,2196,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2196/?format=pcsv
CE4838,,,-4,C45H66N7O17P3S,,,"trans-2-all-cis-6,9,12,15,18-tetracosahexaenoyl-CoA",,"trans-2-all-cis-6,9,12,15,18-tetracosahexaenoyl-CoA",,,"InChI=1/C45H70N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h8-9,11-12,14-15,17-18,20-21,24-25,32-34,38-40,44,55-56H,4-7,10,13,16,19,22-23,26-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/p-4/b9-8-,12-11-,15-14-,18-17-,21-20-,25-24+/t34-,38+,39+,40u,44-/m0/s1",,2016-11-22T15:12:21Z,,2197,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2197/?format=pcsv
CE4839,,,-1,C24H37O2,14505435,,Human Metabolome Database (HMDB): Tetracosapentaenioc acid is intermediate of Linolenic acid metabolism.,,"6,9,12,15,18-all-cis-tetracosapentaenoate",,HMDB06322,"InChI=1/C24H38O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26/h6-7,9-10,12-13,15-16,18-19H,2-5,8,11,14,17,20-23H2,1H3,(H,25,26)/p-1/b7-6-,10-9-,13-12-,16-15-,19-18-",,2016-12-05T15:48:06Z,,2198,,,,,14505435,,,"(6Z,9Z,12Z,15Z,18Z)-tetracosapentaenoate, (6Z,9Z,12Z,15Z,18Z)-tetracosapentaenoic acid, 6,9,12,15,18-All-cis-tetracosapentaenoate, 6,9,12,15,18-All-cis-tetracosapentaenoic acid",http://vmh.uni.lu/_api/metabolites/2198/?format=pcsv
CE4841,,,-4,C41H64N7O18P3S,,,"3-oxoeicosa-cis,cis-11,14-dienoyl-CoA",,"3-oxoeicosa-cis,cis-11,14-dienoyl-CoA",,,"InChI=1/C41H68N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-29(49)24-32(51)70-23-22-43-31(50)20-21-44-39(54)36(53)41(2,3)26-63-69(60,61)66-68(58,59)62-25-30-35(65-67(55,56)57)34(52)40(64-30)48-28-47-33-37(42)45-27-46-38(33)48/h8-9,11-12,27-28,30,34-36,40,52-53H,4-7,10,13-26H2,1-3H3,(H,43,50)(H,44,54)(H,58,59)(H,60,61)(H2,42,45,46)(H2,55,56,57)/p-4/b9-8-,12-11-/t30-,34+,35+,36u,40-/m0/s1",,2016-11-22T15:12:21Z,,2199,,,,,,CE4841,,,http://vmh.uni.lu/_api/metabolites/2199/?format=pcsv
CE4840,,,-4,C41H66N7O18P3S,,,"(3S)-hydroxy-eicosa-cis,cis-11,14-dienoyl-CoA",,"(3S)-hydroxy-eicosa-cis,cis-11,14-dienoyl-CoA",,,"InChI=1/C41H70N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-29(49)24-32(51)70-23-22-43-31(50)20-21-44-39(54)36(53)41(2,3)26-63-69(60,61)66-68(58,59)62-25-30-35(65-67(55,56)57)34(52)40(64-30)48-28-47-33-37(42)45-27-46-38(33)48/h8-9,11-12,27-30,34-36,40,49,52-53H,4-7,10,13-26H2,1-3H3,(H,43,50)(H,44,54)(H,58,59)(H,60,61)(H2,42,45,46)(H2,55,56,57)/p-4/b9-8-,12-11-/t29-,30-,34+,35+,36u,40-/m0/s1",,2016-11-22T15:12:21Z,,2200,,,,,,CE4840,,,http://vmh.uni.lu/_api/metabolites/2200/?format=pcsv
CE4842,,,-4,C41H64N7O17P3S,,,"trans,cis,cis-2,11,14-eicosatrienoyl-CoA",,"trans,cis,cis-2,11,14-eicosatrienoyl-CoA",,,"InChI=1/C41H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-32(50)69-25-24-43-31(49)22-23-44-39(53)36(52)41(2,3)27-62-68(59,60)65-67(57,58)61-26-30-35(64-66(54,55)56)34(51)40(63-30)48-29-47-33-37(42)45-28-46-38(33)48/h8-9,11-12,20-21,28-30,34-36,40,51-52H,4-7,10,13-19,22-27H2,1-3H3,(H,43,49)(H,44,53)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/p-4/b9-8-,12-11-,21-20+/t30-,34+,35+,36u,40-/m0/s1",,2016-11-22T15:12:21Z,,2201,,,,,,CE4842,,,http://vmh.uni.lu/_api/metabolites/2201/?format=pcsv
CE4843,,,-4,C41H66N7O17P3S,,,"cis,cis-11,14-eicosadienoyl-CoA",,"cis,cis-11,14-eicosadienoyl-CoA",,,"InChI=1/C41H70N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-32(50)69-25-24-43-31(49)22-23-44-39(53)36(52)41(2,3)27-62-68(59,60)65-67(57,58)61-26-30-35(64-66(54,55)56)34(51)40(63-30)48-29-47-33-37(42)45-28-46-38(33)48/h8-9,11-12,28-30,34-36,40,51-52H,4-7,10,13-27H2,1-3H3,(H,43,49)(H,44,53)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/p-4/b9-8-,12-11-/t30-,34+,35+,36u,40-/m0/s1",,2016-11-22T15:12:21Z,,2202,,,,,,CE4843,,,http://vmh.uni.lu/_api/metabolites/2202/?format=pcsv
CE4845,,,-4,C43H66N7O18P3S,,,"3-oxo-docosa-cis,cis,cis-10,13,16-trienoyl-CoA",,"3-oxo-docosa-cis,cis,cis-10,13,16-trienoyl-CoA",,,"InChI=1/C43H70N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-31(51)26-34(53)72-25-24-45-33(52)22-23-46-41(56)38(55)43(2,3)28-65-71(62,63)68-70(60,61)64-27-32-37(67-69(57,58)59)36(54)42(66-32)50-30-49-35-39(44)47-29-48-40(35)50/h8-9,11-12,14-15,29-30,32,36-38,42,54-55H,4-7,10,13,16-28H2,1-3H3,(H,45,52)(H,46,56)(H,60,61)(H,62,63)(H2,44,47,48)(H2,57,58,59)/p-4/b9-8-,12-11-,15-14-/t32-,36+,37+,38u,42-/m0/s1",,2016-11-22T15:12:21Z,,2203,,,,,,CE4845,,,http://vmh.uni.lu/_api/metabolites/2203/?format=pcsv
CE4844,,,-4,C43H68N7O18P3S,,,"3(S)-hydroxy-10,13,16-all-cis-docosatrienoyl-CoA",,"3(S)-hydroxy-10,13,16-all-cis-docosatrienoyl-CoA",,,"InChI=1/C43H72N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-31(51)26-34(53)72-25-24-45-33(52)22-23-46-41(56)38(55)43(2,3)28-65-71(62,63)68-70(60,61)64-27-32-37(67-69(57,58)59)36(54)42(66-32)50-30-49-35-39(44)47-29-48-40(35)50/h8-9,11-12,14-15,29-32,36-38,42,51,54-55H,4-7,10,13,16-28H2,1-3H3,(H,45,52)(H,46,56)(H,60,61)(H,62,63)(H2,44,47,48)(H2,57,58,59)/p-4/b9-8-,12-11-,15-14-/t31-,32-,36+,37+,38u,42-/m0/s1",,2016-11-22T15:12:21Z,,2204,,,,,,CE4844,,,http://vmh.uni.lu/_api/metabolites/2204/?format=pcsv
CE4846,,,-4,C43H66N7O17P3S,,,"trans,cis,cis,cis-2,10,13,16-docosatetraenoyl-CoA",,"trans,cis,cis,cis-2,10,13,16-docosatetraenoyl-CoA",,,"InChI=1/C43H70N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-34(52)71-27-26-45-33(51)24-25-46-41(55)38(54)43(2,3)29-64-70(61,62)67-69(59,60)63-28-32-37(66-68(56,57)58)36(53)42(65-32)50-31-49-35-39(44)47-30-48-40(35)50/h8-9,11-12,14-15,22-23,30-32,36-38,42,53-54H,4-7,10,13,16-21,24-29H2,1-3H3,(H,45,51)(H,46,55)(H,59,60)(H,61,62)(H2,44,47,48)(H2,56,57,58)/p-4/b9-8-,12-11-,15-14-,23-22+/t32-,36+,37+,38u,42-/m0/s1",,2016-11-22T15:12:21Z,,2205,,,,,,CE4846,,,http://vmh.uni.lu/_api/metabolites/2205/?format=pcsv
CE4847,,,-4,C43H68N7O17P3S,,,"cis,cis,cis-10,13,16-docosatrienoyl-CoA",,"cis,cis,cis-10,13,16-docosatrienoyl-CoA",,,"InChI=1/C43H72N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-34(52)71-27-26-45-33(51)24-25-46-41(55)38(54)43(2,3)29-64-70(61,62)67-69(59,60)63-28-32-37(66-68(56,57)58)36(53)42(65-32)50-31-49-35-39(44)47-30-48-40(35)50/h8-9,11-12,14-15,30-32,36-38,42,53-54H,4-7,10,13,16-29H2,1-3H3,(H,45,51)(H,46,55)(H,59,60)(H,61,62)(H2,44,47,48)(H2,56,57,58)/p-4/b9-8-,12-11-,15-14-/t32-,36+,37+,38u,42-/m0/s1",,2016-11-22T15:12:21Z,,2206,,,,,,CE4847,,,http://vmh.uni.lu/_api/metabolites/2206/?format=pcsv
CE4852,,,-4,C43H64N7O17P3S,,,"trans,cis,cis,cis,cis-2,10,13,16,19-docosapentaenoyl-CoA",,"trans,cis,cis,cis,cis-2,10,13,16,19-docosapentaenoyl-CoA",,,"InChI=1/C43H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-34(52)71-27-26-45-33(51)24-25-46-41(55)38(54)43(2,3)29-64-70(61,62)67-69(59,60)63-28-32-37(66-68(56,57)58)36(53)42(65-32)50-31-49-35-39(44)47-30-48-40(35)50/h5-6,8-9,11-12,14-15,22-23,30-32,36-38,42,53-54H,4,7,10,13,16-21,24-29H2,1-3H3,(H,45,51)(H,46,55)(H,59,60)(H,61,62)(H2,44,47,48)(H2,56,57,58)/p-4/b6-5-,9-8-,12-11-,15-14-,23-22+/t32-,36+,37+,38u,42-/m0/s1",,2016-11-22T15:12:21Z,,2207,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2207/?format=pcsv
CE4854,,,-4,C43H66N7O17P3S,,,"all-cis-10,13,16,19-docosatetraenoyl-CoA",,"all-cis-10,13,16,19-docosatetraenoyl-CoA",,,"InChI=1/C43H70N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-34(52)71-27-26-45-33(51)24-25-46-41(55)38(54)43(2,3)29-64-70(61,62)67-69(59,60)63-28-32-37(66-68(56,57)58)36(53)42(65-32)50-31-49-35-39(44)47-30-48-40(35)50/h5-6,8-9,11-12,14-15,30-32,36-38,42,53-54H,4,7,10,13,16-29H2,1-3H3,(H,45,51)(H,46,55)(H,59,60)(H,61,62)(H2,44,47,48)(H2,56,57,58)/p-4/b6-5-,9-8-,12-11-,15-14-/t32-,36+,37+,38u,42-/m0/s1",,2016-11-22T15:12:21Z,,2208,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2208/?format=pcsv
CE4850,,,-4,C43H64N7O18P3S,,,"3-oxo-docosa-10,13,16,19-all-cis-tetraenoyl-CoA",,"3-oxo-docosa-10,13,16,19-all-cis-tetraenoyl-CoA",,,"InChI=1/C43H68N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-31(51)26-34(53)72-25-24-45-33(52)22-23-46-41(56)38(55)43(2,3)28-65-71(62,63)68-70(60,61)64-27-32-37(67-69(57,58)59)36(54)42(66-32)50-30-49-35-39(44)47-29-48-40(35)50/h5-6,8-9,11-12,14-15,29-30,32,36-38,42,54-55H,4,7,10,13,16-28H2,1-3H3,(H,45,52)(H,46,56)(H,60,61)(H,62,63)(H2,44,47,48)(H2,57,58,59)/p-4/b6-5-,9-8-,12-11-,15-14-/t32-,36+,37+,38u,42-/m0/s1",,2016-11-22T15:12:21Z,,2209,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2209/?format=pcsv
CE4848,,,-4,C43H66N7O18P3S,,,"3(S)-hydroxy-docosa-10,13,16,19-all-cis-tetraenoyl-CoA",,"3(S)-hydroxy-docosa-10,13,16,19-all-cis-tetraenoyl-CoA",,,"InChI=1/C43H70N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-31(51)26-34(53)72-25-24-45-33(52)22-23-46-41(56)38(55)43(2,3)28-65-71(62,63)68-70(60,61)64-27-32-37(67-69(57,58)59)36(54)42(66-32)50-30-49-35-39(44)47-29-48-40(35)50/h5-6,8-9,11-12,14-15,29-32,36-38,42,51,54-55H,4,7,10,13,16-28H2,1-3H3,(H,45,52)(H,46,56)(H,60,61)(H,62,63)(H2,44,47,48)(H2,57,58,59)/p-4/b6-5-,9-8-,12-11-,15-14-/t31-,32-,36+,37+,38u,42-/m0/s1",,2016-11-22T15:12:21Z,,2210,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2210/?format=pcsv
CE4853,,,-4,C45H68N7O17P3S,,,"trans,cis,cis,cis,cis-2,12,15,18,21-tetracosapentaenoyl-CoA",,"trans,cis,cis,cis,cis-2,12,15,18,21-tetracosapentaenoyl-CoA",,,"InChI=1/C45H72N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h5-6,8-9,11-12,14-15,24-25,32-34,38-40,44,55-56H,4,7,10,13,16-23,26-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/p-4/b6-5-,9-8-,12-11-,15-14-,25-24+/t34-,38+,39+,40u,44-/m0/s1",,2016-11-22T15:12:21Z,,2211,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2211/?format=pcsv
CE4855,,,-4,C45H70N7O17P3S,,,"all-cis-12,15,18,21-tetracosatetraenoyl-CoA",,"all-cis-12,15,18,21-tetracosatetraenoyl-CoA",,,"InChI=1/C45H74N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-36(54)73-29-28-47-35(53)26-27-48-43(57)40(56)45(2,3)31-66-72(63,64)69-71(61,62)65-30-34-39(68-70(58,59)60)38(55)44(67-34)52-33-51-37-41(46)49-32-50-42(37)52/h5-6,8-9,11-12,14-15,32-34,38-40,44,55-56H,4,7,10,13,16-31H2,1-3H3,(H,47,53)(H,48,57)(H,61,62)(H,63,64)(H2,46,49,50)(H2,58,59,60)/p-4/b6-5-,9-8-,12-11-,15-14-/t34-,38+,39+,40u,44-/m0/s1",,2016-11-22T15:12:21Z,,2212,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2212/?format=pcsv
CE4851,,,-4,C45H68N7O18P3S,,,"3-oxo-tetracosa-12,15,18,21-all-cis-tetraenoyl-CoA",,"3-oxo-tetracosa-12,15,18,21-all-cis-tetraenoyl-CoA",,,"InChI=1/C45H72N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-33(53)28-36(55)74-27-26-47-35(54)24-25-48-43(58)40(57)45(2,3)30-67-73(64,65)70-72(62,63)66-29-34-39(69-71(59,60)61)38(56)44(68-34)52-32-51-37-41(46)49-31-50-42(37)52/h5-6,8-9,11-12,14-15,31-32,34,38-40,44,56-57H,4,7,10,13,16-30H2,1-3H3,(H,47,54)(H,48,58)(H,62,63)(H,64,65)(H2,46,49,50)(H2,59,60,61)/p-4/b6-5-,9-8-,12-11-,15-14-/t34-,38+,39+,40u,44-/m0/s1",,2016-11-22T15:12:21Z,,2213,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2213/?format=pcsv
CE4801,,,-4,C32H52N7O18P3S,,,"3(S)-hydroxy-4(R),8-dimethyl-nonanoyl-CoA",,"3(S)-hydroxy-4(R),8-dimethyl-nonanoyl-CoA",,,"InChI=1/C32H56N7O18P3S/c1-18(2)7-6-8-19(3)20(40)13-23(42)61-12-11-34-22(41)9-10-35-30(45)27(44)32(4,5)15-54-60(51,52)57-59(49,50)53-14-21-26(56-58(46,47)48)25(43)31(55-21)39-17-38-24-28(33)36-16-37-29(24)39/h16-21,25-27,31,40,43-44H,6-15H2,1-5H3,(H,34,41)(H,35,45)(H,49,50)(H,51,52)(H2,33,36,37)(H2,46,47,48)/p-4/t19-,20-,21+,25-,26-,27u,31+/m1/s1",,2016-11-22T15:12:21Z,,2214,,,,,,CE4801,,,http://vmh.uni.lu/_api/metabolites/2214/?format=pcsv
CE4803,,,-4,C32H50N7O18P3S,,,"3-oxo-4(R),8-dimethyl-nonanoyl-CoA",,"3-oxo-4(R),8-dimethyl-nonanoyl-CoA",,,"InChI=1/C32H54N7O18P3S/c1-18(2)7-6-8-19(3)20(40)13-23(42)61-12-11-34-22(41)9-10-35-30(45)27(44)32(4,5)15-54-60(51,52)57-59(49,50)53-14-21-26(56-58(46,47)48)25(43)31(55-21)39-17-38-24-28(33)36-16-37-29(24)39/h16-19,21,25-27,31,43-44H,6-15H2,1-5H3,(H,34,41)(H,35,45)(H,49,50)(H,51,52)(H2,33,36,37)(H2,46,47,48)/p-4/t19-,21+,25-,26-,27u,31+/m1/s1",,2016-11-22T15:12:21Z,,2215,,,,,,CE4803,,,http://vmh.uni.lu/_api/metabolites/2215/?format=pcsv
CE4800,,,-4,C30H48N7O18P3S,,,"3(S)-hydroxy-2(S),6-dimethyl-heptanoyl-CoA",,"3(S)-hydroxy-2(S),6-dimethyl-heptanoyl-CoA",,,"InChI=1/C30H52N7O18P3S/c1-16(2)6-7-18(38)17(3)29(43)59-11-10-32-20(39)8-9-33-27(42)24(41)30(4,5)13-52-58(49,50)55-57(47,48)51-12-19-23(54-56(44,45)46)22(40)28(53-19)37-15-36-21-25(31)34-14-35-26(21)37/h14-19,22-24,28,38,40-41H,6-13H2,1-5H3,(H,32,39)(H,33,42)(H,47,48)(H,49,50)(H2,31,34,35)(H2,44,45,46)/p-4/t17-,18+,19+,22-,23-,24u,28+/m1/s1",,2016-11-22T15:12:21Z,,2216,,,,,,CE4800,,,http://vmh.uni.lu/_api/metabolites/2216/?format=pcsv
CE4796,,,-4,C30H46N7O18P3S,,,3-oxo-(2S)-methylisocapryloyl-CoA,,3-oxo-(2S)-methylisocapryloyl-CoA,,,"InChI=1/C30H50N7O18P3S/c1-16(2)6-7-18(38)17(3)29(43)59-11-10-32-20(39)8-9-33-27(42)24(41)30(4,5)13-52-58(49,50)55-57(47,48)51-12-19-23(54-56(44,45)46)22(40)28(53-19)37-15-36-21-25(31)34-14-35-26(21)37/h14-17,19,22-24,28,40-41H,6-13H2,1-5H3,(H,32,39)(H,33,42)(H,47,48)(H,49,50)(H2,31,34,35)(H2,44,45,46)/p-4/t17-,19+,22-,23-,24u,28+/m1/s1",,2016-11-22T15:12:21Z,,2217,,,,,,CE4796,,,http://vmh.uni.lu/_api/metabolites/2217/?format=pcsv
CE4802,,,-4,C27H42N7O18P3S,,,3(S)-hydroxy-4-methyl-pentanoyl-CoA,,3(S)-hydroxy-4-methyl-pentanoyl-CoA,,,"InChI=1/C27H46N7O18P3S/c1-14(2)15(35)9-18(37)56-8-7-29-17(36)5-6-30-25(40)22(39)27(3,4)11-49-55(46,47)52-54(44,45)48-10-16-21(51-53(41,42)43)20(38)26(50-16)34-13-33-19-23(28)31-12-32-24(19)34/h12-16,20-22,26,35,38-39H,5-11H2,1-4H3,(H,29,36)(H,30,40)(H,44,45)(H,46,47)(H2,28,31,32)(H2,41,42,43)/p-4/t15-,16+,20-,21-,22u,26+/m1/s1",,2016-11-22T15:12:21Z,,2218,,,,,,CE4802,,,http://vmh.uni.lu/_api/metabolites/2218/?format=pcsv
CE4804,,,-4,C27H40N7O18P3S,,,3-oxo-4-methyl-pentanoyl-CoA,,3-oxo-4-methyl-pentanoyl-CoA,,,"InChI=1/C27H44N7O18P3S/c1-14(2)15(35)9-18(37)56-8-7-29-17(36)5-6-30-25(40)22(39)27(3,4)11-49-55(46,47)52-54(44,45)48-10-16-21(51-53(41,42)43)20(38)26(50-16)34-13-33-19-23(28)31-12-32-24(19)34/h12-14,16,20-22,26,38-39H,5-11H2,1-4H3,(H,29,36)(H,30,40)(H,44,45)(H,46,47)(H2,28,31,32)(H2,41,42,43)/p-4/t16-,20+,21+,22u,26-/m0/s1",,2016-11-22T15:12:21Z,,2219,,,,,,CE4804,,,http://vmh.uni.lu/_api/metabolites/2219/?format=pcsv
CE5049,,,0,CH2,,,one carbon unit,,one carbon unit,,,,,2016-11-22T15:12:21Z,,2220,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2220/?format=pcsv
CE4806,,,-4,C32H50N7O17P3S,,,"4(R),8-dimethyl-trans-2-nonenoyl-CoA",,"4(R),8-dimethyl-trans-2-nonenoyl-CoA",,,,,2016-11-22T15:12:21Z,,2221,,,,,,CE4806,,,http://vmh.uni.lu/_api/metabolites/2221/?format=pcsv
CE4798,,,-4,C30H48N7O17P3S,,,"2(S),6-dimethyl-heptanoyl-CoA",,"2(S),6-dimethyl-heptanoyl-CoA",,,,,2016-11-22T15:12:21Z,,2222,,,,,,CE4798,,,http://vmh.uni.lu/_api/metabolites/2222/?format=pcsv
CE4799,,,-4,C30H46N7O17P3S,,,"2,6-dimethyl-trans-2-heptenoyl-CoA",,"2,6-dimethyl-trans-2-heptenoyl-CoA",,,,,2016-11-22T15:12:21Z,,2223,,,,,,CE4799,,,http://vmh.uni.lu/_api/metabolites/2223/?format=pcsv
CE4808,,,-4,C27H42N7O17P3S,,,4-methyl-pentanoyl-CoA,,4-methyl-pentanoyl-CoA,,,,,2016-11-22T15:12:21Z,,2224,,,,,,CE4808,,,http://vmh.uni.lu/_api/metabolites/2224/?format=pcsv
CE4807,,,-4,C27H40N7O17P3S,,,4-methyl-trans-2-pentenoyl-CoA,,4-methyl-trans-2-pentenoyl-CoA,,,,,2016-11-22T15:12:21Z,,2225,,,,,,CE4807,,,http://vmh.uni.lu/_api/metabolites/2225/?format=pcsv
CE4797,,,-4,C30H48N7O17P3S,,,"2(R),6-dimethyl-heptanoyl-CoA",,"2(R),6-dimethyl-heptanoyl-CoA",,,,,2016-11-22T15:12:21Z,,2226,,,,,,CE4797,,,http://vmh.uni.lu/_api/metabolites/2226/?format=pcsv
CE1562,,,-1,C9H4NO4,,,"5,6-indolequinone-2-carboxylate",,"5,6-indolequinone-2-carboxylate",,,,,2016-11-22T15:12:21Z,,2227,,,,,,CE1562,,,http://vmh.uni.lu/_api/metabolites/2227/?format=pcsv
CE6031,,,-1,C19H29O5S,,,androsterone sulfate,,androsterone sulfate,,,"InChI=1/C19H30O5S/c1-18-9-7-13(24-25(21,22)23)11-12(18)3-4-14-15-5-6-17(20)19(15,2)10-8-16(14)18/h12-16H,3-11H2,1-2H3,(H,21,22,23)/p-1/t12-,13+,14-,15-,16-,18+,19+/m0/s1",C04555,2016-11-22T15:12:21Z,,2228,,,,,159663,CE6031,,,http://vmh.uni.lu/_api/metabolites/2228/?format=pcsv
CE5144,,,-4,C41H66N7O18P3S,,,3-oxo-11-cis-eicosenoyl-CoA,,3-oxo-11-cis-eicosenoyl-CoA,,,,,2016-11-22T15:12:21Z,,2229,,,,,,CE5144,,,http://vmh.uni.lu/_api/metabolites/2229/?format=pcsv
CE5151,,,-4,C41H68N7O17P3S,,,11-cis-eicosenoyl-CoA,,11-cis-eicosenoyl-CoA,,,,,2016-11-22T15:12:21Z,,2230,,,,,,CE5151,,,http://vmh.uni.lu/_api/metabolites/2230/?format=pcsv
CE5152,,,-4,C43H70N7O18P3S,,,3-oxo-13cis-docosenoyl-CoA,,3-oxo-13cis-docosenoyl-CoA,,,,,2016-11-22T15:12:21Z,,2231,,,,,,CE5152,,,http://vmh.uni.lu/_api/metabolites/2231/?format=pcsv
CE5155,,,-4,C43H72N7O17P3S,,,cis-13-docosenoyl-CoA,,cis-13-docosenoyl-CoA,,,,,2016-11-22T15:12:21Z,,2232,,,,,,CE5155,,,http://vmh.uni.lu/_api/metabolites/2232/?format=pcsv
CE5156,,,-4,C45H74N7O18P3S,,,3-oxo-cis-15-tetracosaenoyl-CoA,,3-oxo-cis-15-tetracosaenoyl-CoA,,,,,2016-11-22T15:12:21Z,,2233,,,,,,CE5156,,,http://vmh.uni.lu/_api/metabolites/2233/?format=pcsv
CE5148,,,-4,C41H68N7O18P3S,,,3(S)-hydroxy-11-cis-eicosenoyl-CoA,,3(S)-hydroxy-11-cis-eicosenoyl-CoA,,,,,2016-11-22T15:12:21Z,,2234,,,,,,CE5148,,,http://vmh.uni.lu/_api/metabolites/2234/?format=pcsv
CE5150,,,-4,C41H66N7O17P3S,,,"trans,cis-2,11-eicosadienoyl-CoA",,"trans,cis-2,11-eicosadienoyl-CoA",,,,,2016-11-22T15:12:21Z,,2235,,,,,,CE5150,,,http://vmh.uni.lu/_api/metabolites/2235/?format=pcsv
CE5153,,,-4,C43H72N7O18P3S,,,3(S)-hydroxy-13cis-docosenoyl-CoA,,3(S)-hydroxy-13cis-docosenoyl-CoA,,,,,2016-11-22T15:12:21Z,,2236,,,,,,CE5153,,,http://vmh.uni.lu/_api/metabolites/2236/?format=pcsv
CE5154,,,-4,C43H70N7O17P3S,,,"trans,cis-2,13-docosadienoyl-CoA",,"trans,cis-2,13-docosadienoyl-CoA",,,,,2016-11-22T15:12:21Z,,2237,,,,,,CE5154,,,http://vmh.uni.lu/_api/metabolites/2237/?format=pcsv
C06199,,,1,C10H16NO,CHEBI:5764,,"Human Metabolome Database (HMDB): Hordenine is a potent phenylethylamine alkaloid with antibacterial and antibiotic properties produced in nature by several varieties of plants in the family Cactacea. The major source of hordenine in humans is beer brewed from barley. Hordenine in urine interferes with tests for morphine, heroin and other opioid drugs.",,Hordenine,,HMDB04366,"InChI=1S/C10H15NO/c1-11(2)8-7-9-3-5-10(12)6-4-9/h3-6,12H,7-8H2,1-2H3",C06199,2016-12-05T15:48:06Z,,2238,,,,,68313,,,"4-(2-Dimethylaminoethyl)phenol, 4-[2-(Dimethylamino)ethyl]phenol, Anhalin, Anhaline, Cactine, Eremursine, Hordenin, Hordetin, N,N-Dimethyl-p-hydroxyphenethylamine, N,N-Dimethyltyramine, Ordenina, Ordenine, p-(2-Dimethylaminoethyl)phenol, p-Hydroxy-N,N-dimethylphenethylamine, p-[2-(Dimethylamino)ethyl]phenol, Peyocactine",http://vmh.uni.lu/_api/metabolites/2238/?format=pcsv
CE6316,,,1,C10H14NO2,,,"N,N-dimethyldopaminequinone",,"N,N-dimethyldopaminequinone",,,,,2016-11-22T15:12:21Z,,2239,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2239/?format=pcsv
CE5157,,,-4,C45H76N7O18P3S,,,3(S)-hydroxy-cis-15-tetracosaenoyl-CoA,,3(S)-hydroxy-cis-15-tetracosaenoyl-CoA,,,,,2016-11-22T15:12:21Z,,2240,,,,,,CE5157,,,http://vmh.uni.lu/_api/metabolites/2240/?format=pcsv
CE5158,,,-4,C45H74N7O17P3S,,,"trans,cis-2,15-tetracosadienoyl-CoA",,"trans,cis-2,15-tetracosadienoyl-CoA",,,,,2016-11-22T15:12:21Z,,2241,,,,,,CE5158,,,http://vmh.uni.lu/_api/metabolites/2241/?format=pcsv
CE5159,,,-4,C45H76N7O17P3S,,,cis-15-tetracosenoyl-CoA,,cis-15-tetracosenoyl-CoA,,,,,2016-11-16T10:44:57Z,,2242,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2242/?format=pcsv
CE2513,,,-1,C24H45O2,65032,,"Human Metabolome Database (HMDB): Nervonic acid is a long chain unsaturated fatty acid that is enriched in sphingomyelin. It consists of choline, sphingosine, phosphoric acid, and fatty acid. Nervonic acid may enhance the brain functions and prevent demyelination (Chemical Land21). Research shows that there is negative relationship between nervonic acid and obesity-related risk factors (PMID: 16394593). Demyelination in adrenoleukodystrophy (ALD) is associated with an accumulation of very long chain saturated fatty acids stemming from a genetic defect in the peroxisomal beta oxidation system responsible for the chain shortening of these fatty acids. Sphingolipids from post mortem ALD brain have decreased levels of nervonic acid, 24:1(n-9), and increased levels of stearic acid, 18:0. (PMID: 8072429).",,15-tetracosenoate,,HMDB02368,,C08323,2016-12-05T15:48:06Z,,2243,,,,,65032,,,"(15Z)-tetracos-15-enoate, (15Z)-tetracos-15-enoic acid, (15Z)-Tetracosenoate, (15Z)-Tetracosenoic acid, (Z)-15-Tetracosenoate, (Z)-15-Tetracosenoic acid, 15-Tetracosenoate, 15-Tetracosenoic acid, 15Z-Tetracosenoate, 15Z-Tetracosenoic acid, cis-15-Teracosenoate, cis-15-Teracosenoic acid, cis-15-Tetracosenate, cis-15-Tetracosenic acid, cis-15-Tetracosenoate, cis-15-Tetracosenoic acid, cis-delta(15)-Tetracosenoate, cis-delta(15)-Tetracosenoic acid, cis-Selacholeate, cis-Selacholeic acid, Nervonate, Selacholeate, Selacholeic acid",http://vmh.uni.lu/_api/metabolites/2243/?format=pcsv
CE2510,,,-1,C20H37O2,CHEBI:32425,,Human Metabolome Database (HMDB): Eicosenoic acid is an monounsaturated omega-9 fatty acid found in a variety of plant oils. It is also found in the red cell membrane with increased concentrations in children with regressive autism (16581239).,,11-cis-eicosenoate,,HMDB02231,,C16526,2016-12-05T15:48:06Z,,2244,,,,,142770,CE2510,,"(11Z)-Icos-11-enoate, (11Z)-Icos-11-enoic acid, 11(Z)-Eicosenoate, 11(Z)-Eicosenoic acid, 11-cis-Eicosenoate, 11-cis-Eicosenoic acid, 11-Eicosenoate, 11-Eicosenoic acid, 11Z-Eicosenoate, 11Z-Eicosenoic acid, 20:1(N-9), 20:1n9, cis-11-Eicosenoate, cis-11-Eicosenoic acid, cis-11-Icosenoate, cis-11-Icosenoic acid, cis-Gondoate, cis-Gondoic acid, Eicosenoate, Eicosenoic acid, Gondoate, Gondoic acid",http://vmh.uni.lu/_api/metabolites/2244/?format=pcsv
CE2512,,,-1,C22H41O2,8216,,"Human Metabolome Database (HMDB): Erucic acid is a monounsaturated omega-9 fatty acid found mainly in the Brassica family of plants such as canola, rapeseed, wallflower seed, mustard seed as well as Brussels spouts and broccoli. Some Brassica cultivars can have up to 40 to 50 percent of their oil recovered as erucic acid. Erucic acid is also known as cis-13-docosenoic acid. The trans isomer is known as brassidic acid. Erucic acid occurs in nature only along with bitter-tasting compounds. Erucic acid has many of the same uses as mineral oils but with the advantage that it is more readily bio-degradable. Its high tolerance to temperature makes it suitable for transmission oil. Its ability to polymerize and dry means it can be - and is - used as a binder for oil paints. Increased levels of eicosenoic acid (20:ln9) and erucic acid (22:1n9) have been found in the red blood cell membranes of autistic subjects with developmental regression (PMID: 16581239). Erucic acid is broken down long-chain acyl-coenzyme A (CoA) dehydrogenase, which is produced in the liver. This enzyme breaks this long chain fatty acid into shorter-chain fatty acids. human infants have relatively low amounts of this enzyme and because of this, babies should not be given foods high in erucic acid.",,13-docosenoate,,HMDB02068,,C08316,2016-12-05T15:48:06Z,,2245,,,,,8216,,,"(13Z)-13-Docosenoate, (13Z)-13-Docosenoic acid, (13Z)-Docosenoate, (13Z)-Docosenoic acid, (Z)-13-Docosenoate, (Z)-13-Docosenoic acid, 13-Docosenoate, 13-Docosenoic acid, 13-Docosenoic acid (ACD/Name 4.0), cis-13-Docosenoate, cis-13-Docosenoic acid, cis-Erucic acid, delta 13-cis-Docosenoate, delta 13-cis-Docosenoic acid, delta.13-cis-Docosenoate, delta.13-cis-Docosenoic acid, Prifrac 2990",http://vmh.uni.lu/_api/metabolites/2245/?format=pcsv
CE5160,,,-4,C39H62N7O18P3S,,,3-oxo-cis-9-octadecenoyl-CoA,,3-oxo-cis-9-octadecenoyl-CoA,,,,,2016-11-22T15:12:21Z,,2246,,,,,,CE5160,,,http://vmh.uni.lu/_api/metabolites/2246/?format=pcsv
CE5161,,,-4,C39H64N7O18P3S,,,3(S)-hydroxy-cis-9-octadecenoyl-CoA,,3(S)-hydroxy-cis-9-octadecenoyl-CoA,,,,,2016-11-22T15:12:21Z,,2247,,,,,,CE5161,,,http://vmh.uni.lu/_api/metabolites/2247/?format=pcsv
CE5162,,,-4,C39H62N7O17P3S,,,"trans,cis-2,9-octadecadienoyl-CoA",,"trans,cis-2,9-octadecadienoyl-CoA",,,,,2016-11-22T15:12:22Z,,2248,,,,,,CE5162,,,http://vmh.uni.lu/_api/metabolites/2248/?format=pcsv
CE5168,,,-4,C48H76N7O21P3S,,,"24(R),25(R)-varanoyl-CoA",,"24(R),25(R)-varanoyl-CoA",,,,,2016-11-22T15:12:22Z,,2249,,,,,,CE5168,,,http://vmh.uni.lu/_api/metabolites/2249/?format=pcsv
CE5169,,,-4,C48H74N7O21P3S,CHEBI:27379,,"Human Metabolome Database (HMDB): 3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA is an intermediate in bile acid synthesis. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",,24-oxo-25(R)-trihydroxycoprostanoyl-CoA,,HMDB06891,,C05467,2016-12-05T15:48:06Z,,2250,,,,,440690,CE5169,,"(24R,25R)-3-alpha,7-alpha,12-alpha,24-tetrahydroxy-5-beta-cholestan-26-oyl-CoA, (24R,25R)-3-alpha,7-alpha,12-alpha,24-tetrahydroxy-5-beta-cholestan-26-oyl-Coenzyme A, 24-Oxo-25(R)-trihydroxycoprostanoyl-CoA, 24-Oxo-25(R)-trihydroxycoprostanoyl-Coenzyme A, 25(R)-24-Oxo-3alpha,7alpha,12alpha-trihydroxycoprostanoyl-CoA, 25(R)-24-Oxo-3alpha,7alpha,12alpha-trihydroxycoprostanoyl-Coenzyme A, 25(R)-3alpha,7alpha,12alpha-trihydroxy-24-oxo-5beta-cholestanoyl-CoA, 25(R)-3alpha,7alpha,12alpha-trihydroxy-24-oxo-5beta-cholestanoyl-Coenzyme A, 25(R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-24-on-26-oyl-CoA, 25(R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-24-on-26-oyl-Coenzyme A, 25(R)-5beta-cholestane-3alpha,7alpha,12alpha-triol-24-on-26-oyl-CoA, 25(R)-5beta-cholestane-3alpha,7alpha,12alpha-triol-24-on-26-oyl-Coenzyme A, 3-alpha,7-alpha,12-alpha,24-Tetrahydroxy-5-beta-cholestan-26-oyl-CoA, 3-alpha,7-alpha,12-alpha,24-Tetrahydroxy-5-beta-cholestan-26-oyl-Coenzyme A, 3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-beta-cholestanoyl-CoA, 3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-beta-cholestanoyl-Coenzyme A, 3a,7a,12a-Trihydroxy-5b-24-oxocholestanoyl-CoA, 3a,7a,12a-Trihydroxy-5b-24-oxocholestanoyl-Coenzyme A, 3alpha,7alpha,12alpha-Trihydroxy-24-oxo-5beta-cholestanoyl-CoA, 3alpha,7alpha,12alpha-Trihydroxy-24-oxo-5beta-cholestanoyl-Coenzyme A, 3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA, 3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-Coenzyme A, R-TrHOCCoA, R-TrHOCCoenzyme A",http://vmh.uni.lu/_api/metabolites/2250/?format=pcsv
CE4874,,,0,C27H48O5,,,"5beta-cholestane-3alpha,7alpha,12alpha,27,27-pentaol",,"5beta-cholestane-3alpha,7alpha,12alpha,27,27-pentaol",,,,,2016-11-22T15:12:22Z,,2251,,,,,,CE4874,,,http://vmh.uni.lu/_api/metabolites/2251/?format=pcsv
C14826,,,-1,C18H31O3,,,"Human Metabolome Database (HMDB): 12,13-EpOME is the 12,13-cis epoxide of linoleic acid, generated by neutrophils during the oxidative burst. The toxicity and biosynthesis of 12,13-EpOME has not been well differentiated from 9,10-EpOME, but has been presumed to be essentially the same.P.",,12(13)-EpOME,,HMDB04702,"InChI=1/C18H32O3/c1-2-3-10-13-16-17(21-16)14-11-8-6-4-5-7-9-12-15-18(19)20/h8,11,16-17H,2-7,9-10,12-15H2,1H3,(H,19,20)/b11-8-",C14826,2016-12-05T15:48:06Z,,2252,,,,,5356421,,,"(+/-)-12(13)-epoxy-9Z-octadecenoate, (+/-)-12(13)-epoxy-9Z-octadecenoic acid, (9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate, (9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoic acid, (9Z)-12,13-epoxyoctadecenoate, (9Z)-12,13-epoxyoctadecenoic acid, 12(13)-EpOME, 12,13-Epoxy-9(Z)-octadecenoate, 12,13-Epoxy-9(Z)-octadecenoic acid, 12,13-Epoxyoctadec-9(Z)-enoate, 12,13-Epoxyoctadec-9(Z)-enoic acid, Vernolic acid",http://vmh.uni.lu/_api/metabolites/2252/?format=pcsv
CE2049,,,-1,C18H33O4,,,"Human Metabolome Database (HMDB): 12,13-DHOME is the epoxide hydrolase metabolite of the leukotoxin12,13-EpOME. 12,13-EpOMEs act as a protoxin, with the corresponding epoxide hydrolase 12,13-DiHOME specifically exerting toxicity. Both the EpOME and the DiHOME are shown to have neutrophil chemotactic activity. 12,13-DiHOME suppress the neutrophil respiratory burst by a mechanism distinct from that of respiratory burst inhibitors such as cyclosporin H or lipoxin A4,which inhibit multiple aspects of neutrophil activation. 12,13-DHOME is a derivative of linoleic acid diol that have been reported to be toxic in human's tissue preparations. 12,13-DHOME is a naturally occurring proliferator-activated receptor (PPAR) gamma2 ligand, which stimulates adipocytes and inhibits osteoblast differentiation. (PMID: 17435320, 12021203, 12127265).",,"12,13-hydroxyoctadec-9(Z)-enoate",,HMDB04705,"InChI=1/C18H34O4/c1-2-3-10-13-16(19)17(20)14-11-8-6-4-5-7-9-12-15-18(21)22/h8,11,16-17,19-20H,2-7,9-10,12-15H2,1H3,(H,21,22)/p-1/b11-8-",C14829,2016-12-05T15:48:06Z,,2253,,,,,53394649,,,"(9Z)-12,13-Dihydroxyoctadec-9-enoate, (9Z)-12,13-Dihydroxyoctadec-9-enoic acid, 12,13-DiHOME, 12,13-Dihydroxy-9Z-octadecenoate, 12,13-Dihydroxy-9Z-octadecenoic acid, 12,13-Dihydroxyoctadec-9(Z)-enoate, 12,13-Dihydroxyoctadec-9(Z)-enoic acid, 12,13-Hydroxyoctadec-9(Z)-enoate, 12,13-Hydroxyoctadec-9(Z)-enoic acid, Isoleukotoxin",http://vmh.uni.lu/_api/metabolites/2253/?format=pcsv
C14825,,,-1,C18H31O3,,,"Human Metabolome Database (HMDB): 9,10-Epoxyoctadecenoic acid (9,10-EOA) is a peroxidation product of linoleic acid (LA). 9,10-EOA is a naturally occurring component of oxidized low density lipoprotein (LDL), the level of which increases with aging, atherosclerosis, and rheumatoid arthritis, perhaps due to an increase in 15-lipoxygenase and free oxygen radicals. 9,10-EOA is a proliferator-activated receptors (PPAR) gamma2 ligand, that is antiosteogenic without stimulating adipocyte differentiation. Studies in dogs suggest that 9,10-EOA has toxic cardiovascular effects. (PMID: 12665667, 12021203, 10667371).",,9(10)-EpOME,,HMDB04701,"InChI=1/C18H32O3/c1-2-3-4-5-7-10-13-16-17(21-16)14-11-8-6-9-12-15-18(19)20/h7,10,16-17H,2-6,8-9,11-15H2,1H3,(H,19,20)/b10-7-",C14825,2016-12-05T15:48:06Z,,2254,,,,,6246154,,,"(+/-)-9(10)-epoxy-12Z-octadecenoate, (+/-)-9(10)-epoxy-12Z-octadecenoic acid, 9(10)-EpOME, 9,10-Epoxyoctadec-12(Z)-enoate, 9,10-Epoxyoctadec-12(Z)-enoic acid",http://vmh.uni.lu/_api/metabolites/2254/?format=pcsv
CE2047,,,-1,C18H33O4,,,"Human Metabolome Database (HMDB): 9,10-DHOME is a derivative of linoleic acid diol that have been reported to be toxic in human's tissue preparations. 9,10-DHOME is a naturally occurring proliferator-activated receptor (PPAR) gamma2 ligand, which stimulates adipocytes and inhibits osteoblast differentiation. 9,10-DHOME is the epoxide hydrolase metabolite of the leukotoxin 9,10--EpOME. 9,10-EpOMEs act as a protoxin, with the corresponding epoxide hydrolase 9,10-DiHOME specifically exerting toxicity. Both the 9,10-EpOME and the 9,10-DiHOME are shown to have neutrophil chemotactic activity. 9,10-DiHOME suppress the neutrophil respiratory burst by a mechanism distinct from that of respiratory burst inhibitors such as cyclosporin H or lipoxin A4,which inhibit multiple aspects of neutrophil activation. (PMID: 12021203, 12127265, 17435320).",,"9,10-hydroxyoctadec-12(Z)-enoate",,HMDB04704,"InChI=1/C18H34O4/c1-2-3-4-5-7-10-13-16(19)17(20)14-11-8-6-9-12-15-18(21)22/h7,10,16-17,19-20H,2-6,8-9,11-15H2,1H3,(H,21,22)/p-1/b10-7-",C14828,2016-12-05T15:48:06Z,,2255,,,,,53394288,,,"(12Z)-9,10-Dihydroxyoctadec-12-enoate, (12Z)-9,10-Dihydroxyoctadec-12-enoic acid, 9,10-DiHOME, 9,10-Dihydroxy-12Z-octadecenoate, 9,10-Dihydroxy-12Z-octadecenoic acid, 9,10-Hydroxyoctadec-12(Z)-enoate, 9,10-Hydroxyoctadec-12(Z)-enoic acid, Leukotoxin",http://vmh.uni.lu/_api/metabolites/2255/?format=pcsv
CE2305,,,-2,C24H40O10,,,12-hydroxy-13-O-D-glucuronoside-octadec-9Z-enoate,,12-hydroxy-13-O-D-glucuronoside-octadec-9Z-enoate,,,"InChI=1/C24H42O10/c1-2-3-10-13-16(25)17(14-11-8-6-4-5-7-9-12-15-18(26)27)33-24-21(30)19(28)20(29)22(34-24)23(31)32/h8,11,16-17,19-22,24-25,28-30H,2-7,9-10,12-15H2,1H3,(H,26,27)(H,31,32)/p-2/b11-8-/t16u,17u,19-,20+,21-,22-,24?/m0/s1",,2016-11-22T15:12:22Z,,2256,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2256/?format=pcsv
CE2303,,,-2,C24H40O10,,,9-hydroxy-10-O-D-glucuronoside-12Z-octadecenoate,,9-hydroxy-10-O-D-glucuronoside-12Z-octadecenoate,,,"InChI=1/C24H42O10/c1-2-3-4-5-8-11-14-17(16(25)13-10-7-6-9-12-15-18(26)27)33-24-21(30)19(28)20(29)22(34-24)23(31)32/h8,11,16-17,19-22,24-25,28-30H,2-7,9-10,12-15H2,1H3,(H,26,27)(H,31,32)/p-2/b11-8-/t16u,17u,19-,20+,21-,22-,24?/m0/s1",,2016-11-22T15:12:22Z,,2257,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2257/?format=pcsv
CE6317,,,1,C10H12NO2,,,"N,N-dimethylindoliumolate",,"N,N-dimethylindoliumolate",,,"InChI=1/C10H11NO2/c1-11(2)4-3-7-5-9(12)10(13)6-8(7)11/h3-6H,1-2H3,(H-,12,13)",,2016-11-22T15:12:22Z,,2258,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2258/?format=pcsv
CE2306,,,-2,C24H40O10,,,12-O-D-glucuronoside-13-hydroxyoctadec-9Z-enoate,,12-O-D-glucuronoside-13-hydroxyoctadec-9Z-enoate,,,"InChI=1/C24H42O10/c1-2-3-10-14-17(33-24-21(30)19(28)20(29)22(34-24)23(31)32)16(25)13-11-8-6-4-5-7-9-12-15-18(26)27/h8,11,16-17,19-22,24-25,28-30H,2-7,9-10,12-15H2,1H3,(H,26,27)(H,31,32)/p-2/b11-8-/t16u,17u,19-,20+,21-,22-,24?/m1/s1",,2016-11-22T15:12:22Z,,2259,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2259/?format=pcsv
CE2304,,,-2,C24H40O10,,,10-hydroxy-octadec-12Z-enoate-9-beta-D-glucuronide,,10-hydroxy-octadec-12Z-enoate-9-beta-D-glucuronide,,,"InChI=1/C24H42O10/c1-2-3-4-5-7-10-13-16(25)17(14-11-8-6-9-12-15-18(26)27)33-24-21(30)19(28)20(29)22(34-24)23(31)32/h7,10,16-17,19-22,24-25,28-30H,2-6,8-9,11-15H2,1H3,(H,26,27)(H,31,32)/p-2/b10-7-/t16u,17u,19-,20+,21-,22-,24?/m1/s1",,2016-11-22T15:12:22Z,,2260,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2260/?format=pcsv
12dgr120,,,0,C27H52O5,,,"1,2-Diacyl-sn-glycerol (didodecanoyl, n-C12:0)",,"1,2-Diacyl-sn-glycerol (didodecanoyl, n-C12:0)",,,,,2016-11-22T15:12:22Z,,2261,,,,,,12dgr120,,,http://vmh.uni.lu/_api/metabolites/2261/?format=pcsv
C14768,,,-1,C20H31O3,,,"Human Metabolome Database (HMDB): 5,6-Epoxy-8,11,14-eicosatrienoic acid is an Epoxyeicosatrienoic acid (EET), a metabolite of arachidonic acid. The epoxyeicosatrienoic acids (EETs) are endogenous lipid mediators produced by P450 epoxygenases and metabolized through multiple pathways including soluble epoxide hydrolase (sEH). The cytochrome P-450 (P450) monooxygenase pathway includes enzymes of the CYP1A, CYP2B, CYP2C, CYP2E, and CYP2J subfamilies that catalyze the formation of four regioisomeric products, 5,6-, 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid. EETs are produced in brain and perform important biological functions, including protection from ischemic injury. Both light flashes and direct glial stimulation produce vasodilatation mediated by EETs. EETs may be involved in the development of hypertension and endothelial dysfunction in DOCA-salt rats, but not in excessive collagen deposition or electrophysiological abnormalities. EETs have vasodilator and natriuretic effect. Blockade of EET formation is associated with salt-sensitive hypertension. (PMID: 17494091, 17468203, 17434916, 17406062, 17361113).",,"5,6-EET",,HMDB02190,"InChI=1/C20H32O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-19(23-18)16-14-17-20(21)22/h6-7,9-10,12-13,18-19H,2-5,8,11,14-17H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",C14768,2016-12-05T15:48:06Z,,2262,,,,,5283202,C14768,,"(+/-)5,6-EpETrE, (8Z,11Z,14Z)-5,6-Epoxyeicosa-8,11,14-trienoate, (8Z,11Z,14Z)-5,6-Epoxyeicosa-8,11,14-trienoic acid, (8Z,11Z,14Z)-5,6-Epoxyicosa-8,11,14-trienoate, (8Z,11Z,14Z)-5,6-Epoxyicosa-8,11,14-trienoic acid, 5,6-Eet, 5,6-EpETrE, 5,6-Epoxy-8Z,11Z,14Z-eicosatrienoate, 5,6-Epoxy-8Z,11Z,14Z-eicosatrienoic acid",http://vmh.uni.lu/_api/metabolites/2262/?format=pcsv
C14770,,,-1,C20H31O3,,,"Human Metabolome Database (HMDB): 11,12-Epoxyeicosatrienoic acid is an epoxyeicosatrienoic acid (EET). Induction of CYP2C8 in native coronary artery endothelial cells by beta-naphthoflavone enhances the formation of 11,12-epoxyeicosatrienoic acid, as well as endothelium-derived hyperpolarizing factor-mediated hyperpolarization and relaxation. Transfection of coronary arteries with CYP2C8 antisense oligonucleotides resulted in decreased levels of CYP2C and attenuated the endothelium-derived hyperpolarizing factor-mediated vascular responses. Thus, a CYP-epoxygenase product is an essential component of the endothelium-derived hyperpolarizing factor-mediated relaxation in the porcine coronary artery, and CYP2C8 fulfills the criteria for the coronary endothelium-derived hyperpolarization factor synthase. The role of EETs in regulation of the cerebral circulation has become more important, since it was realized that EETs are produced in another specialized cell type of the brain, the astrocytes. It has become evident that EETs released from astrocytes may mediate cerebral functional hyperemia. Molecular and pharmacological evidence hve shown that neurotransmitter release and spillover onto astrocytes can generate EETs. Since these EETs may reach the vasculature via astrocyte foot-processes, they have the same potential as their endothelial counterparts to hyperpolarize and dilate cerebral vessels. P450 enzymes contain heme in their catalytic domain and nitric oxide (NO) appears to bind to these heme moieties and block formation of P450 products, including EETs. Thus, there appears to be crosstalk between P450 enzymes and NO/NO synthase. The role of fatty acid metabolites and cerebral blood flow becomes even more complex in light of data demonstrating that cyclooxygenase products can act as substrates for P450 enzymes. (PMID: 17494091, 17468203, 17434916, 17406062, 17361113, 15581597, 11413051, 10519554).",,"11,12-EET",,HMDB04673,"InChI=1/C20H32O3/c1-2-3-4-5-9-12-15-18-19(23-18)16-13-10-7-6-8-11-14-17-20(21)22/h6,8-10,12-13,18-19H,2-5,7,11,14-17H2,1H3,(H,21,22)/b8-6+,12-9+,13-10+",C14770,2016-12-05T15:48:06Z,,2263,,,,,5353269,C14770,,"(5Z,8Z,14Z)-11,12-Epoxyeicosa-5,8,14-trienoate, (5Z,8Z,14Z)-11,12-Epoxyeicosa-5,8,14-trienoic acid, (5Z,8Z,14Z)-11,12-Epoxyicosa-5,8,14-trienoate, (5Z,8Z,14Z)-11,12-Epoxyicosa-5,8,14-trienoic acid, 10-(3-(2-Octenyl)oxiranyl)-5,8-Decadienoate, 10-(3-(2-Octenyl)oxiranyl)-5,8-Decadienoic acid, 11,12-EET, 11,12-Epoxy-(5Z,8Z,14Z)-eicosatrienoate, 11,12-Epoxy-(5Z,8Z,14Z)-eicosatrienoic acid, 11,12-Epoxy-5,8,14-eicosatrienoate, 11,12-Epoxy-5,8,14-eicosatrienoic acid, 11,12-Epoxyeicosatrienoate, 11,12-Epoxyeicosatrienoic acid, 11,12-Oxido-5,8,14-eicosatrienoate, 11,12-Oxido-5,8,14-eicosatrienoic acid",http://vmh.uni.lu/_api/metabolites/2263/?format=pcsv
C14769,,,-1,C20H31O3,,,"Human Metabolome Database (HMDB): 8,9-Epoxyeicosatrienoic acid is an epoxyeicosatrienoic acid eicosanoid, a metabolite of arachidonic acid. The P450 epoxyeicosatrienoic acids (EETs) are endogenous lipid mediators produced by P450 epoxygenases and metabolized through multiple pathways including soluble epoxide hydrolase (sEH). The cytochrome P-450 (P450) monooxygenase pathway includes enzymes of the CYP1A, CYP2B, CYP2C, CYP2E, and CYP2J subfamilies that catalyze the formation of four regioisomeric products, 5,6-, 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid. EETs are produced in brain and perform important biological functions, including protection from ischemic injury. Both light flashes and direct glial stimulation produce vasodilatation mediated by EETs. EETs may be involved in the development of hypertension and endothelial dysfunction in DOCA-salt rats, but not in excessive collagen deposition or electrophysiological abnormalities. EETs have vasodilator and natriuretic effect. Blockade of EET formation is associated with salt-sensitive hypertension. Four regioisomeric cis-EET are primary products of arachidonic acid metabolism by cytochrome P450 epoxygenases. Upon hydration by soluble epoxide hydrolase (sEH), EET are metabolized to dihydroxyeicosatrienoic acids (DHET). These hydration products are more stable and less biologically active than EETs. (PMID: 17494091, 17468203, 17434916, 17406062, 17361113, 15581597).",,"8,9-EET",,HMDB02232,"InChI=1/C20H32O3/c1-2-3-4-5-6-7-8-9-12-15-18-19(23-18)16-13-10-11-14-17-20(21)22/h6-7,9-10,12-13,18-19H,2-5,8,11,14-17H2,1H3,(H,21,22)/b7-6-,12-9-,13-10-",C14769,2016-12-05T15:48:06Z,,2264,,,,,5283203,C14769,,"(+/-)8,9-EpETrE, (5Z,11Z,14Z)-8,9-Epoxyeicosa-5,11,14-trienoate, (5Z,11Z,14Z)-8,9-Epoxyeicosa-5,11,14-trienoic acid, (5Z,11Z,14Z)-8,9-Epoxyicosa-5,11,14-trienoate, (5Z,11Z,14Z)-8,9-Epoxyicosa-5,11,14-trienoic acid, 8,9-Eet, 8,9-Epoxy-5Z,11Z,14Z-eicosatrienoate, 8,9-Epoxy-5Z,11Z,14Z-eicosatrienoic acid, 8,9-Epoxyeicosatrienoate, 8,9-Epoxyeicosatrienoic acid",http://vmh.uni.lu/_api/metabolites/2264/?format=pcsv
C14771,,,-1,C20H31O3,,,"Human Metabolome Database (HMDB): 14,15-epoxy-5,8,11-eicosatrienoic acid is an epoxyeicosatrienoic acid (EET), a metabolite of arachidonic acid. The P450 eicosanoids epoxyeicosatrienoic acids (EETs) are endogenous lipid mediators produced by P450 epoxygenases and metabolized through multiple pathways including soluble epoxide hydrolase (sEH). The cytochrome P-450 (P450) monooxygenase pathway includes enzymes of the CYP1A, CYP2B, CYP2C, CYP2E, and CYP2J subfamilies that catalyze the formation of four regioisomeric products, 5,6-, 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid. EETs are produced in brain and perform important biological functions, including protection from ischemic injury. Both light flashes and direct glial stimulation produce vasodilatation mediated by EETs. EETs may be involved in the development of hypertension and endothelial dysfunction in DOCA-salt rats, but not in excessive collagen deposition or electrophysiological abnormalities. EETs have vasodilator and natriuretic effect. Blockade of EET formation is associated with salt-sensitive hypertension. Four regioisomeric cis-EET are primary products of arachidonic acid metabolism by cytochrome P450 epoxygenases. Upon hydration by soluble epoxide hydrolase (sEH), EET are metabolized to dihydroxyeicosatrienoic acids (DHET). These hydration products are more stable and less biologically active than EETs. (PMID: 17494091, 17468203, 17434916, 17406062, 17361113, 15581597).",,"14,15-EET",,HMDB04264,"InChI=1/C20H32O3/c1-2-3-12-15-18-19(23-18)16-13-10-8-6-4-5-7-9-11-14-17-20(21)22/h4,6-7,9-10,13,18-19H,2-3,5,8,11-12,14-17H2,1H3,(H,21,22)/b6-4-,9-7-,13-10-",C14771,2016-12-05T15:48:06Z,,2265,,,,,5283205,C14771,,"(+/-)14,15-EpETrE, (5Z,8Z,11Z)-14,15-Epoxyeicosa-5.8.11-trienoate, (5Z,8Z,11Z)-14,15-Epoxyeicosa-5.8.11-trienoic acid, (5Z,8Z,11Z)-14,15-Epoxyicosa-5.8.11-trienoate, (5Z,8Z,11Z)-14,15-Epoxyicosa-5.8.11-trienoic acid, 14(15)-EpETrE, 14(15)-EpETrE-EA, 14,15-EET, 14,15-EpETrE, 14,15-Epoxy-5Z,8Z,11Z-eicosatrienoate, 14,15-Epoxy-5Z,8Z,11Z-eicosatrienoic acid",http://vmh.uni.lu/_api/metabolites/2265/?format=pcsv
CE7101,,,0,C28H48O3,,,8alpha-hydroxy-gama-tocopherone,,8alpha-hydroxy-gama-tocopherone,,,"InChI=1/C28H48O3/c1-20(2)11-8-12-21(3)13-9-14-22(4)15-10-17-27(7)18-16-25-19-26(29)23(5)24(6)28(25,30)31-27/h19-22,30H,8-18H2,1-7H3/t21-,22-,27?,28?/m0/s1",,2016-11-22T15:12:22Z,,2266,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2266/?format=pcsv
CE6219,,,0,C28H48O3,,,gama-tocopheryl quinone,,gama-tocopheryl quinone,,,"InChI=1/C28H48O3/c1-20(2)11-8-12-21(3)13-9-14-22(4)15-10-17-28(7,31)18-16-25-19-26(29)23(5)24(6)27(25)30/h19-22,31H,8-18H2,1-7H3/t21-,22-,28-/m0/s1",,2016-11-22T15:12:22Z,,2267,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2267/?format=pcsv
CE2445,,,-1,C20H31O4,,,"Human Metabolome Database (HMDB): 6-trans-Leukotriene B4 is an enzymatic metabolite of leukotriene B4(LTB4). A greater increase in LTB4 and 6-trans-LTB4 (one of its hydroxylated 5-lipoxygenase metabolic derivatives) occurs after stimulation with calcium-ionophore in asthma patients compared to healthy controls. LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 17623009, 2176862, 7649996, 9667737, 2125732)Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,6-trans-leukotriene B4,,HMDB05087,,,2016-12-05T15:48:06Z,,2268,,,,,5283128,CE2445,,"(6E,5S,12R)-Leukotriene B4, 5(S),12(R)-Dihydroxy-6,8,10,14-(trans,trans,trans,cis)-eicosatetraenoate, 5(S),12(R)-Dihydroxy-6,8,10,14-(trans,trans,trans,cis)-eicosatetraenoic acid, 5S,12R-Dihydroxy-6E,8E,10E,14Z-eicosatetraenoate, 5S,12R-Dihydroxy-6E,8E,10E,14Z-eicosatetraenoic acid, 6-trans-LTB4, D6-trans-Leukotriene B4, D6-trans-LTB4, [S-[R*,S*-(E,E,E,Z)]]-5,12-dihydroxy-6,8,10,14-Eicosatetraenoate, [S-[R*,S*-(E,E,E,Z)]]-5,12-dihydroxy-6,8,10,14-Eicosatetraenoic acid",http://vmh.uni.lu/_api/metabolites/2268/?format=pcsv
CE5178,,,-1,C20H29O4,,,5-oxo-6-trans-leukotriene B4,,5-oxo-6-trans-leukotriene B4,,,,,2016-11-22T15:12:22Z,,2269,,,,,53481526,CE5178,,,http://vmh.uni.lu/_api/metabolites/2269/?format=pcsv
CE2446,,,-1,C20H31O4,,,"Human Metabolome Database (HMDB): 6-trans-12-epi-Leukotriene B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 7649996, 17623009, 2853166, 6088485). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,6E-12-epi-leukotriene B4,,HMDB05088,,,2016-12-05T15:48:06Z,,2270,,,,,,,,"12-Epi-D6-trans-Leukotriene B4, 12-Epi-LTB4, 5(S),12(S)-Dihydroxy-6,8,10,14-(trans,trans,trans,cis)-eicosatetraenoate, 5(S),12(S)-Dihydroxy-6,8,10,14-(trans,trans,trans,cis)-eicosatetraenoic acid, 6-trans-12-Epi-LTB4, D6-trans-12-epi-LTB4, D6-trans-12-Epileukotriene B4, [S-[R*,R*-(E,E,E,Z)]]-5,12-dihydroxy-6,8,10,14-Eicosatetraenoate, [S-[R*,R*-(E,E,E,Z)]]-5,12-dihydroxy-6,8,10,14-Eicosatetraenoic acid",http://vmh.uni.lu/_api/metabolites/2270/?format=pcsv
CE5349,,,-1,C20H29O4,,,5-oxo-6E-12-epi-leukotriene B4,,5-oxo-6E-12-epi-leukotriene B4,,,,,2016-11-22T15:12:22Z,,2271,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2271/?format=pcsv
CE5343,,,-1,C20H31O4,,,"6,7-dihydro-5-oxo-12-epi-leukotriene B",,"6,7-dihydro-5-oxo-12-epi-leukotriene B",,,,,2016-11-22T15:12:22Z,,2272,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2272/?format=pcsv
CE5352,,,-1,C20H33O4,,,"6,7-dihydro-leukotriene B4",,"6,7-dihydro-leukotriene B4",,,,,2016-11-22T15:12:22Z,,2273,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2273/?format=pcsv
CE5179,,,-1,C20H31O4,,,"6,7-dihydro-5-oxo-leukotriene B4",,"6,7-dihydro-5-oxo-leukotriene B4",,,,,2016-11-22T15:12:22Z,,2274,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2274/?format=pcsv
CE5348,,,-4,C41H62N7O19P3S,,,"5-oxo-12(R)-hydroxy-eicosa-8E,10E,14Z-trienoyl-CoA",,"5-oxo-12(R)-hydroxy-eicosa-8E,10E,14Z-trienoyl-CoA",,,,,2016-11-22T15:12:22Z,,2275,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2275/?format=pcsv
CE5347,,,-4,C41H60N7O19P3S,,,"5-oxo-12(R)-hydroxy-eicosa-2E,8E,10E,14Z-tetraenoyl-CoA",,"5-oxo-12(R)-hydroxy-eicosa-2E,8E,10E,14Z-tetraenoyl-CoA",,,,,2016-11-22T15:12:22Z,,2276,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2276/?format=pcsv
CE5345,,,-4,C41H60N7O20P3S,,,"3,5-dioxo-12(R)-hydroxy-eicosa-8E,10E,14Z-trienoyl-CoA",,"3,5-dioxo-12(R)-hydroxy-eicosa-8E,10E,14Z-trienoyl-CoA",,,,,2016-11-22T15:12:22Z,,2277,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2277/?format=pcsv
CE5346,,,-4,C39H58N7O19P3S,,,"3-oxo-10(R)-hydroxy-octadeca-6E,8E,12Z-trienoyl-CoA",,"3-oxo-10(R)-hydroxy-octadeca-6E,8E,12Z-trienoyl-CoA",,,,,2016-11-22T15:12:22Z,,2278,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2278/?format=pcsv
CE5344,,,-4,C41H62N7O20P3S,,,"3(S),12(R)-dihydroxy-5-oxo-eicosa-8E,10E,14Z-trienoyl-CoA",,"3(S),12(R)-dihydroxy-5-oxo-eicosa-8E,10E,14Z-trienoyl-CoA",,,,,2016-11-22T15:12:22Z,,2279,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2279/?format=pcsv
CE5307,,,-1,C18H27O4,,,"3-oxo-10(R)-hydroxy-octadeca-6E,8E,12Z-trienoate",,"3-oxo-10(R)-hydroxy-octadeca-6E,8E,12Z-trienoate",,,,,2016-11-22T15:12:22Z,,2280,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2280/?format=pcsv
CE5329,,,-4,C41H62N7O20P3S,,,"3(S),12(S)-dihydroxy-5-oxo-eicosa-8E,10E,14Z-trienoyl-CoA",,"3(S),12(S)-dihydroxy-5-oxo-eicosa-8E,10E,14Z-trienoyl-CoA",,,,,2016-11-22T15:12:22Z,,2281,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2281/?format=pcsv
CE5331,,,-4,C41H60N7O20P3S,,,"3,5-dioxo-12(S)-hydroxy-eicosa-8E,10E,14Z-trienoyl-CoA",,"3,5-dioxo-12(S)-hydroxy-eicosa-8E,10E,14Z-trienoyl-CoA",,,,,2016-11-22T15:12:22Z,,2282,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2282/?format=pcsv
CE5342,,,-4,C41H62N7O19P3S,,,"5-oxo-12(S)-hydroxy-eicosa-8E,10E,14Z-trienoyl-CoA",,"5-oxo-12(S)-hydroxy-eicosa-8E,10E,14Z-trienoyl-CoA",,,,,2016-11-22T15:12:22Z,,2283,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2283/?format=pcsv
CE5341,,,-4,C41H60N7O19P3S,,,"5-oxo-12(S)-hydroxy-eicosa-2E,8E,10E,14Z-tetraenoyl-CoA",,"5-oxo-12(S)-hydroxy-eicosa-2E,8E,10E,14Z-tetraenoyl-CoA",,,,,2016-11-22T15:12:22Z,,2284,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2284/?format=pcsv
CE5337,,,-4,C39H58N7O19P3S,,,"3-oxo-10(S)-hydroxy-octadeca-6E,8E,12Z-trienoyl-CoA",,"3-oxo-10(S)-hydroxy-octadeca-6E,8E,12Z-trienoyl-CoA",,,,,2016-11-22T15:12:22Z,,2285,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2285/?format=pcsv
CE5319,,,-1,C18H27O4,,,"3-oxo-10(S)-hydroxy-octadeca-6E,8E,12Z-trienoate",,"3-oxo-10(S)-hydroxy-octadeca-6E,8E,12Z-trienoate",,,,,2016-11-22T15:12:22Z,,2286,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2286/?format=pcsv
C11821,,,0,C5H4N4O4,CHEBI:18072,,5-Hydroxyisourate,,5-Hydroxyisourate,,,"InChI=1S/C5H4N4O4/c10-2-5(13)1(6-3(11)8-2)7-4(12)9-5/h13H,(H3,6,7,8,9,10,11,12)",C11821,2016-11-22T15:12:22Z,,2287,,,,,250388,,,,http://vmh.uni.lu/_api/metabolites/2287/?format=pcsv
CE7144,,,0,C29H44O3,,,13'-hydroxy-alpha-tocotrienol,,13'-hydroxy-alpha-tocotrienol,,,,,2016-11-22T15:12:22Z,,2288,,,,,53481466,CE7144,,,http://vmh.uni.lu/_api/metabolites/2288/?format=pcsv
CE7145,,,-1,C29H41O4,,,13'-carboxy-alpha-tocotrienol,,13'-carboxy-alpha-tocotrienol,,,,,2016-11-22T15:12:22Z,,2289,,,,,53481462,CE7145,,,http://vmh.uni.lu/_api/metabolites/2289/?format=pcsv
CE5956,,,-3,C20H33O7P2,,,"trans,trans,cis-geranyl-geranyl-PP",,"trans,trans,cis-geranyl-geranyl-PP",,,,,2016-11-22T15:12:22Z,,2290,,,,,735,CE5956,,,http://vmh.uni.lu/_api/metabolites/2290/?format=pcsv
CE5316,,,-1,C16H25O3,,,"8(R)-hydroxy-hexadeca-4E,6E,10Z-trienoate",,"8(R)-hydroxy-hexadeca-4E,6E,10Z-trienoate",,,,,2016-11-22T15:12:22Z,,2291,,,,,6610221,,,,http://vmh.uni.lu/_api/metabolites/2291/?format=pcsv
CE5309,,,-1,C16H25O4,,,"3-oxo-8(R)-hydroxy-hexadeca-6E,10Z-dienoate",,"3-oxo-8(R)-hydroxy-hexadeca-6E,10Z-dienoate",,,,,2016-11-22T15:12:22Z,,2292,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2292/?format=pcsv
CE5313,,,-1,C14H23O3,,,"6(R)-hydroxy-tetradeca-4E,8Z-dienoate",,"6(R)-hydroxy-tetradeca-4E,8Z-dienoate",,,,,2016-11-22T15:12:22Z,,2293,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2293/?format=pcsv
CE5314,,,-1,C16H23O3,,,"8(R)-hydroxy-hexadeca-2E,4E,6E,10Z-tetraenoate",,"8(R)-hydroxy-hexadeca-2E,4E,6E,10Z-tetraenoate",,,,,2016-11-22T15:12:22Z,,2294,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2294/?format=pcsv
CE5315,,,-1,C16H25O3,,,"8(R)-hydroxy-hexadeca-2E,6E,10Z-trienoate",,"8(R)-hydroxy-hexadeca-2E,6E,10Z-trienoate",,,,,2016-11-22T15:12:22Z,,2295,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2295/?format=pcsv
CE5306,,,-1,C16H27O4,,,"3(S),8(R)-dihydroxy-6E,10Z-hexadecadienoate",,"3(S),8(R)-dihydroxy-6E,10Z-hexadecadienoate",,,,,2016-11-22T15:12:22Z,,2296,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2296/?format=pcsv
CE5308,,,-1,C14H23O4,,,3-oxo-6(R)-hydroxy-tetradec-8-cis-enoate,,3-oxo-6(R)-hydroxy-tetradec-8-cis-enoate,,,,,2016-11-22T15:12:22Z,,2297,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2297/?format=pcsv
CE5310,,,-1,C12H21O3,,,4(R)-hydroxy-dodec-6Z-enoate,,4(R)-hydroxy-dodec-6Z-enoate,,,,,2016-11-22T15:12:22Z,,2298,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2298/?format=pcsv
CE5311,,,-1,C14H21O3,,,"6(R)-hydroxy-tetradeca-2E,4E,8Z-trienoate",,"6(R)-hydroxy-tetradeca-2E,4E,8Z-trienoate",,,,,2016-11-22T15:12:22Z,,2299,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2299/?format=pcsv
CE5312,,,-1,C14H23O3,,,"6(R)-hydroxy-tetradeca-2E,8Z-dienoate",,"6(R)-hydroxy-tetradeca-2E,8Z-dienoate",,,,,2016-11-22T15:12:22Z,,2300,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2300/?format=pcsv
CE5305,,,-1,C14H25O4,,,"3(S),6(R)-dihydroxy-tetradec-8Z-enoate",,"3(S),6(R)-dihydroxy-tetradec-8Z-enoate",,,,,2016-11-22T15:12:22Z,,2301,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2301/?format=pcsv
CE5321,,,-1,C16H25O4,,,"3-oxo-8(S)-hydroxy-hexadeca-6E,10Z-dienoate",,"3-oxo-8(S)-hydroxy-hexadeca-6E,10Z-dienoate",,,,,2016-11-22T15:12:22Z,,2302,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2302/?format=pcsv
CE5325,,,-1,C14H23O3,,,"6(S)-hydroxy-tetradeca-4E,8Z-dienoate",,"6(S)-hydroxy-tetradeca-4E,8Z-dienoate",,,,,2016-11-22T15:12:22Z,,2303,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2303/?format=pcsv
CE5323,,,-1,C14H21O3,,,"6(S)-hydroxy-tetradeca-2E,4E,8Z-trienoate",,"6(S)-hydroxy-tetradeca-2E,4E,8Z-trienoate",,,,,2016-11-22T15:12:22Z,,2304,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2304/?format=pcsv
CE5328,,,-1,C16H25O3,,,"8(S)-hydroxy-hexadeca-4E,6E-10Z-trienoate",,"8(S)-hydroxy-hexadeca-4E,6E-10Z-trienoate",,,,,2016-11-22T15:12:22Z,,2305,,,,,6610221,,,,http://vmh.uni.lu/_api/metabolites/2305/?format=pcsv
CE5326,,,-1,C16H23O3,,,"8(S)-hydroxy-hexadeca-2E,4E,6E,10Z-tetraenoate",,"8(S)-hydroxy-hexadeca-2E,4E,6E,10Z-tetraenoate",,,,,2016-11-22T15:12:22Z,,2306,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2306/?format=pcsv
CE5327,,,-1,C16H25O3,,,"8(S)-hydroxy-hexadeca-2E,6E,10Z-trienoate",,"8(S)-hydroxy-hexadeca-2E,6E,10Z-trienoate",,,,,2016-11-22T15:12:22Z,,2307,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2307/?format=pcsv
CE5318,,,-1,C16H27O4,,,"3(S),8(S)-dihydroxy-6E,10Z-hexadecadienoate",,"3(S),8(S)-dihydroxy-6E,10Z-hexadecadienoate",,,,,2016-11-22T15:12:23Z,,2308,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2308/?format=pcsv
CE5320,,,-1,C14H23O4,,,3-oxo-6(S)-hydroxy-tetradec-8Z-enoate,,3-oxo-6(S)-hydroxy-tetradec-8Z-enoate,,,,,2016-11-22T15:12:23Z,,2309,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2309/?format=pcsv
CE5322,,,-1,C12H21O3,,,4(S)-hydroxy-dodec-6Z-enoate,,4(S)-hydroxy-dodec-6Z-enoate,,,,,2016-11-22T15:12:23Z,,2310,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2310/?format=pcsv
CE5324,,,-1,C14H23O3,,,"6(S)-hydroxy-tetradeca-2E,8Z-dienoate",,"6(S)-hydroxy-tetradeca-2E,8Z-dienoate",,,,,2016-11-22T15:12:23Z,,2311,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2311/?format=pcsv
CE5317,,,-1,C14H25O4,,,"3(S),6(S)-dihydroxy-tetradec-8Z-enoate",,"3(S),6(S)-dihydroxy-tetradec-8Z-enoate",,,,,2016-11-22T15:12:23Z,,2312,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2312/?format=pcsv
CE5527,,,-1,C18H30O3,,,"12,13-epoxylinoleic acid radical",,"12,13-epoxylinoleic acid radical",,,,,2016-11-22T15:12:23Z,,2313,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2313/?format=pcsv
CE5922,,,-1,C18H31O5,,,"12,13-epoxy-9-hydroperoxy-10E-octadecenoate",,"12,13-epoxy-9-hydroperoxy-10E-octadecenoate",,,,,2016-11-22T15:12:23Z,,2314,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2314/?format=pcsv
CE5528,,,-1,C18H30O4,,,"12,13-epoxy-9-alkoxy-10E-octadecenoate",,"12,13-epoxy-9-alkoxy-10E-octadecenoate",,,,,2016-11-22T15:12:23Z,,2315,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2315/?format=pcsv
CE2061,,,0,C10H16O2,,,"trans-4,5-epoxy-2(E)-decenal",,"trans-4,5-epoxy-2(E)-decenal",,,,,2016-11-22T15:12:23Z,,2316,,,,,526708,,,,http://vmh.uni.lu/_api/metabolites/2316/?format=pcsv
CE5921,,,0,C8H15O2,,,octanoate radical,,octanoate radical,,,,,2016-11-22T15:12:23Z,,2317,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2317/?format=pcsv
CE6415,,,-1,C18H31O4,,,11-HpODE,,11-HpODE,,,,C07338,2016-11-22T15:12:23Z,,2318,,,,,5230520,CE6415,,,http://vmh.uni.lu/_api/metabolites/2318/?format=pcsv
CE6502,,,-1,C18H31O4,,,"9,10-12,13-diepoxy-octadecanoate",,"9,10-12,13-diepoxy-octadecanoate",,,,C14836,2016-11-22T15:12:23Z,,2319,,,,,18172,,,,http://vmh.uni.lu/_api/metabolites/2319/?format=pcsv
C04717,,,-1,C18H31O4,CHEBI:15655,,"Human Metabolome Database (HMDB): 13-L-Hydroperoxylinoleic acid (13(S)-HPODE) is one of the primary products of the major polyunsaturated fatty acids (linoleic acid and arachidonic acid) from the 15-1ipoxygenase pathway (EC: 1.13.11.31). 13(S)-HPODE is a rather unstable metabolite and is rapidly metabolized to more stable secondary products such as diverse forms of hydroxy fatty acids (via reduction of the hydroperoxy group), alkoxy radicals (via homolytic cleavage of the peroxy group), forms of dihydro(pero)xy fatty acids (via lipoxygenase-catalysed double and triple oxygenation), or epoxy leukotrienes (via a hydrogen abstraction from a doubly allylic methylene group and a homolytic cleavage of the hydroperoxy group). (PMID 9082450).",,13(S)-HPODE(1-),,HMDB03871,"InChI=1S/C18H32O4/c1-2-3-11-14-17(22-21)15-12-9-7-5-4-6-8-10-13-16-18(19)20/h7,9,12,15,17,21H,2-6,8,10-11,13-14,16H2,1H3,(H,19,20)/p-1/b9-7-,15-12+/t17-/m0/s1",C04717,2016-12-05T15:48:06Z,,2320,,,,,5280720,,,"(13S,9z,11e)-13-hydroperoxy-9,11-octadecadienoate, (13S,9z,11e)-13-hydroperoxy-9,11-octadecadienoic acid, (9Z,11e)-(13S)-13-hydroperoxyoctadeca-9,11-dienoate, (9Z,11e)-(13S)-13-hydroperoxyoctadeca-9,11-dienoic acid, 13(S)-Hpode, 13(S)-Hydroperoxy-9Z,11e-octadecadienoate, 13(S)-Hydroperoxy-9Z,11e-octadecadienoic acid, 13(S)-Hydroperoxylinoleic acid, 13-Hpod, 13-Hpode, 13-L-Hydroperoxy-9-cis,11-trans-octadecadienoate, 13-L-Hydroperoxy-9-cis,11-trans-octadecadienoic acid, 13-L-Hydroperoxy-cis-9,trans-11-octadecadienoate, 13-L-Hydroperoxy-cis-9,trans-11-octadecadienoic acid, 13S-Hydroperoxy-9Z,11e-octadecadienoate, 13S-Hydroperoxy-9Z,11e-octadecadienoic acid, Hpode, Linoleic acid 13(S)-hydroperoxide",http://vmh.uni.lu/_api/metabolites/2320/?format=pcsv
C01601,,,-1,C9H17O2,CHEBI:29019,,"Human Metabolome Database (HMDB): Pelargonic acid, or nonanoic acid, is a fatty acid which occurs naturally as esters is the oil of pelargonium. Synthetic esters, such as methyl nonanoate, are used as flavorings. Pelargonic acid is an organic compound composed of a nine-carbon chain terminating in a carboxylic acid. It is an oily liquid with an unpleasant, rancid odor. It is nearly insoluble in water, but well soluble in chloroform and ether. The derivative 4-nonanoylmorpholine is an ingredient in some pepper sprays.",,nonanoate,,HMDB00847,"InChI=1S/C9H18O2/c1-2-3-4-5-6-7-8-9(10)11/h2-8H2,1H3,(H,10,11)/p-1",C01601,2016-12-05T15:48:06Z,,2321,,,,,8158,,,"1-Nonanoate, 1-Nonanoic acid, 1-Octanecarboxylate, 1-Octanecarboxylic acid, Cirrasol 185a, Emery 1202, Emery'S L-114, Emfac 1202, Hexacid C-9, N-Nonanoate, N-Nonanoic acid, N-Nonoate, N-Nonoic acid, N-Nonylate, N-Nonylic acid, N-Pelargonate, N-Pelargonic acid, Nonanoate, Nonanoic acid, Nonoate, Nonoic acid, Nonylate, Nonylic acid, Pelargate, Pelargic acid, Pelargon, Pelargonate, Pelargonic acid, Pergonate, Pergonic acid",http://vmh.uni.lu/_api/metabolites/2321/?format=pcsv
CE6504,,,-1,C18H31O6,,,"1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether",,"1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether",,,,,2016-11-22T15:12:23Z,,2322,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2322/?format=pcsv
CE2006,,,0,C9H16O2,CHEBI:32585,,"Human Metabolome Database (HMDB): 4-Hydroxynonenal (HNE), one of the major end products of lipid peroxidation, has been shown to be involved in signal transduction and available evidence suggests that it can affect cell cycle events in a concentration-dependent manner. glutathione S-transferases (GSTs) can modulate the intracellular concentrations of HNE by affecting its generation during lipid peroxidation by reducing hydroperoxides and also by converting it into a glutathione conjugate. Overexpression of the Alpha class GSTs in cells leads to lower steady-state levels of HNE, and these cells acquire resistance to apoptosis induced by lipid peroxidation-causing agents such as H(2)O(2), UVA, superoxide anion, and pro-oxidant xenobiotics, suggesting that signaling for apoptosis by these agents is transduced through HNE. Cells with the capacity to exclude HNE from the intracellular environment at a faster rate are relatively more resistant to apoptosis caused by H(2)O(2), UVA, superoxide anion, and pro-oxidant xenobiotics as well as by HNE, suggesting that HNE may be a common denominator in mechanisms of apoptosis caused by oxidative stress. Transfection of adherent cells with HNE-metabolizing GSTs leads to transformation of these cells due to depletion of HNE. (PMID 15288119).",,4-hydroxy-2-nonenal,,HMDB04362,"InChI=1S/C9H16O2/c1-2-3-4-6-9(11)7-5-8-10/h5,7-9,11H,2-4,6H2,1H3",,2016-12-05T15:48:06Z,,2323,,,,,5283344,,,"4-Hydroxy-2,3-nonenal, 4-Hydroxy-2-Nonenal, 4-Hydroxynon-2-enal, 4-Hydroxynonenal, trans-4-Hydroxy-2-nonenal",http://vmh.uni.lu/_api/metabolites/2323/?format=pcsv
CE6506,,,0,C9H16O2,,,"3,4-epoxynonanal",,"3,4-epoxynonanal",,,"InChI=1/C9H16O2/c1-2-3-4-5-8-9(11-8)6-7-10/h7-9H,2-6H2,1H3",,2016-11-22T15:12:23Z,,2324,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2324/?format=pcsv
CE5526,,,-1,C18H30O3,,,13-oxy radical-octadecadienoate,,13-oxy radical-octadecadienoate,,,,,2016-11-22T15:12:23Z,,2325,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2325/?format=pcsv
CE5898,,,0,C5H11,,,pentyl radical,,pentyl radical,,,,,2016-11-22T15:12:23Z,,2326,,,,,123167,,,,http://vmh.uni.lu/_api/metabolites/2326/?format=pcsv
CE5920,,,-1,C13H19O3,,,"13-oxo-9Z,11E-tridecadienoate",,"13-oxo-9Z,11E-tridecadienoate",,,,,2016-11-22T15:12:23Z,,2327,,,,,54469261,,,,http://vmh.uni.lu/_api/metabolites/2327/?format=pcsv
C08261,,,-2,C9H14O4,CHEBI:48131,,"Human Metabolome Database (HMDB): Azelaic acid (AZA) is a naturally occurring saturated nine-carbon dicarboxylic acid (COOH (CH2)7-COOH). It possesses a variety of biological actions both in vitro and in vivo. Interest in the biological activity of AZA arose originally out of studies of skin surface lipids and the pathogenesis of hypochromia in pityriasis versicolor infection. Later, it was shown that Pityrosporum can oxidize unsaturated fatty acids to C8-C12 dicarboxylic acids that are cornpetitive inhibitors of tyrosinase in vitro. Azelaic acid was chosen for further investigation and development of a new topical drug for treating hyperpigmentary disorders for the following reasons: it possesses a middle-range of antityrosinase activity, is inexpensive, and more soluble to be incorporated into a base cream than other dicarboxylic acids. Azelaic acid is another option for the topical treatment of mild to moderate inflammatory acne vulgaris. It offers effectiveness similar to that of other agents without the systemic side effects of oral antibiotics or the allergic sensitization of topical benzoyl peroxide and with less irritation than tretinoin. Azelaic acid is less expensive than certain other prescription acne preparations, but it is much more expensive than nonprescription benzoyl peroxide preparations. Whether it is safe and effective when used in combination with other agents is not known. (PMID: 7737781, 8961845).",,Azelaic acid,,HMDB00784,"InChI=1S/C9H16O4/c10-8(11)6-4-2-1-3-5-7-9(12)13/h1-7H2,(H,10,11)(H,12,13)",C08261,2016-12-05T15:48:06Z,,2328,,,,,2266,,,"1,7-Dicarboxyheptane, 1,7-Heptanedicarboxylate, 1,7-Heptanedicarboxylic acid, 1,9-Nonanedioate, 1,9-Nonanedioic acid, Anchoate, Anchoic acid, Azalaic acid, Azelaic acid, Azelaicacidtech, Azelainic acid, Azelate, Azelex, Emerox 1110, Emerox 1144, Emery'S L-110, Finacea, Finevin, Heptanedicarboxylic acid, Lepargylate, Lepargylic acid, N-Nonanedioate, N-Nonanedioic acid, Nonanedioate, Nonanedioic acid, Nonanedioic acid azelaic acid, Nonanedioic acid homopolymer, Poly(azelaic anhydride), Polyazelaic anhydride, Skinorem, Skinoren",http://vmh.uni.lu/_api/metabolites/2328/?format=pcsv
CE4876,,,-1,C20H29O4,,,delta12-Prostaglandin J2,,delta12-Prostaglandin J2,,,"InChI=1/C20H30O4/c1-2-3-6-10-17(21)13-14-18-16(12-15-19(18)22)9-7-4-5-8-11-20(23)24/h4,7,12,14-17,21H,2-3,5-6,8-11,13H2,1H3,(H,23,24)/p-1/b7-4-,18-14+/t16-,17-/m0/s1",,2016-11-22T15:12:23Z,,2329,,,,,114678,CE4876,,,http://vmh.uni.lu/_api/metabolites/2329/?format=pcsv
CE5304,,,-1,C20H29O4,,,15-deoxy-PGD2,,15-deoxy-PGD2,,,"InChI=1/C20H30O4/c1-2-3-4-5-6-9-12-16-17(19(22)15-18(16)21)13-10-7-8-11-14-20(23)24/h6-7,9-10,12,17,19,22H,2-5,8,11,13-15H2,1H3,(H,23,24)/p-1/b9-6-,10-7-,16-12+/t17-,19+/m0/s1",,2016-11-22T15:12:23Z,,2330,,,,,5283052,CE5304,,,http://vmh.uni.lu/_api/metabolites/2330/?format=pcsv
CE5944,,,-1,C20H31O4,,,"10,11-dihydro-12-oxo-LTB4",,"10,11-dihydro-12-oxo-LTB4",,,"InChI=1/C20H32O4/c1-2-3-4-5-6-9-13-18(21)14-10-7-8-11-15-19(22)16-12-17-20(23)24/h6-9,11,15,19,22H,2-5,10,12-14,16-17H2,1H3,(H,23,24)/p-1/b8-7+,9-6-,15-11-/t19-/m0/s1",,2016-11-22T15:12:23Z,,2331,,,,,53481445,CE5944,,,http://vmh.uni.lu/_api/metabolites/2331/?format=pcsv
CE4987,,,-1,C20H33O4,,,"10,11-dihydro-leukotriene B4",,"10,11-dihydro-leukotriene B4",,,"InChI=1/C20H34O4/c1-2-3-4-5-6-9-13-18(21)14-10-7-8-11-15-19(22)16-12-17-20(23)24/h6-9,11,15,18-19,21-22H,2-5,10,12-14,16-17H2,1H3,(H,23,24)/p-1/b8-7+,9-6-,15-11-/t18-,19-/m0/s1",,2016-11-22T15:12:23Z,,2332,,,,,53481449,CE4987,,,http://vmh.uni.lu/_api/metabolites/2332/?format=pcsv
CE4988,,,-1,C20H33O4,,,"10,11-dihydro-12-epi-leukotriene B4",,"10,11-dihydro-12-epi-leukotriene B4",,,"InChI=1/C20H34O4/c1-2-3-4-5-6-9-13-18(21)14-10-7-8-11-15-19(22)16-12-17-20(23)24/h6-9,11,15,18-19,21-22H,2-5,10,12-14,16-17H2,1H3,(H,23,24)/p-1/b8-7+,9-6-,15-11-/t18-,19-/m0/s1",,2016-11-22T15:12:23Z,,2333,,,,,,CE4988,,,http://vmh.uni.lu/_api/metabolites/2333/?format=pcsv
CE4989,,,-1,C20H33O5,,,"20-OH-10,11-dihydro-leukotriene B4",,"20-OH-10,11-dihydro-leukotriene B4",,,,,2016-11-22T15:12:23Z,,2334,,,,,,CE4989,,,http://vmh.uni.lu/_api/metabolites/2334/?format=pcsv
CE5945,,,-1,C20H33O6,,,"10,11-dihydro-20-dihydroxy-LTB4",,"10,11-dihydro-20-dihydroxy-LTB4",,,,,2016-11-22T15:12:23Z,,2335,,,,,53481447,,,,http://vmh.uni.lu/_api/metabolites/2335/?format=pcsv
CE5946,,,-1,C20H33O7,,,"10,11-dihydro-20-trihydroxy-leukotriene B4",,"10,11-dihydro-20-trihydroxy-leukotriene B4",,,,,2016-11-22T15:12:23Z,,2336,,,,,53481448,CE5946,,,http://vmh.uni.lu/_api/metabolites/2336/?format=pcsv
CE5947,,,-2,C20H30O6,,,"20-COOH-10,11-dihydro-LTB4",,"20-COOH-10,11-dihydro-LTB4",,,,,2016-11-22T15:12:23Z,,2337,,,,,53481507,CE5947,,,http://vmh.uni.lu/_api/metabolites/2337/?format=pcsv
CE7074,,,0,C28H42O3,,,13'-hydroxy-gama-tocotrienol,,13'-hydroxy-gama-tocotrienol,,,,,2016-11-22T15:12:23Z,,2338,,,,,53481468,,,,http://vmh.uni.lu/_api/metabolites/2338/?format=pcsv
CE7072,,,-1,C28H39O4,,,13'-carboxy-gama-tocotrienol,,13'-carboxy-gama-tocotrienol,,,,,2016-11-22T15:12:23Z,,2339,,,,,53481464,,,,http://vmh.uni.lu/_api/metabolites/2339/?format=pcsv
CE5966,,,-4,C41H62N7O20P3S,,,"3-oxo-5(S),12(R)-dihydroxy-eicosa-8-trans-6,14-cis-trienoyl-CoA",,"3-oxo-5(S),12(R)-dihydroxy-eicosa-8-trans-6,14-cis-trienoyl-CoA",,,,,2016-11-22T15:12:23Z,,2340,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2340/?format=pcsv
CE5967,,,-4,C39H60N7O19P3S,,,"3(S),10(R)-OH-octadeca-6-trans-4,12-cis-trienoyl-CoA",,"3(S),10(R)-OH-octadeca-6-trans-4,12-cis-trienoyl-CoA",,,,,2016-11-22T15:12:23Z,,2341,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2341/?format=pcsv
CE5968,,,-1,C18H29O4,,,"3(S),10(R)-OH-octadeca-6-trans-4,12-cis-trienoate",,"3(S),10(R)-OH-octadeca-6-trans-4,12-cis-trienoate",,,,,2016-11-22T15:12:23Z,,2342,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2342/?format=pcsv
CE5969,,,-4,C41H64N7O19P3S,,,"10,11-dihydro-LTB4-CoA",,"10,11-dihydro-LTB4-CoA",,,,,2016-11-22T15:12:23Z,,2343,,,,,,CE5969,,,http://vmh.uni.lu/_api/metabolites/2343/?format=pcsv
CE5970,,,-4,C41H62N7O19P3S,,,"5(S),12(R)-dihydroxy-eicosa-2,8-trans-6,14-cis-tetraenoyl-CoA",,"5(S),12(R)-dihydroxy-eicosa-2,8-trans-6,14-cis-tetraenoyl-CoA",,,,,2016-11-22T15:12:23Z,,2344,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2344/?format=pcsv
CE5971,,,-4,C41H64N7O20P3S,,,"3(S),5(S),12(R)-trihydroxy-eicosa-8-trans-6,14-cis-trienoyl-CoA",,"3(S),5(S),12(R)-trihydroxy-eicosa-8-trans-6,14-cis-trienoyl-CoA",,,,,2016-11-22T15:12:23Z,,2345,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2345/?format=pcsv
CE5535,,,-1,C20H30O4,,,"9-peroxy-5Z,7E,11Z,14Z-eicosatetraenoate",,"9-peroxy-5Z,7E,11Z,14Z-eicosatetraenoate",,,"InChI=1/C20H31O4/c1-2-3-4-5-6-7-8-10-13-16-19(24-23)17-14-11-9-12-15-18-20(21)22/h6-7,9-11,13-14,17,19H,2-5,8,12,15-16,18H2,1H3,(H,21,22)/p-1/b7-6-,11-9-,13-10-,17-14+",,2016-11-22T15:12:23Z,,2346,,,,,,CE5535,,,http://vmh.uni.lu/_api/metabolites/2346/?format=pcsv
CE5534,,,-1,C20H31O6,,,"9,11-cycloperoxy-5-hydroperoxy-6E,14Z-eicosadienoate",,"9,11-cycloperoxy-5-hydroperoxy-6E,14Z-eicosadienoate",,,,,2016-11-22T15:12:23Z,,2347,,,,,,CE5534,,,http://vmh.uni.lu/_api/metabolites/2347/?format=pcsv
CE5828,,,-1,C20H33O5,,,"5,9,11-trihydroxyprosta-6E,14Z-dien-1-oate",,"5,9,11-trihydroxyprosta-6E,14Z-dien-1-oate",,,,,2016-11-22T15:12:23Z,,2348,,,,,,CE5828,,,http://vmh.uni.lu/_api/metabolites/2348/?format=pcsv
CE5925,,,-1,C20H30O4,,,"12-peroxy-5Z,8Z,10E,14Z-eicosatetraenoate",,"12-peroxy-5Z,8Z,10E,14Z-eicosatetraenoate",,,"InChI=1/C20H31O4/c1-2-3-4-5-10-13-16-19(24-23)17-14-11-8-6-7-9-12-15-18-20(21)22/h7-11,13-14,17,19H,2-6,12,15-16,18H2,1H3,(H,21,22)/p-1/b9-7-,11-8-,13-10-,17-14+",,2016-11-22T15:12:23Z,,2349,,,,,,CE5925,,,http://vmh.uni.lu/_api/metabolites/2349/?format=pcsv
CE5926,,,-1,C20H31O6,,,"11,15-cyclo-12,14-cycloperoxy-8-hydroperoxy-5Z,9E-eicosadienoic",,"11,15-cyclo-12,14-cycloperoxy-8-hydroperoxy-5Z,9E-eicosadienoic",,,,,2016-11-22T15:12:23Z,,2350,,,,,,CE5926,,,http://vmh.uni.lu/_api/metabolites/2350/?format=pcsv
CE5929,,,-1,C20H33O5,,,"11,15-cyclo-8,12,14-trihydroxy-(5Z,9E)-eicosadienoic acid",,"11,15-cyclo-8,12,14-trihydroxy-(5Z,9E)-eicosadienoic acid",,,,,2016-11-22T15:12:23Z,,2351,,,,,,CE5929,,,http://vmh.uni.lu/_api/metabolites/2351/?format=pcsv
CE5928,,,-1,C20H30O4,,,"8-peroxy-5Z,9E,11Z,14Z-eicosatetraenoate",,"8-peroxy-5Z,9E,11Z,14Z-eicosatetraenoate",,,"InChI=1/C20H31O4/c1-2-3-4-5-6-7-8-9-10-13-16-19(24-23)17-14-11-12-15-18-20(21)22/h6-7,9-11,13-14,16,19H,2-5,8,12,15,17-18H2,1H3,(H,21,22)/p-1/b7-6-,10-9-,14-11-,16-13+",,2016-11-22T15:12:23Z,,2352,,,,,,CE5928,,,http://vmh.uni.lu/_api/metabolites/2352/?format=pcsv
CE5930,,,-1,C20H31O6,,,"5,9-cyclo-6,8-cycloperoxy-12-hydroperoxy-(10E,14Z)-eicosadienoic acid",,"5,9-cyclo-6,8-cycloperoxy-12-hydroperoxy-(10E,14Z)-eicosadienoic acid",,,,,2016-11-22T15:12:23Z,,2353,,,,,,CE5930,,,http://vmh.uni.lu/_api/metabolites/2353/?format=pcsv
CE5931,,,-1,C20H33O5,,,"5,9-cyclo-6,8,12-trihydroxy-(10E,14Z)-eicosadienoic acid",,"5,9-cyclo-6,8,12-trihydroxy-(10E,14Z)-eicosadienoic acid",,,,,2016-11-22T15:12:23Z,,2354,,,,,,CE5931,,,http://vmh.uni.lu/_api/metabolites/2354/?format=pcsv
CE5537,,,-1,C20H30O4,,,"11-peroxy-5Z,8Z,12E,14Z-eicosatetraenoate",,"11-peroxy-5Z,8Z,12E,14Z-eicosatetraenoate",,,"InChI=1/C20H31O4/c1-2-3-4-5-7-10-13-16-19(24-23)17-14-11-8-6-9-12-15-18-20(21)22/h6-7,9-11,13-14,16,19H,2-5,8,12,15,17-18H2,1H3,(H,21,22)/p-1/b9-6-,10-7-,14-11-,16-13+",,2016-11-22T15:12:23Z,,2355,,,,,,CE5537,,,http://vmh.uni.lu/_api/metabolites/2355/?format=pcsv
CE5533,,,-1,C20H31O6,,,"9,11-cycloperoxy-15-hydroperoxy-5Z,13E-eicosadienoate",,"9,11-cycloperoxy-15-hydroperoxy-5Z,13E-eicosadienoate",,,,,2016-11-22T15:12:23Z,,2356,,,,,,CE5533,,,http://vmh.uni.lu/_api/metabolites/2356/?format=pcsv
CE5924,,,-1,C20H33O5,,,"9,11,15-trihydroxyprosta-5Z,13E-dien-1-oate",,"9,11,15-trihydroxyprosta-5Z,13E-dien-1-oate",,,,C00639,2016-11-22T15:12:23Z,,2357,,,,,5283078,,,,http://vmh.uni.lu/_api/metabolites/2357/?format=pcsv
CE7097,,,-1,C20H29O4,,,"5-oxo-12(S)-hydroxy-eicosa-6E,8Z,10E,14Z-tetraenoate",,"5-oxo-12(S)-hydroxy-eicosa-6E,8Z,10E,14Z-tetraenoate",,,,,2016-11-22T15:12:23Z,,2358,,,,,,CE7097,,,http://vmh.uni.lu/_api/metabolites/2358/?format=pcsv
C04805,,,-1,C20H31O3,CHEBI:28209,,"Human Metabolome Database (HMDB): 5-hydroxyeicosatetraenoic acid (5-HETE) is an endogenous eicosanoid. 5-HETE is an intermediate in arachidonic acid metabolism. It is converted from 5(S)-HPETE via the enzyme glutathione peroxidase (EC 1.11.1.9)and then converted to 5-OxoETE. It is also involved in the pathway of leukotriene synthesis. In addition, it is a modulator of tubuloglomerular feedback.",,5(S)-HETE,,HMDB11134,"InChI=1S/C20H32O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19(21)17-15-18-20(22)23/h6-7,9-10,12-14,16,19,21H,2-5,8,11,15,17-18H2,1H3,(H,22,23)/b7-6-,10-9-,13-12-,16-14+/t19-/m1/s1",C04805,2016-12-05T15:48:06Z,,2359,,,,,155383,C04805,,"5(S)-HETE, 5(S)-Hydroxy-6-trans-8,11,14-cis-eicosatetraenoate, 5(S)-Hydroxy-6-trans-8,11,14-cis-eicosatetraenoic acid, 5(S)-Hydroxyeicosatetraenoate, 5(S)-Hydroxyeicosatetraenoic acid, 5-HETE, 5-Hydroxy-6,8,11,14-eicosatetraenoate, 5-Hydroxy-6,8,11,14-eicosatetraenoic acid, 5-Hydroxyeicosatetraenoate, 5-Hydroxyeicosatetraenoic acid, 5-L-Hydroxy-6,8,11,14-eicosatetraenoate, 5-L-Hydroxy-6,8,11,14-eicosatetraenoic acid, 5S-Hydroxy-6,8,11,14-eicosatetraenoate, 5S-Hydroxy-6,8,11,14-eicosatetraenoic acid",http://vmh.uni.lu/_api/metabolites/2359/?format=pcsv
CE5815,,,-1,C20H31O4,,,20-hydroxy-5S-HETE,,20-hydroxy-5S-HETE,,,,,2016-11-22T15:12:23Z,,2360,,,,,,CE5815,,,http://vmh.uni.lu/_api/metabolites/2360/?format=pcsv
CE7096,,,-1,C20H31O4,,,"5,15-DiHETE",,"5,15-DiHETE",,,,,2016-11-22T15:12:23Z,,2361,,,,,5283158,CE7096,,,http://vmh.uni.lu/_api/metabolites/2361/?format=pcsv
CE2084,,,-1,C20H29O3,,,"5-oxo-(6E,8Z,11Z,14Z)-eicosatetraenoic acid",,"5-oxo-(6E,8Z,11Z,14Z)-eicosatetraenoic acid",,,"InChI=1/C20H30O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19(21)17-15-18-20(22)23/h6-7,9-10,12-14,16H,2-5,8,11,15,17-18H2,1H3,(H,22,23)/p-1/b7-6-,10-9-,13-12-,16-14+",,2016-11-22T15:12:23Z,,2362,,,,,1831,CE2084,,,http://vmh.uni.lu/_api/metabolites/2362/?format=pcsv
h2,,,0,H2,18276,,"Human Metabolome Database (HMDB): Hydrogen is a colorless, odorless, nonmetallic, tasteless, highly flammable diatomic gas with the molecular formula H2. With an atomic weight of 1.00794, hydrogen is the lightest element. Besides the common H1 isotope, hydrogen exists as the stable isotope Deuterium and the unstable, radioactive isotope Tritium. Hydrogen is the most abundant of the chemical elements, constituting roughly 75% of the universe's elemental mass. Hydrogen can form compounds with most elements and is present in water and most organic compounds. It plays a particularly important role in acid-base chemistry, in which many reactions involve the exchange of protons between soluble molecules. Oxidation of hydrogen, in the sense of removing its electron, formally gives H+, containing no electrons and a nucleus which is usually composed of one proton. That is why H+ is often called a proton. This species is central to discussion of acids. Under the Bronsted-Lowry theory, acids are proton donors, while bases are proton acceptors. A bare proton H+ cannot exist in solution because of its strong tendency to attach itself to atoms or molecules with electrons. However, the term 'proton' is used loosely to refer to positively charged or cationic hydrogen, denoted H+. H2 is a product of some types of anaerobic metabolism and is produced by several microorganisms, usually via reactions catalyzed by iron- or nickel-containing enzymes called hydrogenases. These enzymes catalyze the reversible redox reaction between H2 and its component two protons and two electrons. Creation of hydrogen gas occurs in the transfer of reducing equivalents produced during pyruvate fermentation to water.",,Hydrogen,,HMDB01362,InChI=1S/H2/h1H,C00282,2016-12-05T15:48:06Z,,2363,,,,,783,,,"Dihydrogen, Hydrogen, Hydrogen cation, Hydrogen gas, Hydrogen ion, Hydronium, Proton",http://vmh.uni.lu/_api/metabolites/2363/?format=pcsv
CE1447,,,-1,C20H31O6,,,11-dehydrothromboxane B2,,11-dehydrothromboxane B2,,,"InChI=1S/C20H32O6/c1-2-3-6-9-15(21)12-13-18-16(17(22)14-20(25)26-18)10-7-4-5-8-11-19(23)24/h4,7,12-13,15-18,21-22H,2-3,5-6,8-11,14H2,1H3,(H,23,24)/b7-4-,13-12+/t15-,16-,17-,18+/m0/s1",C05964,2016-11-22T15:12:23Z,,2364,,,,,440862,CE1447,,,http://vmh.uni.lu/_api/metabolites/2364/?format=pcsv
CE6508,,,-1,C20H29O4,,,5-hydroperoxy-EPA,,5-hydroperoxy-EPA,,,,,2016-11-22T15:12:23Z,,2365,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2365/?format=pcsv
CE7079,,,-1,C20H27O3,,,leukotriene A5,,leukotriene A5,,,,,2016-11-22T15:12:23Z,,2366,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2366/?format=pcsv
CE7091,,,-1,C20H29O4,,,15(R)-hydroperoxy-EPE,,15(R)-hydroperoxy-EPE,,,,,2016-11-22T15:12:23Z,,2367,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2367/?format=pcsv
CE7080,,,-1,C20H29O4,,,15(S)-hydroperoxy-EPE,,15(S)-hydroperoxy-EPE,,,,,2016-11-16T10:44:58Z,,2368,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2368/?format=pcsv
CE7082,,,-1,C20H29O3,,,15(S)-HEPE,,15(S)-HEPE,,,,,2016-11-22T15:12:23Z,,2369,,,,,5283192,,,,http://vmh.uni.lu/_api/metabolites/2369/?format=pcsv
CE7083,,,-1,C20H29O4,,,leukotriene B5,,leukotriene B5,,,,,2016-11-22T15:12:23Z,,2370,,,,,5283125,,,,http://vmh.uni.lu/_api/metabolites/2370/?format=pcsv
CE7084,,,-1,C20H29O4,,,"5,12-dihydroxy-6E-LTB5",,"5,12-dihydroxy-6E-LTB5",,,,,2016-11-22T15:12:24Z,,2371,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2371/?format=pcsv
CE7085,,,-1,C20H29O3,,,5-HEPE,,5-HEPE,,,,,2016-11-22T15:12:24Z,,2372,,,,,1766,,,,http://vmh.uni.lu/_api/metabolites/2372/?format=pcsv
CE7086,,,-2,C30H43N3O9S,,,leukotriene C5,,leukotriene C5,,,,,2016-11-22T15:12:24Z,,2373,,,,,53481570,,,,http://vmh.uni.lu/_api/metabolites/2373/?format=pcsv
CE7087,,,-1,C25H37N2O6S,,,leukotriene D5,,leukotriene D5,,,,,2016-11-22T15:12:24Z,,2374,,,,,53481571,,,,http://vmh.uni.lu/_api/metabolites/2374/?format=pcsv
CE7088,,,-1,C20H29O5,,,PGH3,,PGH3,,,,C00427,2016-11-22T15:12:24Z,,2375,,,,,53481592,,,,http://vmh.uni.lu/_api/metabolites/2375/?format=pcsv
C06439,,,-1,C20H29O5,5280937,,"Human Metabolome Database (HMDB): Prostaglandin E3 is from the cyclooxygenase metabolism of eicosapentaenoic acid.Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,Prostaglandin E3,,HMDB02664,"InChI=1S/C20H30O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h3-4,6-7,12-13,15-17,19,21,23H,2,5,8-11,14H2,1H3,(H,24,25)/b6-3-,7-4-,13-12+/t15-,16+,17+,19+/m0/s1",C06439,2016-12-05T15:48:06Z,,2376,,,,,5280937,,,"(-)-prostaglandin E3, 7-[3-Hydroxy-2-(3-hydroxy-1,5-octadienyl)-5-oxocyclopentyl]-5-Heptenoate, 7-[3-Hydroxy-2-(3-hydroxy-1,5-octadienyl)-5-oxocyclopentyl]-5-Heptenoic acid, 7-[3-Hydroxy-2-(3-hydroxy-1,5-octadienyl)-5-oxocyclopentyl]-5-Heptenoic acid stereoisomer, PGE3, Prostaglandin E3",http://vmh.uni.lu/_api/metabolites/2376/?format=pcsv
CE7081,,,-1,C20H29O3,,,15(R)-HEPE,,15(R)-HEPE,,,,,2016-11-22T15:12:24Z,,2377,,,,,53480357,,,,http://vmh.uni.lu/_api/metabolites/2377/?format=pcsv
CE7109,,,-1,C20H27O4,,,"5(S),6(S)-epoxy-15(R)-HEPE",,"5(S),6(S)-epoxy-15(R)-HEPE",,,,,2016-11-22T15:12:24Z,,2378,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2378/?format=pcsv
CE7110,,,-1,C20H27O4,,,"5,6-epoxy,18R-HEPE",,"5,6-epoxy,18R-HEPE",,,,,2016-11-22T15:12:24Z,,2379,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2379/?format=pcsv
CE7114,,,-1,C20H29O5,,,"5,12,18R-TriHEPE",,"5,12,18R-TriHEPE",,,"InChI=1/C20H30O5/c1-2-17(21)11-8-5-9-14-18(22)12-6-3-4-7-13-19(23)15-10-16-20(24)25/h3-9,11-13,17-19,21-23H,2,10,14-16H2,1H3,(H,24,25)/p-1/b4-3-,9-5-,11-8+,12-6+,13-7+/t17-,18-,19+/m1/s1",,2016-11-22T15:12:24Z,,2380,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2380/?format=pcsv
CE7113,,,-1,C20H29O5,,,15-epi-lipoxin B5,,15-epi-lipoxin B5,,,"InChI=1/C20H30O5/c1-2-3-8-14-18(22)19(23)15-10-7-5-4-6-9-12-17(21)13-11-16-20(24)25/h3-10,12,15,17-19,21-23H,2,11,13-14,16H2,1H3,(H,24,25)/p-1/b6-4-,7-5+,8-3-,12-9+,15-10+/t17-,18+,19+/m0/s1",,2016-11-22T15:12:24Z,,2381,,,,,53481476,,,,http://vmh.uni.lu/_api/metabolites/2381/?format=pcsv
CE7112,,,-1,C20H29O5,,,15-epi-lipoxin A5,,15-epi-lipoxin A5,,,"InChI=1S/C20H30O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h3-4,6-7,12-13,15-17,19,21,23H,2,5,8-11,14H2,1H3,(H,24,25)/b6-3-,7-4-,13-12+/t15-,16+,17+,19+/m0/s1",,2016-11-22T15:12:24Z,,2382,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2382/?format=pcsv
CE7111,,,-1,C20H27O3,,,5-oxo-EPE,,5-oxo-EPE,,,,,2016-11-22T15:12:24Z,,2383,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2383/?format=pcsv
CE7090,,,-1,C20H29O3,,,18R-HEPE,,18R-HEPE,,,,C18177,2016-11-22T15:12:24Z,,2384,,,,,16061126,,,,http://vmh.uni.lu/_api/metabolites/2384/?format=pcsv
CE7115,,,-1,C20H29O5,,,20-hydroxy-leukotriene B5,,20-hydroxy-leukotriene B5,,,"InChI=1S/C20H30O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h3-4,6-7,12-13,15-17,19,21,23H,2,5,8-11,14H2,1H3,(H,24,25)/b6-3-,7-4-,13-12+/t15-,16+,17+,19+/m0/s1",,2016-11-22T15:12:24Z,,2385,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2385/?format=pcsv
CE0347,,,-1,C20H31O3,,,12-hydroxyeicosatetraenoate,,12-hydroxyeicosatetraenoate,,,,,2016-11-22T15:12:24Z,,2386,,,,,5312983,CE0347,,,http://vmh.uni.lu/_api/metabolites/2386/?format=pcsv
CE6247,,,-1,C20H31O5,,,"5,12,20-TriHETE",,"5,12,20-TriHETE",,,,C04853,2016-11-22T15:12:24Z,,2387,,,,,1589,CE6247,,,http://vmh.uni.lu/_api/metabolites/2387/?format=pcsv
C08276,,,-1,C4H7O2S,CHEBI:1438,,Human Metabolome Database (HMDB): 3-methylthiopropionate is one of the metabolites of methionine (especially of D-methionine) and pharmacokinetics of 3-MTP in urine seems to contribute to the clinicopathological investigation of the liver cirrhosis. (PMID 3997054).,,3-(methylthio)propionate,,HMDB01527,"InChI=1S/C4H8O2S/c1-7-3-2-4(5)6/h2-3H2,1H3,(H,5,6)/p-1",C08276,2016-12-05T15:48:07Z,,2388,,,,,563,,,"3-(Methylsulfanyl)propanoate, 3-(Methylsulfanyl)propanoic acid, 3-(Methylthio)propionate, 3-(Methylthio)propionic acid, 3-Methylthiopropionate, 4-Thiapentanoate, 4-Thiapentanoic acid",http://vmh.uni.lu/_api/metabolites/2388/?format=pcsv
ch4s,,,0,CH4S,,,Methanethiol,,Methanethiol,,,"InChI=1S/CH4S/c1-2/h2H,1H3",C00409,2016-11-22T15:12:24Z,,2389,,,,,878,,,,http://vmh.uni.lu/_api/metabolites/2389/?format=pcsv
acryl,,,0,C3H4O2,,,acrylate,,acrylate,,,"InChI=1S/C3H4O2/c1-2-3(4)5/h2H,1H2,(H,4,5)",C00511,2016-11-22T15:12:24Z,,2390,,,,,6581,,,,http://vmh.uni.lu/_api/metabolites/2390/?format=pcsv
C04849,,,-1,C20H31O4,CHEBI:15631,,"(5Z,9E,14Z)-(8xi,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate",,"(5Z,9E,14Z)-(8xi,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate",,,"InChI=1S/C20H32O4/c1-2-3-4-5-6-10-13-18-19(24-18)16-15-17(21)12-9-7-8-11-14-20(22)23/h6-7,9-10,15-19,21H,2-5,8,11-14H2,1H3,(H,22,23)/p-1/b9-7-,10-6-,16-15+/t17?,18-,19+/m0/s1",C04849,2016-11-22T15:12:24Z,,2391,,,,,21158465,,,,http://vmh.uni.lu/_api/metabolites/2391/?format=pcsv
CE6248,,,-1,C20H31O5,,,20-OH-hepoxilin A3,,20-OH-hepoxilin A3,,,,,2016-11-22T15:12:24Z,,2392,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2392/?format=pcsv
C04843,,,-1,C20H33O5,CHEBI:15630,,"(5Z,9E,12S,14Z)-8,11,12-trihydroxyicosa-5,9,14-trienoate",,"(5Z,9E,12S,14Z)-8,11,12-trihydroxyicosa-5,9,14-trienoate",,,"InChI=1S/C20H34O5/c1-2-3-4-5-6-10-13-18(22)19(23)16-15-17(21)12-9-7-8-11-14-20(24)25/h6-7,9-10,15-19,21-23H,2-5,8,11-14H2,1H3,(H,24,25)/p-1/b9-7-,10-6-,16-15+/t17?,18-,19?/m1/s1",,2016-11-22T15:12:24Z,,2393,,,,,46878369,,,,http://vmh.uni.lu/_api/metabolites/2393/?format=pcsv
C05965,,,-1,C20H31O4,5280892,,"Human Metabolome Database (HMDB): 12-HPETE is one of the six monohydroperoxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid (Leukotrienes). Reduction of the hydroperoxide yields the more stable hydroxyl fatty acid (+/-)12-HETE. A family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system.",,12(S)-HPETE(1-),,HMDB04243,"InChI=1S/C20H32O4/c1-2-3-4-5-10-13-16-19(24-23)17-14-11-8-6-7-9-12-15-18-20(21)22/h7-11,13-14,17,19,23H,2-6,12,15-16,18H2,1H3,(H,21,22)/p-1/b9-7-,11-8-,13-10-,17-14+/t19-/m0/s1",C05965,2016-12-05T15:48:07Z,,2394,,,,,5280892,,,"(5Z,8z,10e,14Z)-(12S)-12-hydroperoxyicosa-5,8,10,14-tetraenoate, (5Z,8z,10e,14Z)-(12S)-12-hydroperoxyicosa-5,8,10,14-tetraenoic acid, 12-Hpete, 12-Hydroperoxyeicosatetraenoate, 12-Hydroperoxyeicosatetraenoic acid, 12-Hydroperoxyicosatetraenoate, 12-Hydroperoxyicosatetraenoic acid",http://vmh.uni.lu/_api/metabolites/2394/?format=pcsv
CE6250,,,-2,C30H47N3O10S,,,hepoxilin A3-C,,hepoxilin A3-C,,,,,2016-11-22T15:12:24Z,,2395,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2395/?format=pcsv
CE6251,,,-1,C20H31O4,,,"12,20-DiHETE",,"12,20-DiHETE",,,"InChI=1/C20H32O4/c21-18-14-10-6-5-8-12-16-19(22)15-11-7-3-1-2-4-9-13-17-20(23)24/h2-4,7-8,11-12,15,19,21-22H,1,5-6,9-10,13-14,16-18H2,(H,23,24)/p-1/b4-2-,7-3-,12-8-,15-11+",,2016-11-22T15:12:24Z,,2396,,,,,1412,CE6251,,,http://vmh.uni.lu/_api/metabolites/2396/?format=pcsv
CE6240,,,-1,C20H31O4,,,9-deoxy-delta12-PGD2,,9-deoxy-delta12-PGD2,,,"InChI=1/C20H32O4/c1-2-3-6-10-17(21)13-14-18-16(12-15-19(18)22)9-7-4-5-8-11-20(23)24/h4,7,14,16-17,21H,2-3,5-6,8-13,15H2,1H3,(H,23,24)/p-1/b7-4-,18-14+/t16-,17-/m0/s1",,2016-11-22T15:12:24Z,,2397,,,,,,CE6240,,,http://vmh.uni.lu/_api/metabolites/2397/?format=pcsv
CE6241,,,-2,C30H47N3O10S,,,S-(9-deoxy-delta12-PGD2)-glutathione,,S-(9-deoxy-delta12-PGD2)-glutathione,,,,,2016-11-22T15:12:24Z,,2398,,,,,53481597,CE6241,,,http://vmh.uni.lu/_api/metabolites/2398/?format=pcsv
CE6242,,,-2,C30H45N3O10S,,,S-(PGJ2)-glutathione,,S-(PGJ2)-glutathione,,,,,2016-11-22T15:12:24Z,,2399,,,,,53481603,CE6242,,,http://vmh.uni.lu/_api/metabolites/2399/?format=pcsv
CE6243,,,-2,C30H45N3O10S,,,"S-(9-deoxy-delta9,12-PGD2)-glutathione",,"S-(9-deoxy-delta9,12-PGD2)-glutathione",,,,,2016-11-22T15:12:24Z,,2400,,,,,53481598,CE6243,,,http://vmh.uni.lu/_api/metabolites/2400/?format=pcsv
CE6245,,,-2,C30H47N3O10S,,,"S-(11-OH-9-deoxy-delta9,12-PGD2)-glutathione",,"S-(11-OH-9-deoxy-delta9,12-PGD2)-glutathione",,,,,2016-11-22T15:12:24Z,,2401,,,,,53481596,,,,http://vmh.uni.lu/_api/metabolites/2401/?format=pcsv
CE6244,,,-2,C30H49N3O10S,,,S-(11-hydroxy-9-deoxy-delta12-PGD2)-glutathione,,S-(11-hydroxy-9-deoxy-delta12-PGD2)-glutathione,,,,,2016-11-22T15:12:24Z,,2402,,,,,53481595,,,,http://vmh.uni.lu/_api/metabolites/2402/?format=pcsv
C03577,,,-1,C23H36NO6S,CHEBI:28700,,20-hydroxy-leukotriene E4(1-),,20-hydroxy-leukotriene E4(1-),,,"InChI=1S/C23H37NO6S/c24-19(23(29)30)18-31-21(20(26)14-13-16-22(27)28)15-11-9-7-5-3-1-2-4-6-8-10-12-17-25/h2-5,7,9,11,15,19-21,25-26H,1,6,8,10,12-14,16-18,24H2,(H,27,28)(H,29,30)/b4-2-,5-3-,9-7+,15-11+/t19-,20-,21+/m0/s1",,2016-11-22T15:12:24Z,,2403,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2403/?format=pcsv
CE5994,,,-1,C23H34NO6S,,,20-oxo-leukotriene E4,,20-oxo-leukotriene E4,,,"InChI=1/C23H35NO6S/c24-19(23(29)30)18-31-21(20(26)14-13-16-22(27)28)15-11-9-7-5-3-1-2-4-6-8-10-12-17-25/h2-5,7,9,11,15,17,19-21,26H,1,6,8,10,12-14,16,18,24H2,(H,27,28)(H,29,30)/p-1/b4-2-,5-3-,9-7+,15-11+/t19-,20+,21-/m1/s1",,2016-11-22T15:12:24Z,,2404,,,,,53481512,,,,http://vmh.uni.lu/_api/metabolites/2404/?format=pcsv
CE5995,,,-2,C23H33NO7S,,,20-COOH-leukotriene E4,,20-COOH-leukotriene E4,,,,,2016-11-22T15:12:24Z,,2405,,,,,53481508,,,,http://vmh.uni.lu/_api/metabolites/2405/?format=pcsv
CE6235,,,-2,C30H45N3O10S,,,S-(PGA2)-glutathione,,S-(PGA2)-glutathione,,,,,2016-11-22T15:12:24Z,,2406,,,,,53481602,CE6235,,,http://vmh.uni.lu/_api/metabolites/2406/?format=pcsv
C11304,,,-2,C30H47N3O10S,,,S-(PGA1)-glutathione,,S-(PGA1)-glutathione,,,"InChI=1/C30H49N3O10S/c1-2-3-6-9-19(34)12-13-21-20(10-7-4-5-8-11-27(37)38)24(35)16-25(21)44-18-23(29(41)32-17-28(39)40)33-26(36)15-14-22(31)30(42)43/h12-13,19-23,25,34H,2-11,14-18,31H2,1H3,(H,32,41)(H,33,36)(H,37,38)(H,39,40)(H,42,43)/b13-12+/t19-,20?,21+,22-,23-,25?/m0/s1",C11304,2016-11-22T15:12:24Z,,2407,,,,,5281898,,,,http://vmh.uni.lu/_api/metabolites/2407/?format=pcsv
C04685,,,-1,C20H31O4,5281912,,"Human Metabolome Database (HMDB): Prostaglandin A1 (PGA1, a prostaglandin characterized by a cyclopentenone structure) has a fundamental structure common to punaglandin and clavulone, the antitumor eicosanoids discovered in marine organisms such as corals. It is well established that PGA1, which exert potent antiviral activity in several DNA and RNA virus models, induce heat shock protein (hsp)70 syntheses through cycloheximide sensitive activation of heat shock transcription factor. Antitumor prostaglandins are actively incorporated through cell membrane and control gene expression. P53 (protein 53, is a transcription factor that regulates the cell cycle and functions as a tumor suppressor) independent expression of p21 (also known as cyclin-dependent kinase inhibitor 1A or CDKN1A, is a human gene on chromosome 6 (location 6p21.2), that encodes a cyclin-dependent kinase) and gadd 45 (growth arrest and DNA-damage-inducible, alpha 45, a major breast cancer (BRCA1) target is the DNA damage-responsive gene GADD45) activation of peroxisome proliferative activated receptor gamma (PPARgamma) are involved in antitumor mechanism of these prostaglandins. At the low concentration, these prostaglandins exhibit physiological or pathological activity such as osteoblast calcification, promotion of colon cancer cell proliferation. One of the mechanisms of anti-cancer activity of prostaglandins, has been believed to be that these prostaglandins might have p53 like effect in cells lacking p53. (PMID: 7988663, 11104898)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",,prostaglandin A1(1-),,HMDB02656,"InChI=1S/C20H32O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h12-18,21H,2-11H2,1H3,(H,23,24)/p-1/b14-12+/t16-,17-,18+/m0/s1",C04685,2016-12-05T15:48:07Z,,2408,,,,,5281912,,,"(13E,15S)-15-hydroxy-9-oxo-Prosta-10,13-dien-1-oate, (13E,15S)-15-hydroxy-9-oxo-Prosta-10,13-dien-1-oic acid, 15-Hydroxy-9-oxoprosta-10,13-dienoate, 15-Hydroxy-9-oxoprosta-10,13-dienoic acid, 15a-Hydroxy-9-ketoprosta-10,13-dienoate, 15a-Hydroxy-9-ketoprosta-10,13-dienoic acid, 15a-Hydroxy-9-oxo-10,13E-prostadienoate, 15a-Hydroxy-9-oxo-10,13E-prostadienoic acid, 2-(3-Hydroxy-1-octenyl)-5-oxo-3- cyclopentene-1-heptanoate, 2-(3-Hydroxy-1-octenyl)-5-oxo-3- cyclopentene-1-heptanoic acid, 2-(3-Hydroxy-1-octenyl)-5-oxo-3-Cyclopentene-1-heptanoate, 2-(3-Hydroxy-1-octenyl)-5-oxo-3-Cyclopentene-1-heptanoic acid, PGA1, Prostaglandin A1, Prostaglandin E1-217",http://vmh.uni.lu/_api/metabolites/2408/?format=pcsv
CE6183,,,-5,C41H57N7O22P3S,,,"18,20-dioxo-20-CoA-leukotriene B4",,"18,20-dioxo-20-CoA-leukotriene B4",,,"InChI=1/C41H62N7O22P3S/c1-41(2,23-67-73(64,65)70-72(62,63)66-22-29-35(69-71(59,60)61)34(56)40(68-29)48-25-47-33-37(42)45-24-46-38(33)48)36(57)39(58)44-18-17-30(52)43-19-20-74-32(55)21-28(51)14-9-5-8-13-26(49)11-6-3-4-7-12-27(50)15-10-16-31(53)54/h3-8,11-12,24-27,29,34-36,40,49-50,56-57H,9-10,13-23H2,1-2H3,(H,43,52)(H,44,58)(H,53,54)(H,62,63)(H,64,65)(H2,42,45,46)(H2,59,60,61)/p-5/b4-3+,8-5-,11-6+,12-7-/t26-,27+,29+,34-,35-,36u,40+/m1/s1",,2016-11-22T15:12:24Z,,2409,,,,,53481487,,,,http://vmh.uni.lu/_api/metabolites/2409/?format=pcsv
CE6184,,,-5,C39H55N7O21P3S,,,18-CoA-18-oxo-dinorleukotriene B4,,18-CoA-18-oxo-dinorleukotriene B4,,,"InChI=1/C39H60N7O21P3S/c1-39(2,22-64-70(61,62)67-69(59,60)63-21-27-33(66-68(56,57)58)32(53)38(65-27)46-24-45-31-35(40)43-23-44-36(31)46)34(54)37(55)42-18-17-28(49)41-19-20-71-30(52)16-9-5-8-13-25(47)11-6-3-4-7-12-26(48)14-10-15-29(50)51/h3-8,11-12,23-27,32-34,38,47-48,53-54H,9-10,13-22H2,1-2H3,(H,41,49)(H,42,55)(H,50,51)(H,59,60)(H,61,62)(H2,40,43,44)(H2,56,57,58)/p-5/b4-3+,8-5-,11-6+,12-7-/t25-,26+,27+,32-,33-,34u,38+/m1/s1",,2016-11-22T15:12:24Z,,2410,,,,,53481490,,,,http://vmh.uni.lu/_api/metabolites/2410/?format=pcsv
CE6185,,,-2,C18H24O6,,,omega-carboxy-trinor-leukotriene B4,,omega-carboxy-trinor-leukotriene B4,,,"InChI=1/C18H26O6/c19-15(11-6-3-7-13-17(21)22)9-4-1-2-5-10-16(20)12-8-14-18(23)24/h1-6,9-10,15-16,19-20H,7-8,11-14H2,(H,21,22)(H,23,24)/p-2/b2-1+,6-3-,9-4+,10-5-/t15-,16+/m1/s1",,2016-11-22T15:12:24Z,,2411,,,,,53481589,,,,http://vmh.uni.lu/_api/metabolites/2411/?format=pcsv
CE6182,,,-5,C41H59N7O21P3S,,,20-CoA-20-oxo-leukotriene B4,,20-CoA-20-oxo-leukotriene B4,,,"InChI=1/C41H64N7O21P3S/c1-41(2,24-66-72(63,64)69-71(61,62)65-23-29-35(68-70(58,59)60)34(55)40(67-29)48-26-47-33-37(42)45-25-46-38(33)48)36(56)39(57)44-20-19-30(51)43-21-22-73-32(54)18-11-5-3-4-8-13-27(49)14-9-6-7-10-15-28(50)16-12-17-31(52)53/h4,6-10,14-15,25-29,34-36,40,49-50,55-56H,3,5,11-13,16-24H2,1-2H3,(H,43,51)(H,44,57)(H,52,53)(H,61,62)(H,63,64)(H2,42,45,46)(H2,58,59,60)/p-5/b7-6+,8-4-,14-9+,15-10-/t27-,28-,29-,34+,35+,36u,40-/m0/s1",,2016-11-22T15:12:24Z,,2412,,,,,53481505,CE6182,,,http://vmh.uni.lu/_api/metabolites/2412/?format=pcsv
CE6186,,,-5,C41H57N7O21P3S,,,18E-20-oxo-20-CoA-LTB4,,18E-20-oxo-20-CoA-LTB4,,,"InChI=1/C41H62N7O21P3S/c1-41(2,24-66-72(63,64)69-71(61,62)65-23-29-35(68-70(58,59)60)34(55)40(67-29)48-26-47-33-37(42)45-25-46-38(33)48)36(56)39(57)44-20-19-30(51)43-21-22-73-32(54)18-11-5-3-4-8-13-27(49)14-9-6-7-10-15-28(50)16-12-17-31(52)53/h4,6-11,14-15,18,25-29,34-36,40,49-50,55-56H,3,5,12-13,16-17,19-24H2,1-2H3,(H,43,51)(H,44,57)(H,52,53)(H,61,62)(H,63,64)(H2,42,45,46)(H2,58,59,60)/p-5/b7-6+,8-4-,14-9+,15-10-,18-11+/t27-,28-,29-,34+,35+,36u,40-/m0/s1",,2016-11-22T15:12:24Z,,2413,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2413/?format=pcsv
CE6187,,,-5,C41H59N7O22P3S,,,20-CoA-20-oxo-18R-hydroxyleucotriene B4,,20-CoA-20-oxo-18R-hydroxyleucotriene B4,,,"InChI=1/C41H64N7O22P3S/c1-41(2,23-67-73(64,65)70-72(62,63)66-22-29-35(69-71(59,60)61)34(56)40(68-29)48-25-47-33-37(42)45-24-46-38(33)48)36(57)39(58)44-18-17-30(52)43-19-20-74-32(55)21-28(51)14-9-5-8-13-26(49)11-6-3-4-7-12-27(50)15-10-16-31(53)54/h3-8,11-12,24-29,34-36,40,49-51,56-57H,9-10,13-23H2,1-2H3,(H,43,52)(H,44,58)(H,53,54)(H,62,63)(H,64,65)(H2,42,45,46)(H2,59,60,61)/p-5/b4-3+,8-5-,11-6+,12-7-/t26-,27+,28+,29+,34-,35-,36u,40+/m1/s1",,2016-11-22T15:12:24Z,,2414,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2414/?format=pcsv
CE6230,,,-1,C20H33O4,,,"15-hydroperoxyeicosa-8Z,11Z,13E-trienoate",,"15-hydroperoxyeicosa-8Z,11Z,13E-trienoate",,,"InChI=1/C20H34O4/c1-2-3-13-16-19(24-23)17-14-11-9-7-5-4-6-8-10-12-15-18-20(21)22/h4-5,9,11,14,17,19,23H,2-3,6-8,10,12-13,15-16,18H2,1H3,(H,21,22)/p-1/b5-4-,11-9-,17-14+",,2016-11-22T15:12:24Z,,2415,,,,,53936694,,,,http://vmh.uni.lu/_api/metabolites/2415/?format=pcsv
CE2537,,,-1,C20H33O3,,,"15-hydroxy-(8Z,11Z,13E)-eicosatrienoate",,"15-hydroxy-(8Z,11Z,13E)-eicosatrienoate",,,"InChI=1/C20H34O3/c1-2-3-13-16-19(21)17-14-11-9-7-5-4-6-8-10-12-15-18-20(22)23/h4-5,9,11,14,17,19,21H,2-3,6-8,10,12-13,15-16,18H2,1H3,(H,22,23)/p-1/b5-4-,11-9-,17-14+",,2016-11-22T15:12:24Z,,2416,,,,,1437,,,,http://vmh.uni.lu/_api/metabolites/2416/?format=pcsv
CE2516,,,-1,C20H33O2,CHEBI:53486,,"Human Metabolome Database (HMDB): 8,11,14-Eicosatrienoic acid is a 20-carbon-chain omega-6 fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid (5,8,11,14-eicosatetraenoic acid) only at position 5. 8,11,14-Eicosatrienoic acid is also known as Dihomo-gamma-linolenic acid (DGLA). In physiological literature, it is given the name 20:3(n-6). DGLA is the elongation product of the 18 carbon gamma-linolenic acid (GLA). DGLA can be converted into prostaglandin E1 (PGE1). PGE1 inhibits platelet aggregation and also exerts a vasodilatory effect. DGLA competes with arachadonic acid for COX and lipoxygenase, inhibiting the production of arachadonic acid's eicosanoids.",,"(8Z,11Z,14Z)-eicosatrienoic acid",,HMDB02925,"InChI=1/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/p-1/b7-6-,10-9-,13-12-",,2016-12-05T15:48:07Z,,2417,,,,,3011,,,"(8Z,11Z,14Z)-Icosatrienoate, (8Z,11Z,14Z)-Icosatrienoic acid, (Z,Z,Z)-8,11,14-Eicosatrienoate, (Z,Z,Z)-8,11,14-Eicosatrienoic acid, (Z,Z,Z)-8,11,14-Icosatrienoate, (Z,Z,Z)-8,11,14-Icosatrienoic acid, (Z,Z,Z)-icosatri-8,11,14-enoate, (Z,Z,Z)-icosatri-8,11,14-enoic acid, 8,11,14-All-cis-Eicosatrienoate, 8,11,14-All-cis-Eicosatrienoic acid, 8,11,14-Eicosatrienoate, 8,11,14-Eicosatrienoic acid, 8,11,14-Icosatrienoate, 8,11,14-Icosatrienoic acid, 8Z,11Z,14Z-Eicosatrienoate, 8Z,11Z,14Z-Eicosatrienoic acid, All-cis-8,11,14-Eicosatrienoate, All-cis-8,11,14-Eicosatrienoic acid, Bishomo-gamma-linolenate, Bishomo-gamma-linolenic acid, cis,cis,cis-8,11,14-Eicosatrienoate, cis,cis,cis-8,11,14-Eicosatrienoic acid, cis-8,11,14-Eicosatrienoate, cis-8,11,14-Eicosatrienoic acid, cis-8,cis-11,cis-14-Eicosatrienoate, cis-8,cis-11,cis-14-Eicosatrienoic acid, DGLA, Dihomo-gamma-linolenate, Dihomo-gamma-linolenic acid, Eicosatrienoate, Eicosatrienoic acid, gamma-Homolinolenate, gamma-Homolinolenic acid, Homo-gamma-linolenate",http://vmh.uni.lu/_api/metabolites/2417/?format=pcsv
CE6232,,,-1,C20H33O6,,,prostaglandin G1,,prostaglandin G1,,,"InChI=1/C20H34O6/c1-2-3-6-9-15(24-23)12-13-17-16(18-14-19(17)26-25-18)10-7-4-5-8-11-20(21)22/h12-13,15-19,23H,2-11,14H2,1H3,(H,21,22)/p-1/b13-12+/t15-,16+,17+,18-,19+/m0/s1",,2016-11-22T15:12:24Z,,2418,,,,,53481591,,,,http://vmh.uni.lu/_api/metabolites/2418/?format=pcsv
CE6189,,,-5,C44H62N8O23P3S2,,,CoA-20-COOH-18-oxo-LTE4,,CoA-20-COOH-18-oxo-LTE4,,,"InChI=1/C44H67N8O23P3S2/c1-44(2,24-72-78(69,70)75-77(67,68)71-22-30-37(74-76(64,65)66)36(59)42(73-30)52-26-51-35-39(46)49-25-50-40(35)52)38(60)41(61)48-18-17-32(55)47-19-20-79-34(58)21-27(53)13-10-8-6-4-3-5-7-9-11-15-31(80-23-28(45)43(62)63)29(54)14-12-16-33(56)57/h3,5-9,11,15,25-26,28-31,36-38,42,54,59-60H,4,10,12-14,16-24,45H2,1-2H3,(H,47,55)(H,48,61)(H,56,57)(H,62,63)(H,67,68)(H,69,70)(H2,46,49,50)(H2,64,65,66)/p-5/b5-3-,8-6-,9-7+,15-11+/t28-,29+,30+,31-,36-,37-,38u,42+/m1/s1",,2016-11-22T15:12:24Z,,2419,,,,,53481542,,,,http://vmh.uni.lu/_api/metabolites/2419/?format=pcsv
CE6192,,,-5,C44H64N8O23P3S2,,,18(R)-hydroxy-20-oxo-20-CoA-LTE4,,18(R)-hydroxy-20-oxo-20-CoA-LTE4,,,"InChI=1/C44H69N8O23P3S2/c1-44(2,24-72-78(69,70)75-77(67,68)71-22-30-37(74-76(64,65)66)36(59)42(73-30)52-26-51-35-39(46)49-25-50-40(35)52)38(60)41(61)48-18-17-32(55)47-19-20-79-34(58)21-27(53)13-10-8-6-4-3-5-7-9-11-15-31(80-23-28(45)43(62)63)29(54)14-12-16-33(56)57/h3,5-9,11,15,25-31,36-38,42,53-54,59-60H,4,10,12-14,16-24,45H2,1-2H3,(H,47,55)(H,48,61)(H,56,57)(H,62,63)(H,67,68)(H,69,70)(H2,46,49,50)(H2,64,65,66)/p-5/b5-3-,8-6-,9-7+,15-11+/t27-,28-,29+,30+,31-,36-,37-,38u,42+/m1/s1",,2016-11-22T15:12:24Z,,2420,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2420/?format=pcsv
CE6198,,,-5,C42H60N8O23P3S2,,,"16,18-oxo-18-CoA-dinor-LTE4",,"16,18-oxo-18-CoA-dinor-LTE4",,,"InChI=1/C42H65N8O23P3S2/c1-42(2,22-70-76(67,68)73-75(65,66)69-20-28-35(72-74(62,63)64)34(57)40(71-28)50-24-49-33-37(44)47-23-48-38(33)50)36(58)39(59)46-16-15-30(53)45-17-18-77-32(56)19-25(51)11-8-6-4-3-5-7-9-13-29(78-21-26(43)41(60)61)27(52)12-10-14-31(54)55/h3-5,7,9,13,23-24,26-29,34-36,40,52,57-58H,6,8,10-12,14-22,43H2,1-2H3,(H,45,53)(H,46,59)(H,54,55)(H,60,61)(H,65,66)(H,67,68)(H2,44,47,48)(H2,62,63,64)/p-5/b4-3-,7-5+,13-9+/t26-,27+,28+,29-,34-,35-,36u,40+/m1/s1",,2016-11-22T15:12:24Z,,2421,,,,,53481480,,,,http://vmh.uni.lu/_api/metabolites/2421/?format=pcsv
CE6226,,,-5,C42H62N8O23P3S2,,,16(S)-hydroxy-18-oxo-18-CoA-LTE4,,16(S)-hydroxy-18-oxo-18-CoA-LTE4,,,"InChI=1/C42H67N8O23P3S2/c1-42(2,22-70-76(67,68)73-75(65,66)69-20-28-35(72-74(62,63)64)34(57)40(71-28)50-24-49-33-37(44)47-23-48-38(33)50)36(58)39(59)46-16-15-30(53)45-17-18-77-32(56)19-25(51)11-8-6-4-3-5-7-9-13-29(78-21-26(43)41(60)61)27(52)12-10-14-31(54)55/h3-5,7,9,13,23-29,34-36,40,51-52,57-58H,6,8,10-12,14-22,43H2,1-2H3,(H,45,53)(H,46,59)(H,54,55)(H,60,61)(H,65,66)(H,67,68)(H2,44,47,48)(H2,62,63,64)/p-5/b4-3-,7-5+,13-9+/t25-,26+,27-,28-,29+,34+,35+,36u,40-/m0/s1",,2016-11-22T15:12:24Z,,2422,,,,,53481478,,,,http://vmh.uni.lu/_api/metabolites/2422/?format=pcsv
CE6188,,,-5,C42H60N8O22P3S2,,,CoA-omega-COOH-dinor-LTE4,,CoA-omega-COOH-dinor-LTE4,,,"InChI=1/C42H65N8O22P3S2/c1-42(2,23-69-75(66,67)72-74(64,65)68-21-28-35(71-73(61,62)63)34(56)40(70-28)50-25-49-33-37(44)47-24-48-38(33)50)36(57)39(58)46-18-17-30(52)45-19-20-76-32(55)16-11-9-7-5-3-4-6-8-10-14-29(77-22-26(43)41(59)60)27(51)13-12-15-31(53)54/h3-4,6-10,14,24-29,34-36,40,51,56-57H,5,11-13,15-23,43H2,1-2H3,(H,45,52)(H,46,58)(H,53,54)(H,59,60)(H,64,65)(H,66,67)(H2,44,47,48)(H2,61,62,63)/p-5/b4-3-,8-6+,9-7-,14-10+/t26-,27+,28+,29-,34-,35-,36u,40+/m1/s1",,2016-11-22T15:12:24Z,,2423,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2423/?format=pcsv
CE6193,,,-2,C21H29NO7S,,,18-carboxy-dinor-LTE4,,18-carboxy-dinor-LTE4,,,"InChI=1/C21H31NO7S/c22-16(21(28)29)15-30-18(17(23)11-10-14-20(26)27)12-8-6-4-2-1-3-5-7-9-13-19(24)25/h1-2,4-8,12,16-18,23H,3,9-11,13-15,22H2,(H,24,25)(H,26,27)(H,28,29)/p-2/b2-1-,6-4+,7-5-,12-8+/t16-,17+,18-/m1/s1",,2016-11-22T15:12:24Z,,2424,,,,,53481489,,,,http://vmh.uni.lu/_api/metabolites/2424/?format=pcsv
CE6190,,,-5,C44H64N8O22P3S2,,,CoA-20-COOH-LTE4,,CoA-20-COOH-LTE4,,,"InChI=1/C44H69N8O22P3S2/c1-44(2,25-71-77(68,69)74-76(66,67)70-23-30-37(73-75(63,64)65)36(58)42(72-30)52-27-51-35-39(46)49-26-50-40(35)52)38(59)41(60)48-20-19-32(54)47-21-22-78-34(57)18-13-11-9-7-5-3-4-6-8-10-12-16-31(79-24-28(45)43(61)62)29(53)15-14-17-33(55)56/h4-8,10,12,16,26-31,36-38,42,53,58-59H,3,9,11,13-15,17-25,45H2,1-2H3,(H,47,54)(H,48,60)(H,55,56)(H,61,62)(H,66,67)(H,68,69)(H2,46,49,50)(H2,63,64,65)/p-5/b6-4-,7-5-,10-8+,16-12+/t28-,29+,30+,31-,36-,37-,38u,42+/m1/s1",,2016-11-22T15:12:24Z,,2425,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2425/?format=pcsv
CE6191,,,-5,C44H62N8O22P3S2,,,18E-20-oxo-20-CoA-LTE4,,18E-20-oxo-20-CoA-LTE4,,,"InChI=1/C44H67N8O22P3S2/c1-44(2,25-71-77(68,69)74-76(66,67)70-23-30-37(73-75(63,64)65)36(58)42(72-30)52-27-51-35-39(46)49-26-50-40(35)52)38(59)41(60)48-20-19-32(54)47-21-22-78-34(57)18-13-11-9-7-5-3-4-6-8-10-12-16-31(79-24-28(45)43(61)62)29(53)15-14-17-33(55)56/h4-8,10,12-13,16,18,26-31,36-38,42,53,58-59H,3,9,11,14-15,17,19-25,45H2,1-2H3,(H,47,54)(H,48,60)(H,55,56)(H,61,62)(H,66,67)(H,68,69)(H2,46,49,50)(H2,63,64,65)/p-5/b6-4-,7-5-,10-8+,16-12+,18-13+/t28-,29+,30+,31-,36-,37-,38u,42+/m1/s1",,2016-11-22T15:12:24Z,,2426,,,,,53481494,,,,http://vmh.uni.lu/_api/metabolites/2426/?format=pcsv
CE6204,,,-5,C42H58N8O22P3S2,,,CoA-18-COOH-16E-dinor-LTE5,,CoA-18-COOH-16E-dinor-LTE5,,,,,2016-11-22T15:12:24Z,,2427,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2427/?format=pcsv
CE6227,,,-5,C42H60N8O22P3S2,,,CoA-18-COOH-15E-dinor-LTE4,,CoA-18-COOH-15E-dinor-LTE4,,,"InChI=1/C42H65N8O22P3S2/c1-42(2,23-69-75(66,67)72-74(64,65)68-21-28-35(71-73(61,62)63)34(56)40(70-28)50-25-49-33-37(44)47-24-48-38(33)50)36(57)39(58)46-18-17-30(52)45-19-20-76-32(55)16-11-9-7-5-3-4-6-8-10-14-29(77-22-26(43)41(59)60)27(51)13-12-15-31(53)54/h3-4,6,8-11,14,24-29,34-36,40,51,56-57H,5,7,12-13,15-23,43H2,1-2H3,(H,45,52)(H,46,58)(H,53,54)(H,59,60)(H,64,65)(H,66,67)(H2,44,47,48)(H2,61,62,63)/p-5/b4-3-,8-6+,11-9+,14-10+/t26-,27+,28+,29-,34-,35-,36u,40+/m1/s1",,2016-11-22T15:12:24Z,,2428,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2428/?format=pcsv
CE6225,,,-5,C42H60N8O22P3S2,,,16E-18-oxo-18-CoA-dinor-LTE4,,16E-18-oxo-18-CoA-dinor-LTE4,,,"InChI=1/C42H65N8O22P3S2/c1-42(2,23-69-75(66,67)72-74(64,65)68-21-28-35(71-73(61,62)63)34(56)40(70-28)50-25-49-33-37(44)47-24-48-38(33)50)36(57)39(58)46-18-17-30(52)45-19-20-76-32(55)16-11-9-7-5-3-4-6-8-10-14-29(77-22-26(43)41(59)60)27(51)13-12-15-31(53)54/h3-4,6,8,10-11,14,16,24-29,34-36,40,51,56-57H,5,7,9,12-13,15,17-23,43H2,1-2H3,(H,45,52)(H,46,58)(H,53,54)(H,59,60)(H,64,65)(H,66,67)(H2,44,47,48)(H2,61,62,63)/p-5/b4-3-,8-6+,14-10+,16-11+/t26-,27+,28+,29-,34-,35-,36u,40+/m1/s1",,2016-11-22T15:12:24Z,,2429,,,,,53481482,,,,http://vmh.uni.lu/_api/metabolites/2429/?format=pcsv
CE6228,,,-5,C40H56N8O22P3S2,,,13E-tetranor-16-oxo-16-CoA-LTE4,,13E-tetranor-16-oxo-16-CoA-LTE4,,,"InChI=1/C40H61N8O22P3S2/c1-40(2,21-67-73(64,65)70-72(62,63)66-19-26-33(69-71(59,60)61)32(54)38(68-26)48-23-47-31-35(42)45-22-46-36(31)48)34(55)37(56)44-16-15-28(50)43-17-18-74-30(53)14-9-7-5-3-4-6-8-12-27(75-20-24(41)39(57)58)25(49)11-10-13-29(51)52/h3-9,12,22-27,32-34,38,49,54-55H,10-11,13-21,41H2,1-2H3,(H,43,50)(H,44,56)(H,51,52)(H,57,58)(H,62,63)(H,64,65)(H2,42,45,46)(H2,59,60,61)/p-5/b5-3-,6-4+,9-7+,12-8+/t24-,25+,26+,27-,32-,33-,34u,38+/m1/s1",,2016-11-22T15:12:24Z,,2430,,,,,53481473,,,,http://vmh.uni.lu/_api/metabolites/2430/?format=pcsv
CE6229,,,-2,C19H25NO7S,,,13E-tetranor-16-carboxy-LTE4,,13E-tetranor-16-carboxy-LTE4,,,"InChI=1/C19H27NO7S/c20-14(19(26)27)13-28-16(15(21)9-8-12-18(24)25)10-6-4-2-1-3-5-7-11-17(22)23/h1-7,10,14-16,21H,8-9,11-13,20H2,(H,22,23)(H,24,25)(H,26,27)/p-2/b3-1-,4-2+,7-5+,10-6+/t14-,15+,16-/m1/s1",,2016-11-22T15:12:24Z,,2431,,,,,53481472,,,,http://vmh.uni.lu/_api/metabolites/2431/?format=pcsv
CE6234,,,-1,C20H33O5,,,prostaglandin H1,,prostaglandin H1,,,"InChI=1/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18-14-19(17)25-24-18)10-7-4-5-8-11-20(22)23/h12-13,15-19,21H,2-11,14H2,1H3,(H,22,23)/p-1/b13-12+/t15-,16+,17+,18-,19+/m0/s1",,2016-11-22T15:12:24Z,,2432,,,,,5283048,,,,http://vmh.uni.lu/_api/metabolites/2432/?format=pcsv
CE5976,,,-2,C20H28O6,,,"12-oxo-10,11-dihydro-20-COOH-LTB4",,"12-oxo-10,11-dihydro-20-COOH-LTB4",,,,,2016-11-22T15:12:24Z,,2433,,,,,53481456,CE5976,,,http://vmh.uni.lu/_api/metabolites/2433/?format=pcsv
CE5121,,,-4,C31H48N7O17P3S,16019966,,"Human Metabolome Database (HMDB): trans-3-Decenoyl-CoA is an intermediate in fatty acid metabolism. trans-3-Decenoyl-CoA is the substrate of medium-chain acyl-CoA dehydrogenase (MCAD, EC 1.3.99.3) MCAD acts on C4-C16 acyl-CoAs with its peak activity toward medium-chain (C6-C12) substrates. MCAD is a key enzyme for the beta-oxidation of fatty acids. MCAD deficiency is caused by mutation in the medium-chain acyl-CoA dehydrogenase gene (ACADM; OMIM 607008). Inherited deficiency of medium-chain acyl-CoA dehydrogenase is characterized by intolerance to prolonged fasting, recurrent episodes of hypoglycemic coma with medium-chain dicarboxylic aciduria, impaired ketogenesis, and low plasma and tissue carnitine levels. The disorder may be severe, and even fatal, in young patients. It has been reported that between 19 and 25% of patients with undiagnosed deficiency of MCAD die during their first episode of metabolic decompensation. (PMID: 15850406).",,trans-3-decenoyl-CoA,,HMDB02137,,,2016-12-05T15:48:07Z,,2434,,,,,16019966,,,"(E)-S-3-decenoate, (E)-S-3-decenoate CoA, (E)-S-3-decenoate Coenzyme A, (E)-S-3-decenoic acid, 3-trans-Decenoyl-CoA, 3-trans-Decenoyl-Coenzyme A, S-(3E)-3-Decenoate, S-(3E)-3-DecenoateCoA, S-(3E)-3-DecenoateCoenzyme A, S-(3E)-3-Decenoic acid, trans-3-Decenoyl-CoA, trans-3-Decenoyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/2434/?format=pcsv
CE2089,,,-1,C9H12N3O4S,,,S-[2-carboxy-1-(1 H-imidazol-4-yl)ethyl]-L-cysteine,,S-[2-carboxy-1-(1 H-imidazol-4-yl)ethyl]-L-cysteine,,,,,2016-11-22T15:12:25Z,,2435,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2435/?format=pcsv
CE2088,,,-2,C11H13N3O5S,,,N-acetyl-S-[2-carboxy-1-(1 H-imidazol-4-yl)ethyl]-L-cysteine,,N-acetyl-S-[2-carboxy-1-(1 H-imidazol-4-yl)ethyl]-L-cysteine,,,,,2016-11-22T15:12:25Z,,2436,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2436/?format=pcsv
CE7220,,,-2,C16H21N5O8S,,,S-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]glutathione,,S-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]glutathione,,,,,2016-11-22T15:12:25Z,,2437,,,,,,CE7220,,,http://vmh.uni.lu/_api/metabolites/2437/?format=pcsv
CE7218,,,-2,C9H10N2O5S,,,S-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]-3-thiolactate,,S-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]-3-thiolactate,,,,,2016-11-22T15:12:25Z,,2438,,,,,192636,,,,http://vmh.uni.lu/_api/metabolites/2438/?format=pcsv
C05767,,,-8,C40H30N4O16,CHEBI:27484,,"Human Metabolome Database (HMDB): Uroporphyrin is the porphyrin produced by oxidation of the methylene bridges in uroporphyrinogen. They have four acetic acid and four propionic acid side chains attached to the pyrrole rings. Uroporphyrinogen I and III are formed from polypyrryl methane in the presence of uroporphyrinogen III cosynthetase and uroporphyrin I synthetase, respectively. They can yield uroporphyrins by autooxidation or coproporphyrinogens by decarboxylation.Excessive amounts of uroporphyrin I are excreted in congenital erythropoietic porphyria, and both types I and III are excreted in porphyria cutanea tarda.Uroporphyrin I and III are the most common isomers.",,Uroporphyrin I,,HMDB00936,"InChI=1S/C40H38N4O16/c45-33(46)5-1-17-21(9-37(53)54)29-14-26-19(3-7-35(49)50)23(11-39(57)58)31(43-26)16-28-20(4-8-36(51)52)24(12-40(59)60)32(44-28)15-27-18(2-6-34(47)48)22(10-38(55)56)30(42-27)13-25(17)41-29/h13-16,41,44H,1-12H2,(H,45,46)(H,47,48)(H,49,50)(H,51,52)(H,53,54)(H,55,56)(H,57,58)(H,59,60)/b25-13-,26-14-,27-15-,28-16-,29-14-,30-13-,31-16-,32-15-",C05767,2016-12-05T15:48:07Z,,2439,,,,,,C05767,,"2,7,12,17-Porphinetetrapropionate, 2,7,12,17-Porphinetetrapropionic acid, 3,3',3'',3'''-(3,8,13,18-Tetrakis-carboxymethyl-21H,23H-porphine-2,7,12,17-tetrayl)-tetrakis-propionate, 3,3',3'',3'''-(3,8,13,18-Tetrakis-carboxymethyl-21H,23H-porphine-2,7,12,17-tetrayl)-tetrakis-propionic acid, 3,3',3'',3'''-(3,8,13,18-Tetrakis-carboxymethyl-porphyrin-2,7,12,17-tetrayl)-tetra-propionate, 3,3',3'',3'''-(3,8,13,18-Tetrakis-carboxymethyl-porphyrin-2,7,12,17-tetrayl)-tetra-propionic acid, 3,8,13,18-Tetrakis(carboxymethyl)porphyrin-2,7,12,17-tetrapropanoate, 3,8,13,18-Tetrakis(carboxymethyl)porphyrin-2,7,12,17-tetrapropanoic acid, 3-[7,12,17-Tris-(2-carboxy-ethyl)-3,8,13,18-tetrakis-carboxymethyl-22,24-dihydro-porphin-2-yl]-propionate, 3-[7,12,17-Tris-(2-carboxy-ethyl)-3,8,13,18-tetrakis-carboxymethyl-22,24-dihydro-porphin-2-yl]-propionic acid, Uroporphyrin I",http://vmh.uni.lu/_api/metabolites/2439/?format=pcsv
C05708,,,0,C5H11NO3Se,,,Selenomethionine se-oxide,,Selenomethionine se-oxide,,,"InChI=1/C5H11NO3Se/c1-10(9)3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)",C05708,2016-11-22T15:12:25Z,,2440,,,,,17754089,C05708,,,http://vmh.uni.lu/_api/metabolites/2440/?format=pcsv
C07535,,,0,C20H12,CHEBI:29865,,Benzpyrene,,Benzpyrene,,,InChI=1S/C20H12/c1-2-7-17-15(4-1)12-16-9-8-13-5-3-6-14-10-11-18(17)20(16)19(13)14/h1-12H,C07535,2016-11-22T15:12:25Z,,2441,,,,,2336,,,,http://vmh.uni.lu/_api/metabolites/2441/?format=pcsv
CN0012,,,0,,,,"Benzo[a]pyrene-2,3-oxide",,"Benzo[a]pyrene-2,3-oxide",,,,,2016-11-22T15:12:25Z,,2442,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2442/?format=pcsv
CN0009,,,0,,,,"Benzo[a]pyrene-2,3-diol",,"Benzo[a]pyrene-2,3-diol",,,,,2016-11-22T15:12:25Z,,2443,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2443/?format=pcsv
C14851,,,0,C20H12O,,,"Benzo[a]pyrene-4,5-oxide",,"Benzo[a]pyrene-4,5-oxide",,,"InChI=1/C20H12O/c1-2-6-13-12(4-1)10-16-18-14(13)9-8-11-5-3-7-15(17(11)18)19-20(16)21-19/h1-10,19-20H",C14851,2016-11-22T15:12:25Z,,2444,,,,,37786,,,,http://vmh.uni.lu/_api/metabolites/2444/?format=pcsv
CN0010,,,0,,,,"Benzo[a]pyrene-4,5-diol",,"Benzo[a]pyrene-4,5-diol",,,,,2016-11-22T15:12:25Z,,2445,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2445/?format=pcsv
C14849,,,0,C20H12O,,,"Benzo[a]pyrene-9,10-oxide",,"Benzo[a]pyrene-9,10-oxide",,,"InChI=1/C20H12O/c1-2-11-4-5-13-10-14-7-9-16-20(21-16)19(14)15-8-6-12(3-1)17(11)18(13)15/h1-10,16,20H",C14849,2016-11-22T15:12:25Z,,2446,,,,,37456,,,,http://vmh.uni.lu/_api/metabolites/2446/?format=pcsv
CN0011,,,0,,,,"Benzo[a]pyrene-9,10-diol",,"Benzo[a]pyrene-9,10-diol",,,,,2016-11-22T15:12:25Z,,2447,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2447/?format=pcsv
CN0020,,,0,,,,"7,12-Dimethylbenz[a]anthracene",,"7,12-Dimethylbenz[a]anthracene",,,,,2016-11-22T15:12:25Z,,2448,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2448/?format=pcsv
CN0021,,,0,,,,"7,12-Dimethylbenz[a]anthracene-3,4-oxide",,"7,12-Dimethylbenz[a]anthracene-3,4-oxide",,,,,2016-11-22T15:12:25Z,,2449,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2449/?format=pcsv
CN0022,,,0,,,,"7,12-Dimethylbenz[a]anthracene-3,4-diol",,"7,12-Dimethylbenz[a]anthracene-3,4-diol",,,,,2016-11-22T15:12:25Z,,2450,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2450/?format=pcsv
CN0023,,,0,,,,"7,12-Dimethylbenz[a]anthracene-3,4-diol-1,2-epoxide",,"7,12-Dimethylbenz[a]anthracene-3,4-diol-1,2-epoxide",,,,,2016-11-22T15:12:25Z,,2451,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2451/?format=pcsv
CN0016,,,0,C24H14,,,"Dibenzo[a,l]pyrene",,"Dibenzo[a,l]pyrene",,,InChI=1S/C24H14/c1-2-8-18-16(6-1)14-17-13-12-15-7-5-11-20-19-9-3-4-10-21(19)24(18)23(17)22(15)20/h1-14H,C19174,2016-11-22T15:12:25Z,,2452,,,,,9119,,,,http://vmh.uni.lu/_api/metabolites/2452/?format=pcsv
CN0017,,,0,,,,"Dibenzo[a,l]pyrene-11,12-epoxide",,"Dibenzo[a,l]pyrene-11,12-epoxide",,,,,2016-11-22T15:12:25Z,,2453,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2453/?format=pcsv
CN0018,,,0,,,,"Dibenzo[a,l]pyrene-11,12-diol",,"Dibenzo[a,l]pyrene-11,12-diol",,,,,2016-11-22T15:12:25Z,,2454,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2454/?format=pcsv
CN0019,,,0,,,,"Dibenzo[a,l]pyrene-11,12-diol-13,14-epoxide",,"Dibenzo[a,l]pyrene-11,12-diol-13,14-epoxide",,,,,2016-11-22T15:12:25Z,,2455,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2455/?format=pcsv
adpac,,,-2,C6H8O4,,,"Human Metabolome Database (HMDB): Adipic acid is an important inudstrial dicarboxylic acid with about 2.5 billion kilograms produced per year. It is used mainly in the production of nylon. It occurs relatively rarely in nature. It has a tart taste and is also used as an additive and gelling agent in jello or gelatins. It is also used in some calcium carbonate antacids to make them tart. Adipic acid has also been incorporated into controlled-release formulation matrix tablets to obtain pH-independent release for both weakly basic and weakly acidic drugs. Adipic acid in the urine and in the blood is typically exogenous in origin and is a good biomarker of jello consumption. In fact, a condition known as adipic aciduria is actually an artifact of jello consumption (PMID: 1779643). However, certain disorders (such as diabetes and glutaric aciduria type I.) can lead to elevated levels of adipic acid snd other dicarboxcylic acids (such as suberic acid) in urine (PMID: 17520433; PMID: 6778884).",,adipic acid,,HMDB00448,,C06104,2016-12-05T15:48:07Z,,2456,,,,,196,adpac,,"1,6-Hexanedioate, 1,6-Hexanedioic acid, Acifloctin, Acinetten, Adi-pure, Adilactetten, Adipate, Adipic acid, Adipinate, Adipinic acid, Hexanedioate, Hexanedioic acid, Kyselina adipova, Molten adipate, Molten adipic acid",http://vmh.uni.lu/_api/metabolites/2456/?format=pcsv
adpcoa,,,-5,C27H39N7O19P3S,,,adipoylcoa,,adipoylcoa,,,,C14143,2016-11-22T15:12:25Z,,2457,,,,,9543333,adpcoa,,,http://vmh.uni.lu/_api/metabolites/2457/?format=pcsv
c6dc,,,-1,C13H22NO6,,,adipoyl carnitine,,adipoyl carnitine,,,,,2016-11-22T15:12:25Z,,2458,,,,,,c6dc,,,http://vmh.uni.lu/_api/metabolites/2458/?format=pcsv
3bcrn,,,0,C11H21NO5,,,3-hydroxy butyryl carnitine,,3-hydroxy butyryl carnitine,,,,,2016-11-22T15:12:25Z,,2459,,,,,,3bcrn,,,http://vmh.uni.lu/_api/metabolites/2459/?format=pcsv
c10crn,,,0,C17H33NO4,,,Human Metabolome Database (HMDB): Acylcarnitine useful in the diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency deficiencyoxidation disorders.(PMID: 12385891).,,decanoyl carnitine,,HMDB00651,,,2016-12-05T15:48:07Z,,2460,,,,,10245190,c10crn,,"Decanoyl-L-carnitine, Decanoylcarnitine",http://vmh.uni.lu/_api/metabolites/2460/?format=pcsv
c101coa,,,-4,C31H48N7O17P3S,,,decenoylcoa,,decenoylcoa,,,,,2016-11-22T15:12:25Z,,2461,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2461/?format=pcsv
c101crn,,,0,C17H31NO4,,,decenoyl carnitine,,decenoyl carnitine,,,,,2016-11-22T15:12:25Z,,2462,,,,,53481651,,,,http://vmh.uni.lu/_api/metabolites/2462/?format=pcsv
decdicoa,,,-4,C31H46N7O17P3S,,,decadienoylcoa,,decadienoylcoa,,,,,2016-11-22T15:12:25Z,,2463,,,,,22833562,,,,http://vmh.uni.lu/_api/metabolites/2463/?format=pcsv
decdicrn,,,0,C17H29NO4,,,decadienoyl carnitine,,decadienoyl carnitine,,,,,2016-11-22T15:12:25Z,,2464,,,,,53481669,,,,http://vmh.uni.lu/_api/metabolites/2464/?format=pcsv
c10dc,,,-1,C17H30NO6,,,sebacoyl carnitine,,sebacoyl carnitine,,,,,2016-11-22T15:12:25Z,,2465,,,,,,c10dc,,,http://vmh.uni.lu/_api/metabolites/2465/?format=pcsv
sebcoa,,,-5,C31H47N7O19P3S,,,sebacoylcoa,,sebacoylcoa,,,,,2016-11-22T15:12:25Z,,2466,,,,,,sebcoa,,,http://vmh.uni.lu/_api/metabolites/2466/?format=pcsv
3hdcoa,,,-4,C31H50N7O18P3S,CHEBI:28325,,(S)-3-Hydroxydecanoyl-CoA,,(S)-3-Hydroxydecanoyl-CoA,,,,C05264,2016-11-22T15:12:12Z,,2467,,,,(S)-3-hydroxydecanoyl-CoA,11966158,3hdcoa,,,http://vmh.uni.lu/_api/metabolites/2467/?format=pcsv
3deccrn,,,0,C17H33NO5,,,3-hydroxydecanoylcarnitine,,3-hydroxydecanoylcarnitine,,,,,2016-11-22T15:12:25Z,,2468,,,,,,3deccrn,,,http://vmh.uni.lu/_api/metabolites/2468/?format=pcsv
ddeccrn,,,0,C19H37NO4,,,lauroyl carnitine,,lauroyl carnitine,,,,,2016-11-22T15:12:25Z,,2469,,,,,168381,ddeccrn,,,http://vmh.uni.lu/_api/metabolites/2469/?format=pcsv
ddece1crn,,,0,C19H35NO4,,,dodecenoyl carnitine,,dodecenoyl carnitine,,,,,2016-11-22T15:12:25Z,,2470,,,,,,ddece1crn,,,http://vmh.uni.lu/_api/metabolites/2470/?format=pcsv
c12dccoa,,,-5,C33H51N7O19P3S,,,dodecanedioylcoa,,dodecanedioylcoa,,,,,2016-11-22T15:12:25Z,,2471,,,,,,c12dccoa,,,http://vmh.uni.lu/_api/metabolites/2471/?format=pcsv
dodecanac,,,-2,C12H20O4,,,Dodecanedioic acid,,Dodecanedioic acid,,,,C02678,2016-11-22T15:12:25Z,,2472,,,,,12736,,,,http://vmh.uni.lu/_api/metabolites/2472/?format=pcsv
c12dc,,,-1,C19H34NO6,,,dodecanedioyl carnitine,,dodecanedioyl carnitine,,,,,2016-11-22T15:12:25Z,,2473,,,,,,c12dc,,,http://vmh.uni.lu/_api/metabolites/2473/?format=pcsv
3hddcoa,,,-4,C33H54N7O18P3S,CHEBI:27668,,(S)-3-Hydroxydodecanoyl-CoA,,(S)-3-Hydroxydodecanoyl-CoA,,,,C05262,2016-11-22T15:12:11Z,,2474,,,,(S)-3-hydroxylauroyl-CoA,440603,3hddcoa,,,http://vmh.uni.lu/_api/metabolites/2474/?format=pcsv
3ddcrn,,,0,C19H37NO5,,,3-hydroxydodecanoylcarnitine,,3-hydroxydodecanoylcarnitine,,,,,2016-11-22T15:12:25Z,,2475,,,,,,3ddcrn,,,http://vmh.uni.lu/_api/metabolites/2475/?format=pcsv
tdcrn,,,0,C21H41NO4,53477791,,Human Metabolome Database (HMDB): Tetradecanoylcarnitine is a human carnitine involved in b-oxidation of long-chain fatty acids (PMID: 16425363).,,myristoyl carnitine,,HMDB05066,,,2016-12-05T15:48:07Z,,2476,,,,,53477791,,,"(-)-Myristoylcarnitine, (-)-Tetradecanoylcarnitine, (R)-Tetradecanoylcarnitine, L-Myristoylcarnitine, Myristoyl-L-(-)-carnitine, Myristoyl-L-carnitine, Myristoylcarnitine, Tetradecanoyl-L-carnitine",http://vmh.uni.lu/_api/metabolites/2476/?format=pcsv
3tetd7ecoa,,,-4,C35H56N7O18P3S,,,3-hydroxy tetradecenoyl-7-coa,,3-hydroxy tetradecenoyl-7-coa,,,,,2016-11-22T15:12:25Z,,2477,,,,,,3tetd7ecoa,,,http://vmh.uni.lu/_api/metabolites/2477/?format=pcsv
tetdece1coa,,,-4,C35H56N7O17P3S,,,tetradecenoylcoa,,tetradecenoylcoa,,,,,2016-11-22T15:12:25Z,,2478,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2478/?format=pcsv
tetdece1crn,,,0,C21H39NO4,,,tetradecenoyl carnitine,,tetradecenoyl carnitine,,,,,2016-11-22T15:12:25Z,,2479,,,,,22833575,,,,http://vmh.uni.lu/_api/metabolites/2479/?format=pcsv
3tetd7ecoacrn,,,0,C21H39NO5,,,3-hydroxy tetradecenoyl-7-carnitine,,3-hydroxy tetradecenoyl-7-carnitine,,,,,2016-11-22T15:12:25Z,,2480,,,,,,3tetd7ecoacrn,,,http://vmh.uni.lu/_api/metabolites/2480/?format=pcsv
3ttetddcoa,,,-4,C35H54N7O18P3S,,,"3-hydroxy trans5,8tetradecadienoyl coa",,"3-hydroxy trans5,8tetradecadienoyl coa",,,,,2016-11-22T15:12:25Z,,2481,,,,,,3ttetddcoa,,,http://vmh.uni.lu/_api/metabolites/2481/?format=pcsv
tetdec2coa,,,-4,C35H54N7O17P3S,,,tetradecadienoylcoa,,tetradecadienoylcoa,,,,,2016-11-22T15:12:25Z,,2482,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2482/?format=pcsv
tetdec2crn,,,0,C21H37NO4,,,tetradecadienoyl carnitine,,tetradecadienoyl carnitine,,,,,2016-11-22T15:12:25Z,,2483,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2483/?format=pcsv
3ttetddcoacrn,,,0,C21H37NO5,,,"3-hydroxy trans5,8tetradecadienoyl carnitine",,"3-hydroxy trans5,8tetradecadienoyl carnitine",,,,,2016-11-22T15:12:25Z,,2484,,,,,,3ttetddcoacrn,,,http://vmh.uni.lu/_api/metabolites/2484/?format=pcsv
3htdcoa,,,-4,C35H58N7O18P3S,CHEBI:27466,,(S)-3-Hydroxytetradecanoyl-CoA,,(S)-3-Hydroxytetradecanoyl-CoA,,,,C05260,2016-11-22T15:12:12Z,,2485,,,,(S)-3-hydroxytetradecanoyl-CoA,46173488,3htdcoa,,,http://vmh.uni.lu/_api/metabolites/2485/?format=pcsv
3tdcrn,,,0,C21H41NO5,,,3-hydroxy-tetradecanoyl carnitine,,3-hydroxy-tetradecanoyl carnitine,,,,,2016-11-22T15:12:25Z,,2486,,,,,,3tdcrn,,,http://vmh.uni.lu/_api/metabolites/2486/?format=pcsv
3hdeccoa,,,-4,C37H60N7O18P3S,,,3-hydroxyhexadecenoylcoa,,3-hydroxyhexadecenoylcoa,,,,,2016-11-22T15:12:25Z,,2487,,,,,,3hdeccoa,,,http://vmh.uni.lu/_api/metabolites/2487/?format=pcsv
3hdececrn,,,0,C23H43NO5,,,3-hydroxyhexadecenoylcarnitine,,3-hydroxyhexadecenoylcarnitine,,,,,2016-11-22T15:12:25Z,,2488,,,,,,3hdececrn,,,http://vmh.uni.lu/_api/metabolites/2488/?format=pcsv
3thexddcoa,,,-4,C37H58N7O18P3S,,,"3-hydroxy trans7,10-hexadecadienoylcoa",,"3-hydroxy trans7,10-hexadecadienoylcoa",,,,,2016-11-22T15:12:25Z,,2489,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2489/?format=pcsv
3thexddcoacrn,,,0,C23H41NO5,,,"3-hydroxy trans7,10-hexadecadienoyl carnitine",,"3-hydroxy trans7,10-hexadecadienoyl carnitine",,,,,2016-11-22T15:12:25Z,,2490,,,,,,3thexddcoacrn,,,http://vmh.uni.lu/_api/metabolites/2490/?format=pcsv
hexdicoa,,,-5,C37H59N7O19P3S,,,hexadecanedioylcoa,,hexadecanedioylcoa,,,,,2016-11-22T15:12:25Z,,2491,,,,,,hexdicoa,,,http://vmh.uni.lu/_api/metabolites/2491/?format=pcsv
c16dc,,,-1,C23H42NO6,,,Hexadecanedioic acid mono-L-carnitine ester,,Hexadecanedioic acid mono-L-carnitine ester,,,,,2016-11-22T15:12:25Z,,2492,,,,,566787,c16dc,,,http://vmh.uni.lu/_api/metabolites/2492/?format=pcsv
3hexdcoa,,,-4,C37H62N7O18P3S,,,3-hydroxyhexadecanoylcoa,,3-hydroxyhexadecanoylcoa,,,,C05258,2016-11-22T15:12:25Z,,2493,,,,,440600,3hexdcoa,,,http://vmh.uni.lu/_api/metabolites/2493/?format=pcsv
3hexdcrn,,,0,C23H45NO5,,,3-hydroxyhexadecanoylcarnitine,,3-hydroxyhexadecanoylcarnitine,,,,,2016-11-22T15:12:25Z,,2494,,,,,53481691,3hexdcrn,,,http://vmh.uni.lu/_api/metabolites/2494/?format=pcsv
3octdece1coa,,,-4,C39H64N7O18P3S,,,3-hydroxyoctadecenoylcoa,,3-hydroxyoctadecenoylcoa,,,,,2016-11-22T15:12:25Z,,2495,,,,,,3octdece1coa,,,http://vmh.uni.lu/_api/metabolites/2495/?format=pcsv
3octdece1crn,,,0,C25H47NO5,,,3-hydroxy-octadecenoyl carnitine,,3-hydroxy-octadecenoyl carnitine,,,,,2016-11-22T15:12:25Z,,2496,,,,,,3octdece1crn,,,http://vmh.uni.lu/_api/metabolites/2496/?format=pcsv
3ocddcoa,,,-4,C39H62N7O18P3S,,,3-hydroxyoctadecadienoylcoa,,3-hydroxyoctadecadienoylcoa,,,,,2016-11-22T15:12:25Z,,2497,,,,,,3ocddcoa,,,http://vmh.uni.lu/_api/metabolites/2497/?format=pcsv
3octdec2crn,,,0,C25H45NO5,,,3-hydroxyoctadecadienoylcarnitine,,3-hydroxyoctadecadienoylcarnitine,,,,,2016-11-22T15:12:25Z,,2498,,,,,,3octdec2crn,,,http://vmh.uni.lu/_api/metabolites/2498/?format=pcsv
3hodcoa,,,-4,C39H66N7O18P3S,,,(S)-3-Hydroxyoctadecanoyl-CoA,,(S)-3-Hydroxyoctadecanoyl-CoA,,,,,2016-11-22T15:12:25Z,,2499,,,,,49859586,3hodcoa,,,http://vmh.uni.lu/_api/metabolites/2499/?format=pcsv
3octdeccrn,,,0,C25H49NO5,,,3-hydroxyoctadecanoyl carnitine,,3-hydroxyoctadecanoyl carnitine,,,,,2016-11-22T15:12:25Z,,2500,,,,,,3octdeccrn,,,http://vmh.uni.lu/_api/metabolites/2500/?format=pcsv
c3dc,,,-1,C10H16NO6,,,malonyl carnitine,,malonyl carnitine,,,,,2016-11-22T15:12:25Z,,2501,,,,,22833583,,,,http://vmh.uni.lu/_api/metabolites/2501/?format=pcsv
c4crn,,,0,C11H21NO4,,,"Human Metabolome Database (HMDB): Butyrylcarnitine is elevated in patients with acyl-coa dehydrogenase, short-chain (SCAD) deficiencyin; in infants with acute acidosis and generalized muscle weakness; and in middle-aged patients with chronic myopathy localized in muscle. (OMIM 201470).",,butyryl carnitine,,HMDB02013,,C02862,2016-12-05T15:48:07Z,,2502,,,,,439829,c4crn,,"(3-carboxy-2-hydroxypropyl)trimethyl-L-butyrate, (R)-3-carboxy-N,N,N-trimethyl-2-(1-oxobutoxy)-1-Propanaminium, Butyryl-L-carnitine, Ester with (3-carboxy-2-hydroxypropyl)trimethylammonium  L-Butyric acid, Ester with L-(3-carboxy-2-hydroxypropyl)trimethylammonium Butyric acid, L-Carnitine butyryl ester, N-Butyryl-L(-)-carnitine, O-Butanoylcarnitine",http://vmh.uni.lu/_api/metabolites/2502/?format=pcsv
c4dc,,,-1,C11H18NO6,,,succinyl carnitine,,succinyl carnitine,,,,,2016-11-22T15:12:25Z,,2503,,,,,,c4dc,,,http://vmh.uni.lu/_api/metabolites/2503/?format=pcsv
ivcrn,,,0,C12H23NO4,,,isovaleryl carnitine,,isovaleryl carnitine,,,,,2016-11-22T15:12:25Z,,2504,,,,,6426851,ivcrn,,,http://vmh.uni.lu/_api/metabolites/2504/?format=pcsv
c51crn,,,0,C12H21NO4,,,tiglyl carnitine,,tiglyl carnitine,,,,,2016-11-22T15:12:25Z,,2505,,,,,22833596,c51crn,,,http://vmh.uni.lu/_api/metabolites/2505/?format=pcsv
c5dc,,,0,C12H21NO6,,,glutaryl carnitine,,glutaryl carnitine,,,,,2016-11-22T15:12:25Z,,2506,,,,,53481622,c5dc,,,http://vmh.uni.lu/_api/metabolites/2506/?format=pcsv
hxcoa,,,-4,C27H42N7O17P3S,CHEBI:27540,,Human Metabolome Database (HMDB): Fatty acid coenzyme A derivative that can be involved in the biosynthesis and oxidation of fatty acids as well as in ceramide formation.,,Hexanoyl-CoA (n-C6:0CoA),,HMDB02845,,,2016-12-05T15:48:07Z,,2507,,,,hexanoyl-CoA,,hxcoa,,"6-Carboxyhexanoyl-CoA, 6-Carboxyhexanoyl-Coenzyme A, Caproyl-CoA, Caproyl-Coenzyme A, Hexanoyl-coenzyme A, Pimeloyl-CoA, Pimeloyl-Coenzyme A",http://vmh.uni.lu/_api/metabolites/2507/?format=pcsv
c6crn,,,0,C13H25NO4,,,hexanoyl carnitine,,hexanoyl carnitine,,,,,2016-11-22T15:12:26Z,,2508,,,,,6426853,c6crn,,,http://vmh.uni.lu/_api/metabolites/2508/?format=pcsv
c8crn,,,0,C15H29NO4,CHEBI:18102,,"Human Metabolome Database (HMDB): L-Octanoylcarnitine is the physiologically active form of octanoylcarnitine. (PMID 11274033). Octanoylcarnitine is detected in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. MCAD is characterized by intolerance to prolonged fasting, recurrent episodes of hypoglycemic coma with medium-chain dicarboxylic aciduria, impaired ketogenesis, and low plasma and tissue carnitine levels. (OMIM 201450).",,octanoyl carnitine,,HMDB00791,,C02838,2016-12-05T15:48:07Z,,2509,,,,,11953814,c8crn,,"(-)-Octanoylcarnitine, L-Carnitine octanoyl ester, L-O-Octanoylcarnitine, L-Octanoylcarnitine, Octanoate, Octanoic acid, Octanoic acid ester with L-(3-carboxy-2-hydroxypropyl)trimethylammonium hydroxide inner salt, Octanoyl-L-carnitine, Octanoylcarnitine",http://vmh.uni.lu/_api/metabolites/2509/?format=pcsv
c81coa,,,-4,C29H44N7O17P3S,,,octenoylcoa,,octenoylcoa,,,,C05276,2016-11-22T15:12:26Z,,2510,,,,,5280769,,,,http://vmh.uni.lu/_api/metabolites/2510/?format=pcsv
c81crn,,,0,C15H27NO4,,,octenoyl carnitine,,octenoyl carnitine,,,,,2016-11-22T15:12:26Z,,2511,,,,,53481667,,,,http://vmh.uni.lu/_api/metabolites/2511/?format=pcsv
sbcoa,,,-5,C29H43N7O19P3S,,,suberylcoa,,suberylcoa,,,,,2016-11-22T15:12:26Z,,2512,,,,,,sbcoa,,,http://vmh.uni.lu/_api/metabolites/2512/?format=pcsv
c8dc,,,-1,C15H26NO6,,,suberyl carnitine,,suberyl carnitine,,,,,2016-11-22T15:12:26Z,,2513,,,,,,c8dc,,,http://vmh.uni.lu/_api/metabolites/2513/?format=pcsv
dca,,,-1,C10H19O2,CHEBI:30813,,"Human Metabolome Database (HMDB): Capric acid is a member of the series of fatty acids found in oils and animal fats. The names of Caproic, Caprylic, and Capric acids are all derived from the word caper (Latin: 'goat'). These are colorless light yellowish transparent oily liquids with unconfortable smells. These are used in organic synthesis, manufacture of perfume, medicine, lubricating grease, rubber and dye.(ChemicalLAND21).",,Decanoate (n-C10:0),,HMDB00511,,,2016-12-05T15:48:07Z,,2514,,,,,,dca,,"1-Nonanecarboxylate, 1-Nonanecarboxylic acid, Caprate, Capric acid, Caprinate, Caprinic acid, Caprynate, Caprynic acid, Decoate, Decoic acid, Decylate, Decylic acid, Emery 659, Lunac 10-95, Lunac 10-98, N-Caprate, N-Capric acid, N-Decanoate, N-Decanoic acid, N-Decoate, N-Decoic acid, N-Decylate, N-Decylic acid, Prifac 2906, Prifac 296",http://vmh.uni.lu/_api/metabolites/2514/?format=pcsv
doco13ecoa,,,-4,C43H72N7O17P3S,,,13-docosenoylcoa,,13-docosenoylcoa,,,,C16531,2016-11-22T15:12:26Z,,2515,,,,,24892791,doco13ecoa,,,http://vmh.uni.lu/_api/metabolites/2515/?format=pcsv
doco13ac,,,-1,C22H41O2,CHEBI:28792,,"Human Metabolome Database (HMDB): Erucic acid is a monounsaturated omega-9 fatty acid found mainly in the Brassica family of plants such as canola, rapeseed, wallflower seed, mustard seed as well as Brussels spouts and broccoli. Some Brassica cultivars can have up to 40 to 50 percent of their oil recovered as erucic acid. Erucic acid is also known as cis-13-docosenoic acid. The trans isomer is known as brassidic acid. Erucic acid occurs in nature only along with bitter-tasting compounds. Erucic acid has many of the same uses as mineral oils but with the advantage that it is more readily bio-degradable. Its high tolerance to temperature makes it suitable for transmission oil. Its ability to polymerize and dry means it can be - and is - used as a binder for oil paints. Increased levels of eicosenoic acid (20:ln9) and erucic acid (22:1n9) have been found in the red blood cell membranes of autistic subjects with developmental regression (PMID: 16581239). Erucic acid is broken down long-chain acyl-coenzyme A (CoA) dehydrogenase, which is produced in the liver. This enzyme breaks this long chain fatty acid into shorter-chain fatty acids. human infants have relatively low amounts of this enzyme and because of this, babies should not be given foods high in erucic acid.",,docosenoic acid (C22:1),,HMDB02068,,C08316,2016-12-05T15:48:07Z,,2516,,,,,5281116,doco13ac,,"(13Z)-13-Docosenoate, (13Z)-13-Docosenoic acid, (13Z)-Docosenoate, (13Z)-Docosenoic acid, (Z)-13-Docosenoate, (Z)-13-Docosenoic acid, 13-Docosenoate, 13-Docosenoic acid, 13-Docosenoic acid (ACD/Name 4.0), cis-13-Docosenoate, cis-13-Docosenoic acid, cis-Erucic acid, delta 13-cis-Docosenoate, delta 13-cis-Docosenoic acid, delta.13-cis-Docosenoate, delta.13-cis-Docosenoic acid, Prifrac 2990",http://vmh.uni.lu/_api/metabolites/2516/?format=pcsv
docosac,,,-1,C22H43O2,CHEBI:28941,,"Human Metabolome Database (HMDB): Behenic acid, also docosanoic acid, is a normal carboxylic acid, a fatty acid with formula C21H43COOH. -- Wikipedia; It is an important constituent of the behen oil extracted from the seeds of the Ben-oil tree, and it is so named from the Persian month Bahman when the roots of this tree were harvested. -- Wikipedia.",,Behenic acid,,HMDB00944,,C08281,2016-12-05T15:48:07Z,,2517,,,,,8215,docosac,,"1-Docosanoate, 1-Docosanoic acid, B 95, Behenate, Behenic acid, Edenor C 22-85R, EXL 5, Glycon B 70, Hydrofol 2022-55, Hydrofol acid 560, N-Docosanoate, N-Docosanoic acid, Prifac 2987",http://vmh.uni.lu/_api/metabolites/2517/?format=pcsv
docoscoa,,,-4,C43H74N7O17P3S,CHEBI:65088,,docosanoylcoa,,docosanoylcoa,,,,,2016-11-22T15:12:14Z,,2518,,,,,53481548,docoscoa,,,http://vmh.uni.lu/_api/metabolites/2518/?format=pcsv
docosdiac,,,-2,C22H40O4,,,docosanedioicacid,,docosanedioicacid,,,,C19625,2016-11-22T15:12:26Z,,2519,,,,,244872,docosdiac,,,http://vmh.uni.lu/_api/metabolites/2519/?format=pcsv
3ivcrn,,,0,C12H23NO5,,,3-hydroxy-isovaleryl carnitine,,3-hydroxy-isovaleryl carnitine,,,,,2016-11-22T15:12:26Z,,2520,,,,,,3ivcrn,,,http://vmh.uni.lu/_api/metabolites/2520/?format=pcsv
dece4coa,,,-4,C31H48N7O17P3S,,,4-decenoylcoa,,4-decenoylcoa,,,,,2016-11-22T15:12:26Z,,2521,,,,,6443609,dece4coa,,,http://vmh.uni.lu/_api/metabolites/2521/?format=pcsv
dec24dicoa,,,-4,C31H46N7O17P3S,,,"2,4-decadienoylcoa",,"2,4-decadienoylcoa",,,,,2016-11-22T15:12:24Z,,2522,,,,,22833562,dec24dicoa,,,http://vmh.uni.lu/_api/metabolites/2522/?format=pcsv
dece3coa,,,-4,C31H48N7O17P3S,,,3-decenoylcoa,,3-decenoylcoa,,,,,2016-11-22T15:12:25Z,,2523,,,,,16019966,dece3coa,,,http://vmh.uni.lu/_api/metabolites/2523/?format=pcsv
dec47dicoa,,,-4,C31H46N7O17P3S,,,"4,7-decadienoylcoa",,"4,7-decadienoylcoa",,,,,2016-11-22T15:12:26Z,,2524,,,,,,dec47dicoa,,,http://vmh.uni.lu/_api/metabolites/2524/?format=pcsv
dectricoa,,,-4,C31H44N7O17P3S,,,"2,4,7-decatrienoylcoa",,"2,4,7-decatrienoylcoa",,,,,2016-11-22T15:12:26Z,,2525,,,,,,dectricoa,,,http://vmh.uni.lu/_api/metabolites/2525/?format=pcsv
2decdicoa,,,-4,C31H46N7O17P3S,,,"2,7-decadienoylcoa",,"2,7-decadienoylcoa",,,,,2016-11-22T15:12:26Z,,2526,,,,,,2decdicoa,,,http://vmh.uni.lu/_api/metabolites/2526/?format=pcsv
octe5coa,,,-4,C29H44N7O17P3S,,,5-octenoylcoa,,5-octenoylcoa,,,,,2016-11-22T15:12:26Z,,2527,,,,,,octe5coa,,,http://vmh.uni.lu/_api/metabolites/2527/?format=pcsv
3decdicoa,,,-4,C31H46N7O17P3S,,,"3,7-decadienoylcoa",,"3,7-decadienoylcoa",,,,,2016-11-22T15:12:26Z,,2528,,,,,,3decdicoa,,,http://vmh.uni.lu/_api/metabolites/2528/?format=pcsv
tmuncoa,,,-4,C35H58N7O17P3S,,,"2,6,10-trimethyl undecanoylcoa",,"2,6,10-trimethyl undecanoylcoa",,,,,2016-11-22T15:12:26Z,,2529,,,,,,tmuncoa,,,http://vmh.uni.lu/_api/metabolites/2529/?format=pcsv
undcoa,,,-4,C32H52N7O17P3S,,,undecanoylcoa,,undecanoylcoa,,,,,2016-11-22T15:12:26Z,,2530,,,,,53481608,undcoa,,,http://vmh.uni.lu/_api/metabolites/2530/?format=pcsv
noncoa,,,-4,C30H48N7O17P3S,,,nonanoylcoa,,nonanoylcoa,,,,C01942,2016-11-22T15:12:26Z,,2531,,,,,439607,noncoa,,,http://vmh.uni.lu/_api/metabolites/2531/?format=pcsv
dd5ecoa,,,-4,C33H52N7O17P3S,,,5-dodecenoylcoa,,5-dodecenoylcoa,,,,,2016-11-22T15:12:26Z,,2532,,,,,,dd5ecoa,,,http://vmh.uni.lu/_api/metabolites/2532/?format=pcsv
2ddecdicoa,,,-4,C33H50N7O17P3S,,,"2,6-dodecadienoylcoa",,"2,6-dodecadienoylcoa",,,,C05279,2016-11-22T15:12:26Z,,2533,,,,,53480665,2ddecdicoa,,,http://vmh.uni.lu/_api/metabolites/2533/?format=pcsv
3ddecdicoa,,,-4,C33H50N7O17P3S,,,"3,6-dodecadienoylcoa",,"3,6-dodecadienoylcoa",,,,C05280,2016-11-22T15:12:26Z,,2534,,,,,5280771,3ddecdicoa,,,http://vmh.uni.lu/_api/metabolites/2534/?format=pcsv
2dodtricoa,,,-4,C33H48N7O17P3S,,,"2,6,9-dodecatrienoylcoa",,"2,6,9-dodecatrienoylcoa",,,,,2016-11-22T15:12:26Z,,2535,,,,,,2dodtricoa,,,http://vmh.uni.lu/_api/metabolites/2535/?format=pcsv
3dodtricoa,,,-4,C33H48N7O17P3S,,,"3,6,9-dodecatrienoylcoa",,"3,6,9-dodecatrienoylcoa",,,,,2016-11-22T15:12:26Z,,2536,,,,,,3dodtricoa,,,http://vmh.uni.lu/_api/metabolites/2536/?format=pcsv
tmtrdcoa,,,-4,C37H62N7O17P3S,CHEBI:15495,,"4,8,12-trimethyl tridecanoylcoa",,"4,8,12-trimethyl tridecanoylcoa",,,,,2016-11-22T15:12:26Z,,2537,,,,,,tmtrdcoa,,,http://vmh.uni.lu/_api/metabolites/2537/?format=pcsv
tridcoa,,,-4,C34H56N7O17P3S,,,tridecanoylcoa,,tridecanoylcoa,,,,,2016-11-22T15:12:26Z,,2538,,,,,53481606,tridcoa,,,http://vmh.uni.lu/_api/metabolites/2538/?format=pcsv
tetd7ecoa,,,-4,C35H56N7O17P3S,,,7-tetradecenoylcoa,,7-tetradecenoylcoa,,,,,2016-11-22T15:12:26Z,,2539,,,,,,tetd7ecoa,,,http://vmh.uni.lu/_api/metabolites/2539/?format=pcsv
tetde5coa,,,-4,C35H56N7O17P3S,,,5-tetradecenoylcoa,,5-tetradecenoylcoa,,,,,2016-11-22T15:12:26Z,,2540,,,,,,tetde5coa,,,http://vmh.uni.lu/_api/metabolites/2540/?format=pcsv
tetdecdicoa,,,-4,C35H54N7O17P3S,,,"5,8-tetradecadienoylcoa",,"5,8-tetradecadienoylcoa",,,,,2016-11-22T15:12:26Z,,2541,,,,,21252281,tetdecdicoa,,,http://vmh.uni.lu/_api/metabolites/2541/?format=pcsv
ttetddcoa,,,-4,C35H54N7O17P3S,,,"trans5,8tetradecadienoylcoa",,"trans5,8tetradecadienoylcoa",,,,,2016-11-22T15:12:26Z,,2542,,,,,21252281,ttetddcoa,,,http://vmh.uni.lu/_api/metabolites/2542/?format=pcsv
5tedtricoa,,,-4,C35H52N7O17P3S,,,"5,8,11-tetradecatrienoylcoa",,"5,8,11-tetradecatrienoylcoa",,,,,2016-11-22T15:12:26Z,,2543,,,,,,5tedtricoa,,,http://vmh.uni.lu/_api/metabolites/2543/?format=pcsv
c14dccoa,,,-5,C35H55N7O19P3S,,,tetradecanedioylcoa,,tetradecanedioylcoa,,,,,2016-11-22T15:12:26Z,,2544,,,,,,c14dccoa,,,http://vmh.uni.lu/_api/metabolites/2544/?format=pcsv
hexde7coa,,,-4,C37H60N7O17P3S,,,7-hexadecenoylcoa,,7-hexadecenoylcoa,,,,,2016-11-22T15:12:26Z,,2545,,,,,,hexde7coa,,,http://vmh.uni.lu/_api/metabolites/2545/?format=pcsv
hexddcoa,,,-4,C37H58N7O17P3S,,,"7,10-hexadecadienoylcoa",,"7,10-hexadecadienoylcoa",,,,,2016-11-22T15:12:26Z,,2546,,,,,,hexddcoa,,,http://vmh.uni.lu/_api/metabolites/2546/?format=pcsv
thexddcoa,,,-4,C37H58N7O17P3S,,,"trans7,10-hexadecadienoylcoa",,"trans7,10-hexadecadienoylcoa",,,,,2016-11-22T15:12:26Z,,2547,,,,,,thexddcoa,,,http://vmh.uni.lu/_api/metabolites/2547/?format=pcsv
2hexdtricoa,,,-4,C37H56N7O17P3S,,,"2,7,10-hexadecatrienoylcoa",,"2,7,10-hexadecatrienoylcoa",,,,,2016-11-22T15:12:26Z,,2548,,,,,,2hexdtricoa,,,http://vmh.uni.lu/_api/metabolites/2548/?format=pcsv
hexdtrcoa,,,-4,C37H56N7O17P3S,,,"7,10,13-hexadecatrienoylcoa",,"7,10,13-hexadecatrienoylcoa",,,,,2016-11-22T15:12:26Z,,2549,,,,,,hexdtrcoa,,,http://vmh.uni.lu/_api/metabolites/2549/?format=pcsv
4hexdtricoa,,,-4,C37H56N7O17P3S,,,"4,7,10-hexadecatrienoylcoa",,"4,7,10-hexadecatrienoylcoa",,,,,2016-11-22T15:12:26Z,,2550,,,,,,4hexdtricoa,,,http://vmh.uni.lu/_api/metabolites/2550/?format=pcsv
hexdectecoa,,,-4,C37H54N7O17P3S,,,"2,4,7,10-hexadecatetraenoylcoa",,"2,4,7,10-hexadecatetraenoylcoa",,,,,2016-11-22T15:12:26Z,,2551,,,,,,hexdectecoa,,,http://vmh.uni.lu/_api/metabolites/2551/?format=pcsv
3hexdtricoa,,,-4,C37H56N7O17P3S,,,"3,7,10-hexadecatrienoylcoa",,"3,7,10-hexadecatrienoylcoa",,,,,2016-11-22T15:12:26Z,,2552,,,,,,3hexdtricoa,,,http://vmh.uni.lu/_api/metabolites/2552/?format=pcsv
2hexdtetcoa,,,-4,C37H54N7O17P3S,,,"2,7,10,13-hexadecatetraenoylcoa",,"2,7,10,13-hexadecatetraenoylcoa",,,,,2016-11-22T15:12:26Z,,2553,,,,,,2hexdtetcoa,,,http://vmh.uni.lu/_api/metabolites/2553/?format=pcsv
4hexdtetcoa,,,-4,C37H54N7O17P3S,,,"4,7,10,13-hexadecatetraenoylcoa",,"4,7,10,13-hexadecatetraenoylcoa",,,,,2016-11-22T15:12:26Z,,2554,,,,,,4hexdtetcoa,,,http://vmh.uni.lu/_api/metabolites/2554/?format=pcsv
hedepecoa,,,-4,C37H52N7O17P3S,,,"2,4,7,10,13-hexadecapentenoylcoa",,"2,4,7,10,13-hexadecapentenoylcoa",,,,,2016-11-16T10:44:59Z,,2555,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2555/?format=pcsv
hexdpencoa,,,-4,C37H52N7O17P3S,,,"2,4,7,10,13-hexadecapentaenoylcoa",,"2,4,7,10,13-hexadecapentaenoylcoa",,,,,2016-11-22T15:12:26Z,,2556,,,,,,hexdpencoa,,,http://vmh.uni.lu/_api/metabolites/2556/?format=pcsv
3hexdtetcoa,,,-4,C37H54N7O17P3S,,,"3,7,10,13-hexadecatetraenoylcoa",,"3,7,10,13-hexadecatetraenoylcoa",,,,,2016-11-22T15:12:26Z,,2557,,,,,,3hexdtetcoa,,,http://vmh.uni.lu/_api/metabolites/2557/?format=pcsv
hexdiac,,,-2,C16H28O4,,,hexadecanediocacid,,hexadecanediocacid,,,,C19615,2016-11-22T15:12:26Z,,2558,,,,,10459,hexdiac,,,http://vmh.uni.lu/_api/metabolites/2558/?format=pcsv
omhpal,,,-1,C16H30O3,7058075,,"Human Metabolome Database (HMDB): 16-Hydroxy hexadecanoic acid (or 16-hydroxypalmitic acid) is a hydroxylated fatty acid where the terminal (omega) carbon has been hydroxylated. In animal tissues, a family of enzymes termed cytochromes P450s are involved in fatty acid oxidation, hydroxylating with high specificity at the energetically unfavorable terminal (omega) or omega-1 carbons. Hydroxy fatty acids primarily come from consumption of plant products (vegetables or fruits) or from cowâ€™s milk. Omega hydroxy fatty acids are found in the structure of suberin, a lipid polyester present in plant cell walls, and of cutin, a lipid polyester which is a component of the plant cuticle. These apoplastic structures are important plant-environment interfaces that act as barriers limiting water and nutrient loss and protecting plants from radiation and pathogens. 16-hydroxypalmitic acid and 18-hydroxy stearic acid are particularly abundant in cutin in the plant cuticle. 16-hydroxypalmitic acid has been proposed as a biomarker of beer consumption.",,w-hydroxypalmiticacid,,HMDB06294,,,2016-12-05T15:48:07Z,,2559,,,,,7058075,,,"16-Hydoxy hexadecanoate, 16-Hydoxy hexadecanoic acid, Hydroxy hexadecanoate, Hydroxy hexadecanoic acid, Juniperic acid, Omega hydroxy hexadecanoate, Omega hydroxy hexadecanoate (N-C16:0), Omega hydroxy hexadecanoic acid, Omega-hydroxy hexadecanoate, Omega-hydroxy hexadecanoic acid, w-Hydroxy hexadecanoate, w-Hydroxy hexadecanoic acid",http://vmh.uni.lu/_api/metabolites/2559/?format=pcsv
octd11ecoa,,,-4,C39H64N7O17P3S,,,11-octadecenoylcoa,,11-octadecenoylcoa,,,,,2016-11-22T15:12:26Z,,2560,,,,,,octd11ecoa,,,http://vmh.uni.lu/_api/metabolites/2560/?format=pcsv
ocde9ecoa,,,-4,C39H64N7O17P3S,,,9-octadecenoylcoa,,9-octadecenoylcoa,,,,C00510,2016-11-22T15:12:26Z,,2561,,,,,5280355,ocde9ecoa,,,http://vmh.uni.lu/_api/metabolites/2561/?format=pcsv
octdececoa,,,-4,C39H64N7O17P3S,,,octadecenoylcoa,,octadecenoylcoa,,,,,2016-11-22T15:12:26Z,,2562,,,,,,octdececoa,,,http://vmh.uni.lu/_api/metabolites/2562/?format=pcsv
2octdectecoa,,,-4,C39H58N7O17P3S,,,"2,6,9,12-octadecatetraenoylcoa",,"2,6,9,12-octadecatetraenoylcoa",,,,,2016-11-22T15:12:26Z,,2563,,,,,,2octdectecoa,,,http://vmh.uni.lu/_api/metabolites/2563/?format=pcsv
3octdectecoa,,,-4,C39H58N7O17P3S,,,"3,6,9,12-octadecatetraenoylcoa",,"3,6,9,12-octadecatetraenoylcoa",,,,,2016-11-22T15:12:26Z,,2564,,,,,,3octdectecoa,,,http://vmh.uni.lu/_api/metabolites/2564/?format=pcsv
2octpencoa,,,-4,C39H56N7O17P3S,,,"2,6,9,12,15-octadecapentenoylcoa",,"2,6,9,12,15-octadecapentenoylcoa",,,,,2016-11-22T15:12:26Z,,2565,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2565/?format=pcsv
3octpencoa,,,-4,C39H56N7O17P3S,,,"3,6,9,12,15-octadecapentenoylcoa",,"3,6,9,12,15-octadecapentenoylcoa",,,,,2016-11-22T15:12:26Z,,2566,,,,,,3octpencoa,,,http://vmh.uni.lu/_api/metabolites/2566/?format=pcsv
ei11ecoa,,,-4,C41H68N7O17P3S,,,11-eicosenoylcoa,,11-eicosenoylcoa,,,,C16530,2016-11-22T15:12:26Z,,2567,,,,,24892790,ei11ecoa,,,http://vmh.uni.lu/_api/metabolites/2567/?format=pcsv
eitetcoa,,,-4,C41H62N7O17P3S,,,"5,8,11,14-eicosatetraenoylcoa",,"5,8,11,14-eicosatetraenoylcoa",,,,,2016-11-22T15:12:26Z,,2568,,,,,,eitetcoa,,,http://vmh.uni.lu/_api/metabolites/2568/?format=pcsv
eipencoa,,,-4,C41H60N7O17P3S,,,"2,5,8,11,14-eicosapentaenoylcoa",,"2,5,8,11,14-eicosapentaenoylcoa",,,,,2016-11-22T15:12:26Z,,2569,,,,,,eipencoa,,,http://vmh.uni.lu/_api/metabolites/2569/?format=pcsv
5eipencoa,,,-4,C41H60N7O17P3S,,,"5,8,11,14,17-eicosapentenoylcoa",,"5,8,11,14,17-eicosapentenoylcoa",,,,,2016-11-22T15:12:26Z,,2570,,,,,,5eipencoa,,,http://vmh.uni.lu/_api/metabolites/2570/?format=pcsv
2docopencoa,,,-4,C43H64N7O17P3S,,,"2,7,10,13,16-docosapentenoylcoa",,"2,7,10,13,16-docosapentenoylcoa",,,,,2016-11-22T15:12:26Z,,2571,,,,,,2docopencoa,,,http://vmh.uni.lu/_api/metabolites/2571/?format=pcsv
docohexcoa,,,-4,C43H62N7O17P3S,,,"2,4,7,10,13,16-docosahexenoylcoa",,"2,4,7,10,13,16-docosahexenoylcoa",,,,,2016-11-22T15:12:26Z,,2572,,,,,,docohexcoa,,,http://vmh.uni.lu/_api/metabolites/2572/?format=pcsv
3docopencoa,,,-4,C43H64N7O17P3S,,,"3,7,10,13,16-docosapentenoylcoa",,"3,7,10,13,16-docosapentenoylcoa",,,,,2016-11-22T15:12:26Z,,2573,,,,,,3docopencoa,,,http://vmh.uni.lu/_api/metabolites/2573/?format=pcsv
2docohexecoa,,,-4,C43H62N7O17P3S,,,"2,7,10,13,16,19-docosahexenoylcoa",,"2,7,10,13,16,19-docosahexenoylcoa",,,,,2016-11-22T15:12:26Z,,2574,,,,,,2docohexecoa,,,http://vmh.uni.lu/_api/metabolites/2574/?format=pcsv
docohepcoa,,,-4,C43H60N7O17P3S,,,"2,4,7,10,13,16,19-docosaheptenoylcoa",,"2,4,7,10,13,16,19-docosaheptenoylcoa",,,,,2016-11-22T15:12:26Z,,2575,,,,,,docohepcoa,,,http://vmh.uni.lu/_api/metabolites/2575/?format=pcsv
docosahexcoa,,,-4,C43H62N7O17P3S,,,"3,7,10,13,16,19-docosahexenoylcoa",,"3,7,10,13,16,19-docosahexenoylcoa",,,,,2016-11-22T15:12:26Z,,2576,,,,,,docosahexcoa,,,http://vmh.uni.lu/_api/metabolites/2576/?format=pcsv
omhdocosac,,,-1,C22H42O3,,,w-hydroxydocosanoicacid,,w-hydroxydocosanoicacid,,,,C19623,2016-11-22T15:12:26Z,,2577,,,,,5282922,omhdocosac,,,http://vmh.uni.lu/_api/metabolites/2577/?format=pcsv
pentcoa,,,-4,C26H40N7O17P3S,,,pentanoylcoa,,pentanoylcoa,,,,C00888,2016-11-22T15:12:26Z,,2578,,,,,439337,pentcoa,,,http://vmh.uni.lu/_api/metabolites/2578/?format=pcsv
3ivcoa,,,-4,C26H40N7O18P3S,,,3-hydroxyisovalerylcoa,,3-hydroxyisovalerylcoa,,,,C05998,2016-11-22T15:12:26Z,,2579,,,,,11953876,3ivcoa,,,http://vmh.uni.lu/_api/metabolites/2579/?format=pcsv
hx2coa,,,-4,C27H40N7O17P3S,CHEBI:28706,,trans-Hex-2-enoyl-CoA,,trans-Hex-2-enoyl-CoA,,,,C05271,2016-11-22T15:12:26Z,,2580,,,,trans-hex-2-enoyl-CoA,5280765,hx2coa,,,http://vmh.uni.lu/_api/metabolites/2580/?format=pcsv
hexe3coa,,,-4,C27H40N7O17P3S,,,3-hexenoylcoa,,3-hexenoylcoa,,,,,2016-11-22T15:12:26Z,,2581,,,,,53477848,hexe3coa,,,http://vmh.uni.lu/_api/metabolites/2581/?format=pcsv
hepcoa,,,-4,C28H44N7O17P3S,,,heptanoylcoa,,heptanoylcoa,,,,,2016-11-22T15:12:26Z,,2582,,,,,53481563,hepcoa,,,http://vmh.uni.lu/_api/metabolites/2582/?format=pcsv
dmhepcoa,,,-4,C30H48N7O17P3S,,,"2,6-dimethyl heptanoylcoa",,"2,6-dimethyl heptanoylcoa",,,,,2016-11-22T15:12:26Z,,2583,,,,,53477808,dmhepcoa,,,http://vmh.uni.lu/_api/metabolites/2583/?format=pcsv
omhdecacid,,,-1,C10H19O3,,,w-hydroxydecanoicacid,,w-hydroxydecanoicacid,,,,,2016-11-22T15:12:27Z,,2584,,,,,,omhdecacid,,,http://vmh.uni.lu/_api/metabolites/2584/?format=pcsv
sebacid,,,-2,C10H16O4,,,"Human Metabolome Database (HMDB): Sebacic acid is a saturated, straight-chain naturally occurring dicarboxylic acid with 10 carbon atoms. Sebacic acid is a normal urinary acid. In patients with multiple acyl-CoA-dehydrogenase deficiency (MADD) or glutaric aciduria type II (GAII) are a group of metabolic disorders due to deficiency of either electron transfer flavoprotein or electron transfer flavoprotein ubiquinone oxidoreductase, biochemical data shows an increase in urine sebacic acid excretion. Sebacic acid is a white flake or powdered crystal slightly soluble in water that has been proposed as an alternative energy substrate in total parenteral nutrition. Sebacic Acid was named from the Latin sebaceus (tallow candle) or sebum (tallow) in reference to its use in the manufacture of candles. Sebacic Acid and its derivatives such as azelaic acid have a variety of industrial uses as plasticizers, lubricants, hydraulic fluids, cosmetics, candles, etc. It is used in the synthesis of polyamide and alkyd resins. It is also used as an intermediate for aromatics, antiseptics and painting materials. (PMID: 10556649, 1738216, 8442769, 12706375).",,sebacicacid,,HMDB00792,,C08277,2016-12-05T15:48:07Z,,2585,,,,,5192,sebacid,,"1,10-Decanedioate, 1,10-Decanedioic acid, 1,8-Octanedicarboxylate, 1,8-Octanedicarboxylic acid, 4,7-Dioxosebacic acid, 4-Oxodecanedioate, 4-Oxodecanedioic acid, Acide sebacique, Decanedicarboxylic acid, Decanedioate, Decanedioic acid, Dicarboxylic acid C10, Ipomic acid, N-Decanedioate, N-Decanedioic acid, Sebacate, Sebacic acid, Sebacic acids, Sebacinsaeure, Sebacinsaure, Seracic acid",http://vmh.uni.lu/_api/metabolites/2585/?format=pcsv
tdec4ecoa,,,-4,C31H48N7O17P3S,,,trans4decenoylcoa,,trans4decenoylcoa,,,,,2016-11-22T15:12:27Z,,2586,,,,,,tdec4ecoa,,,http://vmh.uni.lu/_api/metabolites/2586/?format=pcsv
ctdecdcoa,,,-4,C31H46N7O17P3S,,,cis2trans4decadienoylcoa,,cis2trans4decadienoylcoa,,,,,2016-11-22T15:12:27Z,,2587,,,,,,ctdecdcoa,,,http://vmh.uni.lu/_api/metabolites/2587/?format=pcsv
tddedi2coa,,,-4,C33H50N7O17P3S,,,"trans2,6dodecadienoylcoa",,"trans2,6dodecadienoylcoa",,,,,2016-11-22T15:12:27Z,,2588,,,,,,tddedi2coa,,,http://vmh.uni.lu/_api/metabolites/2588/?format=pcsv
tddedicoa,,,-4,C33H50N7O17P3S,,,"trans3,6dodecadienoylcoa",,"trans3,6dodecadienoylcoa",,,,C05280,2016-11-22T15:12:27Z,,2589,,,,,5280771,tddedicoa,,,http://vmh.uni.lu/_api/metabolites/2589/?format=pcsv
ocdececrn,,,0,C25H47NO4,,,11-octadecenoyl carnitine,,11-octadecenoyl carnitine,,,,,2016-11-22T15:12:27Z,,2590,,,,,53477830,ocdececrn,,,http://vmh.uni.lu/_api/metabolites/2590/?format=pcsv
octdececrn,,,0,C25H47NO4,,,"octadecenoyl carnitine (hypothetical, position of double bond unknown)",,"octadecenoyl carnitine (hypothetical, position of double bond unknown)",,,,,2016-11-22T15:12:27Z,,2591,,,,,,octdececrn,,,http://vmh.uni.lu/_api/metabolites/2591/?format=pcsv
subeac,,,-2,C8H12O4,,,"Human Metabolome Database (HMDB): Suberic acid, also octanedioic acid, is a dicarboxylic acid, with formula C6H12(COOH)2. It is present in the urine of patients with Fatty Acid Oxidation Disorders (PMID 10404733). A metabolic breakdown product derived from oleic acid. Elevated levels of this unstaruated dicarboxylic acid are found in individuals with dicarboxylic acid and medium-chain acyl-CoA dehydrogenase deficiency (MCAD).",,suberic acid,,HMDB00893,,C08278,2016-12-05T15:48:07Z,,2592,,,,,10457,subeac,,"1,6-Dicarboxyhexane, 1,6-Hexanedicarboxylate, 1,6-Hexanedicarboxylic acid, 1,8-Octanedioate, 1,8-Octanedioic acid, Cork acid, Hexamethylenedicarboxylate, Hexamethylenedicarboxylic acid, Octane-1,8-dioate, Octane-1,8-dioic acid, Octanedioate, Octanedioic acid, Suberate, Suberic acid",http://vmh.uni.lu/_api/metabolites/2592/?format=pcsv
alaala,,,0,C6H12N2O3,,,D-Alanyl-D-alanine,,D-Alanyl-D-alanine,,,,C00993,2016-11-22T15:12:27Z,,2593,,,,,5460362,alaala,,,http://vmh.uni.lu/_api/metabolites/2593/?format=pcsv
bglc,,,0,C1200000H2200000O1100000,,,beta-glucans,,beta-glucans,,,,,2016-11-22T15:12:27Z,,2594,,,,,,bglc,,,http://vmh.uni.lu/_api/metabolites/2594/?format=pcsv
glgchlo,,,0,C1200026H2200043NO1100006,,,beta glucan-glycocholate complex,,beta glucan-glycocholate complex,,,,,2016-11-22T15:12:27Z,,2595,,,,,,glgchlo,,,http://vmh.uni.lu/_api/metabolites/2595/?format=pcsv
gltcho,,,0,C1200026H2200045NO1100007S,,,beta glucan-taurocholic acid complex,,beta glucan-taurocholic acid complex,,,,,2016-11-22T15:12:27Z,,2596,,,,,,gltcho,,,http://vmh.uni.lu/_api/metabolites/2596/?format=pcsv
tdechola,,,-1,C26H44NO6S,CHEBI:9410,,Taurodeoxycholic acid,,Taurodeoxycholic acid,,HMDB04011,"InChI=1S/C26H45NO6S/c1-16(4-9-24(30)27-12-13-34(31,32)33)20-7-8-21-19-6-5-17-14-18(28)10-11-25(17,2)22(19)15-23(29)26(20,21)3/h16-23,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/p-1/t16-,17-,18-,19+,20-,21+,22+,23+,25+,26-/m1/s1",C05463,2016-11-22T15:12:16Z,,2597,,,,,2733768,tdechola,,,http://vmh.uni.lu/_api/metabolites/2597/?format=pcsv
gltdechol,,,-1,C1200026H2200044NO1100006S,,,beta glucan-taurodeoxycholic acid complex,,beta glucan-taurodeoxycholic acid complex,,,,,2016-11-22T15:12:27Z,,2598,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2598/?format=pcsv
glygly,,,0,C4H8N2O3,,,Glycyl-glycine,,Glycyl-glycine,,,,C02037,2016-11-22T15:12:27Z,,2599,,,,,11163,glygly,,,http://vmh.uni.lu/_api/metabolites/2599/?format=pcsv
glyleu,,,0,C8H16N2O3,,,Human Metabolome Database (HMDB): Glycyl-l-leucine is a dipeptide that appears to be a common substrate for glycyl-leucine dipeptidase. It belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.,,Glycylleucine,,HMDB00759,,C02155,2016-12-05T15:48:07Z,,2600,,,,,92843,glyleu,,"Glycyl-L-leucine, Glycyl-leucine, Glycylleucine, N-Glycyl-L-leucine",http://vmh.uni.lu/_api/metabolites/2600/?format=pcsv
glyphe,,,0,C11H14N2O3,,,Glycylphenylalanine,,Glycylphenylalanine,,,,,2016-11-22T15:12:27Z,,2601,,,,,97415,glyphe,,,http://vmh.uni.lu/_api/metabolites/2601/?format=pcsv
glypro,,,0,C7H12N2O3,,,"Human Metabolome Database (HMDB): Glycylproline is an end product of collagen metabolism that is further cleaved by prolidase (EC 3.4.13.9); the resulting proline molecules are recycled into collagen or other proteins. Prolidase deficiency is a rare autosomal recessive disease characterized by chronic ulcerative dermatitis, mental retardation, frequent infections and massive urinary excretion of iminodipeptides. The disease has been confirmed to be due to hereditary prolidase deficiency. It has been reported that the activity of the enzyme against glycylproline (Gly-Pro) is almost totally deficient in patients with prolidase deficiency, whereas the activity against other substrates is not so deficient. Some patients with prolidase deficiency have a marked urinary excretion of the iminodipeptide Glycylproline. The urine from patients with pressure sores contains significantly more Glycylproline than the urine from the control. (PMID: 16009141, 7629169, 1536787, 10582130).",,Glycylproline,,HMDB00721,,,2016-12-05T15:48:07Z,,2602,,,,,79101,glypro,,"1-(Aminoacetyl)proline, 1-Glycyl-L-Proline, 1-Glycylproline, GLY-pro, N-Glycyl-L-proline, N-Glycylproline",http://vmh.uni.lu/_api/metabolites/2602/?format=pcsv
glysar,,,0,C5H10N2O3,,,Glycylsarcosine,,Glycylsarcosine,,,,,2016-11-22T15:12:27Z,,2603,,,,,93131,glysar,,,http://vmh.uni.lu/_api/metabolites/2603/?format=pcsv
gum,,,0,C2760000H5060000O2530000,,,gums,,gums,,,,,2016-11-22T15:12:27Z,,2604,,,,,,gum,,,http://vmh.uni.lu/_api/metabolites/2604/?format=pcsv
dchac,,,-1,C24H39O4,CHEBI:28834,,"Human Metabolome Database (HMDB): Deoxycholic acid is a bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",,deoxycholic acid,,HMDB00626,,C04483,2016-12-05T15:48:07Z,,2605,,,,,222528,dchac,,"5b-Cholanic acid-3a,12a-diol, 5b-Deoxycholate, 5b-Deoxycholic acid, 7-Deoxycholate, 7-Deoxycholic acid, Cholerebic, Cholorebic, Degalol, Deoxy-Cholate, Deoxy-Cholic acid, Deoxycholatate, Deoxycholate, Deoxycholatic acid, Deoxycholic acid",http://vmh.uni.lu/_api/metabolites/2605/?format=pcsv
gumdchac,,,-1,C2760024H5060039O2530004,,,guar gum-deoxyxholic acid complex,,guar gum-deoxyxholic acid complex,,,,,2016-11-22T15:12:27Z,,2606,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2606/?format=pcsv
gumgchol,,,0,C2760026H5060043NO2530006,,,guar gum-glycocholate complex,,guar gum-glycocholate complex,,,,,2016-11-22T15:12:27Z,,2607,,,,,,gumgchol,,,http://vmh.uni.lu/_api/metabolites/2607/?format=pcsv
gumtchol,,,0,C2760026H5060045NO2530007S,,,guar gum-taurocholic acid complex,,guar gum-taurocholic acid complex,,,,,2016-11-22T15:12:27Z,,2608,,,,,,gumtchol,,,http://vmh.uni.lu/_api/metabolites/2608/?format=pcsv
leugly,,,0,C8H16N2O3,,,Leucylglycine,,Leucylglycine,,,,,2016-11-22T15:12:27Z,,2609,,,,,97364,leugly,,,http://vmh.uni.lu/_api/metabolites/2609/?format=pcsv
leuleu,,,0,C12H24N2O3,,,Leucylleucine,,Leucylleucine,,,,C11332,2016-11-22T15:12:27Z,,2610,,,,,94244,leuleu,,,http://vmh.uni.lu/_api/metabolites/2610/?format=pcsv
pect,,,-1,C2535H3509O2535,,,pectins,,pectins,,,,,2016-11-22T15:12:27Z,,2611,,,,,,pect,,,http://vmh.uni.lu/_api/metabolites/2611/?format=pcsv
pectindchac,,,-1,C2559H3549O2539,,,pectin-deoxycholic acid complex,,pectin-deoxycholic acid complex,,,,,2016-11-22T15:12:27Z,,2612,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2612/?format=pcsv
pectingchol,,,0,C2561H3553NO2541,,,pectin-glycocholate complex,,pectin-glycocholate complex,,,,,2016-11-22T15:12:27Z,,2613,,,,,,pectingchol,,,http://vmh.uni.lu/_api/metabolites/2613/?format=pcsv
pectintchol,,,0,C2561H3555NO2542S,,,pectin-taurocholic acid complex,,pectin-taurocholic acid complex,,,,,2016-11-22T15:12:27Z,,2614,,,,,,pectintchol,,,http://vmh.uni.lu/_api/metabolites/2614/?format=pcsv
progly,,,0,C7H12N2O3,,,L-Prolinylglycine,,L-Prolinylglycine,,,,,2016-11-22T15:12:27Z,,2615,,,,,6426709,progly,,,http://vmh.uni.lu/_api/metabolites/2615/?format=pcsv
psyl,,,0,C9642006H15428700O8667414,,,psyllium,,psyllium,,,,,2016-11-22T15:12:27Z,,2616,,,,,,psyl,,,http://vmh.uni.lu/_api/metabolites/2616/?format=pcsv
psylchol,,,0,C9642032H15428743NO8667420,,,psillium-glycocholic acid complex,,psillium-glycocholic acid complex,,,,,2016-11-22T15:12:27Z,,2617,,,,,,psylchol,,,http://vmh.uni.lu/_api/metabolites/2617/?format=pcsv
psyltchol,,,0,C9642032H15428745NO8667421S,,,psyllium-taurocholic acid complex,,psyllium-taurocholic acid complex,,,,,2016-11-22T15:12:27Z,,2618,,,,,,psyltchol,,,http://vmh.uni.lu/_api/metabolites/2618/?format=pcsv
psyltdechol,,,-1,C9642032H15428744NO8667420S,,,psyllium-taurodeoxycholic acid complex,,psyllium-taurodeoxycholic acid complex,,,,,2016-11-22T15:12:27Z,,2619,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2619/?format=pcsv
oh1,,,-1,HO,CHEBI:16234,,hydroxide ion,,hydroxide ion,,,,C01328,2016-11-22T15:12:27Z,,2620,,,,hydroxide,961,oh1,,,http://vmh.uni.lu/_api/metabolites/2620/?format=pcsv
slfcys,,,-1,C3H8NO5S2,,,"Human Metabolome Database (HMDB): Cysteine-S-sulfate (SSC) is produced by reaction of inorganic sulfite and cystine by a yet unknown pathway and is a very potent NMDA-receptor agonist. Electrophysiological studies have shown that SSC displays depolarizing properties similar to glutamate. Patients affected with either Molybdenum cofactor deficiency (MOCOD, an autosomal recessive disease that leads to a combined deficiency of the enzymes sulphite oxidase, an enzyme that catalyzes the conversion of sulfite to inorganic sulfate, xanthine dehydrogenase and aldehyde oxidase) or isolated sulphite oxidase deficiency (ISOD, an extremely rare autosomal recessive disorder with identical clinical manifestations to MOCOD) excrete elevated levels of SSC. This rare disorder is associated with brain damage (seizures, spastic quadriplegia, and cerebral atrophy), mental retardation, dislocated ocular lenses, blindness, and excretion in the urine of abnormally large amounts of SSC, sulfite, and thiosulfate but no inorganic sulfate. (PMID: 17764028, 15558695).",,S-Sulfo-L-cysteine,,HMDB00731,,C05824,2016-12-05T15:48:07Z,,2621,,,,,115015,slfcys,,"Alaninethiosulfuric acid, Cysteine-S-sulfate, Cysteine-S-sulfonate, Cysteine-S-sulphate, Cysteinyl-S-sulfonate, Cysteinyl-S-sulfonic acid, L-Cysteine hydrogen sulfate (ester), L-Cysteine hydrogen sulphate (ester), L-Cysteine S-sulfate, L-Cysteine S-sulphate, L-Cysteine-S-sulfonate, L-Cysteinesulfonic acid, S-Cysteinesulfonic acid, S-Sulfo-L-cysteine, S-Sulfocysteine, S-Sulphocysteine",http://vmh.uni.lu/_api/metabolites/2621/?format=pcsv
m(em)3gacpail_hs,,,-6,C40H45N11O19,,,10fthf5glu[c],,10fthf5glu[c],,,,,2016-11-16T10:44:59Z,,2622,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2622/?format=pcsv
HC01335,,,-6,C40H45N11O19,,,10fthf5glu[c],,10fthf5glu[c],,,,,2016-11-22T15:12:27Z,,2623,,,,,,HC01335,,,http://vmh.uni.lu/_api/metabolites/2623/?format=pcsv
m_em_3gacpail,,,0,C61H116N4O43P4FULLRCO2FULLR2CO2,,,mannosyl-3-(phosphoethanolaminyl-mannosyl)-glucosaminyl-acylphosphatidylinositol (M4A),,mannosyl-3-(phosphoethanolaminyl-mannosyl)-glucosaminyl-acylphosphatidylinositol (M4A),,,,,2016-11-22T15:12:27Z,,2624,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2624/?format=pcsv
m_em_3gacpail_hs,,,0,C61H116N4O43P4FULLRCO2FULLR2CO2,,,mannosyl-3-(phosphoethanolaminyl-mannosyl)-glucosaminyl-acylphosphatidylinositol (M4A)),,mannosyl-3-(phosphoethanolaminyl-mannosyl)-glucosaminyl-acylphosphatidylinositol (M4A)),,,,,2016-11-22T15:12:27Z,,2625,,,,,,m_em_3gacpail_hs,,,http://vmh.uni.lu/_api/metabolites/2625/?format=pcsv
m_em_3gacpail_prot_hs,,,0,C61H116N4O43P4FULLRCO2FULLR2CO2X,,,mannosyl-3-(phosphoethanolaminyl-mannosyl)-glucosaminyl-acylphosphatidylinositol-Protein (M4A),,mannosyl-3-(phosphoethanolaminyl-mannosyl)-glucosaminyl-acylphosphatidylinositol-Protein (M4A),,,,,2016-11-22T15:12:27Z,,2626,,,,,,m_em_3gacpail_prot_hs,,,http://vmh.uni.lu/_api/metabolites/2626/?format=pcsv
ppal,,,0,C3H6O,[],,Propanal,,Propanal,,,,,2016-11-22T15:12:43Z,,2627,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2627/?format=pcsv
3hppnl,,,0,C3H6O2,17871,,3-Hydroxypropanal,,3-Hydroxypropanal,,,,,2016-11-22T15:12:39Z,,2628,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2628/?format=pcsv
13ppd,,,0,C3H8O2,16109,,"Propane-1,3-diol",,"Propane-1,3-diol",,,,,2016-11-22T15:12:38Z,,2629,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2629/?format=pcsv
23dhmp,,,-1,C6H11O4,[],,"(R)-2,3-Dihydroxy-3-methylpentanoate",,"(R)-2,3-Dihydroxy-3-methylpentanoate",,,,,2016-11-22T15:12:38Z,,2630,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2630/?format=pcsv
3h3mop,,,-1,C6H9O4,[],,(R)-3-Hydroxy-3-methyl-2-oxopentanoate,,(R)-3-Hydroxy-3-methyl-2-oxopentanoate,,,,,2016-11-22T15:12:39Z,,2631,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2631/?format=pcsv
23ccmp,,,-1,C9H11N3O7P,[],,"2,3-Cyclic CMP",,"2,3-Cyclic CMP",,,,,2016-11-22T15:12:29Z,,2632,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2632/?format=pcsv
3cmp,,,-2,C9H12N3O8P,[],,3-cmp,,3-cmp,,,,,2016-11-22T15:12:39Z,,2633,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2633/?format=pcsv
23camp,,,-1,C10H11N5O6P,[],,"2,3-Cyclic AMP",,"2,3-Cyclic AMP",,,,,2016-11-22T15:12:38Z,,2634,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2634/?format=pcsv
23cgmp,,,-1,C10H11N5O7P,[],,"2,3-Cyclic GMP",,"2,3-Cyclic GMP",,,,,2016-11-22T15:12:38Z,,2635,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2635/?format=pcsv
3gmp,,,-2,C10H12N5O8P,[],,3-GMP,,3-GMP,,,,,2016-11-22T15:12:39Z,,2636,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2636/?format=pcsv
25d5o2a,,,-1,C6H5O4,[],,Muconolactone,,Muconolactone,,,,,2016-11-22T15:12:29Z,,2637,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2637/?format=pcsv
5odhf2a,,,-1,C6H5O4,[],,"5-Oxo-4,5-dihydrofuran-2-acetate",,"5-Oxo-4,5-dihydrofuran-2-acetate",,,,,2016-11-22T15:12:40Z,,2638,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2638/?format=pcsv
2ahbut,,,-1,C6H9O4,[],,(S)-2-Aceto-2-hydroxybutanoate,,(S)-2-Aceto-2-hydroxybutanoate,,,,,2016-11-22T15:12:29Z,,2639,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2639/?format=pcsv
2h3oppan,,,-1,C3H3O4,[],,2-Hydroxy-3-oxopropanoate,,2-Hydroxy-3-oxopropanoate,,,,,2016-11-22T15:12:39Z,,2640,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2640/?format=pcsv
2dh3dglc,,,-2,C6H6O7,[],,2-Dehydro-3-deoxy-D-glucarate,,2-Dehydro-3-deoxy-D-glucarate,,,,,2016-11-22T15:12:29Z,,2641,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2641/?format=pcsv
2ins,,,0,C6H10O6,[],,2-Inosose,,2-Inosose,,,,,2016-11-22T15:12:39Z,,2642,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2642/?format=pcsv
dkdi,,,0,C6H8O5,[],,"D-2,3-Diketo 4-deoxy-epi-inositol",,"D-2,3-Diketo 4-deoxy-epi-inositol",,,,,2016-11-22T15:12:33Z,,2643,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2643/?format=pcsv
2mbutACP,,,-1,C16H29N2O8PRS,[],,"2-methylbutanoyl-ACP,2-methylbutyryl-ACP",,"2-methylbutanoyl-ACP,2-methylbutyryl-ACP",,,,,2016-11-22T15:12:30Z,,2644,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2644/?format=pcsv
2ommb,,,0,C48H72O3,[],,"2-Octaprenyl-3-methyl-6-methoxy-1,4-benzoquinone",,"2-Octaprenyl-3-methyl-6-methoxy-1,4-benzoquinone",,,,,2016-11-22T15:12:30Z,,2645,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2645/?format=pcsv
ocmhmxbq,,,-1,C48H71O4,[],,"2-Octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone",,"2-Octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone",,,,,2016-11-22T15:12:35Z,,2646,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2646/?format=pcsv
2omph,,,0,C47H72O2,[],,2-Octaprenyl-6-methoxyphenol,,2-Octaprenyl-6-methoxyphenol,,,,,2016-11-22T15:12:30Z,,2647,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2647/?format=pcsv
2ombz,,,0,C47H70O3,[],,"2-Octaprenyl-6-methoxy-1,4-benzoquinone",,"2-Octaprenyl-6-methoxy-1,4-benzoquinone",,,,,2016-11-22T15:12:30Z,,2648,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2648/?format=pcsv
34dhb,,,-1,C7H5O4,[],,Protocatechuate,,Protocatechuate,,,,,2016-11-22T15:12:39Z,,2649,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2649/?format=pcsv
3cmuc,,,-3,C7H3O6,[],,"3-Carboxy-cis,cis-muconate",,"3-Carboxy-cis,cis-muconate",,,,,2016-11-22T15:12:30Z,,2650,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2650/?format=pcsv
3hdecACP,,,-1,C21H39N2O9PRS,[],,(R)-3-Hydroxydecanoyl-[acyl-carrier protein],,(R)-3-Hydroxydecanoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:30Z,,2651,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2651/?format=pcsv
tdec2eACP,,,-1,C21H37N2O8PRS,[],,trans-Dec-2-enoyl-[acyl-carrier protein],,trans-Dec-2-enoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:44Z,,2652,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2652/?format=pcsv
10m3hundecACP,,,-1,C23H43N2O9PRS,[],,10-methyl-3-hydroxy-undecanoyl-ACP,,10-methyl-3-hydroxy-undecanoyl-ACP,,,,,2016-11-22T15:12:28Z,,2653,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2653/?format=pcsv
10mtundec2eACP,,,-1,C23H41N2O8PRS,[],,10-methyl-trans-undec-2-enoyl-ACP,,10-methyl-trans-undec-2-enoyl-ACP,,,,,2016-11-22T15:12:28Z,,2654,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2654/?format=pcsv
10m3hddcaACP,,,-1,C24H45N2O9PRS,[],,10-methyl-3-hydroxy-dodecanoyl-ACP,,10-methyl-3-hydroxy-dodecanoyl-ACP,,,,,2016-11-22T15:12:28Z,,2655,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2655/?format=pcsv
10mtddec2eACP,,,-1,C24H43N2O8PRS,[],,10-methyl-trans-dodec-2-enoyl-ACP,,10-methyl-trans-dodec-2-enoyl-ACP,,,,,2016-11-22T15:12:28Z,,2656,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2656/?format=pcsv
11m3hddcaACP,,,-1,C24H45N2O9PRS,[],,11-methyl-3-hydroxy-dodecanoyl-ACP,,11-methyl-3-hydroxy-dodecanoyl-ACP,,,,,2016-11-22T15:12:38Z,,2657,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2657/?format=pcsv
11mtddec2eACP,,,-1,C24H43N2O8PRS,[],,11-methyl-trans-dodec-2-enoyl-ACP,,11-methyl-trans-dodec-2-enoyl-ACP,,,,,2016-11-22T15:12:38Z,,2658,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2658/?format=pcsv
3hddecACP,,,-1,C23H43N2O9PRS,[],,(R)-3-Hydroxydodecanoyl-[acyl-carrier protein],,(R)-3-Hydroxydodecanoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:39Z,,2659,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2659/?format=pcsv
tddec2eACP,,,-1,C23H41N2O8PRS,[],,trans-Dodec-2-enoyl-[acyl-carrier protein],,trans-Dodec-2-enoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:44Z,,2660,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2660/?format=pcsv
12m3htridecACP,,,-1,C25H47N2O9PRS,[],,12-methyl-3-hydroxy-tridecanoyl-ACP,,12-methyl-3-hydroxy-tridecanoyl-ACP,,,,,2016-11-22T15:12:28Z,,2661,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2661/?format=pcsv
12mttritec2eACP,,,-1,C25H45N2O8PRS,[],,12-methyl-trans-tridec-2-enoyl-ACP,,12-methyl-trans-tridec-2-enoyl-ACP,,,,,2016-11-22T15:12:38Z,,2662,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2662/?format=pcsv
12m3hmyrsACP,,,-1,C26H49N2O9PRS,[],,12-methyl-3-hydroxy-tetra-decanoyl-ACP,,12-methyl-3-hydroxy-tetra-decanoyl-ACP,,,,,2016-11-22T15:12:28Z,,2663,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2663/?format=pcsv
12mtmrs2eACP,,,-1,C26H47N2O8PRS,[],,12-methyl-trans-tetra-dec-2-enoyl-ACP,,12-methyl-trans-tetra-dec-2-enoyl-ACP,,,,,2016-11-22T15:12:28Z,,2664,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2664/?format=pcsv
13m3hmyrsACP,,,-1,C26H49N2O9PRS,[],,13-methyl-3-hydroxy-tetra-decanoyl-ACP,,13-methyl-3-hydroxy-tetra-decanoyl-ACP,,,,,2016-11-22T15:12:38Z,,2665,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2665/?format=pcsv
13mtmrs2eACP,,,-1,C26H47N2O8PRS,[],,13-methyl-trans-tetra-dec-2-enoyl-ACP,,13-methyl-trans-tetra-dec-2-enoyl-ACP,,,,,2016-11-22T15:12:38Z,,2666,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2666/?format=pcsv
3hmrsACP,,,-1,C25H47N2O9PRS,[],,(R)-3-Hydroxytetradecanoyl-[acyl-carrier protein],,(R)-3-Hydroxytetradecanoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:39Z,,2667,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2667/?format=pcsv
tmrs2eACP,,,-1,C25H45N2O8PRS,[],,trans-Tetradec-2-enoyl-[acyl-carrier protein],,trans-Tetradec-2-enoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:44Z,,2668,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2668/?format=pcsv
14m3hpentdecACP,,,-1,C27H51N2O9PRS,[],,14-methyl-3-hydroxy-pentadecanoyl-ACP,,14-methyl-3-hydroxy-pentadecanoyl-ACP,,,,,2016-11-22T15:12:28Z,,2669,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2669/?format=pcsv
14mtpentdec2eACP,,,-1,C27H49N2O8PRS,[],,14-methyl-trans-pentadec-2-enoyl-ACP,,14-methyl-trans-pentadec-2-enoyl-ACP,,,,,2016-11-22T15:12:38Z,,2670,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2670/?format=pcsv
14m3hpalmACP,,,-1,C28H53N2O9PRS,[],,14-methyl-3-hydroxy-hexa-decanoyl-ACP,,14-methyl-3-hydroxy-hexa-decanoyl-ACP,,,,,2016-11-22T15:12:28Z,,2671,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2671/?format=pcsv
14mtpalm2eACP,,,-1,C28H51N2O8PRS,[],,14-methyl-trans-hexa-dec-2-enoyl-ACP,,14-methyl-trans-hexa-dec-2-enoyl-ACP,,,,,2016-11-22T15:12:28Z,,2672,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2672/?format=pcsv
15m3hpalmACP,,,-1,C28H53N2O9PRS,[],,15-methyl-3-hydroxy-hexa-decanoyl-ACP,,15-methyl-3-hydroxy-hexa-decanoyl-ACP,,,,,2016-11-22T15:12:38Z,,2673,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2673/?format=pcsv
15mtpalm2eACP,,,-1,C28H51N2O8PRS,[],,15-methyl-trans-hexa-dec-2-enoyl-ACP,,15-methyl-trans-hexa-dec-2-enoyl-ACP,,,,,2016-11-22T15:12:38Z,,2674,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2674/?format=pcsv
3hpalmACP,,,-1,C27H51N2O9PRS,[],,R-3-hydroxypalmitoyl-[acyl-carrier protein],,R-3-hydroxypalmitoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:39Z,,2675,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2675/?format=pcsv
tpalm2eACP,,,-1,C27H49N2O8PRS,[],,trans-Hexadec-2-enoyl-[acyl-carrier protein],,trans-Hexadec-2-enoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:44Z,,2676,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2676/?format=pcsv
3hoctaACP,,,-1,C29H55N2O9PRS,[],,(R)-3-Hydroxyoctadecanoyl-[acyl-carrier protein],,(R)-3-Hydroxyoctadecanoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:30Z,,2677,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2677/?format=pcsv
toctd2eACP,,,-1,C29H53N2O8PRS,[],,trans-octadec-2-enoyl-[acyl-carrier protein],,trans-octadec-2-enoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:44Z,,2678,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2678/?format=pcsv
3haACP,,,-1,C15H27N2O9PRS,[],,(3R)-3-Hydroxyacyl-[acyl-carrier protein],,(3R)-3-Hydroxyacyl-[acyl-carrier protein],,,,,2016-11-22T15:12:30Z,,2679,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2679/?format=pcsv
but2eACP,,,-1,C15H25N2O8PRS,[],,But-2-enoyl-[acyl-carrier protein],,But-2-enoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:32Z,,2680,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2680/?format=pcsv
4m3hpentACP,,,-1,C17H31N2O9PRS,[],,4-methyl-3-hydroxy-pentanoyl-ACP,,4-methyl-3-hydroxy-pentanoyl-ACP,,,,,2016-11-22T15:12:39Z,,2681,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2681/?format=pcsv
4mtpent2eACP,,,-1,C17H29N2O8PRS,[],,4-methyl-trans-pent-2-enoyl-ACP,,4-methyl-trans-pent-2-enoyl-ACP,,,,,2016-11-22T15:12:31Z,,2682,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2682/?format=pcsv
4m3hhexACP,,,-1,C18H33N2O9PRS,[],,4-methyl-3-hydroxy-hexanoyl-ACP,,4-methyl-3-hydroxy-hexanoyl-ACP,,,,,2016-11-22T15:12:31Z,,2683,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2683/?format=pcsv
4mthex2eACP,,,-1,C18H31N2O8PRS,[],,4-methyl-trans-hex-2-enoyl-ACP,,4-methyl-trans-hex-2-enoyl-ACP,,,,,2016-11-22T15:12:31Z,,2684,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2684/?format=pcsv
5m3hhexACP,,,-1,C18H33N2O9PRS,[],,5-methyl-3-hydroxy-hexanoyl-ACP,,5-methyl-3-hydroxy-hexanoyl-ACP,,,,,2016-11-22T15:12:39Z,,2685,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2685/?format=pcsv
5mthex2eACP,,,-1,C18H31N2O8PRS,[],,5-methyl-trans-hex-2-enoyl-ACP,,5-methyl-trans-hex-2-enoyl-ACP,,,,,2016-11-22T15:12:39Z,,2686,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2686/?format=pcsv
3hhexACP,,,-1,C17H31N2O9PRS,[],,(R)-3-Hydroxyhexanoyl-[acyl-carrier protein],,(R)-3-Hydroxyhexanoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:30Z,,2687,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2687/?format=pcsv
thex2eACP,,,-1,C17H29N2O8PRS,[],,trans-Hex-2-enoyl-[acyl-carrier protein],,trans-Hex-2-enoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:44Z,,2688,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2688/?format=pcsv
6m3hheptACP,,,-1,C19H35N2O9PRS,[],,6-methyl-3-hydroxy-heptanoyl-ACP,,6-methyl-3-hydroxy-heptanoyl-ACP,,,,,2016-11-22T15:12:40Z,,2689,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2689/?format=pcsv
6mthept2eACP,,,-1,C19H33N2O8PRS,[],,6-methyl-trans-hept-2-enoyl-ACP,,6-methyl-trans-hept-2-enoyl-ACP,,,,,2016-11-22T15:12:31Z,,2690,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2690/?format=pcsv
6m3hocACP,,,-1,C20H37N2O9PRS,[],,6-methyl-3-hydroxy-octanoyl-ACP,,6-methyl-3-hydroxy-octanoyl-ACP,,,,,2016-11-22T15:12:31Z,,2691,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2691/?format=pcsv
6mtoct2eACP,,,-1,C20H35N2O8PRS,[],,6-methyl-trans-oct-2-enoyl-ACP,,6-methyl-trans-oct-2-enoyl-ACP,,,,,2016-11-22T15:12:31Z,,2692,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2692/?format=pcsv
7m3hocACP,,,-1,C20H37N2O9PRS,[],,7-methyl-3-hydroxy-octanoyl-ACP,,7-methyl-3-hydroxy-octanoyl-ACP,,,,,2016-11-22T15:12:40Z,,2693,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2693/?format=pcsv
7mtoct2eACP,,,-1,C20H35N2O8PRS,[],,7-methyl-trans-oct-2-enoyl-ACP,,7-methyl-trans-oct-2-enoyl-ACP,,,,,2016-11-22T15:12:40Z,,2694,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2694/?format=pcsv
3hoctACP,,,-1,C19H35N2O9PRS,[],,(R)-3-Hydroxyoctanoyl-[acyl-carrier protein],,(R)-3-Hydroxyoctanoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:30Z,,2695,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2695/?format=pcsv
toct2eACP,,,-1,C19H33N2O8PRS,[],,trans-Oct-2-enoyl-[acyl-carrier protein],,trans-Oct-2-enoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:44Z,,2696,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2696/?format=pcsv
8m3hdcaACP,,,-1,C22H41N2O9PRS,[],,8-methyl-3-hydroxy-decanoyl-ACP,,8-methyl-3-hydroxy-decanoyl-ACP,,,,,2016-11-22T15:12:31Z,,2697,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2697/?format=pcsv
8mtdec2eACP,,,-1,C22H39N2O8PRS,[],,8-methyl-trans-dec-2-enoyl-ACP,,8-methyl-trans-dec-2-enoyl-ACP,,,,,2016-11-22T15:12:31Z,,2698,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2698/?format=pcsv
8m3hnonACP,,,-1,C21H39N2O9PRS,[],,8-methyl-3-hydroxy-nonanoyl-ACP,,8-methyl-3-hydroxy-nonanoyl-ACP,,,,,2016-11-22T15:12:40Z,,2699,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2699/?format=pcsv
8mtnon2eACP,,,-1,C21H37N2O8PRS,[],,8-methyl-trans-non-2-enoyl-ACP,,8-methyl-trans-non-2-enoyl-ACP,,,,,2016-11-22T15:12:31Z,,2700,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2700/?format=pcsv
9m3hdcaACP,,,-1,C22H41N2O9PRS,[],,9-methyl-3-hydroxy-decanoyl-ACP,,9-methyl-3-hydroxy-decanoyl-ACP,,,,,2016-11-22T15:12:40Z,,2701,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2701/?format=pcsv
9mtdec2eACP,,,-1,C22H39N2O8PRS,[],,9-methyl-trans-dec-2-enoyl-ACP,,9-methyl-trans-dec-2-enoyl-ACP,,,,,2016-11-22T15:12:40Z,,2702,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2702/?format=pcsv
3hcinnm,,,-1,C9H7O3,,,3-hydroxycinnamic acid,,3-hydroxycinnamic acid,,,,,2016-11-22T15:12:27Z,,2703,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2703/?format=pcsv
dhcinnm,,,-1,C9H7O4,[],,"2,3-dihydroxicinnamic acid",,"2,3-dihydroxicinnamic acid",,,,,2016-11-22T15:12:41Z,,2704,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2704/?format=pcsv
3hphac,,,-1,C8H7O3,[],,3-Hydroxyphenylacetate,,3-Hydroxyphenylacetate,,,,,2016-11-22T15:12:39Z,,2705,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2705/?format=pcsv
3hpppn,,,-1,C9H9O3,,,3-(3-hydroxy-phenyl)propionate,,3-(3-hydroxy-phenyl)propionate,,,,,2016-11-22T15:12:27Z,,2706,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2706/?format=pcsv
dhpppn,,,-1,C9H9O4,[],,"3-(2,3-Dihydroxyphenyl)propanoate",,"3-(2,3-Dihydroxyphenyl)propanoate",,,,,2016-11-22T15:12:41Z,,2707,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2707/?format=pcsv
3c3hmp,,,-2,C7H10O5,[],,3-Carboxy-3-hydroxy-4-methylpentanoate,,3-Carboxy-3-hydroxy-4-methylpentanoate,,,,,2016-11-22T15:12:39Z,,2708,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2708/?format=pcsv
3odecACP,,,-1,C21H37N2O9PRS,[],,3-Oxodecanoyl-[acyl-carrier protein],,3-Oxodecanoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:30Z,,2709,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2709/?format=pcsv
10m3oundecACP,,,-1,C23H41N2O9PRS,[],,10-methyl-3-oxo-undecanoyl-ACP,,10-methyl-3-oxo-undecanoyl-ACP,,,,,2016-11-22T15:12:28Z,,2710,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2710/?format=pcsv
10m3oddcaACP,,,-1,C24H43N2O9PRS,[],,10-methyl-3-oxo-dodecanoyl-ACP,,10-methyl-3-oxo-dodecanoyl-ACP,,,,,2016-11-22T15:12:28Z,,2711,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2711/?format=pcsv
11m3oddcaACP,,,-1,C24H43N2O9PRS,[],,11-methyl-3-oxo-dodecanoyl-ACP,,11-methyl-3-oxo-dodecanoyl-ACP,,,,,2016-11-22T15:12:38Z,,2712,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2712/?format=pcsv
3oddecACP,,,-1,C23H41N2O9PRS,[],,3-Oxododecanoyl-[acyl-carrier protein],,3-Oxododecanoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:39Z,,2713,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2713/?format=pcsv
12m3otridecACP,,,-1,C25H45N2O9PRS,[],,12-methyl-3-oxo-tridecanoyl-ACP,,12-methyl-3-oxo-tridecanoyl-ACP,,,,,2016-11-22T15:12:28Z,,2714,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2714/?format=pcsv
12m3omyrsACP,,,-1,C26H47N2O9PRS,[],,12-methyl-3-oxo-tetra-decanoyl-ACP,,12-methyl-3-oxo-tetra-decanoyl-ACP,,,,,2016-11-22T15:12:28Z,,2715,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2715/?format=pcsv
13m3omyrsACP,,,-1,C26H47N2O9PRS,[],,13-methyl-3-oxo-tetra-decanoyl-ACP,,13-methyl-3-oxo-tetra-decanoyl-ACP,,,,,2016-11-22T15:12:38Z,,2716,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2716/?format=pcsv
3omrsACP,,,-1,C25H45N2O9PRS,[],,3-Oxotetradecanoyl-[acyl-carrier protein],,3-Oxotetradecanoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:39Z,,2717,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2717/?format=pcsv
14m3opentdecACP,,,-1,C27H49N2O9PRS,[],,14-methyl-3-oxo-pentadecanoyl-ACP,,14-methyl-3-oxo-pentadecanoyl-ACP,,,,,2016-11-22T15:12:28Z,,2718,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2718/?format=pcsv
14m3opalmACP,,,-1,C28H51N2O9PRS,[],,14-methyl-3-oxo-hexa-decanoyl-ACP,,14-methyl-3-oxo-hexa-decanoyl-ACP,,,,,2016-11-22T15:12:28Z,,2719,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2719/?format=pcsv
15m3opalmACP,,,-1,C28H51N2O9PRS,[],,15-methyl-3-oxo-hexa-decanoyl-ACP,,15-methyl-3-oxo-hexa-decanoyl-ACP,,,,,2016-11-22T15:12:38Z,,2720,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2720/?format=pcsv
3opalmACP,,,-1,C27H49N2O9PRS,[],,3-Oxohexadecanoyl-[acyl-carrier protein],,3-Oxohexadecanoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:39Z,,2721,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2721/?format=pcsv
3ooctdACP,,,-1,C29H53N2O9PRS,[],,3-Oxooctadecanoyl-[acyl-carrier protein],,3-Oxooctadecanoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:39Z,,2722,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2722/?format=pcsv
actACP,,,-1,C15H25N2O9PRS,[],,Acetoacetyl-ACP,,Acetoacetyl-ACP,,,,,2016-11-22T15:12:32Z,,2723,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2723/?format=pcsv
4m3opentACP,,,-1,C17H29N2O9PRS,[],,4-methyl-3-oxo-pentanoyl-ACP,,4-methyl-3-oxo-pentanoyl-ACP,,,,,2016-11-22T15:12:39Z,,2724,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2724/?format=pcsv
4m3ohexACP,,,-1,C18H31N2O9PRS,[],,4-methyl-3-oxo-hexanoyl-ACP,,4-methyl-3-oxo-hexanoyl-ACP,,,,,2016-11-22T15:12:31Z,,2725,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2725/?format=pcsv
5m3ohexACP,,,-1,C18H31N2O9PRS,[],,5-methyl-3-oxo-hexanoyl-ACP,,5-methyl-3-oxo-hexanoyl-ACP,,,,,2016-11-22T15:12:39Z,,2726,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2726/?format=pcsv
3ohexACP,,,-1,C17H29N2O9PRS,[],,3-Oxohexanoyl-[acyl-carrier protein],,3-Oxohexanoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:30Z,,2727,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2727/?format=pcsv
6m3oheptACP,,,-1,C19H33N2O9PRS,[],,6-methyl-3-oxo-heptanoyl-ACP,,6-methyl-3-oxo-heptanoyl-ACP,,,,,2016-11-22T15:12:40Z,,2728,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2728/?format=pcsv
6m3oocACP,,,-1,C20H35N2O9PRS,[],,6-methyl-3-oxo-octanoyl-ACP,,6-methyl-3-oxo-octanoyl-ACP,,,,,2016-11-22T15:12:31Z,,2729,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2729/?format=pcsv
7m3oocACP,,,-1,C20H35N2O9PRS,[],,7-methyl-3-oxo-octanoyl-ACP,,7-methyl-3-oxo-octanoyl-ACP,,,,,2016-11-22T15:12:40Z,,2730,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2730/?format=pcsv
3ooctACP,,,-1,C19H33N2O9PRS,[],,3-Oxooctanoyl-[acyl-carrier protein],,3-Oxooctanoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:30Z,,2731,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2731/?format=pcsv
8m3odcaACP,,,-1,C22H39N2O9PRS,[],,8-methyl-3-oxo-decanoyl-ACP,,8-methyl-3-oxo-decanoyl-ACP,,,,,2016-11-22T15:12:31Z,,2732,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2732/?format=pcsv
8m3ononACP,,,-1,C21H37N2O9PRS,[],,8-methyl-3-oxo-nonanoyl-ACP,,8-methyl-3-oxo-nonanoyl-ACP,,,,,2016-11-22T15:12:40Z,,2733,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2733/?format=pcsv
9m3odcaACP,,,-1,C22H39N2O9PRS,[],,9-methyl-3-oxo-decanoyl-ACP,,9-methyl-3-oxo-decanoyl-ACP,,,,,2016-11-22T15:12:40Z,,2734,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2734/?format=pcsv
ocACP,,,-1,C19H35N2O8PRS,[],,Octanoyl-ACP (n-C8:0ACP),,Octanoyl-ACP (n-C8:0ACP),,,,,2016-11-22T15:12:43Z,,2735,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2735/?format=pcsv
10mundecACP,,,-1,C23H43N2O8PRS,[],,10-methyl-undecanoyl-ACP,,10-methyl-undecanoyl-ACP,,,,,2016-11-22T15:12:38Z,,2736,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2736/?format=pcsv
10mddcaACP,,,-1,C24H45N2O8PRS,[],,10-methyl-dodecanoyl-ACP,,10-methyl-dodecanoyl-ACP,,,,,2016-11-22T15:12:28Z,,2737,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2737/?format=pcsv
11mddcaACP,,,-1,C24H45N2O8PRS,[],,11-methyl-dodecanoyl-ACP,,11-methyl-dodecanoyl-ACP,,,,,2016-11-22T15:12:38Z,,2738,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2738/?format=pcsv
dcaACP,,,-1,C21H39N2O8PRS,[],,Decanoyl-ACP (n-C10:0ACP),,Decanoyl-ACP (n-C10:0ACP),,,,,2016-11-22T15:12:41Z,,2739,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2739/?format=pcsv
12mtridecACP,,,-1,C25H47N2O8PRS,[],,12-methyl-tridecanoyl-ACP,,12-methyl-tridecanoyl-ACP,,,,,2016-11-22T15:12:38Z,,2740,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2740/?format=pcsv
12mmyrsACP,,,-1,C26H49N2O8PRS,[],,12-methyl-tetra-decanoyl-ACP,,12-methyl-tetra-decanoyl-ACP,,,,,2016-11-22T15:12:28Z,,2741,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2741/?format=pcsv
13mmyrsACP,,,-1,C26H49N2O8PRS,[],,13-methyl-tetra-decanoyl-ACP,,13-methyl-tetra-decanoyl-ACP,,,,,2016-11-22T15:12:38Z,,2742,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2742/?format=pcsv
2mpropACP,,,-1,C15H27N2O8PRS,[],,"2-methylpropionyl-ACP,isobutyryl-ACP",,"2-methylpropionyl-ACP,isobutyryl-ACP",,,,,2016-11-22T15:12:30Z,,2743,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2743/?format=pcsv
3mbutACP,,,-1,C16H29N2O8PRS,[],,"3-methylbutanoyl-ACP,isovaleryl-ACP",,"3-methylbutanoyl-ACP,isovaleryl-ACP",,,,,2016-11-22T15:12:39Z,,2744,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2744/?format=pcsv
4mpentACP,,,-1,C17H31N2O8PRS,[],,4-methyl-pentanoyl-ACP,,4-methyl-pentanoyl-ACP,,,,,2016-11-22T15:12:31Z,,2745,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2745/?format=pcsv
4mhexACP,,,-1,C18H33N2O8PRS,[],,4-methyl-hexanoyl-ACP,,4-methyl-hexanoyl-ACP,,,,,2016-11-22T15:12:31Z,,2746,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2746/?format=pcsv
5mhexACP,,,-1,C18H33N2O8PRS,[],,5-methyl-hexanoyl-ACP,,5-methyl-hexanoyl-ACP,,,,,2016-11-22T15:12:39Z,,2747,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2747/?format=pcsv
butACP,,,-1,C15H27N2O8PRS,[],,Butyryl-ACP (n-C4:0ACP),,Butyryl-ACP (n-C4:0ACP),,,,,2016-11-22T15:12:40Z,,2748,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2748/?format=pcsv
6mheptACP,,,-1,C19H35N2O8PRS,[],,6-methyl-heptanoyl-ACP,,6-methyl-heptanoyl-ACP,,,,,2016-11-22T15:12:31Z,,2749,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2749/?format=pcsv
6mocACP,,,-1,C20H37N2O8PRS,[],,6-methyl-octanoyl-ACP,,6-methyl-octanoyl-ACP,,,,,2016-11-22T15:12:31Z,,2750,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2750/?format=pcsv
7mocACP,,,-1,C20H37N2O8PRS,[],,7-methyl-octanoyl-ACP,,7-methyl-octanoyl-ACP,,,,,2016-11-22T15:12:40Z,,2751,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2751/?format=pcsv
hexACP,,,-1,C17H31N2O8PRS,[],,Hexanoyl-ACP (n-C6:0ACP),,Hexanoyl-ACP (n-C6:0ACP),,,,,2016-11-22T15:12:42Z,,2752,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2752/?format=pcsv
8mdcaACP,,,-1,C22H41N2O8PRS,[],,8-methyl-decanoyl-ACP,,8-methyl-decanoyl-ACP,,,,,2016-11-22T15:12:31Z,,2753,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2753/?format=pcsv
8mnonACP,,,-1,C21H39N2O8PRS,[],,8-methyl-nonanoyl-ACP,,8-methyl-nonanoyl-ACP,,,,,2016-11-22T15:12:31Z,,2754,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2754/?format=pcsv
9mdcaACP,,,-1,C22H41N2O8PRS,[],,9-methyl-decanoyl-ACP,,9-methyl-decanoyl-ACP,,,,,2016-11-22T15:12:40Z,,2755,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2755/?format=pcsv
5cmhmsa,,,-2,C8H6O6,17142,,5-Carboxymethyl-2-hydroxymuconate semialdehyde,,5-Carboxymethyl-2-hydroxymuconate semialdehyde,,,,,2016-11-22T15:12:39Z,,2756,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2756/?format=pcsv
5cm2hmu,,,-3,C8H5O7,2040,,5-Carboxymethyl-2-hydroxymuconate,,5-Carboxymethyl-2-hydroxymuconate,,,,,2016-11-22T15:12:39Z,,2757,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2757/?format=pcsv
phthr,,,-2,C4H8NO7P,[],,O-Phospho-4-hydroxy-L-threonine,,O-Phospho-4-hydroxy-L-threonine,,,,,2016-11-22T15:12:36Z,,2758,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2758/?format=pcsv
4hthr,,,0,C4H9NO4,[],,4-Hydroxy-L-threonine,,4-Hydroxy-L-threonine,,,,,2016-11-22T15:12:31Z,,2759,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2759/?format=pcsv
pnp,,,-1,C6H4NO3,[],,"4-Hydroxynitrobenzene, p-Nitrophenol",,"4-Hydroxynitrobenzene, p-Nitrophenol",,,,,2016-11-22T15:12:46Z,,2760,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2760/?format=pcsv
5c2o3ed,,,-3,C8H5O7,15924,,5-Carboxy-2-oxohept-3-enedioate,,5-Carboxy-2-oxohept-3-enedioate,,,,,2016-11-22T15:12:31Z,,2761,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2761/?format=pcsv
2hh24dd,,,-2,C7H6O5,78626,,2-Hydroxyhepta-2-4-dienedioate,,2-Hydroxyhepta-2-4-dienedioate,,,,,2016-11-22T15:12:30Z,,2762,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2762/?format=pcsv
5dgclur,,,-1,C6H9O6,[],,5-Deoxy glucuronic acid,,5-Deoxy glucuronic acid,,,,,2016-11-22T15:12:39Z,,2763,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2763/?format=pcsv
d5kg,,,-1,C6H9O6,27972,,2-deoxy-5-keto-D-gluconic acid,,2-deoxy-5-keto-D-gluconic acid,,,,,2016-11-22T15:12:41Z,,2764,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2764/?format=pcsv
5mthglu,,,0,C25H34N8O12,[],,5_Methyltetrahydropteroyltri_L_glutamate,,5_Methyltetrahydropteroyltri_L_glutamate,,,,,2016-11-22T15:12:31Z,,2765,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2765/?format=pcsv
thglu,,,0,C24H32N8O12,[],,Tetrahydropteroyltri_L_glutamate,,Tetrahydropteroyltri_L_glutamate,,,,,2016-11-22T15:12:37Z,,2766,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2766/?format=pcsv
ab6p3hxl,,,-2,C6H11O9P,[],,D-arabino-6-Phospho-hex-3-ulose,,D-arabino-6-Phospho-hex-3-ulose,,,,,2016-11-22T15:12:40Z,,2767,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2767/?format=pcsv
salc6p,,,-2,C13H17O10P,[],,Salicin 6-phosphate,,Salicin 6-phosphate,,,,,2016-11-22T15:12:37Z,,2768,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2768/?format=pcsv
2hymeph,,,0,C7H8O2,[],,2-(Hydroxymethyl)phenol,,2-(Hydroxymethyl)phenol,,,,,2016-11-22T15:12:39Z,,2769,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2769/?format=pcsv
g6p_B,,,-2,C6H11O9P,[],,beta-D-glucose 6-phosphate,,beta-D-glucose 6-phosphate,,,,,2016-11-22T15:12:41Z,,2770,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2770/?format=pcsv
ara5p,,,-2,C5H9O8P,[],,D-Arabinose 5-phosphate,,D-Arabinose 5-phosphate,,,,,2016-11-22T15:12:40Z,,2771,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2771/?format=pcsv
aacald,,,1,C2H6NO,[],,Aminoacetaldehyde,,Aminoacetaldehyde,,,,,2016-11-22T15:12:31Z,,2772,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2772/?format=pcsv
arbt6p,,,-2,C12H15O10P,[],,Arbutin 6-phosphate,,Arbutin 6-phosphate,,,,,2016-11-22T15:12:32Z,,2773,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2773/?format=pcsv
hqn,,,0,C6H6O2,[],,Hydroquinone,,Hydroquinone,,,,,2016-11-22T15:12:34Z,,2774,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2774/?format=pcsv
abt_D,,,0,C5H12O5,,,D-Arabitol,,D-Arabitol,,,,,2016-11-22T15:12:27Z,,2775,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2775/?format=pcsv
2dhglcn,,,-1,C6H9O7,[],,2-Dehydro-D-gluconate,,2-Dehydro-D-gluconate,,,,,2016-11-22T15:12:39Z,,2776,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2776/?format=pcsv
3ohcoa,,,-4,C27H40N7O18P3S,[],,3-Oxohexanoyl-CoA,,3-Oxohexanoyl-CoA,,,,,2016-11-22T15:12:39Z,,2777,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2777/?format=pcsv
3oocoa,,,-4,C29H44N7O18P3S,[],,3-Oxooctanoyl-CoA,,3-Oxooctanoyl-CoA,,,,,2016-11-22T15:12:39Z,,2778,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2778/?format=pcsv
adocbip,,,-1,C58H83CoN16O14P,[],,Adenosyl cobinamide phosphate,,Adenosyl cobinamide phosphate,,,,,2016-11-22T15:12:32Z,,2779,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2779/?format=pcsv
agdpcbi,,,-1,C68H95CoN21O21P2,[],,Adenosine-GDP-cobinamide,,Adenosine-GDP-cobinamide,,,,,2016-11-22T15:12:32Z,,2780,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2780/?format=pcsv
udcpp,,,-2,C55H89O4P,[],,Undecaprenyl phosphate,,Undecaprenyl phosphate,,,,,2016-11-22T15:12:38Z,,2781,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2781/?format=pcsv
unaga,,,-2,C63H103NO12P2,[],,Undecaprenyl diphospho N-acetyl-glucosamine,,Undecaprenyl diphospho N-acetyl-glucosamine,,,,,2016-11-22T15:12:38Z,,2782,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2782/?format=pcsv
hethmpp,,,-2,C14H20N4O8P2S,[],,Hydroxy ethyl Thiamin diphosphate,,Hydroxy ethyl Thiamin diphosphate,,,,,2016-11-22T15:12:34Z,,2783,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2783/?format=pcsv
actp,,,-2,C2H3O5P,[],,Acetyl phosphate,,Acetyl phosphate,,,,,2016-11-22T15:12:32Z,,2784,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2784/?format=pcsv
alac_S,,,-1,C5H7O4,[],,(S)-2-Acetolactate,,(S)-2-Acetolactate,,,,,2016-11-22T15:12:40Z,,2785,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2785/?format=pcsv
actn_R,,,0,C4H8O2,[],,(R)-Acetoin,,(R)-Acetoin,,,,,2016-11-22T15:12:32Z,,2786,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2786/?format=pcsv
1tdecg3p,,,-2,C17H33O7P1,[],,1-tetradecanoyl-sn-glycerol 3-phosphate,,1-tetradecanoyl-sn-glycerol 3-phosphate,,,,,2016-11-22T15:12:29Z,,2787,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2787/?format=pcsv
pa140,,,-2,C31H59O8P1,[],,"1,2-ditetradecanoyl-sn-glycerol 3-phosphate",,"1,2-ditetradecanoyl-sn-glycerol 3-phosphate",,,,,2016-11-22T15:12:35Z,,2788,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2788/?format=pcsv
1hdecg3p,,,-2,C19H37O7P1,[],,1-hexadecanoyl-sn-glycerol 3-phosphate,,1-hexadecanoyl-sn-glycerol 3-phosphate,,,,,2016-11-22T15:12:29Z,,2789,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2789/?format=pcsv
pa160,,,-2,C35H67O8P1,[],,"1,2-dihexadecanoyl-sn-glycerol 3-phosphate",,"1,2-dihexadecanoyl-sn-glycerol 3-phosphate",,,,,2016-11-22T15:12:35Z,,2790,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2790/?format=pcsv
1odecg3p,,,-2,C21H41O7P1,[],,1-octadecanoyl-sn-glycerol 3-phosphate,,1-octadecanoyl-sn-glycerol 3-phosphate,,,,,2016-11-22T15:12:29Z,,2791,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2791/?format=pcsv
pa180,,,-2,C39H75O8P1,[],,"1,2-dioctadecanoyl-sn-glycerol 3-phosphate",,"1,2-dioctadecanoyl-sn-glycerol 3-phosphate",,,,,2016-11-22T15:12:35Z,,2792,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2792/?format=pcsv
1aipdecg3p,,,-1,C18H36O7P,[],,"1-anteisopentadecanoyl-sn-glycerol 3-phosphate (12-methyl-tetradecanoyl, anteiso-C15)",,"1-anteisopentadecanoyl-sn-glycerol 3-phosphate (12-methyl-tetradecanoyl, anteiso-C15)",,,,,2016-11-22T15:12:29Z,,2793,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2793/?format=pcsv
aipdcoa,,,-4,C36H60N7O17P3S,[],,"fa4coa,Anteiso-C15:0 CoA   Anteisopentadecanoyl-CoA",,"fa4coa,Anteiso-C15:0 CoA   Anteisopentadecanoyl-CoA",,,,,2016-11-22T15:12:40Z,,2794,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2794/?format=pcsv
paai15,,,-2,C33H63O8P,[],,"1,2-dianteisopentadecanoyl-sn-glycerol 3-phosphate (12-methyl-tetradecanoyl, anteiso-C15)",,"1,2-dianteisopentadecanoyl-sn-glycerol 3-phosphate (12-methyl-tetradecanoyl, anteiso-C15)",,,,,2016-11-22T15:12:36Z,,2795,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2795/?format=pcsv
1aihpdecg3p,,,-2,C20H39O7P,[],,"1-anteisoheptadecanoyl-sn-glycerol 3-phosphate (14-methyl-hexadecanoyl, anteiso-C17)",,"1-anteisoheptadecanoyl-sn-glycerol 3-phosphate (14-methyl-hexadecanoyl, anteiso-C17)",,,,,2016-11-22T15:12:29Z,,2796,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2796/?format=pcsv
aihpdcoa,,,-4,C38H64N7O17P3S,[],,"fa12coa,Anteiso-C17:0 CoA   Anteisoheptadecanoyl-CoA",,"fa12coa,Anteiso-C17:0 CoA   Anteisoheptadecanoyl-CoA",,,,,2016-11-22T15:12:40Z,,2797,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2797/?format=pcsv
paai17,,,-2,C37H71O8P,[],,"1,2-dianteisoheptadecanoyl-sn-glycerol 3-phosphate (14-methyl-hexadecanoyl, anteiso-C17)",,"1,2-dianteisoheptadecanoyl-sn-glycerol 3-phosphate (14-methyl-hexadecanoyl, anteiso-C17)",,,,,2016-11-22T15:12:36Z,,2798,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2798/?format=pcsv
itdcoa,,,-4,C35H58N7O17P3S,[],,"fa1coa,Iso-C14:0 CoA   Isotetradecanoyl-CoA",,"fa1coa,Iso-C14:0 CoA   Isotetradecanoyl-CoA",,,,,2016-11-22T15:12:42Z,,2799,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2799/?format=pcsv
1itdecg3p,,,-1,C17H34O7P,[],,"1-isotetradecanoyl-sn-glycerol 3-phosphate (12-methyl-tridecanoyl, iso-C14)",,"1-isotetradecanoyl-sn-glycerol 3-phosphate (12-methyl-tridecanoyl, iso-C14)",,,,,2016-11-22T15:12:29Z,,2800,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2800/?format=pcsv
pai14,,,-2,C31H59O8P,[],,"1,2-diisotetradecanoyl-sn-glycerol 3-phosphate (12-methyl-tridecanoyl, iso-C14)",,"1,2-diisotetradecanoyl-sn-glycerol 3-phosphate (12-methyl-tridecanoyl, iso-C14)",,,,,2016-11-22T15:12:36Z,,2801,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2801/?format=pcsv
ipdcoa,,,-4,C36H60N7O17P3S,[],,"fa3coa,Iso-C15:0 CoA   Isopentadecanoyl-CoA",,"fa3coa,Iso-C15:0 CoA   Isopentadecanoyl-CoA",,,,,2016-11-22T15:12:42Z,,2802,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2802/?format=pcsv
1ipdecg3p,,,-1,C18H36O7P,[],,"1-isopentadecanoyl-sn-glycerol 3-phosphate (13-methyl-tetradecanoyl, iso-C15)",,"1-isopentadecanoyl-sn-glycerol 3-phosphate (13-methyl-tetradecanoyl, iso-C15)",,,,,2016-11-22T15:12:38Z,,2803,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2803/?format=pcsv
pai15,,,-2,C33H63O8P,[],,"1,2-diisopentadecanoyl-sn-glycerol 3-phosphate (13-methyl-tetradecanoyl, iso-C15)",,"1,2-diisopentadecanoyl-sn-glycerol 3-phosphate (13-methyl-tetradecanoyl, iso-C15)",,,,,2016-11-22T15:12:43Z,,2804,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2804/?format=pcsv
ihdcoa,,,-4,C37H62N7O17P3S,[],,"fa6coa,Iso-C16:0 CoA   Isohexadecanoyl-CoA",,"fa6coa,Iso-C16:0 CoA   Isohexadecanoyl-CoA",,,,,2016-11-22T15:12:42Z,,2805,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2805/?format=pcsv
1ihdecg3p,,,-1,C19H38O7P,[],,"1-isohexadecanoyl-sn-glycerol 3-phosphate (14-methyl-pentadecanoyl, iso-C16)",,"1-isohexadecanoyl-sn-glycerol 3-phosphate (14-methyl-pentadecanoyl, iso-C16)",,,,,2016-11-22T15:12:29Z,,2806,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2806/?format=pcsv
pai16,,,-2,C35H67O8P,[],,"1,2-diisohexadecanoyl-sn-glycerol 3-phosphate (14-methyl-pentadecanoyl, iso-C16)",,"1,2-diisohexadecanoyl-sn-glycerol 3-phosphate (14-methyl-pentadecanoyl, iso-C16)",,,,,2016-11-22T15:12:36Z,,2807,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2807/?format=pcsv
ihpdcoa,,,-4,C38H64N7O17P3S,[],,"fa11coa, Iso-C17:0 CoA   Isoheptadecanoyl-CoA",,"fa11coa, Iso-C17:0 CoA   Isoheptadecanoyl-CoA",,,,,2016-11-22T15:12:42Z,,2808,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2808/?format=pcsv
1ihpdecg3p,,,-2,C20H39O7P,[],,"1-isoheptadecanoyl-sn-glycerol 3-phosphate (15-methyl-hexadecanoyl, iso-C17)",,"1-isoheptadecanoyl-sn-glycerol 3-phosphate (15-methyl-hexadecanoyl, iso-C17)",,,,,2016-11-22T15:12:38Z,,2809,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2809/?format=pcsv
pai17,,,-2,C37H71O8P,[],,"1,2-diisoheptadecanoyl-sn-glycerol 3-phosphate (15-methyl-hexadecanoyl, iso-C17)",,"1,2-diisoheptadecanoyl-sn-glycerol 3-phosphate (15-methyl-hexadecanoyl, iso-C17)",,,,,2016-11-22T15:12:43Z,,2810,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2810/?format=pcsv
acon_T,,,-3,C6H3O6,[],,trans-Aconitate,,trans-Aconitate,,,,,2016-11-22T15:12:40Z,,2811,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2811/?format=pcsv
aconm,,,-2,C7H6O6,[],,E-3-carboxy-2-pentenedioate 6-methyl ester,,E-3-carboxy-2-pentenedioate 6-methyl ester,,,,,2016-11-22T15:12:32Z,,2812,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2812/?format=pcsv
acon_C,,,-3,C6H3O6,[],,cis-Aconitate,,cis-Aconitate,,,,,2016-11-22T15:12:40Z,,2813,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2813/?format=pcsv
apoACP,,,0,RHO,[],,apoprotein [acyl carrier protein],,apoprotein [acyl carrier protein],,,,,2016-11-22T15:12:32Z,,2814,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2814/?format=pcsv
diact,,,0,C4H6O2,[],,Diacetyl,,Diacetyl,,,,,2016-11-22T15:12:33Z,,2815,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2815/?format=pcsv
4adcho,,,-1,C10H10NO5,[],,4-amino-4-deoxychorismate,,4-amino-4-deoxychorismate,,,,,2016-11-22T15:12:31Z,,2816,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2816/?format=pcsv
4abz,,,-1,C7H6NO2,[],,4-Aminobenzoate,,4-Aminobenzoate,,,,,2016-11-22T15:12:39Z,,2817,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2817/?format=pcsv
adcobhex,,,0,C55H76CoN15O11,[],,adenosyl-cobyric acid,,adenosyl-cobyric acid,,,,,2016-11-22T15:12:32Z,,2818,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2818/?format=pcsv
appl,,,1,C3H10NO,[],,1-Aminopropan-2-ol,,1-Aminopropan-2-ol,,,,,2016-11-22T15:12:32Z,,2819,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2819/?format=pcsv
adocbi,,,1,C58H84CoN16O11,[],,Adenosyl cobinamide,,Adenosyl cobinamide,,,,,2016-11-22T15:12:32Z,,2820,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2820/?format=pcsv
applp,,,-1,C3H9NO4P,[],,D-1-Aminopropan-2-ol O-phosphate,,D-1-Aminopropan-2-ol O-phosphate,,,,,2016-11-22T15:12:40Z,,2821,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2821/?format=pcsv
chor,,,-2,C10H8O6,[],,chorismate,,chorismate,,,,,2016-11-22T15:12:32Z,,2822,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2822/?format=pcsv
adcobdam,,,-4,C55H68CoN11O15,[],,Adenosyl cobyrinate diamide,,Adenosyl cobyrinate diamide,,,,,2016-11-22T15:12:32Z,,2823,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2823/?format=pcsv
rdmbzi,,,0,C14H18N2O4,[],,"N1-(alpha-D-ribosyl)-5,6-dimethylbenzimidazole",,"N1-(alpha-D-ribosyl)-5,6-dimethylbenzimidazole",,,,,2016-11-22T15:12:37Z,,2824,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2824/?format=pcsv
2aeppn,,,-1,C2H7NO3P,6353,,2-Aminoethylphosphonate,,2-Aminoethylphosphonate,,,,,2016-11-22T15:12:38Z,,2825,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2825/?format=pcsv
ppaca,,,-2,C2H3O4P,18124,,Phosphonoacetaldehyde,,Phosphonoacetaldehyde,,,,,2016-11-22T15:12:36Z,,2826,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2826/?format=pcsv
adphep_DD,,,-2,C17H25N5O16P2,[],,ADP-D-glycero-D-manno-heptose,,ADP-D-glycero-D-manno-heptose,,,,,2016-11-22T15:12:32Z,,2827,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2827/?format=pcsv
adphep_LD,,,-2,C17H25N5O16P2,[],,ADP-L-glycero-D-manno-heptose,,ADP-L-glycero-D-manno-heptose,,,,,2016-11-22T15:12:40Z,,2828,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2828/?format=pcsv
pa120,,,-2,C27H51O8P1,[],,"1,2-didodecanoyl-sn-glycerol 3-phosphate",,"1,2-didodecanoyl-sn-glycerol 3-phosphate",,,,,2016-11-22T15:12:35Z,,2829,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2829/?format=pcsv
1tdec7eg3p,,,-2,C17H31O7P1,[],,1-tetradec-7-enoyl-sn-glycerol 3-phosphate,,1-tetradec-7-enoyl-sn-glycerol 3-phosphate,,,,,2016-11-22T15:12:29Z,,2830,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2830/?format=pcsv
pa141,,,-2,C31H55O8P1,[],,"1,2-ditetradec-7-enoyl-sn-glycerol 3-phosphate",,"1,2-ditetradec-7-enoyl-sn-glycerol 3-phosphate",,,,,2016-11-22T15:12:35Z,,2831,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2831/?format=pcsv
1hdec9eg3p,,,-2,C19H35O7P1,[],,1-hexadec-9-enoyl-sn-glycerol 3-phosphate,,1-hexadec-9-enoyl-sn-glycerol 3-phosphate,,,,,2016-11-22T15:12:29Z,,2832,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2832/?format=pcsv
pa161,,,-2,C35H63O8P1,[],,"1,2-dihexadec-9-enoyl-sn-glycerol 3-phosphate",,"1,2-dihexadec-9-enoyl-sn-glycerol 3-phosphate",,,,,2016-11-22T15:12:35Z,,2833,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2833/?format=pcsv
1odec11eg3p,,,-2,C21H39O7P1,[],,1-octadec-11-enoyl-sn-glycerol 3-phosphate,,1-octadec-11-enoyl-sn-glycerol 3-phosphate,,,,,2016-11-22T15:12:29Z,,2834,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2834/?format=pcsv
pa181,,,-2,C39H71O8P1,[],,"1,2-dioctadec-11-enoyl-sn-glycerol 3-phosphate",,"1,2-dioctadec-11-enoyl-sn-glycerol 3-phosphate",,,,,2016-11-22T15:12:35Z,,2835,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2835/?format=pcsv
rhcys,,,0,C9H17NO6S,[],,S-Ribosyl-L-homocysteine,,S-Ribosyl-L-homocysteine,,,,,2016-11-22T15:12:37Z,,2836,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2836/?format=pcsv
14mpalmACP,,,-1,C28H53N2O8PRS,[],,14-methyl-hexa-decanoyl-ACP,,14-methyl-hexa-decanoyl-ACP,,,,,2016-11-22T15:12:28Z,,2837,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2837/?format=pcsv
dhnpt,,,0,C9H13N5O4,[],,Dihydroneopterin,,Dihydroneopterin,,,,,2016-11-22T15:12:41Z,,2838,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2838/?format=pcsv
alaasp,,,-1,C7H11N2O5,[],,L-alanyl-L-aspartate,,L-alanyl-L-aspartate,,,,,2016-11-22T15:12:32Z,,2839,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2839/?format=pcsv
33hmeoxobut,,,-1,C5H7O4,[],,2-Oxo-3-hydroxyisovalerate,,2-Oxo-3-hydroxyisovalerate,,,,,2016-11-22T15:12:30Z,,2840,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2840/?format=pcsv
alagln,,,0,C8H15N3O4,[],,L-alanyl-L-glutamine,,L-alanyl-L-glutamine,,,,,2016-11-22T15:12:32Z,,2841,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2841/?format=pcsv
alaglu,,,-1,C8H13N2O5,[],,L-alanyl-L-glutamate,,L-alanyl-L-glutamate,,,,,2016-11-22T15:12:40Z,,2842,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2842/?format=pcsv
alagly,,,0,C5H10N2O3,[],,L-alanylglycine,,L-alanylglycine,,,,,2016-11-22T15:12:40Z,,2843,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2843/?format=pcsv
alahis,,,0,C9H14N4O3,57485,,L-alanyl-L-histidine,,L-alanyl-L-histidine,,,,,2016-11-22T15:12:40Z,,2844,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2844/?format=pcsv
alaleu,,,0,C9H18N2O3,[],,L-alanyl-L-leucine,,L-alanyl-L-leucine,,,,,2016-11-22T15:12:40Z,,2845,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2845/?format=pcsv
alathr,,,0,C7H14N2O4,[],,L-alanyl-L-threonine,,L-alanyl-L-threonine,,,,,2016-11-22T15:12:40Z,,2846,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2846/?format=pcsv
allphn,,,-1,C2H3N2O3,[],,Allophanate,,Allophanate,,,,,2016-11-22T15:12:32Z,,2847,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2847/?format=pcsv
altrn,,,-1,C6H11O7,[],,D-Altronate,,D-Altronate,,,,,2016-11-22T15:12:40Z,,2848,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2848/?format=pcsv
2ddglcn,,,-1,C6H9O6,[],,2-Dehydro-3-deoxy-D-gluconate,,2-Dehydro-3-deoxy-D-gluconate,,,,,2016-11-22T15:12:29Z,,2849,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2849/?format=pcsv
8aonn,,,0,C9H17NO3,[],,8-Amino-7-oxononanoate,,8-Amino-7-oxononanoate,,,,,2016-11-22T15:12:31Z,,2850,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2850/?format=pcsv
amob,,,0,C15H19N5O6S,[],,S-Adenosyl-4-methylthio-2-oxobutanoate,,S-Adenosyl-4-methylthio-2-oxobutanoate,,,,,2016-11-22T15:12:32Z,,2851,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2851/?format=pcsv
dann,,,1,C9H21N2O2,[],,"7,8-Diaminononanoate",,"7,8-Diaminononanoate",,,,,2016-11-22T15:12:33Z,,2852,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2852/?format=pcsv
2dmmq8,,,0,C50H70O2,[],,2-Demethylmenaquinone 8,,2-Demethylmenaquinone 8,,,,,2016-11-22T15:12:29Z,,2853,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2853/?format=pcsv
mqn8,,,0,C51H72O2,,,Menaquinone 8,,Menaquinone 8,,,,,2016-11-22T15:12:28Z,,2854,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2854/?format=pcsv
pran,,,-3,C12H13NO9P,[],,N-(5-Phospho-D-ribosyl)anthranilate,,N-(5-Phospho-D-ribosyl)anthranilate,,,,,2016-11-22T15:12:43Z,,2855,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2855/?format=pcsv
pmcoa,,,-5,C28H41N7O19P3S,[],,Pimeloyl-CoA,,Pimeloyl-CoA,,,,,2016-11-22T15:12:36Z,,2856,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2856/?format=pcsv
5apru,,,-2,C9H13N4O9P,[],,5-Amino-6-(5-phosphoribosylamino)uracil,,5-Amino-6-(5-phosphoribosylamino)uracil,,,,,2016-11-22T15:12:31Z,,2857,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2857/?format=pcsv
5aprbu,,,-2,C9H15N4O9P,[],,5-Amino-6-(5-phosphoribitylamino)uracil,,5-Amino-6-(5-phosphoribitylamino)uracil,,,,,2016-11-22T15:12:31Z,,2858,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2858/?format=pcsv
rbl_L,,,0,C5H10O5,[],,L-Ribulose,,L-Ribulose,,,,,2016-11-22T15:12:43Z,,2859,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2859/?format=pcsv
arbt,,,0,C12H16O7,[],,Arbutin,,Arbutin,,,,,2016-11-22T15:12:32Z,,2860,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2860/?format=pcsv
aspsa,,,0,C4H7NO3,[],,L-Aspartate 4-semialdehyde,,L-Aspartate 4-semialdehyde,,,,,2016-11-22T15:12:40Z,,2861,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2861/?format=pcsv
4pasp,,,-2,C4H6NO7P,[],,4-Phospho-L-aspartate,,4-Phospho-L-aspartate,,,,,2016-11-22T15:12:31Z,,2862,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2862/?format=pcsv
ascb6p,,,-2,C6H7O9P,[],,L-ascorbate-6-phosphate,,L-ascorbate-6-phosphate,,,,,2016-11-22T15:12:32Z,,2863,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2863/?format=pcsv
3dhgulnp,,,-3,C6H8O10P,[],,3-keto-L-gulonate-6-phosphate,,3-keto-L-gulonate-6-phosphate,,,,,2016-11-22T15:12:39Z,,2864,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2864/?format=pcsv
aso3,,,-3,AsO3,[],,arsenite,,arsenite,,,,,2016-11-22T15:12:32Z,,2865,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2865/?format=pcsv
aso4,,,-3,AsO4,[],,arsenate,,arsenate,,,,,2016-11-22T15:12:32Z,,2866,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2866/?format=pcsv
iasp,,,-2,C4H3NO4,[],,Iminoaspartate,,Iminoaspartate,,,,,2016-11-22T15:12:34Z,,2867,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2867/?format=pcsv
sucarg,,,-1,C10H17N4O5,[],,N2-Succinyl-L-arginine,,N2-Succinyl-L-arginine,,,,,2016-11-22T15:12:37Z,,2868,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2868/?format=pcsv
prbatp,,,-6,C15H19N5O20P4,[],,1-(5-Phosphoribosyl)-ATP,,1-(5-Phosphoribosyl)-ATP,,,,,2016-11-22T15:12:36Z,,2869,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2869/?format=pcsv
cellb,,,0,C12H22O11,[],,cellobiose,,cellobiose,,,,,2016-11-22T15:12:41Z,,2870,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2870/?format=pcsv
6pgg,,,-2,C12H21O14P,[],,"6-Phospho-beta-D-glucosyl-(1,4)-D-glucose",,"6-Phospho-beta-D-glucosyl-(1,4)-D-glucose",,,,,2016-11-22T15:12:31Z,,2871,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2871/?format=pcsv
glc_bD,,,0,C6H12O6,[],,beta D-glucose,,beta D-glucose,,,,,2016-11-22T15:12:41Z,,2872,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2872/?format=pcsv
btnso,,,-1,C10H15N2O4S,[],,d-biotin d-sulfoxide,,d-biotin d-sulfoxide,,,,,2016-11-22T15:12:32Z,,2873,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2873/?format=pcsv
btd_RR,,,0,C4H10O2,[],,R_R__2_3_Butanediol,,R_R__2_3_Butanediol,,,,,2016-11-22T15:12:32Z,,2874,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2874/?format=pcsv
dtbt,,,-1,C10H17N2O3,[],,Dethiobiotin,,Dethiobiotin,,,,,2016-11-22T15:12:33Z,,2875,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2875/?format=pcsv
s,,,0,S,[],,Sulfur,,Sulfur,,,,,2016-11-22T15:12:37Z,,2876,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2876/?format=pcsv
dad_5,,,0,C10H13N5O3,,,5-Deoxyadenosine,,5-Deoxyadenosine,,,,,2016-11-22T15:12:41Z,,2877,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2877/?format=pcsv
butso3,,,-1,C4H9O3S,[],,butanesulfonate,,butanesulfonate,,,,,2016-11-22T15:12:32Z,,2878,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2878/?format=pcsv
bz12diol,,,-1,C7H7O4,18340,,"cis-1,2-dihydroxycyclohexa-3,5-diene-1-carboxylate",,"cis-1,2-dihydroxycyclohexa-3,5-diene-1-carboxylate",,,,,2016-11-22T15:12:41Z,,2879,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2879/?format=pcsv
15dap,,,2,C5H16N2,[],,"1,5-Diaminopentane",,"1,5-Diaminopentane",,,,,2016-11-22T15:12:38Z,,2880,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2880/?format=pcsv
catechol,,,-1,C6H5O2,18135,,Catechol,,Catechol,,,,,2016-11-22T15:12:32Z,,2881,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2881/?format=pcsv
ccmuac,,,-2,C6H4O4,16508,,"cis,cis-Muconate",,"cis,cis-Muconate",,,,,2016-11-22T15:12:32Z,,2882,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2882/?format=pcsv
cbi,,,0,C48H72CoN11O8,[],,Cobinamide,,Cobinamide,,,,,2016-11-22T15:12:32Z,,2883,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2883/?format=pcsv
cd2,,,2,Cd,[],,Cadmium,,Cadmium,,,,,2016-11-22T15:12:32Z,,2884,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2884/?format=pcsv
cdpdddecg,,,-2,C36H63N3O15P2,[],,"CDP-1,2-didodecanoylglycerol",,"CDP-1,2-didodecanoylglycerol",,,,,2016-11-22T15:12:32Z,,2885,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2885/?format=pcsv
cdpdtdecg,,,-2,C40H71N3O15P2,[],,"CDP-1,2-ditetradecanoylglycerol",,"CDP-1,2-ditetradecanoylglycerol",,,,,2016-11-22T15:12:41Z,,2886,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2886/?format=pcsv
cdpdtdec7eg,,,-2,C40H67N3O15P2,[],,"CDP-1,2-ditetradec-7-enoylglycerol",,"CDP-1,2-ditetradec-7-enoylglycerol",,,,,2016-11-22T15:12:32Z,,2887,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2887/?format=pcsv
cdpdhdecg,,,-2,C44H79N3O15P2,[],,"CDP-1,2-dihexadecanoylglycerol",,"CDP-1,2-dihexadecanoylglycerol",,,,,2016-11-22T15:12:32Z,,2888,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2888/?format=pcsv
cdpdhdec9eg,,,-2,C44H75N3O15P2,[],,"CDP-1,2-dihexadec-9-enoylglycerol",,"CDP-1,2-dihexadec-9-enoylglycerol",,,,,2016-11-22T15:12:32Z,,2889,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2889/?format=pcsv
cdpdodecg,,,-2,C48H87N3O15P2,[],,"CDP-1,2-dioctadecanoylglycerol",,"CDP-1,2-dioctadecanoylglycerol",,,,,2016-11-22T15:12:32Z,,2890,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2890/?format=pcsv
cdpdodec11eg,,,-2,C48H83N3O15P2,[],,"CDP-1,2-dioctadec-11-enoylglycerol",,"CDP-1,2-dioctadec-11-enoylglycerol",,,,,2016-11-22T15:12:32Z,,2891,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2891/?format=pcsv
ckdo,,,-2,C17H24N3O15P,[],,CMP-3-deoxy-D-manno-octulosonate,,CMP-3-deoxy-D-manno-octulosonate,,,,,2016-11-22T15:12:33Z,,2892,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2892/?format=pcsv
kdolipid4,,,-5,C76H137N2O30P2,[],,KDO-lipid IV(A),,KDO-lipid IV(A),,,,,2016-11-22T15:12:35Z,,2893,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2893/?format=pcsv
kdo2lipid4,,,-6,C84H148N2O37P2,[],,KDO(2)-lipid IV(A),,KDO(2)-lipid IV(A),,,,,2016-11-22T15:12:35Z,,2894,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2894/?format=pcsv
4c2me,,,-2,C14H23N3O14P2,[],,4-(cytidine 5-diphospho)-2-C-methyl-D-erythritol,,4-(cytidine 5-diphospho)-2-C-methyl-D-erythritol,,,,,2016-11-22T15:12:31Z,,2895,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2895/?format=pcsv
2p4c2me,,,-4,C14H22N3O17P3,[],,2-phospho-4-(cytidine 5-diphospho)-2-C-methyl-D-erythritol,,2-phospho-4-(cytidine 5-diphospho)-2-C-methyl-D-erythritol,,,,,2016-11-22T15:12:30Z,,2896,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2896/?format=pcsv
chols,,,0,C5H13NO4S,[],,Choline sulfate,,Choline sulfate,,,,,2016-11-22T15:12:32Z,,2897,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2897/?format=pcsv
3psme,,,-4,C10H9O10P,[],,5-O-(1-Carboxyvinyl)-3-phosphoshikimate,,5-O-(1-Carboxyvinyl)-3-phosphoshikimate,,,,,2016-11-22T15:12:30Z,,2898,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2898/?format=pcsv
pg140,,,-1,C34H66O10P1,[],,"Phosphatidylglycerol (ditetradecanoyl, n-C14:0)",,"Phosphatidylglycerol (ditetradecanoyl, n-C14:0)",,,,,2016-11-22T15:12:36Z,,2899,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2899/?format=pcsv
clpn140,,,-2,C65H124O17P2,[],,"cardiolipin (tetratetradecanoyl, n-C14:0)",,"cardiolipin (tetratetradecanoyl, n-C14:0)",,,,,2016-11-22T15:12:33Z,,2900,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2900/?format=pcsv
pg160,,,-1,C38H74O10P1,[],,"Phosphatidylglycerol (dihexadecanoyl, n-C16:0)",,"Phosphatidylglycerol (dihexadecanoyl, n-C16:0)",,,,,2016-11-22T15:12:36Z,,2901,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2901/?format=pcsv
clpn160,,,-2,C73H140O17P2,[],,"cardiolipin (tetrahexadecanoyl, n-C16:0)",,"cardiolipin (tetrahexadecanoyl, n-C16:0)",,,,,2016-11-22T15:12:33Z,,2902,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2902/?format=pcsv
pg180,,,-1,C42H82O10P1,[],,"Phosphatidylglycerol (dioctadecanoyl, n-C18:0)",,"Phosphatidylglycerol (dioctadecanoyl, n-C18:0)",,,,,2016-11-22T15:12:36Z,,2903,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2903/?format=pcsv
clpn180,,,-2,C81H156O17P2,[],,"cardiolipin (tetraoctadecanoyl, n-C18:0)",,"cardiolipin (tetraoctadecanoyl, n-C18:0)",,,,,2016-11-22T15:12:33Z,,2904,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2904/?format=pcsv
pgai15,,,-1,C36H70O10P,[],,"Phosphatidylglycerol (12-methyl-tetradecanoyl, anteiso-C15)",,"Phosphatidylglycerol (12-methyl-tetradecanoyl, anteiso-C15)",,,,,2016-11-22T15:12:36Z,,2905,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2905/?format=pcsv
clpnai15,,,-2,C69H132O17P2,[],,"cardiolipin (12-methyl-tetradecanoyl, anteiso-C15)",,"cardiolipin (12-methyl-tetradecanoyl, anteiso-C15)",,,,,2016-11-22T15:12:33Z,,2906,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2906/?format=pcsv
pgai17,,,-1,C40H78O10P,[],,"Phosphatidylglycerol (14-methyl-hexadecanoyl, anteiso-C17)",,"Phosphatidylglycerol (14-methyl-hexadecanoyl, anteiso-C17)",,,,,2016-11-22T15:12:36Z,,2907,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2907/?format=pcsv
clpnai17,,,-2,C77H148O17P2,[],,"cardiolipin (14-methyl-hexadecanoyl, anteiso-C17)",,"cardiolipin (14-methyl-hexadecanoyl, anteiso-C17)",,,,,2016-11-22T15:12:33Z,,2908,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2908/?format=pcsv
pgi14,,,-1,C34H66O10P,[],,"Phosphatidylglycerol (12-methyltridecanoyl, iso-C14)",,"Phosphatidylglycerol (12-methyltridecanoyl, iso-C14)",,,,,2016-11-22T15:12:36Z,,2909,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2909/?format=pcsv
clpni14,,,-2,C65H124O17P2,[],,"cardiolipin (12-methyl-tridecanoyl, iso-C14)",,"cardiolipin (12-methyl-tridecanoyl, iso-C14)",,,,,2016-11-22T15:12:41Z,,2910,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2910/?format=pcsv
pgi15,,,-1,C36H70O10P,[],,"Phosphatidylglycerol (13-methyltetradecanoyl, iso-C15)",,"Phosphatidylglycerol (13-methyltetradecanoyl, iso-C15)",,,,,2016-11-22T15:12:43Z,,2911,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2911/?format=pcsv
clpni15,,,-2,C69H132O17P2,[],,"cardiolipin (13-methyl-tetradecanoyl, iso-C15)",,"cardiolipin (13-methyl-tetradecanoyl, iso-C15)",,,,,2016-11-22T15:12:41Z,,2912,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2912/?format=pcsv
pgi16,,,-1,C38H74O10P,[],,"Phosphatidylglycerol (14-methylpentadecanoyl, iso-C16)",,"Phosphatidylglycerol (14-methylpentadecanoyl, iso-C16)",,,,,2016-11-22T15:12:36Z,,2913,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2913/?format=pcsv
clpni16,,,-2,C73H140O17P2,[],,"cardiolipin (14-methyl-pentadecanoyl, iso-C16)",,"cardiolipin (14-methyl-pentadecanoyl, iso-C16)",,,,,2016-11-22T15:12:41Z,,2914,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2914/?format=pcsv
pgi17,,,-1,C40H78O10P,[],,"Phosphatidylglycerol (15-methyl-hexadecanoyl, iso-C17)",,"Phosphatidylglycerol (15-methyl-hexadecanoyl, iso-C17)",,,,,2016-11-22T15:12:43Z,,2915,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2915/?format=pcsv
clpni17,,,-2,C77H148O17P2,[],,"cardiolipin (15-methyl-hexadecanoyl, iso-C17)",,"cardiolipin (15-methyl-hexadecanoyl, iso-C17)",,,,,2016-11-22T15:12:41Z,,2916,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2916/?format=pcsv
2c25dho,,,-2,C7H4O6,16993,,"2-Carboxy-2,5-dihydro-5-oxofuran-2-acetate",,"2-Carboxy-2,5-dihydro-5-oxofuran-2-acetate",,,,,2016-11-22T15:12:29Z,,2917,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2917/?format=pcsv
cobalt2,,,2,Co,[],,Co2+,,Co2+,,,,,2016-11-22T15:12:33Z,,2918,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2918/?format=pcsv
copre2,,,-8,C42H38N4O16Co,[],,cobalt-precorrin 2,,cobalt-precorrin 2,,,,,2016-11-22T15:12:33Z,,2919,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2919/?format=pcsv
copre3,,,-8,C43H40N4O16Co,[],,cobalt-precorrin 3,,cobalt-precorrin 3,,,,,2016-11-22T15:12:33Z,,2920,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2920/?format=pcsv
copre4,,,-7,C44H43N4O16Co,[],,cobalt-precorrin 4,,cobalt-precorrin 4,,,,,2016-11-22T15:12:33Z,,2921,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2921/?format=pcsv
copre5,,,-7,C45H45N4O16Co,[],,cobalt-precorrin 5,,cobalt-precorrin 5,,,,,2016-11-22T15:12:33Z,,2922,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2922/?format=pcsv
copre6,,,-7,C44H45N4O16Co,[],,cobalt-precorrin 6,,cobalt-precorrin 6,,,,,2016-11-22T15:12:33Z,,2923,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2923/?format=pcsv
codhpre6,,,-7,C44H47N4O16Co,[],,cobalt-dihydro-precorrin 6,,cobalt-dihydro-precorrin 6,,,,,2016-11-22T15:12:33Z,,2924,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2924/?format=pcsv
copre8,,,-6,C45H52N4O14Co,[],,cobalt-precorrin 8,,cobalt-precorrin 8,,,,,2016-11-22T15:12:41Z,,2925,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2925/?format=pcsv
cobya,,,-6,C45H52N4O14Co,[],,Cobyrinate,,Cobyrinate,,,,,2016-11-22T15:12:33Z,,2926,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2926/?format=pcsv
co1dam,,,-5,C45H56CoN6O12,[],,"Cob(I)yrinate a,c diamide",,"Cob(I)yrinate a,c diamide",,,,,2016-11-22T15:12:33Z,,2927,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2927/?format=pcsv
co2dam,,,-4,C45H56CoN6O12,[],,"Cob(II)yrinate a,c diamide",,"Cob(II)yrinate a,c diamide",,,,,2016-11-22T15:12:33Z,,2928,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2928/?format=pcsv
h2s,,,0,H2S,[],,Hydrogen sulfide,,Hydrogen sulfide,,,,,2016-11-22T15:12:34Z,,2929,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2929/?format=pcsv
acser,,,0,C5H9NO4,[],,O-Acetyl-L-serine,,O-Acetyl-L-serine,,,,,2016-11-22T15:12:40Z,,2930,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2930/?format=pcsv
q8h2,,,0,C49H76O4,[],,Ubiquinol-8,,Ubiquinol-8,,,,,2016-11-22T15:12:37Z,,2931,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2931/?format=pcsv
q8,,,0,C49H74O4,[],,Ubiquinone-8,,Ubiquinone-8,,,,,2016-11-22T15:12:37Z,,2932,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2932/?format=pcsv
mql8,,,0,C51H74O2,[],,Menaquinol 8,,Menaquinol 8,,,,,2016-11-22T15:12:35Z,,2933,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2933/?format=pcsv
cu2,,,2,Cu,[],,Cu2+,,Cu2+,,,,,2016-11-22T15:12:33Z,,2934,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2934/?format=pcsv
d5kgp,,,-3,C6H8O9P,16925,,6-phosphonato-5-dehydro-2-deoxy-D-gluconate(3-),,6-phosphonato-5-dehydro-2-deoxy-D-gluconate(3-),,,,,2016-11-22T15:12:41Z,,2935,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2935/?format=pcsv
12dgr140,,,0,C31H60O5,[],,"1,2-Diacyl-sn-glycerol (ditetradecanoyl, n-C14:0)",,"1,2-Diacyl-sn-glycerol (ditetradecanoyl, n-C14:0)",,,,,2016-11-22T15:12:28Z,,2936,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2936/?format=pcsv
12dgr141,,,0,C31H56O5,[],,"1,2-Diacyl-sn-glycerol (ditetradec-7-enoyl, n-C14:1)",,"1,2-Diacyl-sn-glycerol (ditetradec-7-enoyl, n-C14:1)",,,,,2016-11-22T15:12:28Z,,2937,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2937/?format=pcsv
12dgr160,,,0,C35H68O5,[],,"1,2-Diacyl-sn-glycerol (dihexadecanoyl, n-C16:0)",,"1,2-Diacyl-sn-glycerol (dihexadecanoyl, n-C16:0)",,,,,2016-11-22T15:12:28Z,,2938,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2938/?format=pcsv
12dgr161,,,0,C35H64O5,[],,"1,2-Diacyl-sn-glycerol (dihexadec-9-enoyl, n-C16:1)",,"1,2-Diacyl-sn-glycerol (dihexadec-9-enoyl, n-C16:1)",,,,,2016-11-22T15:12:28Z,,2939,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2939/?format=pcsv
12dgr180,,,0,C39H76O5,[],,"1,2-Diacyl-sn-glycerol (dioctadecanoyl, n-C18:0)",,"1,2-Diacyl-sn-glycerol (dioctadecanoyl, n-C18:0)",,,,,2016-11-22T15:12:28Z,,2940,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2940/?format=pcsv
12dgr181,,,0,C39H72O5,[],,"1,2-Diacyl-sn-glycerol (dioctadec-11-enoyl, n-C18:1)",,"1,2-Diacyl-sn-glycerol (dioctadec-11-enoyl, n-C18:1)",,,,,2016-11-22T15:12:28Z,,2941,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2941/?format=pcsv
26dap_M,,,0,C7H14N2O4,[],,"meso-2,6-Diaminoheptanedioate",,"meso-2,6-Diaminoheptanedioate",,,,,2016-11-22T15:12:38Z,,2942,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2942/?format=pcsv
26dap_LL,,,0,C7H14N2O4,[],,"LL-2,6-Diaminoheptanedioate",,"LL-2,6-Diaminoheptanedioate",,,,,2016-11-22T15:12:29Z,,2943,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2943/?format=pcsv
cdpdaipdecg,,,-2,C42H75N3O15P2,[],,"CDP-1,2-dianteisopentadecanoylglycerol (12-methyl-tetradecanoyl, anteiso-C15)",,"CDP-1,2-dianteisopentadecanoylglycerol (12-methyl-tetradecanoyl, anteiso-C15)",,,,,2016-11-22T15:12:32Z,,2944,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2944/?format=pcsv
cdpdaihpdecg,,,-2,C46H83N3O15P2,[],,"CDP-1,2-dianteisoheptadecanoylglycerol (14-methyl-hexadecanoyl, anteiso-C17)",,"CDP-1,2-dianteisoheptadecanoylglycerol (14-methyl-hexadecanoyl, anteiso-C17)",,,,,2016-11-22T15:12:32Z,,2945,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2945/?format=pcsv
cdpditdecg,,,-2,C40H71N3O15P2,[],,"CDP-1,2-diisotetradecanoylglycerol (12-methyl-tridecanoyl, iso-C14)",,"CDP-1,2-diisotetradecanoylglycerol (12-methyl-tridecanoyl, iso-C14)",,,,,2016-11-22T15:12:32Z,,2946,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2946/?format=pcsv
cdpdipdecg,,,-2,C42H75N3O15P2,[],,"CDP-1,2-diisopentadecanoylglycerol (13-methyl-tetradecanoyl, iso-C15)",,"CDP-1,2-diisopentadecanoylglycerol (13-methyl-tetradecanoyl, iso-C15)",,,,,2016-11-22T15:12:41Z,,2947,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2947/?format=pcsv
cdpdihdecg,,,-2,C44H79N3O15P2,[],,"CDP-1,2-diisohexadecanoylglycerol (14-methyl-pentadecanoyl, iso-C16)",,"CDP-1,2-diisohexadecanoylglycerol (14-methyl-pentadecanoyl, iso-C16)",,,,,2016-11-22T15:12:41Z,,2948,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2948/?format=pcsv
cdpdihpdecg,,,-2,C46H83N3O15P2,[],,"CDP-1,2-diisoheptadecanoylglycerol (15-methyl-hexadecanoyl, iso-C17)",,"CDP-1,2-diisoheptadecanoylglycerol (15-methyl-hexadecanoyl, iso-C17)",,,,,2016-11-22T15:12:41Z,,2949,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2949/?format=pcsv
db4p,,,-2,C4H7O6P,[],,"3,4-dihydroxy-2-butanone 4-phosphate",,"3,4-dihydroxy-2-butanone 4-phosphate",,,,,2016-11-22T15:12:33Z,,2950,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2950/?format=pcsv
2dh3dgal,,,-1,C6H9O6,[],,2-Dehydro-3-deoxy-D-galactonate,,2-Dehydro-3-deoxy-D-galactonate,,,,,2016-11-22T15:12:39Z,,2951,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2951/?format=pcsv
2dh3dgal6p,,,-3,C6H8O9P,[],,2-Dehydro-3-deoxy-D-galactonate 6-phosphate,,2-Dehydro-3-deoxy-D-galactonate 6-phosphate,,,,,2016-11-22T15:12:39Z,,2952,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2952/?format=pcsv
2ddg6p,,,-3,C6H8O9P,[],,2-Dehydro-3-deoxy-D-gluconate 6-phosphate,,2-Dehydro-3-deoxy-D-gluconate 6-phosphate,,,,,2016-11-22T15:12:29Z,,2953,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2953/?format=pcsv
2dda7p,,,-3,C7H10O10P,[],,2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate,,2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate,,,,,2016-11-22T15:12:29Z,,2954,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2954/?format=pcsv
23dhmb,,,-1,C5H9O4,[],,"(R)-2,3-Dihydroxy-3-methylbutanoate",,"(R)-2,3-Dihydroxy-3-methylbutanoate",,,,,2016-11-22T15:12:29Z,,2955,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2955/?format=pcsv
23ddhb,,,-1,C7H7O4,[],,"2,3-Dihydro-2,3-dihydroxybenzoate",,"2,3-Dihydro-2,3-dihydroxybenzoate",,,,,2016-11-22T15:12:29Z,,2956,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2956/?format=pcsv
23dhb,,,-1,C7H5O4,[],,"2,3-Dihydroxybenzoate",,"2,3-Dihydroxybenzoate",,,,,2016-11-22T15:12:38Z,,2957,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2957/?format=pcsv
23dhba,,,-1,C17H17N5O10P,[],,"(2,3-Dihydroxybenzoyl)adenylate",,"(2,3-Dihydroxybenzoyl)adenylate",,,,,2016-11-22T15:12:29Z,,2958,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2958/?format=pcsv
hkntd,,,-2,C9H6O6,[],,2-hydroxy-6-ketononatrienedioate,,2-hydroxy-6-ketononatrienedioate,,,,,2016-11-22T15:12:34Z,,2959,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2959/?format=pcsv
23dhdp,,,-2,C7H5NO4,[],,"2,3-Dihydrodipicolinate",,"2,3-Dihydrodipicolinate",,,,,2016-11-22T15:12:29Z,,2960,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2960/?format=pcsv
thdp,,,-2,C7H7NO4,[],,"2,3,4,5-Tetrahydrodipicolinate",,"2,3,4,5-Tetrahydrodipicolinate",,,,,2016-11-22T15:12:37Z,,2961,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2961/?format=pcsv
24dhhed,,,-2,C7H8O6,58936,,"2,4-Dihydroxyhept-2-enedioate",,"2,4-Dihydroxyhept-2-enedioate",,,,,2016-11-22T15:12:29Z,,2962,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2962/?format=pcsv
dhpt,,,-1,C14H13N6O3,[],,Dihydropteroate,,Dihydropteroate,,,,,2016-11-22T15:12:33Z,,2963,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2963/?format=pcsv
dhna,,,-1,C11H7O4,[],,"1,4-Dihydroxy-2-naphthoate",,"1,4-Dihydroxy-2-naphthoate",,,,,2016-11-22T15:12:33Z,,2964,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2964/?format=pcsv
phyldpp,,,-3,C20H39O7P2,[],,Phytyl diphosphate,,Phytyl diphosphate,,,,,2016-11-22T15:12:36Z,,2965,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2965/?format=pcsv
dmphqno,,,0,C30H44O2,[],,Demethylphylloquinone,,Demethylphylloquinone,,,,,2016-11-22T15:12:33Z,,2966,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2966/?format=pcsv
octdp,,,-3,C40H65O7P2,[],,all-trans-Octaprenyl diphosphate,,all-trans-Octaprenyl diphosphate,,,,,2016-11-22T15:12:35Z,,2967,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2967/?format=pcsv
2dmmql8,,,0,C50H72O2,[],,2-Demethylmenaquinol 8,,2-Demethylmenaquinol 8,,,,,2016-11-22T15:12:29Z,,2968,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2968/?format=pcsv
2ahhmp,,,0,C7H9N5O2,[],,"2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine",,"2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine",,,,,2016-11-22T15:12:29Z,,2969,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2969/?format=pcsv
25dhpp,,,-2,C9H14N5O8P,[],,"2,5-Diamino-6-hydroxy-4-(5-phosphoribosylamino)-pyrimidine",,"2,5-Diamino-6-hydroxy-4-(5-phosphoribosylamino)-pyrimidine",,,,,2016-11-22T15:12:29Z,,2970,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2970/?format=pcsv
3dhq,,,-1,C7H9O6,[],,3-Dehydroquinate,,3-Dehydroquinate,,,,,2016-11-22T15:12:30Z,,2971,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2971/?format=pcsv
3dhsk,,,-1,C7H7O5,[],,3-Dehydroshikimate,,3-Dehydroshikimate,,,,,2016-11-22T15:12:30Z,,2972,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2972/?format=pcsv
25dkglcn,,,-1,C6H7O7,[],,"2,5-diketo-D-gluconate",,"2,5-diketo-D-gluconate",,,,,2016-11-22T15:12:38Z,,2973,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2973/?format=pcsv
2dhguln,,,-1,C6H9O7,[],,2-Dehydro-L-gulonate,,2-Dehydro-L-gulonate,,,,,2016-11-22T15:12:39Z,,2974,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2974/?format=pcsv
dhmtp,,,-1,C6H9O3S,,,dhmtp[c],,dhmtp[c],,,,,2016-11-22T15:12:28Z,,2975,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2975/?format=pcsv
h2mb4p,,,-3,C5H9O8P2,[],,1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate,,1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate,,,,,2016-11-22T15:12:34Z,,2976,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2976/?format=pcsv
dmso,,,0,C2H6OS,[],,Dimethyl sulfoxide,,Dimethyl sulfoxide,,,,,2016-11-22T15:12:33Z,,2977,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2977/?format=pcsv
dms,,,0,C2H6S,[],,Dimethyl sulfide,,Dimethyl sulfide,,,,,2016-11-22T15:12:33Z,,2978,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2978/?format=pcsv
dhptd,,,0,C5H8O4,[],,"4,5-dihydroxy-2,3-pentanedione",,"4,5-dihydroxy-2,3-pentanedione",,,,,2016-11-22T15:12:33Z,,2979,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2979/?format=pcsv
2dhp,,,-1,C6H9O4,[],,2-Dehydropantoate,,2-Dehydropantoate,,,,,2016-11-22T15:12:39Z,,2980,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2980/?format=pcsv
pant_R,,,-1,C6H11O4,[],,(R)-Pantoate,,(R)-Pantoate,,,,,2016-11-22T15:12:43Z,,2981,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2981/?format=pcsv
dxyl5p,,,-2,C5H9O7P,[],,1-deoxy-D-xylulose 5-phosphate,,1-deoxy-D-xylulose 5-phosphate,,,,,2016-11-22T15:12:41Z,,2982,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2982/?format=pcsv
2me4p,,,-2,C5H11O7P,[],,2-C-methyl-D-erythritol 4-phosphate,,2-C-methyl-D-erythritol 4-phosphate,,,,,2016-11-22T15:12:30Z,,2983,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2983/?format=pcsv
4per,,,-3,C4H6O8P,[],,4-Phospho-D-erythronate,,4-Phospho-D-erythronate,,,,,2016-11-22T15:12:31Z,,2984,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2984/?format=pcsv
14mpentdecACP,,,-1,C27H51N2O8PRS,[],,14-methyl-pentadecanoyl-ACP,,14-methyl-pentadecanoyl-ACP,,,,,2016-11-22T15:12:38Z,,2985,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2985/?format=pcsv
15mpalmACP,,,-1,C28H53N2O8PRS,[],,15-methyl-hexa-decanoyl-ACP,,15-methyl-hexa-decanoyl-ACP,,,,,2016-11-22T15:12:38Z,,2986,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2986/?format=pcsv
3hhcoa,,,-4,C27H42N7O18P3S,[],,(S)-3-Hydroxyhexanoyl-CoA,,(S)-3-Hydroxyhexanoyl-CoA,,,,,2016-11-22T15:12:39Z,,2987,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2987/?format=pcsv
3hocoa,,,-4,C29H46N7O18P3S,[],,(S)-3-Hydroxyoctanoyl-CoA,,(S)-3-Hydroxyoctanoyl-CoA,,,,,2016-11-22T15:12:39Z,,2988,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2988/?format=pcsv
oc2coa,,,-4,C29H44N7O17P3S,[],,trans-Oct-2-enoyl-CoA,,trans-Oct-2-enoyl-CoA,,,,,2016-11-22T15:12:43Z,,2989,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2989/?format=pcsv
td2coa,,,-4,C35H56N7O17P3S,[],,trans-Tetradec-2-enoyl-CoA,,trans-Tetradec-2-enoyl-CoA,,,,,2016-11-22T15:12:44Z,,2990,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2990/?format=pcsv
3hhdcoa,,,-4,C37H62N7O18P3S,[],,(S)-3-Hydroxyhexadecanoyl-CoA,,(S)-3-Hydroxyhexadecanoyl-CoA,,,,,2016-11-22T15:12:39Z,,2991,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2991/?format=pcsv
kdo2lipid4L,,,-6,C96H170N2O38P2,[],,KDO(2)-lipid IV(A) with laurate,,KDO(2)-lipid IV(A) with laurate,,,,,2016-11-22T15:12:35Z,,2992,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2992/?format=pcsv
lipa,,,-6,C110H196N2O39P2,[],,KDO(2)-lipid (A),,KDO(2)-lipid (A),,,,,2016-11-22T15:12:35Z,,2993,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2993/?format=pcsv
ethso3,,,-1,C2H5O3S,[],,ethanesulfonate,,ethanesulfonate,,,,,2016-11-22T15:12:33Z,,2994,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2994/?format=pcsv
biomass,,,0,X,[],,Produced biomass,,Produced biomass,,,,,2016-11-22T15:12:40Z,,2995,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2995/?format=pcsv
fe3dcit,,,-3,C12H10FeO14,[],,Fe(III)dicitrate,,Fe(III)dicitrate,,,,,2016-11-22T15:12:33Z,,2996,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2996/?format=pcsv
fecrm,,,0,C27H42FeN9O12,[],,Ferrichrome,,Ferrichrome,,,,,2016-11-22T15:12:33Z,,2997,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2997/?format=pcsv
galct_D,,,-2,C6H8O8,[],,D-Galactarate,,D-Galactarate,,,,,2016-11-22T15:12:41Z,,2998,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2998/?format=pcsv
galctn_D,,,-1,C6H11O7,[],,D-Galactonate,,D-Galactonate,,,,,2016-11-22T15:12:41Z,,2999,,,,,,,,,http://vmh.uni.lu/_api/metabolites/2999/?format=pcsv
galur,,,-1,C6H9O7,[],,D-Galacturonate,,D-Galacturonate,,,,,2016-11-22T15:12:41Z,,3000,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3000/?format=pcsv
glyasn,,,0,C6H11N3O4,[],,Glycyl-L-asparagine,,Glycyl-L-asparagine,,,,,2016-11-22T15:12:34Z,,3001,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3001/?format=pcsv
glyasp,,,-1,C6H9N2O5,[],,Glycyl-L-aspartate,,Glycyl-L-aspartate,,,,,2016-11-22T15:12:34Z,,3002,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3002/?format=pcsv
glycogenb,,,0,X,,,glycogen(n-1),,glycogen(n-1),,,,,2016-11-22T15:12:41Z,,3003,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3003/?format=pcsv
glygln,,,0,C7H13N3O4,[],,Glycyl-L-glutamine,,Glycyl-L-glutamine,,,,,2016-11-22T15:12:34Z,,3004,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3004/?format=pcsv
glyglu,,,-1,C7H11N2O5,[],,Glycyl-L-glutamate,,Glycyl-L-glutamate,,,,,2016-11-22T15:12:41Z,,3005,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3005/?format=pcsv
glymet,,,0,C7H14N2O3S,[],,Glycyl-L-methionine,,Glycyl-L-methionine,,,,,2016-11-22T15:12:34Z,,3006,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3006/?format=pcsv
glytyr,,,0,C11H14N2O4,[],,Glycyl-L-tyrosine,,Glycyl-L-tyrosine,,,,,2016-11-22T15:12:34Z,,3007,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3007/?format=pcsv
hexs,,,-1,C6H13O3S,[],,hexanesulfonate,,hexanesulfonate,,,,,2016-11-22T15:12:34Z,,3008,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3008/?format=pcsv
hg2,,,2,Hg,[],,Hg2+,,Hg2+,,,,,2016-11-22T15:12:34Z,,3009,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3009/?format=pcsv
isetac,,,-1,C2H5O4S,[],,Isethionic acid,,Isethionic acid,,,,,2016-11-22T15:12:35Z,,3010,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3010/?format=pcsv
melib,,,0,C12H22O11,[],,Melibiose,,Melibiose,,,,,2016-11-22T15:12:42Z,,3011,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3011/?format=pcsv
met_D,,,0,C5H10NO2S,[],,D-Methionine,,D-Methionine,,,,,2016-11-22T15:12:35Z,,3012,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3012/?format=pcsv
metala,,,0,C8H16N2O3S,74394,,L-methionyl-L-alanine,,L-methionyl-L-alanine,,,,,2016-11-22T15:12:35Z,,3013,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3013/?format=pcsv
metsox_R_L,,,0,C5H11NO3S,[],,L-methionine-R-sulfoxide,,L-methionine-R-sulfoxide,,,,,2016-11-22T15:12:35Z,,3014,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3014/?format=pcsv
metsox_S_L,,,0,C5H11NO3S,[],,L-Methionine Sulfoxide,,L-Methionine Sulfoxide,,,,,2016-11-22T15:12:42Z,,3015,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3015/?format=pcsv
mg2,,,2,Mg,[],,magnesium,,magnesium,,,,,2016-11-22T15:12:35Z,,3016,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3016/?format=pcsv
mn2,,,2,Mn,[],,Mn2+,,Mn2+,,,,,2016-11-22T15:12:35Z,,3017,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3017/?format=pcsv
mnl,,,0,C6H14O6,[],,D-Mannitol,,D-Mannitol,,,,,2016-11-22T15:12:42Z,,3018,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3018/?format=pcsv
mops,,,-1,C7H14NO4S,[],,3-(n-Morpholino)Propanesulfonic Acid,,3-(n-Morpholino)Propanesulfonic Acid,,,,,2016-11-22T15:12:35Z,,3019,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3019/?format=pcsv
mso3,,,-1,CH3O3S,[],,methanesulfonate,,methanesulfonate,,,,,2016-11-22T15:12:35Z,,3020,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3020/?format=pcsv
ni2,,,2,Ni,[],,nickel,,nickel,,,,,2016-11-22T15:12:35Z,,3021,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3021/?format=pcsv
no3,,,-1,NO3,[],,Nitrate,,Nitrate,,,,,2016-11-22T15:12:43Z,,3022,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3022/?format=pcsv
pb,,,2,Pb,[],,Lead,,Lead,,,,,2016-11-22T15:12:36Z,,3023,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3023/?format=pcsv
pppn,,,-1,C9H9O2,[],,Phenylpropanoate,,Phenylpropanoate,,,,,2016-11-22T15:12:36Z,,3024,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3024/?format=pcsv
rmn,,,0,C6H12O5,[],,L-Rhamnose,,L-Rhamnose,,,,,2016-11-22T15:12:43Z,,3025,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3025/?format=pcsv
salcn,,,0,C13H18O7,[],,Salicin,,Salicin,,,,,2016-11-22T15:12:37Z,,3026,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3026/?format=pcsv
sulfac,,,-2,C2H2O5S,[],,sulfoacetate,,sulfoacetate,,,,,2016-11-22T15:12:37Z,,3027,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3027/?format=pcsv
zn2,,,2,Zn,[],,Zinc,,Zinc,,,,,2016-11-22T15:12:44Z,,3028,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3028/?format=pcsv
fa4,,,-1,C15H29O2,[],,Fatty acid (Anteiso-C15:0),,Fatty acid (Anteiso-C15:0),,,,,2016-11-22T15:12:41Z,,3029,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3029/?format=pcsv
fa12,,,-1,C17H33O2,[],,Fatty acid (Anteiso-C17:0),,Fatty acid (Anteiso-C17:0),,,,,2016-11-22T15:12:41Z,,3030,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3030/?format=pcsv
fa1,,,-1,C14H27O2,[],,Fatty acid (Iso-C14:0),,Fatty acid (Iso-C14:0),,,,,2016-11-22T15:12:41Z,,3031,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3031/?format=pcsv
fa3,,,-1,C15H29O2,[],,Fatty acid (Iso-C15:0),,Fatty acid (Iso-C15:0),,,,,2016-11-22T15:12:41Z,,3032,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3032/?format=pcsv
fa6,,,-1,C16H31O2,[],,Fatty acid (iso-C16:0),,Fatty acid (iso-C16:0),,,,,2016-11-22T15:12:41Z,,3033,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3033/?format=pcsv
fa11,,,-1,C17H33O2,[],,Fatty acid (Iso-C17:0),,Fatty acid (Iso-C17:0),,,,,2016-11-22T15:12:41Z,,3034,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3034/?format=pcsv
s17bp,,,-4,C7H12O13P2,[],,"Sedoheptulose 1,7-bisphosphate",,"Sedoheptulose 1,7-bisphosphate",,,,,2016-11-22T15:12:43Z,,3035,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3035/?format=pcsv
fcl_L,,,0,C6H12O5,[],,L-fuculose,,L-fuculose,,,,,2016-11-22T15:12:41Z,,3036,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3036/?format=pcsv
fc1p,,,-2,C6H11O8P,[],,L-Fuculose 1-phosphate,,L-Fuculose 1-phosphate,,,,,2016-11-22T15:12:41Z,,3037,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3037/?format=pcsv
fmnh2,,,-2,C17H21N4O9P,[],,Reduced FMN,,Reduced FMN,,,,,2016-11-22T15:12:34Z,,3038,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3038/?format=pcsv
btal,,,0,C4H8O,[],,Butanal,,Butanal,,,,,2016-11-22T15:12:32Z,,3039,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3039/?format=pcsv
hxal,,,0,C6H12O,[],,hexanal,,hexanal,,,,,2016-11-22T15:12:42Z,,3040,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3040/?format=pcsv
suc6p,,,-2,C12H21O14P,[],,Sucrose 6-phosphate,,Sucrose 6-phosphate,,,,,2016-11-22T15:12:43Z,,3041,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3041/?format=pcsv
frmd,,,0,CH3NO,16397,,Formamide,,Formamide,,,,,2016-11-22T15:12:34Z,,3042,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3042/?format=pcsv
2ahhmd,,,-3,C7H8N5O8P2,[],,"2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine diphosphate",,"2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine diphosphate",,,,,2016-11-22T15:12:29Z,,3043,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3043/?format=pcsv
thfglu,,,-3,C24H27N8O9,[],,Tetrahydrofolyl-[Glu](2),,Tetrahydrofolyl-[Glu](2),,,,,2016-11-22T15:12:37Z,,3044,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3044/?format=pcsv
fdxrd,,,0,XH2,[],,Reduced ferredoxin,,Reduced ferredoxin,,,,,2016-11-22T15:12:41Z,,3045,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3045/?format=pcsv
fdxox,,,0,X,[],,Oxidized ferredoxin,,Oxidized ferredoxin,,,,,2016-11-22T15:12:41Z,,3046,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3046/?format=pcsv
g15lac,,,0,C6H10O6,[],,Gluconolactone,,Gluconolactone,,,,,2016-11-22T15:12:41Z,,3047,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3047/?format=pcsv
gam1p,,,-1,C6H13NO8P,[],,D-Glucosamine 1-phosphate,,D-Glucosamine 1-phosphate,,,,,2016-11-22T15:12:41Z,,3048,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3048/?format=pcsv
glu1sa,,,0,C5H9NO3,[],,L-Glutamate 1-semialdehyde,,L-Glutamate 1-semialdehyde,,,,,2016-11-22T15:12:41Z,,3049,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3049/?format=pcsv
5dh4dglc,,,-2,C6H6O7,[],,5-Dehydro-4-deoxy-D-glucarate,,5-Dehydro-4-deoxy-D-glucarate,,,,,2016-11-22T15:12:39Z,,3050,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3050/?format=pcsv
galt1p,,,-2,C6H13O9P,[],,Galactitol 1-phosphate,,Galactitol 1-phosphate,,,,,2016-11-22T15:12:41Z,,3051,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3051/?format=pcsv
ggbutal,,,0,C9H16O4N2,[],,gamma-glutamyl-gamma-butyraldehyde,,gamma-glutamyl-gamma-butyraldehyde,,,,,2016-11-22T15:12:34Z,,3052,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3052/?format=pcsv
gg4abut,,,-1,C9H15O5N2,[],,gamma-glutamyl-gamma aminobutyric acid,,gamma-glutamyl-gamma aminobutyric acid,,,,,2016-11-22T15:12:34Z,,3053,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3053/?format=pcsv
glycogen,,,0,C6H10O5,[],,glycogen,,glycogen,,,,,2016-11-22T15:12:34Z,,3054,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3054/?format=pcsv
icolipa,,,-11,C145H251N2O74P4,[],,inner core oligosaccharide lipid A (E coli),,inner core oligosaccharide lipid A (E coli),,,,,2016-11-22T15:12:34Z,,3055,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3055/?format=pcsv
gicolipa,,,-11,C151H261N2O79P4,[],,glucosyl-inner core oligosaccharide lipid A,,glucosyl-inner core oligosaccharide lipid A,,,,,2016-11-22T15:12:34Z,,3056,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3056/?format=pcsv
uaaAgla,,,-3,C94H153N8O26P2,[],,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutamyl-L-lysyl-D-alanyl-D-alanine,,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutamyl-L-lysyl-D-alanyl-D-alanine,,,,,2016-11-22T15:12:37Z,,3057,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3057/?format=pcsv
uaaAgtla,,,-2,C94H155N9O25P2,[],,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutaminyl-L-lysyl-D-alanyl-D-alanine,,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutaminyl-L-lysyl-D-alanyl-D-alanine,,,,,2016-11-22T15:12:37Z,,3058,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3058/?format=pcsv
uaaGgla,,,-3,C94H153N8O26P2,[],,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine,,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine,,,,,2016-11-22T15:12:44Z,,3059,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3059/?format=pcsv
uaaGgtla,,,-2,C94H155N9O25P2,[],,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-D-alanyl-D-alanine,,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-D-alanyl-D-alanine,,,,,2016-11-22T15:12:44Z,,3060,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3060/?format=pcsv
uaagmda,,,-4,C95H152N8O28P2,[],,"Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-ala-D-glu-meso-2,6-diaminopimeloyl-D-ala-D-ala",,"Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-ala-D-glu-meso-2,6-diaminopimeloyl-D-ala-D-ala",,,,,2016-11-22T15:12:37Z,,3061,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3061/?format=pcsv
uaagtmda,,,-3,C95H154N9O27P2,[],,"Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutaminyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",,"Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutaminyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",,,,,2016-11-22T15:12:37Z,,3062,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3062/?format=pcsv
tag6p_D,,,-2,C6H11O9P,[],,D-Tagatose 6-phosphate,,D-Tagatose 6-phosphate,,,,,2016-11-22T15:12:43Z,,3063,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3063/?format=pcsv
glu_D,,,-1,C5H8NO4,[],,D-Glutamate,,D-Glutamate,,,,,2016-11-22T15:12:41Z,,3064,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3064/?format=pcsv
glutrna,,,0,C5H7NO3R,[],,L-Glutamyl-tRNA(Glu),,L-Glutamyl-tRNA(Glu),,,,,2016-11-22T15:12:34Z,,3065,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3065/?format=pcsv
trnaglu,,,0,R,[],,tRNA (Glu),,tRNA (Glu),,,,,2016-11-22T15:12:44Z,,3066,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3066/?format=pcsv
gmhep1p,,,-2,C7H13O10P,[],,D-Glycero-D-manno-heptose 1-phosphate,,D-Glycero-D-manno-heptose 1-phosphate,,,,,2016-11-22T15:12:41Z,,3067,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3067/?format=pcsv
gmhep7p,,,-2,C7H13O10P,[],,D-Glycero-D-manno-heptose 7-phosphate,,D-Glycero-D-manno-heptose 7-phosphate,,,,,2016-11-22T15:12:42Z,,3068,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3068/?format=pcsv
gmhep17bp,,,-4,C7H12O13P2,[],,"D-Glycero-D-manno-heptose 1,7-bisphosphate",,"D-Glycero-D-manno-heptose 1,7-bisphosphate",,,,,2016-11-22T15:12:41Z,,3069,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3069/?format=pcsv
g3pe,,,0,C5H14NO6P,[],,sn-Glycero-3-phosphoethanolamine,,sn-Glycero-3-phosphoethanolamine,,,,,2016-11-22T15:12:34Z,,3070,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3070/?format=pcsv
g3pg,,,-1,C6H14O8P,[],,Glycerophosphoglycerol,,Glycerophosphoglycerol,,,,,2016-11-22T15:12:34Z,,3071,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3071/?format=pcsv
gdptp,,,-7,C10H11N5O20P5,[],,Guanosine 3-diphosphate 5-triphosphate,,Guanosine 3-diphosphate 5-triphosphate,,,,,2016-11-22T15:12:34Z,,3072,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3072/?format=pcsv
ppgpp,,,-6,C10H11N5O17P4,[],,"Guanosine 3,5-bis(diphosphate)",,"Guanosine 3,5-bis(diphosphate)",,,,,2016-11-22T15:12:36Z,,3073,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3073/?format=pcsv
fruur,,,-1,C6H9O7,[],,D-Fructuronate,,D-Fructuronate,,,,,2016-11-22T15:12:41Z,,3074,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3074/?format=pcsv
tagur,,,-1,C6H9O7,[],,D-Tagaturonate,,D-Tagaturonate,,,,,2016-11-22T15:12:43Z,,3075,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3075/?format=pcsv
3hadpcoa,,,-5,C27H39N7O20P3S,[],,(3S)-3-Hydroxyadipyl-CoA,,(3S)-3-Hydroxyadipyl-CoA,,,,,2016-11-22T15:12:39Z,,3076,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3076/?format=pcsv
oxadpcoa,,,-5,C27H37N7O20P3S,[],,3-Oxoadipyl-CoA,,3-Oxoadipyl-CoA,,,,,2016-11-22T15:12:35Z,,3077,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3077/?format=pcsv
3ophb,,,-1,C47H69O3,[],,3-Octaprenyl-4-hydroxybenzoate,,3-Octaprenyl-4-hydroxybenzoate,,,,,2016-11-22T15:12:30Z,,3078,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3078/?format=pcsv
hemeO,,,-2,C49H56FeN4O5,[],,Heme O,,Heme O,,,,,2016-11-22T15:12:34Z,,3079,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3079/?format=pcsv
hlipa,,,-6,C117H208N2O45P2,[],,heptosyl-kdo2-lipidA,,heptosyl-kdo2-lipidA,,,,,2016-11-22T15:12:34Z,,3080,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3080/?format=pcsv
hhlipa,,,-6,C124H220N2O51P2,[],,heptosyl-heptosyl-kdo2-lipidA,,heptosyl-heptosyl-kdo2-lipidA,,,,,2016-11-22T15:12:34Z,,3081,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3081/?format=pcsv
phhlipa,,,-8,C124H219N2O54P3,[],,phospho-heptosyl-heptosyl-kdo2-lipidA,,phospho-heptosyl-heptosyl-kdo2-lipidA,,,,,2016-11-22T15:12:36Z,,3082,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3082/?format=pcsv
hphhlipa,,,-8,C131H231N2O60P3,[],,heptosyl-phospho-heptosyl-heptosyl-kdo2-lipidA,,heptosyl-phospho-heptosyl-heptosyl-kdo2-lipidA,,,,,2016-11-22T15:12:34Z,,3083,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3083/?format=pcsv
4mhetz,,,0,C6H9NOS,[],,4-Methyl-5-(2-hydroxyethyl)-thiazole,,4-Methyl-5-(2-hydroxyethyl)-thiazole,,,,,2016-11-22T15:12:31Z,,3084,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3084/?format=pcsv
4mpetz,,,-2,C6H8NO4PS,[],,4-Methyl-5-(2-phosphoethyl)-thiazole,,4-Methyl-5-(2-phosphoethyl)-thiazole,,,,,2016-11-22T15:12:31Z,,3085,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3085/?format=pcsv
2ohed,,,-2,C7H6O5,1254,,"2-Oxohept-3-ene-1,7-dioate",,"2-Oxohept-3-ene-1,7-dioate",,,,,2016-11-22T15:12:39Z,,3086,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3086/?format=pcsv
histd,,,1,C6H12N3O,[],,L-Histidinol,,L-Histidinol,,,,,2016-11-22T15:12:34Z,,3087,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3087/?format=pcsv
hisp,,,-1,C6H11N3O4P,[],,L-Histidinol phosphate,,L-Histidinol phosphate,,,,,2016-11-22T15:12:34Z,,3088,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3088/?format=pcsv
hkmpp,,,-2,C6H9O6PS,50605,,2-Hydroxy-3-keto-5-methylthiopentenyl-1-phosphate,,2-Hydroxy-3-keto-5-methylthiopentenyl-1-phosphate,,,,,2016-11-22T15:12:42Z,,3089,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3089/?format=pcsv
hkndd,,,-2,C9H8O6,[],,"2-Hydroxy-6-oxonona-2,4-diene-1,9-dioate",,"2-Hydroxy-6-oxonona-2,4-diene-1,9-dioate",,,,,2016-11-22T15:12:34Z,,3090,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3090/?format=pcsv
op4en,,,-1,C5H5O3,[],,2-Oxopent-4-enoate,,2-Oxopent-4-enoate,,,,,2016-11-22T15:12:35Z,,3091,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3091/?format=pcsv
4h2opntn,,,-1,C5H7O4,[],,4-Hydroxy-2-oxopentanoate,,4-Hydroxy-2-oxopentanoate,,,,,2016-11-22T15:12:39Z,,3092,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3092/?format=pcsv
suchms,,,-1,C8H12NO6,[],,O-Succinyl-L-homoserine,,O-Succinyl-L-homoserine,,,,,2016-11-22T15:12:37Z,,3093,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3093/?format=pcsv
imacp,,,-2,C6H7N2O5P,[],,3-(Imidazol-4-yl)-2-oxopropyl phosphate,,3-(Imidazol-4-yl)-2-oxopropyl phosphate,,,,,2016-11-22T15:12:34Z,,3094,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3094/?format=pcsv
12daihdglyc,,,0,C37H72O5,[],,"1,2-Dianteisoheptadecanoyl-sn-glycerol",,"1,2-Dianteisoheptadecanoyl-sn-glycerol",,,,,2016-11-22T15:12:28Z,,3095,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3095/?format=pcsv
12daipdglyc,,,0,C33H64O5,[],,"1,2-Dianteisopentadecanoyl-sn-glycerol",,"1,2-Dianteisopentadecanoyl-sn-glycerol",,,,,2016-11-22T15:12:28Z,,3096,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3096/?format=pcsv
ichor,,,-2,C10H8O6,[],,Isochorismate,,Isochorismate,,,,,2016-11-22T15:12:42Z,,3097,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3097/?format=pcsv
prlp,,,-4,C15H21N5O15P2,[],,5-[(5-phospho-1-deoxyribulos-1-ylamino)methylideneamino]-1-(5-phosphoribosyl)imidazole-4-carboxamide,,5-[(5-phospho-1-deoxyribulos-1-ylamino)methylideneamino]-1-(5-phosphoribosyl)imidazole-4-carboxamide,,,,,2016-11-22T15:12:43Z,,3098,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3098/?format=pcsv
eig3p,,,-2,C6H9N2O6P,[],,D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate,,D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate,,,,,2016-11-22T15:12:33Z,,3099,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3099/?format=pcsv
2cpr5p,,,-3,C12H13NO9P,[],,1-(2-Carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate,,1-(2-Carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate,,,,,2016-11-22T15:12:29Z,,3100,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3100/?format=pcsv
3ig3p,,,-2,C11H12NO6P,[],,C-(3-Indolyl)-glycerol 3-phosphate,,C-(3-Indolyl)-glycerol 3-phosphate,,,,,2016-11-22T15:12:30Z,,3101,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3101/?format=pcsv
12dihdglyc,,,0,C37H72O5,[],,"1,2-Diisoheptadecanoyl-sn-glycerol",,"1,2-Diisoheptadecanoyl-sn-glycerol",,,,,2016-11-22T15:12:38Z,,3102,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3102/?format=pcsv
12dixdglyc,,,0,C35H68O5,[],,"1,2-Diisohexadecanoyl-sn-glycerol",,"1,2-Diisohexadecanoyl-sn-glycerol",,,,,2016-11-22T15:12:38Z,,3103,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3103/?format=pcsv
12dipdglyc,,,0,C33H64O5,[],,"1,2-Diisopentadecanoyl-sn-glycerol",,"1,2-Diisopentadecanoyl-sn-glycerol",,,,,2016-11-22T15:12:38Z,,3104,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3104/?format=pcsv
3c2hmp,,,-2,C7H10O5,[],,3-Carboxy-2-hydroxy-4-methylpentanoate,,3-Carboxy-2-hydroxy-4-methylpentanoate,,,,,2016-11-22T15:12:30Z,,3105,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3105/?format=pcsv
3c4mop,,,-2,C7H8O5,[],,3-Carboxy-4-methyl-2-oxopentanoate,,3-Carboxy-4-methyl-2-oxopentanoate,,,,,2016-11-22T15:12:30Z,,3106,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3106/?format=pcsv
2ippm,,,-2,C7H8O4,[],,2-Isopropylmaleate,,2-Isopropylmaleate,,,,,2016-11-22T15:12:30Z,,3107,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3107/?format=pcsv
12ditdglyc,,,0,C31H60O5,[],,"1,2-Diisotetradecanoyl-sn-glycerol",,"1,2-Diisotetradecanoyl-sn-glycerol",,,,,2016-11-22T15:12:38Z,,3108,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3108/?format=pcsv
kdo,,,-1,C8H13O8,[],,3-Deoxy-D-manno-2-octulosonate,,3-Deoxy-D-manno-2-octulosonate,,,,,2016-11-22T15:12:35Z,,3109,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3109/?format=pcsv
kdo8p,,,-3,C8H12O11P,[],,3-Deoxy-D-manno-octulosonate 8-phosphate,,3-Deoxy-D-manno-octulosonate 8-phosphate,,,,,2016-11-22T15:12:35Z,,3110,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3110/?format=pcsv
xu5p_L,,,-2,C5H9O8P,[],,L-Xylulose 5-phosphate,,L-Xylulose 5-phosphate,,,,,2016-11-22T15:12:44Z,,3111,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3111/?format=pcsv
l2a6o,,,-1,C7H10NO5,[],,L-2-Amino-6-oxopimelate,,L-2-Amino-6-oxopimelate,,,,,2016-11-22T15:12:35Z,,3112,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3112/?format=pcsv
Largn,,,-1,C10H12NO5,17530,,L-Arogenate,,L-Arogenate,,,,,2016-11-22T15:12:35Z,,3113,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3113/?format=pcsv
pphn,,,-2,C10H8O6,[],,Prephenate,,Prephenate,,,,,2016-11-22T15:12:43Z,,3114,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3114/?format=pcsv
lipidX,,,-2,C34H64NO12P,[],,"2,3-Bis(3-hydroxytetradecanoyl)-beta-D-glucosaminyl 1-phosphate",,"2,3-Bis(3-hydroxytetradecanoyl)-beta-D-glucosaminyl 1-phosphate",,,,,2016-11-22T15:12:35Z,,3115,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3115/?format=pcsv
u23ga,,,-2,C43H75N3O20P2,[],,"UDP-2,3-bis(3-hydroxytetradecanoyl)glucosamine",,"UDP-2,3-bis(3-hydroxytetradecanoyl)glucosamine",,,,,2016-11-22T15:12:37Z,,3116,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3116/?format=pcsv
lipidAds,,,-2,C68H127N2O20P,[],,Lipid A Disaccharide,,Lipid A Disaccharide,,,,,2016-11-22T15:12:35Z,,3117,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3117/?format=pcsv
adhlam,,,0,C10H19NO2S2,[],,S-Acetyldihydrolipoamide,,S-Acetyldihydrolipoamide,,,,,2016-11-22T15:12:40Z,,3118,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3118/?format=pcsv
1agpe120,,,0,C17H36NO7P1,[],,1-Acyl-sn-glycero-3-phosphoethanolamine (n-C12:0),,1-Acyl-sn-glycero-3-phosphoethanolamine (n-C12:0),,,,,2016-11-22T15:12:28Z,,3119,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3119/?format=pcsv
1agpe140,,,0,C19H40NO7P1,[],,1-Acyl-sn-glycero-3-phosphoethanolamine (n-C14:0),,1-Acyl-sn-glycero-3-phosphoethanolamine (n-C14:0),,,,,2016-11-22T15:12:29Z,,3120,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3120/?format=pcsv
1agpe141,,,0,C19H38NO7P1,[],,1-Acyl-sn-glycero-3-phosphoethanolamine (n-C14:1),,1-Acyl-sn-glycero-3-phosphoethanolamine (n-C14:1),,,,,2016-11-22T15:12:29Z,,3121,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3121/?format=pcsv
1agpe160,,,0,C21H44NO7P1,[],,1-Acyl-sn-glycero-3-phosphoethanolamine (n-C16:0),,1-Acyl-sn-glycero-3-phosphoethanolamine (n-C16:0),,,,,2016-11-22T15:12:29Z,,3122,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3122/?format=pcsv
1agpe161,,,0,C21H42NO7P1,[],,1-Acyl-sn-glycero-3-phosphoethanolamine (n-C16:1),,1-Acyl-sn-glycero-3-phosphoethanolamine (n-C16:1),,,,,2016-11-22T15:12:29Z,,3123,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3123/?format=pcsv
1agpe180,,,0,C23H48NO7P1,[],,1-Acyl-sn-glycero-3-phosphoethanolamine (n-C18:0),,1-Acyl-sn-glycero-3-phosphoethanolamine (n-C18:0),,,,,2016-11-22T15:12:29Z,,3124,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3124/?format=pcsv
1agpe181,,,0,C23H46NO7P1,[],,1-Acyl-sn-glycero-3-phosphoethanolamine (n-C18:1),,1-Acyl-sn-glycero-3-phosphoethanolamine (n-C18:1),,,,,2016-11-22T15:12:29Z,,3125,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3125/?format=pcsv
1agpg120,,,-1,C18H36O9P1,[],,1-Acyl-sn-glycero-3-phosphoglycerol (n-C12:0),,1-Acyl-sn-glycero-3-phosphoglycerol (n-C12:0),,,,,2016-11-22T15:12:29Z,,3126,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3126/?format=pcsv
1agpg140,,,-1,C20H40O9P1,[],,1-Acyl-sn-glycero-3-phosphoglycerol (n-C14:0),,1-Acyl-sn-glycero-3-phosphoglycerol (n-C14:0),,,,,2016-11-22T15:12:29Z,,3127,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3127/?format=pcsv
1agpg141,,,-1,C20H38O9P1,[],,1-Acyl-sn-glycero-3-phosphoglycerol (n-C14:1),,1-Acyl-sn-glycero-3-phosphoglycerol (n-C14:1),,,,,2016-11-22T15:12:29Z,,3128,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3128/?format=pcsv
1agpg160,,,-1,C22H44O9P1,[],,1-Acyl-sn-glycero-3-phosphoglycerol (n-C16:0),,1-Acyl-sn-glycero-3-phosphoglycerol (n-C16:0),,,,,2016-11-22T15:12:29Z,,3129,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3129/?format=pcsv
1agpg161,,,-1,C22H42O9P1,[],,1-Acyl-sn-glycero-3-phosphoglycerol (n-C16:1),,1-Acyl-sn-glycero-3-phosphoglycerol (n-C16:1),,,,,2016-11-22T15:12:29Z,,3130,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3130/?format=pcsv
1agpg180,,,-1,C24H48O9P1,[],,1-Acyl-sn-glycero-3-phosphoglycerol (n-C18:0),,1-Acyl-sn-glycero-3-phosphoglycerol (n-C18:0),,,,,2016-11-22T15:12:29Z,,3131,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3131/?format=pcsv
1agpg181,,,-1,C24H46O9P1,[],,1-Acyl-sn-glycero-3-phosphoglycerol (n-C18:1),,1-Acyl-sn-glycero-3-phosphoglycerol (n-C18:1),,,,,2016-11-22T15:12:29Z,,3132,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3132/?format=pcsv
2ddecg3p,,,-1,C15H30O7P1,[],,2-dodecanoyl-sn-glycerol 3-phosphate,,2-dodecanoyl-sn-glycerol 3-phosphate,,,,,2016-11-22T15:12:29Z,,3133,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3133/?format=pcsv
2tdecg3p,,,-1,C17H34O7P1,[],,2-tetradecanoyl-sn-glycerol 3-phosphate,,2-tetradecanoyl-sn-glycerol 3-phosphate,,,,,2016-11-22T15:12:30Z,,3134,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3134/?format=pcsv
2tdec7eg3p,,,-1,C17H32O7P1,[],,2-tetradec-7-enoyl-sn-glycerol 3-phosphate,,2-tetradec-7-enoyl-sn-glycerol 3-phosphate,,,,,2016-11-22T15:12:30Z,,3135,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3135/?format=pcsv
2hdecg3p,,,-1,C19H38O7P1,[],,2-hexadecanoyl-sn-glycerol 3-phosphate,,2-hexadecanoyl-sn-glycerol 3-phosphate,,,,,2016-11-22T15:12:30Z,,3136,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3136/?format=pcsv
2hdec9eg3p,,,-1,C19H36O7P1,[],,2-hexadec-9-enoyl-sn-glycerol 3-phosphate,,2-hexadec-9-enoyl-sn-glycerol 3-phosphate,,,,,2016-11-22T15:12:29Z,,3137,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3137/?format=pcsv
2odecg3p,,,-1,C21H42O7P1,[],,2-octadecanoyl-sn-glycerol 3-phosphate,,2-octadecanoyl-sn-glycerol 3-phosphate,,,,,2016-11-22T15:12:30Z,,3138,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3138/?format=pcsv
2odec11eg3p,,,-1,C21H40O7P1,[],,2-octadec-11-enoyl-sn-glycerol 3-phosphate,,2-octadec-11-enoyl-sn-glycerol 3-phosphate,,,,,2016-11-22T15:12:30Z,,3139,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3139/?format=pcsv
2agpe120,,,0,C17H36NO7P1,[],,2-Acyl-sn-glycero-3-phosphoethanolamine (n-C12:0),,2-Acyl-sn-glycero-3-phosphoethanolamine (n-C12:0),,,,,2016-11-22T15:12:38Z,,3140,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3140/?format=pcsv
2agpe140,,,0,C19H40NO7P1,[],,2-Acyl-sn-glycero-3-phosphoethanolamine (n-C14:0),,2-Acyl-sn-glycero-3-phosphoethanolamine (n-C14:0),,,,,2016-11-22T15:12:38Z,,3141,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3141/?format=pcsv
2agpe141,,,0,C19H38NO7P1,[],,2-Acyl-sn-glycero-3-phosphoethanolamine (n-C14:1),,2-Acyl-sn-glycero-3-phosphoethanolamine (n-C14:1),,,,,2016-11-22T15:12:38Z,,3142,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3142/?format=pcsv
2agpe160,,,0,C21H44NO7P1,[],,2-Acyl-sn-glycero-3-phosphoethanolamine (n-C16:0),,2-Acyl-sn-glycero-3-phosphoethanolamine (n-C16:0),,,,,2016-11-22T15:12:38Z,,3143,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3143/?format=pcsv
2agpe161,,,0,C21H42NO7P1,[],,2-Acyl-sn-glycero-3-phosphoethanolamine (n-C16:1),,2-Acyl-sn-glycero-3-phosphoethanolamine (n-C16:1),,,,,2016-11-22T15:12:38Z,,3144,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3144/?format=pcsv
2agpe180,,,0,C23H48NO7P1,[],,2-Acyl-sn-glycero-3-phosphoethanolamine (n-C18:0),,2-Acyl-sn-glycero-3-phosphoethanolamine (n-C18:0),,,,,2016-11-22T15:12:38Z,,3145,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3145/?format=pcsv
2agpe181,,,0,C23H46NO7P1,[],,2-Acyl-sn-glycero-3-phosphoethanolamine (n-C18:1),,2-Acyl-sn-glycero-3-phosphoethanolamine (n-C18:1),,,,,2016-11-22T15:12:38Z,,3146,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3146/?format=pcsv
2agpg120,,,-1,C18H36O9P1,[],,2-Acyl-sn-glycero-3-phosphoglycerol (n-C12:0),,2-Acyl-sn-glycero-3-phosphoglycerol (n-C12:0),,,,,2016-11-22T15:12:38Z,,3147,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3147/?format=pcsv
2agpg140,,,-1,C20H40O9P1,[],,2-Acyl-sn-glycero-3-phosphoglycerol (n-C14:0),,2-Acyl-sn-glycero-3-phosphoglycerol (n-C14:0),,,,,2016-11-22T15:12:38Z,,3148,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3148/?format=pcsv
2agpg141,,,-1,C20H38O9P1,[],,2-Acyl-sn-glycero-3-phosphoglycerol (n-C14:1),,2-Acyl-sn-glycero-3-phosphoglycerol (n-C14:1),,,,,2016-11-22T15:12:38Z,,3149,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3149/?format=pcsv
2agpg160,,,-1,C22H44O9P1,[],,2-Acyl-sn-glycero-3-phosphoglycerol (n-C16:0),,2-Acyl-sn-glycero-3-phosphoglycerol (n-C16:0),,,,,2016-11-22T15:12:38Z,,3150,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3150/?format=pcsv
2agpg161,,,-1,C22H42O9P1,[],,2-Acyl-sn-glycero-3-phosphoglycerol (n-C16:1),,2-Acyl-sn-glycero-3-phosphoglycerol (n-C16:1),,,,,2016-11-22T15:12:38Z,,3151,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3151/?format=pcsv
2agpg180,,,-1,C24H48O9P1,[],,2-Acyl-sn-glycero-3-phosphoglycerol (n-C18:0),,2-Acyl-sn-glycero-3-phosphoglycerol (n-C18:0),,,,,2016-11-22T15:12:38Z,,3152,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3152/?format=pcsv
2agpg181,,,-1,C24H46O9P1,[],,2-Acyl-sn-glycero-3-phosphoglycerol (n-C18:1),,2-Acyl-sn-glycero-3-phosphoglycerol (n-C18:1),,,,,2016-11-22T15:12:38Z,,3153,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3153/?format=pcsv
thrp,,,-2,C4H8NO6P,[],,L-Threonine O-3-phosphate,,L-Threonine O-3-phosphate,,,,,2016-11-22T15:12:44Z,,3154,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3154/?format=pcsv
mnl1p,,,-2,C6H13O9P,[],,D-Mannitol 1-phosphate,,D-Mannitol 1-phosphate,,,,,2016-11-22T15:12:42Z,,3155,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3155/?format=pcsv
madg,,,0,C7H14O6,[],,alpha-Methyl-D-glucoside,,alpha-Methyl-D-glucoside,,,,,2016-11-22T15:12:35Z,,3156,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3156/?format=pcsv
mal_D,,,-2,C4H4O5,[],,D-Malate,,D-Malate,,,,,2016-11-22T15:12:42Z,,3157,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3157/?format=pcsv
malt6p,,,-2,C12H21O14P,[],,Maltose 6-phosphate,,Maltose 6-phosphate,,,,,2016-11-22T15:12:42Z,,3158,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3158/?format=pcsv
acmalt,,,0,C14H24O12,[],,Acetyl-maltose,,Acetyl-maltose,,,,,2016-11-22T15:12:31Z,,3159,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3159/?format=pcsv
mantr,,,0,C18H32O16,[],,"mannotriose (beta-1,4)",,"mannotriose (beta-1,4)",,,,,2016-11-22T15:12:42Z,,3160,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3160/?format=pcsv
mbdg,,,0,C7H14O6,[],,beta-Methylglucoside,,beta-Methylglucoside,,,,,2016-11-22T15:12:42Z,,3161,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3161/?format=pcsv
5mtc,,,0,C5H7N3O,[],,5-Methylcytosine,,5-Methylcytosine,,,,,2016-11-22T15:12:31Z,,3162,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3162/?format=pcsv
2mecdp,,,-2,C5H10O9P2,[],,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate",,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate",,,,,2016-11-22T15:12:30Z,,3163,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3163/?format=pcsv
melt,,,-1,C9H9O3,[],,Melilotate,,Melilotate,,,,,2016-11-22T15:12:42Z,,3164,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3164/?format=pcsv
achms,,,0,C6H11NO4,[],,O-Acetyl-L-homoserine,,O-Acetyl-L-homoserine,,,,,2016-11-22T15:12:31Z,,3165,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3165/?format=pcsv
mana,,,-1,C6H11O7,[],,D-Mannonate,,D-Mannonate,,,,,2016-11-22T15:12:42Z,,3166,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3166/?format=pcsv
lipidA,,,-4,C68H126N2O23P2,[],,"2,3,23-Tetrakis(beta-hydroxymyristoyl)-D-glucosaminyl-1,6-beta-D-glucosamine 1,4-bisphosphate",,"2,3,23-Tetrakis(beta-hydroxymyristoyl)-D-glucosaminyl-1,6-beta-D-glucosamine 1,4-bisphosphate",,,,,2016-11-22T15:12:35Z,,3167,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3167/?format=pcsv
phphhlipa,,,-10,C131H230N2O63P4,[],,phospho-heptosyl-phospho-heptosyl-heptosyl-kdo2-lipidA,,phospho-heptosyl-phospho-heptosyl-heptosyl-kdo2-lipidA,,,,,2016-11-22T15:12:36Z,,3168,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3168/?format=pcsv
kphphhlipa,,,-11,C139H241N2O70P4,[],,kdo-phospho-heptosyl-phospho-heptosyl-heptosyl-kdo2-lipidA,,kdo-phospho-heptosyl-phospho-heptosyl-heptosyl-kdo2-lipidA,,,,,2016-11-22T15:12:35Z,,3169,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3169/?format=pcsv
5mtr,,,0,C6H12O4S,[],,5-Methylthio-D-ribose,,5-Methylthio-D-ribose,,,,,2016-11-22T15:12:31Z,,3170,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3170/?format=pcsv
mucl,,,-1,C6H5O4,18080,,mucolactone,,mucolactone,,,,,2016-11-22T15:12:42Z,,3171,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3171/?format=pcsv
dmbzid,,,0,C9H10N2,[],,"5,6-Dimethylbenzimidazole",,"5,6-Dimethylbenzimidazole",,,,,2016-11-22T15:12:33Z,,3172,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3172/?format=pcsv
5prdmbz,,,-2,C14H17N2O7P,[],,"N1-(5-Phospho-alpha-D-ribosyl)-5,6-dimethylbenzimidazole",,"N1-(5-Phospho-alpha-D-ribosyl)-5,6-dimethylbenzimidazole",,,,,2016-11-22T15:12:31Z,,3173,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3173/?format=pcsv
2oph,,,0,C46H70O,[],,2-Octaprenylphenol,,2-Octaprenylphenol,,,,,2016-11-22T15:12:30Z,,3174,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3174/?format=pcsv
2ohph,,,0,C46H70O2,[],,2-Octaprenyl-6-hydroxyphenol,,2-Octaprenyl-6-hydroxyphenol,,,,,2016-11-22T15:12:30Z,,3175,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3175/?format=pcsv
sbzcoa,,,-5,C32H39N7O20P3S,[],,O-Succinylbenzoyl-CoA,,O-Succinylbenzoyl-CoA,,,,,2016-11-22T15:12:37Z,,3176,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3176/?format=pcsv
14dhnptcoa,,,-4,C32H38N7O19P3S,52668,,"1,4-Dihydroxy-2-naphthoyl-CoA",,"1,4-Dihydroxy-2-naphthoyl-CoA",,,,,2016-11-17T15:26:25Z,,3177,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3177/?format=pcsv
ohpb,,,-3,C4H4O8P,[],,2-Oxo-3-hydroxy-4-phosphobutanoate,,2-Oxo-3-hydroxy-4-phosphobutanoate,,,,,2016-11-22T15:12:35Z,,3178,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3178/?format=pcsv
3oxoadp,,,-2,C6H6O5,37440,,3-Oxoadipate,,3-Oxoadipate,,,,,2016-11-22T15:12:39Z,,3179,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3179/?format=pcsv
uGgla,,,-3,C40H62N9O26P2,[],,UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine,,UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine,,,,,2016-11-22T15:12:38Z,,3180,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3180/?format=pcsv
uaGgla,,,-3,C86H140N7O21P2,[],,Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine,,Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine,,,,,2016-11-22T15:12:38Z,,3181,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3181/?format=pcsv
ugmda,,,-4,C41H61N9O28P2,[],,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",,,,,2016-11-22T15:12:38Z,,3182,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3182/?format=pcsv
uagmda,,,-4,C87H139N7O23P2,[],,"Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",,"Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",,,,,2016-11-22T15:12:38Z,,3183,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3183/?format=pcsv
pre4,,,-8,C44H44N4O17,[],,Precorrin 4,,Precorrin 4,,,,,2016-11-22T15:12:36Z,,3184,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3184/?format=pcsv
pre5,,,-8,C45H46N4O17,[],,Precorrin 5,,Precorrin 5,,,,,2016-11-22T15:12:36Z,,3185,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3185/?format=pcsv
pre3b,,,-6,C43H44N4O17,[],,Precorrin 3B,,Precorrin 3B,,,,,2016-11-22T15:12:36Z,,3186,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3186/?format=pcsv
dscl,,,-7,C42H41N4O16,[],,dihydrosirohydrochlorin,,dihydrosirohydrochlorin,,,,,2016-11-22T15:12:33Z,,3187,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3187/?format=pcsv
pre3a,,,-7,C43H43N4O16,[],,Precorrin 3 A,,Precorrin 3 A,,,,,2016-11-22T15:12:36Z,,3188,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3188/?format=pcsv
pre6a,,,-7,C44H47N4O16,[],,Precorrin 6A,,Precorrin 6A,,,,,2016-11-22T15:12:36Z,,3189,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3189/?format=pcsv
pre6b,,,-7,C44H49N4O16,[],,Precorrin 6B,,Precorrin 6B,,,,,2016-11-22T15:12:36Z,,3190,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3190/?format=pcsv
pre8,,,-7,C45H53N4O14,[],,Precorrin 8,,Precorrin 8,,,,,2016-11-22T15:12:37Z,,3191,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3191/?format=pcsv
hgbyr,,,-6,C45H54N4O14,[],,Hydrogenobyrinate,,Hydrogenobyrinate,,,,,2016-11-22T15:12:34Z,,3192,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3192/?format=pcsv
3a2opp,,,-1,C3H7NO5P,1449,,3-Amino-2-oxopropyl phosphate,,3-Amino-2-oxopropyl phosphate,,,,,2016-11-22T15:12:30Z,,3193,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3193/?format=pcsv
PGPm1,,,0,X,,,Peptidoglycan polymer (n-1 subunits),,Peptidoglycan polymer (n-1 subunits),,,,,2016-11-22T15:12:43Z,,3194,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3194/?format=pcsv
udcpdp,,,-3,C55H89O7P2,[],,Undecaprenyl diphosphate,,Undecaprenyl diphosphate,,,,,2016-11-22T15:12:38Z,,3195,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3195/?format=pcsv
PGP,,,0,C39H64N8O19X,,,Peptidoglycan polymer (n subunits),,Peptidoglycan polymer (n subunits),,,,,2016-11-22T15:12:36Z,,3196,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3196/?format=pcsv
tagdp_D,,,-4,C6H10O12P2,[],,"D-Tagatose 1,6-biphosphate",,"D-Tagatose 1,6-biphosphate",,,,,2016-11-22T15:12:43Z,,3197,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3197/?format=pcsv
pgp120,,,-3,C30H57O13P2,[],,"Phosphatidylglycerophosphate (didodecanoyl, n-C12:0)",,"Phosphatidylglycerophosphate (didodecanoyl, n-C12:0)",,,,,2016-11-22T15:12:36Z,,3198,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3198/?format=pcsv
pg120,,,-1,C30H58O10P1,[],,"Phosphatidylglycerol (didodecanoyl, n-C12:0)",,"Phosphatidylglycerol (didodecanoyl, n-C12:0)",,,,,2016-11-22T15:12:36Z,,3199,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3199/?format=pcsv
pgp140,,,-3,C34H65O13P2,[],,"Phosphatidylglycerophosphate (ditetradecanoyl, n-C14:0)",,"Phosphatidylglycerophosphate (ditetradecanoyl, n-C14:0)",,,,,2016-11-22T15:12:36Z,,3200,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3200/?format=pcsv
pgp141,,,-3,C34H61O13P2,[],,"Phosphatidylglycerophosphate (ditetradec-7-enoyl, n-C14:1)",,"Phosphatidylglycerophosphate (ditetradec-7-enoyl, n-C14:1)",,,,,2016-11-22T15:12:36Z,,3201,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3201/?format=pcsv
pg141,,,-1,C34H62O10P1,[],,"Phosphatidylglycerol (ditetradec-7-enoyl, n-C14:1)",,"Phosphatidylglycerol (ditetradec-7-enoyl, n-C14:1)",,,,,2016-11-22T15:12:36Z,,3202,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3202/?format=pcsv
pgp160,,,-3,C38H73O13P2,[],,"Phosphatidylglycerophosphate (dihexadecanoyl, n-C16:0)",,"Phosphatidylglycerophosphate (dihexadecanoyl, n-C16:0)",,,,,2016-11-22T15:12:36Z,,3203,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3203/?format=pcsv
pgp161,,,-3,C38H69O13P2,[],,"Phosphatidylglycerophosphate (dihexadec-9-enoyl, n-C16:1)",,"Phosphatidylglycerophosphate (dihexadec-9-enoyl, n-C16:1)",,,,,2016-11-22T15:12:36Z,,3204,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3204/?format=pcsv
pg161,,,-1,C38H70O10P1,[],,"Phosphatidylglycerol (dihexadec-9-enoyl, n-C16:1)",,"Phosphatidylglycerol (dihexadec-9-enoyl, n-C16:1)",,,,,2016-11-22T15:12:36Z,,3205,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3205/?format=pcsv
pgp180,,,-3,C42H81O13P2,[],,"Phosphatidylglycerophosphate (dioctadecanoyl, n-C18:0)",,"Phosphatidylglycerophosphate (dioctadecanoyl, n-C18:0)",,,,,2016-11-22T15:12:36Z,,3206,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3206/?format=pcsv
pgp181,,,-3,C42H77O13P2,[],,"Phosphatidylglycerophosphate (dioctadec-11-enoyl, n-C18:1)",,"Phosphatidylglycerophosphate (dioctadec-11-enoyl, n-C18:1)",,,,,2016-11-22T15:12:36Z,,3207,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3207/?format=pcsv
pg181,,,-1,C42H78O10P1,[],,"Phosphatidylglycerol (dioctadec-11-enoyl, n-C18:1)",,"Phosphatidylglycerol (dioctadec-11-enoyl, n-C18:1)",,,,,2016-11-22T15:12:36Z,,3208,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3208/?format=pcsv
pgpai15,,,-3,C36H69O13P2,[],,"Phosphatidylglycerophosphate (12-methyl-tetradecanoyl, anteiso-C15)",,"Phosphatidylglycerophosphate (12-methyl-tetradecanoyl, anteiso-C15)",,,,,2016-11-22T15:12:36Z,,3209,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3209/?format=pcsv
pgpai17,,,-3,C40H77O13P2,[],,"Phosphatidylglycerophosphate (14-methyl-hexadecanoyl, anteiso-C17)",,"Phosphatidylglycerophosphate (14-methyl-hexadecanoyl, anteiso-C17)",,,,,2016-11-22T15:12:36Z,,3210,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3210/?format=pcsv
pgpi14,,,-3,C34H65O13P2,[],,"Phosphatidylglycerophosphate (12-methyltridecanoyl, iso-C14)",,"Phosphatidylglycerophosphate (12-methyltridecanoyl, iso-C14)",,,,,2016-11-22T15:12:43Z,,3211,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3211/?format=pcsv
pgpi15,,,-3,C36H69O13P2,[],,"Phosphatidylglycerophosphate (13-methyltetradecanoyl, iso-C15)",,"Phosphatidylglycerophosphate (13-methyltetradecanoyl, iso-C15)",,,,,2016-11-22T15:12:43Z,,3212,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3212/?format=pcsv
pgpi16,,,-3,C38H73O13P2,[],,"Phosphatidylglycerophosphate (14-methylpentadecanoyl, iso-C16)",,"Phosphatidylglycerophosphate (14-methylpentadecanoyl, iso-C16)",,,,,2016-11-22T15:12:43Z,,3213,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3213/?format=pcsv
pgpi17,,,-3,C40H77O13P2,[],,"Phosphatidylglycerophosphate (15-methyl-hexadecanoyl, iso-C17)",,"Phosphatidylglycerophosphate (15-methyl-hexadecanoyl, iso-C17)",,,,,2016-11-22T15:12:43Z,,3214,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3214/?format=pcsv
amopbut_L,,,-2,C4H6NO7P,77851,,2-Amino-3-oxo-4-phosphonooxybutyrate,,2-Amino-3-oxo-4-phosphonooxybutyrate,,,,,2016-11-22T15:12:40Z,,3215,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3215/?format=pcsv
pe120,,,0,C29H58N1O8P1,[],,"phosphatidylethanolamine (didodecanoyl, n-C12:0)",,"phosphatidylethanolamine (didodecanoyl, n-C12:0)",,,,,2016-11-22T15:12:36Z,,3216,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3216/?format=pcsv
pe140,,,0,C33H66N1O8P1,[],,"phosphatidylethanolamine (ditetradecanoyl, n-C14:0)",,"phosphatidylethanolamine (ditetradecanoyl, n-C14:0)",,,,,2016-11-22T15:12:36Z,,3217,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3217/?format=pcsv
pe141,,,0,C33H62N1O8P1,[],,"phosphatidylethanolamine (ditetradec-7-enoyl, n-C14:1)",,"phosphatidylethanolamine (ditetradec-7-enoyl, n-C14:1)",,,,,2016-11-22T15:12:36Z,,3218,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3218/?format=pcsv
pe160,,,0,C37H74N1O8P1,[],,"phosphatidylethanolamine (dihexadecanoyl, n-C16:0)",,"phosphatidylethanolamine (dihexadecanoyl, n-C16:0)",,,,,2016-11-22T15:12:36Z,,3219,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3219/?format=pcsv
pe161,,,0,C37H70N1O8P1,[],,"phosphatidylethanolamine (dihexadec-9enoyl, n-C16:1)",,"phosphatidylethanolamine (dihexadec-9enoyl, n-C16:1)",,,,,2016-11-22T15:12:36Z,,3220,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3220/?format=pcsv
pe180,,,0,C41H82N1O8P1,[],,"phosphatidylethanolamine (dioctadecanoyl, n-C18:0)",,"phosphatidylethanolamine (dioctadecanoyl, n-C18:0)",,,,,2016-11-22T15:12:36Z,,3221,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3221/?format=pcsv
pe181,,,0,C41H78N1O8P1,[],,"phosphatidylethanolamine (dioctadec-11-enoyl, n-C18:1)",,"phosphatidylethanolamine (dioctadec-11-enoyl, n-C18:1)",,,,,2016-11-22T15:12:36Z,,3222,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3222/?format=pcsv
ppap,,,-2,C3H5O5P,[],,Propanoyl phosphate,,Propanoyl phosphate,,,,,2016-11-22T15:12:36Z,,3223,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3223/?format=pcsv
prbamp,,,-4,C15H19N5O14P2,[],,1-(5-Phosphoribosyl)-AMP,,1-(5-Phosphoribosyl)-AMP,,,,,2016-11-22T15:12:36Z,,3224,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3224/?format=pcsv
prfp,,,-4,C15H21N5O15P2,[],,1-(5-Phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino]imidazole-4-carboxamide,,1-(5-Phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino]imidazole-4-carboxamide,,,,,2016-11-22T15:12:37Z,,3225,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3225/?format=pcsv
rb15bp,,,-4,C5H8O11P2,[],,"D-Ribulose 1,5-bisphosphate",,"D-Ribulose 1,5-bisphosphate",,,,,2016-11-22T15:12:37Z,,3226,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3226/?format=pcsv
skm5p,,,-3,C7H8O8P,[],,Shikimate 5-phosphate,,Shikimate 5-phosphate,,,,,2016-11-22T15:12:37Z,,3227,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3227/?format=pcsv
ps120,,,-1,C30H57N1O10P1,0,,"phosphatidylserine (didodecanoyl, n-C12:0)",,"phosphatidylserine (didodecanoyl, n-C12:0)",,,,,2016-11-22T15:12:37Z,,3228,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3228/?format=pcsv
ps140,,,-1,C34H65N1O10P1,[],,"phosphatidylserine (ditetradecanoyl, n-C14:0)",,"phosphatidylserine (ditetradecanoyl, n-C14:0)",,,,,2016-11-22T15:12:37Z,,3229,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3229/?format=pcsv
ps141,,,-1,C34H61N1O10P1,[],,"phosphatidylserine (ditetradec-7-enoyl, n-C14:1)",,"phosphatidylserine (ditetradec-7-enoyl, n-C14:1)",,,,,2016-11-22T15:12:37Z,,3230,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3230/?format=pcsv
ps160,,,-1,C38H73N1O10P1,[],,"phosphatidylserine (dihexadecanoyl, n-C16:0)",,"phosphatidylserine (dihexadecanoyl, n-C16:0)",,,,,2016-11-22T15:12:37Z,,3231,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3231/?format=pcsv
ps161,,,-1,C38H69N1O10P1,[],,"phosphatidylserine (dihexadec-9-enoyl, n-C16:1)",,"phosphatidylserine (dihexadec-9-enoyl, n-C16:1)",,,,,2016-11-22T15:12:37Z,,3232,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3232/?format=pcsv
ps180,,,-1,C42H81N1O10P1,[],,"phosphatidylserine (dioctadecanoyl, n-C18:0)",,"phosphatidylserine (dioctadecanoyl, n-C18:0)",,,,,2016-11-22T15:12:37Z,,3233,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3233/?format=pcsv
ps181,,,-1,C42H77N1O10P1,[],,"phosphatidylserine (dioctadec-11-enoyl, n-C18:1)",,"phosphatidylserine (dioctadec-11-enoyl, n-C18:1)",,,,,2016-11-22T15:12:37Z,,3234,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3234/?format=pcsv
psai15,,,-1,C36H69NO10P,[],,"Phosphatidylserine (12-methyl-tetradecanoyl, anteiso-C15)",,"Phosphatidylserine (12-methyl-tetradecanoyl, anteiso-C15)",,,,,2016-11-22T15:12:37Z,,3235,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3235/?format=pcsv
peai15,,,0,C35H70NO8P,[],,"Phosphatidylethanolamine (12-methyl-tetradecanoyl, anteiso-C15)",,"Phosphatidylethanolamine (12-methyl-tetradecanoyl, anteiso-C15)",,,,,2016-11-22T15:12:36Z,,3236,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3236/?format=pcsv
psai17,,,-1,C40H77NO10P,[],,"Phosphatidylserine (14-methyl-hexadecanoyl, anteiso-C17)",,"Phosphatidylserine (14-methyl-hexadecanoyl, anteiso-C17)",,,,,2016-11-22T15:12:37Z,,3237,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3237/?format=pcsv
peai17,,,0,C39H78NO8P,[],,"Phosphatidylethanolamine (14-methyl-hexadecanoyl, anteiso-C17)",,"Phosphatidylethanolamine (14-methyl-hexadecanoyl, anteiso-C17)",,,,,2016-11-22T15:12:36Z,,3238,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3238/?format=pcsv
psi14,,,-1,C34H65NO10P,[],,"Phosphatidylserine (12-methyl-tridecanoyl, iso-C14)",,"Phosphatidylserine (12-methyl-tridecanoyl, iso-C14)",,,,,2016-11-22T15:12:37Z,,3239,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3239/?format=pcsv
pei14,,,0,C33H66NO8P,[],,"Phosphatidylethanolamine (12-methyl-tridecanoyl, iso-C14)",,"Phosphatidylethanolamine (12-methyl-tridecanoyl, iso-C14)",,,,,2016-11-22T15:12:36Z,,3240,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3240/?format=pcsv
psi15,,,-1,C36H69NO10P,[],,"Phosphatidylserine (13-methyl-tetradecanoyl, iso-C15)",,"Phosphatidylserine (13-methyl-tetradecanoyl, iso-C15)",,,,,2016-11-22T15:12:43Z,,3241,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3241/?format=pcsv
pei15,,,0,C35H70NO8P,[],,"Phosphatidylethanolamine (13-methyl-tetradecanoyl, iso-C15)",,"Phosphatidylethanolamine (13-methyl-tetradecanoyl, iso-C15)",,,,,2016-11-22T15:12:43Z,,3242,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3242/?format=pcsv
psi16,,,-1,C38H73NO10P,[],,"Phosphatidylserine (14-methyl-pentadecanoyl, iso-C16)",,"Phosphatidylserine (14-methyl-pentadecanoyl, iso-C16)",,,,,2016-11-22T15:12:37Z,,3243,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3243/?format=pcsv
pei16,,,0,C37H74NO8P,[],,"Phosphatidylethanolamine (14-methyl-pentadecanoyl, iso-C16)",,"Phosphatidylethanolamine (14-methyl-pentadecanoyl, iso-C16)",,,,,2016-11-22T15:12:36Z,,3244,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3244/?format=pcsv
psi17,,,-1,C40H77NO10P,[],,"Phosphatidylserine (15-methyl-hexadecanoyl, iso-C17)",,"Phosphatidylserine (15-methyl-hexadecanoyl, iso-C17)",,,,,2016-11-22T15:12:43Z,,3245,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3245/?format=pcsv
pei17,,,0,C39H78NO8P,[],,"Phosphatidylethanolamine (15-methyl-hexadecanoyl, iso-C17)",,"Phosphatidylethanolamine (15-methyl-hexadecanoyl, iso-C17)",,,,,2016-11-22T15:12:43Z,,3246,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3246/?format=pcsv
pqq,,,-3,C14H3N2O8,[],,Pyrroloquinoline-quinone,,Pyrroloquinoline-quinone,,,,,2016-11-22T15:12:36Z,,3247,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3247/?format=pcsv
quint,,,-1,C7H11O6,[],,Quinate,,Quinate,,,,,2016-11-22T15:12:37Z,,3248,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3248/?format=pcsv
pqqh2,,,-3,C14H5N2O8,[],,Reduced pyrroloquinoline-quinone,,Reduced pyrroloquinoline-quinone,,,,,2016-11-22T15:12:36Z,,3249,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3249/?format=pcsv
hgbam,,,-4,C45H58N6O12,27914,,"Hydrogenobyrinate a,c diamide",,"Hydrogenobyrinate a,c diamide",,,,,2016-11-22T15:12:34Z,,3250,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3250/?format=pcsv
raffin,,,0,C18H32O16,[],,Raffinose,,Raffinose,,,,,2016-11-22T15:12:43Z,,3251,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3251/?format=pcsv
ru5p_L,,,-2,C5H9O8P,[],,L-Ribulose 5-phosphate,,L-Ribulose 5-phosphate,,,,,2016-11-22T15:12:43Z,,3252,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3252/?format=pcsv
4r5au,,,0,C9H16N4O6,[],,4-(1-D-Ribitylamino)-5-aminouracil,,4-(1-D-Ribitylamino)-5-aminouracil,,,,,2016-11-22T15:12:31Z,,3253,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3253/?format=pcsv
dmlz,,,0,C13H18N4O6,[],,"6,7-Dimethyl-8-(1-D-ribityl)lumazine",,"6,7-Dimethyl-8-(1-D-ribityl)lumazine",,,,,2016-11-22T15:12:33Z,,3254,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3254/?format=pcsv
rml,,,0,C6H12O5,[],,L-Rhamnulose,,L-Rhamnulose,,,,,2016-11-22T15:12:43Z,,3255,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3255/?format=pcsv
rml1p,,,-2,C6H11O8P,[],,L-Rhamnulose 1-phosphate,,L-Rhamnulose 1-phosphate,,,,,2016-11-22T15:12:43Z,,3256,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3256/?format=pcsv
xu1p_L,,,-2,C5H9O8P,[],,L-Xylulose 1-phosphate,,L-Xylulose 1-phosphate,,,,,2016-11-22T15:12:44Z,,3257,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3257/?format=pcsv
sucorn,,,-1,C9H15N2O5,[],,N2-Succinyl-L-ornithine,,N2-Succinyl-L-ornithine,,,,,2016-11-22T15:12:43Z,,3258,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3258/?format=pcsv
sbt6p,,,-2,C6H13O9P,[],,D-Sorbitol 6-phosphate,,D-Sorbitol 6-phosphate,,,,,2016-11-22T15:12:43Z,,3259,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3259/?format=pcsv
sl26da,,,-2,C11H16N2O7,[],,"N-Succinyl-LL-2,6-diaminoheptanedioate",,"N-Succinyl-LL-2,6-diaminoheptanedioate",,,,,2016-11-22T15:12:37Z,,3260,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3260/?format=pcsv
sl2a6o,,,-3,C11H12NO8,[],,N-Succinyl-2-L-amino-6-oxoheptanedioate,,N-Succinyl-2-L-amino-6-oxoheptanedioate,,,,,2016-11-22T15:12:37Z,,3261,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3261/?format=pcsv
2s5epchc,,,-3,C14H13O9,[],,2-Succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate,,2-Succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate,,,,,2016-11-22T15:12:30Z,,3262,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3262/?format=pcsv
sucglu,,,-3,C9H10NO7,[],,N2-Succinyl-L-glutamate,,N2-Succinyl-L-glutamate,,,,,2016-11-22T15:12:37Z,,3263,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3263/?format=pcsv
sucgsa,,,-2,C9H11NO6,[],,N2-Succinyl-L-glutamate 5-semialdehyde,,N2-Succinyl-L-glutamate 5-semialdehyde,,,,,2016-11-22T15:12:43Z,,3264,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3264/?format=pcsv
scl,,,-7,C42H39N4O16,[],,sirohydrochlorin,,sirohydrochlorin,,,,,2016-11-22T15:12:37Z,,3265,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3265/?format=pcsv
sheme,,,-8,C42H36FeN4O16,[],,Siroheme,,Siroheme,,,,,2016-11-22T15:12:37Z,,3266,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3266/?format=pcsv
skm,,,-1,C7H9O5,[],,Shikimate,,Shikimate,,,,,2016-11-22T15:12:37Z,,3267,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3267/?format=pcsv
srbL1p,,,-1,C6H12O9P,[],,L-Sorbose 1-phosphate,,L-Sorbose 1-phosphate,,,,,2016-11-22T15:12:37Z,,3268,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3268/?format=pcsv
stys,,,0,C24H42O21,[],,Stachyose,,Stachyose,,,,,2016-11-22T15:12:43Z,,3269,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3269/?format=pcsv
sucbz,,,-2,C11H8O5,[],,o-Succinylbenzoate,,o-Succinylbenzoate,,,,,2016-11-22T15:12:37Z,,3270,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3270/?format=pcsv
tartr_L,,,-2,C4H4O6,[],,L-tartrate,,L-tartrate,,,,,2016-11-22T15:12:37Z,,3271,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3271/?format=pcsv
oxglyc,,,-2,C4H2O6,[],,Oxaloglycolate,,Oxaloglycolate,,,,,2016-11-22T15:12:35Z,,3272,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3272/?format=pcsv
tartr_M,,,-2,C4H4O6,[],,meso-Tartrate,,meso-Tartrate,,,,,2016-11-22T15:12:43Z,,3273,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3273/?format=pcsv
dtdp4addg,,,-1,C16H26N3O14P2,[],,"dTDP-4-amino-4,6-dideoxy-D-galactose",,"dTDP-4-amino-4,6-dideoxy-D-galactose",,,,,2016-11-22T15:12:33Z,,3274,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3274/?format=pcsv
dtdp4aaddg,,,-2,C18H27N3O15P2,[],,"dTDP-4-acetamido-4,6-dideoxy-D-galactose",,"dTDP-4-acetamido-4,6-dideoxy-D-galactose",,,,,2016-11-22T15:12:33Z,,3275,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3275/?format=pcsv
myrstca1,,,-24,C115H224O135P24,[],,"Myristoyllipoteichoic acid (n=24), linked, unsubstituted",,"Myristoyllipoteichoic acid (n=24), linked, unsubstituted",,,,,2016-11-22T15:12:42Z,,3276,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3276/?format=pcsv
myrstcaacgam,,,-24,C307H536N24O255P24,[],,"Myristoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,"Myristoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,,,,2016-11-22T15:12:42Z,,3277,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3277/?format=pcsv
palmtca1,,,-24,C119H232O135P24,[],,"Palmitoyllipoteichoic acid (n=24), linked, unsubstituted",,"Palmitoyllipoteichoic acid (n=24), linked, unsubstituted",,,,,2016-11-22T15:12:43Z,,3278,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3278/?format=pcsv
palmtcaacgam,,,-24,C311H544N24O255P24,[],,"Palmitoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,"Palmitoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,,,,2016-11-22T15:12:43Z,,3279,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3279/?format=pcsv
sttca1,,,-24,C123H240O135P24,[],,"Stearoyllipoteichoic acid (n=24), linked, unsubstituted",,"Stearoyllipoteichoic acid (n=24), linked, unsubstituted",,,,,2016-11-22T15:12:37Z,,3280,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3280/?format=pcsv
sttcaacgam,,,-24,C315H552N24O255P24,[],,"Stearoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,"Stearoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,,,,2016-11-22T15:12:37Z,,3281,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3281/?format=pcsv
ai15tca1,,,-24,C117H228O135P24,[],,"Anteisopentadecanoyllipoteichoic acid (n=24), linked, unsubstituted",,"Anteisopentadecanoyllipoteichoic acid (n=24), linked, unsubstituted",,,,,2016-11-22T15:12:32Z,,3282,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3282/?format=pcsv
ai15tcaacgam,,,-24,C309H540N24O255P24,[],,"Anteisopentadecanoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,"Anteisopentadecanoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,,,,2016-11-22T15:12:32Z,,3283,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3283/?format=pcsv
ai17tca1,,,-24,C121H236O135P24,[],,"Anteisoheptadecanoyllipoteichoic acid (n=24), linked, unsubstituted",,"Anteisoheptadecanoyllipoteichoic acid (n=24), linked, unsubstituted",,,,,2016-11-22T15:12:32Z,,3284,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3284/?format=pcsv
ai17tcaacgam,,,-24,C313H548N24O255P24,[],,"Anteisoheptadecanoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,"Anteisoheptadecanoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,,,,2016-11-22T15:12:32Z,,3285,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3285/?format=pcsv
i14tca1,,,-24,C115H224O135P24,[],,"Isotetradecanoyllipoteichoic acid (n=24), linked, unsubstituted",,"Isotetradecanoyllipoteichoic acid (n=24), linked, unsubstituted",,,,,2016-11-22T15:12:34Z,,3286,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3286/?format=pcsv
i14tcaacgam,,,-24,C307H536N24O255P24,[],,"Isotetradecanoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,"Isotetradecanoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,,,,2016-11-22T15:12:34Z,,3287,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3287/?format=pcsv
i15tca1,,,-24,C117H228O135P24,[],,"Isopentadecanoyllipoteichoic acid (n=24), linked, unsubstituted",,"Isopentadecanoyllipoteichoic acid (n=24), linked, unsubstituted",,,,,2016-11-22T15:12:42Z,,3288,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3288/?format=pcsv
i15tcaacgam,,,-24,C309H540N24O255P24,[],,"Isopentadecanoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,"Isopentadecanoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,,,,2016-11-22T15:12:42Z,,3289,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3289/?format=pcsv
i16tca1,,,-24,C119H232O135P24,[],,"Isohexadecanoyllipoteichoic acid (n=24), linked, unsubstituted",,"Isohexadecanoyllipoteichoic acid (n=24), linked, unsubstituted",,,,,2016-11-22T15:12:34Z,,3290,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3290/?format=pcsv
i16tcaacgam,,,-24,C311H544N24O255P24,[],,"Isohexadecanoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,"Isohexadecanoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,,,,2016-11-22T15:12:34Z,,3291,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3291/?format=pcsv
i17tca1,,,-24,C121H236O135P24,[],,"Isoheptadecanoyllipoteichoic acid (n=24), linked, unsubstituted",,"Isoheptadecanoyllipoteichoic acid (n=24), linked, unsubstituted",,,,,2016-11-22T15:12:42Z,,3292,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3292/?format=pcsv
i17tcaacgam,,,-24,C313H548N24O255P24,[],,"Isoheptadecanoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,"Isoheptadecanoyllipoteichoic acid (n=24), linked, N-acetyl-D-glucosamine",,,,,2016-11-22T15:12:42Z,,3293,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3293/?format=pcsv
4hba,,,0,C7H8O2,[],,4-Hydroxy-benzyl alcohol,,4-Hydroxy-benzyl alcohol,,,,,2016-11-22T15:12:39Z,,3294,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3294/?format=pcsv
tmao,,,0,C3H9NO,[],,Trimethylamine N-oxide,,Trimethylamine N-oxide,,,,,2016-11-22T15:12:37Z,,3295,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3295/?format=pcsv
tma,,,1,C3H10N,[],,trimethylamine,,trimethylamine,,,,,2016-11-22T15:12:37Z,,3296,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3296/?format=pcsv
2mahmp,,,-3,C6H8N3O7P2,[],,2-Methyl-4-amino-5-hydroxymethylpyrimidine diphosphate,,2-Methyl-4-amino-5-hydroxymethylpyrimidine diphosphate,,,,,2016-11-22T15:12:30Z,,3297,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3297/?format=pcsv
tre6p,,,-2,C12H21O14P,[],,"alpha,alpha-Trehalose 6-phosphate",,"alpha,alpha-Trehalose 6-phosphate",,,,,2016-11-22T15:12:44Z,,3298,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3298/?format=pcsv
indole,,,0,C8H7N,,,Indole,,Indole,,,,,2016-11-22T15:12:27Z,,3299,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3299/?format=pcsv
u3hga,,,-1,C29H50N3O18P2,[],,UDP-3-O-(3-hydroxytetradecanoyl)-D-glucosamine,,UDP-3-O-(3-hydroxytetradecanoyl)-D-glucosamine,,,,,2016-11-22T15:12:37Z,,3300,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3300/?format=pcsv
uamag,,,-4,C28H39N5O23P2,[],,UDP-N-acetylmuramoyl-L-alanyl-D-glutamate,,UDP-N-acetylmuramoyl-L-alanyl-D-glutamate,,,,,2016-11-22T15:12:38Z,,3301,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3301/?format=pcsv
ugmd,,,-4,C35H51N7O26P2,[],,"UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-meso-2,6-diaminopimelate",,"UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-meso-2,6-diaminopimelate",,,,,2016-11-22T15:12:38Z,,3302,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3302/?format=pcsv
uacmam,,,-2,C17H25N3O17P2,[],,UDP-N-acetyl-D-mannosamine,,UDP-N-acetyl-D-mannosamine,,,,,2016-11-22T15:12:44Z,,3303,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3303/?format=pcsv
u3aga,,,-2,C31H51N3O19P2,[],,UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine,,UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine,,,,,2016-11-22T15:12:37Z,,3304,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3304/?format=pcsv
uaccg,,,-3,C20H26N3O19P2,[],,UDP-N-acetyl-3-O-(1-carboxyvinyl)-D-glucosamine,,UDP-N-acetyl-3-O-(1-carboxyvinyl)-D-glucosamine,,,,,2016-11-22T15:12:37Z,,3305,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3305/?format=pcsv
uama,,,-3,C23H33N4O20P2,[],,UDP-N-acetylmuramoyl-L-alanine,,UDP-N-acetylmuramoyl-L-alanine,,,,,2016-11-22T15:12:38Z,,3306,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3306/?format=pcsv
uamr,,,-3,C20H28N3O19P2,[],,UDP-N-acetylmuramate,,UDP-N-acetylmuramate,,,,,2016-11-22T15:12:38Z,,3307,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3307/?format=pcsv
psd5p,,,-2,C9H11N2O9P,[],,Pseudouridine 5-phosphate,,Pseudouridine 5-phosphate,,,,,2016-11-22T15:12:43Z,,3308,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3308/?format=pcsv
dnarep,,,0,X,,,DNA replication,,DNA replication,,,,,2016-11-22T15:12:41Z,,3309,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3309/?format=pcsv
proteinsynth,,,0,X,,,Protein biosynthesis,,Protein biosynthesis,,,,,2016-11-22T15:12:43Z,,3310,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3310/?format=pcsv
rnatrans,,,0,X,,,RNA transcription,,RNA transcription,,,,,2016-11-22T15:12:43Z,,3311,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3311/?format=pcsv
prodthl,,,0,X,,,Protein dithiol,,Protein dithiol,,,,,2016-11-22T15:12:43Z,,3312,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3312/?format=pcsv
prodslfd,,,0,X,,,Protein disulfide,,Protein disulfide,,,,,2016-11-22T15:12:43Z,,3313,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3313/?format=pcsv
peptmet_L,,,0,X,,,Peptide-L-methionine,,Peptide-L-methionine,,,,,2016-11-22T15:12:43Z,,3314,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3314/?format=pcsv
peptmetox_L,,,0,X,,,Peptide-L-methionine (R)-S-oxide,,Peptide-L-methionine (R)-S-oxide,,,,,2016-11-22T15:12:43Z,,3315,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3315/?format=pcsv
pmACPm,,,-1,C19H33N2O10PRS,[],,Pimeloyl-ACP methyl ester,,Pimeloyl-ACP methyl ester,,,,,2016-11-22T15:12:36Z,,3316,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3316/?format=pcsv
pmACP,,,-2,C18H30N2O10PRS,[],,Pimeloyl-ACP,,Pimeloyl-ACP,,,,,2016-11-22T15:12:36Z,,3317,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3317/?format=pcsv
malcoam,,,-4,C25H36N7O19P3S,[],,Malonyl-CoA methyl ester,,Malonyl-CoA methyl ester,,,,,2016-11-22T15:12:35Z,,3318,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3318/?format=pcsv
3ogACPm,,,-1,C17H27N2O11PRS,[],,3-ketoglutaryl-ACP methyl ester,,3-ketoglutaryl-ACP methyl ester,,,,,2016-11-22T15:12:30Z,,3319,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3319/?format=pcsv
3hgACPm,,,-1,C17H29N2O11PRS,[],,3-hydroxyglutaryl-ACP methyl ester,,3-hydroxyglutaryl-ACP methyl ester,,,,,2016-11-22T15:12:30Z,,3320,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3320/?format=pcsv
egACPm,,,-1,C17H27N2O10PRS,[],,Enoylglutaryl-ACP methyl ester,,Enoylglutaryl-ACP methyl ester,,,,,2016-11-22T15:12:33Z,,3321,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3321/?format=pcsv
gACPm,,,-1,C17H29N2O10PRS,[],,Glutaryl-ACP methyl ester,,Glutaryl-ACP methyl ester,,,,,2016-11-22T15:12:34Z,,3322,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3322/?format=pcsv
3opACPm,,,-1,C19H31N2O11PRS,[],,3-ketopimeloyl-ACP methyl ester,,3-ketopimeloyl-ACP methyl ester,,,,,2016-11-22T15:12:30Z,,3323,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3323/?format=pcsv
3hpACPm,,,-1,C19H33N2O11PRS,[],,3-hydroxypimeloyl-ACP methyl ester,,3-hydroxypimeloyl-ACP methyl ester,,,,,2016-11-22T15:12:30Z,,3324,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3324/?format=pcsv
epACPm,,,-1,C19H31N2O10PRS,[],,Enoylpimeloyl-ACP methyl ester,,Enoylpimeloyl-ACP methyl ester,,,,,2016-11-22T15:12:33Z,,3325,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3325/?format=pcsv
dhpmp,,,-2,C9H12N5O7P,[],,Dihydroneopterin monophosphate,,Dihydroneopterin monophosphate,,,,,2016-11-22T15:12:33Z,,3326,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3326/?format=pcsv
6hmhpt,,,0,C7H9N5O2,[],,6-hydroxymethyl dihydropterin,,6-hydroxymethyl dihydropterin,,,,,2016-11-22T15:12:40Z,,3327,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3327/?format=pcsv
6hmhptpp,,,-3,C7H8N5O8P2,[],,6-hydroxymethyl-dihydropterin pyrophosphate,,6-hydroxymethyl-dihydropterin pyrophosphate,,,,,2016-11-22T15:12:40Z,,3328,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3328/?format=pcsv
25drapp,,,-2,C9H14N5O8P,[],,"2,5-Diamino-6-(ribosylamino)-4-(3H)-pyrimidinone 5-phosphate",,"2,5-Diamino-6-(ribosylamino)-4-(3H)-pyrimidinone 5-phosphate",,,,,2016-11-22T15:12:38Z,,3329,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3329/?format=pcsv
4ampm,,,-2,C6H8N3O4P,[],,4-Amino-2-methyl-5-phosphomethylpyrimidine,,4-Amino-2-methyl-5-phosphomethylpyrimidine,,,,,2016-11-22T15:12:31Z,,3330,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3330/?format=pcsv
4ahmmp,,,0,C6H9N3O,[],,4-Amino-5-hydroxymethyl-2-methylpyrimidine,,4-Amino-5-hydroxymethyl-2-methylpyrimidine,,,,,2016-11-22T15:12:31Z,,3331,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3331/?format=pcsv
t3c5ddeceACP,,,-1,C23H39N2O8PRS,[],,trans-3-cis-5-dodecenoyl-[acyl-carrier protein],,trans-3-cis-5-dodecenoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:37Z,,3332,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3332/?format=pcsv
cddec5eACP,,,-1,C23H41N2O8PRS,[],,cis-dodec-5-enoyl-[acyl-carrier protein] (n-C12:1),,cis-dodec-5-enoyl-[acyl-carrier protein] (n-C12:1),,,,,2016-11-22T15:12:41Z,,3333,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3333/?format=pcsv
t3c7mrseACP,,,-1,C25H43N2O8PRS,[],,trans-3-cis-7-myristoleoyl-[acyl-carrier protein],,trans-3-cis-7-myristoleoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:37Z,,3334,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3334/?format=pcsv
t3c9palmeACP,,,-1,C27H47N2O8PRS,[],,trans-3-cis-9-palmitoleoyl-[acyl-carrier protein],,trans-3-cis-9-palmitoleoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:37Z,,3335,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3335/?format=pcsv
t3c11vaceACP,,,-1,C29H51N2O8PRS,[],,trans-3-cis-11-vacceoyl-[acyl-carrier protein],,trans-3-cis-11-vacceoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:43Z,,3336,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3336/?format=pcsv
3hcddec5eACP,,,-1,C23H41N2O9PRS,[],,(R)-3-hydroxy-cis-dodec-5-enoyl-[acyl-carrier protein],,(R)-3-hydroxy-cis-dodec-5-enoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:39Z,,3337,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3337/?format=pcsv
3hcmrs7eACP,,,-1,C25H45N2O9PRS,[],,(R)-3-hydroxy-cis-myristol-7-eoyl-[acyl-carrier protein],,(R)-3-hydroxy-cis-myristol-7-eoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:39Z,,3338,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3338/?format=pcsv
3hcpalm9eACP,,,-1,C27H49N2O9PRS,[],,(R)-3-hydroxy-cis-palm-9-eoyl-[acyl-carrier protein],,(R)-3-hydroxy-cis-palm-9-eoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:39Z,,3339,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3339/?format=pcsv
3hcvac11eACP,,,-1,C29H53N2O9PRS,[],,(R)-3-hydroxy-cis-vacc-11-enoyl-[acyl-carrier protein],,(R)-3-hydroxy-cis-vacc-11-enoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:30Z,,3340,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3340/?format=pcsv
cdec3eACP,,,-1,C21H37N2O8PRS,[],,cis-dec-3-enoyl-[acyl-carrier protein] (n-C10:1),,cis-dec-3-enoyl-[acyl-carrier protein] (n-C10:1),,,,,2016-11-22T15:12:41Z,,3341,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3341/?format=pcsv
3ocddec5eACP,,,-1,C23H39N2O9PRS,[],,3-oxo-cis-dodec-5-enoyl-[acyl-carrier protein],,3-oxo-cis-dodec-5-enoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:30Z,,3342,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3342/?format=pcsv
3ocmrs7eACP,,,-1,C25H43N2O9PRS,[],,3-oxo-cis-myristol-7-eoyl-[acyl-carrier protein],,3-oxo-cis-myristol-7-eoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:30Z,,3343,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3343/?format=pcsv
3ocpalm9eACP,,,-1,C27H47N2O9PRS,[],,3-oxo-cis-palm-9-eoyl-[acyl-carrier protein],,3-oxo-cis-palm-9-eoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:30Z,,3344,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3344/?format=pcsv
3ocvac11eACP,,,-1,C29H51N2O9PRS,[],,3-oxo-cis-vacc-11-enoyl-[acyl-carrier protein],,3-oxo-cis-vacc-11-enoyl-[acyl-carrier protein],,,,,2016-11-22T15:12:30Z,,3345,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3345/?format=pcsv
5drib,,,0,C5H10O4,[],,5-deoxyribose,,5-deoxyribose,,,,,2016-11-22T15:12:39Z,,3346,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3346/?format=pcsv
kestopt,,,0,C30H52O26,[],,"Kestopentaose (4 fru, 1 glc inulin-type fructo-oligosaccharide)",,"Kestopentaose (4 fru, 1 glc inulin-type fructo-oligosaccharide)",,,,,2016-11-22T15:12:42Z,,3347,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3347/?format=pcsv
kestottr,,,0,C24H42O21,[],,"Kestotetraose (3 fru, 1 glc inulin-type fructo-oligosaccharide)",,"Kestotetraose (3 fru, 1 glc inulin-type fructo-oligosaccharide)",,,,,2016-11-22T15:12:42Z,,3348,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3348/?format=pcsv
kesto,,,0,C18H32O16,[],,"Kestose (2 fru, 1 glc inulin-type fructo-oligosaccharide)",,"Kestose (2 fru, 1 glc inulin-type fructo-oligosaccharide)",,,,,2016-11-22T15:12:42Z,,3349,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3349/?format=pcsv
pprdn,,,0,C5H9N,47858,,Piperideine,,Piperideine,,,,,2016-11-22T15:12:36Z,,3350,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3350/?format=pcsv
5aptn,,,0,C5H11NO2,15887,,5-Aminopentanoate,,5-Aminopentanoate,,,,,2016-11-22T15:12:39Z,,3351,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3351/?format=pcsv
oxptn,,,-1,C5H7O3,39153,,5-Oxopentanoate,,5-Oxopentanoate,,,,,2016-11-22T15:12:43Z,,3352,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3352/?format=pcsv
glutar,,,-2,C5H6O4,,,Glutarate,,Glutarate,,,,,2016-11-22T15:12:34Z,,3353,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3353/?format=pcsv
Naccitr_L,,,0,C8H15N3O4,[],,N-Acetyl-L-citrulline,,N-Acetyl-L-citrulline,,,,,2016-11-22T15:12:42Z,,3354,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3354/?format=pcsv
ncptrc,,,1,C5H14N3O,[],,N-Carbamoylputrescine,,N-Carbamoylputrescine,,,,,2016-11-22T15:12:35Z,,3355,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3355/?format=pcsv
chtbs,,,0,C16H28N2O11,[],,"N,N-diacetylchitobiose",,"N,N-diacetylchitobiose",,,,,2016-11-22T15:12:41Z,,3356,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3356/?format=pcsv
4gudbd,,,1,C5H13N4O,[],,4-Guanidinobutanamide,,4-Guanidinobutanamide,,,,,2016-11-22T15:12:31Z,,3357,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3357/?format=pcsv
4gubut,,,0,C5H11N3O2,[],,4-Guanidinobutanoate,,4-Guanidinobutanoate,,,,,2016-11-22T15:12:31Z,,3358,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3358/?format=pcsv
pad,,,0,C8H9NO,[],,2-Phenylacetamide,,2-Phenylacetamide,,,,,2016-11-22T15:12:36Z,,3359,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3359/?format=pcsv
ad,,,0,C2H5NO,[],,Acetamide,,Acetamide,,,,,2016-11-22T15:12:32Z,,3360,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3360/?format=pcsv
aa,,,0,C3H5NO,[],,Acrylamide,,Acrylamide,,,,,2016-11-22T15:12:31Z,,3361,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3361/?format=pcsv
arabttr,,,0,C15H26O13,[],,Arabinotriose,,Arabinotriose,,,,,2016-11-22T15:12:32Z,,3362,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3362/?format=pcsv
arsenb,,,0,C5H12AsO2,[],,Arsenobetaine,,Arsenobetaine,,,,,2016-11-22T15:12:32Z,,3363,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3363/?format=pcsv
butpi,,,-2,C4H7O5P,[],,Butanoyl phosphate,,Butanoyl phosphate,,,,,2016-11-22T15:12:32Z,,3364,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3364/?format=pcsv
bzam,,,0,C7H7NO,[],,Benzamide,,Benzamide,,,,,2016-11-22T15:12:32Z,,3365,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3365/?format=pcsv
cro4,,,-2,CrO4,[],,chromate,,chromate,,,,,2016-11-22T15:12:33Z,,3366,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3366/?format=pcsv
ctbt,,,0,C7H13NO2,[],,crotonobetaine,,crotonobetaine,,,,,2016-11-22T15:12:33Z,,3367,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3367/?format=pcsv
gbbtn,,,0,C7H15NO2,[],,gamma-butyrobetaine,,gamma-butyrobetaine,,,,,2016-11-22T15:12:41Z,,3368,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3368/?format=pcsv
cdpglc,,,-2,C15H23N3O16P2,[],,CDPglucose,,CDPglucose,,,,,2016-11-22T15:12:32Z,,3369,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3369/?format=pcsv
gagicolipa,,,-11,C157H271N2O84P4,[],,galactosyl-glucosyl-inner core oligosaccharide lipid A,,galactosyl-glucosyl-inner core oligosaccharide lipid A,,,,,2016-11-22T15:12:34Z,,3370,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3370/?format=pcsv
pendp,,,-3,C25H41O7P2,[],,all-trans-Pentaprenyl diphosphate,,all-trans-Pentaprenyl diphosphate,,,,,2016-11-22T15:12:36Z,,3371,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3371/?format=pcsv
ggagicolipa,,,-11,C163H281N2O89P4,[],,glucosyl-galactosyl-glucosyl-inner core oligosaccharide lipid A,,glucosyl-galactosyl-glucosyl-inner core oligosaccharide lipid A,,,,,2016-11-22T15:12:34Z,,3372,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3372/?format=pcsv
gggagicolipa,,,-11,C169H291N2O94P4,[],,glucosyl-glucosyl-galactosyl-glucosyl-inner core oligosaccharide lipid A,,glucosyl-glucosyl-galactosyl-glucosyl-inner core oligosaccharide lipid A,,,,,2016-11-22T15:12:34Z,,3373,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3373/?format=pcsv
colipa,,,-11,C176H303N2O100P4,[],,core oligosaccharide lipid A,,core oligosaccharide lipid A,,,,,2016-11-22T15:12:33Z,,3374,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3374/?format=pcsv
hepdp,,,-3,C35H57O7P2,[],,all-trans-Heptaprenyl diphosphate,,all-trans-Heptaprenyl diphosphate,,,,,2016-11-22T15:12:34Z,,3375,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3375/?format=pcsv
hexdp,,,-3,C30H49O7P2,[],,all-trans-Hexaprenyl diphosphate,,all-trans-Hexaprenyl diphosphate,,,,,2016-11-22T15:12:42Z,,3376,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3376/?format=pcsv
ind3acam,,,0,C10H10N2O,[],,Indole-3-acetamide,,Indole-3-acetamide,,,,,2016-11-22T15:12:42Z,,3377,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3377/?format=pcsv
36dahx,,,1,C6H15N2O2,[],,"(3S)-3,6-Diaminohexanoate",,"(3S)-3,6-Diaminohexanoate",,,,,2016-11-22T15:12:39Z,,3378,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3378/?format=pcsv
g1p_B,,,-2,C6H11O9P,[],,beta D-Glucose 1-phosphate,,beta D-Glucose 1-phosphate,,,,,2016-11-22T15:12:41Z,,3379,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3379/?format=pcsv
2shchc,,,-2,C11H10O6,[],,"2-Succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate",,"2-Succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate",,,,,2016-11-22T15:12:30Z,,3380,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3380/?format=pcsv
diglcpg140,,,0,C43H80O15,[],,"Diglucosyl-1,2 dimyristoylglycerol",,"Diglucosyl-1,2 dimyristoylglycerol",,,,,2016-11-22T15:12:33Z,,3381,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3381/?format=pcsv
cdpglyc,,,-2,C12H19N3O13P2,[],,CDPglycerol,,CDPglycerol,,,,,2016-11-22T15:12:32Z,,3382,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3382/?format=pcsv
diglcpg160,,,0,C47H88O15,[],,"Diglucosyl-1,2 dipalmitoylglycerol",,"Diglucosyl-1,2 dipalmitoylglycerol",,,,,2016-11-22T15:12:33Z,,3383,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3383/?format=pcsv
diglcpg180,,,0,C51H96O15,[],,"Diglucosyl-1,2 distearoylglycerol",,"Diglucosyl-1,2 distearoylglycerol",,,,,2016-11-22T15:12:33Z,,3384,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3384/?format=pcsv
diglcpgai15,,,0,C45H84O15,[],,"Diglucosyl-1,2 dianteisopentadecanoylglycerol",,"Diglucosyl-1,2 dianteisopentadecanoylglycerol",,,,,2016-11-22T15:12:33Z,,3385,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3385/?format=pcsv
diglcpgai17,,,0,C49H92O15,[],,"Diglucosyl-1,2 dianteisoheptadecanoylglycerol",,"Diglucosyl-1,2 dianteisoheptadecanoylglycerol",,,,,2016-11-22T15:12:33Z,,3386,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3386/?format=pcsv
diglcpgi14,,,0,C43H80O15,[],,"Diglucosyl-1,2 diisotetradecanoylglycerol",,"Diglucosyl-1,2 diisotetradecanoylglycerol",,,,,2016-11-22T15:12:41Z,,3387,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3387/?format=pcsv
diglcpgi15,,,0,C45H84O15,[],,"Diglucosyl-1,2 diisopentadecanoylglycerol",,"Diglucosyl-1,2 diisopentadecanoylglycerol",,,,,2016-11-22T15:12:41Z,,3388,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3388/?format=pcsv
diglcpgi16,,,0,C47H88O15,[],,"Diglucosyl-1,2 diisohexadecanoylglycerol",,"Diglucosyl-1,2 diisohexadecanoylglycerol",,,,,2016-11-22T15:12:41Z,,3389,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3389/?format=pcsv
diglcpgi17,,,0,C49H92O15,[],,"Diglucosyl-1,2 diisoheptadecanoylglycerol",,"Diglucosyl-1,2 diisoheptadecanoylglycerol",,,,,2016-11-22T15:12:41Z,,3390,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3390/?format=pcsv
teich_45_BS,,,0,X,,,"teichuronic acid (GlcA + GalNac, 45 repeating unit)",,"teichuronic acid (GlcA + GalNac, 45 repeating unit)",,,,,2016-11-22T15:12:44Z,,3391,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3391/?format=pcsv
acbdma14gapuc,,,-2,C71H116N2O17P2,[],,"N-Acetyl-beta-D-mannosaminyl-1,4-N-acetyl-D- glucosaminyldiphosphoundecaprenol",,"N-Acetyl-beta-D-mannosaminyl-1,4-N-acetyl-D- glucosaminyldiphosphoundecaprenol",,,,,2016-11-22T15:12:31Z,,3392,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3392/?format=pcsv
prl45tca,,,0,X,,,Prenol-45n teichoic acid,,Prenol-45n teichoic acid,,,,,2016-11-22T15:12:43Z,,3393,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3393/?format=pcsv
succitr_L,,,-1,C10H16N3O6,[],,N-succinyl-L-citrulline ,,N-succinyl-L-citrulline ,,,,,2016-11-22T15:12:37Z,,3394,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3394/?format=pcsv
2ommbl,,,0,C48H74O3,[],,"2-Octaprenyl-3-methyl-6-methoxy- 1,4-benzoquinol",,"2-Octaprenyl-3-methyl-6-methoxy- 1,4-benzoquinol",,,,,2016-11-22T15:12:30Z,,3395,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3395/?format=pcsv
2omhmbl,,,0,C48H74O4,[],,"2-Octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinol",,"2-Octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinol",,,,,2016-11-22T15:12:30Z,,3396,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3396/?format=pcsv
2ombzl,,,0,C47H72O3,[],,"2-Octaprenyl-6-methoxy-1,4-benzoquinol",,"2-Octaprenyl-6-methoxy-1,4-benzoquinol",,,,,2016-11-22T15:12:30Z,,3397,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3397/?format=pcsv
isobut,,,-1,C4H7O2,[],,"Isobutyrate, 2-Methylpropanoate",,"Isobutyrate, 2-Methylpropanoate",,,,,2016-11-22T15:12:42Z,,3398,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3398/?format=pcsv
isoval,,,-1,C5H9O2,[],,"Isovalerate, 3-Methylbutanoate",,"Isovalerate, 3-Methylbutanoate",,,,,2016-11-22T15:12:42Z,,3399,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3399/?format=pcsv
isocapr,,,-1,C6H11O2,[],,Isocaproate,,Isocaproate,,,,,2016-11-22T15:12:42Z,,3400,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3400/?format=pcsv
hphaccoa,,,-4,C29H38N7O18P3S,,,4-Hydroxyphenylacetyl-CoA,,4-Hydroxyphenylacetyl-CoA,,,,,2016-11-22T15:12:34Z,,3401,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3401/?format=pcsv
indaccoa,,,-4,C31H39N8O17P3S,[],,S-2-(indol-3-yl)acetyl-CoA,,S-2-(indol-3-yl)acetyl-CoA,,,,,2016-11-22T15:12:35Z,,3402,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3402/?format=pcsv
indpyr,,,-1,C11H8NO3,[],,Indolepyruvate,,Indolepyruvate,,,,,2016-11-22T15:12:35Z,,3403,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3403/?format=pcsv
mannan,,,0,C840H1402O701,[],,"Alpha-mannan, yeast, has a MW of about 25000 (PMID: 5461381), equals ~ 140 mannose units. ID according to iMM904",,"Alpha-mannan, yeast, has a MW of about 25000 (PMID: 5461381), equals ~ 140 mannose units. ID according to iMM904",,,,,2016-11-22T15:12:35Z,,3404,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3404/?format=pcsv
amylopect900,,,0,C5400H9002O4501,,,"Amylopectin, 900 repeat units",,"Amylopectin, 900 repeat units",,,,,2016-11-22T15:12:32Z,,3405,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3405/?format=pcsv
amylose300,,,0,C1800H3002O1501,[],,"amylose (n=300 repeat units, alpha-1,4-glc)",,"amylose (n=300 repeat units, alpha-1,4-glc)",,,,,2016-11-22T15:12:32Z,,3406,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3406/?format=pcsv
arabinan101,,,-2,C509H812O410,[],,"Arabinan, polymer of 1,5-a-L-linked arabinofuranose units substituted by 1,3 or 1,2 linked branches, MW ~ 15000 Da (REF: www.meg... <Preview truncated at 128 characters>",,"Arabinan, polymer of 1,5-a-L-linked arabinofuranose units substituted by 1,3 or 1,2 linked branches, MW ~ 15000 Da (REF: www.meg... <Preview truncated at 128 characters>",,,,,2016-11-22T15:12:32Z,,3407,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3407/?format=pcsv
arabinogal,,,0,C3862H6376O3218,[],,"Larch arabinogalactan, gal/ara 6:1, small amount of glcur, MW ~ 116000",,"Larch arabinogalactan, gal/ara 6:1, small amount of glcur, MW ~ 116000",,,,,2016-11-22T15:12:32Z,,3408,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3408/?format=pcsv
arabinoxyl,,,0,C276H446O223,,,"Arabinoxylan, 30 xyl_D, 18 arab_L, 3 gal, 3 glc_D",,"Arabinoxylan, 30 xyl_D, 18 arab_L, 3 gal, 3 glc_D",,,,,2016-11-22T15:12:32Z,,3409,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3409/?format=pcsv
cspg_a_degr,,,-2,C14H21NO15S,[],,Dimer GalNAc4S-GlcA,,Dimer GalNAc4S-GlcA,,,,,2016-11-22T15:12:41Z,,3410,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3410/?format=pcsv
cspg_b_degr,,,-3,C14H20NO18S2,[],,Dimer GalNAc4S-IdoA2S,,Dimer GalNAc4S-IdoA2S,,,,,2016-11-22T15:12:33Z,,3411,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3411/?format=pcsv
cspg_c_degr,,,-2,C14H21NO15S,[],,Dimer GalNAc6S-GlcA,,Dimer GalNAc6S-GlcA,,,,,2016-11-22T15:12:41Z,,3412,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3412/?format=pcsv
cspg_ab_rest,,,-1,C17H28O17SX,[],,"Not degradable product CSABCPASE_A/B, Gal4S-Gal-Xyl-L-Ser-protein",,"Not degradable product CSABCPASE_A/B, Gal4S-Gal-Xyl-L-Ser-protein",,,,,2016-11-22T15:12:33Z,,3413,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3413/?format=pcsv
cspg_c_rest,,,-1,C17H28O17SX,[],,"Not degradable product CSABCPASE_C, Gal6S-Gal-Xyl-L-Ser-protein",,"Not degradable product CSABCPASE_C, Gal6S-Gal-Xyl-L-Ser-protein",,,,,2016-11-22T15:12:41Z,,3414,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3414/?format=pcsv
acgalglcur,,,-1,C14H22NO12,[],,Dimer GalNAc-GlcA,,Dimer GalNAc-GlcA,,,,,2016-11-22T15:12:31Z,,3415,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3415/?format=pcsv
acgalidour,,,-1,C14H22NO12,[],, Dimer GalNAc-IdoA,, Dimer GalNAc-IdoA,,,,,2016-11-22T15:12:40Z,,3416,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3416/?format=pcsv
acgalidour2s,,,-2,C14H21NO15S,[],, Dimer GalNAc-IdoA2S,, Dimer GalNAc-IdoA2S,,,,,2016-11-22T15:12:31Z,,3417,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3417/?format=pcsv
dextran40,,,0,C480H800O400,[],,"Dextran 40, 1,6-alpha-D-Glucan",,"Dextran 40, 1,6-alpha-D-Glucan",,,,,2016-11-22T15:12:33Z,,3418,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3418/?format=pcsv
hspg_degr_1,,,-7,C24H33O36N2S5,[],,"Product 1 HEPARL1_e, IdoA-GlcN2,6diS-GlcA-GlcN2,3,6triS",,"Product 1 HEPARL1_e, IdoA-GlcN2,6diS-GlcA-GlcN2,3,6triS",,,,,2016-11-22T15:12:34Z,,3419,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3419/?format=pcsv
hspg_degr_2,,,-6,C49H71N2O56S5X,[],,"Product 2 HEPARL1_e, IdoA2S-GlcN2,6diS-IdoA2S-GlcNAc3S-GlcA-Gal-Gal-Xyl-L-Ser (protein)",,"Product 2 HEPARL1_e, IdoA2S-GlcN2,6diS-IdoA2S-GlcNAc3S-GlcA-Gal-Gal-Xyl-L-Ser (protein)",,,,,2016-11-22T15:12:34Z,,3420,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3420/?format=pcsv
hspg_degr_3,,,-6,C18H26O30N2S5,[],,"Product IDOURASE_HS1, GlcN2,6diS-GlcA-GlcN2,3,6triS",,"Product IDOURASE_HS1, GlcN2,6diS-GlcA-GlcN2,3,6triS",,,,,2016-11-22T15:12:34Z,,3421,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3421/?format=pcsv
hspg_degr_4,,,-4,C18H28O24N2S3,[],,"Product AS6TASE_HS1, GlcN2S-GlcA-GlcN2,3diS",,"Product AS6TASE_HS1, GlcN2S-GlcA-GlcN2,3diS",,,,,2016-11-22T15:12:34Z,,3422,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3422/?format=pcsv
hspg_degr_5,,,-3,C18H29O21N2S2,[],,"Product AS3TASE_HS1, GlcN2S-GlcA-GlcN2S",,"Product AS3TASE_HS1, GlcN2S-GlcA-GlcN2S",,,,,2016-11-22T15:12:34Z,,3423,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3423/?format=pcsv
hspg_degr_6,,,-1,C18H31O15N2,[],,"Product GAM2STASE_HS2, GlcN-GlcA-GlcN",,"Product GAM2STASE_HS2, GlcN-GlcA-GlcN",,,,,2016-11-22T15:12:34Z,,3424,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3424/?format=pcsv
hspg_degr_7,,,-6,C49H71N2O50S3X,[],,"Product IS2TASE_HS1, IdoA-GlcN2,6diS-IdoA-GlcNAc3S-GlcA-Gal-Gal-Xyl-L-Ser (protein)",,"Product IS2TASE_HS1, IdoA-GlcN2,6diS-IdoA-GlcNAc3S-GlcA-Gal-Gal-Xyl-L-Ser (protein)",,,,,2016-11-22T15:12:34Z,,3425,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3425/?format=pcsv
hspg_degr_8,,,-5,C43H64N2O44S3X,[],,"Product IDOURASE_HS2, GlcN2,6diS-IdoA-GlcNAc3S-GlcA-Gal-Gal-Xyl-L-Ser (protein)",,"Product IDOURASE_HS2, GlcN2,6diS-IdoA-GlcNAc3S-GlcA-Gal-Gal-Xyl-L-Ser (protein)",,,,,2016-11-22T15:12:34Z,,3426,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3426/?format=pcsv
hspg_degr_9,,,-4,C43H65N2O41S2X,[],,"Product AS6TASE_HS2, GlcN2S-IdoA-GlcNAc3S-GlcA-Gal-Gal-Xyl-L-Ser (protein)",,"Product AS6TASE_HS2, GlcN2S-IdoA-GlcNAc3S-GlcA-Gal-Gal-Xyl-L-Ser (protein)",,,,,2016-11-22T15:12:34Z,,3427,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3427/?format=pcsv
hspg_degr_10,,,-3,C43H66N2O38SX,[],,"Product AS3TASE_HS2, GlcN2S-IdoA-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein)",,"Product AS3TASE_HS2, GlcN2S-IdoA-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein)",,,,,2016-11-22T15:12:34Z,,3428,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3428/?format=pcsv
hspg_degr_11,,,-2,C43H67N2O35X,[],,"Product GAM2STASE_HS3, GlcN-IdoA-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein)",,"Product GAM2STASE_HS3, GlcN-IdoA-GlcNAc-GlcA-Gal-Gal-Xyl-L-Ser (protein)",,,,,2016-11-22T15:12:34Z,,3429,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3429/?format=pcsv
hspg_degr_12,,,-2,C37H56NO31X,[],,"Product GLCNACASE_HS2, GlcA-GlcNAc-IdoA-Gal-Gal-Xyl-L-Ser (protein)",,"Product GLCNACASE_HS2, GlcA-GlcNAc-IdoA-Gal-Gal-Xyl-L-Ser (protein)",,,,,2016-11-22T15:12:42Z,,3430,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3430/?format=pcsv
hspg_degr_13,,,-1,C31H49NO25X,[],,"Product GLCAASE_HS, GlcNAc-IdoA-Gal-Gal-Xyl-L-Ser (protein)",,"Product GLCAASE_HS, GlcNAc-IdoA-Gal-Gal-Xyl-L-Ser (protein)",,,,,2016-11-22T15:12:42Z,,3431,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3431/?format=pcsv
hspg_degr_14,,,-1,C23H36O20X,[],,"Product GLCNACASE_HS3, IdoA-Gal-Gal-Xyl-L-Ser (protein)",,"Product GLCNACASE_HS3, IdoA-Gal-Gal-Xyl-L-Ser (protein)",,,,,2016-11-22T15:12:42Z,,3432,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3432/?format=pcsv
hspg_degr_15,,,0,C17H29O14X,[],,"Product IDOURASE_HS3, Gal-Gal-Xyl-L-Ser (protein)",,"Product IDOURASE_HS3, Gal-Gal-Xyl-L-Ser (protein)",,,,,2016-11-22T15:12:42Z,,3433,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3433/?format=pcsv
hspg_rest,,,0,C5H9O4X,[],,"Undegradable product GALASE_HS, Xyl-L-Ser (protein)",,"Undegradable product GALASE_HS, Xyl-L-Ser (protein)",,,,,2016-11-22T15:12:42Z,,3434,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3434/?format=pcsv
gam26s,,,-2,C6H11NO11S2,[],,"Glucosamine 2,6-sulfate",,"Glucosamine 2,6-sulfate",,,,,2016-11-22T15:12:34Z,,3435,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3435/?format=pcsv
homogal,,,-120,C660H840O660,[],,"Homogalacturonan, 100 galacturonate residues. Assumed to be methylated/ acetylated in every 5th residue. Citrus HG consists of 7... <Preview truncated at 128 characters>",,"Homogalacturonan, 100 galacturonate residues. Assumed to be methylated/ acetylated in every 5th residue. Citrus HG consists of 7... <Preview truncated at 128 characters>",,,,,2016-11-22T15:12:34Z,,3436,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3436/?format=pcsv
inulin,,,0,C180H302O151,[],,"Chicory inulin, 30 monosaccharide units (29 fru, 1 glc) on average",,"Chicory inulin, 30 monosaccharide units (29 fru, 1 glc) on average",,,,,2016-11-22T15:12:35Z,,3437,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3437/?format=pcsv
levan1000,,,0,C6000H10002O5001,[],,"Levan, 1000 fructose units",,"Levan, 1000 fructose units",,,,,2016-11-22T15:12:42Z,,3438,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3438/?format=pcsv
levanb,,,0,C12H22O11,[],,Levanbiose,,Levanbiose,,,,,2016-11-22T15:12:42Z,,3439,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3439/?format=pcsv
levanttr,,,0,C18H32O16,[],,Levantriose,,Levantriose,,,,,2016-11-22T15:12:42Z,,3440,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3440/?format=pcsv
levantttr,,,0,C24H42O21,[],,Levantetraose,,Levantetraose,,,,,2016-11-22T15:12:42Z,,3441,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3441/?format=pcsv
acgal6p,,,-2,C8H14NO9P,[],,N-Acetyl-D-galactosamine 6-phosphate,,N-Acetyl-D-galactosamine 6-phosphate,,,,,2016-11-22T15:12:40Z,,3442,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3442/?format=pcsv
galam6p,,,-1,C6H13NO8P,[],,D-galactosamine-6-phosphate,,D-galactosamine-6-phosphate,,,,,2016-11-22T15:12:41Z,,3443,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3443/?format=pcsv
pecticgal,,,-11,C597H971O503,[],,"Pectic galactan (potato), gal: arab-L: rmn: galur = 78: 9: 4: 9 (www.megazyme.com). Assumed to consist of 100 sugars per macromo... <Preview truncated at 128 characters>",,"Pectic galactan (potato), gal: arab-L: rmn: galur = 78: 9: 4: 9 (www.megazyme.com). Assumed to consist of 100 sugars per macromo... <Preview truncated at 128 characters>",,,,,2016-11-22T15:12:36Z,,3444,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3444/?format=pcsv
pullulan1200,,,0,C7200H12002O6001,[],,"pullulan (n=1200 repeat units, alpha-1,4 and alph-1,6 bounds)",,"pullulan (n=1200 repeat units, alpha-1,4 and alph-1,6 bounds)",,,,,2016-11-22T15:12:37Z,,3445,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3445/?format=pcsv
rhamnogalurI,,,-620,C5840H7862O5281,[],,"Potato rhamnogalacturonan I, MW assumed ~200000, 62 galur, 20 rmn, 12 gal, 3 arab-L, 1 xyl-D (www.megazyme.com, PMID: 16661590)",,"Potato rhamnogalacturonan I, MW assumed ~200000, 62 galur, 20 rmn, 12 gal, 3 arab-L, 1 xyl-D (www.megazyme.com, PMID: 16661590)",,,,,2016-11-22T15:12:37Z,,3446,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3446/?format=pcsv
rhamnogalurII,,,-27,C317H445O273,[],,"Wine rhamnogalacturonan II, MW ~ 5-10 kDa, 37% galur, 16% rmn, 3% fuc-L, 11% arab-L, 6% gal, 5% glcur, 4% 2omfuc, 3% 2omxyl, 6% ... <Preview truncated at 128 characters>",,"Wine rhamnogalacturonan II, MW ~ 5-10 kDa, 37% galur, 16% rmn, 3% fuc-L, 11% arab-L, 6% gal, 5% glcur, 4% 2omfuc, 3% 2omxyl, 6% ... <Preview truncated at 128 characters>",,,,,2016-11-22T15:12:37Z,,3447,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3447/?format=pcsv
2omfuc,,,0,C7H14O5,[],,2-o-methylfucose (rare sugar in rhamnogalacturonan II),,2-o-methylfucose (rare sugar in rhamnogalacturonan II),,,,,2016-11-22T15:12:30Z,,3448,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3448/?format=pcsv
2omxyl,,,0,C6H12O5,[],,2-O-methylxylose (rare sugar in rhamnogalacturonan II),,2-O-methylxylose (rare sugar in rhamnogalacturonan II),,,,,2016-11-22T15:12:39Z,,3449,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3449/?format=pcsv
apio_D,,,0,C5H10O5,[],,D-Apiose (rare sugar in rhamnogalacturonan II),,D-Apiose (rare sugar in rhamnogalacturonan II),,,,,2016-11-22T15:12:40Z,,3450,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3450/?format=pcsv
acerA,,,-1,C6H9O6,[],,Aceric acid (3-C-carboxy-5-deoxy-l-xylose) (rare sugar in rhamnogalacturonan II),,Aceric acid (3-C-carboxy-5-deoxy-l-xylose) (rare sugar in rhamnogalacturonan II),,,,,2016-11-22T15:12:40Z,,3451,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3451/?format=pcsv
3ddlhept,,,-1,C7H9O8,[],,3-deoxy-d-lyxo-heptulosaric acid (rare sugar in rhamnogalacturonan II),,3-deoxy-d-lyxo-heptulosaric acid (rare sugar in rhamnogalacturonan II),,,,,2016-11-22T15:12:30Z,,3452,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3452/?format=pcsv
2hmc,,,-2,C6H4O5,[],,2-Hydroxymuconate,,2-Hydroxymuconate,,,,,2016-11-22T15:12:30Z,,3453,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3453/?format=pcsv
oxalc,,,-2,C6H4O5,[],,4-Oxalocrotonate,,4-Oxalocrotonate,,,,,2016-11-22T15:12:43Z,,3454,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3454/?format=pcsv
n6all26d,,,-1,C9H15N2O5,[],,"N6-Acetyl-LL-2,6-diaminoheptanedioate",,"N6-Acetyl-LL-2,6-diaminoheptanedioate",,,,,2016-11-22T15:12:42Z,,3455,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3455/?format=pcsv
acamoxm,,,-2,C9H11NO6,58117,,N_Acetyl_L_2_amino_6_oxopimelate,,N_Acetyl_L_2_amino_6_oxopimelate,,,,,2016-11-22T15:12:31Z,,3456,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3456/?format=pcsv
prl45tcaala,,,0,X,,,Prenol-45n teichoic acid-alanine substituted,,Prenol-45n teichoic acid-alanine substituted,,,,,2016-11-22T15:12:43Z,,3457,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3457/?format=pcsv
plml24tcaala_D,,,0,X,,,"Palmitoyllipoteichoic acid (n=24), linked, D-alanine substituted",,"Palmitoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:43Z,,3458,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3458/?format=pcsv
msll24tcaala_D,,,0,X,,,"Myristoyllipoteichoic acid (n=24), linked, D-alanine substituted",,"Myristoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:42Z,,3459,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3459/?format=pcsv
stel24tcaala_D,,,0,X,,,"Stearoyllipoteichoic acid (n=24), linked, D-alanine substituted",,"Stearoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:43Z,,3460,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3460/?format=pcsv
ihdl24tcaala_D,,,0,X,,,"Isoheptadecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,"Isoheptadecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:42Z,,3461,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3461/?format=pcsv
aihdl24tcaala_D,,,0,X,,,"Anteisoheptadecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,"Anteisoheptadecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:40Z,,3462,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3462/?format=pcsv
itdl24tcaala_D,,,0,X,,,"Isotetradecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,"Isotetradecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:42Z,,3463,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3463/?format=pcsv
iptd24tcaala_D,,,0,X,,,"Isopentadecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,"Isopentadecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:42Z,,3464,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3464/?format=pcsv
aipdl24tcaala_D,,,0,X,,,"Anteisopentadecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,"Anteisopentadecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:40Z,,3465,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3465/?format=pcsv
ihxdl24tcaala_D,,,0,X,,,"Isohexadecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,"Isohexadecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:42Z,,3466,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3466/?format=pcsv
5dglcn,,,-1,C6H9O7,[],,5-Dehydro-D-gluconate,,5-Dehydro-D-gluconate,,,,,2016-11-22T15:12:39Z,,3467,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3467/?format=pcsv
4hdxbutn,,,-1,C4H7O3,30830,,4-Hydroxybutanoate,,4-Hydroxybutanoate,,,,,2016-11-22T15:12:39Z,,3468,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3468/?format=pcsv
4hbutcoa,,,-4,C25H38N7O18P3S,28522,,4-Hydroxybutyryl-CoA,,4-Hydroxybutyryl-CoA,,,,,2016-11-22T15:12:39Z,,3469,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3469/?format=pcsv
urdgly,,,0,C3H7N3O3,16282,,Ureidoglycine,,Ureidoglycine,,,,,2016-11-22T15:12:38Z,,3470,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3470/?format=pcsv
cdpddg,,,-2,C15H21N3O15P2,[],,CDP-4-dehydro-6-deoxy-D-glucose,,CDP-4-dehydro-6-deoxy-D-glucose,,,,,2016-11-22T15:12:32Z,,3471,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3471/?format=pcsv
ctbtcoa,,,-3,C28H44N8O17P3S,[],,crotonobetainyl-CoA,,crotonobetainyl-CoA,,,,,2016-11-22T15:12:33Z,,3472,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3472/?format=pcsv
crncoa,,,-3,C28H46N8O18P3S,[],,L-Carnitinyl-CoA,,L-Carnitinyl-CoA,,,,,2016-11-22T15:12:33Z,,3473,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3473/?format=pcsv
idon_L,,,-1,C6H11O7,[],,L-Idonate,,L-Idonate,,,,,2016-11-22T15:12:42Z,,3474,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3474/?format=pcsv
gtspmd,,,2,C17H36N6O5S,[],,Glutathionylspermidine,,Glutathionylspermidine,,,,,2016-11-22T15:12:34Z,,3475,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3475/?format=pcsv
np2msucc,,,-2,C15H12O4,[],,Naphthyl-2-methyl-succinic acid,,Naphthyl-2-methyl-succinic acid,,,,,2016-11-22T15:12:35Z,,3476,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3476/?format=pcsv
np2msucccoa,,,-5,C36H43N7O19P3S,[],,Naphthyl-2-methyl-succinyl-CoA,,Naphthyl-2-methyl-succinyl-CoA,,,,,2016-11-22T15:12:35Z,,3477,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3477/?format=pcsv
tcb,,,-3,C6H5O6,5969,,Tricarballylate,,Tricarballylate,,,,,2016-11-22T15:12:37Z,,3478,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3478/?format=pcsv
uacmamu,,,-3,C17H22N3O18P2,[],,UDP-N-acetyl-D-mannosaminouronate,,UDP-N-acetyl-D-mannosaminouronate,,,,,2016-11-22T15:12:37Z,,3479,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3479/?format=pcsv
udpgalfur,,,-2,C15H22N2O17P2,[],,"UDP-D-galacto-1,4-furanose",,"UDP-D-galacto-1,4-furanose",,,,,2016-11-22T15:12:44Z,,3480,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3480/?format=pcsv
urdglyc,,,-1,C3H5N2O4,[],,(-)-Ureidoglycolate,,(-)-Ureidoglycolate,,,,,2016-11-22T15:12:38Z,,3481,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3481/?format=pcsv
oxur,,,-1,C3H3N2O4,[],,Oxalureate,,Oxalureate,,,,,2016-11-22T15:12:35Z,,3482,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3482/?format=pcsv
tet,,,-2,O6S4,[],,Tetrathionate,,Tetrathionate,,,,,2016-11-22T15:12:44Z,,3483,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3483/?format=pcsv
selni,,,-2,SeO3,[],,selenite,,selenite,,,,,2016-11-22T15:12:44Z,,3484,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3484/?format=pcsv
cbmt,,,-1,CH2NO2,[],,Carbamate,,Carbamate,,,,,2016-11-22T15:12:32Z,,3485,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3485/?format=pcsv
cinnm,,,-1,C9H7O2,[],,trans-Cinnamate,,trans-Cinnamate,,,,,2016-11-22T15:12:32Z,,3486,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3486/?format=pcsv
cenchddd,,,-1,C9H9O4,[],,"cis-3-(3-carboxyethenyl)-3,5-cyclohexadiene-1,2-diol",,"cis-3-(3-carboxyethenyl)-3,5-cyclohexadiene-1,2-diol",,,,,2016-11-22T15:12:41Z,,3487,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3487/?format=pcsv
cechddd,,,-1,C9H11O4,[],,"cis-3-(3-carboxyethyl)-3,5-cyclohexadiene-1,2-diol",,"cis-3-(3-carboxyethyl)-3,5-cyclohexadiene-1,2-diol",,,,,2016-11-22T15:12:32Z,,3488,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3488/?format=pcsv
dhdpacoa,,,-4,C29H40N7O20P3S,,,cis-dihydrodiol derivative of phenylacetyl-CoA,,cis-dihydrodiol derivative of phenylacetyl-CoA,,,,,2016-11-22T15:12:33Z,,3489,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3489/?format=pcsv
hoacoa,,,-4,C27H40N7O20P3S,,,3-hydroxyadipyl-CoA,,3-hydroxyadipyl-CoA,,,,,2016-11-22T15:12:34Z,,3490,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3490/?format=pcsv
aclys,,,0,C8H16N2O3,,,N2-Acetyl-L-lysine,,N2-Acetyl-L-lysine,,,,,2016-11-22T15:12:27Z,,3491,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3491/?format=pcsv
dextrin,,,0,C36H62O31,[],,Dextrin,,Dextrin,,,,,2016-11-22T15:12:41Z,,3492,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3492/?format=pcsv
dhsql,,,0,C30H48,[],,Dehydrosqualene,,Dehydrosqualene,,,,,2016-11-22T15:12:33Z,,3493,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3493/?format=pcsv
44dpnspr,,,0,C30H42,[],,"4,4-Diaponeurosporene",,"4,4-Diaponeurosporene",,,,,2016-11-22T15:12:31Z,,3494,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3494/?format=pcsv
pphtd,,,-3,C40H65O7P2,[],,Prephytoene diphosphate,,Prephytoene diphosphate,,,,,2016-11-22T15:12:43Z,,3495,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3495/?format=pcsv
isomal,,,0,C12H22O11,[],,"Isomaltose,  Brachiose",,"Isomaltose,  Brachiose",,,,,2016-11-22T15:12:42Z,,3496,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3496/?format=pcsv
acaadp,,,-2,C8H11NO5,[],,N2-Acetyl-L-aminoadipate,,N2-Acetyl-L-aminoadipate,,,,,2016-11-22T15:12:31Z,,3497,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3497/?format=pcsv
phytn,,,0,C40H64,[],,Phytoene,,Phytoene,,,,,2016-11-22T15:12:43Z,,3498,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3498/?format=pcsv
15phytn,,,0,C40H64,[],,15-cis-Phytoene,,15-cis-Phytoene,,,,,2016-11-22T15:12:28Z,,3499,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3499/?format=pcsv
tcam,,,0,X,,,"minor teichoic acid (acetylgalactosamine glucose phosphate, n=30)",,"minor teichoic acid (acetylgalactosamine glucose phosphate, n=30)",,,,,2016-11-22T15:12:43Z,,3500,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3500/?format=pcsv
prl45tcaglc,,,0,X,,,Prenol-45n teichoic acid-glucose substituted,,Prenol-45n teichoic acid-glucose substituted,,,,,2016-11-22T15:12:43Z,,3501,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3501/?format=pcsv
glyc45tca,,,0,X,,,"glycerol teichoic acid (n=45), linked, unsubstituted",,"glycerol teichoic acid (n=45), linked, unsubstituted",,,,,2016-11-22T15:12:41Z,,3502,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3502/?format=pcsv
glyc45tcaglc,,,0,X,,,"glycerol teichoic acid (n=45), linked, glucose substituted",,"glycerol teichoic acid (n=45), linked, glucose substituted",,,,,2016-11-22T15:12:41Z,,3503,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3503/?format=pcsv
glyc45tcaala_D,,,0,X,,,"glycerol teichoic acid (n=45), linked, D-ala substituted",,"glycerol teichoic acid (n=45), linked, D-ala substituted",,,,,2016-11-22T15:12:41Z,,3504,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3504/?format=pcsv
plml24tcaglu,,,0,X,,,"Palmitoyllipoteichoic acid (n=24), linked, glucose substituted",,"Palmitoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:43Z,,3505,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3505/?format=pcsv
msll24tcaglu,,,0,X,,,"Myristoyllipoteichoic acid (n=24), linked, glucose substituted",,"Myristoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:42Z,,3506,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3506/?format=pcsv
stel24tcaglu,,,0,X,,,"Stearoyllipoteichoic acid (n=24), linked, glucose substituted",,"Stearoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:43Z,,3507,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3507/?format=pcsv
ihdl24tcaglu,,,0,X,,,"Isoheptadecanoyllipoteichoic acid (n=24), linked, glucose substituted",,"Isoheptadecanoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:42Z,,3508,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3508/?format=pcsv
aihdl24tcaglu,,,0,X,,,"Anteisoheptadecanoyllipoteichoic acid (n=24), linked, glucose substituted",,"Anteisoheptadecanoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:40Z,,3509,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3509/?format=pcsv
itdl24tcaglu,,,0,X,,,"Isotetradecanoyllipoteichoic acid (n=24), linked, glucose substituted",,"Isotetradecanoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:42Z,,3510,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3510/?format=pcsv
ipdl24tcaglu,,,0,X,,,"Isopentadecanoyllipoteichoic acid (n=24), linked, glucose substituted",,"Isopentadecanoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:42Z,,3511,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3511/?format=pcsv
aipdl24tcaglu,,,0,X,,,"Anteisopentadecanoyllipoteichoic acid (n=24), linked, glucose substituted",,"Anteisopentadecanoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:40Z,,3512,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3512/?format=pcsv
ihxdl24tcaglu,,,0,X,,,"Isohexadecanoyllipoteichoic acid (n=24), linked, glucose substituted",,"Isohexadecanoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:42Z,,3513,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3513/?format=pcsv
5apentam,,,1,C5H13N2O,[],,5-Aminopentanamide,,5-Aminopentanamide,,,,,2016-11-22T15:12:31Z,,3514,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3514/?format=pcsv
1p4h2cbxl,,,-1,C5H6NO3,,,,,1-Pyrroline-4-hydroxy-2-carboxylate,,,,,2016-11-22T15:12:38Z,,3515,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3515/?format=pcsv
25dop,,,-1,C5H5O4,,,,,"2,5-Dioxopentanoate",,,,,2016-11-22T15:12:29Z,,3516,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3516/?format=pcsv
2m1hptpp,,,-2,C16H24N4O8P2S,,,,,2-Methyl-1-hydroxypropyl-TPP,,,,,2016-11-22T15:12:30Z,,3517,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3517/?format=pcsv
2m1hbtpp,,,-2,C17H26N4O8P2S,,,,,2-Methyl-1-hydroxybutyl-TPP,,,,,2016-11-22T15:12:30Z,,3518,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3518/?format=pcsv
phenol,,,0,C6H6O,,,,,Phenol,,,,,2016-11-22T15:12:46Z,,3519,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3519/?format=pcsv
3m1hbtpp,,,-2,C17H26N4O8P2S,,,,,3-Methyl-1-hydroxybutyl-TPP,,,,,2016-11-22T15:12:39Z,,3520,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3520/?format=pcsv
lac6p,,,-2,C12H21O14P,,,,,Lactose 6-phosphate,,,,,2016-11-22T15:12:42Z,,3521,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3521/?format=pcsv
dgal6p,,,-2,C6H11O9P,,,,,6-Phospho-D-galactose,,,,,2016-11-22T15:12:41Z,,3522,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3522/?format=pcsv
btn_co2,,,-1,C17H26N4O5SX,,,,,Carboxybiotin-carboxyl-carrier protein,,,,,2016-11-22T15:12:46Z,,3523,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3523/?format=pcsv
acaadpdp,,,-2,C8H12NO8P,,,,,N2-Acetyl-L-aminoadipyl-delta-phosphate,,,,,2016-11-22T15:12:46Z,,3524,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3524/?format=pcsv
acaadpsal,,,-1,C8H12NO4,,,,,N2-Acetyl-L-aminoadipate semialdehyde,,,,,2016-11-22T15:12:46Z,,3525,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3525/?format=pcsv
m12dahglyc,,,0,C43H82O10,,,,,"Monoglucosyl-1,2 dianteisoheptadecanoylglycerol",,,,,2016-11-22T15:12:35Z,,3526,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3526/?format=pcsv
m12dapglyc,,,0,C39H74O10,,,,,"Monoglucosyl-1,2 dianteisopentadecanoylglycerol",,,,,2016-11-22T15:12:35Z,,3527,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3527/?format=pcsv
btoh,,,0,C4H10O,,,,,butanol,,,,,2016-11-22T15:12:32Z,,3528,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3528/?format=pcsv
mql7,,,0,C46H66O2,,,,,Menaquinol 7,,,,,2016-11-22T15:12:35Z,,3529,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3529/?format=pcsv
2dmmq7,,,0,C45H62O2,,,,,2-Demethylmenaquinone 7,,,,,2016-11-22T15:12:29Z,,3530,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3530/?format=pcsv
glycys,,,0,C5H10N2O3S,,,,,Gly-Cys,,,,,2016-11-22T15:12:46Z,,3531,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3531/?format=pcsv
plasmetha,,,-1,C8H13NO7PR2,,,,,Plasmenylethanolamine,,,,,2016-11-22T15:12:46Z,,3532,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3532/?format=pcsv
M00512,,,0,C6H8O4R2,,,,,1-Alkenyl-2-acylglycerol,,,,,2016-11-22T15:12:46Z,,3533,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3533/?format=pcsv
mqn7,,,0,C46H64O2,,,,,Menaquinone 7,,,,,2016-11-22T15:12:28Z,,3534,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3534/?format=pcsv
mobd,,,-2,MoO4,,,,,Molybdate,,,,,2016-11-22T15:12:35Z,,3535,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3535/?format=pcsv
rbflvrd,,,0,C17H22N4O6,,,,,Reduced riboflavin,,,,,2016-11-22T15:12:46Z,,3536,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3536/?format=pcsv
M01966,,,0,C6H14O12P2,,,,,"D-Glucose 1,6-bisphosphate",,,,,2016-11-22T15:12:46Z,,3537,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3537/?format=pcsv
imogly,,,0,C2H3NO2,,,,,Iminoglycine,,,,,2016-11-22T15:12:34Z,,3538,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3538/?format=pcsv
histl_L,,,1,C6H10N3O,,,,,L-Histidinal,,,,,2016-11-22T15:12:46Z,,3539,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3539/?format=pcsv
m12dihglyc,,,0,C43H82O10,,,,,"Monoglucosyl-1,2 diisoheptadecanoylglycerol",,,,,2016-11-22T15:12:42Z,,3540,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3540/?format=pcsv
m12dipglyc,,,0,C39H74O10,,,,,"Monoglucosyl-1,2 diisopentadecanoylglycerol",,,,,2016-11-22T15:12:42Z,,3541,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3541/?format=pcsv
m12ditglyc,,,0,C37H70O10,,,,,"Monoglucosyl-1,2 diisotetradecanoylglycerol",,,,,2016-11-22T15:12:35Z,,3542,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3542/?format=pcsv
m12dixglyc,,,0,C41H78O10,,,,,"Monoglucosyl-1,2 diisohexadecanoylglycerol",,,,,2016-11-22T15:12:35Z,,3543,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3543/?format=pcsv
m12dmglyc,,,0,C37H70O10,,,,,"Monoglucosyl-1,2 dimyristoylglycerol",,,,,2016-11-22T15:12:42Z,,3544,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3544/?format=pcsv
2mnptl,,,0,C11H10,,,,,2-Methylnaphthalene,,,,,2016-11-22T15:12:30Z,,3545,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3545/?format=pcsv
pre1,,,-8,C41H38N4O16,,,,,Precorrin 1,,,,,2016-11-22T15:12:46Z,,3546,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3546/?format=pcsv
pslac,,,-4,C3H3O9PS,,,,,(2R)-O-phospho-3-sulfolactic acid,,,,,2016-11-22T15:12:37Z,,3547,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3547/?format=pcsv
m12dpglyc,,,0,C41H78O10,,,,,"Monoglucosyl-1,2 dipalmitoylglycerol",,,,,2016-11-22T15:12:42Z,,3548,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3548/?format=pcsv
salc,,,-1,C7H5O3,,,,,"Salicylic acid, o-Hydroxybenzoic acid",,,,,2016-11-22T15:12:43Z,,3549,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3549/?format=pcsv
m12dsglyc,,,0,C45H86O10,,,,,"Monoglucosyl-1,2 distearoylglycerol",,,,,2016-11-22T15:12:42Z,,3550,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3550/?format=pcsv
sttcaglc,,,-24,C267H480O255P24,,,,,"Stearoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:46Z,,3551,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3551/?format=pcsv
ai17tcaglc,,,-24,C265H476O255P24,,,,,"Anteisoheptadecanoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:46Z,,3552,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3552/?format=pcsv
i17tcaglc,,,-24,C265H476O255P24,,,,,"Isoheptadecanoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:46Z,,3553,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3553/?format=pcsv
sttcaala_D,,,0,C195H336N24O135P24,,,,,"Stearoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:46Z,,3554,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3554/?format=pcsv
ai17tcaala_D,,,0,C193H332N24O135P24,,,,,"Anteisoheptadecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:46Z,,3555,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3555/?format=pcsv
i17tcaala_D,,,0,C193H332O135N24P24,,,,,"Isoheptadecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:46Z,,3556,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3556/?format=pcsv
2mmal,,,-2,C5H6O5,,,,,(R)-2-Methylmalate,,,,,2016-11-22T15:12:46Z,,3557,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3557/?format=pcsv
fmfur,,,-5,C35H39N4O16,,,,,Formylmethanofuran,,,,,2016-11-22T15:12:34Z,,3558,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3558/?format=pcsv
h4mpt,,,-3,C30H42N6O16P,,,,,"5,6,7,8-tetrahydromethanopterin",,,,,2016-11-22T15:12:34Z,,3559,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3559/?format=pcsv
mfur,,,-4,C34H40N4O15,,,,,Methanofuran,,,,,2016-11-22T15:12:35Z,,3560,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3560/?format=pcsv
5fth4mpt,,,-3,C31H42N6O17P,,,,,"N(5)-formyl-5,6,7,8-tetrahydromethanopterin",,,,,2016-11-22T15:12:31Z,,3561,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3561/?format=pcsv
5hxudidzcba,,,-1,C5H5N4O5,,,,,"5-Hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate",,,,,2016-11-22T15:12:31Z,,3562,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3562/?format=pcsv
alltn_R,,,0,C4H6N4O3,,,,,(R)-Allantoin,,,,,2016-11-22T15:12:40Z,,3563,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3563/?format=pcsv
ispre,,,0,C5H8,,,,,Isoprene,,,,,2016-11-22T15:12:35Z,,3564,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3564/?format=pcsv
coF420,,,-4,C29H34N5O18P,,,,,Coenzyme F420,,,,,2016-11-22T15:12:33Z,,3565,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3565/?format=pcsv
mtethnpn,,,-3,C31H42N6O16P,,,,,"5,10-Methylenetetrahydromethanopterin",,,,,2016-11-22T15:12:35Z,,3566,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3566/?format=pcsv
coF420h,,,-4,C29H36N5O18P,,,,,Reduced coenzyme F420,,,,,2016-11-22T15:12:33Z,,3567,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3567/?format=pcsv
mtth4mpt,,,-2,C31H41N6O16P,,,,,"5,10-Methenyl-5,6,7,8-tetrahydromethanopterin",,,,,2016-11-22T15:12:35Z,,3568,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3568/?format=pcsv
mmtsa,,,-1,C4H5O3,,,,,(S)-Methylmalonate semialdehyde,,,,,2016-11-22T15:12:42Z,,3569,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3569/?format=pcsv
hmgth,,,-1,C11H18N3O7S,,,,,hydroxymethylglutathione,,,,,2016-11-22T15:12:46Z,,3570,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3570/?format=pcsv
mmet,,,1,C6H14NO2S,,,,,S-Methyl-L-methionine,,,,,2016-11-22T15:12:46Z,,3571,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3571/?format=pcsv
myrstcaala_D,,,0,C187H320N24O135P24,,,,,"Myristoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:46Z,,3572,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3572/?format=pcsv
palmtcaala_D,,,0,C191H328O135N24P24,,,,,"Palmitoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:46Z,,3573,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3573/?format=pcsv
ai15tcaala_D,,,0,C189H324N24O135P24,,,,,"Anteisopentadecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:46Z,,3574,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3574/?format=pcsv
i14tcaala_D,,,0,C187H320O135N24P24,,,,,"Isotetradecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:46Z,,3575,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3575/?format=pcsv
i15tcaala_D,,,0,C189H324O135N24P24,,,,,"Isopentadecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:46Z,,3576,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3576/?format=pcsv
i16tcaala_D,,,0,C191H328O135N24P24,,,,,"Isohexadecanoyllipoteichoic acid (n=24), linked, D-alanine substituted",,,,,2016-11-22T15:12:46Z,,3577,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3577/?format=pcsv
copre5b,,,-8,C43H42CoN4O16,,,,,Cobalt-precorrin-5b,,,,,2016-11-22T15:12:46Z,,3578,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3578/?format=pcsv
arab_D,,,0,C5H10O5,,,,,D-Arabinose,,,,,2016-11-22T15:12:40Z,,3579,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3579/?format=pcsv
nflgln,,,-1,C6H9N2O4,,,,,N-Formimino-L-glutamate,,,,,2016-11-17T15:09:58Z,,3580,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3580/?format=pcsv
nforglu,,,-2,C6H7NO5,,,,,N-Formyl-L-glutamate,,,,,2016-11-22T15:12:43Z,,3581,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3581/?format=pcsv
oazur,,,2,X,,,,,Oxidized azurin,,,,,2016-11-22T15:12:43Z,,3582,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3582/?format=pcsv
razur,,,1,X,,,,,Reduced azurin,,,,,2016-11-22T15:12:43Z,,3583,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3583/?format=pcsv
up4g,,,-4,C18H22N4O23P4,,,,,"P1,P4-Bis(5-uridyl) tetraphosphate; UppppU",,,,,2016-11-22T15:12:38Z,,3584,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3584/?format=pcsv
dhnacoa,,,-4,C32H38N7O19P3S,,,,,"1,4-Dihydroxy-2-naphthoyl-CoA",,,,,2016-11-22T15:12:46Z,,3585,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3585/?format=pcsv
mppp9mme,,,-1,C35H33N4O4Mg,,,,,Mg-Protoporphyrin IX 13-monomethyl ester,,,,,2016-11-22T15:12:46Z,,3586,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3586/?format=pcsv
hmppp9mme,,,-1,C35H33N4O5Mg,,,,,13(1)-Hydroxy-Mg-protoporphyrin IX 13-monomethyl ester,,,,,2016-11-22T15:12:46Z,,3587,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3587/?format=pcsv
oxomppp9mme,,,-1,C35H31N4O5Mg,,,,,13(1)-Oxo-Mg-protoporphyrin IX 13-monomethyl ester,,,,,2016-11-22T15:12:46Z,,3588,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3588/?format=pcsv
dvprotochloroph,,,-2,C35H28N4O5Mg,,,,,Divinylprotochlorophyllide,,,,,2016-11-22T15:12:47Z,,3589,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3589/?format=pcsv
oxam,,,-1,C2H2NO3,,,,,Oxamate,,,,,2016-11-22T15:12:46Z,,3590,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3590/?format=pcsv
btd_SS,,,0,C4H10O2,,,,,"(S,S)-2,3-Butanediol",,,,,2016-11-22T15:12:40Z,,3591,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3591/?format=pcsv
actn_S,,,0,C4H8O2,,,,,(S)-Acetoin,,,,,2016-11-22T15:12:40Z,,3592,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3592/?format=pcsv
myrstcaglc,,,-24,C259H464O255P24,,,,,"Myristoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:46Z,,3593,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3593/?format=pcsv
palmtcaglc,,,-24,C263H472O255P24,,,,,"Palmitoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:46Z,,3594,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3594/?format=pcsv
ai15tcaglc,,,-24,C261H468O255P24,,,,,"Anteisopentadecanoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:46Z,,3595,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3595/?format=pcsv
i14tcaglc,,,-24,C259H464O255P24,,,,,"Isotetradecanoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:46Z,,3596,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3596/?format=pcsv
i15tcaglc,,,-24,C261H468O255P24,,,,,"Isopentadecanoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:46Z,,3597,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3597/?format=pcsv
i16tcaglc,,,-24,C263H472O255P24,,,,,"Isohexadecanoyllipoteichoic acid (n=24), linked, glucose substituted",,,,,2016-11-22T15:12:46Z,,3598,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3598/?format=pcsv
acmama,,,-1,C14H23N2O9,,,,,N-Acetyl-D-muramoyl-L-alanine,,,,,2016-11-22T15:12:32Z,,3599,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3599/?format=pcsv
acmam,,,-1,C11H18NO8,,,,,N-Acetyl-D-muramoate,,,,,2016-11-22T15:12:32Z,,3600,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3600/?format=pcsv
oxcoa,,,-4,C23H32N7O19P3S,,,,,oxalyl-CoA,,,,,2016-11-22T15:12:35Z,,3601,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3601/?format=pcsv
adcobn,,,0,C55H76CoN15O11,,,,,Adenosylcobyric-acid,,,,,2016-11-17T14:52:56Z,,3602,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3602/?format=pcsv
comSScob,,,-4,C13H22NO10PS3,,,,,CoM-S-S-CoB,,,,,2016-11-22T15:12:33Z,,3603,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3603/?format=pcsv
dhmphze,,,0,C37H52N2O,,,,,Dihydromethanophenazine,,,,,2016-11-22T15:12:33Z,,3604,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3604/?format=pcsv
com,,,-1,C2H5O3S2,,,,,Coenzyme M,,,,,2016-11-22T15:12:33Z,,3605,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3605/?format=pcsv
cob,,,-3,C11H19NO7PS,,,,,Coenzyme B,,,,,2016-11-22T15:12:33Z,,3606,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3606/?format=pcsv
mphze,,,0,C37H50N2O,,,,,Methanophenazine,,,,,2016-11-22T15:12:35Z,,3607,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3607/?format=pcsv
n2,,,0,N2,,,,,Nitrogen,,,,,2016-11-22T15:12:35Z,,3608,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3608/?format=pcsv
35dacap,,,1,C6H15N2O2,,,,,"(3S,5S)-3,5-Diaminocaproate",,,,,2016-11-22T15:12:39Z,,3609,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3609/?format=pcsv
3btcoa,,,-4,C25H36N7O17P3S,,,,,3-Butenoyl-CoA,,,,,2016-11-22T15:12:39Z,,3610,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3610/?format=pcsv
4hpro_D,,,0,C5H9NO3,,,,,cis-4-Hydroxy-D-proline,,,,,2016-11-22T15:12:39Z,,3611,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3611/?format=pcsv
bbtcoa,,,-3,C28H46N8O17P3S,,,,,gamma-butyrobetainyl-CoA,,,,,2016-11-22T15:12:46Z,,3612,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3612/?format=pcsv
Cit_Mg,,,-1,C6H5O7Mg,,,,,Citrate-Mg,,,,,2016-11-22T15:12:33Z,,3613,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3613/?format=pcsv
dmlarg,,,1,C8H19N4O2,,,,,"NG,NG-Dimethyl-L-arginine",,,,,2016-11-22T15:12:33Z,,3614,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3614/?format=pcsv
dma,,,1,C2H8N,,,,,Dimethylamine,,,,,2016-11-22T15:12:33Z,,3615,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3615/?format=pcsv
hcit,,,-3,C7H7O7,,,,,Homocitrate,,,,,2016-11-22T15:12:42Z,,3616,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3616/?format=pcsv
12ethd,,,0,C2H6O2,,,,,"1,2-Ethanediol",,,,,2016-11-22T15:12:46Z,,3617,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3617/?format=pcsv
xylan,,,0,C2640H4226O2113,,,,,"Oat spelt xylan, MW 79200 (DOI: 10.1002/masy.200551405) = 528 xyl_D",,,,,2016-11-22T15:12:38Z,,3618,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3618/?format=pcsv
gdpmanur,,,-3,C16H20N5O17P2,,,,,GDP-D-mannuronate,,,,,2016-11-22T15:12:34Z,,3619,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3619/?format=pcsv
chlphyllide,,,0,C35H33N4O5Mg,,,,,Chlorophyllide,,,,,2016-11-22T15:12:46Z,,3620,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3620/?format=pcsv
chloropha,,,0,C55H71N4O5Mg,,,,,Chlorophyll a,,,,,2016-11-22T15:12:46Z,,3621,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3621/?format=pcsv
mppp9,,,-1,C34H31N4O4Mg,,,,,"Mg-protoporphyrin IX (iMEO21, iAF692)",,,,,2016-11-22T15:12:46Z,,3622,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3622/?format=pcsv
protochloroph,,,-1,C35H30MgN4O5,,,,,Protochlorophyllide,,,,,2016-11-22T15:12:47Z,,3623,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3623/?format=pcsv
cellul,,,0,C3000H5002O2501,,,,,"Cellulose, chain length 500 glc_D assumed, DOI: 10.1002/anie.200460587",,,,,2016-11-22T15:12:32Z,,3624,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3624/?format=pcsv
2ddpent,,,-1,C5H7O5,,,,,2-Dehydro-3-deoxy-L-pentonate,,,,,2016-11-22T15:12:39Z,,3625,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3625/?format=pcsv
xylhl_L,,,0,C6H8O6,,,,,L-xylo-Hexulonolactone,,,,,2016-11-22T15:12:44Z,,3626,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3626/?format=pcsv
pser_D,,,-2,C3H6NO6P,,,,,D-O-Phosphoserine,,,,,2016-11-22T15:12:43Z,,3627,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3627/?format=pcsv
1h2npt,,,-1,C11H7O3,,,,,1-Hydroxy-2-naphthoate,,,,,2016-11-22T15:12:29Z,,3628,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3628/?format=pcsv
12npthldl,,,0,C10H8O2,,,,,"1,2-Naphthalenediol",,,,,2016-11-22T15:12:28Z,,3629,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3629/?format=pcsv
4hmsaclt,,,-1,C8H7O4,,,,,4-Hydroxymethylsalicylate,,,,,2016-11-22T15:12:39Z,,3630,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3630/?format=pcsv
4hmcachl,,,0,C7H8O3,,,,,4-Hydroxymethylcatechol,,,,,2016-11-22T15:12:31Z,,3631,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3631/?format=pcsv
mcrea,,,-1,C8H7O3,,,,,m-Cresotic acid,,,,,2016-11-22T15:12:42Z,,3632,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3632/?format=pcsv
4mcat,,,0,C7H8O2,,,,,4-Methylcatechol,,,,,2016-11-22T15:12:39Z,,3633,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3633/?format=pcsv
3msaclt,,,-1,C8H7O3,,,,,3-Methylsalicylate,,,,,2016-11-22T15:12:39Z,,3634,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3634/?format=pcsv
3mcat,,,0,C7H8O2,,,,,3-Methylcatechol,,,,,2016-11-22T15:12:39Z,,3635,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3635/?format=pcsv
lyx_L,,,0,C5H10O5,,,,,L-Lyxose,,,,,2016-11-22T15:12:42Z,,3636,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3636/?format=pcsv
3abutcoa,,,-4,C25H39N8O17P3S,,,,,L-3-Aminobutyryl-CoA,,,,,2016-11-22T15:12:30Z,,3637,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3637/?format=pcsv
5a3ohex,,,-1,C6H10NO3,,,,,3-keto-5-aminohexanoate,,,,,2016-11-22T15:12:39Z,,3638,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3638/?format=pcsv
2hydog,,,-2,C5H6O5,,,,,2-hydroxyglutarate,,,,,2016-11-22T15:12:30Z,,3639,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3639/?format=pcsv
2hydogcoa,,,-4,C26H38N7O20P3S,,,,,2-hydroxyglutaryl-CoA,,,,,2016-11-22T15:12:30Z,,3640,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3640/?format=pcsv
glutaccoa,,,-4,C26H36N7O19P3S,,,,,Glutaconoyl-CoA,,,,,2016-11-22T15:12:34Z,,3641,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3641/?format=pcsv
2acamsucc,,,-2,C7H7NO5,,,,,2-(Acetamidomethylene)succinate,,,,,2016-11-22T15:12:47Z,,3642,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3642/?format=pcsv
4hbald,,,0,C7H6O2,,,,,4-Hydroxybenzaldehyde (iJN746),,,,,2016-11-17T15:09:46Z,,3643,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3643/?format=pcsv
malylcoa,,,-4,C25H36N7O20P3S,,,,,Malyl-CoA (iSO783),,,,,2016-11-22T15:12:47Z,,3644,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3644/?format=pcsv
xyllac_D,,,0,C5H8O5,,,,,D-Xylonolactone,,,,,2016-11-22T15:12:44Z,,3645,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3645/?format=pcsv
xylt_D,,,-1,C5H9O6,,,,,D-Xylonate,,,,,2016-11-22T15:12:44Z,,3646,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3646/?format=pcsv
2d3dxylt,,,-1,C5H7O5,,,,,2-Dehydro-3-deoxy-D-xylonate,,,,,2016-11-22T15:12:29Z,,3647,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3647/?format=pcsv
2mmale,,,-2,C5H4O4,,,,,2-Methylmaleate,,,,,2016-11-22T15:12:47Z,,3648,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3648/?format=pcsv
e3mmal,,,-2,C5H6O5,,,,,D-erythro-3-Methylmalate,,,,,2016-11-22T15:12:47Z,,3649,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3649/?format=pcsv
n2o,,,0,N2O,,,,,Nitrous oxide,,,,,2016-11-22T15:12:35Z,,3650,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3650/?format=pcsv
xyluglc,,,0,C6438H10610O5245,,,,,"Xyluglucan, PMID:16663672, Fry SC 1989. 600 glc_D, 360 xyl_D, 108 gal, 60 fuc_L, 6 arab_L",,,,,2016-11-22T15:12:38Z,,3651,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3651/?format=pcsv
starch1200,,,0,C7200H12002O6001,,,,,"starch n=1200 repeat units (300 repeat units amylose, 900 repeat units amylopectin, corresponds to potatoe starch)",,,,,2016-11-22T15:12:43Z,,3652,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3652/?format=pcsv
pime,,,-2,C7H10O4,,,,,Pimelate,,,,,2016-11-22T15:12:36Z,,3653,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3653/?format=pcsv
sbt_L,,,0,C6H14O6,,,,,L-Sorbitol (iMM904),,,,,2016-11-17T08:48:08Z,,3654,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3654/?format=pcsv
atnodp,,,-3,C45H73O7P2,,,,,all-trans-Nonaprenyl diphosphate; solanesyl diphosphate,,,,,2016-11-22T15:12:44Z,,3655,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3655/?format=pcsv
dnacsn,,,0,C10H17O8PR2,,,,,DNA cytosine,,,,,2016-11-22T15:12:41Z,,3656,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3656/?format=pcsv
laccoa,,,-4,C24H36N7O18P3S,,,,,Lactoyl-CoA,,,,,2016-11-22T15:12:42Z,,3657,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3657/?format=pcsv
arabt_L,,,-1,C5H9O6,,,,,L-Arabinonate,,,,,2016-11-22T15:12:40Z,,3658,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3658/?format=pcsv
ph2s,,,0,H2S2,,,,,Polysulfide,,,,,2016-11-22T15:12:44Z,,3659,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3659/?format=pcsv
ab14lac_L,,,0,C5H8O5,,,,,"L-Arabinono-1,4-lactone",,,,,2016-11-22T15:12:31Z,,3660,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3660/?format=pcsv
mh4mpt,,,-3,C31H44N6O16P,,,,,"5-Methyl-5,6,7,8-tetrahydromethanopterin",,,,,2016-11-22T15:12:35Z,,3661,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3661/?format=pcsv
cfesp,,,0,C19CoN4R21,,,,,Corrinoid Iron sulfur protein,,,,,2016-11-22T15:12:32Z,,3662,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3662/?format=pcsv
mecfsp,,,1,C20H3CoN4R21,,,,,Methylcorrinoid iron sulfur protein,,,,,2016-11-22T15:12:35Z,,3663,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3663/?format=pcsv
dh6na,,,-1,C11H7O4,,,,,"1,4-dihydroxy-6-naphthoate",,,,,2016-11-17T15:24:14Z,,3664,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3664/?format=pcsv
sacald,,,-1,C2H3O4S,,,,,Sulfoacetaldehyde,,,,,2016-11-22T15:12:37Z,,3665,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3665/?format=pcsv
3hbbut,,,-1,C8H13O5,,,,,(R)-3-((R)-3-Hydroxybutanoyloxy)butanoate,,,,,2016-11-22T15:12:30Z,,3666,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3666/?format=pcsv
citmal,,,-2,C5H6O5,,,,,(S)-Citramalate,,,,,2016-11-16T17:07:16Z,,3667,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3667/?format=pcsv
hacon_C,,,-3,C7H5O6,,,,,cis-Homoaconitate (iAF692),,,,,2016-11-22T15:12:47Z,,3668,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3668/?format=pcsv
dhxft,,,-1,C14H15O7,,,,,Dehypoxanthine futalosinate,,,,,2016-11-22T15:12:47Z,,3669,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3669/?format=pcsv
cdhxft,,,-1,C14H13O7,,,,,Cyclic dehypoxanthine futalosine,,,,,2016-11-17T01:38:23Z,,3670,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3670/?format=pcsv
3cvobz,,,-2,C10H6O5,,,,,3-[(1-Carboxyvinyl)oxy]benzoate,,,,,2016-11-22T15:12:47Z,,3671,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3671/?format=pcsv
6adxft,,,0,C19H19N5O6,,,,,6-Amino-6-deoxyfutalosine,,,,,2016-11-22T15:12:47Z,,3672,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3672/?format=pcsv
lmn30,,,0,C180H302O151,,,,,"laminarin (n=30 repeat units, beta -1,3 glc)",,,,,2016-11-22T15:12:42Z,,3673,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3673/?format=pcsv
lmn2,,,0,C12H22O11,,,,,Laminaribiose,,,,,2016-11-22T15:12:42Z,,3674,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3674/?format=pcsv
2mbut,,,-1,C5H9O2,,,,,2-methylbutyrate,,,,,2016-11-22T15:12:30Z,,3675,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3675/?format=pcsv
plac,,,-1,C9H9O3,,,,,Phenyllactate,,,,,2016-11-22T15:12:43Z,,3676,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3676/?format=pcsv
ind3ppa,,,-1,C11H10NO2,,,,,Indole-3-propionate,,,,,2016-11-22T15:12:34Z,,3677,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3677/?format=pcsv
pcresol,,,-1,C7H7O,,,"Human Metabolome Database (HMDB): p-Cresol (4-methylphenol), a 108.1 Da volatile low-molecular-weight compound, is a phenol. It is a partially lipophilic moiety which strongly binds to plasma protein (close to 100%) under normal conditions. p-Cresol is metabolized through conjugation, mainly sulphation and glucuronization, but removal of the unconjugated p-cresol is, at least in part, via the urine. Therefore it is not surprising that this compound, together with several other phenoles, is retained when the kidneys fail. P-Cresol is an end-product of protein breakdown, and an increase of the nutritional protein load in healthy individuals results in enhanced generation and urinary excretion. The serum p-cresol concentration in uremic patients can be decreased by changing to a low-protein diet. p-Cresol is one of the metabolites of the amino acid tyrosine, and to a certain extent also of phenylalanine, which are converted to 4-hydroxyphenylacetic acid by intestinal bacteria, before being decarboxylated to p-cresol (putrefaction). The main contributing bacteria are aerobes (mainly enterobacteria), but to a certain extent also anaerobes play a role (mainly Clostridium perfringens). In uremia, modifications in the intestinal flora result in the specific overgrowth of bacteria that are specific p-cresol producers. The administration of antibiotics reduces urinary excretion of p-cresol, as a result of the liquidation of the producing bacteria. Environmental factors might also contribute. The liver cytochrome P450 metabolizes toluene to benzyl alcohol, but also to o-cresol and p-cresol. Toluene is not only used industrially, but it is also the most widely abusively inhaled solvent. Furthermore, p-cresol is a metabolite of menthofuran, one of the metabolites of R-(+)-pulegone, which is found in extracts from the plants Mentha pulegium and Hedeoma pulegioides, commonly known as pennyroyal oil and pennyroyal tea. These extracts are popular as unconventional herbal therapeutic agents and are applied as abortiva, diaphoretics, emmenagogues, and psychedelic drugs. Pennyroyal oil is extensively used for its pleasant mint-like smell in the flavoring industry. The toxicity of pennyroyal oil and menthofuran is well known. Another compound used in traditional medicine, especially in Japan, which is a precursor of p-cresol is wood tar creosote. p-Cresol has been reported to affect several biochemical, biological and physiological functions: (i) it diminishes the oxygen uptake of rat cerebral cortex slices; (ii) it increases the free active drug concentration of warfarin and diazepam; (iii) it has been related to growth retardation in the weanling pig; (iv) it alters cell membrane permeability, at least in bacteria; (v) it induces LDH leakage from rat liver slices; (vi) it induces susceptibility to auditive epileptic crises; and (vii) it blocks cell K+ channels. (PMID: 10570076). p-Cresol is a uremic toxin that is at least partially removed by peritoneal dialysis in haemodialysis patients, and has been involved in the progression of renal failure. (MID: 11169029). At concentrations encountered during uremia, p-cresol inhibits phagocyte function and decreases leukocyte adhesion to cytokine-stimulated endothelial cells. (PMID: 14681860).",,p-Cresol,,HMDB01858,,,2016-12-05T15:48:07Z,,3678,,,,,,,,"1-Hydroxy-4-methylbenzene, 1-Methyl-4-hydroxybenzene, 4-(Pentafluorosulfanyl)phenol, 4-Cresol, 4-Hydroxytoluene, 4-Methyl phenol, 4-Methyl-phenol, 4-Methylphenol, p-Cresol, p-Cresylate, p-Cresylic acid, p-Hydroxytoluene, p-Kresol, p-Methyl phenol, p-Methylhydroxybenzene, p-Oxytoluene, p-Toluol, p-Tolyl alcohol, Paracresol, Paramethyl phenol",http://vmh.uni.lu/_api/metabolites/3678/?format=pcsv
galmannan,,,0,C6000H10002O5001,,,,,"Carob galactomannan, Gal:Man ratio 22/78. 220 gal, 780 man assumed",,,,,2016-11-22T15:12:34Z,,3679,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3679/?format=pcsv
glcmannan,,,0,C2574H4292O2146,,,,,"Konjac glucomannan, MW 77,500 (PMID:17962981), Man:Glc ~ 2:1. -> 286 man, 143 glc_D",,,,,2016-11-22T15:12:34Z,,3680,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3680/?format=pcsv
ftz,,,-1,C19H17N4O7,,,,,Futalosinate,,,,,2016-11-22T15:12:47Z,,3681,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3681/?format=pcsv
mcom,,,-1,C3H7O3S2,,,,,Methyl Coenzyme M,,,,,2016-11-22T15:12:35Z,,3682,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3682/?format=pcsv
phppa,,,-1,C9H9O3,,,,,p-hydroxyphenylpropionic acid,,,,,2016-11-22T15:12:43Z,,3683,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3683/?format=pcsv
ch4,,,0,CH4,,,,,Methane,,,,,2016-11-22T15:12:32Z,,3684,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3684/?format=pcsv
aadpsae,,,-1,C6H9NO3RS,,,,,alpha-Aminoadipoyl-S-acyl enzyme,,,,,2016-11-17T08:07:19Z,,3685,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3685/?format=pcsv
hololys2,,,0,HRS,,,,,Holo-Lys2,,,,,2016-11-17T08:07:19Z,,3686,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3686/?format=pcsv
l2aadipad,,,-1,C16H22N6O10P,,,,,L-2-Aminoadipate adenylate,,,,,2016-11-17T08:07:19Z,,3687,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3687/?format=pcsv
lichn,,,0,C1020H1702O851,,,,,"Lichenin from Icelandic moss, 170 glucose residues. DOI: 10.1039/JR9570001951",,,,,2016-11-22T15:12:35Z,,3688,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3688/?format=pcsv
hicit,,,-3,C7H7O7,,,,,Homoisocitrate (iMM904),,,,,2016-11-22T15:12:47Z,,3689,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3689/?format=pcsv
oxag,,,-3,C7H5O7,,,,,Oxaloglutarate (iMM904),,,,,2016-11-22T15:12:47Z,,3690,,,,,,,,,http://vmh.uni.lu/_api/metabolites/3690/?format=pcsv
